Citrus Sinensis ID: 006145
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 659 | 2.2.26 [Sep-21-2011] | |||||||
| Q8LFN2 | 802 | Probable inactive leucine | yes | no | 0.915 | 0.751 | 0.698 | 0.0 | |
| Q9M9S4 | 728 | Probable LRR receptor-lik | no | no | 0.855 | 0.774 | 0.384 | 1e-108 | |
| C0LGJ9 | 742 | Probable LRR receptor-lik | no | no | 0.855 | 0.760 | 0.385 | 1e-103 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.801 | 0.421 | 0.282 | 5e-54 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.761 | 0.401 | 0.298 | 9e-54 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.790 | 0.437 | 0.286 | 1e-53 | |
| C0LGP4 | 1010 | Probable LRR receptor-lik | no | no | 0.748 | 0.488 | 0.292 | 2e-47 | |
| C0LGK4 | 915 | Probable LRR receptor-lik | no | no | 0.833 | 0.6 | 0.287 | 1e-46 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.755 | 0.412 | 0.274 | 9e-45 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.755 | 0.412 | 0.274 | 2e-44 |
| >sp|Q8LFN2|Y3037_ARATH Probable inactive leucine-rich repeat receptor-like protein kinase At3g03770 OS=Arabidopsis thaliana GN=At3g03770 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 819 bits (2115), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/607 (69%), Positives = 494/607 (81%), Gaps = 4/607 (0%)
Query: 46 PAVLSSWNITTEFCNTEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVK 105
P VL+SWN T+FCN+EP+ SLTVVCYE+S+TQLHI+G+ MLP SFS++SFVTTLVK
Sbjct: 44 PKVLNSWNNYTDFCNSEPSPSLTVVCYEDSVTQLHIIGDNGTHMLPKSFSINSFVTTLVK 103
Query: 106 LPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDEN 165
LPD+KVL VSLGLWG L KI+RLSSLEILN+SSNFL G IP ELS L +LQTLILDEN
Sbjct: 104 LPDVKVLTFVSLGLWGWLPQKINRLSSLEILNVSSNFLFGPIPHELSSLATLQTLILDEN 163
Query: 166 MLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGL 225
M +G +PDW+ SLP LAVLSLR N+ NG+LP S S L LRVLAL+NN F G +PD S L
Sbjct: 164 MFSGELPDWIDSLPSLAVLSLRKNVLNGSLPSSLSSLSGLRVLALANNRFNGALPDLSHL 223
Query: 226 TYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAE-VSSYYQLQRLDLSSNRFV 284
T LQVLDLE N+ GP FP++ KLVT+ILSKNKFRSA+ AE VSS YQLQ LDLS N FV
Sbjct: 224 TNLQVLDLEGNSFGPLFPRLSNKLVTLILSKNKFRSAVSAEEVSSLYQLQHLDLSYNTFV 283
Query: 285 GPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGS- 343
GPFP +L+SLP+ITYLNI+ NKLTG+L +LSCN +L FVD+SSNLLTG LP CL S
Sbjct: 284 GPFPTSLMSLPAITYLNISHNKLTGRLSANLSCNSQLMFVDMSSNLLTGSLPTCLKPSSG 343
Query: 344 KNRVVLYARNCLAAGNENQHPLSFCQNEALAVGILPLQKKQKQVSKAVLALSIIGGIIGG 403
+R V+YA NCLA NE+Q P+SFC NEALAVGILP +++ +VSK +AL + I+G
Sbjct: 344 TSRDVVYASNCLATTNEDQRPVSFCSNEALAVGILP--QRRNKVSKVGIALGVTASILGV 401
Query: 404 ISLVVIAFLLVRRTKSKQTMKKTPTRLIQENASTGYTSKFLSDARYISQTMKLGALGLPA 463
+ L F+++RR +K+T+ K+ RLI+ENAS GYTSK LSDARYISQTMKLG LGLPA
Sbjct: 402 LLLAGALFVVLRRLNAKKTVTKSSPRLIRENASMGYTSKLLSDARYISQTMKLGGLGLPA 461
Query: 464 YRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHH 523
YRTFSLEELE ATNNF++SAFMGEGSQGQ+YRGRLK+G+FVAIRCLKMKK ST+N MHH
Sbjct: 462 YRTFSLEELEYATNNFESSAFMGEGSQGQIYRGRLKDGSFVAIRCLKMKKSCSTQNLMHH 521
Query: 524 IELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWT 583
IELI+KLRHRHLVS LGHCFECY DDS+VSR+F +FEYVPNG LR+WIS+GH + LTW
Sbjct: 522 IELIAKLRHRHLVSVLGHCFECYLDDSTVSRMFFVFEYVPNGELRTWISDGHMGRLLTWE 581
Query: 584 QRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVG 643
QRIS AIGVAKGIQFLHTGIVPGV+ NNLK+TDILLD NL AK+SSYNLPLL E KVG
Sbjct: 582 QRISVAIGVAKGIQFLHTGIVPGVYDNNLKMTDILLDNNLAAKLSSYNLPLLVEGLGKVG 641
Query: 644 HVIPYSG 650
V SG
Sbjct: 642 QVGSRSG 648
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M9S4|Y1143_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g14390 OS=Arabidopsis thaliana GN=At1g14390 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 391 bits (1005), Expect = e-108, Method: Compositional matrix adjust.
Identities = 246/639 (38%), Positives = 351/639 (54%), Gaps = 75/639 (11%)
Query: 27 QLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPTSSLTVVCYEESITQLHIVGNKR 86
QL SS+++TLL IQ L P L SW+ T FC + S ++C+ +T+L + GN R
Sbjct: 28 QLISSESRTLLEIQKHLQYPPTLRSWSNWTNFCYLPSSPSFKILCFNGHVTELTVTGN-R 86
Query: 87 APMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGA 146
LP FS DS T L KL S+L+ L++ S ++G
Sbjct: 87 TVKLPGRFSSDSLFTVLTKL------------------------SNLKTLSLVSLGISGP 122
Query: 147 IPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLR 206
+P ++ + L L+L +N +G +P S L+NLR
Sbjct: 123 LPSQI-----------------------IRLSSSLQSLNLSSNFISGNIPKEISSLKNLR 159
Query: 207 VLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQF-PKVGKKLVTMILSKNKFRSAIPA 265
L L+NN F G VPD GL+ LQ L+L N LGP+ P + L+T+ L N F S IP
Sbjct: 160 SLVLANNLFNGSVPDLRGLSNLQELNLGGNKLGPEVVPSLASNLITISLKNNSFGSKIPE 219
Query: 266 EVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVD 325
++ +LQ LDLSSN+F G P+ LLSLPS+ L++A N L+G L + CN +L +D
Sbjct: 220 QIKKLNKLQSLDLSSNKFTGSIPRFLLSLPSLQNLSLAQNLLSGSLPNSSLCNSKLRILD 279
Query: 326 LSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGN----ENQHPLSFCQNEA-LAVGILPL 380
+S NLLTG+LP+C + K V+L+ NCL+ + Q P++FC+NEA AV +
Sbjct: 280 VSRNLLTGKLPSCF-SSKKQTVLLFTFNCLSINGSPSAKYQRPVTFCENEAKQAVAAVKS 338
Query: 381 QKKQKQVSKAVLALSIIGGIIGGI-----SLVVIAFLLVRRTKSKQTMKKTPTRLIQE-- 433
K K+ + + + I I S V+ +LVR KS+ + + +
Sbjct: 339 DTKDKERKEEDTGIELGLVIGIIIGVILVSAVLAGLVLVRMRKSRSKEEPLEANNVDQVT 398
Query: 434 ---NASTGYTSKFLSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFDTSAFMGEGSQ 490
N + TSK + D R + QTM+ +GL YR FSLEELEEATNNFD GE
Sbjct: 399 VCSNTTRSTTSKTVPDLRRVPQTMRSAVIGLSPYRVFSLEELEEATNNFDAENLCGE--- 455
Query: 491 GQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550
Q+Y+G L+ G V +RC+K+K+ +ST+N +E++SKLRH HLVS LGHC Y D
Sbjct: 456 -QLYKGCLREGIAVTVRCIKLKQKNSTQNLAQQMEVLSKLRHMHLVSVLGHCIGTYQDHH 514
Query: 551 --SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVF 608
+ S IF++ EY+ NG+LR ++++ + L W QR+S AIGVA+GIQFLHTG+ PG+F
Sbjct: 515 PYAGSTIFIVQEYISNGSLRDYLTDWRKKEVLKWPQRMSIAIGVARGIQFLHTGVAPGIF 574
Query: 609 SNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIP 647
NNL+I ++LLD+ L K+S Y++PL KVG P
Sbjct: 575 GNNLEIENVLLDETLTVKLSGYSIPL----PSKVGAESP 609
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGJ9|Y2278_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g02780 OS=Arabidopsis thaliana GN=At2g02780 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 377 bits (968), Expect = e-103, Method: Compositional matrix adjust.
Identities = 248/644 (38%), Positives = 353/644 (54%), Gaps = 80/644 (12%)
Query: 27 QLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPTSSLTVVCYEESITQLHIVGNKR 86
Q+ SS++QTLL IQ L P VL SW TT FC+ P+ SL ++C +T+L + GN+
Sbjct: 28 QVASSESQTLLEIQKQLQYPQVLQSWTDTTNFCHIRPSPSLRIICLHGHVTELTVTGNRT 87
Query: 87 APMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGA 146
+ LS S T L +L LK L L SLG+ G LS K
Sbjct: 88 SK---LSGSFHKLFTLLTQLSSLKTLSLTSLGISGSLSPK-------------------- 124
Query: 147 IPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLR 206
I+T L P L L+L +N +G +P+ L+NL+
Sbjct: 125 ------IITKLS--------------------PSLESLNLSSNFISGKIPEEIVSLKNLK 158
Query: 207 VLALSNNHFYGEV-PDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPA 265
L L +N F+G V D GL+ LQ LDL N LGP+ P + KL T+ L N FRS IP
Sbjct: 159 SLVLRDNMFWGFVSDDLRGLSNLQELDLGGNKLGPEVPSLPSKLTTVSLKNNSFRSKIPE 218
Query: 266 EVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVD 325
++ LQ LDLSSN F G P+ L S+PS+ L++ N L+G L + + ++ +D
Sbjct: 219 QIKKLNNLQSLDLSSNEFTGSIPEFLFSIPSLQILSLDQNLLSGSLPNSSCTSSKIITLD 278
Query: 326 LSSNLLTGQLPNCLLAGS-KNRVVLYARNCLA-AGNEN---QHPLSFCQNEA-LAVGILP 379
+S NLLTG+LP+C + S N+ VL++ NCL+ G N Q PLSFCQN+A A+ + P
Sbjct: 279 VSHNLLTGKLPSCYSSKSFSNQTVLFSFNCLSLIGTPNAKYQRPLSFCQNQASKAIAVEP 338
Query: 380 LQKKQKQVSKAVLALSIIGGIIGGISLVVIAFLLV------RRTKSKQ--------TMKK 425
+ K + + S + +I IIG I L I LLV RR++S+ ++
Sbjct: 339 IPKAKDKDSARIKLGLVILIIIGVIILAAILVLLVLIALKRRRSRSEDDPFEVNNSNNER 398
Query: 426 TPTRLIQENASTGYTSKFLSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFDTSAFM 485
+ + ++T +SK L D+R + QTM+ +GLP YR FSLEELEEATN+FD ++
Sbjct: 399 HASDKVSVCSTTTASSKSLPDSRRVPQTMRSAVIGLPPYRVFSLEELEEATNDFDAASLF 458
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFEC 545
E Q+YRG L+ G V +R +K+K+ ++ +E++SKLRH HLVS LGH
Sbjct: 459 CE----QLYRGCLREGIPVTVRVIKLKQKSLPQSLAQQMEVLSKLRHMHLVSVLGHSIAS 514
Query: 546 YFDDSSVS--RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI 603
D + + IF++ EY+ +G+LR +++ + L W QR++ AIGVA+GIQFLH G+
Sbjct: 515 NQDHNQHAGHTIFIVQEYISSGSLRDFLTNCRKKEVLKWPQRMAIAIGVARGIQFLHMGV 574
Query: 604 VPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIP 647
PG+F NNLKI +I+LD+ L KIS Y +PL KVG P
Sbjct: 575 APGIFGNNLKIENIMLDETLTVKISGYTIPL----PSKVGEERP 614
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 213 bits (541), Expect = 5e-54, Method: Compositional matrix adjust.
Identities = 166/588 (28%), Positives = 272/588 (46%), Gaps = 60/588 (10%)
Query: 58 FCNTEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSL 117
F + + S++ +C S + N +PL L K +L LRL
Sbjct: 560 FSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLE---------LGKSTNLDRLRLGKN 610
Query: 118 GLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGS 177
G + ++S L +L++S N L+G IP EL + L + L+ N L+G +P WLG
Sbjct: 611 QFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGK 670
Query: 178 LPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP-DFSGLTYLQVLDLENN 236
LP+L L L +N F G+LP L N+ L L N G +P + L L L+LE N
Sbjct: 671 LPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEEN 730
Query: 237 AL-GPQFPKVGK--KLVTMILSKNKFRSAIPAEVSSYYQLQR-LDLSSNRFVGPFPQALL 292
L GP +GK KL + LS+N IP E+ LQ LDLS N F G P +
Sbjct: 731 QLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTIS 790
Query: 293 SLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYAR 352
+LP + L+++ N+L G++ + LG+++LS N L G+L + V A
Sbjct: 791 TLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAG 850
Query: 353 NCLAAGNENQHPLSFCQNEALAVGILPLQKKQKQVS-KAVLALSIIGGIIGGISLVVIAF 411
C PLS C K Q+ +S K V+ +S I + I+L+V+
Sbjct: 851 LC-------GSPLSHCNRAG--------SKNQRSLSPKTVVIISAISS-LAAIALMVLVI 894
Query: 412 LLVRRTKSKQTMKKTPTRLIQENASTGYTSKFLSDARYISQTMKLGALGLPAYRTFSLEE 471
+L + K + S+ + S+ A ++
Sbjct: 895 ILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGG--------------AKSDIKWDD 940
Query: 472 LEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMK-KCHSTRNFMHHIELISKL 530
+ EAT+ + +G G G++Y+ LKNG +A++ + K S ++F ++ + +
Sbjct: 941 IMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTI 1000
Query: 531 RHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQS------LTWTQ 584
RHRHLV +G+C + LI+EY+ NG++ W+ HA+++ L W
Sbjct: 1001 RHRHLVKLMGYC-----SSKADGLNLLIYEYMANGSVWDWL---HANENTKKKEVLGWET 1052
Query: 585 RISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
R+ A+G+A+G+++LH VP + ++K +++LLD N+ A + + L
Sbjct: 1053 RLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGL 1100
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 212 bits (539), Expect = 9e-54, Method: Compositional matrix adjust.
Identities = 163/546 (29%), Positives = 263/546 (48%), Gaps = 44/546 (8%)
Query: 108 DLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENML 167
+L LRL L G + + ++ L +L+MSSN L G IP +L + L + L+ N L
Sbjct: 600 NLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFL 659
Query: 168 AGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP-DFSGLT 226
+G +P WLG L L L L +N F +LP L VL+L N G +P + L
Sbjct: 660 SGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLG 719
Query: 227 YLQVLDLENNALGPQFPK-VGK--KLVTMILSKNKFRSAIPAEVSSYYQLQR-LDLSSNR 282
L VL+L+ N P+ +GK KL + LS+N IP E+ LQ LDLS N
Sbjct: 720 ALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNN 779
Query: 283 FVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAG 342
F G P + +L + L+++ N+LTG++ + LG++++S N L G+L
Sbjct: 780 FTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL------- 832
Query: 343 SKNRVVLYARNCLAAGNENQHPLSFCQNEALAVGILPLQKKQKQVSKAVLALSIIGGIIG 402
K A + L PLS C + K+Q +++V+ +S I +
Sbjct: 833 KKQFSRWPADSFLGNTGLCGSPLSRCNR------VRSNNKQQGLSARSVVIISAISALTA 886
Query: 403 -GISLVVIAFLLVRRTKSKQTMKKTPTRLIQENASTGYTSKFLSDARYISQTMKLGALGL 461
G+ ++VIA +R KK + ST YTS S + GA
Sbjct: 887 IGLMILVIALFFKQR---HDFFKKVG------HGSTAYTSSSSSSQATHKPLFRNGA--- 934
Query: 462 PAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMK-KCHSTRNF 520
+ E++ EAT+N +G G G++Y+ L+NG VA++ + K S ++F
Sbjct: 935 -SKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSF 993
Query: 521 MHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEG-----H 575
++ + ++RHRHLV +G+C S LI+EY+ NG++ W+ E
Sbjct: 994 SREVKTLGRIRHRHLVKLMGYC-----SSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEK 1048
Query: 576 AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP-L 634
+ L W R+ A+G+A+G+++LH VP + ++K +++LLD N+ A + + L +
Sbjct: 1049 KKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKV 1108
Query: 635 LAENAE 640
L EN +
Sbjct: 1109 LTENCD 1114
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (538), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 165/575 (28%), Positives = 277/575 (48%), Gaps = 54/575 (9%)
Query: 104 VKLPDLKVLRLVSLG---LWGPLSGKISRLSSLEILNMSSNFLNGAIPQ----------- 149
V+L D L + LG L G + KI+ L+ L+ L +S N L+G+IP
Sbjct: 514 VELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEM 573
Query: 150 -ELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVL 208
+LS L L N L+G +P+ LG +L +SL NN +G +P S S L NL +L
Sbjct: 574 PDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTIL 633
Query: 209 ALSNNHFYGEVPDFSGLTY-LQVLDLENNALGPQFPK---VGKKLVTMILSKNKFRSAIP 264
LS N G +P G + LQ L+L NN L P+ + LV + L+KNK +P
Sbjct: 634 DLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVP 693
Query: 265 AEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFV 324
A + + +L +DLS N G L ++ + L I NK TG++ +L +L ++
Sbjct: 694 ASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYL 753
Query: 325 DLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNENQHPLSFCQNEALAVGILPLQKKQ 384
D+S NLL+G++P + + A+N L + CQ+ + A L
Sbjct: 754 DVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSD---GVCQDPSKA-----LLSGN 805
Query: 385 KQVSKAVLALSI------------IGGIIGGISLVVIAFL--LVRRTKSKQTMKKTPTRL 430
K++ V+ I G++ G +++V F+ L R +K+ ++
Sbjct: 806 KELCGRVVGSDCKIEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPER 865
Query: 431 IQENASTGYTSK---FLSDARYISQ-TMKLGALGLPAYRTFSLEELEEATNNFDTSAFMG 486
++E+ G+ + FLS +R ++ + P + L ++ EAT++F +G
Sbjct: 866 MEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKV-RLGDIVEATDHFSKKNIIG 924
Query: 487 EGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECY 546
+G G +Y+ L VA++ L K R FM +E + K++H +LVS LG+C
Sbjct: 925 DGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYC---- 980
Query: 547 FDDSSVSRIFLIFEYVPNGTLRSWI-SEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVP 605
S L++EY+ NG+L W+ ++ + L W++R+ A+G A+G+ FLH G +P
Sbjct: 981 ---SFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIP 1037
Query: 606 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640
+ ++K ++ILLD + K++ + L L E
Sbjct: 1038 HIIHRDIKASNILLDGDFEPKVADFGLARLISACE 1072
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (484), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 176/602 (29%), Positives = 275/602 (45%), Gaps = 109/602 (18%)
Query: 100 VTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSL------EILNMSSNFLNGAIPQELSI 153
+ T +P+LK+L L + L S + L+SL E L + N L G +P ++
Sbjct: 299 IPTFGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIAN 358
Query: 154 LTS-LQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSN 212
L++ L TL L +++G +P +G+L L L L NM +G LP S L NLR L+L +
Sbjct: 359 LSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFS 418
Query: 213 NHFYGEVPDFSG-LTYLQVLDLENNALGPQFP-KVGK--KLVTMILSKNKFRSAIPAEVS 268
N G +P F G +T L+ LDL NN P +G L+ + + NK IP E+
Sbjct: 419 NRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIM 478
Query: 269 SYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKL----------------- 311
QL RLD+S N +G PQ + +L ++ L++ DNKL+GKL
Sbjct: 479 KIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEG 538
Query: 312 ------FDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGN------ 359
DL + VDLS+N L+G +P + SK + + N L
Sbjct: 539 NLFYGDIPDLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIF 598
Query: 360 ENQHPLSFCQNEALAVGILPLQ-------------KKQKQVSKAVLALSIIGGIIGGISL 406
EN +S N L GI+ Q K ++ K V+ +S+ GI+L
Sbjct: 599 ENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSV------GITL 652
Query: 407 VVIAFL-------LVRRTKSKQTMKKTPTRL--IQENASTGYTSKFLSDARYISQTMKLG 457
+++ F+ L +R K+K+T TP+ L + E S G
Sbjct: 653 LLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYG------------------- 693
Query: 458 ALGLPAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHS 516
+L ATN F +S +G GS G +Y+ L VA++ L M++ +
Sbjct: 694 -------------DLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGA 740
Query: 517 TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW-----I 571
++FM E + +RHR+LV L C F + LI+E++PNG+L W +
Sbjct: 741 MKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRA--LIYEFMPNGSLDMWLHPEEV 798
Query: 572 SEGH-AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630
E H ++LT +R++ AI VA + +LH + +LK +++LLD +L A +S +
Sbjct: 799 EEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDF 858
Query: 631 NL 632
L
Sbjct: 859 GL 860
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGK4|Y2165_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g16250 OS=Arabidopsis thaliana GN=At2g16250 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 188 bits (478), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 188/655 (28%), Positives = 285/655 (43%), Gaps = 106/655 (16%)
Query: 50 SSWNITTEFCNTEPTSSLTVVCYEESITQLHIVGNKRAPMLPLS--FSMDSFVTTLVKLP 107
+ W I + C + C SI ++I G +R + L+ FS+D L L
Sbjct: 52 TDWPIKGDPC----VDWRGIQCENGSIIGINISGFRRTRIGKLNPQFSVD----PLRNLT 103
Query: 108 DLKVLRLVSLGLWGPLSGKIS-RLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENM 166
L L L G + L +LE+L++SS +NG +P L LTSL+TL L +N
Sbjct: 104 RLSYFNASGLALPGTIPEWFGVSLLALEVLDLSSCSVNGVVPFTLGNLTSLRTLNLSQNS 163
Query: 167 LAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP------ 220
L VP LG L L+ L L N F G LP SFS L+NL L +S+N+ G +P
Sbjct: 164 LTSLVPSSLGQLLNLSQLDLSRNSFTGVLPQSFSSLKNLLTLDVSSNYLTGPIPPGLGAL 223
Query: 221 -------------------DFSGLTYLQVLDLENNALGPQFPKVGKKLVT---MILSKNK 258
+ L L DL N+L P+ +KL M + N
Sbjct: 224 SKLIHLNFSSNSFSSPIPSELGDLVNLVDFDLSINSLSGSVPQELRKLSKLQLMAIGDNL 283
Query: 259 FRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKL----FD 313
+P ++ S+ QLQ L L N F G P SLP + L+IA N TG L +D
Sbjct: 284 LSGTLPVDLFSAESQLQTLVLRENGFSGSLPDVCWSLPKLRILDIAKNNFTGLLPYSSYD 343
Query: 314 --------DLSCNPELG----------FVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCL 355
D+S N G +DLS N G+LP+ + + V NCL
Sbjct: 344 SDQIAEMVDISSNTFYGELTPILRRFRIMDLSGNYFEGKLPDYVTGEN----VSVTSNCL 399
Query: 356 AAGNENQHPLSFCQNEALAVGI------LP--LQKKQKQVS-----KAVLALSIIGGIIG 402
Q P + C + G+ P Q K S + V+ L+ +GG +
Sbjct: 400 -RNERRQKPSAICAAFYKSRGLDFDDFGRPNLTQPTSKNASSGISRRTVIILAAVGGGVA 458
Query: 403 GISLVV---IAFLLVRRTKSKQTMKKTPTRLIQENASTGYTSKFLSDARYISQTMKLGAL 459
I L V I +L R + + + R ++ K +QT L L
Sbjct: 459 FILLFVILPIILVLCMRHRRRAAQRGNNDRPKPAGEASQQPPKG-------AQTFDLSRL 511
Query: 460 GLPAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRN 519
G FS E+L +AT F+ + + G G ++RG L+NG V I+ + +++ S
Sbjct: 512 G----NAFSYEQLLQATEEFNDANLIKRGHSGNLFRGFLENGIPVVIKKIDVREGKS-EG 566
Query: 520 FMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI-----SEG 574
++ +EL SK H+ LV LGHC E + S+ FL+++++ +G L S + +EG
Sbjct: 567 YISELELFSKAGHQRLVPFLGHCLE------NESQKFLVYKFMRHGDLASSLFRKSENEG 620
Query: 575 HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISS 629
+SL W R+ A+G A+G+ +LH P + +++ + ILLD ++ S
Sbjct: 621 DGLKSLDWITRLKIALGAAEGLSYLHHECSPPLVHRDVQASSILLDDKFEVRLGS 675
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (461), Expect = 9e-45, Method: Compositional matrix adjust.
Identities = 150/547 (27%), Positives = 254/547 (46%), Gaps = 49/547 (8%)
Query: 119 LWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSL 178
L GP+ +S + L +++S+N L+G IP L L++L L L N ++G +P LG+
Sbjct: 511 LTGPIPASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNC 570
Query: 179 PILAVLSLRNNMFNGTLPD---------SFSYLENLRVLALSNN-----HFYGEVPDFSG 224
L L L N NG++P + + L R + + N+ H G + +F G
Sbjct: 571 QSLIWLDLNTNFLNGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECHGAGNLLEFGG 630
Query: 225 LTYLQVLDLENNALGPQFPKVGK-----------KLVTMILSKNKFRSAIPAEVSSYYQL 273
+ Q LD + F +V + ++ + LS NK +IP E+ + Y L
Sbjct: 631 IRQEQ-LDRISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYL 689
Query: 274 QRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG 333
L+L N G PQ L L ++ L+++ N+ G + + L+ LG +DLS+N L+G
Sbjct: 690 SILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSG 749
Query: 334 QLPNCLLAGSKNRVVLYARNCLAAGNENQHPLSFCQNEALAVGILPLQKKQKQVSKAVLA 393
+P + +A N L +PL + QK ++ +A LA
Sbjct: 750 MIPESAPFDTFPDYR-FANNSLCG-----YPLPLPCSSGPKSDANQHQKSHRR--QASLA 801
Query: 394 LSIIGGIIGGI----SLVVIAFLLVRRTKSKQTMKKTPTRLIQENASTGYTSKFLSDARY 449
S+ G++ + L+++A +R + K+ + +A+ KF S
Sbjct: 802 GSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAREA 861
Query: 450 ISQTMKLGALGLPAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCL 509
+S + L A P R + +L EATN F + +G G G +Y+ +LK+G+ VAI+ L
Sbjct: 862 LS--INLAAFEKP-LRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKL 918
Query: 510 KMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRS 569
R F +E I K++HR+LV LG+C L++EY+ G+L
Sbjct: 919 IHVSGQGDREFTAEMETIGKIKHRNLVPLLGYC-------KVGEERLLVYEYMKYGSLED 971
Query: 570 WISEGHAHQ-SLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+ + L W R AIG A+G+ FLH +P + ++K +++LLD+NL A++S
Sbjct: 972 VLHDRKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVS 1031
Query: 629 SYNLPLL 635
+ + L
Sbjct: 1032 DFGMARL 1038
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (459), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 150/547 (27%), Positives = 254/547 (46%), Gaps = 49/547 (8%)
Query: 119 LWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSL 178
L GP+ +S + L +++S+N L+G IP L L++L L L N ++G +P LG+
Sbjct: 511 LTGPIPASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNC 570
Query: 179 PILAVLSLRNNMFNGTLPD---------SFSYLENLRVLALSNN-----HFYGEVPDFSG 224
L L L N NG++P + + L R + + N+ H G + +F G
Sbjct: 571 QSLIWLDLNTNFLNGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECHGAGNLLEFGG 630
Query: 225 LTYLQVLDLENNALGPQFPKVGK-----------KLVTMILSKNKFRSAIPAEVSSYYQL 273
+ Q LD + F +V + ++ + LS NK +IP E+ + Y L
Sbjct: 631 IRQEQ-LDRISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYL 689
Query: 274 QRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG 333
L+L N G PQ L L ++ L+++ N+ G + + L+ LG +DLS+N L+G
Sbjct: 690 SILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSG 749
Query: 334 QLPNCLLAGSKNRVVLYARNCLAAGNENQHPLSFCQNEALAVGILPLQKKQKQVSKAVLA 393
+P + +A N L +PL + QK ++ +A LA
Sbjct: 750 MIPESAPFDTFPDYR-FANNSLCG-----YPLPIPCSSGPKSDANQHQKSHRR--QASLA 801
Query: 394 LSIIGGIIGGI----SLVVIAFLLVRRTKSKQTMKKTPTRLIQENASTGYTSKFLSDARY 449
S+ G++ + L+++A +R + K+ + +A+ KF S
Sbjct: 802 GSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAREA 861
Query: 450 ISQTMKLGALGLPAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCL 509
+S + L A P R + +L EATN F + +G G G +Y+ +LK+G+ VAI+ L
Sbjct: 862 LS--INLAAFEKP-LRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKL 918
Query: 510 KMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRS 569
R F +E I K++HR+LV LG+C L++EY+ G+L
Sbjct: 919 IHVSGQGDREFTAEMETIGKIKHRNLVPLLGYC-------KVGEERLLVYEYMKYGSLED 971
Query: 570 WISE-GHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+ + L W R AIG A+G+ FLH +P + ++K +++LLD+NL A++S
Sbjct: 972 VLHDRKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVS 1031
Query: 629 SYNLPLL 635
+ + L
Sbjct: 1032 DFGMARL 1038
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 659 | ||||||
| 224144836 | 774 | predicted protein [Populus trichocarpa] | 0.965 | 0.821 | 0.750 | 0.0 | |
| 225439195 | 786 | PREDICTED: probable inactive leucine-ric | 0.969 | 0.812 | 0.744 | 0.0 | |
| 224123880 | 784 | predicted protein [Populus trichocarpa] | 0.993 | 0.835 | 0.732 | 0.0 | |
| 255569464 | 782 | leucine-rich repeat protein, putative [R | 0.992 | 0.836 | 0.717 | 0.0 | |
| 356571765 | 781 | PREDICTED: probable inactive leucine-ric | 0.963 | 0.813 | 0.693 | 0.0 | |
| 147854936 | 746 | hypothetical protein VITISV_020032 [Viti | 0.908 | 0.802 | 0.693 | 0.0 | |
| 449523778 | 781 | PREDICTED: probable inactive leucine-ric | 0.993 | 0.838 | 0.675 | 0.0 | |
| 449462762 | 781 | PREDICTED: probable inactive leucine-ric | 0.993 | 0.838 | 0.673 | 0.0 | |
| 357508805 | 774 | hypothetical protein MTR_7g086420 [Medic | 0.942 | 0.802 | 0.699 | 0.0 | |
| 356565741 | 772 | PREDICTED: probable inactive leucine-ric | 0.927 | 0.791 | 0.679 | 0.0 |
| >gi|224144836|ref|XP_002325432.1| predicted protein [Populus trichocarpa] gi|222862307|gb|EEE99813.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 976 bits (2524), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/638 (75%), Positives = 554/638 (86%), Gaps = 2/638 (0%)
Query: 22 VNHSEQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPTSSLTVVCYEESITQLHI 81
++ SEQLQSSQ +TLLRIQ LLN P+ LSSWN TT+FCNTEP +S+TVVCYE SITQLHI
Sbjct: 20 ISGSEQLQSSQGETLLRIQRLLNYPSALSSWNSTTDFCNTEPNASVTVVCYENSITQLHI 79
Query: 82 VGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSN 141
+GNK P+LP +FS+DSFVTTLV LP+LKVL LVSLGLWGPL GKI+RLSSLEILN+SSN
Sbjct: 80 IGNKGTPLLPRNFSIDSFVTTLVGLPNLKVLTLVSLGLWGPLPGKIARLSSLEILNVSSN 139
Query: 142 FLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSY 201
FL A+PQE+S L +LQ+L+LD+NM A VP+W+GSLP+L+VLSL+ NM NG+LPDS S
Sbjct: 140 FLYDAVPQEISSLAALQSLVLDDNMFADEVPNWIGSLPVLSVLSLKKNMLNGSLPDSLSN 199
Query: 202 LENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRS 261
L+NLRVL LS+N+F GEVPD S LT LQVLDLE+NALGPQFP +G KL++++LSKNKFR
Sbjct: 200 LDNLRVLVLSHNYFRGEVPDLSSLTNLQVLDLEDNALGPQFPLLGNKLISLVLSKNKFRD 259
Query: 262 AIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPEL 321
+PAEV+SYYQLQRLDLSSN+FVGPFPQ+LLSLPS+TYLN+ADNK TG LF++ SC+ +L
Sbjct: 260 GLPAEVTSYYQLQRLDLSSNKFVGPFPQSLLSLPSVTYLNVADNKFTGMLFENQSCSADL 319
Query: 322 GFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNENQHPLSFCQNEALAVGILPLQ 381
FVDLSSNL+TGQLPNCLL SK R VLYA NCLA G+ENQHP+S C+NEALAVGILP Q
Sbjct: 320 EFVDLSSNLMTGQLPNCLLQDSK-RKVLYAANCLATGDENQHPISLCRNEALAVGILP-Q 377
Query: 382 KKQKQVSKAVLALSIIGGIIGGISLVVIAFLLVRRTKSKQTMKKTPTRLIQENASTGYTS 441
+K+++ SK +A +IGGI+GGI+LV + +L VR+ KS++T+K+ TRLI ENASTGY S
Sbjct: 378 RKKRKASKETIAFGVIGGIVGGIALVGLIYLAVRKVKSRKTIKRPNTRLIAENASTGYPS 437
Query: 442 KFLSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNG 501
L DARYISQTMKLGALGLP YRTFSLEE+EEATNNFDTSAFMGEGSQGQMYRGRLK+G
Sbjct: 438 NLLPDARYISQTMKLGALGLPPYRTFSLEEVEEATNNFDTSAFMGEGSQGQMYRGRLKDG 497
Query: 502 TFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEY 561
+FVAIRCLKMK+ HST+NFMHHIELISKLRHRHLVSALGHCFECY DDSSVSRIFL+FEY
Sbjct: 498 SFVAIRCLKMKRSHSTQNFMHHIELISKLRHRHLVSALGHCFECYLDDSSVSRIFLVFEY 557
Query: 562 VPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ 621
VPNGTLRSWIS GHA Q L WT RI+AAIGVAKGIQFLHTGIVPGV+SNNLKITD+LLDQ
Sbjct: 558 VPNGTLRSWISGGHAWQKLQWTHRIAAAIGVAKGIQFLHTGIVPGVYSNNLKITDVLLDQ 617
Query: 622 NLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNSAR 659
NL+AKISSYNLPLLAEN V H S D + SAR
Sbjct: 618 NLIAKISSYNLPLLAENKGMVVHGTSSGASKDLSTSAR 655
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439195|ref|XP_002269509.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At3g03770 [Vitis vinifera] gi|296085894|emb|CBI31218.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 957 bits (2474), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 476/639 (74%), Positives = 540/639 (84%)
Query: 4 ASRFSQCTLLVLAYILLQVNHSEQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEP 63
A F LLVL IL + SEQL SSQAQTL+RIQG+LN PA+LSSWN T+FC+TEP
Sbjct: 2 AKGFCHWALLVLVLILGSIRPSEQLPSSQAQTLIRIQGILNFPAILSSWNNNTDFCDTEP 61
Query: 64 TSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPL 123
+SSLTVVCYEESITQLHI+G+K P LP +FS+DSF+TTLVKLP LKVL LVSLGLWGP+
Sbjct: 62 SSSLTVVCYEESITQLHIIGHKGVPPLPRNFSIDSFITTLVKLPSLKVLTLVSLGLWGPM 121
Query: 124 SGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAV 183
KI+RLSSLEILN+SSN+ G IP+E++ LTSLQTLILD+NM G + DWL LP+LAV
Sbjct: 122 PSKIARLSSLEILNISSNYFYGTIPEEIAYLTSLQTLILDDNMFIGELSDWLSLLPVLAV 181
Query: 184 LSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFP 243
LSL+ N FNG+LP S LENLR+L LS+N FYGEVPD S L LQVLDLE+NALGPQFP
Sbjct: 182 LSLKKNSFNGSLPSSLGSLENLRILTLSHNRFYGEVPDLSSLDNLQVLDLEDNALGPQFP 241
Query: 244 KVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIA 303
++G KLVT++L KN+F S IP EVSSYYQL+RLD+S NRF GPFP +LL+LPS+TYLNIA
Sbjct: 242 RLGTKLVTLVLKKNRFSSGIPVEVSSYYQLERLDISYNRFAGPFPPSLLALPSVTYLNIA 301
Query: 304 DNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNENQH 363
NK TG LF SCN L FVDLSSNLLTG LPNCL + SK RVVLY RNCLA G +NQH
Sbjct: 302 GNKFTGMLFGYQSCNAGLEFVDLSSNLLTGNLPNCLKSDSKKRVVLYGRNCLATGEQNQH 361
Query: 364 PLSFCQNEALAVGILPLQKKQKQVSKAVLALSIIGGIIGGISLVVIAFLLVRRTKSKQTM 423
P SFC+NEALAVGI+P +KKQK SKAVLAL IGGI+GGI+L + FL+VRR +K+
Sbjct: 362 PFSFCRNEALAVGIIPHRKKQKGASKAVLALGTIGGILGGIALFCLVFLVVRRVNAKKAT 421
Query: 424 KKTPTRLIQENASTGYTSKFLSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFDTSA 483
K PT+LI ENAST Y+SK SDARY+SQTM LGALGLPAYRTFSLEELEEATNNFDTS
Sbjct: 422 KTPPTKLIAENASTVYSSKLFSDARYVSQTMNLGALGLPAYRTFSLEELEEATNNFDTST 481
Query: 484 FMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCF 543
FMGEGSQGQMYRG+LK+G+ VAIRCLKMKK HST+NFMHHIELI KLRHRHLVS+LGHCF
Sbjct: 482 FMGEGSQGQMYRGKLKDGSLVAIRCLKMKKSHSTQNFMHHIELILKLRHRHLVSSLGHCF 541
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI 603
ECY DD+SVSRIFLIFEYVPNGTLRSWISEG + Q+L+WTQRI+AAIGVAKGI+FLHTGI
Sbjct: 542 ECYLDDASVSRIFLIFEYVPNGTLRSWISEGRSRQTLSWTQRIAAAIGVAKGIEFLHTGI 601
Query: 604 VPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKV 642
+PGV+SNNLKITDILLDQNLVAKISSYNLPLLAEN KV
Sbjct: 602 LPGVYSNNLKITDILLDQNLVAKISSYNLPLLAENMGKV 640
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123880|ref|XP_002319187.1| predicted protein [Populus trichocarpa] gi|222857563|gb|EEE95110.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 955 bits (2469), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/659 (73%), Positives = 564/659 (85%), Gaps = 4/659 (0%)
Query: 1 MARASRFSQCTLLVLAYILLQVNHSEQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCN 60
MA+A R+S +L+ ++L ++ SEQLQSSQ +TLLRIQ LLN P+ LSSWN + +FCN
Sbjct: 1 MAKAFRYS--AILLCVVLVLLISGSEQLQSSQGETLLRIQRLLNYPSSLSSWNSSIDFCN 58
Query: 61 TEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLW 120
+EP +S+TV CYE+SITQLHIVGNK P+LP +FS+DSFVTT+V LP LKVL LVSLGLW
Sbjct: 59 SEPNASVTVACYEKSITQLHIVGNKGTPLLPGNFSIDSFVTTVVGLPTLKVLTLVSLGLW 118
Query: 121 GPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPI 180
GPL GKI+RLSSLEILNMSSNFL AIPQELS L+ LQ+L LD+NM AG+VP+W+GSL +
Sbjct: 119 GPLPGKIARLSSLEILNMSSNFLYDAIPQELSSLSGLQSLGLDDNMFAGKVPNWIGSLQV 178
Query: 181 LAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGP 240
L+VLSLR NM NG+LPDS S LENLRVLAL++N+F GEVPD S LT LQVLDLE+NA GP
Sbjct: 179 LSVLSLRKNMLNGSLPDSLSTLENLRVLALAHNYFKGEVPDLSSLTNLQVLDLEDNAFGP 238
Query: 241 QFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYL 300
QFP++G KLV+++LS+NKFR +PAEV+SYYQLQRLDLS+N FVGPFPQ+LLSLPS+TYL
Sbjct: 239 QFPQLGNKLVSLVLSRNKFRDGLPAEVTSYYQLQRLDLSNNTFVGPFPQSLLSLPSVTYL 298
Query: 301 NIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNE 360
NIADNK TG LF++ SC+ +L FVDLSSNL+TG +PNCLL SK + LYA NCLA G++
Sbjct: 299 NIADNKFTGMLFENQSCSADLEFVDLSSNLMTGHMPNCLLQDSKKK-ALYAGNCLATGDQ 357
Query: 361 NQHPLSFCQNEALAVGILPLQKKQKQVSKAVLALSIIGGIIGGISLVVIAFLLVRRTKSK 420
+QHP+S C+NEALAVGILP QKK+K SKA++A+S+IGGI+GGI+LV + FL VR+ KS
Sbjct: 358 DQHPISICRNEALAVGILPQQKKRKP-SKAIIAISVIGGIVGGIALVGLIFLAVRKVKSG 416
Query: 421 QTMKKTPTRLIQENASTGYTSKFLSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFD 480
+T++K+ RLI ENASTGY +K LSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFD
Sbjct: 417 KTIQKSTIRLIAENASTGYPTKLLSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFD 476
Query: 481 TSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALG 540
TSAFMGEGSQGQ+YRGRLK+G+FV IRCLKMK+ H T NFMHHIELISKLRHRHLVSALG
Sbjct: 477 TSAFMGEGSQGQIYRGRLKDGSFVVIRCLKMKRSHGTHNFMHHIELISKLRHRHLVSALG 536
Query: 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH 600
H FE Y DDSSVSRIFL+FEYVPNGTLRSWIS GHA Q + WT RI+AAIGVAKGIQFLH
Sbjct: 537 HGFEYYLDDSSVSRIFLVFEYVPNGTLRSWISGGHARQKIHWTHRIAAAIGVAKGIQFLH 596
Query: 601 TGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNSAR 659
TGIVPGV+SNNLKITD+LLDQNLVAKISSYNLPLLAEN VGH S D + SAR
Sbjct: 597 TGIVPGVYSNNLKITDVLLDQNLVAKISSYNLPLLAENRGMVGHGASSGASKDLSLSAR 655
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255569464|ref|XP_002525699.1| leucine-rich repeat protein, putative [Ricinus communis] gi|223534999|gb|EEF36682.1| leucine-rich repeat protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 947 bits (2447), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/656 (71%), Positives = 556/656 (84%), Gaps = 2/656 (0%)
Query: 4 ASRFSQCTLLVLAYILLQVNHSEQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEP 63
A F +LV +L+ VNHSEQLQSSQ +TLLRIQ +LN P++L+SWN TT+FCNT+P
Sbjct: 2 AKSFQYSAILVFITVLVSVNHSEQLQSSQGETLLRIQRILNYPSILNSWNSTTDFCNTDP 61
Query: 64 TSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPL 123
SLTVVCYE+SITQLHI+GNK AP+LP +FS++SFVTTLV LP+LKVL LVSLGLWGPL
Sbjct: 62 NPSLTVVCYEDSITQLHIIGNKGAPLLPRNFSIESFVTTLVSLPNLKVLTLVSLGLWGPL 121
Query: 124 SGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAV 183
GKI+RL SLE+LNMSSNFL AIP++LS L SLQTL+LD+NM++G +P+WL S P+L V
Sbjct: 122 PGKIARLPSLEMLNMSSNFLYDAIPEDLSSLGSLQTLVLDDNMVSGELPNWLDSFPLLTV 181
Query: 184 LSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFP 243
LSL+ NMFNG+LP+S S L NLRVLALS+N+FYGEVPD S LT LQVLDLE+NA GPQFP
Sbjct: 182 LSLKKNMFNGSLPNSLSNLANLRVLALSHNYFYGEVPDLSSLTNLQVLDLEDNAFGPQFP 241
Query: 244 KVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIA 303
++G KLVT+ LSKNKFR IPAEVSSYY L++LDLS N+FVGPFP LLSL SITY+N+A
Sbjct: 242 QLGNKLVTLTLSKNKFRDGIPAEVSSYYHLRQLDLSKNKFVGPFPPLLLSLLSITYINVA 301
Query: 304 DNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNENQH 363
DNKLTG LF++ SC+ +L FVDLSSNL+TG LP CL + S+ + VLYA NCLA +NQ+
Sbjct: 302 DNKLTGMLFENQSCSADLEFVDLSSNLITGHLPKCLQSDSREK-VLYAGNCLAIEKQNQN 360
Query: 364 PLSFCQNEALAVGILPLQKKQKQVSKAVLALSIIGGIIGGISLVVIAFLLVRRTKSKQTM 423
P+SFC+NEALAVGIL KK + SK V+ L +IGG+ GGI+ V + FL+VR+ +++ +
Sbjct: 361 PISFCRNEALAVGILTQHKKTRHASK-VITLGVIGGVAGGIAAVGLIFLIVRKVYARKAI 419
Query: 424 KKTPTRLIQENASTGYTSKFLSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFDTSA 483
K+ TRLI ENASTGY SK LSDARY+SQTMKLGALG+PAYRTFSLEELEEATNNFDTSA
Sbjct: 420 KRPTTRLIAENASTGYPSKLLSDARYVSQTMKLGALGIPAYRTFSLEELEEATNNFDTSA 479
Query: 484 FMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCF 543
F+GEGSQGQMYRGRLKNG++VAIRCLKMK+ +ST+NFMHHIELISKLRHRHL+SALGHCF
Sbjct: 480 FIGEGSQGQMYRGRLKNGSYVAIRCLKMKRSYSTQNFMHHIELISKLRHRHLISALGHCF 539
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI 603
ECY DDSSVSRIFL+FEYVPNGTLRSWISE + Q+L W QRI+AAIGVAKGIQFLHTGI
Sbjct: 540 ECYLDDSSVSRIFLVFEYVPNGTLRSWISEKRSRQTLNWAQRIAAAIGVAKGIQFLHTGI 599
Query: 604 VPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNSAR 659
+PGV+S NLKITD+LLDQNLVAKI SYNLPLLAENA K+GH + GS DP AR
Sbjct: 600 LPGVYSKNLKITDVLLDQNLVAKICSYNLPLLAENAGKIGHGVSSGGSTDPITVAR 655
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356571765|ref|XP_003554043.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At3g03770-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 894 bits (2310), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/636 (69%), Positives = 520/636 (81%), Gaps = 1/636 (0%)
Query: 22 VNHSEQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPTSSLTVVCYEESITQLHI 81
++ SEQLQSS +QTLLRIQ LLN PA LS+WN +T+FCNT+ SSLTVVCYE++ITQLHI
Sbjct: 20 IHCSEQLQSSHSQTLLRIQQLLNFPAALSNWNSSTDFCNTDSNSSLTVVCYEDTITQLHI 79
Query: 82 VGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSN 141
+G +R LP +FS+DSFVTTLV+LP LKVL LVSLG+WGPL KI+RLSSLEI+NMSSN
Sbjct: 80 IGERRDTPLPRNFSIDSFVTTLVRLPSLKVLTLVSLGIWGPLPSKIARLSSLEIVNMSSN 139
Query: 142 FLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSY 201
FL G+IPQELS L+SLQTLI D NMLA P WL SL L VLSL+NN FNG+LP S
Sbjct: 140 FLYGSIPQELSSLSSLQTLIFDNNMLADTFPHWLDSLQALTVLSLKNNKFNGSLPKSLGN 199
Query: 202 LENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRS 261
+ENLR L+LS+NHFYG VPD S LT LQVL+L++NA GPQFP++G KLV ++L KN FRS
Sbjct: 200 VENLRTLSLSHNHFYGAVPDLSRLTNLQVLELDDNAFGPQFPQLGNKLVILVLRKNSFRS 259
Query: 262 AIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPEL 321
IPAE+SSYYQL+RLD+SSN FVGPF LLSLPSITYLNI+ NKLTG LF++LSCN EL
Sbjct: 260 GIPAELSSYYQLERLDISSNSFVGPFQPGLLSLPSITYLNISGNKLTGMLFENLSCNSEL 319
Query: 322 GFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNENQHPLSFCQNEALAVGILPLQ 381
VDLSSNLLTG LP CL++ S + VLYARNCL N+NQ P FC EALAVGILP
Sbjct: 320 DVVDLSSNLLTGSLPRCLVSNSSDSTVLYARNCLDTTNQNQQPQPFCHTEALAVGILPET 379
Query: 382 KKQKQVSKAVLALSIIGGIIGGISLVVIAFLLVRRTKSKQTMKKTPTRLIQENASTGYTS 441
KK KQVSK VL+L I+GG +GG++LV++ F +VRR + K PTRLI ENA++GYTS
Sbjct: 380 KKHKQVSKVVLSLGIVGGTLGGVALVLLVFFIVRRGNDRSKTKNPPTRLISENAASGYTS 439
Query: 442 KFLSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNG 501
K SDARYISQT KLGA+GLP YR+FSLEE+E ATN FDT++ MGE S G+MYRG+LKNG
Sbjct: 440 KLFSDARYISQTKKLGAVGLPTYRSFSLEEIESATNYFDTASLMGEDSYGKMYRGQLKNG 499
Query: 502 TFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEY 561
+ VAIRC++MKK HST+NF+ HIELISKLRHRHLVSA+GHCFEC DDSSVS++FL+FEY
Sbjct: 500 SLVAIRCVEMKKRHSTQNFVQHIELISKLRHRHLVSAIGHCFECSLDDSSVSKVFLVFEY 559
Query: 562 VPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ 621
VPNGTLR+WIS+ HA +S +WTQRI AAIGVAKGIQFLHTGIVPGV+SN+LKI D+LLDQ
Sbjct: 560 VPNGTLRNWISDEHARKSFSWTQRIGAAIGVAKGIQFLHTGIVPGVYSNDLKIEDVLLDQ 619
Query: 622 NLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657
NLVAKISSY+LPLL+ N KV SG + +NS
Sbjct: 620 NLVAKISSYHLPLLS-NMGKVRRGNSSSGLKNSSNS 654
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147854936|emb|CAN80270.1| hypothetical protein VITISV_020032 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2285), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/639 (69%), Positives = 501/639 (78%), Gaps = 40/639 (6%)
Query: 4 ASRFSQCTLLVLAYILLQVNHSEQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEP 63
A F LLVL IL + SEQL SSQAQTL+RIQG+LN PA+LSSWN T+FC+TEP
Sbjct: 2 AKGFCHWALLVLVXILGSIRPSEQLPSSQAQTLIRIQGILNFPAILSSWNNNTDFCDTEP 61
Query: 64 TSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPL 123
+SSLTVVCYEESITQLHI+G+K P LP +FS+DSF+TTLVKLP LKVL LVSLGLWGP+
Sbjct: 62 SSSLTVVCYEESITQLHIIGHKGVPPLPRNFSIDSFITTLVKLPSLKVLTLVSLGLWGPM 121
Query: 124 SGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAV 183
KI+RLSSLEILN+SSN+ G IP+E++ LTSLQTLILD+NM G + DWL LP+LAV
Sbjct: 122 PSKIARLSSLEILNISSNYFYGTIPEEIAYLTSLQTLILDDNMFIGELSDWLSLLPVLAV 181
Query: 184 LSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFP 243
LSL+ N FNG+LP S LENLR+L LS+N FYGEVPD S L LQVLDLE+NALGPQFP
Sbjct: 182 LSLKKNSFNGSLPSSLGSLENLRILTLSHNRFYGEVPDLSSLDNLQVLDLEDNALGPQFP 241
Query: 244 KVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIA 303
++G KLVT++L KN+F S IP EVSSYYQL+RLD+S NRF GPFP +LL+LPS+TYLNIA
Sbjct: 242 RLGTKLVTLVLKKNRFSSGIPVEVSSYYQLERLDISYNRFAGPFPPSLLALPSVTYLNIA 301
Query: 304 DNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNENQH 363
NK TG LF SCN L FVDLSSNLLTG LPNCL + SK RVVLY RNCLA G +NQH
Sbjct: 302 GNKFTGMLFGYQSCNAGLEFVDLSSNLLTGNLPNCLKSDSKKRVVLYGRNCLATGEQNQH 361
Query: 364 PLSFCQNEALAVGILPLQKKQKQVSKAVLALSIIGGIIGGISLVVIAFLLVRRTKSKQTM 423
P SFC+NEALAVGI+P +KKQK G S V+A + +
Sbjct: 362 PFSFCRNEALAVGIIPHRKKQK-----------------GASKAVLALGTIGGILGGIAL 404
Query: 424 KKTPTRLIQENASTGYTSKFLSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFDTSA 483
YISQTM LGALGLPAYRTFSLEELEEATNNFDTS
Sbjct: 405 -----------------------FWYISQTMNLGALGLPAYRTFSLEELEEATNNFDTST 441
Query: 484 FMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCF 543
FMGEGSQGQMYRG+LK+G+ VAIRCLKMKK HST+NFMHHIELI KLRHRHLVS+LGHCF
Sbjct: 442 FMGEGSQGQMYRGKLKDGSLVAIRCLKMKKSHSTQNFMHHIELILKLRHRHLVSSLGHCF 501
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI 603
ECY DD+SVSRIFLIFEYVPNGTLRSWISEG + Q+L+WTQRI+AAIGVAKGI+FLHTGI
Sbjct: 502 ECYLDDASVSRIFLIFEYVPNGTLRSWISEGRSRQTLSWTQRIAAAIGVAKGIEFLHTGI 561
Query: 604 VPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKV 642
+PGV+SNNLKITDILLDQNLVAKISSYNLPLLAEN KV
Sbjct: 562 LPGVYSNNLKITDILLDQNLVAKISSYNLPLLAENMGKV 600
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449523778|ref|XP_004168900.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At3g03770-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 882 bits (2279), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/659 (67%), Positives = 534/659 (81%), Gaps = 4/659 (0%)
Query: 1 MARASRFSQCTLLVLAYILLQVNHSEQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCN 60
MA+ R S C +++ ++ +VN SEQLQ SQ +TLLRIQ LLN PAVLS+WN +T+FCN
Sbjct: 1 MAQILRNSLCLAILILFV--RVNFSEQLQLSQIRTLLRIQQLLNFPAVLSNWNYSTDFCN 58
Query: 61 TEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLW 120
EP S +TVVCYE ++TQLHI+G K A +LP +FSM SFV TL KLPDLKVL LVSLGLW
Sbjct: 59 LEPDSYVTVVCYEGNLTQLHIIGKKGALLLPHNFSMKSFVNTLAKLPDLKVLTLVSLGLW 118
Query: 121 GPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPI 180
G + GKI+ LSSLEILNMSSNFL GAIPQE+S+L+ L+TLILD+NMLAG++PDW LP+
Sbjct: 119 GSIPGKIAHLSSLEILNMSSNFLYGAIPQEISLLSGLRTLILDDNMLAGQLPDWFHVLPL 178
Query: 181 LAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGP 240
L VLSL++N NG+LP+S + LENLRVL+LS+NHFYGE+PD S LT LQVL+LE+N GP
Sbjct: 179 LTVLSLKHNNLNGSLPNSLNELENLRVLSLSHNHFYGELPDLSTLTNLQVLELEDNGFGP 238
Query: 241 QFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYL 300
QFP++G KLV + LSKNK RS+IP EVSS+YQLQ D+S N VGP P A SLPS++YL
Sbjct: 239 QFPQLGNKLVAVKLSKNKLRSSIPPEVSSFYQLQYFDVSLNSLVGPLPSAFFSLPSLSYL 298
Query: 301 NIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNE 360
NI+ NKLTG L D++SCN EL VDLSSNLLTG LP CLLA +++RVVLY RNC G +
Sbjct: 299 NISGNKLTGMLMDNISCNDELKVVDLSSNLLTGSLPQCLLADTRDRVVLYLRNCFVTGEQ 358
Query: 361 NQHPLSFCQNEALAVGILPLQKKQKQVSKAVLALSIIGGIIGGISLVVIAFLLVRRTKSK 420
QHP+S+CQNEALAVGI+P +KK+ Q KAVLALSI+GG++G I L+ I +++VRR K
Sbjct: 359 QQHPVSYCQNEALAVGIVPEEKKKDQSRKAVLALSIVGGVVGVIILIGIIYIVVRRRNEK 418
Query: 421 QTMKKTPTRLIQENASTGYTSKFLSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFD 480
T+KK PT LI EN S GYTSK LSDARYISQTM+ LGL YR S EE+E+AT NFD
Sbjct: 419 NTVKKPPTNLIVENPSAGYTSKLLSDARYISQTMQFAPLGLSTYRLLSYEEIEDATKNFD 478
Query: 481 TSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALG 540
+SAFMGEGSQGQMYRG+LK+G+ VAIRCLKMKK +ST+NF HHI+LISKLRHRHLVSALG
Sbjct: 479 SSAFMGEGSQGQMYRGQLKDGSLVAIRCLKMKKRYSTQNFTHHIDLISKLRHRHLVSALG 538
Query: 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH 600
HCFE Y +DSSVSRIFL+FEYVPNGTLRSWIS H+ +SLTWTQRI+AA+G+AKGIQFLH
Sbjct: 539 HCFELYLEDSSVSRIFLVFEYVPNGTLRSWISGRHSRRSLTWTQRIAAAVGIAKGIQFLH 598
Query: 601 TGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNSAR 659
+V GV+SNN+KITD+LLDQNL AKISSYNLPL+AE+ KVG + GS DP R
Sbjct: 599 --MVAGVYSNNIKITDVLLDQNLAAKISSYNLPLMAESMAKVGRGVSSGGSKDPGCHER 655
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462762|ref|XP_004149109.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At3g03770-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 880 bits (2273), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/659 (67%), Positives = 533/659 (80%), Gaps = 4/659 (0%)
Query: 1 MARASRFSQCTLLVLAYILLQVNHSEQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCN 60
MA+ R S C +++ ++ +VN SEQLQ SQ +TLLRIQ LLN PAVLS+WN +T+FCN
Sbjct: 1 MAQIFRNSLCLAILILFV--RVNFSEQLQLSQIRTLLRIQQLLNFPAVLSNWNYSTDFCN 58
Query: 61 TEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLW 120
EP S +TVVCYE ++TQLHI+G K A +LP +FSM S V TL KLPDLKVL LVSLGLW
Sbjct: 59 LEPDSYVTVVCYEGNLTQLHIIGKKGALLLPHNFSMKSLVNTLAKLPDLKVLTLVSLGLW 118
Query: 121 GPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPI 180
G + GKI+ LSSLEILNMSSNFL GAIPQE+S+L+ L+TLILD+NMLAG++PDW LP+
Sbjct: 119 GSIPGKIAHLSSLEILNMSSNFLYGAIPQEISLLSGLRTLILDDNMLAGQLPDWFHVLPL 178
Query: 181 LAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGP 240
L VLSL++N NG+LP+S + LENLRVL+LS+NHFYGE+PD S LT LQVL+LE+N GP
Sbjct: 179 LTVLSLKHNNLNGSLPNSLNELENLRVLSLSHNHFYGELPDLSTLTNLQVLELEDNGFGP 238
Query: 241 QFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYL 300
QFP++G KLV + LSKNK RS+IP EVSS+YQLQ D+S N VGP P A SLPS++YL
Sbjct: 239 QFPQLGNKLVAVKLSKNKLRSSIPPEVSSFYQLQYFDVSLNSLVGPLPSAFFSLPSLSYL 298
Query: 301 NIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNE 360
NI+ NKLTG L D++SCN EL VDLSSNLLTG LP CLLA +++RVVLY RNC G +
Sbjct: 299 NISGNKLTGMLMDNISCNDELKVVDLSSNLLTGSLPQCLLADTRDRVVLYLRNCFVTGEQ 358
Query: 361 NQHPLSFCQNEALAVGILPLQKKQKQVSKAVLALSIIGGIIGGISLVVIAFLLVRRTKSK 420
QHP+S+CQNEALAVGI+P +KK+ Q KAVLALSI+GG++G I L+ I +++VRR K
Sbjct: 359 QQHPVSYCQNEALAVGIVPEEKKKDQSRKAVLALSIVGGVVGVIILIGIIYIVVRRRNEK 418
Query: 421 QTMKKTPTRLIQENASTGYTSKFLSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFD 480
T+KK PT LI EN S GYTSK LSDARYISQTM+ LGL YR S EE+E+AT NFD
Sbjct: 419 NTVKKPPTNLIVENPSAGYTSKLLSDARYISQTMQFAPLGLSTYRLLSYEEIEDATKNFD 478
Query: 481 TSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALG 540
+SAFMGEGSQGQMYRG+LK+G+ VAIRCLKMKK +ST+NF HHI+LISKLRHRHLVSALG
Sbjct: 479 SSAFMGEGSQGQMYRGQLKDGSLVAIRCLKMKKRYSTQNFTHHIDLISKLRHRHLVSALG 538
Query: 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH 600
HCFE Y +DSSVSRIFL+FEYVPNGTLRSWIS H+ +SLTWTQRI+AA+G+AKGIQFLH
Sbjct: 539 HCFELYLEDSSVSRIFLVFEYVPNGTLRSWISGRHSRRSLTWTQRIAAAVGIAKGIQFLH 598
Query: 601 TGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNSAR 659
+V GV+SNN+KITD+LLDQNL AKISSYNLPL+AE+ KVG + GS DP R
Sbjct: 599 --MVAGVYSNNIKITDVLLDQNLAAKISSYNLPLMAESMAKVGRGVSSGGSKDPGCHER 655
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357508805|ref|XP_003624691.1| hypothetical protein MTR_7g086420 [Medicago truncatula] gi|87162732|gb|ABD28527.1| Protein kinase [Medicago truncatula] gi|355499706|gb|AES80909.1| hypothetical protein MTR_7g086420 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 878 bits (2269), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/625 (69%), Positives = 515/625 (82%), Gaps = 4/625 (0%)
Query: 12 LLVLAYILLQVNHSEQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPTSSLTVVC 71
VL ILL +NHSEQLQSS QTLLRIQ LN P+ LS+WN +T+FCNT+ SSLTVVC
Sbjct: 5 FFVLVTILLSINHSEQLQSSHTQTLLRIQQQLNFPSALSNWNNSTDFCNTDSNSSLTVVC 64
Query: 72 YEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLS 131
YE++ITQLHI+G + P LP +FS+DSFVTTLVKLP LKVL LVSLG+WGPL GKI+RLS
Sbjct: 65 YEDTITQLHIIGEGKTPPLPKNFSIDSFVTTLVKLPSLKVLTLVSLGIWGPLPGKIARLS 124
Query: 132 SLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMF 191
SLEI+NMSSN L G+IP ELS L +LQTLILD+NM +G+VP ++ L VLSL+NN+F
Sbjct: 125 SLEIVNMSSNHLYGSIPVELSSLLNLQTLILDDNMFSGQVP----TVSALTVLSLKNNLF 180
Query: 192 NGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVT 251
NG+LP+S S LENLR+++LS+N YG VPD S L LQVL+L++NA GPQFPK+G KLVT
Sbjct: 181 NGSLPNSVSNLENLRIISLSHNKLYGVVPDLSHLRNLQVLELDDNAFGPQFPKLGNKLVT 240
Query: 252 MILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKL 311
++L N FRS IPA+VSSYYQL+R D+SSN FVGPF ALLSLPSI YLNI+ NKLTG L
Sbjct: 241 IVLRNNMFRSGIPADVSSYYQLERFDISSNTFVGPFQPALLSLPSIAYLNISRNKLTGML 300
Query: 312 FDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNENQHPLSFCQNE 371
F +LSCN EL VDLSSNLLTG LP CL++ S +R VLYARNCL +NQ P C E
Sbjct: 301 FGNLSCNSELEVVDLSSNLLTGSLPKCLVSNSIDRTVLYARNCLETTKQNQQPPPSCHTE 360
Query: 372 ALAVGILPLQKKQKQVSKAVLALSIIGGIIGGISLVVIAFLLVRRTKSKQTMKKTPTRLI 431
ALAVGILP +KK+KQVSK VLAL I+GG +GG++LV++ +VRR ++ MK PTRLI
Sbjct: 361 ALAVGILPDRKKKKQVSKVVLALGIVGGTLGGVALVLLILFIVRRGNARSKMKNPPTRLI 420
Query: 432 QENASTGYTSKFLSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFDTSAFMGEGSQG 491
ENA++GYTSK LSDARYISQT K GALGLP YR+FSLEE+E ATNNFDT++ MGE S G
Sbjct: 421 SENAASGYTSKLLSDARYISQTKKFGALGLPTYRSFSLEEIEAATNNFDTASLMGEDSYG 480
Query: 492 QMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551
+MYRG+LKNG+ V IRC+KMKK +ST+NFMHH+ELISKLRHRHLVSALGHCF+C +DSS
Sbjct: 481 EMYRGQLKNGSIVVIRCIKMKKRYSTQNFMHHMELISKLRHRHLVSALGHCFKCSLEDSS 540
Query: 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNN 611
VS+IFL+FEYVPNGTLRSW S+GH +SL WTQRI AAIGVAKGIQFLHTGIVPGV+SNN
Sbjct: 541 VSKIFLVFEYVPNGTLRSWTSDGHTGRSLNWTQRIGAAIGVAKGIQFLHTGIVPGVYSNN 600
Query: 612 LKITDILLDQNLVAKISSYNLPLLA 636
+KI DILLD NLVAKISSYNLPLL+
Sbjct: 601 IKIEDILLDHNLVAKISSYNLPLLS 625
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565741|ref|XP_003551096.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At3g03770-like, partial [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 874 bits (2257), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/612 (67%), Positives = 507/612 (82%), Gaps = 1/612 (0%)
Query: 25 SEQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPTSSLTVVCYEESITQLHIVGN 84
S QLQSS ++TLLRIQ LN P VLSSWN T+FC+T+ TSSLTVVCYE +ITQLHIVG
Sbjct: 4 STQLQSSDSKTLLRIQQQLNFPPVLSSWNKNTDFCSTDSTSSLTVVCYEGTITQLHIVGE 63
Query: 85 KRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLN 144
RA +LP +FS+DSFV TLV+LP LKVL LVSLG+WGPL GKI+ LSSLEI+N+SSNFL
Sbjct: 64 TRALLLPRNFSIDSFVRTLVRLPSLKVLTLVSLGIWGPLPGKIAHLSSLEIVNVSSNFLY 123
Query: 145 GAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLEN 204
G+IP + S+L+ LQTLILD+NM +G +P+WL S P L VLSL+NN+FN +LPDS + LEN
Sbjct: 124 GSIPLQFSLLSHLQTLILDDNMFSGHLPEWLDSFPALTVLSLKNNLFNSSLPDSLNSLEN 183
Query: 205 LRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIP 264
LR+L+LS+NHFYG VPD L LQVL+L++NA GP+FP++G KLVT++L NKFRS+IP
Sbjct: 184 LRILSLSHNHFYGPVPDLGRLANLQVLELDDNAFGPRFPQLGDKLVTIVLRNNKFRSSIP 243
Query: 265 AEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFV 324
EVSSYYQL++LD+S+N FVGPF ALLSLPSITY+NI+ NKLTG LF++LSCNP L V
Sbjct: 244 DEVSSYYQLEKLDISANTFVGPFQLALLSLPSITYVNISGNKLTGMLFENLSCNPGLEAV 303
Query: 325 DLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNENQHPLSFCQNEALAVGILPLQKKQ 384
DLSSNLLTG LP CL++ S +R VLYARNCL N+NQH L FC EA+AVGI+P KK
Sbjct: 304 DLSSNLLTGSLPKCLMSNSNDRTVLYARNCLET-NQNQHALPFCHTEAIAVGIVPEGKKH 362
Query: 385 KQVSKAVLALSIIGGIIGGISLVVIAFLLVRRTKSKQTMKKTPTRLIQENASTGYTSKFL 444
K+VSK VL++ I+ G GG+++V + F ++RR K +K PT+LI ENA++GYTSK +
Sbjct: 363 KRVSKEVLSIGIVCGTFGGVAIVALLFFIIRRESVKSKIKNPPTKLISENAASGYTSKLI 422
Query: 445 SDARYISQTMKLGALGLPAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFV 504
SDARYISQTMK G +GLP YR FSLEE+ ATNNFD+++FMGEGSQG+M+RG+LK+G V
Sbjct: 423 SDARYISQTMKFGTVGLPPYRVFSLEEIVAATNNFDSASFMGEGSQGKMHRGQLKDGLLV 482
Query: 505 AIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPN 564
AIR +KM + +ST++FMH+IE ISK RHRHLVS LGHCFECY DDSSVS IF++FEYVPN
Sbjct: 483 AIRSVKMNRSYSTQDFMHNIEQISKYRHRHLVSVLGHCFECYLDDSSVSSIFVVFEYVPN 542
Query: 565 GTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV 624
GTL+SWIS+GH +SLTW QRI A IGVAKGIQFLHTGIVPGV+SNNLKITD+LLDQN V
Sbjct: 543 GTLKSWISDGHYRKSLTWMQRIEATIGVAKGIQFLHTGIVPGVYSNNLKITDVLLDQNFV 602
Query: 625 AKISSYNLPLLA 636
AKISSY+LPLL+
Sbjct: 603 AKISSYDLPLLS 614
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 659 | ||||||
| TAIR|locus:2079339 | 802 | AT3G03770 [Arabidopsis thalian | 0.966 | 0.794 | 0.670 | 1.2e-221 | |
| TAIR|locus:2167326 | 680 | AT5G63410 [Arabidopsis thalian | 0.660 | 0.639 | 0.399 | 4.7e-80 | |
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.262 | 0.181 | 0.410 | 4.6e-53 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.822 | 0.454 | 0.286 | 6.6e-49 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.482 | 0.253 | 0.304 | 5.9e-48 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.345 | 0.182 | 0.334 | 9.9e-47 | |
| TAIR|locus:2084016 | 937 | AT3G53590 [Arabidopsis thalian | 0.248 | 0.175 | 0.401 | 9.5e-46 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.479 | 0.244 | 0.272 | 1.9e-42 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.273 | 0.185 | 0.370 | 2.6e-41 | |
| TAIR|locus:2041150 | 1143 | BRL2 "BRI1-like 2" [Arabidopsi | 0.418 | 0.241 | 0.325 | 4.8e-41 |
| TAIR|locus:2079339 AT3G03770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2140 (758.4 bits), Expect = 1.2e-221, P = 1.2e-221
Identities = 430/641 (67%), Positives = 499/641 (77%)
Query: 12 LLVLAYILLQVNHSEQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPTSSLTVVC 71
LL+L +L ++ S QLQSSQ+QTLLR+Q LL P VL+SWN T+FCN+EP+ SLTVVC
Sbjct: 10 LLLLVLLLASIDGSTQLQSSQSQTLLRLQQLLYYPKVLNSWNNYTDFCNSEPSPSLTVVC 69
Query: 72 YEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLS 131
YE+S+TQLHI+G+ MLP SFS++SFVTTLVKLPD+KVL VSLGLWG L KI+RLS
Sbjct: 70 YEDSVTQLHIIGDNGTHMLPKSFSINSFVTTLVKLPDVKVLTFVSLGLWGWLPQKINRLS 129
Query: 132 SLEILNMSSNFLNGAIPXXXXXXXXXXXXXXDENMLAGRVPDWLGSLPILAVLSLRNNMF 191
SLEILN+SSNFL G IP DENM +G +PDW+ SLP LAVLSLR N+
Sbjct: 130 SLEILNVSSNFLFGPIPHELSSLATLQTLILDENMFSGELPDWIDSLPSLAVLSLRKNVL 189
Query: 192 NGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVT 251
NG+LP S S L LRVLAL+NN F G +PD S LT LQVLDLE N+ GP FP++ KLVT
Sbjct: 190 NGSLPSSLSSLSGLRVLALANNRFNGALPDLSHLTNLQVLDLEGNSFGPLFPRLSNKLVT 249
Query: 252 MILSKNKFRSAIPAE-VSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGK 310
+ILSKNKFRSA+ AE VSS YQLQ LDLS N FVGPFP +L+SLP+ITYLNI+ NKLTG+
Sbjct: 250 LILSKNKFRSAVSAEEVSSLYQLQHLDLSYNTFVGPFPTSLMSLPAITYLNISHNKLTGR 309
Query: 311 LFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGS-KNRVVLYARNCLAAGNENQHPLSFCQ 369
L +LSCN +L FVD+SSNLLTG LP CL S +R V+YA NCLA NE+Q P+SFC
Sbjct: 310 LSANLSCNSQLMFVDMSSNLLTGSLPTCLKPSSGTSRDVVYASNCLATTNEDQRPVSFCS 369
Query: 370 NEALAVGILPLQKKQKQVSKXXXXXXXXXXXXXXXXXXXXXFLLVRRTKSKQTMKKTPTR 429
NEALAVGILP Q++ K VSK F+++RR +K+T+ K+ R
Sbjct: 370 NEALAVGILP-QRRNK-VSKVGIALGVTASILGVLLLAGALFVVLRRLNAKKTVTKSSPR 427
Query: 430 LIQENASTGYTSKFLSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFDTSAFMGEGS 489
LI+ENAS GYTSK LSDARYISQTMKLG LGLPAYRTFSLEELE ATNNF++SAFMGEGS
Sbjct: 428 LIRENASMGYTSKLLSDARYISQTMKLGGLGLPAYRTFSLEELEYATNNFESSAFMGEGS 487
Query: 490 QGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDD 549
QGQ+YRGRLK+G+FVAIRCLKMKK ST+N MHHIELI+KLRHRHLVS LGHCFECY DD
Sbjct: 488 QGQIYRGRLKDGSFVAIRCLKMKKSCSTQNLMHHIELIAKLRHRHLVSVLGHCFECYLDD 547
Query: 550 SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFS 609
S+VSR+F +FEYVPNG LR+WIS+GH + LTW QRIS AIGVAKGIQFLHTGIVPGV+
Sbjct: 548 STVSRMFFVFEYVPNGELRTWISDGHMGRLLTWEQRISVAIGVAKGIQFLHTGIVPGVYD 607
Query: 610 NNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPYSG 650
NNLK+TDILLD NL AK+SSYNLPLL E KVG V SG
Sbjct: 608 NNLKMTDILLDNNLAAKLSSYNLPLLVEGLGKVGQVGSRSG 648
|
|
| TAIR|locus:2167326 AT5G63410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 804 (288.1 bits), Expect = 4.7e-80, P = 4.7e-80
Identities = 182/456 (39%), Positives = 267/456 (58%)
Query: 198 SFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNAL-GPQFPKVGK--KLVTMI 253
+ S L++LRVL L++ +G +P+ L+ L+ LDL NN L G PK+ KL T
Sbjct: 112 TLSRLKSLRVLTLASLGIWGRLPEKLHRLSSLEYLDLSNNFLFGSVPPKLSTMVKLETFR 171
Query: 254 LSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFD 313
N F +P+ SY+ L+ L SN+ G +LLSL +I Y+++ N L+G L D
Sbjct: 172 FDHNFFNGTLPSWFDSYWYLKVLSFKSNKLSGELHSSLLSLSTIEYIDLRANSLSGSLPD 231
Query: 314 DLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVL-YARNCLAAGNENQHPLSFCQNEA 372
DL C +L F+D+S N LTG+LP CL SK + L + NCL+ + QHP SFC E
Sbjct: 232 DLKCGSKLWFIDISDNKLTGKLPRCL--SSKQDIALRFNGNCLSL-EKQQHPESFCVKEV 288
Query: 373 LAVGILPLQKK--------QKQVSKXXXXXXXXXXXXXXXXXXXXXFLLVRRTKSKQTMK 424
A + + +++ K F+L+RR K T K
Sbjct: 289 RAAAKAEAKAEAEAANESGKRKWKKGALIGLIVGISMSVLVLVCCVFILLRR-KGV-TKK 346
Query: 425 KTPTRLIQEN-ASTGYTSKFLSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFDTSA 483
+Q+N +TG++S+ LS+ARYIS+T K G+ LP R FSLEE+ +AT NFD +
Sbjct: 347 HVHHNTVQDNHPTTGFSSEILSNARYISETSKFGSEDLPVCRQFSLEEIVKATKNFDKTM 406
Query: 484 FMGEGS-QGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHC 542
+GE S G +Y+G L+NGT VAIRCL K +S RN ++L++KLRH +LV LGHC
Sbjct: 407 ILGESSLYGTLYKGNLENGTKVAIRCLPSSKKYSIRNLKLRLDLLAKLRHPNLVCLLGHC 466
Query: 543 FECYF-DDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT 601
+C DD SV ++FLI+EY+PNG +S +S+ + + + W++R++ GVAK + FLHT
Sbjct: 467 IDCGGKDDYSVEKVFLIYEYIPNGNFQSCLSDNSSGKGMNWSERLNVLTGVAKAVHFLHT 526
Query: 602 GIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637
G++PG FSN LK ++LL+Q+ AK+S Y L +++E
Sbjct: 527 GVIPGFFSNRLKTNNVLLNQHRFAKLSDYGLSIVSE 562
|
|
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 334 (122.6 bits), Expect = 4.6e-53, Sum P(2) = 4.6e-53
Identities = 76/185 (41%), Positives = 112/185 (60%)
Query: 465 RTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHI 524
R FS +EL EAT++F +S +G G G++YRG L + T AI+ + F++ I
Sbjct: 612 RGFSFKELAEATDDFSSSTLVGRGGYGKVYRGVLSDNTVAAIKRADEGSLQGEKEFLNEI 671
Query: 525 ELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQ 584
EL+S+L HR+LVS +G+C D+ S L++E++ NGTLR W+S +SL++
Sbjct: 672 ELLSRLHHRNLVSLIGYC-----DEESEQ--MLVYEFMSNGTLRDWLS-AKGKESLSFGM 723
Query: 585 RISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA---ENAEK 641
RI A+G AKGI +LHT P VF ++K ++ILLD N AK++ + L LA E+ E
Sbjct: 724 RIRVALGAAKGILYLHTEANPPVFHRDIKASNILLDPNFNAKVADFGLSRLAPVLEDEED 783
Query: 642 VG-HV 645
V HV
Sbjct: 784 VPKHV 788
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 521 (188.5 bits), Expect = 6.6e-49, P = 6.6e-49
Identities = 167/583 (28%), Positives = 270/583 (46%)
Query: 109 LKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPXXXXXXXXXXXX-------- 160
L L L S L G + KI+ L+ L+ L +S N L+G+IP
Sbjct: 522 LTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQH 581
Query: 161 ----XXDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFY 216
N L+G +P+ LG +L +SL NN +G +P S S L NL +L LS N
Sbjct: 582 HGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALT 641
Query: 217 GEVPDFSGLTY-LQVLDLENNALGPQFPK-VGK--KLVTMILSKNKFRSAIPAEVSSYYQ 272
G +P G + LQ L+L NN L P+ G LV + L+KNK +PA + + +
Sbjct: 642 GSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKE 701
Query: 273 LQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT 332
L +DLS N G L ++ + L I NK TG++ +L +L ++D+S NLL+
Sbjct: 702 LTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLS 761
Query: 333 GQLPNCLLAGSKNRVVL-YARNCLAAGNEN----QHPLS--FCQNEALAVGILPLQKKQK 385
G++P + G N L A+N L + Q P N+ L ++ K +
Sbjct: 762 GEIPT-KICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIE 820
Query: 386 QVSKXXXXXXXXXXXXXXXXXXXXXFLLVRRTKSKQTMKKTPTRLIQENASTGYTSK--- 442
F L R +K+ ++ ++E+ G+ +
Sbjct: 821 GTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLY 880
Query: 443 FLSDARYISQ-TMKLGALGLPAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNG 501
FLS +R ++ + P + L ++ EAT++F +G+G G +Y+ L
Sbjct: 881 FLSGSRSREPLSINIAMFEQPLLKV-RLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGE 939
Query: 502 TFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEY 561
VA++ L K R FM +E + K++H +LVS LG+C F + + L++EY
Sbjct: 940 KTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCS---FSEEKL----LVYEY 992
Query: 562 VPNGTLRSWI-SEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD 620
+ NG+L W+ ++ + L W++R+ A+G A+G+ FLH G +P + ++K ++ILLD
Sbjct: 993 MVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLD 1052
Query: 621 QNLVAKISSYNLPLLAENAEK-VGHVIPYS-GSIDPT--NSAR 659
+ K++ + L L E V VI + G I P SAR
Sbjct: 1053 GDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSAR 1095
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 337 (123.7 bits), Expect = 5.9e-48, Sum P(2) = 5.9e-48
Identities = 104/341 (30%), Positives = 158/341 (46%)
Query: 39 IQGLLNNPAVLSSWNITT-EFCNTEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMD 97
+QG L + ++++ N+T F + + S++ +C S + N +PL
Sbjct: 541 LQGNLPD-SLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLE---- 595
Query: 98 SFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPXXXXXXXXX 157
L K +L LRL G + ++S L +L++S N L+G IP
Sbjct: 596 -----LGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKL 650
Query: 158 XXXXXDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYG 217
+ N L+G +P WLG LP+L L L +N F G+LP L N+ L L N G
Sbjct: 651 THIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNG 710
Query: 218 EVP-DFSGLTYLQVLDLENNAL-GPQFPKVGK--KLVTMILSKNKFRSAIPAEVSSYYQL 273
+P + L L L+LE N L GP +GK KL + LS+N IP E+ L
Sbjct: 711 SIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDL 770
Query: 274 QR-LDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT 332
Q LDLS N F G P + +LP + L+++ N+L G++ + LG+++LS N L
Sbjct: 771 QSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLE 830
Query: 333 GQLPNCLLAGSKNRVVLYA-------RNCLAAGNENQHPLS 366
G+L + V A +C AG++NQ LS
Sbjct: 831 GKLKKQFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLS 871
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 300 (110.7 bits), Expect = 9.9e-47, Sum P(2) = 9.9e-47
Identities = 78/233 (33%), Positives = 115/233 (49%)
Query: 108 DLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPXXXXXXXXXXXXXXDENML 167
+L LRL L G + + ++ L +L+MSSN L G IP + N L
Sbjct: 600 NLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFL 659
Query: 168 AGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP-DFSGLT 226
+G +P WLG L L L L +N F +LP L VL+L N G +P + L
Sbjct: 660 SGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLG 719
Query: 227 YLQVLDLENNALGPQFPK-VGK--KLVTMILSKNKFRSAIPAEVSSYYQLQR-LDLSSNR 282
L VL+L+ N P+ +GK KL + LS+N IP E+ LQ LDLS N
Sbjct: 720 ALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNN 779
Query: 283 FVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQL 335
F G P + +L + L+++ N+LTG++ + LG++++S N L G+L
Sbjct: 780 FTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL 832
|
|
| TAIR|locus:2084016 AT3G53590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 324 (119.1 bits), Expect = 9.5e-46, Sum P(2) = 9.5e-46
Identities = 69/172 (40%), Positives = 107/172 (62%)
Query: 465 RTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHI 524
+ FS EL +ATN FD+S +G GS G++Y+G L N T VAI+ + S + F++ I
Sbjct: 600 KKFSFVELSDATNGFDSSTLIGRGSYGKVYKGILSNKTEVAIKRGEETSLQSEKEFLNEI 659
Query: 525 ELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQ 584
+L+S+L HR+LVS +G+ S + L++EY+PNG +R W+S +A +L+++
Sbjct: 660 DLLSRLHHRNLVSLIGY-------SSDIGEQMLVYEYMPNGNVRDWLS-ANAADTLSFSM 711
Query: 585 RISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636
R A+G AKGI +LHT P V ++K ++ILLD L AK++ + L LA
Sbjct: 712 RSHVALGSAKGILYLHTEANPPVIHRDIKTSNILLDCQLHAKVADFGLSRLA 763
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 278 (102.9 bits), Expect = 1.9e-42, Sum P(2) = 1.9e-42
Identities = 92/337 (27%), Positives = 147/337 (43%)
Query: 29 QSSQAQTLLRIQ-GLLNNPAVLSSWNITTEFCNTEPTSSLTVVCYEESITQLHIVGNKRA 87
+S TL ++ + L +W +E T P S + C ++ + +
Sbjct: 23 ESRDISTLFTLRDSITEGKGFLRNW-FDSE---TPPCSWSGITCIGHNVVAIDL---SSV 75
Query: 88 PML-PLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGA 146
P+ P + +F +LV+L G G L + L +L+ L++S+N L G
Sbjct: 76 PLYAPFPLCIGAF-QSLVRL------NFSGCGFSGELPEALGNLQNLQYLDLSNNELTGP 128
Query: 147 IPXXXXXXXXXXXXXXDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLR 206
IP D N L+G++ + L L LS+ N +G+LP L+NL
Sbjct: 129 IPISLYNLKMLKEMVLDYNSLSGQLSPAIAQLQHLTKLSISMNSISGSLPPDLGSLKNLE 188
Query: 207 VLALSNNHFYGEVP-DFSGLTYLQVLDL-ENNALGPQFPKVGK--KLVTMILSKNKFRSA 262
+L + N F G +P F L+ L D +NN G FP + L+T+ LS N F
Sbjct: 189 LLDIKMNTFNGSIPATFGNLSCLLHFDASQNNLTGSIFPGITSLTNLLTLDLSSNSFEGT 248
Query: 263 IPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELG 322
IP E+ L+ L L N G PQ + SL + L++ + + TGK+ +S L
Sbjct: 249 IPREIGQLENLELLILGKNDLTGRIPQEIGSLKQLKLLHLEECQFTGKIPWSISGLSSLT 308
Query: 323 FVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGN 359
+D+S N +LP+ + N L A+N +GN
Sbjct: 309 ELDISDNNFDAELPSSM-GELGNLTQLIAKNAGLSGN 344
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 315 (115.9 bits), Expect = 2.6e-41, Sum P(2) = 2.6e-41
Identities = 70/189 (37%), Positives = 112/189 (59%)
Query: 457 GALGLPAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHS 516
GA L R FS EEL++ TNNF S+ +G G G++Y+G L++G VAI+ +
Sbjct: 616 GAPQLKGARWFSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIKRAQQGSTQG 675
Query: 517 TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHA 576
F IEL+S++ H++LV +G CFE +I L++EY+ NG+L+ ++ G +
Sbjct: 676 GLEFKTEIELLSRVHHKNLVGLVGFCFE------QGEQI-LVYEYMSNGSLKDSLT-GRS 727
Query: 577 HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636
+L W +R+ A+G A+G+ +LH P + ++K T+ILLD+NL AK++ + L L
Sbjct: 728 GITLDWKRRLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 787
Query: 637 ENAEKVGHV 645
+ K GHV
Sbjct: 788 SDCTK-GHV 795
|
|
| TAIR|locus:2041150 BRL2 "BRI1-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 263 (97.6 bits), Expect = 4.8e-41, Sum P(2) = 4.8e-41
Identities = 95/292 (32%), Positives = 133/292 (45%)
Query: 92 LSFSMDSFV---TTLVKLP-DLKVLRLVSLGLWGPLSGKI-SRLSSLEILNMSSNFLNGA 146
L S + FV T+L+ LP L L L S GL G L S+ S+L + +S N G
Sbjct: 108 LKLSENFFVLNSTSLLLLPLTLTHLELSSSGLIGTLPENFFSKYSNLISITLSYNNFTGK 167
Query: 147 IPXXXXXXXXXXXXXX-DENMLAGRVPDW---LGSLPILAVLSLRNNMFNGTLPDSFSYL 202
+P N + G + L S + L N +G + DS
Sbjct: 168 LPNDLFLSSKKLQTLDLSYNNITGPISGLTIPLSSCVSMTYLDFSGNSISGYISDSLINC 227
Query: 203 ENLRVLALSNNHFYGEVP-DFSGLTYLQVLDLENNAL-GPQFPKVG---KKLVTMILSKN 257
NL+ L LS N+F G++P F L LQ LDL +N L G P++G + L + LS N
Sbjct: 228 TNLKSLNLSYNNFDGQIPKSFGELKLLQSLDLSHNRLTGWIPPEIGDTCRSLQNLRLSYN 287
Query: 258 KFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALL-SLPSITYLNIADNKLTGKLFDDLS 316
F IP +SS LQ LDLS+N GPFP +L S S+ L +++N ++G +S
Sbjct: 288 NFTGVIPESLSSCSWLQSLDLSNNNISGPFPNTILRSFGSLQILLLSNNLISGDFPTSIS 347
Query: 317 CNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNENQHPLSFC 368
L D SSN +G +P L G+ + L + L G E +S C
Sbjct: 348 ACKSLRIADFSSNRFSGVIPPDLCPGAASLEELRLPDNLVTG-EIPPAISQC 398
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q8LFN2 | Y3037_ARATH | No assigned EC number | 0.6985 | 0.9150 | 0.7518 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| estExt_fgenesh4_pm.C_LG_XIX0116 | hypothetical protein (774 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 659 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-36 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-34 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-16 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-15 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-15 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-14 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-14 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-12 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-10 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-07 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-07 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-07 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-07 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-07 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-05 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-05 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-05 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-05 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-05 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 0.001 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 0.001 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 0.001 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.002 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 0.002 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.003 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.003 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 0.003 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 0.003 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.004 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 5e-36
Identities = 147/571 (25%), Positives = 253/571 (44%), Gaps = 95/571 (16%)
Query: 79 LHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNM 138
LH+ N +P++ L LP L+VL+L S G + + + ++L +L++
Sbjct: 313 LHLFSNNFTGKIPVA---------LTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDL 363
Query: 139 SSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDS 198
S+N L G IP+ L +L LIL N L G +P LG+ L + L++N F+G LP
Sbjct: 364 STNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSE 423
Query: 199 FSYLE------------------------NLRVLALSNNHFYGEVPDFSGLTYLQVLDLE 234
F+ L +L++L+L+ N F+G +PD G L+ LDL
Sbjct: 424 FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLS 483
Query: 235 NNALGPQFP-KVGK--KLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQAL 291
N P K+G +L+ + LS+NK IP E+SS +L LDLS N+ G P +
Sbjct: 484 RNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASF 543
Query: 292 LSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYA 351
+P ++ L+++ N+L+G++ +L L V++S N L G LP+ + N +
Sbjct: 544 SEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAG 603
Query: 352 RNCLAAGNENQHPLSFCQNEALAVGILPLQKKQKQVSKAVLALSIIGGIIGGISLVVIAF 411
L G+ G+ P ++ +K S +G + L ++AF
Sbjct: 604 NIDLCGGDT-------------TSGLPPCKRVRKTPSWWFYITCTLGAF---LVLALVAF 647
Query: 412 LLV-RRTKSKQTMKKTPTRLIQENASTGYTSKFLSDARYISQTMKLGALGLPAYRTFSLE 470
V R ++ +K+ EN + +F S+ K + ++
Sbjct: 648 GFVFIRGRNNLELKRV------ENEDGTWELQFFD-----SKVSK----------SITIN 686
Query: 471 ELEEATNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISK 529
++ + + G +G Y+G+ +KNG ++ ++ +S + I + K
Sbjct: 687 DILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVK--EINDVNSIPS--SEIADMGK 739
Query: 530 LRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAA 589
L+H ++V +G C S +LI EY+ L + +L+W +R A
Sbjct: 740 LQHPNIVKLIGLC-------RSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIA 786
Query: 590 IGVAKGIQFLHTGIVPGVFSNNLKITDILLD 620
IG+AK ++FLH P V NL I++D
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 9e-34
Identities = 107/385 (27%), Positives = 171/385 (44%), Gaps = 68/385 (17%)
Query: 8 SQCTLLVLAYILLQVNHSEQLQSSQAQTLLRIQGLLNNP-AVLSSWNITTEFCNTEPTSS 66
C L+ L +N L + + + LL + +N+P LS+WN + + C
Sbjct: 7 QHCPYLIFMLFFLFLN-FSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCLW----- 60
Query: 67 LTVVCYEES-ITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSG 125
+ C S + + + G + + + +LP ++ + L + L GP+
Sbjct: 61 QGITCNNSSRVVSIDLSGKNISGKISSAI---------FRLPYIQTINLSNNQLSGPIPD 111
Query: 126 KISRLSS-----------------------LEILNMSSNFLNGAIPQELSILTSLQTLIL 162
I SS LE L++S+N L+G IP ++ +SL+ L L
Sbjct: 112 DIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDL 171
Query: 163 DENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP-D 221
N+L G++P+ L +L L L+L +N G +P +++L+ + L N+ GE+P +
Sbjct: 172 GGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE 231
Query: 222 FSGLTYLQVLDL-ENNALGPQFPKVG--KKLVTMILSKNKFRSAIPAEVSSYYQLQRLDL 278
GLT L LDL NN GP +G K L + L +NK IP + S +L LDL
Sbjct: 232 IGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291
Query: 279 S------------------------SNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDD 314
S SN F G P AL SLP + L + NK +G++ +
Sbjct: 292 SDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKN 351
Query: 315 LSCNPELGFVDLSSNLLTGQLPNCL 339
L + L +DLS+N LTG++P L
Sbjct: 352 LGKHNNLTVLDLSTNNLTGEIPEGL 376
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-28
Identities = 88/252 (34%), Positives = 130/252 (51%), Gaps = 4/252 (1%)
Query: 109 LKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLA 168
LKVL L L G + ++ L+SLE L ++SN L G IP+EL + SL+ + L N L+
Sbjct: 166 LKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225
Query: 169 GRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP-DFSGLTY 227
G +P +G L L L L N G +P S L+NL+ L L N G +P L
Sbjct: 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQK 285
Query: 228 LQVLDLENNALGPQFPKV---GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFV 284
L LDL +N+L + P++ + L + L N F IP ++S +LQ L L SN+F
Sbjct: 286 LISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFS 345
Query: 285 GPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSK 344
G P+ L ++T L+++ N LTG++ + L + L + L SN L G++P L A
Sbjct: 346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRS 405
Query: 345 NRVVLYARNCLA 356
R V N +
Sbjct: 406 LRRVRLQDNSFS 417
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-27
Identities = 85/273 (31%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 104 VKLPDLKVLRLVSLG---LWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTL 160
+L +K L+ + LG L G + +I L+SL L++ N L G IP L L +LQ L
Sbjct: 206 RELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYL 265
Query: 161 ILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP 220
L +N L+G +P + SL L L L +N +G +P+ L+NL +L L +N+F G++P
Sbjct: 266 FLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
Query: 221 D-FSGLTYLQVLDLENNALGPQFPK-VGKK--------------------------LVTM 252
+ L LQVL L +N + PK +GK L +
Sbjct: 326 VALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL 385
Query: 253 ILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLF 312
IL N IP + + L+R+ L N F G P LP + +L+I++N L G++
Sbjct: 386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRIN 445
Query: 313 DDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKN 345
P L + L+ N G LP+ GSK
Sbjct: 446 SRKWDMPSLQMLSLARNKFFGGLPD--SFGSKR 476
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 5e-16
Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 27/154 (17%)
Query: 486 GEGSQGQMYRGRLKNG-----TFVAIRCLKMKKCHSTRN-FMHHIELISKLRHRHLVSAL 539
GEG+ G++Y+G LK VA++ LK F+ ++ KL H ++V L
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLL 67
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFL 599
G C + + ++ EY+P G L ++ + + + L+ + +S A+ +A+G+++L
Sbjct: 68 GVC-------TEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYL 119
Query: 600 HTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
S N L + L+ +NLV KIS
Sbjct: 120 E--------SKNFIHRDLAARNCLVGENLVVKIS 145
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 37/162 (22%)
Query: 486 GEGSQGQMYRGRLKNG----TFVAIRCLKMKKCHST---RNFMHHIELISKLRHRHLVSA 538
GEG+ G++Y+G+LK T VA++ LK + S ++F+ ++ KL H ++V
Sbjct: 4 GEGAFGEVYKGKLKGKDGKTTEVAVKTLK--EDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISE------GHAHQSLTWTQRISAAIGV 592
LG C E ++L+ EY+ G L ++ + +L+ +S AI +
Sbjct: 62 LGVCTE-------EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 593 AKGIQFLHT-GIVPGVFSNNLKITD-----ILLDQNLVAKIS 628
AKG+++L + V D L+ ++LV KIS
Sbjct: 115 AKGMEYLASKKFVHR---------DLAARNCLVGEDLVVKIS 147
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 17/151 (11%)
Query: 486 GEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHH-IELISKLRHRHLVSALGHCF 543
GEG G +Y R K G VAI+ +K + S + IE++ KL H ++V +
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIV----KLY 57
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH-TG 602
+ D++ ++L+ EY G+L+ + E L+ + + + + +G+++LH G
Sbjct: 58 GVFEDEN---HLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSNG 112
Query: 603 IVPGVFSNNLKITDILLDQ-NLVAKISSYNL 632
I+ +LK +ILLD N K++ + L
Sbjct: 113 IIHR----DLKPENILLDSDNGKVKLADFGL 139
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 34/157 (21%)
Query: 486 GEGSQGQMYRGRLKNGTF-----VAIRCLKMKKCHSTRN----FMHHIELISKLRHRHLV 536
GEG+ G++Y+G+LK VA+ K K ++ F+ ++ KL H ++V
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAV---KTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 537 SALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGI 596
LG C + ++++ EY+ G L S++ + L+ + +S A+ +A+G+
Sbjct: 65 KLLGVC-------TEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGM 115
Query: 597 QFLHTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
++L S N L + L+ +NLV KIS
Sbjct: 116 EYLE--------SKNFIHRDLAARNCLVGENLVVKIS 144
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 8e-14
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 30/155 (19%)
Query: 486 GEGSQGQMYRGRLK-----NGTFVAIRCLKMKKCHSTR-NFMHHIELISKLRHRHLVSAL 539
GEG+ G++Y+G LK T VA++ LK R F+ ++ KL H ++V L
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLL 67
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAH-QSLTWTQRISAAIGVAKGIQF 598
G C + + ++++ EY+P G L ++ H + LT + A+ +AKG+++
Sbjct: 68 GVCTQ---GEP----LYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 599 LHTGIVPGVFSNNLKITD-----ILLDQNLVAKIS 628
L S N D L+ +NLV KIS
Sbjct: 118 LE--------SKNFVHRDLAARNCLVTENLVVKIS 144
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 26/152 (17%)
Query: 485 MGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHH--IELISKLRHRHLVSALGH 541
+G GS G +Y+ + K G VA++ LK + S ++ I ++ +L H ++V
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV----- 61
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT 601
F+D ++L+ EY G L ++S L+ + A+ + +G+++LH
Sbjct: 62 RLIDAFEDKD--HLYLVMEYCEGGDLFDYLSR---GGPLSEDEAKKIALQILRGLEYLH- 115
Query: 602 GIVPGVFSNN-----LKITDILLDQNLVAKIS 628
SN LK +ILLD+N V KI+
Sbjct: 116 -------SNGIIHRDLKPENILLDENGVVKIA 140
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 31/153 (20%)
Query: 486 GEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTR-NFMHHIELISKLRHRHLVSALGHCF 543
GEGS G++Y R K G VAI+ +K KK R + I+++ KL+H ++V +
Sbjct: 8 GEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV----RLY 63
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLT--WTQRISAAIGVAKGIQFLHT 601
+ + D+ ++L+ EY G L + L+ + I +++LH+
Sbjct: 64 DVFEDEDK---LYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQI--LSALEYLHS 115
Query: 602 -GIV-----PGVFSNNLKITDILLDQNLVAKIS 628
GIV P N ILLD++ K++
Sbjct: 116 KGIVHRDLKP---EN------ILLDEDGHVKLA 139
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-12
Identities = 35/85 (41%), Positives = 50/85 (58%)
Query: 136 LNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTL 195
L + + L G IP ++S L LQ++ L N + G +P LGS+ L VL L N FNG++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 196 PDSFSYLENLRVLALSNNHFYGEVP 220
P+S L +LR+L L+ N G VP
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 33/87 (37%), Positives = 49/87 (56%)
Query: 112 LRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRV 171
L L + GL G + IS+L L+ +N+S N + G IP L +TSL+ L L N G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 172 PDWLGSLPILAVLSLRNNMFNGTLPDS 198
P+ LG L L +L+L N +G +P +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-11
Identities = 30/79 (37%), Positives = 47/79 (59%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLI 161
+ KL L+ + L + G + + ++SLE+L++S N NG+IP+ L LTSL+ L
Sbjct: 437 DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN 496
Query: 162 LDENMLAGRVPDWLGSLPI 180
L+ N L+GRVP LG +
Sbjct: 497 LNGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 30/133 (22%), Positives = 56/133 (42%), Gaps = 25/133 (18%)
Query: 485 MGEGSQGQMYRGRLKNG------TFVAIRCLK-MKKCHSTRNFMHHIELISKLRHRHLVS 537
+GEG+ G+++ G + VA++ LK + ++F EL++ +H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTL-----------RSWISEGHAHQSLTWTQRI 586
G C E ++FEY+ +G L S LT +Q +
Sbjct: 73 FYGVCTEG-------DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 587 SAAIGVAKGIQFL 599
A+ +A G+ +L
Sbjct: 126 QIAVQIASGMVYL 138
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 4e-10
Identities = 38/150 (25%), Positives = 72/150 (48%), Gaps = 22/150 (14%)
Query: 486 GEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHST--RNFMHHIELISKLRHRHLVSALGHC 542
G GS G +Y K G +A++ +++ I ++S L+H ++V G
Sbjct: 9 GRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSE 68
Query: 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWI-SEGHAHQSLT--WTQRISAAIGVAKGIQFL 599
+ ++ + IFL EYV G+L S + G + + +T++I +G+ +L
Sbjct: 69 RD---EEKNTLNIFL--EYVSGGSLSSLLKKFGKLPEPVIRKYTRQI------LEGLAYL 117
Query: 600 HT-GIVPGVFSNNLKITDILLDQNLVAKIS 628
H+ GIV ++K +IL+D + V K++
Sbjct: 118 HSNGIVHR----DIKGANILVDSDGVVKLA 143
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 485 MGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
+G G G+++ G KN VAI+ LK ++F ++ + +LRH+HL+S C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-- 71
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWI--SEGHAHQSLTWTQRISAAIGVAKGIQFLHTG 602
S +++I E + G+L +++ EG Q L I A VA+G+ +L
Sbjct: 72 -----SVGEPVYIITELMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEE- 122
Query: 603 IVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+L +IL+ ++LV K++ + L
Sbjct: 123 --QNSIHRDLAARNILVGEDLVCKVADFGL 150
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 39/153 (25%), Positives = 71/153 (46%), Gaps = 23/153 (15%)
Query: 207 VLALSNNHFYGEV-PDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPA 265
+ LS + G++ L Y+Q ++L NN L P + F ++
Sbjct: 73 SIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPD------------DIFTTS--- 117
Query: 266 EVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVD 325
L+ L+LS+N F G P+ S+P++ L++++N L+G++ +D+ L +D
Sbjct: 118 -----SSLRYLNLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD 170
Query: 326 LSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAG 358
L N+L G++PN L + + A N L
Sbjct: 171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQ 203
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 41/159 (25%), Positives = 78/159 (49%), Gaps = 19/159 (11%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHST--RNFMHHIELISKLRHRH 534
A +G+G G + G + VA++CLK ST + F+ +++ LRH +
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYRGQK-VAVKCLK---DDSTAAQAFLAEASVMTTLRHPN 61
Query: 535 LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI-SEGHAHQSLTWTQRISAAIGVA 593
LV LG + ++++ EY+ G+L ++ S G A +T Q++ A+ V
Sbjct: 62 LVQLLGVVL----QGNP---LYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVC 112
Query: 594 KGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+G+++L +L ++L+ ++LVAK+S + L
Sbjct: 113 EGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGL 148
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 485 MGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
+G+G G+++ G T VAI+ LK S F+ +++ KLRH LV
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ------- 65
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIV 604
+ S I+++ EY+ G+L ++ +G + L Q + A +A G+ ++
Sbjct: 66 -LYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER--- 120
Query: 605 PGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640
+L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 13/156 (8%)
Query: 485 MGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
+G+G G+++ G T VAI+ LK F+ +++ KLRH LV
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVP------- 65
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIV 604
+ S I+++ E++ G+L ++ EG + L Q + A +A G+ ++
Sbjct: 66 -LYAVVSEEPIYIVTEFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIER--- 120
Query: 605 PGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640
+L+ +IL+ NLV KI+ + L L E+ E
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 35/124 (28%), Positives = 48/124 (38%), Gaps = 23/124 (18%)
Query: 184 LSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP-DFSGLTYLQVLDLENNALGPQF 242
L L N G +P+ S L +L+ + LS N G +P +T L+VLDL
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDL--------- 473
Query: 243 PKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLP-SITYLN 301
S N F +IP + L+ L+L+ N G P AL N
Sbjct: 474 ------------SYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521
Query: 302 IADN 305
DN
Sbjct: 522 FTDN 525
|
Length = 623 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 17/158 (10%)
Query: 485 MGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
+G G G+++ G T VA++ LK S +F+ +++ KLRH LV +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLV-------Q 65
Query: 545 CYFDDSSVSR--IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTG 602
Y + VS I+++ EY+ G+L ++ +G ++L + A VA G+ ++
Sbjct: 66 LY---AVVSEEPIYIVTEYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIER- 120
Query: 603 IVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640
+L+ +IL+ LV KI+ + L L E+ E
Sbjct: 121 --MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 42/168 (25%), Positives = 75/168 (44%), Gaps = 30/168 (17%)
Query: 485 MGEGSQGQMYRGRL------KNGTFVAIRCLKMKKCHSTRN-FMHHIELISKLRHRHLVS 537
+GEG+ G++Y+G L + T VAI+ LK + F EL+S L+H ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI-------------SEGHAHQSLTWTQ 584
LG C + + ++FEY+ +G L ++ + SL +
Sbjct: 73 LLGVCTK----EQPTC---MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 585 RISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+ AI +A G+++L + +L + L+ + L KIS + L
Sbjct: 126 FLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 30/84 (35%), Positives = 43/84 (51%), Gaps = 3/84 (3%)
Query: 231 LDLENNALGPQFPK---VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPF 287
L L+N L P + L ++ LS N R IP + S L+ LDLS N F G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 288 PQALLSLPSITYLNIADNKLTGKL 311
P++L L S+ LN+ N L+G++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 39/164 (23%), Positives = 76/164 (46%), Gaps = 26/164 (15%)
Query: 485 MGEGSQGQMYRGRLKN------GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSA 538
+GEG+ G+++ N VA++ LK ++ ++F EL++ L+H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI----------SEGHAHQSLTWTQRISA 588
G C E + ++FEY+ +G L ++ +EG+ LT +Q +
Sbjct: 73 YGVCVEG-------DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 589 AIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
A +A G+ +L + +L + L+ +NL+ KI + +
Sbjct: 126 AQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGM 166
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 34/155 (21%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMK--KCHSTRNFMHHIELISKLRHRHLVSALGHC 542
GEG+ GQ+Y+ R K G VA++ ++M+ K + I+L+ KLRH ++V
Sbjct: 8 GEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIV 67
Query: 543 FECYFDDSSVSRIFLIFEYVP---NGTLRS---WISEGH----AHQSLTWTQRISAAIGV 592
I+++FEY+ G L S +E Q L
Sbjct: 68 TSKGKGS-----IYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL------------ 110
Query: 593 AKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKI 627
+G+Q+LH+ G+ ++K ++IL++ + V K+
Sbjct: 111 -EGLQYLHSN---GILHRDIKGSNILINNDGVLKL 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 17/161 (10%)
Query: 485 MGEGSQGQMYRGRL----KNGTFVAIRCLKMKKCHSTR-NFMHHIELISKLRHRHLVSAL 539
+G G G++ RGRL K VAI+ LK R +F+ ++ + H +++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFL 599
G + + +I EY+ NG+L ++ T Q + G+A G+++L
Sbjct: 72 GVV-------TKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYL 122
Query: 600 HTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640
+L +IL++ NLV K+S + L E++E
Sbjct: 123 SE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 16/154 (10%)
Query: 485 MGEGSQGQMYRGR---LKNGTF--VAIRCLK-MKKCHSTRNFMHHIELISKLRHRHLVSA 538
+GEG G++ R L + T VA++ L + +F IE++ L H ++V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQF 598
G C + + LI EY+P+G+LR ++ +L + + + + KG+ +
Sbjct: 72 KGVC-----EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL--KRLLLFSSQICKGMDY 124
Query: 599 LHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
L + +L +IL++ + KIS + L
Sbjct: 125 LGS---QRYIHRDLAARNILVESEDLVKISDFGL 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 485 MGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
+G G G+++ G T VA++ LK S F+ +++ KLRH LV C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVC-- 70
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIV 604
S I+++ EY+ G+L ++ G + L Q + A +A+G+ +L +
Sbjct: 71 -----SEEEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLES--- 121
Query: 605 PGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640
+L +IL+ +NLV KI+ + L L E+ E
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 39/168 (23%), Positives = 74/168 (44%), Gaps = 20/168 (11%)
Query: 478 NFDTSAFMGEGSQGQMYR-GRLKNGTFVA-----IRCLKMKKCHSTRNFMHHIELISKLR 531
+F +G+GS G +Y+ RL + F A + + K+ N I +++ +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN---EIRILASVN 57
Query: 532 HRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRI-SAAI 590
H +++ ++ F D +++ ++ EY P G L IS+ + L Q I I
Sbjct: 58 HPNII-----SYKEAFLDG--NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110
Query: 591 GVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAEN 638
+ +G+Q LH + +LK +ILL N + KI + + +
Sbjct: 111 QLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK 155
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 35/146 (23%), Positives = 75/146 (51%), Gaps = 17/146 (11%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
G+G G++Y+ R + G VAI+ +K++ ++ I+++ K +H ++V G
Sbjct: 9 GKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG---- 64
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISA-AIGVAKGIQFLHT-G 602
Y ++++ E+ G+L+ + +Q+LT +Q I+ + KG+++LH+ G
Sbjct: 65 SYLKK---DELWIVMEFCSGGSLKDLLK--STNQTLTESQ-IAYVCKELLKGLEYLHSNG 118
Query: 603 IVPGVFSNNLKITDILLDQNLVAKIS 628
I+ ++K +ILL + K+
Sbjct: 119 IIHR----DIKAANILLTSDGEVKLI 140
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 52.8 bits (125), Expect = 3e-07
Identities = 32/149 (21%), Positives = 68/149 (45%), Gaps = 14/149 (9%)
Query: 478 NFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLK---MKKCHSTRNFMHHIELISKLRHRH 534
++ +GEGS G++Y R + VA++ L K F+ I++++ L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 535 LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAK 594
+ L F+ ++L+ EYV G+L + + L+ ++ + +
Sbjct: 59 NIVKLYDFFQDE------GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112
Query: 595 GIQFLHTGIVPGVFSNNLKITDILLDQNL 623
+++LH+ G+ ++K +ILLD++
Sbjct: 113 ALEYLHSK---GIIHRDIKPENILLDRDG 138
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 24/150 (16%)
Query: 486 GEGSQGQMYRG-RLKNGTFVAIRCLKM--KKCHSTRNFMHHIELISKLRHRHLVSALGHC 542
G G+ G +Y+G L+ G FVAI+ + + K + ++ M I+L+ L+H ++V +G
Sbjct: 9 GRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS- 67
Query: 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISE-GHAHQSLTWTQRISAAIGVA---KGIQF 598
+ S I L EY NG+LR I + G +SL A+ V +G+ +
Sbjct: 68 ----IETSDSLYIIL--EYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGLAY 114
Query: 599 LHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
LH GV ++K +IL ++ V K++
Sbjct: 115 LHE---QGVIHRDIKAANILTTKDGVVKLA 141
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 31/85 (36%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 160 LILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEV 219
L LD L G +P+ + L L ++L N G +P S + +L VL LS N F G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 220 PDFSG-LTYLQVLDLENNALGPQFP 243
P+ G LT L++L+L N+L + P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 485 MGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
+G G G+++ G T VAI+ LK + S F+ L+ +L+H LV
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLY----- 67
Query: 545 CYFDDSSVSR--IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTG 602
+ V++ I++I EY+ NG+L ++ + LT + I A +A+G+ F+
Sbjct: 68 -----AVVTQEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIE-- 119
Query: 603 IVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640
+L+ +IL+ + L KI+ + L L E+ E
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 28/166 (16%)
Query: 485 MGEGSQGQMYRGRLKN------GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSA 538
+GEG+ G+++ N VA++ LK + ++F EL++ L+H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI------------SEGHAHQSLTWTQRI 586
G C E + ++FEY+ +G L ++ E A LT Q +
Sbjct: 73 YGVCTEG-------RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 587 SAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+ A +A G+ +L + +L + L+ Q LV KI + +
Sbjct: 126 AIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGM 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 20/155 (12%)
Query: 485 MGEGSQGQ--MYRGRLKN---GTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVS 537
+GEG G+ +Y N G VA++ LK ++C +T + I ++ L H ++V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-RECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQ 597
G C + + LI EYVP G+LR ++ + L Q + A + +G+
Sbjct: 71 YKGCC-----SEQGGKGLQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMA 121
Query: 598 FLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+LH+ +L ++LLD + + KI + L
Sbjct: 122 YLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGL 153
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 28/166 (16%)
Query: 485 MGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHST---RNFMHHIELISKL-RHRHLVSAL 539
+GEG+ GQ+ + R+ K+G + +MK+ S R+F +E++ KL H ++++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGH----------AHQS---LTWTQRI 586
G C ++L EY P+G L ++ + A+ + L+ Q +
Sbjct: 75 GAC-------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 587 SAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
A VA+G+ +L +L +IL+ +N VAKI+ + L
Sbjct: 128 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 170
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 41/166 (24%), Positives = 74/166 (44%), Gaps = 28/166 (16%)
Query: 485 MGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHST----RNFMHHIELISKL-RHRHLVSAL 539
+GEG+ GQ+ R +K +KM K ++ R+F +E++ KL H ++++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI-------------SEGHAHQSLTWTQRI 586
G C + +++ EY P G L ++ E +LT Q +
Sbjct: 70 GAC-------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 587 SAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
A VA G+Q+L +L ++L+ +NL +KI+ + L
Sbjct: 123 QFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGL 165
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 39/154 (25%), Positives = 75/154 (48%), Gaps = 23/154 (14%)
Query: 485 MGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHST------RNFMHHIELISKLRHRHLVSA 538
+G+G+ G +Y+G LK T VA+ K C ST R F+ E++ + H ++V
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAV-----KTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQF 598
+G C + I+++ E VP G+L +++ + LT + + ++ A G+++
Sbjct: 58 IGVCVQKQ-------PIYIVMELVPGGSLLTFLRKKKN--RLTVKKLLQMSLDAAAGMEY 108
Query: 599 LHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
L + +L + L+ +N V KIS + +
Sbjct: 109 LES---KNCIHRDLAARNCLVGENNVLKISDFGM 139
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 485 MGEGSQGQMYRGRLK----NGTFVAIRCLKMKKCHSTR-NFMHHIELISKLRHRHLVSAL 539
+G G G++ GRLK VAI+ LK R +F+ ++ + H +++
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFL 599
G + + ++ EY+ NG+L +++ + T Q + G+A G+++L
Sbjct: 72 GVVTKS-------KPVMIVTEYMENGSLDAFLRKHDGQ--FTVIQLVGMLRGIASGMKYL 122
Query: 600 HTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAEN 638
G +L +IL++ NLV K+S + L + E+
Sbjct: 123 SD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 51/175 (29%), Positives = 77/175 (44%), Gaps = 9/175 (5%)
Query: 90 LPLSFS-MDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIP 148
L LSF+ + L L +L L L + L +I LS+LE L++S+N + +
Sbjct: 168 LDLSFNDLSDLPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSII-ELL 225
Query: 149 QELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVL 208
LS L +L L L N L +P+ +G+L L L L NN + S L NLR L
Sbjct: 226 SSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ--ISSISSLGSLTNLREL 282
Query: 209 ALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAI 263
LS N +P + L +L L + KL +++L+ N +
Sbjct: 283 DLSGNSLSNALPL---IALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGE 334
|
Length = 394 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 34/148 (22%), Positives = 66/148 (44%), Gaps = 13/148 (8%)
Query: 485 MGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
+G G G ++ G VAI+ ++ + S +F+ +++ KL H LV G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIV 604
S I L+FE++ +G L ++ + + + V +G+ +L +
Sbjct: 71 -------RSPICLVFEFMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESS-- 119
Query: 605 PGVFSNNLKITDILLDQNLVAKISSYNL 632
V +L + L+ +N V K+S + +
Sbjct: 120 -NVIHRDLAARNCLVGENQVVKVSDFGM 146
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 28/134 (20%), Positives = 59/134 (44%), Gaps = 26/134 (19%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLR---- 531
++ + +G+GS G +Y+ R K G A +KK H + +L+ +L+
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYA-----LKKIHVDGDEEFRKQLLRELKTLRS 55
Query: 532 --HRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAA 589
++V C+ ++ + +S ++ EY+ G+L + + + + A
Sbjct: 56 CESPYVVK----CYGAFYKEGEIS---IVLEYMDGGSLADLLKK-----VGKIPEPVLAY 103
Query: 590 IG--VAKGIQFLHT 601
I + KG+ +LHT
Sbjct: 104 IARQILKGLDYLHT 117
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 35/152 (23%), Positives = 64/152 (42%), Gaps = 21/152 (13%)
Query: 485 MGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
+G G G + G+ + VAI+ +K + S F+ +++ KL H LV G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC-- 68
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAH----QSLTWTQRISAAIGVAKGIQFLH 600
+ I+++ EY+ NG L +++ E Q L + + + + QF+H
Sbjct: 69 -----TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123
Query: 601 TGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+L + L+D K+S + L
Sbjct: 124 ---------RDLAARNCLVDDQGCVKVSDFGL 146
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 41/165 (24%), Positives = 76/165 (46%), Gaps = 36/165 (21%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCL------KMKKCHSTRNFMHHI----E 525
++F +GEGS + + K AI+ L K KK + ++ E
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK-------VKYVKIEKE 53
Query: 526 LISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSL--TWT 583
++++L + L + F+ D+ ++ + + EY PNG L +I + SL T
Sbjct: 54 VLTRLNGHPGIIKLYYTFQ---DEENL---YFVLEYAPNGELLQYI---RKYGSLDEKCT 104
Query: 584 QRISAAIGVAKGIQFLHT-GIVPGVFSNNLKITDILLDQNLVAKI 627
+ +A I +++LH+ GI+ +LK +ILLD+++ KI
Sbjct: 105 RFYAAEI--LLALEYLHSKGII----HRDLKPENILLDKDMHIKI 143
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 485 MGEGSQGQMYRGRLK----NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSAL 539
+G G G++ RGRLK FVAI+ LK R+F+ ++ + H +++
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 540 GHCFECYFDDSSVSR-IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQF 598
G + SR + +I E++ NG L S++ + T Q + G+A G+++
Sbjct: 72 GVV--------TKSRPVMIITEFMENGALDSFLRQNDGQ--FTVIQLVGMLRGIAAGMKY 121
Query: 599 LHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAEN 638
L +L +IL++ NLV K+S + L E+
Sbjct: 122 LSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 30/128 (23%), Positives = 57/128 (44%), Gaps = 19/128 (14%)
Query: 484 FMGEGSQGQMYRGRLKN----GT---FVAIRCLKMKKCHSTR-NFMHHIELISKLRHRHL 535
F+G G+ G++Y G + G+ VA++ L+ + F+ L+S H ++
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 536 VSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQS----LTWTQRISAAIG 591
V LG C ++ ++I E + G L S++ + + LT + + +
Sbjct: 62 VKLLGVCLL---NEP----QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114
Query: 592 VAKGIQFL 599
VAKG +L
Sbjct: 115 VAKGCVYL 122
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 26/86 (30%), Positives = 44/86 (51%)
Query: 254 LSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFD 313
L R IP ++S LQ ++LS N G P +L S+ S+ L+++ N G + +
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 314 DLSCNPELGFVDLSSNLLTGQLPNCL 339
L L ++L+ N L+G++P L
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 34/149 (22%), Positives = 71/149 (47%), Gaps = 15/149 (10%)
Query: 485 MGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
+G G G ++ G+ + VAI+ ++ + S +F+ +++ KL H +LV G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-- 68
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRI-SAAIGVAKGIQFLHTGI 603
+ IF++ EY+ NG L +++ E + T+ + V + +++L +
Sbjct: 69 -----TKQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESN- 119
Query: 604 VPGVFSNNLKITDILLDQNLVAKISSYNL 632
G +L + L+ ++ V K+S + L
Sbjct: 120 --GFIHRDLAARNCLVGEDNVVKVSDFGL 146
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 36/163 (22%), Positives = 71/163 (43%), Gaps = 34/163 (20%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHST----RNFMHHIELISKLR 531
N ++ +GEG+ G + + R K G VAI+ K K+ + + ++++ +LR
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK--KFKESEDDEDVKKTALREVKVLRQLR 58
Query: 532 HRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEG------HAHQSLTWTQR 585
H ++V+ R++L+FEYV TL + A +S W
Sbjct: 59 HENIVNLKEAF-------RRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQ-- 108
Query: 586 ISAAIGVAKGIQFLHT-GIVPGVFSNNLKITDILLDQNLVAKI 627
+ + I + H+ I+ ++K +IL+ ++ V K+
Sbjct: 109 ------LLQAIAYCHSHNII----HRDIKPENILVSESGVLKL 141
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 28/101 (27%), Positives = 44/101 (43%), Gaps = 10/101 (9%)
Query: 471 ELEEATNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISK 529
E E + +G+G+ G +Y R L +AI+ + + + I L S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 530 LRHRHLVSALGHCFECYFDDSSVSRIFLIF-EYVPNGTLRS 569
L+HR++V LG S + F IF E VP G+L +
Sbjct: 62 LKHRNIVQYLGSD--------SENGFFKIFMEQVPGGSLSA 94
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 35/156 (22%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 485 MGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
+G G G+++ G N T VA++ LK S + F+ L+ L+H LV
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLV-------R 65
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIV 604
Y + I++I EY+ G+L ++ + + + I + +A+G+ ++
Sbjct: 66 LYAVVTKEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIER--- 121
Query: 605 PGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640
+L+ ++L+ ++L+ KI+ + L + E+ E
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 37/167 (22%), Positives = 74/167 (44%), Gaps = 29/167 (17%)
Query: 485 MGEGSQGQMYRGR------LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSA 538
+GEG+ G+++ K+ VA++ LK + ++F EL++ L+H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWIS----------EGHAHQS---LTWTQR 585
G C + + ++FEY+ +G L ++ +G Q+ L +Q
Sbjct: 73 YGVCGDG-------DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 586 ISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+ A +A G+ +L + +L + L+ NL+ KI + +
Sbjct: 126 LHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGM 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 7e-05
Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 28/167 (16%)
Query: 484 FMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHST----RNFMHHIELISKL-RHRHLVSA 538
+GEG+ GQ+ + R+K +K K +++ R+F +E++ KL H ++++
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQ-------------SLTWTQR 585
LG C ++L EY P+G L ++ + + +L+ Q
Sbjct: 62 LGAC-------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 586 ISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+ A VA+G+ +L +L +IL+ +N VAKI+ + L
Sbjct: 115 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 158
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 36/155 (23%), Positives = 68/155 (43%), Gaps = 19/155 (12%)
Query: 484 FMGEGSQGQMYRG-RLKNGTFVAIRCLKMKKCHST-----RNFMHHIELISKLRHRHLVS 537
+G GS G +Y G L +G F A++ + + T + I L+SKL+H ++V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQ 597
LG + +++ E VP G+L + + + S + G++
Sbjct: 67 YLG-------TEREEDNLYIFLELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLE 116
Query: 598 FLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+LH ++K +IL+D N V K++ + +
Sbjct: 117 YLHDR---NTVHRDIKGANILVDTNGVVKLADFGM 148
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 8/209 (3%)
Query: 128 SRLSSLEILNMSSNFLNGA--IPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLS 185
S LS L L++ S + + L L L +L L+ N L + + L L L L
Sbjct: 64 SSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELL-ELTNLTSLD 122
Query: 186 LRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKV 245
L NN P NL+ L LS+N L L+ LDL N L +
Sbjct: 123 LDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSDLPKLL 182
Query: 246 GKK--LVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIA 303
L + LS NK +P E+ L+ LDLS+N + +L +L +++ L ++
Sbjct: 183 SNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELS 240
Query: 304 DNKLTGKLFDDLSCNPELGFVDLSSNLLT 332
+NKL L + + L +DLS+N ++
Sbjct: 241 NNKLE-DLPESIGNLSNLETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 36/159 (22%), Positives = 74/159 (46%), Gaps = 25/159 (15%)
Query: 484 FMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRN-FMHHIELISKLRHRHLVSALGHC 542
F+GEG+ + L VA++ L+ + RN F+ I+++S+L++ +++ LG C
Sbjct: 32 FLGEGAPEFDGQPVL-----VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVC 86
Query: 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISA---------AIGVA 593
DD + +I EY+ NG L ++S+ + T I + A+ +A
Sbjct: 87 VS---DDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIA 139
Query: 594 KGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
G+++L + +L + L+ + KI+ + +
Sbjct: 140 SGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGM 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 31/157 (19%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMH---HIELISKLRH 532
++F+ +G GS G++ R K +G + A++ L K + H ++ +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 533 RHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI------SEGHAHQSLTWTQRI 586
LV+ G + DDS+ ++L+ EYVP G L S + E A R
Sbjct: 61 PFLVNLYGS----FQDDSN---LYLVMEYVPGGELFSHLRKSGRFPEPVA--------RF 105
Query: 587 SAAIGVAKGIQFLHT-GIVPGVFSNNLKITDILLDQN 622
AA V +++LH+ IV +LK ++LLD +
Sbjct: 106 YAA-QVVLALEYLHSLDIV----YRDLKPENLLLDSD 137
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 34/150 (22%), Positives = 70/150 (46%), Gaps = 13/150 (8%)
Query: 484 FMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTR-NFMHHIELISKLRHRHLVSALGHC 542
+G+G+ G++++G LK+ T VA++ K + F+ ++ + H ++V +G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTG 602
+ I+++ E VP G S++ + L Q + A+ A G+ +L +
Sbjct: 62 -------TQRQPIYIVMELVPGGDFLSFLRK--KKDELKTKQLVKFALDAAAGMAYLES- 111
Query: 603 IVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+L + L+ +N V KIS + +
Sbjct: 112 --KNCIHRDLAARNCLVGENNVLKISDFGM 139
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 1e-04
Identities = 22/60 (36%), Positives = 29/60 (48%)
Query: 156 SLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHF 215
+L++L L N L LP L VL L N P++FS L +LR L LS N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 41/169 (24%), Positives = 82/169 (48%), Gaps = 30/169 (17%)
Query: 485 MGEGSQGQMYRG-RLKNGTFVAIRCLKMKKCHSTRN----------FMHHIELISKLRHR 533
+G+G+ G++Y + G +A++ +++ + R+ IE + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 534 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISE-GHAHQSLT--WTQRISAAI 590
++V LG FE + S IFL EYVP G++ S + G + L +T++
Sbjct: 69 NIVQYLG--FETTEEYLS---IFL--EYVPGGSIGSCLRTYGRFEEQLVRFFTEQ----- 116
Query: 591 GVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENA 639
V +G+ +LH+ G+ +LK ++L+D + + KIS + + +++
Sbjct: 117 -VLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 39/152 (25%), Positives = 77/152 (50%), Gaps = 19/152 (12%)
Query: 483 AFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHST-RNFMHHIELISKLRHRHLVSALGH 541
+GEG G + +G G VA+ K KC T + F+ +++KL H++LV LG
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAV---KNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWI-SEGHAHQSLTWTQRISAAIGVAKGIQFLH 600
+ ++++ E + G L +++ + G A S+ Q + ++ VA+G+++L
Sbjct: 68 ILH--------NGLYIVMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEYLE 117
Query: 601 TGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+ + +L +IL+ ++ VAK+S + L
Sbjct: 118 S---KKLVHRDLAARNILVSEDGVAKVSDFGL 146
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 4e-04
Identities = 22/60 (36%), Positives = 31/60 (51%)
Query: 272 QLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLL 331
L+ LDLS+NR A LP++ L+++ N LT + S P L +DLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 36/159 (22%), Positives = 68/159 (42%), Gaps = 17/159 (10%)
Query: 485 MGEGSQGQMYRGRLK----NGTFVAIRCLKMKKCHSTRN-FMHHIELISKLRHRHLVSAL 539
+G G G+++RG LK VAI+ LK R F+ ++ + H +++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFL 599
G + +I EY+ NG L ++ + + Q + G+A G+++L
Sbjct: 73 GVV-------TKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYL 123
Query: 600 HTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAEN 638
+L +IL++ NL K+S + L + E+
Sbjct: 124 SD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 30/121 (24%), Positives = 58/121 (47%), Gaps = 13/121 (10%)
Query: 485 MGEGSQGQMYRGRL-----KNGTFVAIRCLKMKKCHS-TRNFMHHIELISKLRHRHLVSA 538
+GEG G++ R G VA++ LK + + + IE++ L H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQF 598
G C + + I LI E++P+G+L+ ++ +L Q++ A+ + KG+ +
Sbjct: 72 KGIC-----TEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDY 124
Query: 599 L 599
L
Sbjct: 125 L 125
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 33/158 (20%), Positives = 68/158 (43%), Gaps = 46/158 (29%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTR--NFMHHIELISKLR-HRHLVSALGH 541
GEG+ ++ + + K G + AI+C+K K S N + I+ + +L H +++ +
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLI-- 64
Query: 542 CFECYFDDSSVSRIFLIFE---------------YVPNGTLRSWISEGHAHQSLTWTQRI 586
E FD + R+ L+FE +P ++S++ +Q L
Sbjct: 65 --EVLFDRKT-GRLALVFELMDMNLYELIKGRKRPLPEKRVKSYM-----YQLL------ 110
Query: 587 SAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV 624
K + +H G+F ++K +IL+ +++
Sbjct: 111 -------KSLDHMHRN---GIFHRDIKPENILIKDDIL 138
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 38/153 (24%), Positives = 73/153 (47%), Gaps = 22/153 (14%)
Query: 485 MGEGSQGQMYRGRLKNGTFVAIRCLK---MKKCHSTRNFMHHIELISKLRHRHLVSALGH 541
+G G G+++ G N T VA++ LK M ++F+ +++ KLRH L+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFL-- 599
C + I+++ E + G+L ++ +G A ++L Q I A VA G+ +L
Sbjct: 70 C-------TLEEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLEA 121
Query: 600 HTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
I +L ++L+ +N + K++ + L
Sbjct: 122 QNYI-----HRDLAARNVLVGENNICKVADFGL 149
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 41/178 (23%), Positives = 72/178 (40%), Gaps = 64/178 (35%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCL------KMKKCHSTRNFMHHIELISK 529
++ +GEGS G + + + K G VAI+ KM K + M I ++ +
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVK----KIAMREIRMLKQ 56
Query: 530 LRHRHLVSALGHCFECYFDDSSVSRIFLIFEYV-----------PNG----TLRSWISEG 574
LRH +LV+ + R++L+FE+V PNG +R ++ +
Sbjct: 57 LRHENLVNLIEVF-------RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQ- 108
Query: 575 HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNL-----KITDILLDQNLVAKI 627
+ +GI+F H S+N+ K +IL+ Q+ V K+
Sbjct: 109 -----------------ILRGIEFCH--------SHNIIHRDIKPENILVSQSGVVKL 141
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.001
Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 19/141 (13%)
Query: 486 GEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMH-HIE--LISKLRHRHLVSALGH 541
G+GS G++ R K+ G A++ LK KK + H E ++S++ H +V
Sbjct: 2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIV----- 56
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT 601
F +++L+ EY P G L S +S+ S + +A I +A +++LH+
Sbjct: 57 KLHYAFQTEE--KLYLVLEYAPGGELFSHLSK-EGRFSEERARFYAAEIVLA--LEYLHS 111
Query: 602 -GIVPGVFSNNLKITDILLDQ 621
GI+ +LK +ILLD
Sbjct: 112 LGIIYR----DLKPENILLDA 128
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 40/162 (24%), Positives = 62/162 (38%), Gaps = 23/162 (14%)
Query: 479 FDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMK------KCHSTRNFMHHIELISKLR 531
F A +G G G++ K G AI+ LK + S E + R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 532 HRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQR-ISAAI 590
H LV+ CF+ + + + EY G L H H + R + A
Sbjct: 61 HPFLVNLFA-CFQ------TEDHVCFVMEYAAGGDLMM-----HIHTDVFSEPRAVFYAA 108
Query: 591 GVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
V G+Q+LH + +LK+ ++LLD KI+ + L
Sbjct: 109 CVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 16/126 (12%)
Query: 483 AFMGEGSQGQMYRGRLKNGT--FVAIRCL-KMKKCHSTRNFMHHIELISKLRHRHLVSAL 539
AF GE +G YRGR + VA++ L + +F+ ++SK H+++V +
Sbjct: 18 AF-GEVYEGL-YRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLI 75
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQ----SLTWTQRISAAIGVAKG 595
G FE + R F++ E + G L+S++ E SLT + A VAKG
Sbjct: 76 GVSFE------RLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 596 IQFLHT 601
++L
Sbjct: 129 CKYLEE 134
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 38/176 (21%)
Query: 485 MGEGSQGQMYRG---RLKNG---TFVAIRCLKMKKCHST-RNFMHHIELISKLRHRHLVS 537
+GEG G++ + RLK T VA++ LK S R+ + L+ ++ H H++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHA--------------------- 576
G C S + LI EY G+LRS++ E
Sbjct: 68 LYGAC-------SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 577 HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
++LT IS A +++G+Q+L + +L ++L+ + KIS + L
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGL 173
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 38/167 (22%), Positives = 64/167 (38%), Gaps = 23/167 (13%)
Query: 487 EGSQGQMYRGRLKNGTFVAIRCLK-MKKCHST--RNFMHHIELISKLRHRHLVSALGHCF 543
E Q +Y+G N V IR K K H + I+ + ++ +++ G
Sbjct: 30 ENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG--- 85
Query: 544 ECYFDDSSVS--RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT 601
+ D R+ LI EY G LR + + + L++ ++ AI KG+ L+
Sbjct: 86 --FIIDIVDDLPRLSLILEYCTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYK 140
Query: 602 GIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPY 648
NL L+ +N KI + L EK+ P+
Sbjct: 141 YT--NKPYKNLTSVSFLVTENYKLKIICHGL-------EKILSSPPF 178
|
Length = 283 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 41/162 (25%), Positives = 72/162 (44%), Gaps = 36/162 (22%)
Query: 485 MGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRH-------RHLV 536
+G GS ++ RLK N A++ +K + H + I+ + +H +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDED----IDWVQTEKHVFEQASSNPFL 58
Query: 537 SALGHCFECYFDDSSVSRIFLIFEYVPNGTL------RSWISEGHAHQSLTWTQRISAAI 590
L CF+ + SR+FL+ EYV G L + + E HA + +A I
Sbjct: 59 VGLHSCFQ------TTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYAAEI 105
Query: 591 GVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+A + FLH G+ +LK+ ++LLD + K++ Y +
Sbjct: 106 CIA--LNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 53/252 (21%), Positives = 84/252 (33%), Gaps = 62/252 (24%)
Query: 105 KLPDLKVLRLVSLGL-WGPLSGKISRL---SSLEILNMSSNFLNGAIPQELSILTSLQTL 160
KL L+VLRL L S L SL+ L +S N G IP+ L
Sbjct: 21 KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNET-GRIPRGL--------- 70
Query: 161 ILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP 220
+ L L L L +N G +
Sbjct: 71 --------QSLLQGLTKGCGLQELDLSDNALGPDGC--------------------GVLE 102
Query: 221 DFSGLTYLQVLDLENNALGPQ--------FPKVGKKLVTMILSKNKF--RSAIPA--EVS 268
+ LQ L L NN LG + + L ++L +N+ S +
Sbjct: 103 SLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162
Query: 269 SYYQLQRLDLSSNRFVGP----FPQALLSLPSITYLNIADNKLT----GKLFDDLSCNPE 320
+ L+ L+L++N + L + ++ L++ +N LT L + L+
Sbjct: 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKS 222
Query: 321 LGFVDLSSNLLT 332
L ++L N LT
Sbjct: 223 LEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 18/153 (11%)
Query: 485 MGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCF 543
+G+GS G+++ LK F AI+ LK M + + R L A H F
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPF 57
Query: 544 ----ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFL 599
C F + +F + EY+ G L I H + A + G+QFL
Sbjct: 58 LTHLYCTF--QTKENLFFVMEYLNGGDLMFHIQSCH---KFDLPRATFYAAEIICGLQFL 112
Query: 600 HTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
H+ G+ +LK+ +ILLD + KI+ + +
Sbjct: 113 HS---KGIVYRDLKLDNILLDTDGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 28/152 (18%), Positives = 69/152 (45%), Gaps = 16/152 (10%)
Query: 485 MGEGSQGQ--MYRGRLKNGTFVAIRCLKMKKCHST--RNFMHHIELISKLRHRHLVSALG 540
+G+G+ G+ +YR R ++ + V + + + + R+ ++ I ++S L+H ++++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH 600
H + DD++ + + EY GTL I Q + + + ++H
Sbjct: 67 H----FMDDNT---LLIEMEYANGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIH 118
Query: 601 TGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
G+ ++K +I L + + K+ + +
Sbjct: 119 KA---GILHRDIKTLNIFLTKAGLIKLGDFGI 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 32/147 (21%), Positives = 73/147 (49%), Gaps = 13/147 (8%)
Query: 485 MGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCF 543
+G+G+ G++Y+ + K G A + ++ K ++M IE+++ H ++V LG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG--- 76
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI 603
Y+D +++++ E+ P G + + + E + LT Q + + +Q+LH+
Sbjct: 77 AFYWD----GKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHS-- 128
Query: 604 VPGVFSNNLKITDILLDQNLVAKISSY 630
+ +LK ++LL + K++ +
Sbjct: 129 -MKIIHRDLKAGNVLLTLDGDIKLADF 154
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 31/152 (20%), Positives = 68/152 (44%), Gaps = 25/152 (16%)
Query: 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMH-HIE--LISKLRHR 533
+ + +G G+ G+++ R + + + A++ + + + + H H E ++ ++ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 534 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLT---WTQRISAAI 590
++ F D ++++ EYVP G L S++ + T + I A
Sbjct: 62 FIIRL----FWTEHDQRF---LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA- 113
Query: 591 GVAKGIQFLHT-GIVPGVFSNNLKITDILLDQ 621
+++LH+ IV +LK +ILLD+
Sbjct: 114 -----LEYLHSKEIV----YRDLKPENILLDK 136
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 659 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.96 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.96 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.96 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.95 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.95 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.95 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.95 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.95 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.95 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.95 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.95 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.95 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.95 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.94 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.94 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.94 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.94 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.94 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.94 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.94 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.94 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.94 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.94 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.94 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.94 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.94 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.94 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.94 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.94 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.94 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.94 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.94 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.94 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.94 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.94 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.94 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.93 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.93 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.93 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.93 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.93 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.93 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.93 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.93 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.93 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.93 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.93 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.93 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.93 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.93 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.93 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.93 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.93 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.93 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.93 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.93 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.93 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.93 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.93 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.93 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.92 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.92 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.92 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.92 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.92 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.92 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.92 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.92 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.92 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.92 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.92 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.92 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.92 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.92 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.92 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.92 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.92 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.92 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.92 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.92 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.92 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.92 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.92 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.92 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.92 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.92 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.92 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.92 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.92 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.92 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.91 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.91 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.91 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.91 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.91 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.91 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.91 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.91 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.91 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.91 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.91 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.91 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.91 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.91 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.91 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.91 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.91 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.91 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.91 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.91 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.91 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.91 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.91 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.91 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.91 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.91 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.91 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.91 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.91 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.91 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.91 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.91 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.91 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.91 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.91 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.91 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.9 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.9 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.9 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.9 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.9 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.9 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.9 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.9 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.9 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.9 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.9 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.9 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.9 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.9 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.9 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.9 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.9 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.9 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.9 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.9 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.9 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.9 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.9 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.9 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.9 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.9 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.9 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.89 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.89 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.89 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.89 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.89 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.89 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.89 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.89 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.89 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.89 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.89 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.89 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.89 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.89 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.89 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.88 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.88 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.88 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.88 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.88 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.88 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.88 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.88 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.88 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.88 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.88 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.88 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.88 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.88 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.88 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.88 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.88 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.87 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.87 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.87 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.87 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.87 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.87 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.87 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.87 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.87 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.86 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.86 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.86 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.86 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.86 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.85 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.85 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.84 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.84 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.82 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.82 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.82 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.81 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.8 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.8 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.79 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.79 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.77 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.77 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.77 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.7 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.7 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.68 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.67 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.66 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.66 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.58 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.57 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.43 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.41 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.12 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.11 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.11 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.08 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.04 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.03 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.03 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.99 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.97 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.97 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.95 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.94 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.93 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.93 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.81 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.72 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.69 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.67 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.61 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.59 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.56 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.54 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.43 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.42 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.35 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.35 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.26 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.2 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.18 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.18 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.18 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.17 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.15 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-68 Score=636.31 Aligned_cols=168 Identities=24% Similarity=0.450 Sum_probs=139.0
Q ss_pred cCHHHHHHhhcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeec
Q 006145 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFEC 545 (659)
Q Consensus 467 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 545 (659)
++++++. ..|...+.||+|+||.||+|+. .+|..||||+++.... ...+|++++++++|||||+++|+|.+
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~- 754 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRS- 754 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEc-
Confidence 4555554 3477889999999999999996 4699999999864332 12356889999999999999999976
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcce
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVA 625 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~ 625 (659)
.+..++|||||++|+|.+++++ ++|.++.+|+.|+|+||+|||+.+.++|+||||||+||++|+++.+
T Consensus 755 ------~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~ 822 (968)
T PLN00113 755 ------EKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEP 822 (968)
T ss_pred ------CCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCce
Confidence 4568999999999999999963 8999999999999999999998878899999999999999999988
Q ss_pred EEccCccccccccccccceecccccccCCCCCC
Q 006145 626 KISSYNLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 626 kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
++. ||.+...... ....+|+.|||||+..
T Consensus 823 ~~~-~~~~~~~~~~---~~~~~t~~y~aPE~~~ 851 (968)
T PLN00113 823 HLR-LSLPGLLCTD---TKCFISSAYVAPETRE 851 (968)
T ss_pred EEE-eccccccccC---CCccccccccCccccc
Confidence 876 6665443221 2346889999999863
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=366.11 Aligned_cols=187 Identities=36% Similarity=0.710 Sum_probs=167.0
Q ss_pred ccccCHHHHHHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeee
Q 006145 464 YRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCF 543 (659)
Q Consensus 464 ~~~~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 543 (659)
.+.|+++++..||++|+..+.||+|+||.||+|.+++|..||||++.....+..++|.+|++++++++|||+|+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 45799999999999999999999999999999999999999999887655321567999999999999999999999998
Q ss_pred eccccCCCCc-eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC
Q 006145 544 ECYFDDSSVS-RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN 622 (659)
Q Consensus 544 ~~~~~~~~~~-~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~ 622 (659)
+ .+ +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.|.|+||||||||+|||+|++
T Consensus 142 e-------~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 142 E-------GGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred c-------CCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 6 34 589999999999999999975333 89999999999999999999999999999999999999999999
Q ss_pred cceEEccCcccccccc-cccccee-cccccccCCCCCC
Q 006145 623 LVAKISSYNLPLLAEN-AEKVGHV-IPYSGSIDPTNSA 658 (659)
Q Consensus 623 ~~~kl~DFGla~~~~~-~~~~~~~-~gt~~y~aPE~~~ 658 (659)
+++||+|||+|+.... ....... .||.+|+||||..
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~ 251 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAS 251 (361)
T ss_pred CCEEccCccCcccCCccccceeeecCCCCccCChhhhc
Confidence 9999999999977754 3333333 8999999999973
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=309.66 Aligned_cols=170 Identities=25% Similarity=0.409 Sum_probs=152.5
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
..+|...+.||+|+||+||+|+++ ++.+||||.+.+.. .+..+-...|+++|++++|||||+++++++. .
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-------~ 81 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-------D 81 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-------C
Confidence 456777888999999999999976 48999999998764 2334568899999999999999999999987 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC------cceE
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN------LVAK 626 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~------~~~k 626 (659)
+.+|||||||.+|||.++++.. ..+++.....++.|+|.||++||++ +||||||||.||||+.. -.+|
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEE
Confidence 6899999999999999999973 4799999999999999999999999 99999999999999864 4689
Q ss_pred EccCccccccccccccceecccccccCCCCCC
Q 006145 627 ISSYNLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 627 l~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|+|||+|+...+.......||++.|||||+.+
T Consensus 156 IADFGfAR~L~~~~~a~tlcGSplYMAPEV~~ 187 (429)
T KOG0595|consen 156 IADFGFARFLQPGSMAETLCGSPLYMAPEVIM 187 (429)
T ss_pred ecccchhhhCCchhHHHHhhCCccccCHHHHH
Confidence 99999999999888889999999999999863
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.68 Aligned_cols=167 Identities=24% Similarity=0.463 Sum_probs=144.3
Q ss_pred CceeccCcCceEEEEEecCCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEE
Q 006145 482 SAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIF 559 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~ 559 (659)
.+.+|+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.+. ....++||
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~------~~~~~iVt 119 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP------PGSLCIVT 119 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC------CCceEEEE
Confidence 35699999999999999744449999997654332 45899999999999999999999999861 22589999
Q ss_pred eccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCC-ccccCCCCCceeecCCc-ceEEccCccccccc
Q 006145 560 EYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPG-VFSNNLKITDILLDQNL-VAKISSYNLPLLAE 637 (659)
Q Consensus 560 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-iiHrDlk~~NILld~~~-~~kl~DFGla~~~~ 637 (659)
|||++|+|.+++++. ....++|..++++|.|||+||.|||++ . ||||||||+|||++.++ ++||+|||+++...
T Consensus 120 Ey~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999863 346799999999999999999999998 5 99999999999999997 99999999998775
Q ss_pred cc-cccceecccccccCCCCCC
Q 006145 638 NA-EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 638 ~~-~~~~~~~gt~~y~aPE~~~ 658 (659)
.. ...+...||+.|||||.+.
T Consensus 196 ~~~~~~~~~~GT~~wMAPEv~~ 217 (362)
T KOG0192|consen 196 ISKTSMTSVAGTYRWMAPEVLR 217 (362)
T ss_pred cccccccCCCCCccccChhhhc
Confidence 54 3445589999999999875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=285.99 Aligned_cols=170 Identities=21% Similarity=0.333 Sum_probs=148.8
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCc-------hHHHHHHHHHHhCCCCCCccceeeeeeeccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHS-------TRNFMHHIELISKLRHRHLVSALGHCFECYF 547 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 547 (659)
.+.|-..+.+|+|+||.|-+|.- ++|+.||||++.++.... .....+|+++|++++|||||++++++..
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~--- 247 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV--- 247 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec---
Confidence 34566778999999999999985 469999999997654221 2335799999999999999999999986
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC---cc
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN---LV 624 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~---~~ 624 (659)
++..|||||||+||+|.+.+-. .+.+.......++.|++.|+.|||+. +|+||||||+|||+..+ ..
T Consensus 248 ----~ds~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~l 317 (475)
T KOG0615|consen 248 ----PDSSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCL 317 (475)
T ss_pred ----CCceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceE
Confidence 5668999999999999999875 34677788899999999999999999 99999999999999755 78
Q ss_pred eEEccCccccccccccccceecccccccCCCCCC
Q 006145 625 AKISSYNLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 625 ~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+||+|||+|+...+.....+.|||+.|.|||+++
T Consensus 318 lKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~ 351 (475)
T KOG0615|consen 318 LKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLA 351 (475)
T ss_pred EEecccchhhccccceehhhhcCCccccChhhee
Confidence 9999999999998888889999999999999975
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=279.01 Aligned_cols=172 Identities=19% Similarity=0.356 Sum_probs=149.7
Q ss_pred cCHHHHHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeee
Q 006145 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFE 544 (659)
Q Consensus 467 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 544 (659)
++.+|+++. +.||+|..|+|||++++ +++.+|+|.+..... ...+++.+|++++++++||+||+++|.|..
T Consensus 76 i~~~dle~~-------~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERL-------GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhh-------hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 456666544 89999999999999976 599999999954432 234789999999999999999999999987
Q ss_pred ccccCCCCc-eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc
Q 006145 545 CYFDDSSVS-RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL 623 (659)
Q Consensus 545 ~~~~~~~~~-~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~ 623 (659)
.. .+.++||||.+|||++++... +.+++...-+||.+|++||.|||+. ..||||||||+|||+...|
T Consensus 149 -------~~~~isI~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskG 216 (364)
T KOG0581|consen 149 -------NGEEISICMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKG 216 (364)
T ss_pred -------CCceEEeehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCC
Confidence 33 599999999999999999863 5689999999999999999999963 3999999999999999999
Q ss_pred ceEEccCccccccccccccceecccccccCCCCCC
Q 006145 624 VAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 624 ~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
++||||||.++...+. .....+||..|||||.+.
T Consensus 217 eVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~ 250 (364)
T KOG0581|consen 217 EVKICDFGVSGILVNS-IANTFVGTSAYMSPERIS 250 (364)
T ss_pred CEEeccccccHHhhhh-hcccccccccccChhhhc
Confidence 9999999999877655 667899999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=287.00 Aligned_cols=170 Identities=22% Similarity=0.367 Sum_probs=148.2
Q ss_pred cCCCCCceeccCcCceEEEEE-ecCCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
+.|+..++||+|.||.||||+ ..+|+.||+|++..+.. ....-..|||.+|++++|||||+|.+...+. ...
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~-----~~~ 191 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK-----LSG 191 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec-----CCc
Confidence 446666899999999999999 55799999999986653 2345678999999999999999999999863 145
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
.+|||+|||++ ||.-++.. +...++..+...++.|++.||+|+|+. +|+|||||.+|||||.+|.+||+|||||
T Consensus 192 siYlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLA 265 (560)
T ss_pred eEEEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccce
Confidence 79999999988 99988874 245799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccc--ccceecccccccCCCCC
Q 006145 634 LLAENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
++++... .++..+.|.||+|||-+
T Consensus 266 r~y~~~~~~~~T~rVvTLWYRpPELL 291 (560)
T KOG0600|consen 266 RFYTPSGSAPYTSRVVTLWYRPPELL 291 (560)
T ss_pred eeccCCCCcccccceEEeeccChHHh
Confidence 9775443 56889999999999965
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=291.40 Aligned_cols=170 Identities=20% Similarity=0.401 Sum_probs=153.6
Q ss_pred cCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
..|...+.||+|||+.||+++. .+|+.||+|++.+.. ....+...+||++.+.++|||||++++||.+ .
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-------s 90 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-------S 90 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-------C
Confidence 5688899999999999999996 779999999997643 2334679999999999999999999999986 6
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+.+|||.|+|++|+|.+++++ .+++++..+..+.+||+.||.|||+. +|||||||-.|+++++++++||+||||
T Consensus 91 ~nVYivLELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGL 164 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGL 164 (592)
T ss_pred CceEEEEEecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccce
Confidence 789999999999999999985 46899999999999999999999999 999999999999999999999999999
Q ss_pred ccccccc-cccceecccccccCCCCCCC
Q 006145 633 PLLAENA-EKVGHVIPYSGSIDPTNSAR 659 (659)
Q Consensus 633 a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 659 (659)
|...+.+ +...+.||||.|+|||++.+
T Consensus 165 At~le~~~Erk~TlCGTPNYIAPEVl~k 192 (592)
T KOG0575|consen 165 ATQLEYDGERKKTLCGTPNYIAPEVLNK 192 (592)
T ss_pred eeeecCcccccceecCCCcccChhHhcc
Confidence 9877644 66788999999999999753
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-33 Score=276.96 Aligned_cols=171 Identities=20% Similarity=0.339 Sum_probs=149.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
-++|+..++||+|+||+||.++.+ +++.+|+|++++... .+.+...+|..+|.+++||.||+++-.+.+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt------- 96 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT------- 96 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc-------
Confidence 456888899999999999999965 599999999987653 234668999999999999999999877765
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+.+|||+||+.||+|+.+|++. ..+++....-++..|+.||.|||+. +||||||||+|||||++|.++|+|||
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccc
Confidence 67899999999999999999863 5688888899999999999999999 99999999999999999999999999
Q ss_pred cccccccc-cccceecccccccCCCCCCC
Q 006145 632 LPLLAENA-EKVGHVIPYSGSIDPTNSAR 659 (659)
Q Consensus 632 la~~~~~~-~~~~~~~gt~~y~aPE~~~~ 659 (659)
|++..... ......|||+.|||||++.+
T Consensus 171 L~k~~~~~~~~t~tfcGT~eYmAPEil~~ 199 (357)
T KOG0598|consen 171 LCKEDLKDGDATRTFCGTPEYMAPEILLG 199 (357)
T ss_pred cchhcccCCCccccccCCccccChHHHhc
Confidence 99855433 44556799999999998753
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=322.17 Aligned_cols=277 Identities=32% Similarity=0.483 Sum_probs=263.5
Q ss_pred CEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCC
Q 006145 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSIL 154 (659)
Q Consensus 75 ~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 154 (659)
+++.|++++|.+.+.+|. .+.++++|+.|+|++|.+.+.+|..++.+++|+.|+|++|.+++.+|..+..+
T Consensus 309 ~L~~L~l~~n~~~~~~~~---------~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~ 379 (968)
T PLN00113 309 NLEILHLFSNNFTGKIPV---------ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379 (968)
T ss_pred CCcEEECCCCccCCcCCh---------hHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCc
Confidence 688999999988776554 56789999999999999999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEc
Q 006145 155 TSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDL 233 (659)
Q Consensus 155 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L 233 (659)
++|+.|++++|.+.+.+|..++.+++|+.|++++|.+++.+|..|.++++|+.|++++|.+++.+|. +..+++|+.|+|
T Consensus 380 ~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 459 (968)
T PLN00113 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL 459 (968)
T ss_pred CCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEEC
Confidence 9999999999999999999999999999999999999999999999999999999999999998886 788999999999
Q ss_pred ccCCCCCCCCCC--CcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcC
Q 006145 234 ENNALGPQFPKV--GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKL 311 (659)
Q Consensus 234 ~~N~l~~~~~~~--~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~ 311 (659)
++|.+.+.+|.. ..+|+.|++++|++++.+|..+.++++|+.|+|++|++.+.+|..+..+++|++|+|++|.++|.+
T Consensus 460 ~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 539 (968)
T PLN00113 460 ARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQI 539 (968)
T ss_pred cCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccC
Confidence 999999988875 478999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccCCCC
Q 006145 312 FDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNE 360 (659)
Q Consensus 312 p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~~~ 360 (659)
|..+..+++|+.|||++|+++|.+|..+..+..++.+++++|.+.+..|
T Consensus 540 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 540 PASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred ChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 9999999999999999999999999999999999999999999998655
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=258.12 Aligned_cols=168 Identities=21% Similarity=0.365 Sum_probs=146.5
Q ss_pred cCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.+|...+.+|+|.||.||+|+. .+|+.||||+++.....+ .....|||+.|+.++|+||+.+++++.. .+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-------~~ 74 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-------KS 74 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-------CC
Confidence 3577789999999999999994 569999999998664322 3568999999999999999999999875 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..-||+|||+. ||+..+++. ...++..+...++.++.+|++|||++ .|+||||||.|+|++++|.+||+|||+|
T Consensus 75 ~l~lVfEfm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 75 NLSLVFEFMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred ceEEEEEeccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccch
Confidence 68899999987 999999863 46799999999999999999999999 9999999999999999999999999999
Q ss_pred cccccc-cccceecccccccCCCCC
Q 006145 634 LLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
+.+.+. ....+.+.|.+|+|||-+
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELL 173 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELL 173 (318)
T ss_pred hccCCCCcccccceeeeeccChHHh
Confidence 887543 334556899999999954
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=274.94 Aligned_cols=167 Identities=19% Similarity=0.391 Sum_probs=141.0
Q ss_pred CCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhC--CCCCCccceeeeeeeccccCCCCceeEE
Q 006145 480 DTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISK--LRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 480 ~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+..++||+|+||.||||++. ++.||||++.... .+.|..|-++.+. ++|+||++++++-..+.. ...+++|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~---~~~eywL 285 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA---DRMEYWL 285 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCc---cccceeE
Confidence 34578999999999999986 5999999997543 4568888777665 589999999987654322 1347899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCC------CCCCccccCCCCCceeecCCcceEEccCc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTG------IVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
|+||.++|+|.+||.. ..++|....+|+..+|+||+|||+. .+|+|+|||||++|||+..|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 9999999999999985 5799999999999999999999975 46899999999999999999999999999
Q ss_pred ccccccccc---ccceecccccccCCCCC
Q 006145 632 LPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
||...+.+. .....+||.+|||||.+
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvL 390 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVL 390 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHH
Confidence 997665433 23458999999999976
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=264.88 Aligned_cols=169 Identities=20% Similarity=0.294 Sum_probs=144.1
Q ss_pred cCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCC-ch-HHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCH-ST-RNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~-~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
+.|+...++|+|+||+||||+.++ |+.||||++...... .. +-.+|||++|+.++|+|+|.|+++|.. ..
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-------kr 74 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-------KR 74 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-------cc
Confidence 346667889999999999999765 999999999654332 22 447899999999999999999999975 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..+||+|||+. ++.+-|.+. ..-++.....+|..|+++|+.|+|++ +||||||||+|||+..++.+|+||||+|
T Consensus 75 klhLVFE~~dh-TvL~eLe~~--p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 75 KLHLVFEYCDH-TVLHELERY--PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFA 148 (396)
T ss_pred eeEEEeeecch-HHHHHHHhc--cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhh
Confidence 78999999987 555555532 23478888999999999999999999 9999999999999999999999999999
Q ss_pred cccc-cccccceecccccccCCCCCC
Q 006145 634 LLAE-NAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 634 ~~~~-~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+... +...++..+-|.||+|||-+.
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLv 174 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLV 174 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhc
Confidence 8876 666778999999999999764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=273.40 Aligned_cols=171 Identities=20% Similarity=0.400 Sum_probs=145.8
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCC--CCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKL--RHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l--~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
..+....+.||+|.||+||+|+++ |+.||||++... +++.+.+|.++.+.+ ||+||+.+++.-.. +..+-.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~---~~gs~T 282 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNK---DNGSWT 282 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhcccc---CCCceE
Confidence 345667899999999999999997 899999999743 356799999998864 99999999987653 223356
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCC-----CCCCccccCCCCCceeecCCcceEEc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTG-----IVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
+++||+||.++|||+|+|.+ ..++-...++++..+|.||+|||.. -.|.|.|||||+.|||+..++.+.|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 89999999999999999986 5799999999999999999999964 36899999999999999999999999
Q ss_pred cCcccccccccc-----ccceecccccccCCCCC
Q 006145 629 SYNLPLLAENAE-----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~~-----~~~~~~gt~~y~aPE~~ 657 (659)
|+|||....... .....+||.+|||||++
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvL 392 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVL 392 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHh
Confidence 999995553332 23678999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-33 Score=265.78 Aligned_cols=176 Identities=18% Similarity=0.331 Sum_probs=147.3
Q ss_pred cCCCCCceeccCcCceEEEEE-ecCCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.+|++.++||+|.||+|||+. +.+|..||.|.++-+.... .++...|+.+|+.++|||||+++++-... +..
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~-----~~e 93 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE-----DNE 93 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc-----cch
Confidence 345667999999999999998 5689999999998554332 35689999999999999999998744321 123
Q ss_pred eeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCC--ccccCCCCCceeecCCcceEEccC
Q 006145 554 RIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPG--VFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiHrDlk~~NILld~~~~~kl~DF 630 (659)
-++||||||..|||.++++.. ..++.+++..+.++..|+++||.++|+. .|+ |+||||||.||+||.+|.+|++||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccc
Confidence 378999999999999999742 2345689999999999999999999994 446 999999999999999999999999
Q ss_pred ccccccccccc-cceecccccccCCCCCC
Q 006145 631 NLPLLAENAEK-VGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 631 Gla~~~~~~~~-~~~~~gt~~y~aPE~~~ 658 (659)
||++....... ....+|||.||+||.+.
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~ 201 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERIH 201 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHHh
Confidence 99998866544 46789999999999763
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=277.97 Aligned_cols=170 Identities=18% Similarity=0.307 Sum_probs=151.6
Q ss_pred hcCCCCCceeccCcCceEEEEE-ecCCcEEEEEEecccCCCchHH--HHHHHHHHhCCC-CCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRN--FMHHIELISKLR-HRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~--~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||.|.||.||+|+ ..+|..||||+++..-.. .++ =+||++.|+++. |||||++.+++.+.
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~------ 81 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDN------ 81 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc------
Confidence 4567778999999999999999 456999999999865433 344 379999999998 99999999999872
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
...+++|||||+. +|+++++++ .+.++......|+.||.+||+|+|.+ ++.|||+||+|||+.....+||+|||
T Consensus 82 ~~~L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 82 DRILYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred CceEeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccc
Confidence 2279999999977 999999864 56899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+|+.......++..+.|.||+|||.+-
T Consensus 156 LARev~SkpPYTeYVSTRWYRAPEvLL 182 (538)
T KOG0661|consen 156 LAREVRSKPPYTEYVSTRWYRAPEVLL 182 (538)
T ss_pred cccccccCCCcchhhhcccccchHHhh
Confidence 999999888999999999999999874
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=262.10 Aligned_cols=170 Identities=21% Similarity=0.344 Sum_probs=147.5
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|+..+.|++|.||.||+|+.+ +++.||+|+++...... .-.-+|||.+|.+++|||||.+..+.... .-+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~-----~~d 150 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS-----NMD 150 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc-----ccc
Confidence 44556699999999999999965 58999999998765221 12468999999999999999999998863 346
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
.+|||||||+. ||..+++.- .+++...+...++.|+++|++|||+. -|+|||||++|+|+.+.|.+||+|||+|
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchh
Confidence 79999999988 999999853 35788999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccc-ccceecccccccCCCCC
Q 006145 634 LLAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
+.+.+.. ..+..+.|.+|+|||.+
T Consensus 225 R~ygsp~k~~T~lVVTLWYRaPELL 249 (419)
T KOG0663|consen 225 REYGSPLKPYTPLVVTLWYRAPELL 249 (419)
T ss_pred hhhcCCcccCcceEEEeeecCHHHh
Confidence 9886653 45889999999999964
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=274.82 Aligned_cols=165 Identities=26% Similarity=0.440 Sum_probs=142.8
Q ss_pred CCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEe
Q 006145 481 TSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 481 ~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
..+.||+|.||+||.|++.....||||.++.... ..++|.+|+++|++++|+|||+++|+|.. .+.+|||||
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-------~~piyIVtE 281 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTK-------QEPIYIVTE 281 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEec-------CCceEEEEE
Confidence 3488999999999999998777999999987643 45789999999999999999999999986 346999999
Q ss_pred ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccccccc
Q 006145 561 YVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640 (659)
Q Consensus 561 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 640 (659)
||+.|+|.++|+. .....+.-.+.+.+|.|||+||+||+++ ++|||||.++|||++++..+||+|||||+...+++
T Consensus 282 ~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 282 YMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred ecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 9999999999996 3346788899999999999999999999 99999999999999999999999999999665544
Q ss_pred cc--ceecccccccCCCCC
Q 006145 641 KV--GHVIPYSGSIDPTNS 657 (659)
Q Consensus 641 ~~--~~~~gt~~y~aPE~~ 657 (659)
.. ....-...|.|||-+
T Consensus 358 Y~~~~~~kfPIkWtAPEa~ 376 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEAL 376 (468)
T ss_pred eeecCCCCCCceecCHHHH
Confidence 32 222334579999965
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=251.13 Aligned_cols=167 Identities=22% Similarity=0.356 Sum_probs=148.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+....+|.|+||+|..++.+ +|..+|+|.++++..- ..+....|.++|+.+.||.++++.+-|.+ .
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-------~ 116 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-------N 116 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-------C
Confidence 45667799999999999999966 5999999999876533 33457899999999999999999998876 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..||||||++||.|++++++. +.++.+...-+|.+|+.|++|||+. .|++||+||+|||||.+|.+||+|||+
T Consensus 117 ~~lymvmeyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGF 190 (355)
T KOG0616|consen 117 SNLYMVMEYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGF 190 (355)
T ss_pred CeEEEEEeccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccc
Confidence 6799999999999999999973 5699999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|+....- +-..||||.|+|||.+.
T Consensus 191 AK~v~~r--T~TlCGTPeYLAPEii~ 214 (355)
T KOG0616|consen 191 AKRVSGR--TWTLCGTPEYLAPEIIQ 214 (355)
T ss_pred eEEecCc--EEEecCCccccChHHhh
Confidence 9877543 56789999999999863
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=262.00 Aligned_cols=168 Identities=24% Similarity=0.376 Sum_probs=153.0
Q ss_pred cCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchH---HHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTR---NFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~---~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.+|...+.||+|.||.|-+|.. ..|+.||||.+++...++.+ .+.+||++|+.++||||++++.+|.. .
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-------k 125 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-------K 125 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-------C
Confidence 4566678999999999999985 56999999999887766554 47899999999999999999999875 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+.+.+||||..+|+|++|+.+. ..|++.....+++||..|+.|+|.+ +++|||||.+|||+|+++++||+||||
T Consensus 126 dKIvivMEYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGL 199 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGL 199 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccch
Confidence 6799999999999999999873 5799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+-++........+||++-|.+||..
T Consensus 200 SNly~~~kfLqTFCGSPLYASPEIv 224 (668)
T KOG0611|consen 200 SNLYADKKFLQTFCGSPLYASPEIV 224 (668)
T ss_pred hhhhccccHHHHhcCCcccCCcccc
Confidence 9998888888999999999999975
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=261.48 Aligned_cols=172 Identities=19% Similarity=0.357 Sum_probs=143.8
Q ss_pred HHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--------------chHHHHHHHHHHhCCCCCCccc
Q 006145 473 EEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--------------STRNFMHHIELISKLRHRHLVS 537 (659)
Q Consensus 473 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--------------~~~~~~~Ei~~l~~l~H~niv~ 537 (659)
.+..++|...+.||+|.||+|-+|+.. +++.||||++.+.... ..+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345678999999999999999999954 5999999999643211 1257889999999999999999
Q ss_pred eeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCC-CCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCc
Q 006145 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQS-LTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITD 616 (659)
Q Consensus 538 l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~N 616 (659)
|+++..+ +..+.+|||+|||..|.+...=. ..+ ++..+..+|.+++..||+|||.+ +||||||||+|
T Consensus 173 LiEvLDD-----P~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsN 240 (576)
T KOG0585|consen 173 LIEVLDD-----PESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSN 240 (576)
T ss_pred EEEeecC-----cccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhh
Confidence 9998765 33577999999999988875322 234 99999999999999999999999 99999999999
Q ss_pred eeecCCcceEEccCcccccc------ccccccceecccccccCCCC
Q 006145 617 ILLDQNLVAKISSYNLPLLA------ENAEKVGHVIPYSGSIDPTN 656 (659)
Q Consensus 617 ILld~~~~~kl~DFGla~~~------~~~~~~~~~~gt~~y~aPE~ 656 (659)
+|++++|++||+|||.+... +........+|||.|||||-
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~ 286 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL 286 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence 99999999999999998655 22233456899999999995
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=281.34 Aligned_cols=173 Identities=24% Similarity=0.422 Sum_probs=146.3
Q ss_pred hhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYF 547 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 547 (659)
.+.+....+.||+|.||+||+|+.. +.+.||||.++..... ...+|.||+++++.++|||||+|+|+|.+
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~--- 560 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE--- 560 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc---
Confidence 3444556689999999999999943 3568999999877654 45789999999999999999999999987
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCCC-----------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCc
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGHA-----------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITD 616 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~N 616 (659)
.+..|||+|||..|||.++|+...+ ..+|+..+.+.||.|||.||+||-++ .+|||||.++|
T Consensus 561 ----~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRN 633 (774)
T KOG1026|consen 561 ----GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRN 633 (774)
T ss_pred ----CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhh
Confidence 5679999999999999999974211 23489999999999999999999998 99999999999
Q ss_pred eeecCCcceEEccCcccccccccccc---ceecccccccCCCCC
Q 006145 617 ILLDQNLVAKISSYNLPLLAENAEKV---GHVIPYSGSIDPTNS 657 (659)
Q Consensus 617 ILld~~~~~kl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~ 657 (659)
+|+.++..+||+|||+++..-....+ ....-..+|||||-+
T Consensus 634 CLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI 677 (774)
T KOG1026|consen 634 CLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI 677 (774)
T ss_pred ceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHh
Confidence 99999999999999999876544333 245567799999954
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=257.40 Aligned_cols=171 Identities=22% Similarity=0.378 Sum_probs=145.3
Q ss_pred CCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
++...+.||+|+||.||++...+ |...|||.+........+.+.+|+++|++++|||||+.+|...... ...++
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~-----~~~~~ 92 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE-----NDEYN 92 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc-----CeeeE
Confidence 35567899999999999999654 9999999997664333567899999999999999999999754310 12589
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC-CcceEEccCccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ-NLVAKISSYNLPLL 635 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~ 635 (659)
+.|||+++|+|.+++.+..+ .++.....++++||++||+|||++ +||||||||+|||++. ++.+||+|||+++.
T Consensus 93 i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 99999999999999986432 699999999999999999999998 9999999999999999 79999999999976
Q ss_pred ccc----ccccceecccccccCCCCCC
Q 006145 636 AEN----AEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 636 ~~~----~~~~~~~~gt~~y~aPE~~~ 658 (659)
... ........||+.|||||+..
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~ 194 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIR 194 (313)
T ss_pred cccccccccccccccCCccccCchhhc
Confidence 653 22235689999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=267.13 Aligned_cols=167 Identities=19% Similarity=0.356 Sum_probs=148.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|...+.||+|+||.||||+.+ +.+.||+|.+.+.... +.+...+|++++++++|||||.++++|.. ..
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-------~~ 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-------SA 74 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-------cc
Confidence 56778899999999999999965 5899999999766543 34678999999999999999999999976 57
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
+.++|.||+.+ +|+.+|... ..+++.....|+.++..||.|||+. +|+|||+||.|||++..+.+|++|||+|
T Consensus 75 ~~~vVte~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 75 HLWVVTEYAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLA 147 (808)
T ss_pred eEEEEehhhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhh
Confidence 89999999987 999999863 5699999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccc-cceecccccccCCCCC
Q 006145 634 LLAENAEK-VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~-~~~~~gt~~y~aPE~~ 657 (659)
+.+..... .+...|||.|||||..
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv 172 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELV 172 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHH
Confidence 98765443 4678899999999965
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=267.39 Aligned_cols=172 Identities=20% Similarity=0.343 Sum_probs=150.8
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC----C-CchHHHHHHHHHHhCCC-CCCccceeeeeeecc
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK----C-HSTRNFMHHIELISKLR-HRHLVSALGHCFECY 546 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 546 (659)
.....|...+.||+|+||+||.|+.. +|..||||.+.... . ...+...+|+.++++++ ||||++++.++..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-- 91 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-- 91 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--
Confidence 34567888999999999999999854 68999999776541 1 12345678999999999 9999999999986
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC-cce
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN-LVA 625 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~-~~~ 625 (659)
....|+||||+.+|+|++++.+ ...+.+....+++.|++.|++|+|+. +|+||||||+|||+|.+ +++
T Consensus 92 -----~~~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~ 160 (370)
T KOG0583|consen 92 -----PTKIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNL 160 (370)
T ss_pred -----CCeEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCE
Confidence 5569999999999999999986 35688899999999999999999998 99999999999999999 999
Q ss_pred EEccCcccccc-ccccccceecccccccCCCCCC
Q 006145 626 KISSYNLPLLA-ENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 626 kl~DFGla~~~-~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
||+|||++... .........+||+.|+|||.+.
T Consensus 161 Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~ 194 (370)
T KOG0583|consen 161 KLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLS 194 (370)
T ss_pred EEeccccccccCCCCCcccCCCCCcccCCHHHhC
Confidence 99999999888 4666778899999999999874
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=253.86 Aligned_cols=176 Identities=20% Similarity=0.358 Sum_probs=146.4
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCC-ccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRH-LVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~~~~ 552 (659)
..|+..++||+|+||+||+|+.+ +|+.||+|++.....+ -.....+|+.+|++++|+| ||.|++++..... ....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~-~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN-HRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc-cccc
Confidence 34555678999999999999954 6999999999765432 2355789999999999999 9999999986332 1223
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCC-CCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAH-QSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
...++||||+.. +|.+++...... ..++......++.|+++||+|||++ +|+||||||.|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 478999999977 999999863221 3466678999999999999999999 99999999999999999999999999
Q ss_pred cccccc-cccccceecccccccCCCCC
Q 006145 632 LPLLAE-NAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~-~~~~~~~~~gt~~y~aPE~~ 657 (659)
+|+... +....++.++|.+|+|||.+
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvL 192 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVL 192 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHh
Confidence 998765 44457889999999999975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=265.12 Aligned_cols=170 Identities=19% Similarity=0.386 Sum_probs=150.4
Q ss_pred hcCCCCCceeccCcCceEEEEE-ecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
...|..-..||+|+.|.||.|+ ..+++.||||++........+-..+|+.+|+..+|+|||.+++.|.. .++
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-------~de 344 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV-------GDE 344 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc-------cce
Confidence 3456667899999999999998 45699999999987765555668999999999999999999998876 467
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
+|+|||||++|+|.+.+.. ..+++.+...|++++++||+|||.. +|||||||++|||++.++.+||+|||++.
T Consensus 345 LWVVMEym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred eEEEEeecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence 9999999999999999875 4699999999999999999999999 99999999999999999999999999997
Q ss_pred cccccc-ccceecccccccCCCCCCC
Q 006145 635 LAENAE-KVGHVIPYSGSIDPTNSAR 659 (659)
Q Consensus 635 ~~~~~~-~~~~~~gt~~y~aPE~~~~ 659 (659)
.+.... .-...+||++|||||++.|
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtr 443 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTR 443 (550)
T ss_pred ccccccCccccccCCCCccchhhhhh
Confidence 775544 4467899999999998754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=267.53 Aligned_cols=178 Identities=22% Similarity=0.384 Sum_probs=150.7
Q ss_pred cCHHHHHHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeee
Q 006145 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFE 544 (659)
Q Consensus 467 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 544 (659)
.+.+++....+.+...+.||+|.||+||||++. ..||||.+......+ .++|+.|+.++++-||.||+-+.|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 444666667777778899999999999999985 369999998776543 4679999999999999999999999985
Q ss_pred ccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc
Q 006145 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV 624 (659)
Q Consensus 545 ~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~ 624 (659)
....+|+-+|+|-+|+.++|-. ...++-.+.+.||.|||+||.|||.+ +|||||||+.||+++++++
T Consensus 460 --------p~~AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~k 526 (678)
T KOG0193|consen 460 --------PPLAIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLK 526 (678)
T ss_pred --------CceeeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCc
Confidence 3359999999999999999953 25688899999999999999999999 9999999999999999999
Q ss_pred eEEccCccccccc---cccccceecccccccCCCCCCC
Q 006145 625 AKISSYNLPLLAE---NAEKVGHVIPYSGSIDPTNSAR 659 (659)
Q Consensus 625 ~kl~DFGla~~~~---~~~~~~~~~gt~~y~aPE~~~~ 659 (659)
+||+||||+.... .........|..-|||||++++
T Consensus 527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRm 564 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRM 564 (678)
T ss_pred EEEecccceeeeeeeccccccCCCccchhhhcHHHHhh
Confidence 9999999994432 2233344567788999998753
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=254.08 Aligned_cols=170 Identities=22% Similarity=0.303 Sum_probs=141.7
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
.|...+++|.|+||.||+|++. +++.||||++..+.... -+|+++|++++|||||+|.-++...... +.-...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~--d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTES--DEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCC--chhHHH
Confidence 3556789999999999999966 47999999997544322 3799999999999999999888753221 122456
Q ss_pred EEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC-cceEEccCcccc
Q 006145 557 LIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN-LVAKISSYNLPL 634 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla~ 634 (659)
+||||||. +|++.++.. ..+..++-....-++.|+.+||+|||+. +|+||||||.|+|+|.+ +.+||||||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999998 999998731 1235677778889999999999999997 99999999999999966 999999999999
Q ss_pred ccccccccceecccccccCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.....+.....+.|..|+|||-+
T Consensus 175 ~L~~~epniSYicSRyYRaPELi 197 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELI 197 (364)
T ss_pred eeccCCCceeEEEeccccCHHHH
Confidence 99888888889999999999965
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=243.24 Aligned_cols=170 Identities=19% Similarity=0.368 Sum_probs=151.2
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC----c----hHHHHHHHHHHhCC-CCCCccceeeeeee
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH----S----TRNFMHHIELISKL-RHRHLVSALGHCFE 544 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----~----~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 544 (659)
..+.|...+++|+|..++|-++..+ +|++.|+|++...... . .++-.+|+.+|+++ .||+|+++.++|.+
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456788899999999999998865 5899999999654321 1 14567899999998 59999999999986
Q ss_pred ccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc
Q 006145 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV 624 (659)
Q Consensus 545 ~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~ 624 (659)
+...++|+|.|+.|.|+++|.+ ...+++....+|++|+.+|++|||.. .|||||+||+|||+|++.+
T Consensus 95 -------~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~ 161 (411)
T KOG0599|consen 95 -------DAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMN 161 (411)
T ss_pred -------cchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccc
Confidence 4568999999999999999986 46799999999999999999999999 9999999999999999999
Q ss_pred eEEccCccccccccccccceecccccccCCCCC
Q 006145 625 AKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 ~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+||+|||+|...+.++.....||||+|+|||.+
T Consensus 162 i~isDFGFa~~l~~GekLrelCGTPgYLAPEti 194 (411)
T KOG0599|consen 162 IKISDFGFACQLEPGEKLRELCGTPGYLAPETI 194 (411)
T ss_pred eEEeccceeeccCCchhHHHhcCCCcccChhhe
Confidence 999999999999999999999999999999975
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=236.88 Aligned_cols=170 Identities=23% Similarity=0.364 Sum_probs=148.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|+..+.||+|.||.||.|+.+ ++-.||+|++.+... +-.+++.+|+++-+.++||||++++||+.+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd------- 93 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD------- 93 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-------
Confidence 356778899999999999999965 588999999965432 335789999999999999999999999987
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....||++||.++|+++..|++. ....++......++.|+|.|+.|+|.. +||||||||+|+|++.++..||+|||
T Consensus 94 ~~riyLilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCC
Confidence 56799999999999999999853 235688888899999999999999998 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
-+.... ...-...|||.-|.+||-.
T Consensus 170 wsV~~p-~~kR~tlcgt~dyl~pEmv 194 (281)
T KOG0580|consen 170 WSVHAP-SNKRKTLCGTLDYLPPEMV 194 (281)
T ss_pred ceeecC-CCCceeeecccccCCHhhc
Confidence 987665 3345678999999999953
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=250.25 Aligned_cols=172 Identities=17% Similarity=0.358 Sum_probs=147.8
Q ss_pred hcCCCCCceeccCcCceEEEEE-ecCCcEEEEEEecccCCCc-hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHS-TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.+.|...+.||.|..++||+|+ .+.+..||||++..+.... ..+..+|+..|+.++||||++++..|.. ..
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-------~~ 97 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-------DS 97 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-------cc
Confidence 4668888999999999999999 4568999999998776544 4789999999999999999999887765 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
.+|+||.||.+|++.+++...-+ .-+++.....|.+++++||.|||++ +.||||||+.|||||++|.+||+|||..
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceee
Confidence 79999999999999999986322 3488999999999999999999999 9999999999999999999999999976
Q ss_pred -ccccccccc----ceecccccccCCCCCC
Q 006145 634 -LLAENAEKV----GHVIPYSGSIDPTNSA 658 (659)
Q Consensus 634 -~~~~~~~~~----~~~~gt~~y~aPE~~~ 658 (659)
.+.+.+... ...+||+.|||||+++
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~ 203 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLM 203 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhh
Confidence 333333222 5569999999999965
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=267.53 Aligned_cols=167 Identities=25% Similarity=0.417 Sum_probs=144.1
Q ss_pred CCCceeccCcCceEEEEEecC----CcEEEEEEecccCCCc-hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 480 DTSAFMGEGSQGQMYRGRLKN----GTFVAIRCLKMKKCHS-TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 480 ~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++++||.|.||.||+|+++. ...||||.++....+. .++|+.|+.||++++||||++|.|+... ...
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-------s~P 704 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-------SKP 704 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-------Cce
Confidence 455889999999999999763 4579999999887654 4679999999999999999999999975 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
+++|+|||+||+|..+|+... ..++|.+...+.++||.||.||.+. +.|||||.++|||++.+..+||+||||++
T Consensus 705 vMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccccee
Confidence 899999999999999999653 4599999999999999999999998 99999999999999999999999999999
Q ss_pred ccccccc-cceec---ccccccCCCCCC
Q 006145 635 LAENAEK-VGHVI---PYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~~~~~~-~~~~~---gt~~y~aPE~~~ 658 (659)
..+++.. ..... -..+|-|||-++
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa 807 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIA 807 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhh
Confidence 8865542 22222 235799999764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=259.49 Aligned_cols=172 Identities=23% Similarity=0.349 Sum_probs=146.4
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCC-CCCCccceeeeeeecccc
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKL-RHRHLVSALGHCFECYFD 548 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 548 (659)
+...+|...+.||+|+|++||+|+.. +++++|||++.+...- ..+-..+|-++|.+| .||.||+|+--+.+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD---- 145 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD---- 145 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec----
Confidence 34567888899999999999999954 5999999999765432 223467888899999 89999999877765
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
...+|+|+||++||+|.++|++. ..++......+|.+|+.||+|||++ +||||||||+|||+|+||++||+
T Consensus 146 ---~~sLYFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikIT 216 (604)
T KOG0592|consen 146 ---EESLYFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKIT 216 (604)
T ss_pred ---ccceEEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEe
Confidence 45799999999999999999863 5699999999999999999999999 99999999999999999999999
Q ss_pred cCcccccccccccc--------------ceecccccccCCCCCC
Q 006145 629 SYNLPLLAENAEKV--------------GHVIPYSGSIDPTNSA 658 (659)
Q Consensus 629 DFGla~~~~~~~~~--------------~~~~gt~~y~aPE~~~ 658 (659)
|||-|+.+.+.... ...+||..|.+||.+.
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~ 260 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN 260 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhc
Confidence 99999877432111 4589999999999874
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=256.19 Aligned_cols=172 Identities=19% Similarity=0.353 Sum_probs=145.4
Q ss_pred hhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCch-HHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHST-RNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~-~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
+++.....++||+|.||.|..|....+..||||.++....... ++|.+||++|.+++|||||+|+|+|.. .+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-------De 608 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-------DD 608 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-------CC
Confidence 4455666789999999999999988789999999987765544 789999999999999999999999986 46
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
.+++|+|||++|+|.+++.++.. ....-...++||.|||.||+||.+. ++||||+.++|+|+|.++++||+|||.+
T Consensus 609 PicmI~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence 78999999999999999986422 2244556788999999999999998 9999999999999999999999999999
Q ss_pred ccccccccc---ceecccccccCCCCC
Q 006145 634 LLAENAEKV---GHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~~---~~~~gt~~y~aPE~~ 657 (659)
+-.-....+ +..+-...|||||-+
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsi 711 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESI 711 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHH
Confidence 844333222 445677899999953
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-29 Score=262.76 Aligned_cols=176 Identities=20% Similarity=0.367 Sum_probs=145.7
Q ss_pred HHHHHhhcCCCCCceeccCcCceEEEEEecC--C--cE-EEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeee
Q 006145 470 EELEEATNNFDTSAFMGEGSQGQMYRGRLKN--G--TF-VAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGH 541 (659)
Q Consensus 470 ~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~--g--~~-vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~ 541 (659)
+.++...++....++||+|+||.||+|++.. + .. ||||..+... .....+|++|+++|+.++|||||+++|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3444455566667999999999999999763 2 23 8999987522 3345789999999999999999999999
Q ss_pred eeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC
Q 006145 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ 621 (659)
Q Consensus 542 ~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~ 621 (659)
+.. ...+|+|||+|.||+|.++|+... ..++..++..++.++|+||+|||++ ++|||||.++|+|++.
T Consensus 230 a~~-------~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~ 297 (474)
T KOG0194|consen 230 AVL-------EEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSK 297 (474)
T ss_pred EcC-------CCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecC
Confidence 986 567999999999999999999632 3699999999999999999999999 9999999999999999
Q ss_pred CcceEEccCccccccccccccc-eecccccccCCCCC
Q 006145 622 NLVAKISSYNLPLLAENAEKVG-HVIPYSGSIDPTNS 657 (659)
Q Consensus 622 ~~~~kl~DFGla~~~~~~~~~~-~~~gt~~y~aPE~~ 657 (659)
++.+||+|||+++......... ...-...|+|||-+
T Consensus 298 ~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl 334 (474)
T KOG0194|consen 298 KGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETL 334 (474)
T ss_pred CCeEEeCccccccCCcceeeccccccCcceecChhhh
Confidence 9999999999987664222222 23466789999965
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=251.64 Aligned_cols=147 Identities=19% Similarity=0.338 Sum_probs=131.8
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
..++|+....||+|+||.||.|+-+ +|..+|+|++++... ...+..+.|-.+|...++|.||+|+-.+.+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD------ 212 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD------ 212 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC------
Confidence 4578889999999999999999965 599999999986543 334568899999999999999999977765
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+.+||||||+||||+..+|.+ ...|+......++.+.+-|++-+|.. ++|||||||+|+|||..|++|++||
T Consensus 213 -~~~LYLiMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 213 -KEYLYLIMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred -CCeeEEEEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccc
Confidence 6789999999999999999986 35788888999999999999999999 9999999999999999999999999
Q ss_pred cccc
Q 006145 631 NLPL 634 (659)
Q Consensus 631 Gla~ 634 (659)
||+.
T Consensus 286 GLs~ 289 (550)
T KOG0605|consen 286 GLST 289 (550)
T ss_pred cccc
Confidence 9983
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=248.92 Aligned_cols=169 Identities=20% Similarity=0.267 Sum_probs=144.4
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
|...+.||+|+||+||+|... +|+.||||.+..... .....+.+|++++++++|+||+++++++.+ .+.
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-------~~~ 74 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-------KDA 74 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-------CCe
Confidence 667789999999999999964 699999999865432 223458899999999999999999998875 457
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 75 ~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~ 150 (285)
T cd05631 75 LCLVLTIMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence 89999999999999887642 224689999999999999999999998 99999999999999999999999999998
Q ss_pred ccccccccceecccccccCCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
............||..|||||+..
T Consensus 151 ~~~~~~~~~~~~g~~~y~aPE~~~ 174 (285)
T cd05631 151 QIPEGETVRGRVGTVGYMAPEVIN 174 (285)
T ss_pred EcCCCCeecCCCCCCCccCHhhhc
Confidence 765444445678999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=256.51 Aligned_cols=174 Identities=21% Similarity=0.360 Sum_probs=141.5
Q ss_pred hhcCCCCCceeccCcCceEEEEEe------cCCcEEEEEEecccCCC-chHHHHHHHHHHhCC-CCCCccceeeeeeecc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRL------KNGTFVAIRCLKMKKCH-STRNFMHHIELISKL-RHRHLVSALGHCFECY 546 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 546 (659)
+.++|...+.||+|+||.||+|+. .+++.||||+++..... ..+.+.+|++++.++ +|||||+++|+|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 356788889999999999999974 23578999999754322 235799999999999 899999999998641
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCC--------------------------------------------------
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHA-------------------------------------------------- 576 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------------------------------------------- 576 (659)
....++||||+++|+|.++++....
T Consensus 84 -----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 84 -----NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 3457999999999999999874210
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccccc---cce
Q 006145 577 ---------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEK---VGH 644 (659)
Q Consensus 577 ---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~---~~~ 644 (659)
...+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++....... ...
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 235 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccC
Confidence 13488899999999999999999998 999999999999999999999999999976532211 233
Q ss_pred ecccccccCCCCC
Q 006145 645 VIPYSGSIDPTNS 657 (659)
Q Consensus 645 ~~gt~~y~aPE~~ 657 (659)
..++..|||||+.
T Consensus 236 ~~~~~~y~aPE~~ 248 (338)
T cd05102 236 ARLPLKWMAPESI 248 (338)
T ss_pred CCCCccccCcHHh
Confidence 4567789999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=257.89 Aligned_cols=147 Identities=18% Similarity=0.295 Sum_probs=129.8
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||+||+|+.. +++.||||+++.... .....+.+|++++.+++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-------~ 73 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-------K 73 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-------C
Confidence 46888899999999999999865 589999999975432 223568899999999999999999998875 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...|+||||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 74 LNLYLIMEFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred CeEEEEEcCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccC
Confidence 6789999999999999999752 4689999999999999999999998 999999999999999999999999999
Q ss_pred cccc
Q 006145 633 PLLA 636 (659)
Q Consensus 633 a~~~ 636 (659)
++..
T Consensus 148 a~~~ 151 (363)
T cd05628 148 CTGL 151 (363)
T ss_pred cccc
Confidence 8654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=251.44 Aligned_cols=163 Identities=18% Similarity=0.286 Sum_probs=139.8
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLI 558 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV 558 (659)
+.||+|+||.||+|+.. +|+.||||+++.... .....+.+|++++++++||||+++++++.. .+..++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-------~~~~~lv 73 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-------HDRLCFV 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-------CCEEEEE
Confidence 46899999999999965 599999999975432 223568899999999999999999998875 5678999
Q ss_pred EeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc-
Q 006145 559 FEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE- 637 (659)
Q Consensus 559 ~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~- 637 (659)
|||+++|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 74 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 147 (323)
T cd05571 74 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence 999999999999875 24689999999999999999999998 99999999999999999999999999997542
Q ss_pred cccccceecccccccCCCCCC
Q 006145 638 NAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 638 ~~~~~~~~~gt~~y~aPE~~~ 658 (659)
........+||+.|||||+..
T Consensus 148 ~~~~~~~~~gt~~y~aPE~~~ 168 (323)
T cd05571 148 DGATMKTFCGTPEYLAPEVLE 168 (323)
T ss_pred CCCcccceecCccccChhhhc
Confidence 223345578999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=254.99 Aligned_cols=165 Identities=23% Similarity=0.396 Sum_probs=144.2
Q ss_pred cCHHHHHHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeecc
Q 006145 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECY 546 (659)
Q Consensus 467 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 546 (659)
+.++++.. .+-+|+|+.|.||+|++. ++.||||+++..+ +.+|+.|++++|+||+.+.|+|..
T Consensus 121 iPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq-- 183 (904)
T KOG4721|consen 121 IPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ-- 183 (904)
T ss_pred CCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC--
Confidence 45555543 478999999999999997 7899999986433 257899999999999999999975
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceE
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAK 626 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~k 626 (659)
...+|||||||+.|-|+++|+. ...++....+.+..+||.||.|||.+ .|||||||+-||||..+..+|
T Consensus 184 -----sPcyCIiMEfCa~GqL~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 184 -----SPCYCIIMEFCAQGQLYEVLKA---GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred -----CceeEEeeeccccccHHHHHhc---cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEE
Confidence 4568999999999999999986 35688888999999999999999998 999999999999999999999
Q ss_pred EccCccccccccccccceecccccccCCCCCCC
Q 006145 627 ISSYNLPLLAENAEKVGHVIPYSGSIDPTNSAR 659 (659)
Q Consensus 627 l~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~ 659 (659)
|+|||-++...+....-.++||..|||||++++
T Consensus 253 IsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrn 285 (904)
T KOG4721|consen 253 ISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRN 285 (904)
T ss_pred eccccchHhhhhhhhhhhhhhhHhhhCHHHhhc
Confidence 999999987766555567899999999999853
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=256.06 Aligned_cols=170 Identities=24% Similarity=0.383 Sum_probs=148.5
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCC-CCCCccceeeeeeeccccC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 549 (659)
..++|....+||+|.||+|+.+..+ +++.+|||.++++.. ++.+..+.|-+++.-. +||.++.++..+.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT----- 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT----- 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-----
Confidence 3567888899999999999999976 488999999987753 3456788888888777 59999999988876
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEcc
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISS 629 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 629 (659)
.+++|+||||+.|||+..+.+. ..++..+..-||..|+.||+|||++ +||+||||-+|||||.+|.+||+|
T Consensus 441 --~~~l~fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiAD 511 (694)
T KOG0694|consen 441 --KEHLFFVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIAD 511 (694)
T ss_pred --CCeEEEEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecc
Confidence 6789999999999997776663 4699999999999999999999999 999999999999999999999999
Q ss_pred Cccccccc-cccccceecccccccCCCCCC
Q 006145 630 YNLPLLAE-NAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 630 FGla~~~~-~~~~~~~~~gt~~y~aPE~~~ 658 (659)
||+++..- .+..+++.|||+.|||||++.
T Consensus 512 FGlcKe~m~~g~~TsTfCGTpey~aPEil~ 541 (694)
T KOG0694|consen 512 FGLCKEGMGQGDRTSTFCGTPEFLAPEVLT 541 (694)
T ss_pred cccccccCCCCCccccccCChhhcChhhhc
Confidence 99997653 445678899999999999863
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=240.37 Aligned_cols=173 Identities=18% Similarity=0.296 Sum_probs=147.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecc--cCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKM--KKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
...|...+.||+|+||.|+.+... +|+.||||++.. ......++..||+++|+.++|+||+.+.+.+..... ..-
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~--~~f 98 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR--DKF 98 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc--ccc
Confidence 445666789999999999999965 699999999973 333445789999999999999999999998865222 124
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
..+|+|+|+|+. ||.+.++. .+.|+......+..|+++||.|+|+. +|+|||+||+|++++.+...||+|||+
T Consensus 99 ~DvYiV~elMet-DL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELMET-DLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHHhh-HHHHHHHc---CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 679999999955 99999986 24589999999999999999999998 999999999999999999999999999
Q ss_pred cccccc---ccccceecccccccCCCCC
Q 006145 633 PLLAEN---AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~---~~~~~~~~gt~~y~aPE~~ 657 (659)
|+..+. ....+..+.|.+|+|||..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPEll 199 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELL 199 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHH
Confidence 998863 5556889999999999964
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=256.99 Aligned_cols=173 Identities=16% Similarity=0.267 Sum_probs=146.9
Q ss_pred HHHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeecc
Q 006145 471 ELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECY 546 (659)
Q Consensus 471 ~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 546 (659)
++....++|...+.||+|+||.||+++.. +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.+
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-- 114 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-- 114 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--
Confidence 34445678999999999999999999975 588999999964321 223458899999999999999999998875
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceE
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAK 626 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~k 626 (659)
.+..|+||||+++|+|.+++.. ..+++.....++.|++.||+|||+. +|+||||||+|||+++++.+|
T Consensus 115 -----~~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~k 182 (370)
T cd05621 115 -----DKYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLK 182 (370)
T ss_pred -----CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEE
Confidence 5678999999999999999974 3478888999999999999999998 999999999999999999999
Q ss_pred EccCccccccccccc--cceecccccccCCCCC
Q 006145 627 ISSYNLPLLAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 627 l~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
|+|||+++....... ....+||+.|||||+.
T Consensus 183 L~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~ 215 (370)
T cd05621 183 LADFGTCMKMDETGMVRCDTAVGTPDYISPEVL 215 (370)
T ss_pred EEecccceecccCCceecccCCCCcccCCHHHH
Confidence 999999976643222 2456799999999965
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=251.58 Aligned_cols=167 Identities=20% Similarity=0.321 Sum_probs=145.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++..++||||+++++++.. .
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-------~ 73 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-------D 73 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-------C
Confidence 36788899999999999999976 489999999975432 234568899999999999999999998875 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..|+||||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 74 EYLYLAMEYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred CEEEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcC
Confidence 6789999999999999999752 4688999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
++.... .....+||+.|+|||+..
T Consensus 148 a~~~~~--~~~~~~gt~~y~aPE~~~ 171 (333)
T cd05600 148 SKGIVT--YANSVVGSPDYMAPEVLR 171 (333)
T ss_pred Cccccc--ccCCcccCccccChhHhc
Confidence 976543 334567999999999853
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=256.59 Aligned_cols=147 Identities=18% Similarity=0.298 Sum_probs=130.0
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|++++..++||||+++++++.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-------~ 73 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-------E 73 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-------C
Confidence 36888899999999999999965 589999999975431 223568899999999999999999999876 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 74 NYLYLIMEYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred CeEEEEECCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeeccc
Confidence 6789999999999999999752 4589999999999999999999998 999999999999999999999999999
Q ss_pred cccc
Q 006145 633 PLLA 636 (659)
Q Consensus 633 a~~~ 636 (659)
++..
T Consensus 148 ~~~~ 151 (364)
T cd05599 148 CTGL 151 (364)
T ss_pred ceec
Confidence 8654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=249.72 Aligned_cols=163 Identities=20% Similarity=0.317 Sum_probs=139.5
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLI 558 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV 558 (659)
+.||+|+||.||+++.. +|+.||||++..... .....+.+|+++++.++||||+++++++.. .+..++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~~~lv 73 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-------KDRLCFV 73 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-------CCEEEEE
Confidence 46899999999999965 599999999975422 234578899999999999999999998875 5678999
Q ss_pred EeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc-
Q 006145 559 FEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE- 637 (659)
Q Consensus 559 ~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~- 637 (659)
|||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 74 ~Ey~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~ 147 (328)
T cd05593 74 MEYVNGGELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT 147 (328)
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence 9999999999988752 4689999999999999999999998 99999999999999999999999999997542
Q ss_pred cccccceecccccccCCCCCC
Q 006145 638 NAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 638 ~~~~~~~~~gt~~y~aPE~~~ 658 (659)
........+||+.|||||+..
T Consensus 148 ~~~~~~~~~gt~~y~aPE~~~ 168 (328)
T cd05593 148 DAATMKTFCGTPEYLAPEVLE 168 (328)
T ss_pred cccccccccCCcCccChhhhc
Confidence 222334567999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=249.59 Aligned_cols=163 Identities=17% Similarity=0.291 Sum_probs=139.1
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLI 558 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV 558 (659)
+.||+|+||.||+++.. +|+.||+|.++.... .....+.+|++++++++||||+++++++.. .+..++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-------~~~~~lv 73 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-------HDRLCFV 73 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-------CCEEEEE
Confidence 46899999999999965 599999999975422 233567889999999999999999998875 4678999
Q ss_pred EeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc-c
Q 006145 559 FEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA-E 637 (659)
Q Consensus 559 ~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~-~ 637 (659)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.. .
T Consensus 74 ~E~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 147 (323)
T cd05595 74 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence 9999999999988752 4689999999999999999999998 9999999999999999999999999998753 2
Q ss_pred cccccceecccccccCCCCCC
Q 006145 638 NAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 638 ~~~~~~~~~gt~~y~aPE~~~ 658 (659)
.........||+.|||||+..
T Consensus 148 ~~~~~~~~~gt~~y~aPE~~~ 168 (323)
T cd05595 148 DGATMKTFCGTPEYLAPEVLE 168 (323)
T ss_pred CCCccccccCCcCcCCccccc
Confidence 222334567999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=252.76 Aligned_cols=167 Identities=17% Similarity=0.280 Sum_probs=143.7
Q ss_pred hcCCCCCceeccCcCceEEEEEecC--CcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN--GTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~--g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.++|+..+.||+|+||.||+|+... +..||+|++.... ....+.+.+|+++++.++|||||++++++.+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~------ 102 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD------ 102 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe------
Confidence 3467788999999999999998653 4689999986432 2234568899999999999999999999976
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+..++||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 103 -~~~~~lv~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 103 -ESYLYLVLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecC
Confidence 46789999999999999999753 4689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccccceecccccccCCCCC
Q 006145 631 NLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+++.... .....+||+.|||||+.
T Consensus 176 G~a~~~~~--~~~~~~gt~~y~aPE~~ 200 (340)
T PTZ00426 176 GFAKVVDT--RTYTLCGTPEYIAPEIL 200 (340)
T ss_pred CCCeecCC--CcceecCChhhcCHHHH
Confidence 99986643 23456899999999975
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=251.50 Aligned_cols=166 Identities=17% Similarity=0.355 Sum_probs=144.2
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||.||+|+.. +|+.||||.++... ....+.+.+|++++++++||||+++++++.+ .
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~ 90 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-------E 90 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-------C
Confidence 56778899999999999999976 58999999997542 2234568999999999999999999999875 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccC
Confidence 6789999999999999999752 4588888999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++..... .....||+.|||||+.
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~ 187 (329)
T PTZ00263 165 AKKVPDR--TFTLCGTPEYLAPEVI 187 (329)
T ss_pred ceEcCCC--cceecCChhhcCHHHH
Confidence 9766432 2346899999999975
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=247.89 Aligned_cols=160 Identities=14% Similarity=0.226 Sum_probs=137.8
Q ss_pred eccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEe
Q 006145 485 MGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 485 ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++.+ .+..++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-------PEKLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-------CCeEEEEEc
Confidence 699999999999965 58899999997532 2234568899999999999999999998875 467899999
Q ss_pred ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc-cc
Q 006145 561 YVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE-NA 639 (659)
Q Consensus 561 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~-~~ 639 (659)
|+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++... ..
T Consensus 74 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 147 (312)
T cd05585 74 FINGGELFHHLQRE---GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147 (312)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence 99999999999752 4689999999999999999999998 99999999999999999999999999997542 22
Q ss_pred cccceecccccccCCCCC
Q 006145 640 EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 640 ~~~~~~~gt~~y~aPE~~ 657 (659)
......+||+.|||||+.
T Consensus 148 ~~~~~~~gt~~y~aPE~~ 165 (312)
T cd05585 148 DKTNTFCGTPEYLAPELL 165 (312)
T ss_pred CccccccCCcccCCHHHH
Confidence 334456899999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=255.85 Aligned_cols=145 Identities=14% Similarity=0.243 Sum_probs=128.0
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.|...+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++|+|||++++++.+ .+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-------~~ 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-------KD 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-------CC
Confidence 5777899999999999999865 589999999975432 223568999999999999999999999876 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++|+|.+++.+. ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~ 148 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLC 148 (381)
T ss_pred EEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCC
Confidence 799999999999999999752 4588899999999999999999998 9999999999999999999999999997
Q ss_pred cc
Q 006145 634 LL 635 (659)
Q Consensus 634 ~~ 635 (659)
+.
T Consensus 149 ~~ 150 (381)
T cd05626 149 TG 150 (381)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=247.48 Aligned_cols=166 Identities=14% Similarity=0.314 Sum_probs=143.4
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~ 73 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-------Q 73 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-------C
Confidence 36788899999999999999975 589999999965432 234568899999999999999999988865 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||+++|+|.++++.. ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 74 RFLYMLMEYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred CeEEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCc
Confidence 6789999999999999999752 4689999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++..... ....+||+.|+|||+.
T Consensus 148 ~~~~~~~--~~~~~gt~~y~aPE~~ 170 (291)
T cd05612 148 AKKLRDR--TWTLCGTPEYLAPEVI 170 (291)
T ss_pred chhccCC--cccccCChhhcCHHHH
Confidence 9766432 2345799999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=254.97 Aligned_cols=146 Identities=18% Similarity=0.285 Sum_probs=128.5
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||+||+++.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-------~ 73 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-------A 73 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-------C
Confidence 36788899999999999999865 69999999986532 1223568899999999999999999999876 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...|+||||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 74 QYLYLIMEFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred CeeEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccc
Confidence 6799999999999999999752 4688889999999999999999998 999999999999999999999999999
Q ss_pred ccc
Q 006145 633 PLL 635 (659)
Q Consensus 633 a~~ 635 (659)
++.
T Consensus 148 a~~ 150 (377)
T cd05629 148 STG 150 (377)
T ss_pred ccc
Confidence 853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=252.70 Aligned_cols=167 Identities=17% Similarity=0.293 Sum_probs=150.3
Q ss_pred CCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 479 FDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
|...+.||.|+-|.|-.|+. .+|+.+|||++.+.... ....+++||-+|+-+.||||+++++++.+ ..+
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-------~~~ 86 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-------KQH 86 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-------Cce
Confidence 55678999999999999995 47999999999766322 23458999999999999999999999976 678
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
+|+|.||+++|.|++++-+ +..++..+..++.+||+.|+.|+|+. +|+|||+||+|+|||+.+++||+|||+|.
T Consensus 87 lylvlEyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAs 160 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMAS 160 (786)
T ss_pred EEEEEEecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceee
Confidence 9999999999999999986 35799999999999999999999998 99999999999999999999999999999
Q ss_pred ccccccccceecccccccCCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+-.++....+.||.+.|.|||+++
T Consensus 161 Le~~gklLeTSCGSPHYA~PEIV~ 184 (786)
T KOG0588|consen 161 LEVPGKLLETSCGSPHYAAPEIVS 184 (786)
T ss_pred cccCCccccccCCCcccCCchhhc
Confidence 888888888999999999999875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=244.79 Aligned_cols=171 Identities=19% Similarity=0.389 Sum_probs=140.2
Q ss_pred cCCCCCceeccCcCceEEEEEecC-----------------CcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN-----------------GTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSA 538 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l 538 (659)
++|...+.||+|+||.||+|++++ +..||+|.+...... ...+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467778999999999999997532 347999998754322 23579999999999999999999
Q ss_pred eeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCC----------------CCCCCCHHHHHHHHHHHHHHhhhhcCC
Q 006145 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGH----------------AHQSLTWTQRISAAIGVAKGIQFLHTG 602 (659)
Q Consensus 539 ~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~ 602 (659)
++++.+ .+..++||||+++|+|.+++.... ....++|....+++.|+++||+|||+.
T Consensus 85 ~~~~~~-------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 85 LGVCVD-------EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEEEec-------CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 999975 456899999999999999886421 113578999999999999999999998
Q ss_pred CCCCccccCCCCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 603 IVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 603 ~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
+|+||||||+||++++++.+||+|||+++....... .....++..|||||+.
T Consensus 158 ---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 212 (304)
T cd05096 158 ---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212 (304)
T ss_pred ---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH
Confidence 999999999999999999999999999976533221 2234557889999974
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=246.74 Aligned_cols=162 Identities=17% Similarity=0.283 Sum_probs=138.0
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLI 558 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV 558 (659)
+.||+|+||.||+++.. +|+.||+|.++.... ....++.+|+++++.++||||+++++++.. .+..++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-------~~~~~lv 73 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-------HDRLCFV 73 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-------CCEEEEE
Confidence 46899999999999864 689999999975432 233567889999999999999999998875 5678999
Q ss_pred EeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcC-CCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 559 FEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT-GIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 559 ~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+|||+++++.+||+|||+++...
T Consensus 74 ~E~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 74 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 9999999999988752 468999999999999999999996 6 89999999999999999999999999987532
Q ss_pred -cccccceecccccccCCCCC
Q 006145 638 -NAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 -~~~~~~~~~gt~~y~aPE~~ 657 (659)
.........||+.|||||+.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~ 168 (325)
T cd05594 148 KDGATMKTFCGTPEYLAPEVL 168 (325)
T ss_pred CCCcccccccCCcccCCHHHH
Confidence 22333456799999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-29 Score=234.57 Aligned_cols=171 Identities=19% Similarity=0.307 Sum_probs=145.6
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
+++|+..+.||+|.|+.||++.. ++|+.+|+|.+.... ..+.++..+|+++.+.++|||||+|.+-+.+ .
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~-------~ 82 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-------E 82 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc-------c
Confidence 45677789999999999999985 469999999986443 3356789999999999999999999987765 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC---cceEEcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN---LVAKISS 629 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~---~~~kl~D 629 (659)
...|||+|+|.||+|..-+-. +...++...-.+++||++||+|+|.+ +|||||+||+|+++-.. --+|++|
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~ 156 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLAD 156 (355)
T ss_pred ceeEEEEecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecc
Confidence 678999999999999754432 13567888899999999999999999 99999999999999633 4589999
Q ss_pred CccccccccccccceecccccccCCCCCCC
Q 006145 630 YNLPLLAENAEKVGHVIPYSGSIDPTNSAR 659 (659)
Q Consensus 630 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~ 659 (659)
||+|....+.......+|||+|||||++.|
T Consensus 157 FGvAi~l~~g~~~~G~~GtP~fmaPEvvrk 186 (355)
T KOG0033|consen 157 FGLAIEVNDGEAWHGFAGTPGYLSPEVLKK 186 (355)
T ss_pred cceEEEeCCccccccccCCCcccCHHHhhc
Confidence 999998887777788999999999998764
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=254.09 Aligned_cols=144 Identities=15% Similarity=0.266 Sum_probs=127.3
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.|...+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++|+|||++++++.+ .+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-------~~ 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-------KD 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-------CC
Confidence 4778899999999999999965 588999999975432 223568899999999999999999999876 46
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..|+|||||++|+|.+++.+. ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla 148 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLC 148 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCC
Confidence 789999999999999999752 4578888899999999999999998 9999999999999999999999999997
Q ss_pred c
Q 006145 634 L 634 (659)
Q Consensus 634 ~ 634 (659)
+
T Consensus 149 ~ 149 (382)
T cd05625 149 T 149 (382)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=252.95 Aligned_cols=144 Identities=15% Similarity=0.248 Sum_probs=127.4
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
+|...+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++|+||+++++++.+ .+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-------~~ 74 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-------KD 74 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-------CC
Confidence 5788899999999999999965 58999999996532 1234568899999999999999999998875 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 75 ~~~lv~E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a 148 (376)
T cd05598 75 NLYFVMDYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLC 148 (376)
T ss_pred EEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence 799999999999999999752 4578888899999999999999998 9999999999999999999999999997
Q ss_pred c
Q 006145 634 L 634 (659)
Q Consensus 634 ~ 634 (659)
.
T Consensus 149 ~ 149 (376)
T cd05598 149 T 149 (376)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=253.85 Aligned_cols=170 Identities=16% Similarity=0.259 Sum_probs=144.4
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccC
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 549 (659)
...++|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~----- 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD----- 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 34567888999999999999999965 58999999996432 1233457899999999999999999988875
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEcc
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISS 629 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 629 (659)
....++||||+++|+|.++++. ..++......++.|++.||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 115 --~~~~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 115 --DKYLYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred --CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEe
Confidence 5678999999999999999875 2477888889999999999999998 999999999999999999999999
Q ss_pred Ccccccccccc--ccceecccccccCCCCC
Q 006145 630 YNLPLLAENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
||+++...... .....+||+.|||||+.
T Consensus 186 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 215 (370)
T cd05596 186 FGTCMKMDANGMVRCDTAVGTPDYISPEVL 215 (370)
T ss_pred ccceeeccCCCcccCCCCCCCcCeECHHHh
Confidence 99997654332 22456799999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=269.35 Aligned_cols=173 Identities=25% Similarity=0.460 Sum_probs=144.4
Q ss_pred hcCCCCCceeccCcCceEEEEEecC--Cc----EEEEEEecccC-CCchHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN--GT----FVAIRCLKMKK-CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~--g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
..+.+..+.||+|.||.||+|.+.+ |. .||||.++... .+...+|.+|..+|++++|||||+++|+|.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~---- 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD---- 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC----
Confidence 3344566899999999999999764 43 49999997654 3445789999999999999999999999987
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCC----CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHA----HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV 624 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~ 624 (659)
....++++|||++|||..+|++.+. ...++-.+.+.+|.|||+|+.||+++ ++|||||.++|+||++...
T Consensus 767 ---~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~ 840 (1025)
T KOG1095|consen 767 ---SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRV 840 (1025)
T ss_pred ---CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCc
Confidence 4568999999999999999996422 34688999999999999999999999 9999999999999999999
Q ss_pred eEEccCcccccccccccc---ceecccccccCCCCCC
Q 006145 625 AKISSYNLPLLAENAEKV---GHVIPYSGSIDPTNSA 658 (659)
Q Consensus 625 ~kl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~ 658 (659)
+||+|||+|+.+.....+ ....-...|||||.+.
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~ 877 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLK 877 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHh
Confidence 999999999955433332 1223446899999875
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=247.08 Aligned_cols=169 Identities=18% Similarity=0.327 Sum_probs=150.7
Q ss_pred hcCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCCc---hHHHHHHHHHHhCCC-CCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHS---TRNFMHHIELISKLR-HRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~ 550 (659)
...|+..+.||+|.||+||+|+.+. |+.+|+|.+.+..... .+...+|+++|+++. |||||.+.+++.+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~------ 107 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED------ 107 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc------
Confidence 4567778999999999999999765 9999999998765443 357999999999998 9999999999986
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC----cceE
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN----LVAK 626 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~----~~~k 626 (659)
....++|||++.||+|++.+... .++..+...++.|++.|+.|||+. +|+|||+||+|+|+... +.+|
T Consensus 108 -~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik 179 (382)
T KOG0032|consen 108 -PDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIK 179 (382)
T ss_pred -CCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEE
Confidence 56799999999999999999863 389999999999999999999998 99999999999999643 4799
Q ss_pred EccCccccccccccccceecccccccCCCCCC
Q 006145 627 ISSYNLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 627 l~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
++|||++............+||+.|+|||.+.
T Consensus 180 ~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~ 211 (382)
T KOG0032|consen 180 LIDFGLAKFIKPGERLHTIVGTPEYVAPEVLG 211 (382)
T ss_pred EeeCCCceEccCCceEeeecCCccccCchhhc
Confidence 99999999888777788999999999999875
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=244.88 Aligned_cols=163 Identities=18% Similarity=0.272 Sum_probs=137.8
Q ss_pred ceeccCcCceEEEEEec----CCcEEEEEEecccCC----CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 483 AFMGEGSQGQMYRGRLK----NGTFVAIRCLKMKKC----HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~----~g~~vavK~l~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+.||+|+||.||+++.. +++.||||.++.... .....+.+|+++++.++||||+++++++.. .+.
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-------~~~ 74 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-------GGK 74 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-------CCe
Confidence 67999999999999853 588999999975321 223467899999999999999999998875 457
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.|+||||+++|+|.+++... ..+.+.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (323)
T cd05584 75 LYLILEYLSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK 148 (323)
T ss_pred EEEEEeCCCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence 89999999999999999752 4578888999999999999999998 99999999999999999999999999987
Q ss_pred ccc-cccccceecccccccCCCCCC
Q 006145 635 LAE-NAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~~-~~~~~~~~~gt~~y~aPE~~~ 658 (659)
... .........||+.|+|||+..
T Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~ 173 (323)
T cd05584 149 ESIHEGTVTHTFCGTIEYMAPEILM 173 (323)
T ss_pred ecccCCCcccccCCCccccChhhcc
Confidence 542 222334567999999999863
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=251.48 Aligned_cols=175 Identities=15% Similarity=0.257 Sum_probs=148.2
Q ss_pred HHHHHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeee
Q 006145 469 LEELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFE 544 (659)
Q Consensus 469 ~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 544 (659)
..++....++|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3455556788999999999999999999976 58899999986432 1223458899999999999999999998875
Q ss_pred ccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc
Q 006145 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV 624 (659)
Q Consensus 545 ~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~ 624 (659)
.+..++||||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 115 -------~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ 180 (371)
T cd05622 115 -------DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 180 (371)
T ss_pred -------CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCC
Confidence 4678999999999999999875 3478888899999999999999998 9999999999999999999
Q ss_pred eEEccCcccccccccc--ccceecccccccCCCCC
Q 006145 625 AKISSYNLPLLAENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 ~kl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
+||+|||+++...... .....+||+.|||||++
T Consensus 181 ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l 215 (371)
T cd05622 181 LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215 (371)
T ss_pred EEEEeCCceeEcCcCCcccccCcccCccccCHHHH
Confidence 9999999997654322 22456799999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-28 Score=236.41 Aligned_cols=165 Identities=21% Similarity=0.376 Sum_probs=145.2
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
|+..+++|+|+||.||||.++ +|++||||.+.... +.+++.+||.+|++++.|+||+++|-|.. ...+++
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK-------~sDLWI 105 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFK-------HSDLWI 105 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhcc-------CCceEe
Confidence 445689999999999999876 59999999997654 56889999999999999999999998875 467999
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
|||||-.|+..++++-+ +++|++.....+.+..++||+|||.. .-||||||+.|||+..+|.+|++|||.|-...
T Consensus 106 VMEYCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred ehhhcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhh
Confidence 99999999999999853 46899999999999999999999998 88999999999999999999999999996554
Q ss_pred cc-cccceecccccccCCCCC
Q 006145 638 NA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 ~~-~~~~~~~gt~~y~aPE~~ 657 (659)
+. ..-..++||+.|||||++
T Consensus 181 DTMAKRNTVIGTPFWMAPEVI 201 (502)
T KOG0574|consen 181 DTMAKRNTVIGTPFWMAPEVI 201 (502)
T ss_pred hhHHhhCccccCcccccHHHH
Confidence 32 233678999999999975
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-28 Score=250.31 Aligned_cols=163 Identities=18% Similarity=0.330 Sum_probs=140.4
Q ss_pred CCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCc---hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 479 FDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHS---TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
|+..+.||.|+||.||-|+. .+.++||||++.....+. ..++..|++.|.+++|||+|.+.|+|.. ...
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-------e~T 100 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-------EHT 100 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-------cch
Confidence 44568899999999999995 468899999997655443 4679999999999999999999999875 345
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.|||||||-| +-.+++.-. ++++..-....|+.|++.||+|||+. +.||||||+.|||+.+.|.+|++|||.|.
T Consensus 101 aWLVMEYClG-SAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAs 174 (948)
T KOG0577|consen 101 AWLVMEYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSAS 174 (948)
T ss_pred HHHHHHHHhc-cHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchh
Confidence 7999999965 777766522 25788888999999999999999998 99999999999999999999999999998
Q ss_pred ccccccccceecccccccCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.+.+ ...++|||+|||||++
T Consensus 175 i~~P---AnsFvGTPywMAPEVI 194 (948)
T KOG0577|consen 175 IMAP---ANSFVGTPYWMAPEVI 194 (948)
T ss_pred hcCc---hhcccCCccccchhHh
Confidence 7754 4578999999999986
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=239.54 Aligned_cols=168 Identities=15% Similarity=0.311 Sum_probs=141.9
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|...+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|++++++++||||+++++++.. .+.
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------~~~ 77 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-------ERC 77 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-------CCe
Confidence 46888899999999999999965 589999999975432 233568899999999999999999999875 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 78 ~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 78 LTLVFEYLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred EEEEEeCCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCccee
Confidence 8999999975 999988743 23578999999999999999999998 99999999999999999999999999997
Q ss_pred ccccc-cccceecccccccCCCCC
Q 006145 635 LAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
..... .......+++.|||||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~ 175 (288)
T cd07871 152 AKSVPTKTYSNEVVTLWYRPPDVL 175 (288)
T ss_pred eccCCCccccCceecccccChHHh
Confidence 54322 223456789999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=251.62 Aligned_cols=172 Identities=18% Similarity=0.352 Sum_probs=147.2
Q ss_pred CCceeccCcCceEEEEEe-cCCcEEEEEEecccC-CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEE
Q 006145 481 TSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKK-CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLI 558 (659)
Q Consensus 481 ~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV 558 (659)
..+.||+|+||.||+|+. .+|+.||||..+... ....+...+|+++|++++|+|||++++.-.+... ........+|
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~-~~~~~~~vlv 95 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL-GLVTRLPVLV 95 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc-CcccccceEE
Confidence 347899999999999994 469999999997644 3455779999999999999999999986544221 1224567899
Q ss_pred EeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec--CCc--ceEEccCcccc
Q 006145 559 FEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD--QNL--VAKISSYNLPL 634 (659)
Q Consensus 559 ~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld--~~~--~~kl~DFGla~ 634 (659)
||||.+|||+..|++.....-|+....+.+..+++.||.|||++ +|+||||||.||++- +++ --||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999999999755556799999999999999999999998 999999999999984 444 37999999999
Q ss_pred ccccccccceecccccccCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTN 656 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~ 656 (659)
..+++......+||..|.+||.
T Consensus 173 el~d~s~~~S~vGT~~YLhPel 194 (732)
T KOG4250|consen 173 ELDDNSLFTSLVGTEEYLHPEL 194 (732)
T ss_pred cCCCCCeeeeecCchhhcChHH
Confidence 9999888899999999999985
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=245.39 Aligned_cols=169 Identities=17% Similarity=0.239 Sum_probs=144.6
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++++.++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-------~ 73 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-------K 73 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-------C
Confidence 36888899999999999999965 589999999975432 233568899999999999999999998875 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++|+|.+++.+. ...+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 74 DNLYLVMEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred CeEEEEECCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCC
Confidence 5789999999999999999753 24689999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccc--cceecccccccCCCCC
Q 006145 633 PLLAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
++....... .....||+.|+|||+.
T Consensus 149 a~~~~~~~~~~~~~~~gt~~y~aPE~~ 175 (330)
T cd05601 149 AARLTANKMVNSKLPVGTPDYIAPEVL 175 (330)
T ss_pred CeECCCCCceeeecccCCccccCHHHh
Confidence 976643322 2335799999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=245.47 Aligned_cols=169 Identities=17% Similarity=0.231 Sum_probs=143.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||+||+++.. +++.||||.+.... ....+.|.+|+.++..++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------~ 73 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-------E 73 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-------C
Confidence 36888899999999999999965 58999999996432 1233568899999999999999999998875 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..|+||||+++|+|.+++.+. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 74 NNLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred CeEEEEEecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCc
Confidence 6799999999999999999742 24588999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccc--cceecccccccCCCCC
Q 006145 633 PLLAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
+........ .....||+.|||||++
T Consensus 149 ~~~~~~~~~~~~~~~~gt~~y~aPE~~ 175 (331)
T cd05597 149 CLRLLADGTVQSNVAVGTPDYISPEIL 175 (331)
T ss_pred eeecCCCCCccccceeccccccCHHHH
Confidence 865533222 2335799999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=248.65 Aligned_cols=147 Identities=17% Similarity=0.296 Sum_probs=129.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||+||+++.. +++.||||+++... ....+.+.+|++++..++|+||+++++++.+ .
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-------~ 73 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-------K 73 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-------C
Confidence 36778899999999999999965 58999999997432 2234568899999999999999999998875 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 74 RNLYLIMEFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred CEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccC
Confidence 6789999999999999999752 4689999999999999999999998 999999999999999999999999999
Q ss_pred cccc
Q 006145 633 PLLA 636 (659)
Q Consensus 633 a~~~ 636 (659)
++..
T Consensus 148 ~~~~ 151 (360)
T cd05627 148 CTGL 151 (360)
T ss_pred Cccc
Confidence 8644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=245.55 Aligned_cols=169 Identities=15% Similarity=0.195 Sum_probs=143.4
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||+||+++.. +++.||+|.+.... ....+.+.+|+.++..++|+||+++++++.+ .
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-------~ 73 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-------E 73 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-------C
Confidence 46888899999999999999965 58899999986532 1223458889999999999999999998875 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..|+||||+++|+|.+++++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~lv~Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 74 NYLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred CEEEEEEeCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccc
Confidence 6789999999999999999752 24688999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccc--cceecccccccCCCCC
Q 006145 633 PLLAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
++....... .....||+.|||||+.
T Consensus 149 a~~~~~~~~~~~~~~~gt~~y~aPE~~ 175 (331)
T cd05624 149 CLKMNQDGTVQSSVAVGTPDYISPEIL 175 (331)
T ss_pred eeeccCCCceeeccccCCcccCCHHHH
Confidence 976543322 2335799999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=243.85 Aligned_cols=163 Identities=19% Similarity=0.284 Sum_probs=138.6
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||.||+|+.. +++.||||.++.... ...+.+.+|+.++.++ +||||+++++++.+ ....|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-------~~~~~l 73 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-------ESRLFF 73 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-------CCEEEE
Confidence 46899999999999965 589999999975432 2234588999999998 69999999998875 467899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc-
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA- 636 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~- 636 (659)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 74 v~e~~~~g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 74 VIEFVSGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI 147 (329)
T ss_pred EEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccc
Confidence 99999999999988752 4699999999999999999999998 9999999999999999999999999998643
Q ss_pred ccccccceecccccccCCCCCC
Q 006145 637 ENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 637 ~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
.........+||+.|||||+..
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~ 169 (329)
T cd05588 148 RPGDTTSTFCGTPNYIAPEILR 169 (329)
T ss_pred cCCCccccccCCccccCHHHHc
Confidence 2223344578999999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=238.75 Aligned_cols=169 Identities=19% Similarity=0.278 Sum_probs=144.1
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
+|+..+.||+|+||+||++... +++.||||.+...... ....+.+|++++++++||||+++++++.+ .+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~ 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-------KD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-------CC
Confidence 3667789999999999999964 6899999999654321 23457899999999999999999998875 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++|+|.+++... ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCc
Confidence 789999999999999988642 234689999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccccceecccccccCCCCC
Q 006145 634 LLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
............+|+..|||||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~ 173 (285)
T cd05605 150 VEIPEGETIRGRVGTVGYMAPEVV 173 (285)
T ss_pred eecCCCCccccccCCCCccCcHHh
Confidence 876544444556899999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=247.69 Aligned_cols=169 Identities=16% Similarity=0.292 Sum_probs=145.7
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|++++..++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------~ 73 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-------E 73 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-------C
Confidence 36788899999999999999976 599999999975431 234578999999999999999999998875 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCC
Confidence 6789999999999999999863 4689999999999999999999998 999999999999999999999999999
Q ss_pred cccccccc------------------------------ccceecccccccCCCCCC
Q 006145 633 PLLAENAE------------------------------KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 633 a~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~ 658 (659)
++...... ......||+.|+|||+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 203 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR 203 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence 97654332 234567999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=235.74 Aligned_cols=177 Identities=19% Similarity=0.254 Sum_probs=144.5
Q ss_pred ccCHHHHHHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCc---hHHHHHHHHHHhCCCCCCccceeeee
Q 006145 466 TFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHS---TRNFMHHIELISKLRHRHLVSALGHC 542 (659)
Q Consensus 466 ~~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~ 542 (659)
.++.+++. ......||+|++|.||+|++ +|+.||||+++...... .+.|.+|+++|++++|||||+++|++
T Consensus 14 ~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 87 (283)
T PHA02988 14 CIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87 (283)
T ss_pred ecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence 45566662 23347899999999999998 58999999997654333 35688999999999999999999998
Q ss_pred eeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC
Q 006145 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN 622 (659)
Q Consensus 543 ~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~ 622 (659)
.+... .....++||||+++|+|.+++++. ..++|..+.+++.+++.||+|||+.. +++||||||+||+++++
T Consensus 88 ~~~~~---~~~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 88 IDIVD---DLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTEN 159 (283)
T ss_pred Eeccc---CCCceEEEEEeCCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCC
Confidence 75111 134679999999999999999863 46899999999999999999999731 67899999999999999
Q ss_pred cceEEccCccccccccccccceecccccccCCCCCC
Q 006145 623 LVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 623 ~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+.+||+|||+++..... .....++..|+|||+..
T Consensus 160 ~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~ 193 (283)
T PHA02988 160 YKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLN 193 (283)
T ss_pred CcEEEcccchHhhhccc--cccccCcccccCHHHhh
Confidence 99999999999765432 22456889999999863
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=248.90 Aligned_cols=173 Identities=23% Similarity=0.344 Sum_probs=141.2
Q ss_pred hhcCCCCCceeccCcCceEEEEEe------cCCcEEEEEEecccCC-CchHHHHHHHHHHhCC-CCCCccceeeeeeecc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRL------KNGTFVAIRCLKMKKC-HSTRNFMHHIELISKL-RHRHLVSALGHCFECY 546 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 546 (659)
..++|...+.||+|+||.||+|+. .++..||||+++.... ...+.+.+|++++..+ +|||||+++|+|.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-- 110 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV-- 110 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--
Confidence 345678889999999999999973 2366899999975432 2345689999999999 89999999999976
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCC--------------------------------------------------
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHA-------------------------------------------------- 576 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------------------------------------------- 576 (659)
.+..++||||+++|+|.++++....
T Consensus 111 -----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (375)
T cd05104 111 -----GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK 185 (375)
T ss_pred -----CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence 4568999999999999999864210
Q ss_pred ----------------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 577 ----------------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 577 ----------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
...++|..+.+++.||++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 262 (375)
T cd05104 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 262 (375)
T ss_pred ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccce
Confidence 12578999999999999999999998 99999999999999999999999999997
Q ss_pred ccccccc---cceecccccccCCCCC
Q 006145 635 LAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
....... .....++..|||||+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 288 (375)
T cd05104 263 DIRNDSNYVVKGNARLPVKWMAPESI 288 (375)
T ss_pred eccCcccccccCCCCCCcceeChhHh
Confidence 6543221 1223456689999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=256.12 Aligned_cols=170 Identities=11% Similarity=0.153 Sum_probs=142.9
Q ss_pred CCCCceeccCcCceEEEEEec-C-CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-N-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
|...+.||+|+||.||+|... + +..||+|.+..........+.+|+++++.++|||||+++++|.. .+..|
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-------~~~~~ 141 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-------DDKLL 141 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-------CCEEE
Confidence 777899999999999999854 3 67889998755443334568889999999999999999999976 56799
Q ss_pred EEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 557 LIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
+||||+++|+|.++++.. .....+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 999999999999988632 2234688999999999999999999998 999999999999999999999999999986
Q ss_pred ccccc---ccceecccccccCCCCCC
Q 006145 636 AENAE---KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 636 ~~~~~---~~~~~~gt~~y~aPE~~~ 658 (659)
..... .....+||+.|||||+..
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~ 244 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWE 244 (478)
T ss_pred cCCccccccccccCCCccccCHhHhC
Confidence 64322 134567999999999863
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=242.03 Aligned_cols=168 Identities=21% Similarity=0.296 Sum_probs=140.4
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCC-CccceeeeeeeccccCCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHR-HLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~~~~ 552 (659)
+|...+.||+|+||.||+|+.. +++.||||+++... ....+.+..|++++..++|+ +|+++++++.+ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-------~ 73 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-------M 73 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-------C
Confidence 4777899999999999999965 47899999997542 22345688999999999765 57788887765 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05587 74 DRLYFVMEYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGM 147 (324)
T ss_pred CEEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCc
Confidence 5789999999999999998752 4588999999999999999999998 999999999999999999999999999
Q ss_pred ccccc-cccccceecccccccCCCCCC
Q 006145 633 PLLAE-NAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 633 a~~~~-~~~~~~~~~gt~~y~aPE~~~ 658 (659)
++... ........+||+.|+|||+..
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~ 174 (324)
T cd05587 148 CKENIFGGKTTRTFCGTPDYIAPEIIA 174 (324)
T ss_pred ceecCCCCCceeeecCCccccChhhhc
Confidence 86432 223344568999999999853
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=242.38 Aligned_cols=162 Identities=19% Similarity=0.282 Sum_probs=138.9
Q ss_pred ceeccCcCceEEEEEe----cCCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 483 AFMGEGSQGQMYRGRL----KNGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~----~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
+.||+|+||.||+++. .+|+.||+|+++.... .....+.+|++++++++||||+++++++.+ .+..|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------~~~~~ 74 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-------EGKLY 74 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-------CCEEE
Confidence 5799999999999874 3589999999975432 223467889999999999999999999875 46789
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 75 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 75 LILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 148 (318)
T ss_pred EEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCccc
Confidence 99999999999999975 24689999999999999999999998 9999999999999999999999999999765
Q ss_pred ccc-cccceecccccccCCCCC
Q 006145 637 ENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
... .......||+.|||||+.
T Consensus 149 ~~~~~~~~~~~g~~~y~aPE~~ 170 (318)
T cd05582 149 IDHEKKAYSFCGTVEYMAPEVV 170 (318)
T ss_pred CCCCCceecccCChhhcCHHHH
Confidence 433 233456899999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=242.84 Aligned_cols=162 Identities=20% Similarity=0.290 Sum_probs=137.2
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||.||+|+.. +++.||+|.++.... ...+.+.+|+.++.++ +||||+++++++.. .+..++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-------~~~~~l 73 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-------ESRLFF 73 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-------CCEEEE
Confidence 46999999999999965 588999999976432 2234577899888776 79999999998876 567899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 74 v~E~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 74 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147 (329)
T ss_pred EEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence 99999999999988752 4689999999999999999999998 99999999999999999999999999997532
Q ss_pred -cccccceecccccccCCCCC
Q 006145 638 -NAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 -~~~~~~~~~gt~~y~aPE~~ 657 (659)
.........||+.|+|||+.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~ 168 (329)
T cd05618 148 RPGDTTSTFCGTPNYIAPEIL 168 (329)
T ss_pred CCCCccccccCCccccCHHHH
Confidence 22233456899999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=244.43 Aligned_cols=171 Identities=20% Similarity=0.278 Sum_probs=141.1
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||+|+||.||+|+.. +|+.||||++.... .....++.+|++++++++||||+++++++...... ....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~--~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR--EFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC--CCce
Confidence 4677899999999999999965 58999999987432 22345689999999999999999999998653211 1245
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.|+||||+. ++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 79 IYVVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 899999995 6999988752 4589999999999999999999998 99999999999999999999999999997
Q ss_pred cccccc----ccceecccccccCCCCC
Q 006145 635 LAENAE----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~----~~~~~~gt~~y~aPE~~ 657 (659)
...... .....+||+.|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~ 178 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELC 178 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHH
Confidence 543221 12346799999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=241.27 Aligned_cols=162 Identities=20% Similarity=0.346 Sum_probs=135.3
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHH-HHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIE-LISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||+||+|+.. +|+.||||++..... ...+++.+|.. +++.++||||+++++++.. .+..++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-------~~~~~l 73 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-------ADKLYF 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-------CCEEEE
Confidence 46899999999999975 599999999975421 22344556655 5688999999999998875 467899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc-
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA- 636 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~- 636 (659)
||||+++|+|.+++... ..+++.....++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 74 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 74 VLDYVNGGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred EEcCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 99999999999998752 4688999999999999999999998 9999999999999999999999999998753
Q ss_pred ccccccceecccccccCCCCC
Q 006145 637 ENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.........+||+.|||||+.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~ 168 (323)
T cd05575 148 EHSKTTSTFCGTPEYLAPEVL 168 (323)
T ss_pred cCCCccccccCChhhcChhhh
Confidence 222334556899999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=209.77 Aligned_cols=167 Identities=18% Similarity=0.303 Sum_probs=142.1
Q ss_pred CCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..++||+|.||+||||+- .+++.||+|+++..... -.....+||.+++.++|+|||+++++... .+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-------dkk 75 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-------DKK 75 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-------Cce
Confidence 456668999999999999994 45899999999765432 23578999999999999999999998764 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.-+|+|||.. +|..+...- ...++......++.|+.+||.|+|++ .+.|||+||.|.||..+|+.|++|||+|+
T Consensus 76 ltlvfe~cdq-dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 76 LTLVFEFCDQ-DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred eEEeHHHhhH-HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhh
Confidence 8899999976 888887653 34688899999999999999999998 99999999999999999999999999998
Q ss_pred cccccc-ccceecccccccCCCCC
Q 006145 635 LAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
-..-.. .....+.|.+|++|.++
T Consensus 150 afgipvrcysaevvtlwyrppdvl 173 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVL 173 (292)
T ss_pred hcCCceEeeeceeeeeeccCccee
Confidence 664332 45667899999999864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=236.75 Aligned_cols=174 Identities=19% Similarity=0.338 Sum_probs=141.5
Q ss_pred cCCCCCceeccCcCceEEEEEec--CCcEEEEEEecccCCC--chHHHHHHHHHHhCC---CCCCccceeeeeeeccccC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK--NGTFVAIRCLKMKKCH--STRNFMHHIELISKL---RHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~--~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~ 549 (659)
++|...+.||+|+||+||+|+.. +|+.||||+++..... ....+.+|+++++.+ +||||++++++|.....+
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~- 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD- 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC-
Confidence 36888899999999999999863 3788999998754322 234577788777665 699999999998642211
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEcc
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISS 629 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 629 (659)
.....++||||++ |+|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 80 -~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 80 -RETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred -CCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcc
Confidence 2356899999996 69999987532 24589999999999999999999998 999999999999999999999999
Q ss_pred CccccccccccccceecccccccCCCCC
Q 006145 630 YNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
||+++............||+.|+|||+.
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~ 181 (290)
T cd07862 154 FGLARIYSFQMALTSVVVTLWYRAPEVL 181 (290)
T ss_pred ccceEeccCCcccccccccccccChHHH
Confidence 9999876554445567899999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=241.59 Aligned_cols=166 Identities=22% Similarity=0.348 Sum_probs=138.3
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHH---hCCCCCCccceeeeeeeccccCCC
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELI---SKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++ +.++||||+++++++..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~------- 73 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT------- 73 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-------
Confidence 456789999999999999965 58999999997543 12234567776654 56789999999999875
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..|+||||+++|+|..++++ ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 74 ~~~~~lv~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05589 74 EDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFG 146 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCccc
Confidence 5678999999999999988864 3689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccc-ccccceecccccccCCCCCC
Q 006145 632 LPLLAEN-AEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 632 la~~~~~-~~~~~~~~gt~~y~aPE~~~ 658 (659)
+++.... .......+|++.|||||+..
T Consensus 147 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 174 (324)
T cd05589 147 LCKEGMGFGDRTSTFCGTPEFLAPEVLT 174 (324)
T ss_pred CCccCCCCCCcccccccCccccCHhHhc
Confidence 9865422 22334568999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=242.95 Aligned_cols=167 Identities=17% Similarity=0.269 Sum_probs=140.7
Q ss_pred CCCCCceeccCcCceEEEEEec----CCcEEEEEEecccC----CCchHHHHHHHHHHhCCC-CCCccceeeeeeecccc
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK----NGTFVAIRCLKMKK----CHSTRNFMHHIELISKLR-HRHLVSALGHCFECYFD 548 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 548 (659)
+|...+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|++++..++ |+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT---- 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----
Confidence 4677899999999999999853 58899999996432 122356889999999995 9999999988765
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
.+..++||||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 77 ---~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~ 147 (332)
T cd05614 77 ---EAKLHLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLT 147 (332)
T ss_pred ---CCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEe
Confidence 45689999999999999998752 4689999999999999999999998 99999999999999999999999
Q ss_pred cCccccccccc--cccceecccccccCCCCC
Q 006145 629 SYNLPLLAENA--EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~--~~~~~~~gt~~y~aPE~~ 657 (659)
|||+++..... ......+||+.|||||++
T Consensus 148 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 178 (332)
T cd05614 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178 (332)
T ss_pred eCcCCccccccCCCccccccCCccccCHHHh
Confidence 99999754322 223456799999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=241.47 Aligned_cols=170 Identities=14% Similarity=0.272 Sum_probs=145.0
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|+..+.||+|+||.||+++.. +|..||+|.+...... ..+++.+|++++++++||||+++++++.. .+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~ 76 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-------DG 76 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-------CC
Confidence 367888899999999999999966 5889999999754322 23579999999999999999999999876 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. .+|+||||||+||++++++.+||+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 151 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccc
Confidence 789999999999999999752 4588999999999999999999974 16999999999999999999999999999
Q ss_pred cccccccccceecccccccCCCCCC
Q 006145 634 LLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 634 ~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
...... ......|++.|+|||+..
T Consensus 152 ~~~~~~-~~~~~~g~~~y~aPE~~~ 175 (331)
T cd06649 152 GQLIDS-MANSFVGTRSYMSPERLQ 175 (331)
T ss_pred cccccc-ccccCCCCcCcCCHhHhc
Confidence 755332 234567999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=241.10 Aligned_cols=162 Identities=22% Similarity=0.345 Sum_probs=134.6
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHH-HHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIE-LISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||.||+|+.. +|+.||+|.+..... ....++.+|+. +++.++||||+++++++.+ .+..++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-------~~~~~l 73 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-------AEKLYF 73 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-------CCEEEE
Confidence 46999999999999975 589999999965421 22345666654 6788999999999998875 567899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc-
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA- 636 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~- 636 (659)
||||+++|+|.+++.. ...+++.....++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 74 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 147 (321)
T cd05603 74 VLDYVNGGELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGV 147 (321)
T ss_pred EEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence 9999999999988875 24578888999999999999999998 9999999999999999999999999998753
Q ss_pred ccccccceecccccccCCCCC
Q 006145 637 ENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.........+||+.|+|||+.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~ 168 (321)
T cd05603 148 EPEETTSTFCGTPEYLAPEVL 168 (321)
T ss_pred CCCCccccccCCcccCCHHHh
Confidence 222334556799999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=243.30 Aligned_cols=169 Identities=16% Similarity=0.209 Sum_probs=142.4
Q ss_pred cCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||.||+++.+. ++.||+|.+.... ......|.+|+.++..++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------~ 73 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-------E 73 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-------C
Confidence 367888999999999999999764 8899999986432 1223458899999999999999999998875 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++|+|.+++++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 74 NNLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred CEEEEEEeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecch
Confidence 6789999999999999999752 23589999999999999999999998 999999999999999999999999999
Q ss_pred cccccccc--ccceecccccccCCCCC
Q 006145 633 PLLAENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
++...... .....+||+.|||||++
T Consensus 149 a~~~~~~~~~~~~~~~gt~~y~aPE~~ 175 (332)
T cd05623 149 CLKLMEDGTVQSSVAVGTPDYISPEIL 175 (332)
T ss_pred heecccCCcceecccccCccccCHHHH
Confidence 86543222 22345799999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=241.72 Aligned_cols=162 Identities=23% Similarity=0.303 Sum_probs=137.2
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|++++..+ +||||+++++++.+ .+..|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-------~~~~~l 73 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-------KDRLFF 73 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-------CCeEEE
Confidence 46899999999999965 48899999997542 22335678899999876 79999999999875 467899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 74 v~E~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 74 VMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999988752 4689999999999999999999998 99999999999999999999999999987542
Q ss_pred -cccccceecccccccCCCCC
Q 006145 638 -NAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 -~~~~~~~~~gt~~y~aPE~~ 657 (659)
.........||+.|||||+.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~ 168 (321)
T cd05591 148 LNGVTTTTFCGTPDYIAPEIL 168 (321)
T ss_pred cCCccccccccCccccCHHHH
Confidence 22233456799999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=238.12 Aligned_cols=169 Identities=18% Similarity=0.320 Sum_probs=142.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|...+.||+|+||.||+|+.. +++.||||.++.... .....+.+|+++++.++||||+++++++.+ ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-------KE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-------CC
Confidence 467888999999999999999976 589999999975432 223467899999999999999999999875 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||++ |+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 77 TLTLVFEYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred eEEEEEECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcc
Confidence 7899999995 6888888642 24588899999999999999999998 9999999999999999999999999998
Q ss_pred ccccc-ccccceecccccccCCCCC
Q 006145 634 LLAEN-AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~-~~~~~~~~gt~~y~aPE~~ 657 (659)
+.... ........+|+.|||||+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~ 175 (303)
T cd07869 151 RAKSVPSHTYSNEVVTLWYRPPDVL 175 (303)
T ss_pred eeccCCCccCCCCcccCCCCChHHH
Confidence 65432 2223456789999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=241.56 Aligned_cols=163 Identities=22% Similarity=0.340 Sum_probs=137.7
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|++++..+ +||||+++++++.+ .+..|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-------~~~~~i 73 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-------PDRLFF 73 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-------CCEEEE
Confidence 46899999999999965 58999999997542 22345678899998877 69999999998875 567899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 74 v~Ey~~~g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 74 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred EEcCCCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 99999999999998753 4689999999999999999999998 99999999999999999999999999987542
Q ss_pred -cccccceecccccccCCCCCC
Q 006145 638 -NAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 638 -~~~~~~~~~gt~~y~aPE~~~ 658 (659)
.........||+.|||||+..
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~ 169 (320)
T cd05590 148 FNGKTTSTFCGTPDYIAPEILQ 169 (320)
T ss_pred cCCCcccccccCccccCHHHHc
Confidence 223334567999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=241.37 Aligned_cols=168 Identities=21% Similarity=0.302 Sum_probs=140.8
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~ 552 (659)
+|...+.||+|+||.||+|+.. +++.||||.++.... ...+.+..|.+++..+ +|++|+++++++.+ .
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-------~ 73 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-------M 73 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-------C
Confidence 4777899999999999999966 488999999975432 2234577888888877 58999999988875 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~ 147 (323)
T cd05616 74 DRLYFVMEYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCC
Confidence 6789999999999999998752 4589999999999999999999998 999999999999999999999999999
Q ss_pred ccccc-cccccceecccccccCCCCCC
Q 006145 633 PLLAE-NAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 633 a~~~~-~~~~~~~~~gt~~y~aPE~~~ 658 (659)
++... ........+||+.|||||+..
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05616 148 CKENMWDGVTTKTFCGTPDYIAPEIIA 174 (323)
T ss_pred ceecCCCCCccccCCCChhhcCHHHhc
Confidence 97543 223344568999999999763
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=241.23 Aligned_cols=163 Identities=18% Similarity=0.306 Sum_probs=135.7
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHH-HHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIE-LISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||+||+|+.. +|+.||||++..... ....++.+|.. +++.++||||+++++++.. .+..++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-------~~~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-------TEKLYF 73 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-------CCEEEE
Confidence 46899999999999964 699999999965421 22345666665 4778999999999998875 567899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||||+++|+|..++.. ...+++.....++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 74 VLDFVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (325)
T ss_pred EEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence 9999999999998875 24689999999999999999999998 99999999999999999999999999987532
Q ss_pred -cccccceecccccccCCCCCC
Q 006145 638 -NAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 638 -~~~~~~~~~gt~~y~aPE~~~ 658 (659)
........+||+.|||||+..
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~ 169 (325)
T cd05604 148 AQSDTTTTFCGTPEYLAPEVIR 169 (325)
T ss_pred CCCCCcccccCChhhCCHHHHc
Confidence 222335567999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=247.38 Aligned_cols=174 Identities=22% Similarity=0.352 Sum_probs=141.0
Q ss_pred hhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCC-chHHHHHHHHHHhCC-CCCCccceeeeeeecc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCH-STRNFMHHIELISKL-RHRHLVSALGHCFECY 546 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 546 (659)
..++|+..+.||+|+||.||+|+.. ++..||||+++..... ..+.+.+|+++++.+ +|+|||+++|+|..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 4457888899999999999999842 2458999999754332 235688999999999 89999999999976
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCC---------------------------------------------------
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGH--------------------------------------------------- 575 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~--------------------------------------------------- 575 (659)
.+..++||||+++|+|.++++...
T Consensus 114 -----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 114 -----GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred -----CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 456899999999999999885321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccc
Q 006145 576 ----------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENA 639 (659)
Q Consensus 576 ----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 639 (659)
....+++.+..+++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence 012478899999999999999999998 9999999999999999999999999999765432
Q ss_pred ccc---ceecccccccCCCCCC
Q 006145 640 EKV---GHVIPYSGSIDPTNSA 658 (659)
Q Consensus 640 ~~~---~~~~gt~~y~aPE~~~ 658 (659)
... ....++..|||||+..
T Consensus 266 ~~~~~~~~~~~~~~y~aPE~~~ 287 (374)
T cd05106 266 SNYVVKGNARLPVKWMAPESIF 287 (374)
T ss_pred cceeeccCCCCccceeCHHHhc
Confidence 211 2234566899999753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=244.48 Aligned_cols=162 Identities=15% Similarity=0.292 Sum_probs=136.5
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
|+..+.||+|+||.||+|+.. +|+.||||.+...... ..+++.+|++++++++|+||+++++++.. .+..+
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~~~~ 148 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-------NGEIQ 148 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-------CCeEE
Confidence 345588999999999999965 5899999999654322 23578999999999999999999999875 46789
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.+.. ..++.....++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 149 lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 149 VLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred EEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 999999999987532 345777889999999999999998 9999999999999999999999999999766
Q ss_pred cccc-ccceecccccccCCCCC
Q 006145 637 ENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
.... ......||..|+|||++
T Consensus 219 ~~~~~~~~~~~gt~~y~aPE~~ 240 (353)
T PLN00034 219 AQTMDPCNSSVGTIAYMSPERI 240 (353)
T ss_pred ccccccccccccCccccCcccc
Confidence 4332 23456899999999985
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=255.01 Aligned_cols=179 Identities=17% Similarity=0.266 Sum_probs=143.5
Q ss_pred cCCCCCceeccCcCceEEEEEecCC-cEEEEEEecccCCCchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNG-TFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++.+++.|.+|||+.||.|+...+ ..+|+|++-..+.+..+...+||++|++|+ |+|||.+++..........+.-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3455679999999999999997765 999999997666566688999999999997 99999999932211111111246
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
++|.||||++|.|-++|..+ ....|++.++++|+.|+++|+++||. +.|+|||||||.+||||+.++..||||||-|.
T Consensus 117 vllLmEyC~gg~Lvd~mn~R-lq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTR-LQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHH-HhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 88999999999999999853 23459999999999999999999999 68999999999999999999999999999984
Q ss_pred cc--cc--ccc------cceecccccccCCCCC
Q 006145 635 LA--EN--AEK------VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~--~~--~~~------~~~~~gt~~y~aPE~~ 657 (659)
.. .. ... .-..-.|+.|+|||-+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI 227 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI 227 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHH
Confidence 32 11 110 1235578999999953
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=241.20 Aligned_cols=169 Identities=14% Similarity=0.278 Sum_probs=144.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|+..+.||+|+||.||+++.. +|..+|+|.+...... ..+++.+|++++++++|+||++++++|.+ .+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~ 76 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-------DG 76 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-------CC
Confidence 467888999999999999999976 5889999998754322 23569999999999999999999999986 46
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++|+|.+++... ..+++.....++.++++||+|||+. .+|+||||||+||++++++.+||+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~ 151 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcc
Confidence 789999999999999999752 4588999999999999999999974 26999999999999999999999999999
Q ss_pred cccccccccceecccccccCCCCC
Q 006145 634 LLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
...... ......|+..|+|||+.
T Consensus 152 ~~~~~~-~~~~~~~~~~y~aPE~~ 174 (333)
T cd06650 152 GQLIDS-MANSFVGTRSYMSPERL 174 (333)
T ss_pred hhhhhh-ccccCCCCccccCHHHh
Confidence 755332 22345789999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=245.46 Aligned_cols=163 Identities=12% Similarity=0.174 Sum_probs=139.5
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..+|...+.||+|+||.||+|+.. +++.||+|... ...+.+|++++++++|||||++++++.. ...
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~-------~~~ 157 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY-------NKF 157 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-------CCe
Confidence 357999999999999999999964 58999999753 2357899999999999999999999875 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++|+||+. ++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+|+
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred eEEEEecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 899999995 6999888752 4589999999999999999999998 99999999999999999999999999997
Q ss_pred ccccc--cccceecccccccCCCCCC
Q 006145 635 LAENA--EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~~~~--~~~~~~~gt~~y~aPE~~~ 658 (659)
..... ......+||+.|+|||+..
T Consensus 231 ~~~~~~~~~~~~~~gt~~y~aPE~~~ 256 (391)
T PHA03212 231 FPVDINANKYYGWAGTIATNAPELLA 256 (391)
T ss_pred ccccccccccccccCccCCCChhhhc
Confidence 54221 2234568999999999863
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-28 Score=249.54 Aligned_cols=257 Identities=24% Similarity=0.220 Sum_probs=201.0
Q ss_pred ccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCC
Q 006145 103 LVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILA 182 (659)
Q Consensus 103 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (659)
+..-.++++|+|++|.++..-.+.|.+|.+|..|.|+.|+++...+..|.+|++|+.|+|..|+|.-.---.|.+|++|+
T Consensus 169 fp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~ 248 (873)
T KOG4194|consen 169 FPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQ 248 (873)
T ss_pred CCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhh
Confidence 44446677788888887777777788888888888888888765556677788888888888877633245677788888
Q ss_pred EEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCC---CcccceEecCCCc
Q 006145 183 VLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKV---GKKLVTMILSKNK 258 (659)
Q Consensus 183 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~---~~~L~~L~l~~N~ 258 (659)
.|.|..|.++..-...|..|.++++|+|+.|+++..-.. +.+|+.|+.|+||+|.|...-++. .++|+.|+|++|+
T Consensus 249 nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~ 328 (873)
T KOG4194|consen 249 NLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNR 328 (873)
T ss_pred hhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccc
Confidence 888888887766666788888888888888888765544 778888888888888887766654 5788999999999
Q ss_pred CCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCc---CCCCCCCCCEEECcCCCCcccC
Q 006145 259 FRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFD---DLSCNPELGFVDLSSNLLTGQL 335 (659)
Q Consensus 259 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~---~~~~~~~L~~L~ls~N~l~g~i 335 (659)
|+...+..|..+..|++|+|++|.++..--..|..+++|+.|||++|.+++.+.+ .|..++.|+.|++.+|++...-
T Consensus 329 i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~ 408 (873)
T KOG4194|consen 329 ITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIP 408 (873)
T ss_pred cccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecc
Confidence 9888888888888999999999988876667788889999999999998887765 3667888999999999988333
Q ss_pred ChhhhCCCCCCEEEcCCccccCCC
Q 006145 336 PNCLLAGSKNRVVLYARNCLAAGN 359 (659)
Q Consensus 336 p~~~~~~~~l~~l~~~~N~l~~~~ 359 (659)
-..+..+..|+.|++.+|.+....
T Consensus 409 krAfsgl~~LE~LdL~~NaiaSIq 432 (873)
T KOG4194|consen 409 KRAFSGLEALEHLDLGDNAIASIQ 432 (873)
T ss_pred hhhhccCcccceecCCCCcceeec
Confidence 346777888899999998776543
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=239.37 Aligned_cols=162 Identities=23% Similarity=0.328 Sum_probs=135.6
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||.||+|+.. +++.||||.++... ....+.+..|.+++... +||||+++++++.. .+..++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-------~~~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-------KEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-------CCEEEE
Confidence 46899999999999965 48899999997542 12334566777777754 89999999998875 457899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 74 v~e~~~gg~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 74 VMEYLNGGDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred EEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 99999999999998752 4588999999999999999999998 99999999999999999999999999997542
Q ss_pred -cccccceecccccccCCCCC
Q 006145 638 -NAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 -~~~~~~~~~gt~~y~aPE~~ 657 (659)
........+||+.|||||+.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~ 168 (316)
T cd05592 148 NGEGKASTFCGTPDYIAPEIL 168 (316)
T ss_pred CCCCccccccCCccccCHHHH
Confidence 22334556899999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-26 Score=238.38 Aligned_cols=162 Identities=24% Similarity=0.346 Sum_probs=136.8
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||+||+|+.. +++.||||.++... ....+.+..|.+++... +||||+++++++.+ .+..++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-------~~~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-------KENLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-------CCEEEE
Confidence 46899999999999976 48899999997542 12345577788888764 89999999999876 467899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||||+++|+|.+++... ..+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 74 v~ey~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 74 VMEYLNGGDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENM 147 (316)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence 99999999999999752 4688999999999999999999998 99999999999999999999999999986432
Q ss_pred -cccccceecccccccCCCCC
Q 006145 638 -NAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 -~~~~~~~~~gt~~y~aPE~~ 657 (659)
.........||+.|||||+.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~ 168 (316)
T cd05619 148 LGDAKTCTFCGTPDYIAPEIL 168 (316)
T ss_pred CCCCceeeecCCccccCHHHH
Confidence 22234557899999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-27 Score=247.38 Aligned_cols=275 Identities=24% Similarity=0.186 Sum_probs=241.6
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
++++.|+|.+|.++..- .+.+.-++.|+.|||+.|.++...-..|..=.++++|+|++|.|+..-...|.+
T Consensus 125 ghl~~L~L~~N~I~sv~---------se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~ 195 (873)
T KOG4194|consen 125 GHLEKLDLRHNLISSVT---------SEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDS 195 (873)
T ss_pred cceeEEeeecccccccc---------HHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccc
Confidence 57999999998765321 136778899999999999998887788888889999999999999877888999
Q ss_pred CCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEE
Q 006145 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLD 232 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~ 232 (659)
+.+|..|.|+.|+++...+..|.+|++|+.|+|..|+|.-.---.|.+|++|+.|.|..|.++..-.. |.++.++++|+
T Consensus 196 lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~ 275 (873)
T KOG4194|consen 196 LNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLN 275 (873)
T ss_pred cchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceee
Confidence 99999999999999976667899999999999999999854456799999999999999999876554 99999999999
Q ss_pred cccCCCCCCCCCC---CcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCC
Q 006145 233 LENNALGPQFPKV---GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG 309 (659)
Q Consensus 233 L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 309 (659)
|+.|+++..-... +++|+.|+||+|.|...-++.+.-.++|++|||++|+|+...+..|..|..|+.|+|++|+++.
T Consensus 276 L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~ 355 (873)
T KOG4194|consen 276 LETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDH 355 (873)
T ss_pred cccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHH
Confidence 9999997655544 5789999999999999889999999999999999999999889999999999999999999987
Q ss_pred cCCcCCCCCCCCCEEECcCCCCcccCCh---hhhCCCCCCEEEcCCccccC
Q 006145 310 KLFDDLSCNPELGFVDLSSNLLTGQLPN---CLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 310 ~~p~~~~~~~~L~~L~ls~N~l~g~ip~---~~~~~~~l~~l~~~~N~l~~ 357 (659)
.-...|.++.+|+.|||++|.+++.|.+ .+..+++|+.|.+.+|++..
T Consensus 356 l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~ 406 (873)
T KOG4194|consen 356 LAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKS 406 (873)
T ss_pred HHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeee
Confidence 7777788999999999999999988865 35567889999999998764
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=235.44 Aligned_cols=168 Identities=18% Similarity=0.292 Sum_probs=141.4
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|...+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++.. .+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~ 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-------RG 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-------CC
Confidence 36888899999999999999976 588999999975432 224568899999999999999999998875 46
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||++++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 74 KLYLVFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred EEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 78999999999877655432 24589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccc--ccceecccccccCCCCC
Q 006145 634 LLAENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
+...... ......|++.|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 173 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELL 173 (287)
T ss_pred ccccccccccccccccccccCCcHHH
Confidence 7654322 22346789999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=259.22 Aligned_cols=171 Identities=17% Similarity=0.303 Sum_probs=142.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||.||+|+.. +|+.||||++...... ..++|.+|++++++++||||+++++++.+ .
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-------~ 74 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-------G 74 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-------C
Confidence 46888899999999999999965 5899999999754322 23579999999999999999999999976 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGH--------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV 624 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~ 624 (659)
+..++||||+++|+|.+++.... .....++..+++++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~ 151 (932)
T PRK13184 75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGE 151 (932)
T ss_pred CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCC
Confidence 67899999999999999986311 123467888899999999999999998 9999999999999999999
Q ss_pred eEEccCccccccccc-------------------cccceecccccccCCCCC
Q 006145 625 AKISSYNLPLLAENA-------------------EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 ~kl~DFGla~~~~~~-------------------~~~~~~~gt~~y~aPE~~ 657 (659)
+||+|||+++..... ......+||+.|||||+.
T Consensus 152 vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l 203 (932)
T PRK13184 152 VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL 203 (932)
T ss_pred EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh
Confidence 999999999765110 011235799999999975
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=245.07 Aligned_cols=174 Identities=22% Similarity=0.366 Sum_probs=142.3
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCC-chHHHHHHHHHHhCCC-CCCccceeeeeeec
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCH-STRNFMHHIELISKLR-HRHLVSALGHCFEC 545 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 545 (659)
...++|...+.||+|+||.||+|+.. .+..||||+++..... ..+.|.+|++++++++ |||||+++|+|.+
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~- 112 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK- 112 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-
Confidence 34667888899999999999999853 1357999999754332 2357999999999996 9999999999975
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCC--------------------------------------------------
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGH-------------------------------------------------- 575 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~-------------------------------------------------- 575 (659)
....|+|||||++|+|.++++...
T Consensus 113 ------~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (400)
T cd05105 113 ------SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT 186 (400)
T ss_pred ------CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence 456899999999999999886321
Q ss_pred -------------------------------------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCC
Q 006145 576 -------------------------------------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNL 612 (659)
Q Consensus 576 -------------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl 612 (659)
....++|..+.+++.|+++||+|||+. +|+||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~di 263 (400)
T cd05105 187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDL 263 (400)
T ss_pred ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCC
Confidence 012478899999999999999999998 9999999
Q ss_pred CCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 613 KITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 613 k~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
||+||++++++.+||+|||+++....... .....++..|||||+.
T Consensus 264 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 311 (400)
T cd05105 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI 311 (400)
T ss_pred ChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh
Confidence 99999999999999999999976533221 2334567889999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=239.89 Aligned_cols=162 Identities=22% Similarity=0.308 Sum_probs=137.8
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.++.++ +||||+++++++.+ .+..++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-------~~~~~l 73 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-------TSRLFL 73 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-------CCEEEE
Confidence 46999999999999965 588999999976432 2235588999999888 69999999998875 467899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc-
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA- 636 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~- 636 (659)
||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 74 v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 74 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147 (327)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence 99999999999988752 4699999999999999999999998 9999999999999999999999999999753
Q ss_pred ccccccceecccccccCCCCC
Q 006145 637 ENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.........+||+.|+|||+.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~ 168 (327)
T cd05617 148 GPGDTTSTFCGTPNYIAPEIL 168 (327)
T ss_pred CCCCceecccCCcccCCHHHH
Confidence 222334557899999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-26 Score=238.27 Aligned_cols=163 Identities=20% Similarity=0.327 Sum_probs=137.0
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||.||+|+.. +|+.||+|.++... ....+.+..|++++... +||||+++++++.+ .+..|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-------~~~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-------KEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-------CCEEEE
Confidence 46999999999999976 58999999997542 12345577888888764 89999999998875 567899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||||+++|+|.+++... ..+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 74 v~E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 74 VMEFLNGGDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENV 147 (316)
T ss_pred EECCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence 99999999999998752 4588999999999999999999998 99999999999999999999999999986432
Q ss_pred -cccccceecccccccCCCCCC
Q 006145 638 -NAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 638 -~~~~~~~~~gt~~y~aPE~~~ 658 (659)
........+||+.|+|||+..
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~ 169 (316)
T cd05620 148 FGDNRASTFCGTPDYIAPEILQ 169 (316)
T ss_pred cCCCceeccCCCcCccCHHHHc
Confidence 222345578999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=233.89 Aligned_cols=163 Identities=19% Similarity=0.288 Sum_probs=136.9
Q ss_pred eccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEe
Q 006145 485 MGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 485 ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
||+|+||+||+++.. +|+.||||.+...... ..+.+..|++++++++|+||+++.+++.. ....++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-------~~~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-------KTDLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-------CCeEEEEEe
Confidence 699999999999965 6899999999654322 23567889999999999999999988865 456899999
Q ss_pred ccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccc
Q 006145 561 YVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENA 639 (659)
Q Consensus 561 y~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 639 (659)
|+++|+|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 99999999887532 1234689999999999999999999998 9999999999999999999999999999765432
Q ss_pred c-ccceecccccccCCCCC
Q 006145 640 E-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 640 ~-~~~~~~gt~~y~aPE~~ 657 (659)
. ......||+.|+|||+.
T Consensus 151 ~~~~~~~~g~~~y~aPE~~ 169 (280)
T cd05608 151 QSKTKGYAGTPGFMAPELL 169 (280)
T ss_pred CccccccCCCcCccCHHHh
Confidence 2 23446799999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-27 Score=239.08 Aligned_cols=169 Identities=18% Similarity=0.321 Sum_probs=146.2
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..|...+.||+|.||.||||... +++.||+|++..+..+ ..++..+|+.+|..++++||.+++|.|.. ...
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-------g~~ 85 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-------GTK 85 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-------ccc
Confidence 34666789999999999999954 5999999999876544 35789999999999999999999999986 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
++++||||.+|++.+.|... ..+++....-|.+++..|+.|||+. +.+|||||+.|||+..+|.+|++|||.+.
T Consensus 86 LwiiMey~~gGsv~~lL~~~---~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSG---NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred HHHHHHHhcCcchhhhhccC---CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceee
Confidence 89999999999999999853 3457777788999999999999999 99999999999999999999999999997
Q ss_pred ccccccc-cceecccccccCCCCCC
Q 006145 635 LAENAEK-VGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~~~~~~-~~~~~gt~~y~aPE~~~ 658 (659)
....... ....+||+.|||||++.
T Consensus 160 ql~~~~~rr~tfvGTPfwMAPEVI~ 184 (467)
T KOG0201|consen 160 QLTNTVKRRKTFVGTPFWMAPEVIK 184 (467)
T ss_pred eeechhhccccccccccccchhhhc
Confidence 6654433 37799999999999863
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=239.44 Aligned_cols=167 Identities=21% Similarity=0.284 Sum_probs=139.3
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~ 552 (659)
+|+..+.||+|+||+||+|+.. +|+.||+|++.... ....+.+..|+++++.+. |++|+++++++.+ .
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-------~ 73 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-------V 73 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-------C
Confidence 3667789999999999999965 58999999997542 223356888999998886 5778888887765 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 74 DRLYFVMEYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred CEEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEecccc
Confidence 5789999999999999998752 4689999999999999999999998 999999999999999999999999999
Q ss_pred cccccc-ccccceecccccccCCCCC
Q 006145 633 PLLAEN-AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~-~~~~~~~~gt~~y~aPE~~ 657 (659)
++.... ........||+.|||||+.
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~ 173 (323)
T cd05615 148 CKEHMVDGVTTRTFCGTPDYIAPEII 173 (323)
T ss_pred ccccCCCCccccCccCCccccCHHHH
Confidence 875432 2223456799999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=237.66 Aligned_cols=169 Identities=20% Similarity=0.351 Sum_probs=139.9
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCc----EEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGT----FVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.+|+..+.||+|+||.||+|++. +|. .||||.++.... ...++|.+|+.+++.++||||++++|+|..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence 45888899999999999999864 344 489999875432 234679999999999999999999999974
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
...++|+||+++|+|.++++.. ...+++.....++.||++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 --~~~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~Df 153 (316)
T cd05108 81 --STVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDF 153 (316)
T ss_pred --CCceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccc
Confidence 3468999999999999999853 24588999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccc---ceecccccccCCCCCC
Q 006145 631 NLPLLAENAEKV---GHVIPYSGSIDPTNSA 658 (659)
Q Consensus 631 Gla~~~~~~~~~---~~~~gt~~y~aPE~~~ 658 (659)
|+++........ ....++..|||||+..
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~y~apE~~~ 184 (316)
T cd05108 154 GLAKLLGADEKEYHAEGGKVPIKWMALESIL 184 (316)
T ss_pred cccccccCCCcceeccCCccceeecChHHhc
Confidence 999866433222 2233467899999863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-27 Score=235.91 Aligned_cols=172 Identities=18% Similarity=0.264 Sum_probs=151.0
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.+.|..-++||+||||.||-++.+ +|+.+|.|++.+... +...-.+.|-.+|.+++.+.||.+--+|.+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT------- 256 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET------- 256 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-------
Confidence 456788899999999999999966 599999999965432 233457889999999999999998766654
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+.+++|+..|.||||.-+|.... ..-++..+.+-+|.+|+.||++||+. +||.||+||+|||+|++|+++|+|.|
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLG 332 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLG 332 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccc
Confidence 678999999999999998887633 35689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
||..+.........+||.+|||||++.
T Consensus 333 LAvei~~g~~~~~rvGT~GYMAPEvl~ 359 (591)
T KOG0986|consen 333 LAVEIPEGKPIRGRVGTVGYMAPEVLQ 359 (591)
T ss_pred eEEecCCCCccccccCcccccCHHHHc
Confidence 999888888888889999999999875
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-27 Score=226.83 Aligned_cols=171 Identities=22% Similarity=0.295 Sum_probs=143.4
Q ss_pred cCCCCCceeccCcCceEEEEEecC-----CcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN-----GTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 549 (659)
..|+....||+|.||.||||+-.+ .+.+|+|+++..+.. -.....|||.+++.++|||||.|..++.+.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence 457778999999999999997432 237999999865322 235688999999999999999999998752
Q ss_pred CCCceeEEEEeccCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC----c
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISE--GHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN----L 623 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~----~ 623 (659)
...++|++||.+. ||.++++- ....+.++......|..||+.|+.|||++ =|+||||||.|||+..+ |
T Consensus 100 --d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG 173 (438)
T KOG0666|consen 100 --DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERG 173 (438)
T ss_pred --CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccC
Confidence 4578999999998 99999873 23345789999999999999999999999 89999999999999877 8
Q ss_pred ceEEccCcccccccccc----ccceecccccccCCCCC
Q 006145 624 VAKISSYNLPLLAENAE----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 624 ~~kl~DFGla~~~~~~~----~~~~~~gt~~y~aPE~~ 657 (659)
.+||+|||+|+.+.+.- ....++.|.+|+|||-+
T Consensus 174 ~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELL 211 (438)
T KOG0666|consen 174 RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELL 211 (438)
T ss_pred eeEeecccHHHHhhccccccccCCceEEEEEecChHHh
Confidence 99999999999886533 34678999999999965
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=240.63 Aligned_cols=171 Identities=19% Similarity=0.329 Sum_probs=150.1
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|...+.+|+|+||.++..+.+ +++.+++|.+....... .+....|+.++++++|||||.+.+.+.+ .+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~-------~~ 76 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE-------DG 76 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc-------CC
Confidence 56777899999999999998865 47899999997655332 3468899999999999999999998876 34
Q ss_pred e-eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 554 R-IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 554 ~-~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
. .+|||+|++||++.+.+.+.+ ...+++.+..+++.|++.|+.|||+. .|+|||||+.||++..+..+||+|||+
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhh
Confidence 4 899999999999999998644 35688899999999999999999988 999999999999999999999999999
Q ss_pred cccccccc-ccceecccccccCCCCCC
Q 006145 633 PLLAENAE-KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 633 a~~~~~~~-~~~~~~gt~~y~aPE~~~ 658 (659)
|+...+.. .....+||+.||.||.+.
T Consensus 153 aK~l~~~~~~a~tvvGTp~YmcPEil~ 179 (426)
T KOG0589|consen 153 AKILNPEDSLASTVVGTPYYMCPEILS 179 (426)
T ss_pred hhhcCCchhhhheecCCCcccCHHHhC
Confidence 99987766 678899999999999764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=228.26 Aligned_cols=168 Identities=19% Similarity=0.327 Sum_probs=141.7
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
++|+..+.||+|+||.||++++.++..+|+|.+.... ...++|.+|++++++++||||++++++|.. .+..+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~~~ 75 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-------QKPLY 75 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEcc-------CCCEE
Confidence 3466778999999999999998888899999986443 235679999999999999999999999875 45689
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.++++... ..++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 76 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~ 150 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150 (256)
T ss_pred EEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcccc
Confidence 9999999999999997532 3589999999999999999999998 9999999999999999999999999998755
Q ss_pred cccccc--ceecccccccCCCCC
Q 006145 637 ENAEKV--GHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~~--~~~~gt~~y~aPE~~ 657 (659)
...... ....++..|+|||+.
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~ 173 (256)
T cd05114 151 LDDEYTSSSGAKFPVKWSPPEVF 173 (256)
T ss_pred CCCceeccCCCCCchhhCChhhc
Confidence 322221 223456689999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=244.67 Aligned_cols=165 Identities=21% Similarity=0.333 Sum_probs=140.8
Q ss_pred CceeccCcCceEEEEEec-CCcEEEEEEecccCC----CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 482 SAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC----HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
..+||+|+|-+||||... +|.+||.-.++.... ...++|..|+++|+.|+|+|||+++.++.+. .....-
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~-----~n~~in 119 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT-----DNKTIN 119 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC-----CCceee
Confidence 478999999999999965 499999877754332 2236799999999999999999999988762 235578
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC-cceEEccCccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN-LVAKISSYNLPLL 635 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla~~ 635 (659)
+|+|.|..|+|+.|..+. +.++.....+|++||++||.|||++ .|||||||||-+||+|..+ |.+||+|.|||..
T Consensus 120 ~iTEL~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeecccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 999999999999999864 4588889999999999999999995 7899999999999999855 9999999999988
Q ss_pred cccccccceecccccccCCCC
Q 006145 636 AENAEKVGHVIPYSGSIDPTN 656 (659)
Q Consensus 636 ~~~~~~~~~~~gt~~y~aPE~ 656 (659)
.... .....+|||.|||||-
T Consensus 196 ~r~s-~aksvIGTPEFMAPEm 215 (632)
T KOG0584|consen 196 LRKS-HAKSVIGTPEFMAPEM 215 (632)
T ss_pred hhcc-ccceeccCccccChHH
Confidence 8654 3455999999999994
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=231.24 Aligned_cols=169 Identities=22% Similarity=0.323 Sum_probs=140.6
Q ss_pred cCCCCCceeccCcCceEEEEEec----CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK----NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
++|+..+.||+|+||.||+|++. .+..||+|.++.... ...+.|.+|+.++++++||||++++|++..
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 77 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR------- 77 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-------
Confidence 45778899999999999999854 367899999976532 223579999999999999999999999875
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..++||||+++|+|.+++... ...++|..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg 152 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFR 152 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCc
Confidence 45689999999999999999753 24689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccc--ceecccccccCCCCC
Q 006145 632 LPLLAENAEKV--GHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~--~~~~gt~~y~aPE~~ 657 (659)
.+......... ....++..|+|||+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (266)
T cd05064 153 RLQEDKSEAIYTTMSGKSPVLWAAPEAI 180 (266)
T ss_pred ccccccccchhcccCCCCceeecCHHHH
Confidence 87544222111 223456789999964
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-28 Score=254.19 Aligned_cols=276 Identities=28% Similarity=0.343 Sum_probs=207.6
Q ss_pred CEeEEEeCCCCCCC-CCCCCC--------------cCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcc
Q 006145 75 SITQLHIVGNKRAP-MLPLSF--------------SMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMS 139 (659)
Q Consensus 75 ~v~~L~l~~~~~~~-~l~~~~--------------~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls 139 (659)
-|...|+++|.++| ..|.+. ....+|+.++.+.+|++|.+++|++.. +.+.++.|+.|+.+++.
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LRsv~~R 86 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLRSVIVR 86 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhhChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhHHHhhh
Confidence 36677788877663 344321 123466777777888888888887753 44567778888888888
Q ss_pred cCcCc-ccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCc-ccCCCCCCcEEecccccccc
Q 006145 140 SNFLN-GAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPD-SFSYLENLRVLALSNNHFYG 217 (659)
Q Consensus 140 ~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~ 217 (659)
.|++. .-+|..+..|..|..||||+|++. +.|..+..-+++-+|+||+|+|. .||. -|.+|+.|-.||||+|++..
T Consensus 87 ~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~ 164 (1255)
T KOG0444|consen 87 DNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEM 164 (1255)
T ss_pred ccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhh
Confidence 88774 346777888888888888888887 77888888888888888888888 4554 46788888888888888888
Q ss_pred CCCCCCCCCcCCEEEcccCCCCCCCC---CCCcccceEecCCCcCC-ccCchhccCCccccEEeccCcccccCCchhhcC
Q 006145 218 EVPDFSGLTYLQVLDLENNALGPQFP---KVGKKLVTMILSKNKFR-SAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLS 293 (659)
Q Consensus 218 ~~p~~~~l~~L~~L~L~~N~l~~~~~---~~~~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 293 (659)
.+|.+..|..|++|+|++|.+...-- ..+++|+.|.+++.+=+ ..+|.++..+.+|..+|||.|++. .+|+.+.+
T Consensus 165 LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~ 243 (1255)
T KOG0444|consen 165 LPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYK 243 (1255)
T ss_pred cCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhh
Confidence 88888888888888888887643211 12456777777765432 457888888888888999998887 68888888
Q ss_pred CCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCcccc
Q 006145 294 LPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 294 l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
+++|+.|+||+|+|+ .+....+...+|+.|++|.|+++ .+|+++..+++|+.|++.+|.++
T Consensus 244 l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~ 304 (1255)
T KOG0444|consen 244 LRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT 304 (1255)
T ss_pred hhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc
Confidence 888999999998887 44445566678888888888888 78888888888888888888664
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-26 Score=231.78 Aligned_cols=162 Identities=18% Similarity=0.290 Sum_probs=137.7
Q ss_pred eccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEe
Q 006145 485 MGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 485 ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
||+|+||.||+++.+ +|+.||+|++..... ...+.+..|++++++++||||+++++++.. ....++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-------~~~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-------KTHLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-------CCeEEEEEe
Confidence 699999999999965 599999999964322 123456779999999999999999998875 457899999
Q ss_pred ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccccccc
Q 006145 561 YVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640 (659)
Q Consensus 561 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 640 (659)
|+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 74 ~~~g~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 74 LMNGGDLKYHIYNV-GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK 149 (277)
T ss_pred cCCCCCHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc
Confidence 99999999888642 234589999999999999999999998 99999999999999999999999999997665544
Q ss_pred ccceecccccccCCCCC
Q 006145 641 KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 641 ~~~~~~gt~~y~aPE~~ 657 (659)
......|+..|+|||+.
T Consensus 150 ~~~~~~~~~~y~aPE~~ 166 (277)
T cd05607 150 TITQRAGTNGYMAPEIL 166 (277)
T ss_pred eeeccCCCCCccCHHHH
Confidence 44556799999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=240.02 Aligned_cols=169 Identities=16% Similarity=0.302 Sum_probs=150.1
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
....|.....||+|.|+.|..|+.. +|..||||.+++..... .+.+.+|+++|..++|||||+++.+...
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t------- 126 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET------- 126 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-------
Confidence 3566888899999999999999965 59999999997665433 2458999999999999999999999876
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
...+|+||||+.+|.+++++... ..........+..|+.+|++|||++ .|+|||||++|||||.++++||+|||
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccc
Confidence 56799999999999999999864 2345577888999999999999999 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTN 656 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~ 656 (659)
++..++........+|++.|.|||.
T Consensus 201 fS~~~~~~~~lqt~cgsppyAaPEl 225 (596)
T KOG0586|consen 201 FSTFFDYGLMLQTFCGSPPYAAPEL 225 (596)
T ss_pred cceeecccccccccCCCCCccChHh
Confidence 9998888888899999999999996
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=238.28 Aligned_cols=162 Identities=19% Similarity=0.313 Sum_probs=133.7
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHH-HHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIE-LISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||+||+|+.. +++.||+|++..... ....++.+|.. +++.++|+||+++++++.+ .+..++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-------~~~~~l 73 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-------ADKLYF 73 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-------CCeEEE
Confidence 46899999999999965 578999999975321 22234555544 5788999999999998875 567899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc-
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA- 636 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~- 636 (659)
||||+++|+|.+++... ..+.+.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 74 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 74 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 99999999999999752 4577888889999999999999998 9999999999999999999999999999753
Q ss_pred ccccccceecccccccCCCCC
Q 006145 637 ENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.........+||+.|||||+.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~ 168 (325)
T cd05602 148 EHNGTTSTFCGTPEYLAPEVL 168 (325)
T ss_pred cCCCCcccccCCccccCHHHH
Confidence 223334556899999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=234.63 Aligned_cols=165 Identities=15% Similarity=0.272 Sum_probs=141.1
Q ss_pred CceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEE
Q 006145 482 SAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLI 558 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV 558 (659)
.+.+|+|.||+||-|+.+ +|+.||||.+.+.. .+...+..+|+.+|++++||.||.+--.|.+ ++.+++|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-------~ervFVV 641 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-------PERVFVV 641 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-------CceEEEE
Confidence 478999999999999965 69999999997654 2344679999999999999999999877765 6789999
Q ss_pred EeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC---cceEEccCccccc
Q 006145 559 FEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN---LVAKISSYNLPLL 635 (659)
Q Consensus 559 ~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~---~~~kl~DFGla~~ 635 (659)
||-+.| |..+.+-. .....|+.....-...||+.||.|||.. +|+|+||||+|||+.+. -.+||+|||+|+.
T Consensus 642 MEKl~G-DMLEMILS-sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 642 MEKLHG-DMLEMILS-SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred ehhhcc-hHHHHHHH-hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceee
Confidence 999955 66665543 2245688888888999999999999999 99999999999999643 5799999999999
Q ss_pred cccccccceecccccccCCCCCC
Q 006145 636 AENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 636 ~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+.+...-..++||+.|+|||++.
T Consensus 717 IgEksFRrsVVGTPAYLaPEVLr 739 (888)
T KOG4236|consen 717 IGEKSFRRSVVGTPAYLAPEVLR 739 (888)
T ss_pred cchhhhhhhhcCCccccCHHHHh
Confidence 98887788899999999999875
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.5e-26 Score=236.46 Aligned_cols=163 Identities=22% Similarity=0.319 Sum_probs=138.0
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||+||+|+.. +++.||||.++... ......+.+|++++..+ +||||+++++++.+ .+..++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-------~~~~~l 73 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-------KDRLFF 73 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-------CCEEEE
Confidence 46899999999999976 48899999997542 22345678899999888 69999999998875 567899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 74 VMEYVNGGDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred EEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 99999999999988752 4689999999999999999999998 99999999999999999999999999986532
Q ss_pred -cccccceecccccccCCCCCC
Q 006145 638 -NAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 638 -~~~~~~~~~gt~~y~aPE~~~ 658 (659)
........+|++.|||||+..
T Consensus 148 ~~~~~~~~~~g~~~y~aPE~~~ 169 (318)
T cd05570 148 LGGVTTSTFCGTPDYIAPEILS 169 (318)
T ss_pred cCCCcccceecCccccCHHHhc
Confidence 222334567999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=231.73 Aligned_cols=168 Identities=18% Similarity=0.262 Sum_probs=142.5
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
|...+.||+|+||+||+|+.. +++.||+|.+...... ..+.+.+|++++++++|+||+++.+++.. .+.
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-------~~~ 74 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-------KDA 74 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-------CCE
Confidence 556688999999999999965 6899999999654322 23457899999999999999999988865 457
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~ 150 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEeccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcce
Confidence 89999999999999988642 234699999999999999999999998 99999999999999999999999999997
Q ss_pred ccccccccceecccccccCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
............|+..|+|||+.
T Consensus 151 ~~~~~~~~~~~~g~~~~~aPE~~ 173 (285)
T cd05632 151 KIPEGESIRGRVGTVGYMAPEVL 173 (285)
T ss_pred ecCCCCcccCCCCCcCccChHHh
Confidence 65443334456799999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=230.96 Aligned_cols=171 Identities=21% Similarity=0.383 Sum_probs=141.2
Q ss_pred cCCCCCceeccCcCceEEEEEec-----CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-----NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.+|...+.||+|+||.||+|+.. ++..||+|++........+.|.+|++++++++||||+++++++... +
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA-----G 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC-----C
Confidence 45777899999999999999843 4889999998765544456799999999999999999999988642 2
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++||||+++|+|.+++.+. ...++|..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg 153 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFG 153 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCc
Confidence 34589999999999999999753 23589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccc----ceecccccccCCCCC
Q 006145 632 LPLLAENAEKV----GHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~----~~~~gt~~y~aPE~~ 657 (659)
+++........ ....++..|+|||+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 183 (284)
T cd05081 154 LTKVLPQDKEYYKVREPGESPIFWYAPESL 183 (284)
T ss_pred ccccccCCCcceeecCCCCCceEeeCHHHh
Confidence 99765432221 112234569999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-26 Score=246.74 Aligned_cols=175 Identities=14% Similarity=0.220 Sum_probs=140.7
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccC-CCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDD-SSV 552 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~-~~~ 552 (659)
...+|...+.||+|+||.||+|+.. +++.||||++.... ....+|+.+|+.++|||||++++++.....+. ...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467889999999999999999965 58999999885432 23457999999999999999999876532211 112
Q ss_pred ceeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC-cceEEccC
Q 006145 553 SRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN-LVAKISSY 630 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DF 630 (659)
...++||||+++ +|.+++... .....+++.....++.|+++||+|||+. +|+||||||+|||++.+ +.+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 346799999985 787776521 2235689999999999999999999998 99999999999999966 47999999
Q ss_pred ccccccccccccceecccccccCCCCC
Q 006145 631 NLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+|+...........+||+.|||||+.
T Consensus 216 Gla~~~~~~~~~~~~~~t~~y~aPE~~ 242 (440)
T PTZ00036 216 GSAKNLLAGQRSVSYICSRFYRAPELM 242 (440)
T ss_pred ccchhccCCCCcccCCCCcCccCHHHh
Confidence 999876554455567889999999975
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=237.21 Aligned_cols=160 Identities=16% Similarity=0.232 Sum_probs=133.4
Q ss_pred eccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCC---CCCCccceeeeeeeccccCCCCceeEE
Q 006145 485 MGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKL---RHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 485 ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
||+|+||+||+|+.. +|+.||||++...... ....+..|.+++.+. +||||+++++++.+ ....|+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-------~~~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-------DSDLYL 73 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-------CCeEEE
Confidence 699999999999965 5899999999653321 223456677777665 69999999998875 467899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||||+++|+|.+++.. ...+++.....++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 74 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 74 VTDYMSGGELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred EEcCCCCChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 9999999999999875 24689999999999999999999998 99999999999999999999999999986532
Q ss_pred -cccccceecccccccCCCCC
Q 006145 638 -NAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 -~~~~~~~~~gt~~y~aPE~~ 657 (659)
........+||+.|||||+.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~ 168 (330)
T cd05586 148 TDNKTTNTFCGTTEYLAPEVL 168 (330)
T ss_pred CCCCCccCccCCccccCHHHH
Confidence 22334457899999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=227.02 Aligned_cols=169 Identities=18% Similarity=0.348 Sum_probs=145.2
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..+|+..+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++.. .+.
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-------~~~ 80 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-------REK 80 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-------CCE
Confidence 34688889999999999999996 4689999999976544445678899999999999999999999875 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++|+|.++++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccce
Confidence 89999999999999998752 4689999999999999999999998 99999999999999999999999999997
Q ss_pred ccccc-cccceecccccccCCCCC
Q 006145 635 LAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
..... .......++..|+|||+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~PE~~ 178 (267)
T cd06646 155 KITATIAKRKSFIGTPYWMAPEVA 178 (267)
T ss_pred eecccccccCccccCccccCHhHc
Confidence 65322 222445788999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=231.01 Aligned_cols=168 Identities=18% Similarity=0.280 Sum_probs=143.0
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
|+..+.||+|+||.||++... +++.||||.+...... ..+.+.+|+.++++++|+||+++++.+.+ .+.
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-------~~~ 74 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-------KDA 74 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-------CCE
Confidence 566789999999999999965 5899999998654322 22457889999999999999999998875 457
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeecccee
Confidence 89999999999999988642 234689999999999999999999998 99999999999999999999999999997
Q ss_pred ccccccccceecccccccCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
............|+..|||||+.
T Consensus 151 ~~~~~~~~~~~~g~~~y~aPE~~ 173 (285)
T cd05630 151 HVPEGQTIKGRVGTVGYMAPEVV 173 (285)
T ss_pred ecCCCccccCCCCCccccChHHH
Confidence 66544444456899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=226.16 Aligned_cols=171 Identities=21% Similarity=0.364 Sum_probs=144.0
Q ss_pred hhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..++|+..+.||+|+||.||+|...+++.||+|.++... ...++|.+|++++++++|+||+++++++.. .+.
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~ 75 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-------EEP 75 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec-------CCC
Confidence 345688889999999999999998778899999987543 235679999999999999999999998875 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++|+|.+++.... ...++|..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred eeeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 899999999999999997532 34689999999999999999999998 99999999999999999999999999997
Q ss_pred cccccccc--ceecccccccCCCCC
Q 006145 635 LAENAEKV--GHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~--~~~~gt~~y~aPE~~ 657 (659)
........ .....+..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~ 176 (261)
T cd05068 152 VIKEDIYEAREGAKFPIKWTAPEAA 176 (261)
T ss_pred EccCCcccccCCCcCceeccCcccc
Confidence 66432211 112234579999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=227.64 Aligned_cols=169 Identities=21% Similarity=0.365 Sum_probs=143.4
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
++|+..+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+ .+..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~~~ 77 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK-------EEPIY 77 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-------CCCcE
Confidence 4677789999999999999998888899999986543 235689999999999999999999998865 45689
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.+++++. ....+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 78 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 78 IITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred EEEecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceec
Confidence 999999999999999753 234689999999999999999999998 9999999999999999999999999999766
Q ss_pred ccccc--cceecccccccCCCCC
Q 006145 637 ENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
..... .....++..|+|||+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~ 176 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAI 176 (261)
T ss_pred CCCceeccCCCccceecCCHHHh
Confidence 43222 1233456789999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=230.87 Aligned_cols=173 Identities=19% Similarity=0.327 Sum_probs=141.4
Q ss_pred hhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYF 547 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 547 (659)
.+++|+..+.||+|+||.||+|+.. ++..||||++..... ....+|.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--- 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence 4667889999999999999999753 256899999864332 234569999999999999999999999865
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGHA-------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD 620 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld 620 (659)
....++||||+++|+|.++++.... ...++|..+..++.|+++||+|||+. +++||||||+||+++
T Consensus 81 ----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~ 153 (277)
T cd05062 81 ----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 153 (277)
T ss_pred ----CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEc
Confidence 4568999999999999999874221 23468899999999999999999998 999999999999999
Q ss_pred CCcceEEccCcccccccccccc---ceecccccccCCCCC
Q 006145 621 QNLVAKISSYNLPLLAENAEKV---GHVIPYSGSIDPTNS 657 (659)
Q Consensus 621 ~~~~~kl~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~ 657 (659)
+++.+||+|||+++........ ....++..|||||+.
T Consensus 154 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05062 154 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 193 (277)
T ss_pred CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHh
Confidence 9999999999998754322211 223457789999985
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=221.46 Aligned_cols=172 Identities=19% Similarity=0.339 Sum_probs=148.0
Q ss_pred CHHHHHHhhcCCCCCceeccCcCceEEEEE-ecCCcEEEEEEecccCCCchHHHHHHHHHHhCCC-CCCccceeeeeeec
Q 006145 468 SLEELEEATNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRHLVSALGHCFEC 545 (659)
Q Consensus 468 ~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 545 (659)
+++|+.+.|+ +.||+|+|+.|--|+ +.+|.++|||++.+...+...+..+|++++...+ |+||++|++|+.+
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd- 147 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED- 147 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-
Confidence 5788888875 899999999999998 7789999999998887666778999999999995 9999999999986
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC---
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN--- 622 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~--- 622 (659)
....|||||-|.||.|.+++++ ...+++....++..+||.||.|||.+ +|.|||+||+|||..+.
T Consensus 148 ------d~~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~v 215 (463)
T KOG0607|consen 148 ------DTRFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKV 215 (463)
T ss_pred ------cceEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCc
Confidence 5678999999999999999986 35689999999999999999999999 99999999999998754
Q ss_pred cceEEccCccccccc--------cccccceecccccccCCCCC
Q 006145 623 LVAKISSYNLPLLAE--------NAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 623 ~~~kl~DFGla~~~~--------~~~~~~~~~gt~~y~aPE~~ 657 (659)
--+||+||-|+.-+. ........+|+..|||||+.
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVV 258 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVV 258 (463)
T ss_pred CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHH
Confidence 348999998874331 11223457899999999974
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=232.59 Aligned_cols=168 Identities=15% Similarity=0.317 Sum_probs=141.5
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|...+.||+|+||.||+|+.+ +++.||+|.++..... ....+.+|++++++++||||+++++++.. .+.
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~~ 78 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-------DKS 78 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-------CCe
Confidence 46788899999999999999965 5889999999754432 33568899999999999999999999876 457
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++ +|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 79 LTLVFEYLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred EEEEEeCCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccce
Confidence 8999999975 898888653 24588999999999999999999998 99999999999999999999999999997
Q ss_pred ccccc-cccceecccccccCCCCC
Q 006145 635 LAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
..... .......+++.|+|||+.
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~ 176 (309)
T cd07872 153 AKSVPTKTYSNEVVTLWYRPPDVL 176 (309)
T ss_pred ecCCCccccccccccccccCCHHH
Confidence 54322 223445789999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=228.90 Aligned_cols=173 Identities=24% Similarity=0.400 Sum_probs=148.0
Q ss_pred HhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++..+|+..+.||+|+||.||+|+..+++.+|+|.+.........++.+|+.+++.++|+||+++++++.+ .+
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~ 75 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-------GE 75 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec-------CC
Confidence 34566888899999999999999988899999999986655456789999999999999999999999875 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++|+|.++++... ...+++.++.+++.|++.|++|||+. +|+||||||+||++++++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~ 151 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLA 151 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccch
Confidence 6899999999999999998532 35689999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccc-cceecccccccCCCCC
Q 006145 634 LLAENAEK-VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~-~~~~~gt~~y~aPE~~ 657 (659)
........ .....++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~PE~~ 176 (261)
T cd05148 152 RLIKEDVYLSSDKKIPYKWTAPEAA 176 (261)
T ss_pred hhcCCccccccCCCCceEecCHHHH
Confidence 76543222 2233456789999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=240.93 Aligned_cols=175 Identities=21% Similarity=0.370 Sum_probs=142.6
Q ss_pred HHhhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCCc-hHHHHHHHHHHhCCC-CCCccceeeeeee
Q 006145 473 EEATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCHS-TRNFMHHIELISKLR-HRHLVSALGHCFE 544 (659)
Q Consensus 473 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~-H~niv~l~g~~~~ 544 (659)
....++|...+.||+|+||.||+|++. .+..||||+++...... .+.+.+|+++|.++. |||||+++|+|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344556777899999999999999853 24689999997543322 346899999999997 9999999999975
Q ss_pred ccccCCCCceeEEEEeccCCCChhhhhcCCC-------------------------------------------------
Q 006145 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGH------------------------------------------------- 575 (659)
Q Consensus 545 ~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~------------------------------------------------- 575 (659)
.+..++||||+++|+|.+++++..
T Consensus 113 -------~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (401)
T cd05107 113 -------GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDE 185 (401)
T ss_pred -------CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcc
Confidence 456899999999999999986421
Q ss_pred ----------------------------------------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccc
Q 006145 576 ----------------------------------------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFS 609 (659)
Q Consensus 576 ----------------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 609 (659)
....++|.+..+++.|+++||+|||+. +|+|
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH 262 (401)
T cd05107 186 SADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVH 262 (401)
T ss_pred ccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCc
Confidence 012478888999999999999999998 9999
Q ss_pred cCCCCCceeecCCcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 610 NNLKITDILLDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 610 rDlk~~NILld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
|||||+|||+++++.+|++|||+++...... ......++..|||||+.
T Consensus 263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 313 (401)
T cd05107 263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI 313 (401)
T ss_pred ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh
Confidence 9999999999999999999999997653221 12335678899999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=238.09 Aligned_cols=165 Identities=12% Similarity=0.177 Sum_probs=140.4
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
...+|...+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++|+||+++++++.. ..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~ 130 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS-------GA 130 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe-------CC
Confidence 3457999999999999999999976 4789999975322 24579999999999999999999986 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++|+||+. |+|.+++... ...++|..+..|+.||+.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 131 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 204 (357)
T PHA03209 131 ITCMVLPHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA 204 (357)
T ss_pred eeEEEEEccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccc
Confidence 6899999995 6999988642 34689999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccccceecccccccCCCCCC
Q 006145 634 LLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 634 ~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+............||+.|+|||+..
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~ 229 (357)
T PHA03209 205 QFPVVAPAFLGLAGTVETNAPEVLA 229 (357)
T ss_pred cccccCcccccccccccccCCeecC
Confidence 7654444445577999999999864
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=229.09 Aligned_cols=171 Identities=23% Similarity=0.364 Sum_probs=139.8
Q ss_pred cCCCCCceeccCcCceEEEEEe-----cCCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRL-----KNGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
++|+..+.||+|+||+||+|+. .++..||+|.++.... ....+|.+|++++++++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------ 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ------ 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec------
Confidence 3566778999999999999984 2467899999975332 223578999999999999999999999875
Q ss_pred CCceeEEEEeccCCCChhhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCc
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGH--------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITD 616 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~N 616 (659)
....++||||+++|+|.+++.... ....+++.+...++.|+++||+|||+. +|+||||||+|
T Consensus 79 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~n 154 (283)
T cd05090 79 -EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARN 154 (283)
T ss_pred -CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---Ceehhccccce
Confidence 456899999999999999985321 123588999999999999999999998 99999999999
Q ss_pred eeecCCcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 617 ILLDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 617 ILld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
|++++++.+||+|||+++...... ......++..|+|||+.
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (283)
T cd05090 155 ILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI 198 (283)
T ss_pred EEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHh
Confidence 999999999999999997553221 12334456789999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=236.84 Aligned_cols=174 Identities=22% Similarity=0.356 Sum_probs=140.8
Q ss_pred hhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCC-chHHHHHHHHHHhCC-CCCCccceeeeeeecc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCH-STRNFMHHIELISKL-RHRHLVSALGHCFECY 546 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 546 (659)
+.++|...+.||+|+||.||+|+.. +++.||+|+++..... ..+.+.+|++++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 3456888899999999999999742 2578999998754322 235688999999999 799999999988741
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCC--------------------------------------------------
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHA-------------------------------------------------- 576 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------------------------------------------- 576 (659)
....++||||+++|+|.+++.....
T Consensus 84 -----~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (337)
T cd05054 84 -----GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE 158 (337)
T ss_pred -----CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhccc
Confidence 3468899999999999998863211
Q ss_pred --------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccccc---ccee
Q 006145 577 --------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEK---VGHV 645 (659)
Q Consensus 577 --------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~ 645 (659)
...++|..+.+++.||++||+|||+. +|+||||||+||++++++.+||+|||+++....... ....
T Consensus 159 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~ 235 (337)
T cd05054 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235 (337)
T ss_pred chhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCC
Confidence 12689999999999999999999998 999999999999999999999999999976532221 2334
Q ss_pred cccccccCCCCC
Q 006145 646 IPYSGSIDPTNS 657 (659)
Q Consensus 646 ~gt~~y~aPE~~ 657 (659)
.++..|||||++
T Consensus 236 ~~~~~y~aPE~~ 247 (337)
T cd05054 236 RLPLKWMAPESI 247 (337)
T ss_pred CCCccccCcHHh
Confidence 567789999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-27 Score=243.24 Aligned_cols=166 Identities=17% Similarity=0.309 Sum_probs=143.5
Q ss_pred CCceeccCcCceEEEEEecC-CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEE
Q 006145 481 TSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIF 559 (659)
Q Consensus 481 ~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~ 559 (659)
+...||.|+||.||||+-++ +-..|.|.+.....+..++|+-||+||+.++||+||+|++.|+. .+.+++..
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-------enkLwili 108 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-------ENKLWILI 108 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-------cCceEEEE
Confidence 34678999999999999664 66778898887776677899999999999999999999998875 46799999
Q ss_pred eccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc-cccc
Q 006145 560 EYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL-LAEN 638 (659)
Q Consensus 560 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~-~~~~ 638 (659)
|||.||-+..++-+- ...|+..+..-++.+++.||.|||+. .|||||||+.|||+.-+|.++++|||.+. ....
T Consensus 109 EFC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred eecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH
Confidence 999999999887642 35799999999999999999999999 99999999999999999999999999874 3333
Q ss_pred ccccceecccccccCCCCCC
Q 006145 639 AEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 639 ~~~~~~~~gt~~y~aPE~~~ 658 (659)
-..-..++|||+|||||+.|
T Consensus 184 ~qkRDsFIGTPYWMAPEVvm 203 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVM 203 (1187)
T ss_pred HhhhccccCCcccccchhee
Confidence 33446789999999999875
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=248.02 Aligned_cols=185 Identities=15% Similarity=0.191 Sum_probs=148.3
Q ss_pred HHHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccc
Q 006145 471 ELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYF 547 (659)
Q Consensus 471 ~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 547 (659)
+.....++|...+.||+|+||+||+|+.. +|+.||||++...... ....+.+|+..+..++|+||+++++.+.....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 33445678999999999999999999854 6999999999755332 23568899999999999999999887754221
Q ss_pred cC-CCCceeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcce
Q 006145 548 DD-SSVSRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVA 625 (659)
Q Consensus 548 ~~-~~~~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~ 625 (659)
.. ......++||||+++|+|.++++.. .....+++.....++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 10 0112468999999999999998742 2234689999999999999999999998 99999999999999999999
Q ss_pred EEccCccccccccc---cccceecccccccCCCCCC
Q 006145 626 KISSYNLPLLAENA---EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 626 kl~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~~ 658 (659)
||+|||+++..... ......+||+.|||||+..
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 218 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhC
Confidence 99999999765432 1234568999999999863
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=227.07 Aligned_cols=176 Identities=19% Similarity=0.255 Sum_probs=145.8
Q ss_pred HHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 472 LEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 472 l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
++.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 76 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE------ 76 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc------
Confidence 4456777777889999999999999955 588999999876554455689999999999999999999999876
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC-CcceEEcc
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ-NLVAKISS 629 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~D 629 (659)
.+..++|+||+++++|.++++........++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~d 152 (268)
T cd06624 77 -NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISD 152 (268)
T ss_pred -CCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEec
Confidence 467899999999999999998532211237888999999999999999998 9999999999999986 67999999
Q ss_pred Cccccccccc-cccceecccccccCCCCC
Q 006145 630 YNLPLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
||++...... .......+++.|+|||+.
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~ 181 (268)
T cd06624 153 FGTSKRLAGINPCTETFTGTLQYMAPEVI 181 (268)
T ss_pred chhheecccCCCccccCCCCccccChhhh
Confidence 9998655322 222335688999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=239.35 Aligned_cols=171 Identities=19% Similarity=0.305 Sum_probs=140.9
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||+|+||.||+|+.. +|+.||||++.... ....+++.+|+++++.++|+||+++++++.....+ ....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID--PFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc--ccce
Confidence 4778899999999999999964 69999999986432 22346789999999999999999999998753210 1236
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.|+|+||+. ++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 79 ~~lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEEEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccccee
Confidence 899999997 588888764 24689999999999999999999998 99999999999999999999999999997
Q ss_pred cccccc--ccceecccccccCCCCC
Q 006145 635 LAENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
...... ......+++.|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~ 176 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEIL 176 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHH
Confidence 653322 22445789999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=246.92 Aligned_cols=306 Identities=24% Similarity=0.344 Sum_probs=204.3
Q ss_pred ccCCCHHHHHHHHHHHhcCCCCCCCCC----CCCCCCCCcCCC-----------CCCCceEeCCCCEeEEEeCCCCCCCC
Q 006145 25 SEQLQSSQAQTLLRIQGLLNNPAVLSS----WNITTEFCNTEP-----------TSSLTVVCYEESITQLHIVGNKRAPM 89 (659)
Q Consensus 25 ~~~~~~~~~~aLl~~k~~l~~~~~l~~----W~~~~~~C~w~~-----------~~~~gv~C~~~~v~~L~l~~~~~~~~ 89 (659)
+....++|.+.+++..+.|..|+.+.+ |+..+++|.-++ .+...|.|.++.||.+...+...+..
T Consensus 57 ~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~~ 136 (754)
T PRK15370 57 PETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQASS 136 (754)
T ss_pred CCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCCCccccccccccccccc
Confidence 445678899999999999999986666 998899998876 56778999999999999887543221
Q ss_pred CCC-----------------------------------------------CCcCCcccccccCCCCCCEEEecCCCCcCC
Q 006145 90 LPL-----------------------------------------------SFSMDSFVTTLVKLPDLKVLRLVSLGLWGP 122 (659)
Q Consensus 90 l~~-----------------------------------------------~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~ 122 (659)
... ......+|..+. +.|+.|+|++|+++.
T Consensus 137 ~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~Lts- 213 (754)
T PRK15370 137 ASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTTIPACIP--EQITTLILDNNELKS- 213 (754)
T ss_pred CCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCCc-
Confidence 100 001122232222 356777777777764
Q ss_pred CCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCC
Q 006145 123 LSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYL 202 (659)
Q Consensus 123 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 202 (659)
+|..+. ++|+.|++++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. ++|+.|+|++|+|+ .+|..+.
T Consensus 214 LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~-- 282 (754)
T PRK15370 214 LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP-- 282 (754)
T ss_pred CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--
Confidence 444333 46777777777776 4565443 36777777777776 5666553 46777777777777 4666553
Q ss_pred CCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcc
Q 006145 203 ENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNR 282 (659)
Q Consensus 203 ~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 282 (659)
++|+.|+|++|+|++.++.+. ++|+.|++++|.++..++...++|+.|++++|.+++ +|..+. ++|+.|+|++|+
T Consensus 283 ~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~ 357 (754)
T PRK15370 283 EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLTALPETLPPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQ 357 (754)
T ss_pred CCCcEEECCCCccccCcccch--hhHHHHHhcCCccccCCccccccceeccccCCcccc-CChhhc--CcccEEECCCCC
Confidence 467777777777775443332 367777777777775444445677788888887765 555543 578888888888
Q ss_pred cccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhh----hCCCCCCEEEcCCcccc
Q 006145 283 FVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCL----LAGSKNRVVLYARNCLA 356 (659)
Q Consensus 283 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~----~~~~~l~~l~~~~N~l~ 356 (659)
|+ .+|..+. ++|+.|+|++|+|+. +|+.+. ..|+.|++++|+|+ .+|..+ ...+.+..+++.+|.++
T Consensus 358 L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 358 IT-VLPETLP--PTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CC-cCChhhc--CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 77 4666553 578888888888873 454443 35777888888887 455443 33466677888888764
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-25 Score=228.34 Aligned_cols=173 Identities=20% Similarity=0.355 Sum_probs=140.9
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCC---CCCCccceeeeeeeccccCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKL---RHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~~~ 551 (659)
+|...+.||+|+||+||+|+.. +|+.||+|.++..... ....+.+|+++++++ +||||+++++++.....+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~--~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD--R 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC--C
Confidence 4777899999999999999965 5899999999754322 234567788777665 799999999998652211 2
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++||||+++ +|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 79 ~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 79 ETKVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred CceEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccC
Confidence 3468999999974 8999887532 24589999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+++............+|..|+|||+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 179 (288)
T cd07863 154 LARIYSCQMALTPVVVTLWYRAPEVL 179 (288)
T ss_pred ccccccCcccCCCccccccccCchHh
Confidence 99876554444556789999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=236.68 Aligned_cols=173 Identities=17% Similarity=0.201 Sum_probs=142.7
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
..++|...+.||+|+||.||+|+.. +|+.||||++..... ....++.+|+.+++.++||||+++++++...... ..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL-EE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc-cc
Confidence 3577889999999999999999965 589999999965422 2345788999999999999999999988642110 01
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....|+||||+++ +|.+.++. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 2357999999975 67766653 478888999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+++............||+.|+|||+.
T Consensus 169 ~a~~~~~~~~~~~~~~t~~y~aPE~~ 194 (359)
T cd07876 169 LARTACTNFMMTPYVVTRYYRAPEVI 194 (359)
T ss_pred CccccccCccCCCCcccCCCCCchhc
Confidence 99766544445567899999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=224.59 Aligned_cols=169 Identities=24% Similarity=0.398 Sum_probs=142.0
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.++|...+.||+|+||.||+|+..+...||+|+++.... ..++|.+|++++++++|+||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--------~~~ 75 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--------EPI 75 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC--------CCc
Confidence 355788899999999999999987767899999975332 34679999999999999999999987643 347
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.+++++.. ...++|..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||.++.
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred EEEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceee
Confidence 99999999999999997532 24589999999999999999999998 999999999999999999999999999976
Q ss_pred cccccc--cceecccccccCCCCC
Q 006145 636 AENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
...... .....++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~ 175 (262)
T cd05071 152 IEDNEYTARQGAKFPIKWTAPEAA 175 (262)
T ss_pred ccccccccccCCcccceecCHhHh
Confidence 543322 1234566789999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-25 Score=225.83 Aligned_cols=165 Identities=22% Similarity=0.364 Sum_probs=135.2
Q ss_pred ceeccCcCceEEEEEecC---CcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEE
Q 006145 483 AFMGEGSQGQMYRGRLKN---GTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLI 558 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~---g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV 558 (659)
+.||+|+||.||+|+..+ +..+|+|.++.... .....|.+|+.++++++||||+++++++.+ ....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-------VTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-------CCCcEEE
Confidence 368999999999998643 46799999875442 233578999999999999999999998875 4568999
Q ss_pred EeccCCCChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 559 FEYVPNGTLRSWISEGH--AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 559 ~Ey~~~GsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
|||+++|+|.++++... .....++..+..++.|+++|++|||+. +++||||||+||++++++++|++|||+++..
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~ 150 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNK 150 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccc
Confidence 99999999999997432 123567888899999999999999998 9999999999999999999999999999754
Q ss_pred ccccc---cceecccccccCCCCC
Q 006145 637 ENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
..... .....++..|+|||+.
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~ 174 (269)
T cd05087 151 YKEDYYVTPDQLWVPLRWIAPELV 174 (269)
T ss_pred cCcceeecCCCcCCcccccCHhHh
Confidence 33221 1234577889999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-25 Score=226.87 Aligned_cols=159 Identities=21% Similarity=0.332 Sum_probs=131.0
Q ss_pred eeccCcCceEEEEEecC-------------------------CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccce
Q 006145 484 FMGEGSQGQMYRGRLKN-------------------------GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSA 538 (659)
Q Consensus 484 ~ig~G~~g~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l 538 (659)
.||+|+||.||+|++.. ...||+|.+........++|.+|+++++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 68999999999998521 23589999875543344678999999999999999999
Q ss_pred eeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCcee
Q 006145 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDIL 618 (659)
Q Consensus 539 ~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 618 (659)
+|+|.+ ....++||||+++|+|..++.+. ...+++..+.+++.|+++||+|||+. +|+||||||+||+
T Consensus 82 ~~~~~~-------~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nil 149 (274)
T cd05076 82 HGVCVR-------GSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNIL 149 (274)
T ss_pred EEEEEe-------CCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEE
Confidence 999986 45689999999999999998742 24688999999999999999999998 9999999999999
Q ss_pred ecCCc-------ceEEccCccccccccccccceecccccccCCCCC
Q 006145 619 LDQNL-------VAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 619 ld~~~-------~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+++++ .+|++|||++...... ....++..|+|||+.
T Consensus 150 l~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~ 192 (274)
T cd05076 150 LARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECV 192 (274)
T ss_pred EeccCcccCccceeeecCCccccccccc---cccccCCcccCchhh
Confidence 98643 3799999998544221 224578889999976
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-25 Score=223.95 Aligned_cols=169 Identities=24% Similarity=0.378 Sum_probs=141.2
Q ss_pred cCCCCCceeccCcCceEEEEEecC----CcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN----GTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
++|+..+.||+|+||+||+|++.. ...||||.++..... ...+|.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 76 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK------- 76 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-------
Confidence 467888999999999999999742 458999998754432 34579999999999999999999998875
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..++||||+++|+|.+++.... ..++|..+.+++.|++.|++|||+. +|+||||||+||++++++.+|++|||
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg 151 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFG 151 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccc
Confidence 456899999999999999997532 3689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccc-ccc--cceecccccccCCCCC
Q 006145 632 LPLLAEN-AEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~-~~~--~~~~~gt~~y~aPE~~ 657 (659)
+++.... ... .....++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~ 180 (266)
T cd05033 152 LSRRLEDSEATYTTKGGKIPIRWTAPEAI 180 (266)
T ss_pred hhhcccccccceeccCCCCCccccChhhh
Confidence 9976642 111 1223446789999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=226.39 Aligned_cols=164 Identities=21% Similarity=0.344 Sum_probs=132.7
Q ss_pred eeccCcCceEEEEEecC---CcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEE
Q 006145 484 FMGEGSQGQMYRGRLKN---GTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIF 559 (659)
Q Consensus 484 ~ig~G~~g~Vy~~~~~~---g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~ 559 (659)
.||+|+||+||+|+..+ ...+|+|.+...... ...+|.+|+++++.++|+||++++++|.. ....++||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-------~~~~~lv~ 74 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-------SIPYLLVL 74 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-------CCceEEEE
Confidence 58999999999997543 457888887644322 23568999999999999999999999875 45689999
Q ss_pred eccCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 560 EYVPNGTLRSWISEGHA--HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 560 Ey~~~GsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||+++|+|.+++..... ....++.....++.|+++|++|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence 99999999999975322 23456888899999999999999998 99999999999999999999999999986542
Q ss_pred ccc---ccceecccccccCCCCC
Q 006145 638 NAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 ~~~---~~~~~~gt~~y~aPE~~ 657 (659)
... ......++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~ 174 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELV 174 (269)
T ss_pred cchheeccCCCCCcccccCHHHH
Confidence 211 11334567789999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=242.11 Aligned_cols=164 Identities=14% Similarity=0.195 Sum_probs=138.8
Q ss_pred hcCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..+|...+.||+|+||.||+|+... ++.||||... ...+.+|++++++++|+|||++++++.. .+.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-------~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV-------GGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-------CCE
Confidence 3468888999999999999999764 8899999643 2346789999999999999999999876 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+. |+|.+++... ...++|.++..|+.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 235 ~~lv~e~~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 235 TCLVLPKYR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred EEEEEEccC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCce
Confidence 899999995 7999988642 23699999999999999999999998 99999999999999999999999999997
Q ss_pred ccccccc---cceecccccccCCCCCC
Q 006145 635 LAENAEK---VGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~~~~~~---~~~~~gt~~y~aPE~~~ 658 (659)
....... .....||..|||||+..
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~ 335 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLA 335 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHc
Confidence 6533211 23457999999999863
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=235.30 Aligned_cols=174 Identities=23% Similarity=0.370 Sum_probs=140.1
Q ss_pred hhcCCCCCceeccCcCceEEEEEe------cCCcEEEEEEecccCCC-chHHHHHHHHHHhCC-CCCCccceeeeeeecc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRL------KNGTFVAIRCLKMKKCH-STRNFMHHIELISKL-RHRHLVSALGHCFECY 546 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 546 (659)
..++|...+.||+|+||.||+|+. .+++.||||+++..... ..+.+.+|++++.++ +|+||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 345788899999999999999973 24789999999754322 235688999999999 689999999988641
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCC--------------------------------------------------
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHA-------------------------------------------------- 576 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------------------------------------------- 576 (659)
....++||||+++|+|.++++....
T Consensus 84 -----~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (343)
T cd05103 84 -----GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSL 158 (343)
T ss_pred -----CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcc
Confidence 3457899999999999999864210
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccccc-
Q 006145 577 --------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEK- 641 (659)
Q Consensus 577 --------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~- 641 (659)
...++|.++.+++.|+++||+|||+. +|+||||||+||++++++++||+|||+++.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 159 SDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred ccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcch
Confidence 12478899999999999999999998 999999999999999999999999999975432211
Q ss_pred --cceecccccccCCCCC
Q 006145 642 --VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 642 --~~~~~gt~~y~aPE~~ 657 (659)
.....++..|+|||+.
T Consensus 236 ~~~~~~~~~~~y~aPE~~ 253 (343)
T cd05103 236 VRKGDARLPLKWMAPETI 253 (343)
T ss_pred hhcCCCCCCcceECcHHh
Confidence 1223456789999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=236.26 Aligned_cols=173 Identities=17% Similarity=0.201 Sum_probs=143.6
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
..++|...+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++...... ..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL-EE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc-cc
Confidence 4578999999999999999999865 589999999975432 2235688999999999999999999988642210 11
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++||||+++ ++.+.+.. .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 2457999999965 77777653 488999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+++............||..|+|||+.
T Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~ 190 (355)
T cd07874 165 LARTAGTSFMMTPYVVTRYYRAPEVI 190 (355)
T ss_pred ccccCCCccccCCccccCCccCHHHH
Confidence 99876555445567899999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=223.93 Aligned_cols=167 Identities=22% Similarity=0.325 Sum_probs=140.7
Q ss_pred CCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+|...+.||+|+||+||+|+..++..||||.++... ....+|.+|++++++++||||++++++|.+ ....++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~~~l 76 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-------QRPIYI 76 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-------CCCcEE
Confidence 466678999999999999998777789999987543 235679999999999999999999999875 345799
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||||+++|+|.+++.... ..++|..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.++...
T Consensus 77 v~e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 77 VTEYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL 151 (256)
T ss_pred EEEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecC
Confidence 999999999999997532 3689999999999999999999998 99999999999999999999999999987553
Q ss_pred ccccc--ceecccccccCCCCC
Q 006145 638 NAEKV--GHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 ~~~~~--~~~~gt~~y~aPE~~ 657 (659)
..... ....++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~ 173 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVL 173 (256)
T ss_pred CCceeecCCCccChhhCCHHHH
Confidence 32211 223456789999975
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-25 Score=226.05 Aligned_cols=177 Identities=18% Similarity=0.349 Sum_probs=146.7
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~ 552 (659)
+++.|+..+.||+|+||.||+|+.. +++.||+|++.... ....++.+|++++.++ +|+||+++++++...... ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~-~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP-GMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC-CCC
Confidence 4566778899999999999999965 58899999986543 3446789999999998 699999999998753211 113
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||+++|+|.+++... ....++|..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 4689999999999999998853 234689999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc-cccceecccccccCCCCC
Q 006145 633 PLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
++..... .......|+..|+|||+.
T Consensus 158 ~~~~~~~~~~~~~~~g~~~y~aPE~~ 183 (272)
T cd06637 158 SAQLDRTVGRRNTFIGTPYWMAPEVI 183 (272)
T ss_pred ceecccccccCCcccccccccCHhHh
Confidence 9765432 223456789999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-25 Score=228.31 Aligned_cols=167 Identities=17% Similarity=0.324 Sum_probs=144.8
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.+|+..+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+++++.++|+||+++++++.. ....
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-------~~~~ 92 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-------GDEL 92 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-------CCEE
Confidence 46778899999999999999854 589999999986655556779999999999999999999999875 4578
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.+++++ ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred EEeecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchh
Confidence 999999999999999874 3588999999999999999999998 999999999999999999999999999875
Q ss_pred ccccc-ccceecccccccCCCCC
Q 006145 636 AENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
..... ......+++.|+|||+.
T Consensus 166 ~~~~~~~~~~~~~~~~y~aPE~~ 188 (296)
T cd06654 166 ITPEQSKRSTMVGTPYWMAPEVV 188 (296)
T ss_pred ccccccccCcccCCccccCHHHH
Confidence 53322 22345788999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=229.85 Aligned_cols=168 Identities=13% Similarity=0.255 Sum_probs=143.1
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|+..+.||+|+||.||+++.. ++..+|+|.++..... ..+++.+|++++.+++||||++++++|.+ .+.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~~ 73 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-------DGE 73 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-------CCE
Confidence 36888899999999999999965 5889999998754322 23568999999999999999999999976 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++|+|.++++.. ..+++..+..++.|+++||+|||+. .+++||||||+||++++++.+||+|||++.
T Consensus 74 ~~lv~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 74 ISICMEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred EEEEeeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcc
Confidence 99999999999999999753 4688999999999999999999973 189999999999999999999999999987
Q ss_pred ccccccccceecccccccCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
..... ......++..|+|||+.
T Consensus 149 ~~~~~-~~~~~~~~~~~~aPE~~ 170 (308)
T cd06615 149 QLIDS-MANSFVGTRSYMSPERL 170 (308)
T ss_pred ccccc-ccccCCCCcCccChhHh
Confidence 65332 23456789999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=228.07 Aligned_cols=171 Identities=23% Similarity=0.423 Sum_probs=141.9
Q ss_pred cCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.+|...+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||++++++|..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 78 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE------ 78 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 46777899999999999999842 356799999875543345679999999999999999999999975
Q ss_pred CCceeEEEEeccCCCChhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGH----------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD 620 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld 620 (659)
.+..++||||+++|+|.++++... ....++|..+..++.|++.||+|||+. +++||||||+||+++
T Consensus 79 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~ 154 (288)
T cd05093 79 -GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVG 154 (288)
T ss_pred -CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence 456899999999999999987421 123589999999999999999999998 999999999999999
Q ss_pred CCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 621 QNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 621 ~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
+++.+||+|||+++....... .....++..|+|||+.
T Consensus 155 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 194 (288)
T cd05093 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 194 (288)
T ss_pred cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHh
Confidence 999999999999975533221 1234457789999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=229.93 Aligned_cols=165 Identities=19% Similarity=0.277 Sum_probs=134.1
Q ss_pred CceeccCcCceEEEEEec---CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEE
Q 006145 482 SAFMGEGSQGQMYRGRLK---NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLI 558 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV 558 (659)
..+||+|+||+||+|+.. +++.||+|.++... ....+.+|++++++++||||+++++++... .....++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH-----ADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecC-----CCcEEEEE
Confidence 468999999999999864 46789999986543 235678999999999999999999988642 23568999
Q ss_pred EeccCCCChhhhhcCCC------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceee----cCCcceEEc
Q 006145 559 FEYVPNGTLRSWISEGH------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL----DQNLVAKIS 628 (659)
Q Consensus 559 ~Ey~~~GsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl----d~~~~~kl~ 628 (659)
|||+.+ +|.+++.... ....+++.....++.|++.||+|||+. +|+||||||+|||+ +.++.+||+
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 999965 8888875321 123588999999999999999999998 99999999999999 456889999
Q ss_pred cCcccccccccc----ccceecccccccCCCCC
Q 006145 629 SYNLPLLAENAE----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~~----~~~~~~gt~~y~aPE~~ 657 (659)
|||+++...... ......||+.|||||+.
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 187 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHH
Confidence 999997664322 23456889999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=226.18 Aligned_cols=165 Identities=30% Similarity=0.525 Sum_probs=135.3
Q ss_pred CceeccCcCceEEEEEec-----CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 482 SAFMGEGSQGQMYRGRLK-----NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.+.||.|.||.||+|.+. .+..|+||.++..... ..++|.+|++.+++++||||++++|+|.. .+..
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-------~~~~ 76 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-------NEPL 76 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-------SSSE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-------cccc
Confidence 478999999999999977 2678999999654332 25789999999999999999999999985 3458
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.++|+.. ....++|..+.+|+.|||+||+|||+. +++|+||+++||++++++.+||+|||+++.
T Consensus 77 ~lv~e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRP 152 (259)
T ss_dssp EEEEE--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred ccccccccccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999999999999863 235799999999999999999999998 999999999999999999999999999976
Q ss_pred cccccc---cceecccccccCCCCC
Q 006145 636 AENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
...... .........|+|||.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~ 177 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVL 177 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHH
T ss_pred ccccccccccccccccccccccccc
Confidence 632211 2335577889999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=226.25 Aligned_cols=171 Identities=22% Similarity=0.416 Sum_probs=142.5
Q ss_pred cCCCCCceeccCcCceEEEEEecC------CcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN------GTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 549 (659)
++|...+.||+|+||.||+|+..+ ++.||||.++..... ..++|.+|++++++++|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE----- 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-----
Confidence 457777999999999999998642 578999999765433 34679999999999999999999999976
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCcee
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGH-----------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDIL 618 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 618 (659)
....++||||+++|+|.++++... ....+++.+...++.|++.|++|||+. +++||||||+||+
T Consensus 80 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nil 154 (280)
T cd05049 80 --GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCL 154 (280)
T ss_pred --CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEE
Confidence 456899999999999999997431 124588999999999999999999998 9999999999999
Q ss_pred ecCCcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 619 LDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 619 ld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
++.++.+||+|||+++...... ......+++.|+|||+.
T Consensus 155 i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (280)
T cd05049 155 VGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI 196 (280)
T ss_pred EcCCCeEEECCcccceecccCcceecCCCCcccceecChhhh
Confidence 9999999999999997543222 12344567889999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=223.00 Aligned_cols=160 Identities=20% Similarity=0.341 Sum_probs=133.0
Q ss_pred ceeccCcCceEEEEEecC-------------CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccC
Q 006145 483 AFMGEGSQGQMYRGRLKN-------------GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 549 (659)
+.||+|+||.||+|+..+ ...||+|.+..........|.+|+.+++.++||||++++++|..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~----- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR----- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence 468999999999998532 23589998865544445678999999999999999999999975
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc-----
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV----- 624 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~----- 624 (659)
....++||||+++|+|..+++.. ...+++..+.+++.|+++||+|||+. +|+||||||+|||++.++.
T Consensus 76 --~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~ 148 (262)
T cd05077 76 --DVENIMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECG 148 (262)
T ss_pred --CCCCEEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCC
Confidence 45679999999999999988742 24589999999999999999999998 9999999999999987654
Q ss_pred --eEEccCccccccccccccceecccccccCCCCC
Q 006145 625 --AKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 --~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+|++|||++..... .....++..|||||+.
T Consensus 149 ~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~ 180 (262)
T cd05077 149 PFIKLSDPGIPITVLS---RQECVERIPWIAPECV 180 (262)
T ss_pred ceeEeCCCCCCccccC---cccccccccccChhhh
Confidence 89999999865532 2335678899999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=225.39 Aligned_cols=168 Identities=19% Similarity=0.307 Sum_probs=136.8
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCc----EEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGT----FVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
++|...+.||+|+||+||+|++. +++ .|++|.+..... ...+++..|+..+++++||||++++|++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------ 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence 35667789999999999999964 354 477787753322 123568888899999999999999998853
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
...++|+||+++|+|.++++.. ...++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 --~~~~~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Df 153 (279)
T cd05111 81 --ASLQLVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADF 153 (279)
T ss_pred --CccEEEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCC
Confidence 3468999999999999999753 24689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccc---ccceecccccccCCCCC
Q 006145 631 NLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
|+++...... ......++..|+|||+.
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~ 183 (279)
T cd05111 154 GVADLLYPDDKKYFYSEHKTPIKWMALESI 183 (279)
T ss_pred ccceeccCCCcccccCCCCCcccccCHHHh
Confidence 9997653222 12345577789999985
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=222.26 Aligned_cols=169 Identities=24% Similarity=0.418 Sum_probs=142.1
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.++|+..+.||+|+||.||+|...++..||+|.++.... ..++|.+|++++++++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--------~~~ 75 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE--------EPI 75 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC--------CCc
Confidence 346777899999999999999988888999999975443 34679999999999999999999988743 347
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.++++.. ....+++.++..++.+++.||+|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARL 151 (260)
T ss_pred EEEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeee
Confidence 9999999999999999753 234589999999999999999999998 999999999999999999999999999976
Q ss_pred cccccc--cceecccccccCCCCC
Q 006145 636 AENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
...... .....++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~ 175 (260)
T cd05070 152 IEDNEYTARQGAKFPIKWTAPEAA 175 (260)
T ss_pred ccCcccccccCCCCCccccChHHH
Confidence 543221 1223456789999974
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=227.37 Aligned_cols=171 Identities=26% Similarity=0.400 Sum_probs=137.9
Q ss_pred cCCCCCceeccCcCceEEEEEecC-Cc--EEEEEEecccC-CCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN-GT--FVAIRCLKMKK-CHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~-g~--~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~ 551 (659)
++|+..+.||+|+||.||+|+..+ +. .+++|.++... ....+.|.+|+++++++ +||||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~------- 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN------- 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-------
Confidence 467888999999999999998754 43 57888887432 22346799999999999 79999999999875
Q ss_pred CceeEEEEeccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCcee
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGH-------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDIL 618 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 618 (659)
.+..++|+||+++|+|.++++... ....+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil 151 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVL 151 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEE
Confidence 456899999999999999997421 113588999999999999999999998 9999999999999
Q ss_pred ecCCcceEEccCccccccccccccceecccccccCCCCC
Q 006145 619 LDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 619 ld~~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+++++.+||+|||++..............+..|+|||+.
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 190 (297)
T cd05089 152 VGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESL 190 (297)
T ss_pred ECCCCeEEECCcCCCccccceeccCCCCcCccccCchhh
Confidence 999999999999998644322112222335679999975
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-25 Score=223.62 Aligned_cols=169 Identities=19% Similarity=0.358 Sum_probs=141.6
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.+|...+.||+|+||.||+|... +++.||+|.++... ...+++.+|++++++++|+||++++++|.. .+..
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~~ 77 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-------EPPF 77 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcC-------CCCc
Confidence 34667789999999999999965 48899999987543 335679999999999999999999999875 4568
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.+++.... ...++|..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 99999999999999997532 34689999999999999999999998 999999999999999999999999999976
Q ss_pred ccccccc--ceecccccccCCCCC
Q 006145 636 AENAEKV--GHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~~--~~~~gt~~y~aPE~~ 657 (659)
....... ....++..|+|||+.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~ 177 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESL 177 (263)
T ss_pred cccceeeccCCCCCccccCCHHHh
Confidence 6443222 122345689999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=227.56 Aligned_cols=173 Identities=17% Similarity=0.313 Sum_probs=140.3
Q ss_pred hhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYF 547 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 547 (659)
..++|+..+.||+|+||.||+|..+ .+..||+|.++.... ....++.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK--- 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence 4577888999999999999999743 255899999864432 223468899999999999999999999875
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGH-------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD 620 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld 620 (659)
.+..++||||+++|+|.++++... .....++.....++.|++.||+|||+. +|+||||||+||+++
T Consensus 81 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~ 153 (288)
T cd05061 81 ----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVA 153 (288)
T ss_pred ----CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEc
Confidence 456899999999999999997421 123467888899999999999999998 999999999999999
Q ss_pred CCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 621 QNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 621 ~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
+++.+|++|||+++....... .....++..|+|||+.
T Consensus 154 ~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~ 193 (288)
T cd05061 154 HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193 (288)
T ss_pred CCCcEEECcCCccccccccccccccCCCcccccccCHHHh
Confidence 999999999999975532221 1223456789999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.6e-25 Score=224.79 Aligned_cols=169 Identities=23% Similarity=0.364 Sum_probs=142.0
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|...+.||+|++|.||+|+.. +++.||||.++.... ...+.+.+|++++++++||||+++++++.+ .+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~ 73 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-------ESR 73 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-------CCe
Confidence 4677789999999999999965 589999999865432 223578899999999999999999999976 457
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||++ |+|.++++.......+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 149 (285)
T cd07861 74 LYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149 (285)
T ss_pred EEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECccccee
Confidence 899999997 69999887543345789999999999999999999998 99999999999999999999999999986
Q ss_pred cccccc-ccceecccccccCCCCC
Q 006145 635 LAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
...... ......+++.|+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~ 173 (285)
T cd07861 150 AFGIPVRVYTHEVVTLWYRAPEVL 173 (285)
T ss_pred ecCCCcccccCCcccccccChHHh
Confidence 543222 22345678999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=225.17 Aligned_cols=171 Identities=26% Similarity=0.429 Sum_probs=140.8
Q ss_pred cCCCCCceeccCcCceEEEEEecC------CcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN------GTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 549 (659)
++|+..+.||+|+||.||+|.... ...||+|.++..... ...+|.+|++++++++||||+++++++..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----- 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK----- 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-----
Confidence 356778999999999999998643 257999998754322 23569999999999999999999999875
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCc
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHA-------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITD 616 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~N 616 (659)
.+..+++|||+++|+|.+++..... ...+++.....++.|++.||+|||+. +++||||||+|
T Consensus 80 --~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~N 154 (283)
T cd05048 80 --EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARN 154 (283)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccccce
Confidence 4568999999999999999874311 14588999999999999999999998 99999999999
Q ss_pred eeecCCcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 617 ILLDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 617 ILld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
|++++++.+||+|||+++...... ......+++.|||||+.
T Consensus 155 il~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (283)
T cd05048 155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI 198 (283)
T ss_pred EEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHh
Confidence 999999999999999997543221 22345667889999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-25 Score=221.97 Aligned_cols=167 Identities=21% Similarity=0.337 Sum_probs=139.8
Q ss_pred CCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+|+..+.||+|+||.||+|+.+++..+|+|.+.... ....+|.+|++++++++|+||+++++++.+ .+..++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~~~~l 76 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK-------QRPIFI 76 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC-------CCceEE
Confidence 466778999999999999998777889999986433 234679999999999999999999998865 456899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||||+++++|.++++... ..++|..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 77 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 77 VTEYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred EEecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecc
Confidence 999999999999997532 3689999999999999999999998 99999999999999999999999999997653
Q ss_pred ccccc--ceecccccccCCCCC
Q 006145 638 NAEKV--GHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 ~~~~~--~~~~gt~~y~aPE~~ 657 (659)
+.... ....++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~ 173 (256)
T cd05059 152 DDQYTSSQGTKFPVKWAPPEVF 173 (256)
T ss_pred cccccccCCCCCCccccCHHHh
Confidence 32211 122334579999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-25 Score=226.92 Aligned_cols=185 Identities=14% Similarity=0.235 Sum_probs=151.4
Q ss_pred cCHHHHHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeee
Q 006145 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFE 544 (659)
Q Consensus 467 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 544 (659)
+.++++..+.++|+..+.||+|+||.||+|+.. +++.+|+|.++... ....++.+|+.+++++ +||||++++++|..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 455677778899999999999999999999865 58899999886432 2245788999999999 69999999999864
Q ss_pred ccccCCCCceeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc
Q 006145 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL 623 (659)
Q Consensus 545 ~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~ 623 (659)
... ......++||||+++|+|.++++.. .....+++..+..++.|+++||.|||+. +|+||||||+||++++++
T Consensus 87 ~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 87 KDV--KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred ccc--CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 221 1235689999999999999987632 1234688999999999999999999998 999999999999999999
Q ss_pred ceEEccCccccccccc-cccceecccccccCCCCC
Q 006145 624 VAKISSYNLPLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 624 ~~kl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
.+|++|||+++..... .......|++.|+|||+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196 (286)
T ss_pred CEEEccCCceeecccCCCccccccCCCcccChhhh
Confidence 9999999999765332 223445799999999975
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=224.88 Aligned_cols=168 Identities=19% Similarity=0.357 Sum_probs=143.7
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
++|...+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++.. .+..
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-------~~~~ 81 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-------RDKL 81 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-------CCEE
Confidence 35666688999999999999864 589999999976544445668899999999999999999999876 4678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.+++... ..+++.+...++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 82 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred EEEEeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 9999999999999998752 4689999999999999999999998 999999999999999999999999999865
Q ss_pred ccc-ccccceecccccccCCCCC
Q 006145 636 AEN-AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~-~~~~~~~~gt~~y~aPE~~ 657 (659)
... ........|+..|+|||+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~ 178 (267)
T cd06645 156 ITATIAKRKSFIGTPYWMAPEVA 178 (267)
T ss_pred ccCcccccccccCcccccChhhh
Confidence 432 2223456789999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-26 Score=234.87 Aligned_cols=177 Identities=19% Similarity=0.363 Sum_probs=150.0
Q ss_pred HHHHHhhcCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 470 EELEEATNNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 470 ~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
++++..+.+.....+||-|.||.||.|.|+. ...||||.++.+.. ..++|+.|+.+|+.++|||+|+|+|+|..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~---- 334 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTH---- 334 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhcc----
Confidence 5555556667778999999999999999876 77899999986553 46899999999999999999999999986
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
....|||+|||.+|+|.+||++... ..++--..+.+|.||+.||+||... .+|||||.++|+|+.++..+||+
T Consensus 335 ---EpPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvA 407 (1157)
T KOG4278|consen 335 ---EPPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVA 407 (1157)
T ss_pred ---CCCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEee
Confidence 3468999999999999999997533 4566667789999999999999998 99999999999999999999999
Q ss_pred cCccccccccccccce--ecccccccCCCCCC
Q 006145 629 SYNLPLLAENAEKVGH--VIPYSGSIDPTNSA 658 (659)
Q Consensus 629 DFGla~~~~~~~~~~~--~~gt~~y~aPE~~~ 658 (659)
||||++++..+....+ ..=...|-|||-++
T Consensus 408 DFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLA 439 (1157)
T KOG4278|consen 408 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 439 (1157)
T ss_pred ccchhhhhcCCceecccCccCcccccCccccc
Confidence 9999999976544322 22244799999765
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-25 Score=228.87 Aligned_cols=171 Identities=26% Similarity=0.427 Sum_probs=137.9
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCc--EEEEEEecccCC-CchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGT--FVAIRCLKMKKC-HSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~--~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~ 551 (659)
++|+..+.||+|+||.||+|+.+ ++. .+|+|.++.... ...++|.+|++++.++ +|+||+++++++.+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~------- 79 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH------- 79 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-------
Confidence 46777899999999999999965 454 468887764322 2345789999999999 89999999999875
Q ss_pred CceeEEEEeccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCcee
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGH-------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDIL 618 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 618 (659)
.+..++||||+++|+|.++++... ....+++.+++.++.|+++|++|||+. +|+||||||+||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nil 156 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL 156 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEE
Confidence 456899999999999999997431 123588999999999999999999998 9999999999999
Q ss_pred ecCCcceEEccCccccccccccccceecccccccCCCCC
Q 006145 619 LDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 619 ld~~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+++++.+||+|||+++............++..|+|||+.
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 195 (303)
T cd05088 157 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL 195 (303)
T ss_pred ecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHH
Confidence 999999999999998644322222223346689999974
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=226.91 Aligned_cols=171 Identities=22% Similarity=0.410 Sum_probs=142.3
Q ss_pred cCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.+|...+.||+|+||.||+|+.. ++..+++|.++.......+.+.+|++++++++|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 78 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD------ 78 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc------
Confidence 34667789999999999999842 356799999876554445679999999999999999999999975
Q ss_pred CCceeEEEEeccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCce
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGH-------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDI 617 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NI 617 (659)
.+..++||||+++|+|.+++.... ....++|..+++++.|++.|++|||+. +|+||||||+||
T Consensus 79 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 154 (291)
T cd05094 79 -GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNC 154 (291)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceE
Confidence 456899999999999999997422 123589999999999999999999998 999999999999
Q ss_pred eecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 618 LLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 618 Lld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
++++++.+||+|||+++....... .....++..|+|||+.
T Consensus 155 l~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 197 (291)
T cd05094 155 LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 197 (291)
T ss_pred EEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHh
Confidence 999999999999999975533221 2345567889999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=219.85 Aligned_cols=163 Identities=20% Similarity=0.368 Sum_probs=135.2
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEe
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
+.||+|+||.||+|+.. +++.||+|.+..... +....|.+|++++++++||||++++++|.. ....++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~~~lv~e 73 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-------KQPIYIVME 73 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-------CCCeEEEEe
Confidence 46899999999999965 689999998864432 223569999999999999999999999875 456899999
Q ss_pred ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccccccc
Q 006145 561 YVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640 (659)
Q Consensus 561 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 640 (659)
|+++|+|.++++.. ...++|..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||++....+..
T Consensus 74 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 74 LVQGGDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred eccCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccc
Confidence 99999999999753 24589999999999999999999998 99999999999999999999999999987553321
Q ss_pred cc---ceecccccccCCCCC
Q 006145 641 KV---GHVIPYSGSIDPTNS 657 (659)
Q Consensus 641 ~~---~~~~gt~~y~aPE~~ 657 (659)
.. .....+..|+|||+.
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~ 168 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEAL 168 (252)
T ss_pred ccccCCCCCCceeecCchhh
Confidence 11 111234579999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=220.58 Aligned_cols=166 Identities=23% Similarity=0.464 Sum_probs=142.6
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
++|+..+.||+|+||.||+|... |+.||||.++.... ..+++.+|+.++++++|+||+++++++.+ ....+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~~~~ 76 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-------GNPLY 76 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-------CCCeE
Confidence 46777899999999999999875 88999999976543 45789999999999999999999999875 45689
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.++++... ...++|..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 77 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEA 152 (256)
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccc
Confidence 9999999999999997532 23689999999999999999999998 9999999999999999999999999999766
Q ss_pred ccccccceecccccccCCCCC
Q 006145 637 ENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.... .....+..|+|||+.
T Consensus 153 ~~~~--~~~~~~~~~~ape~~ 171 (256)
T cd05039 153 SQGQ--DSGKLPVKWTAPEAL 171 (256)
T ss_pred cccc--ccCCCcccccCchhh
Confidence 3322 233456689999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-25 Score=252.93 Aligned_cols=179 Identities=13% Similarity=0.260 Sum_probs=146.4
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
...++|...+.||+|+||+||+|+.. ++..||+|.+...... ....|..|+.++++++|||||++++++...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de----- 84 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK----- 84 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec-----
Confidence 34567889999999999999999965 4889999998754322 245799999999999999999999988652
Q ss_pred CCceeEEEEeccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHhhhhcCCCC----CCccccCCCCCceeecCC---
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGH-AHQSLTWTQRISAAIGVAKGIQFLHTGIV----PGVFSNNLKITDILLDQN--- 622 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~iiHrDlk~~NILld~~--- 622 (659)
.....|+||||+++|+|.+++.... ....+++...+.|+.||+.||+|||+... .+||||||||+|||++.+
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 2356899999999999999987421 12469999999999999999999998521 359999999999999642
Q ss_pred --------------cceEEccCccccccccccccceecccccccCCCCC
Q 006145 623 --------------LVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 623 --------------~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
..+||+|||+++...........+||+.|||||++
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL 213 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELL 213 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHH
Confidence 34899999999876554444567899999999975
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=211.28 Aligned_cols=179 Identities=15% Similarity=0.196 Sum_probs=151.8
Q ss_pred hhcCCCCCceeccCcCceEEEEE-ecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
..++|...+.+|+|||+-||.++ ..+++.+|+|++.....++.+..++|++..++++||||+++++++.....| ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D--~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD--GKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc--Cce
Confidence 34678888999999999999999 667999999999887777778899999999999999999999998763332 245
Q ss_pred eeEEEEeccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGH-AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
..|++++|...|+|.+.+++.+ ++..+++.+.+.|+.+|++||++||+. .|+.+||||||.|||+.+++.+++.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 7899999999999999998533 234799999999999999999999995 66899999999999999999999999999
Q ss_pred cccccc----cc------ccceecccccccCCCC
Q 006145 633 PLLAEN----AE------KVGHVIPYSGSIDPTN 656 (659)
Q Consensus 633 a~~~~~----~~------~~~~~~gt~~y~aPE~ 656 (659)
+..+.- .. .-.....|..|+|||-
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPEL 209 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPEL 209 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchh
Confidence 865521 11 1134568999999995
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-25 Score=225.08 Aligned_cols=167 Identities=17% Similarity=0.344 Sum_probs=141.9
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
|+..+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|+++++.++||||++++++|.. ....++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-------~~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-------ENNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-------CCEEEE
Confidence 445678999999999999976 488899999875544445679999999999999999999999876 456899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||||+++|+|..++.+. ...++|..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 80 v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 80 LIEFCAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccc
Confidence 99999999999988642 24689999999999999999999998 99999999999999999999999999986543
Q ss_pred cc-cccceecccccccCCCCC
Q 006145 638 NA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 ~~-~~~~~~~gt~~y~aPE~~ 657 (659)
.. .......++..|+|||+.
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~ 175 (282)
T cd06643 155 RTIQRRDSFIGTPYWMAPEVV 175 (282)
T ss_pred ccccccccccccccccCHhhc
Confidence 22 223446789999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-25 Score=226.77 Aligned_cols=167 Identities=17% Similarity=0.320 Sum_probs=145.2
Q ss_pred cCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.+|+..+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++.. .+..
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-------~~~~ 91 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-------GDEL 91 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-------CCEE
Confidence 5688889999999999999995 4699999999976554555678999999999999999999999975 4678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.+++.+ ..+++.++..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 92 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred EEeecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceE
Confidence 999999999999999874 3588999999999999999999998 999999999999999999999999999875
Q ss_pred ccccc-ccceecccccccCCCCC
Q 006145 636 AENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
..... ......+++.|+|||+.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~ 187 (297)
T cd06656 165 ITPEQSKRSTMVGTPYWMAPEVV 187 (297)
T ss_pred ccCCccCcCcccCCccccCHHHH
Confidence 53322 22345788999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=232.42 Aligned_cols=173 Identities=14% Similarity=0.248 Sum_probs=143.1
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
...++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++...... .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI-E 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc-c
Confidence 34577889999999999999999864 588999999875422 2335688999999999999999999988642211 1
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.....|+++|++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 124579999998 7799988764 3589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccccceecccccccCCCCC
Q 006145 631 NLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+++.... ......||+.|+|||+.
T Consensus 163 g~~~~~~~--~~~~~~~t~~y~aPE~~ 187 (343)
T cd07878 163 GLARQADD--EMTGYVATRWYRAPEIM 187 (343)
T ss_pred ccceecCC--CcCCccccccccCchHh
Confidence 99976643 23456789999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=221.12 Aligned_cols=158 Identities=21% Similarity=0.372 Sum_probs=133.2
Q ss_pred ceeccCcCceEEEEEecC-C----------cEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 483 AFMGEGSQGQMYRGRLKN-G----------TFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~-g----------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
+.||+|+||.||+|+..+ + ..|++|.+...... ..+|.+|++++++++||||++++++|..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-------
Confidence 468999999999999764 3 25788877654432 5789999999999999999999999874
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc-------c
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL-------V 624 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~-------~ 624 (659)
...++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~ 146 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPF 146 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCcee
Confidence 24699999999999999998532 2689999999999999999999998 999999999999999887 7
Q ss_pred eEEccCccccccccccccceecccccccCCCCC
Q 006145 625 AKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 ~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+||+|||++..... .....++..|+|||+.
T Consensus 147 ~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~ 176 (259)
T cd05037 147 IKLSDPGIPITVLS---REERVERIPWIAPECI 176 (259)
T ss_pred EEeCCCCccccccc---ccccccCCCccChhhh
Confidence 99999999976533 2234577889999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-25 Score=234.99 Aligned_cols=173 Identities=16% Similarity=0.194 Sum_probs=143.5
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
..++|...+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.+++.++||||+++++++...... ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~-~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL-EE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccc-cc
Confidence 3567889999999999999999965 58899999997543 22345788999999999999999999987642110 11
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....|+||||+++ +|.+++.. .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 3457999999975 78777753 478999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+++............+|..|+|||+.
T Consensus 172 ~a~~~~~~~~~~~~~~t~~y~aPE~~ 197 (364)
T cd07875 172 LARTAGTSFMMTPYVVTRYYRAPEVI 197 (364)
T ss_pred CccccCCCCcccCCcccCCcCCHHHH
Confidence 99876554445567899999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=220.03 Aligned_cols=169 Identities=17% Similarity=0.300 Sum_probs=144.3
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||+|++|.||+|+.. +++.|++|.+..... ...+++.+|++++++++||||+++++++.+ .+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~ 73 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-------KGK 73 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-------CCE
Confidence 4667789999999999999965 589999999865432 234679999999999999999999999875 467
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++++|.++++.. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~ 149 (256)
T cd08529 74 LNIVMEYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAK 149 (256)
T ss_pred EEEEEEeCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccce
Confidence 89999999999999999853 235689999999999999999999998 99999999999999999999999999987
Q ss_pred ccccccc-cceecccccccCCCCC
Q 006145 635 LAENAEK-VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~-~~~~~gt~~y~aPE~~ 657 (659)
....... .....+++.|+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~ 173 (256)
T cd08529 150 LLSDNTNFANTIVGTPYYLSPELC 173 (256)
T ss_pred eccCccchhhccccCccccCHHHh
Confidence 6543322 2345788999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=222.06 Aligned_cols=171 Identities=15% Similarity=0.277 Sum_probs=143.4
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||.||+|+.. +++.||||.++.... ....+|.+|+++++.++||||+++++++.+ .
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~ 74 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-------D 74 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-------C
Confidence 46888899999999999999965 689999998864332 223468999999999999999999999876 4
Q ss_pred ceeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
+..++|+||+++|+|.+++... .....+++.....++.|+++||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g 151 (267)
T cd08228 75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence 5789999999999999988632 1234588899999999999999999998 99999999999999999999999999
Q ss_pred cccccccccc-cceecccccccCCCCC
Q 006145 632 LPLLAENAEK-VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~-~~~~~gt~~y~aPE~~ 657 (659)
++........ .....++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~ 178 (267)
T cd08228 152 LGRFFSSKTTAAHSLVGTPYYMSPERI 178 (267)
T ss_pred cceeccchhHHHhcCCCCccccChhhh
Confidence 9876643222 2345788899999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=223.24 Aligned_cols=162 Identities=15% Similarity=0.316 Sum_probs=138.7
Q ss_pred CCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 478 NFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
+|+..+.||+|+||.||+|+. .+++.||+|.+..... ...++|.+|++++++++||||++++++|.. .+..
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~~~ 74 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-------ENRI 74 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-------CCEE
Confidence 567788999999999999985 4689999999865432 234579999999999999999999999986 4568
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|..+. .+++.....++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++..
T Consensus 75 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 75 SICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred EEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 9999999999997542 367888999999999999999998 999999999999999999999999999976
Q ss_pred cccccccceecccccccCCCCC
Q 006145 636 AENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.... ......++..|+|||+.
T Consensus 145 ~~~~-~~~~~~~~~~y~aPE~~ 165 (279)
T cd06619 145 LVNS-IAKTYVGTNAYMAPERI 165 (279)
T ss_pred cccc-cccCCCCChhhcCceee
Confidence 5432 23446899999999975
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=226.83 Aligned_cols=171 Identities=18% Similarity=0.359 Sum_probs=139.1
Q ss_pred cCCCCCceeccCcCceEEEEEecC---------------CcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN---------------GTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALG 540 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~---------------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g 540 (659)
++|...+.||+|+||.||+|+... ...||+|.++..... ...+|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 567888999999999999987532 235899998754322 2356999999999999999999999
Q ss_pred eeeeccccCCCCceeEEEEeccCCCChhhhhcCCC---------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccC
Q 006145 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGH---------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNN 611 (659)
Q Consensus 541 ~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrD 611 (659)
++.. ....++||||+++|+|.+++.... ....++|..++.++.|+++||+|||+. +++|||
T Consensus 85 ~~~~-------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~d 154 (295)
T cd05097 85 VCVS-------DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRD 154 (295)
T ss_pred EEcC-------CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceeccc
Confidence 9975 456899999999999999986421 112478999999999999999999998 999999
Q ss_pred CCCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 612 LKITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 612 lk~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
|||+||++++++.+||+|||++........ .....++..|+|||+.
T Consensus 155 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 203 (295)
T cd05097 155 LATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI 203 (295)
T ss_pred cChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh
Confidence 999999999999999999999975432221 1233456789999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=220.17 Aligned_cols=169 Identities=18% Similarity=0.291 Sum_probs=142.8
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-----chHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-----STRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
++|...+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|++++++++||||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------ 75 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD------ 75 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc------
Confidence 46888999999999999999864 5899999998643211 23468899999999999999999999976
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+..++|+||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 76 -~~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~df 148 (263)
T cd06625 76 -DETLSIFMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDF 148 (263)
T ss_pred -CCeEEEEEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 45789999999999999998752 4588999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccc----ceecccccccCCCCCC
Q 006145 631 NLPLLAENAEKV----GHVIPYSGSIDPTNSA 658 (659)
Q Consensus 631 Gla~~~~~~~~~----~~~~gt~~y~aPE~~~ 658 (659)
|+++........ ....++..|+|||+..
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 180 (263)
T cd06625 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180 (263)
T ss_pred ccceeccccccccccccCCCcCccccCcceec
Confidence 998755332111 2356788999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=231.98 Aligned_cols=171 Identities=18% Similarity=0.384 Sum_probs=144.6
Q ss_pred HhhcCCCCCceeccCcCceEEEEEecC---C--cEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccc
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLKN---G--TFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYF 547 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~---g--~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 547 (659)
..++.....++||.|.||.||+|.+.+ | ..||||.-+.... ++.+.|+.|+-+|++++|||||+|+|+|.+
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e--- 462 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE--- 462 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec---
Confidence 344455667899999999999999643 3 3689998876443 345679999999999999999999999985
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEE
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKI 627 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl 627 (659)
...++|||.++-|.|+++|+.. +..|+......++.||+.||+|||+. ++|||||.++|||+...--+|+
T Consensus 463 -----~P~WivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKL 532 (974)
T KOG4257|consen 463 -----QPMWIVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKL 532 (974)
T ss_pred -----cceeEEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeee
Confidence 5689999999999999999853 45688889999999999999999999 9999999999999999999999
Q ss_pred ccCcccccccccccccee--cccccccCCCCC
Q 006145 628 SSYNLPLLAENAEKVGHV--IPYSGSIDPTNS 657 (659)
Q Consensus 628 ~DFGla~~~~~~~~~~~~--~gt~~y~aPE~~ 657 (659)
+|||+++..++...++.. .-...|||||-+
T Consensus 533 aDFGLSR~~ed~~yYkaS~~kLPIKWmaPESI 564 (974)
T KOG4257|consen 533 ADFGLSRYLEDDAYYKASRGKLPIKWMAPESI 564 (974)
T ss_pred cccchhhhccccchhhccccccceeecCcccc
Confidence 999999988776555443 345579999954
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=223.71 Aligned_cols=166 Identities=23% Similarity=0.359 Sum_probs=138.2
Q ss_pred CCCceeccCcCceEEEEEe-----cCCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 480 DTSAFMGEGSQGQMYRGRL-----KNGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 480 ~~~~~ig~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
+..+.||+|+||+||++.. .++..||+|.++.... ...+.|.+|++++++++||||++++++|... ...
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 81 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ-----GGK 81 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CCc
Confidence 7778999999999988653 3578999999975432 2346789999999999999999999988651 134
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++|+|.+++.. ..++|.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccc
Confidence 58999999999999999975 3589999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccc----cceecccccccCCCCC
Q 006145 634 LLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
+....... .....++..|+|||+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~ 182 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECL 182 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHh
Confidence 76643322 1223456679999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=222.14 Aligned_cols=174 Identities=17% Similarity=0.316 Sum_probs=137.6
Q ss_pred CCCceeccCcCceEEEEEecC-Cc--EEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 480 DTSAFMGEGSQGQMYRGRLKN-GT--FVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 480 ~~~~~ig~G~~g~Vy~~~~~~-g~--~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
...+.||+|+||.||+|+..+ +. .||+|.++.... ...+.|.+|+++++.++|+||++++++|..... ......
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVE-SEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCc-ccCCCC
Confidence 456889999999999999764 33 699999875432 234678999999999999999999999864221 111235
Q ss_pred eEEEEeccCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 555 IFLIFEYVPNGTLRSWISEG---HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.++||||+++|+|.+++... .....++|.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 78999999999999987421 1224589999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccc---cceecccccccCCCCC
Q 006145 632 LPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
+++....... .....+++.|+|||+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 186 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESL 186 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHc
Confidence 9976643221 1223456789999985
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=225.21 Aligned_cols=166 Identities=22% Similarity=0.368 Sum_probs=144.1
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||.||+++.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+ .
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~ 73 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-------D 73 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-------C
Confidence 36778899999999999999965 589999999865432 234568999999999999999999999875 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||+++|+|.++++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 74 ~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 74 SNLYLVMEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred CeEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCC
Confidence 6789999999999999999753 4689999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++..... .....+++.|+|||+.
T Consensus 148 ~~~~~~~--~~~~~~~~~y~aPE~~ 170 (290)
T cd05580 148 AKRVKGR--TYTLCGTPEYLAPEII 170 (290)
T ss_pred ccccCCC--CCCCCCCccccChhhh
Confidence 9776443 3345789999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=225.43 Aligned_cols=170 Identities=21% Similarity=0.380 Sum_probs=145.6
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|+..+.||.|+||.||+|+.. ++..||+|.++.......++|.+|++++++++|+||+++++++.. ...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-------ENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-------CCe
Confidence 456777889999999999999975 589999999976544445679999999999999999999999875 457
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++|+|.+++... ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 77 LWILIEFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred EEEEeeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccch
Confidence 89999999999999998753 24689999999999999999999998 99999999999999999999999999986
Q ss_pred cccc-ccccceecccccccCCCCC
Q 006145 635 LAEN-AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~-~~~~~~~~gt~~y~aPE~~ 657 (659)
.... ........+++.|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~ 175 (280)
T cd06611 152 KNKSTLQKRDTFIGTPYWMAPEVV 175 (280)
T ss_pred hhcccccccceeecchhhcCHHHH
Confidence 5432 2223446789999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=226.93 Aligned_cols=172 Identities=20% Similarity=0.406 Sum_probs=140.9
Q ss_pred hcCCCCCceeccCcCceEEEEEec--------CCcEEEEEEecccC-CCchHHHHHHHHHHhCC-CCCCccceeeeeeec
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK--------NGTFVAIRCLKMKK-CHSTRNFMHHIELISKL-RHRHLVSALGHCFEC 545 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 545 (659)
.++|...+.||+|+||.||+|+.. ++..||+|.++... ....+++.+|+++++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence 456777899999999999999741 24579999987543 22346799999999999 89999999999875
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCC
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHA-------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNL 612 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl 612 (659)
....++||||+++|+|.+++..... ...++|..+..++.|+++||+|||+. +|+||||
T Consensus 93 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dl 163 (304)
T cd05101 93 ------DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDL 163 (304)
T ss_pred ------CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccc
Confidence 4568999999999999999975311 23588999999999999999999998 9999999
Q ss_pred CCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 613 KITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 613 k~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
||+||++++++.+||+|||+++....... .....+++.|+|||+.
T Consensus 164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 211 (304)
T cd05101 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL 211 (304)
T ss_pred ccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh
Confidence 99999999999999999999976643221 2234466789999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=219.73 Aligned_cols=166 Identities=20% Similarity=0.402 Sum_probs=139.8
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
++|...+.||+|+||.||++... |..||+|.++... ..+.|.+|+.++++++|+|++++++++... ....+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~~ 76 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE------KGGLY 76 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC------CCceE
Confidence 46778899999999999999865 7889999986433 346799999999999999999999987541 34589
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.++++.. ....++|..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||+++..
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred EEEECCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceec
Confidence 999999999999999753 224589999999999999999999998 9999999999999999999999999998755
Q ss_pred ccccccceecccccccCCCCC
Q 006145 637 ENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.... ....++..|+|||+.
T Consensus 153 ~~~~--~~~~~~~~y~aPE~~ 171 (256)
T cd05082 153 SSTQ--DTGKLPVKWTAPEAL 171 (256)
T ss_pred cccC--CCCccceeecCHHHH
Confidence 3322 233456789999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=222.75 Aligned_cols=169 Identities=18% Similarity=0.327 Sum_probs=139.2
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCc----EEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGT----FVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 549 (659)
.++|+..+.||+|+||+||+|+.. +|+ .||+|.++..... ..+++.+|+.+++.++|+||++++++|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 345777899999999999999853 454 4899998754332 34578999999999999999999999874
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEcc
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISS 629 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 629 (659)
...++++||+++|+|.++++.. ...+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 81 ---~~~~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~d 152 (279)
T cd05109 81 ---STVQLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITD 152 (279)
T ss_pred ---CCcEEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECC
Confidence 3468999999999999999753 24689999999999999999999998 999999999999999999999999
Q ss_pred Ccccccccccccc---ceecccccccCCCCC
Q 006145 630 YNLPLLAENAEKV---GHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~~~~---~~~~gt~~y~aPE~~ 657 (659)
||+++........ ....++..|||||+.
T Consensus 153 fG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 183 (279)
T cd05109 153 FGLARLLDIDETEYHADGGKVPIKWMALESI 183 (279)
T ss_pred CCceeecccccceeecCCCccchhhCCHHHh
Confidence 9999766432221 223446789999975
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=225.72 Aligned_cols=174 Identities=20% Similarity=0.390 Sum_probs=142.4
Q ss_pred HhhcCCCCCceeccCcCceEEEEEecC------CcEEEEEEecccCC-CchHHHHHHHHHHhCC-CCCCccceeeeeeec
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLKN------GTFVAIRCLKMKKC-HSTRNFMHHIELISKL-RHRHLVSALGHCFEC 545 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 545 (659)
...++|+..+.||+|+||.||++.... ...+|+|.+..... +...++.+|++++.++ +|+||++++++|..
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 87 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ- 87 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC-
Confidence 345668888999999999999998642 36899999875432 2235688999999999 79999999999875
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCC
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEG-------------HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNL 612 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl 612 (659)
.+..++||||+++|+|.+++++. .....++|..+++++.|++.||+|||+. +|+||||
T Consensus 88 ------~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dl 158 (293)
T cd05053 88 ------EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDL 158 (293)
T ss_pred ------CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccc
Confidence 45689999999999999998642 1234689999999999999999999998 9999999
Q ss_pred CCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 613 KITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 613 k~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
||+||++++++.+|++|||+++....... .....++..|+|||+.
T Consensus 159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 206 (293)
T cd05053 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL 206 (293)
T ss_pred ceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHh
Confidence 99999999999999999999986643322 1223456789999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=221.81 Aligned_cols=164 Identities=20% Similarity=0.339 Sum_probs=132.5
Q ss_pred eeccCcCceEEEEEecCC---cEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEE
Q 006145 484 FMGEGSQGQMYRGRLKNG---TFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIF 559 (659)
Q Consensus 484 ~ig~G~~g~Vy~~~~~~g---~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~ 559 (659)
.||+|+||+||+|+..++ ..+++|.++.... ...+.|.+|+++++.++||||++++++|.. ....++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-------~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-------AIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-------CCccEEEE
Confidence 689999999999985443 3566777654332 234679999999999999999999999975 45689999
Q ss_pred eccCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccccc
Q 006145 560 EYVPNGTLRSWISEGHA-HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAEN 638 (659)
Q Consensus 560 Ey~~~GsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 638 (659)
||+++|+|.+++++... ....++.....++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCc
Confidence 99999999999975321 23467777889999999999999998 999999999999999999999999999854321
Q ss_pred c---cccceecccccccCCCCC
Q 006145 639 A---EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 639 ~---~~~~~~~gt~~y~aPE~~ 657 (659)
. .......++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~ 173 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELV 173 (268)
T ss_pred chhhhcccCCcCcccccCchhc
Confidence 1 112345688899999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=222.17 Aligned_cols=171 Identities=21% Similarity=0.380 Sum_probs=141.9
Q ss_pred cCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 549 (659)
++|+....||+|+||.||+|+.+ +.+.||+|.+...... ..++|.+|++++++++|+||+++++++.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE----- 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-----
Confidence 56778899999999999999964 2467999988654433 24679999999999999999999999865
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCC------CCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAH------QSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL 623 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~ 623 (659)
.+..++||||+++|+|.++++..... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++
T Consensus 80 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~ 154 (275)
T cd05046 80 --AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQR 154 (275)
T ss_pred --CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCC
Confidence 45689999999999999999753211 2589999999999999999999998 999999999999999999
Q ss_pred ceEEccCccccccccc--cccceecccccccCCCCC
Q 006145 624 VAKISSYNLPLLAENA--EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 624 ~~kl~DFGla~~~~~~--~~~~~~~gt~~y~aPE~~ 657 (659)
.+|++|||+++..... .......++..|+|||+.
T Consensus 155 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 190 (275)
T cd05046 155 EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV 190 (275)
T ss_pred cEEEcccccccccCcccccccCCceeEEeecChhhh
Confidence 9999999998644322 122345677889999975
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=223.23 Aligned_cols=169 Identities=19% Similarity=0.362 Sum_probs=144.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
+.|...+.||+|+||.||+|+.. +++.||+|.+........+++.+|+++++.++|+||+++++++.. ....
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~~ 84 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-------DGKL 84 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-------CCeE
Confidence 55777889999999999999975 489999999976554445679999999999999999999999875 4568
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.+++.+. ...+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred EEEEecCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 9999999999999887642 24589999999999999999999998 999999999999999999999999999865
Q ss_pred ccc-ccccceecccccccCCCCC
Q 006145 636 AEN-AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~-~~~~~~~~gt~~y~aPE~~ 657 (659)
... ........+++.|+|||+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~ 182 (292)
T cd06644 160 NVKTLQRRDSFIGTPYWMAPEVV 182 (292)
T ss_pred ccccccccceecCCccccCceee
Confidence 422 2223456788999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=219.85 Aligned_cols=168 Identities=25% Similarity=0.416 Sum_probs=140.5
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
++|...+.||+|+||.||+|....+..||+|.+.... ...+.|.+|++++++++|+|++++++++.. +..+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~ 76 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE--------EPIY 76 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC--------CCcE
Confidence 4577788999999999999998777789999886543 234679999999999999999999988742 3478
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.++++.. ....++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 77 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred EEEEcCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 999999999999999753 234589999999999999999999998 9999999999999999999999999999765
Q ss_pred ccccc--cceecccccccCCCCC
Q 006145 637 ENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
..... .....++..|+|||+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~Pe~~ 175 (260)
T cd05069 153 EDNEYTARQGAKFPIKWTAPEAA 175 (260)
T ss_pred cCCcccccCCCccchhhCCHHHh
Confidence 43221 1233466789999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=219.26 Aligned_cols=167 Identities=22% Similarity=0.359 Sum_probs=143.7
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-----CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-----HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
+|+..+.||+|+||+||+|... +++.||+|.+..... +..+.+.+|++++++++|+||+++++++.+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------- 73 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE------- 73 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-------
Confidence 3667789999999999999976 699999999865432 123578999999999999999999999875
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++||||+++++|.+++++. ..+++..+..++.|+++|++|||+. +|+|+||||+||++++++.+||+|||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 74 EDNLYIFLELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred CCeEEEEEEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCc
Confidence 45689999999999999999752 3588999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++.............++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~pe~~ 173 (258)
T cd06632 148 MAKQVVEFSFAKSFKGSPYWMAPEVI 173 (258)
T ss_pred cceeccccccccccCCCcceeCHHHh
Confidence 98766544434556789999999964
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=219.73 Aligned_cols=161 Identities=21% Similarity=0.306 Sum_probs=132.7
Q ss_pred eeccCcCceEEEEEec---CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEE
Q 006145 484 FMGEGSQGQMYRGRLK---NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIF 559 (659)
Q Consensus 484 ~ig~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~ 559 (659)
.||+|+||.||+|++. ++..||+|.+...... ..++|.+|++++++++|+||++++++|.. ...++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--------~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--------EALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--------CCeEEEE
Confidence 3899999999999864 3567999998755322 23569999999999999999999998853 3579999
Q ss_pred eccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccc
Q 006145 560 EYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENA 639 (659)
Q Consensus 560 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 639 (659)
||+++|+|.+++... ...+++..+.+++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 74 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 74 EMASGGPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred EeCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 999999999998742 24689999999999999999999998 9999999999999999999999999999755332
Q ss_pred cc----cceecccccccCCCCC
Q 006145 640 EK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 640 ~~----~~~~~gt~~y~aPE~~ 657 (659)
.. .....++..|+|||+.
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~ 170 (257)
T cd05115 149 DSYYKARSAGKWPLKWYAPECI 170 (257)
T ss_pred ccceeccCCCCCCcccCCHHHH
Confidence 21 1112335789999974
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=224.74 Aligned_cols=170 Identities=16% Similarity=0.309 Sum_probs=143.1
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
+|+..+.||+|+||.||+++.. +|+.||+|.++.... ....++.+|++++++++|+||+++++++.. .+..
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------~~~~ 74 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-------EGAV 74 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-------CCeE
Confidence 5677899999999999999976 699999999875422 223579999999999999999999998875 4678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++++|.++++.......+++..+..++.+++.||.|||+. .+|+||||||+||+++.++.+||+|||++..
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 152 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence 99999999999999987532234689999999999999999999963 2899999999999999999999999999875
Q ss_pred cccccccceecccccccCCCCC
Q 006145 636 AENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.... ......+++.|+|||+.
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE~~ 173 (286)
T cd06622 153 LVAS-LAKTNIGCQSYMAPERI 173 (286)
T ss_pred ccCC-ccccCCCccCccCcchh
Confidence 5322 22345688899999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=220.42 Aligned_cols=169 Identities=25% Similarity=0.386 Sum_probs=143.3
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.++|+..++||+|+||.||+|...+++.||+|.+..... ..++|.+|++++++++|+||+++++++.. +..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~ 75 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ--------EPI 75 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEcc--------CCc
Confidence 456788899999999999999988899999999875443 45689999999999999999999987642 458
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++++|||++..
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 151 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARL 151 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceee
Confidence 99999999999999987532 35689999999999999999999998 999999999999999999999999999976
Q ss_pred cccccc--cceecccccccCCCCC
Q 006145 636 AENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
...... .....++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~ 175 (260)
T cd05067 152 IEDNEYTAREGAKFPIKWTAPEAI 175 (260)
T ss_pred cCCCCcccccCCcccccccCHHHh
Confidence 542221 1234456789999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=220.29 Aligned_cols=170 Identities=16% Similarity=0.259 Sum_probs=140.6
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--C---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--H---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.+|...+.||+|+||.||+|+.. +|..||||.+..... . ..+.+.+|++++++++||||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 76 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP----- 76 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC-----
Confidence 46788899999999999999965 589999999864321 1 134688999999999999999999987641
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.....++||||+++|+|.+++... ..+++....+++.|++.||+|||+. +|+|+||||+||++++++.+||+||
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Df 150 (265)
T cd06652 77 MERTLSIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDF 150 (265)
T ss_pred CCceEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcC
Confidence 134578999999999999998752 3578888999999999999999998 9999999999999999999999999
Q ss_pred ccccccccc----cccceecccccccCCCCC
Q 006145 631 NLPLLAENA----EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~----~~~~~~~gt~~y~aPE~~ 657 (659)
|+++..... .......++..|+|||+.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 181 (265)
T cd06652 151 GASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181 (265)
T ss_pred ccccccccccccccccccCCCCccccChhhh
Confidence 998754321 122345688999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=217.22 Aligned_cols=163 Identities=22% Similarity=0.406 Sum_probs=136.4
Q ss_pred ceeccCcCceEEEEEecCCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEec
Q 006145 483 AFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEY 561 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey 561 (659)
++||+|+||.||+|...++..||+|.+...... ....|.+|++++++++||||++++++|.. .+..++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-------RQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-------CCccEEEEEC
Confidence 468999999999999888999999998754322 23468999999999999999999999875 4568999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccccc
Q 006145 562 VPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEK 641 (659)
Q Consensus 562 ~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 641 (659)
+++|+|.+++... ...++|..+..++.|++.||.|+|+. +++||||||+||++++++.+|++|||++........
T Consensus 74 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 74 VPGGDFLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY 148 (250)
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc
Confidence 9999999998753 23589999999999999999999998 999999999999999999999999999865433221
Q ss_pred c--ceecccccccCCCCC
Q 006145 642 V--GHVIPYSGSIDPTNS 657 (659)
Q Consensus 642 ~--~~~~gt~~y~aPE~~ 657 (659)
. ....++..|+|||+.
T Consensus 149 ~~~~~~~~~~~y~aPE~~ 166 (250)
T cd05085 149 SSSGLKQIPIKWTAPEAL 166 (250)
T ss_pred ccCCCCCCcccccCHHHh
Confidence 1 122445679999974
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=218.65 Aligned_cols=160 Identities=20% Similarity=0.294 Sum_probs=133.5
Q ss_pred eeccCcCceEEEEEec---CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEE
Q 006145 484 FMGEGSQGQMYRGRLK---NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLI 558 (659)
Q Consensus 484 ~ig~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV 558 (659)
.||+|+||.||+|+++ ++..||+|+++..... ..+++.+|++++++++|+||++++|++.. +..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA--------ESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--------CCcEEE
Confidence 5899999999999753 4789999998754322 23579999999999999999999998853 346899
Q ss_pred EeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccccc
Q 006145 559 FEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAEN 638 (659)
Q Consensus 559 ~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 638 (659)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 74 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 74 MELAELGPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147 (257)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCC
Confidence 9999999999999752 4689999999999999999999998 999999999999999999999999999976543
Q ss_pred ccc----cceecccccccCCCCC
Q 006145 639 AEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 639 ~~~----~~~~~gt~~y~aPE~~ 657 (659)
... .....++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~ 170 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECM 170 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHh
Confidence 221 1223345789999965
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=224.35 Aligned_cols=168 Identities=17% Similarity=0.326 Sum_probs=141.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|...+.||+|+||.||+|+.. +++.||+|.++..... ....+.+|++++++++||||+++++++.. .+.
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-------~~~ 78 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-------EKS 78 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-------CCe
Confidence 46778899999999999999965 5889999998754322 23568899999999999999999999875 457
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||++ ++|.+++... ...+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 79 LTLVFEYLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred EEEEEeccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 899999997 5999988753 24588999999999999999999998 99999999999999999999999999996
Q ss_pred ccccc-cccceecccccccCCCCC
Q 006145 635 LAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
..... .......+++.|+|||+.
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~ 176 (301)
T cd07873 153 AKSIPTKTYSNEVVTLWYRPPDIL 176 (301)
T ss_pred ccCCCCCcccccceeecccCcHHH
Confidence 54322 223345678999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=220.42 Aligned_cols=169 Identities=23% Similarity=0.401 Sum_probs=139.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-C---CcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-N---GTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~---g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.+|+..+.||+|+||.||+|+.. + +..+|+|.++..... ..+.|.+|++++++++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 76 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK------- 76 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-------
Confidence 45777899999999999999864 2 347999998754322 23579999999999999999999999875
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..++||||+++|+|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg 151 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFG 151 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCC
Confidence 45689999999999999999753 24689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccc----ceecccccccCCCCC
Q 006145 632 LPLLAENAEKV----GHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~----~~~~gt~~y~aPE~~ 657 (659)
+++........ ....++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~ 181 (267)
T cd05066 152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181 (267)
T ss_pred cccccccccceeeecCCCccceeecCHhHh
Confidence 99766432211 112235679999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=223.61 Aligned_cols=172 Identities=18% Similarity=0.346 Sum_probs=142.0
Q ss_pred hcCCCCCceeccCcCceEEEEEecC-----------------CcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN-----------------GTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVS 537 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~ 537 (659)
..+|...+.||+|+||.||+|+... +..||+|.+...... ..++|.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4568888999999999999998542 246899998755322 3467999999999999999999
Q ss_pred eeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccc
Q 006145 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGH--------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFS 609 (659)
Q Consensus 538 l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 609 (659)
++++|.. .+..++||||+++++|.+++.+.. ....+++..+..++.|++.||+|||+. +|+|
T Consensus 84 ~~~~~~~-------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H 153 (296)
T cd05051 84 LLGVCTV-------DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVH 153 (296)
T ss_pred EEEEEec-------CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccc
Confidence 9999875 356899999999999999997532 113689999999999999999999998 9999
Q ss_pred cCCCCCceeecCCcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 610 NNLKITDILLDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 610 rDlk~~NILld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
|||||+||++++++.++|+|||+++...... ......+++.|||||+.
T Consensus 154 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 204 (296)
T cd05051 154 RDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV 204 (296)
T ss_pred cccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh
Confidence 9999999999999999999999987543222 12334567789999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=224.42 Aligned_cols=169 Identities=24% Similarity=0.336 Sum_probs=138.0
Q ss_pred CCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCCc-hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCHS-TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
|...+.||+|+||.||+|+.. +++.||||+++...... .+.|.+|+++++.++||||+++++++.+
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~------- 79 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK------- 79 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------
Confidence 445688999999999999853 25789999997543222 3568999999999999999999999975
Q ss_pred CceeEEEEeccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCcee
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGH-------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDIL 618 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 618 (659)
....++++||+++++|.+++.... ....+++..+..++.|+++||+|||+. +|+||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil 156 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL 156 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence 456899999999999999985211 123588999999999999999999998 9999999999999
Q ss_pred ecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 619 LDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 619 ld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
+++++.+||+|||+++....... .....+++.|||||+.
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI 198 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHH
Confidence 99999999999999875532221 2334567899999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=218.38 Aligned_cols=167 Identities=18% Similarity=0.371 Sum_probs=141.6
Q ss_pred CCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCC------chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH------STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
+|...+.||+|+||+||+|...+|+.+|||.++..... ..+.+.+|++++++++|+||++++++|.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------- 73 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD------- 73 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-------
Confidence 46678899999999999999888999999998644211 12458899999999999999999999976
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..++||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 147 (265)
T cd06631 74 DNTISIFMEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFG 147 (265)
T ss_pred CCeEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccch
Confidence 46789999999999999999752 3588999999999999999999998 99999999999999999999999999
Q ss_pred ccccccc-------ccccceecccccccCCCCC
Q 006145 632 LPLLAEN-------AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~-------~~~~~~~~gt~~y~aPE~~ 657 (659)
++..... ........++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 180 (265)
T cd06631 148 CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180 (265)
T ss_pred hhHhhhhccccccccccccccCCCccccChhhh
Confidence 9865421 1122345689999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=217.50 Aligned_cols=169 Identities=15% Similarity=0.309 Sum_probs=144.5
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||+|+||.||.++.. +++.+++|.+.... ....+++.+|++++++++|+||+++++++.+ .+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-------~~~ 73 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-------DNT 73 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-------CCe
Confidence 4778899999999999999854 58999999986543 2334678999999999999999999999976 467
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++|+|.+++.... ...+++.++..++.|+++|++|||+. +++||||||+||++++++.+||+|||++.
T Consensus 74 ~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~ 149 (256)
T cd08221 74 LLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISK 149 (256)
T ss_pred EEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceE
Confidence 899999999999999997532 34689999999999999999999998 99999999999999999999999999997
Q ss_pred cccccc-ccceecccccccCCCCC
Q 006145 635 LAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
...... ......+++.|+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~y~ape~~ 173 (256)
T cd08221 150 ILGSEYSMAETVVGTPYYMSPELC 173 (256)
T ss_pred EcccccccccccCCCccccCHhhc
Confidence 664332 33456789999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=224.95 Aligned_cols=165 Identities=19% Similarity=0.283 Sum_probs=133.7
Q ss_pred CceeccCcCceEEEEEec---CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEE
Q 006145 482 SAFMGEGSQGQMYRGRLK---NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLI 558 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV 558 (659)
..+||+|+||+||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++... .....++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSH-----SDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEecc-----CCCeEEEE
Confidence 368999999999999965 35789999986543 235688999999999999999999988642 24568999
Q ss_pred EeccCCCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceee----cCCcceEEc
Q 006145 559 FEYVPNGTLRSWISEG------HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL----DQNLVAKIS 628 (659)
Q Consensus 559 ~Ey~~~GsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl----d~~~~~kl~ 628 (659)
|||+++ +|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 999975 888777521 1123588999999999999999999998 99999999999999 466899999
Q ss_pred cCcccccccccc----ccceecccccccCCCCC
Q 006145 629 SYNLPLLAENAE----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~~----~~~~~~gt~~y~aPE~~ 657 (659)
|||+++...... ......+|+.|+|||+.
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 187 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHh
Confidence 999997664322 22456789999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=223.59 Aligned_cols=167 Identities=23% Similarity=0.361 Sum_probs=142.1
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-----chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-----STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
+|+..+.||+|+||.||+|... +|+.||||.++..... ....+..|++++++++|+||+++++++.+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------- 73 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH------- 73 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-------
Confidence 3677789999999999999965 5899999999755432 22457789999999999999999999976
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++||||+ +|+|.++++... ..+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||
T Consensus 74 ~~~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg 147 (298)
T cd07841 74 KSNINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFG 147 (298)
T ss_pred CCEEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccce
Confidence 45789999999 899999997532 3699999999999999999999998 99999999999999999999999999
Q ss_pred cccccccc-cccceecccccccCCCCC
Q 006145 632 LPLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
+++..... .......+++.|+|||++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~ 174 (298)
T cd07841 148 LARSFGSPNRKMTHQVVTRWYRAPELL 174 (298)
T ss_pred eeeeccCCCccccccccceeeeCHHHH
Confidence 99766443 223445678899999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=222.20 Aligned_cols=170 Identities=22% Similarity=0.374 Sum_probs=140.6
Q ss_pred CCCCCceeccCcCceEEEEEe-----cCCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRL-----KNGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.|+..+.||+|+||.||++++ .++..||+|.++.... ...+++.+|++++++++||||+++++++... .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 79 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED-----G 79 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC-----C
Confidence 356778999999999999984 2478999999875432 2346799999999999999999999998752 1
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++||||+++|+|.+++.+. ...++|..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg 154 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG 154 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCc
Confidence 34579999999999999999753 23589999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccc----cceecccccccCCCCC
Q 006145 632 LPLLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
+++....... .....++..|+|||+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 184 (284)
T cd05079 155 LTKAIETDKEYYTVKDDLDSPVFWYAPECL 184 (284)
T ss_pred cccccccCccceeecCCCCCCccccCHHHh
Confidence 9976543221 1234567789999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=234.13 Aligned_cols=163 Identities=13% Similarity=0.217 Sum_probs=138.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec---CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK---NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
..+|...+.||+|+||.||+|... .+..||||.+... +.+.+|++++++++|||||++++++.. .
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~-------~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW-------K 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee-------C
Confidence 457888999999999999999753 3678999988642 345689999999999999999998875 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||+. ++|.+++.. ...++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~ 231 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGA 231 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcc
Confidence 56899999996 689998853 35699999999999999999999998 999999999999999999999999999
Q ss_pred cccccccc---ccceecccccccCCCCC
Q 006145 633 PLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
++...... ......||+.|+|||++
T Consensus 232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 259 (392)
T PHA03207 232 ACKLDAHPDTPQCYGWSGTLETNSPELL 259 (392)
T ss_pred ccccCcccccccccccccccCccCHhHh
Confidence 97554322 12346799999999986
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=217.27 Aligned_cols=165 Identities=27% Similarity=0.481 Sum_probs=141.4
Q ss_pred ceeccCcCceEEEEEecC----CcEEEEEEecccCCCc-hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLKN----GTFVAIRCLKMKKCHS-TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||.||+|+... +..||+|.++...... .+++.+|++.++.++|+||+++++++.. ....++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------~~~~~l 73 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-------EEPLYL 73 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-------CCceEE
Confidence 468999999999999653 7899999997654333 5689999999999999999999999875 456899
Q ss_pred EEeccCCCChhhhhcCCCC------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 558 IFEYVPNGTLRSWISEGHA------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
||||+++|+|.+++..... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+|++|||
T Consensus 74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg 150 (262)
T cd00192 74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFG 150 (262)
T ss_pred EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccc
Confidence 9999999999999986311 25689999999999999999999998 99999999999999999999999999
Q ss_pred cccccccc---cccceecccccccCCCCC
Q 006145 632 LPLLAENA---EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~---~~~~~~~gt~~y~aPE~~ 657 (659)
.+...... .......++..|+|||+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 179 (262)
T cd00192 151 LSRDVYDDDYYRKKTGGKLPIRWMAPESL 179 (262)
T ss_pred cccccccccccccccCCCcCccccCHHHh
Confidence 99766443 223456678899999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=222.70 Aligned_cols=167 Identities=17% Similarity=0.342 Sum_probs=144.7
Q ss_pred cCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.+|+..+.||.|+||.||+|+. .+|+.||+|.+........+.+.+|+++++.++|+||+++++++.. .+..
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------~~~~ 91 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-------GDEL 91 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-------CceE
Confidence 4577889999999999999985 4699999999976554455678999999999999999999999875 4578
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++|+||+++|+|.+++.. ..++|.++..++.+++.|++|||+. +++||||||+||++++++.+||+|||++..
T Consensus 92 ~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred EEEEEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchh
Confidence 999999999999999874 3589999999999999999999998 999999999999999999999999999875
Q ss_pred ccccc-ccceecccccccCCCCC
Q 006145 636 AENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
..... ......++..|+|||+.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~ 187 (296)
T cd06655 165 ITPEQSKRSTMVGTPYWMAPEVV 187 (296)
T ss_pred cccccccCCCcCCCccccCcchh
Confidence 53322 22345788999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=221.23 Aligned_cols=168 Identities=16% Similarity=0.271 Sum_probs=142.7
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|+..+.||+|+||.||+|+.+ +|+.||+|++..... ...+.+.+|++++++++|+||+++++++.. ..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-------~~ 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-------KR 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-------CC
Confidence 35778899999999999999976 589999999864432 223568899999999999999999999876 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++++|..++.. ...++|..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 74 ~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (286)
T cd07847 74 KLHLVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFA 147 (286)
T ss_pred EEEEEEeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccc
Confidence 68999999999998887764 23589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccc-ccceecccccccCCCCC
Q 006145 634 LLAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
....... ......++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~ 172 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELL 172 (286)
T ss_pred eecCCCcccccCcccccccCCHHHH
Confidence 7664433 23345678899999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=221.79 Aligned_cols=171 Identities=23% Similarity=0.392 Sum_probs=141.2
Q ss_pred cCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.+|...+.||+|+||.||++... ++..+|+|.++.......++|.+|+++++.++|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 78 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE------ 78 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec------
Confidence 45667899999999999999742 366899999876544445679999999999999999999999875
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCcee
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHA------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDIL 618 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 618 (659)
....++||||+++|+|.++++.... ...+++..+..++.|++.|++|||+. +++||||||+||+
T Consensus 79 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil 154 (280)
T cd05092 79 -GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCL 154 (280)
T ss_pred -CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEE
Confidence 4568999999999999999875321 13589999999999999999999998 9999999999999
Q ss_pred ecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 619 LDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 619 ld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
+++++.+||+|||+++....... .....+++.|+|||+.
T Consensus 155 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (280)
T cd05092 155 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI 196 (280)
T ss_pred EcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHh
Confidence 99999999999999975533221 1233456789999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=216.88 Aligned_cols=171 Identities=20% Similarity=0.372 Sum_probs=147.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|...+.||+|+||.||+|+.. +++.+|+|.+........+.+.+|++++++++||||+++++++.+ ...
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-------~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-------RDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-------CCE
Confidence 457888899999999999999965 588999999986655556789999999999999999999998875 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.+++|||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++.
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence 89999999999999998752 24689999999999999999999998 99999999999999999999999999997
Q ss_pred cccccc-ccceecccccccCCCCCC
Q 006145 635 LAENAE-KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~~~~~-~~~~~~gt~~y~aPE~~~ 658 (659)
...... ......++..|+|||+..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~Pe~~~ 174 (262)
T cd06613 150 QLTATIAKRKSFIGTPYWMAPEVAA 174 (262)
T ss_pred hhhhhhhccccccCCccccCchhhc
Confidence 654322 234567888999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=221.03 Aligned_cols=173 Identities=20% Similarity=0.302 Sum_probs=142.7
Q ss_pred hcCCCCCceeccCcCceEEEEEecC-----CcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN-----GTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 549 (659)
.++|...+.||+|+||.||+|.... +..||+|+++.... ...+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---- 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---- 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence 4678888999999999999999765 68899999874432 2345689999999999999999999998752
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCC-----CCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAH-----QSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV 624 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~ 624 (659)
....++++||+++|+|.+++...... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.
T Consensus 81 --~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 81 --GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQ 155 (280)
T ss_pred --CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCc
Confidence 34679999999999999998753221 4689999999999999999999998 9999999999999999999
Q ss_pred eEEccCccccccccccc---cceecccccccCCCCC
Q 006145 625 AKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 ~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
+||+|||+++....... .....++..|+|||+.
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 191 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHH
Confidence 99999999976532221 1223456789999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=220.51 Aligned_cols=171 Identities=15% Similarity=0.279 Sum_probs=144.0
Q ss_pred cCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||.||+|+. .+++.+|||.+...... ...+|.+|+++++.++|+||+++++++.+ .
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-------~ 74 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-------D 74 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-------C
Confidence 3577789999999999999995 46999999988653322 23578999999999999999999999876 4
Q ss_pred ceeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
+..++||||+++++|.+++... .....++|..+..++.|+++||+|||+. +++|+||||+||+++.++.++++|||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg 151 (267)
T cd08229 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence 5789999999999999988632 2234689999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccc-cceecccccccCCCCC
Q 006145 632 LPLLAENAEK-VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~-~~~~~gt~~y~aPE~~ 657 (659)
++........ .....++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~ape~~ 178 (267)
T cd08229 152 LGRFFSSKTTAAHSLVGTPYYMSPERI 178 (267)
T ss_pred hhhccccCCcccccccCCcCccCHHHh
Confidence 9876543222 2345789999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=219.75 Aligned_cols=165 Identities=27% Similarity=0.423 Sum_probs=132.9
Q ss_pred ceeccCcCceEEEEEecC-Cc--EEEEEEecccC-CCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLKN-GT--FVAIRCLKMKK-CHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~-g~--~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||.||+|+..+ +. .+|+|.++... ....+.+.+|++++.++ +||||++++++|.. .+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-------~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-------RGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-------CCCceE
Confidence 468999999999999754 43 57888887433 22345789999999999 79999999999875 456899
Q ss_pred EEeccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc
Q 006145 558 IFEYVPNGTLRSWISEGH-------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV 624 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~ 624 (659)
||||+++|+|.++++... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~ 150 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 150 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCe
Confidence 999999999999987421 113588999999999999999999997 9999999999999999999
Q ss_pred eEEccCccccccccccccceecccccccCCCCC
Q 006145 625 AKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 ~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+|++|||++..............+..|+|||+.
T Consensus 151 ~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~ 183 (270)
T cd05047 151 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL 183 (270)
T ss_pred EEECCCCCccccchhhhccCCCCccccCChHHH
Confidence 999999998643322111222345679999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=224.43 Aligned_cols=171 Identities=24% Similarity=0.358 Sum_probs=141.1
Q ss_pred hcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCC-CchHHHHHHHHHHhCC-CCCCccceeeeeeeccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKC-HSTRNFMHHIELISKL-RHRHLVSALGHCFECYF 547 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 547 (659)
.++|...+.||+|+||.||+|... ++..||||+++.... ...+.+.+|+++++++ +||||++++++|..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec---
Confidence 456888899999999999999741 356899999875432 2235689999999999 79999999999875
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEE
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKI 627 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl 627 (659)
.+..++||||+++|+|.+++++.. ...+++.++..++.|++.||+|||+. +|+|+||||+||++++++.+|+
T Consensus 111 ----~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 111 ----GGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred ----CCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEE
Confidence 456899999999999999997532 23489999999999999999999998 9999999999999999999999
Q ss_pred ccCccccccccccc---cceecccccccCCCCC
Q 006145 628 SSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 628 ~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
+|||+++....... .....++..|+|||+.
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 215 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhh
Confidence 99999975533221 1233467789999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=221.39 Aligned_cols=172 Identities=19% Similarity=0.324 Sum_probs=142.0
Q ss_pred hcCCCCCceeccCcCceEEEEEecC------CcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN------GTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
.++|...+.||+|+||.||+|...+ +..||+|.+..... ....+|.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---- 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST---- 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC----
Confidence 4567788999999999999998642 46899999865432 233568999999999999999999999875
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHA-------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ 621 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~ 621 (659)
....++||||+++|+|.+++..... ...++|..+..++.|++.||+|||+. +|+||||||+||++++
T Consensus 81 ---~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~ 154 (277)
T cd05032 81 ---GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAE 154 (277)
T ss_pred ---CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcC
Confidence 4568999999999999999874221 23478999999999999999999998 9999999999999999
Q ss_pred CcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 622 NLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 622 ~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
++.+||+|||+++...... ......++..|+|||+.
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05032 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193 (277)
T ss_pred CCCEEECCcccchhhccCcccccCCCCCccccccCHHHH
Confidence 9999999999987553322 22344567899999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=217.66 Aligned_cols=171 Identities=14% Similarity=0.292 Sum_probs=145.0
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||.||+|... +|+.||+|.++.... ...+++.+|++++++++|+||+++++++.. .
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-------~ 74 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-------N 74 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-------C
Confidence 57888899999999999999976 799999999864322 224579999999999999999999999875 4
Q ss_pred ceeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
+..++||||+++|+|.+++... .....+++.++..++.++++||+|||+. +|+||||||+||++++++.++|+|||
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence 5689999999999999998642 2234689999999999999999999998 99999999999999999999999999
Q ss_pred cccccccc-cccceecccccccCCCCC
Q 006145 632 LPLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
++...... .......++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~apE~~ 178 (267)
T cd08224 152 LGRFFSSKTTAAHSLVGTPYYMSPERI 178 (267)
T ss_pred eeeeccCCCcccceecCCccccCHHHh
Confidence 98755332 223446788999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=218.87 Aligned_cols=176 Identities=16% Similarity=0.315 Sum_probs=139.5
Q ss_pred CCCCceeccCcCceEEEEEecC----CcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 479 FDTSAFMGEGSQGQMYRGRLKN----GTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
|...+.||+|+||.||+|+... +..||||+++..... ...++.+|++.++.++|+||+++++++...... ...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL-QKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc-ccC
Confidence 4567899999999999998642 478999999754322 235799999999999999999999998752210 112
Q ss_pred ceeEEEEeccCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEG---HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISS 629 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 629 (659)
...++|+||+++|+|.+++... .....+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence 3479999999999999998532 1234689999999999999999999998 999999999999999999999999
Q ss_pred Cccccccccccc---cceecccccccCCCCCC
Q 006145 630 YNLPLLAENAEK---VGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 630 FGla~~~~~~~~---~~~~~gt~~y~aPE~~~ 658 (659)
||+++....... .....++..|+|||+..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 188 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA 188 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcc
Confidence 999976533221 12234567899999753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-25 Score=222.51 Aligned_cols=166 Identities=21% Similarity=0.452 Sum_probs=142.2
Q ss_pred CCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCCch--HHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 479 FDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHST--RNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~--~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
|...+.||+|+||+||+++... ++.||+|.+........ ....+|++++++++||||+++++++.. ....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-------~~~~ 73 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-------DNYL 73 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-------SSEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-------cccc
Confidence 3456899999999999999764 77999999986653322 234569999999999999999999986 4678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||.+..
T Consensus 74 ~~v~~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 74 YIVMEYCPGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEETTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred cccccccccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 999999999999999983 25689999999999999999999998 999999999999999999999999999975
Q ss_pred c-ccccccceecccccccCCCCC
Q 006145 636 A-ENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~-~~~~~~~~~~gt~~y~aPE~~ 657 (659)
. ..........++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~ 170 (260)
T PF00069_consen 148 LSENNENFNPFVGTPEYMAPEVL 170 (260)
T ss_dssp STSTTSEBSSSSSSGGGSCHHHH
T ss_pred ccccccccccccccccccccccc
Confidence 3 334445667899999999974
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=218.02 Aligned_cols=170 Identities=17% Similarity=0.284 Sum_probs=141.2
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-----CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-----HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.+|...+.||+|+||.||+|... ++..||+|++..... +..+.+.+|++++++++||||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 76 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR----- 76 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC-----
Confidence 36888899999999999999865 589999999864321 1234688999999999999999999987641
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.....++++||+++++|.+++... ..+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 77 ~~~~~~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~df 150 (266)
T cd06651 77 AEKTLTIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDF 150 (266)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 135678999999999999999752 3588999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccc----cccceecccccccCCCCC
Q 006145 631 NLPLLAENA----EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~----~~~~~~~gt~~y~aPE~~ 657 (659)
|+++..... .......++..|+|||+.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 181 (266)
T cd06651 151 GASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181 (266)
T ss_pred CCccccccccccCCccccCCccccccCHHHh
Confidence 998754321 112335688999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=218.10 Aligned_cols=171 Identities=26% Similarity=0.441 Sum_probs=144.5
Q ss_pred hhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..++|...+.||+|+||.||+|...+++.||||.+.... ...+++.+|++++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~ 75 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-------EEP 75 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-------CCc
Confidence 356788889999999999999998878899999987543 245679999999999999999999998865 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++++|.+++... ....+++..+..++.+++.|++|||+. +++|+||||+||++++++.+|++|||+++
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~ 151 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLAR 151 (261)
T ss_pred eEEEEeccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccce
Confidence 89999999999999999753 234689999999999999999999998 99999999999999999999999999987
Q ss_pred ccccccc--cceecccccccCCCCC
Q 006145 635 LAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
....... ......+..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~ 176 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAA 176 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHh
Confidence 6543211 1223345689999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=234.98 Aligned_cols=181 Identities=14% Similarity=0.188 Sum_probs=136.7
Q ss_pred hhcCCCCCceeccCcCceEEEEEe-----------------cCCcEEEEEEecccCCCchH--------------HHHHH
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRL-----------------KNGTFVAIRCLKMKKCHSTR--------------NFMHH 523 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~--------------~~~~E 523 (659)
..++|...++||+|+||+||+|.+ .+++.||||++........+ .+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 23568999999754322222 24457
Q ss_pred HHHHhCCCCCCc-----cceeeeeeeccccC-CCCceeEEEEeccCCCChhhhhcCCCC---------------------
Q 006145 524 IELISKLRHRHL-----VSALGHCFECYFDD-SSVSRIFLIFEYVPNGTLRSWISEGHA--------------------- 576 (659)
Q Consensus 524 i~~l~~l~H~ni-----v~l~g~~~~~~~~~-~~~~~~~lV~Ey~~~GsL~~~l~~~~~--------------------- 576 (659)
+.++.+++|.++ +++++||.....+. ...+..+|||||+++|+|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 77888886422111 113468999999999999999874211
Q ss_pred CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccccccce--ecccccccCC
Q 006145 577 HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGH--VIPYSGSIDP 654 (659)
Q Consensus 577 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~--~~gt~~y~aP 654 (659)
...++|..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.......... ..+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12357888999999999999999998 999999999999999999999999999976543332222 3347899999
Q ss_pred CCCC
Q 006145 655 TNSA 658 (659)
Q Consensus 655 E~~~ 658 (659)
|+..
T Consensus 380 E~l~ 383 (507)
T PLN03224 380 EELV 383 (507)
T ss_pred hhhc
Confidence 9863
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=221.00 Aligned_cols=160 Identities=19% Similarity=0.345 Sum_probs=133.2
Q ss_pred ceeccCcCceEEEEEecC--------CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 483 AFMGEGSQGQMYRGRLKN--------GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+.||+|+||.||+|.... ...||+|.+........++|.+|+.+++.++||||+++++++.. .+.
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-------~~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-------GDE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-------CCC
Confidence 468999999999998542 23488888865444445678999999999999999999999986 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc--------eE
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV--------AK 626 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~--------~k 626 (659)
.++||||+++|+|.++++.. ...++|..++.++.|++.||+|||+. +|+||||||+||+++.++. +|
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~ 148 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIK 148 (258)
T ss_pred cEEEEecCCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEE
Confidence 89999999999999999853 23689999999999999999999998 9999999999999987765 59
Q ss_pred EccCccccccccccccceecccccccCCCCC
Q 006145 627 ISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 627 l~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++|||++...... ....++..|+|||+.
T Consensus 149 l~d~g~~~~~~~~---~~~~~~~~y~aPE~~ 176 (258)
T cd05078 149 LSDPGISITVLPK---EILLERIPWVPPECI 176 (258)
T ss_pred ecccccccccCCc---hhccccCCccCchhc
Confidence 9999998655332 235678899999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=224.66 Aligned_cols=172 Identities=20% Similarity=0.396 Sum_probs=140.0
Q ss_pred hcCCCCCceeccCcCceEEEEEec--------CCcEEEEEEecccCC-CchHHHHHHHHHHhCC-CCCCccceeeeeeec
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK--------NGTFVAIRCLKMKKC-HSTRNFMHHIELISKL-RHRHLVSALGHCFEC 545 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 545 (659)
.++|...+.||+|+||.||+++.. ++..+|+|.++.... ....++.+|++++.++ +|+||++++++|..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 356888899999999999999752 235799999975432 2345688999999999 79999999999975
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCC
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHA-------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNL 612 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl 612 (659)
.+..++||||+++|+|.+++..... ...++|.++++++.|++.||+|||+. +++||||
T Consensus 96 ------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dl 166 (307)
T cd05098 96 ------DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDL 166 (307)
T ss_pred ------CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ccccccc
Confidence 4568999999999999999975321 13589999999999999999999998 9999999
Q ss_pred CCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 613 KITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 613 k~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
||+||++++++.+||+|||+++....... .....+++.|||||+.
T Consensus 167 kp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 214 (307)
T cd05098 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 214 (307)
T ss_pred cHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHh
Confidence 99999999999999999999975533211 1222345689999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=222.27 Aligned_cols=185 Identities=17% Similarity=0.290 Sum_probs=151.8
Q ss_pred cCHHHHHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeee
Q 006145 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFE 544 (659)
Q Consensus 467 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 544 (659)
++.+++..++++|...+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.+++++ +||||++++++|..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455677778899999999999999999999964 58999999986432 2345688999999999 79999999999875
Q ss_pred ccccCCCCceeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc
Q 006145 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL 623 (659)
Q Consensus 545 ~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~ 623 (659)
... ......++||||+++|+|.++++.. .....++|..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 91 ~~~--~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 91 ADK--LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred ccc--cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 221 1234689999999999999988632 1234689999999999999999999998 999999999999999999
Q ss_pred ceEEccCcccccccccc-ccceecccccccCCCCC
Q 006145 624 VAKISSYNLPLLAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 624 ~~kl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
.+||+|||+++...... ......|+..|+|||+.
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 200 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200 (291)
T ss_pred CEEEeecccchhcccccccccCccCCccccChhhh
Confidence 99999999987654322 22345788999999974
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=222.57 Aligned_cols=168 Identities=21% Similarity=0.350 Sum_probs=142.5
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|+..+.||+|+||.||+|..+ +++.||+|++...... ..+.+.+|+++++.++||||+++++++.. .+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~ 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-------KK 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-------CC
Confidence 35778899999999999999976 4899999998654322 23568899999999999999999999875 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++++|.++.... ..++|..+..++.|+++||+|||+. +|+||||+|+||++++++.+||+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 74 RLYLVFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred eEEEEEecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeee
Confidence 789999999999998877642 3589999999999999999999998 9999999999999999999999999998
Q ss_pred cccccc-cccceecccccccCCCCC
Q 006145 634 LLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
...... .......++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~ 172 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELL 172 (286)
T ss_pred eeccCCccccCcccceeeccCcHHh
Confidence 765332 223445688999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=219.92 Aligned_cols=167 Identities=20% Similarity=0.340 Sum_probs=143.9
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++|+||+++++++.. ...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------~~~ 73 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-------GSG 73 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-------CCe
Confidence 4677889999999999999965 589999999976542 234679999999999999999999999875 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+ +++|.+++... ...+++.++..++.|+++||+|||+. +++|+||||+||++++++.++++|||++.
T Consensus 74 ~~~v~e~~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 74 FVLVMEYM-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred eEEEeccc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 89999999 99999998753 25689999999999999999999998 99999999999999999999999999997
Q ss_pred cccccc--ccceecccccccCCCCC
Q 006145 635 LAENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
...... ......++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~ 172 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELL 172 (286)
T ss_pred cccCCCCCccccccCcccccCceee
Confidence 664432 23456789999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=215.57 Aligned_cols=169 Identities=17% Similarity=0.244 Sum_probs=143.0
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC-CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK-CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
+|+..+.||+|+||.||+++.. +++.+|+|.++... ....+.+.+|+++++.++|+||+++++++.+ .+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~~ 73 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-------DGHL 73 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-------CCEE
Confidence 4677899999999999999965 58999999986433 2234678899999999999999999999876 5678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.+++... ....+++.....++.|+++||+|||+. +|+|+||||+||++++++.++++|||++..
T Consensus 74 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 149 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149 (255)
T ss_pred EEEEeeCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCccee
Confidence 9999999999999988642 234578999999999999999999998 999999999999999999999999999976
Q ss_pred ccccc-ccceecccccccCCCCC
Q 006145 636 AENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
..... ......+++.|+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~aPE~~ 172 (255)
T cd08219 150 LTSPGAYACTYVGTPYYVPPEIW 172 (255)
T ss_pred ecccccccccccCCccccCHHHH
Confidence 54322 23446789999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=216.94 Aligned_cols=164 Identities=20% Similarity=0.354 Sum_probs=133.5
Q ss_pred ceeccCcCceEEEEEec----CCcEEEEEEecccC-CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK----NGTFVAIRCLKMKK-CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|+.+++.++||||++++++|... ....++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS------EGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC------CCCcEE
Confidence 46899999999999853 24579999985432 22346789999999999999999999988641 345789
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
|+||+++|+|.+++++. ...+++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 75 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 75 VLPYMKHGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999999999753 23578888999999999999999998 99999999999999999999999999997553
Q ss_pred ccc-----ccceecccccccCCCCC
Q 006145 638 NAE-----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 ~~~-----~~~~~~gt~~y~aPE~~ 657 (659)
... ......++..|+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~ 174 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESL 174 (262)
T ss_pred CCcceeecccccCcCCccccChhHh
Confidence 221 11234567789999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=245.04 Aligned_cols=168 Identities=17% Similarity=0.303 Sum_probs=144.5
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc---hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS---TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||.||+|+.. +++.||||+++...... .+.+.+|+++++.++|+||+++++++.. .
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-------~ 76 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-------A 76 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-------C
Confidence 56788899999999999999976 58999999997543222 3568899999999999999999988875 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...|+||||+++|+|.++++.. ..+++.....|+.||+.||+|||.. +||||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~lVmEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 77 NNVYLVMEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred CEEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 6789999999999999999752 3588999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc-cccceecccccccCCCCC
Q 006145 633 PLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
++..... .......+|+.|++||+.
T Consensus 151 s~~~~~~~~~~~~~~~t~~~~~pe~~ 176 (669)
T cd05610 151 SKVTLNRELNMMDILTTPSMAKPKND 176 (669)
T ss_pred CccccCCcccccccccCccccCcccc
Confidence 9866432 234567899999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-24 Score=216.70 Aligned_cols=166 Identities=22% Similarity=0.389 Sum_probs=139.7
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc---------hHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS---------TRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
|.....||+|+||.||+|... +++.||+|.+....... .+.+.+|++++++++||||+++++++.+
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 77 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD---- 77 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----
Confidence 566789999999999999865 58899999886543211 1458899999999999999999999876
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 78 ---~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~ 148 (267)
T cd06628 78 ---ADHLNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKIS 148 (267)
T ss_pred ---CCccEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEec
Confidence 45689999999999999999752 4688999999999999999999998 99999999999999999999999
Q ss_pred cCcccccccccc-------ccceecccccccCCCCC
Q 006145 629 SYNLPLLAENAE-------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~~-------~~~~~~gt~~y~aPE~~ 657 (659)
|||+++...... ......|+..|+|||+.
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~ 184 (267)
T cd06628 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184 (267)
T ss_pred ccCCCcccccccccCCccccccccCCCcCccChhHh
Confidence 999997664211 11234688899999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=220.16 Aligned_cols=170 Identities=18% Similarity=0.273 Sum_probs=140.9
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc-hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS-TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++++|...+.||+|+||.||+|... +|+.||+|++....... ...+.+|+++++.++|+||+++.+++.. .
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-------~ 75 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-------K 75 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-------C
Confidence 3567888999999999999999865 58999999997543322 3467899999999999999999999875 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+. +++.+++... ...+++.....++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 149 (291)
T cd07870 76 ETLTFVFEYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGL 149 (291)
T ss_pred CeEEEEEeccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccc
Confidence 56899999996 6887776542 23578888999999999999999998 999999999999999999999999999
Q ss_pred ccccccc-cccceecccccccCCCCC
Q 006145 633 PLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
++..... .......+++.|+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 175 (291)
T cd07870 150 ARAKSIPSQTYSSEVVTLWYRPPDVL 175 (291)
T ss_pred ccccCCCCCCCCCccccccccCCcee
Confidence 8754322 222445678999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=223.92 Aligned_cols=162 Identities=18% Similarity=0.337 Sum_probs=139.3
Q ss_pred CceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEe
Q 006145 482 SAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
...||+|+||.||++... ++..||||.+........+.+.+|+.++++++|+||+++++.+.. .+..++|||
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-------~~~~~lv~e 99 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-------GDELWVVME 99 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-------CCeEEEEEe
Confidence 467999999999999865 588999999876544445679999999999999999999999875 467899999
Q ss_pred ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccccc-c
Q 006145 561 YVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAEN-A 639 (659)
Q Consensus 561 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~-~ 639 (659)
|+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..... .
T Consensus 100 ~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 100 FLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 9999999998864 3588999999999999999999998 999999999999999999999999999865432 2
Q ss_pred cccceecccccccCCCCC
Q 006145 640 EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 640 ~~~~~~~gt~~y~aPE~~ 657 (659)
.......++..|+|||+.
T Consensus 173 ~~~~~~~~~~~y~aPE~~ 190 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVI 190 (292)
T ss_pred ccCceeecCccccCHHHH
Confidence 223446789999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=219.99 Aligned_cols=171 Identities=13% Similarity=0.274 Sum_probs=139.4
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHH-HhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIEL-ISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|+..+.||+|+||.||+++.. +|+.||+|+++.... +...++..|+.+ ++..+||||+++++++.. .+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-------~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-------EG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-------CC
Confidence 36788899999999999999975 599999999975432 233456667765 666789999999999975 45
Q ss_pred eeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 554 RIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
..++||||++ |+|.++++.. .....+++.....++.|++.||+|||+.+ +++||||||+||++++++.+||+|||+
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~ 150 (283)
T cd06617 74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI 150 (283)
T ss_pred cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 6899999997 6888887642 22356899999999999999999999852 799999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+.............++..|+|||+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~ 175 (283)
T cd06617 151 SGYLVDSVAKTIDAGCKPYMAPERI 175 (283)
T ss_pred ccccccccccccccCCccccChhhc
Confidence 9766443333446788999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-25 Score=247.55 Aligned_cols=176 Identities=18% Similarity=0.244 Sum_probs=151.0
Q ss_pred HHHHHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEeccc---CCCchHHHHHHHHHHhCCCCCCccceeeeeee
Q 006145 469 LEELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMK---KCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544 (659)
Q Consensus 469 ~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 544 (659)
..++....++|...++||+|+||.|..++++ +++++|+|++.+. ......-|..|-.+|..-+.+=||.++-+|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3466666788999999999999999999976 5999999999763 23344568999999999999999999877765
Q ss_pred ccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc
Q 006145 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV 624 (659)
Q Consensus 545 ~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~ 624 (659)
..++|+|||||+||||-.+|.+. ..++.....-++..|.-||+-+|+. +.|||||||+|||||.+|+
T Consensus 147 -------~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GH 213 (1317)
T KOG0612|consen 147 -------ERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGH 213 (1317)
T ss_pred -------ccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCc
Confidence 67899999999999999999863 2578888888999999999999999 9999999999999999999
Q ss_pred eEEccCccccccccccc--cceecccccccCCCCC
Q 006145 625 AKISSYNLPLLAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 ~kl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
+|++|||-+-.++.+.. ....+|||-|++||++
T Consensus 214 ikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvL 248 (1317)
T KOG0612|consen 214 IKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVL 248 (1317)
T ss_pred EeeccchhHHhcCCCCcEEeccccCCCCccCHHHH
Confidence 99999998865544333 3678999999999976
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-24 Score=218.15 Aligned_cols=169 Identities=22% Similarity=0.389 Sum_probs=139.2
Q ss_pred cCCCCCceeccCcCceEEEEEec-CC---cEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NG---TFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g---~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
++|+..+.||+|+||.||+|+.. ++ ..+|+|.++.... ...+++..|++++++++|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 77 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK------- 77 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-------
Confidence 46777899999999999999975 33 3799999875432 234579999999999999999999999875
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..++||||+++|+|.++++.. ...++|.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg 152 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFG 152 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCc
Confidence 45689999999999999999753 24689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccc----ceecccccccCCCCC
Q 006145 632 LPLLAENAEKV----GHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~----~~~~gt~~y~aPE~~ 657 (659)
++......... .....+..|+|||+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 182 (268)
T cd05063 153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182 (268)
T ss_pred cceecccccccceeccCCCcCceecCHHHh
Confidence 98755332211 112234579999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-25 Score=214.47 Aligned_cols=170 Identities=19% Similarity=0.291 Sum_probs=145.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc---hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS---TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|+..+++|+|.||+|-.++-+ +|+.+|+|++++...-. ...-+.|-++|+..+||.+..|.-.+..
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt------- 239 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT------- 239 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc-------
Confidence 456777799999999999999955 69999999998765332 2346788899999999999998765554
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+.+|+||||+.||.|+-+|.+. ..+++.+..-+...|..||.|||+. +||.||+|.+|+|+|.||.+||+|||
T Consensus 240 ~drlCFVMeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred CceEEEEEEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecc
Confidence 67899999999999999988763 5688888889999999999999998 99999999999999999999999999
Q ss_pred ccccc-ccccccceecccccccCCCCCC
Q 006145 632 LPLLA-ENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 632 la~~~-~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+++.. ..+......||||.|+|||++-
T Consensus 314 LCKE~I~~g~t~kTFCGTPEYLAPEVle 341 (516)
T KOG0690|consen 314 LCKEEIKYGDTTKTFCGTPEYLAPEVLE 341 (516)
T ss_pred cchhcccccceeccccCChhhcCchhhc
Confidence 99753 3445567899999999999873
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=220.60 Aligned_cols=170 Identities=23% Similarity=0.357 Sum_probs=137.8
Q ss_pred CCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
+|+..+.||+|+||.||+|+.. ....||+|.+..... ...+++.+|+++++.++||||++++++|..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ------ 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec------
Confidence 4677899999999999999853 235789998865432 224579999999999999999999999875
Q ss_pred CCceeEEEEeccCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccc
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGH---------------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFS 609 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 609 (659)
.+..++|+||+++|+|.+++.... ....++|.....++.|++.||+|||+. +|+|
T Consensus 75 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH 150 (290)
T cd05045 75 -DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVH 150 (290)
T ss_pred -CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceeh
Confidence 456899999999999999886321 123588999999999999999999998 9999
Q ss_pred cCCCCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 610 NNLKITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 610 rDlk~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
|||||+||++++++.+||+|||+++....... .....++..|+|||+.
T Consensus 151 ~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 201 (290)
T cd05045 151 RDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL 201 (290)
T ss_pred hhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH
Confidence 99999999999999999999999975432211 1233456789999974
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=215.09 Aligned_cols=171 Identities=18% Similarity=0.297 Sum_probs=142.7
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|...+.||+|++|.||+++.. +++.||+|++..... ...+.+.+|++++++++|+|++++++.+.. ....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 74 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG------EDGL 74 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC------CCCE
Confidence 4677899999999999999965 488999999965432 234568999999999999999999987653 1345
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++++|.+++... ....+++.++..++.+++.|++|||+. +|+||||||+||++++++.++|+|||++.
T Consensus 75 ~~lv~e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~ 150 (257)
T cd08223 75 LYIVMGFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIAR 150 (257)
T ss_pred EEEEecccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceE
Confidence 79999999999999999753 234689999999999999999999998 99999999999999999999999999997
Q ss_pred cccccc-ccceecccccccCCCCCC
Q 006145 635 LAENAE-KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~~~~~-~~~~~~gt~~y~aPE~~~ 658 (659)
...... ......+++.|+|||+..
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~ 175 (257)
T cd08223 151 VLENQCDMASTLIGTPYYMSPELFS 175 (257)
T ss_pred EecccCCccccccCCcCccChhHhc
Confidence 664322 234456889999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=217.11 Aligned_cols=169 Identities=20% Similarity=0.339 Sum_probs=142.1
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.++|...+.||+|+||.||++...++..+|+|.++... ...+.|.+|++++++++|+||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------~~~ 75 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--------EPI 75 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC--------CCe
Confidence 46788889999999999999998778889999887543 234679999999999999999999998764 347
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.+++.+. ....++|..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 76 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 151 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 151 (260)
T ss_pred EEEEEeCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceee
Confidence 9999999999999999753 234689999999999999999999998 999999999999999999999999999975
Q ss_pred cccccc--cceecccccccCCCCC
Q 006145 636 AENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
...... .....++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~ 175 (260)
T cd05073 152 IEDNEYTAREGAKFPIKWTAPEAI 175 (260)
T ss_pred ccCCCcccccCCcccccccCHhHh
Confidence 543221 1233456789999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=217.97 Aligned_cols=167 Identities=20% Similarity=0.320 Sum_probs=144.7
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC-CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK-CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
+|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++++.+ ....
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~~ 74 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-------GSKL 74 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-------CCeE
Confidence 5777889999999999999965 58999999987543 2334678999999999999999999999876 4578
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++|+||+++|+|.++++. ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||+++.
T Consensus 75 ~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred EEEEEeeCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccccccee
Confidence 999999999999999975 2689999999999999999999998 999999999999999999999999999977
Q ss_pred cccc-cccceecccccccCCCCCC
Q 006145 636 AENA-EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 636 ~~~~-~~~~~~~gt~~y~aPE~~~ 658 (659)
.... .......++..|+|||+..
T Consensus 148 ~~~~~~~~~~~~~~~~y~~PE~~~ 171 (274)
T cd06609 148 LTSTMSKRNTFVGTPFWMAPEVIK 171 (274)
T ss_pred ecccccccccccCCccccChhhhc
Confidence 6543 2334567888999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=218.48 Aligned_cols=168 Identities=25% Similarity=0.438 Sum_probs=137.9
Q ss_pred CCCCCceeccCcCceEEEEEecC-C---cEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKN-G---TFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~-g---~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.|...+.||+|+||.||+|+... + ..||||.++.... ...++|..|++++++++||||+++++++.. .
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-------~ 77 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-------S 77 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-------C
Confidence 46677999999999999999653 3 3699999875432 234679999999999999999999998865 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||+++|+|.++++.. ...+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~ 152 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGL 152 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcc
Confidence 5689999999999999999753 24689999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccc---ceec---ccccccCCCCC
Q 006145 633 PLLAENAEKV---GHVI---PYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~---~~~~---gt~~y~aPE~~ 657 (659)
++........ .... .+..|+|||+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 183 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHhHh
Confidence 8765432211 1111 24579999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=224.62 Aligned_cols=172 Identities=21% Similarity=0.415 Sum_probs=139.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec--------CCcEEEEEEecccCC-CchHHHHHHHHHHhCC-CCCCccceeeeeeec
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK--------NGTFVAIRCLKMKKC-HSTRNFMHHIELISKL-RHRHLVSALGHCFEC 545 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 545 (659)
.++|...+.||+|+||.||+|+.. ....||+|.++.... ....++.+|+++++++ +||||++++++|..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ- 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence 456778899999999999999742 245799999875432 2345689999999999 69999999999875
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCC
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGH-------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNL 612 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl 612 (659)
.+..++||||+++|+|.+++.... ....++|..+++++.|++.||+|||+. +|+||||
T Consensus 90 ------~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dl 160 (314)
T cd05099 90 ------EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDL 160 (314)
T ss_pred ------CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccc
Confidence 456899999999999999996421 123589999999999999999999998 9999999
Q ss_pred CCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 613 KITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 613 k~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
||+||++++++.+||+|||+++....... .....++..|||||+.
T Consensus 161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 208 (314)
T cd05099 161 AARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL 208 (314)
T ss_pred cceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHH
Confidence 99999999999999999999976543211 1222345679999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=224.24 Aligned_cols=161 Identities=16% Similarity=0.159 Sum_probs=126.0
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec--CCcEEEEEEecccCC-----CchHHHHHHHHHHhCCCCCCccceeeeeeecc
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK--NGTFVAIRCLKMKKC-----HSTRNFMHHIELISKLRHRHLVSALGHCFECY 546 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~--~g~~vavK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 546 (659)
....+|...+.||+|+||+||+|+.. +++.||||++..... ...+.|.+|+++|++++|+||++.+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34567999999999999999999865 478889998753311 1235699999999999999999633211
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCC-CCCceeecCCcce
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNL-KITDILLDQNLVA 625 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl-k~~NILld~~~~~ 625 (659)
+..|+||||+++++|... .. .. ...++.++++||+|||+. +|+|||| ||+|||++.++.+
T Consensus 91 ------~~~~LVmE~~~G~~L~~~-~~---~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 91 ------GKDGLVRGWTEGVPLHLA-RP---HG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred ------CCcEEEEEccCCCCHHHh-Cc---cc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCE
Confidence 236999999999999732 21 01 146788999999999998 9999999 9999999999999
Q ss_pred EEccCcccccccccc---------ccceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENAE---------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~~---------~~~~~~gt~~y~aPE~~ 657 (659)
||+|||+|+...... ......+++.|+|||+.
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~ 192 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL 192 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence 999999997553322 22456788889999975
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=223.37 Aligned_cols=162 Identities=20% Similarity=0.338 Sum_probs=140.0
Q ss_pred CceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEe
Q 006145 482 SAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
...||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++||||+++++++.. .+..++|||
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-------~~~~~iv~e 98 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-------GEELWVLME 98 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-------CCeEEEEEe
Confidence 457999999999999965 589999999976554455678999999999999999999999875 467899999
Q ss_pred ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccc-
Q 006145 561 YVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENA- 639 (659)
Q Consensus 561 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~- 639 (659)
|+++++|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++......
T Consensus 99 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 99 FLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred cCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 9999999998764 3589999999999999999999998 9999999999999999999999999998654332
Q ss_pred cccceecccccccCCCCC
Q 006145 640 EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 640 ~~~~~~~gt~~y~aPE~~ 657 (659)
.......++..|+|||+.
T Consensus 172 ~~~~~~~~~~~y~aPE~~ 189 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVI 189 (297)
T ss_pred ccccceecCccccCHHHH
Confidence 223456789999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=219.90 Aligned_cols=172 Identities=23% Similarity=0.364 Sum_probs=139.6
Q ss_pred hcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
.++|...+.||+|+||.||+|... .+..||+|.+...... ...+|.+|+.++++++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE---- 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 466888899999999999999965 3568999988644322 23569999999999999999999998875
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCC----CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc-
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHA----HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL- 623 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~- 623 (659)
.+..++||||+++|+|.++++.... ...++|.++.+++.||++||+|||+. +++||||||+||++++++
T Consensus 81 ---~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~ 154 (277)
T cd05036 81 ---RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGP 154 (277)
T ss_pred ---CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCC
Confidence 3457999999999999999975321 13589999999999999999999998 999999999999998654
Q ss_pred --ceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 624 --VAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 624 --~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
.+|++|||+++....... ......+..|||||+.
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05036 155 GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF 193 (277)
T ss_pred CcceEeccCccccccCCccceecCCCCCccHhhCCHHHH
Confidence 699999999976632221 1223345689999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=217.87 Aligned_cols=168 Identities=20% Similarity=0.370 Sum_probs=138.4
Q ss_pred cCCCCCceeccCcCceEEEEEecC-Cc----EEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN-GT----FVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~-g~----~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.+|+..+.||+|+||.||+|..++ |. .||+|.+...... ...++.+|++++++++|+||++++++|..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 456677999999999999998643 33 6899988655432 33578999999999999999999999874
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
...++||||+++|+|.++++.. ...+++.....++.|+++|++|||+. +|+||||||+||++++++.+||+||
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~df 153 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDF 153 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCC
Confidence 3579999999999999999753 23589999999999999999999997 9999999999999999999999999
Q ss_pred cccccccccccc---ceecccccccCCCCC
Q 006145 631 NLPLLAENAEKV---GHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~~---~~~~gt~~y~aPE~~ 657 (659)
|+++........ ....++..|+|||+.
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 183 (279)
T cd05057 154 GLAKLLDVDEKEYHAEGGKVPIKWMALESI 183 (279)
T ss_pred cccccccCcccceecCCCcccccccCHHHh
Confidence 999765432221 112235679999964
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=215.55 Aligned_cols=168 Identities=21% Similarity=0.375 Sum_probs=145.8
Q ss_pred hcCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|+..+.||+|+||.||+|+..+ ++.+|+|.+..... .+++.+|++++++++|+||+++++++.+ ...
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~-------~~~ 72 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK-------NTD 72 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec-------CCc
Confidence 3568888999999999999999765 88999999875432 5789999999999999999999999876 467
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++++||+++++|.++++.. ...++|..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||++.
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~ 147 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG 147 (256)
T ss_pred EEEEEecCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccch
Confidence 89999999999999999742 24689999999999999999999998 99999999999999999999999999997
Q ss_pred cccccc-ccceecccccccCCCCC
Q 006145 635 LAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
...... ......++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~PE~~ 171 (256)
T cd06612 148 QLTDTMAKRNTVIGTPFWMAPEVI 171 (256)
T ss_pred hcccCccccccccCCccccCHHHH
Confidence 664432 33445688999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=225.65 Aligned_cols=171 Identities=20% Similarity=0.404 Sum_probs=139.3
Q ss_pred cCCCCCceeccCcCceEEEEEec--------CCcEEEEEEecccCC-CchHHHHHHHHHHhCC-CCCCccceeeeeeecc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK--------NGTFVAIRCLKMKKC-HSTRNFMHHIELISKL-RHRHLVSALGHCFECY 546 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 546 (659)
.+|...+.||+|+||.||+|+.. .+..||+|.++.... ...+++.+|+++++++ +||||++++++|..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence 45778899999999999999742 124799998875432 2346799999999999 79999999999975
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCC
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGH-------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLK 613 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 613 (659)
.+..++||||+++|+|.+++.... ....++|.+++.++.|+++||+|||+. +|+|||||
T Consensus 90 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlk 161 (334)
T cd05100 90 -----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLA 161 (334)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccc
Confidence 456899999999999999987421 123589999999999999999999998 99999999
Q ss_pred CCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 614 ITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 614 ~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
|+||++++++.+||+|||+++....... .....++..|||||+.
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 208 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL 208 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHh
Confidence 9999999999999999999976543221 1223345689999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=215.96 Aligned_cols=171 Identities=18% Similarity=0.299 Sum_probs=141.8
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC-----CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK-----CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.+|...+.||+|+||.||+|+.. +++.||+|.+.... .+..+.+.+|++++++++|+||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~----- 76 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP----- 76 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC-----
Confidence 46788899999999999999965 59999999885321 12235789999999999999999999988652
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.....++|+||+++++|.+++... ..+++....+++.|++.||+|||+. +++||||||+||++++++.++|+||
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~df 150 (264)
T cd06653 77 EEKKLSIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDF 150 (264)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcc
Confidence 134578999999999999998752 3588999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccc----cccceecccccccCCCCCC
Q 006145 631 NLPLLAENA----EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 631 Gla~~~~~~----~~~~~~~gt~~y~aPE~~~ 658 (659)
|+++..... .......++..|+|||+..
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (264)
T cd06653 151 GASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182 (264)
T ss_pred ccccccccccccCccccccCCcccccCHhhhc
Confidence 999755321 1223456899999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=215.77 Aligned_cols=163 Identities=22% Similarity=0.374 Sum_probs=137.3
Q ss_pred ceeccCcCceEEEEEecC--C--cEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLKN--G--TFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|++|.||+|.+.+ + ..||||.+..... ...++|.+|++++++++||||+++++++.. ...++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~ 72 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--------HPLMM 72 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--------CeEEE
Confidence 468999999999999653 3 3699999987655 445689999999999999999999998864 45799
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||||+++|+|.+++..... ..++|.....++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 73 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~ 148 (257)
T cd05040 73 VTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALP 148 (257)
T ss_pred EEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccc
Confidence 9999999999999986322 4689999999999999999999998 99999999999999999999999999997664
Q ss_pred cccc----cceecccccccCCCCC
Q 006145 638 NAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 ~~~~----~~~~~gt~~y~aPE~~ 657 (659)
.... .....++..|+|||+.
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~ 172 (257)
T cd05040 149 QNEDHYVMEEHLKVPFAWCAPESL 172 (257)
T ss_pred ccccceecccCCCCCceecCHHHh
Confidence 3211 1234567889999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=218.26 Aligned_cols=167 Identities=19% Similarity=0.349 Sum_probs=145.2
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
+|+..+.||.|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+ ..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~ 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-------EE 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-------CC
Confidence 4777899999999999999976 589999999975432 234679999999999999999999988865 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++|+||+++++|.+++... ..+++.....++.|+++||+|||+. +++|+||||+||++++++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~ 147 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA 147 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccc
Confidence 789999999999999999752 4689999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccccceecccccccCCCCC
Q 006145 634 LLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.............|+..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~PE~~ 171 (258)
T cd05578 148 TKVTPDTLTTSTSGTPGYMAPEVL 171 (258)
T ss_pred cccCCCccccccCCChhhcCHHHH
Confidence 766554444556788999999975
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=214.72 Aligned_cols=168 Identities=19% Similarity=0.410 Sum_probs=143.6
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||+|+||.||+|... +++.||+|.++..... ..+++.+|++++++++|+||+++++++.. .+.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-------~~~ 73 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-------REK 73 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-------CCE
Confidence 4777899999999999999965 6899999999765443 45679999999999999999999998865 467
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++|+||+++++|.++++.. ..+++..+..++.++++|++|||+. +|+|+||||+||++++++.+||+|||++.
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 74 VYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred EEEEEecCCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccccccc
Confidence 89999999999999999852 3578999999999999999999998 99999999999999999999999999987
Q ss_pred ccccccc-----cceecccccccCCCCCC
Q 006145 635 LAENAEK-----VGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~~~~~~-----~~~~~gt~~y~aPE~~~ 658 (659)
....... .....++..|+|||+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 176 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhcc
Confidence 6533222 12356788999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=230.22 Aligned_cols=165 Identities=21% Similarity=0.293 Sum_probs=141.8
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCC-C-----CCccceeeeeeeccccCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-H-----RHLVSALGHCFECYFDDS 550 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~~ 550 (659)
+|.+.+.||+|.||.|-||... +++.||||+++.... -.++-..|+++|..++ | -|+|++++|+..
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f------ 259 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF------ 259 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc------
Confidence 6888999999999999999954 699999999986542 2356678999999997 4 499999999987
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC--cceEEc
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN--LVAKIS 628 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~--~~~kl~ 628 (659)
.++.|||+|.+.. +|+++++..+ ...++......|+.||+.||.+||+. +|||+||||+||||.+. ..+||+
T Consensus 260 -r~HlciVfELL~~-NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVI 333 (586)
T KOG0667|consen 260 -RNHLCIVFELLST-NLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVI 333 (586)
T ss_pred -ccceeeeehhhhh-hHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEE
Confidence 6789999999976 9999998643 34588999999999999999999998 99999999999999754 579999
Q ss_pred cCccccccccccccceecccccccCCCCC
Q 006145 629 SYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|||.+....... ...+.+..|+|||++
T Consensus 334 DFGSSc~~~q~v--ytYiQSRfYRAPEVI 360 (586)
T KOG0667|consen 334 DFGSSCFESQRV--YTYIQSRFYRAPEVI 360 (586)
T ss_pred ecccccccCCcc--eeeeeccccccchhh
Confidence 999998775433 378899999999986
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=216.25 Aligned_cols=142 Identities=20% Similarity=0.294 Sum_probs=126.5
Q ss_pred CCceeccCcCceEEEEEecC-CcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 481 TSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 481 ~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
..+.||+|.-|+||.+++++ +..+|+|++.+.... ...+...|-+||+.++||.++.|++.+.. .+..|
T Consensus 81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-------~~~~c 153 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-------DKYSC 153 (459)
T ss_pred HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-------cceeE
Confidence 44789999999999999875 689999999766433 33467778899999999999999999876 56789
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
+|||||+||+|..+.+++ ..+.++.....-+|..|.-||+|||.. +||.|||||+|||+-++|.+-++||-|+
T Consensus 154 l~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS 226 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLS 226 (459)
T ss_pred EEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecccc
Confidence 999999999999998864 456799999999999999999999998 9999999999999999999999999886
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=221.61 Aligned_cols=169 Identities=15% Similarity=0.213 Sum_probs=148.5
Q ss_pred cCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.-|+.++.||+|.|+.|-.|++ -+|..||||++.+.+... .....+|++.|+-++|||||+|+++... ..
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT-------QT 90 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT-------QT 90 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc-------cc
Confidence 3477789999999999999984 479999999998766543 3468899999999999999999998765 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC-CcceEEccCcc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ-NLVAKISSYNL 632 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~DFGl 632 (659)
.+|||+|.-.+|+|++|+-++. .-+.+....+++.||..|+.|+|.. .+|||||||+||.+-+ -|-+|++|||+
T Consensus 91 KlyLiLELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGF 165 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGF 165 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccc
Confidence 7999999999999999987542 3488888999999999999999998 9999999999998764 58999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+-.+.++......||...|-|||.+
T Consensus 166 SNkf~PG~kL~TsCGSLAYSAPEIL 190 (864)
T KOG4717|consen 166 SNKFQPGKKLTTSCGSLAYSAPEIL 190 (864)
T ss_pred cccCCCcchhhcccchhhccCchhh
Confidence 9888888889999999999999986
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=220.22 Aligned_cols=168 Identities=15% Similarity=0.233 Sum_probs=140.6
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||.||+++.. +++.||+|.+..... ...+.+.+|+++++.++||||+++++.+.. .
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------~ 73 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-------K 73 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-------C
Confidence 36788899999999999999965 488999999875432 223568899999999999999999998875 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++|+|.+++... ..+++.....++.++++||+|||+. +++||||||+||++++++.+|++|||+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 74 RHLCMVMEYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred CEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCC
Confidence 5789999999999999999752 4689999999999999999999998 999999999999999999999999999
Q ss_pred cccccccc----------------ccceecccccccCCCCC
Q 006145 633 PLLAENAE----------------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~----------------~~~~~~gt~~y~aPE~~ 657 (659)
++...... ......++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 188 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhc
Confidence 86421100 01224678899999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=220.42 Aligned_cols=172 Identities=23% Similarity=0.385 Sum_probs=141.0
Q ss_pred hcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
.++|...+.||+|+||.||+|+.+ ++..||+|.+..... ...++|.+|++++++++||||++++++|..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~---- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV---- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence 467888899999999999999853 467899999875432 224579999999999999999999999875
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGH-------------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFS 609 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 609 (659)
....++||||+++|+|.++++... ....+++..++.++.|++.||+|||+. +++|
T Consensus 80 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H 153 (288)
T cd05050 80 ---GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVH 153 (288)
T ss_pred ---CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 456899999999999999997421 113478999999999999999999998 9999
Q ss_pred cCCCCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 610 NNLKITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 610 rDlk~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
|||||+||++++++.+||+|||+++....... ......+..|+|||+.
T Consensus 154 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 204 (288)
T cd05050 154 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI 204 (288)
T ss_pred ccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHH
Confidence 99999999999999999999999875432211 2223456779999963
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=213.36 Aligned_cols=169 Identities=20% Similarity=0.357 Sum_probs=143.9
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||+|+||.||++... +++.+|||.+..... ...+++.+|++++++++||||+++++++.. .+.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------~~~ 73 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-------DKA 73 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-------CCE
Confidence 4777899999999999999864 588999999875432 234679999999999999999999998765 457
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC-cceEEccCccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN-LVAKISSYNLP 633 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla 633 (659)
.++||||+++|+|.++++... ...+++..+.+++.++++|++|||+. +++||||||+||+++++ ..+|++|||++
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~ 149 (256)
T cd08220 74 LMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGIS 149 (256)
T ss_pred EEEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCc
Confidence 899999999999999997532 34589999999999999999999998 99999999999999855 56899999999
Q ss_pred cccccccccceecccccccCCCCC
Q 006145 634 LLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.............++..|+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~ 173 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELC 173 (256)
T ss_pred eecCCCccccccccCCcccCchhc
Confidence 877554444556789999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=216.92 Aligned_cols=167 Identities=19% Similarity=0.330 Sum_probs=140.0
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--C--------chHHHHHHHHHHhCCCCCCccceeeeeeecc
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--H--------STRNFMHHIELISKLRHRHLVSALGHCFECY 546 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 546 (659)
+|...+.||+|+||.||+|... +|+.||+|.++.... . ..+.+.+|++++++++|+||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 3567789999999999999864 589999998864211 0 12458889999999999999999999875
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceE
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAK 626 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~k 626 (659)
.+..++||||+++|+|.+++++. ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+|
T Consensus 80 -----~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~ 148 (272)
T cd06629 80 -----EEYLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICK 148 (272)
T ss_pred -----CCceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEE
Confidence 45689999999999999999863 4689999999999999999999998 999999999999999999999
Q ss_pred EccCcccccccccc---ccceecccccccCCCCC
Q 006145 627 ISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 627 l~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
++|||+++...... ......++..|+|||+.
T Consensus 149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 182 (272)
T cd06629 149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182 (272)
T ss_pred EeeccccccccccccccccccccCCccccCHHHh
Confidence 99999997653321 12345688899999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=220.82 Aligned_cols=172 Identities=18% Similarity=0.355 Sum_probs=139.5
Q ss_pred hcCCCCCceeccCcCceEEEEEec-----------------CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-----------------NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVS 537 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-----------------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~ 537 (659)
.++|+..+.||+|+||.||+++.. ++..||+|.+...... ...+|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 456888899999999999998532 2457999999754322 3457999999999999999999
Q ss_pred eeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCC--------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccc
Q 006145 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHA--------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFS 609 (659)
Q Consensus 538 l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 609 (659)
+++++.. .+..++||||+++|+|.+++..... ...+++.....++.|++.|++|||+. +++|
T Consensus 84 ~~~~~~~-------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H 153 (296)
T cd05095 84 LLAVCIT-------SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVH 153 (296)
T ss_pred EEEEEec-------CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence 9999875 4568999999999999999875321 13478899999999999999999998 9999
Q ss_pred cCCCCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 610 NNLKITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 610 rDlk~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
|||||+||++++++.+|++|||+++....... .....++..|+|||+.
T Consensus 154 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 204 (296)
T cd05095 154 RDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI 204 (296)
T ss_pred ccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH
Confidence 99999999999999999999999975533211 1223446789999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-25 Score=211.81 Aligned_cols=171 Identities=18% Similarity=0.252 Sum_probs=143.7
Q ss_pred hcCCCCC-ceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTS-AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~-~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~ 552 (659)
+++|... ++||-|-.|.|-.|..+ +|+.+|+|++.. .....+|+++--.. .|||||.++++|..... ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~---~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQ---GR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc---Cc
Confidence 4555544 67899999999999865 699999999863 23456888875555 59999999999975322 25
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec---CCcceEEcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD---QNLVAKISS 629 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld---~~~~~kl~D 629 (659)
..+++|||.|+||+|++.+++ ++...+++.+.-.|+.||+.|++|||+. +|.||||||+|+|.. .|-..|++|
T Consensus 132 kcLLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeeEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 678899999999999999986 4457899999999999999999999999 999999999999996 356799999
Q ss_pred CccccccccccccceecccccccCCCCCC
Q 006145 630 YNLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 630 FGla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
||+|+..+........+-|+.|.|||++.
T Consensus 208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg 236 (400)
T KOG0604|consen 208 FGFAKETQEPGDLMTPCFTPYYVAPEVLG 236 (400)
T ss_pred cccccccCCCccccCCcccccccCHHHhC
Confidence 99999887666777889999999999974
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=217.36 Aligned_cols=168 Identities=18% Similarity=0.328 Sum_probs=138.7
Q ss_pred cCCCCCceeccCcCceEEEEEecC----CcEEEEEEecccC-CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN----GTFVAIRCLKMKK-CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
++|...+.||+|+||.||+|+..+ ...||||...... ....+.|.+|++++++++||||++++++|.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------- 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------- 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-------
Confidence 457778999999999999998643 3479999886544 2334579999999999999999999998864
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
...++||||+++|+|.+++... ...+++..+..++.+++.||+|||+. +++||||||+||+++.++.+|++|||
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCc
Confidence 3468999999999999999753 23589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccc--ceecccccccCCCCC
Q 006145 632 LPLLAENAEKV--GHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~--~~~~gt~~y~aPE~~ 657 (659)
+++........ ....++..|+|||+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (270)
T cd05056 153 LSRYLEDESYYKASKGKLPIKWMAPESI 180 (270)
T ss_pred eeeecccccceecCCCCccccccChhhh
Confidence 99765433221 223345689999975
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=220.23 Aligned_cols=165 Identities=18% Similarity=0.336 Sum_probs=139.9
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
|+..+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++||||+++++++.. ....+
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~~~ 78 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-------GTKLW 78 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-------CCceE
Confidence 445578999999999999865 588999999875432 234578999999999999999999999875 45689
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.+++.. ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++.+|++|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 79 IIMEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred EEEEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccc
Confidence 99999999999999864 4689999999999999999999998 9999999999999999999999999999765
Q ss_pred cccc-ccceecccccccCCCCC
Q 006145 637 ENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
.... ......++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~ 173 (277)
T cd06642 152 TDTQIKRNTFVGTPFWMAPEVI 173 (277)
T ss_pred cCcchhhhcccCcccccCHHHh
Confidence 4322 22345688999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=237.05 Aligned_cols=174 Identities=14% Similarity=0.248 Sum_probs=137.6
Q ss_pred HHHHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCC------CCccceeeee
Q 006145 470 EELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRH------RHLVSALGHC 542 (659)
Q Consensus 470 ~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H------~niv~l~g~~ 542 (659)
+++...+++|...+.||+|+||+||+|+.. +++.||||+++... ...+++..|++++++++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556788999999999999999999965 58899999996432 123456667777776654 4588888888
Q ss_pred eeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC
Q 006145 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN 622 (659)
Q Consensus 543 ~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~ 622 (659)
.. .....|+|||++ +++|.+++.+. ..+++..+..|+.||+.||+|||+. .+||||||||+|||++.+
T Consensus 201 ~~------~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~ 268 (467)
T PTZ00284 201 QN------ETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETS 268 (467)
T ss_pred Ec------CCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecC
Confidence 64 135689999998 77999988752 4689999999999999999999972 289999999999999876
Q ss_pred c----------------ceEEccCccccccccccccceecccccccCCCCCC
Q 006145 623 L----------------VAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 623 ~----------------~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+ .+||+|||++..... .....+||+.|||||++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~ 318 (467)
T PTZ00284 269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVL 318 (467)
T ss_pred CcccccccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhh
Confidence 5 499999998864322 234578999999999863
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-24 Score=231.55 Aligned_cols=184 Identities=17% Similarity=0.336 Sum_probs=156.5
Q ss_pred CHHHHHHhhcCCCCCceeccCcCceEEEEE-ecCCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeec
Q 006145 468 SLEELEEATNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFEC 545 (659)
Q Consensus 468 ~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 545 (659)
.++.+...++-|...+.||.|.+|.||+++ .++|+.+|||+...... ..++.+.|.++++.. .|||++.++|++...
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344444556778889999999999999999 45699999999876543 346788899999888 599999999999753
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcce
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVA 625 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~ 625 (659)
.. ...+++|||||||.+||.-|++..-. ...+.|.....|++.+++|+.+||.+ .+||||||=.|||+++++.+
T Consensus 89 ~~--~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 89 DP--GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred cC--CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence 32 45789999999999999999998644 46799999999999999999999999 99999999999999999999
Q ss_pred EEccCcccccccccc-ccceecccccccCCCCCC
Q 006145 626 KISSYNLPLLAENAE-KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 626 kl~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~~ 658 (659)
|+.|||++...+.+. .-...+||+.|||||+++
T Consensus 163 KLvDFGvSaQldsT~grRnT~iGtP~WMAPEVia 196 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIA 196 (953)
T ss_pred EEeeeeeeeeeecccccccCcCCCcccccceeee
Confidence 999999987765443 346679999999999875
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-24 Score=218.69 Aligned_cols=168 Identities=18% Similarity=0.336 Sum_probs=140.5
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|+..+.||+|++|.||+|+.+ +++.||||.+...... ....+.+|++++++++|+||+++++++.+ .+.
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------~~~ 77 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-------KKT 77 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-------CCe
Confidence 56788899999999999999976 5899999998754322 23457889999999999999999999875 467
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++ +|.+++.+. ...+++.....++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 78 ~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 78 LTLVFEYLDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred EEEEEecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccccc
Confidence 8999999985 999988753 23688999999999999999999998 99999999999999999999999999986
Q ss_pred ccccc-cccceecccccccCCCCC
Q 006145 635 LAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
..... .......++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~aPE~~ 175 (291)
T cd07844 152 AKSVPSKTYSNEVVTLWYRPPDVL 175 (291)
T ss_pred ccCCCCccccccccccccCCcHHh
Confidence 54321 112334578899999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-24 Score=218.11 Aligned_cols=185 Identities=18% Similarity=0.354 Sum_probs=150.2
Q ss_pred cCHHHHHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeee
Q 006145 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFE 544 (659)
Q Consensus 467 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 544 (659)
.++.++..+.+.|+..+.||+|+||.||+|+.. +++.||+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 355566667788999999999999999999964 58999999986543 2345688999999998 69999999999864
Q ss_pred ccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc
Q 006145 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV 624 (659)
Q Consensus 545 ~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~ 624 (659)
... .......++||||+++|+|.+++.... ...+++..+..++.|+++|++|||+. +|+||||||+||++++++.
T Consensus 85 ~~~-~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSP-PGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccc-cCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 211 112456899999999999999987532 34588888999999999999999998 9999999999999999999
Q ss_pred eEEccCccccccccc-cccceecccccccCCCCC
Q 006145 625 AKISSYNLPLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 ~kl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
++|+|||++...... .......|+..|+|||++
T Consensus 160 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l 193 (282)
T cd06636 160 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193 (282)
T ss_pred EEEeeCcchhhhhccccCCCcccccccccCHhhc
Confidence 999999998755321 223446789999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-24 Score=214.79 Aligned_cols=172 Identities=18% Similarity=0.337 Sum_probs=145.5
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|+..+.||.|+||+||+|... ++..+|+|++..... ...+.+.+|+++++.++|+||+++++.+.. ...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~~ 73 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-------GDE 73 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-------CCE
Confidence 36888899999999999999965 588999999865432 244679999999999999999999998875 467
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++|+||+++++|.++++.......+++.....++.|++.|++|||+. +|+||||||+||++++++.+|++|||++.
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~ 150 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSA 150 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHH
Confidence 899999999999999997533334689999999999999999999998 99999999999999999999999999986
Q ss_pred ccccccc-----cceecccccccCCCCCC
Q 006145 635 LAENAEK-----VGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~~~~~~-----~~~~~gt~~y~aPE~~~ 658 (659)
....... .....|+..|+|||++.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~ 179 (267)
T cd06610 151 SLADGGDRTRKVRKTFVGTPCWMAPEVME 179 (267)
T ss_pred HhccCccccccccccccCChhhcChHHHc
Confidence 5543221 13456899999999853
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-24 Score=219.89 Aligned_cols=168 Identities=16% Similarity=0.297 Sum_probs=142.1
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|+..+.||+|+||+||+++.. +|+.||+|++..... ...+++.+|+++++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------~~~ 77 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-------ENN 77 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-------CCE
Confidence 45666789999999999999965 589999999865432 234679999999999999999999999986 467
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++|+|.++++.. ..+++.....++.++++||.|||+. .+++||||||+||++++++.++|+|||++.
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~ 152 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSG 152 (284)
T ss_pred EEEEEecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCccc
Confidence 89999999999999998752 4689999999999999999999973 279999999999999999999999999986
Q ss_pred ccccccccceecccccccCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
..... ......|+..|+|||+.
T Consensus 153 ~~~~~-~~~~~~~~~~~~aPE~~ 174 (284)
T cd06620 153 ELINS-IADTFVGTSTYMSPERI 174 (284)
T ss_pred chhhh-ccCccccCcccCCHHHH
Confidence 54322 22345789999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-24 Score=217.84 Aligned_cols=169 Identities=21% Similarity=0.359 Sum_probs=142.3
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
+|+..+.||+|++|.||+|+.. +|+.||||.++..... ....+.+|++++++++|+||+++++++.+ .+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------~~~~ 73 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-------ENKL 73 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-------CCcE
Confidence 4778899999999999999975 5899999999765432 34568899999999999999999999986 4568
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++ +|.+++........+++..+..++.|+++||+|||+. +++||||||+||++++++.+|++|||+++.
T Consensus 74 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~ 149 (284)
T cd07836 74 MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARA 149 (284)
T ss_pred EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence 999999985 8998887543335689999999999999999999998 999999999999999999999999999965
Q ss_pred ccccc-ccceecccccccCCCCC
Q 006145 636 AENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
..... ......++..|+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~y~~PE~~ 172 (284)
T cd07836 150 FGIPVNTFSNEVVTLWYRAPDVL 172 (284)
T ss_pred hcCCccccccccccccccChHHh
Confidence 43321 22345678899999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-24 Score=219.54 Aligned_cols=170 Identities=22% Similarity=0.365 Sum_probs=142.4
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|+..+.||+|+||.||+|+.+ +++.||+|.++..... ....+.+|++++++++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS-----NLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec-----CCC
Confidence 46778899999999999999976 5899999999754322 224578899999999999999999998752 126
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..|+||||++ ++|.+++.... ..+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||++
T Consensus 80 ~~~lv~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~ 153 (293)
T cd07843 80 KIYMVMEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLA 153 (293)
T ss_pred cEEEEehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCce
Confidence 7899999997 49999887532 3689999999999999999999998 9999999999999999999999999999
Q ss_pred cccccc-cccceecccccccCCCCC
Q 006145 634 LLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
+..... .......+++.|+|||+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~ 178 (293)
T cd07843 154 REYGSPLKPYTQLVVTLWYRAPELL 178 (293)
T ss_pred eeccCCccccccccccccccCchhh
Confidence 765443 233445678899999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-24 Score=222.50 Aligned_cols=165 Identities=15% Similarity=0.245 Sum_probs=134.7
Q ss_pred CceeccC--cCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 482 SAFMGEG--SQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 482 ~~~ig~G--~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
.++||+| +|++||+++.+ +|+.||||+++..... ..+.+.+|+++++.++||||++++++|.. .+..+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-------~~~~~ 75 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-------DNELW 75 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-------CCEEE
Confidence 4789999 67899999865 6999999999755322 23457789999999999999999999986 46789
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+...
T Consensus 76 lv~e~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred EEEeccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 9999999999999986422 23589999999999999999999998 9999999999999999999999999865332
Q ss_pred cc-cc-------ccceecccccccCCCCC
Q 006145 637 EN-AE-------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~-~~-------~~~~~~gt~~y~aPE~~ 657 (659)
.. .. ......++..|||||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (327)
T cd08227 152 INHGQRLRVVHDFPKYSVKVLPWLSPEVL 180 (327)
T ss_pred ccccccccccccccccccceecccChHHh
Confidence 11 11 11224567789999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-24 Score=221.44 Aligned_cols=149 Identities=22% Similarity=0.386 Sum_probs=130.7
Q ss_pred cCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||.||+|+..+ ++.||+|.+...... ..+.+.+|+++++.++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~ 73 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-------E 73 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-------C
Confidence 367788999999999999999764 899999999765432 34568999999999999999999998875 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||+++|+|.+++... ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~ 149 (316)
T cd05574 74 TYLCLVMDYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDL 149 (316)
T ss_pred CEEEEEEEecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecch
Confidence 6789999999999999998742 235689999999999999999999998 999999999999999999999999999
Q ss_pred cccc
Q 006145 633 PLLA 636 (659)
Q Consensus 633 a~~~ 636 (659)
+...
T Consensus 150 ~~~~ 153 (316)
T cd05574 150 SKQS 153 (316)
T ss_pred hhcc
Confidence 8644
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-24 Score=214.34 Aligned_cols=164 Identities=21% Similarity=0.431 Sum_probs=138.4
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
++|...+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++||||+++++++.. +..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--------~~~~ 74 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH--------NGLY 74 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC--------CCcE
Confidence 4577789999999999999975 58889999986432 34679999999999999999999998864 3469
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.+++... ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 75 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 75 IVMELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred EEEECCCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceec
Confidence 999999999999999753 234689999999999999999999998 9999999999999999999999999999755
Q ss_pred ccccccceecccccccCCCCC
Q 006145 637 ENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~~~~~~gt~~y~aPE~~ 657 (659)
... ......+..|+|||+.
T Consensus 151 ~~~--~~~~~~~~~y~~pe~~ 169 (254)
T cd05083 151 SMG--VDNSKLPVKWTAPEAL 169 (254)
T ss_pred ccc--CCCCCCCceecCHHHh
Confidence 322 2233456789999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=213.67 Aligned_cols=175 Identities=15% Similarity=0.281 Sum_probs=144.0
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||.|+||.||++... +|+.||+|.+...... ..+++..|++++++++|+||+++++++... ....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR-----SNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC-----CCCE
Confidence 4677899999999999999854 5889999998754332 235688999999999999999999987641 2346
Q ss_pred eEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCC--CCCccccCCCCCceeecCCcceEEccCc
Q 006145 555 IFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGI--VPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+++|||+++|+|.+++... .....+++..+..++.++++||+|||..+ ..+++|+||||+||++++++.+|++|||
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccc
Confidence 79999999999999998742 22357899999999999999999999321 2399999999999999999999999999
Q ss_pred cccccccccc-cceecccccccCCCCC
Q 006145 632 LPLLAENAEK-VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~-~~~~~gt~~y~aPE~~ 657 (659)
++........ .....+++.|+|||+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~ 182 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQL 182 (265)
T ss_pred ccccccCCcccccccccCCCccChhhh
Confidence 9987654433 3456789999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-24 Score=227.07 Aligned_cols=162 Identities=22% Similarity=0.310 Sum_probs=139.3
Q ss_pred eeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEecc
Q 006145 484 FMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYV 562 (659)
Q Consensus 484 ~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~ 562 (659)
++|+|.||+||.|+.. +...+|||-+...+....+...+||.+-+.++|.|||+++|.|.+ .+..-+.||-+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-------nGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-------NGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-------CCeEEEEeecC
Confidence 6999999999999955 477899999987665556678899999999999999999999865 45678999999
Q ss_pred CCCChhhhhcCCCCCCCC--CHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC-CcceEEccCcccccccc-
Q 006145 563 PNGTLRSWISEGHAHQSL--TWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ-NLVAKISSYNLPLLAEN- 638 (659)
Q Consensus 563 ~~GsL~~~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~~~- 638 (659)
|||+|.++|+.. ..++ .+...-.+.+||++||.|||+. .|||||||-+|||++. .|.+||+|||-++....
T Consensus 655 PGGSLSsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 655 PGGSLSSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred CCCcHHHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC
Confidence 999999999863 3445 6777888999999999999999 9999999999999984 69999999999865533
Q ss_pred ccccceecccccccCCCCC
Q 006145 639 AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 639 ~~~~~~~~gt~~y~aPE~~ 657 (659)
........||..|||||++
T Consensus 730 nP~TETFTGTLQYMAPEvI 748 (1226)
T KOG4279|consen 730 NPCTETFTGTLQYMAPEVI 748 (1226)
T ss_pred CccccccccchhhhChHhh
Confidence 3345668899999999986
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-24 Score=219.98 Aligned_cols=167 Identities=17% Similarity=0.309 Sum_probs=139.8
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||+|+||.||+|+.. +|+.||+|+++..... ....+.+|++++++++|+||+++++++.+ ...
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-------~~~ 73 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-------DKK 73 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-------CCc
Confidence 3677789999999999999975 5999999999754322 23568899999999999999999999875 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++|+||++ |+|.+++... ...+++.....++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 74 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 74 LTLVFEYCD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred eEEEEecCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhh
Confidence 899999997 5888887642 24589999999999999999999998 99999999999999999999999999997
Q ss_pred ccccc-cccceecccccccCCCCC
Q 006145 635 LAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
..... .......++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~ 171 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVL 171 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHH
Confidence 55332 223445678999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-24 Score=216.38 Aligned_cols=167 Identities=19% Similarity=0.337 Sum_probs=140.7
Q ss_pred CCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCC------chHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCH------STRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
+|+..+.||+|+||.||+|+. .+++.||+|.+...... ..+++.+|++++++++|+||+++++++.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 74 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE------ 74 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc------
Confidence 477789999999999999985 46899999998643311 23578999999999999999999999875
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc-ceEEcc
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL-VAKISS 629 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~D 629 (659)
.+..++||||+++++|.+++.+. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++ .+||+|
T Consensus 75 -~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 75 -DSHFNLFVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred -CCeEEEEEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcc
Confidence 45789999999999999999752 4688999999999999999999998 999999999999998775 699999
Q ss_pred Ccccccccccc-----ccceecccccccCCCCC
Q 006145 630 YNLPLLAENAE-----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~~-----~~~~~~gt~~y~aPE~~ 657 (659)
||++....... ......++..|+|||+.
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~ 180 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHh
Confidence 99986654321 12335688999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.5e-24 Score=218.66 Aligned_cols=167 Identities=17% Similarity=0.326 Sum_probs=143.7
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
++|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||++++++|.. .+..
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-------~~~~ 91 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-------GDEL 91 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-------CCcE
Confidence 56778899999999999999854 688999999875544455679999999999999999999999875 4568
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++|+||+++|+|.+++.+ ..+++..+..++.+++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 92 ~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred EEEEecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 999999999999999875 3578999999999999999999998 999999999999999999999999999865
Q ss_pred cccc-cccceecccccccCCCCC
Q 006145 636 AENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
.... .......+++.|+|||..
T Consensus 165 ~~~~~~~~~~~~~~~~y~~PE~~ 187 (293)
T cd06647 165 ITPEQSKRSTMVGTPYWMAPEVV 187 (293)
T ss_pred ccccccccccccCChhhcCchhh
Confidence 4322 223445788999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=217.47 Aligned_cols=168 Identities=18% Similarity=0.297 Sum_probs=140.4
Q ss_pred CCCCCceeccCcCceEEEEEe----cCCcEEEEEEecccCC----CchHHHHHHHHHHhCC-CCCCccceeeeeeecccc
Q 006145 478 NFDTSAFMGEGSQGQMYRGRL----KNGTFVAIRCLKMKKC----HSTRNFMHHIELISKL-RHRHLVSALGHCFECYFD 548 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 548 (659)
+|+..+.||+|+||.||+++. .+|..||+|+++.... ...+.+.+|+++++++ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 367788999999999999985 3689999999975321 2235688999999999 59999999988765
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
....++||||+++|+|.+++... ..+++.....++.|+++||+|||+. +++||||||+||++++++.+||+
T Consensus 77 ---~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~ 147 (290)
T cd05613 77 ---DTKLHLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT 147 (290)
T ss_pred ---CCeEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEe
Confidence 45689999999999999998752 4588899999999999999999998 99999999999999999999999
Q ss_pred cCccccccccc--cccceecccccccCCCCCC
Q 006145 629 SYNLPLLAENA--EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 629 DFGla~~~~~~--~~~~~~~gt~~y~aPE~~~ 658 (659)
|||+++..... .......|+..|+|||+..
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 179 (290)
T cd05613 148 DFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179 (290)
T ss_pred eCccceecccccccccccccCCcccCChhhcc
Confidence 99999765332 2223466899999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8e-24 Score=220.29 Aligned_cols=168 Identities=23% Similarity=0.380 Sum_probs=137.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCc----EEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGT----FVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
++|...+.||+|+||.||+|+.. +|. .||+|.+...... ...++.+|+.++++++||||++++|+|..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------ 80 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS------ 80 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC------
Confidence 45667789999999999999864 454 4788888654322 23468999999999999999999999864
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
...++|+||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 --~~~~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Df 153 (303)
T cd05110 81 --PTIQLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDF 153 (303)
T ss_pred --CCceeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccc
Confidence 2357999999999999998753 23589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccc---cceecccccccCCCCC
Q 006145 631 NLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
|+++....... .....++..|||||+.
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 183 (303)
T cd05110 154 GLARLLEGDEKEYNADGGKMPIKWMALECI 183 (303)
T ss_pred cccccccCcccccccCCCccccccCCHHHh
Confidence 99976543222 1223456789999975
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-24 Score=217.56 Aligned_cols=168 Identities=20% Similarity=0.366 Sum_probs=141.0
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||+|++|.||+|+.. +|+.||||+++.... .....+.+|++++++++||||+++++++.+ .+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------~~~ 73 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-------ENK 73 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-------CCc
Confidence 4778899999999999999965 589999999875432 223578999999999999999999999875 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+. ++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.+|++|||+++
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~ 148 (284)
T cd07860 74 LYLVFEFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 148 (284)
T ss_pred EEEEeeccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchh
Confidence 899999996 68999887532 35689999999999999999999998 99999999999999999999999999987
Q ss_pred ccccc-cccceecccccccCCCCC
Q 006145 635 LAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
..... .......++..|+|||+.
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~ 172 (284)
T cd07860 149 AFGVPVRTYTHEVVTLWYRAPEIL 172 (284)
T ss_pred hcccCccccccccccccccCCeEE
Confidence 55332 223445678899999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=212.37 Aligned_cols=167 Identities=25% Similarity=0.447 Sum_probs=140.4
Q ss_pred CCCceeccCcCceEEEEEecC-C----cEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 480 DTSAFMGEGSQGQMYRGRLKN-G----TFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 480 ~~~~~ig~G~~g~Vy~~~~~~-g----~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
+..+.||.|+||.||+|+... + ..||+|.++..... ..+.+.+|++.+..++|+||+++++++.+ .+
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~ 74 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-------EE 74 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-------CC
Confidence 456899999999999999754 3 88999999755433 45679999999999999999999999876 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..+++|||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||++
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~ 150 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLS 150 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCc
Confidence 68999999999999999975321 2289999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccccc--eecccccccCCCCC
Q 006145 634 LLAENAEKVG--HVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~~~--~~~gt~~y~aPE~~ 657 (659)
+......... ...+++.|+|||+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~~Pe~~ 176 (258)
T smart00219 151 RDLYDDDYYKKKGGKLPIRWMAPESL 176 (258)
T ss_pred eecccccccccccCCCcccccChHHh
Confidence 7664432221 23467899999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.6e-24 Score=217.97 Aligned_cols=168 Identities=19% Similarity=0.309 Sum_probs=142.5
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||+|+||.||+|... +++.||||.++.... ...+.+.+|++++++++|+||+++++++.. .+.
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~~ 74 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-------KGR 74 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-------CCE
Confidence 5778899999999999999976 588999999875432 234679999999999999999999999976 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||++++.+..+... ...+++.+...++.|++.||+|||+. +++||||||+||++++++.+||+|||++.
T Consensus 75 ~~iv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~ 148 (288)
T cd07833 75 LYLVFEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFAR 148 (288)
T ss_pred EEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeeccc
Confidence 8999999998777766553 24589999999999999999999998 99999999999999999999999999997
Q ss_pred cccccc--ccceecccccccCCCCCC
Q 006145 635 LAENAE--KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~~~~~--~~~~~~gt~~y~aPE~~~ 658 (659)
...... ......++..|+|||+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~PE~~~ 174 (288)
T cd07833 149 ALRARPASPLTDYVATRWYRAPELLV 174 (288)
T ss_pred ccCCCccccccCcccccCCcCCchhc
Confidence 665433 334567889999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-26 Score=236.95 Aligned_cols=266 Identities=26% Similarity=0.263 Sum_probs=195.6
Q ss_pred EeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCC
Q 006145 76 ITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILT 155 (659)
Q Consensus 76 v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 155 (659)
++.|||+.|++. ..|..+.+-.++-.|+|++|++..+.-.-|.+|+.|-+||||+|++. .+|+.+..|.
T Consensus 105 Lt~lDLShNqL~----------EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~ 173 (1255)
T KOG0444|consen 105 LTILDLSHNQLR----------EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLS 173 (1255)
T ss_pred ceeeecchhhhh----------hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHh
Confidence 455555555543 23445555556666666666665544444556666666666666665 4555566666
Q ss_pred CCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCC-ccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcc
Q 006145 156 SLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFN-GTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLE 234 (659)
Q Consensus 156 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~ 234 (659)
.|++|+|++|.+.----..+..|++|++|.+++.+-+ ..+|.++..|.||..+|||.|++...+..+.++.+|+.|+||
T Consensus 174 ~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS 253 (1255)
T KOG0444|consen 174 MLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLS 253 (1255)
T ss_pred hhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccC
Confidence 6666666666553211122344566666666665422 357888888999999999999988665568899999999999
Q ss_pred cCCCCCCCCCC--CcccceEecCCCcCCccCchhccCCccccEEeccCcccc-cCCchhhcCCCcccEEeccCCcCCCcC
Q 006145 235 NNALGPQFPKV--GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFV-GPFPQALLSLPSITYLNIADNKLTGKL 311 (659)
Q Consensus 235 ~N~l~~~~~~~--~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~l~~N~l~~~~ 311 (659)
+|.|+..--.. ..+|++|+||.|+++. +|+.+..+++|+.|.+.+|+++ .-+|+.++++..|+++..++|++. .+
T Consensus 254 ~N~iteL~~~~~~W~~lEtLNlSrNQLt~-LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lV 331 (1255)
T KOG0444|consen 254 GNKITELNMTEGEWENLETLNLSRNQLTV-LPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LV 331 (1255)
T ss_pred cCceeeeeccHHHHhhhhhhccccchhcc-chHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cC
Confidence 99987544332 4789999999999964 8889999999999999999876 247899999999999999999887 78
Q ss_pred CcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccc
Q 006145 312 FDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCL 355 (659)
Q Consensus 312 p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l 355 (659)
|+.+..+..|+.|.|+.|.+- .+|+.+.-++.+.+|++..|.-
T Consensus 332 PEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 332 PEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred chhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence 899999999999999999987 7899998899999999998853
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=212.16 Aligned_cols=167 Identities=21% Similarity=0.364 Sum_probs=140.4
Q ss_pred CCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+|+..+.||+|+||.||+|...++..+|+|.++.... ...+|.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~~~~~ 76 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTE-------RSPICL 76 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEcc-------CCceEE
Confidence 5667789999999999999987788999999875432 34679999999999999999999998865 456899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||||+++|+|.++++.. ...++|..+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVL 151 (256)
T ss_pred EEEcCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecc
Confidence 99999999999998753 23588999999999999999999998 99999999999999999999999999987543
Q ss_pred cccc--cceecccccccCCCCC
Q 006145 638 NAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 ~~~~--~~~~~gt~~y~aPE~~ 657 (659)
.... .....++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~aPe~~ 173 (256)
T cd05112 152 DDQYTSSTGTKFPVKWSSPEVF 173 (256)
T ss_pred cCcccccCCCccchhhcCHhHh
Confidence 2211 1223456789999975
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=215.81 Aligned_cols=162 Identities=20% Similarity=0.289 Sum_probs=137.8
Q ss_pred eccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEe
Q 006145 485 MGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 485 ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
||+|+||+||+|... +|+.||+|.+..... ...+.+.+|++++++++||||+++++++.. .+..|+|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-------KDDLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-------CCeEEEEEe
Confidence 689999999999865 589999999865321 223457889999999999999999998865 457899999
Q ss_pred ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccccccc
Q 006145 561 YVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640 (659)
Q Consensus 561 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 640 (659)
|+++|+|.+++.+.. ...+++..+..++.|+++|+.|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 74 LMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK 149 (277)
T ss_pred cCCCCcHHHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC
Confidence 999999999997532 24689999999999999999999998 99999999999999999999999999997665444
Q ss_pred ccceecccccccCCCCC
Q 006145 641 KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 641 ~~~~~~gt~~y~aPE~~ 657 (659)
......++..|+|||+.
T Consensus 150 ~~~~~~~~~~y~~PE~~ 166 (277)
T cd05577 150 KIKGRAGTPGYMAPEVL 166 (277)
T ss_pred ccccccCCCCcCCHHHh
Confidence 44556788899999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=215.61 Aligned_cols=166 Identities=16% Similarity=0.318 Sum_probs=141.8
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.|+..+.||.|+||.||+|... ++..||+|.++.... .....+.+|++++++++|+||+++++++.+ ....
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~~ 77 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-------GTKL 77 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-------CCEE
Confidence 4666788999999999999965 588999999875432 234578999999999999999999999986 4678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.+++.. ..+++.+...++.|++.||+|||+. +++|+||+|+||++++++.++++|||++..
T Consensus 78 ~lv~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~ 150 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred EEEEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEccccccee
Confidence 999999999999999874 3588999999999999999999998 999999999999999999999999999965
Q ss_pred ccccc-ccceecccccccCCCCC
Q 006145 636 AENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
..... ......++..|+|||+.
T Consensus 151 ~~~~~~~~~~~~~~~~y~apE~~ 173 (277)
T cd06640 151 LTDTQIKRNTFVGTPFWMAPEVI 173 (277)
T ss_pred ccCCccccccccCcccccCHhHh
Confidence 53322 23345688899999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=214.06 Aligned_cols=165 Identities=18% Similarity=0.342 Sum_probs=140.6
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
|+..+.||+|+||.||+|... ++..||||.+..... ...+.+.+|++++++++||||+++++++.. ....+
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------~~~~~ 78 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-------DTKLW 78 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-------CCeEE
Confidence 556789999999999999864 588999999864432 233568899999999999999999999976 45689
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.+++.. ..+++.....++.+++.|++|||+. +++|+||||+||+++.++.++++|||++...
T Consensus 79 lv~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 79 IIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred EEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceec
Confidence 99999999999999874 3589999999999999999999998 9999999999999999999999999998655
Q ss_pred cccc-ccceecccccccCCCCC
Q 006145 637 ENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
.... ......++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~ 173 (277)
T cd06641 152 TDTQIKRNTFVGTPFWMAPEVI 173 (277)
T ss_pred ccchhhhccccCCccccChhhh
Confidence 3321 22345688899999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=212.40 Aligned_cols=161 Identities=20% Similarity=0.306 Sum_probs=133.6
Q ss_pred ceeccCcCceEEEEEecC----CcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLKN----GTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||.||+|++.. +..||+|.+...... ..+++.+|++++++++|+|||++++++.. +..++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~~~~~ 72 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG--------EPLML 72 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC--------CceEE
Confidence 478999999999998542 368999999755432 34679999999999999999999998753 35799
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 73 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~ 146 (257)
T cd05060 73 VMELAPLGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALG 146 (257)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceee
Confidence 99999999999999853 3689999999999999999999998 99999999999999999999999999997653
Q ss_pred ccccc----ceecccccccCCCCC
Q 006145 638 NAEKV----GHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 ~~~~~----~~~~gt~~y~aPE~~ 657 (659)
..... ....++..|+|||+.
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~ 170 (257)
T cd05060 147 AGSDYYRATTAGRWPLKWYAPECI 170 (257)
T ss_pred cCCcccccccCccccccccCHHHh
Confidence 32211 112234679999974
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=211.02 Aligned_cols=163 Identities=23% Similarity=0.429 Sum_probs=137.2
Q ss_pred ceeccCcCceEEEEEecCCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEec
Q 006145 483 AFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEY 561 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey 561 (659)
++||+|+||.||++...+++.||+|.++..... ..++|.+|++++++++|+||+++++++.. ....++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-------KQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-------CCCeEEEEEc
Confidence 468999999999999877999999998765433 34679999999999999999999999875 4568999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccccc
Q 006145 562 VPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEK 641 (659)
Q Consensus 562 ~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~ 641 (659)
+++++|.++++.. ...+++..+..++.+++.|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 74 ~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 74 VPGGSLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY 148 (251)
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcc
Confidence 9999999999753 23588999999999999999999998 999999999999999999999999999976542221
Q ss_pred c---ceecccccccCCCCC
Q 006145 642 V---GHVIPYSGSIDPTNS 657 (659)
Q Consensus 642 ~---~~~~gt~~y~aPE~~ 657 (659)
. .....+..|+|||+.
T Consensus 149 ~~~~~~~~~~~~y~~PE~~ 167 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEAL 167 (251)
T ss_pred eeccccCcceeccCChHhh
Confidence 1 122345679999975
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=214.79 Aligned_cols=166 Identities=19% Similarity=0.388 Sum_probs=141.6
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCC---CCCccceeeeeeeccccCCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLR---HRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~~~~ 552 (659)
.|+..+.||+|+||.||+|+.. +++.||+|.+..... ....++.+|++++++++ |||+++++++|.. .
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-------~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-------G 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-------C
Confidence 4667789999999999999964 689999999865432 23467889999999997 9999999999875 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||+++++|.++++. ..+++.....++.|+++||+|||+. +|+||||+|+||++++++.++++|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGV 147 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCc
Confidence 568999999999999999874 3689999999999999999999998 999999999999999999999999999
Q ss_pred cccccccc-ccceecccccccCCCCC
Q 006145 633 PLLAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
+....... ......|+..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 173 (277)
T cd06917 148 AALLNQNSSKRSTFVGTPYWMAPEVI 173 (277)
T ss_pred eeecCCCccccccccCCcceeCHHHh
Confidence 87654322 23445789999999974
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=212.70 Aligned_cols=160 Identities=18% Similarity=0.295 Sum_probs=138.3
Q ss_pred eccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEe
Q 006145 485 MGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 485 ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
||.|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+ ....++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-------KKYIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-------CCccEEEEe
Confidence 689999999999975 489999999975432 233579999999999999999999998875 456899999
Q ss_pred ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccccccc
Q 006145 561 YVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640 (659)
Q Consensus 561 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 640 (659)
|+++|+|.+++++. ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+|++|||+++......
T Consensus 74 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~ 147 (262)
T cd05572 74 YCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147 (262)
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence 99999999999853 3589999999999999999999998 99999999999999999999999999997765443
Q ss_pred ccceecccccccCCCCC
Q 006145 641 KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 641 ~~~~~~gt~~y~aPE~~ 657 (659)
......++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~PE~~ 164 (262)
T cd05572 148 KTWTFCGTPEYVAPEII 164 (262)
T ss_pred ccccccCCcCccChhHh
Confidence 33446789999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=211.56 Aligned_cols=167 Identities=17% Similarity=0.361 Sum_probs=145.4
Q ss_pred CCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
+|+..+.||+|++|.||+|+... ++.||||++..... ...+++.+|++.+.+++|+||+++++++.. ....
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~~~ 74 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-------EGEI 74 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-------CCeE
Confidence 57788999999999999999764 99999999876543 335679999999999999999999999876 4678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcC-CCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT-GIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
++||||+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~ 148 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISK 148 (264)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccce
Confidence 9999999999999999753 568999999999999999999999 8 99999999999999999999999999997
Q ss_pred cccccccc-ceecccccccCCCCC
Q 006145 635 LAENAEKV-GHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~-~~~~gt~~y~aPE~~ 657 (659)
........ ....++..|+|||+.
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~ 172 (264)
T cd06623 149 VLENTLDQCNTFVGTVTYMSPERI 172 (264)
T ss_pred ecccCCCcccceeecccccCHhhh
Confidence 66433322 356788999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.3e-25 Score=245.83 Aligned_cols=171 Identities=20% Similarity=0.392 Sum_probs=145.9
Q ss_pred hhcCCCCCceeccCcCceEEEEE-ecCCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.+-+++....||.|.||.||-|. ..+|...|||-++..... ......+|+.++..++|||+|+++|+-.+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH------- 1305 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH------- 1305 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-------
Confidence 34456778899999999999999 556999999998765433 33568899999999999999999998876
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
++..+|.||||++|+|.+.++.. ...++.....+..|++.|++|||+. +||||||||.||++|.+|.+|.+|||
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeeccc
Confidence 56789999999999999999852 4567777788899999999999999 99999999999999999999999999
Q ss_pred ccccccccc-----ccceecccccccCCCCCC
Q 006145 632 LPLLAENAE-----KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 632 la~~~~~~~-----~~~~~~gt~~y~aPE~~~ 658 (659)
.|....+.. ......||+.|||||.+-
T Consensus 1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit 1411 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVIT 1411 (1509)
T ss_pred ceeEecCchhcCCHHHHhhcCCchhcCchhhc
Confidence 996654332 346789999999999863
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=214.68 Aligned_cols=160 Identities=20% Similarity=0.281 Sum_probs=130.2
Q ss_pred eeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHH---hCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 484 FMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELI---SKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 484 ~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
.||+|+||.||+++.. +++.||+|.+...... ....+.+|..++ ...+||||+.+.+++.. .+..+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-------~~~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-------PDKLC 73 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-------CCeEE
Confidence 4899999999999965 5899999998654321 123345555443 34479999999988875 45689
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.+++... ..++|.....++.|++.||+|||+. +|+||||||+||++++++.+|++|||++...
T Consensus 74 lv~e~~~~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 74 FILDLMNGGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred EEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 999999999999998752 4699999999999999999999998 9999999999999999999999999998655
Q ss_pred ccccccceecccccccCCCCC
Q 006145 637 ENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~~~~~~gt~~y~aPE~~ 657 (659)
... ......|+..|+|||+.
T Consensus 148 ~~~-~~~~~~~~~~y~aPE~~ 167 (279)
T cd05633 148 SKK-KPHASVGTHGYMAPEVL 167 (279)
T ss_pred ccc-CccCcCCCcCccCHHHh
Confidence 332 22345799999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=214.02 Aligned_cols=170 Identities=21% Similarity=0.347 Sum_probs=140.7
Q ss_pred CCCCCceeccCcCceEEEEEec-----CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-----NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.|+..+.||+|+||.||+|++. ++..||||.++..... ..++|.+|++++++++|+||+++++++... .
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~-----~ 79 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP-----G 79 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC-----C
Confidence 4566789999999999999854 3789999999765432 356799999999999999999999988642 2
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++||||+++|+|.+++.... ..++|..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 154 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFG 154 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence 346899999999999999998532 3599999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccc----ceecccccccCCCCC
Q 006145 632 LPLLAENAEKV----GHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~----~~~~gt~~y~aPE~~ 657 (659)
++......... ....++..|+|||+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~ 184 (284)
T cd05038 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECL 184 (284)
T ss_pred cccccccCCcceeccCCCCCcccccCcHHH
Confidence 99766422111 123455679999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=211.78 Aligned_cols=169 Identities=15% Similarity=0.277 Sum_probs=142.9
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||+|+||.||+++.. +|+.||+|.+..... ...+++.+|++++++++||||+++++++.+ .+.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~~ 73 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-------NGN 73 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-------CCe
Confidence 4777899999999999999965 589999999875432 234579999999999999999999998865 467
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++++|.++++... ...+++.++.+++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~ 149 (256)
T cd08218 74 LYIVMDYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR 149 (256)
T ss_pred EEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeecccee
Confidence 899999999999999987522 23578999999999999999999998 99999999999999999999999999997
Q ss_pred ccccccc-cceecccccccCCCCC
Q 006145 635 LAENAEK-VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~-~~~~~gt~~y~aPE~~ 657 (659)
....... .....|++.|+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~pe~~ 173 (256)
T cd08218 150 VLNSTVELARTCIGTPYYLSPEIC 173 (256)
T ss_pred ecCcchhhhhhccCCccccCHHHh
Confidence 6543222 2345688899999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-24 Score=230.49 Aligned_cols=163 Identities=21% Similarity=0.327 Sum_probs=135.9
Q ss_pred CCceeccCcCceEEEEEe-cCC----cEEEEEEecccC-CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 481 TSAFMGEGSQGQMYRGRL-KNG----TFVAIRCLKMKK-CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 481 ~~~~ig~G~~g~Vy~~~~-~~g----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..++||+|+||+||||.+ +.| .+||||.+.... .+...++++|+-+|++++|||+++|+|+|.. ..
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~--------s~ 771 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML--------ST 771 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc--------ch
Confidence 358999999999999984 443 479999986544 3345789999999999999999999999985 33
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
..||++|||.|+|.++++.+ +..+.-...+.|..|||+||.|||.+ +++||||.++|||+.+...+||.|||+|+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ 846 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAK 846 (1177)
T ss_pred HHHHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhh
Confidence 78999999999999999864 34678888999999999999999998 99999999999999999999999999998
Q ss_pred cccccccc---ceecccccccCCCC
Q 006145 635 LAENAEKV---GHVIPYSGSIDPTN 656 (659)
Q Consensus 635 ~~~~~~~~---~~~~gt~~y~aPE~ 656 (659)
....+... ......+.|||=|-
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~ 871 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALES 871 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHH
Confidence 87554332 22334456777664
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-25 Score=209.67 Aligned_cols=173 Identities=16% Similarity=0.340 Sum_probs=140.3
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccC-CCCce
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDD-SSVSR 554 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~-~~~~~ 554 (659)
|....+||+|.||.||+|+.+ +|+.||+|++-.+. ..-.....+|+++|..++|+|++.+++.|....-.+ .....
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 334478999999999999965 48889999875432 222356789999999999999999999997533211 12345
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.|+||++|+. ||+-+|... ...++.....+++.++..||.|+|+. .|+|||+||.|+||+.++..||+|||+|+
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence 8999999988 999988753 35688899999999999999999999 99999999999999999999999999996
Q ss_pred cccc-----ccccceecccccccCCCCC
Q 006145 635 LAEN-----AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~-----~~~~~~~~gt~~y~aPE~~ 657 (659)
.... ...++..+.|.+|++||-+
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEll 200 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELL 200 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHh
Confidence 5421 2234667889999999954
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=214.08 Aligned_cols=167 Identities=16% Similarity=0.313 Sum_probs=143.1
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
+|+..+.||+|+||.||++... +++.||+|++..... ...+++.+|++++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------~~~~ 74 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-------NGDI 74 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-------CCEE
Confidence 5667789999999999999976 589999999876543 234579999999999999999999999876 4678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcC-CCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT-GIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
++|+||+++++|.+++.... ..+++.....++.|+++|++|||+ . +++||||||+||++++++.+||+|||.+.
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred EEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccch
Confidence 99999999999999998532 568899999999999999999999 7 99999999999999999999999999986
Q ss_pred ccccccccceecccccccCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
....... ....++..|+|||+.
T Consensus 150 ~~~~~~~-~~~~~~~~y~~PE~~ 171 (265)
T cd06605 150 QLVNSLA-KTFVGTSSYMAPERI 171 (265)
T ss_pred hhHHHHh-hcccCChhccCHHHH
Confidence 6533222 227788999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=221.33 Aligned_cols=172 Identities=19% Similarity=0.342 Sum_probs=141.8
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC-CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK-CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|...+.||+|+||.||+|+.. +|+.||||.+.... .....++.+|+.++++++|+||+++++++...... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE--SFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc--ccc
Confidence 467888999999999999999854 68999999986432 22345688999999999999999999988653321 134
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++|+||+++ +|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred eEEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 67999999975 88888764 4689999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccc----cceecccccccCCCCC
Q 006145 634 LLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
+....... .....|+..|||||+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 181 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIM 181 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHh
Confidence 76533221 1335789999999974
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=215.42 Aligned_cols=175 Identities=21% Similarity=0.298 Sum_probs=140.6
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||.||+|+.. +|+.||||.++.... .....+.+|++++++++ |+||+++++++..... .+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~--~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK--NGK 78 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC--CCC
Confidence 36788899999999999999965 589999999865432 22357889999999995 6999999998875221 112
Q ss_pred ceeEEEEeccCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC-CcceEEcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHA--HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ-NLVAKISS 629 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~D 629 (659)
...|+||||+++ +|.+++..... ...+++..+..++.||++||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence 347999999985 89988864321 24689999999999999999999998 9999999999999998 89999999
Q ss_pred Ccccccccc-ccccceecccccccCCCCC
Q 006145 630 YNLPLLAEN-AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~-~~~~~~~~gt~~y~aPE~~ 657 (659)
||+++.... ........+++.|+|||+.
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~ 183 (295)
T cd07837 155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVL 183 (295)
T ss_pred cccceecCCCccccCCcccccCCCChHHh
Confidence 999875432 2223445678899999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=213.19 Aligned_cols=178 Identities=18% Similarity=0.317 Sum_probs=147.1
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++++|+..+.||+|+||.||+|... +++.+|+|.+..... ..++|.+|+++++++ +|+||+++++++...... ...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~-~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP-GND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC-Ccc
Confidence 5678999999999999999999975 588999999875443 346799999999999 699999999999753210 113
Q ss_pred ceeEEEEeccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGH-AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
...++||||+++++|.++++... ....+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+|++|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 46899999999999999987421 135689999999999999999999998 99999999999999999999999999
Q ss_pred cccccccc-cccceecccccccCCCCC
Q 006145 632 LPLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
++...... .......++..|+|||+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~ 185 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVI 185 (275)
T ss_pred cceecccchhhhcCccccccccCHhHh
Confidence 98655332 222446689999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=211.93 Aligned_cols=171 Identities=17% Similarity=0.320 Sum_probs=140.8
Q ss_pred CCCCCceeccCcCceEEEEEecC--CcEEEEEEecccCC----------CchHHHHHHHHHHhC-CCCCCccceeeeeee
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKN--GTFVAIRCLKMKKC----------HSTRNFMHHIELISK-LRHRHLVSALGHCFE 544 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~--g~~vavK~l~~~~~----------~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~ 544 (659)
+|+..+.||+|+||.||+|.... ++.+|+|.+..... ....++.+|++++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999999764 78899998853221 122457789988875 799999999999875
Q ss_pred ccccCCCCceeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc
Q 006145 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL 623 (659)
Q Consensus 545 ~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~ 623 (659)
.+..++||||+++++|.+++... .....+++..+.+++.|++.||+|||+. .+++|+||||+||++++++
T Consensus 81 -------~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~ 151 (269)
T cd08528 81 -------NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDD 151 (269)
T ss_pred -------CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCC
Confidence 46789999999999999987531 1234689999999999999999999963 1799999999999999999
Q ss_pred ceEEccCccccccccccccceecccccccCCCCC
Q 006145 624 VAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 624 ~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.+||+|||++.............++..|+|||+.
T Consensus 152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~ 185 (269)
T cd08528 152 KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV 185 (269)
T ss_pred cEEEecccceeecccccccccccCcccCcChhhh
Confidence 9999999999876554444566789999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-24 Score=239.91 Aligned_cols=180 Identities=21% Similarity=0.331 Sum_probs=140.1
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC-CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccC--
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK-CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDD-- 549 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~-- 549 (659)
+-..+|.+.+.||+||||.|||++-+ ||+.+|||++.... ...-....+|+++|++++|||||+++..+.+...+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45567788899999999999999954 79999999997654 122356899999999999999999987643321000
Q ss_pred ------------------------------------------------C-------------------------------
Q 006145 550 ------------------------------------------------S------------------------------- 550 (659)
Q Consensus 550 ------------------------------------------------~------------------------------- 550 (659)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred -----------------------C--------CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhh
Q 006145 551 -----------------------S--------VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFL 599 (659)
Q Consensus 551 -----------------------~--------~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL 599 (659)
. ...+||=||||+.-++++++++..... .-....+++++|++||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 0 023678899999988888887532111 2455688999999999999
Q ss_pred cCCCCCCccccCCCCCceeecCCcceEEccCccccccc-------------------cccccceecccccccCCCCCC
Q 006145 600 HTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE-------------------NAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 600 H~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~-------------------~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|+. +||||||||.||++|++..+||+|||+|.... +....+..+||.-|+|||+..
T Consensus 714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999 99999999999999999999999999997611 112336689999999999864
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=214.11 Aligned_cols=171 Identities=20% Similarity=0.287 Sum_probs=142.1
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
+|...+.||.|++|.||+|... +++.+|+|.+..... ...+++.+|++++++++||||++++++|.+. ..+..
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~~ 76 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE-----SSSSI 76 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc-----CCCeE
Confidence 5777899999999999999975 589999999875432 2346799999999999999999999998652 23468
Q ss_pred EEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 556 FLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
++||||+++|+|.+++... .....+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 153 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG 153 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccc
Confidence 9999999999999887531 1234688999999999999999999998 99999999999999999999999999986
Q ss_pred ccccccccceecccccccCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
...... .....++..|+|||+.
T Consensus 154 ~~~~~~-~~~~~~~~~y~~pE~~ 175 (287)
T cd06621 154 ELVNSL-AGTFTGTSFYMAPERI 175 (287)
T ss_pred cccccc-cccccCCccccCHHHh
Confidence 543221 2245678899999975
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=217.26 Aligned_cols=171 Identities=23% Similarity=0.340 Sum_probs=139.5
Q ss_pred CCCCCceeccCcCceEEEEEec---CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK---NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~---~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
+|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. .
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH-----A 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC-----C
Confidence 3667789999999999999964 47899999997633 23346788999999999999999999999762 1
Q ss_pred CceeEEEEeccCCCChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC----Ccce
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGH--AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ----NLVA 625 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~----~~~~ 625 (659)
....++||||+++ ++.+++.... ....+++.....++.|++.||+|||+. +|+||||||+||+++. ++.+
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~ 151 (316)
T cd07842 76 DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVV 151 (316)
T ss_pred CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceE
Confidence 3578999999975 7777765321 123688899999999999999999998 9999999999999999 8999
Q ss_pred EEccCcccccccccc----ccceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENAE----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~~----~~~~~~gt~~y~aPE~~ 657 (659)
||+|||+++...... ......++..|+|||+.
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 187 (316)
T cd07842 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELL 187 (316)
T ss_pred EECCCccccccCCCcccccccCCccccccccCHHHH
Confidence 999999997653322 12345788999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=215.97 Aligned_cols=171 Identities=22% Similarity=0.347 Sum_probs=141.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|+..+.||+|+||.||+|+.. +|+.||+|.++..... ....+.+|++++++++|+||+++++++.+. ..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 80 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK-----HL 80 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC-----CC
Confidence 467888999999999999999975 5999999998754322 123577899999999999999999998652 13
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++ +|.+++... ...+++.++..++.|+++||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 81 ~~~~lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~ 154 (309)
T cd07845 81 DSIFLVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGL 154 (309)
T ss_pred CeEEEEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccce
Confidence 468999999974 898888753 24689999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc-cccceecccccccCCCCC
Q 006145 633 PLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
+...... .......++..|+|||+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (309)
T cd07845 155 ARTYGLPAKPMTPKVVTLWYRAPELL 180 (309)
T ss_pred eeecCCccCCCCcccccccccChhhh
Confidence 9766432 223344568889999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-23 Score=215.50 Aligned_cols=178 Identities=20% Similarity=0.338 Sum_probs=143.4
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeecccc--
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFD-- 548 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-- 548 (659)
...++|+..+.||+|+||.||+|..+ +|+.||||.++.... .....+.+|++++++++||||+++++++.+....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45677888999999999999999976 489999999975432 2235688999999999999999999998752200
Q ss_pred -CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEE
Q 006145 549 -DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKI 627 (659)
Q Consensus 549 -~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl 627 (659)
.......++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 0012368999999986 777777642 34689999999999999999999998 9999999999999999999999
Q ss_pred ccCcccccccccc--ccceecccccccCCCCC
Q 006145 628 SSYNLPLLAENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 628 ~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
+|||++....... ......++..|+|||+.
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 189 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELL 189 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHh
Confidence 9999997654322 22334567889999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=213.13 Aligned_cols=166 Identities=19% Similarity=0.351 Sum_probs=141.4
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
|...+.||+|++|.||++... +++.||+|++........+.+.+|+.+++.++|+||+++++++.. .+..++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-------~~~~~~ 93 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-------GDELWV 93 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-------CCeEEE
Confidence 444589999999999999954 689999999875544445678999999999999999999998875 456899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
|+||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||++....
T Consensus 94 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 94 VMEFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred EEeccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 9999999999999875 3589999999999999999999998 99999999999999999999999999886543
Q ss_pred cc-cccceecccccccCCCCCC
Q 006145 638 NA-EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 638 ~~-~~~~~~~gt~~y~aPE~~~ 658 (659)
.. .......|++.|+|||+..
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~ 188 (285)
T cd06648 167 KEVPRRKSLVGTPYWMAPEVIS 188 (285)
T ss_pred cCCcccccccCCccccCHHHhc
Confidence 32 2223457899999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-23 Score=207.34 Aligned_cols=167 Identities=25% Similarity=0.462 Sum_probs=144.2
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||+|++|.||+++.. +++.||+|.+..... ...+++.+|++++++++|+|++++++++.+ ...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~~ 73 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-------SDS 73 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-------CCE
Confidence 4677899999999999999865 588999999976543 234679999999999999999999999875 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++++|.+++... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 147 (254)
T cd06627 74 LYIILEYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVAT 147 (254)
T ss_pred EEEEEecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccce
Confidence 89999999999999998753 4689999999999999999999998 99999999999999999999999999997
Q ss_pred ccccccc-cceecccccccCCCCC
Q 006145 635 LAENAEK-VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~-~~~~~gt~~y~aPE~~ 657 (659)
....... .....++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~pe~~ 171 (254)
T cd06627 148 KLNDVSKDDASVVGTPYWMAPEVI 171 (254)
T ss_pred ecCCCcccccccccchhhcCHhhh
Confidence 6643322 2446788999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-23 Score=213.68 Aligned_cols=167 Identities=21% Similarity=0.342 Sum_probs=141.9
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCCcee
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
|+..+.||+|++|+||+|+.. +++.||||++...... ......+|+..+++++ |+||+++++++.. .+..
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-------~~~~ 73 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-------NDEL 73 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-------CCcE
Confidence 456789999999999999976 4889999998754322 2234567999999999 9999999999875 4578
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+ +|+|.+++.... ...++|..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||++..
T Consensus 74 ~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~ 148 (283)
T cd07830 74 YFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLARE 148 (283)
T ss_pred EEEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeeccccee
Confidence 9999999 889999987532 24689999999999999999999998 999999999999999999999999999987
Q ss_pred cccccccceecccccccCCCCC
Q 006145 636 AENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
...........++..|+|||+.
T Consensus 149 ~~~~~~~~~~~~~~~~~aPE~~ 170 (283)
T cd07830 149 IRSRPPYTDYVSTRWYRAPEIL 170 (283)
T ss_pred ccCCCCcCCCCCcccccCceee
Confidence 7554444556789999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-23 Score=212.18 Aligned_cols=167 Identities=20% Similarity=0.347 Sum_probs=140.1
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
|+..+.||+|++|.||+|... +|..||+|++..... ...+.+.+|++++++++|+||+++++++.+ .+..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-------~~~~ 73 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-------ENKL 73 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-------CCeE
Confidence 556789999999999999965 699999999875432 223568899999999999999999999975 4678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||++ ++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.+||+|||+++.
T Consensus 74 ~iv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~ 148 (283)
T cd07835 74 YLVFEFLD-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARA 148 (283)
T ss_pred EEEEeccC-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence 99999995 69999987532 24689999999999999999999998 999999999999999999999999999975
Q ss_pred ccccc-ccceecccccccCCCCC
Q 006145 636 AENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
..... ......++..|+|||+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~aPE~~ 171 (283)
T cd07835 149 FGVPVRTYTHEVVTLWYRAPEIL 171 (283)
T ss_pred cCCCccccCccccccCCCCCcee
Confidence 53221 22344678899999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=214.74 Aligned_cols=165 Identities=19% Similarity=0.314 Sum_probs=139.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
+.|+..+.||+|+||.||+|+.. +|+.||+|.+...... ..+++.+|++++++++||||++++++|.+ .
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-------~ 87 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-------E 87 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-------C
Confidence 44777899999999999999965 5899999998644322 23568899999999999999999999986 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||++ |++.+++... ...+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||+
T Consensus 88 ~~~~lv~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~ 161 (307)
T cd06607 88 HTAWLVMEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGS 161 (307)
T ss_pred CeEEEEHHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCc
Confidence 56899999997 5787777532 24689999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+...... ....+++.|+|||+.
T Consensus 162 ~~~~~~~---~~~~~~~~y~aPE~~ 183 (307)
T cd06607 162 ASLVSPA---NSFVGTPYWMAPEVI 183 (307)
T ss_pred ceecCCC---CCccCCccccCceee
Confidence 9765432 235688899999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=213.39 Aligned_cols=166 Identities=22% Similarity=0.406 Sum_probs=135.0
Q ss_pred ceeccCcCceEEEEEecC-------CcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 483 AFMGEGSQGQMYRGRLKN-------GTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+.||+|+||.||+|+..+ ++.||||.+..... ....+|.+|+++++.++||||++++++|.. .+.
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~ 73 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-------NEP 73 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-------CCC
Confidence 368999999999998642 36799999865432 335679999999999999999999999875 456
Q ss_pred eEEEEeccCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc-----ce
Q 006145 555 IFLIFEYVPNGTLRSWISEGH----AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL-----VA 625 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~-----~~ 625 (659)
.++||||+++|+|.++++... ....++|.+++.++.|+++||+|||+. +++|+||||+||+++.+. .+
T Consensus 74 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~ 150 (269)
T cd05044 74 QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVV 150 (269)
T ss_pred eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcce
Confidence 899999999999999997421 223588999999999999999999998 999999999999999877 89
Q ss_pred EEccCccccccccccc---cceecccccccCCCCCC
Q 006145 626 KISSYNLPLLAENAEK---VGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 626 kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~ 658 (659)
|++|||+++....... .....++..|+|||+..
T Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (269)
T cd05044 151 KIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLL 186 (269)
T ss_pred EECCcccccccccccccccCcccCCCccccCHHHHc
Confidence 9999999875532211 12334567899999753
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-23 Score=211.99 Aligned_cols=167 Identities=19% Similarity=0.308 Sum_probs=137.8
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCCcee
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
|...+.||+|+||.||+|+.. +++.||+|+++.... .......+|+.++.++. |+||+++++++.+. ..+..
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR-----KTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC-----CCCcE
Confidence 455688999999999999965 589999999875432 22234568999999985 99999999999762 12568
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++|+||++ |++.+++... ...++|.++..++.|+++||+|||+. +++||||||+||++++ +.+||+|||+++.
T Consensus 76 ~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~ 148 (282)
T cd07831 76 ALVFELMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRG 148 (282)
T ss_pred EEEEecCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccc
Confidence 99999997 5888888753 24689999999999999999999998 9999999999999999 9999999999987
Q ss_pred cccccccceecccccccCCCCC
Q 006145 636 AENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
...........++..|+|||+.
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~ 170 (282)
T cd07831 149 IYSKPPYTEYISTRWYRAPECL 170 (282)
T ss_pred cccCCCcCCCCCCcccCChhHh
Confidence 6544444456788999999964
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=209.91 Aligned_cols=169 Identities=20% Similarity=0.365 Sum_probs=141.7
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|...+.||+|+||.||+|... +|..||+|.+..... ...+.+.+|++++++++|+||+++++++.. ...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-------~~~ 73 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-------NGR 73 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-------CCe
Confidence 4677889999999999999976 488999999865422 234578899999999999999999998875 457
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc-ceEEccCccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL-VAKISSYNLP 633 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla 633 (659)
.++|+||+++++|.+++.+.. ...++|..+..++.|+++||+|||+. +++|+||||+||++++++ .+|++|||.+
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~ 149 (257)
T cd08225 74 LFIVMEYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIA 149 (257)
T ss_pred EEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccc
Confidence 899999999999999997532 24589999999999999999999998 999999999999999875 5799999998
Q ss_pred ccccccc-ccceecccccccCCCCC
Q 006145 634 LLAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
....... ......|++.|+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~ 174 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEIC 174 (257)
T ss_pred hhccCCcccccccCCCccccCHHHH
Confidence 7654332 22345688999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-23 Score=211.95 Aligned_cols=160 Identities=21% Similarity=0.294 Sum_probs=130.2
Q ss_pred eeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHH---HHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 484 FMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIE---LISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 484 ~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~---~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
.||+|+||.||+|+.. +|+.||+|.+...... ....+..|.. .++..+||||+++++++.+ .+..+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-------~~~~~ 73 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-------PDKLS 73 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-------CCEEE
Confidence 4799999999999864 5899999998654322 1123444443 4455689999999988875 46789
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.+++.. ...++|..+..++.|+++|++|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 74 ~v~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 74 FILDLMNGGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 99999999999998865 24699999999999999999999998 9999999999999999999999999998755
Q ss_pred ccccccceecccccccCCCCC
Q 006145 637 ENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~~~~~~gt~~y~aPE~~ 657 (659)
... ......|+..|+|||+.
T Consensus 148 ~~~-~~~~~~~~~~y~aPE~~ 167 (278)
T cd05606 148 SKK-KPHASVGTHGYMAPEVL 167 (278)
T ss_pred Ccc-CCcCcCCCcCCcCcHHh
Confidence 332 22345789999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-23 Score=220.70 Aligned_cols=173 Identities=17% Similarity=0.226 Sum_probs=142.9
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
..++|+..+.||+|+||.||+|+.. +|+.||||.+.... .....++.+|++++++++|+||+++++++..... ...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKS-LEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCC-ccc
Confidence 3577888999999999999999965 69999999986432 2233568899999999999999999998864211 011
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....|+||||+. |+|.+.+.. .+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 245799999996 589888864 288899999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+++............++..|+|||+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 189 (353)
T cd07850 164 LARTAGTSFMMTPYVVTRYYRAPEVI 189 (353)
T ss_pred cceeCCCCCCCCCCcccccccCHHHH
Confidence 99876554444556788999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=219.35 Aligned_cols=169 Identities=18% Similarity=0.301 Sum_probs=140.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|+..+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++++ +|+||++++++|... .
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~-----~ 80 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE-----N 80 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC-----C
Confidence 456778899999999999999975 58899999986432 22335678899999999 999999999988641 1
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++||||++ ++|.+++.. ..++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g 152 (337)
T cd07852 81 DKDIYLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFG 152 (337)
T ss_pred CceEEEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeecc
Confidence 345799999997 599998875 2688999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccc------ccceecccccccCCCCC
Q 006145 632 LPLLAENAE------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~------~~~~~~gt~~y~aPE~~ 657 (659)
+++...... ......|+..|+|||+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 184 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEIL 184 (337)
T ss_pred chhccccccccccCcchhcccccccccCceee
Confidence 997553221 22345789999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=211.73 Aligned_cols=168 Identities=23% Similarity=0.378 Sum_probs=140.6
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
|+..+.||+|+||.||+|+.. +|+.+|+|++.... ....+.+.+|++++++++|+|++++++++.... .+..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG-----KGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC-----CCcE
Confidence 456788999999999999976 48999999997653 223457899999999999999999999997520 2578
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++ +|.+++... ...+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||++..
T Consensus 76 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~ 149 (287)
T cd07840 76 YMVFEYMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARP 149 (287)
T ss_pred EEEeccccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceee
Confidence 999999975 999888753 24689999999999999999999998 999999999999999999999999999976
Q ss_pred ccccc--ccceecccccccCCCCC
Q 006145 636 AENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
..... ......++..|+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~ 173 (287)
T cd07840 150 YTKRNSADYTNRVITLWYRPPELL 173 (287)
T ss_pred ccCCCcccccccccccccCCceee
Confidence 64332 23445678899999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=213.76 Aligned_cols=161 Identities=18% Similarity=0.358 Sum_probs=138.5
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEec
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEY 561 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey 561 (659)
..||+|+||.||++... +|+.||||++..........+.+|+.++++++|+||+++++++.. .+..++||||
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------~~~~~lv~e~ 98 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-------GDELWVVMEF 98 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-------CCEEEEEEec
Confidence 67999999999999864 689999999865444445679999999999999999999999876 4678999999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccc-c
Q 006145 562 VPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENA-E 640 (659)
Q Consensus 562 ~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~-~ 640 (659)
+++++|.+++.. ..+++.....++.|++.|++|||+. +++||||||+||++++++.++|+|||++...... .
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 99 LEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 999999998864 3589999999999999999999998 9999999999999999999999999998655332 2
Q ss_pred ccceecccccccCCCCC
Q 006145 641 KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 641 ~~~~~~gt~~y~aPE~~ 657 (659)
......+++.|+|||+.
T Consensus 172 ~~~~~~~~~~y~~pE~~ 188 (292)
T cd06657 172 RRKSLVGTPYWMAPELI 188 (292)
T ss_pred cccccccCccccCHHHh
Confidence 23445788999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=205.74 Aligned_cols=168 Identities=21% Similarity=0.447 Sum_probs=146.2
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
+|+..+.||+|++|.||++... +++.+++|++........+++.+|++.+++++|+||+++++++.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-------KDELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-------CCeEE
Confidence 3677789999999999999976 689999999976554455789999999999999999999998875 45689
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+++||+++++|.+++.... ..+++..+..++.++++|++|||+. +++||||+|+||++++++.++|+|||.+...
T Consensus 74 l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred EEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 9999999999999987532 4689999999999999999999998 9999999999999999999999999999776
Q ss_pred ccccccceecccccccCCCCC
Q 006145 637 ENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~~~~~~gt~~y~aPE~~ 657 (659)
..........++..|+|||+.
T Consensus 149 ~~~~~~~~~~~~~~~~~PE~~ 169 (253)
T cd05122 149 SDTKARNTMVGTPYWMAPEVI 169 (253)
T ss_pred cccccccceecCCcccCHHHH
Confidence 543324456788999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=211.79 Aligned_cols=170 Identities=19% Similarity=0.375 Sum_probs=145.8
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++.|+..+.||+|+||.||+|..+ ++..||+|.+..... ..+++.+|+++++.++|+||+++++++.. ..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~ 88 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-------GD 88 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-------CC
Confidence 4566778899999999999999976 589999999976543 45679999999999999999999999986 46
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++|+||+++++|.+++.... ..+++..+..++.+++.||+|||+. +|+|+||||+||+++.++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchh
Confidence 7899999999999999998632 3799999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccc-ccceecccccccCCCCC
Q 006145 634 LLAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
....... ......++..|+|||+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~ 188 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVI 188 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHh
Confidence 6543221 22344578899999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-23 Score=212.70 Aligned_cols=169 Identities=17% Similarity=0.322 Sum_probs=138.6
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|+..+.||+|++|.||+|+.. +|+.||+|.+..... ...+.+.+|++++++++|+||+++++++.. ..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~ 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-------EK 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-------CC
Confidence 46888899999999999999975 589999999865432 223568899999999999999999999975 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC-CcceEEccCcc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ-NLVAKISSYNL 632 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~DFGl 632 (659)
..++||||++ ++|.+++.... ...+++.....++.|++.||+|||+. +++||||||+||++++ ++.+||+|||+
T Consensus 75 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~ 149 (294)
T PLN00009 75 RLYLVFEYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGL 149 (294)
T ss_pred eEEEEEeccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccccc
Confidence 7899999996 58888876422 23467888889999999999999998 9999999999999985 56799999999
Q ss_pred ccccccc-cccceecccccccCCCCC
Q 006145 633 PLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
+...... .......+++.|+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~ 175 (294)
T PLN00009 150 ARAFGIPVRTFTHEVVTLWYRAPEIL 175 (294)
T ss_pred ccccCCCccccccCceeecccCHHHH
Confidence 9755322 222445678899999975
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-23 Score=210.87 Aligned_cols=160 Identities=19% Similarity=0.349 Sum_probs=136.9
Q ss_pred eccCcCceEEEEEecC-CcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEe
Q 006145 485 MGEGSQGQMYRGRLKN-GTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 485 ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
||+|+||.||+++... |+.||+|.+..... ...+.+.+|++++++++|+||+++++.+.. ....|+|||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-------~~~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-------KKNLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-------CcEEEEEEe
Confidence 6899999999999764 99999999975443 234578999999999999999999988765 467899999
Q ss_pred ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccccccc
Q 006145 561 YVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640 (659)
Q Consensus 561 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 640 (659)
|+++|+|.+++++. ..+++..+..++.|+++||+|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~ 147 (265)
T cd05579 74 YLPGGDLASLLENV---GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147 (265)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence 99999999999853 3689999999999999999999998 99999999999999999999999999986543321
Q ss_pred ---------ccceecccccccCCCCC
Q 006145 641 ---------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 641 ---------~~~~~~gt~~y~aPE~~ 657 (659)
......++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~ 173 (265)
T cd05579 148 QINLNDDEKEDKRIVGTPDYIAPEVI 173 (265)
T ss_pred ccccccccccccCcccCccccCHHHh
Confidence 22345688899999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-23 Score=213.75 Aligned_cols=176 Identities=16% Similarity=0.320 Sum_probs=141.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeecccc-CCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFD-DSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~~~ 551 (659)
.++|+..+.||+|+||.||+|+.. +++.||||.+...... ....+.+|++++++++||||++++++|...... ...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 356888899999999999999965 5999999998654322 234567899999999999999999998753221 112
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++||||+.+ +|.+++... ...+++.+...++.|+++||+|||+. +++||||||+||++++++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 3457999999965 888888642 23689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccc-----ccceecccccccCCCCC
Q 006145 632 LPLLAENAE-----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~-----~~~~~~gt~~y~aPE~~ 657 (659)
++....... ......++..|+|||+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 195 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELL 195 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHh
Confidence 996553221 12345678899999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=219.13 Aligned_cols=181 Identities=14% Similarity=0.225 Sum_probs=148.2
Q ss_pred ccCHHHHHHhhcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeee
Q 006145 466 TFSLEELEEATNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHC 542 (659)
Q Consensus 466 ~~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 542 (659)
+....++...+++|...+.||+|+||.||+|.. .+|+.||+|+++... ....+.+.+|++++++++||||+++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 345567778889999999999999999999985 469999999997532 22245688999999999999999999988
Q ss_pred eeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC
Q 006145 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN 622 (659)
Q Consensus 543 ~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~ 622 (659)
...... ......++++|++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++++
T Consensus 86 ~~~~~~-~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~ 156 (345)
T cd07877 86 TPARSL-EEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED 156 (345)
T ss_pred eecccc-cccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCC
Confidence 642211 1123468888887 7899988864 3589999999999999999999998 99999999999999999
Q ss_pred cceEEccCccccccccccccceecccccccCCCCC
Q 006145 623 LVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 623 ~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+.+||+|||+++.... ......++..|+|||+.
T Consensus 157 ~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~ 189 (345)
T cd07877 157 CELKILDFGLARHTDD--EMTGYVATRWYRAPEIM 189 (345)
T ss_pred CCEEEecccccccccc--cccccccCCCccCHHHH
Confidence 9999999999876533 23345788999999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=232.01 Aligned_cols=173 Identities=12% Similarity=0.147 Sum_probs=132.2
Q ss_pred hhcCCCCCceeccCcCceEEEEEecC--CcEEEEEEe--------------ccc---CCCchHHHHHHHHHHhCCCCCCc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKN--GTFVAIRCL--------------KMK---KCHSTRNFMHHIELISKLRHRHL 535 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~--g~~vavK~l--------------~~~---~~~~~~~~~~Ei~~l~~l~H~ni 535 (659)
..++|...+.||+|+||+||+|+.+. +..+++|.+ .+. .......+.+|+++|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35789999999999999999987542 323333211 100 11123468899999999999999
Q ss_pred cceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCC
Q 006145 536 VSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHA--HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLK 613 (659)
Q Consensus 536 v~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 613 (659)
|++++++.. .+..|+|+|++. ++|.+++..... ...........|+.|++.||+|||+. +|||||||
T Consensus 226 v~l~~~~~~-------~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLK 294 (501)
T PHA03210 226 LKIEEILRS-------EANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIK 294 (501)
T ss_pred CcEeEEEEE-------CCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 999999976 456899999995 588887754211 12233556778999999999999998 99999999
Q ss_pred CCceeecCCcceEEccCccccccccccc--cceecccccccCCCCCC
Q 006145 614 ITDILLDQNLVAKISSYNLPLLAENAEK--VGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 614 ~~NILld~~~~~kl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~~ 658 (659)
|+|||++.++.+||+|||+++....... ....+||..|+|||+..
T Consensus 295 P~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 341 (501)
T PHA03210 295 LENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA 341 (501)
T ss_pred HHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhc
Confidence 9999999999999999999976644322 23468999999999863
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-25 Score=223.93 Aligned_cols=251 Identities=29% Similarity=0.348 Sum_probs=200.8
Q ss_pred cccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccC-
Q 006145 98 SFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLG- 176 (659)
Q Consensus 98 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~- 176 (659)
..|+..-+++.|++||..+|-+ +.+|+.++.+.+|+.|+|.+|+|. .+| +|.+++.|++|+++.|++. .+|.+..
T Consensus 174 ~l~~~~i~m~~L~~ld~~~N~L-~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~ 249 (565)
T KOG0472|consen 174 ALPENHIAMKRLKHLDCNSNLL-ETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLK 249 (565)
T ss_pred hCCHHHHHHHHHHhcccchhhh-hcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhc
Confidence 3445555688899999988877 567888999999999999999997 677 7899999999999999987 6776655
Q ss_pred CCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCC----------------
Q 006145 177 SLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGP---------------- 240 (659)
Q Consensus 177 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~---------------- 240 (659)
++++|.+|||..|++. ..|+++..+++|++||+|+|.+++.+++++++ .|+.|.+.+|.+..
T Consensus 250 ~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKy 327 (565)
T KOG0472|consen 250 HLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKY 327 (565)
T ss_pred ccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHH
Confidence 8999999999999998 78999999999999999999999999999999 89999999987620
Q ss_pred --------------------------CCCCC--Cc--------------------------ccceEecCCCcC-------
Q 006145 241 --------------------------QFPKV--GK--------------------------KLVTMILSKNKF------- 259 (659)
Q Consensus 241 --------------------------~~~~~--~~--------------------------~L~~L~l~~N~l------- 259 (659)
.+|.. .. -....+++.|++
T Consensus 328 Lrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L 407 (565)
T KOG0472|consen 328 LRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRL 407 (565)
T ss_pred HHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhh
Confidence 01110 00 012233343333
Q ss_pred ----------------CccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCC--------------
Q 006145 260 ----------------RSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG-------------- 309 (659)
Q Consensus 260 ----------------~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~-------------- 309 (659)
.+.+|..+..+++|..|+|++|-+. .+|..++.+..|+.||++.|+|..
T Consensus 408 ~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtl 486 (565)
T KOG0472|consen 408 VELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETL 486 (565)
T ss_pred HHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHH
Confidence 2456777788899999999988887 689999999889999999988752
Q ss_pred --------cC-CcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCcccc
Q 006145 310 --------KL-FDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 310 --------~~-p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
.+ |+.+..+.+|..|||.+|.+. +||..++++.+++.+.+.+|.|.
T Consensus 487 las~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 487 LASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 22 333778889999999999998 89999999999999999999886
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=218.27 Aligned_cols=172 Identities=12% Similarity=0.229 Sum_probs=142.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|+..+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~ 80 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG---ADF 80 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC---CCC
Confidence 367888899999999999999965 599999999975432 23456888999999999999999999876422 123
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||+. |+|.+++... ..+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~ 153 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGM 153 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccc
Confidence 56899999995 6999998752 4589999999999999999999998 999999999999999999999999999
Q ss_pred cccccccc-----ccceecccccccCCCCC
Q 006145 633 PLLAENAE-----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~-----~~~~~~gt~~y~aPE~~ 657 (659)
++...... ......++..|+|||+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 183 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELL 183 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHh
Confidence 96553221 12345789999999974
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=213.52 Aligned_cols=163 Identities=17% Similarity=0.325 Sum_probs=137.8
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
|+..+.||+|+||.||+++.. ++..||+|.+...... ...++.+|++++++++|+|+++++++|.+ ...
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------~~~ 99 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-------EHT 99 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-------CCe
Confidence 556789999999999999965 5899999998754322 23468899999999999999999999976 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||++ |++.+++... ...++|.++..++.+++.||.|||+. +|+||||+|+||+++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~ 173 (317)
T cd06635 100 AWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSAS 173 (317)
T ss_pred EEEEEeCCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCcc
Confidence 899999997 5888877542 24689999999999999999999998 99999999999999999999999999987
Q ss_pred ccccccccceecccccccCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.... .....++..|+|||+.
T Consensus 174 ~~~~---~~~~~~~~~y~aPE~~ 193 (317)
T cd06635 174 IASP---ANSFVGTPYWMAPEVI 193 (317)
T ss_pred ccCC---cccccCCccccChhhh
Confidence 5533 2345688999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=207.41 Aligned_cols=175 Identities=14% Similarity=0.277 Sum_probs=136.8
Q ss_pred CCCCceeccCcCceEEEEEec----CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK----NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
|...+.||+|+||.||+|.+. +++.||||.+..... ...+++.+|++++++++||||+++++++...... ...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAK-GRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCC-Ccc
Confidence 455688999999999999853 368999999975432 2345789999999999999999999988652110 001
Q ss_pred ceeEEEEeccCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEG---HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISS 629 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 629 (659)
...++++||+++|+|.+++... .....+++....+++.|++.||+|||+. +|+||||||+||++++++.+|++|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence 2347899999999999887532 1123588999999999999999999998 999999999999999999999999
Q ss_pred Cccccccccccc---cceecccccccCCCCC
Q 006145 630 YNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
||+++....... .....+++.|++||+.
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 187 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESL 187 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHH
Confidence 999976532221 1223456789999974
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-24 Score=194.08 Aligned_cols=172 Identities=15% Similarity=0.269 Sum_probs=138.1
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccC-CCchHHHHHHHHHHhC-CCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKK-CHSTRNFMHHIELISK-LRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++......||+|+||.|-+-++ ++|+..|||+++..- .+.+++.++|+.+..+ ...|.+|.++|.+.. .
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-------e 117 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-------E 117 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-------c
Confidence 34444568899999999988874 469999999997653 2345678889987555 479999999998875 4
Q ss_pred ceeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
...++.||.|.- ||..+-++. ......++.-.-+||..|.+||.|||++ ..+||||+||+||||+.+|.+|+||||
T Consensus 118 gdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 118 GDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccc
Confidence 679999999965 777655421 1235688888899999999999999997 489999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++-...+....+-..|-..|||||.+
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri 220 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERI 220 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhc
Confidence 99766554444556789999999975
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-26 Score=227.79 Aligned_cols=262 Identities=29% Similarity=0.362 Sum_probs=234.8
Q ss_pred CEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCC
Q 006145 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSIL 154 (659)
Q Consensus 75 ~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 154 (659)
.++.+.+++|.+.. +.+.+.++..|..|++.+|+++. +|.+++.+..++.|+.++|+++ .+|+.++++
T Consensus 46 ~l~~lils~N~l~~----------l~~dl~nL~~l~vl~~~~n~l~~-lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~ 113 (565)
T KOG0472|consen 46 DLQKLILSHNDLEV----------LREDLKNLACLTVLNVHDNKLSQ-LPAAIGELEALKSLNVSHNKLS-ELPEQIGSL 113 (565)
T ss_pred chhhhhhccCchhh----------ccHhhhcccceeEEEeccchhhh-CCHHHHHHHHHHHhhcccchHh-hccHHHhhh
Confidence 35677788876542 33467889999999999999965 6778999999999999999998 899999999
Q ss_pred CCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcc
Q 006145 155 TSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLE 234 (659)
Q Consensus 155 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~ 234 (659)
.+|+.|+.++|.+. .+|+.++.+-.|+.|+..+|+++ ..|+.++++.+|..|++.+|++...+|+.-+++.|+.||..
T Consensus 114 ~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~ 191 (565)
T KOG0472|consen 114 ISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCN 191 (565)
T ss_pred hhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccc
Confidence 99999999999998 78889999999999999999999 78999999999999999999999999987679999999999
Q ss_pred cCCCCCCCCCC--CcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhc-CCCcccEEeccCCcCCCcC
Q 006145 235 NNALGPQFPKV--GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALL-SLPSITYLNIADNKLTGKL 311 (659)
Q Consensus 235 ~N~l~~~~~~~--~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~l~~N~l~~~~ 311 (659)
.|-++..+|.. +.+|..|+|.+|++.. +| +|.++..|++|+++.|+|. .+|.... .+++|.+|||.+|+++ ..
T Consensus 192 ~N~L~tlP~~lg~l~~L~~LyL~~Nki~~-lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~ 267 (565)
T KOG0472|consen 192 SNLLETLPPELGGLESLELLYLRRNKIRF-LP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EV 267 (565)
T ss_pred hhhhhcCChhhcchhhhHHHHhhhccccc-CC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cC
Confidence 99998887776 5899999999999975 56 8999999999999999998 6777666 8999999999999998 78
Q ss_pred CcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCcccc
Q 006145 312 FDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 312 p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
|+.+.-+.+|+.||+|+|.++ .+|..++++ .+..+-+.+|.+.
T Consensus 268 Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 268 PDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR 310 (565)
T ss_pred chHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH
Confidence 999988999999999999999 688889988 8899999999764
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=205.56 Aligned_cols=169 Identities=21% Similarity=0.353 Sum_probs=145.7
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++|+||+++++.+... ....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE-----EKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC-----CCCe
Confidence 4677899999999999999976 699999999875543 2356799999999999999999999998751 1257
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++|+||+++++|.+++... ..++|..+..++.++++||+|||+. +++|+||+|+||++++++.+||+|||.+.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~ 149 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAK 149 (260)
T ss_pred EEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEE
Confidence 89999999999999999853 3799999999999999999999998 99999999999999999999999999997
Q ss_pred ccccccc---cceecccccccCCCCC
Q 006145 635 LAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
....... .....++..|+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~ 175 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVI 175 (260)
T ss_pred ecccccccccccCCCCCccccCHhhh
Confidence 7655432 3456788999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=204.95 Aligned_cols=170 Identities=16% Similarity=0.352 Sum_probs=145.5
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||+|+||.||++... +++.||+|++..... ...+++.+|++++++++|+|++++++.+.. ...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-------~~~ 73 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-------KGK 73 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-------CCE
Confidence 4677889999999999999975 589999999976543 344678999999999999999999998875 467
Q ss_pred eEEEEeccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGH-AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
.++|+||+++++|.+++++.. ....+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 74 LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred EEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccce
Confidence 899999999999999997532 135799999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccc-ccceecccccccCCCCC
Q 006145 634 LLAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
....... ......+++.|+|||+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~ 175 (258)
T cd08215 151 KVLSSTVDLAKTVVGTPYYLSPELC 175 (258)
T ss_pred eecccCcceecceeeeecccChhHh
Confidence 7664433 33446788999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=217.14 Aligned_cols=173 Identities=16% Similarity=0.244 Sum_probs=142.2
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||+||+|+.. +++.||||.+.... .....++.+|+++++.++|+||+++++++..... ...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~--~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR--EAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccc--ccc
Confidence 356888899999999999999954 58999999987532 2234567899999999999999999998864221 112
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||+. ++|.+++.. ...+++.....++.|+++||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 45899999996 689988875 24689999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc-cccceecccccccCCCCC
Q 006145 633 PLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
++..... .......++..|+|||+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (337)
T cd07858 155 ARTTSEKGDFMTEYVVTRWYRAPELL 180 (337)
T ss_pred ccccCCCcccccccccccCccChHHH
Confidence 9765433 223445688999999974
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-24 Score=206.23 Aligned_cols=168 Identities=12% Similarity=0.183 Sum_probs=136.9
Q ss_pred CCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCceeEE
Q 006145 481 TSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 481 ~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
....||.|.||+|+|-.++ .|+..|||+++.... .++++++.|.++..+- +.||||+++|++.. ++..|+
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-------EGdcWi 140 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-------EGDCWI 140 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-------CCceee
Confidence 3478999999999999865 599999999986654 4557899999865554 68999999999986 567899
Q ss_pred EEeccCCCChhhhhcCC--CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 558 IFEYVPNGTLRSWISEG--HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
.||.|.- |+..+.... .....+++.-.-+|+.-+..||.||-+. ..|||||+||+|||+|..|.+|++|||++-.
T Consensus 141 CMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 141 CMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHh
Confidence 9999954 665443210 1124578888888999999999999986 4899999999999999999999999999976
Q ss_pred cccccccceecccccccCCCCCC
Q 006145 636 AENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 636 ~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
..+....+.-+|-..|||||.+.
T Consensus 218 Lv~SiAkT~daGCrpYmAPERi~ 240 (361)
T KOG1006|consen 218 LVDSIAKTVDAGCRPYMAPERID 240 (361)
T ss_pred HHHHHHhhhccCCccccChhccC
Confidence 66655567778999999999763
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=205.34 Aligned_cols=166 Identities=14% Similarity=0.194 Sum_probs=133.5
Q ss_pred HHHHhhcCCCCCcee--ccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeecc
Q 006145 471 ELEEATNNFDTSAFM--GEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFECY 546 (659)
Q Consensus 471 ~l~~~~~~~~~~~~i--g~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 546 (659)
+.....++|+..+.+ |+|+||.||+++.+ ++..+|+|.+........ |+.....+ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~-- 80 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT-- 80 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec--
Confidence 444445666666666 99999999999964 588999999875432211 22222222 79999999999976
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc-ce
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL-VA 625 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~-~~ 625 (659)
.+..++||||+++|+|.+++... ..++|.+...++.|+++||+|||+. +++||||||+||+++.++ .+
T Consensus 81 -----~~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~ 149 (267)
T PHA03390 81 -----LKGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRI 149 (267)
T ss_pred -----CCeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeE
Confidence 45789999999999999999753 3799999999999999999999998 999999999999999988 99
Q ss_pred EEccCccccccccccccceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+|+|||+++..... ....++..|+|||+.
T Consensus 150 ~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~ 178 (267)
T PHA03390 150 YLCDYGLCKIIGTP---SCYDGTLDYFSPEKI 178 (267)
T ss_pred EEecCccceecCCC---ccCCCCCcccChhhh
Confidence 99999998765432 234688999999986
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=214.70 Aligned_cols=170 Identities=15% Similarity=0.267 Sum_probs=139.0
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++|+||+++++++...... ...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG-DEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC-CCC
Confidence 368888999999999999999964 699999999865322 1235688999999999999999999998652211 112
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++|+||+.. +|.++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+|++|||+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 457999999975 7777653 2588999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++.... ......++..|+|||++
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~ 186 (342)
T cd07879 164 ARHADA--EMTGYVVTRWYRAPEVI 186 (342)
T ss_pred CcCCCC--CCCCceeeecccChhhh
Confidence 976533 22345778899999975
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=210.63 Aligned_cols=171 Identities=16% Similarity=0.315 Sum_probs=139.4
Q ss_pred hcCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCC-chHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCH-STRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|+..+.||+|+||.||+|+..+ ++.||||.++..... ...++.+|++++.+.. |+||++++++|.+ .
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-------~ 86 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-------D 86 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-------C
Confidence 3557778999999999999999875 999999999754322 3356778888777775 9999999999976 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||+++ ++.+++... ...+++..+..++.|+++||+|||+. ++|+||||+|+||++++++.+||+|||+
T Consensus 87 ~~~~~v~e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~ 161 (296)
T cd06618 87 SDVFICMELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGI 161 (296)
T ss_pred CeEEEEeeccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECcccc
Confidence 568999999854 777776542 23689999999999999999999973 2899999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+.............++..|+|||+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 187 (296)
T cd06618 162 SGRLVDSKAKTRSAGCAAYMAPERID 187 (296)
T ss_pred chhccCCCcccCCCCCccccCHhhcC
Confidence 97664443334456788999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=213.85 Aligned_cols=167 Identities=17% Similarity=0.277 Sum_probs=136.7
Q ss_pred cCCC-CCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc--------------hHHHHHHHHHHhCCCCCCccceee
Q 006145 477 NNFD-TSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS--------------TRNFMHHIELISKLRHRHLVSALG 540 (659)
Q Consensus 477 ~~~~-~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~Ei~~l~~l~H~niv~l~g 540 (659)
++|. ..+.||+|+||+||+|+.. +++.||||.++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3443 3477999999999999965 59999999986543211 125789999999999999999999
Q ss_pred eeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec
Q 006145 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD 620 (659)
Q Consensus 541 ~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld 620 (659)
++.. .+..++||||++ |+|.+++.. ...+++.....++.|+++||+|||+. +|+||||||+||+++
T Consensus 88 ~~~~-------~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~ 153 (335)
T PTZ00024 88 VYVE-------GDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFIN 153 (335)
T ss_pred EEec-------CCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEEC
Confidence 9875 456899999997 699999875 24588999999999999999999998 999999999999999
Q ss_pred CCcceEEccCcccccccc---------------ccccceecccccccCCCCC
Q 006145 621 QNLVAKISSYNLPLLAEN---------------AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 621 ~~~~~kl~DFGla~~~~~---------------~~~~~~~~gt~~y~aPE~~ 657 (659)
.++.+|++|||+++.... ........++..|+|||+.
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 205 (335)
T PTZ00024 154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELL 205 (335)
T ss_pred CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhc
Confidence 999999999999865531 1112334578899999975
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-23 Score=211.86 Aligned_cols=170 Identities=14% Similarity=0.227 Sum_probs=136.4
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|...+.||+|+||.||+++.. +|+.||+|.+..... ....++.+|+.++.++. |+||+++++++.. ...
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-------~~~ 77 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-------EGD 77 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-------CCc
Confidence 3445578999999999999965 589999999875432 23457899999999996 9999999998875 456
Q ss_pred eEEEEeccCCCChhhhh---cCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 555 IFLIFEYVPNGTLRSWI---SEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+++|||+.. ++.++. .. .....+++.....++.++++||+|||+. .+|+||||||+||++++++.+||+|||
T Consensus 78 ~~~~~e~~~~-~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg 153 (288)
T cd06616 78 CWICMELMDI-SLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFG 153 (288)
T ss_pred EEEEEecccC-CHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecc
Confidence 8999999864 555433 22 1225689999999999999999999974 289999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+++............|+..|+|||+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 180 (288)
T cd06616 154 ISGQLVDSIAKTRDAGCRPYMAPERID 180 (288)
T ss_pred hhHHhccCCccccccCccCccCHHHhc
Confidence 997654433334457899999999753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=215.62 Aligned_cols=172 Identities=14% Similarity=0.246 Sum_probs=141.1
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
..++|+..+.||+|+||.||+|... +|..||||++...... ..+.+.+|++++++++||||+++++++...... ..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL-DR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc-cc
Confidence 4677888999999999999999854 6999999998643221 234688999999999999999999988642110 01
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+|++|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 23468999999 7799988864 3589999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++...... .....+++.|+|||+.
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~aPE~~ 187 (343)
T cd07880 164 LARQTDSE--MTGYVVTRWYRAPEVI 187 (343)
T ss_pred cccccccC--ccccccCCcccCHHHH
Confidence 99765432 2345678999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.9e-23 Score=215.04 Aligned_cols=171 Identities=20% Similarity=0.266 Sum_probs=143.4
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++..... .....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP--EDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc--ccccc
Confidence 4777899999999999999975 48999999997543 2334679999999999999999999999876321 11246
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.|+||||++ ++|.+++++. ..+++..+..++.++++||+|||+. +|+||||||+||++++++.++|+|||++.
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred eEEEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 899999998 4899998752 3799999999999999999999998 99999999999999999999999999997
Q ss_pred cccccc----ccceecccccccCCCCC
Q 006145 635 LAENAE----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~----~~~~~~gt~~y~aPE~~ 657 (659)
...... ......++..|+|||+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~ 178 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELL 178 (330)
T ss_pred eecccccccccccccccccCcCCceee
Confidence 665432 23456788999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-23 Score=210.05 Aligned_cols=169 Identities=15% Similarity=0.254 Sum_probs=139.5
Q ss_pred CCCCceeccCcCceEEEEEe-cCCcEEEEEEecccC-CCc------hHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 479 FDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKK-CHS------TRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
|-...+||+|||+.||||.. ...+.||||+-.... ..+ .+...+|.++-+.++||.||++++|+.-
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl------ 538 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL------ 538 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee------
Confidence 44456799999999999984 448899999864322 111 1346789999999999999999999975
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC---CcceEE
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ---NLVAKI 627 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl 627 (659)
+.+..|-|+|||+|-||.-+|... +.+++.....|+.||+.||.||.+ ..|+|||-||||.|||+.+ -|++||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEe
Confidence 256789999999999999999753 468999999999999999999998 5889999999999999953 488999
Q ss_pred ccCccccccccccc--------cceecccccccCCCCC
Q 006145 628 SSYNLPLLAENAEK--------VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 628 ~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~~ 657 (659)
+||||++.++++.. .....||+||++||-.
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcF 652 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECF 652 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCccee
Confidence 99999998865432 2457899999999953
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=207.50 Aligned_cols=172 Identities=23% Similarity=0.357 Sum_probs=139.1
Q ss_pred CCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCC--chHHHHHHHHHHhCC---CCCCccceeeeeeeccccCCCC
Q 006145 479 FDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCH--STRNFMHHIELISKL---RHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~~~~ 552 (659)
|+..+.||+|+||.||+|+.+. ++.||+|+++..... ....+.+|++++.++ +|+||+++++++.....+ ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~--~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD--RE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC--CC
Confidence 5567899999999999999764 899999999754322 234577788776655 699999999999863211 12
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...+++|||+.+ +|.+++.... ...++|..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||+
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCc
Confidence 348999999974 8999887532 23689999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+.............++..|+|||+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~PE~~ 178 (287)
T cd07838 154 ARIYSFEMALTSVVVTLWYRAPEVL 178 (287)
T ss_pred ceeccCCcccccccccccccChHHh
Confidence 9777554444555688899999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=204.67 Aligned_cols=159 Identities=18% Similarity=0.255 Sum_probs=131.1
Q ss_pred ceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHH-hCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELI-SKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||.||+|... +|+.||||.++..... ....+..|..++ ...+|+||+++++++.. .+..++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-------~~~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-------KDYLYL 74 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-------CCeEEE
Confidence 56899999999999865 5899999998654321 123455565544 45589999999999875 457899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
|+||+++|+|.++++.. ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++...
T Consensus 75 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 75 VMEYLNGGDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred EEeccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 99999999999999752 4588999999999999999999998 99999999999999999999999999987543
Q ss_pred cccccceecccccccCCCCC
Q 006145 638 NAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 ~~~~~~~~~gt~~y~aPE~~ 657 (659)
. .....++..|+|||+.
T Consensus 149 ~---~~~~~~~~~y~~pe~~ 165 (260)
T cd05611 149 E---NKKFVGTPDYLAPETI 165 (260)
T ss_pred c---cccCCCCcCccChhhh
Confidence 2 2345688999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-24 Score=206.30 Aligned_cols=171 Identities=18% Similarity=0.282 Sum_probs=140.1
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEeccc--CCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMK--KCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.+..+.||.|+||.||....+ +|+.||.|++..- .....+.+.+|+++|..++|.|++..++...-...+. -.++
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~df--FqEi 132 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSF--FQEL 132 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchH--HHHH
Confidence 345689999999999999854 6999999998542 2234578999999999999999999988765321110 1357
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
|+|+|.|.. ||..++-. .+.++.....-+..||++||.|||+. +|.||||||.|.|++.+...||+|||+|+.
T Consensus 133 YV~TELmQS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHHh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 899999965 88888764 35688778888899999999999998 999999999999999999999999999987
Q ss_pred ccccc--ccceecccccccCCCCCC
Q 006145 636 AENAE--KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 636 ~~~~~--~~~~~~gt~~y~aPE~~~ 658 (659)
-+.+. ..+..+.|.+|+|||.+|
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLM 230 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLM 230 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhh
Confidence 65443 346788999999999876
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=209.34 Aligned_cols=167 Identities=19% Similarity=0.278 Sum_probs=138.6
Q ss_pred CCCCCceeccCcCceEEEEEec----CCcEEEEEEecccCC----CchHHHHHHHHHHhCC-CCCCccceeeeeeecccc
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK----NGTFVAIRCLKMKKC----HSTRNFMHHIELISKL-RHRHLVSALGHCFECYFD 548 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~l~~~~~----~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 548 (659)
+|+..+.||+|+||.||+++.. ++..||||.++.... ...+.+.+|++++.++ +|+||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence 3667789999999999999843 478899999874321 2235688999999999 59999999988764
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
....++||||+++|+|.+++... ..+++.....++.|+++||+|||+. +++||||||+||++++++.++++
T Consensus 77 ---~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~ 147 (288)
T cd05583 77 ---DTKLHLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLT 147 (288)
T ss_pred ---CCEEEEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEE
Confidence 45689999999999999998752 4688999999999999999999998 99999999999999999999999
Q ss_pred cCcccccccccc--ccceecccccccCCCCC
Q 006145 629 SYNLPLLAENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
|||+++...... ......|+..|+|||+.
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 178 (288)
T cd05583 148 DFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178 (288)
T ss_pred ECccccccccccccccccccCCccccCHHHh
Confidence 999986543222 12335688999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=205.38 Aligned_cols=169 Identities=20% Similarity=0.344 Sum_probs=143.6
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|+..+.||+|+||.||+++.. +++.+|+|.+..... ....++.+|++++++++|+||+++++++.+ ...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~~ 73 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-------GNK 73 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-------CCE
Confidence 4677899999999999999854 688999999875432 234568899999999999999999998875 467
Q ss_pred eEEEEeccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGH-AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
.++||||+++++|.+++.+.. ....+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+|++|||++
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred EEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccch
Confidence 899999999999999987521 234689999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccccceecccccccCCCCC
Q 006145 634 LLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+..... ......+++.|+|||+.
T Consensus 151 ~~~~~~-~~~~~~~~~~~~~Pe~~ 173 (256)
T cd08530 151 KVLKKN-MAKTQIGTPHYMAPEVW 173 (256)
T ss_pred hhhccC-CcccccCCccccCHHHH
Confidence 776544 33345688899999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=212.20 Aligned_cols=170 Identities=19% Similarity=0.302 Sum_probs=142.0
Q ss_pred HHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 472 LEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 472 l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
+...+++|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++.+++...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 81 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP--- 81 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC---
Confidence 3456788999999999999999999855 699999999864322 2346788999999999999999999988641
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
....++|+||+ +++|.++++. ..+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+
T Consensus 82 ---~~~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~ 150 (328)
T cd07856 82 ---LEDIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKIC 150 (328)
T ss_pred ---CCcEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeC
Confidence 34579999999 5699988864 3578888899999999999999998 99999999999999999999999
Q ss_pred cCccccccccccccceecccccccCCCCC
Q 006145 629 SYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|||++..... ......++..|+|||+.
T Consensus 151 dfg~~~~~~~--~~~~~~~~~~y~aPE~~ 177 (328)
T cd07856 151 DFGLARIQDP--QMTGYVSTRYYRAPEIM 177 (328)
T ss_pred ccccccccCC--CcCCCcccccccCceee
Confidence 9999875532 22345678899999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-23 Score=212.58 Aligned_cols=168 Identities=16% Similarity=0.218 Sum_probs=143.7
Q ss_pred cCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCC--------chHHHHHHHHHHhCCC---CCCccceeeeeee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCH--------STRNFMHHIELISKLR---HRHLVSALGHCFE 544 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~ 544 (659)
.+|...+.+|+|+||.|+.|.++. ..+|+||.+.+.+.- .....-.||.+|+.++ |+||+++++++.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 457888999999999999999875 678999999765421 1123567999999997 9999999999986
Q ss_pred ccccCCCCceeEEEEecc-CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc
Q 006145 545 CYFDDSSVSRIFLIFEYV-PNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL 623 (659)
Q Consensus 545 ~~~~~~~~~~~~lV~Ey~-~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~ 623 (659)
.+.+||+||-. ++-||++++.. +..+++.....|.+||+.|+++||+. +|||||||-+||.+|.+|
T Consensus 641 -------dd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g 707 (772)
T KOG1152|consen 641 -------DDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNG 707 (772)
T ss_pred -------CCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCC
Confidence 56789999975 56799999986 35699999999999999999999999 999999999999999999
Q ss_pred ceEEccCccccccccccccceecccccccCCCCCC
Q 006145 624 VAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 624 ~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
-+|+.|||.|....++ .....+||..|.|||.+.
T Consensus 708 ~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~ 741 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLG 741 (772)
T ss_pred eEEEeeccchhhhcCC-CcceeeeeccccchhhhC
Confidence 9999999999766554 345689999999999874
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=208.13 Aligned_cols=168 Identities=20% Similarity=0.363 Sum_probs=142.5
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~ 551 (659)
++|...+.||+|+||.||+|+.. +|+.||+|.+..... ...+.+.+|++++++++ |+||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~------- 73 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD------- 73 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-------
Confidence 36778899999999999999965 699999999875332 22356889999999998 9999999998865
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 74 EENLYFVLEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred CceEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCc
Confidence 45789999999999999999853 3699999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccc---------------------ccceecccccccCCCCC
Q 006145 632 LPLLAENAE---------------------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~---------------------~~~~~~gt~~y~aPE~~ 657 (659)
++....... ......++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~ 194 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL 194 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHh
Confidence 986543211 12345678899999975
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-23 Score=216.36 Aligned_cols=144 Identities=15% Similarity=0.271 Sum_probs=123.9
Q ss_pred CCCCCceeccCcCceEEEEE-ecCCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 478 NFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
-|...+.||-|+||+|..++ .++...+|+|.+++.+. ......+.|-.||+..+.+=||+|+--|.+ .+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD-------kd 702 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD-------KD 702 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc-------CC
Confidence 47777899999999999987 45578899999976542 223457889999999999999999866665 67
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
.+|+||||++|||+-.+|-+ ...+.+.....++..++.|+++.|.. ++|||||||+|||||.||.+|++||||+
T Consensus 703 nLYFVMdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred ceEEEEeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccc
Confidence 89999999999999999875 24577777778888999999999999 9999999999999999999999999998
Q ss_pred c
Q 006145 634 L 634 (659)
Q Consensus 634 ~ 634 (659)
.
T Consensus 777 T 777 (1034)
T KOG0608|consen 777 T 777 (1034)
T ss_pred c
Confidence 3
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=211.36 Aligned_cols=164 Identities=17% Similarity=0.296 Sum_probs=132.2
Q ss_pred ceeccC--cCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEG--SQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G--~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
..||+| +||+||+++.. +|+.||||.+...... ..+.+.+|+.+++.++||||+++++++.. .+..++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-------~~~~~~ 76 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-------GSWLWV 76 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-------CCceEE
Confidence 456666 89999999964 6999999998754322 23568899999999999999999999976 456899
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
|+||+++|++.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++||+.+....
T Consensus 77 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 77 ISPFMAYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLV 152 (328)
T ss_pred EEecccCCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence 999999999999987532 23589999999999999999999998 99999999999999999999999998653221
Q ss_pred c-ccc-------cceecccccccCCCCC
Q 006145 638 N-AEK-------VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 ~-~~~-------~~~~~gt~~y~aPE~~ 657 (659)
. ... .....++..|||||+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELL 180 (328)
T ss_pred ccCccccccccccccccCccCccChhhh
Confidence 1 110 0112356679999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=211.18 Aligned_cols=170 Identities=16% Similarity=0.222 Sum_probs=137.4
Q ss_pred CCCCCceeccCcCceEEEEEec-C--CcEEEEEEecccCC--CchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-N--GTFVAIRCLKMKKC--HSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~--g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~ 551 (659)
+|...+.||+|+||.||+++.. + +..||+|++..... ...+.+.+|+++++++ +||||+++++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~---~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP---GN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc---cc
Confidence 3667789999999999999965 3 77999999864321 2245688999999999 5999999999765321 11
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++++||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 78 ~~~~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg 150 (332)
T cd07857 78 FNELYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFG 150 (332)
T ss_pred CCcEEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCC
Confidence 345789999986 699999875 24689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccc-----ccceecccccccCCCCC
Q 006145 632 LPLLAENAE-----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~-----~~~~~~gt~~y~aPE~~ 657 (659)
+++...... ......|+..|+|||+.
T Consensus 151 ~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 181 (332)
T cd07857 151 LARGFSENPGENAGFMTEYVATRWYRAPEIM 181 (332)
T ss_pred CceecccccccccccccCcccCccccCcHHH
Confidence 997553211 12345789999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=207.24 Aligned_cols=163 Identities=16% Similarity=0.301 Sum_probs=137.1
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
|...+.||+|+||+||+|+.. +|+.||+|++...... ..+++.+|++++++++|||++++++++.+ ...
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~~ 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-------EHT 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-------CCE
Confidence 445678999999999999965 5899999998754322 22468899999999999999999999986 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.|+||||+. |++.+++... ...++|..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||++.
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred EEEEEecCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCc
Confidence 899999996 5888877642 24689999999999999999999998 99999999999999999999999999986
Q ss_pred ccccccccceecccccccCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.... .....|+..|+|||+.
T Consensus 170 ~~~~---~~~~~~~~~y~aPE~~ 189 (313)
T cd06633 170 KSSP---ANSFVGTPYWMAPEVI 189 (313)
T ss_pred ccCC---CCCccccccccChhhc
Confidence 4322 2345788999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-22 Score=210.25 Aligned_cols=163 Identities=11% Similarity=0.150 Sum_probs=130.7
Q ss_pred ceeccCcCceEEEEEecCCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEe
Q 006145 483 AFMGEGSQGQMYRGRLKNGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
+.+|.|+++.||+++. +++.||||++.... ....+.+.+|+++++.++|+||+++++++.+ .+..+++||
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-------~~~~~~~~e 79 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-------DSELYVVSP 79 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-------CCeEEEEEe
Confidence 3344555555555544 69999999997542 2334679999999999999999999998875 456899999
Q ss_pred ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccccccc
Q 006145 561 YVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640 (659)
Q Consensus 561 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~ 640 (659)
|+++|+|.++++... ...+++.....++.|+++||+|||+. +|+||||||+||++++++.+|++|||.+.......
T Consensus 80 ~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 80 LMAYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred ccCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence 999999999998532 24588899999999999999999998 99999999999999999999999999885442211
Q ss_pred --------ccceecccccccCCCCC
Q 006145 641 --------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 641 --------~~~~~~gt~~y~aPE~~ 657 (659)
......++..|+|||+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVL 180 (314)
T ss_pred ccccccccccccccccccccCHHHh
Confidence 12334677889999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-22 Score=206.04 Aligned_cols=166 Identities=20% Similarity=0.366 Sum_probs=140.5
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+ .+..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------~~~~ 73 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-------ERKL 73 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-------CCce
Confidence 455688999999999999976 49999999997653 2234678899999999999999999999875 4578
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||++ ++|.+++.... ..+++..+..++.++++||+|||+. +|+||||+|+||++++++.+||+|||+++.
T Consensus 74 ~~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 74 YLVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred EEEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccc
Confidence 99999998 59999998532 4689999999999999999999998 999999999999999999999999999976
Q ss_pred ccccc-ccceecccccccCCCCC
Q 006145 636 AENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
..... ......++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~ 170 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEIL 170 (282)
T ss_pred cCCCccccCccccCcCcCChHHh
Confidence 54322 23445667889999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-22 Score=208.36 Aligned_cols=176 Identities=19% Similarity=0.345 Sum_probs=140.9
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeecccc-CCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFD-DSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~~~ 551 (659)
.++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++|+||+++++++.+.... ...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888999999999999999965 5899999998654322 234678999999999999999999987652211 012
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++|+||+.+ ++.+.+... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 3457999999975 787777642 34699999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccc------------ccceecccccccCCCCC
Q 006145 632 LPLLAENAE------------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~------------~~~~~~gt~~y~aPE~~ 657 (659)
+++...... ......+++.|+|||+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELL 198 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHh
Confidence 996543221 11334678899999964
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.3e-23 Score=216.19 Aligned_cols=164 Identities=23% Similarity=0.383 Sum_probs=138.8
Q ss_pred CceeccCcCceEEEEEecC--Cc--EEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 482 SAFMGEGSQGQMYRGRLKN--GT--FVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~~--g~--~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
.++||+|.||.|++|.|.. |+ .||||+++..... ...+|++|+.+|-+++|+|+|+|+|+..+ ....
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--------qp~m 186 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--------QPAM 186 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--------chhh
Confidence 4889999999999999763 44 6899999876544 45789999999999999999999999974 4578
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
||||.++.|+|.+.|+. .....+-......++.|||.||.||.++ ++|||||.++|+|+-....+||+||||.+-.
T Consensus 187 MV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred HHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceecc
Confidence 99999999999999997 3345677888899999999999999999 9999999999999999999999999999766
Q ss_pred cccccc----ceecccccccCCCCC
Q 006145 637 ENAEKV----GHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~~----~~~~gt~~y~aPE~~ 657 (659)
...+.. ...-....|-|||-+
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsL 287 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESL 287 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHh
Confidence 433322 233445578999965
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-22 Score=200.36 Aligned_cols=160 Identities=23% Similarity=0.360 Sum_probs=138.0
Q ss_pred eccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEe
Q 006145 485 MGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 485 ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
||+|+||.||++... +++.+|+|.+...... ....+.+|++++++++|+||+++++.+.. ....++|||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-------EEKLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-------CCeeEEEEe
Confidence 689999999999976 4899999998765432 34578999999999999999999988865 567899999
Q ss_pred ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccc-
Q 006145 561 YVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENA- 639 (659)
Q Consensus 561 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~- 639 (659)
|+++++|.+++... ..+++.....++.|+++|+.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 74 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~ 147 (250)
T cd05123 74 YAPGGELFSHLSKE---GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG 147 (250)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence 99999999999753 3689999999999999999999997 9999999999999999999999999999765433
Q ss_pred cccceecccccccCCCCC
Q 006145 640 EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 640 ~~~~~~~gt~~y~aPE~~ 657 (659)
.......++..|+|||+.
T Consensus 148 ~~~~~~~~~~~~~~Pe~~ 165 (250)
T cd05123 148 SRTNTFCGTPEYLAPEVL 165 (250)
T ss_pred CcccCCcCCccccChHHh
Confidence 234556788999999975
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-22 Score=205.34 Aligned_cols=166 Identities=22% Similarity=0.376 Sum_probs=141.0
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
|+..+.||+|++|.||+|+.. +|+.+|+|.++..... ....+.+|++++++++|+||+++++++.. .+..
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------~~~~ 73 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-------KGDL 73 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-------CCCE
Confidence 456688999999999999965 5899999998754432 34678899999999999999999999875 4678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++|+||+++ ++.+++... ...+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||.+..
T Consensus 74 ~~v~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 74 YLVFEFMDT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred EEEEeccCC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 999999975 898888753 24789999999999999999999998 999999999999999999999999999976
Q ss_pred ccccc-ccceecccccccCCCCC
Q 006145 636 AENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
..... ......++..|+|||..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~ 170 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELL 170 (283)
T ss_pred cCCCcccccCccCcccccCcHHH
Confidence 64433 33446688899999974
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-22 Score=207.79 Aligned_cols=163 Identities=20% Similarity=0.341 Sum_probs=136.9
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
|+..+.||+|+||.||+|+.. ++..||+|.+..... ...+++.+|+++++.++|+|++++++++.. ...
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~ 89 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-------EHT 89 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-------CCe
Confidence 556688999999999999965 588999999864322 223568899999999999999999999976 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+. |++.+++... ...+++..+..++.|++.|+.|||+. +++||||||+||++++++.+||+|||++.
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 163 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (308)
T ss_pred eEEEEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccce
Confidence 899999996 6888877542 24588999999999999999999998 99999999999999999999999999987
Q ss_pred ccccccccceecccccccCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
..... ....++..|+|||+.
T Consensus 164 ~~~~~---~~~~~~~~y~aPE~~ 183 (308)
T cd06634 164 IMAPA---NXFVGTPYWMAPEVI 183 (308)
T ss_pred eecCc---ccccCCccccCHHHH
Confidence 65432 345688999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-22 Score=211.75 Aligned_cols=173 Identities=16% Similarity=0.286 Sum_probs=139.8
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccC------
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDD------ 549 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~------ 549 (659)
.+|...+.||.|+||.||+|+.. +|+.||+|.+........+.+.+|++++++++||||+++++++.......
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 56888899999999999999965 58999999997665555677999999999999999999998776421100
Q ss_pred -CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec-CCcceEE
Q 006145 550 -SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD-QNLVAKI 627 (659)
Q Consensus 550 -~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld-~~~~~kl 627 (659)
......++||||++ ++|.+++.. ..+++.....++.|+++||+|||+. +|+||||||+||+++ +++.+|+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 01235789999997 599988864 3588999999999999999999998 999999999999998 4568999
Q ss_pred ccCcccccccccc----ccceecccccccCCCCC
Q 006145 628 SSYNLPLLAENAE----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 628 ~DFGla~~~~~~~----~~~~~~gt~~y~aPE~~ 657 (659)
+|||+++...... ......++..|+|||+.
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 190 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL 190 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHH
Confidence 9999997653221 11234678899999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-23 Score=218.38 Aligned_cols=171 Identities=19% Similarity=0.372 Sum_probs=149.2
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
..++|.....+|.|.||.|||++.. +++..|||.++.....+..-...|+-+++..+|+|||.++|-|.. .+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-------~d 85 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-------RD 85 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-------hc
Confidence 4567888899999999999999954 699999999998766666667789999999999999999998875 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++.||||.+|+|++.-+- -.++++.+...+++...+|++|||+. +-+|||||-.||++.+.+.+|++|||.+
T Consensus 86 klwicMEycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred CcEEEEEecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCch
Confidence 78999999999999998774 35789999999999999999999998 8899999999999999999999999998
Q ss_pred cccccc-cccceecccccccCCCCCC
Q 006145 634 LLAENA-EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 634 ~~~~~~-~~~~~~~gt~~y~aPE~~~ 658 (659)
..+... .....++||++|||||+.+
T Consensus 160 aqitati~KrksfiGtpywmapEvaa 185 (829)
T KOG0576|consen 160 AQITATIAKRKSFIGTPYWMAPEVAA 185 (829)
T ss_pred hhhhhhhhhhhcccCCccccchhHHH
Confidence 666432 2346789999999999753
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-22 Score=208.77 Aligned_cols=168 Identities=11% Similarity=0.222 Sum_probs=140.6
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCC--CchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKC--HSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~~ 553 (659)
..|+..+.||+||.+.||++...+.+.+|+|++..... +....|..|++.|.+++ |.+||+|++|-.. .+
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-------d~ 433 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-------DG 433 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-------Cc
Confidence 44677799999999999999988888899998864433 33467999999999996 9999999999876 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
.+||||||-+- ||.++|+... ....+| .++.+..|++.|+.++|.+ +|||.||||.|+|+- .|.+||.|||+|
T Consensus 434 ~lYmvmE~Gd~-DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA 506 (677)
T KOG0596|consen 434 YLYMVMECGDI-DLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIA 506 (677)
T ss_pred eEEEEeecccc-cHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechh
Confidence 79999999865 9999998632 233446 6788999999999999999 999999999999986 688999999999
Q ss_pred ccccccccc---ceecccccccCCCCCC
Q 006145 634 LLAENAEKV---GHVIPYSGSIDPTNSA 658 (659)
Q Consensus 634 ~~~~~~~~~---~~~~gt~~y~aPE~~~ 658 (659)
..+..+... ...+||+.||+||-++
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~ 534 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALT 534 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHh
Confidence 877654432 5689999999999653
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.8e-23 Score=190.63 Aligned_cols=166 Identities=17% Similarity=0.274 Sum_probs=144.2
Q ss_pred hcCCCCCceeccCcCceEEEEE-ecCCcEEEEEEecccCCCchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|+..+++|+|.|++||.|. ..+.+.++||.++... .+.+.+|+++|..++ ||||++|++...+.. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~-----Sk 108 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPE-----SK 108 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCcc-----cc
Confidence 4567778999999999999998 5568889999997543 467899999999997 999999999987632 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC-CcceEEccCcc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ-NLVAKISSYNL 632 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~DFGl 632 (659)
...||+||+.+-+...+.. .++-.+...++.++++||.|+|+. +|+|||+||.||+||. .-..++.|+|+
T Consensus 109 tpaLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred CchhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecch
Confidence 5789999999988887654 477888899999999999999999 9999999999999995 46799999999
Q ss_pred ccccccccccceecccccccCCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|.++.+.....-.+.+..|..||-++
T Consensus 180 AEFYHp~~eYnVRVASRyfKGPELLV 205 (338)
T KOG0668|consen 180 AEFYHPGKEYNVRVASRYFKGPELLV 205 (338)
T ss_pred HhhcCCCceeeeeeehhhcCCchhee
Confidence 99998888888888888999999765
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=193.71 Aligned_cols=164 Identities=14% Similarity=0.291 Sum_probs=133.9
Q ss_pred CceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCCceeEEE
Q 006145 482 SAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSVSRIFLI 558 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~~~lV 558 (659)
...||.|..|.|++++.+ +|..+|||.+..... +..++++..+.++.+.+ .|.||+.+||+.. ...+++.
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-------n~dV~Ic 169 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-------NTDVFIC 169 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-------CchHHHH
Confidence 367899999999999976 499999999976543 33466888888877765 8999999999986 3457889
Q ss_pred EeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccccc
Q 006145 559 FEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAEN 638 (659)
Q Consensus 559 ~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 638 (659)
||.|.. -...++.+- ..++++.-.-++...+.+||.||.++ ++|||||+||+|||+|+.|++|++|||++-..-+
T Consensus 170 MelMs~-C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 170 MELMST-CAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHH-HHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeec
Confidence 999854 555566542 34677777788999999999999987 4999999999999999999999999999965544
Q ss_pred ccccceecccccccCCCCC
Q 006145 639 AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 639 ~~~~~~~~gt~~y~aPE~~ 657 (659)
....+..+|-+.|||||.+
T Consensus 245 SkAhtrsAGC~~YMaPERi 263 (391)
T KOG0983|consen 245 SKAHTRSAGCAAYMAPERI 263 (391)
T ss_pred ccccccccCCccccCcccc
Confidence 4455667899999999975
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=217.24 Aligned_cols=220 Identities=28% Similarity=0.309 Sum_probs=156.7
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
++|++|+|++|+|+. +|.. .++|+.|+|++|.++ .+|.. .++|+.|+|++|+++ .+|.. +++|+.|+|
T Consensus 242 ~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdL 309 (788)
T PRK15387 242 PELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLT-HLPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSV 309 (788)
T ss_pred CCCcEEEecCCccCc-ccCc---ccccceeeccCCchh-hhhhc---hhhcCEEECcCCccc-ccccc---ccccceeEC
Confidence 566666666666654 3321 346666666666665 34432 245667777777776 34542 356777778
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchh
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAE 266 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~ 266 (659)
++|+|++ +|... .+|+.|++++|++++ +|.+ ..+|+.|+|++|+|++ +|....+|..|++++|+|++ +|..
T Consensus 310 S~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l--p~~Lq~LdLS~N~Ls~-LP~lp~~L~~L~Ls~N~L~~-LP~l 380 (788)
T PRK15387 310 SDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL--PSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTS-LPAL 380 (788)
T ss_pred CCCcccc-CCCCc---ccccccccccCcccc-cccc--ccccceEecCCCccCC-CCCCCcccceehhhcccccc-Cccc
Confidence 7777774 44422 346677777777765 3332 2478899999999885 45556788889999999875 6653
Q ss_pred ccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCC
Q 006145 267 VSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNR 346 (659)
Q Consensus 267 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~ 346 (659)
..+|+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|.. ..+|+.|++++|+|+ .+|..+..+.++.
T Consensus 381 ---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~ 448 (788)
T PRK15387 381 ---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSET 448 (788)
T ss_pred ---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCC
Confidence 3578999999999985 5643 3679999999999985 5653 346888999999998 7999999999999
Q ss_pred EEEcCCccccCCC
Q 006145 347 VVLYARNCLAAGN 359 (659)
Q Consensus 347 ~l~~~~N~l~~~~ 359 (659)
.+++++|+|++..
T Consensus 449 ~LdLs~N~Ls~~~ 461 (788)
T PRK15387 449 TVNLEGNPLSERT 461 (788)
T ss_pred eEECCCCCCCchH
Confidence 9999999998653
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.8e-22 Score=200.30 Aligned_cols=169 Identities=21% Similarity=0.253 Sum_probs=135.0
Q ss_pred CCCCCceeccCcCceEEEEEecC-CcEEEEEEecccC-----CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKK-----CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
+|...+.||+|+||.||+++... +..+++|.++... .....++.+|+.++++++||||+++++++.+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 73 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE------- 73 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-------
Confidence 46778999999999999998653 4556666654321 1223457789999999999999999998875
Q ss_pred CceeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
....++||||+++++|.++++.. .....+++..+..++.|+++|++|||+. +++|+||||+||++++ +.+||+||
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~ 149 (260)
T cd08222 74 RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDF 149 (260)
T ss_pred CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeeccc
Confidence 45689999999999999988642 1235699999999999999999999998 9999999999999975 56999999
Q ss_pred cccccccccc-ccceecccccccCCCCC
Q 006145 631 NLPLLAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
|+++...... ......+++.|+|||+.
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~~pe~~ 177 (260)
T cd08222 150 GVSRLLMGSCDLATTFTGTPYYMSPEAL 177 (260)
T ss_pred CceeecCCCcccccCCCCCcCccCHHHH
Confidence 9987653322 22345688899999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-22 Score=221.95 Aligned_cols=175 Identities=12% Similarity=0.112 Sum_probs=121.5
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-C----CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-N----GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 549 (659)
..++|...+.||+|+||.||+|++. + +..||||++.... ..+.+..| .+....+.+++.++..+..... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~-~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVS-S 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccc-c
Confidence 4678899999999999999999965 4 6899999986432 11222222 2222233333333322211000 0
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCC-----------------CCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCC
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAH-----------------QSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNL 612 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl 612 (659)
......++||||+++|+|.++++..... ....+.....++.|+++||+|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 1245789999999999999998742110 0111233567999999999999998 9999999
Q ss_pred CCCceeecC-CcceEEccCccccccccc--cccceecccccccCCCCC
Q 006145 613 KITDILLDQ-NLVAKISSYNLPLLAENA--EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 613 k~~NILld~-~~~~kl~DFGla~~~~~~--~~~~~~~gt~~y~aPE~~ 657 (659)
||+|||+++ ++.+||+|||+|+..... ......++++.|||||+.
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~ 329 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY 329 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHh
Confidence 999999996 589999999999765332 223557899999999964
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-23 Score=211.75 Aligned_cols=167 Identities=16% Similarity=0.226 Sum_probs=146.2
Q ss_pred CCCCCceeccCcCceEEEEEecCCc-EEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKNGT-FVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~g~-~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
+++....||-|+||.|-.++..... .+|+|++++.... ..+....|-++|...+.|.||+++--|.+ .+
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-------~k 493 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-------SK 493 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-------ch
Confidence 3444578999999999998876433 4899999766532 33457889999999999999999987765 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
.+|+.||-|-||.|...|++ +..++.....-++..+.+|++|||++ +||.|||||+|.++|.+|.+|+.|||+|
T Consensus 494 yvYmLmEaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFA 567 (732)
T ss_pred hhhhhHHhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhH
Confidence 79999999999999999986 35688888899999999999999999 9999999999999999999999999999
Q ss_pred cccccccccceecccccccCCCCC
Q 006145 634 LLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+.......+-+.|||+.|.|||.+
T Consensus 568 Kki~~g~KTwTFcGTpEYVAPEII 591 (732)
T KOG0614|consen 568 KKIGSGRKTWTFCGTPEYVAPEII 591 (732)
T ss_pred HHhccCCceeeecCCcccccchhh
Confidence 999998888899999999999986
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.9e-22 Score=209.04 Aligned_cols=172 Identities=15% Similarity=0.262 Sum_probs=141.2
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++|+||+++++++...... ..
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL-ED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc-cc
Confidence 3567888899999999999999975 58899999986532 22335678899999999999999999877642110 11
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 23489999999 6699999874 3689999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++...... .....++..|+|||..
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~aPE~~ 187 (343)
T cd07851 164 LARHTDDE--MTGYVATRWYRAPEIM 187 (343)
T ss_pred cccccccc--ccCCcccccccCHHHH
Confidence 99765432 3445788899999964
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=194.74 Aligned_cols=150 Identities=15% Similarity=0.110 Sum_probs=125.6
Q ss_pred CcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEeccCCCC
Q 006145 488 GSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT 566 (659)
Q Consensus 488 G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~Gs 566 (659)
|.||.||+++.. +++.||+|++.... .+.+|...+....||||+++++++.+ .+..++||||+++|+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~-------~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVS-------EDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheec-------CCeEEEEEecCCCCC
Confidence 889999999965 58999999996542 33455566666679999999998875 467899999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccccccceec
Q 006145 567 LRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVI 646 (659)
Q Consensus 567 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 646 (659)
|.+++.+. ..+++.....++.|+++||+|||+. +|+||||||+||++++++.++++|||.+...... .....
T Consensus 72 L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~ 143 (237)
T cd05576 72 LWSHISKF---LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEA 143 (237)
T ss_pred HHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCC
Confidence 99998752 3589999999999999999999998 9999999999999999999999999988655432 23345
Q ss_pred ccccccCCCCC
Q 006145 647 PYSGSIDPTNS 657 (659)
Q Consensus 647 gt~~y~aPE~~ 657 (659)
++..|+|||+.
T Consensus 144 ~~~~y~aPE~~ 154 (237)
T cd05576 144 VENMYCAPEVG 154 (237)
T ss_pred cCccccCCccc
Confidence 67789999975
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-21 Score=199.96 Aligned_cols=171 Identities=10% Similarity=0.076 Sum_probs=124.4
Q ss_pred cCCCCCceeccCcCceEEEEEecC----CcEEEEEEecccCCCch-----------HHHHHHHHHHhCCCCCCccceeee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN----GTFVAIRCLKMKKCHST-----------RNFMHHIELISKLRHRHLVSALGH 541 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~-----------~~~~~Ei~~l~~l~H~niv~l~g~ 541 (659)
++|...+.||+|+||+||+|+..+ +..+|+|.......... .....+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 568888999999999999999654 34666665433221110 112334455677899999999997
Q ss_pred eeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC
Q 006145 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ 621 (659)
Q Consensus 542 ~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~ 621 (659)
+..... .....++++|++.. ++.+.+... ...++.....|+.|+++||+|||+. +|+||||||+|||+++
T Consensus 92 ~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 92 GSFKRC---RMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred eeEecC---CceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 654211 11245788888754 666666531 2357888899999999999999998 9999999999999999
Q ss_pred CcceEEccCcccccccccc--------ccceecccccccCCCCC
Q 006145 622 NLVAKISSYNLPLLAENAE--------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 622 ~~~~kl~DFGla~~~~~~~--------~~~~~~gt~~y~aPE~~ 657 (659)
++.+||+|||+|+...... ......||+.|+|||+.
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~ 205 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH 205 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHh
Confidence 9999999999997552211 11235799999999975
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=219.96 Aligned_cols=176 Identities=23% Similarity=0.392 Sum_probs=143.2
Q ss_pred HHHhhcCCCCCceeccCcCceEEEEEec----C----CcEEEEEEecccCCC-chHHHHHHHHHHhCCC-CCCccceeee
Q 006145 472 LEEATNNFDTSAFMGEGSQGQMYRGRLK----N----GTFVAIRCLKMKKCH-STRNFMHHIELISKLR-HRHLVSALGH 541 (659)
Q Consensus 472 l~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~----g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~-H~niv~l~g~ 541 (659)
++...+++...+.+|+|.||.|++|... . ...||||.++..... +.+.+..|+++|+.+. |+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 4444555556679999999999999843 1 457999999865543 3467999999999995 9999999999
Q ss_pred eeeccccCCCCceeEEEEeccCCCChhhhhcCCC------C-----C--CCCCHHHHHHHHHHHHHHhhhhcCCCCCCcc
Q 006145 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGH------A-----H--QSLTWTQRISAAIGVAKGIQFLHTGIVPGVF 608 (659)
Q Consensus 542 ~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~------~-----~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 608 (659)
|.. .+..++|+||++.|+|.++++..+ . . ..++-.+.+.++.|||.||+||++. ++|
T Consensus 371 ~t~-------~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~v 440 (609)
T KOG0200|consen 371 CTQ-------DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCV 440 (609)
T ss_pred ecc-------CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Ccc
Confidence 986 467899999999999999998643 0 0 1388999999999999999999999 999
Q ss_pred ccCCCCCceeecCCcceEEccCccccccccccccc--eec--ccccccCCCCC
Q 006145 609 SNNLKITDILLDQNLVAKISSYNLPLLAENAEKVG--HVI--PYSGSIDPTNS 657 (659)
Q Consensus 609 HrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~--~~~--gt~~y~aPE~~ 657 (659)
|||+.++|||+.++..+||+|||+|+...+...+. ... -...|||||-+
T Consensus 441 HRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl 493 (609)
T KOG0200|consen 441 HRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESL 493 (609)
T ss_pred chhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHh
Confidence 99999999999999999999999998765443332 222 24469999965
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-22 Score=199.64 Aligned_cols=169 Identities=21% Similarity=0.301 Sum_probs=141.3
Q ss_pred cCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCC---CchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKC---HSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~ 551 (659)
.+|....+||+|+||.|..|..+. .+.+|||++++... .+.+--+.|-++|+-- +-|.+++++..+.+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT------- 421 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT------- 421 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh-------
Confidence 457888999999999999998663 77899999986542 2233356677788776 57899999987765
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+.+|+||||+.||+|--.++.- ..+.++..+-+|..||-||-|||+. +||.||||.+||++|.+|.+||+|||
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 495 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecc
Confidence 67799999999999998888752 3467778899999999999999999 99999999999999999999999999
Q ss_pred ccccc-ccccccceecccccccCCCCCC
Q 006145 632 LPLLA-ENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 632 la~~~-~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+++.- -+.......+||+-|+|||.++
T Consensus 496 mcKEni~~~~TTkTFCGTPdYiAPEIi~ 523 (683)
T KOG0696|consen 496 MCKENIFDGVTTKTFCGTPDYIAPEIIA 523 (683)
T ss_pred cccccccCCcceeeecCCCcccccceEE
Confidence 99753 3445567899999999999864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-21 Score=185.12 Aligned_cols=141 Identities=12% Similarity=0.145 Sum_probs=109.9
Q ss_pred CceeccCcCceEEEEEecCCcEEEEEEecccCCC--c-------hHHH-----------------HHHHHHHhCCCCCCc
Q 006145 482 SAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH--S-------TRNF-----------------MHHIELISKLRHRHL 535 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~-------~~~~-----------------~~Ei~~l~~l~H~ni 535 (659)
...||+|+||.||+|..++|+.||||+++..... . ...| .+|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999754211 1 1122 349999999988877
Q ss_pred cceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhh-cCCCCCCccccCCCC
Q 006145 536 VSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFL-HTGIVPGVFSNNLKI 614 (659)
Q Consensus 536 v~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHrDlk~ 614 (659)
.....+.. ...++||||++++++...... ...+++.....++.|++.+|+|+ |+. +|+||||||
T Consensus 82 ~~p~~~~~---------~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP 146 (190)
T cd05147 82 PCPEPILL---------KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSE 146 (190)
T ss_pred CCCcEEEe---------cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCH
Confidence 54433322 124899999999877654322 23688899999999999999999 576 999999999
Q ss_pred CceeecCCcceEEccCcccccccc
Q 006145 615 TDILLDQNLVAKISSYNLPLLAEN 638 (659)
Q Consensus 615 ~NILld~~~~~kl~DFGla~~~~~ 638 (659)
+||+++ ++.++++|||+|...+.
T Consensus 147 ~NIli~-~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 147 YNLLYH-DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred HHEEEE-CCcEEEEEccccccCCC
Confidence 999998 47899999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=212.54 Aligned_cols=166 Identities=22% Similarity=0.284 Sum_probs=128.9
Q ss_pred CCCCCceeccCcCce-EEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCCcee
Q 006145 478 NFDTSAFMGEGSQGQ-MYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
-|...+++|.|+.|+ ||+|.+. |+.||||++-... ..-..+||..|+.-+ |||||++++.-. +....
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~-------d~qF~ 578 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQ-------DRQFL 578 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeecc-------CCceE
Confidence 356668899999885 7999985 8899999986432 234568999999885 999999865333 36789
Q ss_pred EEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC---C--cceEEcc
Q 006145 556 FLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ---N--LVAKISS 629 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~---~--~~~kl~D 629 (659)
|+..|.|.. +|.+++... .......-.....+..|+++|+++||+. +||||||||.||||+. + ..|+|+|
T Consensus 579 YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSD 654 (903)
T KOG1027|consen 579 YIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISD 654 (903)
T ss_pred EEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecc
Confidence 999999966 999999853 1111111134567888999999999997 9999999999999975 3 5799999
Q ss_pred Cccccccccccc----cceecccccccCCCCCC
Q 006145 630 YNLPLLAENAEK----VGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 630 FGla~~~~~~~~----~~~~~gt~~y~aPE~~~ 658 (659)
||+++....+.. .....||.+|+|||++.
T Consensus 655 fglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~ 687 (903)
T KOG1027|consen 655 FGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLR 687 (903)
T ss_pred cccccccCCCcchhhcccCCCCcccccCHHHHh
Confidence 999987654433 24578999999999974
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=212.09 Aligned_cols=207 Identities=28% Similarity=0.306 Sum_probs=169.1
Q ss_pred CCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEE
Q 006145 106 LPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLS 185 (659)
Q Consensus 106 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 185 (659)
.++|+.|+|++|.++. +|.. .++|+.|+|++|+++ .+|. .+++|+.|+|++|+|++ +|... .+|+.|+
T Consensus 261 p~sL~~L~Ls~N~L~~-Lp~l---p~~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~ 328 (788)
T PRK15387 261 PPGLLELSIFSNPLTH-LPAL---PSGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLAS-LPALP---SELCKLW 328 (788)
T ss_pred ccccceeeccCCchhh-hhhc---hhhcCEEECcCCccc-cccc---cccccceeECCCCcccc-CCCCc---ccccccc
Confidence 3588999999999875 4442 367889999999998 5665 35789999999999985 56532 4688899
Q ss_pred ccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCch
Q 006145 186 LRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPA 265 (659)
Q Consensus 186 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~ 265 (659)
+++|+|++ +|.. ..+|+.|+|++|+|++.++ + ..+|+.|++++|+|+. +|....+|+.|++++|+|++ +|.
T Consensus 329 Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~LP~-l--p~~L~~L~Ls~N~L~~-LP~l~~~L~~LdLs~N~Lt~-LP~ 399 (788)
T PRK15387 329 AYNNQLTS-LPTL---PSGLQELSVSDNQLASLPT-L--PSELYKLWAYNNRLTS-LPALPSGLKELIVSGNRLTS-LPV 399 (788)
T ss_pred cccCcccc-cccc---ccccceEecCCCccCCCCC-C--Ccccceehhhcccccc-CcccccccceEEecCCcccC-CCC
Confidence 99999984 6642 2589999999999997543 2 3578899999999985 66667889999999999986 554
Q ss_pred hccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhC
Q 006145 266 EVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLA 341 (659)
Q Consensus 266 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~ 341 (659)
. .++|+.|++++|+|++ +|... .+|+.|++++|+|+ .+|..+..++.|+.|+|++|+|+|.+|..+..
T Consensus 400 l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 400 L---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred c---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence 3 3679999999999985 67643 46889999999998 68999999999999999999999999887744
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=185.03 Aligned_cols=167 Identities=23% Similarity=0.410 Sum_probs=143.4
Q ss_pred CCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 479 FDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
|...+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++.. ....+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-------~~~~~ 73 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-------PEPLY 73 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-------CCceE
Confidence 4556889999999999999775 899999999765443 45789999999999999999999999875 45689
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+++||+++++|.+++.... ..+++.....++.++++++.|||.. +++|+|++|+||+++.++.++|+|||.+...
T Consensus 74 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 74 LVMEYCEGGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred EEEeccCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 9999999999999998532 1289999999999999999999998 9999999999999999999999999999776
Q ss_pred cccc--ccceecccccccCCCCC
Q 006145 637 ENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
.... ......++..|++||..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~pe~~ 171 (225)
T smart00221 149 HRDLAALLKTVKGTPFYLAPEVL 171 (225)
T ss_pred cCcccccccceeccCCcCCHhHh
Confidence 5432 33456788899999974
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-20 Score=178.62 Aligned_cols=140 Identities=12% Similarity=0.156 Sum_probs=112.3
Q ss_pred CceeccCcCceEEEEEecCCcEEEEEEecccCCC---------------------c-----hHHHHHHHHHHhCCCCCCc
Q 006145 482 SAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH---------------------S-----TRNFMHHIELISKLRHRHL 535 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------------------~-----~~~~~~Ei~~l~~l~H~ni 535 (659)
...||+|+||.||+|+..+|+.||||+++..... . ...+.+|.+.+.+++|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999999754211 0 1124678999999999988
Q ss_pred cceeeeeeeccccCCCCceeEEEEeccCCCChhhh-hcCCCCCCCCCHHHHHHHHHHHHHHhhhhcC-CCCCCccccCCC
Q 006145 536 VSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW-ISEGHAHQSLTWTQRISAAIGVAKGIQFLHT-GIVPGVFSNNLK 613 (659)
Q Consensus 536 v~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk 613 (659)
.....+... ..+|||||++++++... +.. ..++..+...++.+++.++.|+|+ . +|+|||||
T Consensus 82 ~~p~~~~~~---------~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlk 145 (190)
T cd05145 82 PVPEPILLK---------KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLS 145 (190)
T ss_pred CCceEEEec---------CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCC
Confidence 665544432 24899999998865443 432 357778899999999999999999 7 99999999
Q ss_pred CCceeecCCcceEEccCcccccccc
Q 006145 614 ITDILLDQNLVAKISSYNLPLLAEN 638 (659)
Q Consensus 614 ~~NILld~~~~~kl~DFGla~~~~~ 638 (659)
|+||+++ ++.++|+|||++...+.
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceecCC
Confidence 9999999 88999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.3e-20 Score=185.20 Aligned_cols=156 Identities=22% Similarity=0.401 Sum_probs=136.9
Q ss_pred cCceEEEEEecC-CcEEEEEEecccCCCc-hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEeccCCCC
Q 006145 489 SQGQMYRGRLKN-GTFVAIRCLKMKKCHS-TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGT 566 (659)
Q Consensus 489 ~~g~Vy~~~~~~-g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~Gs 566 (659)
+||.||+|+... |+.+|+|++....... .+.+.+|++.+++++|+||+++++++.. ....++|+||+++++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-------~~~~~l~~e~~~~~~ 73 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-------EDKLYLVMEYCDGGD 73 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-------CCEEEEEEeCCCCCC
Confidence 589999999764 8999999997665444 6789999999999999999999999976 456899999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccccccceec
Q 006145 567 LRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVI 646 (659)
Q Consensus 567 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 646 (659)
|.+++... ..+++..+..++.+++++++|||+. +++|+||+|+||++++++.++++|||.+.............
T Consensus 74 L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 147 (244)
T smart00220 74 LFDLLKKR---GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFV 147 (244)
T ss_pred HHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccccccccc
Confidence 99998753 2389999999999999999999998 99999999999999999999999999998775544556677
Q ss_pred ccccccCCCCC
Q 006145 647 PYSGSIDPTNS 657 (659)
Q Consensus 647 gt~~y~aPE~~ 657 (659)
++..|+|||+.
T Consensus 148 ~~~~~~~pE~~ 158 (244)
T smart00220 148 GTPEYMAPEVL 158 (244)
T ss_pred CCcCCCCHHHH
Confidence 89999999975
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.6e-19 Score=215.25 Aligned_cols=242 Identities=21% Similarity=0.230 Sum_probs=158.7
Q ss_pred CCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEE
Q 006145 106 LPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLS 185 (659)
Q Consensus 106 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 185 (659)
..+|+.|+|.+|.+. .++..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..++++++|+.|+
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 456666666666654 3455556666666666666554445553 55666666666666655556666666666666666
Q ss_pred ccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCC---------------------
Q 006145 186 LRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPK--------------------- 244 (659)
Q Consensus 186 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~--------------------- 244 (659)
+++|...+.+|..+ ++++|+.|++++|...+.+|.+ .++|++|+|++|.+...+..
T Consensus 688 L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~--~~nL~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~ 764 (1153)
T PLN03210 688 MSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI--STNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWE 764 (1153)
T ss_pred CCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc--cCCcCeeecCCCccccccccccccccccccccccchhhccc
Confidence 66654444555544 5666666666665544444432 23455555555554321110
Q ss_pred -----------CCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCc
Q 006145 245 -----------VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFD 313 (659)
Q Consensus 245 -----------~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 313 (659)
..++|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|..+ ++++|+.|++++|.....+|.
T Consensus 765 ~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~ 843 (1153)
T PLN03210 765 RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD 843 (1153)
T ss_pred cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc
Confidence 12467888888888777888888888888888888876555677665 688888888888766555554
Q ss_pred CCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCC-ccccC
Q 006145 314 DLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYAR-NCLAA 357 (659)
Q Consensus 314 ~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~-N~l~~ 357 (659)
. .++|+.|+|++|.++ .+|..+..+++|..+++.+ |.+..
T Consensus 844 ~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~ 884 (1153)
T PLN03210 844 I---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQR 884 (1153)
T ss_pred c---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCc
Confidence 3 357888999999988 6888888899999999887 45553
|
syringae 6; Provisional |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8e-21 Score=185.54 Aligned_cols=170 Identities=20% Similarity=0.302 Sum_probs=141.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchH---HHHHHHHHHhCC-CCCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTR---NFMHHIELISKL-RHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~---~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~ 550 (659)
.++|+...+||+|+|++|..+++. +.+.+|+|+++++-..+.+ =...|-.+.... +||.+|.++.++.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt------ 322 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT------ 322 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc------
Confidence 467888899999999999999965 5889999999865432222 234455555555 69999999987765
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
...+++|.||+++|+|--++++ ...+++....-+...|.-||.|||+. +||.||+|..|||+|..|.+|++|+
T Consensus 323 -esrlffvieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 323 -ESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred -cceEEEEEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeeccc
Confidence 5678999999999999888875 35688888889999999999999999 9999999999999999999999999
Q ss_pred cccccc-ccccccceecccccccCCCCCC
Q 006145 631 NLPLLA-ENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 631 Gla~~~-~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|.++.. .+.......+||+.|+|||.++
T Consensus 396 gmcke~l~~gd~tstfcgtpnyiapeilr 424 (593)
T KOG0695|consen 396 GMCKEGLGPGDTTSTFCGTPNYIAPEILR 424 (593)
T ss_pred chhhcCCCCCcccccccCCCcccchhhhc
Confidence 999754 4445567899999999999874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-19 Score=173.06 Aligned_cols=161 Identities=25% Similarity=0.494 Sum_probs=137.6
Q ss_pred eccCcCceEEEEEecC-CcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEecc
Q 006145 485 MGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYV 562 (659)
Q Consensus 485 ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~ 562 (659)
||+|++|.||+++... ++.+++|++...... ..+.+.+|++.++.++|++|+++++++.. ....++++||+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-------~~~~~~~~e~~ 73 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-------ENHLYLVMEYC 73 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-------CCeEEEEEecC
Confidence 6899999999999764 899999999765432 24679999999999999999999999875 35689999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC-CcceEEccCcccccccccc-
Q 006145 563 PNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ-NLVAKISSYNLPLLAENAE- 640 (659)
Q Consensus 563 ~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~~~~~~~- 640 (659)
++++|.+++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 74 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 74 EGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred CCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence 9999999987521 3689999999999999999999998 9999999999999999 8999999999997664332
Q ss_pred ccceecccccccCCCCC
Q 006145 641 KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 641 ~~~~~~gt~~y~aPE~~ 657 (659)
......+...|++||..
T Consensus 149 ~~~~~~~~~~~~~pe~~ 165 (215)
T cd00180 149 LLKTIVGTPAYMAPEVL 165 (215)
T ss_pred hhhcccCCCCccChhHh
Confidence 23446688899999974
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=203.47 Aligned_cols=206 Identities=21% Similarity=0.314 Sum_probs=168.6
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
++|+.|+|++|+++. +|..+. .+|+.|+|++|.+. .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|+|
T Consensus 220 ~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~L 290 (754)
T PRK15370 220 GNIKTLYANSNQLTS-IPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSV 290 (754)
T ss_pred cCCCEEECCCCcccc-CChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEEC
Confidence 589999999999985 566553 48999999999998 7787765 58999999999998 5787664 58999999
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchh
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAE 266 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~ 266 (659)
++|+|++ +|..+. ++|+.|++++|+++..++.+. ++|+.|++++|.+++.+....++|+.|++++|+|+. +|..
T Consensus 291 s~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~L~~-LP~~ 364 (754)
T PRK15370 291 YDNSIRT-LPAHLP--SGITHLNVQSNSLTALPETLP--PGLKTLEAGENALTSLPASLPPELQVLDVSKNQITV-LPET 364 (754)
T ss_pred CCCcccc-Ccccch--hhHHHHHhcCCccccCCcccc--ccceeccccCCccccCChhhcCcccEEECCCCCCCc-CChh
Confidence 9999994 666553 579999999999997544443 689999999999987554556899999999999974 6766
Q ss_pred ccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcC----CCCCCCCCEEECcCCCCcc
Q 006145 267 VSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDD----LSCNPELGFVDLSSNLLTG 333 (659)
Q Consensus 267 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~----~~~~~~L~~L~ls~N~l~g 333 (659)
+. ++|+.|+|++|+|+ .+|..+. .+|+.|++++|+|+ .+|.. ++.++.+..|++.+|.++.
T Consensus 365 lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 365 LP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred hc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH
Confidence 53 68999999999999 4676654 37999999999998 45554 3455889999999999973
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-21 Score=193.57 Aligned_cols=249 Identities=22% Similarity=0.196 Sum_probs=193.2
Q ss_pred CCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeec-CCCCCCCccccCCCCCCCEEEcc
Q 006145 109 LKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDE-NMLAGRVPDWLGSLPILAVLSLR 187 (659)
Q Consensus 109 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L~ 187 (659)
-..++|..|+|+...|++|+.+++|+.||||+|+|+-+-|++|.++.+|..|-+.+ |+|+...-..|++|.+|+.|.+.
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence 35678888888888888888888888888888888877788888888877766655 77874444678888888888888
Q ss_pred CCcCCccCCcccCCCCCCcEEeccccccccCCC-CCCCCCcCCEEEcccCCCCC------------CCCCC---------
Q 006145 188 NNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP-DFSGLTYLQVLDLENNALGP------------QFPKV--------- 245 (659)
Q Consensus 188 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~------------~~~~~--------- 245 (659)
-|++.-...+.|..|++|..|.+..|.+..... .|..+.+++.+.+..|.+-- ..|..
T Consensus 149 an~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p 228 (498)
T KOG4237|consen 149 ANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP 228 (498)
T ss_pred hhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence 888887777788888888888888888775544 37778888888887776310 00000
Q ss_pred -------------------CcccceEecCCCcCCccCch-hccCCccccEEeccCcccccCCchhhcCCCcccEEeccCC
Q 006145 246 -------------------GKKLVTMILSKNKFRSAIPA-EVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADN 305 (659)
Q Consensus 246 -------------------~~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N 305 (659)
.+.+..-..+.....+.-|. -|..+++|+.|+|++|++++.-+.+|..+.+++.|.|..|
T Consensus 229 ~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N 308 (498)
T KOG4237|consen 229 YRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRN 308 (498)
T ss_pred HHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcc
Confidence 00111112223333344454 4899999999999999999999999999999999999999
Q ss_pred cCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 306 KLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 306 ~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
+|...--..|..+..|+.|+|.+|+|+..-|..|..+..+..+++..|.+.+
T Consensus 309 ~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 309 KLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred hHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccC
Confidence 9987777788899999999999999999889999999999999999998764
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.8e-18 Score=207.51 Aligned_cols=249 Identities=22% Similarity=0.228 Sum_probs=197.2
Q ss_pred cccccCCC-CCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCC
Q 006145 100 VTTLVKLP-DLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSL 178 (659)
Q Consensus 100 ~~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 178 (659)
|..+..++ +|+.|++.++.+ ..+|..| .+.+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+|. ++.+
T Consensus 581 p~~~~~lp~~Lr~L~~~~~~l-~~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l 656 (1153)
T PLN03210 581 PEGFDYLPPKLRLLRWDKYPL-RCMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMA 656 (1153)
T ss_pred CcchhhcCcccEEEEecCCCC-CCCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccC
Confidence 44454554 588888888766 4456666 5789999999999987 6788889999999999999876667875 8889
Q ss_pred CCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCc
Q 006145 179 PILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNK 258 (659)
Q Consensus 179 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~ 258 (659)
++|+.|+|++|.....+|.+++++++|+.|++++|...+.+|...++++|+.|++++|...+.+|....+|+.|++++|.
T Consensus 657 ~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~ 736 (1153)
T PLN03210 657 TNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETA 736 (1153)
T ss_pred CcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCCc
Confidence 99999999998877789999999999999999998666667765589999999999998878888888899999999999
Q ss_pred CCccCchhc------------------------------cCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCC
Q 006145 259 FRSAIPAEV------------------------------SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLT 308 (659)
Q Consensus 259 l~~~~p~~~------------------------------~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 308 (659)
+.. +|..+ ...++|+.|+|++|...+.+|.+++++++|+.|++++|...
T Consensus 737 i~~-lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L 815 (1153)
T PLN03210 737 IEE-FPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINL 815 (1153)
T ss_pred ccc-ccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCc
Confidence 754 45432 11246777888888777778888888888888888887655
Q ss_pred CcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 309 GKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 309 ~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
+.+|..+ .+++|+.|++++|.....+|... .+++.+++++|.++.
T Consensus 816 ~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~---~nL~~L~Ls~n~i~~ 860 (1153)
T PLN03210 816 ETLPTGI-NLESLESLDLSGCSRLRTFPDIS---TNISDLNLSRTGIEE 860 (1153)
T ss_pred CeeCCCC-CccccCEEECCCCCccccccccc---cccCEeECCCCCCcc
Confidence 5677665 67888888888876655666542 467788888887763
|
syringae 6; Provisional |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.6e-19 Score=170.67 Aligned_cols=142 Identities=11% Similarity=0.226 Sum_probs=108.7
Q ss_pred CCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCC-----CCCCccceeeeeeeccccCCCCc
Q 006145 479 FDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKL-----RHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++..+.||+|+||.||. ...++.. +||++........+++.+|+++++.+ +||||++++|++.+.. +.+
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~----g~g 77 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC----GTG 77 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC----CCe
Confidence 45568999999999996 2223444 79988765444567899999999999 5799999999998621 123
Q ss_pred eeE-EEEec--cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHh-hhhcCCCCCCccccCCCCCceeecC----Ccce
Q 006145 554 RIF-LIFEY--VPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGI-QFLHTGIVPGVFSNNLKITDILLDQ----NLVA 625 (659)
Q Consensus 554 ~~~-lV~Ey--~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiHrDlk~~NILld~----~~~~ 625 (659)
..+ +|+|| +++|+|.+++.+. .+++. ..++.+++.++ +|||+. +|+||||||+|||++. +..+
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcE
Confidence 334 78999 6689999999752 35554 35677888877 999999 9999999999999974 3479
Q ss_pred EEcc-Cccccc
Q 006145 626 KISS-YNLPLL 635 (659)
Q Consensus 626 kl~D-FGla~~ 635 (659)
+|+| ||....
T Consensus 149 ~LiDg~G~~~~ 159 (210)
T PRK10345 149 VVCDNIGESTF 159 (210)
T ss_pred EEEECCCCcce
Confidence 9999 555444
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.4e-20 Score=180.37 Aligned_cols=169 Identities=17% Similarity=0.209 Sum_probs=137.2
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEeccc--CCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMK--KCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+|.....+|.|.- .|..+-.. .++.||+|++... .....++..+|...+..+.|+||++++.++.-... .....+
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~-l~~~~e 95 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT-LEEFQE 95 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc-HHHHHh
Confidence 4555567777776 55555433 4889999998543 23345678899999999999999999998853211 112346
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.|+|||||.. +|.+.++. .++......|..|++.|+.|||+. +|+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence 8999999955 99988874 478888899999999999999999 99999999999999999999999999998
Q ss_pred ccccccccceecccccccCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
..+.+-..+..+.|..|+|||.+
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevi 189 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVI 189 (369)
T ss_pred ccCcccccCchhheeeccCchhe
Confidence 87776677889999999999975
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-19 Score=180.51 Aligned_cols=167 Identities=16% Similarity=0.224 Sum_probs=136.5
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCC--C----Cccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRH--R----HLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~----niv~l~g~~~~~~~~ 548 (659)
+++|.....+|+|.||.|-++..+ .+..||||+++.-.. -.++.+-|+++++++.+ | -+|++.+|+..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy---- 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY---- 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc----
Confidence 677888899999999999999965 489999999975432 23567789999999942 2 37777777654
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC-------
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ------- 621 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~------- 621 (659)
.++.|+|+|.| |-|++++|.+. .-.+++-.....++.|++++++|||+. .++|.||||+|||+.+
T Consensus 163 ---rghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 163 ---RGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred ---cCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEe
Confidence 67899999999 55999999863 345788889999999999999999999 9999999999999842
Q ss_pred -------------CcceEEccCccccccccccccceecccccccCCCCC
Q 006145 622 -------------NLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 622 -------------~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+..+||.|||-|....... ...+.|..|+|||++
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEVi 281 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVI 281 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchhe
Confidence 1247999999998765433 667899999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-19 Score=171.82 Aligned_cols=165 Identities=17% Similarity=0.323 Sum_probs=130.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.+.|++.+.+|+|.||.+-.++++ +.+.+++|.+.... ...++|.+|...=-.+ .|.||+.-++.... +.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq------t~d 95 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ------TSD 95 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhh------cCc
Confidence 355788899999999999999976 47889999987544 3468899998765556 49999998876543 356
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceee-c-CCcceEEccCc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL-D-QNLVAKISSYN 631 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl-d-~~~~~kl~DFG 631 (659)
.+++++||+|.|||.+-+.. .-+.+....+++.|++.|++|+|++ .+||||||.+|||| + +...+|++|||
T Consensus 96 ~YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred eEEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecc
Confidence 78899999999999988764 2477888899999999999999999 99999999999998 3 34689999999
Q ss_pred cccccccccccceecccccccCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTN 656 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~ 656 (659)
+.+..... ....--+..|-|||.
T Consensus 169 ~t~k~g~t--V~~~~~~~~y~~pe~ 191 (378)
T KOG1345|consen 169 LTRKVGTT--VKYLEYVNNYHAPEL 191 (378)
T ss_pred cccccCce--ehhhhhhcccCCcHH
Confidence 98655332 222223445667764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-19 Score=190.56 Aligned_cols=163 Identities=17% Similarity=0.210 Sum_probs=134.9
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++.|.....+|.|+|+.|-++... +++..+||++.... .+-.+|+.++... +||||+++.+.|.+ ..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~-------~~ 389 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYED-------GK 389 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecC-------Cc
Confidence 567777788999999999999854 58999999997652 2234577676666 69999999999976 57
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceee-cCCcceEEccCcc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL-DQNLVAKISSYNL 632 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl-d~~~~~kl~DFGl 632 (659)
+.|+|||++.+|-+.+.+... ......+..|+.+++.|+.|||++ +|||||+||+|||+ ++.+.++|+|||.
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~ 462 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGF 462 (612)
T ss_pred eeeeeehhccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEech
Confidence 799999999999888777642 222367788999999999999998 99999999999999 5889999999999
Q ss_pred ccccccccccceecccccccCCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
++..+.. .-..+-|..|.|||.++
T Consensus 463 a~~~~~~--~~tp~~t~~y~APEvl~ 486 (612)
T KOG0603|consen 463 WSELERS--CDTPALTLQYVAPEVLA 486 (612)
T ss_pred hhhCchh--hcccchhhcccChhhhc
Confidence 9877654 33457788999999876
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-20 Score=206.80 Aligned_cols=196 Identities=28% Similarity=0.369 Sum_probs=137.5
Q ss_pred CCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcc
Q 006145 155 TSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLE 234 (659)
Q Consensus 155 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~ 234 (659)
.+|+++++++|+++ .+|+|++.+.+|+.|++.+|+|+ .+|..+..+++|+.|++.+|.++-.+|...++++|++|+|.
T Consensus 241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeeh
Confidence 57888999999988 56799999999999999999995 78888888888888888888888777777788888889988
Q ss_pred cCCCCCCCCCC----------------------------CcccceEecCCCcCCccCchhccCCccccEEeccCcccccC
Q 006145 235 NNALGPQFPKV----------------------------GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGP 286 (659)
Q Consensus 235 ~N~l~~~~~~~----------------------------~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 286 (659)
.|+|...++.. ...|+.|++.+|.|+...-..+.++.+|+.|+|++|+|...
T Consensus 319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f 398 (1081)
T KOG0618|consen 319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF 398 (1081)
T ss_pred hccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence 88885433210 12355566666666665555556666666666666666533
Q ss_pred CchhhcCCCcccEEeccCCcCCC----------------------cCCcCCCCCCCCCEEECcCCCCcc-cCChhhhCCC
Q 006145 287 FPQALLSLPSITYLNIADNKLTG----------------------KLFDDLSCNPELGFVDLSSNLLTG-QLPNCLLAGS 343 (659)
Q Consensus 287 ~p~~l~~l~~L~~L~l~~N~l~~----------------------~~p~~~~~~~~L~~L~ls~N~l~g-~ip~~~~~~~ 343 (659)
....+.+++.|+.|+||+|+|+. ..| .+..++.|+++|+|.|+|+- .+|... ..+
T Consensus 399 pas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~-p~p 476 (1081)
T KOG0618|consen 399 PASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL-PSP 476 (1081)
T ss_pred CHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccchhhhhhhhhhC-CCc
Confidence 33445566666666666666652 234 56677778888888888763 333332 236
Q ss_pred CCCEEEcCCcc
Q 006145 344 KNRVVLYARNC 354 (659)
Q Consensus 344 ~l~~l~~~~N~ 354 (659)
+|+.+++++|.
T Consensus 477 ~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 477 NLKYLDLSGNT 487 (1081)
T ss_pred ccceeeccCCc
Confidence 77888888885
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.6e-19 Score=179.58 Aligned_cols=145 Identities=15% Similarity=0.324 Sum_probs=125.2
Q ss_pred HHHhhcCCCCCceeccCcCceEEEEEec----CCcEEEEEEecccCCCchHHHHHHHHHHhCCC-CCCccceeeeeeecc
Q 006145 472 LEEATNNFDTSAFMGEGSQGQMYRGRLK----NGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRHLVSALGHCFECY 546 (659)
Q Consensus 472 l~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 546 (659)
+....+.|...++||+|.|++||++.+. ..+.||+|.+.... .......|++.|..+. +.||+++.++...
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rn-- 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRN-- 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhcc--
Confidence 3444567888999999999999999854 36789999997544 3466899999999995 9999999988765
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC-cce
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN-LVA 625 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~-~~~ 625 (659)
.+...+|+||++.-+..++... ++......+.+.+..||+|+|+. +||||||||+|+|.+.. +.-
T Consensus 107 -----nd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg 172 (418)
T KOG1167|consen 107 -----NDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRG 172 (418)
T ss_pred -----CCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCc
Confidence 5779999999999898888764 67888999999999999999999 99999999999999854 778
Q ss_pred EEccCcccc
Q 006145 626 KISSYNLPL 634 (659)
Q Consensus 626 kl~DFGla~ 634 (659)
.|.|||+|.
T Consensus 173 ~LvDFgLA~ 181 (418)
T KOG1167|consen 173 VLVDFGLAQ 181 (418)
T ss_pred eEEechhHH
Confidence 899999996
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-20 Score=205.00 Aligned_cols=240 Identities=29% Similarity=0.350 Sum_probs=178.5
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
.+|+++++++|++++. |+.++.+.+|+.|+..+|+|+ .+|..+..+++|+.|.+.+|.+. .+|.....++.|+.|+|
T Consensus 241 ~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhhcc-hHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 3678888888888664 477888888888888888885 67777777888888888888876 66777777888888888
Q ss_pred cCCcCCccCCcccC--------------------------CCCCCcEEecccccccc-CCCCCCCCCcCCEEEcccCCCC
Q 006145 187 RNNMFNGTLPDSFS--------------------------YLENLRVLALSNNHFYG-EVPDFSGLTYLQVLDLENNALG 239 (659)
Q Consensus 187 ~~N~l~~~~p~~~~--------------------------~l~~L~~L~Ls~N~l~~-~~p~~~~l~~L~~L~L~~N~l~ 239 (659)
..|+|. .+|+.+- .++.|+.|++.+|.|+. .+|.+.+...|+.|+|++|+|.
T Consensus 318 ~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~ 396 (1081)
T KOG0618|consen 318 QSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN 396 (1081)
T ss_pred hhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc
Confidence 888776 3343211 23456777888888875 3566888899999999999986
Q ss_pred CCCCCC---CcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCC
Q 006145 240 PQFPKV---GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLS 316 (659)
Q Consensus 240 ~~~~~~---~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~ 316 (659)
..+... +..|++|+||+|+++. +|..+.++..|+.|...+|++. .+| .+..++.|+.+|++.|+|+-..-..-.
T Consensus 397 ~fpas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~ 473 (1081)
T KOG0618|consen 397 SFPASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL 473 (1081)
T ss_pred cCCHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhC
Confidence 444333 4678899999999965 7899999999999999999998 678 789999999999999999865433333
Q ss_pred CCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCc
Q 006145 317 CNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARN 353 (659)
Q Consensus 317 ~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N 353 (659)
..++|++|||++|.-.-.--..+..++.+...+..-|
T Consensus 474 p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 474 PSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred CCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 3489999999999732122233444444555555444
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.8e-20 Score=194.95 Aligned_cols=253 Identities=26% Similarity=0.245 Sum_probs=150.8
Q ss_pred cccCCCCCCEEEecCCCCcCC----CCcccCCCCCCcEEEcccCcCcc------cCChhccCCCCCcEEEeecCCCCCCC
Q 006145 102 TLVKLPDLKVLRLVSLGLWGP----LSGKISRLSSLEILNMSSNFLNG------AIPQELSILTSLQTLILDENMLAGRV 171 (659)
Q Consensus 102 ~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~ 171 (659)
.+..++.|+.|+++++.++.. ++..+...++|+.|+++.|.+.+ .++..+..+++|+.|+|++|.+.+..
T Consensus 18 ~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~ 97 (319)
T cd00116 18 LLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDG 97 (319)
T ss_pred HHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhH
Confidence 344555677777777776432 44455566667777777776652 23445666777777777777776555
Q ss_pred ccccCCCCC---CCEEEccCCcCCc----cCCcccCCC-CCCcEEeccccccccCCC-----CCCCCCcCCEEEcccCCC
Q 006145 172 PDWLGSLPI---LAVLSLRNNMFNG----TLPDSFSYL-ENLRVLALSNNHFYGEVP-----DFSGLTYLQVLDLENNAL 238 (659)
Q Consensus 172 p~~l~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~~p-----~~~~l~~L~~L~L~~N~l 238 (659)
+..+..+.+ |++|++++|.+++ .+...+..+ ++|+.|++++|.+++... .+..+++|++|++++|.+
T Consensus 98 ~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l 177 (319)
T cd00116 98 CGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGI 177 (319)
T ss_pred HHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCC
Confidence 555554444 7777777777662 233344555 677777777777764221 155566777777777777
Q ss_pred CCCC----CCC---CcccceEecCCCcCCcc----CchhccCCccccEEeccCcccccCCchhhc-----CCCcccEEec
Q 006145 239 GPQF----PKV---GKKLVTMILSKNKFRSA----IPAEVSSYYQLQRLDLSSNRFVGPFPQALL-----SLPSITYLNI 302 (659)
Q Consensus 239 ~~~~----~~~---~~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-----~l~~L~~L~l 302 (659)
++.- +.. .++|+.|++++|.+.+. ++..+..+++|+.|++++|.+++.....+. ..+.|+.|++
T Consensus 178 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l 257 (319)
T cd00116 178 GDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSL 257 (319)
T ss_pred chHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEc
Confidence 6421 111 23677777777766533 233455667777777777777653222222 1367777777
Q ss_pred cCCcCCC----cCCcCCCCCCCCCEEECcCCCCccc----CChhhhCC-CCCCEEEcCCcc
Q 006145 303 ADNKLTG----KLFDDLSCNPELGFVDLSSNLLTGQ----LPNCLLAG-SKNRVVLYARNC 354 (659)
Q Consensus 303 ~~N~l~~----~~p~~~~~~~~L~~L~ls~N~l~g~----ip~~~~~~-~~l~~l~~~~N~ 354 (659)
++|.++. .+...+..+++|+++|+++|.++.. +...+... +.++.+++..|.
T Consensus 258 ~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 258 SCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred cCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 7777762 2233445557777777777777743 33333333 455566655553
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-18 Score=173.23 Aligned_cols=181 Identities=20% Similarity=0.296 Sum_probs=145.3
Q ss_pred CHHHHHHhhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceee
Q 006145 468 SLEELEEATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALG 540 (659)
Q Consensus 468 ~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g 540 (659)
...++.....++.....+-+|.||.||+|.++ +.+.|-||.++....+ +...|+.|.-.+..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34566667777888889999999999999654 3456788888754432 2356899999999999999999999
Q ss_pred eeeeccccCCCCceeEEEEeccCCCChhhhhc-----CCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCC
Q 006145 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWIS-----EGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKIT 615 (659)
Q Consensus 541 ~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~ 615 (659)
++.+. ....+.+|.++.-|+|..+|+ +....+.++-.+.+.+|.|++.||+|||+. +|||.||.++
T Consensus 355 V~ie~------~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaR 425 (563)
T KOG1024|consen 355 VSIED------YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAAR 425 (563)
T ss_pred EEeec------cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhh
Confidence 99862 456799999999999999998 334456788899999999999999999998 9999999999
Q ss_pred ceeecCCcceEEccCccccccccccc--cce-ecccccccCCCCC
Q 006145 616 DILLDQNLVAKISSYNLPLLAENAEK--VGH-VIPYSGSIDPTNS 657 (659)
Q Consensus 616 NILld~~~~~kl~DFGla~~~~~~~~--~~~-~~gt~~y~aPE~~ 657 (659)
|++||+...+|++|=.+++..-+... .+. .--...||+||-+
T Consensus 426 NCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal 470 (563)
T KOG1024|consen 426 NCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEAL 470 (563)
T ss_pred cceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHH
Confidence 99999999999999999976532211 111 1234579999855
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.9e-20 Score=165.93 Aligned_cols=130 Identities=36% Similarity=0.535 Sum_probs=65.5
Q ss_pred cCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCE
Q 006145 104 VKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAV 183 (659)
Q Consensus 104 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 183 (659)
.++++.+.|.|++|.++. +|+.+..|.+|++|++++|+++ .+|..++.++.|+.|+++-|++. .+|..|+.++.|++
T Consensus 30 f~~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred cchhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 344445555555555543 2333555555555555555554 44555555555555555555554 44555555555555
Q ss_pred EEccCCcCCc-cCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccC
Q 006145 184 LSLRNNMFNG-TLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENN 236 (659)
Q Consensus 184 L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N 236 (659)
|||.+|+++. .+|..|..++.|+-|+|+.|.+.-.+|+++++++|+.|.+..|
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdn 160 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDN 160 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccC
Confidence 5555555432 3444455555555555555554444444444444444444433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.6e-18 Score=167.68 Aligned_cols=145 Identities=10% Similarity=0.098 Sum_probs=112.2
Q ss_pred hcCCCCCceeccCcCceEEEEE--ecCCcEEEEEEecccCCC-------------------c-----hHHHHHHHHHHhC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGR--LKNGTFVAIRCLKMKKCH-------------------S-----TRNFMHHIELISK 529 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~--~~~g~~vavK~l~~~~~~-------------------~-----~~~~~~Ei~~l~~ 529 (659)
...|...+.||+|+||.||+|+ ..+|+.||||+++..... . ...+.+|++.+.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3357778999999999999998 567999999998753210 0 0235689999999
Q ss_pred CCCCC--ccceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCC-
Q 006145 530 LRHRH--LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPG- 606 (659)
Q Consensus 530 l~H~n--iv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~- 606 (659)
+.+.. +.+++++ ...++||||+++++|..+.... ..+...+...++.|++.+++|||+. +
T Consensus 107 L~~~~i~~p~~~~~-----------~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~ 169 (237)
T smart00090 107 LYEAGVPVPKPIAW-----------RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GE 169 (237)
T ss_pred HHhcCCCCCeeeEe-----------cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CC
Confidence 97633 3333332 1248999999998987765321 2355666789999999999999998 8
Q ss_pred ccccCCCCCceeecCCcceEEccCcccccccc
Q 006145 607 VFSNNLKITDILLDQNLVAKISSYNLPLLAEN 638 (659)
Q Consensus 607 iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 638 (659)
|+||||||+||+++ +++++++|||.+.....
T Consensus 170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 170 LVHGDLSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEeCCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence 99999999999999 88999999999976544
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.9e-20 Score=165.07 Aligned_cols=156 Identities=31% Similarity=0.507 Sum_probs=103.0
Q ss_pred cCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCc
Q 006145 127 ISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLR 206 (659)
Q Consensus 127 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 206 (659)
+.++++.+.|-||+|+++ .+|..+..+.+|+.|++++|++. .+|..++++++|+.|+++-|++. .+|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 345666777777888877 56667777777777777777776 66777777777777777777776 6777777777777
Q ss_pred EEecccccccc-CCCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccc
Q 006145 207 VLALSNNHFYG-EVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFV 284 (659)
Q Consensus 207 ~L~Ls~N~l~~-~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 284 (659)
.|||.+|+++. ..|. |..++.|+-|+|++|.+ ..+|..++++++|+.|.+..|.+-
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndf----------------------e~lp~dvg~lt~lqil~lrdndll 163 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDF----------------------EILPPDVGKLTNLQILSLRDNDLL 163 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCc----------------------ccCChhhhhhcceeEEeeccCchh
Confidence 77777777653 2232 44444444444444433 345666666666666666666665
Q ss_pred cCCchhhcCCCcccEEeccCCcCC
Q 006145 285 GPFPQALLSLPSITYLNIADNKLT 308 (659)
Q Consensus 285 ~~~p~~l~~l~~L~~L~l~~N~l~ 308 (659)
.+|..++.+..|+.|++.+|+++
T Consensus 164 -~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 164 -SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred -hCcHHHHHHHHHHHHhcccceee
Confidence 45666666666666666666665
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-17 Score=159.69 Aligned_cols=133 Identities=14% Similarity=0.066 Sum_probs=106.1
Q ss_pred CCCceeccCcCceEEEEEecCCcEEEEEEecccCCCc----hHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCCce
Q 006145 480 DTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHS----TRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 480 ~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.+...|++|+||+||.+.. .+..++.+.+.....-. ...|.+|+++|++++ |++|++++++. .
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----------~ 72 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----------G 72 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----------C
Confidence 3457899999999997765 57788888776543211 124889999999995 58899998752 2
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCC-CCCceeecCCcceEEccCccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNL-KITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl-k~~NILld~~~~~kl~DFGla 633 (659)
.+++|||++|.+|.+.+.. ....+..+++++++|+|+. +|+|||| ||+|||+++++.++|+|||+|
T Consensus 73 ~~lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A 139 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLA 139 (218)
T ss_pred EEEEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCc
Confidence 5999999999998764321 1135778999999999999 9999999 799999999999999999999
Q ss_pred cccc
Q 006145 634 LLAE 637 (659)
Q Consensus 634 ~~~~ 637 (659)
....
T Consensus 140 ~~~~ 143 (218)
T PRK12274 140 VRGN 143 (218)
T ss_pred eecC
Confidence 7544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7e-18 Score=158.64 Aligned_cols=163 Identities=14% Similarity=0.172 Sum_probs=129.2
Q ss_pred hcCCCCCceeccCcCceEEEEE-ecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCC-CCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRH-RHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~~~~~ 553 (659)
...|...+.||+|+||.+|.|. ..+|..||||.-+....+ .+...|.++.+.++| ..|..+..|..+ ..
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e-------~~ 84 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTE-------KD 84 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccc-------cc
Confidence 3568888999999999999999 567999999997654433 457788889888875 556666655544 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC---cceEEccC
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN---LVAKISSY 630 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~---~~~kl~DF 630 (659)
.-.+|||.. |.+|+++..-. ...++-...+..|-|+..-++|+|.. +.|||||||+|+|+.-+ ..+.+.||
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred cceeeeecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEec
Confidence 568999999 77999887632 24688889999999999999999998 99999999999999733 56899999
Q ss_pred cccccccccc--------ccceecccccccC
Q 006145 631 NLPLLAENAE--------KVGHVIPYSGSID 653 (659)
Q Consensus 631 Gla~~~~~~~--------~~~~~~gt~~y~a 653 (659)
|+|+.+.+.. ......||..|.+
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYAS 189 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYAS 189 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehh
Confidence 9997664322 2245788988865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=161.37 Aligned_cols=144 Identities=14% Similarity=0.139 Sum_probs=111.7
Q ss_pred HHHHHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCC----------------------chHHHHHHHHHH
Q 006145 470 EELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH----------------------STRNFMHHIELI 527 (659)
Q Consensus 470 ~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~----------------------~~~~~~~Ei~~l 527 (659)
+++......|...+.||+|+||.||+|..++|+.||||++...... ....+.+|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444457778999999999999999888999999987543200 012367889999
Q ss_pred hCCCCCC--ccceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCC
Q 006145 528 SKLRHRH--LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVP 605 (659)
Q Consensus 528 ~~l~H~n--iv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 605 (659)
.++.|++ +...++. ...++||||+++++|.+.... .....++.++++++.++|+.
T Consensus 88 ~~l~~~~i~v~~~~~~-----------~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~--- 144 (198)
T cd05144 88 KALYEEGFPVPKPIDW-----------NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH--- 144 (198)
T ss_pred HHHHHcCCCCCceeec-----------CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---
Confidence 9998874 4444331 235899999999999875431 23457888999999999997
Q ss_pred CccccCCCCCceeecCCcceEEccCcccccc
Q 006145 606 GVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 606 ~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+|+||||||+||+++++++++|+|||.+...
T Consensus 145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999999999999999544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=161.99 Aligned_cols=136 Identities=13% Similarity=0.297 Sum_probs=113.4
Q ss_pred ceeccCcCceEEEEEecCCcEEEEEEecccCCCc--------hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 483 AFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHS--------TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
+.||+|++|.||+|+. +|..|+||......... ...+.+|++++..++|++|.....++.. ...
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-------~~~ 73 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-------PEN 73 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-------CCC
Confidence 5789999999999987 57789999865432211 2358899999999999999888777654 345
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++++|.+++... .+ .+..++.+++.+|+++|+. +++|||++|+||+++ ++.++|+|||.+.
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 78999999999999998642 22 7889999999999999998 999999999999999 7889999999987
Q ss_pred ccc
Q 006145 635 LAE 637 (659)
Q Consensus 635 ~~~ 637 (659)
...
T Consensus 143 ~~~ 145 (211)
T PRK14879 143 FSK 145 (211)
T ss_pred CCC
Confidence 543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.3e-19 Score=185.32 Aligned_cols=246 Identities=24% Similarity=0.210 Sum_probs=191.2
Q ss_pred EEEecCCCCc-CCCCcccCCCCCCcEEEcccCcCccc----CChhccCCCCCcEEEeecCCCCC------CCccccCCCC
Q 006145 111 VLRLVSLGLW-GPLSGKISRLSSLEILNMSSNFLNGA----IPQELSILTSLQTLILDENMLAG------RVPDWLGSLP 179 (659)
Q Consensus 111 ~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~l~~l~ 179 (659)
.|+|..+.++ ...+..|..+.+|+.|+++++.++.. ++..+...++|++|++++|.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4677778887 45566778888999999999999643 56677888999999999998873 2445678899
Q ss_pred CCCEEEccCCcCCccCCcccCCCCC---CcEEeccccccccCCC-----CCCCC-CcCCEEEcccCCCCCCCCC------
Q 006145 180 ILAVLSLRNNMFNGTLPDSFSYLEN---LRVLALSNNHFYGEVP-----DFSGL-TYLQVLDLENNALGPQFPK------ 244 (659)
Q Consensus 180 ~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p-----~~~~l-~~L~~L~L~~N~l~~~~~~------ 244 (659)
+|+.|++++|.+.+..+..+..+.+ |+.|++++|++++... .+..+ ++|+.|++++|.+++....
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 9999999999998777776666655 9999999999874211 24566 8999999999999853221
Q ss_pred -CCcccceEecCCCcCCcc----CchhccCCccccEEeccCcccccC----CchhhcCCCcccEEeccCCcCCCcCCcCC
Q 006145 245 -VGKKLVTMILSKNKFRSA----IPAEVSSYYQLQRLDLSSNRFVGP----FPQALLSLPSITYLNIADNKLTGKLFDDL 315 (659)
Q Consensus 245 -~~~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~p~~~ 315 (659)
...+|+.|++++|.+++. ++..+..+++|+.|+|++|.+++. ++..+..+++|++|++++|.+++.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 135899999999999853 344556677999999999998743 34556788999999999999986322222
Q ss_pred C-----CCCCCCEEECcCCCCc----ccCChhhhCCCCCCEEEcCCcccc
Q 006145 316 S-----CNPELGFVDLSSNLLT----GQLPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 316 ~-----~~~~L~~L~ls~N~l~----g~ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
. ..+.|+.|++++|.++ ..++..+...++++.+++++|.++
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 1 2478999999999997 344556666788999999999887
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.9e-17 Score=185.22 Aligned_cols=140 Identities=13% Similarity=0.211 Sum_probs=111.7
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEE-ecccCCC-------chHHHHHHHHHHhCCCCCCccceeeeeeeccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRC-LKMKKCH-------STRNFMHHIELISKLRHRHLVSALGHCFECYF 547 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~-l~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 547 (659)
...|...+.||+|+||+||+|.+.... +++|+ +...... ..+++.+|++++.+++|++++....++..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--- 407 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--- 407 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe---
Confidence 344566799999999999999876443 44443 3221111 12468899999999999999988777764
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEE
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKI 627 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl 627 (659)
....++||||+++++|.+++. .+..++.+++++|.|||+. +++|||+||+||++ +++.++|
T Consensus 408 ----~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 408 ----PEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred ----CCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEE
Confidence 345689999999999998875 3567999999999999998 99999999999999 5789999
Q ss_pred ccCcccccccc
Q 006145 628 SSYNLPLLAEN 638 (659)
Q Consensus 628 ~DFGla~~~~~ 638 (659)
+|||+++....
T Consensus 469 iDFGla~~~~~ 479 (535)
T PRK09605 469 IDFGLGKYSDL 479 (535)
T ss_pred EeCcccccCCc
Confidence 99999986643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.2e-18 Score=174.27 Aligned_cols=169 Identities=18% Similarity=0.280 Sum_probs=139.5
Q ss_pred hcCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCCchHHHHHHHHHHhCCC------CCCccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLR------HRHLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~------H~niv~l~g~~~~~~~~ 548 (659)
-..|.+....|+|-|++|.+|..+. |+.||||+|..... ..+.=++|+++|+++. -.|+++++-.|..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h---- 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH---- 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh----
Confidence 4567778888999999999999765 88999999975432 2244568999999994 3578888877765
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC-cceEE
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN-LVAKI 627 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl 627 (659)
..++|||+|-+.- +|.++|.......-|....+..++.|+.-||..|-.+ +|+|.||||.|||+.+. ..+||
T Consensus 506 ---knHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 506 ---KNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred ---cceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeee
Confidence 5789999999855 9999998654445677888999999999999999997 99999999999999976 67899
Q ss_pred ccCccccccccccccceecccccccCCCCC
Q 006145 628 SSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 628 ~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
||||-|..+... ..+++..+..|+|||.+
T Consensus 579 CDfGSA~~~~en-eitPYLVSRFYRaPEIi 607 (752)
T KOG0670|consen 579 CDFGSASFASEN-EITPYLVSRFYRAPEII 607 (752)
T ss_pred ccCccccccccc-cccHHHHHHhccCccee
Confidence 999999877543 45667788899999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.8e-17 Score=158.38 Aligned_cols=132 Identities=17% Similarity=0.289 Sum_probs=106.6
Q ss_pred eeccCcCceEEEEEecCCcEEEEEEecccCC-C-------chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 484 FMGEGSQGQMYRGRLKNGTFVAIRCLKMKKC-H-------STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 484 ~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.||+|+||.||+|.+ +|..|++|....... . ..+++.+|++++..++|+++.....++.. ....
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-------~~~~ 72 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-------PDNK 72 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-------CCCC
Confidence 479999999999985 578899998653321 1 12457889999999998876665555543 3346
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++++|.+++... . . .++.+++++|+++|+. +++|+|++|+||+++ ++.+++.|||+++.
T Consensus 73 ~lv~e~~~g~~l~~~~~~~---~-~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 73 TIVMEYIEGKPLKDVIEEG---N-D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEEECCccHHHHHhhc---H-H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 8999999999999987642 1 0 7899999999999998 999999999999999 88999999999876
Q ss_pred cc
Q 006145 636 AE 637 (659)
Q Consensus 636 ~~ 637 (659)
..
T Consensus 139 ~~ 140 (199)
T TIGR03724 139 SD 140 (199)
T ss_pred CC
Confidence 54
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.6e-17 Score=160.55 Aligned_cols=168 Identities=15% Similarity=0.183 Sum_probs=132.1
Q ss_pred cCCCCCceeccCcCceEEEEE-ecCCcEEEEEEecccCCCchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
-.|.+.++||+|.||++|.|+ +-+++.||||.-..... .-+...|.+..+.+. .++|...+-|-.+ ..+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqe-------G~~ 98 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQE-------GKY 98 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccc-------cch
Confidence 457888999999999999999 66799999998765442 335666777777664 5788877644333 455
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC-----cceEEcc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN-----LVAKISS 629 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~-----~~~kl~D 629 (659)
-.||+|.. |.||+|+..-. ...++...+..||.|++.-++|+|++ ..|.|||||+|+||... ..+.|.|
T Consensus 99 NiLVidLL-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 99 NILVIDLL-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred hhhhhhhh-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEe
Confidence 68999998 66888876532 34689999999999999999999999 99999999999999743 3589999
Q ss_pred Ccccccccccccc--------ceecccccccC------CCCCCC
Q 006145 630 YNLPLLAENAEKV--------GHVIPYSGSID------PTNSAR 659 (659)
Q Consensus 630 FGla~~~~~~~~~--------~~~~gt~~y~a------PE~~~~ 659 (659)
||+|+.+.+.... ....||..||+ -|||+|
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR 216 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRR 216 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhh
Confidence 9999988554322 45789999997 477754
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.7e-17 Score=158.01 Aligned_cols=145 Identities=12% Similarity=0.107 Sum_probs=115.3
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHH---------HHHHHHHHhCCCCCCccceeeeeeecc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRN---------FMHHIELISKLRHRHLVSALGHCFECY 546 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~---------~~~Ei~~l~~l~H~niv~l~g~~~~~~ 546 (659)
..+|...+.+|.|+||.||.... ++..+|||.+........+. |.+|++.+.+++|++|..+.+++....
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 57899999999999999999766 57789999997554333322 689999999999999999998866421
Q ss_pred ccC-CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcce
Q 006145 547 FDD-SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVA 625 (659)
Q Consensus 547 ~~~-~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~ 625 (659)
... .-....++||||++|.+|.++.. ++. ....+++.++..+|+. +++|||+||+||++++++ +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence 100 00235789999999999988732 222 2456899999999999 999999999999999988 9
Q ss_pred EEccCcccccc
Q 006145 626 KISSYNLPLLA 636 (659)
Q Consensus 626 kl~DFGla~~~ 636 (659)
++.|||.....
T Consensus 174 ~liDfg~~~~~ 184 (232)
T PRK10359 174 RIIDLSGKRCT 184 (232)
T ss_pred EEEECCCcccc
Confidence 99999988655
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-16 Score=163.54 Aligned_cols=167 Identities=22% Similarity=0.422 Sum_probs=139.4
Q ss_pred CCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCc---hHHHHHHHHHHhCCCCC-CccceeeeeeeccccCCCCce
Q 006145 479 FDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHS---TRNFMHHIELISKLRHR-HLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~~~~~~ 554 (659)
|...+.||.|+||.||++... ..+|+|.+....... ...|.+|+.+++.+.|+ +|+++.+++.. ...
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-------~~~ 72 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-------EGS 72 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-------CCE
Confidence 456688999999999999976 789999997655432 56799999999999988 79999998854 344
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc-ceEEccCccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL-VAKISSYNLP 633 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla 633 (659)
.++++||+.++++.+++........+.......+..+++.++.|+|+. +++|||+||+||+++... .++++|||.+
T Consensus 73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~ 149 (384)
T COG0515 73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLA 149 (384)
T ss_pred EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcc
Confidence 799999999999997776421102688889999999999999999998 899999999999999888 7999999999
Q ss_pred ccccccc-------ccceecccccccCCCCC
Q 006145 634 LLAENAE-------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~-------~~~~~~gt~~y~aPE~~ 657 (659)
+...... ......|+..|+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~ 180 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHh
Confidence 7554332 34678999999999975
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-16 Score=165.05 Aligned_cols=167 Identities=15% Similarity=0.172 Sum_probs=130.2
Q ss_pred CCCCCceeccCcCceEEEEEecCC--cEEEEEEecccCCCchHHHHHHHHHHhCCCC----CCccceeeeeeeccccCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKNG--TFVAIRCLKMKKCHSTRNFMHHIELISKLRH----RHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H----~niv~l~g~~~~~~~~~~~ 551 (659)
+|...+.||+|+||.||.+..... ..+|+|............+..|+.++..+.+ +++..+++.... .
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~------~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRS------T 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccC------C
Confidence 788899999999999999996543 5788888765533322378889999888863 578888776631 1
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC-----cceE
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN-----LVAK 626 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~-----~~~k 626 (659)
....++||+.+ |.+|.++..... ...++-....+|+.|++.+|+++|+. +++||||||.|+++... ..+.
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEE
Confidence 45679999998 679999876433 46799999999999999999999998 99999999999999854 4689
Q ss_pred EccCcccc--ccc-cc-------cc-cceecccccccCCC
Q 006145 627 ISSYNLPL--LAE-NA-------EK-VGHVIPYSGSIDPT 655 (659)
Q Consensus 627 l~DFGla~--~~~-~~-------~~-~~~~~gt~~y~aPE 655 (659)
+.|||+++ .+- .. .. .....||..|.++.
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~ 207 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASIN 207 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccHH
Confidence 99999998 321 11 01 13456999998874
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.9e-18 Score=172.98 Aligned_cols=229 Identities=22% Similarity=0.198 Sum_probs=180.4
Q ss_pred CCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccC-CcCCccCCcccCCCCCCcEEec
Q 006145 132 SLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRN-NMFNGTLPDSFSYLENLRVLAL 210 (659)
Q Consensus 132 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L 210 (659)
.-..++|..|+|+...|.+|..+.+|+.||||+|+|+.+-|++|.++.+|..|-+.+ |+|+...-..|++|.+|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 557899999999987788899999999999999999999999999999988887666 9999666678999999999999
Q ss_pred cccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCC---CcccceEecCCCcCC------------ccCchhccCCcccc
Q 006145 211 SNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKV---GKKLVTMILSKNKFR------------SAIPAEVSSYYQLQ 274 (659)
Q Consensus 211 s~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~---~~~L~~L~l~~N~l~------------~~~p~~~~~l~~L~ 274 (659)
.-|++.-...+ |..+++|..|.+.+|.+....-.. ...++.+.+..|.+. -..|.+++.+.-..
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 99999876665 999999999999999886443322 356677777777632 12233333332222
Q ss_pred EEeccCc-------------------------ccccCCc-hhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcC
Q 006145 275 RLDLSSN-------------------------RFVGPFP-QALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSS 328 (659)
Q Consensus 275 ~L~Ls~N-------------------------~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~ 328 (659)
...+.++ ...+.-| ..|..|++|+.|+|++|++++.-+.+|.....++.|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 2222222 2223333 3588999999999999999999999999999999999999
Q ss_pred CCCcccCChhhhCCCCCCEEEcCCccccCCCC
Q 006145 329 NLLTGQLPNCLLAGSKNRVVLYARNCLAAGNE 360 (659)
Q Consensus 329 N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~~~ 360 (659)
|++...--..+.++..|..|.+.+|+++...+
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~ 339 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAP 339 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEec
Confidence 99985555667788899999999999986544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.7e-16 Score=163.00 Aligned_cols=139 Identities=20% Similarity=0.345 Sum_probs=115.6
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCCC-----C---CCccceeeeeeecc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-----H---RHLVSALGHCFECY 546 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~g~~~~~~ 546 (659)
..+|...++||=|.|++||.|+. ++.+.||+|+.+... +-.+..+.||++|++++ | ..||+|+++|...+
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 46788899999999999999994 568899999997543 23466789999999884 2 47999999987633
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN 622 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~ 622 (659)
+...++|||+|+. |-+|..++.... .+-++...+.+|++||+.||.|||..| +|||.||||+|||+...
T Consensus 156 ---pNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 ---PNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred ---CCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 3467899999999 669999988532 345888999999999999999999998 99999999999999643
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.5e-16 Score=173.91 Aligned_cols=165 Identities=26% Similarity=0.377 Sum_probs=127.9
Q ss_pred cCCCHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCcCCCCCCCceEeCCCCEeEEEeCCCCCCCCCCCCCcCCcccccccC
Q 006145 26 EQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVK 105 (659)
Q Consensus 26 ~~~~~~~~~aLl~~k~~l~~~~~l~~W~~~~~~C~w~~~~~~gv~C~~~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~ 105 (659)
..+.++|.+||+++|..+.++.. .+|+ .++|......|.||.|.....+ .
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~-~~W~--g~~C~p~~~~w~Gv~C~~~~~~---------------------------~ 416 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR-FGWN--GDPCVPQQHPWSGADCQFDSTK---------------------------G 416 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc-CCCC--CCCCCCcccccccceeeccCCC---------------------------C
Confidence 34567899999999999876643 4795 3566322223458999521100 0
Q ss_pred CCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEE
Q 006145 106 LPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLS 185 (659)
Q Consensus 106 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 185 (659)
...++.|+|++|.+.|.+|..|+.|++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|+.++++++|+.|+
T Consensus 417 ~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~ 496 (623)
T PLN03150 417 KWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN 496 (623)
T ss_pred ceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEE
Confidence 11245677888888888899999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCcCCccCCcccCCC-CCCcEEeccccccccCCC
Q 006145 186 LRNNMFNGTLPDSFSYL-ENLRVLALSNNHFYGEVP 220 (659)
Q Consensus 186 L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p 220 (659)
|++|.++|.+|..++.+ .++..+++.+|......|
T Consensus 497 Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 497 LNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 99999999999888764 567888999887544333
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.1e-16 Score=141.85 Aligned_cols=136 Identities=13% Similarity=0.132 Sum_probs=113.5
Q ss_pred CceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCC--CCccceeeeeeeccccCCCCceeEEEE
Q 006145 482 SAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRH--RHLVSALGHCFECYFDDSSVSRIFLIF 559 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~~~~~~~~lV~ 559 (659)
.+.||+|.++.||++...+ ..+++|....... ..++.+|+.++..++| ..+.+++++... .+..+++|
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-------~~~~~~v~ 72 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGES-------DGWSYLLM 72 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-------CCccEEEE
Confidence 4679999999999999754 7899999865432 4578999999999976 588888876653 35689999
Q ss_pred eccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 560 EYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 560 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
||++++++..+ ++.....++.+++++++++|....++++|+|++|+||++++.+.+++.|||.++...
T Consensus 73 e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 73 EWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred EecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 99998777653 556778899999999999998655689999999999999998999999999997654
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.3e-15 Score=144.93 Aligned_cols=137 Identities=13% Similarity=0.212 Sum_probs=97.5
Q ss_pred CceeccCcCceEEEEEecCCcEEEEEEecccCCCc--hHHH----------------------HHHHHHHhCCCCCC--c
Q 006145 482 SAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHS--TRNF----------------------MHHIELISKLRHRH--L 535 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--~~~~----------------------~~Ei~~l~~l~H~n--i 535 (659)
.+.||+|+||+||+|+..+|+.||||++....... ...+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 36799999999999998889999999986532211 1111 34555555554332 3
Q ss_pred cceeeeeeeccccCCCCceeEEEEeccCCCChhh-hhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcC-CCCCCccccCCC
Q 006145 536 VSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRS-WISEGHAHQSLTWTQRISAAIGVAKGIQFLHT-GIVPGVFSNNLK 613 (659)
Q Consensus 536 v~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk 613 (659)
.+.+++ ...++||||+++|++.. .+... ... .+...++.+++.++.++|. . +|+|||||
T Consensus 82 ~~~~~~-----------~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~ 142 (187)
T cd05119 82 PKPIDL-----------NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLS 142 (187)
T ss_pred CceEec-----------CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCC
Confidence 333321 23589999999965532 22211 011 5568899999999999998 6 99999999
Q ss_pred CCceeecCCcceEEccCcccccccc
Q 006145 614 ITDILLDQNLVAKISSYNLPLLAEN 638 (659)
Q Consensus 614 ~~NILld~~~~~kl~DFGla~~~~~ 638 (659)
|+||+++ ++.++++|||.+.....
T Consensus 143 p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 143 EYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred hhhEEEE-CCcEEEEECcccccccC
Confidence 9999999 89999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=145.26 Aligned_cols=141 Identities=16% Similarity=0.174 Sum_probs=108.1
Q ss_pred Cceec-cCcCceEEEEEecCCcEEEEEEecccCC-------------CchHHHHHHHHHHhCCCCCCc--cceeeeeeec
Q 006145 482 SAFMG-EGSQGQMYRGRLKNGTFVAIRCLKMKKC-------------HSTRNFMHHIELISKLRHRHL--VSALGHCFEC 545 (659)
Q Consensus 482 ~~~ig-~G~~g~Vy~~~~~~g~~vavK~l~~~~~-------------~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~ 545 (659)
...|| .||.|+||+++.. +..++||++..... .....+.+|++++.+++|++| +..++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46787 8999999999875 77899998854210 122468899999999998875 6777765431
Q ss_pred cccCCCCceeEEEEeccCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc
Q 006145 546 YFDDSSVSRIFLIFEYVPN-GTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV 624 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~-GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~ 624 (659)
.. .....++||||+++ .+|.+++.. ..++.. .+.++++++++||+. +|+||||||.|||++.++.
T Consensus 115 ~~---~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~ 180 (239)
T PRK01723 115 HG---LFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGK 180 (239)
T ss_pred cC---cceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCC
Confidence 10 01224699999997 699998864 234433 356899999999998 9999999999999999899
Q ss_pred eEEccCccccccc
Q 006145 625 AKISSYNLPLLAE 637 (659)
Q Consensus 625 ~kl~DFGla~~~~ 637 (659)
++|+|||.+....
T Consensus 181 v~LIDfg~~~~~~ 193 (239)
T PRK01723 181 FWLIDFDRGELRT 193 (239)
T ss_pred EEEEECCCcccCC
Confidence 9999999987654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.5e-16 Score=149.42 Aligned_cols=162 Identities=22% Similarity=0.418 Sum_probs=129.2
Q ss_pred CceeccCcCceEEEEEecCCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEE
Q 006145 482 SAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIF 559 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~ 559 (659)
..+|.+...|+.|+|+++ |..+++|++...... ..++|..|.-.|+-+.||||+.++|.|.. +....++.
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-------ppnlv~is 266 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-------PPNLVIIS 266 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-------CCCceEee
Confidence 356788889999999997 677888888765432 34789999999999999999999999986 56789999
Q ss_pred eccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc--cCccccccc
Q 006145 560 EYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS--SYNLPLLAE 637 (659)
Q Consensus 560 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~--DFGla~~~~ 637 (659)
.||+.|+|+..||+. .....+..+.+++|.++|+||+|||+. .|-|..-.+.+..|++|++.+++|+ |--++...
T Consensus 267 q~mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe- 343 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE- 343 (448)
T ss_pred eeccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec-
Confidence 999999999999974 335678899999999999999999994 5556666799999999999999886 32222111
Q ss_pred cccccceecccccccCCCCCCC
Q 006145 638 NAEKVGHVIPYSGSIDPTNSAR 659 (659)
Q Consensus 638 ~~~~~~~~~gt~~y~aPE~~~~ 659 (659)
....-.+.||+||-+.|
T Consensus 344 -----~gr~y~pawmspealqr 360 (448)
T KOG0195|consen 344 -----VGRAYSPAWMSPEALQR 360 (448)
T ss_pred -----cccccCcccCCHHHHhc
Confidence 11234578999997643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.1e-15 Score=179.44 Aligned_cols=124 Identities=17% Similarity=0.183 Sum_probs=91.7
Q ss_pred CCCC-CCccceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCc
Q 006145 529 KLRH-RHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGV 607 (659)
Q Consensus 529 ~l~H-~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 607 (659)
.++| +||++++++|..+..+.......+.++||+ .++|+++++.. ...+++.++..++.||++||+|||+. +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4455 688889998754332222234577889988 55999999742 34699999999999999999999998 99
Q ss_pred cccCCCCCceeecC-------------------CcceEEccCcccccccccc-----------------ccceecccccc
Q 006145 608 FSNNLKITDILLDQ-------------------NLVAKISSYNLPLLAENAE-----------------KVGHVIPYSGS 651 (659)
Q Consensus 608 iHrDlk~~NILld~-------------------~~~~kl~DFGla~~~~~~~-----------------~~~~~~gt~~y 651 (659)
|||||||+||||+. ++.+|++|||+++...... .....+||++|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999953 4567778888775432100 00124689999
Q ss_pred cCCCCCC
Q 006145 652 IDPTNSA 658 (659)
Q Consensus 652 ~aPE~~~ 658 (659)
||||++.
T Consensus 182 ~APE~~~ 188 (793)
T PLN00181 182 TSPEEDN 188 (793)
T ss_pred EChhhhc
Confidence 9999863
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.3e-14 Score=162.29 Aligned_cols=110 Identities=25% Similarity=0.409 Sum_probs=101.5
Q ss_pred cceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcC
Q 006145 249 LVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSS 328 (659)
Q Consensus 249 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~ 328 (659)
+..|+|++|.+.|.+|..+..+++|+.|+|++|+|.|.+|..++.+++|+.|+|++|+++|.+|+.++.+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 77899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcccCChhhhCC-CCCCEEEcCCccccCC
Q 006145 329 NLLTGQLPNCLLAG-SKNRVVLYARNCLAAG 358 (659)
Q Consensus 329 N~l~g~ip~~~~~~-~~l~~l~~~~N~l~~~ 358 (659)
|+++|.+|..+... .++..+++.+|...+.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~ 530 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccC
Confidence 99999999998764 3566788888875543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.2e-13 Score=149.66 Aligned_cols=145 Identities=17% Similarity=0.186 Sum_probs=103.5
Q ss_pred CCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCc----------------------------------------h
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHS----------------------------------------T 517 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----------------------------------------~ 517 (659)
.|+ .+.||.|++|.||+|++++|+.||||+.+....+. .
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 36899999999999999999999999986431100 0
Q ss_pred HHHHHHHHHHhCC----CCCCccceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHH
Q 006145 518 RNFMHHIELISKL----RHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVA 593 (659)
Q Consensus 518 ~~~~~Ei~~l~~l----~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia 593 (659)
-+|.+|++.+.++ +|.+-|.+-.+|++. ....+|||||++|++|.++..... ... .+.+++..++
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~------~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~ 266 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDR------TSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLA 266 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhh------cCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHH
Confidence 1355666655555 233334444444321 234799999999999998765311 112 3456777766
Q ss_pred H-HhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 594 K-GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 594 ~-~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
+ .+..+|.. +++|+|++|.||++++++.+++.|||++....
T Consensus 267 ~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 267 RSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 6 47788887 99999999999999999999999999996654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.9e-15 Score=158.07 Aligned_cols=187 Identities=28% Similarity=0.428 Sum_probs=152.6
Q ss_pred CCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcE
Q 006145 128 SRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRV 207 (659)
Q Consensus 128 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 207 (659)
..|+.-...||+.|++. .+|..+..+..|+.|.|..|.+. .+|..+.++..|++|||+.|+++ .+|..+..|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 45666677888888887 78888888888888888888886 77888888888888888888888 7777777776 888
Q ss_pred EeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCC
Q 006145 208 LALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPF 287 (659)
Q Consensus 208 L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 287 (659)
|-+++|+++..+++++.+..|..||.+.|.+ -.+|..++++.+|+.|.+..|++. .+
T Consensus 148 li~sNNkl~~lp~~ig~~~tl~~ld~s~nei----------------------~slpsql~~l~slr~l~vrRn~l~-~l 204 (722)
T KOG0532|consen 148 LIVSNNKLTSLPEEIGLLPTLAHLDVSKNEI----------------------QSLPSQLGYLTSLRDLNVRRNHLE-DL 204 (722)
T ss_pred EEEecCccccCCcccccchhHHHhhhhhhhh----------------------hhchHHhhhHHHHHHHHHhhhhhh-hC
Confidence 8888888887777777777777777777665 347888999999999999999998 57
Q ss_pred chhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCC
Q 006145 288 PQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSK 344 (659)
Q Consensus 288 p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~ 344 (659)
|..+..|+ |..||++.|+++ .+|-.|..+..|++|-|.+|.|. +.|+.+....+
T Consensus 205 p~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGk 258 (722)
T KOG0532|consen 205 PEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGK 258 (722)
T ss_pred CHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccc
Confidence 88888665 889999999998 78888999999999999999998 66776654443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.4e-15 Score=155.37 Aligned_cols=196 Identities=27% Similarity=0.379 Sum_probs=167.6
Q ss_pred CCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEE
Q 006145 105 KLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVL 184 (659)
Q Consensus 105 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (659)
.+..-...||+.|.+ ..+|..+..+..|+.|.|..|.+. .+|..+.++..|++|||+.|+++ .+|..+..|+ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~-~elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRF-SELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhcccccc-ccCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 455567789999998 468889999999999999999998 89999999999999999999998 7898899887 9999
Q ss_pred EccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCc
Q 006145 185 SLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIP 264 (659)
Q Consensus 185 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p 264 (659)
-+++|+++ .+|+.++.+..|..||.+.|.+...++.++++.+|+.|.+..|++. .+|
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~----------------------~lp 205 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE----------------------DLP 205 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh----------------------hCC
Confidence 99999998 8999999999999999999999988888999999999999888873 366
Q ss_pred hhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCC---CCCCEEECcCCC
Q 006145 265 AEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCN---PELGFVDLSSNL 330 (659)
Q Consensus 265 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~---~~L~~L~ls~N~ 330 (659)
.++..| .|..||+|.|+++ .+|-.|.+|..|++|-|.+|.|.. .|..+... -=-++|+..-.+
T Consensus 206 ~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS-PPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 206 EELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS-PPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred HHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC-ChHHHHhccceeeeeeecchhcc
Confidence 777744 5899999999998 799999999999999999999984 34433221 123566666554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.6e-14 Score=156.46 Aligned_cols=164 Identities=18% Similarity=0.295 Sum_probs=125.2
Q ss_pred CCCceeccCcCceEEEEEec-CCcEEEEEEeccc--CCCchH----HHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 480 DTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMK--KCHSTR----NFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 480 ~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~----~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
...+++|.|++|.|+..... .....+.|..+.. .....+ .+..|..+=..++|+|++..+..+.+ .
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~-------~ 393 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE-------I 393 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh-------c
Confidence 34678999999988877743 3444455543311 111222 25567777888999999988887765 2
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...+-+||||++ ||+..+.+. ..++..++..+..|+.+|++|+|+. +|.|||+|++|++++.++.+||+|||.
T Consensus 394 ~~~~~~mE~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 394 DGILQSMEYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred ccchhhhhcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCc
Confidence 233444999999 999998752 3588888999999999999999999 999999999999999999999999999
Q ss_pred ccccccc-----cccceecccccccCCCCC
Q 006145 633 PLLAENA-----EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~-----~~~~~~~gt~~y~aPE~~ 657 (659)
+....-+ ......+|+..|+|||..
T Consensus 467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~ 496 (601)
T KOG0590|consen 467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVL 496 (601)
T ss_pred ceeeccCcchhhhhhcCcccCCcCcCcccc
Confidence 8544221 334678999999999986
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-13 Score=156.82 Aligned_cols=165 Identities=20% Similarity=0.264 Sum_probs=119.1
Q ss_pred HHHHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCC---CCCccceeeeeeeccc
Q 006145 471 ELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLR---HRHLVSALGHCFECYF 547 (659)
Q Consensus 471 ~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~ 547 (659)
+.+.-.+.|.+...||+|+||+||+|...+|+.||+|.-+....= +|.-=.+++.+|+ -+-|..+..++..
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~--- 765 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVF--- 765 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHcc---
Confidence 334445678888999999999999999888999999987643310 1111112333333 1234444333332
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec-------
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD------- 620 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld------- 620 (659)
.+.-+||+||.+.|+|.+++.. .+..+|...+.++.++++-+++||.. +|||+||||+|+||.
T Consensus 766 ----~~~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 766 ----QNASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred ----CCcceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCC
Confidence 3456899999999999999984 46799999999999999999999998 999999999999994
Q ss_pred CCcceEEccCcccccc---ccccccceecccccc
Q 006145 621 QNLVAKISSYNLPLLA---ENAEKVGHVIPYSGS 651 (659)
Q Consensus 621 ~~~~~kl~DFGla~~~---~~~~~~~~~~gt~~y 651 (659)
+...++|.|||-+-.+ .+...-...++|-.+
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f 869 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLF 869 (974)
T ss_pred cccceEEEecccceeeeEcCCCcEEeeeeccccc
Confidence 2346899999998433 344344445555544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.4e-14 Score=151.65 Aligned_cols=159 Identities=17% Similarity=0.212 Sum_probs=128.4
Q ss_pred eeccCcCceEEEEE----ecCCcEEEEEEecccCCCc--hHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCCceeE
Q 006145 484 FMGEGSQGQMYRGR----LKNGTFVAIRCLKMKKCHS--TRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 484 ~ig~G~~g~Vy~~~----~~~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
.+|+|.||.|+.++ ...|+.+|+|.+++..... ......|..++..++ ||.+|++.-.+.. ....+
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-------~~kl~ 73 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-------DGKLY 73 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-------ccchh
Confidence 36899999999876 2237889999887653221 124567788899997 9999999866654 56789
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
++.+|..+|+|...+.. ....+......+...+|-|++++|.. +|+|||+|++||++|.+|.+|+.|||+.+..
T Consensus 74 l~ld~~rgg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~ 147 (612)
T KOG0603|consen 74 LILDFLRGGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEA 147 (612)
T ss_pred Hhhhhcccchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHh
Confidence 99999999999988765 24567777777888899999999998 9999999999999999999999999999866
Q ss_pred ccccccceecccccccCCCCCC
Q 006145 637 ENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 637 ~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
-.... .|||..|||||...
T Consensus 148 v~~~~---~cgt~eymApEI~~ 166 (612)
T KOG0603|consen 148 VKEKI---ACGTYEYRAPEIIN 166 (612)
T ss_pred Hhhhh---cccchhhhhhHhhh
Confidence 33222 29999999999863
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=9e-13 Score=142.47 Aligned_cols=198 Identities=30% Similarity=0.391 Sum_probs=135.6
Q ss_pred EEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCC-CCCEEEccCCcCCccCCcccCCCCCCcEEecccc
Q 006145 135 ILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLP-ILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNN 213 (659)
Q Consensus 135 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 213 (659)
.|+++.|.+... +..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 566666666422 233445566777777777766 5555555563 6777777777776 45556677777777777777
Q ss_pred ccccCCCCCCCCCcCCEEEcccCCCCCCCCC--CCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhh
Q 006145 214 HFYGEVPDFSGLTYLQVLDLENNALGPQFPK--VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQAL 291 (659)
Q Consensus 214 ~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~--~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 291 (659)
+++...+..+.+++|+.|++++|+++...+. ....|+++.+++|.+. .++..+.++.++..|.+++|++. .++..+
T Consensus 174 ~l~~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~ 251 (394)
T COG4886 174 DLSDLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESI 251 (394)
T ss_pred hhhhhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchh
Confidence 7765555555667777777777777655554 3445777777777532 35566778888888888888876 347778
Q ss_pred cCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhh
Q 006145 292 LSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCL 339 (659)
Q Consensus 292 ~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~ 339 (659)
+.+++|+.|++++|.++...+ ++.+.+++.||+++|.++..+|...
T Consensus 252 ~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 252 GNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred ccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence 888888888888888885433 7788888888888888886666543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.3e-12 Score=141.35 Aligned_cols=199 Identities=31% Similarity=0.397 Sum_probs=152.5
Q ss_pred EEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCC-CCcEEEeecCCCCCCCccccCCCCCCCEEEccCC
Q 006145 111 VLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILT-SLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189 (659)
Q Consensus 111 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 189 (659)
.|++..|.+...+. .+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~~~-~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccCch-hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 57777777644332 3556688889999999888 6676677774 8899999999887 66677888889999999999
Q ss_pred cCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCC--CCcccceEecCCCcCCccCchhc
Q 006145 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPK--VGKKLVTMILSKNKFRSAIPAEV 267 (659)
Q Consensus 190 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~--~~~~L~~L~l~~N~l~~~~p~~~ 267 (659)
+++ .+|...+.+++|+.|++++|+++..++....+..|++|.+++|.+...+.. ...++..+.+.+|++.. ++..+
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~ 251 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED-LPESI 251 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee-ccchh
Confidence 888 566666688888899999998886665555666788888988853333222 24667777788888754 36788
Q ss_pred cCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCC
Q 006145 268 SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLS 316 (659)
Q Consensus 268 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~ 316 (659)
+.+++++.|++++|.++. ++. ++.+.+|+.|++++|.++..+|....
T Consensus 252 ~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 252 GNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred ccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhhhc
Confidence 889999999999999984 444 88999999999999999877776544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.5e-11 Score=116.26 Aligned_cols=132 Identities=14% Similarity=0.025 Sum_probs=97.5
Q ss_pred ceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccc-eeeeeeeccccCCCCceeEEEEec
Q 006145 483 AFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVS-ALGHCFECYFDDSSVSRIFLIFEY 561 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~~~~~~~~~~~~~~lV~Ey 561 (659)
+.++.|.++.||+++.. +..|++|....... ....+.+|++++..+.+.++++ ++++. ....++||||
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~---------~~~~~lv~e~ 72 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD---------PETGVLITEF 72 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe---------CCCCeEEEEe
Confidence 56788999999999875 77899998754331 2345788999999887655554 44322 1234899999
Q ss_pred cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCC--CCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 562 VPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI--VPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 562 ~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
+++.++.+. . .....++.+++++++.||... .+.++|+|++|.||+++ ++.+++.|||.+...+
T Consensus 73 i~G~~l~~~-~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~~ 138 (170)
T cd05151 73 IEGSELLTE-D----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMND 138 (170)
T ss_pred cCCCccccc-c----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCCC
Confidence 999887653 1 011345678999999999972 22369999999999999 6689999999987654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.2e-11 Score=135.60 Aligned_cols=145 Identities=14% Similarity=0.155 Sum_probs=94.4
Q ss_pred hcCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCC--------------------------c--------h---
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCH--------------------------S--------T--- 517 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~--------------------------~--------~--- 517 (659)
-..|+. +.||+|++|.||+|++++ |+.||||+++..-.+ + .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 789999999999999987 999999999643100 0 0
Q ss_pred ---HHHHHHHHHHhCCC----CCCccceeeeeeeccccCCCCceeEEEEeccCCCChhhh--hcCCC-CCCCCCHHHHHH
Q 006145 518 ---RNFMHHIELISKLR----HRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW--ISEGH-AHQSLTWTQRIS 587 (659)
Q Consensus 518 ---~~~~~Ei~~l~~l~----H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~--l~~~~-~~~~l~~~~~~~ 587 (659)
-+|.+|++-+.+++ +.+.+.+-.++++ -....+|||||++|+.+.++ +.... ....+.......
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d------~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~ 271 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWD------YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV 271 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecc------cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence 12455555444442 4444444444442 12457899999999999874 22210 000122222222
Q ss_pred HHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc----ceEEccCccccccc
Q 006145 588 AAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL----VAKISSYNLPLLAE 637 (659)
Q Consensus 588 i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~----~~kl~DFGla~~~~ 637 (659)
++.|+ +.. +++|+|+||.||+++.++ .+++.|||++...+
T Consensus 272 ~~~Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 272 FFTQV-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHH-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 33333 334 999999999999999888 99999999986553
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.8e-12 Score=131.72 Aligned_cols=99 Identities=13% Similarity=0.281 Sum_probs=86.5
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..|+.|++|.-.+|.+|+.+.......+|.....++.|++.|++| + +.+|||+||.||....+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999865555678899999999999999999 4 8899999999999999999999999998
Q ss_pred ccccccc-------ccceecccccccCCCCCC
Q 006145 634 LLAENAE-------KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 634 ~~~~~~~-------~~~~~~gt~~y~aPE~~~ 658 (659)
....... ..+..+||.+||+|||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~ 435 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIR 435 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHh
Confidence 6654444 446789999999999985
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.1e-10 Score=110.56 Aligned_cols=148 Identities=17% Similarity=0.243 Sum_probs=113.3
Q ss_pred ceeccCcCceEEEEEecCCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCC--CccceeeeeeeccccCCCCceeEEEE
Q 006145 483 AFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHR--HLVSALGHCFECYFDDSSVSRIFLIF 559 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~~~~~~~~~~~~~lV~ 559 (659)
+.++.|..+.||+++..+|..+++|....... ....++.+|+++++.+++. .+.++++++.... ..+..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~----~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS----VLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC----ccCCceEEE
Confidence 56899999999999987778999999765432 1345789999999999763 4567777665311 012468999
Q ss_pred eccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCC------------------------------------
Q 006145 560 EYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI------------------------------------ 603 (659)
Q Consensus 560 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------ 603 (659)
||++++++.+.+.. ..++..++..++.+++++|++||+..
T Consensus 80 e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 80 ERVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 99999988876532 24778888889999999999998521
Q ss_pred -----------------CCCccccCCCCCceeecC--CcceEEccCcccccccc
Q 006145 604 -----------------VPGVFSNNLKITDILLDQ--NLVAKISSYNLPLLAEN 638 (659)
Q Consensus 604 -----------------~~~iiHrDlk~~NILld~--~~~~kl~DFGla~~~~~ 638 (659)
...++|+|+.+.||++++ ++.+.|.||+.+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g~~ 209 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLGDP 209 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccCCh
Confidence 245799999999999998 66789999998875543
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.5e-11 Score=118.76 Aligned_cols=171 Identities=15% Similarity=0.167 Sum_probs=104.4
Q ss_pred CCCceeccCcCceEEEEEecC-CcEEEEEEecccCC---CchHHHHHHHHHHhCCCC----------CCccceeeeeeec
Q 006145 480 DTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKC---HSTRNFMHHIELISKLRH----------RHLVSALGHCFEC 545 (659)
Q Consensus 480 ~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H----------~niv~l~g~~~~~ 545 (659)
...+.||.|+++.||.++... |+.+|||....... ...+++.+|.-....+.+ -.++.-++.....
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 346889999999999999764 99999999864432 233567777655544322 2222223332211
Q ss_pred cccC----CC-Cc-----eeEEEEeccCCCChhhhhc---CC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccC
Q 006145 546 YFDD----SS-VS-----RIFLIFEYVPNGTLRSWIS---EG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNN 611 (659)
Q Consensus 546 ~~~~----~~-~~-----~~~lV~Ey~~~GsL~~~l~---~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrD 611 (659)
.... .. .. ..+++|+-+ .+||.+++. .. .....+....|..+..|+++.+++||+. +++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 1000 00 01 236778877 458887754 21 1112345566788889999999999999 999999
Q ss_pred CCCCceeecCCcceEEccCccccccccccccceecccccccCCCC
Q 006145 612 LKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTN 656 (659)
Q Consensus 612 lk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~ 656 (659)
|||+|++++++|.++++||+........... ...+..|.+||.
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~ 213 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPEL 213 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhh
Confidence 9999999999999999999877655332221 334567888874
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.8e-11 Score=118.59 Aligned_cols=120 Identities=16% Similarity=0.226 Sum_probs=88.1
Q ss_pred CCCCCccceeeeeeecccc--------------------CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHH
Q 006145 530 LRHRHLVSALGHCFECYFD--------------------DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAA 589 (659)
Q Consensus 530 l~H~niv~l~g~~~~~~~~--------------------~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~ 589 (659)
.+|||||++.+++.+.-.- .+.+...|+||.-++. +|++++.. ...+...+.-+.
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHH
Confidence 3699999999988653210 0234568999998877 99999985 345666677788
Q ss_pred HHHHHHhhhhcCCCCCCccccCCCCCceee--cCCc--ceEEccCccccccccc-----c--ccceecccccccCCCCC
Q 006145 590 IGVAKGIQFLHTGIVPGVFSNNLKITDILL--DQNL--VAKISSYNLPLLAENA-----E--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 590 ~~ia~~L~yLH~~~~~~iiHrDlk~~NILl--d~~~--~~kl~DFGla~~~~~~-----~--~~~~~~gt~~y~aPE~~ 657 (659)
.|+++|+.|||.+ +|.|||+|++|||+ |+|. ...|+|||.+--.+.. . ..-..-|.-.-||||++
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 8999999999998 99999999999998 4443 4689999976332220 0 11223466678999975
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.8e-10 Score=107.85 Aligned_cols=136 Identities=9% Similarity=0.090 Sum_probs=98.0
Q ss_pred ceeccCcCceEEEEEecC-------CcEEEEEEecccC---------C------------Cc-hHHH----HHHHHHHhC
Q 006145 483 AFMGEGSQGQMYRGRLKN-------GTFVAIRCLKMKK---------C------------HS-TRNF----MHHIELISK 529 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~-------g~~vavK~l~~~~---------~------------~~-~~~~----~~Ei~~l~~ 529 (659)
..||.|.-+.||.|.-.+ +..+|||..+... . .. .+.+ .+|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998543 4799999875321 0 00 1122 389999998
Q ss_pred CCC--CCccceeeeeeeccccCCCCceeEEEEeccCCCChhh-hhcCCCCCCCCCHHHHHHHHHHHHHHhhhh-cCCCCC
Q 006145 530 LRH--RHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRS-WISEGHAHQSLTWTQRISAAIGVAKGIQFL-HTGIVP 605 (659)
Q Consensus 530 l~H--~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~ 605 (659)
+.. -++.+++++. ..++||||+.++.+.. .+.+ ..++..+...+..+++.+|.++ |..
T Consensus 83 l~~~Gv~vP~pi~~~-----------~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~--- 144 (197)
T cd05146 83 MQKAGIPCPEVVVLK-----------KHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC--- 144 (197)
T ss_pred HHHcCCCCCeEEEec-----------CCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---
Confidence 853 4666666532 2589999997754432 2332 2344455677889999999999 776
Q ss_pred CccccCCCCCceeecCCcceEEccCccccccc
Q 006145 606 GVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 606 ~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
++||+|+++.||+++ ++.+.|.|||.+...+
T Consensus 145 glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 145 NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999999999997 4679999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.5e-11 Score=137.94 Aligned_cols=165 Identities=16% Similarity=0.177 Sum_probs=123.4
Q ss_pred CCCCCceeccCcCceEEEEEecCCcEEEEEEecccC-CCchHHHHHHHHH--HhCCCCCCccceeeeeeeccccCCCCce
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKK-CHSTRNFMHHIEL--ISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++...+.+|++.|=+|.||+.+.|. |+||++-+.. .-..+.|.++++- ...++|||++++.-+-.. .+.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t-------~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT-------DKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh-------hHH
Confidence 5666789999999999999998887 8999986554 3344556555443 445689999998765432 345
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.|||=+|+.+ +|+|.+..+ .-+...+.+=||.|+..|+.-+|.. +|.|+|||.+|||+..-.=+.++||.--|
T Consensus 96 AylvRqyvkh-nLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 96 AYLVRQYVKH-NLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHHHHHHHhh-hhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccC
Confidence 6888889876 999988752 3467777888999999999999998 99999999999999998889999997654
Q ss_pred cc----ccccccceecccc----cccCCCCC
Q 006145 635 LA----ENAEKVGHVIPYS----GSIDPTNS 657 (659)
Q Consensus 635 ~~----~~~~~~~~~~gt~----~y~aPE~~ 657 (659)
.. +++...+-.--|. =|+|||.-
T Consensus 169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERF 199 (1431)
T KOG1240|consen 169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERF 199 (1431)
T ss_pred CccCCCCCcccceEEEecCCceeeecChHhh
Confidence 22 2222222222222 49999953
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.6e-11 Score=111.87 Aligned_cols=126 Identities=29% Similarity=0.334 Sum_probs=46.7
Q ss_pred ccCCCCCCEEEecCCCCcCCCCcccC-CCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCcccc-CCCCC
Q 006145 103 LVKLPDLKVLRLVSLGLWGPLSGKIS-RLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWL-GSLPI 180 (659)
Q Consensus 103 l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~ 180 (659)
+.+...++.|+|.+|.++.. +.++ .+.+|+.|||++|.|+. ++ .+..++.|++|++++|+++. +++.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 34455678888888888653 2354 57888888888888874 43 47778888888888888874 44344 46788
Q ss_pred CCEEEccCCcCCccCC-cccCCCCCCcEEeccccccccCCCC----CCCCCcCCEEEc
Q 006145 181 LAVLSLRNNMFNGTLP-DSFSYLENLRVLALSNNHFYGEVPD----FSGLTYLQVLDL 233 (659)
Q Consensus 181 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~l~~L~~L~L 233 (659)
|++|+|++|+|...-- ..++.+++|+.|+|.+|.++...-. +..+++|+.||-
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 8888888888864211 3456788888888888888754221 566778887764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-10 Score=110.48 Aligned_cols=77 Identities=13% Similarity=0.071 Sum_probs=65.8
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccccccce
Q 006145 565 GTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGH 644 (659)
Q Consensus 565 GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 644 (659)
|||.++++.. ...++|.++..|+.|+++||+|||+. + ||+||++++++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 7899999752 24699999999999999999999997 3 999999999999999 99998764432
Q ss_pred ecccccccCCCCCC
Q 006145 645 VIPYSGSIDPTNSA 658 (659)
Q Consensus 645 ~~gt~~y~aPE~~~ 658 (659)
..||+.|||||++.
T Consensus 64 ~~g~~~y~aPE~~~ 77 (176)
T smart00750 64 SRVDPYFMAPEVIQ 77 (176)
T ss_pred CCCcccccChHHhc
Confidence 36899999999863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-10 Score=125.16 Aligned_cols=120 Identities=23% Similarity=0.365 Sum_probs=99.4
Q ss_pred HhCCCCCCccceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCC
Q 006145 527 ISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPG 606 (659)
Q Consensus 527 l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 606 (659)
|+.+.|.|+.+++|.|.+ ....+.|.+||..|+|.+.+... ...++|.....+.+++++||+|+|+. +
T Consensus 1 l~~l~h~n~~~f~g~~~~-------~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s---~ 68 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD-------GPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS---P 68 (484)
T ss_pred CcccchhhhhhheeeEec-------CCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC---c
Confidence 457899999999999997 35689999999999999999852 46799999999999999999999986 4
Q ss_pred c-cccCCCCCceeecCCcceEEccCccccccccc---cccceecccccccCCCCCC
Q 006145 607 V-FSNNLKITDILLDQNLVAKISSYNLPLLAENA---EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 607 i-iHrDlk~~NILld~~~~~kl~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~~ 658 (659)
| .|+.++++|+++|....+|++|||+....+.. .......-..-|.|||-++
T Consensus 69 i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr 124 (484)
T KOG1023|consen 69 IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLR 124 (484)
T ss_pred ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhc
Confidence 4 99999999999999999999999998766421 1112223444688999764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-09 Score=101.08 Aligned_cols=134 Identities=14% Similarity=0.267 Sum_probs=98.1
Q ss_pred ceeccCcCceEEEEEecCCcEEEEEE-ecccCCCc-------hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 483 AFMGEGSQGQMYRGRLKNGTFVAIRC-LKMKKCHS-------TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~g~~vavK~-l~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..+++|+-+.+|.+.+. |..+++|. +++....+ .++..+|++++.+++--.|....=|..+ ++.
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-------~~~ 73 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-------PDN 73 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-------CCC
Confidence 35788999999999775 44455554 44443332 1457899999999875444444334443 455
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
..++|||+++-.|.+.+.+. +..++..|-+-+.-||.. +|||+|+.++||++..+. +.+.||||+.
T Consensus 74 ~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 74 GLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred CEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccc
Confidence 78999999999999888752 245666666677789998 999999999999998665 8999999997
Q ss_pred cccc
Q 006145 635 LAEN 638 (659)
Q Consensus 635 ~~~~ 638 (659)
..+.
T Consensus 140 ~s~~ 143 (204)
T COG3642 140 FSDE 143 (204)
T ss_pred cccc
Confidence 6543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.3e-11 Score=123.19 Aligned_cols=181 Identities=22% Similarity=0.274 Sum_probs=92.4
Q ss_pred CCCCCCcEEEcccCcCcccCC--hhccCCCCCcEEEeecCCCCCCCc--cccCCCCCCCEEEccCCcCCccCCcccCCCC
Q 006145 128 SRLSSLEILNMSSNFLNGAIP--QELSILTSLQTLILDENMLAGRVP--DWLGSLPILAVLSLRNNMFNGTLPDSFSYLE 203 (659)
Q Consensus 128 ~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 203 (659)
+++++|+...|.+.... ..+ .-...|++++.||||.|-|....| .....|++|+.|+|+.|++.-...+..
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~---- 192 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNT---- 192 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccc----
Confidence 45666666666666554 222 234456666666666666654333 233455566666666665542211111
Q ss_pred CCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCC----CCCCCcccceEecCCCcCCccCchhccCCccccEEecc
Q 006145 204 NLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQ----FPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLS 279 (659)
Q Consensus 204 ~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~----~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 279 (659)
-..++.|+.|.|+.|.|+-. +-..+++|+.|+|..|.....-......+..|+.|||+
T Consensus 193 ------------------~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs 254 (505)
T KOG3207|consen 193 ------------------TLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLS 254 (505)
T ss_pred ------------------hhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhcccc
Confidence 11234444555555544311 11123455555555553222222233445566667776
Q ss_pred CcccccCCc--hhhcCCCcccEEeccCCcCCCcC-CcC-----CCCCCCCCEEECcCCCCc
Q 006145 280 SNRFVGPFP--QALLSLPSITYLNIADNKLTGKL-FDD-----LSCNPELGFVDLSSNLLT 332 (659)
Q Consensus 280 ~N~l~~~~p--~~l~~l~~L~~L~l~~N~l~~~~-p~~-----~~~~~~L~~L~ls~N~l~ 332 (659)
+|++-. .+ ...+.++.|..|+++.+.++..- |+. ...+++|++|+++.|++.
T Consensus 255 ~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 255 NNNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred CCcccc-cccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 666652 23 34566677777777777665421 222 245677788888887774
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.4e-11 Score=131.92 Aligned_cols=195 Identities=30% Similarity=0.353 Sum_probs=93.7
Q ss_pred CCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEE
Q 006145 105 KLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVL 184 (659)
Q Consensus 105 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (659)
.+..++.+++..|.+.. +-..+..+++|+.|++..|+|.+ +...+..+++|++|+|++|.|+... .+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhh
Confidence 34455555555555543 22335556666666666666653 2222455666666666666665332 23444556666
Q ss_pred EccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCC-CCcccceEecCCCcCCcc
Q 006145 185 SLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPK-VGKKLVTMILSKNKFRSA 262 (659)
Q Consensus 185 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~-~~~~L~~L~l~~N~l~~~ 262 (659)
++++|.++.. ..+..+++|+.+++++|++....+. ...+.+|+.+++.+|.+...-.. ....+..+++..|.++..
T Consensus 146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~~~~~~~~l~~~~l~~n~i~~~ 223 (414)
T KOG0531|consen 146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIEGLDLLKKLVLLSLLDNKISKL 223 (414)
T ss_pred eeccCcchhc--cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhcccchHHHHHHHHhhcccccceec
Confidence 6666665522 2344455666666666665543332 34555555566655555322211 122333334444444332
Q ss_pred CchhccCCc--cccEEeccCcccccCCchhhcCCCcccEEeccCCcCC
Q 006145 263 IPAEVSSYY--QLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLT 308 (659)
Q Consensus 263 ~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 308 (659)
-+. ..+. .|+.+++++|++. ..+..+..+..+..|++.+|++.
T Consensus 224 ~~l--~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 224 EGL--NELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred cCc--ccchhHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 111 1111 2455555555554 22233444444555555555444
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.8e-11 Score=116.88 Aligned_cols=134 Identities=25% Similarity=0.322 Sum_probs=82.8
Q ss_pred cCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEec
Q 006145 175 LGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMIL 254 (659)
Q Consensus 175 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l 254 (659)
+.....|+.||||+|.|+ .+.++..-++.++.|++|+|.+.. +..+..|.+|+.|||++|.++
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~nLa~L~~L~~LDLS~N~Ls--------------- 342 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQNLAELPQLQLLDLSGNLLA--------------- 342 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-ehhhhhcccceEeecccchhH---------------
Confidence 334455666666666666 455566666666666666666652 223555555666666555543
Q ss_pred CCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcC-CcCCCCCCCCCEEECcCCCCcc
Q 006145 255 SKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKL-FDDLSCNPELGFVDLSSNLLTG 333 (659)
Q Consensus 255 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~-p~~~~~~~~L~~L~ls~N~l~g 333 (659)
. +..+-..+.+.+.|.|+.|.|.. -+.++++-+|..||+++|++.... -..++++|.|+.+.|.+|.+.+
T Consensus 343 ------~-~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 343 ------E-CVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred ------h-hhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 2 33344455667777777776642 234666777777788777775322 2457788888888888888875
Q ss_pred c
Q 006145 334 Q 334 (659)
Q Consensus 334 ~ 334 (659)
.
T Consensus 414 ~ 414 (490)
T KOG1259|consen 414 S 414 (490)
T ss_pred c
Confidence 3
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.5e-11 Score=130.61 Aligned_cols=196 Identities=28% Similarity=0.282 Sum_probs=150.9
Q ss_pred CCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcE
Q 006145 128 SRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRV 207 (659)
Q Consensus 128 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 207 (659)
..+..++.+++..|.+.. +-..+..+++|+.|++.+|+|.+. ...+..+++|++|+|++|.|+... .+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhh
Confidence 567888888899999974 445578899999999999999843 434788999999999999998654 4677888999
Q ss_pred EeccccccccCCCCCCCCCcCCEEEcccCCCCCCCC---CCCcccceEecCCCcCCccCchhccCCccccEEeccCcccc
Q 006145 208 LALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFP---KVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFV 284 (659)
Q Consensus 208 L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~---~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 284 (659)
|++++|.++ .+..+..+++|+.+++++|.+...-+ ....+++.+++.+|.+... ..+..+..+..+++..|.++
T Consensus 145 L~l~~N~i~-~~~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 145 LNLSGNLIS-DISGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred heeccCcch-hccCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccce
Confidence 999999997 45567779999999999999987777 5577888899999988643 33444556666688888887
Q ss_pred cCCchhhcCCC--cccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcc
Q 006145 285 GPFPQALLSLP--SITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG 333 (659)
Q Consensus 285 ~~~p~~l~~l~--~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g 333 (659)
-.-+ +..+. .|+.+++++|++.- ++..+..+..+..+|+.+|++..
T Consensus 222 ~~~~--l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~ 269 (414)
T KOG0531|consen 222 KLEG--LNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISN 269 (414)
T ss_pred eccC--cccchhHHHHHHhcccCcccc-ccccccccccccccchhhccccc
Confidence 4322 22223 37888999998873 33556677888888998888874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.8e-10 Score=129.12 Aligned_cols=171 Identities=18% Similarity=0.212 Sum_probs=130.8
Q ss_pred hcCCCCCceeccCcCceEEEEEec--CCcEEEEEEecccC--CCchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK--NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~ 550 (659)
...|...+.||+|.|+.|-..... ....+|+|.+.... ....+....|..+-..+. |+|++.+++....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~------ 92 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS------ 92 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC------
Confidence 344566677999999999877643 35567778776543 112233445777777776 9999999987765
Q ss_pred CCceeEEEEeccCCCChhhhh-cCCCCCCCCCHHHHHHHHHHHHHHhhhhc-CCCCCCccccCCCCCceeecCCc-ceEE
Q 006145 551 SVSRIFLIFEYVPNGTLRSWI-SEGHAHQSLTWTQRISAAIGVAKGIQFLH-TGIVPGVFSNNLKITDILLDQNL-VAKI 627 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l-~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiHrDlk~~NILld~~~-~~kl 627 (659)
....+++.||..+|++++.+ +.. ....+....-.+..|+..++.|+| +. ++.|||+||+|.+++..+ ..|+
T Consensus 93 -~~~~~~~~~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~ 166 (601)
T KOG0590|consen 93 -PRSYLLSLSYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKI 166 (601)
T ss_pred -CcccccccCcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccC
Confidence 56789999999999999988 432 113555667788999999999999 76 999999999999999999 9999
Q ss_pred ccCcccccccc----ccccceecc-cccccCCCCCC
Q 006145 628 SSYNLPLLAEN----AEKVGHVIP-YSGSIDPTNSA 658 (659)
Q Consensus 628 ~DFGla~~~~~----~~~~~~~~g-t~~y~aPE~~~ 658 (659)
+|||+|..+.. .......+| ++.|+|||...
T Consensus 167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~ 202 (601)
T KOG0590|consen 167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLS 202 (601)
T ss_pred CCchhhccccccCCcceeeecccCCCCCCCCccccc
Confidence 99999965533 222355688 99999999764
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.3e-11 Score=118.68 Aligned_cols=92 Identities=26% Similarity=0.337 Sum_probs=62.8
Q ss_pred hhccCCccccEEeccCccccc----CCchhhcCCCcccEEeccCCcCCCcCCcC----C-CCCCCCCEEECcCCCCcc--
Q 006145 265 AEVSSYYQLQRLDLSSNRFVG----PFPQALLSLPSITYLNIADNKLTGKLFDD----L-SCNPELGFVDLSSNLLTG-- 333 (659)
Q Consensus 265 ~~~~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~l~~N~l~~~~p~~----~-~~~~~L~~L~ls~N~l~g-- 333 (659)
..+..+++|+.|||.+|-|+. .+...+..+++|+.|+++++.+...=... + ...|+|+.|.+.+|.++-
T Consensus 207 eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da 286 (382)
T KOG1909|consen 207 EALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDA 286 (382)
T ss_pred HHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHH
Confidence 346677788888888887763 23345667778888888888776432211 1 235788888888888862
Q ss_pred --cCChhhhCCCCCCEEEcCCcccc
Q 006145 334 --QLPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 334 --~ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
.+-.++...+.+..|++++|.+.
T Consensus 287 ~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 287 ALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHHHHHhcchhhHHhcCCccccc
Confidence 34445666778888888888874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=5.3e-09 Score=96.00 Aligned_cols=144 Identities=15% Similarity=0.223 Sum_probs=102.9
Q ss_pred CCceeccCcCceEEEEEecCCcEEEEEE-ecccCCCc-------hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 481 TSAFMGEGSQGQMYRGRLKNGTFVAIRC-LKMKKCHS-------TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 481 ~~~~ig~G~~g~Vy~~~~~~g~~vavK~-l~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
....+.+|+-+.|+++.++ |+...||. ..+...++ .++..+|++.|.+++--.|.-..=++.+ .
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D-------~ 82 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID-------T 82 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe-------c
Confidence 3478889999999999986 77766664 44444332 2568899999999875444444434443 2
Q ss_pred ceeEEEEeccCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc---ceEEc
Q 006145 553 SRIFLIFEYVPN-GTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL---VAKIS 628 (659)
Q Consensus 553 ~~~~lV~Ey~~~-GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~---~~kl~ 628 (659)
..-.++|||+++ -++.+++...-. ...+.......+..|-+.+.-||.+ .|||+||..+||++.+++ .+.+.
T Consensus 83 ~~~~i~ME~~~g~~~vk~~i~~~~~-~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lI 158 (229)
T KOG3087|consen 83 YGGQIYMEFIDGASTVKDFILSTME-DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILI 158 (229)
T ss_pred CCCeEEEEeccchhHHHHHHHHHcc-CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEE
Confidence 335799999976 478888764221 1222222367888888999999999 999999999999997554 46899
Q ss_pred cCcccccc
Q 006145 629 SYNLPLLA 636 (659)
Q Consensus 629 DFGla~~~ 636 (659)
|||++...
T Consensus 159 dfgls~~s 166 (229)
T KOG3087|consen 159 DFGLSSVS 166 (229)
T ss_pred eecchhcc
Confidence 99998544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.6e-10 Score=105.87 Aligned_cols=108 Identities=32% Similarity=0.417 Sum_probs=38.6
Q ss_pred cCCCCCCcEEEcccCcCcccCChhcc-CCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCccc-CCCCC
Q 006145 127 ISRLSSLEILNMSSNFLNGAIPQELS-ILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSF-SYLEN 204 (659)
Q Consensus 127 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~ 204 (659)
+.+..+++.|+|++|.|+. +. .++ .+.+|+.|+|++|.++. ++ .+..+++|+.|++++|+|+. +++.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 4556678999999999983 43 455 57889999999999984 33 47788999999999999984 44444 46889
Q ss_pred CcEEeccccccccC--CCCCCCCCcCCEEEcccCCCC
Q 006145 205 LRVLALSNNHFYGE--VPDFSGLTYLQVLDLENNALG 239 (659)
Q Consensus 205 L~~L~Ls~N~l~~~--~p~~~~l~~L~~L~L~~N~l~ 239 (659)
|+.|+|++|++... +-.+..+++|+.|+|.+|.+.
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 99999999998753 233667788888888877764
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.2e-10 Score=119.07 Aligned_cols=185 Identities=25% Similarity=0.220 Sum_probs=121.9
Q ss_pred cCCCCCCEEEecCCCCcCCCC-cccCCCCCCcEEEcccCcCcccCC--hhccCCCCCcEEEeecCCCCCCCccc-cCCCC
Q 006145 104 VKLPDLKVLRLVSLGLWGPLS-GKISRLSSLEILNMSSNFLNGAIP--QELSILTSLQTLILDENMLAGRVPDW-LGSLP 179 (659)
Q Consensus 104 ~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~ 179 (659)
.++..|+...|.+....-... .....|++++.||||.|-|....| .-...|++|+.|+|+.|++.-..... -..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 478889999998887643221 356789999999999999985444 34578999999999999987433322 23567
Q ss_pred CCCEEEccCCcCCccCC-cccCCCCCCcEEecccccc-ccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCC
Q 006145 180 ILAVLSLRNNMFNGTLP-DSFSYLENLRVLALSNNHF-YGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKN 257 (659)
Q Consensus 180 ~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N 257 (659)
.|+.|.|+.|.|+..-- .....+++|+.|+|..|.. ....-....+..|+.|||++|++-...
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~--------------- 262 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFD--------------- 262 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccc---------------
Confidence 88888888888873211 1234567888888888852 111122445566777777776652111
Q ss_pred cCCccCchhccCCccccEEeccCcccccC-Cchh-----hcCCCcccEEeccCCcCC
Q 006145 258 KFRSAIPAEVSSYYQLQRLDLSSNRFVGP-FPQA-----LLSLPSITYLNIADNKLT 308 (659)
Q Consensus 258 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~-----l~~l~~L~~L~l~~N~l~ 308 (659)
.-...+.++.|+.|+++.+.+... +|+. ...+++|++|++..|++.
T Consensus 263 -----~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 263 -----QGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred -----cccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 012345566677777777666532 2332 456778888888888875
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.8e-10 Score=112.33 Aligned_cols=133 Identities=29% Similarity=0.230 Sum_probs=97.4
Q ss_pred CCCCCcCCEEEcccCCCCCCCCC--CCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccE
Q 006145 222 FSGLTYLQVLDLENNALGPQFPK--VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITY 299 (659)
Q Consensus 222 ~~~l~~L~~L~L~~N~l~~~~~~--~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 299 (659)
+..+..|++|||++|.++..-.. ..++++.|++|+|.++.. ..+..+++|+.||||+|.++ .+..|-.++-+++.
T Consensus 280 ~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT 356 (490)
T ss_pred cchHhhhhhccccccchhhhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence 33445566677777766543322 246677777777777543 33788999999999999998 56677778999999
Q ss_pred EeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccC-ChhhhCCCCCCEEEcCCccccCCC
Q 006145 300 LNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQL-PNCLLAGSKNRVVLYARNCLAAGN 359 (659)
Q Consensus 300 L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~i-p~~~~~~~~l~~l~~~~N~l~~~~ 359 (659)
|.|+.|.+.. -..+..+-+|..||+++|++...- -..+++++-+..+.+.+|.+.+..
T Consensus 357 L~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 357 LKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred eehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 9999998863 234667788999999999987211 135667777889999999998654
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.8e-10 Score=114.98 Aligned_cols=242 Identities=24% Similarity=0.288 Sum_probs=126.5
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCC----CCc-------ccCCCCCCcEEEcccCc
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGP----LSG-------KISRLSSLEILNMSSNF 142 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~----~p~-------~~~~l~~L~~L~Ls~N~ 142 (659)
..++.|+|+||.+...- ...+-..+.+.++|+..++++- ++|. +|+ .+...++|++||||.|.
T Consensus 30 ~s~~~l~lsgnt~G~EA-----a~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEA-----ARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred CceEEEeccCCchhHHH-----HHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 46788888887543110 0012234556667777777664 3332 233 23445567777777776
Q ss_pred CcccCChh----ccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccC
Q 006145 143 LNGAIPQE----LSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGE 218 (659)
Q Consensus 143 l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 218 (659)
|.-.-+.. +..++.|++|.|.+|.+.-.--..++. .|..|. .| .-...-++|+.+..++|++...
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~-------kk~~~~~~Lrv~i~~rNrlen~ 172 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VN-------KKAASKPKLRVFICGRNRLENG 172 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HH-------hccCCCcceEEEEeeccccccc
Confidence 65333322 345666666666666553111111110 011000 00 0112234455555555554322
Q ss_pred CC-----CCCCCCcCCEEEcccCCCCCCCCC-------CCcccceEecCCCcCCcc----CchhccCCccccEEeccCcc
Q 006145 219 VP-----DFSGLTYLQVLDLENNALGPQFPK-------VGKKLVTMILSKNKFRSA----IPAEVSSYYQLQRLDLSSNR 282 (659)
Q Consensus 219 ~p-----~~~~l~~L~~L~L~~N~l~~~~~~-------~~~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~ 282 (659)
.- .|...+.|+.+.+..|.+...--. .+++|+.|||..|.|+.. +...+..+++|+.|++++|.
T Consensus 173 ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcl 252 (382)
T KOG1909|consen 173 GATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCL 252 (382)
T ss_pred cHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccc
Confidence 11 134445555555555554321110 134555555666655432 23446677788888888888
Q ss_pred cccCCchh----h-cCCCcccEEeccCCcCCCc----CCcCCCCCCCCCEEECcCCCCc
Q 006145 283 FVGPFPQA----L-LSLPSITYLNIADNKLTGK----LFDDLSCNPELGFVDLSSNLLT 332 (659)
Q Consensus 283 l~~~~p~~----l-~~l~~L~~L~l~~N~l~~~----~p~~~~~~~~L~~L~ls~N~l~ 332 (659)
+...-... + ...|+|++|.+.+|.++-. +...+...+.|..|+|++|.+.
T Consensus 253 l~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 253 LENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 86432222 2 2468889999999988732 2233456788999999999884
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.2e-09 Score=122.84 Aligned_cols=133 Identities=19% Similarity=0.335 Sum_probs=90.7
Q ss_pred hcCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..+|+..+.|..|+||.||..+++. .+.+|+| +.++.. + + +||..+.| .
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----i------l-----Rnilt~a~-------------n 131 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----I------L-----RNILTFAG-------------N 131 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----h------h-----hccccccC-------------C
Confidence 3578888999999999999999764 6778883 332221 1 1 12333221 1
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.+.| ||=...+.. ..+++... +.+++|+|+- +|+|||+||+|.+|..-|.+|++|||+.+
T Consensus 132 pfvv------gDc~tllk~---~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 132 PFVV------GDCATLLKN---IGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSK 191 (1205)
T ss_pred ccee------chhhhhccc---CCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhh
Confidence 2333 444444443 12232221 7789999998 99999999999999999999999999985
Q ss_pred cc---------ccc-------cccceecccccccCCCCCC
Q 006145 635 LA---------ENA-------EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~---------~~~-------~~~~~~~gt~~y~aPE~~~ 658 (659)
.. +.. -....++||+.|+|||++-
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil 231 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL 231 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence 33 000 0124579999999999863
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.5e-08 Score=95.01 Aligned_cols=126 Identities=14% Similarity=0.188 Sum_probs=82.8
Q ss_pred eEEEEEecCCcEEEEEEecccCC------------Cc--------------hHHHHHHHHHHhCCCCC--Cccceeeeee
Q 006145 492 QMYRGRLKNGTFVAIRCLKMKKC------------HS--------------TRNFMHHIELISKLRHR--HLVSALGHCF 543 (659)
Q Consensus 492 ~Vy~~~~~~g~~vavK~l~~~~~------------~~--------------~~~~~~Ei~~l~~l~H~--niv~l~g~~~ 543 (659)
.||.|...+|..||||..+.... .. .....+|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999988899999998754210 00 12367899999999765 456665432
Q ss_pred eccccCCCCceeEEEEeccC--CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhh-cCCCCCCccccCCCCCceeec
Q 006145 544 ECYFDDSSVSRIFLIFEYVP--NGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFL-HTGIVPGVFSNNLKITDILLD 620 (659)
Q Consensus 544 ~~~~~~~~~~~~~lV~Ey~~--~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHrDlk~~NILld 620 (659)
..++||||++ +..+..+... .++......+..++++.+..+ |.. +|||+|+.+.||+++
T Consensus 80 ----------~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~ 141 (188)
T PF01163_consen 80 ----------RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVD 141 (188)
T ss_dssp ----------TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEE
T ss_pred ----------CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEee
Confidence 2489999998 5445443322 122344566777788866664 676 999999999999999
Q ss_pred CCcceEEccCccccccc
Q 006145 621 QNLVAKISSYNLPLLAE 637 (659)
Q Consensus 621 ~~~~~kl~DFGla~~~~ 637 (659)
++ .+.|.|||.+....
T Consensus 142 ~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 142 DG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp TT-CEEE--GTTEEETT
T ss_pred cc-eEEEEecCcceecC
Confidence 88 99999999986554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.2e-09 Score=81.12 Aligned_cols=59 Identities=32% Similarity=0.347 Sum_probs=30.2
Q ss_pred CCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCC
Q 006145 108 DLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENM 166 (659)
Q Consensus 108 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 166 (659)
+|++|++++|+++...+..|.++++|++|++++|.++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555554444455555555555555555554444445555555555555544
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=4e-09 Score=81.22 Aligned_cols=58 Identities=47% Similarity=0.623 Sum_probs=24.2
Q ss_pred CcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccc
Q 006145 157 LQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNH 214 (659)
Q Consensus 157 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 214 (659)
|++|++++|+++...+..|.++++|++|++++|.++...|..|.++++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 3444444444443333344444444444444444443333444444444444444443
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.5e-07 Score=95.17 Aligned_cols=146 Identities=12% Similarity=0.092 Sum_probs=101.1
Q ss_pred ceeccCcCceEEEEEecCCcEEEEEEecccCC-----------CchHHHHHHHHHHhCCCCCC--ccceeeeeeeccccC
Q 006145 483 AFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKC-----------HSTRNFMHHIELISKLRHRH--LVSALGHCFECYFDD 549 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----------~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~ 549 (659)
+.+-+-....|++..+ +|+.+.||+...... .....+.+|.+.+.++...+ +.++++|..... .
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~--~ 104 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGS--N 104 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecC--C
Confidence 4444444445777766 478899997743221 11125789998888885333 344455553211 0
Q ss_pred CCCceeEEEEeccCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC-------
Q 006145 550 SSVSRIFLIFEYVPNG-TLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ------- 621 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~G-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~------- 621 (659)
......++|+|++++- +|.+++.... ....+...+..++.++++.++-||.. +|+|+|++++|||++.
T Consensus 105 ~~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 105 PATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred CccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCC
Confidence 1123468999999886 8998875311 12345567789999999999999999 9999999999999985
Q ss_pred CcceEEccCccccc
Q 006145 622 NLVAKISSYNLPLL 635 (659)
Q Consensus 622 ~~~~kl~DFGla~~ 635 (659)
+..+.+.||+.+..
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 47899999998854
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.1e-08 Score=118.80 Aligned_cols=249 Identities=20% Similarity=0.184 Sum_probs=153.3
Q ss_pred CCCCCCEEEecCCC--CcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCC
Q 006145 105 KLPDLKVLRLVSLG--LWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILA 182 (659)
Q Consensus 105 ~l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (659)
..+.|+.|-+..|. +....++.|..++.|++|||++|.=-+.+|..+++|-+|++|+|++..+. .+|..+++|..|.
T Consensus 543 ~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~ 621 (889)
T KOG4658|consen 543 ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLI 621 (889)
T ss_pred CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhh
Confidence 34578888888886 44444555788999999999998877889999999999999999999987 7899999999999
Q ss_pred EEEccCCcCCccCCcccCCCCCCcEEeccccccccCC---CCCCCCCcCCEEEcccCCCCCCCC-CCCc----ccceEec
Q 006145 183 VLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEV---PDFSGLTYLQVLDLENNALGPQFP-KVGK----KLVTMIL 254 (659)
Q Consensus 183 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~l~~L~~L~L~~N~l~~~~~-~~~~----~L~~L~l 254 (659)
+|++..+.-...+|.....|++|++|.+......... .++.+|.+|+.|............ .... ..+.+.+
T Consensus 622 ~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~~~~e~l~~~~~L~~~~~~l~~ 701 (889)
T KOG4658|consen 622 YLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSVLLLEDLLGMTRLRSLLQSLSI 701 (889)
T ss_pred eeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchhHhHhhhhhhHHHHHHhHhhhh
Confidence 9999988766667777777999999988766533221 224555556655554333200000 0111 1223333
Q ss_pred CCCcCCccCchhccCCccccEEeccCcccccCCchhhcC------CCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcC
Q 006145 255 SKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLS------LPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSS 328 (659)
Q Consensus 255 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~------l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~ 328 (659)
..+.. ...+..++.+.+|+.|.+.++.+......+... ++++..+...+...- ..+.+....++|+.|++..
T Consensus 702 ~~~~~-~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~ 779 (889)
T KOG4658|consen 702 EGCSK-RTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVS 779 (889)
T ss_pred ccccc-ceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEec
Confidence 23222 234556778888888888888775332222211 112222222222111 2233334568888888887
Q ss_pred CCCcccCChhhhCCCCCCEEEcCCcccc
Q 006145 329 NLLTGQLPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 329 N~l~g~ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
......+.+....+..+..+.+..+.+.
T Consensus 780 ~~~~e~~i~~~k~~~~l~~~i~~f~~~~ 807 (889)
T KOG4658|consen 780 CRLLEDIIPKLKALLELKELILPFNKLE 807 (889)
T ss_pred ccccccCCCHHHHhhhcccEEecccccc
Confidence 6655555544444444444444444444
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=2e-08 Score=116.83 Aligned_cols=109 Identities=28% Similarity=0.330 Sum_probs=90.5
Q ss_pred ccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCC
Q 006145 103 LVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILA 182 (659)
Q Consensus 103 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (659)
|..++.|+.|||++|.-.+.+|..++.|-+|++|+|+...++ .+|..+.+|..|.+|++..+.-...+|..+..|++|+
T Consensus 567 f~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr 645 (889)
T KOG4658|consen 567 FRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLR 645 (889)
T ss_pred HhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhccccc
Confidence 678999999999999888999999999999999999999998 8999999999999999999987767788888899999
Q ss_pred EEEccCCcC--CccCCcccCCCCCCcEEeccc
Q 006145 183 VLSLRNNMF--NGTLPDSFSYLENLRVLALSN 212 (659)
Q Consensus 183 ~L~L~~N~l--~~~~p~~~~~l~~L~~L~Ls~ 212 (659)
+|.+..-.. ....-..+.++++|+.|....
T Consensus 646 ~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~ 677 (889)
T KOG4658|consen 646 VLRLPRSALSNDKLLLKELENLEHLENLSITI 677 (889)
T ss_pred EEEeeccccccchhhHHhhhcccchhhheeec
Confidence 999876542 222223445566666665543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.6e-08 Score=98.83 Aligned_cols=127 Identities=18% Similarity=0.297 Sum_probs=93.9
Q ss_pred HhCCCCCCccceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCC
Q 006145 527 ISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVP 605 (659)
Q Consensus 527 l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 605 (659)
|-.+.|.|||+++.|+.+..+++ .....++.|||+.|++.++|++- +....+....-.+++.||..||.|||+ |.|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e--~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEE--KPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHhhccccccc--ccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 44457999999999887644322 45678999999999999999852 234456677778999999999999999 799
Q ss_pred CccccCCCCCceeecCCcceEEccCcccccc---c--cccccceecccccccCCCC
Q 006145 606 GVFSNNLKITDILLDQNLVAKISSYNLPLLA---E--NAEKVGHVIPYSGSIDPTN 656 (659)
Q Consensus 606 ~iiHrDlk~~NILld~~~~~kl~DFGla~~~---~--~~~~~~~~~gt~~y~aPE~ 656 (659)
+|+|+++..+-|.+..++-+|++--.-.... . .........+-++|-|||+
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~s 253 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPES 253 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCc
Confidence 9999999999999999988887632211111 0 0111223456778888886
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.4e-07 Score=102.47 Aligned_cols=123 Identities=18% Similarity=0.218 Sum_probs=98.7
Q ss_pred ecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCC
Q 006145 498 LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAH 577 (659)
Q Consensus 498 ~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~ 577 (659)
..++.+|.|...+...........+.++.|+.+|||||++++..+.. .+..|+|+|-+. -|..++.+
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-------~~~~ylvTErV~--Pl~~~lk~---- 100 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-------EGTLYLVTERVR--PLETVLKE---- 100 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-------cCceEEEeeccc--cHHHHHHH----
Confidence 44688999998876654333457788899999999999999987764 457899999985 46666654
Q ss_pred CCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 578 QSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 578 ~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
+.-....-.+.||+.||.|||+.| +++|++|.-..|++++.|+-||++|-++...+
T Consensus 101 --l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 101 --LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred --hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 334456667889999999999775 89999999999999999999999999875443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.2e-07 Score=96.61 Aligned_cols=142 Identities=17% Similarity=0.216 Sum_probs=111.2
Q ss_pred ceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEEeccCC-CChh
Q 006145 491 GQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPN-GTLR 568 (659)
Q Consensus 491 g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~-GsL~ 568 (659)
.+.||+... ||..++.|++.............-++..+++.|+|||++++++....+. ...+++||+|+|+ ++|.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~---D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFG---DLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccC---cceEEEEEecCCCCchHH
Confidence 578999854 7999999999544333333344567789999999999999999865553 3468999999986 6888
Q ss_pred hhhcCCC------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 569 SWISEGH------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 569 ~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
++.-... .....++...+.++.|++.||.++|+. +...+-|.+++|+++.+.+++|+..|+....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 7653211 123466778899999999999999998 9999999999999999999999999988665
Q ss_pred cc
Q 006145 637 EN 638 (659)
Q Consensus 637 ~~ 638 (659)
..
T Consensus 444 ~~ 445 (655)
T KOG3741|consen 444 QE 445 (655)
T ss_pred cC
Confidence 43
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.54 E-value=9.5e-08 Score=102.76 Aligned_cols=166 Identities=14% Similarity=0.142 Sum_probs=121.9
Q ss_pred CCCCceecc--CcCceEEEEEe--c-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCC
Q 006145 479 FDTSAFMGE--GSQGQMYRGRL--K-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 479 ~~~~~~ig~--G~~g~Vy~~~~--~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~ 550 (659)
|.....+|. |.+|.||.+.. + ++..+|+|+-+.... .....=.+|+....+++ |+|.|+.+..+.+
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~------ 189 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG------ 189 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc------
Confidence 455678899 99999999987 3 588899998543222 22223346666677775 9999996666554
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH----HhhhhcCCCCCCccccCCCCCceeecCC-cce
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAK----GIQFLHTGIVPGVFSNNLKITDILLDQN-LVA 625 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiHrDlk~~NILld~~-~~~ 625 (659)
.+..++-+|++. .+|.++.+... ..++......+..+..+ |+.++|.. .|+|-|+||.||.+.++ ...
T Consensus 190 -~~~lfiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 190 -SGILFIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred -CCcceeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccccee
Confidence 566788889885 68888877521 22444555566666666 99999998 99999999999999998 889
Q ss_pred EEccCcccccccccccc------ceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENAEKV------GHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~~~~------~~~~gt~~y~aPE~~ 657 (659)
+.+|||+...+.+.... ....|...|++||..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~ 300 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL 300 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhh
Confidence 99999998777554422 223577889999964
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.5e-07 Score=64.66 Aligned_cols=39 Identities=41% Similarity=0.685 Sum_probs=29.5
Q ss_pred CHHHHHHHHHHHhcCCC-C-CCCCCCCCC--CCCCcCCCCCCCceEeC
Q 006145 29 QSSQAQTLLRIQGLLNN-P-AVLSSWNIT--TEFCNTEPTSSLTVVCY 72 (659)
Q Consensus 29 ~~~~~~aLl~~k~~l~~-~-~~l~~W~~~--~~~C~w~~~~~~gv~C~ 72 (659)
+++|++||++||+.+.+ | ..+.+|+.+ .+||+|. ||+|+
T Consensus 1 ~~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~-----GV~Cd 43 (43)
T PF08263_consen 1 PNQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWS-----GVTCD 43 (43)
T ss_dssp -HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCST-----TEEE-
T ss_pred CcHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeec-----cEEeC
Confidence 36899999999999984 5 589999987 7999997 69995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.2e-06 Score=86.10 Aligned_cols=134 Identities=14% Similarity=0.196 Sum_probs=94.5
Q ss_pred CCCceeccCcCceEEEEEecCCcEEEEEEecccCC----------------C------chHHHHHHHHHHhCCCCC--Cc
Q 006145 480 DTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKC----------------H------STRNFMHHIELISKLRHR--HL 535 (659)
Q Consensus 480 ~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~----------------~------~~~~~~~Ei~~l~~l~H~--ni 535 (659)
...+.||-|.-+.||.|..+.|..+|||.=+.... + ......+|.++|.++.-. .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 44589999999999999999999999995432110 0 013467899999999644 66
Q ss_pred cceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCC
Q 006145 536 VSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKIT 615 (659)
Q Consensus 536 v~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~ 615 (659)
.+.+++ +...+||||+++-.|...= ++....-.+...|++-+.-.-+. +|||+|+..=
T Consensus 174 P~P~~~-----------nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSef 231 (304)
T COG0478 174 PKPIAW-----------NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEF 231 (304)
T ss_pred CCcccc-----------ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchh
Confidence 666653 3468999999986665431 11222233444444444433355 9999999999
Q ss_pred ceeecCCcceEEccCccccc
Q 006145 616 DILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 616 NILld~~~~~kl~DFGla~~ 635 (659)
||++++||.+.+.||--+..
T Consensus 232 NIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 232 NILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred eEEEecCCCEEEEeCccccc
Confidence 99999999999999976643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.42 E-value=2e-07 Score=100.28 Aligned_cols=151 Identities=12% Similarity=0.162 Sum_probs=115.2
Q ss_pred HHHhhcCCCCCceeccCcCceEEEEEec--CCcEEEEEEecccCCCchHH--HHHHHHHHhCC-CCCCccceeeeeeecc
Q 006145 472 LEEATNNFDTSAFMGEGSQGQMYRGRLK--NGTFVAIRCLKMKKCHSTRN--FMHHIELISKL-RHRHLVSALGHCFECY 546 (659)
Q Consensus 472 l~~~~~~~~~~~~ig~G~~g~Vy~~~~~--~g~~vavK~l~~~~~~~~~~--~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 546 (659)
....+.+|.....||.|.|+.||+...+ ++..+++|.+...-.....+ -..|+-+...+ -|.+++..+..+..
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-- 337 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-- 337 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--
Confidence 3445667888999999999999998854 48899999987654333222 24565555555 37788876554432
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC-cce
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN-LVA 625 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~-~~~ 625 (659)
....|+=-||++++++.....- ...++...++++..+++.++.++|+. .++|+|+||+||++..+ +.-
T Consensus 338 -----~r~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~ 406 (524)
T KOG0601|consen 338 -----LRQGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFS 406 (524)
T ss_pred -----cccccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhh
Confidence 3456788999999988765421 34577788899999999999999987 99999999999999876 888
Q ss_pred EEccCccccc
Q 006145 626 KISSYNLPLL 635 (659)
Q Consensus 626 kl~DFGla~~ 635 (659)
+++|||.+..
T Consensus 407 ~~~~~~~~t~ 416 (524)
T KOG0601|consen 407 KLGDFGCWTR 416 (524)
T ss_pred hccccccccc
Confidence 9999999853
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.9e-06 Score=84.16 Aligned_cols=112 Identities=19% Similarity=0.176 Sum_probs=85.5
Q ss_pred hHHHHHHHHHHhCCC--CCCccceeeeeeeccccCCCCceeEEEEeccCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHH
Q 006145 517 TRNFMHHIELISKLR--HRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNG-TLRSWISEGHAHQSLTWTQRISAAIGVA 593 (659)
Q Consensus 517 ~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~G-sL~~~l~~~~~~~~l~~~~~~~i~~~ia 593 (659)
...+.+|.+.+..+. .-.+.+.+++...... .....++|+|++++- +|.+++... ...+...+..++.+++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~---~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKG---GGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALA 128 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC---CceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHH
Confidence 346788888877774 3345566666654211 123458999999984 899998752 1256677889999999
Q ss_pred HHhhhhcCCCCCCccccCCCCCceeecCCc---ceEEccCccccccc
Q 006145 594 KGIQFLHTGIVPGVFSNNLKITDILLDQNL---VAKISSYNLPLLAE 637 (659)
Q Consensus 594 ~~L~yLH~~~~~~iiHrDlk~~NILld~~~---~~kl~DFGla~~~~ 637 (659)
+.++-||.. +|+|+|+++.|||++.+. .+.+.||+-++...
T Consensus 129 ~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 129 RLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999999 999999999999999876 89999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.7e-09 Score=113.49 Aligned_cols=124 Identities=31% Similarity=0.311 Sum_probs=68.0
Q ss_pred CCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCC--CCcccceEecCCCc
Q 006145 181 LAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPK--VGKKLVTMILSKNK 258 (659)
Q Consensus 181 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~--~~~~L~~L~l~~N~ 258 (659)
|...+.++|.+. .+.+++.-++.|+.|||++|+++..- .+..++.|++|||+.|.+....-- ..-+|..|.+++|.
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L~lrnN~ 243 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLLNLRNNA 243 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhccccccchhhhhheeeeecccH
Confidence 444455555554 34444445555555555555554322 344455555555555555322111 12235666666666
Q ss_pred CCccCchhccCCccccEEeccCcccccCC-chhhcCCCcccEEeccCCcCC
Q 006145 259 FRSAIPAEVSSYYQLQRLDLSSNRFVGPF-PQALLSLPSITYLNIADNKLT 308 (659)
Q Consensus 259 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~l~~N~l~ 308 (659)
++.. ..+.++.+|+.||+++|-|.+.- -.-++.|..|+.|+|.+|.+-
T Consensus 244 l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 244 LTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred HHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 5542 34667778888888888776532 123556677778888888764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.3e-05 Score=77.07 Aligned_cols=144 Identities=10% Similarity=0.058 Sum_probs=103.4
Q ss_pred ceeccCcCceEEEEEecCCcEEEEEEecccC------CCchHHHHHHHHHHhCCCC--CCccceeeeeeeccccCCCCce
Q 006145 483 AFMGEGSQGQMYRGRLKNGTFVAIRCLKMKK------CHSTRNFMHHIELISKLRH--RHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~~~~~~ 554 (659)
---|+||-+-||+-.+. |+.+=+|+-...- .-+...|.+|...|.++.. -.+.+.+ |+..... ...-.
T Consensus 24 pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~--~~~~r 99 (216)
T PRK09902 24 PNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKI--EGEWR 99 (216)
T ss_pred CCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeecc--CCceE
Confidence 33477888899998775 5568888764211 1234679999999998853 3344544 3321111 11234
Q ss_pred eEEEEeccCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc--eEEccCc
Q 006145 555 IFLIFEYVPN-GTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV--AKISSYN 631 (659)
Q Consensus 555 ~~lV~Ey~~~-GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~--~kl~DFG 631 (659)
.+||+|-+++ -||.+++.+. ...+.+...+..+..+|++.++-||+. ++.|+|+-+.||+++.++. +++.||.
T Consensus 100 A~LVTe~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 100 ALLVTEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEEEEEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 6899998864 4999998652 223567778899999999999999999 9999999999999986666 9999997
Q ss_pred ccc
Q 006145 632 LPL 634 (659)
Q Consensus 632 la~ 634 (659)
-++
T Consensus 176 k~r 178 (216)
T PRK09902 176 KSR 178 (216)
T ss_pred ccc
Confidence 664
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=4.6e-08 Score=85.25 Aligned_cols=103 Identities=29% Similarity=0.385 Sum_probs=49.6
Q ss_pred CCEEEecCCCCcCCCCcc---cCCCCCCcEEEcccCcCcccCChhccC-CCCCcEEEeecCCCCCCCccccCCCCCCCEE
Q 006145 109 LKVLRLVSLGLWGPLSGK---ISRLSSLEILNMSSNFLNGAIPQELSI-LTSLQTLILDENMLAGRVPDWLGSLPILAVL 184 (659)
Q Consensus 109 L~~L~L~~n~l~~~~p~~---~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (659)
+..++|++|.+ +.+++. +.....|+..+|++|.|. .+|..|.. .+.++.|+|++|.++ .+|..+..++.|+.|
T Consensus 29 ~h~ldLssc~l-m~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQL-MYIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchh-hHHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 34455666555 223332 233334444556666555 33443332 335555555555554 445555555555555
Q ss_pred EccCCcCCccCCcccCCCCCCcEEecccccc
Q 006145 185 SLRNNMFNGTLPDSFSYLENLRVLALSNNHF 215 (659)
Q Consensus 185 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 215 (659)
+++.|.+. ..|..|..|.+|-.|+..+|.+
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~ 135 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENAR 135 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCcc
Confidence 55555554 3444444455555555444443
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=4.5e-08 Score=85.31 Aligned_cols=106 Identities=28% Similarity=0.355 Sum_probs=61.5
Q ss_pred CCcEEEcccCcCcccCChh---ccCCCCCcEEEeecCCCCCCCccccC-CCCCCCEEEccCCcCCccCCcccCCCCCCcE
Q 006145 132 SLEILNMSSNFLNGAIPQE---LSILTSLQTLILDENMLAGRVPDWLG-SLPILAVLSLRNNMFNGTLPDSFSYLENLRV 207 (659)
Q Consensus 132 ~L~~L~Ls~N~l~~~~p~~---~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 207 (659)
.+..+||+++.+- .+++. +.....|+..+|++|.|. .+|+.|. ..+.++.|+|++|.|+ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3455666666653 34433 333444555566666665 3444443 3346666666666666 56666666666666
Q ss_pred EeccccccccCCCCCCCCCcCCEEEcccCCCCC
Q 006145 208 LALSNNHFYGEVPDFSGLTYLQVLDLENNALGP 240 (659)
Q Consensus 208 L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~ 240 (659)
|+++.|.+...+..+..|.+|-.|+..+|.+..
T Consensus 105 lNl~~N~l~~~p~vi~~L~~l~~Lds~~na~~e 137 (177)
T KOG4579|consen 105 LNLRFNPLNAEPRVIAPLIKLDMLDSPENARAE 137 (177)
T ss_pred cccccCccccchHHHHHHHhHHHhcCCCCcccc
Confidence 666666666555445556666666666666543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=8.4e-06 Score=89.39 Aligned_cols=145 Identities=14% Similarity=0.176 Sum_probs=94.9
Q ss_pred CCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCc--------------------------h----H---------
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHS--------------------------T----R--------- 518 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--------------------------~----~--------- 518 (659)
.|+. +.|+.++-|.||+|++++|+.||||+.+..-.+. . +
T Consensus 127 eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 127 EFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 3443 6899999999999999999999999875321100 0 0
Q ss_pred -HHHHHHHHHhCC----CCCCccceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHH
Q 006145 519 -NFMHHIELISKL----RHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVA 593 (659)
Q Consensus 519 -~~~~Ei~~l~~l----~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia 593 (659)
+|.+|+.-+.++ ++.-=+.+=.+|++ -.....|+|||++|-.+.+...-.. ...+ +..++..++
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we------~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d---~k~ia~~~~ 274 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVYWE------YTTRRVLTMEWIDGIKISDIAALKS--AGID---RKELAELLV 274 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceeehh------ccCCcEEEEEeeCCEecccHHHHHh--cCCC---HHHHHHHHH
Confidence 244566555554 23333334444543 1345799999999988888743111 1233 344444444
Q ss_pred HH-hhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 594 KG-IQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 594 ~~-L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
++ +.-+-.. +++|.|..|.||+++.+++.-.-|||+....+
T Consensus 275 ~~f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 275 RAFLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 42 2222233 89999999999999999999999999985543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.18 E-value=5.3e-06 Score=79.44 Aligned_cols=104 Identities=17% Similarity=0.231 Sum_probs=81.8
Q ss_pred HHHHHHhCCCC-CCccceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhc
Q 006145 522 HHIELISKLRH-RHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH 600 (659)
Q Consensus 522 ~Ei~~l~~l~H-~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH 600 (659)
.|.-+++.+.+ +++.+++|+|- .++|.||...+++...-..-.....-+|..|.+||.++++.+++++
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG-----------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG-----------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC-----------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHh
Confidence 47778888876 69999999994 3789999998766532100000124689999999999999999999
Q ss_pred CCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 601 TGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 601 ~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+.....+.-.|++++|+-+++++++|+.|..-+...
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 965446777999999999999999999999876433
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.5e-08 Score=108.00 Aligned_cols=126 Identities=30% Similarity=0.281 Sum_probs=92.0
Q ss_pred CCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEcc
Q 006145 108 DLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLR 187 (659)
Q Consensus 108 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 187 (659)
.|...+.+.|.+. .+..++.-++.|+.|||++|+++.. +.+..|+.|++|||++|++. .+|..=..-..|+.|.+.
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhhheeeeec
Confidence 3555566667664 3455677788889999999998743 37888899999999999887 556432222348889999
Q ss_pred CCcCCccCCcccCCCCCCcEEeccccccccC--CCCCCCCCcCCEEEcccCCCC
Q 006145 188 NNMFNGTLPDSFSYLENLRVLALSNNHFYGE--VPDFSGLTYLQVLDLENNALG 239 (659)
Q Consensus 188 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~l~~L~~L~L~~N~l~ 239 (659)
+|.++.. ..+.+|++|+.|||++|-|++. +..++.|..|+.|.|.+|.+-
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 9988743 2577888899999999988763 233677888888888888763
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.9e-07 Score=90.25 Aligned_cols=87 Identities=25% Similarity=0.287 Sum_probs=54.7
Q ss_pred CCCCCcEEEcccCcCccc--CChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCcc-CCcccCCCCCC
Q 006145 129 RLSSLEILNMSSNFLNGA--IPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGT-LPDSFSYLENL 205 (659)
Q Consensus 129 ~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L 205 (659)
..+.++.|||.+|.|+.. +-.-+.+|+.|++|+|+.|+++..|...-..+.+|+.|-|.+..+.-. .-..+..++.+
T Consensus 69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v 148 (418)
T KOG2982|consen 69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV 148 (418)
T ss_pred HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence 456777788888877632 333456777788888888877644432223456777777777665432 22345567777
Q ss_pred cEEecccccc
Q 006145 206 RVLALSNNHF 215 (659)
Q Consensus 206 ~~L~Ls~N~l 215 (659)
+.|++|.|++
T Consensus 149 telHmS~N~~ 158 (418)
T KOG2982|consen 149 TELHMSDNSL 158 (418)
T ss_pred hhhhhccchh
Confidence 7777777744
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 659 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-21 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-21 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-16 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-16 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-14 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-14 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-13 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-05 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-05 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-05 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 659 | |||
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-51 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 5e-32 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-21 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-49 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-48 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-47 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-46 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-46 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-42 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-39 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-23 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-08 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-47 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-40 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-34 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-34 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-33 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-32 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-31 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-29 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-28 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-27 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-26 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-17 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-13 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-32 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-29 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-28 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-27 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-06 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-06 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-32 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 7e-27 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-26 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 9e-26 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-25 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-25 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 8e-31 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-26 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-25 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-25 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 8e-23 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-05 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 8e-30 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-28 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-27 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 7e-26 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-25 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-22 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-21 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-17 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 6e-28 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-26 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-26 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-23 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-21 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-20 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 8e-20 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-18 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-26 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-22 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-15 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-13 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-10 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-24 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-20 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 8e-17 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-15 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-13 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-24 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-23 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 7e-23 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-19 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-16 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-24 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-24 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-20 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-19 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-18 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-14 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-07 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-06 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-24 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-21 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-15 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-12 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-06 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-24 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-21 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-15 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 7e-14 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-12 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-05 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-24 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-20 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 7e-18 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-17 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 8e-24 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 9e-24 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-19 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 7e-18 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-14 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-12 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-06 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-23 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-18 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-17 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-17 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-13 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-23 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 7e-22 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-21 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 5e-18 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-23 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-17 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-12 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 8e-04 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-23 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-20 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-20 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-18 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-18 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-14 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-06 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-23 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-21 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-11 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-22 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 4e-21 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-18 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-14 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-12 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 7e-22 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-22 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-18 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-17 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-15 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-21 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 6e-18 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-15 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-12 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-21 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 5e-21 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-20 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-12 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-09 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-09 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-06 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-20 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-15 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-13 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 8e-20 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 5e-11 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-19 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-17 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-12 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-19 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-18 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-18 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 6e-17 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-18 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-17 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-11 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 8e-05 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-18 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-16 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-09 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 8e-18 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-17 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-14 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-06 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 8e-06 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-05 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-17 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-17 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-17 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-16 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-13 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 8e-07 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-17 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-12 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 5e-17 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 7e-17 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-16 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 5e-16 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-15 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 4e-13 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 7e-11 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-15 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-15 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 9e-08 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-14 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 9e-14 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 6e-13 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-12 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-11 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 9e-06 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-11 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 8e-09 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-13 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-13 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-06 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-13 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-12 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-10 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-13 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 7e-13 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 9e-13 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-12 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-12 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-12 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-06 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-12 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-12 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-12 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 7e-12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-09 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-07 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-07 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-04 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 4e-12 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 4e-12 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 6e-12 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-11 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-11 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-11 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-11 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-11 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-11 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-11 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-11 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-11 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-08 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-11 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-11 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 5e-11 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 5e-11 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 7e-11 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-10 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-10 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-06 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-05 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-10 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-10 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-10 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-10 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-10 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-10 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-10 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-10 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-10 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 7e-06 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-10 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-08 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 5e-10 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 5e-10 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-10 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-10 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 5e-10 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 6e-10 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 6e-10 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 6e-10 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-04 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 7e-10 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 8e-10 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-09 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-09 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-09 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-09 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-09 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-05 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-09 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-09 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-09 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 4e-09 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 5e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 6e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 8e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-04 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 6e-09 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 7e-09 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 9e-09 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-04 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-08 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-08 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-08 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-08 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 5e-08 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-08 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 7e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 7e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 7e-06 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-07 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-07 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-07 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 8e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-04 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 4e-07 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-07 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-06 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-07 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-05 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 5e-07 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 6e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-05 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-06 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-06 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-06 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 4e-06 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 5e-06 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 7e-06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 7e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 8e-06 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-05 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-05 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-05 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-05 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 6e-05 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 6e-05 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 7e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-04 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-04 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-04 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-04 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-04 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-04 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-04 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 5e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 6e-04 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 6e-04 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 6e-04 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 8e-04 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 8e-04 |
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-51
Identities = 80/316 (25%), Positives = 128/316 (40%), Gaps = 42/316 (13%)
Query: 30 SSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPTSSLT-VVCYEESITQLHIVGNKRAP 88
Q LL+I+ L NP LSSW TT+ CN + V+C ++ TQ + V
Sbjct: 5 PQDKQALLQIKKDLGNPTTLSSWLPTTDCCN----RTWLGVLC--DTDTQTYRV------ 52
Query: 89 MLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWG--PLSGKISRLSSLEILNMSS-NFLNG 145
L L L L P+ ++ L L L + N L G
Sbjct: 53 ---------------------NNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91
Query: 146 AIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL 205
IP ++ LT L L + ++G +PD+L + L L N +GTLP S S L NL
Sbjct: 92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 206 RVLALSNNHFYGEVPD-FSGLTYL-QVLDLENNALGPQFPK-VGK-KLVTMILSKNKFRS 261
+ N G +PD + + L + + N L + P L + LS+N
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG 211
Query: 262 AIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPEL 321
S Q++ L+ N + + ++ L++ +N++ G L L+ L
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270
Query: 322 GFVDLSSNLLTGQLPN 337
+++S N L G++P
Sbjct: 271 HSLNVSFNNLCGEIPQ 286
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 58/219 (26%), Positives = 86/219 (39%), Gaps = 30/219 (13%)
Query: 128 SRLSS-LEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGR--VPDWLGSLPILAVL 184
+ LSS L + + G + + + L L L +P L +LP L L
Sbjct: 22 TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81
Query: 185 SLRN-NMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDF-SGLTYLQVLDLENNAL-GPQ 241
+ N G +P + + L L L +++ + G +PDF S + L LD NAL G
Sbjct: 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGT- 140
Query: 242 FPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPS-ITYL 300
+P +SS L + NR G P + S T +
Sbjct: 141 ---------------------LPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179
Query: 301 NIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCL 339
I+ N+LTGK+ + N L FVDLS N+L G
Sbjct: 180 TISRNRLTGKIPPTFA-NLNLAFVDLSRNMLEGDASVLF 217
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 39/206 (18%), Positives = 71/206 (34%), Gaps = 33/206 (16%)
Query: 148 PQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRV 207
PQ+ L ++ + + L+ WL + N + G L D+ + +
Sbjct: 5 PQDKQALLQIKKDLGNPTTLS----SWLPTTD------CCNRTWLGVLCDTDTQTYRVNN 54
Query: 208 LALSNNHFYGEV---PDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIP 264
L LS + + L YL L + N IP
Sbjct: 55 LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI--------------------NNLVGPIP 94
Query: 265 AEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFV 324
++ QL L ++ G P L + ++ L+ + N L+G L +S P L +
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 325 DLSSNLLTGQLPNCLLAGSKNRVVLY 350
N ++G +P+ + SK +
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMT 180
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-49
Identities = 83/353 (23%), Positives = 141/353 (39%), Gaps = 48/353 (13%)
Query: 31 SQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPTSSLTVVCYEESITQLHIVGNKRAPML 90
+ L+ + +L + +L W+ C + V C ++ +T + +
Sbjct: 12 REIHQLISFKDVLPDKNLLPDWSSNKNPCTFD-----GVTCRDDKVTSIDLSSK------ 60
Query: 91 PLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGP-------------------LSGKI---- 127
PL+ + ++L+ L L+ L L + + G LSG +
Sbjct: 61 PLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLT 120
Query: 128 --SRLSSLEILNMSSNFLNGAIPQELSI-LTSLQTLILDENMLAGRVPDWL---GSLPIL 181
S L+ LN+SSN L+ + L SL+ L L N ++G L
Sbjct: 121 SLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGEL 180
Query: 182 AVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQ 241
L++ N +G + S NL L +S+N+F +P + LQ LD+ N L
Sbjct: 181 KHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGD 238
Query: 242 FPK-VG--KKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALL-SLPSI 297
F + + +L + +S N+F IP LQ L L+ N+F G P L + ++
Sbjct: 239 FSRAISTCTELKLLNISSNQFVGPIPPLPLK--SLQYLSLAENKFTGEIPDFLSGACDTL 296
Query: 298 TYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLY 350
T L+++ N G + L + LSSN +G+LP L + VL
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLD 349
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-48
Identities = 73/243 (30%), Positives = 119/243 (48%), Gaps = 8/243 (3%)
Query: 105 KLPDLKVLRLVSLGLWGPL-SGKISRLSSLEILNMSSNFLNGAIPQELSILT-SLQTLIL 162
L+ L L S G L + ++ L++L++S N +G +P+ L+ L+ SL TL L
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 163 DENMLAGRVPDWLG--SLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP 220
N +G + L L L L+NN F G +P + S L L LS N+ G +P
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435
Query: 221 -DFSGLTYLQVLDLENNALGPQFPK---VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRL 276
L+ L+ L L N L + P+ K L T+IL N IP+ +S+ L +
Sbjct: 436 SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI 495
Query: 277 DLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLP 336
LS+NR G P+ + L ++ L +++N +G + +L L ++DL++NL G +P
Sbjct: 496 SLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
Query: 337 NCL 339
+
Sbjct: 556 AAM 558
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-47
Identities = 73/238 (30%), Positives = 100/238 (42%), Gaps = 4/238 (1%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLI 161
TL +L L L L G + + LS L L + N L G IPQEL + +L+TLI
Sbjct: 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472
Query: 162 LDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD 221
LD N L G +P L + L +SL NN G +P LENL +L LSNN F G +P
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
Query: 222 -FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSS 280
L LDL N P K ++ N + + + +
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK-IAANFIAGKRYVYIKNDGMKKECHGAG 591
Query: 281 N--RFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLP 336
N F G + L L + NI G N + F+D+S N+L+G +P
Sbjct: 592 NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP 649
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-46
Identities = 71/252 (28%), Positives = 113/252 (44%), Gaps = 13/252 (5%)
Query: 103 LVKLPDLKVLRLVSLGLWGPLSGKI---SRLSSLEILNMSSNFLNGAIPQELSILTSLQT 159
+KL L+VL L + + G L+ L +S N ++G + +S +L+
Sbjct: 147 GLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEF 204
Query: 160 LILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEV 219
L + N + +P +LG L L + N +G + S L++L +S+N F G +
Sbjct: 205 LDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 263
Query: 220 PDFSGLTYLQVLDLENNALGPQFPKVG----KKLVTMILSKNKFRSAIPAEVSSYYQLQR 275
P L LQ L L N + P L + LS N F A+P S L+
Sbjct: 264 PPLP-LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322
Query: 276 LDLSSNRFVGPFPQALLS-LPSITYLNIADNKLTGKLFDDLS-CNPELGFVDLSSNLLTG 333
L LSSN F G P L + + L+++ N+ +G+L + L+ + L +DLSSN +G
Sbjct: 323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382
Query: 334 QLPNCLLAGSKN 345
+ L KN
Sbjct: 383 PILPNLCQNPKN 394
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-46
Identities = 76/241 (31%), Positives = 105/241 (43%), Gaps = 12/241 (4%)
Query: 107 PDLKVLRLVSLGLWGPLSGKISR--LSSLEILNMSSNFLNGAIPQELSILTSLQTLILDE 164
L L L S GP+ + + ++L+ L + +N G IP LS + L +L L
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427
Query: 165 NMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FS 223
N L+G +P LGSL L L L NM G +P Y++ L L L N GE+P S
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
Query: 224 GLTYLQVLDLENNALGPQFPK---VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSS 280
T L + L NN L + PK + L + LS N F IPAE+ L LDL++
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547
Query: 281 NRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNL--LTGQLPNC 338
N F G P A+ IA N + GK + + + + NL G
Sbjct: 548 NLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603
Query: 339 L 339
L
Sbjct: 604 L 604
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-42
Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 10/244 (4%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLI 161
L+ + L+ L L L G + +S ++L +++S+N L G IP+ + L +L L
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520
Query: 162 LDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP- 220
L N +G +P LG L L L N+FNGT+P + ++ N G+
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYV 576
Query: 221 DFSGLTYLQVLDLENNAL---GPQFPKVGK--KLVTMILSKNKFRSAIPAEVSSYYQLQR 275
+ N L G + ++ + ++ + + +
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636
Query: 276 LDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQL 335
LD+S N G P+ + S+P + LN+ N ++G + D++ L +DLSSN L G++
Sbjct: 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI 696
Query: 336 PNCL 339
P +
Sbjct: 697 PQAM 700
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-39
Identities = 60/242 (24%), Positives = 97/242 (40%), Gaps = 10/242 (4%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLI 161
L +L + L + L G + I RL +L IL +S+N +G IP EL SL L
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLD 544
Query: 162 LDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNN--HFYGEV 219
L+ N+ G +P + + N G + + N F G
Sbjct: 545 LNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIR 600
Query: 220 P-DFSGLTYLQVLDLENNALGPQFPKVGKKLVTMI---LSKNKFRSAIPAEVSSYYQLQR 275
+ L+ ++ + G +M+ +S N IP E+ S L
Sbjct: 601 SEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFI 660
Query: 276 LDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQL 335
L+L N G P + L + L+++ NKL G++ +S L +DLS+N L+G +
Sbjct: 661 LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPI 720
Query: 336 PN 337
P
Sbjct: 721 PE 722
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-23
Identities = 41/134 (30%), Positives = 62/134 (46%)
Query: 103 LVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLIL 162
L +L + S G S S+ L+MS N L+G IP+E+ + L L L
Sbjct: 604 LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNL 663
Query: 163 DENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDF 222
N ++G +PD +G L L +L L +N +G +P + S L L + LSNN+ G +P+
Sbjct: 664 GHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
Query: 223 SGLTYLQVLDLENN 236
NN
Sbjct: 724 GQFETFPPAKFLNN 737
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 24/100 (24%), Positives = 40/100 (40%), Gaps = 3/100 (3%)
Query: 257 NKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKL--FDD 314
N SA+ + + S L+ L LS++ G S+T L+++ N L+G +
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 315 LSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNC 354
L L F+++SSN L + VL
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 63/189 (33%), Positives = 95/189 (50%), Gaps = 11/189 (5%)
Query: 441 SKFLSDARYISQTMKLGALGLPAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKN 500
SK+ I+ + L L +LEEATNNFD +G G G++Y+G L++
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 501 GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFE 560
G VA++ + F IE +S RH HLVS +G C E I LI++
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE------RNEMI-LIYK 115
Query: 561 YVPNGTLRSWIS-EGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL 619
Y+ NG L+ + S++W QR+ IG A+G+ +LHT + ++K +ILL
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILL 172
Query: 620 DQNLVAKIS 628
D+N V KI+
Sbjct: 173 DENFVPKIT 181
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 54/166 (32%), Positives = 89/166 (53%), Gaps = 9/166 (5%)
Query: 465 RTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH-STRNFMHH 523
+ FSL EL+ A++NF +G G G++Y+GRL +GT VA++ LK ++ F
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 524 IELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQS-LTW 582
+E+IS HR+L+ G C R+ L++ Y+ NG++ S + E Q L W
Sbjct: 78 VEMISMAVHRNLLRLRGFCMT------PTERL-LVYPYMANGSVASCLRERPESQPPLDW 130
Query: 583 TQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+R A+G A+G+ +LH P + ++K +ILLD+ A +
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 58/177 (32%), Positives = 85/177 (48%), Gaps = 27/177 (15%)
Query: 465 RTFSLEELEEATNNFDTSA------FMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHST- 517
+FS EL+ TNNFD MGEG G +Y+G + N T VA++ L +T
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 518 ---RNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEG 574
+ F I++++K +H +LV LG + D L++ Y+PNG+L +S
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSD---GDD---LC-LVYVYMPNGSLLDRLSCL 124
Query: 575 HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSN---NLKITDILLDQNLVAKIS 628
L+W R A G A GI FLH + ++K +ILLD+ AKIS
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHEN------HHIHRDIKSANILLDEAFTAKIS 175
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-34
Identities = 55/252 (21%), Positives = 84/252 (33%), Gaps = 11/252 (4%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLI 161
KLP LKVL L L + ++L L++ SN + +L TL
Sbjct: 68 LCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD 127
Query: 162 LDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLEN--LRVLALSNNHFYGEV 219
L N L+ L L L L NN + N L+ L LS+N
Sbjct: 128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFS 187
Query: 220 PD-FSGLTYLQVLDLENNALGPQFPKV------GKKLVTMILSKNKFRSAIPAEVSS--Y 270
P F + L L L N LGP + + + LS ++ + +
Sbjct: 188 PGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKW 247
Query: 271 YQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNL 330
L LDLS N + LP + Y + N + L + +++L +
Sbjct: 248 TNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSF 307
Query: 331 LTGQLPNCLLAG 342
+ L
Sbjct: 308 TKQSISLASLPK 319
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-33
Identities = 57/249 (22%), Positives = 89/249 (35%), Gaps = 17/249 (6%)
Query: 106 LPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIP-QELSILTSLQTLILDE 164
L +L L + S S L LE+L++ N + + QE L ++ + L
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439
Query: 165 NMLAGRVPDWLGSLPILAVLSLRNNMFNG--TLPDSFSYLENLRVLALSNNHFYGEVPD- 221
N + +P L L LR + P F L NL +L LSNN+ D
Sbjct: 440 NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499
Query: 222 FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSN 281
GL L++LDL++N L L K+ + L L+L SN
Sbjct: 500 LEGLEKLEILDLQHNNLA-------------RLWKHANPGGPIYFLKGLSHLHILNLESN 546
Query: 282 RFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLA 341
F + L + +++ N L + L ++L NL+T
Sbjct: 547 GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP 606
Query: 342 GSKNRVVLY 350
+N L
Sbjct: 607 AFRNLTELD 615
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-32
Identities = 55/277 (19%), Positives = 103/277 (37%), Gaps = 12/277 (4%)
Query: 101 TTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTL 160
+ L L + + +L L++LN+ N L+ + + T+L L
Sbjct: 43 ANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTEL 102
Query: 161 ILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYG--- 217
L N + + L L L +N + T + LENL+ L LSNN
Sbjct: 103 HLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162
Query: 218 EVPDFSGLTYLQVLDLENNAL---GPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYY--- 271
E D + L+ L+L +N + P +L + L+ + ++ ++
Sbjct: 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANT 222
Query: 272 QLQRLDLSSNRFVGPFPQAL--LSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSN 329
++ L LS+++ L ++T L+++ N L D + P+L + L N
Sbjct: 223 SIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYN 282
Query: 330 LLTGQLPNCLLAGSKNRVVLYARNCLAAGNENQHPLS 366
+ L + L G N L + + + L
Sbjct: 283 NIQH-LFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-31
Identities = 49/217 (22%), Positives = 97/217 (44%), Gaps = 9/217 (4%)
Query: 130 LSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189
+++ +LN++ N L + + L +L + N ++ P+ LP+L VL+L++N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNAL-GPQFPKVG- 246
+ +F++ NL L L +N + F L LDL +N L +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 247 -KKLVTMILSKNKFRSAIPAEVS--SYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIA 303
+ L ++LS NK ++ E+ + L++L+LSSN+ P ++ + L +
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203
Query: 304 DNKLTGKLFDDLS---CNPELGFVDLSSNLLTGQLPN 337
+ +L L + L N + + LS++ L+
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-29
Identities = 55/306 (17%), Positives = 105/306 (34%), Gaps = 28/306 (9%)
Query: 60 NTEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGL 119
T L + SI L + ++ + +F +K +L +L L L
Sbjct: 208 GPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL-------GLKWTNLTMLDLSYNNL 260
Query: 120 WGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRV-------- 171
+ + L LE + N + L L +++ L L + +
Sbjct: 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI 320
Query: 172 -PDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD---FSGL-- 225
L L L++ +N G + F+ L NL+ L+LSN+ F L
Sbjct: 321 DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH 380
Query: 226 TYLQVLDLENNAL---GPQFPKVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSN 281
+ L +L+L N + L + L N+ + + + + LS N
Sbjct: 381 SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYN 440
Query: 282 RFVGPFPQALLSLPSITYLNIADNKLTG--KLFDDLSCNPELGFVDLSSNLLTGQLPNCL 339
+++ + +PS+ L + L L +DLS+N + + + +
Sbjct: 441 KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN-INDDM 499
Query: 340 LAGSKN 345
L G +
Sbjct: 500 LEGLEK 505
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 49/224 (21%), Positives = 86/224 (38%), Gaps = 16/224 (7%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGK-ISRLSSLEILNMSSNFLNGAIPQELSILTSLQTL 160
L L+VL L + L+G+ L ++ + +S N +++ SLQ L
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459
Query: 161 ILDENMLAG--RVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHF--- 215
+L L P L L +L L NN D LE L +L L +N+
Sbjct: 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL 519
Query: 216 ------YGEVPDFSGLTYLQVLDLENNAL---GPQFPKVGKKLVTMILSKNKFRSAIPAE 266
G + GL++L +L+LE+N + K +L + L N + +
Sbjct: 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
Query: 267 VSSYYQLQRLDLSSNRFVGPFPQALL-SLPSITYLNIADNKLTG 309
++ L+ L+L N + + ++T L++ N
Sbjct: 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 49/221 (22%), Positives = 79/221 (35%), Gaps = 9/221 (4%)
Query: 132 SLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMF 191
S E+ + S L +P + + T++ L L N L L L + N
Sbjct: 5 SHEVADCSHLKLT-QVPDD--LPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 192 NGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKV---GK 247
+ P+ L L+VL L +N F+ T L L L +N++ K
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 248 KLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQAL--LSLPSITYLNIADN 305
L+T+ LS N S LQ L LS+N+ + L + S+ L ++ N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 306 KLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNR 346
++ L + L++ L L L N
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANT 222
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-26
Identities = 50/272 (18%), Positives = 93/272 (34%), Gaps = 53/272 (19%)
Query: 91 PLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKIS--RLSSLEILNMSSNFLNGAIP 148
L S+ + + ++ L L + L + + ++L +L++S N LN
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 149 QELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTL---------PDSF 199
+ L L+ L+ N + L L + L+L+ + ++ SF
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
Query: 200 SYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNK 258
+L+ L L + +N G + F+GL L+ L L N+ + L+
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR-----------TLTNET 374
Query: 259 FRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCN 318
F S ++ L L+L+ N+ A L + L
Sbjct: 375 FVS------LAHSPLHILNLTKNKISKIESDAFSWLGHLEVL------------------ 410
Query: 319 PELGFVDLSSNLLTGQLPNCLLAGSKNRVVLY 350
DL N + +L G +N +Y
Sbjct: 411 ------DLGLNEIGQELTGQEWRGLENIFEIY 436
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-17
Identities = 34/154 (22%), Positives = 53/154 (34%), Gaps = 10/154 (6%)
Query: 95 SMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLN--------GA 146
++DS + L +L +L L + + + L LEIL++ N L G
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGG 527
Query: 147 IPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLR 206
L L+ L L L+ N + L L ++ L N N F+ +L+
Sbjct: 528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK 587
Query: 207 VLALSNNHFYGEVPDF--SGLTYLQVLDLENNAL 238
L L N L LD+ N
Sbjct: 588 SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 33/152 (21%), Positives = 52/152 (34%), Gaps = 15/152 (9%)
Query: 102 TLVKLPDLKVL--------RLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153
L L L++L RL G + LS L ILN+ SN + +
Sbjct: 499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558
Query: 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSY-LENLRVLALSN 212
L L+ + L N L + L L+L+ N+ F NL L +
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618
Query: 213 NHFYGEVPDFSGL------TYLQVLDLENNAL 238
N F + T+ + +L ++ L
Sbjct: 619 NPFDCTCESIAWFVNWINETHTNIPELSSHYL 650
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-32
Identities = 40/252 (15%), Positives = 84/252 (33%), Gaps = 22/252 (8%)
Query: 109 LKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENML- 167
+ + K L L + + + +P L L +Q + + N
Sbjct: 227 WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI 286
Query: 168 -------AGRVPDWLGSLPILAVLSLRNNMF-NGTLPDSFSYLENLRVLALSNNHFYGEV 219
+ + ++ + N + S ++ L +L N G++
Sbjct: 287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346
Query: 220 PDFSGLTYLQVLDLENNALG---PQFPKVGKKLVTMILSKNKFRSAIPA--EVSSYYQLQ 274
P F L L+L N + F +++ + + NK IP + S +
Sbjct: 347 PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMS 405
Query: 275 RLDLSSNRFVG-------PFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLS 327
+D S N P +++ +N+++N+++ + S L ++L
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLM 465
Query: 328 SNLLTGQLPNCL 339
N+LT N L
Sbjct: 466 GNMLTEIPKNSL 477
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-29
Identities = 44/254 (17%), Positives = 85/254 (33%), Gaps = 32/254 (12%)
Query: 127 ISRLSSLEILNMSSNFLNGAIPQELSI--LTSLQTLILDENMLAGRVPDWLGSLPI---- 180
+E L+ + N L IP ++ + + N + L
Sbjct: 373 CGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431
Query: 181 ---LAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHF--------YGEVPDFSGLTYLQ 229
++ ++L NN + + FS L + L N E +F L
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT 491
Query: 230 VLDLENNALG--PQFPKVGK--KLVTMILSKNKFRSAIPAEVSSYYQLQRL------DLS 279
+DL N L + LV + LS N F P + + L+ D
Sbjct: 492 SIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQ 550
Query: 280 SNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCL 339
NR + +P+ + PS+T L I N + + + ++ P + +D+ N + +
Sbjct: 551 GNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKIT--PNISVLDIKDNPNISIDLSYV 607
Query: 340 LAGSKNRVVLYARN 353
+ + + +
Sbjct: 608 CPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-28
Identities = 43/251 (17%), Positives = 80/251 (31%), Gaps = 36/251 (14%)
Query: 105 KLPDLKVLRL-------VSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSL 157
+ + + V + PL + ++ +N+S+N ++ + S + L
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL 459
Query: 158 QTLILDENMLAG-------RVPDWLGSLPILAVLSLRNNMFNGTLPDSFSY--LENLRVL 208
++ L NML + + +L + LR N L D F L L +
Sbjct: 460 SSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGI 518
Query: 209 ALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVS 268
LS N F + L+ + N N+ P ++
Sbjct: 519 DLSYNSFSKFPTQPLNSSTLKGFGIRNQ---------------RDAQGNRTLREWPEGIT 563
Query: 269 SYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSS 328
L +L + SN + + P+I+ L+I DN + E G L
Sbjct: 564 LCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFY 620
Query: 329 NLLTGQLPNCL 339
+ + C
Sbjct: 621 DKTQ-DIRGCD 630
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-27
Identities = 34/246 (13%), Positives = 77/246 (31%), Gaps = 17/246 (6%)
Query: 109 LKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNG----AIPQELSILTSLQTLILDE 164
+ L L G G + I +L+ LE+L + S+ P+ +S S +
Sbjct: 83 VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR 142
Query: 165 NMLAGRVPDWLG--SLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDF 222
D+ L + ++ ++ S + +N+
Sbjct: 143 MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAV 202
Query: 223 SGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNR 282
LT L+ + N+ + + + + + L +++ +
Sbjct: 203 MRLTKLRQFYMGNSPFVAENICEAWENEN--SEYAQQYKTEDLKWDNLKDLTDVEVYNCP 260
Query: 283 FVGPFPQALLSLPSITYLNIADNKLT--------GKLFDDLSCNPELGFVDLSSN-LLTG 333
+ P L +LP + +N+A N+ + D ++ + + N L T
Sbjct: 261 NLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTF 320
Query: 334 QLPNCL 339
+ L
Sbjct: 321 PVETSL 326
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 22/170 (12%), Positives = 47/170 (27%), Gaps = 8/170 (4%)
Query: 193 GTLPDSFSYLENLRVLALSNNHFYGEV-PDFSGLTYLQVLDLENNALGPQFPKVGKKLVT 251
+ D + E L N G + + + LD+ G G+ +
Sbjct: 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGR-VTG 85
Query: 252 MILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGP----FPQALLSLPSITYLNIADNKL 307
+ L +P + +L+ L L S+ P+ + + S
Sbjct: 86 LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHY 145
Query: 308 TGKLFDDLSCN--PELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCL 355
D +L ++S+ + K+ + N +
Sbjct: 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 12/89 (13%), Positives = 27/89 (30%), Gaps = 3/89 (3%)
Query: 101 TTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTL 160
+TL I+ SL L + SN + + ++ I ++ L
Sbjct: 536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEK--ITPNISVL 592
Query: 161 ILDENMLAGRVPDWLGSLPILAVLSLRNN 189
+ +N ++ + L +
Sbjct: 593 DIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-32
Identities = 55/289 (19%), Positives = 88/289 (30%), Gaps = 30/289 (10%)
Query: 92 LSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLN------- 144
L + +D + L ++ LVS+ + S + L + +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKL 324
Query: 145 ------------GAIPQELSILTSLQTLILDENMLA--GRVPDWLGSLPILAVLSLRNNM 190
G L SL+ L L N L+ G L L L N
Sbjct: 325 KSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 191 FNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENN---ALGPQFPKV 245
T+ +F LE L L +++ F L L LD+ +
Sbjct: 385 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443
Query: 246 GKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIAD 304
L + ++ N F+ ++ + L LDLS + P A SL S+ LN++
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503
Query: 305 NKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARN 353
N C L +D S N + L + L
Sbjct: 504 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 552
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-27
Identities = 45/239 (18%), Positives = 80/239 (33%), Gaps = 14/239 (5%)
Query: 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENM 166
K L L L S L++L++S + L+ L TLIL N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 167 LAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHF-YGEVPD-FSG 224
+ L L L +L+ L+ L +++N ++P+ FS
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 225 LTYLQVLDLENNALG-------PQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLD 277
LT L+ LDL +N + ++ +++ LS N I +L +L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLT 206
Query: 278 LSSNRFVGPFPQ-ALLSLPSITYLNIADNKLTGK---LFDDLSCNPELGFVDLSSNLLT 332
L +N + + L + + + + D S L + + L
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-26
Identities = 58/258 (22%), Positives = 88/258 (34%), Gaps = 18/258 (6%)
Query: 101 TTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTL 160
+ P+L+VL L + G LS L L ++ N + S L+SLQ L
Sbjct: 46 YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105
Query: 161 ILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGT-LPDSFSYLENLRVLALSNNHFYGEV 219
+ E LA +G L L L++ +N+ LP+ FS L NL L LS+N
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165
Query: 220 P-DFSGLTYLQV----LDLENNALGPQFPKVGK--KLVTMILSKNKFRSAIPAEV-SSYY 271
D L + + LDL N + P K +L + L N +
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLA 225
Query: 272 QLQRLDLSSNRFVGPFPQALLS---LPSITYLNIADNKLT------GKLFDDLSCNPELG 322
L+ L F L + L I + +L + D +C +
Sbjct: 226 GLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS 285
Query: 323 FVDLSSNLLTGQLPNCLL 340
L S +
Sbjct: 286 SFSLVSVTIERVKDFSYN 303
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-26
Identities = 56/253 (22%), Positives = 86/253 (33%), Gaps = 14/253 (5%)
Query: 130 LSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189
+ ++ M NF IP L S + L L N L S P L VL L
Sbjct: 7 VPNITYQCMELNFY--KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62
Query: 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNAL-GPQFPKVG- 246
++ L +L L L+ N FSGL+ LQ L L + +G
Sbjct: 63 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 247 -KKLVTMILSKNKFRSA-IPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITY----L 300
K L + ++ N +S +P S+ L+ LDLSSN+ + L L + L
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 301 NIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNE 360
+++ N + L + L +N + + + G V
Sbjct: 183 DLSLNPMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241
Query: 361 NQHPLSFCQNEAL 373
N E L
Sbjct: 242 NLEKFDKSALEGL 254
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 46/191 (24%), Positives = 66/191 (34%), Gaps = 8/191 (4%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQE-LSILTSLQTL 160
+ LK L L G+ +S L LE L+ + L L +L L
Sbjct: 368 SDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426
Query: 161 ILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTL-PDSFSYLENLRVLALSNNHFYGEV 219
+ L L VL + N F PD F+ L NL L LS
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486
Query: 220 PD-FSGLTYLQVLDLENNALGPQFPKVG---KKLVTMILSKNKFRSAIPAEVSS-YYQLQ 274
P F+ L+ LQVL++ +N L + S N ++ E+ L
Sbjct: 487 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 546
Query: 275 RLDLSSNRFVG 285
L+L+ N F
Sbjct: 547 FLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 48/285 (16%), Positives = 83/285 (29%), Gaps = 35/285 (12%)
Query: 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGL-WGPLSGKISRLSSL 133
+ +V + L S + L L ++ RL L + + L+++
Sbjct: 226 GLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL-TIEEFRLAYLDYYLDDIIDLFNCLTNV 284
Query: 134 EILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNG 193
++ S + S Q L L +L + ++ L G
Sbjct: 285 SSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ-----FPTLKLKSLKRLTFTSNKG 337
Query: 194 TLPDSFSYLENLRVLALSNNH--FYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLV 250
S L +L L LS N F G G T L+ LDL N +
Sbjct: 338 GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV------------ 385
Query: 251 TMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQ-ALLSLPSITYLNIADNKLTG 309
+ + QL+ LD + LSL ++ YL+I+
Sbjct: 386 ----------ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 310 KLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNC 354
+ L + ++ N + +N L C
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 8e-31
Identities = 46/263 (17%), Positives = 86/263 (32%), Gaps = 25/263 (9%)
Query: 101 TTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTL 160
T D + + S L L + + + +P L L LQ+L
Sbjct: 461 TYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSL 520
Query: 161 ILDENMLAG---------RVPDWLGSLPILAVLSLRNNMFNGTLPDS--FSYLENLRVLA 209
+ N R+ D + P + + + N P S + L +L
Sbjct: 521 NIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLD 579
Query: 210 LSNNHFYGEVPDFSGLTYLQVLDLENNALG---PQFPKVGKKLVTMILSKNKFRSAIP-- 264
+N + F L L L+ N + F ++ + S NK IP
Sbjct: 580 CVHNKV-RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKL-KYIPNI 637
Query: 265 AEVSSYYQLQRLDLSSNRFVGPFPQALLSLP-----SITYLNIADNKLTGKLFDDLSCNP 319
S Y + +D S N+ S+ + + + ++ N++ + +
Sbjct: 638 FNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGS 697
Query: 320 ELGFVDLSSNLLTGQLPNCLLAG 342
+ + LS+NL+T +P L
Sbjct: 698 PISTIILSNNLMT-SIPENSLKP 719
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 46/285 (16%), Positives = 87/285 (30%), Gaps = 30/285 (10%)
Query: 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWG------PLSGKIS 128
++ + ++R + L + + + + L + +S I
Sbjct: 386 HYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQ 445
Query: 129 RLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRN 188
RL+ L+I+ +++ + D +L L + L N
Sbjct: 446 RLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500
Query: 189 NMFNGTLPDSFSYLENLRVLALSNNHFYGEV----------PDFSGLTYLQVLDLENNAL 238
LPD L L+ L ++ N D +Q+ + N L
Sbjct: 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560
Query: 239 G--PQFPKVGK--KLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSL 294
P + K KL + NK R + + +L L L N+
Sbjct: 561 EEFPASASLQKMVKLGLLDCVHNKVRH-LE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFT 618
Query: 295 PSITYLNIADNKLTGKLFDDLSCN--PELGFVDLSSNLLTGQLPN 337
+ L + NKL + + + +G VD S N + + N
Sbjct: 619 DQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 41/242 (16%), Positives = 83/242 (34%), Gaps = 34/242 (14%)
Query: 127 ISRLSSLEILNMSSNFLNGAIPQEL-SILTSLQTLILDENMLAGRVPDW--LGSLPILAV 183
L L + N + IP++ + ++ L N L +P+ S+ ++
Sbjct: 591 FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGS 648
Query: 184 LSLRNNMFNGTLPDSFSYLE-----NLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNA 237
+ N + ++ N + LS N + F+ + + + L NN
Sbjct: 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708
Query: 238 LGPQFPKVG-----------KKLVTMILSKNKFRSAIPAE--VSSYYQLQRLDLSSNRFV 284
+ P+ L T+ L NK S + + ++ L +D+S N F
Sbjct: 709 MT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS 766
Query: 285 GPFPQALLSLPSITYLNI------ADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNC 338
FP L+ + I N++ + ++ P L + + SN + +
Sbjct: 767 S-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEK 824
Query: 339 LL 340
L
Sbjct: 825 LT 826
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 52/356 (14%), Positives = 113/356 (31%), Gaps = 57/356 (16%)
Query: 40 QGLLNNPAVLSSWNITTEFCNTEPTSSLTVVCYEES-ITQLHIVGNKRAPMLPLSFSMDS 98
G +NN +WN E V +T L + G +P +
Sbjct: 290 SGTINNTIHSLNWNFNKELDM--WGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG--- 344
Query: 99 FVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQE-LSILTSL 157
+L +LKVL + + ++ + + + L L
Sbjct: 345 ------QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398
Query: 158 QTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNG------TLPDSFSYLENLRVLALS 211
L ++ + R P+ + + + +SL++ + + L L+++ +
Sbjct: 399 NLSDLLQDAIN-RNPE-MKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFA 456
Query: 212 NNHFYGEVPD--------------------FSGLTYLQVLDLENNALGPQFPK-VG--KK 248
N+ F + +S L L ++L N Q P + +
Sbjct: 457 NSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPE 516
Query: 249 LVTMILSKNKFRSAIP---------AEVSSYYQLQRLDLSSNRFVG-PFPQALLSLPSIT 298
L ++ ++ N+ SA + + ++Q + N P +L + +
Sbjct: 517 LQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLG 576
Query: 299 YLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNC 354
L+ NK+ + N +L + L N + ++P A + L +
Sbjct: 577 LLDCVHNKVRH--LEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHN 629
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-23
Identities = 37/241 (15%), Positives = 76/241 (31%), Gaps = 33/241 (13%)
Query: 103 LVKLPDLKVL-----RLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSL 157
+ + + ++ S G S + + + +S N + + + + +
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI 699
Query: 158 QTLILDENML-------AGRVPDWLGSLPILAVLSLRNNMFNGTLPDS--FSYLENLRVL 208
T+IL N++ + +L + LR N +L D + L L +
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNM 758
Query: 209 ALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVS 268
+S N F + L+ + + N+ P ++
Sbjct: 759 DVSYNCFSSFPTQPLNSSQLKAFGIRHQ---------------RDAEGNRILRQWPTGIT 803
Query: 269 SYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSS 328
+ L +L + SN + L P + L+IADN + E G L
Sbjct: 804 TCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLY 860
Query: 329 N 329
+
Sbjct: 861 D 861
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 11/96 (11%), Positives = 24/96 (25%)
Query: 272 QLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLL 331
++ L L+ G P A+ L + L+ + T + + +
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 332 TGQLPNCLLAGSKNRVVLYARNCLAAGNENQHPLSF 367
L + + N P+
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 8e-30
Identities = 61/262 (23%), Positives = 104/262 (39%), Gaps = 12/262 (4%)
Query: 103 LVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAI-PQELSILTSLQTLI 161
LV L LK L L + S SL L++ N + L L +L+ L
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356
Query: 162 LDENMLA--GRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEV 219
L + + L +L L L+L N ++F L +L L+ +
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416
Query: 220 PD--FSGLTYLQVLDLENNAL---GPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYY--- 271
F L L+VL+L ++ L Q L + L N F + +S
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476
Query: 272 QLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLL 331
+L+ L LS A SL + +++++ N+LT + LS + +++L+SN +
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535
Query: 332 TGQLPNCLLAGSKNRVVLYARN 353
+ LP+ L S+ R + +N
Sbjct: 536 SIILPSLLPILSQQRTINLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 54/292 (18%), Positives = 91/292 (31%), Gaps = 20/292 (6%)
Query: 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLS--S 132
L+ G + ++ + + L + + L S
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNST-------IQSLWLGTFEDMDDEDISPAVFEGLCEMS 255
Query: 133 LEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFN 192
+E +N+ ++ + LQ L L L+ +P L L L L L N F
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFE 314
Query: 193 GTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVG---- 246
S S +L L++ N E+ L L+ LDL ++ +
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374
Query: 247 -KKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLS-LPSITYLNIAD 304
L ++ LS N+ S QL+ LDL+ R Q+ L + LN++
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSH 434
Query: 305 NKLTGKLFDDLSCNPELGFVDLSSNLLTG--QLPNCLLAGSKNRVVLYARNC 354
+ L P L ++L N L +L C
Sbjct: 435 SLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC 486
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 60/243 (24%), Positives = 93/243 (38%), Gaps = 12/243 (4%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPL-SGKISRLSSLEILNMSSNFLN--GAIPQELSILTSLQ 158
+ P L L + L +G + L +L L++S + + +L L+ LQ
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQ 379
Query: 159 TLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDS-FSYLENLRVLALSNNHFYG 217
+L L N + P L +L L S F L L+VL LS++
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 218 EVPD-FSGLTYLQVLDLENNAL------GPQFPKVGKKLVTMILSKNKFRSAIPAEVSSY 270
F GL LQ L+L+ N + +L ++LS S +S
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499
Query: 271 YQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNL 330
+ +DLS NR +AL L I YLN+A N ++ L L + ++L N
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNP 558
Query: 331 LTG 333
L
Sbjct: 559 LDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-26
Identities = 45/248 (18%), Positives = 81/248 (32%), Gaps = 10/248 (4%)
Query: 101 TTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTL 160
TT +L +L L L ++ L+ L +++N L LS +L+ L
Sbjct: 51 TTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHL 110
Query: 161 ILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYG-EV 219
+ ++ L + L L L +N + E L+VL NN +
Sbjct: 111 FFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170
Query: 220 PDFSGLTYLQV--LDLENNALG--PQFPKVGKKLVTMILSKNKFRSAIPAEVS--SYYQL 273
D S L L+L N + ++ + I + + L
Sbjct: 171 EDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSL 230
Query: 274 QRLDLSSNRFVGPFPQALLSLP--SITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLL 331
P L S+ +N+ + + C L +DL++ L
Sbjct: 231 WLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290
Query: 332 TGQLPNCL 339
+ +LP+ L
Sbjct: 291 S-ELPSGL 297
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 44/254 (17%), Positives = 82/254 (32%), Gaps = 14/254 (5%)
Query: 106 LPDLKVLRLVSLGL----WGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI--LTSLQT 159
+ L+ +SL L + + + LN I + L + SL
Sbjct: 173 MSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWL 232
Query: 160 LILDENMLAGRVPDWLGSLPILAV--LSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYG 217
++ P L ++V ++L+ + F ++F L+ L L+ H
Sbjct: 233 GTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE 292
Query: 218 EVPDFSGLTYLQVLDLENNALG---PQFPKVGKKLVTMILSKNKFRSAIPAEV-SSYYQL 273
GL+ L+ L L N L + + N R + + L
Sbjct: 293 LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352
Query: 274 QRLDLSSNR--FVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLL 331
+ LDLS + L +L + LN++ N+ + P+L +DL+ L
Sbjct: 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412
Query: 332 TGQLPNCLLAGSKN 345
+
Sbjct: 413 KVKDAQSPFQNLHL 426
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-22
Identities = 42/226 (18%), Positives = 61/226 (26%), Gaps = 9/226 (3%)
Query: 130 LSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189
+S E L S N L S L +L L L + D S L L L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVG-- 246
+ S + L+ L L+ L L +N + G
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
Query: 247 -KKLVTMILSKNKFRSAIPAEVSSYYQLQR--LDLSSNRFVGPFPQALLSLPSITYLNIA 303
+KL + N ++SS Q L+L+ N G LN
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFG 210
Query: 304 DNKLTGKLFDDLSCN--PELGFVDLSSNLLTGQLPNCLLAGSKNRV 347
+ +F L + L P + V
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-21
Identities = 40/212 (18%), Positives = 65/212 (30%), Gaps = 10/212 (4%)
Query: 134 EILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNG 193
+ N + LN IP ++ S + L N+L L L L L
Sbjct: 15 KTYNCENLGLN-EIPG--TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 194 TLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNAL---GPQFPKVGKKL 249
D+F L L L+ N SG L+ L + K L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 250 VTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSIT--YLNIADNKL 307
++ L N S + +L+ LD +N + + SL T LN+ N +
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 308 TGKLFDDLSCNPELGFVDLSSNLLTGQLPNCL 339
G + + ++ + L
Sbjct: 192 AG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGL 222
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 48/242 (19%), Positives = 85/242 (35%), Gaps = 43/242 (17%)
Query: 102 TLVKLPDLKVL-----RLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTS 156
+ P L++L RL P L L++LN+S + L+ + Q L +
Sbjct: 395 AFKECPQLELLDLAFTRLKVKDAQSPFQN----LHLLKVLNLSHSLLDISSEQLFDGLPA 450
Query: 157 LQTLILDENMLAG---RVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNN 213
LQ L L N + + L +L L +L L + +F+ L+ + + LS+N
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510
Query: 214 HFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQ 272
+ S L + L+ L+ N +P+ + Q
Sbjct: 511 RLTSSSIEALSHLKGI-YLN---------------------LASNHISIILPSLLPILSQ 548
Query: 273 LQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCN--PELGFVDLSSNL 330
+ ++L N ++ + + KL +D C P L V LS
Sbjct: 549 QRTINLRQNPLDCTCS----NIYFLEWYKENMQKLED--TEDTLCENPPLLRGVRLSDVT 602
Query: 331 LT 332
L+
Sbjct: 603 LS 604
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 29/169 (17%), Positives = 66/169 (39%), Gaps = 16/169 (9%)
Query: 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIEL 526
E L + G G +++ +L +VA++ ++ S + + +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYS 71
Query: 527 ISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRI 586
+ ++H +++ +G S ++LI + G+L ++ ++W +
Sbjct: 72 LPGMKHENILQFIGAEKR---GTSVDVDLWLITAFHEKGSLSDFLK----ANVVSWNELC 124
Query: 587 SAAIGVAKGIQFLHTGIVPGVFSNNLKI-------TDILLDQNLVAKIS 628
A +A+G+ +LH I + I ++LL NL A I+
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 54/235 (22%), Positives = 86/235 (36%), Gaps = 11/235 (4%)
Query: 106 LPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSIL--TSLQTLILD 163
LP LK L L L SL L++S N L+ + S L SL+ L L
Sbjct: 327 LPFLKSLTLTMNKGSISFK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 164 ENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDS-FSYLENLRVLALSNNHFYGEVPD- 221
N + L L L +++ S F LE L L +S + +
Sbjct: 385 FNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 222 FSGLTYLQVLDLENNAL----GPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLD 277
F GLT L L + N+ L + LSK + + ++LQ L+
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503
Query: 278 LSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT 332
+S N + L S++ L+ + N++ L F +L++N +
Sbjct: 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-26
Identities = 55/272 (20%), Positives = 93/272 (34%), Gaps = 15/272 (5%)
Query: 90 LPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQ 149
+ L+ ++ + K + L ++ L + L L+ L ++ N G+I
Sbjct: 290 MSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLD---LPFLKSLTLTMN--KGSISF 344
Query: 150 ELSILTSLQTLILDENMLAGRVPD--WLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRV 207
+ L SL L L N L+ L L L N + +F LE L+
Sbjct: 345 KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQH 403
Query: 208 LALSNNHFYG--EVPDFSGLTYLQVLDLENNALGPQFPKVGK---KLVTMILSKNKFRSA 262
L ++ E F L L LD+ F + L T+ ++ N F+
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN 463
Query: 263 IPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPEL 321
+ V ++ L LDLS + +L + LN++ N L + L
Sbjct: 464 TLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSL 523
Query: 322 GFVDLSSNLLTGQLPNCLLAGSKNRVVLYARN 353
+D S N + L K+ N
Sbjct: 524 STLDCSFNRIET-SKGILQHFPKSLAFFNLTN 554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 43/252 (17%), Positives = 74/252 (29%), Gaps = 21/252 (8%)
Query: 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENM 166
K + L L S S S L+ L++S + + L L LIL N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 167 LAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSG 224
+ P L L L L L+ L +++N + FS
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 225 LTYLQVLDLENNALG-------PQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLD 277
LT L +DL N + + + +++ +S N I + +L L
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELT 210
Query: 278 LSSNRFVG-PFPQALLSLPSITYLNIADNKLTG---------KLFDDLSCNPELGFVDLS 327
L N L +L + + + + + L C+ + L+
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGL-CDVTIDEFRLT 269
Query: 328 SNLLTGQLPNCL 339
Sbjct: 270 YTNDFSDDIVKF 281
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 45/286 (15%), Positives = 86/286 (30%), Gaps = 13/286 (4%)
Query: 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLE 134
+ +L + GN + + + + + +L + +L ++ P + +++
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264
Query: 135 ILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGT 194
++ + L ++ + L + + LS+
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED--VPKHFKWQSLSIIRCQLKQF 322
Query: 195 LPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNAL-----GPQFPKVGKKL 249
L L+ L L+ N L L LDL NAL L
Sbjct: 323 ---PTLDLPFLKSLTLTMNKG-SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL 378
Query: 250 VTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVG-PFPQALLSLPSITYLNIADNKLT 308
+ LS N + A +LQ LD + A LSL + YL+I+
Sbjct: 379 RHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 309 GKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNC 354
L + ++ N + + A + N L C
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-20
Identities = 46/257 (17%), Positives = 79/257 (30%), Gaps = 24/257 (9%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGA-IPQELSILTSLQTL 160
+ L L+ L V L S I +L +L+ LN++ NF++ +P S LT+L +
Sbjct: 99 SFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHV 158
Query: 161 ILDENMLAGRVPDWLGSL----PILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFY 216
L N + + L L + L + N + +F + L L L N
Sbjct: 159 DLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNS 217
Query: 217 GEVPD--FSGLTYLQVLDLENN---------ALGPQFPKVGKKLVTMIL--SKNKFRSAI 263
+ L L V L P + + + S
Sbjct: 218 SNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDD 277
Query: 264 PAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGF 323
+ + + L+ + L+I +L DL P L
Sbjct: 278 IVKFHCLANVSAMSLAGVSIKYLED--VPKHFKWQSLSIIRCQLKQFPTLDL---PFLKS 332
Query: 324 VDLSSNLLTGQLPNCLL 340
+ L+ N + L
Sbjct: 333 LTLTMNKGSISFKKVAL 349
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 8e-20
Identities = 43/220 (19%), Positives = 73/220 (33%), Gaps = 15/220 (6%)
Query: 136 LNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTL 195
L+ +P ++ +S + + L N L + L L L
Sbjct: 16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72
Query: 196 PDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNAL----GPQFPKVGKKLV 250
++ L +L L L+ N P FSGLT L+ L L ++ L
Sbjct: 73 DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQL-ITLK 131
Query: 251 TMILSKNKFRSA-IPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSIT----YLNIADN 305
+ ++ N S +PA S+ L +DLS N L L L+++ N
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191
Query: 306 KLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKN 345
+ + D +L + L N + + L
Sbjct: 192 PID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAG 230
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 28/139 (20%), Positives = 46/139 (33%), Gaps = 2/139 (1%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQE-LSILTSLQTL 160
+ L L L + G L+SL L M+ N + T+L L
Sbjct: 419 AFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFL 478
Query: 161 ILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP 220
L + L +L L +L++ +N ++ L +L L S N
Sbjct: 479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG 538
Query: 221 D-FSGLTYLQVLDLENNAL 238
L +L NN++
Sbjct: 539 ILQHFPKSLAFFNLTNNSV 557
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 44/204 (21%), Positives = 78/204 (38%), Gaps = 9/204 (4%)
Query: 130 LSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189
+ +I ++ + L A+ +++ L L N L+ L L +L+L +N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKL 249
+ D L LR L L+NN+ + ++ L NN + G+
Sbjct: 69 VLY-ETLD-LESLSTLRTLDLNNNYV----QELLVGPSIETLHAANNNISRVSCSRGQGK 122
Query: 250 VTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVG-PFPQALLSLPSITYLNIADNKLT 308
+ L+ NK + ++Q LDL N F + S ++ +LN+ N +
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 309 GKLFDDLSCNPELGFVDLSSNLLT 332
+L +DLSSN L
Sbjct: 183 D--VKGQVVFAKLKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 59/269 (21%), Positives = 104/269 (38%), Gaps = 22/269 (8%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLI 161
++K L L L + ++ + LE+LN+SSN L +L L++L+TL
Sbjct: 29 LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLD 86
Query: 162 LDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD 221
L+ N + L P + L NN + + S + + + L+NN + D
Sbjct: 87 LNNNYVQE-----LLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKI-TMLRD 137
Query: 222 --FSGLTYLQVLDLENNAL----GPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQR 275
+ +Q LDL+ N + + L + L N + +V +L+
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVF-AKLKT 195
Query: 276 LDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT-GQ 334
LDLSSN+ S +T++++ +NKL + L + L DL N G
Sbjct: 196 LDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253
Query: 335 LPNCLLAGSKNRVVLYARNCLAAGNENQH 363
L + + + V G +
Sbjct: 254 LRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 36/223 (16%), Positives = 66/223 (29%), Gaps = 29/223 (13%)
Query: 101 TTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTL 160
L+ P ++ L + + SR + + +++N + + + +Q L
Sbjct: 93 QELLVGPSIETLHAANNNI---SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149
Query: 161 ILDENMLAG-RVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEV 219
L N + + S L L+L+ N + L+ L LS+N
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLAFMG 207
Query: 220 PDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLS 279
P+F + + L NN L I + L+ DL
Sbjct: 208 PEFQSAAGVTWISLRNNKL----------------------VLIEKALRFSQNLEHFDLR 245
Query: 280 SNRFV-GPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPEL 321
N F G + + K ++ P L
Sbjct: 246 GNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 27/183 (14%), Positives = 60/183 (32%), Gaps = 25/183 (13%)
Query: 172 PDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYG-EVPDFSGLTYLQV 230
+ + + + ++ L N++ L LS N D + T L++
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 231 LDLENNALG--PQFPK------------------VGKKLVTMILSKNKFRSAIPAEVSSY 270
L+L +N L VG + T+ + N +
Sbjct: 63 LNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISR-VSCSRGQ- 120
Query: 271 YQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCN-PELGFVDLSSN 329
+ + L++N+ + YL++ N++ F +L+ + L ++L N
Sbjct: 121 -GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 330 LLT 332
+
Sbjct: 180 FIY 182
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 31/161 (19%), Positives = 59/161 (36%), Gaps = 17/161 (10%)
Query: 195 LPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNAL----GPQFPKVGKKL 249
+ + ++ ++++ + ++ LDL N L KL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPF-TKL 60
Query: 250 VTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG 309
+ LS N ++ S L+ LDL++N Q LL PSI L+ A+N ++
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 310 KLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLY 350
++ S + L++N +T L + L
Sbjct: 113 RV--SCSRGQGKKNIYLANNKIT-MLRDLDEGCRSRVQYLD 150
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 44/204 (21%), Positives = 78/204 (38%), Gaps = 9/204 (4%)
Query: 130 LSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189
+ +I ++ + L A+ +++ L L N L+ L L +L+L +N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKL 249
+ D L LR L L+NN+ + ++ L NN + G+
Sbjct: 69 VLY-ETLD-LESLSTLRTLDLNNNYV----QELLVGPSIETLHAANNNISRVSCSRGQGK 122
Query: 250 VTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVG-PFPQALLSLPSITYLNIADNKLT 308
+ L+ NK + ++Q LDL N F + S ++ +LN+ N +
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 309 GKLFDDLSCNPELGFVDLSSNLLT 332
+L +DLSSN L
Sbjct: 183 D--VKGQVVFAKLKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-20
Identities = 54/258 (20%), Positives = 99/258 (38%), Gaps = 21/258 (8%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLI 161
++K L L L + ++ + LE+LN+SSN L +L L++L+TL
Sbjct: 29 LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLD 86
Query: 162 LDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD 221
L+ N + L P + L NN + + + L+NN + D
Sbjct: 87 LNNNYVQE-----LLVGPSIETLHAANNNISRVSCSRGQ---GKKNIYLANNKI-TMLRD 137
Query: 222 --FSGLTYLQVLDLENNAL----GPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQR 275
+ +Q LDL+ N + + L + L N + +V + +L+
Sbjct: 138 LDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKT 195
Query: 276 LDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQL 335
LDLSSN+ S +T++++ +NKL + L + L DL N
Sbjct: 196 LDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253
Query: 336 PNCLLAGSKNRVVLYARN 353
+ ++ + +
Sbjct: 254 LRDFFSKNQRVQTVAKQT 271
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 8e-17
Identities = 32/248 (12%), Positives = 70/248 (28%), Gaps = 20/248 (8%)
Query: 102 TLVKLPDLKVL-----RLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTS 156
++ L + ++ + + +LE LN+ NF+ + ++
Sbjct: 139 DEGCRSRVQYLDLKLNEIDTV----NFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAK 192
Query: 157 LQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFY 216
L+TL L N LA + S + +SLRNN + + + +NL L N F+
Sbjct: 193 LKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
Query: 217 GEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRL 276
+V + + + ++ L +L L
Sbjct: 251 CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIAL 310
Query: 277 DLSSNRF-------VGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSN 329
+ + ++ + + ++
Sbjct: 311 KRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKK 370
Query: 330 LLTGQLPN 337
L Q+ N
Sbjct: 371 ALDEQVSN 378
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 2e-15
Identities = 33/234 (14%), Positives = 64/234 (27%), Gaps = 31/234 (13%)
Query: 101 TTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTL 160
L+ P ++ L + + SR + + +++N + + + +Q L
Sbjct: 93 QELLVGPSIETLHAANNNI---SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149
Query: 161 ILDENMLAG-RVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEV 219
L N + + S L L+L+ N + L+ L LS+N
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLAFMG 207
Query: 220 PDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLS 279
P+F + + L NN L I + L+ DL
Sbjct: 208 PEFQSAAGVTWISLRNNKL----------------------VLIEKALRFSQNLEHFDLR 245
Query: 280 SNRFV-GPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT 332
N F G + + + + +
Sbjct: 246 GNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 32/186 (17%), Positives = 65/186 (34%), Gaps = 12/186 (6%)
Query: 171 VPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQ 229
+ + + + + ++ L N++ L LS N + T L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 230 VLDLENNALG--PQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPF 287
+L+L +N L + L T+ L+ N + E+ ++ L ++N
Sbjct: 62 LLNLSSNVLYETLDLESL-STLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-V 114
Query: 288 PQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRV 347
+ + +A+NK+T D C + ++DL N + L A S
Sbjct: 115 SCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 348 VLYARN 353
L +
Sbjct: 173 HLNLQY 178
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 52/240 (21%), Positives = 91/240 (37%), Gaps = 14/240 (5%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLI 161
L +L+ L L S L G + LS+L L++S N + + L +L++L
Sbjct: 75 AFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134
Query: 162 LDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD 221
+ +N L L L L+L ++ S+L L VL L + + + D
Sbjct: 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRD 193
Query: 222 --FSGLTYLQVLDLENNALGPQFPKV---GKKLVTMILSKNKFRSAIPAEV-SSYYQLQR 275
F L L+VL++ + G L ++ ++ + +P L+
Sbjct: 194 YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRF 252
Query: 276 LDLSSNRFVGPFPQALLSLPSITYLNIADNKLT---GKLFDDLSCNPELGFVDLSSNLLT 332
L+LS N L L + + + +L F L L +++S N LT
Sbjct: 253 LNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGL---NYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 54/245 (22%), Positives = 91/245 (37%), Gaps = 15/245 (6%)
Query: 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENM 166
+ ++L L + + + LE L ++ N ++ P + L +L+TL L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 167 LAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSG 224
L L L L + N L F L NL+ L + +N + FSG
Sbjct: 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL-VYISHRAFSG 150
Query: 225 LTYLQVLDLENNALGPQFPKVG----KKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSS 280
L L+ L LE L P L+ + L + Y+L+ L++S
Sbjct: 151 LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 281 NRFVGPFPQALLSLPSITYLNIADNKLTG---KLFDDLSCNPELGFVDLSSNLLTGQLPN 337
++ L ++T L+I LT L L F++LS N ++ +
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHL---VYLRFLNLSYNPIS-TIEG 265
Query: 338 CLLAG 342
+L
Sbjct: 266 SMLHE 270
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-23
Identities = 48/226 (21%), Positives = 81/226 (35%), Gaps = 9/226 (3%)
Query: 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM 190
+ +L++ N + E + L+ L L+EN+++ P +L L L LR+N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 191 FNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNAL---GPQFPKV 245
F+ L NL L +S N + D F L L+ L++ +N L +
Sbjct: 92 LKLIPLGVFTGLSNLTKLDISENKI-VILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150
Query: 246 GKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIAD 304
L + L K S IP E S + L L L + L + L I+
Sbjct: 151 LNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 305 NKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLY 350
+ + L + ++ LT +P + L
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLN 254
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 46/204 (22%), Positives = 76/204 (37%), Gaps = 12/204 (5%)
Query: 146 AIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL 205
A+P+ + T + L L +N + D S P L L L N+ + P +F+ L NL
Sbjct: 25 AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 206 RVLALSNNHFYGEVPD--FSGLTYLQVLDLENNAL----GPQFPKVGKKLVTMILSKNKF 259
R L L +N +P F+GL+ L LD+ N + F + L ++ + N
Sbjct: 83 RTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY-NLKSLEVGDNDL 140
Query: 260 RSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCN 318
I S L++L L +AL L + L + +
Sbjct: 141 VY-ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199
Query: 319 PELGFVDLSSNLLTGQLPNCLLAG 342
L +++S + L G
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYG 223
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 36/209 (17%), Positives = 61/209 (29%), Gaps = 26/209 (12%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLI 161
L L+ L L L + +S L L +L + +N L L+ L
Sbjct: 147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206
Query: 162 LDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD 221
+ + L LS+ + + +L LR L LS N +
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI-STIEG 265
Query: 222 --FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDL 278
L LQ + L L + + L+ L++
Sbjct: 266 SMLHELLRLQEIQLVGGQL----------------------AVVEPYAFRGLNYLRVLNV 303
Query: 279 SSNRFVGPFPQALLSLPSITYLNIADNKL 307
S N+ S+ ++ L + N L
Sbjct: 304 SGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 59/335 (17%), Positives = 113/335 (33%), Gaps = 30/335 (8%)
Query: 5 SRFSQCTLLVLAYILLQVNHSEQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPT 64
S L L L L + + ++ + S+N +
Sbjct: 193 DILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL- 251
Query: 65 SSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTL--VKLPDLKVLRLVSLGLWGP 122
++++ + + S V+ L V+ ++ L + L+
Sbjct: 252 ----------ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYD 301
Query: 123 LSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDW---LGSLP 179
LS S L ++ + + ++ + L SL+ L L EN++ G+ P
Sbjct: 302 LSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361
Query: 180 ILAVLSLRNNMFN--GTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNA 237
L L L N + L+NL L +S N F+ ++ L+L +
Sbjct: 362 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTG 421
Query: 238 LGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSI 297
+ + + L + +S N S + LQ L +S N+ +L P +
Sbjct: 422 IRVVKTCIPQTLEVLDVSNNNLDS-FSLFLPR---LQELYISRNKLKTLPDASL--FPVL 475
Query: 298 TYLNIADNKLT---GKLFDDLSCNPELGFVDLSSN 329
+ I+ N+L +FD L L + L +N
Sbjct: 476 LVMKISRNQLKSVPDGIFDRL---TSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-24
Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 20/238 (8%)
Query: 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLE 134
+I +LHI L +S L +K + + + ++ L SLE
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYS---------LLEKVKRITVENSKVFLVPCSFSQHLKSLE 337
Query: 135 ILNMSSNFLNGAIPQE---LSILTSLQTLILDENMLA--GRVPDWLGSLPILAVLSLRNN 189
L++S N + + SLQTL+L +N L + + L +L L L + N
Sbjct: 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRN 397
Query: 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKL 249
F+ +PDS + E +R L LS+ V L+VLD+ NN L F +L
Sbjct: 398 TFH-PMPDSCQWPEKMRFLNLSSTGI--RVVKTCIPQTLEVLDVSNNNLD-SFSLFLPRL 453
Query: 250 VTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKL 307
+ +S+NK ++ +P L + +S N+ L S+ + + N
Sbjct: 454 QELYISRNKLKT-LPDASLFP-VLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 5e-20
Identities = 43/209 (20%), Positives = 75/209 (35%), Gaps = 6/209 (2%)
Query: 130 LSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189
++++ L++S N + +L +LQ LIL + + D SL L L L +N
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 190 MFNGTLPDSFSYLENLRVLALSNNHFY--GEVPDFSGLTYLQVLDLENNALGPQFPKVG- 246
+ F L +L+ L L N + G F LT LQ L + N + ++
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144
Query: 247 ---KKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIA 303
L + + R+ + S + L L + L S+ YL +
Sbjct: 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELR 204
Query: 304 DNKLTGKLFDDLSCNPELGFVDLSSNLLT 332
D L F L + + + +
Sbjct: 205 DTNLARFQFSPLPVDEVSSPMKKLAFRGS 233
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-19
Identities = 43/211 (20%), Positives = 82/211 (38%), Gaps = 13/211 (6%)
Query: 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM 190
+ + + S +IP + ++++L L N + L + L VL L+++
Sbjct: 5 DASGVCDGRSRSFT-SIPS--GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 191 FNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNAL-----GPQFP 243
N D+F L +L L LS+NH + F L+ L+ L+L N FP
Sbjct: 62 INTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120
Query: 244 KVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNI 302
+ L T+ + + S I + L L++ + Q+L S+ I +L +
Sbjct: 121 NL-TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 303 ADNKLTGKLFDDLSCNPELGFVDLSSNLLTG 333
++ L + +++L L
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 8e-18
Identities = 38/237 (16%), Positives = 84/237 (35%), Gaps = 11/237 (4%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLI 161
L L L + +L L S + + + L + + + IL+S++ L
Sbjct: 143 DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202
Query: 162 LDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD 221
L + LA L + + + + +SF+ L L L +
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE----- 257
Query: 222 FSGLTYLQVLDLENNALG--PQFPKVGK-KLVTMILSKNKFRSAIPAEVSSYYQLQRLDL 278
F T + D + + KV + + + + + S +++R+ +
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317
Query: 279 SSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCN---PELGFVDLSSNLLT 332
+++ L S+ +L++++N + + + +C P L + LS N L
Sbjct: 318 ENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 42/252 (16%), Positives = 77/252 (30%), Gaps = 19/252 (7%)
Query: 101 TTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTL 160
L +L+VL L S + L SLE L++S N L+ L+SL+ L
Sbjct: 44 GDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYL 103
Query: 161 ILDENMLAG-RVPDWLGSLPILAVLSL-RNNMFNGTLPDSFSYLENLRVLALSNNHFYG- 217
L N V +L L L + F+ F+ L +L L +
Sbjct: 104 NLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163
Query: 218 EVPDFSGLTYLQVLDLENN---ALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQ 274
+ + + L L + L F + + + L + +
Sbjct: 164 QSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSS 223
Query: 275 RLDLSSNRFV-------GPFPQALLSLPSITYLNIADNKLTG------KLFDDLSCNPEL 321
+ + R + L + ++ + D L G D +S ++
Sbjct: 224 PMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV 283
Query: 322 GFVDLSSNLLTG 333
V + +
Sbjct: 284 ETVTIRRLHIPQ 295
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 32/139 (23%), Positives = 49/139 (35%), Gaps = 20/139 (14%)
Query: 95 SMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLN---GAIPQEL 151
SM L+ L +L L + P+ + LN+SS + IPQ L
Sbjct: 375 SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTL 433
Query: 152 SIL--------------TSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPD 197
+L LQ L + N L +PD P+L V+ + N
Sbjct: 434 EVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDG 491
Query: 198 SFSYLENLRVLALSNNHFY 216
F L +L+ + L N +
Sbjct: 492 IFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 29/127 (22%), Positives = 48/127 (37%), Gaps = 8/127 (6%)
Query: 228 LQVLDLENNALGPQFPK-VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGP 286
V D + + P + + ++ LS NK ++ + LQ L L S+R
Sbjct: 7 SGVCDGRSRSF-TSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65
Query: 287 FPQALLSLPSITYLNIADNKLT---GKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGS 343
A SL S+ +L+++DN L+ F L L +++L N L
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPL---SSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 344 KNRVVLY 350
N L
Sbjct: 123 TNLQTLR 129
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 54/231 (23%), Positives = 86/231 (37%), Gaps = 13/231 (5%)
Query: 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENM 166
+ + L L+ + + L LE+L + N + + L SL TL L +N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 167 LAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSG 224
L L L L LRNN +F+ + +L L L + + F G
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
Query: 225 LTYLQVLDLENNALG--PQFPKVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSN 281
L L+ L+L + P + L + +S N F I L++L + ++
Sbjct: 195 LFNLKYLNLGMCNIKDMPNLTPL-VGLEELEMSGNHFPE-IRPGSFHGLSSLKKLWVMNS 252
Query: 282 RFVGPFPQALLSLPSITYLNIADNKLT---GKLFDDLSCNPELGFVDLSSN 329
+ A L S+ LN+A N L+ LF L L + L N
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL---RYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-21
Identities = 54/233 (23%), Positives = 90/233 (38%), Gaps = 18/233 (7%)
Query: 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM 190
S+ LN+ N + L L+ L L N + L L L L +N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 191 FNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENN----ALGPQ-FP 243
+F YL LR L L NN +P F+ + L LDL + F
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193
Query: 244 KVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIA 303
+ L + L + +P ++ L+ L++S N F P + L S+ L +
Sbjct: 194 GLF-NLKYLNLGMCNIKD-MPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250
Query: 304 DNKLT---GKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARN 353
+++++ FD L L ++L+ N L+ LP+ L + V L+ +
Sbjct: 251 NSQVSLIERNAFDGL---ASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHH 299
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 43/191 (22%), Positives = 70/191 (36%), Gaps = 31/191 (16%)
Query: 146 AIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL 205
+PQ + ++ + L L EN + D L L VL L N +F+ L +L
Sbjct: 68 EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 206 RVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAI 263
L L +N +P F L+ L+ L L NN + +I
Sbjct: 126 NTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPI----------------------ESI 162
Query: 264 PAEV-SSYYQLQRLDLSS-NRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPEL 321
P+ + L RLDL + A L ++ YLN+ + +L+ L
Sbjct: 163 PSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGL 220
Query: 322 GFVDLSSNLLT 332
+++S N
Sbjct: 221 EELEMSGNHFP 231
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 35/140 (25%), Positives = 58/140 (41%), Gaps = 6/140 (4%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKI-SRLSSLEILNMSSNFLNGAIPQELSILTSLQTL 160
++P L L L L +S L +L+ LN+ + +P L+ L L+ L
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEEL 223
Query: 161 ILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP 220
+ N P L L L + N+ + ++F L +L L L++N+ +P
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL-SSLP 282
Query: 221 D--FSGLTYLQVLDLENNAL 238
F+ L YL L L +N
Sbjct: 283 HDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 24/95 (25%), Positives = 36/95 (37%)
Query: 98 SFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSL 157
+ L L L+ L + G LSSL+ L + ++ ++ L SL
Sbjct: 209 KDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268
Query: 158 QTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFN 192
L L N L+ D L L L L +N +N
Sbjct: 269 VELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 57/210 (27%), Positives = 83/210 (39%), Gaps = 13/210 (6%)
Query: 128 SRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLR 187
L LEIL +S N + + L +L TL L +N L L L L LR
Sbjct: 85 KHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR 144
Query: 188 NNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALG--PQFP 243
NN +F+ + +LR L L + + F GL+ L+ L+L L P
Sbjct: 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLT 204
Query: 244 KVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNI 302
+ KL + LS N + I LQ+L + ++ A +L S+ +N+
Sbjct: 205 PLI-KLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINL 262
Query: 303 ADNKLT---GKLFDDLSCNPELGFVDLSSN 329
A N LT LF L L + L N
Sbjct: 263 AHNNLTLLPHDLFTPL---HHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 53/233 (22%), Positives = 89/233 (38%), Gaps = 18/233 (7%)
Query: 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM 190
++ +LN+ N + L L+ L L N + L L L L +N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 191 FNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENN----ALGPQ-FP 243
+F YL L+ L L NN +P F+ + L+ LDL + F
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182
Query: 244 KVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIA 303
+ L + L+ R IP ++ +L LDLS N P + L + L +
Sbjct: 183 GLS-NLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI 239
Query: 304 DNKLT---GKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARN 353
+++ FD+L L ++L+ N LT LP+ L + ++ +
Sbjct: 240 QSQIQVIERNAFDNL---QSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHH 288
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 49/191 (25%), Positives = 76/191 (39%), Gaps = 31/191 (16%)
Query: 146 AIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL 205
+P +S T+ + L L EN + + L L +L L N +F+ L NL
Sbjct: 57 EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 206 RVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAI 263
L L +N +P+ F L+ L+ L L NN + +I
Sbjct: 115 NTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPI----------------------ESI 151
Query: 264 PAEV-SSYYQLQRLDLSS-NRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPEL 321
P+ + L+RLDL R A L ++ YLN+A L +L+ +L
Sbjct: 152 PSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKL 209
Query: 322 GFVDLSSNLLT 332
+DLS N L+
Sbjct: 210 DELDLSGNHLS 220
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 41/184 (22%), Positives = 70/184 (38%), Gaps = 29/184 (15%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQE-LSILTSLQTL 160
V L LK L L + + S +R+ SL L++ I + L++L+ L
Sbjct: 131 AFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL 190
Query: 161 ILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP 220
L L +P+ L L L L L N + P SF L +L+ L + + +
Sbjct: 191 NLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI-QVIE 247
Query: 221 D--FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLD 277
F L L ++L +N L + +P ++ + + L+R+
Sbjct: 248 RNAFDNLQSLVEINLAHNNL----------------------TLLPHDLFTPLHHLERIH 285
Query: 278 LSSN 281
L N
Sbjct: 286 LHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 36/140 (25%), Positives = 61/140 (43%), Gaps = 6/140 (4%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKI-SRLSSLEILNMSSNFLNGAIPQELSILTSLQTL 160
++P L+ L L L +S LS+L LN++ L IP L+ L L L
Sbjct: 155 AFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDEL 212
Query: 161 ILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP 220
L N L+ P L L L + + ++F L++L + L++N+ +P
Sbjct: 213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL-TLLP 271
Query: 221 D--FSGLTYLQVLDLENNAL 238
F+ L +L+ + L +N
Sbjct: 272 HDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 23/95 (24%), Positives = 31/95 (32%)
Query: 98 SFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSL 157
+ L L L L L L G L L+ L M + + L SL
Sbjct: 198 REIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257
Query: 158 QTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFN 192
+ L N L D L L + L +N +N
Sbjct: 258 VEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 35/170 (20%), Positives = 67/170 (39%), Gaps = 18/170 (10%)
Query: 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMH--HI 524
+ E +N +G G G +Y+G L + VA+ K+ + +NF++ +I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAV---KVFSFANRQNFINEKNI 58
Query: 525 ELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQ 584
+ + H ++ + L+ EY PNG+L ++S + W
Sbjct: 59 YRVPLMEHDNIARFIVGDERV--TADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVS 112
Query: 585 RISAAIGVAKGIQFLHTGIVPGVFSN------NLKITDILLDQNLVAKIS 628
A V +G+ +LHT + G +L ++L+ + IS
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-24
Identities = 72/363 (19%), Positives = 120/363 (33%), Gaps = 31/363 (8%)
Query: 7 FSQCTLLVLAYILLQVNHSEQLQSSQAQTLLRIQGLLNNPAV----LSSWNITTE----F 58
L++ L N L S + + N + +S T + F
Sbjct: 168 LEPLQGKTLSFFSLAAN---SLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNF 224
Query: 59 CNTEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLG 118
N S + I + D + ++ L L
Sbjct: 225 SNAISKSQAFSLILAHHIMGAGFGFHN-------IKDPDQNTFAGLARSSVRHLDLSHGF 277
Query: 119 LWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSL 178
++ S L L++LN++ N +N + L +LQ L L N+L L
Sbjct: 278 VFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGL 337
Query: 179 PILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNAL 238
P +A + L+ N +F +LE L+ L L +N + + + L N L
Sbjct: 338 PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL----TTIHFIPSIPDIFLSGNKL 393
Query: 239 GPQFPKVGKKLVTMILSKNKFRS-AIPAEVSSYYQLQRLDLSSNRFVGPFPQALLS-LPS 296
PK+ + LS+N+ + I + LQ L L+ NRF S PS
Sbjct: 394 V-TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPS 452
Query: 297 ITYLNIADNKL-----TGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYA 351
+ L + +N L T +D L + L+ N L LP + + L
Sbjct: 453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSL 511
Query: 352 RNC 354
+
Sbjct: 512 NSN 514
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 6e-19
Identities = 51/226 (22%), Positives = 79/226 (34%), Gaps = 34/226 (15%)
Query: 128 SRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRV-PDWLGSLPILAVLSL 186
L++ E L +S N++ L LQ L L + + +LP L +L L
Sbjct: 21 QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80
Query: 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD---FSGLTYLQVLDLENNALGPQFP 243
++ PD+F L +L L L V F L L LD
Sbjct: 81 GSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLD----------- 129
Query: 244 KVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQAL--LSLPSITYL 300
LSKN+ RS L+ +D SSN+ L L ++++
Sbjct: 130 ----------LSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFF 179
Query: 301 NIADNKLTGKLFDDLS------CNPELGFVDLSSNLLTGQLPNCLL 340
++A N L ++ D N L +D+S N T +
Sbjct: 180 SLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFS 225
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 7e-18
Identities = 53/260 (20%), Positives = 89/260 (34%), Gaps = 29/260 (11%)
Query: 101 TTLVKLPDLKVLRLVSLGLWG-PLSGKISRLSSLEILNMSSNFLNGAIPQELSILT--SL 157
L L L L + L +L+SL+ ++ SSN + EL L +L
Sbjct: 117 GYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTL 176
Query: 158 QTLILDENMLAGRVP-DWLGSLPILAVLSLR-----------------NNMFNGTLPDSF 199
L N L RV DW + + L +N + + S
Sbjct: 177 SFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSL 236
Query: 200 SYLENLRVLALSNNHFYG-EVPDFSGL--TYLQVLDLENNAL----GPQFPKVGKKLVTM 252
++ ++ + F+GL + ++ LDL + + F + K L +
Sbjct: 237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL-KDLKVL 295
Query: 253 ILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLF 312
L+ NK LQ L+LS N + LP + Y+++ N +
Sbjct: 296 NLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD 355
Query: 313 DDLSCNPELGFVDLSSNLLT 332
+L +DL N LT
Sbjct: 356 QTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 61/274 (22%), Positives = 101/274 (36%), Gaps = 35/274 (12%)
Query: 67 LTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGK 126
LT + + SI + + GNK + ++ + + L RL +L +
Sbjct: 374 LTTIHFIPSIPDIFLSGNKLVTLPKINLTANLI--------HLSENRLENL----DILYF 421
Query: 127 ISRLSSLEILNMSSNFLNGAIPQEL-SILTSLQTLILDENMLAGRV-----PDWLGSLPI 180
+ R+ L+IL ++ N + + S SL+ L L ENML D L
Sbjct: 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481
Query: 181 LAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGP 240
L VL L +N N P FS+L LR L+L++N + L++LD+ N L
Sbjct: 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL-TVLSHNDLPANLEILDISRNQLLA 540
Query: 241 QFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYL 300
P V L + ++ NKF +LS+ ++ P
Sbjct: 541 PNPDVFVSLSVLDITHNKFICEC-------------ELSTFINWLNHTNVTIAGPPADIY 587
Query: 301 NIADNKLTGKL---FDDLSCNPELGFVDLSSNLL 331
+ + +G C+ E L +L
Sbjct: 588 CVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLF 621
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 31/155 (20%), Positives = 50/155 (32%), Gaps = 13/155 (8%)
Query: 188 NNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP--DFSGLTYLQVLDLENNALGPQFPKV 245
F L L L LS N+ V F L LQ+L+L + K
Sbjct: 10 FYRFCN-LTQVPQVLNTTERLLLSFNYI-RTVTASSFPFLEQLQLLELGSQYTPLTIDKE 67
Query: 246 G----KKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRF--VGPFPQALLSLPSIT 298
L + L +K + + + L L L +L ++T
Sbjct: 68 AFRNLPNLRILDLGSSKIYF-LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126
Query: 299 YLNIADNKLTG-KLFDDLSCNPELGFVDLSSNLLT 332
L+++ N++ L L +D SSN +
Sbjct: 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 25/119 (21%), Positives = 44/119 (36%), Gaps = 3/119 (2%)
Query: 229 QVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPF- 287
++ L Q P+V ++LS N R+ + QLQ L+L S
Sbjct: 7 RIAFYRFCNL-TQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 288 PQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT-GQLPNCLLAGSKN 345
+A +LP++ L++ +K+ D L + L L+ L + K
Sbjct: 66 KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA 124
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 44/209 (21%), Positives = 82/209 (39%), Gaps = 9/209 (4%)
Query: 128 SRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLR 187
L +L L + +N ++ P + L L+ L L +N L +P+ L L +
Sbjct: 73 KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVH 129
Query: 188 NNMFNGTLPDSFSYLENLRVLALSNNHFY-GEVPD--FSGLTYLQVLDLENNALGPQFPK 244
N F+ L + V+ L N + + F G+ L + + + +
Sbjct: 130 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG 189
Query: 245 VGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIA 303
+ L + L NK + A L +L LS N +L + P + L++
Sbjct: 190 LPPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248
Query: 304 DNKLTGKLFDDLSCNPELGFVDLSSNLLT 332
+NKL K+ L+ + + V L +N ++
Sbjct: 249 NNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 47/212 (22%), Positives = 83/212 (39%), Gaps = 20/212 (9%)
Query: 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM 190
+L++ +N + + L +L TLIL N ++ P L L L L N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 191 FNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVG-- 246
LP+ + L+ L + N +V F+GL + V++L N L + G
Sbjct: 112 LK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 247 ---KKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIA 303
KKL + ++ + IP + L L L N+ +L L ++ L ++
Sbjct: 168 QGMKKLSYIRIADTNITT-IPQGLPP--SLTELHLDGNKITKVDAASLKGLNNLAKLGLS 224
Query: 304 DNKLTG---KLFDDLSCNPELGFVDLSSNLLT 332
N ++ + P L + L++N L
Sbjct: 225 FNSISAVDNGSLANT---PHLRELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 47/210 (22%), Positives = 73/210 (34%), Gaps = 24/210 (11%)
Query: 102 TLVKLPDLKVLRLVS--LGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQT 159
L + V+ L + L G +G + L + ++ + IPQ L SL
Sbjct: 140 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTE 196
Query: 160 LILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEV 219
L LD N + L L LA L L N + S + +LR L L+NN +V
Sbjct: 197 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KV 255
Query: 220 PD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDL 278
P + Y+QV+ L NN + + N F P + + L
Sbjct: 256 PGGLADHKYIQVVYLHNNNI-------------SAIGSNDFCP--PGYNTKKASYSGVSL 300
Query: 279 SSNRFVGPF--PQALLSLPSITYLNIADNK 306
SN P + + + + K
Sbjct: 301 FSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 37/217 (17%), Positives = 69/217 (31%), Gaps = 44/217 (20%)
Query: 128 SRLSSLEILNMSSNFL-NGAIPQE-LSILTSLQTLILDENMLAGRVPDWLGSLPILAVLS 185
+ L+ + ++ + +N L + I + L + + + + +P G P L L
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELH 198
Query: 186 LRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFP 243
L N S L NL L LS N V + + +L+ L L NN L
Sbjct: 199 LDGNKITKVDAASLKGLNNLAKLGLSFNSI-SAVDNGSLANTPHLRELHLNNNKL----- 252
Query: 244 KVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRF------VGPFPQALLSLPSI 297
+P ++ + +Q + L +N P S
Sbjct: 253 -----------------VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 295
Query: 298 TYLNIADNKLTGK-----LFDDLSCNPELGFVDLSSN 329
+ +++ N + F + V L +
Sbjct: 296 SGVSLFSNPVQYWEIQPSTFRCV---YVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 25/211 (11%)
Query: 156 SLQTLILDENMLAGRVPDWLGSLPI-LAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNH 214
L+ + + L +VP LP A+L L+NN F L+NL L L NN
Sbjct: 32 HLRVVQCSDLGLE-KVPK---DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 87
Query: 215 FYGEVPD--FSGLTYLQVLDLENNALGPQFPK-VGKKLVTMILSKNKFRSAIPAEV-SSY 270
++ F+ L L+ L L N L + P+ + K L + + +N+ + V +
Sbjct: 88 I-SKISPGAFAPLVKLERLYLSKNQL-KELPEKMPKTLQELRVHENEITK-VRKSVFNGL 144
Query: 271 YQLQRLDLSSNRFVGPF--PQALLSLPSITYLNIADNKLTG---KLFDDLSCNPELGFVD 325
Q+ ++L +N A + ++Y+ IAD +T L L+ EL
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT---EL---H 198
Query: 326 LSSNLLTGQLPNCLLAGSKNRVVLY-ARNCL 355
L N +T ++ L G N L + N +
Sbjct: 199 LDGNKIT-KVDAASLKGLNNLAKLGLSFNSI 228
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 50/214 (23%), Positives = 78/214 (36%), Gaps = 17/214 (7%)
Query: 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGR--VPDWLGSLPILAVLSLRN 188
SS L + SN L LT L L L N L+ + L L L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 189 NMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD---FSGLTYLQVLDLENNALGPQFPKV 245
N T+ +F LE L L +++ ++ + F L L LD+ + F +
Sbjct: 88 NGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 145
Query: 246 ---GKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLN 301
L + ++ N F+ ++ + L LDLS + P A SL S+ LN
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205
Query: 302 IADNKLTG---KLFDDLSCNPELGFVDLSSNLLT 332
++ N + L L +D S N +
Sbjct: 206 MSHNNFFSLDTFPYKCL---NSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 18/215 (8%)
Query: 128 SRLSSLEILNMSSNFLN--GAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLS 185
+L+ L L++SSN L+ G Q TSL+ L L N + + L L L
Sbjct: 49 DKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD 107
Query: 186 LRNNMFNGTLPDS-FSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQF 242
+++ S F L NL L +S+ H + F+GL+ L+VL + N+ F
Sbjct: 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENF 166
Query: 243 PKVG----KKLVTMILSKNKFRSAIPAEVSSY-YQLQRLDLSSNRFVGPFPQALLSLPSI 297
+ L + LS+ + + + LQ L++S N F L S+
Sbjct: 167 LPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 225
Query: 298 TYLNIADNKLT---GKLFDDLSCNPELGFVDLSSN 329
L+ + N + + + L F++L+ N
Sbjct: 226 QVLDYSLNHIMTSKKQELQHFPSS--LAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 61/244 (25%), Positives = 89/244 (36%), Gaps = 23/244 (9%)
Query: 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVS--LGLWGPLSGKISRLSS 132
S T+L + NK + F KL L L L S L G S +S
Sbjct: 29 SATRLELESNKLQSLPHGVFD---------KLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 133 LEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPD--WLGSLPILAVLSLRNNM 190
L+ L++S N + + L L+ L + L ++ + SL L L + +
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTH 137
Query: 191 FNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENN---ALGPQFPKV 245
F+ L +L VL ++ N F F+ L L LDL L P
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197
Query: 246 GKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLP-SITYLNIA 303
L + +S N F S + LQ LD S N + Q L P S+ +LN+
Sbjct: 198 LSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 256
Query: 304 DNKL 307
N
Sbjct: 257 QNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 54/222 (24%), Positives = 76/222 (34%), Gaps = 27/222 (12%)
Query: 132 SLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM- 190
S + +S L ++P I +S L L+ N L L L LSL +N
Sbjct: 8 SGTEIRCNSKGLT-SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 191 -FNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKL 249
F G S +L+ L LS N +F GL L+ LD +++ L
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL----------- 113
Query: 250 VTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG 309
+ + F S L LD+S F L S+ L +A N
Sbjct: 114 -KQMSEFSVFLSLR--------NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164
Query: 310 KLFDDLSCN-PELGFVDLSSNLLTGQLPNCLLAGSKNRVVLY 350
D+ L F+DLS L QL + VL
Sbjct: 165 NFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLN 205
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 51/210 (24%), Positives = 80/210 (38%), Gaps = 17/210 (8%)
Query: 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM 190
++ + + + N ++ +L L L N+LA L +L L L +N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 191 FNGTLP-DSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNAL----GPQFP 243
++ +F L L L L E+ F GL LQ L L++NAL F
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 244 KVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNI 302
+G L + L N+ S +P + L RL L NR P A L + L +
Sbjct: 151 DLG-NLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 303 ADNKLT---GKLFDDLSCNPELGFVDLSSN 329
N L+ + L L ++ L+ N
Sbjct: 209 FANNLSALPTEALAPL---RALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 47/196 (23%), Positives = 75/196 (38%), Gaps = 15/196 (7%)
Query: 146 AIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL 205
A+P + + Q + L N ++ + L +L L +N+ +F+ L L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 206 RVLALSNNHFYGEVPD--FSGLTYLQVLDLENN---ALGPQFPKVGKKLVTMILSKNKFR 260
L LS+N V F GL L L L+ LGP + L + L N +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 261 SAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLT---GKLFDDLS 316
+ +P + L L L NR +A L S+ L + N++ F DL
Sbjct: 143 A-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL- 200
Query: 317 CNPELGFVDLSSNLLT 332
L + L +N L+
Sbjct: 201 --GRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 52/208 (25%), Positives = 75/208 (36%), Gaps = 27/208 (12%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQE-LSILTSLQTL 160
+ +L +L L S L + + L+ LE L++S N ++ L L TL
Sbjct: 51 SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110
Query: 161 ILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP 220
LD L P L L L L++N D+F L NL L L N VP
Sbjct: 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI-SSVP 169
Query: 221 D--FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLD 277
+ F GL L L L N + + + +L L
Sbjct: 170 ERAFRGLHSLDRLLLHQNRV----------------------AHVHPHAFRDLGRLMTLY 207
Query: 278 LSSNRFVGPFPQALLSLPSITYLNIADN 305
L +N +AL L ++ YL + DN
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 42/172 (24%), Positives = 60/172 (34%), Gaps = 23/172 (13%)
Query: 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVL-----RLVSLGLWGPLSGKISR 129
+ QL + N + + T L L L L LG G
Sbjct: 81 LLEQLDLSDNAQLRSVD--------PATFHGLGRLHTLHLDRCGLQELG-----PGLFRG 127
Query: 130 LSSLEILNMSSNFLNGAIPQE-LSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRN 188
L++L+ L + N L A+P + L +L L L N ++ L L L L
Sbjct: 128 LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 189 NMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNAL 238
N P +F L L L L N+ +P + L LQ L L +N
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNL-SALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 24/91 (26%), Positives = 33/91 (36%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLI 161
T L +L L L + L SL+ L + N + P L L TL
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 162 LDENMLAGRVPDWLGSLPILAVLSLRNNMFN 192
L N L+ + L L L L L +N +
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 54/311 (17%), Positives = 96/311 (30%), Gaps = 32/311 (10%)
Query: 5 SRFSQCTLLVLAYILLQVNHSEQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPT 64
+F + L L + ++ L + L N + +
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303
Query: 65 SSLTVVCYEE-SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLV--SLGLWG 121
+ Q + K L + + + V LP L+ L L L G
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG 363
Query: 122 PLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDW--LGSLP 179
S +SL+ L++S N + + L L+ L + L ++ ++ SL
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLR 421
Query: 180 ILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNA 237
L L + + F+ L +L VL ++ N F F+ L L LDL
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 238 LGPQFPKVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPS 296
L + +S LQ L+++SN+ L S
Sbjct: 482 L----------------------EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTS 519
Query: 297 ITYLNIADNKL 307
+ + + N
Sbjct: 520 LQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-20
Identities = 54/266 (20%), Positives = 101/266 (37%), Gaps = 25/266 (9%)
Query: 92 LSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQEL 151
L + +D + L ++ LVS+ + S + L + + P
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF--SYNFGWQHLELVNCKFGQ-FPT-- 321
Query: 152 SILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFN--GTLPDSFSYLENLRVLA 209
L SL+ L N LP L L L N + G S +L+ L
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 210 LSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVG-----KKLVTMILSKNKFRSAIP 264
LS N +F GL L+ LD +++ L Q + + L+ + +S R
Sbjct: 380 LSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRV-AF 437
Query: 265 AEV-SSYYQLQRLDLSSNRFVGPFPQALLS-LPSITYLNIADNKLTG---KLFDDLSCNP 319
+ + L+ L ++ N F F + + L ++T+L+++ +L F+ L
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL---S 494
Query: 320 ELGFVDLSSNLLTGQLPNCLLAGSKN 345
L ++++SN L +P+ + +
Sbjct: 495 SLQVLNMASNQLK-SVPDGIFDRLTS 519
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-20
Identities = 42/232 (18%), Positives = 75/232 (32%), Gaps = 13/232 (5%)
Query: 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENM 166
K L L L S L++L++S + L+ L TLIL N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 167 LAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFY--GEVPDFSG 224
+ L L L +L+ L+ L +++N FS
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 225 LTYLQVLDLENNALG-------PQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLD 277
LT L+ LDL +N + ++ +++ LS N I +L +L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLT 206
Query: 278 LSSNRF-VGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSS 328
L +N + + L + + + + +L + L +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF--RNEGNLEKFDKSALEGLCN 256
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-18
Identities = 51/241 (21%), Positives = 78/241 (32%), Gaps = 19/241 (7%)
Query: 139 SSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDS 198
IP L S + L L N L S P L VL L +
Sbjct: 15 MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 199 FSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALG---PQFPKVGKKLVTMIL 254
+ L +L L L+ N FSGL+ LQ L L K L + +
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 255 SKNKFRS-AIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITY----LNIADNKLTG 309
+ N +S +P S+ L+ LDLSSN+ + L L + L+++ N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191
Query: 310 ---KLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNENQHPLS 366
F ++ L + L +N + + + G V N
Sbjct: 192 IQPGAFKEIR----LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 367 F 367
Sbjct: 248 K 248
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-18
Identities = 56/276 (20%), Positives = 92/276 (33%), Gaps = 22/276 (7%)
Query: 94 FSMDSFVTTLVKLPDLKVLRLVSLG------LWGPLSGKISRLSSLEILNMSSNFLNG-- 145
S++ T + L L+V RLV L + L +L I +L+
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271
Query: 146 -AIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLEN 204
I + LT++ + L + RV D+ L L N F L++
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSY-NFGWQHLELVNCKFGQ---FPTLKLKS 326
Query: 205 LRVLALSNNHFYGEVPDFSGLTYLQVLDLENNAL-----GPQFPKVGKKLVTMILSKNKF 259
L+ L ++N G L L+ LDL N L Q L + LS N
Sbjct: 327 LKRLTFTSNKG-GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 260 RSAIPAEVSSYYQLQRLDLSSNRFVG-PFPQALLSLPSITYLNIADNKLTGKLFDDLSCN 318
+ + + QL+ LD + LSL ++ YL+I+ +
Sbjct: 386 IT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444
Query: 319 PELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNC 354
L + ++ N + +N L C
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 46/251 (18%), Positives = 77/251 (30%), Gaps = 27/251 (10%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLN-GAIPQELSILTSLQTL 160
L L+ L V L + I L +L+ LN++ N + +P+ S LT+L+ L
Sbjct: 95 AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154
Query: 161 ILDENMLAGRVPDWLGSLPIL----AVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFY 216
L N + L L + L L N N P +F + L L L NN
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDS 213
Query: 217 GEVPD--FSGLTYLQVLDLENNALGPQ------FPKVGKKLVTMILSKNK------FRSA 262
V GL L+V L + + L + + + + +
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273
Query: 263 IPAEVSSYYQLQRLDLSSNRFVGPFPQA-LLSLPSITYLNIADNKLTGKLFDDLSCNPEL 321
I + + L S + + +N + L
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR---- 329
Query: 322 GFVDLSSNLLT 332
+ +SN
Sbjct: 330 --LTFTSNKGG 338
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 23/97 (23%), Positives = 37/97 (38%), Gaps = 1/97 (1%)
Query: 102 TLVKLPDLKVLRLVSLGL-WGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTL 160
L L+VL++ L + L +L L++S L P + L+SLQ L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 161 ILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPD 197
+ N L L L + L N ++ + P
Sbjct: 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 6e-23
Identities = 48/236 (20%), Positives = 94/236 (39%), Gaps = 17/236 (7%)
Query: 100 VTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQT 159
V T +L + L + + + G I L++LE LN++ N + P LS L L
Sbjct: 37 VVTQEELESITKLVVAGEKVAS-IQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTN 92
Query: 160 LILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEV 219
L + N + L +L L L L + + + L + L L NH ++
Sbjct: 93 LYIGTNKI--TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDL 148
Query: 220 PDFSGLTYLQVLDLENNALGPQFPKVG--KKLVTMILSKNKFRSAIPAEVSSYYQLQRLD 277
S +T L L + + + + L ++ L+ N+ P ++S L
Sbjct: 149 SPLSNMTGLNYLTVTESKVK-DVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFT 205
Query: 278 LSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG 333
N+ + ++ + L I +NK+T L+ +L ++++ +N ++
Sbjct: 206 AYVNQITD--ITPVANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 4e-21
Identities = 46/232 (19%), Positives = 95/232 (40%), Gaps = 15/232 (6%)
Query: 103 LVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLIL 162
L L + L L + LS +S ++ L L ++ + + P ++ LT L +L L
Sbjct: 128 LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184
Query: 163 DENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDF 222
+ N + P L SL L + N + + L L + NN ++
Sbjct: 185 NYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKI-TDLSPL 239
Query: 223 SGLTYLQVLDLENNALGPQFPKVG--KKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSS 280
+ L+ L L++ N + V KL + + N+ + +++ QL L L++
Sbjct: 240 ANLSQLTWLEIGTNQIS-DINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNN 296
Query: 281 NRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT 332
N+ + + L ++T L ++ N +T L+ ++ D ++ ++
Sbjct: 297 NQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 32/179 (17%), Positives = 62/179 (34%), Gaps = 13/179 (7%)
Query: 157 LQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFY 216
TL + P L L+ + T + LE++ L ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKA--SVTDVVTQEELESITKLVVAGEKV- 56
Query: 217 GEVPDFSGLTYLQVLDLENNALG--PQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQ 274
+ LT L+ L+L N + + KL + + NK + + + L+
Sbjct: 57 ASIQGIEYLTNLEYLNLNGNQITDISPLSNL-VKLTNLYIGTNKITD--ISALQNLTNLR 113
Query: 275 RLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG 333
L L+ + P L +L + LN+ N L LS L ++ ++ + +
Sbjct: 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKD 169
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 15/234 (6%)
Query: 100 VTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQT 159
+ L + L+ LG+ + G + L++L +N S+N L P L LT L
Sbjct: 39 TVSQTDLDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 94
Query: 160 LILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEV 219
++++ N +A P L +L L L+L NN D L NL L LS+N ++
Sbjct: 95 ILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTI-SDI 149
Query: 220 PDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLS 279
SGLT LQ L N + L + +S NK + ++ L+ L +
Sbjct: 150 SALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIAT 207
Query: 280 SNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG 333
+N+ P L L ++ L++ N+L L+ L +DL++N ++
Sbjct: 208 NNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 257
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-21
Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 19/230 (8%)
Query: 127 ISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186
++ L++LE L++SSN ++ L+ LT+L++LI N ++ P LG L L LSL
Sbjct: 173 LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSL 228
Query: 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVG 246
N + + L NL L L+NN + SGLT L L L N + +
Sbjct: 229 NGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQIS-NISPLA 284
Query: 247 --KKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIAD 304
L + L++N+ P +S+ L L L N P + SL + L +
Sbjct: 285 GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN 340
Query: 305 NKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNC 354
NK++ L+ + ++ N ++ P LA L +
Sbjct: 341 NKVSD--VSSLANLTNINWLSAGHNQISDLTP---LANLTRITQLGLNDQ 385
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 8e-18
Identities = 53/236 (22%), Positives = 89/236 (37%), Gaps = 14/236 (5%)
Query: 98 SFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSL 157
S ++ L KL +L+ L + + ++ + L++L+ L+++ N L L+ LT+L
Sbjct: 190 SDISVLAKLTNLESLIATNNQISD-ITP-LGILTNLDELSLNGNQLKD--IGTLASLTNL 245
Query: 158 QTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYG 217
L L N ++ P L L L L L N + + L L L L+ N
Sbjct: 246 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI--SPLAGLTALTNLELNENQLED 301
Query: 218 EVPDFSGLTYLQVLDLENNALGPQFPKVG-KKLVTMILSKNKFRSAIPAEVSSYYQLQRL 276
+ S L L L L N + P KL + NK + +++ + L
Sbjct: 302 -ISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWL 358
Query: 277 DLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT 332
N+ P L +L IT L + D T + + V + L
Sbjct: 359 SAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI 412
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 42/226 (18%), Positives = 73/226 (32%), Gaps = 35/226 (15%)
Query: 129 RLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRN 188
L S I +N + L +L + + V L + L
Sbjct: 2 PLGSATITQ--DTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADR 55
Query: 189 NMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGK- 247
D YL NL + SNN + LT L + + NN + +
Sbjct: 56 L--GIKSIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQI-ADITPLANL 111
Query: 248 -KLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLS------------- 293
L + L N+ P + + L RL+LSSN + L+
Sbjct: 112 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD 169
Query: 294 ------LPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG 333
L ++ L+I+ NK++ L+ L + ++N ++
Sbjct: 170 LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD 213
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 38/191 (19%), Positives = 66/191 (34%), Gaps = 11/191 (5%)
Query: 103 LVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLIL 162
L L L L L L IS L +L L + N ++ P +S LT LQ L
Sbjct: 283 LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338
Query: 163 DENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDF 222
N ++ L +L + LS +N + P + L + L L++ + ++
Sbjct: 339 YNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNY 394
Query: 223 SGLTYLQ--VLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSS 280
+ V ++ + P G ++ N ++ Q + +
Sbjct: 395 KANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGT 453
Query: 281 NRFVGPFPQAL 291
F G Q L
Sbjct: 454 TTFSGTVTQPL 464
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-22
Identities = 34/146 (23%), Positives = 75/146 (51%), Gaps = 10/146 (6%)
Query: 485 MGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHC 542
+ E G++++GR + G + ++ LK++ + +R+F + H +++ LG C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTG 602
LI ++P G+L + + EG + + +Q + A+ +A+G+ FLHT
Sbjct: 77 -----QSPPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHT- 129
Query: 603 IVPGVFSNNLKITDILLDQNLVAKIS 628
+ P + + L +++D+++ A+IS
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARIS 155
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 49/249 (19%), Positives = 84/249 (33%), Gaps = 21/249 (8%)
Query: 106 LPDLKVLRLVSLGLWG----PLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLI 161
L D V+L L + RLS L+ + + + L +P + L+TL
Sbjct: 75 LEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLT 133
Query: 162 LDENMLAGRVPDWLGSLPILAVLSLRNN---------MFNGTLPDSFSYLENLRVLALSN 212
L N L +P + SL L LS+R + + L NL+ L L
Sbjct: 134 LARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW 192
Query: 213 NHFYGEVPD-FSGLTYLQVLDLENNALGPQFPK-VGK--KLVTMILSKNKFRSAIPAEVS 268
+P + L L+ L + N+ L + KL + L P
Sbjct: 193 TGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFG 250
Query: 269 SYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSS 328
L+RL L + P + L + L++ +L ++ P + +
Sbjct: 251 GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310
Query: 329 NLLTGQLPN 337
+L +
Sbjct: 311 HLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 33/183 (18%), Positives = 68/183 (37%), Gaps = 15/183 (8%)
Query: 127 ISRLSSLEILNMSSN---------FLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGS 177
I+ L+ L L++ + + E L +LQ+L L+ + +P + +
Sbjct: 146 IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN 204
Query: 178 LPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENN 236
L L L +RN+ + L + +L L L L P F G L+ L L++
Sbjct: 205 LQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263
Query: 237 ALGPQFPK-VG--KKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLS 293
+ P + +L + L S +P+ ++ + + + ++
Sbjct: 264 SNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVA 323
Query: 294 LPS 296
P+
Sbjct: 324 RPA 326
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 35/166 (21%), Positives = 59/166 (35%), Gaps = 3/166 (1%)
Query: 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLE 134
+ +L I LP + L +L+ LRL G+ L I+ L +L+
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLK 209
Query: 135 ILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGT 194
L + ++ L+ A+ + L L+ L L P G L L L++ T
Sbjct: 210 SLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268
Query: 195 LPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALG 239
LP L L L L +P + L ++ + +
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 42/246 (17%), Positives = 75/246 (30%), Gaps = 25/246 (10%)
Query: 109 LKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLA 168
+ L P +S+ + + + + Q L
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRALK 69
Query: 169 GRVPDWLGSL--PILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGL 225
D L P L LR+ PD L +L+ + + E+PD
Sbjct: 70 -ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQF 126
Query: 226 TYLQVLDLENNALGPQFPK-VG--KKLVTMILSKNKFRSAIPAEVSSYY---------QL 273
L+ L L N L P + +L + + + +P ++S L
Sbjct: 127 AGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 274 QRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG 333
Q L L P ++ +L ++ L I ++ L+ L + P+L +DL
Sbjct: 186 QSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243
Query: 334 QLPNCL 339
P
Sbjct: 244 NYPPIF 249
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 10/209 (4%)
Query: 128 SRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLR 187
L L L + +N ++ + S L LQ L + +N L +P L L +
Sbjct: 75 KGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIH 131
Query: 188 NNMFNGTLPDSFSYLENLRVLALSNNHFY-GEVPD--FSGLTYLQVLDLENNALGPQFPK 244
+N FS L N+ + + N F GL L L + L
Sbjct: 132 DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLTGIPKD 190
Query: 245 VGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIA 303
+ + L + L NK ++ I E Y +L RL L N+ +L LP++ L++
Sbjct: 191 LPETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLD 249
Query: 304 DNKLTGKLFDDLSCNPELGFVDLSSNLLT 332
+NKL+ ++ L L V L +N +T
Sbjct: 250 NNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 46/211 (21%), Positives = 80/211 (37%), Gaps = 19/211 (9%)
Query: 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM 190
+L++ +N ++ + L L L+L N ++ L L L + N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 191 FNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVGK- 247
P+ S L LR + +N +VP FSGL + +++ N L + G
Sbjct: 114 LVEIPPNLPSSLVELR---IHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169
Query: 248 ---KLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIAD 304
KL + +S+ K IP ++ L L L N+ + LL + L +
Sbjct: 170 DGLKLNYLRISEAKLTG-IPKDLPE--TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGH 226
Query: 305 NKLT---GKLFDDLSCNPELGFVDLSSNLLT 332
N++ L P L + L +N L+
Sbjct: 227 NQIRMIENGSLSFL---PTLRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 48/236 (20%), Positives = 74/236 (31%), Gaps = 32/236 (13%)
Query: 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGL-WGPLSGKISRLSSL 133
S+ +L I N+ + FS L ++ + + L L
Sbjct: 124 SLVELRIHDNRIRKVPKGVFS---------GLRNMNCIEMGGNPLENSGFEPGAFDGLKL 174
Query: 134 EILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNG 193
L +S L IP++L +L L LD N + + L L L L +N
Sbjct: 175 NYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM 231
Query: 194 TLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTM 252
S S+L LR L L NN VP L LQV+ L N +
Sbjct: 232 IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI-------------T 277
Query: 253 ILSKNKFRSAIPAEVSSYYQLQRLDLSSNR--FVGPFPQALLSLPSITYLNIADNK 306
+ N F + + L +N + P + + + K
Sbjct: 278 KVGVNDFCPVGFGVKRA--YYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 51/208 (24%), Positives = 81/208 (38%), Gaps = 20/208 (9%)
Query: 156 SLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHF 215
L+ + + L VP + P +L L+NN + D F L++L L L NN
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 216 YGEVPD--FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEV-SSYYQ 272
++ + FS L LQ L + N L P + LV + + N+ R +P V S
Sbjct: 91 -SKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRK-VPKGVFSGLRN 148
Query: 273 LQRLDLSSNRF-VGPFPQALLSLPSITYLNIADNKLTG---KLFDDLSCNPELGFVDLSS 328
+ +++ N F + YL I++ KLTG L + L+ EL L
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLN---EL---HLDH 202
Query: 329 NLLTGQLPNCLLAGSKNRVVLY-ARNCL 355
N + + L L N +
Sbjct: 203 NKIQ-AIELEDLLRYSKLYRLGLGHNQI 229
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 29/144 (20%), Positives = 61/144 (42%), Gaps = 13/144 (9%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFEC 545
G G+ G + + + + VAI+ +++ + F+ + +S++ H ++V G C
Sbjct: 17 GRGAFGVVCKAKWR-AKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP 73
Query: 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVP 605
L+ EY G+L + + T +S + ++G+ +LH+
Sbjct: 74 VC---------LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 606 GVFSNNLKITDILLDQN-LVAKIS 628
+ +LK ++LL V KI
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKIC 148
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 38/145 (26%), Positives = 72/145 (49%), Gaps = 11/145 (7%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHST--RNFMHHIELISKLRHRHLVSALGHCF 543
G GS G ++R G+ VA++ L + H+ F+ + ++ +LRH ++V +G
Sbjct: 46 GAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV- 103
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI 603
+ + ++ EY+ G+L + + A + L +R+S A VAKG+ +LH
Sbjct: 104 ------TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-R 156
Query: 604 VPGVFSNNLKITDILLDQNLVAKIS 628
P + NLK ++L+D+ K+
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVC 181
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 2e-20
Identities = 59/311 (18%), Positives = 110/311 (35%), Gaps = 26/311 (8%)
Query: 6 RFSQCTLLVLAYILLQVNHSEQLQSSQAQTLLRIQGL-----LNNPAVLSSWNITTEFCN 60
S T+ L ++ + S L ++Q L + ++WN
Sbjct: 183 DVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ 242
Query: 61 TEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLW 120
+++ SI+ + + G S + L L + ++VS
Sbjct: 243 LVWHTTVWYF----SISNVKLQGQLDFRDFDYSGT---------SLKALSIHQVVSDVFG 289
Query: 121 GPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPI 180
P S S++ I N + + S ++ L N+L V + G L
Sbjct: 290 FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTE 349
Query: 181 LAVLSLRNNMFNGTLPDS---FSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLEN 235
L L L+ N L + +++L+ L +S N + S L L++ +
Sbjct: 350 LETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS 408
Query: 236 NALGP-QFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSL 294
N L F + ++ + L NK +S IP +V LQ L+++SN+ L
Sbjct: 409 NILTDTIFRCLPPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRL 467
Query: 295 PSITYLNIADN 305
S+ + + N
Sbjct: 468 TSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 37/225 (16%), Positives = 78/225 (34%), Gaps = 13/225 (5%)
Query: 135 ILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGT 194
+++ S N L +P++LS L + +N ++ + SL L +L + +N
Sbjct: 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 195 LPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNAL-----GPQFPKVGKKL 249
F + + L L LS+N ++ L+ LDL NA +F + +L
Sbjct: 61 DISVFKFNQELEYLDLSHNKL-VKIS-CHPTVNLKHLDLSFNAFDALPICKEFGNM-SQL 117
Query: 250 VTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG 309
+ LS + ++ + L + + + L ++ T
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTN 175
Query: 310 KLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNC 354
K F + +L + + L + + + + N
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNP 220
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 46/335 (13%), Positives = 107/335 (31%), Gaps = 32/335 (9%)
Query: 75 SITQLHIVGN--KRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLS- 131
+ L + +++ +LP++ S V ++ + L + S I +
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN 175
Query: 132 --SLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189
IL++S + + + ++LA + S L + N
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVP------DFSGLTYLQVLDLENNALGPQFP 243
F L + + ++SN G++ + L L + + ++ G
Sbjct: 236 SFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQS 293
Query: 244 KVGKKLVTM---ILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYL 300
+ + M + + R S LD S+N + L + L
Sbjct: 294 YIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353
Query: 301 NIADNKLT-----GKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLY-ARNC 354
+ N+L ++ + L +D+S N ++ + +K+ + L + N
Sbjct: 354 ILQMNQLKELSKIAEMTTQM---KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI 410
Query: 355 LAAGNENQHP-------LSFCQNEALAVGILPLQK 382
L P L + +++ ++ L+
Sbjct: 411 LTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEA 445
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 43/242 (17%), Positives = 74/242 (30%), Gaps = 26/242 (10%)
Query: 124 SGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAV 183
+ I LS L IL +S N + L+ L L N L + L
Sbjct: 38 TSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVN---LKH 94
Query: 184 LSLRNNMFNGTLPDS--FSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQ 241
L L N F+ LP F + L+ L LS H + +L + +
Sbjct: 95 LDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKS--SVLPIAHLNISKVLLVLGETY 151
Query: 242 FPKVG---------KKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALL 292
K + L + + +F + V + L+ ++ L
Sbjct: 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211
Query: 293 SLPSI------TYLNIADNKLTGKLFDDLSCNP---ELGFVDLSSNLLTGQLPNCLLAGS 343
L + + L + + + T F + + + +S+ L GQL S
Sbjct: 212 ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYS 271
Query: 344 KN 345
Sbjct: 272 GT 273
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 26/135 (19%), Positives = 50/135 (37%), Gaps = 24/135 (17%)
Query: 105 KLPDLKVLRLVS--LGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQEL-SILTSLQTLI 161
L +L+ L L L ++ +++ SL+ L++S N ++ + S SL +L
Sbjct: 346 HLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405
Query: 162 LDENMLAGRVPDWLGS---------------------LPILAVLSLRNNMFNGTLPDSFS 200
+ N+L + L L L L++ +N F
Sbjct: 406 MSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFD 465
Query: 201 YLENLRVLALSNNHF 215
L +L+ + L N +
Sbjct: 466 RLTSLQKIWLHTNPW 480
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 27/214 (12%)
Query: 127 ISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186
+ S L+I+++ +N L +P SL+ + N L +P+ L +LP L +
Sbjct: 149 LQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYA 202
Query: 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVG 246
NN LPD +L + NN E+P+ L +L + +NN L P +
Sbjct: 203 DNNSLK-KLPDL---PLSLESIVAGNNIL-EELPELQNLPFLTTIYADNNLLK-TLPDLP 256
Query: 247 KKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLP-SITYLNIADN 305
L + + N +P S L LD+S N F L LP ++ YLN + N
Sbjct: 257 PSLEALNVRDNYLTD-LPELPQS---LTFLDVSENIF-----SGLSELPPNLYYLNASSN 307
Query: 306 KLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCL 339
++ L D P L +++S+N L +LP
Sbjct: 308 EIR-SLCDLP---PSLEELNVSNNKLI-ELPALP 336
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 44/223 (19%), Positives = 80/223 (35%), Gaps = 31/223 (13%)
Query: 130 LSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189
+ L+ S+ L +P E + S + P G +AV LR+
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 190 MFNG------------TLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENN 236
+ +LP+ +L L S N E+P+ L L V +
Sbjct: 69 LDRQAHELELNNLGLSSLPEL---PPHLESLVASCNSL-TELPELPQSLKSLLVDNNNLK 124
Query: 237 ALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPS 296
AL + L + +S N+ +P E+ + L+ +D+ +N PS
Sbjct: 125 AL----SDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPD----LPPS 174
Query: 297 ITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCL 339
+ ++ +N+L +L P L + +N L +LP+
Sbjct: 175 LEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLK-KLPDLP 214
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 36/181 (19%), Positives = 67/181 (37%), Gaps = 21/181 (11%)
Query: 128 SRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLR 187
+L LN SSN + ++ SL+ L + N L +P L L
Sbjct: 294 ELPPNLYYLNASSNEIR-SLCDLP---PSLEELNVSNNKLI-ELPALPPRL---ERLIAS 345
Query: 188 NNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGK 247
N +P+ +NL+ L + N E PD ++ L + ++ + P++ +
Sbjct: 346 FNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD--IPESVEDLRMNSHLA--EVPELPQ 396
Query: 248 KLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKL 307
L + + N R P S ++ L ++S R V P+ A + + +
Sbjct: 397 NLKQLHVETNPLRE-FPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
Query: 308 T 308
Sbjct: 453 H 453
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 8e-20
Identities = 44/262 (16%), Positives = 96/262 (36%), Gaps = 24/262 (9%)
Query: 126 KISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLS 185
K ++ L ++ L+ ++P + + L + +N L +P+ SL L
Sbjct: 54 KECLINQFSELQLNRLNLS-SLPDN--LPPQITVLEITQNAL-ISLPELPASLE---YLD 106
Query: 186 LRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKV 245
+N + TLP+ + +L+ L + NN +P+ L+ ++ +NN L P++
Sbjct: 107 ACDNRLS-TLPELPA---SLKHLDVDNNQL-TMLPE--LPALLEYINADNNQLT-MLPEL 158
Query: 246 GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVG--PFPQALLSLPS-ITYLNI 302
L + + N+ +P S L+ LD+S+N P +
Sbjct: 159 PTSLEVLSVRNNQLTF-LPELPES---LEALDVSTNLLESLPAVPVRNHHSEETEIFFRC 214
Query: 303 ADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNENQ 362
+N++T + +++ + L N L+ L+ + + + ++ Q
Sbjct: 215 RENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272
Query: 363 HPLSFCQNEALAVGILPLQKKQ 384
P K+
Sbjct: 273 QNTLHRPLADAVTAWFPENKQS 294
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 39/169 (23%), Positives = 66/169 (39%), Gaps = 21/169 (12%)
Query: 178 LPILAVLSLRNNMFNGTLP----DSFSYLENLRVLALSNNHF--YGEVPDFSGLTYLQVL 231
LPI SL N F T+ D FS + AL + + + L
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSEL 64
Query: 232 DLENNALGPQFPK-VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQA 290
L L P + ++ + +++N S +P + L+ LD NR P+
Sbjct: 65 QLNRLNL-SSLPDNLPPQITVLEITQNALIS-LPELPA---SLEYLDACDNRLST-LPEL 118
Query: 291 LLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCL 339
SL +L++ +N+LT + +L L +++ +N LT LP
Sbjct: 119 PASL---KHLDVDNNQLT--MLPELPAL--LEYINADNNQLT-MLPELP 159
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 51/289 (17%), Positives = 88/289 (30%), Gaps = 31/289 (10%)
Query: 101 TTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTL 160
+ L + + + L++ +I+ ++ + L ++ L
Sbjct: 15 SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 74
Query: 161 ILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP 220
L++ + + L + N P F + L VL L N +P
Sbjct: 75 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-SSLP 133
Query: 221 D--FSGLTYLQVLDLENN---ALGPQFPKVGKKLVTMILSKNKFRSAIPA---------- 265
F L L + NN + + L + LS N+ +
Sbjct: 134 RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDLSLIPSLFHAN 192
Query: 266 -------EVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCN 318
++ ++ LD S N + L T L + N LT L
Sbjct: 193 VSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVEL---TILKLQHNNLTD--TAWLLNY 247
Query: 319 PELGFVDLSSNLLTGQLPNCLLAGSKNRVVLY-ARNCLAAGNENQHPLS 366
P L VDLS N L ++ + LY + N L A N P+
Sbjct: 248 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIP 295
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 50/249 (20%), Positives = 83/249 (33%), Gaps = 35/249 (14%)
Query: 102 TLVKLPDLKVL-----RLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTS 156
P L L L + +SL+ L +SSN L + LS++ S
Sbjct: 136 IFHNTPKLTTLSMSNNNLERIE-----DDTFQATTSLQNLQLSSNRLT-HVD--LSLIPS 187
Query: 157 LQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFY 216
L + N+L+ L + L +N N + L +L L +N+
Sbjct: 188 LFHANVSYNLLST-----LAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL- 238
Query: 217 GEVPDFSGLTYLQVLDLENNAL----GPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQ 272
+ L +DL N L F K+ ++L + +S N+ + +
Sbjct: 239 TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKM-QRLERLYISNNRLVA-LNLYGQPIPT 296
Query: 273 LQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT 332
L+ LDLS N + + + L + N + L + LS N
Sbjct: 297 LKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLKLSTH---HTLKNLTLSHNDWD 352
Query: 333 GQLPNCLLA 341
N L A
Sbjct: 353 ---CNSLRA 358
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 28/171 (16%), Positives = 57/171 (33%), Gaps = 14/171 (8%)
Query: 171 VPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYL 228
+ L + + + + L N +++ N+ ++P +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQV 71
Query: 229 QVLDLENNALG---PQFPKVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFV 284
++L+L + + + + + N R +P V + L L L N
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 130
Query: 285 GPFPQALLSLPSITYLNIADNKLT---GKLFDDLSCNPELGFVDLSSNLLT 332
+ P +T L++++N L F L + LSSN LT
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT---TSLQNLQLSSNRLT 178
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 31/155 (20%), Positives = 65/155 (41%), Gaps = 23/155 (14%)
Query: 486 GEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHST-------RNFMHHIELISKLRHRHLVS 537
G+G G +++GRL + + VAI+ L + + F + ++S L H ++V
Sbjct: 28 GKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQ 597
G ++ E+VP G L + + W+ ++ + +A GI+
Sbjct: 88 LYGLMHNPPR---------MVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIE 136
Query: 598 FLHTGIVPGVF----SNNLKITDILLDQNLVAKIS 628
++ P V S N+ + + + + AK++
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 34/149 (22%), Positives = 63/149 (42%), Gaps = 23/149 (15%)
Query: 486 GEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
G+G GQ + + G + ++ L + R F+ ++++ L H +++ +G
Sbjct: 19 GKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL-- 76
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIV 604
R+ I EY+ GTLR I + W+QR+S A +A G+ +LH
Sbjct: 77 -----YKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH---- 125
Query: 605 PGVFSNN-----LKITDILLDQNLVAKIS 628
S N L + L+ +N ++
Sbjct: 126 ----SMNIIHRDLNSHNCLVRENKNVVVA 150
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 4e-18
Identities = 54/309 (17%), Positives = 94/309 (30%), Gaps = 31/309 (10%)
Query: 81 IVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSS 140
+ G +R + P + L + + + L++ +I+ +
Sbjct: 1 VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60
Query: 141 NFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFS 200
+ + L ++ L L++ + + L + N P F
Sbjct: 61 STMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQ 120
Query: 201 YLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENN---ALGPQFPKVGKKLVTMILS 255
+ L VL L N +P F L L + NN + + L + LS
Sbjct: 121 NVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS 179
Query: 256 KNKFRSAIPA-----------------EVSSYYQLQRLDLSSNRFVGPFPQALLSLPSIT 298
N+ + ++ ++ LD S N + L T
Sbjct: 180 SNRLTH-VDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVEL---T 235
Query: 299 YLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLY-ARNCLAA 357
L + N LT L P L VDLS N L ++ + LY + N L A
Sbjct: 236 ILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA 292
Query: 358 GNENQHPLS 366
N P+
Sbjct: 293 LNLYGQPIP 301
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 6e-17
Identities = 51/253 (20%), Positives = 84/253 (33%), Gaps = 35/253 (13%)
Query: 102 TLVKLPDLKVL-----RLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTS 156
P L L L + +SL+ L +SSN L + LS++ S
Sbjct: 142 IFHNTPKLTTLSMSNNNLERIE-----DDTFQATTSLQNLQLSSNRLT-HVD--LSLIPS 193
Query: 157 LQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFY 216
L + N+L+ L + L +N N L +L L +N+
Sbjct: 194 LFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNV---ELTILKLQHNNL- 244
Query: 217 GEVPDFSGLTYLQVLDLENNAL----GPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQ 272
+ L +DL N L F K+ ++L + +S N+ + +
Sbjct: 245 TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKM-QRLERLYISNNRLVA-LNLYGQPIPT 302
Query: 273 LQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT 332
L+ LDLS N + + + L + N + L + LS N
Sbjct: 303 LKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLKLSTH---HTLKNLTLSHNDWD 358
Query: 333 GQLPNCLLAGSKN 345
N L A +N
Sbjct: 359 ---CNSLRALFRN 368
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 43/194 (22%), Positives = 70/194 (36%), Gaps = 15/194 (7%)
Query: 106 LPDLKVLRL--VSLGLWGPLSGKISRLS--SLEILNMSSNFLNGAIPQELSILTSLQTLI 161
PDL +L L VS ++ + L++L+++ +++ + +L TL
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 162 LDENMLAGRVPDW----LGSLPILAVLSLRNNMFN---GTLPDSFSYLENLRVLALSNNH 214
L +N G P L VL+LRN G + L+ L LS+N
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 215 FYGEVPD--FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQ 272
+ L L+L L + KL + LS N+ P+ Q
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLSYNRLDR-NPSP-DELPQ 297
Query: 273 LQRLDLSSNRFVGP 286
+ L L N F+
Sbjct: 298 VGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 64/306 (20%), Positives = 96/306 (31%), Gaps = 40/306 (13%)
Query: 46 PAVLSSWNITTEFCNTEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVK 105
P L + + F + +P S C + +L+ G +L +
Sbjct: 5 PCELDEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDI 64
Query: 106 LPDLKVLRLVSLGLWGPLSG-----KISRLSSLEILNMSSNFLNGAIPQELSILT--SLQ 158
+ L + RL P ++ +S L+ L + + + G P L T L
Sbjct: 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLN 124
Query: 159 TLILDENMLAGRVPDWLGSLPI-----LAVLSLRNNMFNGTLPDSFSYLENLRVLALSNN 213
L L A R WL L L VLS+ + L L LS+N
Sbjct: 125 ILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN 183
Query: 214 HFYGEVP-----DFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVS 268
GE LQVL L N + A +
Sbjct: 184 PELGERGLISALCPLKFPTLQVLALRNAGM------------------ETPSGVCSALAA 225
Query: 269 SYYQLQRLDLSSNRFVG-PFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLS 327
+ QLQ LDLS N + + LN++ L ++ L +L +DLS
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLS 282
Query: 328 SNLLTG 333
N L
Sbjct: 283 YNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 36/206 (17%), Positives = 67/206 (32%), Gaps = 21/206 (10%)
Query: 160 LILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLEN---LRVLALSNNHFY 216
+D G+ D + SL + L++R + + L+ L L N
Sbjct: 50 KRVDTEADLGQFTDIIKSLSLKR-LTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 217 GEVPD---FSGLTYLQVLDLENNALGPQ-------FPKVGKKLVTMILSKNKFRSAIPAE 266
G P + L +L+L N + + + L + +++ + +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 267 VSSYYQLQRLDLSSNRFVGPFP----QALLSLPSITYLNIADNKLT---GKLFDDLSCNP 319
V + L LDLS N +G L P++ L + + + G +
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228
Query: 320 ELGFVDLSSNLLTGQLPNCLLAGSKN 345
+L +DLS N L
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQ 254
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 29/179 (16%), Positives = 52/179 (29%), Gaps = 27/179 (15%)
Query: 166 MLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGE----VPD 221
+ A V + G + +L + + +L+ L +
Sbjct: 31 LGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALR 90
Query: 222 FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSN 281
G++ LQ L LEN + P P ++ L L+L +
Sbjct: 91 VLGISGLQELTLENLEVTGTAP-------------------PPLLEATGPDLNILNLRNV 131
Query: 282 RFVGPFPQAL----LSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLP 336
+ P + L+IA + + P L +DLS N G+
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 6e-18
Identities = 46/214 (21%), Positives = 80/214 (37%), Gaps = 28/214 (13%)
Query: 126 KISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLS 185
+ + +LN+ + L +P + + TL++ +N L +P L L
Sbjct: 35 RACLNNGNAVLNVGESGLT-TLPDC--LPAHITTLVIPDNNLT-SLPALPPEL---RTLE 87
Query: 186 LRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKV 245
+ N +LP L L + + H + L L + N L P +
Sbjct: 88 VSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL------PSGLCKLWIFGNQLT-SLPVL 139
Query: 246 GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADN 305
L + +S N+ S +PA S +L +L +N+ P + L+++DN
Sbjct: 140 PPGLQELSVSDNQLAS-LPALPS---ELCKLWAYNNQLTS-LPM---LPSGLQELSVSDN 191
Query: 306 KLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCL 339
+L L S EL + +N LT LP
Sbjct: 192 QLA-SLPTLPS---ELYKLWAYNNRLT-SLPALP 220
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 53/244 (21%), Positives = 87/244 (35%), Gaps = 24/244 (9%)
Query: 130 LSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189
L+ L++S N L ++P S L L N L +P L LS+ +N
Sbjct: 140 PPGLQELSVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPSGL---QELSVSDN 191
Query: 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKL 249
+LP S L L NN +P + L+ L + N L P + +L
Sbjct: 192 QLA-SLPTLPSELYKLW---AYNNRLT-SLPAL--PSGLKELIVSGNRLT-SLPVLPSEL 243
Query: 250 VTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG 309
+++S N+ S +P S L L + N+ P++L+ L S T +N+ N L+
Sbjct: 244 KELMVSGNRLTS-LPMLPS---GLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSE 298
Query: 310 KLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNENQHPLSFCQ 369
+ L E+ S + A + R + A P +
Sbjct: 299 R---TLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADR 355
Query: 370 NEAL 373
Sbjct: 356 WHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 30/140 (21%), Positives = 51/140 (36%), Gaps = 19/140 (13%)
Query: 103 LVKLPDLKVLRLVSLGLWGPLSGKISRL----SSLEILNMSSNFLNGAIPQELSILTSLQ 158
L LP L L L + +++ L S L+ L +S N L ++P + L+
Sbjct: 193 LASLPTL-PSELYKLWA---YNNRLTSLPALPSGLKELIVSGNRLT-SLPVLP---SELK 244
Query: 159 TLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGE 218
L++ N L +P L LS+ N LP+S +L + + L N
Sbjct: 245 ELMVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL--S 297
Query: 219 VPDFSGLTYLQVLDLENNAL 238
L + + +
Sbjct: 298 ERTLQALREITSAPGYSGPI 317
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 48/305 (15%), Positives = 99/305 (32%), Gaps = 20/305 (6%)
Query: 7 FSQCTLLVLAYILLQVNHSEQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPTSS 66
+ L L+ I L + ++L + ++ L + + + +
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPT--------LLNVTLQHIETTWKCSVK 268
Query: 67 LTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGK 126
L + + L+I + + F + L L + + +
Sbjct: 269 LFQFFWPRPVEYLNIYNLT----ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324
Query: 127 ISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186
S + + I +S + +S L +N+ V +L L L L
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384
Query: 187 RNNMFNGTLPDSFSYLENLRVLALSNNHF----YGEVPD-FSGLTYLQVLDLENNALGPQ 241
+ N +N+ L + + + VL+L +N L
Sbjct: 385 QRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443
Query: 242 -FPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYL 300
F + K+ + L N+ +IP +V+ LQ L+++SN+ L S+ Y+
Sbjct: 444 VFRCLPPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYI 502
Query: 301 NIADN 305
+ DN
Sbjct: 503 WLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 42/277 (15%), Positives = 90/277 (32%), Gaps = 20/277 (7%)
Query: 76 ITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEI 135
T LH+V + + + +M ++L ++K+ L LS + L +
Sbjct: 196 TTVLHLVFHPN-SLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNV 254
Query: 136 LNMSSNFLNGAIPQELSIL--TSLQTLILDENMLAGRVPD-----WLGSLPILAVLSLRN 188
+ ++ L + + R+ +L L + ++N
Sbjct: 255 TLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314
Query: 189 NMFNGTLPDSFSYLENLRVLALSNNHFYG-EVPDFSGLTYLQVLDLENNALGPQFPKVGK 247
+F + +S + + LS + + + L+ N +
Sbjct: 315 QVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCS 374
Query: 248 KLV---TMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFV----GPFPQALLSLPSITYL 300
L T+IL +N ++ + L+ + + SI L
Sbjct: 375 TLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL 433
Query: 301 NIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPN 337
N++ N LTG +F L + +DL +N + +P
Sbjct: 434 NLSSNMLTGSVFRCLPPK--VKVLDLHNNRIM-SIPK 467
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 40/224 (17%), Positives = 76/224 (33%), Gaps = 60/224 (26%)
Query: 119 LWGPLSGKISRLS--SLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLG 176
+ G ++ S +++ S+ L +P++ + + L L +N ++
Sbjct: 17 ALALIVGSMTPFSNELESMVDYSNRNLT-HVPKD--LPPRTKALSLSQNSIS-------- 65
Query: 177 SLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLE 234
L S+L LRVL LS+N + F L+ LD+
Sbjct: 66 ELR----------------MPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVS 108
Query: 235 NNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRF-VGPFPQALLS 293
+N L I + L+ LDLS N F V P + +
Sbjct: 109 HNRL----------------------QNISCCPMA--SLRHLDLSFNDFDVLPVCKEFGN 144
Query: 294 LPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPN 337
L +T+L ++ K ++ L + +L++ +
Sbjct: 145 LTKLTFLGLSAAKFRQLDLLPVA---HLHLSCILLDLVSYHIKG 185
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 41/282 (14%), Positives = 88/282 (31%), Gaps = 55/282 (19%)
Query: 103 LVKLPDLKVLRLVSLGLWG------PLSGKISRLSSLEILNMSSNFLNGAIPQELSILTS 156
L + + L L L P+ + L+ L L +S+ +L +
Sbjct: 112 LQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAH 168
Query: 157 LQTLILDENMLAGRVPD------WLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLAL 210
L + ++++ + + + +L ++ N++F+ + S + L +L++ +
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
Query: 211 SNNHFYGEVPD--------------------------------FSGLTYLQVLDLENNAL 238
N + F ++ L++ N +
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288
Query: 239 GPQFPKVG--------KKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQA 290
+ + K L+ + F + A S + ++ LS +
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVC 348
Query: 291 LLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT 332
S S T+LN N T +F S L + L N L
Sbjct: 349 PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 26/116 (22%), Positives = 52/116 (44%), Gaps = 9/116 (7%)
Query: 105 KLPDLKVLRLVSLGL----WGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTL 160
++ L + + L + S+ +LN+SSN L G++ + L ++ L
Sbjct: 398 MTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVL 455
Query: 161 ILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPD-SFSYLENLRVLALSNNHF 215
L N + +P + L L L++ +N ++PD F L +L+ + L +N +
Sbjct: 456 DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 31/150 (20%), Positives = 62/150 (41%), Gaps = 18/150 (12%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMH--HIELISKLRHRHLVSALGHCF 543
G+G G+++ G+ + G VA+ K+ ++ I +RH +++ +
Sbjct: 46 GKGRYGEVWMGKWR-GEKVAV---KVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI 603
+ S ++++LI +Y NG+L ++ +L + A G+ LHT I
Sbjct: 102 K---GTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 604 VPGVFSNN-----LKITDILLDQNLVAKIS 628
LK +IL+ +N I+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 32/150 (21%), Positives = 61/150 (40%), Gaps = 18/150 (12%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIEL--ISKLRHRHLVSALGHCF 543
G+G G+++RG G VA+ K+ +++ EL LRH +++ +
Sbjct: 17 GKGRYGEVWRGSW-QGENVAV---KIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI 603
S ++++LI Y G+L ++ +L + + +A G+ LH I
Sbjct: 73 T---SRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 604 VPGVFSNN-----LKITDILLDQNLVAKIS 628
LK +IL+ +N I+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 51/243 (20%), Positives = 91/243 (37%), Gaps = 19/243 (7%)
Query: 114 LVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPD 173
++SL + I SS LN +IP L+ ++++L L N +
Sbjct: 14 IISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNS 70
Query: 174 WLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVL 231
L L L L +N N DSFS L +L L LS N+ + F L+ L L
Sbjct: 71 DLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFL 129
Query: 232 DLENNAL-----GPQFPKVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVG 285
+L N F + KL + + + I + + L+ L++ ++
Sbjct: 130 NLLGNPYKTLGETSLFSHL-TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188
Query: 286 PFPQALLSLPSITYLNIADNKLT---GKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAG 342
P++L S+ ++++L + + D + ++L L + L G
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVT---SSVECLELRDTDLDTFHFSELSTG 245
Query: 343 SKN 345
N
Sbjct: 246 ETN 248
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 41/222 (18%), Positives = 75/222 (33%), Gaps = 27/222 (12%)
Query: 128 SRLSSLEILNMSSNFLNGAIPQEL-SILTSLQTLILDENMLAGRVPD--WLGSLPILAVL 184
S L SLE L++S N+L + L+SL L L N + + L L +L
Sbjct: 97 SSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQIL 154
Query: 185 SLRNNMFNGTLPD-SFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENN---AL 238
+ N + F+ L L L + + + + L L L
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDL-QSYEPKSLKSIQNVSHLILHMKQHILL 213
Query: 239 GPQFPKVGKKLVTMILSKNKFRSAIPAEVSS--------YYQLQRLDLSSNRFVGPFPQA 290
F V + + L + +E+S+ + + + ++ +
Sbjct: 214 LEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKL 272
Query: 291 LLSLPSITYLNIADNKLTG---KLFDDLSCNPELGFVDLSSN 329
L + + L + N+L +FD L L + L +N
Sbjct: 273 LNQISGLLELEFSRNQLKSVPDGIFDRL---TSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 38/200 (19%), Positives = 72/200 (36%), Gaps = 23/200 (11%)
Query: 102 TLVKLPDLKVLRL-----VSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQE-LSILT 155
L L L L +LG S L+ L+IL + + I ++ + LT
Sbjct: 119 WFKPLSSLTFLNLLGNPYKTLGETSLFSH----LTKLQILRVGNMDTFTKIQRKDFAGLT 174
Query: 156 SLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHF 215
L+ L +D + L P L S+ ++ L L L ++ L L +
Sbjct: 175 FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDL 234
Query: 216 Y---------GEVPDFSGLTYLQVLDLENNAL--GPQFPKVGKKLVTMILSKNKFRSAIP 264
GE + + + + +L + L+ + S+N+ +S +P
Sbjct: 235 DTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VP 293
Query: 265 AEV-SSYYQLQRLDLSSNRF 283
+ LQ++ L +N +
Sbjct: 294 DGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 23/123 (18%), Positives = 42/123 (34%), Gaps = 9/123 (7%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI-------- 153
+L + ++ L L L + SS+E L + L+ ELS
Sbjct: 193 SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
Query: 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNN 213
+ + + + + L +V L + L L N F L +L+ + L N
Sbjct: 253 KFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
Query: 214 HFY 216
+
Sbjct: 312 PWD 314
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 40/192 (20%), Positives = 71/192 (36%), Gaps = 12/192 (6%)
Query: 124 SGKISRLSSLEILNMSSNFLNGAIPQEL-SILTSLQTLILDENMLAGRVPDWLGSLPILA 182
S L++L++S + I L+ L TLIL N + L L
Sbjct: 45 SYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQ 103
Query: 183 VLSLRNNMFNGTLPDSFSYLENLRVLALSNNHF-YGEVPD-FSGLTYLQVLDLENNALG- 239
L +L+ L+ L +++N ++P+ FS LT L+ LDL +N +
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 240 ------PQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLS 293
++ +++ LS N I +L+ L L +N+
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDR 222
Query: 294 LPSITYLNIADN 305
L S+ + + N
Sbjct: 223 LTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 41/195 (21%), Positives = 67/195 (34%), Gaps = 33/195 (16%)
Query: 146 AIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL 205
IP ++ S + L L N L S P L VL L ++ L +L
Sbjct: 21 KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 206 RVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAI 263
L L+ N + FSGL+ LQ L L +++
Sbjct: 79 STLILTGNPI-QSLALGAFSGLSSLQKLVAVETNL----------------------ASL 115
Query: 264 PAEV-SSYYQLQRLDLSSNRF-VGPFPQALLSLPSITYLNIADNKLT---GKLFDDLSCN 318
L+ L+++ N P+ +L ++ +L+++ NK+ L
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175
Query: 319 PELGFV-DLSSNLLT 332
P L DLS N +
Sbjct: 176 PLLNLSLDLSLNPMN 190
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 34/150 (22%), Positives = 72/150 (48%), Gaps = 18/150 (12%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMH--HIELISKLRHRHLVSALGHCF 543
G+G G+++RG+ + G VA+ K+ R++ I LRH +++ +
Sbjct: 51 GKGRFGEVWRGKWR-GEEVAV---KIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI 603
+ + + ++++L+ +Y +G+L +++ ++T I A+ A G+ LH I
Sbjct: 107 KD---NGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 604 V-----PGVFSNNLKITDILLDQNLVAKIS 628
V P + +LK +IL+ +N I+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 32/155 (20%), Positives = 65/155 (41%), Gaps = 24/155 (15%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHST----RNFMHHIELISKLRHRHLVSALGH 541
G G G++YR G VA++ + N +L + L+H ++++ G
Sbjct: 16 GIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT 601
C + L+ E+ G L +S + + ++ A+ +A+G+ +LH
Sbjct: 75 C-------LKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHD 123
Query: 602 GIVPGVFSNNLKITDILLDQ--------NLVAKIS 628
+ + +LK ++IL+ Q N + KI+
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 30/146 (20%), Positives = 66/146 (45%), Gaps = 19/146 (13%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHST--RNFMHHIELISKLRHRHLVSALGHCF 543
G GS G +Y+G+ +G VA++ L + + F + + ++ K RH +++ +G+
Sbjct: 33 GSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQ-SLTWTQRISAAIGVAKGIQFLHTG 602
+ ++ ++ ++ +L + HA + + I A A+G+ +LH
Sbjct: 90 -------TAPQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHA- 138
Query: 603 IVPGVFSNNLKITDILLDQNLVAKIS 628
+ +LK +I L ++ KI
Sbjct: 139 --KSIIHRDLKSNNIFLHEDNTVKIG 162
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 50/234 (21%), Positives = 80/234 (34%), Gaps = 20/234 (8%)
Query: 100 VTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQT 159
+ + + + +L++L L+ ++ + + + LT L
Sbjct: 11 FNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTK 68
Query: 160 LILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEV 219
LI N + + L L L+ +N L + L L L N
Sbjct: 69 LICTSNNITT-LD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL--TK 120
Query: 220 PDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLS 279
D S L L+ N L +L + NK + + V+ QL LD S
Sbjct: 121 LDVSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCS 178
Query: 280 SNRFVG-PFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT 332
N+ Q + LN N +T DL+ N +L F+D SSN LT
Sbjct: 179 FNKITELDVSQ----NKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 44/235 (18%), Positives = 72/235 (30%), Gaps = 41/235 (17%)
Query: 127 ISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186
++ L+ L LN +N L ++S L L N L + + L L
Sbjct: 102 VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDC 155
Query: 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVG 246
N + L L S N D S L L+ + N + +
Sbjct: 156 HLN--KKITKLDVTPQTQLTTLDCSFNKITEL--DVSQNKLLNRLNCDTNNI--TKLDLN 209
Query: 247 K--KLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRF----VGPFPQ----------- 289
+ +L + S NK +V+ QL D S N V +
Sbjct: 210 QNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDL 266
Query: 290 ---ALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT----GQLPN 337
L + Y + +L D++ N +L +D + +T Q P
Sbjct: 267 LEIDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGITELDLSQNPK 319
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 45/294 (15%), Positives = 87/294 (29%), Gaps = 46/294 (15%)
Query: 71 CYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRL 130
C ++T++ + N + L + + L L + +S+
Sbjct: 134 CARNTLTEIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKI---TELDVSQN 190
Query: 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM 190
L LN +N + + L+ L L N L + + L L N
Sbjct: 191 KLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNP 244
Query: 191 FNGTLPDS-------------------FSYLENLRVLALSNNHFYGEVPDFSGLTYLQVL 231
L S ++ L + D + T L +L
Sbjct: 245 LT-ELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKI-KELDVTHNTQLYLL 302
Query: 232 DLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQAL 291
D + + KLV + L+ + + VS +L+ L + F ++
Sbjct: 303 DCQAAGITELDLSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD-FS-SV 357
Query: 292 LSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKN 345
+P++ A+ + + L++N LT + LL N
Sbjct: 358 GKIPALNNNFEAEGQTI-----------TMPKETLTNNSLTIAVSPDLLDQFGN 400
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 36/145 (24%), Positives = 62/145 (42%), Gaps = 17/145 (11%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHST--RNFMHHIELISKLRHRHLVSALGHCF 543
G+G GQ+Y GR +G VAIR + +++ + + F + + RH ++V +G C
Sbjct: 42 GKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC- 98
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI 603
S + +I TL S + A L + A + KG+ +LH
Sbjct: 99 ------MSPPHLAIITSLCKGRTLYSVVR--DAKIVLDVNKTRQIAQEIVKGMGYLHA-- 148
Query: 604 VPGVFSNNLKITDILLDQNLVAKIS 628
G+ +LK ++ D V I+
Sbjct: 149 -KGILHKDLKSKNVFYDNGKV-VIT 171
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 45/187 (24%), Positives = 68/187 (36%), Gaps = 18/187 (9%)
Query: 154 LTSLQTLILDENMLAGRVPDWLGSLPI-LAVLSLRNNMFNGTLPDSFSYLENLRVLALSN 212
+ S + D+ L +P LP +L L N+ + L L L
Sbjct: 9 VASHLEVNCDKRNLT-ALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 213 NHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGK---KLVTMILSKNKFRSAIPAEV-S 268
++ L L LDL +N L P +G+ L + +S N+ S +P
Sbjct: 65 AEL-TKLQVDGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTS-LPLGALR 121
Query: 269 SYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLT---GKLFDDLSCNPELGFVD 325
+LQ L L N P L P + L++A+N LT L + L L +
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL---ENLDTLL 178
Query: 326 LSSNLLT 332
L N L
Sbjct: 179 LQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 49/176 (27%), Positives = 60/176 (34%), Gaps = 16/176 (9%)
Query: 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLV-------------KLPDLKVLRLVSLGLWG 121
T LH+ N + + +T L LP L L L L
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQS 91
Query: 122 PLSGKISRLSSLEILNMSSNFLNGAIPQEL-SILTSLQTLILDENMLAGRVPDWLGSLPI 180
L L +L +L++S N L ++P L LQ L L N L P L P
Sbjct: 92 -LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149
Query: 181 LAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENN 236
L LSL NN + LENL L L N Y F G L L N
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 41/213 (19%), Positives = 69/213 (32%), Gaps = 29/213 (13%)
Query: 146 AIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLP-DSFSYLEN 204
+P + + + L N +A L L L + + ++F L +
Sbjct: 24 QVP---ELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 205 LRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVG-----KKLVTMILSKN 257
L +L L N F ++ F+GL L+VL L L L ++L N
Sbjct: 81 LIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139
Query: 258 KFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSI--TYLNIADNKLTG----- 309
+ PA + + LDL+ N+ + LL+ T L ++ L
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW 199
Query: 310 ------KLFDDLSCNPELGFVDLSSNLLTGQLP 336
+ L DLS N +
Sbjct: 200 LGWEKCGNPFKNTSITTL---DLSGNGFKESMA 229
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 48/261 (18%), Positives = 77/261 (29%), Gaps = 36/261 (13%)
Query: 124 SGKISRLSSLEILNMSSNFLNGAIPQEL-SILTSLQTLILDENMLAGRVPDWLGSLPILA 182
SRL L+ L + I L+SL L LD N L L
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLE 106
Query: 183 VLSLRNNMFNGTL--PDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNAL 238
VL+L +G + + F L +L +L L +N+ P F + VLDL N +
Sbjct: 107 VLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV 166
Query: 239 GPQFPK------VGKKLVTMILSKNKFRSAIPAEVSSY--------YQLQRLDLSSNRFV 284
+ GK + LS + + + LDLS N F
Sbjct: 167 -KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK 225
Query: 285 GPFPQALLSLPSITYLNIADNKLTGKLFDDLSCN---------------PELGFVDLSSN 329
+ + T + + + + DLS +
Sbjct: 226 ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKS 285
Query: 330 LLTGQLPNCLLAGSKNRVVLY 350
+ L + + + L
Sbjct: 286 KIF-ALLKSVFSHFTDLEQLT 305
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 50/292 (17%), Positives = 91/292 (31%), Gaps = 48/292 (16%)
Query: 77 TQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEIL 136
L + L ++F L L +L+L +G + L++LE+L
Sbjct: 57 QFLKVEQQT----PGLVIRNNTFR----GLSSLIILKLDYNQFLQLETGAFNGLANLEVL 108
Query: 137 NMSSNFLNGA-IPQEL-SILTSLQTLILDENMLAGRVPDWL-GSLPILAVLSLRNNMFNG 193
++ L+GA + LTSL+ L+L +N + P ++ VL L N
Sbjct: 109 TLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168
Query: 194 TLPDSFSYLE--NLRVLALSNNHFY---------GEVPDFSGLTYLQVLDLENNALGPQF 242
+ + + +L LS+ + + T + LDL N
Sbjct: 169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESM 228
Query: 243 PKV----------------GKKLVTMILSKNKFRSAIPAEVS---SYYQLQRLDLSSNRF 283
K + F+ ++ DLS ++
Sbjct: 229 AKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKD-PDNFTFKGLEASGVKTCDLSKSKI 287
Query: 284 VGPFPQALLSLPSITYLNIADNKLT---GKLFDDLSCNPELGFVDLSSNLLT 332
+ L +A N++ F L+ L ++LS N L
Sbjct: 288 FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLT---HLLKLNLSQNFLG 336
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 49/268 (18%), Positives = 87/268 (32%), Gaps = 48/268 (17%)
Query: 75 SITQLHIVGNKRAPMLPLSF-SMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSL 133
L + NK + + TL++L + + + L G + +S+
Sbjct: 155 RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSI 214
Query: 134 EILNMSSNFLNGAIPQELSIL---TSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM 190
L++S N ++ + T +Q+LIL + G S N
Sbjct: 215 TTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG------SSFGHTNFKDPDNFT 268
Query: 191 FNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVGKK 248
F G L S ++ LS + + FS T L+ L L N +
Sbjct: 269 FKG-LEAS-----GVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEI---------- 311
Query: 249 LVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKL 307
+ I L +L+LS N + +L + L+++ N +
Sbjct: 312 ------------NKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359
Query: 308 T---GKLFDDLSCNPELGFVDLSSNLLT 332
+ F L P L + L +N L
Sbjct: 360 RALGDQSFLGL---PNLKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 53/294 (18%), Positives = 88/294 (29%), Gaps = 47/294 (15%)
Query: 15 LAYILLQVNHSEQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPTSSLTVVCYEE 74
+ L N +++S + LL QG LSS +
Sbjct: 156 FHVLDLTFN---KVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212
Query: 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLE 134
SIT L + GN SM + ++ L L + S
Sbjct: 213 SITTLDLSGNG------FKESMAKRFFDAIAGTKIQSLILSNSYN------MGSSFGHTN 260
Query: 135 ILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGT 194
+ + G + ++T L ++ + + L L+L N N
Sbjct: 261 FKDPDNFTFKGLEA------SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKI 314
Query: 195 LPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVGKKLVTM 252
++F L +L L LS N G + F L L+VLDL N +
Sbjct: 315 DDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHI-------------- 359
Query: 253 ILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADN 305
A+ + L+ L L +N+ L S+ + + N
Sbjct: 360 --------RALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 28/89 (31%), Positives = 41/89 (46%), Gaps = 4/89 (4%)
Query: 129 RLSSLEILNMSSNFLNGAIPQEL-SILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLR 187
L+ L LN+S NFL G+I + L L+ L L N + LP L L+L
Sbjct: 321 GLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALD 379
Query: 188 NNMFNGTLPDS-FSYLENLRVLALSNNHF 215
N ++PD F L +L+ + L N +
Sbjct: 380 TNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 36/175 (20%), Positives = 71/175 (40%), Gaps = 25/175 (14%)
Query: 460 GLPAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHST-R 518
+ A F +G+G G + G + G VA+ K K +T +
Sbjct: 4 SVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAV---KCIKNDATAQ 59
Query: 519 NFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQ 578
F+ ++++LRH +LV LG E ++++ EY+ G+L ++
Sbjct: 60 AFLAEASVMTQLRHSNLVQLLGVIVE------EKGGLYIVTEYMAKGSLVDYLRS-RGRS 112
Query: 579 SLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
L + ++ V + +++L NN L ++L+ ++ VAK+S
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYLE--------GNNFVHRDLAARNVLVSEDNVAKVS 159
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 23/137 (16%), Positives = 60/137 (43%), Gaps = 4/137 (2%)
Query: 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLI 161
T ++ L + L ++ + L+G I +++ L +++ P +S L++L+ L
Sbjct: 39 TEAQMNSLTYITLANINVTD-LTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 162 LDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD 221
+ + L L L +L + ++ + ++ + L + + LS N ++
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
Query: 222 FSGLTYLQVLDLENNAL 238
L L+ L+++ + +
Sbjct: 155 LKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 27/138 (19%), Positives = 56/138 (40%), Gaps = 7/138 (5%)
Query: 199 FSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVG---KKLVTMILS 255
Y N++ L ++N H SGL+ L+ L + + L + +S
Sbjct: 62 IEYAHNIKDLTINNIHA-TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120
Query: 256 KNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDL 315
+ +I ++++ ++ +DLS N + L +LP + LNI + + + +
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDGVHD--YRGI 177
Query: 316 SCNPELGFVDLSSNLLTG 333
P+L + S + G
Sbjct: 178 EDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 8e-09
Identities = 26/163 (15%), Positives = 55/163 (33%), Gaps = 26/163 (15%)
Query: 192 NGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVT 251
+ T + + + +L + L+N V D +G+ Y +
Sbjct: 33 SSTANITEAQMNSLTYITLANI----NVTDLTGIEYA------------------HNIKD 70
Query: 252 MILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKL 311
+ ++ + P +S L+RL + L L S+T L+I+ + +
Sbjct: 71 LTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128
Query: 312 FDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNC 354
++ P++ +DLS N + L L +
Sbjct: 129 LTKINTLPKVNSIDLSYNGAITDIMP--LKTLPELKSLNIQFD 169
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 39/233 (16%), Positives = 65/233 (27%), Gaps = 18/233 (7%)
Query: 132 SLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMF 191
S + + + IP + + L L L + + N
Sbjct: 10 SNRVFLCQESKVT-EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 192 NGTLP-DSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALG--PQFPKVG 246
+ D FS L L + + + + F L LQ L + N + P K+
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 126
Query: 247 -KKLVTMILSKNKFRSAIPAEVSSY--YQLQRLDLSSNRFVGPFPQALLSLPSITYLNIA 303
+ V + + N I ++ L L+ N A
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSD 186
Query: 304 DNKLT---GKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARN 353
+N L +F S L D+S + LP+ L K N
Sbjct: 187 NNNLEELPNDVFHGASGPVIL---DISRTRIH-SLPSYGLENLKKLRARSTYN 235
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 48/231 (20%), Positives = 77/231 (33%), Gaps = 12/231 (5%)
Query: 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQE-LSILTSLQTL-ILDE 164
+ LR V L G S LE + +S N + I + S L L + I
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 165 NMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--F 222
N L P+ +LP L L + N + +L + +N + F
Sbjct: 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149
Query: 223 SGLTY-LQVLDLENNALG--PQFPKVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDL 278
GL++ +L L N + G +L + LS N +P +V LD+
Sbjct: 150 VGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209
Query: 279 SSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSN 329
S R L +L + + + K + L L L+
Sbjct: 210 SRTRIHSLPSYGLENLKKLRARSTYNLKKLP-TLEKL---VALMEASLTYP 256
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 32/153 (20%), Positives = 62/153 (40%), Gaps = 25/153 (16%)
Query: 486 GEGSQGQMYRGRLK-----NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALG 540
G+G+ G + R G VA++ L+ R+F I+++ L +V G
Sbjct: 32 GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRG 91
Query: 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH 600
+ + L+ EY+P+G LR ++ A L ++ + + + KG+++L
Sbjct: 92 VSY-----GPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYSSQICKGMEYLG 144
Query: 601 TGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
S L +IL++ KI+
Sbjct: 145 --------SRRCVHRDLAARNILVESEAHVKIA 169
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 36/148 (24%), Positives = 65/148 (43%), Gaps = 23/148 (15%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFEC 545
G G G+++ G T VA++ LK + S F+ L+ +L+H+ LV +
Sbjct: 22 GAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79
Query: 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVP 605
I++I EY+ NG+L ++ + LT + + A +A+G+ F+
Sbjct: 80 -------EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIE----- 126
Query: 606 GVFSNN-----LKITDILLDQNLVAKIS 628
N L+ +IL+ L KI+
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIA 151
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 57/217 (26%), Positives = 83/217 (38%), Gaps = 44/217 (20%)
Query: 131 SSLEILNMSSNFLNGAIPQE--LSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRN 188
S +L++S N L + E + LT+L +L+L N L + +P L L L +
Sbjct: 39 SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97
Query: 189 NMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVG 246
N + FS L+ L VL L NNH V F + LQ L L N +
Sbjct: 98 NHLHTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQI-------- 148
Query: 247 KKLVTMILSKNKFRSAIPAEV----SSYYQLQRLDLSSNRFVGPFPQALLSLPSIT--YL 300
S P E+ + +L LDLSSN+ L LP+ L
Sbjct: 149 --------------SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 301 NIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPN 337
+ +N L C+ +L L S+ QL +
Sbjct: 195 YLHNNPLE--------CDCKL--YQLFSHWQYRQLSS 221
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 30/126 (23%), Positives = 47/126 (37%), Gaps = 19/126 (15%)
Query: 102 TLVKLPDLKVLRL-----VSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQE-LSILT 155
V +P+L+ L L +L S L +LE+L + +N + + + +
Sbjct: 83 AFVPVPNLRYLDLSSNHLHTLD-----EFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMA 136
Query: 156 SLQTLILDENMLAGRVP----DWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL--RVLA 209
LQ L L +N ++ R P LP L +L L +N L L
Sbjct: 137 QLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
Query: 210 LSNNHF 215
L NN
Sbjct: 196 LHNNPL 201
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 35/183 (19%), Positives = 67/183 (36%), Gaps = 12/183 (6%)
Query: 151 LSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLAL 210
L + + ++ + V L + LS + YL NL L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70
Query: 211 SNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVG-KKLVTMILSKNKFRSAIPAEVSS 269
+N ++ LT + L+L N L G + + T+ L+ + P ++
Sbjct: 71 KDNQI-TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP--LAG 127
Query: 270 YYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSN 329
LQ L L N+ L L ++ YL+I + +++ L+ +L + N
Sbjct: 128 LSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDN 183
Query: 330 LLT 332
++
Sbjct: 184 KIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 46/211 (21%), Positives = 79/211 (37%), Gaps = 16/211 (7%)
Query: 100 VTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQT 159
T L + L G+ + G + L++L L + N + P L LT +
Sbjct: 34 TVTQADLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKDNQITDLAP--LKNLTKITE 89
Query: 160 LILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEV 219
L L N L + + L + L L + + L NL+VL L N +
Sbjct: 90 LELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQI-TNI 144
Query: 220 PDFSGLTYLQVLDLENNALGPQFPKVG--KKLVTMILSKNKFRSAIPAEVSSYYQLQRLD 277
+GLT LQ L + N + + KL T+ NK P ++S L +
Sbjct: 145 SPLAGLTNLQYLSIGNAQVS-DLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVH 201
Query: 278 LSSNRFVGPFPQALLSLPSITYLNIADNKLT 308
L +N+ L + ++ + + + +T
Sbjct: 202 LKNNQISDV--SPLANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 47/185 (25%), Positives = 78/185 (42%), Gaps = 14/185 (7%)
Query: 100 VTTLVKLPDLKVLRLVS--LGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSL 157
V+ + L +K L L S + PL+G LS+L++L + N + P L+ LT+L
Sbjct: 100 VSAIAGLQSIKTLDLTSTQITDVTPLAG----LSNLQVLYLDLNQITNISP--LAGLTNL 153
Query: 158 QTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYG 217
Q L + ++ P L +L L L +N + + L NL + L NN
Sbjct: 154 QYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI--SDISPLASLPNLIEVHLKNNQI-S 208
Query: 218 EVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAI-PAEVSSYYQLQRL 276
+V + + L ++ L N + Q LV + K + I PA +S
Sbjct: 209 DVSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASP 268
Query: 277 DLSSN 281
+L+ N
Sbjct: 269 NLTWN 273
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 30/148 (20%), Positives = 59/148 (39%), Gaps = 23/148 (15%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFEC 545
G G G+++ T VA++ +K S F+ ++ L+H LV +
Sbjct: 197 GAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 254
Query: 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVP 605
I++I E++ G+L ++ + I + +A+G+ F+
Sbjct: 255 -------EPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFIE----- 301
Query: 606 GVFSNN-----LKITDILLDQNLVAKIS 628
N L+ +IL+ +LV KI+
Sbjct: 302 ---QRNYIHRDLRAANILVSASLVCKIA 326
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 35/154 (22%), Positives = 65/154 (42%), Gaps = 28/154 (18%)
Query: 486 GEGSQGQMYRGRLKN-----GTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSAL 539
GEG G++ G VA++ LK + I+++ L H H++
Sbjct: 40 GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYK 99
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFL 599
G C + + + + L+ EYVP G+LR ++ S+ Q + A + +G+ +L
Sbjct: 100 GCCED-----AGAASLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYL 150
Query: 600 HTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
H + + L ++LLD + + KI
Sbjct: 151 H--------AQHYIHRDLAARNVLLDNDRLVKIG 176
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 35/154 (22%), Positives = 67/154 (43%), Gaps = 26/154 (16%)
Query: 486 GEGSQGQMYRGRLK-----NGTFVAIRCLKMKKCHSTRN-FMHHIELISKLRHRHLVSAL 539
GEG G++ R G VA++ LK + + IE++ L H ++V
Sbjct: 30 GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYK 89
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFL 599
G C E + I LI E++P+G+L+ ++ + ++ + Q++ A+ + KG+ +L
Sbjct: 90 GICTE-----DGGNGIKLIMEFLPSGSLKEYL-PKNKNK-INLKQQLKYAVQICKGMDYL 142
Query: 600 HTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
S L ++L++ KI
Sbjct: 143 G--------SRQYVHRDLAARNVLVESEHQVKIG 168
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 33/153 (21%), Positives = 64/153 (41%), Gaps = 25/153 (16%)
Query: 486 GEGSQGQMYRGRLK-----NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALG 540
G+G+ G + R G VA++ L+ R+F IE++ L+H ++V G
Sbjct: 19 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKG 78
Query: 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH 600
C+ + + LI EY+P G+LR ++ + + + + + KG+++L
Sbjct: 79 VCYS-----AGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLG 131
Query: 601 TGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
+ L +IL++ KI
Sbjct: 132 --------TKRYIHRDLATRNILVENENRVKIG 156
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 34/149 (22%), Positives = 67/149 (44%), Gaps = 25/149 (16%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHST-RNFMHHIELISKLRHRHLVSALGHCFE 544
G+G G + G + G VA+ K K +T + F+ ++++LRH +LV LG E
Sbjct: 202 GKGEFGDVMLGDYR-GNKVAV---KCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIV 604
++++ EY+ G+L ++ L + ++ V + +++L
Sbjct: 258 EK------GGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE---- 306
Query: 605 PGVFSNN-----LKITDILLDQNLVAKIS 628
NN L ++L+ ++ VAK+S
Sbjct: 307 ----GNNFVHRDLAARNVLVSEDNVAKVS 331
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 1e-12
Identities = 51/210 (24%), Positives = 80/210 (38%), Gaps = 14/210 (6%)
Query: 100 VTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQT 159
T +L + + + + + G I L ++ L ++ N L P L+ L +L
Sbjct: 36 AVTQNELNSIDQIIANNSDI-KSVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGW 91
Query: 160 LILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEV 219
L LDEN + L L L LSL +N + + +L L L L NN ++
Sbjct: 92 LFLDENKIKDLSS--LKDLKKLKSLSLEHN--GISDINGLVHLPQLESLYLGNNKIT-DI 146
Query: 220 PDFSGLTYLQVLDLENNALG--PQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLD 277
S LT L L LE+N + + KL + LSKN ++ L L+
Sbjct: 147 TVLSRLTKLDTLSLEDNQISDIVPLAGL-TKLQNLYLSKNHISDLRA--LAGLKNLDVLE 203
Query: 278 LSSNRFVGPFPQALLSLPSITYLNIADNKL 307
L S + +L + D L
Sbjct: 204 LFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 23/138 (16%), Positives = 47/138 (34%), Gaps = 14/138 (10%)
Query: 199 FSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNAL----GPQFPKVGKKLVTMIL 254
L + + L + + N+ + G Q+ + + L
Sbjct: 17 DDAFAETIKDNLKKKSV-TDAVTQNELNSIDQIIANNSDIKSVQGIQYL---PNVTKLFL 72
Query: 255 SKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDD 314
+ NK P +++ L L L N+ L L + L++ N ++ +
Sbjct: 73 NGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS--DING 126
Query: 315 LSCNPELGFVDLSSNLLT 332
L P+L + L +N +T
Sbjct: 127 LVHLPQLESLYLGNNKIT 144
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 33/153 (21%), Positives = 64/153 (41%), Gaps = 25/153 (16%)
Query: 486 GEGSQGQMYRGRL-----KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALG 540
G+G+ G + R G VA++ L+ R+F IE++ L+H ++V G
Sbjct: 50 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKG 109
Query: 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH 600
C+ + + LI EY+P G+LR ++ + + + + + KG+++L
Sbjct: 110 VCY-----SAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLG 162
Query: 601 TGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
+ L +IL++ KI
Sbjct: 163 --------TKRYIHRDLATRNILVENENRVKIG 187
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 37/148 (25%), Positives = 65/148 (43%), Gaps = 23/148 (15%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFEC 545
G+G G+++ G T VAI+ LK S F+ +++ KLRH LV E
Sbjct: 193 GQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250
Query: 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVP 605
I+++ EY+ G+L ++ + L Q + A +A G+ ++
Sbjct: 251 -------EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVE----- 297
Query: 606 GVFSNN-----LKITDILLDQNLVAKIS 628
N L+ +IL+ +NLV K++
Sbjct: 298 ---RMNYVHRDLRAANILVGENLVCKVA 322
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 30/149 (20%), Positives = 62/149 (41%), Gaps = 23/149 (15%)
Query: 486 GEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
G G G++Y G K VA++ LK + F+ ++ +++H +LV LG C
Sbjct: 229 GGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIV 604
++I E++ G L ++ E Q ++ + A ++ +++L
Sbjct: 288 EP-------PFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLE---- 335
Query: 605 PGVFSNN-----LKITDILLDQNLVAKIS 628
N L + L+ +N + K++
Sbjct: 336 ----KKNFIHRNLAARNCLVGENHLVKVA 360
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 34/181 (18%), Positives = 70/181 (38%), Gaps = 32/181 (17%)
Query: 459 LGLPAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHST 517
G+ +R ++ + +G G+ G+++ GRL+ + T VA+ K +
Sbjct: 96 SGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAV---KSCRETLP 152
Query: 518 ----RNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI-S 572
F+ ++ + H ++V +G C + I+++ E V G +++ +
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-------QPIYIVMELVQGGDFLTFLRT 205
Query: 573 EGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNN-----LKITDILLDQNLVAKI 627
EG L + A G+++L S L + L+ + V KI
Sbjct: 206 EGA---RLRVKTLLQMVGDAAAGMEYLE--------SKCCIHRDLAARNCLVTEKNVLKI 254
Query: 628 S 628
S
Sbjct: 255 S 255
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 51/194 (26%), Positives = 76/194 (39%), Gaps = 18/194 (9%)
Query: 146 AIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL 205
AIP +I + L L N L+ L L +L L +N F L+NL
Sbjct: 30 AIPS--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 206 RVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALG--PQ--FPKVGKKLVTMILSKNKF 259
L +++N +P F L L L L+ N L P F + KL + L N+
Sbjct: 88 ETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLT-KLTYLSLGYNEL 145
Query: 260 RSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLT---GKLFDDL 315
+S +P V L+ L L +N+ A L + L + +N+L FD L
Sbjct: 146 QS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204
Query: 316 SCNPELGFVDLSSN 329
+L + L N
Sbjct: 205 ---EKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 49/183 (26%), Positives = 74/183 (40%), Gaps = 12/183 (6%)
Query: 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM 190
+ + L++ SN L+ + LT L+ L L++N L L L L + +N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96
Query: 191 FNGTLPDS-FSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALG--PQ--FP 243
LP F L NL L L N +P F LT L L L N L P+ F
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFD 154
Query: 244 KVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNI 302
K+ L + L N+ + +P +L+ L L +N+ A SL + L +
Sbjct: 155 KLTS-LKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 303 ADN 305
+N
Sbjct: 213 QEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 42/159 (26%), Positives = 66/159 (41%), Gaps = 14/159 (8%)
Query: 183 VLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENN---A 237
L L++N + +F L LR+L L++N +P F L L+ L + +N A
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQA 99
Query: 238 LGPQFPKVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPS 296
L L + L +N+ +S +P V S +L L L N L S
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTS 158
Query: 297 ITYLNIADNKLT---GKLFDDLSCNPELGFVDLSSNLLT 332
+ L + +N+L FD L+ EL + L +N L
Sbjct: 159 LKELRLYNNQLKRVPEGAFDKLT---ELKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 39/139 (28%), Positives = 61/139 (43%), Gaps = 16/139 (11%)
Query: 204 NLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVG-----KKLVTMILSKN 257
+ + L L +N F LT L++L L +N L Q G K L T+ ++ N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL--QTLPAGIFKELKNLETLWVTDN 95
Query: 258 KFRSAIPAEVSSY-YQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLT---GKLFD 313
K ++ +P V L L L N+ P+ SL +TYL++ N+L +FD
Sbjct: 96 KLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFD 154
Query: 314 DLSCNPELGFVDLSSNLLT 332
L+ L + L +N L
Sbjct: 155 KLT---SLKELRLYNNQLK 170
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 40/136 (29%), Positives = 58/136 (42%), Gaps = 7/136 (5%)
Query: 105 KLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQEL-SILTSLQTLILD 163
+L +L+ L + L G +L +L L + N L ++P + LT L L L
Sbjct: 83 ELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLG 141
Query: 164 ENMLAGRVPDWL-GSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD- 221
N L +P + L L L L NN +F L L+ L L NN VP+
Sbjct: 142 YNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEG 199
Query: 222 -FSGLTYLQVLDLENN 236
F L L++L L+ N
Sbjct: 200 AFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 24/93 (25%), Positives = 40/93 (43%), Gaps = 9/93 (9%)
Query: 261 SAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLT---GKLFDDLSC 317
+AIP+ + + ++LDL SN+ +A L + L + DNKL +F +L
Sbjct: 29 TAIPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELK- 85
Query: 318 NPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLY 350
L + ++ N L LP + N L
Sbjct: 86 --NLETLWVTDNKLQ-ALPIGVFDQLVNLAELR 115
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 27/158 (17%), Positives = 59/158 (37%), Gaps = 26/158 (16%)
Query: 486 GEGSQGQMYRGRLKNG----TFVAIRCLKMKKCHSTR---NFMHHIELISKLRHRHLVSA 538
GEG G + G LK VA++ +K S R F+ + H +++
Sbjct: 43 GEGEFGSVMEGNLKQEDGTSLKVAVKTMK-LDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAH---QSLTWTQRISAAIGVAKG 595
LG C E + + +I ++ G L +++ + + + + +A G
Sbjct: 102 LGVCIEM--SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 596 IQFLHTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
+++L + N L + +L ++ ++
Sbjct: 160 MEYLS--------NRNFLHRDLAARNCMLRDDMTVCVA 189
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 37/148 (25%), Positives = 65/148 (43%), Gaps = 23/148 (15%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFEC 545
G+G G+++ G T VAI+ LK S F+ +++ KLRH LV E
Sbjct: 276 GQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333
Query: 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVP 605
I+++ EY+ G+L ++ + L Q + A +A G+ ++
Sbjct: 334 -------EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVE----- 380
Query: 606 GVFSNN-----LKITDILLDQNLVAKIS 628
N L+ +IL+ +NLV K++
Sbjct: 381 ---RMNYVHRDLRAANILVGENLVCKVA 405
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 6e-12
Identities = 36/172 (20%), Positives = 64/172 (37%), Gaps = 23/172 (13%)
Query: 462 PAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFM 521
P+ E + +G G G + G+ + VAI+ +K + S F+
Sbjct: 9 PSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFI 67
Query: 522 HHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLT 581
+++ L H LV G C + IF+I EY+ NG L +++ E
Sbjct: 68 EEAKVMMNLSHEKLVQLYGVCTKQ-------RPIFIITEYMANGCLLNYLREMRHR--FQ 118
Query: 582 WTQRISAAIGVAKGIQFLHTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
Q + V + +++L S L + L++ V K+S
Sbjct: 119 TQQLLEMCKDVCEAMEYLE--------SKQFLHRDLAARNCLVNDQGVVKVS 162
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 32/187 (17%), Positives = 70/187 (37%), Gaps = 23/187 (12%)
Query: 456 LGALGLPAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNG----TFVAIRCLKM 511
L +LG+ LE++ F +G+G G + +LK VA++ LK
Sbjct: 2 LDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA 61
Query: 512 KKCHSTR--NFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRS 569
S+ F+ + + H H+ +G + +I ++ +G L +
Sbjct: 62 DIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR-AKGRLPIPMVILPFMKHGDLHA 120
Query: 570 WI---SEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNN-----LKITDILLDQ 621
++ G +L + + +A G+++L S N L + +L +
Sbjct: 121 FLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS--------SRNFIHRDLAARNCMLAE 172
Query: 622 NLVAKIS 628
++ ++
Sbjct: 173 DMTVCVA 179
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 40/166 (24%), Positives = 67/166 (40%), Gaps = 38/166 (22%)
Query: 486 GEGSQGQMYRGRLKNG------TFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSAL 539
GEG+ G+++ N VA++ LK + ++F EL++ L+H+H+V
Sbjct: 50 GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFF 109
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSW------------ISEGHAHQSLTWTQRIS 587
G C E + ++FEY+ +G L + E A L Q ++
Sbjct: 110 GVCTEG-------RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 588 AAIGVAKGIQFLHTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
A VA G+ +L + L + L+ Q LV KI
Sbjct: 163 VASQVAAGMVYLA--------GLHFVHRDLATRNCLVGQGLVVKIG 200
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 33/148 (22%), Positives = 59/148 (39%), Gaps = 23/148 (15%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFEC 545
G G G ++ G N VAI+ ++ + S +F+ E++ KL H LV G C E
Sbjct: 17 GSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVP 605
+ I L+ E++ +G L ++ + + V +G+ +L
Sbjct: 76 -------APICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE----- 121
Query: 606 GVFSNN-----LKITDILLDQNLVAKIS 628
L + L+ +N V K+S
Sbjct: 122 ---EACVIHRDLAARNCLVGENQVIKVS 146
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 39/149 (26%), Positives = 64/149 (42%), Gaps = 25/149 (16%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFEC 545
G G G + G+ K VA++ +K + S F + + KL H LV G C
Sbjct: 17 GSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC--- 72
Query: 546 YFDDSSVSRIFLIFEYVPNGTLRSWI-SEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIV 604
S I+++ EY+ NG L +++ S G L +Q + V +G+ FL
Sbjct: 73 ----SKEYPIYIVTEYISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLE---- 121
Query: 605 PGVFSNN-----LKITDILLDQNLVAKIS 628
S+ L + L+D++L K+S
Sbjct: 122 ----SHQFIHRDLAARNCLVDRDLCVKVS 146
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 30/151 (19%), Positives = 62/151 (41%), Gaps = 27/151 (17%)
Query: 486 GEGSQGQMYRGRLKNG-TFVAIRCLKMKKCHST--RNFMHHIELISKLRHRHLVSALGHC 542
G G G++Y G K VA+ K K + F+ ++ +++H +LV LG C
Sbjct: 22 GGGQYGEVYEGVWKKYSLTVAV---KTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTG 602
+ ++I E++ G L ++ E Q ++ + A ++ +++L
Sbjct: 79 -------TREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 603 IVPGVFSNN-----LKITDILLDQNLVAKIS 628
N L + L+ +N + K++
Sbjct: 129 ------KKNFIHRDLAARNCLVGENHLVKVA 153
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 41/169 (24%), Positives = 69/169 (40%), Gaps = 44/169 (26%)
Query: 486 GEGSQGQMYRGRLKNG---TFVAIRCLKMKKCHST----RNFMHHIELISKL-RHRHLVS 537
GEG+ GQ+ + R+K AI K K +++ R+F +E++ KL H ++++
Sbjct: 34 GEGNFGQVLKARIKKDGLRMDAAI---KRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW-------------ISEGHAHQSLTWTQ 584
LG C ++L EY P+G L + +L+ Q
Sbjct: 91 LLGACEHR-------GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 585 RISAAIGVAKGIQFLHTGIVPGVFSNNLKITD-----ILLDQNLVAKIS 628
+ A VA+G+ +L D IL+ +N VAKI+
Sbjct: 144 LLHFAADVARGMDYLS--------QKQFIHRDLAARNILVGENYVAKIA 184
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 31/173 (17%), Positives = 70/173 (40%), Gaps = 39/173 (22%)
Query: 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRH 534
++F+ A +G+G+ GQ+ + R + + AI+ ++ + + + L++ L H++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQY 63
Query: 535 LVSALGHCFECYFDDS----------SVSRIFLIFEYVPNGTLRSWISEGHAH----QSL 580
+V + + + S +F+ EY NGTL I + + +
Sbjct: 64 VV----RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 581 TWTQRISAAIGVAKGIQFLHTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
++I + + ++H S LK +I +D++ KI
Sbjct: 120 RLFRQI------LEALSYIH--------SQGIIHRDLKPMNIFIDESRNVKIG 158
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 31/162 (19%), Positives = 61/162 (37%), Gaps = 34/162 (20%)
Query: 486 GEGSQGQMYRGRLKNG------TFVAIRCLKMKKCHSTRN-FMHHIELISKLRHRHLVSA 538
G+GS G +Y G K T VAI+ + R F++ ++ + H+V
Sbjct: 34 GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW-------ISEGHAHQSLTWTQRISAAIG 591
LG + +I E + G L+S+ ++ + ++ I A
Sbjct: 94 LGVVSQ---GQP----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 592 VAKGIQFLHTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
+A G+ +L+ +N L + ++ ++ KI
Sbjct: 147 IADGMAYLN--------ANKFVHRDLAARNCMVAEDFTVKIG 180
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 43/207 (20%), Positives = 75/207 (36%), Gaps = 12/207 (5%)
Query: 106 LPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQEL-SILTSLQTLILDE 164
P + L+L+ L S S L ++ + +S + + L+ + + +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 165 NMLAGRVP-DWLGSLPILAVLSLRNNMFNGTLPD--SFSYLENLRVLALSNNHFYGEVPD 221
+ D L LP+L L + N PD + +L +++N + +P
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 222 --FSGLT-YLQVLDLENNALG--PQFPKVGKKLVTMILSKNKFRSAIPAEV--SSYYQLQ 274
F GL L L NN + G KL + L+KNK+ + I + Y
Sbjct: 149 NAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 275 RLDLSSNRFVGPFPQALLSLPSITYLN 301
LD+S + L L + N
Sbjct: 209 LLDVSQTSVTALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 40/231 (17%), Positives = 71/231 (30%), Gaps = 60/231 (25%)
Query: 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM 190
E ++ + IP S+ S QTL L E L ++P
Sbjct: 11 HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR--------TIP----------- 47
Query: 191 FNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVGKK 248
+FS L N+ + +S + ++ F L+ + +++ N +
Sbjct: 48 -----SHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT----------RN 92
Query: 249 LVTMILSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVG-PFPQALLSLPSITYLNIADNK 306
L + I + L+ L + + P + S L I DN
Sbjct: 93 L-----------TYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNP 141
Query: 307 ----LTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARN 353
+ F L E + L +N T + G+K V +N
Sbjct: 142 YMTSIPVNAFQGLC--NETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN 189
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 34/157 (21%), Positives = 61/157 (38%), Gaps = 34/157 (21%)
Query: 486 GEGSQGQMYRGRLKNG----TFVAIRCLKMKKCHST----RNFMHHIELISKLRHRHLVS 537
G G G +Y G L + A+ K + F+ ++ H +++S
Sbjct: 34 GRGHFGCVYHGTLLDNDGKKIHCAV---KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI-SEGHAHQSLTWTQRISAAIGVAKGI 596
LG C S ++ Y+ +G LR++I +E H + T I + VAKG+
Sbjct: 91 LLGICLR------SEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGM 141
Query: 597 QFLHTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
++L S L + +LD+ K++
Sbjct: 142 KYLA--------SKKFVHRDLAARNCMLDEKFTVKVA 170
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 35/166 (21%), Positives = 69/166 (41%), Gaps = 37/166 (22%)
Query: 477 NNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCL---KMKKCHSTRNFMHHIELISKLRH 532
+F+ +G+G G +Y R ++ +A++ L +++K +E+ S LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 533 RHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI------SEGHA----HQSLTW 582
+++ G YF D++ R++LI EY P GT+ + E +
Sbjct: 69 PNILRLYG-----YFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE---- 117
Query: 583 TQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+A + + H+ V ++K ++LL KI+
Sbjct: 118 ---------LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIA 151
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 30/156 (19%), Positives = 60/156 (38%), Gaps = 33/156 (21%)
Query: 486 GEGSQGQMYRGRLKNG-----TFVAIRCLK---MKKCHSTRNFMHHIELISKLRHRHLVS 537
G G+ G +Y+G VAI+ L+ K + + + +++ + + H+
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCR 81
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQ 597
LG C S + LI + +P G L ++ E + + ++ + +AKG+
Sbjct: 82 LLGICLT--------STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 131
Query: 598 FLHTGIVPGVFSNNLKITD-----ILLDQNLVAKIS 628
+L L D +L+ KI+
Sbjct: 132 YLE--------DRRLVHRDLAARNVLVKTPQHVKIT 159
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 33/155 (21%), Positives = 58/155 (37%), Gaps = 30/155 (19%)
Query: 486 GEGSQGQMYRGRLK----NGTFVAIRCLK---MKKCHSTRNFMHHIELISKLRHRHLVSA 538
G+GS G + RG VA++CLK + + + +F+ + + L HR+L+
Sbjct: 27 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 86
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQF 598
G + ++ E P G+L + + H A+ VA+G+ +
Sbjct: 87 YGVVLT--------PPMKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGY 136
Query: 599 LHTGIVPGVFSNNLKITD-----ILLDQNLVAKIS 628
L S D +LL + KI
Sbjct: 137 LE--------SKRFIHRDLAARNLLLATRDLVKIG 163
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 35/157 (22%), Positives = 61/157 (38%), Gaps = 34/157 (21%)
Query: 486 GEGSQGQMYRGRLKNG----TFVAIRCLKMKKCHST----RNFMHHIELISKLRHRHLVS 537
G G G +Y G L + A+ K + F+ ++ H +++S
Sbjct: 98 GRGHFGCVYHGTLLDNDGKKIHCAV---KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI-SEGHAHQSLTWTQRISAAIGVAKGI 596
LG C S ++ Y+ +G LR++I +E H + T I + VAKG+
Sbjct: 155 LLGICLR------SEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGM 205
Query: 597 QFLHTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
+FL S L + +LD+ K++
Sbjct: 206 KFLA--------SKKFVHRDLAARNCMLDEKFTVKVA 234
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 30/152 (19%), Positives = 56/152 (36%), Gaps = 27/152 (17%)
Query: 486 GEGSQGQMYRGRLKNG---TFVAIRCLKM-KKCHSTRNFMHHIELISKLRHRHLVSALGH 541
G G+ G + +G + VAI+ LK + T M +++ +L + ++V +G
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT 601
C + L+ E G L ++ + + V+ G+++L
Sbjct: 79 CQA--------EALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLE- 127
Query: 602 GIVPGVFSNN-----LKITDILLDQNLVAKIS 628
N L ++LL AKIS
Sbjct: 128 -------EKNFVHRDLAARNVLLVNRHYAKIS 152
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 31/164 (18%), Positives = 54/164 (32%), Gaps = 29/164 (17%)
Query: 146 AIPQELSILTSLQTLILDENMLAGRVPD-WLGSLPILAVLSLRNNMFNGTLPDSFSYLEN 204
IP+ + L L+ N LP L ++ NN +F
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 205 LRVLALSNNHFYGEVP--DFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSA 262
+ + L++N V F GL L+ L L +N + +
Sbjct: 83 VNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRI----------------------TC 119
Query: 263 IPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADN 305
+ + ++ L L N+ P A +L S++ LN+ N
Sbjct: 120 VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 30/111 (27%), Positives = 47/111 (42%)
Query: 105 KLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDE 164
KLP L+ + + + G S + + ++SN L + L SL+TL+L
Sbjct: 55 KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114
Query: 165 NMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHF 215
N + D L + +LSL +N P +F L +L L L N F
Sbjct: 115 NRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 25/135 (18%), Positives = 42/135 (31%), Gaps = 31/135 (22%)
Query: 204 NLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRS 261
L L+NN F F L L+ ++ NN + +
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI----------------------T 70
Query: 262 AIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLT---GKLFDDLSC 317
I + + L+SNR + L S+ L + N++T F L
Sbjct: 71 DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGL-- 128
Query: 318 NPELGFVDLSSNLLT 332
+ + L N +T
Sbjct: 129 -SSVRLLSLYDNQIT 142
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 37/167 (22%), Positives = 66/167 (39%), Gaps = 39/167 (23%)
Query: 486 GEGSQGQMYRGRLKNG------TFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSAL 539
GEG+ G+++ N VA++ LK + ++F EL++ L+H H+V
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSW-------------ISEGHAHQSLTWTQRI 586
G C + + ++FEY+ +G L + A L +Q +
Sbjct: 84 GVCGDG-------DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 587 SAAIGVAKGIQFLHTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
A +A G+ +L S + L + L+ NL+ KI
Sbjct: 137 HIASQIASGMVYLA--------SQHFVHRDLATRNCLVGANLLVKIG 175
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 29/154 (18%), Positives = 57/154 (37%), Gaps = 28/154 (18%)
Query: 486 GEGSQGQMYRGRLKNG----TFVAIRCLKMKKCHSTRN-FMHHIELISKLRHRHLVSALG 540
G+G G +Y G + AI+ L F+ L+ L H ++++ +G
Sbjct: 30 GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIG 89
Query: 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWI-SEGHAHQSLTWTQRISAAIGVAKGIQFL 599
++ Y+ +G L +I S + T IS + VA+G+++L
Sbjct: 90 IMLP------PEGLPHVLLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYL 140
Query: 600 HTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
L + +LD++ K++
Sbjct: 141 A--------EQKFVHRDLAARNCMLDESFTVKVA 166
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 28/154 (18%), Positives = 56/154 (36%), Gaps = 31/154 (20%)
Query: 486 GEGSQGQMYRGRLKNG---TFVAIRCLK---MKKCHSTRNFMHHIELISKLRHRHLVSAL 539
G G+ G + +G + VA++ LK + ++ +L + ++V +
Sbjct: 26 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMI 84
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFL 599
G C L+ E G L ++ + ++ + I V+ G+++L
Sbjct: 85 GIC--------EAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYL 133
Query: 600 HTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
+N L ++LL AKIS
Sbjct: 134 E--------ESNFVHRDLAARNVLLVTQHYAKIS 159
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 27/125 (21%), Positives = 50/125 (40%), Gaps = 18/125 (14%)
Query: 486 GEGSQGQMYRGRLKNG------TFVAIRCLKMKKCHSTRN-FMHHIELISKLRHRHLVSA 538
G G+ G++Y G++ VA++ L F+ +ISK H+++V
Sbjct: 39 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI----SEGHAHQSLTWTQRISAAIGVAK 594
+G + F++ E + G L+S++ SL + A +A
Sbjct: 99 IGVSLQS-------LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 595 GIQFL 599
G Q+L
Sbjct: 152 GCQYL 156
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 31/155 (20%)
Query: 486 GEGSQGQMYRGRLKNG----TFVAIRCLK---MKKCHSTRNFMHHIELISKLRHRHLVSA 538
G G G++ GRLK VAI+ LK +K R+F+ ++ + H +++
Sbjct: 54 GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFLGEASIMGQFDHPNIIRL 111
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQF 598
G + + ++ EY+ NG+L S++ + H Q T Q + G+A G+++
Sbjct: 112 EGVV-------TKSKPVMIVTEYMENGSLDSFLRK-HDAQ-FTVIQLVGMLRGIASGMKY 162
Query: 599 LHTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
L L +IL++ NLV K+S
Sbjct: 163 LS--------DMGYVHRDLAARNILINSNLVCKVS 189
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 27/125 (21%), Positives = 50/125 (40%), Gaps = 18/125 (14%)
Query: 486 GEGSQGQMYRGRLKNG------TFVAIRCLKMKKCHSTRN-FMHHIELISKLRHRHLVSA 538
G G+ G++Y G++ VA++ L F+ +ISK H+++V
Sbjct: 80 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 139
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI----SEGHAHQSLTWTQRISAAIGVAK 594
+G + F++ E + G L+S++ SL + A +A
Sbjct: 140 IGVSLQS-------LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 595 GIQFL 599
G Q+L
Sbjct: 193 GCQYL 197
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 27/144 (18%), Positives = 56/144 (38%), Gaps = 8/144 (5%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
GEG + L +G F A++ + + ++ H +++ + +C
Sbjct: 38 GEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLR 97
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHA-HQSLTWTQRISAAIGVAKGIQFLHTGI 603
+ + +L+ + GTL + I LT Q + +G+ +G++ +H
Sbjct: 98 ---ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-- 152
Query: 604 VPGVFSNNLKITDILLDQNLVAKI 627
G +LK T+ILL +
Sbjct: 153 -KGYAHRDLKPTNILLGDEGQPVL 175
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 36/155 (23%), Positives = 65/155 (41%), Gaps = 31/155 (20%)
Query: 486 GEGSQGQMYRGRLK----NGTFVAIRCLK---MKKCHSTRNFMHHIELISKLRHRHLVSA 538
G G G++ GRL+ VAI+ LK ++ R+F+ ++ + H +++
Sbjct: 58 GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLSEASIMGQFDHPNIIRL 115
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQF 598
G ++ EY+ NG+L +++ H Q T Q + GV G+++
Sbjct: 116 EGVVTRG-------RLAMIVTEYMENGSLDTFLRT-HDGQ-FTIMQLVGMLRGVGAGMRY 166
Query: 599 LHTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
L L ++L+D NLV K+S
Sbjct: 167 LS--------DLGYVHRDLAARNVLVDSNLVCKVS 193
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 36/162 (22%), Positives = 69/162 (42%), Gaps = 29/162 (17%)
Query: 477 NNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCL---KMKKCHSTRNFMHHIELISKLRH 532
++FD +G+G G +Y R +N +A++ L +++K IE+ S LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 533 RHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI------SEGHAHQSLTWTQRI 586
+++ YF D RI+L+ E+ P G L + E + T+ + +
Sbjct: 74 PNILRMYN-----YFHDRK--RIYLMLEFAPRGELYKELQKHGRFDEQRSA---TFMEEL 123
Query: 587 SAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+ A + + H V ++K ++L+ KI+
Sbjct: 124 ADA------LHYCHE---RKVIHRDIKPENLLMGYKGELKIA 156
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 25/122 (20%), Positives = 52/122 (42%), Gaps = 17/122 (13%)
Query: 486 GEGSQGQMYRGRLKN--------GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVS 537
G+G+ ++++G + T V ++ L + + +F ++SKL H+HLV
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVL 76
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQ 597
G C L+ E+V G+L +++ + + ++ A +A +
Sbjct: 77 NYGVCVCG-------DENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMH 127
Query: 598 FL 599
FL
Sbjct: 128 FL 129
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 36/163 (22%), Positives = 58/163 (35%), Gaps = 28/163 (17%)
Query: 146 AIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL 205
IP L ++ + L++N + P L + L NN + PD+F L +L
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82
Query: 206 RVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAI 263
L L N E+P F GL LQ+L L N + + +
Sbjct: 83 NSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKI----------------------NCL 119
Query: 264 PAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADN 305
+ + L L L N+ L +I +++A N
Sbjct: 120 RVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 27/88 (30%), Positives = 41/88 (46%), Gaps = 2/88 (2%)
Query: 129 RLSSLEILNMSSNFLNGAIPQEL-SILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLR 187
L SL L + N + +P+ L L SLQ L+L+ N + D L L +LSL
Sbjct: 78 GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLY 136
Query: 188 NNMFNGTLPDSFSYLENLRVLALSNNHF 215
+N +FS L ++ + L+ N F
Sbjct: 137 DNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 4e-10
Identities = 45/256 (17%), Positives = 81/256 (31%), Gaps = 14/256 (5%)
Query: 58 FCNTEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRL--V 115
+ P +SL + + + + + + L + + L L
Sbjct: 300 WLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVE 359
Query: 116 SLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWL 175
+ L LE N + + L L + + + L P
Sbjct: 360 KSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRA 419
Query: 176 GSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLEN 235
L + F ++RVL L++ + L + LDL +
Sbjct: 420 AYLDD------LRSKFLLENSVLKMEYADVRVLHLAHKDL-TVLCHLEQLLLVTHLDLSH 472
Query: 236 NALGPQFPKVG--KKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVG-PFPQALL 292
N L P + + L + S N + + V++ +LQ L L +NR Q L+
Sbjct: 473 NRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLV 530
Query: 293 SLPSITYLNIADNKLT 308
S P + LN+ N L
Sbjct: 531 SCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 36/194 (18%), Positives = 58/194 (29%), Gaps = 7/194 (3%)
Query: 140 SNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSF 199
++ + L L + L S L L N T+
Sbjct: 334 LKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLM 392
Query: 200 SYLENLRVLALSNNHFYG-EVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNK 258
L+ L + +F + D YL L + + + L+
Sbjct: 393 RALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
Query: 259 FRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCN 318
+ + LDLS NR P AL +L + L +DN L D ++
Sbjct: 453 LTV--LCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN--VDGVANL 507
Query: 319 PELGFVDLSSNLLT 332
P L + L +N L
Sbjct: 508 PRLQELLLCNNRLQ 521
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 42/244 (17%), Positives = 81/244 (33%), Gaps = 38/244 (15%)
Query: 400 IIGGISLVVIA---FLLVRRTKSKQTMKKTPTRLIQENAS--TGYTSKFLSDARYISQTM 454
+I G +V ++R K + + +L +T Y
Sbjct: 313 LIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIID 372
Query: 455 KLGALGLPAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNG----TFVAIRCLK 510
+ +P+ R + E + +GEG G +++G + VAI+ K
Sbjct: 373 EEDTYTMPSTR-----DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK 427
Query: 511 MKKCHSTR-NFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRS 569
S R F+ + + H H+V +G E + +++I E G LRS
Sbjct: 428 NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--------NPVWIIMELCTLGELRS 479
Query: 570 WISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNN-----LKITDILLDQNLV 624
++ L I A ++ + +L S + ++L+ N
Sbjct: 480 FLQV-RKFS-LDLASLILYAYQLSTALAYLE--------SKRFVHRDIAARNVLVSSNDC 529
Query: 625 AKIS 628
K+
Sbjct: 530 VKLG 533
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 38/168 (22%), Positives = 64/168 (38%), Gaps = 40/168 (23%)
Query: 486 GEGSQGQMYRGRLKNG------TFVAIRCLKMKKCHSTRN-FMHHIELISKLRHRHLVSA 538
GE G++Y+G L VAI+ LK K R F H L ++L+H ++V
Sbjct: 18 GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCL 77
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW-------------ISEGHAHQSLTWTQR 585
LG + D + +IF Y +G L + + +L
Sbjct: 78 LGVVTK---DQP----LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 586 ISAAIGVAKGIQFLHTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
+ +A G+++L S++ L ++L+ L KIS
Sbjct: 131 VHLVAQIAAGMEYLS--------SHHVVHKDLATRNVLVYDKLNVKIS 170
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 26/169 (15%), Positives = 64/169 (37%), Gaps = 32/169 (18%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVA---IRCLKMKKCHSTRNFMHHIELISKLRH 532
+F+ +G G G ++ + K + A IR + + M ++ ++KL H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEH 62
Query: 533 RHLVSALGHCFECYFDDSSVSR---------IFLIFEYVPNGTLRSWISEGHAHQSLTWT 583
+V F + + ++ + +++ + L+ W++ + +
Sbjct: 63 PGIV----RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 584 QRISAAIGVAKGIQFLHTGIVPGVFSNN-----LKITDILLDQNLVAKI 627
+ + +A+ ++FLH S LK ++I + V K+
Sbjct: 119 VCLHIFLQIAEAVEFLH--------SKGLMHRDLKPSNIFFTMDDVVKV 159
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 29/154 (18%), Positives = 57/154 (37%), Gaps = 29/154 (18%)
Query: 486 GEGSQGQMYRGRLKNG-----TFVAIRCLKMKKCHSTR-NFMHHIELISKLRHRHLVSAL 539
G G+ G +Y+G VAI+ L+ + +++ + + H+ L
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFL 599
G C S + LI + +P G L ++ E + + ++ + +AKG+ +L
Sbjct: 84 GICLT--------STVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYL 133
Query: 600 HTGIVPGVFSNNLKITD-----ILLDQNLVAKIS 628
L D +L+ KI+
Sbjct: 134 E--------DRRLVHRDLAARNVLVKTPQHVKIT 159
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 29/154 (18%), Positives = 58/154 (37%), Gaps = 29/154 (18%)
Query: 486 GEGSQGQMYRGRLK-----NGTFVAIRCLKMKKCHSTRN-FMHHIELISKLRHRHLVSAL 539
G G G +++G V I+ ++ K + H+ I L H H+V L
Sbjct: 22 GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLL 81
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFL 599
G C S + L+ +Y+P G+L + + L ++ + +AKG+ +L
Sbjct: 82 GLCPG--------SSLQLVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAKGMYYL 131
Query: 600 HTGIVPGVFSNNLKITD-----ILLDQNLVAKIS 628
+ + + +LL +++
Sbjct: 132 E--------EHGMVHRNLAARNVLLKSPSQVQVA 157
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 30/162 (18%), Positives = 59/162 (36%), Gaps = 31/162 (19%)
Query: 478 NFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCL---KMKKCHSTRNFMHHIELISKLRHR 533
+ F+G+G + + A + + + K H I + L H+
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 534 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLT-------WTQRI 586
H+V F +F+D+ +F++ E +L ++LT Q +
Sbjct: 102 HVVG-----FHGFFEDND--FVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIV 151
Query: 587 SAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
Q+LH V +LK+ ++ L+++L KI
Sbjct: 152 LG-------CQYLHR---NRVIHRDLKLGNLFLNEDLEVKIG 183
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 6e-10
Identities = 31/155 (20%), Positives = 55/155 (35%), Gaps = 32/155 (20%)
Query: 486 GEGSQGQMYRGRLKNG----TFVAIRCLK---MKKCHSTRNFMHHIELISKLRHRHLVSA 538
GEG G++Y G N VA++ K + FM ++ L H H+V
Sbjct: 21 GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVIMKNLDHPHIVKL 78
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQF 598
+G ++I E P G L ++ SL + ++ + K + +
Sbjct: 79 IGII--------EEEPTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAY 128
Query: 599 LHTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
L S N + + +IL+ K+
Sbjct: 129 LE--------SINCVHRDIAVRNILVASPECVKLG 155
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 6e-10
Identities = 60/306 (19%), Positives = 89/306 (29%), Gaps = 58/306 (18%)
Query: 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGL----WGPLSGKISR 129
I L I S + L L +V+RL GL +S +
Sbjct: 3 LDIQSLDIQCE--------ELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRV 54
Query: 130 LSSLEILNMSSNFLNGAIPQELSIL-----TSLQTLILDENML----AGRVPDWLGSLPI 180
+L LN+ SN L + +Q L L L G + L +LP
Sbjct: 55 NPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPT 114
Query: 181 LAVLSLRNNMFNGT--------LPDSFSYLENLRVLALSNNHFYGE-----VPDFSGLTY 227
L L L +N+ L D LE L+ L
Sbjct: 115 LQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQ---LEYCSLSAASCEPLASVLRAKPD 171
Query: 228 LQVLDLENNALGPQ--------FPKVGKKLVTMILSKNKFR----SAIPAEVSSYYQLQR 275
+ L + NN + +L + L + V+S L+
Sbjct: 172 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRE 231
Query: 276 LDLSSNRF----VGPFPQALL-SLPSITYLNIADNKLTGK----LFDDLSCNPELGFVDL 326
L L SN+ + LL + L I + +T K L L L + L
Sbjct: 232 LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSL 291
Query: 327 SSNLLT 332
+ N L
Sbjct: 292 AGNELG 297
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 40/241 (16%), Positives = 73/241 (30%), Gaps = 40/241 (16%)
Query: 132 SLEILNMSSNFLN----GAIPQELSILTSLQTLILDENMLAGR-----VPDWLGSLPILA 182
LE L + S + + ++ SL+ L L N L P L L
Sbjct: 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 259
Query: 183 VLSLRNNMFN----GTLPDSFSYLENLRVLALSNNHFYGE-VPDFSGL-----TYLQVLD 232
L + G L E+L+ L+L+ N E L+ L
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW 319
Query: 233 LENNALGPQF-------PKVGKKLVTMILSKNKFRSA-----IPAEVSSYYQLQRLDLSS 280
+++ + + L+ + +S N+ A L+ L L+
Sbjct: 320 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 379
Query: 281 NRF----VGPFPQALLSLPSITYLNIADNKLTGK----LFDDL-SCNPELGFVDLSSNLL 331
LL+ S+ L++++N L L + + L + L
Sbjct: 380 CDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
Query: 332 T 332
+
Sbjct: 440 S 440
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 24/87 (27%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 484 FMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHC 542
+G+G+ G +Y GR L N +AI+ + + ++ I L L+H+++V LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-- 86
Query: 543 FECYFDDSSVSRIFLIFEYVPNGTLRS 569
+ ++ + IF+ E VP G+L +
Sbjct: 87 --SFSENGFIK-IFM--EQVPGGSLSA 108
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 30/152 (19%), Positives = 56/152 (36%), Gaps = 27/152 (17%)
Query: 486 GEGSQGQMYRGRLKNG---TFVAIRCLKM-KKCHSTRNFMHHIELISKLRHRHLVSALGH 541
G G+ G + +G + VAI+ LK + T M +++ +L + ++V +G
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT 601
C + L+ E G L ++ + + V+ G+++L
Sbjct: 405 C--------QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLE- 453
Query: 602 GIVPGVFSNN-----LKITDILLDQNLVAKIS 628
N L ++LL AKIS
Sbjct: 454 -------EKNFVHRNLAARNVLLVNRHYAKIS 478
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 1e-09
Identities = 30/162 (18%), Positives = 59/162 (36%), Gaps = 31/162 (19%)
Query: 478 NFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCL---KMKKCHSTRNFMHHIELISKLRHR 533
+ F+G+G + + A + + + K H I + L H+
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 534 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLT-------WTQRI 586
H+V F +F+D+ +F++ E +L ++LT Q +
Sbjct: 76 HVVG-----FHGFFEDND--FVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIV 125
Query: 587 SAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
Q+LH V +LK+ ++ L+++L KI
Sbjct: 126 LG-------CQYLHR---NRVIHRDLKLGNLFLNEDLEVKIG 157
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 1e-09
Identities = 37/167 (22%), Positives = 74/167 (44%), Gaps = 38/167 (22%)
Query: 477 NNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCL---KMKKCHSTRNFMHHIELISKLRH 532
+F +G+GS +YR + G VAI+ + M K + + +++ +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 533 RHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI-------SEGHA----HQSLT 581
++ YF+DS+ ++L+ E NG + ++ SE A HQ
Sbjct: 71 PSILE-----LYNYFEDSN--YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ--- 120
Query: 582 WTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+ G+ +LH+ G+ +L ++++LL +N+ KI+
Sbjct: 121 ----------IITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIA 154
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 32/153 (20%), Positives = 57/153 (37%), Gaps = 28/153 (18%)
Query: 486 GEGSQGQMYRGRLKNG----TFVAIRCLKMKKCHSTR-NFMHHIELISKLRHRHLVSALG 540
GEG G +++G + VAI+ K S R F+ + + H H+V +G
Sbjct: 24 GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 83
Query: 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH 600
E + +++I E G LRS++ SL I A ++ + +L
Sbjct: 84 VITE--------NPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLE 133
Query: 601 TGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
S + ++L+ N K+
Sbjct: 134 --------SKRFVHRDIAARNVLVSSNDCVKLG 158
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 35/178 (19%), Positives = 65/178 (36%), Gaps = 52/178 (29%)
Query: 486 GEGSQGQMYRGRLKNG------TFVAIRCLKMKKCHSTRN-FMHHIELISKLRHRHLVSA 538
GEG+ G++++ R T VA++ LK + + F L+++ + ++V
Sbjct: 56 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKL 115
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW---------------------ISEGHAH 577
LG C + L+FEY+ G L +
Sbjct: 116 LGVCAV---GKP----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 578 QSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKIT--D-----ILLDQNLVAKIS 628
L+ +++ A VA G+ +L + K D L+ +N+V KI+
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYL----------SERKFVHRDLATRNCLVGENMVVKIA 216
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 41/192 (21%), Positives = 68/192 (35%), Gaps = 13/192 (6%)
Query: 127 ISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186
++ L +L L + N + L L L++L L+ N + + L LP L L L
Sbjct: 86 LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYL 141
Query: 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALG--PQFPK 244
NN T S L L L+L +N ++ +GLT LQ L L N +
Sbjct: 142 GNN--KITDITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHISDLRALAG 198
Query: 245 VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFP---QALLSLPSITYLN 301
+ K L + L + + S+ + + V P P++ +
Sbjct: 199 L-KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHL 257
Query: 302 IADNKLTGKLFD 313
+F
Sbjct: 258 PEFTNEVSFIFY 269
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 23/155 (14%), Positives = 49/155 (31%), Gaps = 10/155 (6%)
Query: 179 PILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNAL 238
P+ + D L + + L + + N+ +
Sbjct: 2 PLGSETITVPTPIKQIFSDD--AFAETIKDNLKKKSV-TDAVTQNELNSIDQIIANNSDI 58
Query: 239 GPQFP-KVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSI 297
+ + + L+ NK P +++ L L L N+ L L +
Sbjct: 59 KSVQGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS--LKDLKKL 114
Query: 298 TYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT 332
L++ N ++ + L P+L + L +N +T
Sbjct: 115 KSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT 147
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 39/174 (22%), Positives = 62/174 (35%), Gaps = 50/174 (28%)
Query: 486 GEGSQGQMYRGRLKN------GTFVAIRCLKMKKCHST----RNFMHHIELISKL-RHRH 534
G G+ GQ+ VA+ KM K +T R M ++++ + H +
Sbjct: 36 GRGAFGQVIEADAFGIDKTATCRTVAV---KMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 535 LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW-------------ISEGHAHQSLT 581
+V+ LG C + + +I E+ G L ++ E LT
Sbjct: 93 VVNLLGACTK------PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 582 WTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKIT--D-----ILLDQNLVAKIS 628
I + VAKG++FL + K D ILL + V KI
Sbjct: 147 LEHLICYSFQVAKGMEFL----------ASRKCIHRDLAARNILLSEKNVVKIC 190
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 35/167 (20%), Positives = 63/167 (37%), Gaps = 39/167 (23%)
Query: 486 GEGSQGQMYRGRLK------NGTFVAIRCLKMKKCHSTRN-FMHHIELISKL-RHRHLVS 537
G G+ G++ VA++ LK + M ++++S L +H ++V+
Sbjct: 55 GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 114
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW-----------ISEGHAHQSLTWTQRI 586
LG C + + +I EY G L ++ + A+ + + +
Sbjct: 115 LLGAC-------THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 587 SAAIGVAKGIQFLHTGIVPGVFSNNLKITD-----ILLDQNLVAKIS 628
+ VA+G+ FL S N D +LL VAKI
Sbjct: 168 HFSSQVAQGMAFLA--------SKNCIHRDVAARNVLLTNGHVAKIG 206
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 38/154 (24%), Positives = 68/154 (44%), Gaps = 28/154 (18%)
Query: 486 GEGSQGQMYRGRLKNGTF-----VAIRCLKMKKCHSTR-NFMHHIELISKLRHRHLVSAL 539
G G G++Y+G LK + VAI+ LK R +F+ ++ + H +++
Sbjct: 53 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLE 112
Query: 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFL 599
G S + +I EY+ NG L ++ E + + Q + G+A G+++L
Sbjct: 113 GVI-------SKYKPMMIITEYMENGALDKFLRE-KDGE-FSVLQLVGMLRGIAAGMKYL 163
Query: 600 HTGIVPGVFSNN-----LKITDILLDQNLVAKIS 628
+ N L +IL++ NLV K+S
Sbjct: 164 A--------NMNYVHRDLAARNILVNSNLVCKVS 189
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 23/166 (13%), Positives = 61/166 (36%), Gaps = 34/166 (20%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHH-----------------IELIS 528
+G ++ K+ F A++ + R+F +++I+
Sbjct: 40 NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 529 KLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISA 588
+++ + + C + +++I+EY+ N ++ + +T I
Sbjct: 99 DIKNEYCL----TCEG-IITNYD--EVYIIYEYMENDSILKFDEY-FFVLDKNYTCFIPI 150
Query: 589 AIG------VAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+ V ++H + ++K ++IL+D+N K+S
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLS 194
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 37/181 (20%), Positives = 69/181 (38%), Gaps = 58/181 (32%)
Query: 486 GEGSQGQMYRGRLKNG------TFVAIRCLKMKKCHST----RNFMHHIELISKLRHRHL 535
GEG G++ + + T VA+ KM K +++ R+ + ++ ++ H H+
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAV---KMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 536 VSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW---------------------ISEG 574
+ G C + + LI EY G+LR + +
Sbjct: 89 IKLYGACSQD-------GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 575 HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKIT--D-----ILLDQNLVAKI 627
++LT IS A +++G+Q+L +K+ D IL+ + KI
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYL----------AEMKLVHRDLAARNILVAEGRKMKI 191
Query: 628 S 628
S
Sbjct: 192 S 192
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 23/95 (24%), Positives = 33/95 (34%), Gaps = 3/95 (3%)
Query: 146 AIPQELSILTSLQTLILDENMLAGRVPDW-LGSLPILAVLSLRNNMFNGTLPDSFSYLEN 204
L +L L ++ + L L L L++ + PD+F +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 205 LRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNAL 238
L L LS N GL+ LQ L L N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 8e-06
Identities = 22/117 (18%), Positives = 34/117 (29%), Gaps = 29/117 (24%)
Query: 220 PDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEV-SSYYQLQRLDL 278
G L L +EN + + +L+ L +
Sbjct: 25 HHLPGAENLTELYIENQ--------------------QHLQH-LELRDLRGLGELRNLTI 63
Query: 279 SSNRFVGPFPQALLSLPSITYLNIADNKLT---GKLFDDLSCNPELGFVDLSSNLLT 332
+ P A P ++ LN++ N L K LS L + LS N L
Sbjct: 64 VKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS----LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 17/90 (18%), Positives = 29/90 (32%), Gaps = 1/90 (1%)
Query: 262 AIPAEVSSYYQLQRLDLSSNRFVGPFP-QALLSLPSITYLNIADNKLTGKLFDDLSCNPE 320
+ L L + + + + + L L + L I + L D P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 321 LGFVDLSSNLLTGQLPNCLLAGSKNRVVLY 350
L ++LS N L + S +VL
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLSLQELVLS 111
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 44/166 (26%), Positives = 60/166 (36%), Gaps = 10/166 (6%)
Query: 146 AIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL 205
++P I + L L LA L L L+L N F L L
Sbjct: 28 SVPSG--IPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85
Query: 206 RVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVGKKLV---TMILSKNKFR 260
L L+NN +P F LT L L L N L V +L + L+ N+ +
Sbjct: 86 GTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ 144
Query: 261 SAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADN 305
S IPA LQ L LS+N+ A L + + + N
Sbjct: 145 S-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 35/176 (19%), Positives = 70/176 (39%), Gaps = 53/176 (30%)
Query: 486 GEGSQGQMYRGRL--------KNGTFVAIRCLKMKKCHST----RNFMHHIELISKL-RH 532
GEG+ GQ+ K VA+ KM K +T + + +E++ + +H
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAV---KMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 533 RHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW-------------ISEGHAHQS 579
+++++ LG C + +++I EY G LR + +
Sbjct: 101 KNIINLLGACTQD-------GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 580 LTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKIT--D-----ILLDQNLVAKIS 628
+T+ +S +A+G+++L + K D +L+ +N V KI+
Sbjct: 154 MTFKDLVSCTYQLARGMEYL----------ASQKCIHRDLAARNVLVTENNVMKIA 199
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 24/144 (16%), Positives = 55/144 (38%), Gaps = 3/144 (2%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRHLVSALGHCF 543
EG +Y + + +G A++ L + R + + + KL H ++V
Sbjct: 37 AEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI 603
+ + FL+ + G L ++ + + L+ + + +Q +H
Sbjct: 97 IGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-Q 155
Query: 604 VPGVFSNNLKITDILLDQNLVAKI 627
P + +LK+ ++LL K+
Sbjct: 156 KPPIIHRDLKVENLLLSNQGTIKL 179
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 34/173 (19%), Positives = 68/173 (39%), Gaps = 47/173 (27%)
Query: 486 GEGSQGQMYRGRL--------KNGTFVAIRCLKMKKCHSTRN-FMHHIELISKL-RHRHL 535
GEG GQ+ K VA++ LK + + +E++ + +H+++
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 536 VSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRS-------------WISEGHAHQSLTW 582
++ LG C + D +++I EY G LR + + +T+
Sbjct: 150 INLLGACTQ---DGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 583 TQRISAAIGVAKGIQFLHTGIVPGVFSNNLKIT--D-----ILLDQNLVAKIS 628
+S +A+G+++L + K D +L+ +N V KI+
Sbjct: 203 KDLVSCTYQLARGMEYL----------ASQKCIHRDLAARNVLVTENNVMKIA 245
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 29/111 (26%), Positives = 39/111 (35%), Gaps = 6/111 (5%)
Query: 128 SRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLR 187
S + L + N SN G + L+ L L + + L L L L L
Sbjct: 17 SDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 188 NNMFNGTLPDSFSYLENLRVLALSNNHF--YGEVPDFSGLTYLQVLDLENN 236
+N +G L NL L LS N + L L+ LDL N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-06
Identities = 26/91 (28%), Positives = 38/91 (41%), Gaps = 5/91 (5%)
Query: 125 GKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVL 184
G LE L+ + L +I L L L+ L L +N ++G + P L L
Sbjct: 36 GLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93
Query: 185 SLRNNMFN--GTLPDSFSYLENLRVLALSNN 213
+L N T+ + LENL+ L L N
Sbjct: 94 NLSGNKIKDLSTI-EPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 20/88 (22%), Positives = 39/88 (44%), Gaps = 3/88 (3%)
Query: 103 LVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLIL 162
+ +L+ L +++GL ++ + +L+ L+ L +S N ++G + +L L L
Sbjct: 38 TDEFEELEFLSTINVGL-TSIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95
Query: 163 DENMLAG-RVPDWLGSLPILAVLSLRNN 189
N + + L L L L L N
Sbjct: 96 SGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 33/147 (22%), Positives = 56/147 (38%), Gaps = 21/147 (14%)
Query: 486 GEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTR-NFMHHIELISKLRHRHLVSALGHCF 543
G+G+ ++RGR K G AI+ M E++ KL H+++V F
Sbjct: 18 GQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL----F 73
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT-G 602
+ ++ LI E+ P G+L + + E L ++ + V G+ L G
Sbjct: 74 AIEEETTT-RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 603 IV-------------PGVFSNNLKITD 616
IV + K+TD
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTD 159
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 38/181 (20%), Positives = 63/181 (34%), Gaps = 58/181 (32%)
Query: 486 GEGSQGQMYRGRLKNG------TFVAIRCLKM-KKCHSTR---NFMHHIELISKL-RHRH 534
G G+ G++ VA+ KM K+ + M ++++++L H +
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAV---KMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 535 LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW--------------------ISEG 574
+V+ LG C I+LIFEY G L ++ + E
Sbjct: 111 IVNLLGACTL---SGP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 575 HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKIT--D-----ILLDQNLVAKI 627
LT+ + A VAKG++FL D +L+ V KI
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFL----------EFKSCVHRDLAARNVLVTHGKVVKI 213
Query: 628 S 628
Sbjct: 214 C 214
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 28/119 (23%), Positives = 51/119 (42%), Gaps = 9/119 (7%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHST--RNFMHHIELISKLRHRHLVSALGHC 542
G GS +Y+G + VA L+ +K + + F E++ L+H ++V
Sbjct: 35 GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSW 94
Query: 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT 601
I L+ E + +GTL++++ + + S + KG+QFLHT
Sbjct: 95 ESTVKGKK---CIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT 147
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 35/173 (20%), Positives = 58/173 (33%), Gaps = 47/173 (27%)
Query: 486 GEGSQGQMYRGRLKN------GTFVAIRCLKMKKCHSTRN-FMHHIELISKL-RHRHLVS 537
G G+ G++ VA++ LK + R M ++++S L H ++V+
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW---------------ISEGHAHQSLTW 582
LG C + +I EY G L ++ +L
Sbjct: 92 LLGAC-------TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 583 TQRISAAIGVAKGIQFLHTGIVPGVFSNNLKIT--D-----ILLDQNLVAKIS 628
+S + VAKG+ FL + D ILL + KI
Sbjct: 145 EDLLSFSYQVAKGMAFL----------ASKNCIHRDLAARNILLTHGRITKIC 187
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 34/171 (19%), Positives = 68/171 (39%), Gaps = 43/171 (25%)
Query: 486 GEGSQGQMYRGRLKN--------GTFVAIRCLKMKKCHSTRN-FMHHIELISKL-RHRHL 535
GEG+ GQ+ T VA++ LK + + +E++ + +H+++
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137
Query: 536 VSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW-------------ISEGHAHQSLTW 582
++ LG C + +++I EY G LR + + + L+
Sbjct: 138 INLLGACTQD-------GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 583 TQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITD-----ILLDQNLVAKIS 628
+S A VA+G+++L S D +L+ ++ V KI+
Sbjct: 191 KDLVSCAYQVARGMEYLA--------SKKCIHRDLAARNVLVTEDNVMKIA 233
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 32/149 (21%), Positives = 60/149 (40%), Gaps = 11/149 (7%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTR-NFMHHIELISKLRHRHLVSALGHCF 543
G G G + R G VAI+ + + R + I+++ KL H ++V +
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV-SAREVP 81
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT-G 602
+ + L EY G LR ++++ L + ++ +++LH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 603 IVPGVFSNNLKITDILLD---QNLVAKIS 628
I+ +LK +I+L Q L+ KI
Sbjct: 142 IIH----RDLKPENIVLQPGPQRLIHKII 166
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 49/266 (18%), Positives = 85/266 (31%), Gaps = 56/266 (21%)
Query: 122 PLSGKISRLSSLEILNMSSNFLNG----AIPQELSILTSLQTLILDENMLAGRVPDW--- 174
+ + S++ + +S N + + + ++ L+ + GRV D
Sbjct: 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT-GRVKDEIPE 81
Query: 175 --------LGSLPILAVLSLRNNMFNGT----LPDSFSYLENLRVLALSNNHF------- 215
L P L + L +N F T L D S L L L NN
Sbjct: 82 ALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAK 141
Query: 216 -------YGEVPDFSGLTYLQVLDLENNALGP-------QFPKVGKKLVTMILSKNKFRS 261
L+ + N L + + + L T+ + +N R
Sbjct: 142 IARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 201
Query: 262 -----AIPAEVSSYYQLQRLDLSSNRF----VGPFPQALLSLPSITYLNIADNKLTGK-- 310
+ ++ +L+ LDL N F AL S P++ L + D L+ +
Sbjct: 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 261
Query: 311 --LFDDLSC--NPELGFVDLSSNLLT 332
+ D S N L + L N +
Sbjct: 262 AAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 7e-08
Identities = 33/111 (29%), Positives = 43/111 (38%), Gaps = 6/111 (5%)
Query: 128 SRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLR 187
+ + L + N SN +G I + +L+ L L L V + L LP L L L
Sbjct: 24 AAVRELVLDNCKSN--DGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 188 NNMFNGTLPDSFSYLENLRVLALSNNHF--YGEVPDFSGLTYLQVLDLENN 236
N G L L NL L LS N + L L+ LDL N
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 7e-06
Identities = 30/111 (27%), Positives = 45/111 (40%), Gaps = 6/111 (5%)
Query: 106 LPDLKVLRLVSLGL-WGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDE 164
++ L L + G + G + +LE L++ + L L L L+ L L E
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSE 80
Query: 165 NMLAGRVPDWLGSLPILAVLSLRNNMFN--GTLPDSFSYLENLRVLALSNN 213
N + G + LP L L+L N TL + LE L+ L L N
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 33/147 (22%), Positives = 56/147 (38%), Gaps = 21/147 (14%)
Query: 486 GEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCF 543
G+G+ ++RGR K G AI+ M E++ KL H+++V F
Sbjct: 18 GQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL----F 73
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT-G 602
+ ++ LI E+ P G+L + + E L ++ + V G+ L G
Sbjct: 74 AIEEETTT-RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 603 IV-------------PGVFSNNLKITD 616
IV + K+TD
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTD 159
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 33/175 (18%), Positives = 61/175 (34%), Gaps = 46/175 (26%)
Query: 477 NNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHL 535
+F +G G GQ+++ + +G I+ +K ++ ++KL H ++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 536 VSALGHCFECYFDDSSVS-------------RIFLIFEYVPNGTLRSWISEGHAH----- 577
V H C+ +F+ E+ GTL WI +
Sbjct: 67 V----HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 578 QSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNN-----LKITDILLDQNLVAKI 627
+L ++I KG+ ++H S LK ++I L KI
Sbjct: 123 LALELFEQI------TKGVDYIH--------SKKLINRDLKPSNIFLVDTKQVKI 163
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 24/155 (15%), Positives = 60/155 (38%), Gaps = 35/155 (22%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRH--RHLVSALGH 541
G G ++++ + AI+ + +++ + ++ + I ++KL+ ++
Sbjct: 37 GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD- 95
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLT-------WTQRISAAIGVAK 594
Y I+++ E N L SW+ + +S+ W + +
Sbjct: 96 ----YEITD--QYIYMVMECG-NIDLNSWLKK---KKSIDPWERKSYWKN-------MLE 138
Query: 595 GIQFLHT-GIVPGVFSNNLKITDILLDQNLVAKIS 628
+ +H GIV +LK + L+ ++ K+
Sbjct: 139 AVHTIHQHGIVHS----DLKPANFLIVDGML-KLI 168
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 24/155 (15%), Positives = 59/155 (38%), Gaps = 35/155 (22%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRH--RHLVSALGH 541
G G ++++ + AI+ + +++ + ++ + I ++KL+ ++
Sbjct: 18 GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD- 76
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLT-------WTQRISAAIGVAK 594
Y I+++ E N L SW+ +S+ W + +
Sbjct: 77 ----YEITD--QYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKN-------MLE 119
Query: 595 GIQFLHT-GIVPGVFSNNLKITDILLDQNLVAKIS 628
+ +H GIV +LK + L+ ++ K+
Sbjct: 120 AVHTIHQHGIVHS----DLKPANFLIVDGML-KLI 149
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 22/109 (20%), Positives = 36/109 (33%), Gaps = 5/109 (4%)
Query: 130 LSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189
L++ + I + L + +N + R D L L L + NN
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNN 74
Query: 190 MFNGTLPDSFSYLENLRVLALSNNHF--YGEVPDFSGLTYLQVLDLENN 236
L +L L L+NN G++ + L L L + N
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-07
Identities = 29/131 (22%), Positives = 51/131 (38%), Gaps = 14/131 (10%)
Query: 89 MLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKI----SRLSSLEILNMSSNFLN 144
M+ L+ + + + + R L L G I + L + ++ S N +
Sbjct: 1 MVKLTAEL---IEQAAQYTNAVRDR--ELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR 55
Query: 145 GAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFN--GTLPDSFSYL 202
+L L+TL+++ N + +LP L L L NN G L D + L
Sbjct: 56 KL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASL 112
Query: 203 ENLRVLALSNN 213
++L L + N
Sbjct: 113 KSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 23/138 (16%), Positives = 45/138 (32%), Gaps = 32/138 (23%)
Query: 197 DSFSYLENLRVLALSNNHFYGEVPDFSGL----TYLQVLDLENNALGPQFPKVGKKLVTM 252
++ R L L ++P L +D +N + +KL
Sbjct: 13 AQYTNAVRDRELDLRGY----KIPVIENLGATLDQFDAIDFSDNEI--------RKLDG- 59
Query: 253 ILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG-KL 311
+ +L+ L +++NR +LP +T L + +N L
Sbjct: 60 -FPLLR-------------RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD 105
Query: 312 FDDLSCNPELGFVDLSSN 329
D L+ L ++ + N
Sbjct: 106 LDPLASLKSLTYLCILRN 123
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 25/155 (16%), Positives = 59/155 (38%), Gaps = 35/155 (22%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRH--RHLVSALGH 541
G G ++++ + AI+ + +++ + ++ + I ++KL+ ++
Sbjct: 65 GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD- 123
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLT-------WTQRISAAIGVAK 594
Y I+++ E N L SW+ +S+ W + A
Sbjct: 124 ----YEITD--QYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEA------ 167
Query: 595 GIQFLHT-GIVPGVFSNNLKITDILLDQNLVAKIS 628
+ +H GIV +LK + L+ ++ K+
Sbjct: 168 -VHTIHQHGIVHS----DLKPANFLIVDGML-KLI 196
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 34/184 (18%), Positives = 60/184 (32%), Gaps = 37/184 (20%)
Query: 127 ISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186
LS ++ N ++ + + T+L+ L L N + L L L LS+
Sbjct: 37 QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSHNQI--SDLSPLKDLTKLEELSV 92
Query: 187 RNNMFNGTLPDSFSYLE--NLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPK 244
N + + + L L L NN + L L++L + NN L
Sbjct: 93 NRNRLK-----NLNGIPSACLSRLFLDNNELR-DTDSLIHLKNLEILSIRNNKL------ 140
Query: 245 VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIAD 304
+I + +L+ LDL N L L + ++++
Sbjct: 141 ----------------KSIVM-LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTG 181
Query: 305 NKLT 308
K
Sbjct: 182 QKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 26/137 (18%), Positives = 50/137 (36%), Gaps = 15/137 (10%)
Query: 200 SYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNAL----GPQFPKVGKKLVTMILS 255
L N L ++ L+ +Q + +N+ + G QF L + LS
Sbjct: 16 PGLANAVKQNLGKQSV-TDLVSQKELSGVQNFNGDNSNIQSLAGMQFF---TNLKELHLS 71
Query: 256 KNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDL 315
N+ P + +L+ L ++ NR + ++ L + +N+L D L
Sbjct: 72 HNQISDLSP--LKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFLDNNELRD--TDSL 124
Query: 316 SCNPELGFVDLSSNLLT 332
L + + +N L
Sbjct: 125 IHLKNLEILSIRNNKLK 141
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 45/194 (23%), Positives = 73/194 (37%), Gaps = 32/194 (16%)
Query: 153 ILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSN 212
L + + L + + N+ ++ YL N+R LAL
Sbjct: 17 AFAETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGG 72
Query: 213 NHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLV---TMILSKNKFRSAIPAEV-S 268
N ++ LT L L L N L V KL ++L +N+ +S +P V
Sbjct: 73 NKL-HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-LPDGVFD 130
Query: 269 SYYQLQRLDLSSNRFVGPFPQALLSLPS--------ITYLNIADNKLT---GKLFDDLSC 317
L L+L+ N+ L SLP +T L+++ N+L +FD L+
Sbjct: 131 KLTNLTYLNLAHNQ--------LQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLT- 181
Query: 318 NPELGFVDLSSNLL 331
+L + L N L
Sbjct: 182 --QLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 47/190 (24%), Positives = 74/190 (38%), Gaps = 30/190 (15%)
Query: 132 SLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMF 191
N+ + A+ Q L S+ +I + + + + LP + L+L N
Sbjct: 20 ETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKL 75
Query: 192 NGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVGKKL 249
+ + + L NL L L+ N +P+ F LT L+ L L N L V KL
Sbjct: 76 H-DIS-ALKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKL 132
Query: 250 VTMI---LSKNKFRSAIPAEV-SSYYQLQRLDLSSNRFVGPFPQALLSLP--------SI 297
+ L+ N+ +S +P V L LDLS N+ L SLP +
Sbjct: 133 TNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQ--------LQSLPEGVFDKLTQL 183
Query: 298 TYLNIADNKL 307
L + N+L
Sbjct: 184 KDLRLYQNQL 193
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 31/118 (26%), Positives = 52/118 (44%), Gaps = 11/118 (9%)
Query: 123 LSGKISRLSSLEILNMSSNFLNGAIPQ--ELSILTSLQTLILDENMLAGRVPDWLGSLPI 180
+ +S L + + L +S+N I + LS + +L+ L L N++ ++ +
Sbjct: 40 MDATLSTLKACKHLALSTN----NIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADT 94
Query: 181 LAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHF--YGEVPDFSGLTYLQVLDLENN 236
L L + N L NLRVL +SNN +GE+ + L L+ L L N
Sbjct: 95 LEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 28/119 (23%), Positives = 51/119 (42%), Gaps = 6/119 (5%)
Query: 195 LPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALG--PQFPKVGKKLVTM 252
+ + S L+ + LALS N+ ++ SG+ L++L L N + V L +
Sbjct: 40 MDATLSTLKACKHLALSTNNI-EKISSLSGMENLRILSLGRNLIKKIENLDAVADTLEEL 98
Query: 253 ILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFP-QALLSLPSITYLNIADNKLTGK 310
+S N+ S + + L+ L +S+N+ L +L + L +A N L
Sbjct: 99 WISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 25/113 (22%), Positives = 43/113 (38%), Gaps = 6/113 (5%)
Query: 124 SGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAV 183
S + +E+ M + LS L + + L L N + L + L +
Sbjct: 19 SVVATEAEKVELHGMIPPIEK--MDATLSTLKACKHLALSTNNI--EKISSLSGMENLRI 74
Query: 184 LSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENN 236
LSL N+ + + + + L L +S N + L L+VL + NN
Sbjct: 75 LSLGRNLIK-KIENLDAVADTLEELWISYNQI-ASLSGIEKLVNLRVLYMSNN 125
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 27/139 (19%), Positives = 54/139 (38%), Gaps = 23/139 (16%)
Query: 471 ELEEATNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISK 529
E E + +G GS G+++R + + G A+ KK + + +
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAV-----KKVRLEVFRVEELVACAG 106
Query: 530 LRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHA---HQSLTWTQRI 586
L +V G + V+ IF+ E + G+L I + ++L + +
Sbjct: 107 LSSPRIVPLYG----AVREGPWVN-IFM--ELLEGGSLGQLIKQMGCLPEDRALYYLGQA 159
Query: 587 SAAIGVAKGIQFLHT-GIV 604
+G+++LHT I+
Sbjct: 160 ------LEGLEYLHTRRIL 172
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (117), Expect = 2e-06
Identities = 31/232 (13%), Positives = 69/232 (29%), Gaps = 34/232 (14%)
Query: 137 NMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM------ 190
+ + I + + L + + W+ + + VL +
Sbjct: 121 GEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIK 180
Query: 191 FNGTLPDSFSYLENLRVLALSNNHFYGEVP------DFSGLTYLQVLDLENNALGPQFPK 244
L NL+ L + + V D L L + +
Sbjct: 181 GTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFD---- 236
Query: 245 VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLS---LPSITYLN 301
+ + SK++F + L+ L + + L LP + ++
Sbjct: 237 GDMNVFRPLFSKDRFPN-----------LKWLGIVDAEEQNVVVEMFLESDILPQLETMD 285
Query: 302 IADNKLTGK----LFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVL 349
I+ LT + L D + L F+++ N L+ ++ L ++ +
Sbjct: 286 ISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDV 337
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 38/128 (29%), Positives = 52/128 (40%), Gaps = 7/128 (5%)
Query: 183 VLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGP 240
+L L +N P F L NL+ L L +N G +P F LT L VLDL N L
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 241 QFPKVGKKLV---TMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSI 297
V +LV + + NK +P + L L L N+ A L S+
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161
Query: 298 TYLNIADN 305
T+ + N
Sbjct: 162 THAYLFGN 169
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 3e-06
Identities = 91/644 (14%), Positives = 169/644 (26%), Gaps = 234/644 (36%)
Query: 100 VTTLVKLPD--LKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELS-ILTS 156
+ ++ D LRL W E++ F+ + +++
Sbjct: 51 IDHIIMSKDAVSGTLRL----FW------TLLSKQEEMVQK---FVEEVLRINYKFLMSP 97
Query: 157 LQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLR---VLALSNN 213
++T E R P S+ + R+ ++N F+ R L L
Sbjct: 98 IKT----EQ----RQP----SMMTRMYIEQRDRLYND--NQVFAKYNVSRLQPYLKLRQA 143
Query: 214 HFYGEVPDFSGLTYLQVLDLENNA-----LGPQFPKVGKK-LVTMILSKNKFRSAIPAEV 267
L L N LG GK + + K + + ++
Sbjct: 144 --------------LLELRPAKNVLIDGVLG-----SGKTWVALDVCLSYKVQCKMDFKI 184
Query: 268 SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLS 327
++ L+L + + L L I N + D S N +L +
Sbjct: 185 --FW----LNLKNCNSPETVLEMLQKL----LYQIDPNWTSR---SDHSSNIKLRIHSIQ 231
Query: 328 ---SNLLTG-QLPNCLL----AGSKN---------RVVLYARNC-----LAAGNE----- 360
LL NCLL + +++L R L+A
Sbjct: 232 AELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISL 291
Query: 361 NQHPLSFCQNEALA-----VGI----LPLQKKQKQVSKAVLALSIIGGIIGGISLVVIAF 411
+ H ++ +E + + LP + + LSII
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREV--LTTNP--RRLSIIA-----------ES 336
Query: 412 L---LVRRTKSKQTMKKTPTRLIQ---ENASTGYTSK-------FLSDARYISQTMKLGA 458
+ L K T +I+ K F A + + L
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSL-- 394
Query: 459 LGLPAYRTFSL-EELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHST 517
+ ++ + D + + L L K+ +
Sbjct: 395 ----------IWFDVIK----SDVMVVVNK----------LHK------YSLVEKQPKES 424
Query: 518 RNFMHHIELISKLR-------HRHLVSALGHCFECY-----FDDSSVSRIFL---IFEYV 562
+ I L K++ HR +V + Y FD + +L + ++
Sbjct: 425 TISIPSIYLELKVKLENEYALHRSIV-------DHYNIPKTFDSDDLIPPYLDQYFYSHI 477
Query: 563 PNGTLRSWISEGHAH-QSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ 621
GH H +++ +R++ +F + LD
Sbjct: 478 -----------GH-HLKNIEHPERMT-------------------LFRM------VFLDF 500
Query: 622 N-LVAKI--SSYNLPLLAENAEKVGHVIPYSGSI---DPTNSAR 659
L KI S + + Y I DP
Sbjct: 501 RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERL 544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 23/152 (15%), Positives = 60/152 (39%), Gaps = 25/152 (16%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTR---NFMHHIELISKLRHRHLVSALGH 541
G G ++YR L +G VA++ +++ + + + I+L+ +L H +++
Sbjct: 41 GRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK---- 96
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRI-SAAIGVAKGIQFLH 600
+ + +D+ + ++ E G L I + L + + + + ++ +H
Sbjct: 97 YYASFIEDNE---LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 601 TGIVPGVFSNN-----LKITDILLDQNLVAKI 627
S +K ++ + V K+
Sbjct: 154 --------SRRVMHRDIKPANVFITATGVVKL 177
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 21/151 (13%), Positives = 55/151 (36%), Gaps = 26/151 (17%)
Query: 486 GEGSQGQMYRGR-LKNGTFVA---IRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGH 541
GEGS G+ + ++G I +M + +++ ++H ++V
Sbjct: 33 GEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIV----Q 87
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT 601
E + ++ S ++++ +Y G L I+ Q + + + ++ +H
Sbjct: 88 YRESFEENGS---LYIVMDYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVH- 142
Query: 602 GIVPGVFSNN-----LKITDILLDQNLVAKI 627
+K +I L ++ ++
Sbjct: 143 -------DRKILHRDIKSQNIFLTKDGTVQL 166
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 28/149 (18%), Positives = 61/149 (40%), Gaps = 13/149 (8%)
Query: 486 GEGSQGQMYRGR-LKNGTFVA---IRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGH 541
G GS G+ + R +G + + M + + + + L+ +L+H ++V
Sbjct: 15 GTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVR---- 69
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISE-GHAHQSLTWTQRISAAIGVAKGIQFLH 600
++ D ++ + ++++ EY G L S I++ Q L + + ++ H
Sbjct: 70 YYDRIIDRTN-TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 601 TGIVPG--VFSNNLKITDILLDQNLVAKI 627
G V +LK ++ LD K+
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKL 157
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 5e-06
Identities = 33/155 (21%), Positives = 64/155 (41%), Gaps = 29/155 (18%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHH----IELISKLRHRHLVSALG 540
GEGS G++ + A++ LK KK N + I+L+ +LRH++++
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI---- 69
Query: 541 HCFECYFDDSSVSRIFLIFEYVPNGTL-------RSWISEGHAHQSLTWTQRISAAIGVA 593
+ +++ +++++ EY G AH Q I
Sbjct: 70 QLVDVLYNEEK-QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF--CQLID------ 120
Query: 594 KGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
G+++LH+ G+ ++K ++LL KIS
Sbjct: 121 -GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKIS 151
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 25/166 (15%), Positives = 53/166 (31%), Gaps = 20/166 (12%)
Query: 470 EELEEATNNFDTSAFMGEGSQGQMYRGR------LKNGTFVAIRCLKMKKCHSTRNFMHH 523
E + + +GEG+ Q+Y KN ++ K
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 524 IELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQS--LT 581
+E + + + + + L+ E GTL + I+ +
Sbjct: 118 MERLKPSMQHMFM----KFYSAHLFQN---GSVLVGELYSYGTLLNAINLYKNTPEKVMP 170
Query: 582 WTQRISAAIGVAKGIQFLHT-GIVPGVFSNNLKITDILLDQNLVAK 626
IS A+ + I+ +H I+ G ++K + +L + +
Sbjct: 171 QGLVISFAMRMLYMIEQVHDCEIIHG----DIKPDNFILGNGFLEQ 212
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 51/259 (19%), Positives = 87/259 (33%), Gaps = 45/259 (17%)
Query: 127 ISRLSSLEILNMSSNFLNGAIPQEL-----SILTSLQTLILDENML----AGRVPDWLGS 177
S + L++S N L EL + S+ +L L N L + + L +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 178 LPI-LAVLSLRNNMFNGT----LPDSFSYL-ENLRVLALSNNHFYGE-VPDFSGL----- 225
+P + L+L N + L + + + + VL L N F + +F
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 226 TYLQVLDLENNALGPQ--------FPKVGKKLVTMILSKNKFRS----AIPAEV--SSYY 271
+ L+L N LG + + + ++ L N S + A+ S
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAEL-AKFLASIPA 196
Query: 272 QLQRLDLSSNRF----VGPFPQALLSLP-SITYLNIADNKLTGK----LFDDLSCNPELG 322
+ LDLS+N S+P + LN+ N L G L L
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256
Query: 323 FVDLSSNLLTGQLPNCLLA 341
V L +++ A
Sbjct: 257 TVYLDYDIVKNMSKEQCKA 275
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 8e-06
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 146 AIPQELSILTSLQTLILDENMLAGRVPDWL-GSLPILAVLSLRNNMFNGTLPDSFSYLEN 204
IP++ I L+L++N L D L G LP L L L+ N G P++F +
Sbjct: 22 EIPRD--IPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 205 LRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNAL 238
++ L L N E+ + F GL L+ L+L +N +
Sbjct: 80 IQELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQI 114
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 30/148 (20%), Positives = 57/148 (38%), Gaps = 30/148 (20%)
Query: 486 GEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
G G+ G ++R + G A + + I+ +S LRH LV+ +
Sbjct: 166 GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN----LHD 221
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAK----GIQFLH 600
+ DD+ + +I+E++ G L +++ H ++ A+ + G+ +H
Sbjct: 222 AFEDDNEM---VMIYEFMSGGELFEKVADEHNK----MSED--EAVEYMRQVCKGLCHMH 272
Query: 601 T-GIV-----PGVF------SNNLKITD 616
V P SN LK+ D
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLID 300
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 30/149 (20%), Positives = 57/149 (38%), Gaps = 32/149 (21%)
Query: 486 GEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
G G GQ+++ G +A + +K + + I ++++L H +L+ ++
Sbjct: 98 GGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ----LYD 153
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWI-SEGHAHQSLTWTQRISAAIGVAK----GIQFL 599
+ + + L+ EYV G L I E + T+ I K GI+ +
Sbjct: 154 AFESKNDI---VLVMEYVDGGELFDRIIDESYNL-----TEL--DTILFMKQICEGIRHM 203
Query: 600 HT-GIV-----PGVF------SNNLKITD 616
H I+ P + +KI D
Sbjct: 204 HQMYILHLDLKPENILCVNRDAKQIKIID 232
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 24/158 (15%), Positives = 54/158 (34%), Gaps = 24/158 (15%)
Query: 478 NFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLV 536
+F +G G++G + + + VA++ + + ++L+ + H +++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81
Query: 537 SALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGI 596
F D ++ E TL+ ++ + + G+
Sbjct: 82 ----RYFCTEKDRQFQ---YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQT--TSGL 131
Query: 597 QFLHT-GIV-----PGVFSNNLKITDILLDQNLVAKIS 628
LH+ IV P N+ I+ + A IS
Sbjct: 132 AHLHSLNIVHRDLKPH----NILISMPNAHGKIKAMIS 165
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 27/149 (18%), Positives = 56/149 (37%), Gaps = 32/149 (21%)
Query: 486 GEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
G G+ G ++R K G + + + I ++++L H L++ +
Sbjct: 60 GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN----LHD 115
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWI-SEGHAHQSLTWTQRISAAIGVAK----GIQFL 599
+ D + LI E++ G L I +E + ++ I + G++ +
Sbjct: 116 AFEDKYEM---VLILEFLSGGELFDRIAAEDYKM-----SEA--EVINYMRQACEGLKHM 165
Query: 600 HT-GIV-----PGVF------SNNLKITD 616
H IV P ++++KI D
Sbjct: 166 HEHSIVHLDIKPENIMCETKKASSVKIID 194
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 31/146 (21%), Positives = 69/146 (47%), Gaps = 19/146 (13%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
G+G+ G +Y + G VAIR + +++ ++ I ++ + ++ ++V+ L
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD---- 84
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAI--GVAKGIQFLHTG 602
Y ++++ EY+ G+L ++E + Q I AA+ + ++FLH+
Sbjct: 85 SYLVG---DELWVVMEYLAGGSLTDVVTET----CMDEGQ-I-AAVCRECLQALEFLHSN 135
Query: 603 IVPGVFSNNLKITDILLDQNLVAKIS 628
V ++K +ILL + K++
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLT 158
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 20/114 (17%), Positives = 42/114 (36%), Gaps = 14/114 (12%)
Query: 486 GEGSQGQMYRGRL----KNGTFVAIRCLKMKKCHS---TRNFMHHIELISKL-RHRHLVS 537
G G+ GQ+ K T + +K+ + R M ++++ + H ++V+
Sbjct: 31 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIG 591
LG C + + +I E+ G L +++ T+ G
Sbjct: 91 LLGACTK------PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQG 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 6e-05
Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 11/107 (10%)
Query: 206 RVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVG-----KKLVTMILSKNKFR 260
L L N F + S +L ++DL NN + +L+T+ILS N+ R
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRI--STLSNQSFSNMTQLLTLILSYNRLR 91
Query: 261 SAIPAEV-SSYYQLQRLDLSSNRFVGPFPQ-ALLSLPSITYLNIADN 305
IP L+ L L N + P+ A L ++++L I N
Sbjct: 92 C-IPPRTFDGLKSLRLLSLHGND-ISVVPEGAFNDLSALSHLAIGAN 136
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 31/168 (18%), Positives = 59/168 (35%), Gaps = 34/168 (20%)
Query: 458 ALGLPAYRTFSLEELEEATNNFDTSAF---------MGEGSQGQMYRGRLKN-GTFVAIR 507
AL L + F +L + A +G G+ G++ + VAIR
Sbjct: 107 ALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIR 166
Query: 508 CLKMKKCHSTR--------NFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIF 559
+ +K N IE++ KL H ++ + +FD +++
Sbjct: 167 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCII-----KIKNFFDAEDY---YIVL 218
Query: 560 EYVPNGTLRSWISEGHAHQSLTWTQRISAAI--GVAKGIQFLHT-GIV 604
E + G L + ++ L + + +Q+LH GI+
Sbjct: 219 ELMEGGELFDKVVG---NKRL--KEATCKLYFYQMLLAVQYLHENGII 261
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 1e-04
Identities = 25/194 (12%), Positives = 53/194 (27%), Gaps = 47/194 (24%)
Query: 475 ATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKK--------------------- 513
T +GEG G++++ T VAI+ + ++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 514 ----CHSTRNFMHHIELISKLRHRHLV-----SALGHCFECY----------FDDSSVSR 554
+ + E L H V L ++ Y D +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKI 614
+F++ E+ G E + + S + + +L
Sbjct: 137 LFIVLEFEFGGIDL----EQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 615 TDILLDQNLVAKIS 628
++LL + + K+
Sbjct: 191 GNVLLKKTSLKKLH 204
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 32/146 (21%), Positives = 62/146 (42%), Gaps = 19/146 (13%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
GEGS G + R +G VA++ + ++K + + ++ +H ++V
Sbjct: 54 GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK---- 109
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAI--GVAKGIQFLHTG 602
Y ++++ E++ G L +S+ L Q I A + V + + +LH
Sbjct: 110 SYLVG---EELWVLMEFLQGGALTDIVSQV----RLNEEQ-I-ATVCEAVLQALAYLHA- 159
Query: 603 IVPGVFSNNLKITDILLDQNLVAKIS 628
GV ++K ILL + K+S
Sbjct: 160 --QGVIHRDIKSDSILLTLDGRVKLS 183
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 36/154 (23%), Positives = 65/154 (42%), Gaps = 31/154 (20%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMH---HIELISKLRHRHLVSALGH 541
G G+ G++ G G VA++ L +K S I+ + RH H++
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII----K 75
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLT-------WTQRISAAIGVAK 594
++ S+ + F++ EYV G L +I + H + + Q +SA
Sbjct: 76 LYQVI---STPTDFFMVMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSA------ 123
Query: 595 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+ + H V +LK ++LLD ++ AKI+
Sbjct: 124 -VDYCHRH---MVVHRDLKPENVLLDAHMNAKIA 153
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 31/153 (20%), Positives = 62/153 (40%), Gaps = 30/153 (19%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCL--KMKKCHSTRNFMHHIELISKLRHRHLVSALGHC 542
G+G+ ++ R + G VAI+ + S + + ++ L H ++V
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV----KL 79
Query: 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLT-------WTQRISAAIGVAKG 595
FE + ++LI EY G + ++ H + + Q +SA
Sbjct: 80 FEVI---ETEKTLYLIMEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSA------- 126
Query: 596 IQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+Q+ H + +LK ++LLD ++ KI+
Sbjct: 127 VQYCHQK---RIVHRDLKAENLLLDADMNIKIA 156
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 25/125 (20%), Positives = 60/125 (48%), Gaps = 18/125 (14%)
Query: 485 MGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCF 543
+G G+ +++ + + G A++C+K + + I ++ K++H ++V+
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT-----L 71
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISE-GHAHQSLTWTQRISAAI--GVAKGIQFLH 600
E ++ + + +L+ + V G L I E G +T++ ++ + V +++LH
Sbjct: 72 EDIYEST--THYYLVMQLVSGGELFDRILERGV------YTEKDASLVIQQVLSAVKYLH 123
Query: 601 T-GIV 604
GIV
Sbjct: 124 ENGIV 128
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 26/145 (17%), Positives = 67/145 (46%), Gaps = 17/145 (11%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
G+G+ G++Y+ + + G A + ++ K +++ IE+++ H ++V
Sbjct: 28 GDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK----LLG 83
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAI--GVAKGIQFLHTG 602
Y+ D +++++ E+ P G + + + + LT Q I + + + + FLH+
Sbjct: 84 AYYHD---GKLWIMIEFCPGGAVDAIML--ELDRGLTEPQ-I-QVVCRQMLEALNFLHSK 136
Query: 603 IVPGVFSNNLKITDILLDQNLVAKI 627
+ +LK ++L+ ++
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRL 158
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 35/177 (19%), Positives = 68/177 (38%), Gaps = 25/177 (14%)
Query: 476 TNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHST--RNFMHHIELISKL-R 531
T F +G G G +++ +G AI+ K S +N + + + L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 532 HRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIG 591
H H+V F + +D + I EY G+L ISE + S + +
Sbjct: 70 HSHVVR----YFSAWAEDDHML-IQN--EYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 592 -VAKGIQFLHTGIVPGVFSNN-----LKITDILLDQNLVAKISSYNLPLLAENAEKV 642
V +G++++H S + +K ++I + + + +S + KV
Sbjct: 123 QVGRGLRYIH--------SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 22/134 (16%), Positives = 49/134 (36%), Gaps = 17/134 (12%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHL 535
N + +G GS G + G VA++ + + C I+L+++ H ++
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNV 71
Query: 536 VSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAK- 594
+ + C +++ E N L+ + + Q+ I + +
Sbjct: 72 I-----RYYCSETTDRF--LYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 595 ---GIQFLHT-GIV 604
G+ LH+ I+
Sbjct: 124 IASGVAHLHSLKII 137
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 44/135 (32%), Positives = 54/135 (40%), Gaps = 11/135 (8%)
Query: 108 DLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENML 167
L L + L +G L+SL L + N L + LTSL L L N L
Sbjct: 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL 88
Query: 168 AG---RVPDWLGSLPILAVLSLRNNMFNGTLPD-SFSYLENLRVLALSNNHFYGEVPD-- 221
V D L L L+L N +LPD F L L+ L L N VPD
Sbjct: 89 QSLPNGVFD---KLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGV 143
Query: 222 FSGLTYLQVLDLENN 236
F LT LQ + L +N
Sbjct: 144 FDRLTSLQYIWLHDN 158
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 23/107 (21%), Positives = 49/107 (45%), Gaps = 16/107 (14%)
Query: 524 IELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEG--HAHQSLT 581
I ++ KL H ++V E DD + ++++FE V G + + Q+
Sbjct: 87 IAILKKLDHPNVV----KLVEVL-DDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARF 141
Query: 582 WTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+ Q + KGI++LH + ++K +++L+ ++ KI+
Sbjct: 142 YFQDL------IKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIA 179
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 37/154 (24%), Positives = 66/154 (42%), Gaps = 31/154 (20%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMH---HIELISKLRHRHLVSALGH 541
G G+ G++ G+ G VA++ L +K S I+ + RH H++
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII----K 80
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLT-------WTQRISAAIGVAK 594
++ S+ S IF++ EYV G L +I + + L + Q +S
Sbjct: 81 LYQVI---STPSDIFMVMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSG------ 128
Query: 595 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+ + H V +LK ++LLD ++ AKI+
Sbjct: 129 -VDYCHRH---MVVHRDLKPENVLLDAHMNAKIA 158
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 8e-04
Identities = 29/154 (18%), Positives = 53/154 (34%), Gaps = 33/154 (21%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCL-KMKKCHSTRNFMHHIELISKLRHRHLVSALGHCF 543
GEG+ G++ VA++ + + N I + L H ++V +
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV----KFY 71
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTL------RSWISEGHAH---QSLTWTQRISAAIGVAK 594
+ +L EY G L + E A Q ++
Sbjct: 72 GHR---REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-----QLMAG------ 117
Query: 595 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+ +LH G+ ++K ++LLD+ KIS
Sbjct: 118 -VVYLHG---IGITHRDIKPENLLLDERDNLKIS 147
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 29/183 (15%), Positives = 67/183 (36%), Gaps = 47/183 (25%)
Query: 460 GLPAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTR 518
G+ ++ +E+ +D +G G + + R K G A + +K ++ ++R
Sbjct: 1 GMETFKQQKVEDF------YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR 54
Query: 519 ------NFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI- 571
+ ++ ++ H ++++ + Y + + V LI E V G L ++
Sbjct: 55 RGVCREEIEREVSILRQVLHPNIIT----LHDVYENRTDV---VLILELVSGGELFDFLA 107
Query: 572 SEGHAHQSLTWTQRISAAIGVAK----GIQFLHT-GIV-------------PGVFSNNLK 613
+ ++ A K G+ +LHT I + ++K
Sbjct: 108 QKES------LSEE--EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 614 ITD 616
+ D
Sbjct: 160 LID 162
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 659 | |||
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.98 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.98 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.98 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.98 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.97 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.97 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.97 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.97 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.97 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.97 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.97 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.96 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.96 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.96 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.96 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.96 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.96 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.96 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.96 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.96 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.96 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.96 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.96 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.96 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.96 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.96 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.96 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.96 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.96 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.96 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.96 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.96 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.95 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.95 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.95 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.95 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.95 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.95 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.95 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.95 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.95 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.95 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.95 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.95 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.95 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.95 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.95 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.95 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.95 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.95 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.95 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.95 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.95 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.95 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.95 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.95 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.95 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.95 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.95 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.95 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.95 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.95 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.95 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.95 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.95 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.95 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.95 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.95 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.95 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.95 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.95 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.95 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.95 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.95 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.95 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.95 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.95 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.95 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.95 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.95 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.95 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.95 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.95 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.95 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.95 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.95 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.95 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.95 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.95 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.95 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.95 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.94 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.94 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.94 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.94 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.94 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.94 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.94 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.94 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.94 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.94 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.94 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.94 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.94 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.94 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.94 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.94 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.94 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.94 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.94 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.94 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.94 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.94 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.94 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.94 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.94 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.94 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.94 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.94 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.94 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.94 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.94 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.94 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.94 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.94 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.94 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.94 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.94 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.94 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.94 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.94 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.94 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.94 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.94 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.94 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.94 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.94 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.94 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.94 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.94 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.94 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.94 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.94 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.94 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.94 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.94 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.94 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.94 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.94 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.94 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.94 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.94 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.94 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.94 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.94 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.94 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.94 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.94 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.94 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.94 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.94 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.94 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.93 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.93 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.93 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.93 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.93 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.93 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.93 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.93 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.93 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.93 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.93 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.93 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.93 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.93 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.93 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.93 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.93 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.93 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.93 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.93 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.93 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.93 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.92 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.92 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.92 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.92 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.92 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.92 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.92 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.92 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.92 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.91 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.91 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.91 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.89 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.88 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.84 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.84 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.78 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.71 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.61 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.61 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.6 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.59 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.58 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.42 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.35 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.33 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.31 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.93 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.9 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.88 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.84 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.71 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.53 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.51 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.5 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.5 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.43 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.38 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.35 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.25 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.24 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.14 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.08 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.0 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.81 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.74 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.71 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.53 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.49 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.11 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.08 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.96 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.84 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.81 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.76 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.63 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.62 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.56 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.53 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.48 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.47 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.11 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.77 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.93 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.65 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.48 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.5 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.7 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 86.21 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.06 |
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=376.50 Aligned_cols=293 Identities=29% Similarity=0.434 Sum_probs=240.0
Q ss_pred CCCHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCc--CCCCCCCceEeCC----CCEeEEEeCCCCCCC--CCCCCCcCCc
Q 006145 27 QLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCN--TEPTSSLTVVCYE----ESITQLHIVGNKRAP--MLPLSFSMDS 98 (659)
Q Consensus 27 ~~~~~~~~aLl~~k~~l~~~~~l~~W~~~~~~C~--w~~~~~~gv~C~~----~~v~~L~l~~~~~~~--~l~~~~~~~~ 98 (659)
.|.++|++||++||+++.+|..+++|+.+++||. |. ||+|+. ++|+.|+|+++.+.+ .+|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~-----gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~------- 69 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWL-----GVLCDTDTQTYRVNNLDLSGLNLPKPYPIP------- 69 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCST-----TEEECCSSSCCCEEEEEEECCCCSSCEECC-------
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCc-----ceEeCCCCCCceEEEEECCCCCccCCcccC-------
Confidence 5899999999999999988878899988889998 86 799964 689999999988876 444
Q ss_pred ccccccCCCCCCEEEecC-CCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCC
Q 006145 99 FVTTLVKLPDLKVLRLVS-LGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGS 177 (659)
Q Consensus 99 ~~~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 177 (659)
..+.++++|++|+|++ |.+.+.+|..|+++++|++|+|++|.+++.+|..|.++++|++|+|++|.+++.+|..+..
T Consensus 70 --~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 147 (313)
T 1ogq_A 70 --SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147 (313)
T ss_dssp --GGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGG
T ss_pred --hhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhc
Confidence 4677889999999995 8899899999999999999999999999889999999999999999999998889999999
Q ss_pred CCCCCEEEccCCcCCccCCcccCCCC-CCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEecC
Q 006145 178 LPILAVLSLRNNMFNGTLPDSFSYLE-NLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILS 255 (659)
Q Consensus 178 l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~ 255 (659)
+++|++|+|++|.+++.+|..++.++ +|+.|++++|++++.+|. +..++ |++|+|++|.
T Consensus 148 l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~------------------ 208 (313)
T 1ogq_A 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM------------------ 208 (313)
T ss_dssp CTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE------------------
T ss_pred CCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc------------------
Confidence 99999999999999988998898887 899999999998877765 66554 6666665555
Q ss_pred CCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccC
Q 006145 256 KNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQL 335 (659)
Q Consensus 256 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~i 335 (659)
+++.+|..+..+++|+.|+|++|++++.+|. +..+++|++|++++|++++.+|..+..+++|+.|++++|+++|.+
T Consensus 209 ---l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~i 284 (313)
T 1ogq_A 209 ---LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284 (313)
T ss_dssp ---EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEEC
T ss_pred ---ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccC
Confidence 4556666777777777777777777766555 677777777777777777777777777777778888888777777
Q ss_pred ChhhhCCCCCCEEEcCCcc-ccC
Q 006145 336 PNCLLAGSKNRVVLYARNC-LAA 357 (659)
Q Consensus 336 p~~~~~~~~l~~l~~~~N~-l~~ 357 (659)
|.. ..+++++.+++.+|. ++|
T Consensus 285 p~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 285 PQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp CCS-TTGGGSCGGGTCSSSEEES
T ss_pred CCC-ccccccChHHhcCCCCccC
Confidence 776 566677777777776 443
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=406.63 Aligned_cols=327 Identities=26% Similarity=0.328 Sum_probs=225.9
Q ss_pred cCCCHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCcCCCCCCCceEeCCCCEeEEEeCCCCCCCC---CCCCCc-------
Q 006145 26 EQLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPTSSLTVVCYEESITQLHIVGNKRAPM---LPLSFS------- 95 (659)
Q Consensus 26 ~~~~~~~~~aLl~~k~~l~~~~~l~~W~~~~~~C~w~~~~~~gv~C~~~~v~~L~l~~~~~~~~---l~~~~~------- 95 (659)
.++.++|++||++||+++.||..+++|+.++|||+|. ||+|+.++|+.|+|+++.+.|. +|..+.
T Consensus 7 ~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C~w~-----gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~ 81 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFD-----GVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGGGST-----TEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred ccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCcCCc-----ceEECCCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence 3456889999999999998887899999888999997 6999988999999999988775 443111
Q ss_pred -------CCcccccccCCCCCCEEEecCCCCcCCCCc--ccCCCCCCcEEEcccCcCcccCChhc-cCCCCCcEEEeecC
Q 006145 96 -------MDSFVTTLVKLPDLKVLRLVSLGLWGPLSG--KISRLSSLEILNMSSNFLNGAIPQEL-SILTSLQTLILDEN 165 (659)
Q Consensus 96 -------~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N 165 (659)
...+|..+.++++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|+|++|
T Consensus 82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 112336788888999999999998888888 88888888888888888888887765 77888888888888
Q ss_pred CCCCCCccc---cCCCCCCCEEEccCCcCCcc----------------------CCcccCCCCCCcEEeccccccccCCC
Q 006145 166 MLAGRVPDW---LGSLPILAVLSLRNNMFNGT----------------------LPDSFSYLENLRVLALSNNHFYGEVP 220 (659)
Q Consensus 166 ~l~~~~p~~---l~~l~~L~~L~L~~N~l~~~----------------------~p~~~~~l~~L~~L~Ls~N~l~~~~p 220 (659)
++++..|.. +.++++|++|++++|.+++. +|. ++++++|++|+|++|++++.+|
T Consensus 162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~ 240 (768)
T 3rgz_A 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFS 240 (768)
T ss_dssp CCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHH
T ss_pred ccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCccc
Confidence 887777665 55555555555555555544 443 4444444444444444444433
Q ss_pred C-CCCCCcCCEEEcccCCCCCCCCCC-CcccceEecCCCcCCccCchhccCC-ccccEEeccCcccccCCchhhcCCCcc
Q 006145 221 D-FSGLTYLQVLDLENNALGPQFPKV-GKKLVTMILSKNKFRSAIPAEVSSY-YQLQRLDLSSNRFVGPFPQALLSLPSI 297 (659)
Q Consensus 221 ~-~~~l~~L~~L~L~~N~l~~~~~~~-~~~L~~L~l~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L 297 (659)
. +..+++|++|+|++|.+.+.+|.. +++|++|++++|++++.+|..+... ++|++|+|++|++++.+|..++.+++|
T Consensus 241 ~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L 320 (768)
T 3rgz_A 241 RAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 320 (768)
T ss_dssp HHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTC
T ss_pred HHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCc
Confidence 2 444445555555555544444432 3556666666666666666666554 667777777777766666666677777
Q ss_pred cEEeccCCcCCCcCCcC-CCCCCCCCEEECcCCCCcccCChhhhCCC-CCCEEEcCCccccCC
Q 006145 298 TYLNIADNKLTGKLFDD-LSCNPELGFVDLSSNLLTGQLPNCLLAGS-KNRVVLYARNCLAAG 358 (659)
Q Consensus 298 ~~L~l~~N~l~~~~p~~-~~~~~~L~~L~ls~N~l~g~ip~~~~~~~-~l~~l~~~~N~l~~~ 358 (659)
++|++++|+++|.+|.. +..+++|+.|++++|+++|.+|..+..+. +++.+++++|.+++.
T Consensus 321 ~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~ 383 (768)
T 3rgz_A 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGP 383 (768)
T ss_dssp CEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEE
T ss_pred cEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCC
Confidence 77777777776666654 66666777777777777766776666665 667777777766653
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=373.98 Aligned_cols=314 Identities=20% Similarity=0.292 Sum_probs=274.1
Q ss_pred CHHHHHHHHHHHhcCCCCC---------CCCCCCCCCCCCcCCCCCCCceEeC-CCCEeEEEeCCCCCCCCCCCCCcCCc
Q 006145 29 QSSQAQTLLRIQGLLNNPA---------VLSSWNITTEFCNTEPTSSLTVVCY-EESITQLHIVGNKRAPMLPLSFSMDS 98 (659)
Q Consensus 29 ~~~~~~aLl~~k~~l~~~~---------~l~~W~~~~~~C~w~~~~~~gv~C~-~~~v~~L~l~~~~~~~~l~~~~~~~~ 98 (659)
...|++||.+++..+..+. ...+|+.+++||.|. .+.||+|+ .++|++|+|+++++.|.+|
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~--~~~GV~C~~~~~V~~L~L~~~~l~g~lp------- 98 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWG--AQPGVSLNSNGRVTGLSLEGFGASGRVP------- 98 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTT--CCTTEEECTTCCEEEEECTTSCCEEEEC-------
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCccccc--CCCCeEEcCCCCEEEEEecCcccCCcCC-------
Confidence 3568999999999886542 234799889999992 12379995 4799999999999887665
Q ss_pred ccccccCCCCCCEEEecCCC------------------------------------------------------------
Q 006145 99 FVTTLVKLPDLKVLRLVSLG------------------------------------------------------------ 118 (659)
Q Consensus 99 ~~~~l~~l~~L~~L~L~~n~------------------------------------------------------------ 118 (659)
+.+++|++|++|+|++|.
T Consensus 99 --~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~ 176 (636)
T 4eco_A 99 --DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIK 176 (636)
T ss_dssp --GGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCC
T ss_pred --hHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccc
Confidence 478899999999999884
Q ss_pred ------------------CcCCCCcccCCCCCCcEEEcccCcCccc-----------------CChhcc--CCCCCcEEE
Q 006145 119 ------------------LWGPLSGKISRLSSLEILNMSSNFLNGA-----------------IPQELS--ILTSLQTLI 161 (659)
Q Consensus 119 ------------------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~ 161 (659)
++| +|..|+++++|++|+|++|.++|. +|..++ ++++|++|+
T Consensus 177 ~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~ 255 (636)
T 4eco_A 177 KSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255 (636)
T ss_dssp CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred cccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEE
Confidence 445 788999999999999999999986 999999 999999999
Q ss_pred eecCCCCCCCccccCCCCCCCEEEccCCc-CCc-cCCcccCCC------CCCcEEeccccccccCCC--CCCCCCcCCEE
Q 006145 162 LDENMLAGRVPDWLGSLPILAVLSLRNNM-FNG-TLPDSFSYL------ENLRVLALSNNHFYGEVP--DFSGLTYLQVL 231 (659)
Q Consensus 162 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~-~~p~~~~~l------~~L~~L~Ls~N~l~~~~p--~~~~l~~L~~L 231 (659)
|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..++++ ++|++|+|++|+++..++ .+.++++|++|
T Consensus 256 L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L 335 (636)
T 4eco_A 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGML 335 (636)
T ss_dssp EECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEE
T ss_pred ecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEE
Confidence 99999999999999999999999999998 998 899988887 999999999999994444 49999999999
Q ss_pred EcccCCCCCCCCCC--CcccceEecCCCcCCccCchhccCCcc-ccEEeccCcccccCCchhhcCCC--cccEEeccCCc
Q 006145 232 DLENNALGPQFPKV--GKKLVTMILSKNKFRSAIPAEVSSYYQ-LQRLDLSSNRFVGPFPQALLSLP--SITYLNIADNK 306 (659)
Q Consensus 232 ~L~~N~l~~~~~~~--~~~L~~L~l~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~l~~l~--~L~~L~l~~N~ 306 (659)
++++|.++|.+|.. +++|+.|++++|+++ .+|..+..+++ |+.|++++|.++ .+|..+..++ +|+.|++++|+
T Consensus 336 ~L~~N~l~g~ip~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~ 413 (636)
T 4eco_A 336 ECLYNQLEGKLPAFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNE 413 (636)
T ss_dssp ECCSCCCEEECCCCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSC
T ss_pred eCcCCcCccchhhhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCc
Confidence 99999999888843 478999999999998 78999999999 999999999999 7898887765 89999999999
Q ss_pred CCCcCCcCCC-------CCCCCCEEECcCCCCcccCChhhh-CCCCCCEEEcCCccccC
Q 006145 307 LTGKLFDDLS-------CNPELGFVDLSSNLLTGQLPNCLL-AGSKNRVVLYARNCLAA 357 (659)
Q Consensus 307 l~~~~p~~~~-------~~~~L~~L~ls~N~l~g~ip~~~~-~~~~l~~l~~~~N~l~~ 357 (659)
+++.+|..+. .+++|+.|++++|+++ .+|..+. .+++++.+++++|.++.
T Consensus 414 l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~~ 471 (636)
T 4eco_A 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLTE 471 (636)
T ss_dssp TTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCSB
T ss_pred CCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCCC
Confidence 9999999888 7889999999999999 6676554 58899999999999883
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=374.40 Aligned_cols=314 Identities=20% Similarity=0.257 Sum_probs=263.0
Q ss_pred CCCHHHHHHHHHHHhcCCCCCCCCCCCCCC-----CC--CcCCC----CCC---CceEeC-CCCEeEEEeCCCCCCCCCC
Q 006145 27 QLQSSQAQTLLRIQGLLNNPAVLSSWNITT-----EF--CNTEP----TSS---LTVVCY-EESITQLHIVGNKRAPMLP 91 (659)
Q Consensus 27 ~~~~~~~~aLl~~k~~l~~~~~l~~W~~~~-----~~--C~w~~----~~~---~gv~C~-~~~v~~L~l~~~~~~~~l~ 91 (659)
++..+|++||++||.++.+| +|+.+. +| |.|+- ..| .||.|+ .++|++|+|+++++.|.+|
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip 340 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP 340 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEEC
T ss_pred ccchHHHHHHHHHHHHcCCC----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCc
Confidence 34567999999999999876 787554 66 99911 112 489997 5899999999999887665
Q ss_pred CCCcCCcccccccCCCCCCEEEe-cCCCCcCC------------------------------------------------
Q 006145 92 LSFSMDSFVTTLVKLPDLKVLRL-VSLGLWGP------------------------------------------------ 122 (659)
Q Consensus 92 ~~~~~~~~~~~l~~l~~L~~L~L-~~n~l~~~------------------------------------------------ 122 (659)
. .+++|++|++|+| ++|.++|.
T Consensus 341 ~---------~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~ 411 (876)
T 4ecn_A 341 D---------AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN 411 (876)
T ss_dssp G---------GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTC
T ss_pred h---------HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhC
Confidence 4 6789999999999 77755444
Q ss_pred ----------------------------CCcccCCCCCCcEEEcccCcCcc-----------------cCChhcc--CCC
Q 006145 123 ----------------------------LSGKISRLSSLEILNMSSNFLNG-----------------AIPQELS--ILT 155 (659)
Q Consensus 123 ----------------------------~p~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~ 155 (659)
+|..|++|++|++|+|++|.|+| .+|..++ +++
T Consensus 412 ~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~ 491 (876)
T 4ecn_A 412 PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLK 491 (876)
T ss_dssp TTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCT
T ss_pred ccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCC
Confidence 78889999999999999999998 4898887 999
Q ss_pred CCcEEEeecCCCCCCCccccCCCCCCCEEEccCCc-CCc-cCCcccCCCC-------CCcEEeccccccccCCC--CCCC
Q 006145 156 SLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM-FNG-TLPDSFSYLE-------NLRVLALSNNHFYGEVP--DFSG 224 (659)
Q Consensus 156 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p--~~~~ 224 (659)
+|++|+|++|++.+.+|..|+++++|+.|+|++|+ ++| .+|..+++++ +|+.|+|++|+++..++ .+.+
T Consensus 492 ~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~ 571 (876)
T 4ecn_A 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQK 571 (876)
T ss_dssp TCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTT
T ss_pred CCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhc
Confidence 99999999999999999999999999999999998 998 8888766655 99999999999994444 4899
Q ss_pred CCcCCEEEcccCCCCCCCCCC--CcccceEecCCCcCCccCchhccCCcc-ccEEeccCcccccCCchhhcCCCc--ccE
Q 006145 225 LTYLQVLDLENNALGPQFPKV--GKKLVTMILSKNKFRSAIPAEVSSYYQ-LQRLDLSSNRFVGPFPQALLSLPS--ITY 299 (659)
Q Consensus 225 l~~L~~L~L~~N~l~~~~~~~--~~~L~~L~l~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~l~~l~~--L~~ 299 (659)
+++|+.|+|++|.++ .+|.. +++|+.|+|++|+++ .+|..+..+++ |+.|+|++|+++ .+|..+..++. |+.
T Consensus 572 L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~ 648 (876)
T 4ecn_A 572 MVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGS 648 (876)
T ss_dssp CTTCCEEECTTSCCC-BCCCCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEE
T ss_pred CCCCCEEECCCCCcc-cchhhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCE
Confidence 999999999999998 66643 478999999999998 78888999998 999999999998 78888877754 999
Q ss_pred EeccCCcCCCcCCcCC---C--CCCCCCEEECcCCCCcccCChhhh-CCCCCCEEEcCCccccC
Q 006145 300 LNIADNKLTGKLFDDL---S--CNPELGFVDLSSNLLTGQLPNCLL-AGSKNRVVLYARNCLAA 357 (659)
Q Consensus 300 L~l~~N~l~~~~p~~~---~--~~~~L~~L~ls~N~l~g~ip~~~~-~~~~l~~l~~~~N~l~~ 357 (659)
|+|++|+++|.+|... . .+++|+.|++++|+++ .+|..+. .+++|+.+++++|.++.
T Consensus 649 L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ 711 (876)
T 4ecn_A 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTS 711 (876)
T ss_dssp EECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSC
T ss_pred EECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCc
Confidence 9999999998776432 2 3458999999999999 7787765 77899999999998873
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=331.13 Aligned_cols=171 Identities=23% Similarity=0.430 Sum_probs=145.3
Q ss_pred cCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
++|...+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~------ 86 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE------ 86 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee------
Confidence 45677799999999999999864 478999999986554455789999999999999999999999986
Q ss_pred CCceeEEEEeccCCCChhhhhcCC----------CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEG----------HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD 620 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld 620 (659)
.+..|||||||++|||.++|+.. .....++|.++.+|+.|||+||+|||+. +||||||||+|||+|
T Consensus 87 -~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~ 162 (299)
T 4asz_A 87 -GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVG 162 (299)
T ss_dssp -SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEEC
Confidence 46789999999999999999742 1235799999999999999999999998 999999999999999
Q ss_pred CCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 621 QNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 621 ~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
+++.+||+|||+|+....... .....||+.|||||++
T Consensus 163 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~ 202 (299)
T 4asz_A 163 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 202 (299)
T ss_dssp GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHH
T ss_pred CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHH
Confidence 999999999999986643322 2346799999999975
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=332.99 Aligned_cols=172 Identities=23% Similarity=0.381 Sum_probs=140.7
Q ss_pred cCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
++|...++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~------ 114 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE------ 114 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE------
Confidence 45666789999999999999864 478999999986554455789999999999999999999999986
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCcee
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHA------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDIL 618 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 618 (659)
.+..|||||||++|+|.++++.... ..+++|.++++|+.|||+||+|||+. +||||||||+|||
T Consensus 115 -~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NIL 190 (329)
T 4aoj_A 115 -GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCL 190 (329)
T ss_dssp -SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEE
Confidence 4678999999999999999975321 24699999999999999999999998 9999999999999
Q ss_pred ecCCcceEEccCcccccccccc---ccceecccccccCCCCCC
Q 006145 619 LDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 619 ld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~ 658 (659)
+|+++.+||+|||+|+...... .....+||+.|||||++.
T Consensus 191 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~ 233 (329)
T 4aoj_A 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL 233 (329)
T ss_dssp EETTTEEEECCCC----------------CCCCGGGCCHHHHT
T ss_pred ECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhc
Confidence 9999999999999998664322 224578999999999753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=324.51 Aligned_cols=168 Identities=20% Similarity=0.340 Sum_probs=141.0
Q ss_pred hhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
..+++...+.||+|+||+||+|+++. .||||+++..... ..++|.+|+++|++++|||||+++|+|.+
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-------- 103 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-------- 103 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--------
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--------
Confidence 34667788999999999999999753 6999999754432 23679999999999999999999999863
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..+||||||++|+|.++|+.. ...++|.++..|+.|||+||+|||+. +||||||||+|||+|+++.+||+|||+
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGl 178 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGL 178 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred CeEEEEEEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccC
Confidence 3579999999999999999753 34699999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc---cccceecccccccCCCCC
Q 006145 633 PLLAENA---EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~---~~~~~~~gt~~y~aPE~~ 657 (659)
|+..... ......+||+.|||||++
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l 206 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVI 206 (307)
T ss_dssp CBC------------CCCCTTSCCHHHH
T ss_pred ceecccCCcceeecccccCCCccCHHHh
Confidence 9876432 234567899999999975
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=361.19 Aligned_cols=287 Identities=30% Similarity=0.430 Sum_probs=217.2
Q ss_pred CCEeEEEeCCCCCCCCCCCCCc------------C----CcccccccC--CCCCCEEEecCCCCcCCCCcccCCCCCCcE
Q 006145 74 ESITQLHIVGNKRAPMLPLSFS------------M----DSFVTTLVK--LPDLKVLRLVSLGLWGPLSGKISRLSSLEI 135 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~------------~----~~~~~~l~~--l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 135 (659)
.+++.|++++|.+.+.+|..+. . +.++..+.. +++|++|+|++|.+++.+|..|+++++|++
T Consensus 343 ~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 422 (768)
T 3rgz_A 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422 (768)
T ss_dssp TTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCE
T ss_pred CCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCE
Confidence 3567777777776655554221 0 112333333 566777777777777777777777777777
Q ss_pred EEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEecccccc
Q 006145 136 LNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHF 215 (659)
Q Consensus 136 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 215 (659)
|+|++|.+++.+|..+.++++|++|+|++|.+++.+|..++.+++|++|+|++|++++.+|..++++++|++|+|++|++
T Consensus 423 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 502 (768)
T 3rgz_A 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 502 (768)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred EECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCcc
Confidence 77777777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred ccCCCC-CCCCCcCCEEEcccCCCCCCCCCC---CcccceEecCCCcCCccCch--------------------------
Q 006145 216 YGEVPD-FSGLTYLQVLDLENNALGPQFPKV---GKKLVTMILSKNKFRSAIPA-------------------------- 265 (659)
Q Consensus 216 ~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~~~p~-------------------------- 265 (659)
++.+|. ++.+++|++|+|++|.+++.+|.. +++|+.|++++|+++|.+|.
T Consensus 503 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (768)
T 3rgz_A 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDG 582 (768)
T ss_dssp CSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCS
T ss_pred CCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccc
Confidence 766664 666777777777777776666654 35666777777766666554
Q ss_pred --------------------------------------------hccCCccccEEeccCcccccCCchhhcCCCcccEEe
Q 006145 266 --------------------------------------------EVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLN 301 (659)
Q Consensus 266 --------------------------------------------~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 301 (659)
.++.+++|+.|||++|+++|.+|..++++++|+.|+
T Consensus 583 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 662 (768)
T 3rgz_A 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILN 662 (768)
T ss_dssp CCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEE
T ss_pred ccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEe
Confidence 344567899999999999999999999999999999
Q ss_pred ccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccCCCC
Q 006145 302 IADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNE 360 (659)
Q Consensus 302 l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~~~ 360 (659)
|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..++.|+.+++++|+++|..|
T Consensus 663 Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP 721 (768)
T 3rgz_A 663 LGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721 (768)
T ss_dssp CCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECC
T ss_pred CcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCC
Confidence 99999999999999999999999999999999999999999999999999999998765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=326.55 Aligned_cols=169 Identities=24% Similarity=0.336 Sum_probs=143.2
Q ss_pred CCCCceeccCcCceEEEEEec------CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
+...+.||+|+||+||+|++. +++.||||+++.... ...++|.+|++++++++|||||+++|+|.+
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------- 100 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK------- 100 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-------
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-------
Confidence 445678999999999999963 478999999975543 234689999999999999999999999976
Q ss_pred CceeEEEEeccCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCcee
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHA-------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDIL 618 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 618 (659)
.+..+||||||++|||.++|+.... ...++|.++++|+.|||+||+|||+. +||||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence 4568999999999999999974321 24699999999999999999999998 9999999999999
Q ss_pred ecCCcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 619 LDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 619 ld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
+|+++.+||+|||+|+...... ..+..+||+.|||||++
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l 219 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAI 219 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHH
Confidence 9999999999999998664322 23557899999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=327.21 Aligned_cols=169 Identities=17% Similarity=0.346 Sum_probs=151.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.+.|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+ .+.
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-------~~~ 145 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-------GDE 145 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-------TTE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-------CCE
Confidence 356888899999999999999975 699999999987665666779999999999999999999999987 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.|||||||++|+|.++++. ..+++.+...|+.||+.||+|||+. +||||||||+|||+++++.+||+|||+|+
T Consensus 146 ~~ivmEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence 9999999999999999975 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccccc-cccceecccccccCCCCCC
Q 006145 635 LAENA-EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~~~~-~~~~~~~gt~~y~aPE~~~ 658 (659)
..... ......+||+.|||||++.
T Consensus 219 ~~~~~~~~~~~~~GTp~YmAPEvl~ 243 (346)
T 4fih_A 219 QVSKEVPRRKSLVGTPYWMAPELIS 243 (346)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHT
T ss_pred ecCCCCCcccccccCcCcCCHHHHC
Confidence 76443 3456789999999999763
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=326.79 Aligned_cols=172 Identities=12% Similarity=0.247 Sum_probs=144.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||+||+|+.. +|+.||||++...... ..++|.+|+++|++++|||||++++++.+ .
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-------~ 95 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-------N 95 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-------T
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-------C
Confidence 367889999999999999999965 6999999999765432 23579999999999999999999999986 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..|||||||++|+|.+++... ....+++.+...|+.||+.||+|||+. +||||||||+|||+++++.+||+|||+
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred CEEEEEEeCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccccc
Confidence 6799999999999999999753 234678999999999999999999998 999999999999999999999999999
Q ss_pred cccccccc-ccceecccccccCCCCCC
Q 006145 633 PLLAENAE-KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 633 a~~~~~~~-~~~~~~gt~~y~aPE~~~ 658 (659)
|+...... .....+||+.|||||++.
T Consensus 172 a~~~~~~~~~~~~~~GT~~YmAPE~l~ 198 (350)
T 4b9d_A 172 ARVLNSTVELARACIGTPYYLSPEICE 198 (350)
T ss_dssp ESCCCHHHHHHHHHHSCCTTCCHHHHT
T ss_pred ceeecCCcccccccCCCccccCHHHHC
Confidence 98775433 335678999999999863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.98 Aligned_cols=168 Identities=18% Similarity=0.297 Sum_probs=148.6
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+ .
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-------~ 104 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-------D 104 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-------S
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-------C
Confidence 46889999999999999999965 69999999997542 2345679999999999999999999999976 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..|+|||||++|+|.+++++. ..+++.+...|+.||+.||+|||++ +||||||||+|||+++++.+||+|||+
T Consensus 105 ~~~yivmEy~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGl 178 (311)
T 4aw0_A 105 EKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGT 178 (311)
T ss_dssp SEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCC
Confidence 6799999999999999999852 4699999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc---cccceecccccccCCCCC
Q 006145 633 PLLAENA---EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~---~~~~~~~gt~~y~aPE~~ 657 (659)
|+..... ......+||+.|||||++
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl 206 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELL 206 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHH
T ss_pred ceecCCCCCcccccCcccCcccCCHHHH
Confidence 9876432 234567999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.08 Aligned_cols=169 Identities=21% Similarity=0.359 Sum_probs=138.1
Q ss_pred CCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHH--HHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNF--MHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~--~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
+|...+.||+|+||+||+|++ +|+.||||+++... .+++ ++|+..+.+++|||||+++|+|.+... .....
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~---~~~~~ 76 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNG---TWTQL 76 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS---SSEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC---CceEE
Confidence 456678999999999999998 58999999996543 2333 455666678899999999999986321 12468
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCC-----CCCccccCCCCCceeecCCcceEEccC
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI-----VPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
|||||||++|+|.++++. ..++|..+.+++.|+|+||+|||+.+ .++||||||||+|||+|+++++||+||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 999999999999999985 36999999999999999999999863 569999999999999999999999999
Q ss_pred ccccccccccc-----cceecccccccCCCCC
Q 006145 631 NLPLLAENAEK-----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~-----~~~~~gt~~y~aPE~~ 657 (659)
|+|+....... ....+||+.|||||++
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l 184 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHH
T ss_pred CCCccccCCCCceeeecccccccccccCHHHh
Confidence 99987654322 2346899999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=328.83 Aligned_cols=169 Identities=17% Similarity=0.346 Sum_probs=151.6
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||+++++|.+ .+.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-------~~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-------GDE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-------TTE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-------CCE
Confidence 356888899999999999999965 599999999987665666779999999999999999999999987 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.|||||||++|+|.++++. ..+++.+...|+.||+.||+|||+. +||||||||+||||+.++.+||+|||+|+
T Consensus 223 ~~iVmEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccce
Confidence 9999999999999999975 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccccc-cccceecccccccCCCCCC
Q 006145 635 LAENA-EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~~~~-~~~~~~~gt~~y~aPE~~~ 658 (659)
..... ......+||+.|||||++.
T Consensus 296 ~~~~~~~~~~~~~GTp~YmAPEvl~ 320 (423)
T 4fie_A 296 QVSKEVPRRKSLVGTPYWMAPELIS 320 (423)
T ss_dssp ECCSSCCCBCCCEECTTTCCHHHHT
T ss_pred ECCCCCccccccccCcCcCCHHHHC
Confidence 76443 3456789999999999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=312.69 Aligned_cols=170 Identities=23% Similarity=0.282 Sum_probs=143.3
Q ss_pred CCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 480 DTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 480 ~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
...+.||+|+||+||+|+.. ++..||||++...... ..++|.+|+++|++++|||||+++++|.+... .....|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~---~~~~~~ 105 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK---GKKCIV 105 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET---TEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC---CCcEEE
Confidence 34567999999999999965 5899999999755432 23579999999999999999999999865221 134589
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec-CCcceEEccCccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD-QNLVAKISSYNLPLL 635 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~~ 635 (659)
||||||++|+|.+++++. ..+++..+..|+.||++||+|||++ .++||||||||+|||++ +++.+||+|||+|+.
T Consensus 106 lvmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 999999999999999852 4699999999999999999999996 23499999999999998 479999999999986
Q ss_pred cccccccceecccccccCCCCC
Q 006145 636 AENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
... ......+||+.|||||++
T Consensus 182 ~~~-~~~~~~~GTp~YmAPE~~ 202 (290)
T 3fpq_A 182 KRA-SFAKAVIGTPEFMAPEMY 202 (290)
T ss_dssp CCT-TSBEESCSSCCCCCGGGG
T ss_pred CCC-CccCCcccCccccCHHHc
Confidence 543 345667999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=309.60 Aligned_cols=168 Identities=18% Similarity=0.303 Sum_probs=133.6
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+ .
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-------~ 85 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-------K 85 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-------S
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-------C
Confidence 57999999999999999999964 699999999975432 234579999999999999999999999976 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..|+||||+ +|+|.+++.+. ..+++.+...++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 86 ~~~~ivmEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 86 DEIIMVIEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGL 158 (275)
T ss_dssp SEEEEEEECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred CEEEEEEeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCC
Confidence 6799999999 68999999752 4699999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|+...+.......+||+.|||||++.
T Consensus 159 a~~~~~~~~~~~~~GT~~Y~APE~~~ 184 (275)
T 3hyh_A 159 SNIMTDGNFLKTSCGSPNYAAPEVIS 184 (275)
T ss_dssp C---------------CTTSCHHHHS
T ss_pred CeecCCCCccCCeeECcccCChhhhc
Confidence 98876666667789999999999863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.40 Aligned_cols=179 Identities=16% Similarity=0.344 Sum_probs=138.5
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccC-----
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDD----- 549 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~----- 549 (659)
++|+..+.||+|+||+||+|+.. +|+.||||+++....+ ..+++.+|+++|++++|||||++++++.+....+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888899999999999999965 6999999999765433 2357999999999999999999999987532110
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEcc
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISS 629 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 629 (659)
......|+|||||++|+|.++++........++.....|+.||++||+|||+. +||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 11234799999999999999998643334567788899999999999999998 999999999999999999999999
Q ss_pred Cccccccccccc-------------cceecccccccCCCCCC
Q 006145 630 YNLPLLAENAEK-------------VGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 630 FGla~~~~~~~~-------------~~~~~gt~~y~aPE~~~ 658 (659)
||+|+..+.... ....+||+.|||||++.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~ 203 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH 203 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHT
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHc
Confidence 999987643221 23468999999999753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.92 Aligned_cols=164 Identities=16% Similarity=0.229 Sum_probs=140.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
+.|...++||+|+||+||+|+.. +|+.||||+++.... +.+|+++|++++|||||++++++.+ .+..
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~-------~~~~ 125 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVRE-------GPWV 125 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEE-------TTEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEE-------CCEE
Confidence 45667788999999999999965 599999999975432 2479999999999999999999986 5679
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc-ceEEccCcccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL-VAKISSYNLPL 634 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~ 634 (659)
|||||||++|+|.+++++. ..+++.+...|+.||+.||+|||+. +||||||||+|||++.++ .+||+|||+|+
T Consensus 126 ~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp EEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred EEEEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 9999999999999999852 4699999999999999999999998 999999999999999987 69999999998
Q ss_pred ccccccc------cceecccccccCCCCCC
Q 006145 635 LAENAEK------VGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 635 ~~~~~~~------~~~~~gt~~y~aPE~~~ 658 (659)
....... ....+||+.|||||++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~ 229 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHT
T ss_pred EccCCCcccceecCCccccCccccCHHHHC
Confidence 7643321 23468999999999863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=314.56 Aligned_cols=168 Identities=18% Similarity=0.258 Sum_probs=140.0
Q ss_pred cCCCCCceeccCcCceEEEEEec----CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK----NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
++|+..+.||+|+||+||+|+.. +++.||||+++.... ....++.+|+++|++++|||||++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT------ 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE------
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE------
Confidence 46888999999999999999852 478999999975432 223468999999999999999999999986
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+..|+|||||++|+|.+++++. ..+++.+...++.|++.||+|||+. +||||||||+|||+++++.+||+||
T Consensus 98 -~~~~~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DF 170 (304)
T 3ubd_A 98 -EGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDF 170 (304)
T ss_dssp -TTEEEEEECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESS
T ss_pred -CCEEEEEEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccc
Confidence 56799999999999999999852 4699999999999999999999998 9999999999999999999999999
Q ss_pred cccccccc-ccccceecccccccCCCCC
Q 006145 631 NLPLLAEN-AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~-~~~~~~~~gt~~y~aPE~~ 657 (659)
|+|+.... .......+||+.|||||++
T Consensus 171 Gla~~~~~~~~~~~~~~GT~~YmAPE~~ 198 (304)
T 3ubd_A 171 GLSKESIDHEKKAYSFCGTVEYMAPEVV 198 (304)
T ss_dssp EEEEC-----CCCCSCCCCGGGCCHHHH
T ss_pred ccceeccCCCccccccccCcccCCHHHh
Confidence 99986533 3345668999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.46 Aligned_cols=182 Identities=22% Similarity=0.345 Sum_probs=152.8
Q ss_pred cCHHHHHHhhcCCCCCceeccCcCceEEEEEecC------CcEEEEEEecccCCC-chHHHHHHHHHHhCCCC-CCccce
Q 006145 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKN------GTFVAIRCLKMKKCH-STRNFMHHIELISKLRH-RHLVSA 538 (659)
Q Consensus 467 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H-~niv~l 538 (659)
++.++++...++|...+.||+|+||+||+|++.. ++.||||+++..... ..++|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3456677778899999999999999999998642 468999999765433 34679999999999975 899999
Q ss_pred eeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCC
Q 006145 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGH-------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVP 605 (659)
Q Consensus 539 ~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 605 (659)
+|+|.+. .+..++|||||++|+|.++|+... ....++|.+++.|+.|||+||+|||+.
T Consensus 134 ~g~~~~~------~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~--- 204 (353)
T 4ase_A 134 LGACTKP------GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--- 204 (353)
T ss_dssp EEEECCT------TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred EEEEEec------CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---
Confidence 9999751 345899999999999999997421 134589999999999999999999998
Q ss_pred CccccCCCCCceeecCCcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 606 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 606 ~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
+||||||||+|||+++++.+||+|||+|+...... ..+..+||+.|||||++
T Consensus 205 ~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l 259 (353)
T 4ase_A 205 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 259 (353)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH
T ss_pred CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHH
Confidence 99999999999999999999999999998764332 23457899999999975
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.92 Aligned_cols=291 Identities=22% Similarity=0.233 Sum_probs=223.2
Q ss_pred CCCcCCCCCCCceEeCC----------CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCC-Cc
Q 006145 57 EFCNTEPTSSLTVVCYE----------ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPL-SG 125 (659)
Q Consensus 57 ~~C~w~~~~~~gv~C~~----------~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~-p~ 125 (659)
..|.|.+ ..|.|.. .+++.|+|++|.+.+..|. .+.++++|++|+|++|.+.+.+ +.
T Consensus 6 ~~c~~~~---~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~---------~~~~l~~L~~L~L~~n~~~~~i~~~ 73 (455)
T 3v47_A 6 SECSVIG---YNAICINRGLHQVPELPAHVNYVDLSLNSIAELNET---------SFSRLQDLQFLKVEQQTPGLVIRNN 73 (455)
T ss_dssp -CCEEET---TEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTT---------TTSSCTTCCEEECCCCSTTCEECTT
T ss_pred ceeEEEc---cccCcCCCCcccCCCCCCccCEEEecCCccCcCChh---------HhccCccccEEECcCCcccceECcc
Confidence 3466542 3477753 3589999999988755443 4567778888888888776554 55
Q ss_pred ccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccc--cCCCCCCCEEEccCCcCCccCCcc-cCCC
Q 006145 126 KISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDW--LGSLPILAVLSLRNNMFNGTLPDS-FSYL 202 (659)
Q Consensus 126 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~~p~~-~~~l 202 (659)
.|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++.+|.. +..+++|++|+|++|.+++..|.. |.++
T Consensus 74 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l 153 (455)
T 3v47_A 74 TFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNM 153 (455)
T ss_dssp TTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGC
T ss_pred cccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCC
Confidence 6778888888888888887777777888888888888888887655544 777888888888888887776765 6778
Q ss_pred CCCcEEeccccccccCCCC-CC----------------------------------CCCcCCEEEcccCCCCCCCCCC--
Q 006145 203 ENLRVLALSNNHFYGEVPD-FS----------------------------------GLTYLQVLDLENNALGPQFPKV-- 245 (659)
Q Consensus 203 ~~L~~L~Ls~N~l~~~~p~-~~----------------------------------~l~~L~~L~L~~N~l~~~~~~~-- 245 (659)
++|++|++++|++++..+. +. .+++|++|++++|.+++..|..
T Consensus 154 ~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~ 233 (455)
T 3v47_A 154 RRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFF 233 (455)
T ss_dssp TTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHH
T ss_pred CcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhh
Confidence 8888888888887776553 32 3367888888888765422210
Q ss_pred ----------------------------------------CcccceEecCCCcCCccCchhccCCccccEEeccCccccc
Q 006145 246 ----------------------------------------GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVG 285 (659)
Q Consensus 246 ----------------------------------------~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 285 (659)
..+|+.|++++|++++.+|..+..+++|+.|+|++|++++
T Consensus 234 ~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 313 (455)
T 3v47_A 234 DAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK 313 (455)
T ss_dssp HHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCE
T ss_pred ccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccc
Confidence 1468888888888888888888888899999999999888
Q ss_pred CCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccCCC
Q 006145 286 PFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGN 359 (659)
Q Consensus 286 ~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~~ 359 (659)
..|..|..+++|+.|+|++|++++..|..+..+++|+.|++++|++++..|..+..+++|+.+++++|.+++..
T Consensus 314 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 387 (455)
T 3v47_A 314 IDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVP 387 (455)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred cChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCC
Confidence 88888888899999999999988888888888888999999999998888888888888999999988887543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=309.48 Aligned_cols=273 Identities=18% Similarity=0.214 Sum_probs=143.8
Q ss_pred CCHHHHHHHHHHHhcC-CCC-CCCCCC----CCCCCCCcCCCCCCCceEeCC----------CCEeEEEeCCCCCCCCCC
Q 006145 28 LQSSQAQTLLRIQGLL-NNP-AVLSSW----NITTEFCNTEPTSSLTVVCYE----------ESITQLHIVGNKRAPMLP 91 (659)
Q Consensus 28 ~~~~~~~aLl~~k~~l-~~~-~~l~~W----~~~~~~C~w~~~~~~gv~C~~----------~~v~~L~l~~~~~~~~l~ 91 (659)
+..+|++||++||..+ .++ ..+.+| ....++|.|. |+.|.. .+|+.|+|+++.+. .
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~-----g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~-- 95 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRT-----GRALKATADLLEDATQPGRVALELRSVPLP-Q-- 95 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSH-----HHHHHHHHHHHHHHTSTTCCEEEEESSCCS-S--
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccC-----CcchhhhHHHHhcccccceeEEEccCCCch-h--
Confidence 5578999999999987 344 356778 4457889996 688841 45556665555543 1
Q ss_pred CCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCC
Q 006145 92 LSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRV 171 (659)
Q Consensus 92 ~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 171 (659)
+|..+.++++|++|+|++|.++ .+|..|+++++|++|+|++|.++ .+|..+.++++|++|+|++|++.+.+
T Consensus 96 -------lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~ 166 (328)
T 4fcg_A 96 -------FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTEL 166 (328)
T ss_dssp -------CCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCC
T ss_pred -------cChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCcccc
Confidence 2223444555555555555555 45555555555555555555555 44555555555555555555555555
Q ss_pred ccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccce
Q 006145 172 PDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVT 251 (659)
Q Consensus 172 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~ 251 (659)
|..++.. .++..|.++++|++|+|++|+++..+..+..+++|++|+|++|.+++
T Consensus 167 p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~----------- 220 (328)
T 4fcg_A 167 PEPLAST---------------DASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA----------- 220 (328)
T ss_dssp CSCSEEE---------------C-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC-----------
T ss_pred ChhHhhc---------------cchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc-----------
Confidence 5444320 00001122555555555555555322235555555555555554432
Q ss_pred EecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCC
Q 006145 252 MILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLL 331 (659)
Q Consensus 252 L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l 331 (659)
+|..++.+++|+.|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..+..+++|+.|+|++|++
T Consensus 221 -----------l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~ 289 (328)
T 4fcg_A 221 -----------LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289 (328)
T ss_dssp -----------CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTT
T ss_pred -----------CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCc
Confidence 223344444444444444444444444444444444444444444444444444444455555555555
Q ss_pred cccCChhhhCCCCCCEEEcCCcc
Q 006145 332 TGQLPNCLLAGSKNRVVLYARNC 354 (659)
Q Consensus 332 ~g~ip~~~~~~~~l~~l~~~~N~ 354 (659)
.|.+|..+..+++++.+.+..|.
T Consensus 290 ~~~iP~~l~~L~~L~~l~l~~~~ 312 (328)
T 4fcg_A 290 LSRLPSLIAQLPANCIILVPPHL 312 (328)
T ss_dssp CCCCCGGGGGSCTTCEEECCGGG
T ss_pred hhhccHHHhhccCceEEeCCHHH
Confidence 45555555555555554444443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.63 Aligned_cols=232 Identities=26% Similarity=0.384 Sum_probs=204.7
Q ss_pred CCCCEEEecCCCCcC--CCCcccCCCCCCcEEEccc-CcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCE
Q 006145 107 PDLKVLRLVSLGLWG--PLSGKISRLSSLEILNMSS-NFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAV 183 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 183 (659)
.+++.|+|++|.+++ .+|..|.++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|..+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 468889999999988 8888999999999999994 8898889988999999999999999998888988999999999
Q ss_pred EEccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCC-cCCEEEcccCCCCCCCCCCCcccceEecCCCcCCc
Q 006145 184 LSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLT-YLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRS 261 (659)
Q Consensus 184 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~-~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~ 261 (659)
|+|++|.+++.+|..|..+++|++|+|++|++++.+|. +..++ +|++|+|++ |++++
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~---------------------N~l~~ 188 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR---------------------NRLTG 188 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCS---------------------SEEEE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcC---------------------Ceeec
Confidence 99999999888888888899999999999988877664 66665 666665554 55567
Q ss_pred cCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhC
Q 006145 262 AIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLA 341 (659)
Q Consensus 262 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~ 341 (659)
.+|..+..++ |+.|+|++|.+++.+|..+..+++|+.|++++|++++.+|. +..+++|+.|++++|+++|.+|..+..
T Consensus 189 ~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 266 (313)
T 1ogq_A 189 KIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQ 266 (313)
T ss_dssp ECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGG
T ss_pred cCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhc
Confidence 7888888887 99999999999999999999999999999999999988776 788999999999999999999999999
Q ss_pred CCCCCEEEcCCccccCCCCC
Q 006145 342 GSKNRVVLYARNCLAAGNEN 361 (659)
Q Consensus 342 ~~~l~~l~~~~N~l~~~~~~ 361 (659)
+++++.+++++|.+++..|.
T Consensus 267 l~~L~~L~Ls~N~l~~~ip~ 286 (313)
T 1ogq_A 267 LKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp CTTCCEEECCSSEEEEECCC
T ss_pred CcCCCEEECcCCcccccCCC
Confidence 99999999999999976543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=302.32 Aligned_cols=274 Identities=19% Similarity=0.119 Sum_probs=216.4
Q ss_pred CEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCC
Q 006145 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSIL 154 (659)
Q Consensus 75 ~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 154 (659)
.++.|+|++|.+.+..+. .+.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+..|.++
T Consensus 33 ~l~~L~L~~n~l~~~~~~---------~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 103 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQD---------EFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGL 103 (477)
T ss_dssp TCSEEECCSSCCCEECTT---------TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTC
T ss_pred CCcEEECCCCccceECHh---------HccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCC
Confidence 577888888887654333 56678888888888888888888888888888888888888886666667888
Q ss_pred CCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEc
Q 006145 155 TSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDL 233 (659)
Q Consensus 155 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L 233 (659)
++|++|+|++|.+.+..|..|..+++|+.|+|++|.+++..|..|.++++|+.|+|++|++++.++. |..+++|+.|+|
T Consensus 104 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l 183 (477)
T 2id5_A 104 SNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRL 183 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEE
T ss_pred CCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeC
Confidence 8888888888888888888888888888888888888888888888888888888888888876654 778888888888
Q ss_pred ccCCCCCCCCCC---CcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCc
Q 006145 234 ENNALGPQFPKV---GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGK 310 (659)
Q Consensus 234 ~~N~l~~~~~~~---~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 310 (659)
++|.+.+..+.. +++|+.|++++|.+.+.+|.......+|+.|+|++|++++..+..+..+++|+.|+|++|++++.
T Consensus 184 ~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 263 (477)
T 2id5_A 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI 263 (477)
T ss_dssp ESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCcc
Confidence 888887665543 46777888888777777776666666788888888877755556777778888888888887777
Q ss_pred CCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 311 LFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 311 ~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
.+..+..+++|+.|+|++|++++..|..+..+++|+.+++++|.+++
T Consensus 264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 310 (477)
T 2id5_A 264 EGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT 310 (477)
T ss_dssp CTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSC
T ss_pred ChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCce
Confidence 77777777788888888888877777777777778888888877764
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=298.52 Aligned_cols=253 Identities=21% Similarity=0.206 Sum_probs=229.9
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccC-ChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEE
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAI-PQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLS 185 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 185 (659)
++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 68999999999999999999999999999999999998666 56799999999999999999999999999999999999
Q ss_pred ccCCcCCccCCcc--cCCCCCCcEEeccccccccCCCC--CCCCCcCCEEEcccCCCCCCCCCCC---------------
Q 006145 186 LRNNMFNGTLPDS--FSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKVG--------------- 246 (659)
Q Consensus 186 L~~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p~--~~~l~~L~~L~L~~N~l~~~~~~~~--------------- 246 (659)
|++|.+++.+|.. |.++++|++|+|++|++++..|. +.++++|++|++++|.+++..+...
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 9999999866665 99999999999999999998776 8899999999999999988766532
Q ss_pred ----------------------cccceEecCCCcCCccCchhccC-----------------------------------
Q 006145 247 ----------------------KKLVTMILSKNKFRSAIPAEVSS----------------------------------- 269 (659)
Q Consensus 247 ----------------------~~L~~L~l~~N~l~~~~p~~~~~----------------------------------- 269 (659)
++|+.|++++|++++.+|..+..
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~ 269 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTT
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccccc
Confidence 46888999999888766655432
Q ss_pred ----CccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCC
Q 006145 270 ----YYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKN 345 (659)
Q Consensus 270 ----l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l 345 (659)
.++|+.|++++|.+++.+|..+..+++|+.|++++|++++..|..+..+++|+.|++++|.+++..|..+..+++|
T Consensus 270 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 349 (455)
T 3v47_A 270 KGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKL 349 (455)
T ss_dssp GGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTC
T ss_pred ccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccC
Confidence 2589999999999999999999999999999999999999999999999999999999999998889999999999
Q ss_pred CEEEcCCccccCCC
Q 006145 346 RVVLYARNCLAAGN 359 (659)
Q Consensus 346 ~~l~~~~N~l~~~~ 359 (659)
+.+++++|.+++..
T Consensus 350 ~~L~Ls~N~l~~~~ 363 (455)
T 3v47_A 350 EVLDLSYNHIRALG 363 (455)
T ss_dssp CEEECCSSCCCEEC
T ss_pred CEEECCCCcccccC
Confidence 99999999998654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.00 Aligned_cols=173 Identities=14% Similarity=0.255 Sum_probs=145.5
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|...+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++|++++|||||++++++..... ....+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP-YGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC-TTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc-cccCC
Confidence 56888999999999999999965 6999999999754332 23568999999999999999999998864211 11245
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..|||||||+ |+|.+++.. ...+++.....|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 689999976 35799999999999999999999998 9999999999999999999999999999
Q ss_pred ccccc-----ccccceecccccccCCCCC
Q 006145 634 LLAEN-----AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~-----~~~~~~~~gt~~y~aPE~~ 657 (659)
+.... .......+||+.|||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~ 234 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELM 234 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHH
T ss_pred eecccCccccccccccceeChHhcCHHHh
Confidence 86532 2233567999999999974
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-32 Score=308.03 Aligned_cols=251 Identities=22% Similarity=0.213 Sum_probs=214.7
Q ss_pred cccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCC
Q 006145 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPIL 181 (659)
Q Consensus 102 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 181 (659)
.+.++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|
T Consensus 70 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L 149 (597)
T 3oja_B 70 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKL 149 (597)
T ss_dssp HHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred HHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCC
Confidence 35678999999999999999888899999999999999999998888889999999999999999996666667999999
Q ss_pred CEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCC-------------------cCCEEEcccCCCCCCC
Q 006145 182 AVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLT-------------------YLQVLDLENNALGPQF 242 (659)
Q Consensus 182 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~-------------------~L~~L~L~~N~l~~~~ 242 (659)
++|+|++|.+++..|..|+++++|+.|+|++|.+++.. +..++ +|+.|++++|.++...
T Consensus 150 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~ 227 (597)
T 3oja_B 150 TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVR 227 (597)
T ss_dssp CEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC--GGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEE
T ss_pred CEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC--hhhhhhhhhhhcccCccccccCCchhheeeccCCcccccc
Confidence 99999999999988889999999999999999998753 23333 4555555555555444
Q ss_pred CCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCC
Q 006145 243 PKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELG 322 (659)
Q Consensus 243 ~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~ 322 (659)
+....+|+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|..|..+++|+.|+|++|++++ +|..+..+++|+
T Consensus 228 ~~~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~ 304 (597)
T 3oja_B 228 GPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLK 304 (597)
T ss_dssp CSCCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCC
T ss_pred cccCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCc
Confidence 4445689999999999987 4678899999999999999999999999999999999999999987 466777889999
Q ss_pred EEECcCCCCcccCChhhhCCCCCCEEEcCCccccCC
Q 006145 323 FVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAG 358 (659)
Q Consensus 323 ~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~ 358 (659)
.|+|++|.++ .+|..+..+++|+.+++++|.+++.
T Consensus 305 ~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~ 339 (597)
T 3oja_B 305 VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL 339 (597)
T ss_dssp EEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC
T ss_pred EEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc
Confidence 9999999998 6888888889999999999988754
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-32 Score=300.41 Aligned_cols=275 Identities=20% Similarity=0.149 Sum_probs=252.2
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.+++.|+|++|.+.+..|. .+.++++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.+
T Consensus 56 ~~L~~L~L~~n~i~~~~~~---------~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~ 126 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPG---------AFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQD 126 (477)
T ss_dssp TTCCEEECTTSCCCEECTT---------TTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred CCCCEEECCCCccCEeChh---------hhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccc
Confidence 4789999999987755443 5778999999999999999888888999999999999999999999999999
Q ss_pred CCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEE
Q 006145 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLD 232 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~ 232 (659)
+++|++|+|++|.+.+..|..|.++++|+.|+|++|.+++..+..|.++++|+.|+|++|.+.+..+. |..+++|+.|+
T Consensus 127 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 206 (477)
T 2id5_A 127 LYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206 (477)
T ss_dssp CTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEE
T ss_pred cccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceee
Confidence 99999999999999999999999999999999999999987777899999999999999999987774 99999999999
Q ss_pred cccCCCCCCCCCC---CcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCC
Q 006145 233 LENNALGPQFPKV---GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG 309 (659)
Q Consensus 233 L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 309 (659)
+++|.+.+.+|.. ..+|+.|++++|++++..+..+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++
T Consensus 207 l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 286 (477)
T 2id5_A 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV 286 (477)
T ss_dssp EECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSE
T ss_pred CCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccce
Confidence 9999887766653 3589999999999997666789999999999999999998888899999999999999999999
Q ss_pred cCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 310 KLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 310 ~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
..|..+..+++|+.|++++|++++..+..+..+++|+.+++++|.+.+
T Consensus 287 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 287 VEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp ECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred ECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence 999999999999999999999998777778888999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=295.89 Aligned_cols=167 Identities=12% Similarity=0.212 Sum_probs=142.0
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec----CCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeecccc
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK----NGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFD 548 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 548 (659)
...+.|...+.||+|+||+||+|+.+ +++.||||++.... ...++.+|+++|+.+ +|||||++++++.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~---- 91 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK---- 91 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE----
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE----
Confidence 34678999999999999999999853 47899999986543 356789999999998 69999999999876
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC-cceEE
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN-LVAKI 627 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl 627 (659)
.+..|+|||||++|+|.++++ .+++.+...++.|++.||+|||+. +||||||||+|||++.+ +.+||
T Consensus 92 ---~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl 159 (361)
T 4f9c_A 92 ---NDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYAL 159 (361)
T ss_dssp ---TTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred ---CCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEE
Confidence 567999999999999999985 388999999999999999999998 99999999999999977 89999
Q ss_pred ccCcccccccccc-----------------------------ccceecccccccCCCCCC
Q 006145 628 SSYNLPLLAENAE-----------------------------KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 628 ~DFGla~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~ 658 (659)
+|||+|+...+.. .....+||+.|||||++.
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 219 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLT 219 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHT
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence 9999997543221 123468999999999753
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-31 Score=287.42 Aligned_cols=268 Identities=20% Similarity=0.198 Sum_probs=220.2
Q ss_pred CEeEEEeCCCCCCCCCCCCCcCCcccc-cccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 75 SITQLHIVGNKRAPMLPLSFSMDSFVT-TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 75 ~v~~L~l~~~~~~~~l~~~~~~~~~~~-~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.++.|++.++.+. .+|. .+.++++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|.+
T Consensus 46 ~l~~l~l~~~~l~----------~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 115 (390)
T 3o6n_A 46 NQKIVTFKNSTMR----------KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN 115 (390)
T ss_dssp CCSEEEEESCEES----------EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred CceEEEecCCchh----------hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcC
Confidence 3555666665433 2333 3577899999999999998888889999999999999999999888888999
Q ss_pred CCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCC-------
Q 006145 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLT------- 226 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~------- 226 (659)
+++|++|+|++|.++...+..|..+++|++|++++|.+++..|..|.++++|+.|++++|++++.. +..++
T Consensus 116 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l 193 (390)
T 3o6n_A 116 VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANV 193 (390)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEEC
T ss_pred CCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc--cccccccceeec
Confidence 999999999999998554455789999999999999999888888999999999999999988653 23333
Q ss_pred ------------cCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCC
Q 006145 227 ------------YLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSL 294 (659)
Q Consensus 227 ------------~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 294 (659)
+|++|++++|.++........+|+.|++++|.+++. ..+..+++|+.|+|++|.+++..|..+..+
T Consensus 194 ~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l 271 (390)
T 3o6n_A 194 SYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKM 271 (390)
T ss_dssp CSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTC
T ss_pred ccccccccCCCCcceEEECCCCeeeeccccccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcccc
Confidence 455556666655544444456899999999999874 578899999999999999999889999999
Q ss_pred CcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccCC
Q 006145 295 PSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAG 358 (659)
Q Consensus 295 ~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~ 358 (659)
++|+.|++++|++++ +|..+..+++|+.|++++|+++ .+|..+..+++++.+++++|.++..
T Consensus 272 ~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~ 333 (390)
T 3o6n_A 272 QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL 333 (390)
T ss_dssp SSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC
T ss_pred ccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee
Confidence 999999999999986 4666778899999999999998 6788888889999999999998743
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.3e-33 Score=309.72 Aligned_cols=169 Identities=21% Similarity=0.290 Sum_probs=144.8
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHH---HHHHHHhCCCCCCccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFM---HHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~---~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
.++|...+.||+|+||+||+|+.. +|+.||||++++.. ......+. +++++++.++|||||++++++.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~---- 263 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---- 263 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE----
Confidence 367889999999999999999965 59999999996532 12223333 44677888999999999999986
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
.+..|||||||+||+|.++|.+. ..+++.....|+.||+.||+|||+. +||||||||+|||||++|.+||+
T Consensus 264 ---~~~lylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~ 334 (689)
T 3v5w_A 264 ---PDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS 334 (689)
T ss_dssp ---SSEEEEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred ---CCEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEec
Confidence 56799999999999999999852 4699999999999999999999998 99999999999999999999999
Q ss_pred cCccccccccccccceecccccccCCCCCC
Q 006145 629 SYNLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 629 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|||+|+..... .....+||+.|||||++.
T Consensus 335 DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~ 363 (689)
T 3v5w_A 335 DLGLACDFSKK-KPHASVGTHGYMAPEVLQ 363 (689)
T ss_dssp CCTTCEECSSC-CCCSCCSCGGGCCHHHHS
T ss_pred ccceeeecCCC-CCCCccCCcCccCHHHHh
Confidence 99999876543 345679999999999863
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.98 E-value=5e-32 Score=308.95 Aligned_cols=279 Identities=19% Similarity=0.212 Sum_probs=242.3
Q ss_pred CCEeEEEeCCCCCCCC-CCCCCcC-------Cccccccc--CCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCc-
Q 006145 74 ESITQLHIVGNKRAPM-LPLSFSM-------DSFVTTLV--KLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNF- 142 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~-l~~~~~~-------~~~~~~l~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~- 142 (659)
.+++.|+|++|.+.+. ++..... +.+|..+. ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~ 285 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence 5799999999998873 1111111 11566788 99999999999999999999999999999999999998
Q ss_pred Ccc-cCChhccCC------CCCcEEEeecCCCCCCCcc--ccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEecccc
Q 006145 143 LNG-AIPQELSIL------TSLQTLILDENMLAGRVPD--WLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNN 213 (659)
Q Consensus 143 l~~-~~p~~~~~l------~~L~~L~Ls~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 213 (659)
++| .+|..++++ ++|++|+|++|+++ .+|. .++.+++|++|++++|+++|.+| .|+++++|+.|+|++|
T Consensus 286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N 363 (636)
T 4eco_A 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYN 363 (636)
T ss_dssp SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSS
T ss_pred CccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCC
Confidence 999 899999887 99999999999999 8998 99999999999999999999999 9999999999999999
Q ss_pred ccccCCCCCCCCCc-CCEEEcccCCCCCCCCCC-----CcccceEecCCCcCCccCchhcc-------CCccccEEeccC
Q 006145 214 HFYGEVPDFSGLTY-LQVLDLENNALGPQFPKV-----GKKLVTMILSKNKFRSAIPAEVS-------SYYQLQRLDLSS 280 (659)
Q Consensus 214 ~l~~~~p~~~~l~~-L~~L~L~~N~l~~~~~~~-----~~~L~~L~l~~N~l~~~~p~~~~-------~l~~L~~L~Ls~ 280 (659)
+++..+..+..+++ |++|++++|.++ .+|.. ..+|+.|++++|.+++.+|..+. .+++|+.|+|++
T Consensus 364 ~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~ 442 (636)
T 4eco_A 364 QITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSN 442 (636)
T ss_dssp EEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCS
T ss_pred ccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcC
Confidence 99955556999999 999999999999 55554 23799999999999999999888 888999999999
Q ss_pred cccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCC-C-------CCCCEEECcCCCCcccCChhhh--CCCCCCEEEc
Q 006145 281 NRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSC-N-------PELGFVDLSSNLLTGQLPNCLL--AGSKNRVVLY 350 (659)
Q Consensus 281 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~-~-------~~L~~L~ls~N~l~g~ip~~~~--~~~~l~~l~~ 350 (659)
|+++...+..+..+++|+.|+|++|+++ .+|..... . ++|+.|++++|+++ .+|..+. .+++++.+++
T Consensus 443 N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~L 520 (636)
T 4eco_A 443 NQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDL 520 (636)
T ss_dssp SCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEEC
T ss_pred CccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEEC
Confidence 9999544455667999999999999999 55654332 2 28999999999999 7998887 8899999999
Q ss_pred CCccccC
Q 006145 351 ARNCLAA 357 (659)
Q Consensus 351 ~~N~l~~ 357 (659)
++|.+++
T Consensus 521 s~N~l~~ 527 (636)
T 4eco_A 521 SYNSFSK 527 (636)
T ss_dssp CSSCCSS
T ss_pred CCCCCCC
Confidence 9999985
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-31 Score=301.28 Aligned_cols=300 Identities=21% Similarity=0.231 Sum_probs=191.5
Q ss_pred CCCcCCCCCCCceEeCC-----------CCEeEEEeCCCCCCCCCCCCCc-----------C---Ccc-cccccCCCCCC
Q 006145 57 EFCNTEPTSSLTVVCYE-----------ESITQLHIVGNKRAPMLPLSFS-----------M---DSF-VTTLVKLPDLK 110 (659)
Q Consensus 57 ~~C~w~~~~~~gv~C~~-----------~~v~~L~l~~~~~~~~l~~~~~-----------~---~~~-~~~l~~l~~L~ 110 (659)
++|.|. .....|.|.+ .+++.|+|++|.+.+..+..|. . ..+ +..+.++++|+
T Consensus 5 ~~c~~~-~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~ 83 (606)
T 3vq2_A 5 NPCIEV-VPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83 (606)
T ss_dssp -CCEEE-ETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCceec-CCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence 456652 1223577743 3689999999988765543221 1 112 34566777777
Q ss_pred EEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCC-CCccccCCCCCCCEEEccCC
Q 006145 111 VLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAG-RVPDWLGSLPILAVLSLRNN 189 (659)
Q Consensus 111 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N 189 (659)
+|+|++|.+++..|..|+++++|++|+|++|.+++..|..++++++|++|+|++|.+.+ .+|..|+++++|++|++++|
T Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp EEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred EeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 77777777777777777777777777777777776666667777777777777777765 56777777777777777777
Q ss_pred cCCccCCcccCCCC------------------------------------------------------------------
Q 006145 190 MFNGTLPDSFSYLE------------------------------------------------------------------ 203 (659)
Q Consensus 190 ~l~~~~p~~~~~l~------------------------------------------------------------------ 203 (659)
++++..|..|+.++
T Consensus 164 ~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~ 243 (606)
T 3vq2_A 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243 (606)
T ss_dssp CCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTT
T ss_pred cceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhcccccccccccccccccc
Confidence 77655443322111
Q ss_pred ----------------------------------------------------------------CCcEEeccccccccCC
Q 006145 204 ----------------------------------------------------------------NLRVLALSNNHFYGEV 219 (659)
Q Consensus 204 ----------------------------------------------------------------~L~~L~Ls~N~l~~~~ 219 (659)
+|+.|++++|.+ +.+
T Consensus 244 ~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l-~~l 322 (606)
T 3vq2_A 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQL-KQF 322 (606)
T ss_dssp SCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCC-SSC
T ss_pred CCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccC-ccc
Confidence 111222222221 111
Q ss_pred CC---------------------CCCCCcCCEEEcccCCCCCC--------------------------CCC--CCcccc
Q 006145 220 PD---------------------FSGLTYLQVLDLENNALGPQ--------------------------FPK--VGKKLV 250 (659)
Q Consensus 220 p~---------------------~~~l~~L~~L~L~~N~l~~~--------------------------~~~--~~~~L~ 250 (659)
|. +..+++|++|++++|.+++. ... .+++|+
T Consensus 323 p~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~ 402 (606)
T 3vq2_A 323 PTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQ 402 (606)
T ss_dssp CCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCC
T ss_pred ccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCC
Confidence 11 11223333444444433221 100 124567
Q ss_pred eEecCCCcCCccCc-hhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCC-cCCcCCCCCCCCCEEECcC
Q 006145 251 TMILSKNKFRSAIP-AEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG-KLFDDLSCNPELGFVDLSS 328 (659)
Q Consensus 251 ~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~-~~p~~~~~~~~L~~L~ls~ 328 (659)
.|++++|++.+..| ..+..+++|+.|++++|.+++..|..+..+++|+.|++++|++++ .+|..+..+++|+.|++++
T Consensus 403 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~ 482 (606)
T 3vq2_A 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482 (606)
T ss_dssp EEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred eeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCC
Confidence 77777777777666 567778888888888888877777777788888888888888777 3677777778888888888
Q ss_pred CCCcccCChhhhCCCCCCEEEcCCccccCC
Q 006145 329 NLLTGQLPNCLLAGSKNRVVLYARNCLAAG 358 (659)
Q Consensus 329 N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~ 358 (659)
|++++..|..+..+++|+.+++++|.+++.
T Consensus 483 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 512 (606)
T 3vq2_A 483 CQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512 (606)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCSCE
T ss_pred CcCCccChhhhcccccCCEEECCCCcCCCc
Confidence 888777777777777788888888777653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=297.85 Aligned_cols=273 Identities=21% Similarity=0.156 Sum_probs=232.8
Q ss_pred CEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCC
Q 006145 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSIL 154 (659)
Q Consensus 75 ~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 154 (659)
+++.|++++|.+.+..+. .+.++++|++|+|++|.++ .+|..+.++++|++|++++|.+++..|..+.++
T Consensus 255 ~L~~L~l~~n~l~~~~~~---------~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l 324 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSN---------TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNF 324 (606)
T ss_dssp EEEEEECTTCCCSSCCTT---------TTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGC
T ss_pred ceeEEEeecCccCccCHH---------HhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhcc
Confidence 688999999887654433 4667889999999999887 677788999999999999999988888888999
Q ss_pred CCCcEEEeecCCCCCCCcc-ccCCCCCCCEEEccCCcCCccC--CcccCCCCCCcEEeccccccccCCCC-CCCCCcCCE
Q 006145 155 TSLQTLILDENMLAGRVPD-WLGSLPILAVLSLRNNMFNGTL--PDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQV 230 (659)
Q Consensus 155 ~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~ 230 (659)
++|++|++++|.+.+.+|. .+..+++|++|++++|.+++.. |..+..+++|++|++++|++++..|. |..+++|++
T Consensus 325 ~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 404 (606)
T 3t6q_A 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLEL 404 (606)
T ss_dssp TTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSE
T ss_pred CcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCe
Confidence 9999999999998877765 4888999999999999988765 77888999999999999998887765 888899999
Q ss_pred EEcccCCCCCCCCCC----CcccceEecCCCcCCccCchhccCCccccEEeccCcccccC---CchhhcCCCcccEEecc
Q 006145 231 LDLENNALGPQFPKV----GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGP---FPQALLSLPSITYLNIA 303 (659)
Q Consensus 231 L~L~~N~l~~~~~~~----~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~l~~l~~L~~L~l~ 303 (659)
|++++|.+.+..+.. +++|+.|++++|.+++..|..+..+++|+.|++++|++++. .+..+..+++|+.|+++
T Consensus 405 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls 484 (606)
T 3t6q_A 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484 (606)
T ss_dssp EECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECT
T ss_pred EECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECC
Confidence 999999988766542 57889999999999888888889999999999999998862 34678889999999999
Q ss_pred CCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccCC
Q 006145 304 DNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAG 358 (659)
Q Consensus 304 ~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~ 358 (659)
+|++++..|..+..+++|+.|++++|++++.+|..+..++.+ .+++++|.+++.
T Consensus 485 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~ 538 (606)
T 3t6q_A 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISII 538 (606)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCC
T ss_pred CCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCccccc
Confidence 999998888889899999999999999999888888888888 899999988853
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=308.43 Aligned_cols=170 Identities=18% Similarity=0.274 Sum_probs=152.2
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|+..+.||+|+||+||+|+.+ +|+.||||++........+.+.+|+++|+.++|||||++++++.+ .+.
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-------~~~ 228 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-------DNE 228 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-------SSE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-------CCE
Confidence 367889999999999999999965 599999999976554445679999999999999999999999976 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC--cceEEccCcc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN--LVAKISSYNL 632 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~--~~~kl~DFGl 632 (659)
.|||||||++|+|.+++... ...+++.+...++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred EEEEEeecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccc
Confidence 99999999999999999743 24699999999999999999999998 99999999999999854 8999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+...........+||+.|||||++
T Consensus 304 a~~~~~~~~~~~~~GT~~y~APEv~ 328 (573)
T 3uto_A 304 TAHLDPKQSVKVTTGTAEFAAPEVA 328 (573)
T ss_dssp CEECCTTSEEEEECSSGGGCCHHHH
T ss_pred eeEccCCCceeeeEECccccCHHHh
Confidence 9988777777788999999999975
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=300.80 Aligned_cols=303 Identities=24% Similarity=0.271 Sum_probs=219.3
Q ss_pred CCCCCCCCC----CCCcCCCCCCCceEeCC-----------CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEE
Q 006145 48 VLSSWNITT----EFCNTEPTSSLTVVCYE-----------ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVL 112 (659)
Q Consensus 48 ~l~~W~~~~----~~C~w~~~~~~gv~C~~-----------~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L 112 (659)
.+++|+.+. ++|.+. .+...|.|.. ..++.|||++|+++...+. .|.++++|++|
T Consensus 12 ~~~~~~~~~p~~~~~c~~~-~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~---------~f~~l~~L~~L 81 (635)
T 4g8a_A 12 KLAAANSSIPESWEPCVEV-VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSY---------SFFSFPELQVL 81 (635)
T ss_dssp -------------CCSEEE-ETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTT---------TTTTCTTCCEE
T ss_pred hhhcccCCCCCCCCCcccc-CCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHH---------HHhCCCCCCEE
Confidence 466665432 345442 1234688953 2689999999988754443 46678888888
Q ss_pred EecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCC
Q 006145 113 RLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFN 192 (659)
Q Consensus 113 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 192 (659)
+|++|++++..|++|.+|++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|+++++|++|+|++|.++
T Consensus 82 ~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~ 161 (635)
T 4g8a_A 82 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 161 (635)
T ss_dssp ECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccc
Confidence 88888888888888888888888888888888776777888888888888888888776677888888888888888886
Q ss_pred c-cCCcccCCCCCCcEEeccccccccCCCC-C------------------------------------------------
Q 006145 193 G-TLPDSFSYLENLRVLALSNNHFYGEVPD-F------------------------------------------------ 222 (659)
Q Consensus 193 ~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~------------------------------------------------ 222 (659)
+ .+|..++.+++|++|+|++|++++..+. |
T Consensus 162 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~ 241 (635)
T 4g8a_A 162 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVM 241 (635)
T ss_dssp CCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHH
T ss_pred cCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhccccccccc
Confidence 5 4677788888888888888766432210 0
Q ss_pred --------------------------------------------------------------------------------
Q 006145 223 -------------------------------------------------------------------------------- 222 (659)
Q Consensus 223 -------------------------------------------------------------------------------- 222 (659)
T Consensus 242 ~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~ 321 (635)
T 4g8a_A 242 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV 321 (635)
T ss_dssp HHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC
T ss_pred chhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc
Confidence
Q ss_pred ----------------------------------------------CCCCcCCEEEcccCCCCCC--C------------
Q 006145 223 ----------------------------------------------SGLTYLQVLDLENNALGPQ--F------------ 242 (659)
Q Consensus 223 ----------------------------------------------~~l~~L~~L~L~~N~l~~~--~------------ 242 (659)
..+++|+.|++++|.+... .
T Consensus 322 ~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~ 401 (635)
T 4g8a_A 322 KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKY 401 (635)
T ss_dssp GGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCE
T ss_pred cccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhh
Confidence 0123344444444443210 0
Q ss_pred -----------------------------------C----CCCcccceEecCCCcCCccCchhccCCccccEEeccCccc
Q 006145 243 -----------------------------------P----KVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRF 283 (659)
Q Consensus 243 -----------------------------------~----~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 283 (659)
+ ....++..++++.|.+.+..|..+..+++|+.|+|++|++
T Consensus 402 L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~ 481 (635)
T 4g8a_A 402 LDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 481 (635)
T ss_dssp EECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEE
T ss_pred hhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhccc
Confidence 0 0013456677778888888888888888999999988875
Q ss_pred c-cCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccCCCC
Q 006145 284 V-GPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGNE 360 (659)
Q Consensus 284 ~-~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~~~ 360 (659)
. +.+|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|+|++..|..+..+++|+.+++++|.+++..+
T Consensus 482 ~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~ 559 (635)
T 4g8a_A 482 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 559 (635)
T ss_dssp GGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCS
T ss_pred ccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCH
Confidence 4 4567888888899999999999988888888888999999999999988888888888889999999998887654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=301.70 Aligned_cols=273 Identities=23% Similarity=0.224 Sum_probs=251.1
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChh-cc
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQE-LS 152 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~ 152 (659)
.+++.|++++|.+. .+ |..+.++++|++|++++|.+.+..|..+.++++|+.|++++|.+.+.+|.. +.
T Consensus 278 ~~L~~L~l~~n~l~-~l---------p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~ 347 (606)
T 3t6q_A 278 SGLQELDLTATHLS-EL---------PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347 (606)
T ss_dssp TTCSEEECTTSCCS-CC---------CSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTT
T ss_pred cCCCEEeccCCccC-CC---------ChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhh
Confidence 47899999999876 33 446788999999999999999999999999999999999999999887765 89
Q ss_pred CCCCCcEEEeecCCCCCCC--ccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCC--CCCCCcC
Q 006145 153 ILTSLQTLILDENMLAGRV--PDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYL 228 (659)
Q Consensus 153 ~l~~L~~L~Ls~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~l~~L 228 (659)
++++|++|++++|.+.+.. |..+..+++|++|++++|.+.+..|..|..+++|+.|++++|++++..+. +..+++|
T Consensus 348 ~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 427 (606)
T 3t6q_A 348 NLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427 (606)
T ss_dssp TCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTC
T ss_pred ccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccC
Confidence 9999999999999998776 78899999999999999999999999999999999999999999987654 8999999
Q ss_pred CEEEcccCCCCCCCCCC---CcccceEecCCCcCCcc---CchhccCCccccEEeccCcccccCCchhhcCCCcccEEec
Q 006145 229 QVLDLENNALGPQFPKV---GKKLVTMILSKNKFRSA---IPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNI 302 (659)
Q Consensus 229 ~~L~L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l 302 (659)
++|++++|.+++..|.. +++|++|++++|++++. .+..+..+++|+.|++++|++++..|..|..+++|+.|+|
T Consensus 428 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 507 (606)
T 3t6q_A 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDL 507 (606)
T ss_dssp CEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEEC
Confidence 99999999999888765 57899999999999873 3467899999999999999999999999999999999999
Q ss_pred cCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 303 ADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 303 ~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
++|++++..|..+..++.| .|++++|++++.+|..+..+++++.+++++|.+.+
T Consensus 508 s~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 561 (606)
T 3t6q_A 508 SHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561 (606)
T ss_dssp CSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEEC
T ss_pred CCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccc
Confidence 9999999999999999999 99999999999989889999999999999999875
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=272.21 Aligned_cols=266 Identities=20% Similarity=0.230 Sum_probs=231.7
Q ss_pred EeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCC
Q 006145 76 ITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILT 155 (659)
Q Consensus 76 v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 155 (659)
++.++++++.+. .+|. .+. ++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.+++
T Consensus 33 l~~l~~~~~~l~-~lp~---------~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 100 (330)
T 1xku_A 33 LRVVQCSDLGLE-KVPK---------DLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLV 100 (330)
T ss_dssp TTEEECTTSCCC-SCCC---------SCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCT
T ss_pred CeEEEecCCCcc-ccCc---------cCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCC
Confidence 455677766554 2332 222 5899999999999998888999999999999999999988899999999
Q ss_pred CCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEecccccccc--CCC-CCCCCCcCCEEE
Q 006145 156 SLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYG--EVP-DFSGLTYLQVLD 232 (659)
Q Consensus 156 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p-~~~~l~~L~~L~ 232 (659)
+|++|+|++|+++ .+|..+. ++|++|++++|.+++..+..|.++++|+.|++++|.++. ..+ .+.++++|++|+
T Consensus 101 ~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~ 177 (330)
T 1xku_A 101 KLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177 (330)
T ss_dssp TCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEE
T ss_pred CCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEE
Confidence 9999999999998 5676654 799999999999998888889999999999999999964 444 388999999999
Q ss_pred cccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCC
Q 006145 233 LENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLF 312 (659)
Q Consensus 233 L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 312 (659)
+++|.++.......++|+.|++++|++++..|..+..+++|+.|+|++|.+++..+..+..+++|+.|++++|+++ .+|
T Consensus 178 l~~n~l~~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp 256 (330)
T 1xku_A 178 IADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256 (330)
T ss_dssp CCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCC
T ss_pred CCCCccccCCccccccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCC
Confidence 9999998766666789999999999999999999999999999999999999888889999999999999999999 788
Q ss_pred cCCCCCCCCCEEECcCCCCcccCChhhhC------CCCCCEEEcCCccccC
Q 006145 313 DDLSCNPELGFVDLSSNLLTGQLPNCLLA------GSKNRVVLYARNCLAA 357 (659)
Q Consensus 313 ~~~~~~~~L~~L~ls~N~l~g~ip~~~~~------~~~l~~l~~~~N~l~~ 357 (659)
..+..+++|+.|++++|++++..+..+.. ...+..+++.+|.+..
T Consensus 257 ~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 257 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp TTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred hhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccc
Confidence 88999999999999999999765555533 3567889999998763
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=272.70 Aligned_cols=264 Identities=22% Similarity=0.234 Sum_probs=230.0
Q ss_pred EeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCC
Q 006145 76 ITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILT 155 (659)
Q Consensus 76 v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 155 (659)
++.++++++.+. .+|. .+ .++|+.|+|++|.+++..|..|.++++|++|+|++|.+++..|..|.+++
T Consensus 35 l~~l~~~~~~l~-~ip~---------~~--~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 102 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPK---------EI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLR 102 (332)
T ss_dssp TTEEECCSSCCS-SCCS---------CC--CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCT
T ss_pred CCEEECCCCCcc-ccCC---------CC--CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcC
Confidence 456777776654 3333 22 26899999999999998899999999999999999999988899999999
Q ss_pred CCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEecccccccc--CCCC-CCCCCcCCEEE
Q 006145 156 SLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYG--EVPD-FSGLTYLQVLD 232 (659)
Q Consensus 156 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~-~~~l~~L~~L~ 232 (659)
+|++|+|++|+++ .+|..+. ++|++|++++|.+++..+..|.++++|+.|++++|.++. ..+. +..+ +|++|+
T Consensus 103 ~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~ 178 (332)
T 2ft3_A 103 KLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLR 178 (332)
T ss_dssp TCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCB
T ss_pred CCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEE
Confidence 9999999999998 6776655 899999999999997777789999999999999999963 4454 7777 999999
Q ss_pred cccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCC
Q 006145 233 LENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLF 312 (659)
Q Consensus 233 L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 312 (659)
+++|.+++......++|+.|++++|.+++..|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|+++ .+|
T Consensus 179 l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp 257 (332)
T 2ft3_A 179 ISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP 257 (332)
T ss_dssp CCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCC
T ss_pred CcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecC
Confidence 9999999866666789999999999999988899999999999999999999988889999999999999999999 788
Q ss_pred cCCCCCCCCCEEECcCCCCcccCChhhhC------CCCCCEEEcCCcccc
Q 006145 313 DDLSCNPELGFVDLSSNLLTGQLPNCLLA------GSKNRVVLYARNCLA 356 (659)
Q Consensus 313 ~~~~~~~~L~~L~ls~N~l~g~ip~~~~~------~~~l~~l~~~~N~l~ 356 (659)
..+..+++|+.|++++|++++..+..+.. ...+..+++.+|.+.
T Consensus 258 ~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 258 AGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp TTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred hhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccc
Confidence 88999999999999999999766665544 356788999999876
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=306.96 Aligned_cols=289 Identities=19% Similarity=0.181 Sum_probs=207.9
Q ss_pred eEeCCCCEeEEEeCCCCCCCCCCCCCc---------------CCcc-cccccCCCCCCEEEecCCCCcCCCCcccCCCCC
Q 006145 69 VVCYEESITQLHIVGNKRAPMLPLSFS---------------MDSF-VTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSS 132 (659)
Q Consensus 69 v~C~~~~v~~L~l~~~~~~~~l~~~~~---------------~~~~-~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 132 (659)
|.+...+++.|+|++|.+.+..|..|. ...+ +..+.++++|++|+|++|.+++..|..|+++++
T Consensus 19 vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~ 98 (844)
T 3j0a_A 19 VPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFH 98 (844)
T ss_dssp CCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSS
T ss_pred CCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcc
Confidence 444346789999999988765554321 1122 344666666666666666666666666666666
Q ss_pred CcEEEcccCcCcccCChh--ccCCCCCcEEEeecCCCCCCCc-cccCCCCCCCEEEccCCcCCccCCcccCCC--CCCcE
Q 006145 133 LEILNMSSNFLNGAIPQE--LSILTSLQTLILDENMLAGRVP-DWLGSLPILAVLSLRNNMFNGTLPDSFSYL--ENLRV 207 (659)
Q Consensus 133 L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~ 207 (659)
|++|+|++|.+++.+|.. |.++++|++|+|++|.+++..| ..|+++++|++|+|++|.+++..|..+..+ ++|+.
T Consensus 99 L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~ 178 (844)
T 3j0a_A 99 LFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSF 178 (844)
T ss_dssp CCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCC
T ss_pred cCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccce
Confidence 666666666666655544 6666666666666666665543 456666666666666666666666666555 56666
Q ss_pred EeccccccccCCCC-CCCCCc------CCEEEcccCCCCCCCCCC-----------------------------------
Q 006145 208 LALSNNHFYGEVPD-FSGLTY------LQVLDLENNALGPQFPKV----------------------------------- 245 (659)
Q Consensus 208 L~Ls~N~l~~~~p~-~~~l~~------L~~L~L~~N~l~~~~~~~----------------------------------- 245 (659)
|++++|.+.+..|. +..+.+ |+.|++++|.+++..+..
T Consensus 179 L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~ 258 (844)
T 3j0a_A 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258 (844)
T ss_dssp CEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGT
T ss_pred EECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChh
Confidence 66666666655443 444443 888888888776544321
Q ss_pred ------CcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCC
Q 006145 246 ------GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNP 319 (659)
Q Consensus 246 ------~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 319 (659)
..+|+.|++++|.+.+..|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..+..++
T Consensus 259 ~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 338 (844)
T 3j0a_A 259 TFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLP 338 (844)
T ss_dssp TTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCT
T ss_pred hhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCC
Confidence 14688899999999888888899999999999999999988888899999999999999999988888899999
Q ss_pred CCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 320 ELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 320 ~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
+|+.|++++|++++..|..+..+++|+.+++++|.+++
T Consensus 339 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~ 376 (844)
T 3j0a_A 339 KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT 376 (844)
T ss_dssp TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC
T ss_pred CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc
Confidence 99999999999987777778888888888888887764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-30 Score=268.50 Aligned_cols=265 Identities=19% Similarity=0.213 Sum_probs=230.4
Q ss_pred CEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCC
Q 006145 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSIL 154 (659)
Q Consensus 75 ~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 154 (659)
.++.|++++|++.+..+. .+.++++|++|+|++|.+++..|..|.++++|++|+|++|.++ .+|..+.
T Consensus 53 ~l~~L~L~~n~i~~~~~~---------~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~-- 120 (330)
T 1xku_A 53 DTALLDLQNNKITEIKDG---------DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP-- 120 (330)
T ss_dssp TCCEEECCSSCCCCBCTT---------TTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--
T ss_pred CCeEEECCCCcCCEeChh---------hhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--
Confidence 578899999987754332 5778999999999999999999999999999999999999998 6676654
Q ss_pred CCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCc--cCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEE
Q 006145 155 TSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNG--TLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLD 232 (659)
Q Consensus 155 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~ 232 (659)
++|++|++++|.+++..+..+..+++|++|++++|.+.. ..+..|.++++|+.|++++|.++..+..+. ++|++|+
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~--~~L~~L~ 198 (330)
T 1xku_A 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP--PSLTELH 198 (330)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCC--TTCSEEE
T ss_pred ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCcccc--ccCCEEE
Confidence 899999999999998888899999999999999999964 788899999999999999999987555443 8999999
Q ss_pred cccCCCCCCCCCC---CcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCC
Q 006145 233 LENNALGPQFPKV---GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG 309 (659)
Q Consensus 233 L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 309 (659)
+++|.+++..|.. +++|+.|++++|.+++..+..+..+++|+.|+|++|+++ .+|..+..+++|++|++++|++++
T Consensus 199 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~ 277 (330)
T 1xku_A 199 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277 (330)
T ss_dssp CTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCc
Confidence 9999999876654 578999999999999988889999999999999999999 789999999999999999999998
Q ss_pred cCCcCCCC------CCCCCEEECcCCCCcc--cCChhhhCCCCCCEEEcCCcc
Q 006145 310 KLFDDLSC------NPELGFVDLSSNLLTG--QLPNCLLAGSKNRVVLYARNC 354 (659)
Q Consensus 310 ~~p~~~~~------~~~L~~L~ls~N~l~g--~ip~~~~~~~~l~~l~~~~N~ 354 (659)
..+..+.. .+.|+.+++++|.+.. ..|..+..+..++.+++++|+
T Consensus 278 ~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 278 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred cChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 77776643 3788999999999863 456677778889999998874
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-30 Score=270.16 Aligned_cols=264 Identities=21% Similarity=0.240 Sum_probs=230.6
Q ss_pred CEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCC
Q 006145 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSIL 154 (659)
Q Consensus 75 ~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 154 (659)
+++.|++++|.+.+..| ..+.++++|++|+|++|.+++..|..|.++++|++|+|++|.++ .+|..+.
T Consensus 55 ~l~~L~l~~n~i~~~~~---------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~-- 122 (332)
T 2ft3_A 55 DTTLLDLQNNDISELRK---------DDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP-- 122 (332)
T ss_dssp TCCEEECCSSCCCEECT---------TTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--
T ss_pred CCeEEECCCCcCCccCH---------hHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--
Confidence 57899999988764433 35778999999999999999999999999999999999999998 6776655
Q ss_pred CCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCC--ccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEE
Q 006145 155 TSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFN--GTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLD 232 (659)
Q Consensus 155 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~ 232 (659)
++|++|++++|++.+..+..|..+++|+.|++++|.++ +..|..+..+ +|+.|++++|++++.+..+. ++|++|+
T Consensus 123 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~~~--~~L~~L~ 199 (332)
T 2ft3_A 123 SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLP--ETLNELH 199 (332)
T ss_dssp TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSSSC--SSCSCCB
T ss_pred ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCcccc--CCCCEEE
Confidence 89999999999999777778999999999999999996 4788889888 99999999999998655554 7999999
Q ss_pred cccCCCCCCCCCC---CcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCC
Q 006145 233 LENNALGPQFPKV---GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG 309 (659)
Q Consensus 233 L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 309 (659)
+++|.+++..+.. +++|+.|++++|++++..|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|++++
T Consensus 200 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~ 278 (332)
T 2ft3_A 200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK 278 (332)
T ss_dssp CCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCB
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCc
Confidence 9999999887654 578999999999999988889999999999999999999 789999999999999999999998
Q ss_pred cCCcCCCC------CCCCCEEECcCCCCc--ccCChhhhCCCCCCEEEcCCcc
Q 006145 310 KLFDDLSC------NPELGFVDLSSNLLT--GQLPNCLLAGSKNRVVLYARNC 354 (659)
Q Consensus 310 ~~p~~~~~------~~~L~~L~ls~N~l~--g~ip~~~~~~~~l~~l~~~~N~ 354 (659)
..+..+.. .+.|+.|++++|.+. +..|..+..+++++.+++++|.
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred cChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 77776654 367899999999998 6677788889999999998874
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=289.63 Aligned_cols=269 Identities=19% Similarity=0.226 Sum_probs=164.6
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.+++.|++++|.+.+..| ..+.++++|++|+|++|.+++..|..|+++++|++|+|++|+++ .+|.. .
T Consensus 21 ~~L~~L~Ls~n~i~~~~~---------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~ 88 (520)
T 2z7x_B 21 QKTTILNISQNYISELWT---------SDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--P 88 (520)
T ss_dssp TTCSEEECCSSCCCCCCH---------HHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--C
T ss_pred ccccEEECCCCcccccCh---------hhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--c
Confidence 467778888777664433 23455566666666666665555556666666666666666655 34443 5
Q ss_pred CCCCcEEEeecCCCCC-CCccccCCCCCCCEEEccCCcC-------------------------CccCCcccCCCC----
Q 006145 154 LTSLQTLILDENMLAG-RVPDWLGSLPILAVLSLRNNMF-------------------------NGTLPDSFSYLE---- 203 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l-------------------------~~~~p~~~~~l~---- 203 (659)
+++|++|+|++|.+++ .+|..|+++++|++|++++|.+ .+..|..+..++
T Consensus 89 l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l 168 (520)
T 2z7x_B 89 TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESL 168 (520)
T ss_dssp CCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEE
T ss_pred cCCccEEeccCCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeecccccccccccccccccccceE
Confidence 5556666666665554 3455555555555555555554 344454444422
Q ss_pred -------------------------------------------------------------------------------C
Q 006145 204 -------------------------------------------------------------------------------N 204 (659)
Q Consensus 204 -------------------------------------------------------------------------------~ 204 (659)
+
T Consensus 169 ~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~ 248 (520)
T 2z7x_B 169 HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248 (520)
T ss_dssp EEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSS
T ss_pred EEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCc
Confidence 5
Q ss_pred CcEEeccccccccCCCC-C-----CCCCcCCEEEcccCCC--------------------------CCCC-CCCCcccce
Q 006145 205 LRVLALSNNHFYGEVPD-F-----SGLTYLQVLDLENNAL--------------------------GPQF-PKVGKKLVT 251 (659)
Q Consensus 205 L~~L~Ls~N~l~~~~p~-~-----~~l~~L~~L~L~~N~l--------------------------~~~~-~~~~~~L~~ 251 (659)
|++|++++|+++|.+|. + ..+++|+.+++++|.+ .+.. +..+++|++
T Consensus 249 L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~ 328 (520)
T 2z7x_B 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLH 328 (520)
T ss_dssp CSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCE
T ss_pred ccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccE
Confidence 66666666666655554 3 4444444444443333 2111 134567778
Q ss_pred EecCCCcCCccCchhccCCccccEEeccCccccc--CCchhhcCCCcccEEeccCCcCCCcCCc-CCCCCCCCCEEECcC
Q 006145 252 MILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVG--PFPQALLSLPSITYLNIADNKLTGKLFD-DLSCNPELGFVDLSS 328 (659)
Q Consensus 252 L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~L~~L~ls~ 328 (659)
|++++|++++.+|..++.+++|+.|+|++|++++ .+|..+..+++|++|++++|++++.+|. .+..+++|+.|++++
T Consensus 329 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~ 408 (520)
T 2z7x_B 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS 408 (520)
T ss_dssp EECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCS
T ss_pred EEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcC
Confidence 8888888877777777788888888888888776 5566777788888888888888775554 366667777777777
Q ss_pred CCCcccCChhhhCCCCCCEEEcCCcccc
Q 006145 329 NLLTGQLPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 329 N~l~g~ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
|++++.+|..+. ++++.+++++|.++
T Consensus 409 N~l~~~~~~~l~--~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 409 NILTDTIFRCLP--PRIKVLDLHSNKIK 434 (520)
T ss_dssp SCCCGGGGGSCC--TTCCEEECCSSCCC
T ss_pred CCCCcchhhhhc--ccCCEEECCCCccc
Confidence 777666665543 45666666666665
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=297.32 Aligned_cols=275 Identities=19% Similarity=0.175 Sum_probs=207.5
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.+++.|+|++|.+.+..+ ..+.++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|++
T Consensus 25 ~~l~~L~Ls~n~l~~~~~---------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~ 95 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPA---------ANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95 (680)
T ss_dssp TTCSEEECCSSCCCCCCG---------GGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred CCCcEEECCCCCCCCcCH---------HHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhcc
Confidence 368999999988775433 25678889999999999999888888999999999999999998655557889
Q ss_pred CCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCC---CCCCCcCCE
Q 006145 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD---FSGLTYLQV 230 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~l~~L~~ 230 (659)
+++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|++++|.+++..+. +..+++|++
T Consensus 96 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~ 175 (680)
T 1ziw_A 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKK 175 (680)
T ss_dssp CTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESE
T ss_pred CCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccE
Confidence 99999999999999877778899999999999999999988888888999999999999998887764 345678888
Q ss_pred EEcccCCCCCCCCCCC------------------------------cccceEecCCCcCCccCchhccCCcc--ccEEec
Q 006145 231 LDLENNALGPQFPKVG------------------------------KKLVTMILSKNKFRSAIPAEVSSYYQ--LQRLDL 278 (659)
Q Consensus 231 L~L~~N~l~~~~~~~~------------------------------~~L~~L~l~~N~l~~~~p~~~~~l~~--L~~L~L 278 (659)
|++++|.+++..|..+ ++|+.|++++|.+++..|..+..++. |+.|+|
T Consensus 176 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~L 255 (680)
T 1ziw_A 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255 (680)
T ss_dssp EECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEEC
T ss_pred EECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEEC
Confidence 8888888877665421 35667777777777777777776654 777777
Q ss_pred cCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcc-----cCCh----hhhCCCCCCEEE
Q 006145 279 SSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG-----QLPN----CLLAGSKNRVVL 349 (659)
Q Consensus 279 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g-----~ip~----~~~~~~~l~~l~ 349 (659)
++|++++..|..|..+++|++|++++|++++..|..+..+++|+.|++++|...+ .+|. .+..+++++.++
T Consensus 256 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~ 335 (680)
T 1ziw_A 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335 (680)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEE
T ss_pred CCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEE
Confidence 7777777777777777777777777777777666666666666666665554433 2222 344455555555
Q ss_pred cCCccccC
Q 006145 350 YARNCLAA 357 (659)
Q Consensus 350 ~~~N~l~~ 357 (659)
+++|.+++
T Consensus 336 l~~n~l~~ 343 (680)
T 1ziw_A 336 MEDNDIPG 343 (680)
T ss_dssp CCSCCBCC
T ss_pred CCCCccCC
Confidence 55555554
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=302.29 Aligned_cols=277 Identities=20% Similarity=0.201 Sum_probs=230.5
Q ss_pred CCEeEEEeCCCCCCC-CCCCCCcC-------Cccccccc--CCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCc-
Q 006145 74 ESITQLHIVGNKRAP-MLPLSFSM-------DSFVTTLV--KLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNF- 142 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~-~l~~~~~~-------~~~~~~l~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~- 142 (659)
.+++.|+|++|.+.+ .+|..+.. +.+|..+. ++++|++|+|++|.+.+.+|..|++|++|+.|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 579999999999887 23322211 12666777 99999999999999999999999999999999999998
Q ss_pred Ccc-cCChhccCCC-------CCcEEEeecCCCCCCCcc--ccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccc
Q 006145 143 LNG-AIPQELSILT-------SLQTLILDENMLAGRVPD--WLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSN 212 (659)
Q Consensus 143 l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 212 (659)
++| .+|..+++++ +|++|+|++|+++ .+|. .++++++|+.|+|++|.++ .+| .|+++++|+.|+|++
T Consensus 528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~ 604 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDY 604 (876)
T ss_dssp SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCS
T ss_pred cccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcC
Confidence 998 8998777665 9999999999999 8998 9999999999999999999 888 899999999999999
Q ss_pred cccccCCCCCCCCCc-CCEEEcccCCCCCCCCCCC-----cccceEecCCCcCCccCchh---cc--CCccccEEeccCc
Q 006145 213 NHFYGEVPDFSGLTY-LQVLDLENNALGPQFPKVG-----KKLVTMILSKNKFRSAIPAE---VS--SYYQLQRLDLSSN 281 (659)
Q Consensus 213 N~l~~~~p~~~~l~~-L~~L~L~~N~l~~~~~~~~-----~~L~~L~l~~N~l~~~~p~~---~~--~l~~L~~L~Ls~N 281 (659)
|+++..++.+..+++ |+.|+|++|.++ .+|... .+|+.|+|++|++.+.+|.. +. .+++|+.|+|++|
T Consensus 605 N~l~~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N 683 (876)
T 4ecn_A 605 NQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYN 683 (876)
T ss_dssp SCCSCCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSS
T ss_pred CccccchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCC
Confidence 999944446999999 999999999998 555542 34899999999998876643 22 3458999999999
Q ss_pred ccccCCchhh-cCCCcccEEeccCCcCCCcCCcCCCCC--------CCCCEEECcCCCCcccCChhhh--CCCCCCEEEc
Q 006145 282 RFVGPFPQAL-LSLPSITYLNIADNKLTGKLFDDLSCN--------PELGFVDLSSNLLTGQLPNCLL--AGSKNRVVLY 350 (659)
Q Consensus 282 ~l~~~~p~~l-~~l~~L~~L~l~~N~l~~~~p~~~~~~--------~~L~~L~ls~N~l~g~ip~~~~--~~~~l~~l~~ 350 (659)
+++ .+|..+ ..+++|+.|+|++|+++ .+|..+... ++|+.|+|++|+++ .+|..+. .+++|+.|++
T Consensus 684 ~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~L 760 (876)
T 4ecn_A 684 EIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDV 760 (876)
T ss_dssp CCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEEC
T ss_pred cCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEe
Confidence 998 455554 58899999999999998 555544332 28999999999998 7888887 8889999999
Q ss_pred CCccccC
Q 006145 351 ARNCLAA 357 (659)
Q Consensus 351 ~~N~l~~ 357 (659)
++|.+++
T Consensus 761 s~N~L~~ 767 (876)
T 4ecn_A 761 SYNCFSS 767 (876)
T ss_dssp CSSCCSS
T ss_pred CCCCCCc
Confidence 9998885
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=271.18 Aligned_cols=214 Identities=21% Similarity=0.225 Sum_probs=171.3
Q ss_pred CCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEE
Q 006145 106 LPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLS 185 (659)
Q Consensus 106 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 185 (659)
.+.++.|+|++|.++ .+|..++++++|++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..++.+++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 466777777777776 56666777777777777777777 67777777777777777777776 6677777777777777
Q ss_pred ccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCch
Q 006145 186 LRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPA 265 (659)
Q Consensus 186 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~ 265 (659)
|++|++.+.+|..+... .+ ...|.++++|++|+|++|.+ + .+|.
T Consensus 157 L~~n~~~~~~p~~~~~~-----------~~---~~~~~~l~~L~~L~L~~n~l---------------------~-~lp~ 200 (328)
T 4fcg_A 157 IRACPELTELPEPLAST-----------DA---SGEHQGLVNLQSLRLEWTGI---------------------R-SLPA 200 (328)
T ss_dssp EEEETTCCCCCSCSEEE-----------C----CCCEEESTTCCEEEEEEECC---------------------C-CCCG
T ss_pred CCCCCCccccChhHhhc-----------cc---hhhhccCCCCCEEECcCCCc---------------------C-cchH
Confidence 77777766666654421 11 11245677788888777765 3 5778
Q ss_pred hccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCC
Q 006145 266 EVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKN 345 (659)
Q Consensus 266 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l 345 (659)
.++.+++|+.|+|++|++++ +|..+..+++|++|++++|++.+.+|..+..+++|+.|++++|++.+.+|..+..+++|
T Consensus 201 ~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L 279 (328)
T 4fcg_A 201 SIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL 279 (328)
T ss_dssp GGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTC
T ss_pred hhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCC
Confidence 89999999999999999995 67789999999999999999999999999999999999999999999999999999999
Q ss_pred CEEEcCCccccCCC
Q 006145 346 RVVLYARNCLAAGN 359 (659)
Q Consensus 346 ~~l~~~~N~l~~~~ 359 (659)
+.+++++|.+.+..
T Consensus 280 ~~L~L~~n~~~~~i 293 (328)
T 4fcg_A 280 EKLDLRGCVNLSRL 293 (328)
T ss_dssp CEEECTTCTTCCCC
T ss_pred CEEeCCCCCchhhc
Confidence 99999999988644
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=296.88 Aligned_cols=157 Identities=23% Similarity=0.192 Sum_probs=126.7
Q ss_pred CEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCC
Q 006145 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSIL 154 (659)
Q Consensus 75 ~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 154 (659)
+++.|++++|.+.+..|. .+.++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++
T Consensus 27 ~L~~L~Ls~n~l~~~~~~---------~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 97 (549)
T 2z81_A 27 AMKSLDLSFNKITYIGHG---------DLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPL 97 (549)
T ss_dssp TCCEEECCSSCCCEECSS---------TTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTC
T ss_pred CccEEECcCCccCccChh---------hhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccC
Confidence 689999999887754443 56788899999999999988888889999999999999999988777778999
Q ss_pred CCCcEEEeecCCCCC-CCccccCCCCCCCEEEccCCcCCccCC-cccCCCCCCcEEeccccccccCCCC-CCC-------
Q 006145 155 TSLQTLILDENMLAG-RVPDWLGSLPILAVLSLRNNMFNGTLP-DSFSYLENLRVLALSNNHFYGEVPD-FSG------- 224 (659)
Q Consensus 155 ~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~------- 224 (659)
++|++|+|++|.+++ .+|..++++++|++|++++|.+.+.+| ..|.++++|++|++++|++++..|. +..
T Consensus 98 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 177 (549)
T 2z81_A 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177 (549)
T ss_dssp TTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEE
T ss_pred CCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceE
Confidence 999999999999886 467788899999999999988544554 6788899999999999988886654 444
Q ss_pred -----------------CCcCCEEEcccCCCCC
Q 006145 225 -----------------LTYLQVLDLENNALGP 240 (659)
Q Consensus 225 -----------------l~~L~~L~L~~N~l~~ 240 (659)
+++|++|++++|.+++
T Consensus 178 ~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 210 (549)
T 2z81_A 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210 (549)
T ss_dssp EEECSBSTTHHHHHHHSTTTBSEEEEESCBCTT
T ss_pred ecccCcccccchhhHhhcccccEEEccCCcccc
Confidence 4566666677776665
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-30 Score=289.99 Aligned_cols=285 Identities=21% Similarity=0.178 Sum_probs=231.4
Q ss_pred CCEeEEEeCCCCCCCCCCCCCc-----------C---Cc-ccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEc
Q 006145 74 ESITQLHIVGNKRAPMLPLSFS-----------M---DS-FVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNM 138 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~-----------~---~~-~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 138 (659)
.+++.|++++|.+.+..|..|. . .. .|..+.++++|++|+|++|.+++..+..|+++++|++|+|
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 3566777777666544333221 1 11 2557889999999999999999988889999999999999
Q ss_pred ccCcCcc-cCChhccCCCCCcEEEeecCCCCCCCccccC-----------------------------------------
Q 006145 139 SSNFLNG-AIPQELSILTSLQTLILDENMLAGRVPDWLG----------------------------------------- 176 (659)
Q Consensus 139 s~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~----------------------------------------- 176 (659)
++|.+++ .+|..++++++|++|+|++|++++..|..++
T Consensus 136 ~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~ 215 (606)
T 3vq2_A 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNF 215 (606)
T ss_dssp CSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCC
T ss_pred CCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCc
Confidence 9999986 6799999999999999999998765443221
Q ss_pred --------------------------------------------------------------------------------
Q 006145 177 -------------------------------------------------------------------------------- 176 (659)
Q Consensus 177 -------------------------------------------------------------------------------- 176 (659)
T Consensus 216 ~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~ 295 (606)
T 3vq2_A 216 NSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295 (606)
T ss_dssp SCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESC
T ss_pred cchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCc
Confidence
Q ss_pred ----------------------------------------------------CCCCCCEEEccCCcCCcc--CCcccCCC
Q 006145 177 ----------------------------------------------------SLPILAVLSLRNNMFNGT--LPDSFSYL 202 (659)
Q Consensus 177 ----------------------------------------------------~l~~L~~L~L~~N~l~~~--~p~~~~~l 202 (659)
.+++|++|++++|.+++. +|..+..+
T Consensus 296 ~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~ 375 (606)
T 3vq2_A 296 SIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGT 375 (606)
T ss_dssp CCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCC
T ss_pred cchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccC
Confidence 123334444444444433 24555566
Q ss_pred CCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCC-C---CCcccceEecCCCcCCccCchhccCCccccEEec
Q 006145 203 ENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFP-K---VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDL 278 (659)
Q Consensus 203 ~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~-~---~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 278 (659)
++|++|++++|.+++.++.+..+++|++|++++|.+.+..| . .+++|+.|++++|.+++.+|..+..+++|+.|++
T Consensus 376 ~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 455 (606)
T 3vq2_A 376 NSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM 455 (606)
T ss_dssp SCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEEC
T ss_pred CcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEEC
Confidence 66666666666666655568889999999999999988877 2 2589999999999999999999999999999999
Q ss_pred cCccccc-CCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 279 SSNRFVG-PFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 279 s~N~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
++|++++ .+|..+..+++|+.|++++|++++..|..+..+++|+.|++++|++++.+|..+..+++++.+++++|.++.
T Consensus 456 ~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 535 (606)
T 3vq2_A 456 AGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET 535 (606)
T ss_dssp TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC
T ss_pred CCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc
Confidence 9999998 478899999999999999999999999999999999999999999999999999999999999999999984
Q ss_pred C
Q 006145 358 G 358 (659)
Q Consensus 358 ~ 358 (659)
.
T Consensus 536 ~ 536 (606)
T 3vq2_A 536 S 536 (606)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=289.47 Aligned_cols=262 Identities=19% Similarity=0.176 Sum_probs=210.0
Q ss_pred eEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCC
Q 006145 77 TQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTS 156 (659)
Q Consensus 77 ~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 156 (659)
+.|++++++++ .+|. .+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++
T Consensus 3 ~~l~ls~n~l~-~ip~---------~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 70 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPK---------DLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQE 70 (520)
T ss_dssp CEEECTTSCCS-SCCC---------SCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTT
T ss_pred ceEecCCCCcc-cccc---------ccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccC
Confidence 46888998877 3443 233 79999999999999999999999999999999999999988999999999
Q ss_pred CcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCc-cCCcccCCCCCCcEEeccccccccCCCCCCCCCcC--CEEEc
Q 006145 157 LQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNG-TLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYL--QVLDL 233 (659)
Q Consensus 157 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L--~~L~L 233 (659)
|++|+|++|+++ .+|.. .+++|++|+|++|.+++ .+|..|+++++|++|++++|++++ ..+..+++| ++|++
T Consensus 71 L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~L~L~~L~l 145 (520)
T 2z7x_B 71 LEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK--SSVLPIAHLNISKVLL 145 (520)
T ss_dssp CCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG--GGGGGGTTSCEEEEEE
T ss_pred CCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch--hhccccccceeeEEEe
Confidence 999999999998 57766 89999999999999997 588999999999999999999986 346667777 88888
Q ss_pred ccCCC--CCCCCCCC-----------------------------------------------------------------
Q 006145 234 ENNAL--GPQFPKVG----------------------------------------------------------------- 246 (659)
Q Consensus 234 ~~N~l--~~~~~~~~----------------------------------------------------------------- 246 (659)
++|.+ .+..|..+
T Consensus 146 ~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L 225 (520)
T 2z7x_B 146 VLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225 (520)
T ss_dssp EECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEE
T ss_pred ecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhc
Confidence 88887 44433321
Q ss_pred ---------------------cccceEecCCCcCCccCchhc-----cCCccccEEeccCcccccCCc-hh---------
Q 006145 247 ---------------------KKLVTMILSKNKFRSAIPAEV-----SSYYQLQRLDLSSNRFVGPFP-QA--------- 290 (659)
Q Consensus 247 ---------------------~~L~~L~l~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~p-~~--------- 290 (659)
++|++|++++|+++|.+|..+ +.+++|+.+++++|.+ .+| ..
T Consensus 226 ~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~ 303 (520)
T 2z7x_B 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMN 303 (520)
T ss_dssp EEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCC
T ss_pred cccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCc
Confidence 156677777777777777776 6666666666666655 233 11
Q ss_pred ----------------hcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcc--cCChhhhCCCCCCEEEcCC
Q 006145 291 ----------------LLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG--QLPNCLLAGSKNRVVLYAR 352 (659)
Q Consensus 291 ----------------l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g--~ip~~~~~~~~l~~l~~~~ 352 (659)
+..+++|++|++++|++++.+|..+..+++|+.|++++|++++ .+|..+..+++++.+++++
T Consensus 304 L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~ 383 (520)
T 2z7x_B 304 IKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQ 383 (520)
T ss_dssp CSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCS
T ss_pred eeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCC
Confidence 1567788888888888888788888888888888888888886 6667777888888888888
Q ss_pred ccccC
Q 006145 353 NCLAA 357 (659)
Q Consensus 353 N~l~~ 357 (659)
|.+++
T Consensus 384 N~l~~ 388 (520)
T 2z7x_B 384 NSVSY 388 (520)
T ss_dssp SCCBC
T ss_pred CcCCc
Confidence 88775
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-30 Score=286.65 Aligned_cols=266 Identities=21% Similarity=0.233 Sum_probs=171.2
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.+++.|++++|.+.+..| ..+.++++|++|+|++|.+++..|+.|.++++|++|||++|.++ .+|.. .
T Consensus 52 ~~L~~L~Ls~N~i~~~~~---------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~ 119 (562)
T 3a79_B 52 PRTKALSLSQNSISELRM---------PDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--P 119 (562)
T ss_dssp TTCCEEECCSSCCCCCCG---------GGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--C
T ss_pred CCcCEEECCCCCccccCh---------hhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--c
Confidence 357777777777664433 35677888888888888888888888888888888888888887 56655 7
Q ss_pred CCCCcEEEeecCCCCC-CCccccCCCCCCCEEEccCCcCCccCCcccCCCCCC--cEEecccccc--ccCCCC-CCCCC-
Q 006145 154 LTSLQTLILDENMLAG-RVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL--RVLALSNNHF--YGEVPD-FSGLT- 226 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~-~~~l~- 226 (659)
+++|++|+|++|++++ .+|..|+++++|++|+|++|.+++. .+..+++| +.|++++|.+ ++..|. +..+.
T Consensus 120 l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~ 196 (562)
T 3a79_B 120 MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNT 196 (562)
T ss_dssp CTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCE
T ss_pred cccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCc
Confidence 8888888888888876 3567888888888888888877642 23333333 5555555544 322221 11111
Q ss_pred --------------------------------------------------------------------------------
Q 006145 227 -------------------------------------------------------------------------------- 226 (659)
Q Consensus 227 -------------------------------------------------------------------------------- 226 (659)
T Consensus 197 ~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~ 276 (562)
T 3a79_B 197 TVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276 (562)
T ss_dssp EEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTS
T ss_pred ceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcc
Confidence
Q ss_pred cCCEEEcccCCCCCCCC--------------------------------------------------------CCCcccc
Q 006145 227 YLQVLDLENNALGPQFP--------------------------------------------------------KVGKKLV 250 (659)
Q Consensus 227 ~L~~L~L~~N~l~~~~~--------------------------------------------------------~~~~~L~ 250 (659)
+|++|++++|.+++.+| ...++|+
T Consensus 277 ~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~ 356 (562)
T 3a79_B 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356 (562)
T ss_dssp SEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCC
T ss_pred cccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCce
Confidence 33344444444333222 2235667
Q ss_pred eEecCCCcCCccCchhccCCccccEEeccCccccc--CCchhhcCCCcccEEeccCCcCCCcCCc-CCCCCCCCCEEECc
Q 006145 251 TMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVG--PFPQALLSLPSITYLNIADNKLTGKLFD-DLSCNPELGFVDLS 327 (659)
Q Consensus 251 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~L~~L~ls 327 (659)
+|++++|++++.+|..++++++|+.|+|++|++++ .+|..+..+++|+.|++++|++++.+|. .+..+++|+.|+++
T Consensus 357 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~ 436 (562)
T 3a79_B 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436 (562)
T ss_dssp EEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECC
T ss_pred EEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECC
Confidence 77777777777777777777777777777777765 2345667777777777777777764443 35566666666666
Q ss_pred CCCCcccCChhhhCCCCCCEEEcCCcccc
Q 006145 328 SNLLTGQLPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 328 ~N~l~g~ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
+|++++.+|..+. ++++.+++++|.++
T Consensus 437 ~n~l~~~~~~~l~--~~L~~L~L~~N~l~ 463 (562)
T 3a79_B 437 SNMLTGSVFRCLP--PKVKVLDLHNNRIM 463 (562)
T ss_dssp SSCCCGGGGSSCC--TTCSEEECCSSCCC
T ss_pred CCCCCcchhhhhc--CcCCEEECCCCcCc
Confidence 6666665555443 45566666666555
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-30 Score=300.02 Aligned_cols=247 Identities=23% Similarity=0.254 Sum_probs=202.4
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
++|+.|+|++|.+.+..|..|..+++|+.|+|++|.+++..|..|.++++|++|+|++|.+++..|..|..+++|+.|+|
T Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 345 (844)
T 3j0a_A 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345 (844)
T ss_dssp SCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEEC
T ss_pred CCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEEC
Confidence 67888888888888888888888888899999888888888888888888889999888888888888888888888888
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccCCC------------------C-----------------------CCCC
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP------------------D-----------------------FSGL 225 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p------------------~-----------------------~~~l 225 (659)
++|.+++..+..|.++++|+.|+|++|.+++... . +.++
T Consensus 346 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l 425 (844)
T 3j0a_A 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRV 425 (844)
T ss_dssp CSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTC
T ss_pred CCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcC
Confidence 8888887777788888888888888888765211 0 2256
Q ss_pred CcCCEEEcccCCCCCCCCC----CCcccceEecCCCcCC-----ccCchhccCCccccEEeccCcccccCCchhhcCCCc
Q 006145 226 TYLQVLDLENNALGPQFPK----VGKKLVTMILSKNKFR-----SAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPS 296 (659)
Q Consensus 226 ~~L~~L~L~~N~l~~~~~~----~~~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 296 (659)
++|++|+|++|.+++..+. ..++|+.|+|++|.++ +..|..|..+++|+.|+|++|+|++..|..|..+++
T Consensus 426 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 505 (844)
T 3j0a_A 426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505 (844)
T ss_dssp TTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCS
T ss_pred CccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhh
Confidence 7788888888888755433 3577888888888886 444566888899999999999999888888899999
Q ss_pred ccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccCC
Q 006145 297 ITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAG 358 (659)
Q Consensus 297 L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~ 358 (659)
|+.|+|++|++++..+..+. ++|+.|||++|++++.+|..+. ++..+++++|.+.+.
T Consensus 506 L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 506 LRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICE 562 (844)
T ss_dssp CSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCCEEEEEEECCCCS
T ss_pred hheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---CcCEEEecCCCcccc
Confidence 99999999999987776665 7899999999999988887653 678899999988764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-30 Score=287.51 Aligned_cols=265 Identities=20% Similarity=0.151 Sum_probs=196.3
Q ss_pred EeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCC
Q 006145 76 ITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILT 155 (659)
Q Consensus 76 v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 155 (659)
.+.+++++++++. +|. .+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.+++
T Consensus 33 ~~~l~ls~~~L~~-ip~---------~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 100 (562)
T 3a79_B 33 ESMVDYSNRNLTH-VPK---------DLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQ 100 (562)
T ss_dssp CCEEECTTSCCCS-CCT---------TSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCT
T ss_pred CcEEEcCCCCCcc-CCC---------CCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCC
Confidence 3789999998874 443 222 7899999999999999999999999999999999999999899999999
Q ss_pred CCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCc-cCCcccCCCCCCcEEeccccccccCCCCCCCCCcC--CEEE
Q 006145 156 SLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNG-TLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYL--QVLD 232 (659)
Q Consensus 156 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L--~~L~ 232 (659)
+|++|+|++|+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|++++ ..+..+++| ++|+
T Consensus 101 ~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~L~L~~L~ 175 (562)
T 3a79_B 101 DLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ--LDLLPVAHLHLSCIL 175 (562)
T ss_dssp TCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT--TTTGGGTTSCEEEEE
T ss_pred CCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc--CchhhhhhceeeEEE
Confidence 9999999999998 67766 89999999999999997 457899999999999999999986 345566666 9999
Q ss_pred cccCCC--CCCCCCCC----------------------------------------------------------------
Q 006145 233 LENNAL--GPQFPKVG---------------------------------------------------------------- 246 (659)
Q Consensus 233 L~~N~l--~~~~~~~~---------------------------------------------------------------- 246 (659)
+++|.+ ++..|..+
T Consensus 176 L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~ 255 (562)
T 3a79_B 176 LDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255 (562)
T ss_dssp EEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEE
T ss_pred eecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEE
Confidence 999998 55544321
Q ss_pred --------------------cccceEecCCCcCCccCchhc---------------------------------------
Q 006145 247 --------------------KKLVTMILSKNKFRSAIPAEV--------------------------------------- 267 (659)
Q Consensus 247 --------------------~~L~~L~l~~N~l~~~~p~~~--------------------------------------- 267 (659)
.+|++|++++|.++|.+|..+
T Consensus 256 L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~ 335 (562)
T 3a79_B 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335 (562)
T ss_dssp EEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSE
T ss_pred ecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceE
Confidence 156666777777777676654
Q ss_pred --------------cCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCC--cCCcCCCCCCCCCEEECcCCCC
Q 006145 268 --------------SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG--KLFDDLSCNPELGFVDLSSNLL 331 (659)
Q Consensus 268 --------------~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~--~~p~~~~~~~~L~~L~ls~N~l 331 (659)
..+++|++|++++|++++.+|..+..+++|+.|++++|++++ .+|..+..+++|+.|++++|++
T Consensus 336 L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l 415 (562)
T 3a79_B 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSL 415 (562)
T ss_dssp EEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCC
T ss_pred EEccCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcC
Confidence 444555666666666655555555666666666666666554 2234455556666666666666
Q ss_pred cccCChh-hhCCCCCCEEEcCCccccC
Q 006145 332 TGQLPNC-LLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 332 ~g~ip~~-~~~~~~l~~l~~~~N~l~~ 357 (659)
++.+|.. +..+++++.+++++|.+++
T Consensus 416 ~~~~~~~~~~~l~~L~~L~l~~n~l~~ 442 (562)
T 3a79_B 416 NSHAYDRTCAWAESILVLNLSSNMLTG 442 (562)
T ss_dssp BSCCSSCCCCCCTTCCEEECCSSCCCG
T ss_pred CCccChhhhcCcccCCEEECCCCCCCc
Confidence 5544443 4445555666666665543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-29 Score=284.40 Aligned_cols=285 Identities=22% Similarity=0.203 Sum_probs=198.0
Q ss_pred CEeEEEeCCCCCCCCCCCCCc--------------CCcc-cccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcc
Q 006145 75 SITQLHIVGNKRAPMLPLSFS--------------MDSF-VTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMS 139 (659)
Q Consensus 75 ~v~~L~l~~~~~~~~l~~~~~--------------~~~~-~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls 139 (659)
+++.|++++|.+.+..+..|. ...+ +..+.++++|++|+|++|.+++..|..|+++++|++|+++
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 577888888776644332111 1112 2346677777777777777777777777777777777777
Q ss_pred cCcCcccCChhccCCCCCcEEEeecCCCCC-CCccccCCCCCCCEEEccCCcCCccCCcccCCC----------------
Q 006145 140 SNFLNGAIPQELSILTSLQTLILDENMLAG-RVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYL---------------- 202 (659)
Q Consensus 140 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l---------------- 202 (659)
+|.+++..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|.+++..|..|+.+
T Consensus 109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~ 188 (570)
T 2z63_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (570)
T ss_dssp TSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred ccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCC
Confidence 777775544457777777777777777776 467777777778877777777665444333222
Q ss_pred --------------------------------------------------------------------------------
Q 006145 203 -------------------------------------------------------------------------------- 202 (659)
Q Consensus 203 -------------------------------------------------------------------------------- 202 (659)
T Consensus 189 l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~ 268 (570)
T 2z63_A 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268 (570)
T ss_dssp CCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETT
T ss_pred ceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcch
Confidence
Q ss_pred -------------CCCcEEeccccccccCCCCC------------------------------------------CCCCc
Q 006145 203 -------------ENLRVLALSNNHFYGEVPDF------------------------------------------SGLTY 227 (659)
Q Consensus 203 -------------~~L~~L~Ls~N~l~~~~p~~------------------------------------------~~l~~ 227 (659)
++|+.|++++|.+++.++.+ ..+++
T Consensus 269 ~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~ 348 (570)
T 2z63_A 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS 348 (570)
T ss_dssp EEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTT
T ss_pred hhhhhchhhhcCcCcccEEEecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCC
Confidence 23333333333332211111 22344
Q ss_pred CCEEEcccCCCCCCC--C------------------------C--CCcccceEecCCCcCCccCc-hhccCCccccEEec
Q 006145 228 LQVLDLENNALGPQF--P------------------------K--VGKKLVTMILSKNKFRSAIP-AEVSSYYQLQRLDL 278 (659)
Q Consensus 228 L~~L~L~~N~l~~~~--~------------------------~--~~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~L 278 (659)
|++|++++|.+++.. | . .+++|+.|++++|.+.+..| ..+.++++|+.|++
T Consensus 349 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l 428 (570)
T 2z63_A 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428 (570)
T ss_dssp CCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEEC
T ss_pred CCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeC
Confidence 455555555443221 0 0 12467777777788777666 56889999999999
Q ss_pred cCcccccCCchhhcCCCcccEEeccCCcCC-CcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 279 SSNRFVGPFPQALLSLPSITYLNIADNKLT-GKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 279 s~N~l~~~~p~~l~~l~~L~~L~l~~N~l~-~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
++|.+.+..|..+..+++|+.|++++|.++ +.+|..+..+++|+.|++++|++++..|..+..+++|+.+++++|.+++
T Consensus 429 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 508 (570)
T 2z63_A 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS 508 (570)
T ss_dssp TTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred cCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCC
Confidence 999999989999999999999999999998 6788899999999999999999998889999999999999999999886
Q ss_pred CC
Q 006145 358 GN 359 (659)
Q Consensus 358 ~~ 359 (659)
..
T Consensus 509 ~~ 510 (570)
T 2z63_A 509 VP 510 (570)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-30 Score=264.75 Aligned_cols=227 Identities=26% Similarity=0.265 Sum_probs=179.5
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcc--cCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEE
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNG--AIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVL 184 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (659)
++|++|+|++|.++...+..|.++++|++|+|++|.++. ..|..+..+++|++|+|++|.+. .+|..+..+++|++|
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L 106 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEE
Confidence 579999999999987666678999999999999999983 34777888999999999999997 577789999999999
Q ss_pred EccCCcCCccCC-cccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCC-CCCCC---CcccceEecCCCc
Q 006145 185 SLRNNMFNGTLP-DSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGP-QFPKV---GKKLVTMILSKNK 258 (659)
Q Consensus 185 ~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~-~~~~~---~~~L~~L~l~~N~ 258 (659)
++++|.+++..+ ..+..+++|++|++++|.+++..+. +.++++|++|++++|.+++ .+|.. +++|+.|++++|+
T Consensus 107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 186 (306)
T 2z66_A 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186 (306)
T ss_dssp ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence 999999987655 5788999999999999999887776 8888999999999888865 33332 4567777777777
Q ss_pred CCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCC-CCCEEECcCCCCccc
Q 006145 259 FRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNP-ELGFVDLSSNLLTGQ 334 (659)
Q Consensus 259 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~-~L~~L~ls~N~l~g~ 334 (659)
+++..|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|++++..|..+..++ +|+.|++++|.+++.
T Consensus 187 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred cCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 7776666777777777777777777766666667777777777777777777666666663 677777777777654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=271.97 Aligned_cols=187 Identities=31% Similarity=0.597 Sum_probs=161.3
Q ss_pred ccccCHHHHHHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeee
Q 006145 464 YRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHC 542 (659)
Q Consensus 464 ~~~~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~ 542 (659)
...++++++....++|...+.||+|+||.||+|+..+|+.||||++...... ...++.+|++++++++||||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 3568899999999999999999999999999999888999999999765432 234799999999999999999999999
Q ss_pred eeccccCCCCceeEEEEeccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC
Q 006145 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISEGH-AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ 621 (659)
Q Consensus 543 ~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~ 621 (659)
.+ .+..++||||+++|+|.++++... ....++|..+..++.|++.||+|||+.+.++|+||||||+||++++
T Consensus 97 ~~-------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 97 MT-------PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE 169 (326)
T ss_dssp CC-------SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred ec-------CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence 75 456899999999999999998642 2345999999999999999999999988889999999999999999
Q ss_pred CcceEEccCccccccccc--cccceecccccccCCCCC
Q 006145 622 NLVAKISSYNLPLLAENA--EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 622 ~~~~kl~DFGla~~~~~~--~~~~~~~gt~~y~aPE~~ 657 (659)
++.+||+|||+++..... .......||+.|+|||+.
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 207 (326)
T ss_dssp TCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHH
T ss_pred CCCEEeccCccccccCcccccccccccCCcCccCHHHh
Confidence 999999999999866432 223456699999999974
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-29 Score=286.24 Aligned_cols=248 Identities=18% Similarity=0.117 Sum_probs=213.7
Q ss_pred ccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCC
Q 006145 101 TTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPI 180 (659)
Q Consensus 101 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 180 (659)
..+.++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|++|+|++|.+++..|..|+.+++
T Consensus 93 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 172 (597)
T 3oja_B 93 YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS 172 (597)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTT
T ss_pred HHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCc
Confidence 47889999999999999999999999999999999999999999766666899999999999999999999999999999
Q ss_pred CCEEEccCCcCCccCCcccCCCCCCcEEecccccccc-------------------CCCCCCCCCcCCEEEcccCCCCCC
Q 006145 181 LAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYG-------------------EVPDFSGLTYLQVLDLENNALGPQ 241 (659)
Q Consensus 181 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-------------------~~p~~~~l~~L~~L~L~~N~l~~~ 241 (659)
|++|+|++|.+++.. ++.+++|+.|++++|.+++ ..+.+ .++|+.|+|++|.+++.
T Consensus 173 L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~--~~~L~~L~L~~n~l~~~ 247 (597)
T 3oja_B 173 LQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTDT 247 (597)
T ss_dssp CCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSC--CSCCCEEECCSSCCCCC
T ss_pred CcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccccCCchhheeeccCCccccccccc--CCCCCEEECCCCCCCCC
Confidence 999999999999753 3445566666666655544 22222 36899999999999875
Q ss_pred CCC-CCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCC
Q 006145 242 FPK-VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPE 320 (659)
Q Consensus 242 ~~~-~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ 320 (659)
..- .+++|+.|+|++|.+++.+|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++
T Consensus 248 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~ 325 (597)
T 3oja_B 248 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 325 (597)
T ss_dssp GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTT
T ss_pred hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCC
Confidence 211 26899999999999999999999999999999999999996 6888889999999999999999 57777888999
Q ss_pred CCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccCC
Q 006145 321 LGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAG 358 (659)
Q Consensus 321 L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~ 358 (659)
|+.|+|++|.+++. | +..+++++.+++++|.+++.
T Consensus 326 L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 326 LENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred CCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCCh
Confidence 99999999999864 3 55678899999999998753
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-29 Score=272.27 Aligned_cols=226 Identities=23% Similarity=0.199 Sum_probs=197.1
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 58999999999999999999999999999999999999988899999999999999999999877788999999999999
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccCCC-C-CCCCCcCCEEEcccCCCCCCCCCC--CcccceEecCCCcCCcc
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP-D-FSGLTYLQVLDLENNALGPQFPKV--GKKLVTMILSKNKFRSA 262 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~-~~~l~~L~~L~L~~N~l~~~~~~~--~~~L~~L~l~~N~l~~~ 262 (659)
++|.+++..+..|.++++|+.|+|++|+..+.++ . |.++++|++|+|++|.+++. |.. +.+|+.|+|++|++++.
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~ 233 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPEI 233 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSEE
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCccc
Confidence 9999998777889999999999999955444444 3 89999999999999999865 332 46788888888888888
Q ss_pred CchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcc
Q 006145 263 IPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG 333 (659)
Q Consensus 263 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g 333 (659)
.|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+.-
T Consensus 234 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred CcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 88888888888888888888888778888888888888888888887777777888888888888887763
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-30 Score=270.62 Aligned_cols=250 Identities=22% Similarity=0.239 Sum_probs=189.6
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..++++++|++|+|
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 47888888888888777778888888888888888888777778888888888888888888655556888888888888
Q ss_pred cCCcCCccCC-cccCCCCCCcEEeccccc-cccCCCC-CCCCCcCCEEEcccCCCCCCCCCC---CcccceEecCCCcCC
Q 006145 187 RNNMFNGTLP-DSFSYLENLRVLALSNNH-FYGEVPD-FSGLTYLQVLDLENNALGPQFPKV---GKKLVTMILSKNKFR 260 (659)
Q Consensus 187 ~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~-l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~---~~~L~~L~l~~N~l~ 260 (659)
++|.+++..+ ..|.++++|++|++++|+ +.+..+. |.++++|++|++++|.+++..|.. +++|++|++++|.+.
T Consensus 132 ~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred CCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 8888884433 367888888888888884 5555443 788888888888888887776654 467888888888886
Q ss_pred ccCchhccCCccccEEeccCcccccCCchhhc---CCCcccEEeccCCcCCC----cCCcCCCCCCCCCEEECcCCCCcc
Q 006145 261 SAIPAEVSSYYQLQRLDLSSNRFVGPFPQALL---SLPSITYLNIADNKLTG----KLFDDLSCNPELGFVDLSSNLLTG 333 (659)
Q Consensus 261 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~---~l~~L~~L~l~~N~l~~----~~p~~~~~~~~L~~L~ls~N~l~g 333 (659)
...+..+..+++|+.|++++|.+++..+..+. ..+.++.+++++|.+++ .+|+.+..+++|+.||+++|+++
T Consensus 212 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~- 290 (353)
T 2z80_A 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK- 290 (353)
T ss_dssp THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-
T ss_pred cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-
Confidence 54444455678888888888888875554433 35667778888887776 35666777888888888888888
Q ss_pred cCChhh-hCCCCCCEEEcCCccccC
Q 006145 334 QLPNCL-LAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 334 ~ip~~~-~~~~~l~~l~~~~N~l~~ 357 (659)
.+|..+ ..+++++.+++++|.+.+
T Consensus 291 ~i~~~~~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 291 SVPDGIFDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ccCHHHHhcCCCCCEEEeeCCCccC
Confidence 566654 677888888888887764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=271.59 Aligned_cols=181 Identities=35% Similarity=0.609 Sum_probs=156.0
Q ss_pred cCHHHHHHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeecc
Q 006145 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECY 546 (659)
Q Consensus 467 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 546 (659)
+++.++..++++|+..+.||+|+||.||+|+.++|+.||||++........+++.+|++++++++||||++++++|.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 106 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-- 106 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--
Confidence 445566678899999999999999999999988899999999877655556789999999999999999999999875
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcce
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGH-AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVA 625 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~ 625 (659)
.+..++||||+++|+|.+++.... ....++|..+..++.|+++||+|||+. +|+||||||+||++++++.+
T Consensus 107 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~ 178 (321)
T 2qkw_B 107 -----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVP 178 (321)
T ss_dssp -----TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCE
T ss_pred -----CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCE
Confidence 456899999999999999997532 224699999999999999999999998 99999999999999999999
Q ss_pred EEccCccccccccc---cccceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENA---EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~ 657 (659)
||+|||+++..... .......||+.|+|||+.
T Consensus 179 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 213 (321)
T 2qkw_B 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF 213 (321)
T ss_dssp EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHH
T ss_pred EEeecccccccccccccccccccCCCccccCHHHh
Confidence 99999999764322 223445789999999964
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-30 Score=267.45 Aligned_cols=178 Identities=20% Similarity=0.330 Sum_probs=155.4
Q ss_pred ccCHHHHHHhhcC----------CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCC
Q 006145 466 TFSLEELEEATNN----------FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRH 534 (659)
Q Consensus 466 ~~~~~~l~~~~~~----------~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n 534 (659)
.++.+++..+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4677888777764 556678999999999999976 69999999998766556678999999999999999
Q ss_pred ccceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCC
Q 006145 535 LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKI 614 (659)
Q Consensus 535 iv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~ 614 (659)
|++++++|.. .+..++||||+++|+|.+++.. ..++|..+..++.|+++||+|||+. +|+||||||
T Consensus 104 iv~~~~~~~~-------~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp 169 (321)
T 2c30_A 104 VVEMYKSYLV-------GEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKS 169 (321)
T ss_dssp BCCEEEEEEE-------TTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred cceEEEEEEE-------CCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCH
Confidence 9999999986 4578999999999999999874 3699999999999999999999998 999999999
Q ss_pred CceeecCCcceEEccCccccccccc-cccceecccccccCCCCC
Q 006145 615 TDILLDQNLVAKISSYNLPLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 615 ~NILld~~~~~kl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
+||+++.++.+||+|||+++..... .......||+.|+|||+.
T Consensus 170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~ 213 (321)
T 2c30_A 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213 (321)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHH
T ss_pred HHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhh
Confidence 9999999999999999999766433 233567899999999975
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=268.01 Aligned_cols=265 Identities=17% Similarity=0.109 Sum_probs=222.3
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.+++.|++++|.+.+..+ ..+.++++|++|+|++|.+++..|..|+++++|++|+|++|.++...+..|.+
T Consensus 69 ~~L~~L~L~~n~i~~~~~---------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~ 139 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDT---------YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHN 139 (390)
T ss_dssp CCCSEEECTTSCCCEECT---------TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred ccCcEEECCCCcccccCh---------hhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcC
Confidence 368899999988764333 25678999999999999999999999999999999999999999554555799
Q ss_pred CCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEecccccccc----------------
Q 006145 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYG---------------- 217 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---------------- 217 (659)
+++|++|+|++|.+.+..|..+..+++|++|++++|.+++.. ++.+++|+.|++++|.+++
T Consensus 140 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~ 216 (390)
T 3o6n_A 140 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNS 216 (390)
T ss_dssp CTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSC
T ss_pred CCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeecccccccccCCCCcceEEECCCCe
Confidence 999999999999999888889999999999999999998653 4455566665555555543
Q ss_pred ---CCCCCCCCCcCCEEEcccCCCCCCCCC-CCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcC
Q 006145 218 ---EVPDFSGLTYLQVLDLENNALGPQFPK-VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLS 293 (659)
Q Consensus 218 ---~~p~~~~l~~L~~L~L~~N~l~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 293 (659)
... ...++|+.|++++|.+++...- .+++|+.|++++|.+++..|..+..+++|+.|+|++|++++ +|..+..
T Consensus 217 l~~~~~--~~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~ 293 (390)
T 3o6n_A 217 INVVRG--PVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQP 293 (390)
T ss_dssp CCEEEC--CCCSSCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSC
T ss_pred eeeccc--cccccccEEECCCCCCcccHHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCC
Confidence 221 2246899999999999875211 25899999999999999999999999999999999999985 6777889
Q ss_pred CCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 294 LPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 294 l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
+++|+.|++++|+++ .+|..+..+++|+.|++++|+++.. | +..+++++.+++++|.+.+
T Consensus 294 l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 294 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp CTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred CCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence 999999999999998 4666778889999999999999854 4 6677899999999998874
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-29 Score=269.63 Aligned_cols=225 Identities=25% Similarity=0.232 Sum_probs=192.0
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
++++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 57999999999999999999999999999999999999888899999999999999999999777778999999999999
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccCCCC--CCCCCcCCEEEcccCCCCCCCCCC--CcccceEecCCCcCCcc
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD--FSGLTYLQVLDLENNALGPQFPKV--GKKLVTMILSKNKFRSA 262 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~l~~L~~L~L~~N~l~~~~~~~--~~~L~~L~l~~N~l~~~ 262 (659)
++|.+++..+..|.++++|+.|+|++|+..+.++. |.++++|++|+|++|.++.. |.. +++|+.|+|++|++++.
T Consensus 144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~ 222 (440)
T 3zyj_A 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-PNLTPLIKLDELDLSGNHLSAI 222 (440)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-CCCTTCSSCCEEECTTSCCCEE
T ss_pred CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc-cccCCCcccCEEECCCCccCcc
Confidence 99999988888999999999999999655444443 89999999999999998754 332 46778888888888777
Q ss_pred CchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCc
Q 006145 263 IPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT 332 (659)
Q Consensus 263 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~ 332 (659)
.|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+.
T Consensus 223 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred ChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 7777888888888888888887777777778888888888888887777777777778888888887765
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=283.16 Aligned_cols=178 Identities=15% Similarity=0.202 Sum_probs=152.9
Q ss_pred CHHHHHHhhcCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeee
Q 006145 468 SLEELEEATNNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCF 543 (659)
Q Consensus 468 ~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 543 (659)
.+.++....++|+..+.||+|+||+||+|+... ++.||||+++... ....+.+.+|++++..++|||||+++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 455666678899999999999999999999764 8899999997532 222345899999999999999999999998
Q ss_pred eccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc
Q 006145 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL 623 (659)
Q Consensus 544 ~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~ 623 (659)
+ .+..|+|||||++|+|.++++.. ...+++..+..++.|++.||+|||+. +||||||||+|||+|.++
T Consensus 145 ~-------~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g 212 (437)
T 4aw2_A 145 D-------DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNG 212 (437)
T ss_dssp C-------SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred e-------CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCC
Confidence 6 56799999999999999999852 24699999999999999999999998 999999999999999999
Q ss_pred ceEEccCccccccccccc--cceecccccccCCCCC
Q 006145 624 VAKISSYNLPLLAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 624 ~~kl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
.+||+|||+++....... ....+||+.|||||++
T Consensus 213 ~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l 248 (437)
T 4aw2_A 213 HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248 (437)
T ss_dssp CEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHH
T ss_pred CEEEcchhhhhhcccCCCcccccccCCcCeeChHHH
Confidence 999999999976543322 2446899999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=270.30 Aligned_cols=169 Identities=17% Similarity=0.281 Sum_probs=150.1
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+. .+|+.||||++...... ..+++.+|+++++.++||||+++++++.+ .
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-------~ 86 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-------E 86 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-------S
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-------C
Confidence 45788899999999999999996 46999999999765432 23568999999999999999999999975 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred CEEEEEEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccC
Confidence 6789999999999999999752 4589999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++...........+||+.|+|||+.
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~ 185 (328)
T 3fe3_A 161 SNEFTVGGKLDAFCGAPPYAAPELF 185 (328)
T ss_dssp CGGGSSSCGGGTTSSSGGGCCHHHH
T ss_pred ceecCCCCccccccCCcceeCcccc
Confidence 9877666666778999999999974
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-29 Score=284.75 Aligned_cols=250 Identities=22% Similarity=0.209 Sum_probs=228.3
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+..|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 68999999999999988889999999999999999999999999999999999999999999766668999999999999
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCC-----CcccceEecCCCcCC
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKV-----GKKLVTMILSKNKFR 260 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~-----~~~L~~L~l~~N~l~ 260 (659)
++|.+++..|..|+++++|++|+|++|.+++.+|. +.++++|++|++++|.+++..+.. .++|+.|++++|+++
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 184 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccc
Confidence 99999988888999999999999999999998776 889999999999999999877652 378999999999999
Q ss_pred ccCchhccCC---------------------------ccccEEeccCcccccCCchhhcCCCc--ccEEeccCCcCCCcC
Q 006145 261 SAIPAEVSSY---------------------------YQLQRLDLSSNRFVGPFPQALLSLPS--ITYLNIADNKLTGKL 311 (659)
Q Consensus 261 ~~~p~~~~~l---------------------------~~L~~L~Ls~N~l~~~~p~~l~~l~~--L~~L~l~~N~l~~~~ 311 (659)
+..|..+..+ ++|+.|++++|.+++..|.++..++. |+.|++++|++++..
T Consensus 185 ~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~ 264 (680)
T 1ziw_A 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264 (680)
T ss_dssp CBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEEC
T ss_pred ccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccC
Confidence 9888877654 45788888899999888989988865 999999999999998
Q ss_pred CcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCcccc
Q 006145 312 FDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 312 p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
|..+..+++|+.|++++|++++..|..+..+++++.+++++|...
T Consensus 265 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~ 309 (680)
T 1ziw_A 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCC
T ss_pred cccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhh
Confidence 899999999999999999999999999999999999999887544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-30 Score=268.71 Aligned_cols=170 Identities=18% Similarity=0.304 Sum_probs=148.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEeccc---CCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMK---KCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------- 76 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT------- 76 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-------
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-------
Confidence 356888899999999999999975 5999999999754 23345678999999999999999999999976
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG 150 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeecc
Confidence 56789999999999999999752 4689999999999999999999998 99999999999999999999999999
Q ss_pred ccccc-ccccccceecccccccCCCCCC
Q 006145 632 LPLLA-ENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 632 la~~~-~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+++.. .........+||+.|||||+..
T Consensus 151 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 178 (337)
T 1o6l_A 151 LCKEGISDGATMKTFCGTPEYLAPEVLE 178 (337)
T ss_dssp TCBCSCCTTCCBCCCEECGGGCCGGGGS
T ss_pred chhhcccCCCcccccccChhhCChhhhc
Confidence 99764 2333456678999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-30 Score=265.92 Aligned_cols=169 Identities=21% Similarity=0.393 Sum_probs=145.9
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
++|...+.||+|+||+||+|+.. +++.||+|++........+.|.+|++++++++||||+++++++.+ .+..
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~~ 82 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-------DKRL 82 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-------TTEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-------CCee
Confidence 45777899999999999999975 599999999866544455789999999999999999999999986 4678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.++++.. ...++|.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp EEEEECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 9999999999999999853 34699999999999999999999998 999999999999999999999999999976
Q ss_pred ccccccc---------------ceecccccccCCCCC
Q 006145 636 AENAEKV---------------GHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~~---------------~~~~gt~~y~aPE~~ 657 (659)
....... ...+||+.|+|||+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 194 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHH
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHh
Confidence 6432221 146799999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-30 Score=262.52 Aligned_cols=168 Identities=17% Similarity=0.325 Sum_probs=149.4
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|...+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.++++++||||+++++++.. .+.
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~ 91 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-------GDE 91 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-------TTE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-------CCE
Confidence 46788999999999999999995 4699999999987666666789999999999999999999999986 467
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++|+|.+++.+ ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 92 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp EEEEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEECCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence 8999999999999999985 3589999999999999999999998 99999999999999999999999999997
Q ss_pred cccccc-ccceecccccccCCCCC
Q 006145 635 LAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
...... .....+||+.|+|||+.
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~ 188 (297)
T 3fxz_A 165 QITPEQSKRSTMVGTPYWMAPEVV 188 (297)
T ss_dssp ECCSTTCCBCCCCSCGGGCCHHHH
T ss_pred ecCCcccccCCccCCcCccChhhh
Confidence 664332 34557899999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-30 Score=272.14 Aligned_cols=169 Identities=15% Similarity=0.301 Sum_probs=150.7
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++|||||++++++.+ .
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-------~ 87 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-------E 87 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-------S
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-------C
Confidence 56788899999999999999965 58999999996532 3345679999999999999999999999976 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNI 161 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccce
Confidence 678999999999999999986 24699999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
++...........+||+.|||||++.
T Consensus 162 a~~~~~~~~~~~~~gt~~Y~aPE~~~ 187 (384)
T 4fr4_A 162 AAMLPRETQITTMAGTKPYMAPEMFS 187 (384)
T ss_dssp CEECCTTCCBCCCCSCGGGCCGGGTC
T ss_pred eeeccCCCceeccCCCccccCCeeec
Confidence 98876666667789999999999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=278.96 Aligned_cols=175 Identities=15% Similarity=0.257 Sum_probs=151.5
Q ss_pred HHHHHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeee
Q 006145 469 LEELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFE 544 (659)
Q Consensus 469 ~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 544 (659)
+.++....++|...+.||+|+||+||+|+.. +++.||+|+++... ....+.+.+|+++++.++|||||+++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455566788999999999999999999976 58999999996532 2234568899999999999999999999976
Q ss_pred ccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc
Q 006145 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV 624 (659)
Q Consensus 545 ~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~ 624 (659)
.+..|+||||+++|+|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+|||+|.++.
T Consensus 141 -------~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ 206 (410)
T 3v8s_A 141 -------DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 206 (410)
T ss_dssp -------SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred -------CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCC
Confidence 5678999999999999999975 3589999999999999999999998 9999999999999999999
Q ss_pred eEEccCcccccccccc--ccceecccccccCCCCC
Q 006145 625 AKISSYNLPLLAENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 ~kl~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
+||+|||+++...... .....+||+.|||||++
T Consensus 207 ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l 241 (410)
T 3v8s_A 207 LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241 (410)
T ss_dssp EEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHH
T ss_pred EEEeccceeEeeccCCcccccCCcCCccccCHHHh
Confidence 9999999998765433 23467899999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=265.16 Aligned_cols=179 Identities=17% Similarity=0.346 Sum_probs=146.2
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeecccc-----
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFD----- 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~----- 548 (659)
.++|+..+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|++++++++|||||+++++|.+....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 456888899999999999999976 6999999999755433 346799999999999999999999998653210
Q ss_pred ---------------------------------------------CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHH
Q 006145 549 ---------------------------------------------DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWT 583 (659)
Q Consensus 549 ---------------------------------------------~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~ 583 (659)
.......++||||+++|+|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 00122479999999999999999875444567888
Q ss_pred HHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccccccc-------------ccceeccccc
Q 006145 584 QRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE-------------KVGHVIPYSG 650 (659)
Q Consensus 584 ~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~-------------~~~~~~gt~~ 650 (659)
.+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...... .....+||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999998 99999999999999999999999999997765432 2244679999
Q ss_pred ccCCCCC
Q 006145 651 SIDPTNS 657 (659)
Q Consensus 651 y~aPE~~ 657 (659)
|+|||+.
T Consensus 242 y~aPE~~ 248 (332)
T 3qd2_B 242 YMSPEQI 248 (332)
T ss_dssp GSCHHHH
T ss_pred ccChHHh
Confidence 9999974
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-31 Score=275.11 Aligned_cols=223 Identities=26% Similarity=0.271 Sum_probs=108.8
Q ss_pred CCEEEecCCCC-cCCCCcccC-------CCCCCcEEEcccCcCcccCChhc--cCCCCCcEEEeecCCCCCCCccccCCC
Q 006145 109 LKVLRLVSLGL-WGPLSGKIS-------RLSSLEILNMSSNFLNGAIPQEL--SILTSLQTLILDENMLAGRVPDWLGSL 178 (659)
Q Consensus 109 L~~L~L~~n~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~l~~l 178 (659)
|+.|+|++|.+ .+.+|..+. ++++|++|+|++|.+++.+|..+ ..+++|++|+|++|++++. |..++.+
T Consensus 65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l 143 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAEL 143 (312)
T ss_dssp HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHH
T ss_pred HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHH
Confidence 44444555544 233444333 45555555555555555555443 4555555555555555544 4444443
Q ss_pred -----CCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccC---CCCC--CCCCcCCEEEcccCCCCCCCCCCCcc
Q 006145 179 -----PILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGE---VPDF--SGLTYLQVLDLENNALGPQFPKVGKK 248 (659)
Q Consensus 179 -----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~--~~l~~L~~L~L~~N~l~~~~~~~~~~ 248 (659)
++|++|+|++|++++..|..|+++++|++|+|++|++.+. ++.+ ..+++|++|+|++|.+++..
T Consensus 144 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~------ 217 (312)
T 1wwl_A 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS------ 217 (312)
T ss_dssp HTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHH------
T ss_pred HHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchH------
Confidence 4555555555555544445555555555555555554443 1112 44455555555555443210
Q ss_pred cceEecCCCcCCccCc-hhccCCccccEEeccCcccccCCc-hhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEEC
Q 006145 249 LVTMILSKNKFRSAIP-AEVSSYYQLQRLDLSSNRFVGPFP-QALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDL 326 (659)
Q Consensus 249 L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~l 326 (659)
.++ ..+..+++|+.|+|++|++++..| ..+..+++|++|+|++|+++ .+|..+. ++|+.||+
T Consensus 218 -------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~L 281 (312)
T 1wwl_A 218 -------------GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDL 281 (312)
T ss_dssp -------------HHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEEC
T ss_pred -------------HHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEEC
Confidence 111 223345555555555555555443 33444555555555555555 4444443 55555555
Q ss_pred cCCCCcccCChhhhCCCCCCEEEcCCcccc
Q 006145 327 SSNLLTGQLPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 327 s~N~l~g~ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
++|++++. |. +..+++++.+++++|.++
T Consensus 282 s~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 282 SYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred CCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 55555543 43 445555555555555554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=267.26 Aligned_cols=169 Identities=18% Similarity=0.293 Sum_probs=149.2
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC------chHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH------STRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
.+.|...+.||+|+||.||+|+.. +|+.||||.++..... ..+++.+|++++++++||||+++++++.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---- 86 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN---- 86 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe----
Confidence 456888899999999999999976 5999999999765322 24679999999999999999999999975
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc----c
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL----V 624 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~----~ 624 (659)
....++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||++++++ .
T Consensus 87 ---~~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~ 157 (361)
T 2yab_A 87 ---RTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPH 157 (361)
T ss_dssp ---SSEEEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCC
T ss_pred ---CCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccC
Confidence 5678999999999999999975 24699999999999999999999998 999999999999998776 7
Q ss_pred eEEccCccccccccccccceecccccccCCCCC
Q 006145 625 AKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 ~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+||+|||+++...........+||+.|+|||+.
T Consensus 158 vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~ 190 (361)
T 2yab_A 158 IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190 (361)
T ss_dssp EEECCCSSCEECCTTCCCCCCCSCGGGCCHHHH
T ss_pred EEEEecCCceEcCCCCccccCCCCccEECchHH
Confidence 999999999887666566678899999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=277.30 Aligned_cols=179 Identities=15% Similarity=0.196 Sum_probs=153.1
Q ss_pred cCHHHHHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeee
Q 006145 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHC 542 (659)
Q Consensus 467 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 542 (659)
+.+++.....++|...+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345566667789999999999999999999975 699999999965321 2234588999999999999999999999
Q ss_pred eeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC
Q 006145 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN 622 (659)
Q Consensus 543 ~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~ 622 (659)
.+ .+..|+||||+++|+|.+++++. ...+++..+..++.||+.||+|||+. +||||||||+|||+|.+
T Consensus 131 ~~-------~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~ 198 (412)
T 2vd5_A 131 QD-------ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRC 198 (412)
T ss_dssp EC-------SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred ee-------CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCC
Confidence 76 56789999999999999999752 23689999999999999999999998 99999999999999999
Q ss_pred cceEEccCccccccccccc--cceecccccccCCCCC
Q 006145 623 LVAKISSYNLPLLAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 623 ~~~kl~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
+.+||+|||+++....... ....+||+.|||||++
T Consensus 199 g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l 235 (412)
T 2vd5_A 199 GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235 (412)
T ss_dssp SCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHH
T ss_pred CCEEEeechhheeccCCCccccceeccccCcCCHHHH
Confidence 9999999999977644332 2346899999999975
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-29 Score=253.58 Aligned_cols=230 Identities=23% Similarity=0.235 Sum_probs=172.5
Q ss_pred ceEeCCCCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccC
Q 006145 68 TVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAI 147 (659)
Q Consensus 68 gv~C~~~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 147 (659)
++.|.....+.++.+++.+.. +|. .+ .++|++|+|++|.+++..+..|..+++|++|+|++|.+++..
T Consensus 5 ~C~C~~~~~~~~~c~~~~l~~-ip~---------~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 72 (285)
T 1ozn_A 5 ACVCYNEPKVTTSCPQQGLQA-VPV---------GI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72 (285)
T ss_dssp TCEEECSSSCEEECCSSCCSS-CCT---------TC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CceECCCCCeEEEcCcCCccc-CCc---------CC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeC
Confidence 366755444667777766542 222 11 358999999999999988888999999999999999999888
Q ss_pred ChhccCCCCCcEEEeecCC-CCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCC
Q 006145 148 PQELSILTSLQTLILDENM-LAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGL 225 (659)
Q Consensus 148 p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l 225 (659)
|..|.++++|++|+|++|. +....|..+..+++|++|++++|.+++..|..|.++++|++|++++|++++.++. |..+
T Consensus 73 ~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 152 (285)
T 1ozn_A 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152 (285)
T ss_dssp TTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred HhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccC
Confidence 9999999999999999997 7766688899999999999999999988888899999999999999999987766 8888
Q ss_pred CcCCEEEcccCCCCCCCCCC---CcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEec
Q 006145 226 TYLQVLDLENNALGPQFPKV---GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNI 302 (659)
Q Consensus 226 ~~L~~L~L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l 302 (659)
++|++|+|++|.+++..+.. +++|+.|++++|.+++..|..+..+++|+.|++++|++++..+..+..+++|+.|++
T Consensus 153 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 232 (285)
T 1ozn_A 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232 (285)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEec
Confidence 99999988888876544432 345555555555555555555555555555555555555544445555555555555
Q ss_pred cCCcCCC
Q 006145 303 ADNKLTG 309 (659)
Q Consensus 303 ~~N~l~~ 309 (659)
++|.++.
T Consensus 233 ~~N~~~c 239 (285)
T 1ozn_A 233 NDNPWVC 239 (285)
T ss_dssp CSSCEEC
T ss_pred cCCCccC
Confidence 5555543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=8e-30 Score=272.94 Aligned_cols=170 Identities=21% Similarity=0.309 Sum_probs=147.0
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCC-CCCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKL-RHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~ 550 (659)
.++|+..+.||+|+||+||+|+.. +++.||||+++..... ..+.+.+|..++.++ +|||||++++++.+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~------ 124 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT------ 124 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC------
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE------
Confidence 456888899999999999999976 5889999999765322 234688999999887 89999999999876
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+|.++.+||+||
T Consensus 125 -~~~~~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 197 (396)
T 4dc2_A 125 -ESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY 197 (396)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred -CCEEEEEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeec
Confidence 56799999999999999999852 4699999999999999999999998 9999999999999999999999999
Q ss_pred cccccc-ccccccceecccccccCCCCCC
Q 006145 631 NLPLLA-ENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 631 Gla~~~-~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|+++.. .........+||+.|||||++.
T Consensus 198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~ 226 (396)
T 4dc2_A 198 GMCKEGLRPGDTTSTFCGTPNYIAPEILR 226 (396)
T ss_dssp TTCBCCCCTTCCBCCCCBCGGGCCHHHHT
T ss_pred ceeeecccCCCccccccCCcccCCchhhc
Confidence 999863 3344456789999999999753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=258.89 Aligned_cols=182 Identities=32% Similarity=0.535 Sum_probs=157.3
Q ss_pred cccCHHHHHHhhcCCCCC------ceeccCcCceEEEEEecCCcEEEEEEecccC----CCchHHHHHHHHHHhCCCCCC
Q 006145 465 RTFSLEELEEATNNFDTS------AFMGEGSQGQMYRGRLKNGTFVAIRCLKMKK----CHSTRNFMHHIELISKLRHRH 534 (659)
Q Consensus 465 ~~~~~~~l~~~~~~~~~~------~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~n 534 (659)
..|+++++..++++|+.. +.||+|+||.||+|+. +++.||||++.... ....+.|.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 468999999999999988 8999999999999987 58899999996532 122467999999999999999
Q ss_pred ccceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCC
Q 006145 535 LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKI 614 (659)
Q Consensus 535 iv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~ 614 (659)
|+++++++.+ .+..++||||+++|+|.+++........++|..+..++.|+++||+|||+. +|+||||||
T Consensus 92 i~~~~~~~~~-------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp 161 (307)
T 2nru_A 92 LVELLGFSSD-------GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKS 161 (307)
T ss_dssp BCCEEEEECS-------SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred eEEEEEEEec-------CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCH
Confidence 9999999975 456899999999999999997533345799999999999999999999998 999999999
Q ss_pred CceeecCCcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 615 TDILLDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 615 ~NILld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
+||++++++.+||+|||+++...... ......||+.|+|||+.
T Consensus 162 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 207 (307)
T 2nru_A 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL 207 (307)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHH
T ss_pred HHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHh
Confidence 99999999999999999997654322 22446799999999964
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=268.51 Aligned_cols=169 Identities=22% Similarity=0.340 Sum_probs=141.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~ 550 (659)
.++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++++.+ +||||+++++++.+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~------ 95 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT------ 95 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC------
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe------
Confidence 467888999999999999999965 59999999997542 23346688999999988 69999999999976
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+..|+||||+++|+|.++++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 96 -~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DF 168 (353)
T 3txo_A 96 -PDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADF 168 (353)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccc
Confidence 56789999999999999999752 4699999999999999999999998 9999999999999999999999999
Q ss_pred ccccccc-cccccceecccccccCCCCC
Q 006145 631 NLPLLAE-NAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~-~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+++... ........+||+.|||||++
T Consensus 169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~ 196 (353)
T 3txo_A 169 GMCKEGICNGVTTATFCGTPDYIAPEIL 196 (353)
T ss_dssp TTCBCSCC---------CCGGGCCHHHH
T ss_pred cceeecccCCccccccCCCcCeEChhhc
Confidence 9998643 33344567899999999964
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=254.70 Aligned_cols=242 Identities=24% Similarity=0.202 Sum_probs=212.6
Q ss_pred EEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCC--CCccccCCCCCCCEEEccCC
Q 006145 112 LRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAG--RVPDWLGSLPILAVLSLRNN 189 (659)
Q Consensus 112 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~N 189 (659)
++.++++++. +|..+. ++|++|+|++|.++...+..|.++++|++|+|++|.++. ..|..+..+++|++|+|++|
T Consensus 12 l~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n 88 (306)
T 2z66_A 12 IRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88 (306)
T ss_dssp EECCSSCCSS-CCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSC
T ss_pred EEcCCCCccc-CCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCC
Confidence 4444444433 343332 689999999999995555568999999999999999983 34677788999999999999
Q ss_pred cCCccCCcccCCCCCCcEEeccccccccCCC--CCCCCCcCCEEEcccCCCCCCCCCC---CcccceEecCCCcCCc-cC
Q 006145 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVP--DFSGLTYLQVLDLENNALGPQFPKV---GKKLVTMILSKNKFRS-AI 263 (659)
Q Consensus 190 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~l~~L~~L~L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~-~~ 263 (659)
.++ .+|..+..+++|++|++++|++++..+ .+..+++|++|++++|.+.+..+.. +++|++|++++|.+++ .+
T Consensus 89 ~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 167 (306)
T 2z66_A 89 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 167 (306)
T ss_dssp SEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEE
T ss_pred ccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccc
Confidence 998 577789999999999999999998775 5899999999999999998877764 5789999999999987 68
Q ss_pred chhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCC
Q 006145 264 PAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGS 343 (659)
Q Consensus 264 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~ 343 (659)
|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|++++..+..+..+++|+.||+++|++++..|..+..++
T Consensus 168 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 247 (306)
T 2z66_A 168 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 247 (306)
T ss_dssp CSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCC
T ss_pred hhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhh
Confidence 88999999999999999999998899999999999999999999988888899999999999999999999999998884
Q ss_pred -CCCEEEcCCccccC
Q 006145 344 -KNRVVLYARNCLAA 357 (659)
Q Consensus 344 -~l~~l~~~~N~l~~ 357 (659)
+++.+++++|.+++
T Consensus 248 ~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 248 SSLAFLNLTQNDFAC 262 (306)
T ss_dssp TTCCEEECTTCCEEC
T ss_pred ccCCEEEccCCCeec
Confidence 89999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=257.40 Aligned_cols=171 Identities=18% Similarity=0.297 Sum_probs=142.8
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--------------------------chHHHHHHHHHHh
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--------------------------STRNFMHHIELIS 528 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--------------------------~~~~~~~Ei~~l~ 528 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ..+++.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 457888899999999999999965 5899999999654311 1256899999999
Q ss_pred CCCCCCccceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCcc
Q 006145 529 KLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVF 608 (659)
Q Consensus 529 ~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 608 (659)
+++||||+++++++.+. ..+..++||||+++|+|.+++.. ..+++..+..++.|+++||+|||+. +|+
T Consensus 92 ~l~h~~iv~~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~iv 159 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDP-----NEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KII 159 (298)
T ss_dssp TCCCTTBCCEEEEEECS-----SSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred hCCCCCCCeEEEEEEcC-----CCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence 99999999999998752 24578999999999999987653 4699999999999999999999998 999
Q ss_pred ccCCCCCceeecCCcceEEccCccccccccc-cccceecccccccCCCCCC
Q 006145 609 SNNLKITDILLDQNLVAKISSYNLPLLAENA-EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 609 HrDlk~~NILld~~~~~kl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~ 658 (659)
||||||+||+++.++.+||+|||+++..... .......||+.|+|||+..
T Consensus 160 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 210 (298)
T 2zv2_A 160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLS 210 (298)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCC
T ss_pred ccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhc
Confidence 9999999999999999999999999766433 2335578999999999863
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=261.60 Aligned_cols=169 Identities=15% Similarity=0.211 Sum_probs=149.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|...+.||+|+||.||+|+.. +++.||+|.++... ...+.+.+|+++++.++||||+++++++.+ .+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-------~~~ 75 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES-------MEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-------TTE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEec-------CCE
Confidence 457888899999999999999976 58999999997443 234568999999999999999999999976 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC--CcceEEccCcc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ--NLVAKISSYNL 632 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~--~~~~kl~DFGl 632 (659)
.++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEEEEeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 89999999999999999753 24689999999999999999999998 9999999999999997 78999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++............||+.|+|||+.
T Consensus 151 a~~~~~~~~~~~~~gt~~y~aPE~~ 175 (321)
T 1tki_A 151 ARQLKPGDNFRLLFTAPEYYAPEVH 175 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHH
T ss_pred CeECCCCCccccccCChhhcCcHHh
Confidence 9887666666778899999999975
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-28 Score=263.83 Aligned_cols=226 Identities=20% Similarity=0.169 Sum_probs=207.0
Q ss_pred CCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEec
Q 006145 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLAL 210 (659)
Q Consensus 131 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 210 (659)
++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..|.++++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 68999999999999999999999999999999999999988899999999999999999999887788999999999999
Q ss_pred cccccccCCCC-CCCCCcCCEEEcccCCCCCCCCC----CCcccceEecCCCcCCccCchhccCCccccEEeccCccccc
Q 006145 211 SNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPK----VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVG 285 (659)
Q Consensus 211 s~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~----~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 285 (659)
++|+++..++. |.++++|++|+|++|+..+.++. .+++|+.|+|++|++++. | .+..+++|+.|+|++|+|++
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~ 232 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPE 232 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSE
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcc
Confidence 99999987764 99999999999999554444433 257999999999999874 4 58899999999999999999
Q ss_pred CCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccCC
Q 006145 286 PFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAG 358 (659)
Q Consensus 286 ~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~ 358 (659)
..|..|..+++|+.|+|++|++++..+..+..+++|+.|||++|++++..+..+..+++++.+++++|.+.+.
T Consensus 233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence 9999999999999999999999999999999999999999999999977777888899999999999988753
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=268.68 Aligned_cols=227 Identities=21% Similarity=0.200 Sum_probs=175.8
Q ss_pred ccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcC-cccCChhcc-------CCCCCcEEEeecCCCCCCCccc
Q 006145 103 LVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFL-NGAIPQELS-------ILTSLQTLILDENMLAGRVPDW 174 (659)
Q Consensus 103 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~ 174 (659)
+...++|+.|++++|.+ .+|..+... |+.|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 34556677778888887 667666554 88888888888 456676665 6788888888888888777776
Q ss_pred c--CCCCCCCEEEccCCcCCccCCcccCCC-----CCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCCC
Q 006145 175 L--GSLPILAVLSLRNNMFNGTLPDSFSYL-----ENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVG 246 (659)
Q Consensus 175 l--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~ 246 (659)
+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++.+|. |..+++|++|+|++|.+
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-------- 185 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE-------- 185 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTT--------
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCc--------
Confidence 5 7788888888888888866 7766666 7788888888888776653 77777777777766654
Q ss_pred cccceEecCCCcCCcc--Cchhc--cCCccccEEeccCccccc--CCc-hhhcCCCcccEEeccCCcCCCcCC-cCCCCC
Q 006145 247 KKLVTMILSKNKFRSA--IPAEV--SSYYQLQRLDLSSNRFVG--PFP-QALLSLPSITYLNIADNKLTGKLF-DDLSCN 318 (659)
Q Consensus 247 ~~L~~L~l~~N~l~~~--~p~~~--~~l~~L~~L~Ls~N~l~~--~~p-~~l~~l~~L~~L~l~~N~l~~~~p-~~~~~~ 318 (659)
.+. +|..+ ..+++|++|+|++|+|++ .++ ..+..+++|+.|++++|++++.+| ..+..+
T Consensus 186 -------------~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 252 (312)
T 1wwl_A 186 -------------LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252 (312)
T ss_dssp -------------CHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCC
T ss_pred -------------CcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhc
Confidence 333 23344 789999999999999983 223 445688999999999999999875 456678
Q ss_pred CCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccCC
Q 006145 319 PELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAG 358 (659)
Q Consensus 319 ~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~ 358 (659)
++|+.|++++|+++ .+|..+. ++++.+++++|.+++.
T Consensus 253 ~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~ 289 (312)
T 1wwl_A 253 SQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN 289 (312)
T ss_dssp TTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC
T ss_pred CCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC
Confidence 99999999999999 8898876 7899999999999865
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-30 Score=265.33 Aligned_cols=176 Identities=23% Similarity=0.422 Sum_probs=139.3
Q ss_pred HHHHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 471 ELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 471 ~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
++.....+|...+.||+|+||+||+|+. +|+.||||++....... .++|.+|++++++++||||+++++++.+
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 105 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ---- 105 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----
Confidence 3334466788899999999999999987 58899999997654322 3579999999999999999999999975
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCC--ccccCCCCCceeecCCcceE
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPG--VFSNNLKITDILLDQNLVAK 626 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiHrDlk~~NILld~~~~~k 626 (659)
.+..++||||+++|+|.++++.......+++..+..++.|+++||+|||+. + |+||||||+||++++++.+|
T Consensus 106 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~k 179 (309)
T 3p86_A 106 ---PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVK 179 (309)
T ss_dssp ---TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEE
T ss_pred ---CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEE
Confidence 456899999999999999998632223489999999999999999999997 6 99999999999999999999
Q ss_pred EccCcccccccccc-ccceecccccccCCCCC
Q 006145 627 ISSYNLPLLAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 627 l~DFGla~~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
|+|||+++...... ......||+.|+|||+.
T Consensus 180 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~ 211 (309)
T 3p86_A 180 VCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211 (309)
T ss_dssp ECCCC-----------------CCTTSCHHHH
T ss_pred ECCCCCCccccccccccccCCCCccccChhhh
Confidence 99999997654332 23557899999999975
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-28 Score=273.70 Aligned_cols=254 Identities=23% Similarity=0.179 Sum_probs=213.4
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
+++++|+|++|+|++..+..|.++++|++|||++|+|++..|.+|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 37899999999999999999999999999999999999888889999999999999999999887889999999999999
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccC-CCC-CCCCCcCCEEEcccCCCCCCCCCC-------------------
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGE-VPD-FSGLTYLQVLDLENNALGPQFPKV------------------- 245 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~-~~~l~~L~~L~L~~N~l~~~~~~~------------------- 245 (659)
++|++++..+..|+++++|++|+|++|.+++. +|. +..+++|++|+|++|++++..+..
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 99999988778899999999999999999864 444 788999999999999774321100
Q ss_pred --------------------------------------------------------------------------------
Q 006145 246 -------------------------------------------------------------------------------- 245 (659)
Q Consensus 246 -------------------------------------------------------------------------------- 245 (659)
T Consensus 212 ~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~ 291 (635)
T 4g8a_A 212 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 291 (635)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECC
T ss_pred cccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhh
Confidence
Q ss_pred ------------------------------------------------------------------------------Cc
Q 006145 246 ------------------------------------------------------------------------------GK 247 (659)
Q Consensus 246 ------------------------------------------------------------------------------~~ 247 (659)
++
T Consensus 292 ~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~ 371 (635)
T 4g8a_A 292 DYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP 371 (635)
T ss_dssp CSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCT
T ss_pred cccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccccc
Confidence 01
Q ss_pred ccceEecCCCcCCcc--------------------------------------------------CchhccCCccccEEe
Q 006145 248 KLVTMILSKNKFRSA--------------------------------------------------IPAEVSSYYQLQRLD 277 (659)
Q Consensus 248 ~L~~L~l~~N~l~~~--------------------------------------------------~p~~~~~l~~L~~L~ 277 (659)
+|+.|++++|.+... .+..+..+.+++.++
T Consensus 372 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ 451 (635)
T 4g8a_A 372 SLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 451 (635)
T ss_dssp TCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEE
T ss_pred ccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccccccccc
Confidence 122333344433210 011234566778888
Q ss_pred ccCcccccCCchhhcCCCcccEEeccCCcC-CCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCcccc
Q 006145 278 LSSNRFVGPFPQALLSLPSITYLNIADNKL-TGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 278 Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l-~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
+++|.+.+..|..+..+++|+.|++++|++ .+.+|..+..+++|+.|||++|++++..|..+..+++|+.|++++|.++
T Consensus 452 ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~ 531 (635)
T 4g8a_A 452 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 531 (635)
T ss_dssp CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred ccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCC
Confidence 899999999999999999999999999985 4567888999999999999999999999999999999999999999998
Q ss_pred CCCC
Q 006145 357 AGNE 360 (659)
Q Consensus 357 ~~~~ 360 (659)
+..+
T Consensus 532 ~l~~ 535 (635)
T 4g8a_A 532 SLDT 535 (635)
T ss_dssp BCCC
T ss_pred CCCh
Confidence 7543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=261.06 Aligned_cols=173 Identities=22% Similarity=0.348 Sum_probs=150.0
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC-CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK-CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++... ....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 83 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET-----TTRH 83 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT-----TTCC
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC-----CCce
Confidence 56778899999999999999976 49999999997544 23456789999999999999999999998752 2346
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceee----cCCcceEEccC
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL----DQNLVAKISSY 630 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl----d~~~~~kl~DF 630 (659)
.++||||+++|+|.+++........+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 899999999999999998643334599999999999999999999998 99999999999999 78889999999
Q ss_pred ccccccccccccceecccccccCCCCC
Q 006145 631 NLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+++............||+.|+|||+.
T Consensus 161 g~a~~~~~~~~~~~~~gt~~y~aPE~~ 187 (319)
T 4euu_A 161 GAARELEDDEQFVSLYGTEEYLHPDMY 187 (319)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHH
T ss_pred CCceecCCCCceeecccCCCccCHHHh
Confidence 999887666666677899999999964
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=265.16 Aligned_cols=171 Identities=23% Similarity=0.345 Sum_probs=147.4
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCC-CCCCccceeeeeeecccc
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFD 548 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 548 (659)
...++|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|.+++..+ +||||+++++++.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~---- 89 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT---- 89 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe----
Confidence 34578889999999999999999976 59999999997542 23456788999999877 89999999999976
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
.+..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 90 ---~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 90 ---KENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp ---SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred ---CCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEe
Confidence 56799999999999999999752 4689999999999999999999998 99999999999999999999999
Q ss_pred cCccccccc-cccccceecccccccCCCCC
Q 006145 629 SYNLPLLAE-NAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~-~~~~~~~~~gt~~y~aPE~~ 657 (659)
|||+++... ........+||+.|+|||+.
T Consensus 161 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~ 190 (345)
T 1xjd_A 161 DFGMCKENMLGDAKTNTFCGTPDYIAPEIL 190 (345)
T ss_dssp CCTTCBCCCCTTCCBCCCCSCGGGCCHHHH
T ss_pred EChhhhhcccCCCcccCCCCCcccCChhhh
Confidence 999997643 23345667899999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=260.83 Aligned_cols=167 Identities=22% Similarity=0.341 Sum_probs=146.6
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|+..+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~------- 77 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD------- 77 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-------
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-------
Confidence 356788899999999999999975 59999999997542 2345678899999999999999999999975
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....|+||||+++|+|.++++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 78 ~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg 151 (318)
T 1fot_A 78 AQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 151 (318)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred CCEEEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecC
Confidence 56789999999999999999852 4689999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+++.... .....+||+.|+|||+.
T Consensus 152 ~a~~~~~--~~~~~~gt~~y~aPE~~ 175 (318)
T 1fot_A 152 FAKYVPD--VTYTLCGTPDYIAPEVV 175 (318)
T ss_dssp SCEECSS--CBCCCCSCTTTCCHHHH
T ss_pred cceecCC--ccccccCCccccCHhHh
Confidence 9986643 23456899999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=262.88 Aligned_cols=169 Identities=20% Similarity=0.287 Sum_probs=148.8
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------- 80 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT------- 80 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-------
Confidence 35688889999999999999996 469999999996432 2234679999999999999999999999976
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..++||||+ +|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~~~lv~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 81 PTDIVMVIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp SSEEEEEECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred CCEEEEEEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEec
Confidence 56789999999 78999988752 4699999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
++............+||+.|+|||+..
T Consensus 154 ~s~~~~~~~~~~~~~gt~~y~aPE~~~ 180 (336)
T 3h4j_B 154 LSNIMTDGNFLKTSCGSPNYAAPEVIN 180 (336)
T ss_dssp CTBTTTTSBTTCCCTTSTTTSCGGGSC
T ss_pred cceeccCCcccccccCCcCcCCHHHHc
Confidence 998877666667789999999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=260.94 Aligned_cols=168 Identities=19% Similarity=0.308 Sum_probs=147.9
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC------chHHHHHHHHHHhCCCCCCccceeeeeeeccccC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH------STRNFMHHIELISKLRHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 549 (659)
+.|...+.||+|+||.||+|+.. +|+.||||.++..... ..+++.+|++++++++||||+++++++.+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----- 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence 45778899999999999999975 5999999999754322 34679999999999999999999999975
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc----ce
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL----VA 625 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~----~~ 625 (659)
....++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++ .+
T Consensus 86 --~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 157 (326)
T 2y0a_A 86 --KTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRI 157 (326)
T ss_dssp --SSEEEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCE
T ss_pred --CCEEEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCE
Confidence 5678999999999999999975 24699999999999999999999998 999999999999999887 89
Q ss_pred EEccCccccccccccccceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
||+|||+++............||+.|+|||+.
T Consensus 158 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 189 (326)
T 2y0a_A 158 KIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189 (326)
T ss_dssp EECCCTTCEECCTTSCCCCCCSCTTTCCHHHH
T ss_pred EEEECCCCeECCCCCccccccCCcCcCCceee
Confidence 99999999877655555667899999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=265.16 Aligned_cols=169 Identities=21% Similarity=0.310 Sum_probs=148.0
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++|||||++++++.+ .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-------~ 100 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-------E 100 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-------S
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-------C
Confidence 467888999999999999999975 5999999999765432 23568999999999999999999999976 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC---cceEEcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN---LVAKISS 629 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~---~~~kl~D 629 (659)
+..|+||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.+ +.+||+|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~D 174 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLAD 174 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred CEEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEee
Confidence 6789999999999999998752 4689999999999999999999998 99999999999999865 4599999
Q ss_pred CccccccccccccceecccccccCCCCC
Q 006145 630 YNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
||+++...........+||+.|+|||+.
T Consensus 175 fG~a~~~~~~~~~~~~~gt~~y~aPE~~ 202 (362)
T 2bdw_A 175 FGLAIEVNDSEAWHGFAGTPGYLSPEVL 202 (362)
T ss_dssp CTTCBCCTTCCSCCCSCSCTTTCCHHHH
T ss_pred cCcceEecCCcccccCCCCccccCHHHH
Confidence 9999877665555667899999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=263.72 Aligned_cols=168 Identities=20% Similarity=0.312 Sum_probs=145.8
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc---hHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS---TRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~ 551 (659)
++|...+.||+|+||.||+|+.. +|+.||||+++...... .+.+.+|++++.++ +|||||++++++.+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~------- 81 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT------- 81 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-------
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-------
Confidence 46778899999999999999976 58999999997654322 34588999999988 89999999999876
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG 155 (345)
T 3a8x_A 82 ESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG 155 (345)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGG
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecc
Confidence 56789999999999999999752 4689999999999999999999998 99999999999999999999999999
Q ss_pred ccccc-ccccccceecccccccCCCCC
Q 006145 632 LPLLA-ENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~-~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+++.. .........+||+.|+|||+.
T Consensus 156 ~a~~~~~~~~~~~~~~gt~~y~aPE~~ 182 (345)
T 3a8x_A 156 MCKEGLRPGDTTSTFCGTPNYIAPEIL 182 (345)
T ss_dssp GCBCSCCTTCCBCCCCSCGGGCCHHHH
T ss_pred ccccccCCCCcccccCCCccccCcccc
Confidence 99764 233345667899999999975
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=274.36 Aligned_cols=139 Identities=27% Similarity=0.362 Sum_probs=128.1
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 68999999999999999999999999999999999999988899999999999999999999888888999999999999
Q ss_pred cCCcCCc-cCCcccCCCCCCcEEeccccccccCCC--CCCCCCcCCEEEcccCCCCCCCCCC
Q 006145 187 RNNMFNG-TLPDSFSYLENLRVLALSNNHFYGEVP--DFSGLTYLQVLDLENNALGPQFPKV 245 (659)
Q Consensus 187 ~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~l~~L~~L~L~~N~l~~~~~~~ 245 (659)
++|.+++ ..|..|+++++|++|++++|.+.+.+| .|.++++|++|++++|.+++..|..
T Consensus 106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 167 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS 167 (549)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTT
T ss_pred CCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhh
Confidence 9999997 467889999999999999999655554 4999999999999999998866643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=264.44 Aligned_cols=169 Identities=19% Similarity=0.278 Sum_probs=147.3
Q ss_pred hcCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccC---CCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKK---CHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~ 550 (659)
.++|...+.||+|+||+||+|+... |+.||||+++... ....+.+.+|.+++..+ +||||+++++++.+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~------ 92 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT------ 92 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC------
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc------
Confidence 4678889999999999999999764 8899999997542 23456789999999998 79999999999875
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+|.++.+||+||
T Consensus 93 -~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF 165 (353)
T 2i0e_A 93 -MDRLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADF 165 (353)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeC
Confidence 56789999999999999999852 4589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccc-cccccceecccccccCCCCC
Q 006145 631 NLPLLAE-NAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~-~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+++... ........+||+.|||||++
T Consensus 166 G~a~~~~~~~~~~~~~~gt~~y~aPE~~ 193 (353)
T 2i0e_A 166 GMCKENIWDGVTTKTFCGTPDYIAPEII 193 (353)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHH
T ss_pred CcccccccCCcccccccCCccccChhhh
Confidence 9997642 33345667899999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-29 Score=256.90 Aligned_cols=169 Identities=20% Similarity=0.319 Sum_probs=141.1
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc---hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS---TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+|+.. +++.||+|.+....... .+.|.+|++++++++||||+++++++.+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~------- 82 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE------- 82 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-------
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-------
Confidence 356888899999999999999965 58999999986544332 3578999999999999999999999875
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg 156 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFG 156 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCC
Confidence 56789999999999999999752 4689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccc--ccceecccccccCCCCC
Q 006145 632 LPLLAENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
+++...... ......||+.|+|||+.
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 184 (294)
T 4eqm_A 157 IAKALSETSLTQTNHVLGTVQYFSPEQA 184 (294)
T ss_dssp SSTTC-------------CCSSCCHHHH
T ss_pred CccccccccccccCccccCccccCHhHh
Confidence 997664332 23456799999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=277.87 Aligned_cols=171 Identities=19% Similarity=0.286 Sum_probs=150.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------- 255 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET------- 255 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-------
Confidence 456888899999999999999975 69999999996532 2345678999999999999999999999876
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..|+||||+++|+|.+++... ....+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFG 331 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLG 331 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecc
Confidence 56799999999999999999753 234599999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+++...........+||+.|||||++
T Consensus 332 la~~~~~~~~~~~~~GT~~Y~APEvl 357 (576)
T 2acx_A 332 LAVHVPEGQTIKGRVGTVGYMAPEVV 357 (576)
T ss_dssp TCEECCTTCCEECCCSCGGGCCHHHH
T ss_pred cceecccCccccccCCCccccCHHHH
Confidence 99877665555667999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-29 Score=265.91 Aligned_cols=170 Identities=16% Similarity=0.241 Sum_probs=149.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|...+.||+|+||.||+|+.. +|+.||+|.+..........+.+|++++++++|||||++++++.+ ...
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-------~~~ 122 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-------KYE 122 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-------SSE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-------CCE
Confidence 457888999999999999999975 589999999976543345679999999999999999999999976 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC--CcceEEccCcc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ--NLVAKISSYNL 632 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~--~~~~kl~DFGl 632 (659)
.++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEeccc
Confidence 89999999999999999753 24699999999999999999999998 9999999999999984 47899999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++............||+.|+|||+.
T Consensus 198 a~~~~~~~~~~~~~gt~~y~aPE~~ 222 (387)
T 1kob_A 198 ATKLNPDEIVKVTTATAEFAAPEIV 222 (387)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHH
T ss_pred ceecCCCcceeeeccCCCccCchhc
Confidence 9887665556677899999999975
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=260.58 Aligned_cols=272 Identities=19% Similarity=0.188 Sum_probs=224.0
Q ss_pred CCCCCCCCCcCCCCCCCceEeCC-----------CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCC
Q 006145 51 SWNITTEFCNTEPTSSLTVVCYE-----------ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGL 119 (659)
Q Consensus 51 ~W~~~~~~C~w~~~~~~gv~C~~-----------~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l 119 (659)
.|.....+|.|.+ .+.|.. .+++.|++++|.+.+..+ ..+.++++|++|+|++|.+
T Consensus 22 ~~~~~~~~C~~~~----~c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~---------~~~~~l~~L~~L~L~~n~l 88 (353)
T 2z80_A 22 SSNQASLSCDRNG----ICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISN---------SDLQRCVNLQALVLTSNGI 88 (353)
T ss_dssp -----CCEECTTS----EEECCSTTCSSCCTTCCTTCCEEECTTSCCCEECT---------TTTTTCTTCCEEECTTSCC
T ss_pred CCCccCCCCCCCe----EeeCCCCCcccccccccccCcEEECCCCcCcccCH---------HHhccCCCCCEEECCCCcc
Confidence 3555567788864 133322 268899999888764322 2577899999999999999
Q ss_pred cCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCc-cccCCCCCCCEEEccCC-cCCccCCc
Q 006145 120 WGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVP-DWLGSLPILAVLSLRNN-MFNGTLPD 197 (659)
Q Consensus 120 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N-~l~~~~p~ 197 (659)
++..|..|.++++|++|+|++|.+++..+..+.++++|++|+|++|++++..+ ..+..+++|++|++++| .+.+..|.
T Consensus 89 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~ 168 (353)
T 2z80_A 89 NTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168 (353)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTT
T ss_pred CccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHH
Confidence 99999999999999999999999997656669999999999999999985444 48999999999999999 57777788
Q ss_pred ccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCC---CcccceEecCCCcCCccCchhcc---CC
Q 006145 198 SFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKV---GKKLVTMILSKNKFRSAIPAEVS---SY 270 (659)
Q Consensus 198 ~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~~~p~~~~---~l 270 (659)
.|.++++|++|++++|++++..|. +..+++|++|++++|.++...+.. .++|+.|++++|.+++..+..+. ..
T Consensus 169 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~ 248 (353)
T 2z80_A 169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248 (353)
T ss_dssp TTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CC
T ss_pred HccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccccccc
Confidence 999999999999999999998765 999999999999999986443322 57999999999999987665543 46
Q ss_pred ccccEEeccCccccc----CCchhhcCCCcccEEeccCCcCCCcCCcC-CCCCCCCCEEECcCCCCcccCC
Q 006145 271 YQLQRLDLSSNRFVG----PFPQALLSLPSITYLNIADNKLTGKLFDD-LSCNPELGFVDLSSNLLTGQLP 336 (659)
Q Consensus 271 ~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~L~~L~ls~N~l~g~ip 336 (659)
..++.++|++|.+++ .+|..+..+++|+.|++++|+++. +|.. +..+++|+.|++++|++++..|
T Consensus 249 ~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 249 SLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred chhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc-cCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 678899999998876 478899999999999999999995 5554 6899999999999999998876
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-27 Score=250.22 Aligned_cols=260 Identities=19% Similarity=0.252 Sum_probs=208.9
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.+++.|++++|.+... +. +.++++|++|+|++|.++.. +.|.++++|++|++++|.+++. |. +..
T Consensus 66 ~~L~~L~l~~n~i~~~----------~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l~~n~i~~~-~~-~~~ 130 (347)
T 4fmz_A 66 TNLEYLNLNGNQITDI----------SP-LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDI-SP-LAN 130 (347)
T ss_dssp TTCCEEECCSSCCCCC----------GG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEECTTSCCCCC-GG-GTT
T ss_pred CCccEEEccCCccccc----------hh-hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEECcCCcccCc-hh-hcc
Confidence 4577777777765422 22 67788888888888888763 3588888888888888888754 33 788
Q ss_pred CCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEc
Q 006145 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDL 233 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L 233 (659)
+++|++|++++|.....++. +..+++|++|++++|.+.+..+ +..+++|+.|++++|.+.+..+ +..+++|+.|++
T Consensus 131 l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l 206 (347)
T 4fmz_A 131 LTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP-LASLTSLHYFTA 206 (347)
T ss_dssp CTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG-GGGCTTCCEEEC
T ss_pred CCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc-ccCCCccceeec
Confidence 88888888888866655444 8888888888888888875443 7888889999999888876544 788888999999
Q ss_pred ccCCCCCCCCC-CCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCC
Q 006145 234 ENNALGPQFPK-VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLF 312 (659)
Q Consensus 234 ~~N~l~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 312 (659)
++|.+.+..+. .+++|+.|++++|++++..+ +..+++|+.|++++|.+++. +.+..+++|+.|++++|++++.
T Consensus 207 ~~n~l~~~~~~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-- 280 (347)
T 4fmz_A 207 YVNQITDITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI-- 280 (347)
T ss_dssp CSSCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--
T ss_pred ccCCCCCCchhhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--
Confidence 99888776542 35789999999999987544 88899999999999999863 4688999999999999999875
Q ss_pred cCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccCC
Q 006145 313 DDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAG 358 (659)
Q Consensus 313 ~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~ 358 (659)
+.+..+++|+.|++++|++++..|..+..+++++.+++++|.+++.
T Consensus 281 ~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 326 (347)
T 4fmz_A 281 SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326 (347)
T ss_dssp GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence 4578889999999999999998889999999999999999998854
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=265.82 Aligned_cols=172 Identities=20% Similarity=0.416 Sum_probs=144.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec--------CCcEEEEEEecccCCC-chHHHHHHHHHHhCC-CCCCccceeeeeeec
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK--------NGTFVAIRCLKMKKCH-STRNFMHHIELISKL-RHRHLVSALGHCFEC 545 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 545 (659)
.++|...+.||+|+||.||+|+.. ++..||||+++..... ..+++.+|+++++++ +|||||+++++|..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence 467788899999999999999852 3568999999765322 245799999999999 89999999999975
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCC
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHA-------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNL 612 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl 612 (659)
.+..|+||||+++|+|.++++.... ...+++.++..++.||++||+|||+. +|+||||
T Consensus 159 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDl 229 (370)
T 2psq_A 159 ------DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDL 229 (370)
T ss_dssp ------SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred ------CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceecccc
Confidence 4568999999999999999975321 23589999999999999999999998 9999999
Q ss_pred CCCceeecCCcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 613 KITDILLDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 613 k~~NILld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
||+|||+++++.+||+|||+++...... ......+|+.|||||+.
T Consensus 230 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 277 (370)
T 2psq_A 230 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 277 (370)
T ss_dssp CGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHH
T ss_pred chhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHh
Confidence 9999999999999999999998654322 22345678899999964
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-27 Score=259.55 Aligned_cols=252 Identities=23% Similarity=0.186 Sum_probs=186.7
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.+++.|++++|.+.+. | .+..+++|++|+|++|.+++. | ++.+++|++|+|++|.+++. | +++
T Consensus 42 ~~L~~L~Ls~n~l~~~-~----------~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~ 104 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T----------GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTP 104 (457)
T ss_dssp TTCCEEECCSSCCCCC-T----------TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTT
T ss_pred CCCCEEEccCCCcccC-h----------hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCC
Confidence 4688888888877642 2 356788888888888888774 3 78888888888888888864 3 778
Q ss_pred CCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEc
Q 006145 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDL 233 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L 233 (659)
+++|++|+|++|++++ +| ++.+++|++|++++|.+++. | ++++++|++|++++|+..+.+ .+..+++|++|++
T Consensus 105 l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~-~~~~l~~L~~L~l 177 (457)
T 3bz5_A 105 LTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL-DVTPQTQLTTLDC 177 (457)
T ss_dssp CTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC-CCTTCTTCCEEEC
T ss_pred CCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc-ccccCCcCCEEEC
Confidence 8888888888888876 44 78888888888888888863 3 778888888888888666555 4777888888888
Q ss_pred ccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCc
Q 006145 234 ENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFD 313 (659)
Q Consensus 234 ~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~ 313 (659)
++|++++.....+++|+.|++++|++++. .++.+++|+.|++++|++++ +| +..+++|+.|++++|++++..+.
T Consensus 178 s~n~l~~l~l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~ 251 (457)
T 3bz5_A 178 SFNKITELDVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS 251 (457)
T ss_dssp CSSCCCCCCCTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT
T ss_pred CCCccceeccccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH
Confidence 88888775544467788888888888774 37777888888888888876 55 77788888888888888876555
Q ss_pred CCCCCC-------CCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 314 DLSCNP-------ELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 314 ~~~~~~-------~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
.+..+. +|+.|++++|.+.|.+| +..+++++.+++++|.+.+
T Consensus 252 ~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~ 300 (457)
T 3bz5_A 252 TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLY 300 (457)
T ss_dssp TCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCC
T ss_pred HCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccc
Confidence 554443 45566666666666666 3455667777777776543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-27 Score=259.43 Aligned_cols=231 Identities=21% Similarity=0.192 Sum_probs=208.9
Q ss_pred CCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCC
Q 006145 123 LSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYL 202 (659)
Q Consensus 123 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 202 (659)
+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+
T Consensus 58 iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 135 (440)
T 3zyj_A 58 VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYL 135 (440)
T ss_dssp CCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSC
T ss_pred CCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhcc
Confidence 444443 689999999999999888999999999999999999998888999999999999999999997777789999
Q ss_pred CCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCC----CCcccceEecCCCcCCccCchhccCCccccEEe
Q 006145 203 ENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPK----VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLD 277 (659)
Q Consensus 203 ~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~----~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 277 (659)
++|++|+|++|+++...+. |.++++|++|+|++|+..+.++. .+++|+.|+|++|+++. +| .+..+++|+.|+
T Consensus 136 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~ 213 (440)
T 3zyj_A 136 SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELD 213 (440)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEE
T ss_pred ccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEE
Confidence 9999999999999987774 99999999999999654444433 25799999999999985 45 488999999999
Q ss_pred ccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 278 LSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 278 Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|||++|++++..+..+..+++++.+++++|.+.+
T Consensus 214 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred CCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 99999999999999999999999999999999999999999999999999999998777788889999999999998875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=266.05 Aligned_cols=170 Identities=15% Similarity=0.140 Sum_probs=144.1
Q ss_pred hhcCCCCCceeccCcCceEEEEE------ecCCcEEEEEEecccCCCchHHHHHHHHHHhCCC---CCCccceeeeeeec
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGR------LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLR---HRHLVSALGHCFEC 545 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~ 545 (659)
..++|...+.||+|+||+||+|+ ..+++.||||+++.. ...++.+|++++.+++ |+||+++++++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~- 138 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF- 138 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec-
Confidence 35678888999999999999994 346899999999743 3567888988888887 9999999999986
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCC--CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC--
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEG--HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ-- 621 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~-- 621 (659)
.+..++|||||++|+|.++++.. .....++|..+..|+.|+++||+|||+. +||||||||+|||++.
T Consensus 139 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 139 ------QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGF 209 (365)
T ss_dssp ------SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGG
T ss_pred ------CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccc
Confidence 46689999999999999999731 1235699999999999999999999998 9999999999999998
Q ss_pred ---------CcceEEccCccccccc---cccccceecccccccCCCCC
Q 006145 622 ---------NLVAKISSYNLPLLAE---NAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 622 ---------~~~~kl~DFGla~~~~---~~~~~~~~~gt~~y~aPE~~ 657 (659)
++.+||+|||+|+... ........+||+.|||||+.
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 257 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML 257 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh
Confidence 8999999999996543 33344567899999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-29 Score=266.42 Aligned_cols=165 Identities=21% Similarity=0.280 Sum_probs=140.2
Q ss_pred CCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEE
Q 006145 481 TSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIF 559 (659)
Q Consensus 481 ~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~ 559 (659)
..+.||+|+||.||+|+.. +|+.||||+++.......+++.+|++++++++|||||+++++|.+ .+..++||
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-------~~~~~lv~ 165 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-------KNDIVLVM 165 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-------SSEEEEEE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-------CCEEEEEE
Confidence 3578999999999999965 599999999986554456789999999999999999999999976 56789999
Q ss_pred eccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceee--cCCcceEEccCccccccc
Q 006145 560 EYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL--DQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 560 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl--d~~~~~kl~DFGla~~~~ 637 (659)
||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||+ ++++.+||+|||+++...
T Consensus 166 E~~~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 166 EYVDGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp ECCTTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 999999999988742 24689999999999999999999998 99999999999999 567899999999998876
Q ss_pred cccccceecccccccCCCCC
Q 006145 638 NAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 ~~~~~~~~~gt~~y~aPE~~ 657 (659)
........+||+.|+|||+.
T Consensus 241 ~~~~~~~~~gt~~y~aPE~~ 260 (373)
T 2x4f_A 241 PREKLKVNFGTPEFLAPEVV 260 (373)
T ss_dssp TTCBCCCCCSSCTTCCHHHH
T ss_pred CccccccccCCCcEeChhhc
Confidence 66556667899999999964
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-29 Score=259.81 Aligned_cols=169 Identities=21% Similarity=0.307 Sum_probs=144.6
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|+..+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++++.++||||+++++++.+ .+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-------~~ 78 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-------GN 78 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-------SS
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-------CC
Confidence 357888899999999999999976 699999999975443 233568999999999999999999999976 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeecc
Confidence 789999999999999999752 4699999999999999999999998 9999999999999999999999999999
Q ss_pred cccccc---cccceecccccccCCCCC
Q 006145 634 LLAENA---EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~---~~~~~~~gt~~y~aPE~~ 657 (659)
+..... ......+||+.|+|||+.
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~ 179 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELL 179 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHH
T ss_pred ceeccCCcccccCCCccCcCccCcHHh
Confidence 765322 223467899999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-29 Score=254.98 Aligned_cols=168 Identities=19% Similarity=0.375 Sum_probs=140.9
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhC--CCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISK--LRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|...+.||+|+||+||+|+. +|+.||||++... ..+.+.+|.+++.. ++||||+++++++..... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~---~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRH---SST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET---TEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC---CCc
Confidence 45788899999999999999988 5899999998643 34556677777665 799999999999875321 235
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhc--------CCCCCCccccCCCCCceeecCCcce
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH--------TGIVPGVFSNNLKITDILLDQNLVA 625 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiHrDlk~~NILld~~~~~ 625 (659)
..++||||+++|+|.++++. ..+++..+.+++.|+++||+||| +. +|+||||||+|||++.++.+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 68999999999999999974 46999999999999999999999 65 99999999999999999999
Q ss_pred EEccCccccccccccc-----cceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENAEK-----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~~ 657 (659)
||+|||+++....... ....+||+.|+|||+.
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 189 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHH
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhh
Confidence 9999999976543322 2334899999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=267.01 Aligned_cols=169 Identities=18% Similarity=0.270 Sum_probs=137.4
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--------CchHHHHHHHHHHhCCCCCCccceeeeeeec
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--------HSTRNFMHHIELISKLRHRHLVSALGHCFEC 545 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 545 (659)
..++|...+.||+|+||.||+|+.. +++.||||++..... .....+.+|+++|++++|||||++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4578999999999999999999965 589999999975421 112358999999999999999999999853
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC---
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN--- 622 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~--- 622 (659)
+..++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.+
T Consensus 212 -------~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~ 278 (419)
T 3i6u_A 212 -------EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED 278 (419)
T ss_dssp -------SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSS
T ss_pred -------CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCc
Confidence 457999999999999999875 24699999999999999999999998 99999999999999754
Q ss_pred cceEEccCccccccccccccceecccccccCCCCC
Q 006145 623 LVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 623 ~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+.+||+|||+++...........+||+.|+|||+.
T Consensus 279 ~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~ 313 (419)
T 3i6u_A 279 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313 (419)
T ss_dssp CCEEECCSSTTTSCC-----------CTTCCTTTT
T ss_pred ceEEEeecccceecCCCccccccCCCCCccCceee
Confidence 45999999999887666556678899999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-29 Score=259.87 Aligned_cols=170 Identities=22% Similarity=0.393 Sum_probs=141.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec----CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK----NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.++|...+.||+|+||.||+|+.. .+..||||+++..... ..++|.+|++++++++||||++++++|.+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 121 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR------ 121 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG------
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe------
Confidence 356777899999999999999974 3556999999765332 34579999999999999999999999975
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+..++||||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 122 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 195 (325)
T 3kul_A 122 -GRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDF 195 (325)
T ss_dssp -GGCCEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred -CCccEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCC
Confidence 45689999999999999999753 24699999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccc----cceecccccccCCCCC
Q 006145 631 NLPLLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
|+++....... .....+|+.|+|||+.
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 226 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHH
T ss_pred CcccccccCccceeeccCCCCcccccCHhHh
Confidence 99987643321 2334567789999974
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-29 Score=265.74 Aligned_cols=170 Identities=24% Similarity=0.419 Sum_probs=134.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec----CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK----NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.++|...+.||+|+||.||+|+.. ++..||||+++..... ..++|.+|++++++++||||++++++|.+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------ 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK------ 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee------
Confidence 357888999999999999999965 4778999999765322 34579999999999999999999999975
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+..++||||+++|+|.++++.. ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 118 -~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 191 (373)
T 2qol_A 118 -SKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDF 191 (373)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred -CCceEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcC
Confidence 45689999999999999999853 34699999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccc----cceecccccccCCCCC
Q 006145 631 NLPLLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
|+++....... .....+++.|+|||+.
T Consensus 192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 222 (373)
T 2qol_A 192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222 (373)
T ss_dssp ----------------------CTTSCHHHH
T ss_pred ccccccccCCccceeccCCCcCCCccChhhh
Confidence 99987643321 1223457789999974
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-29 Score=260.28 Aligned_cols=173 Identities=17% Similarity=0.342 Sum_probs=145.3
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.++|+..+.||+|+||+||+|+.. ++.||||++.... .....+.+|+.++++++|||||++++++..... .....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS---VDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS---SSEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC---CCceE
Confidence 467888899999999999999875 8999999996543 223457779999999999999999999986321 13457
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCC-------CCCccccCCCCCceeecCCcceEEc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI-------VPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
++||||+++|+|.++++. ..++|..+..++.|+++||+|||+.+ .++|+||||||+||++++++.+||+
T Consensus 98 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 999999999999999985 35999999999999999999999852 3489999999999999999999999
Q ss_pred cCccccccccccc---cceecccccccCCCCC
Q 006145 629 SYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
|||+++....... ....+||+.|+|||+.
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 205 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhc
Confidence 9999976643322 2346899999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-29 Score=270.99 Aligned_cols=168 Identities=22% Similarity=0.350 Sum_probs=149.5
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+ .
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-------~ 88 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-------P 88 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-------S
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-------C
Confidence 56788899999999999999975 69999999996542 2234679999999999999999999999976 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~ 162 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGL 162 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred CEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccc
Confidence 678999999999999999975 24699999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++...........+||+.|+|||+.
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~ 187 (476)
T 2y94_A 163 SNMMSDGEFLRTSCGSPNYAAPEVI 187 (476)
T ss_dssp CEECCTTCCBCCCCSCSTTCCHHHH
T ss_pred hhhccccccccccCCCcCeEChhhc
Confidence 9887665556678899999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-29 Score=262.07 Aligned_cols=166 Identities=17% Similarity=0.271 Sum_probs=146.4
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+ .
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~ 113 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-------N 113 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-------S
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-------C
Confidence 56888899999999999999975 59999999996542 2345678999999999999999999999876 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..|+||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccccc
Confidence 6789999999999999999852 4589999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++..... ....+||+.|+|||+.
T Consensus 188 a~~~~~~--~~~~~gt~~y~aPE~~ 210 (350)
T 1rdq_E 188 AKRVKGR--TWTLCGTPEALAPEII 210 (350)
T ss_dssp CEECSSC--BCCCEECGGGCCHHHH
T ss_pred ceeccCC--cccccCCccccCHHHh
Confidence 9876442 3456899999999975
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-27 Score=258.26 Aligned_cols=253 Identities=23% Similarity=0.162 Sum_probs=142.2
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.+++.|++++|.+.+. | +..+++|++|+|++|.+++. | ++++++|++|++++|.+++ +| ++.
T Consensus 64 ~~L~~L~Ls~n~l~~~-~-----------~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~ 125 (457)
T 3bz5_A 64 TGLTKLICTSNNITTL-D-----------LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQ 125 (457)
T ss_dssp TTCSEEECCSSCCSCC-C-----------CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTT
T ss_pred CCCCEEEccCCcCCeE-c-----------cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCC
Confidence 5788899988887652 1 44566666666666666653 2 6666666666666666665 33 666
Q ss_pred CCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEc
Q 006145 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDL 233 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L 233 (659)
+++|++|++++|++++. | ++.+++|++|++++|...+.+ .++.+++|+.|++++|++++. | +..+++|+.|++
T Consensus 126 l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~-l~~l~~L~~L~l 198 (457)
T 3bz5_A 126 NPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL-D-VSQNKLLNRLNC 198 (457)
T ss_dssp CTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC-C-CTTCTTCCEEEC
T ss_pred CCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcccee-c-cccCCCCCEEEC
Confidence 66666666666666652 2 555666666666666444444 255556666666666665553 2 555555555555
Q ss_pred ccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhh----------------------
Q 006145 234 ENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQAL---------------------- 291 (659)
Q Consensus 234 ~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l---------------------- 291 (659)
++|.+++.....+++|+.|++++|++++ +| ++.+++|+.|++++|++++..+..+
T Consensus 199 ~~N~l~~~~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~ 275 (457)
T 3bz5_A 199 DTNNITKLDLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNT 275 (457)
T ss_dssp CSSCCSCCCCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCT
T ss_pred cCCcCCeeccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCc
Confidence 5555555432334555555555555555 33 4555555555555555555433333
Q ss_pred -------cCCCcccEEeccCCcCCCcCCc--------CCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCcccc
Q 006145 292 -------LSLPSITYLNIADNKLTGKLFD--------DLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 292 -------~~l~~L~~L~l~~N~l~~~~p~--------~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
+.+++|+.|++++|.+.+.+|. .+..+++|+.|++++|+++| +| +..+++++.+++++|+++
T Consensus 276 ~~~~~~~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~ 352 (457)
T 3bz5_A 276 QLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQ 352 (457)
T ss_dssp TCCEEECTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCC
T ss_pred cCCcccccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCC
Confidence 3344455555555544444332 13344555555555555555 22 455555555555555555
Q ss_pred C
Q 006145 357 A 357 (659)
Q Consensus 357 ~ 357 (659)
+
T Consensus 353 ~ 353 (457)
T 3bz5_A 353 D 353 (457)
T ss_dssp B
T ss_pred C
Confidence 3
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.2e-29 Score=251.12 Aligned_cols=168 Identities=21% Similarity=0.355 Sum_probs=146.0
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
++|...+.||+|+||.||+|+..+++.||||++..... ..+++.+|++++++++||||+++++++.+ .+..+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------~~~~~ 81 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-------QAPIC 81 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-------SSSEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEec-------CCceE
Confidence 56777899999999999999988899999999975542 45779999999999999999999999975 45689
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred EEEEeCCCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccc
Confidence 999999999999999753 24689999999999999999999998 9999999999999999999999999999766
Q ss_pred cccc--ccceecccccccCCCCC
Q 006145 637 ENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
.... ......+|+.|+|||+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~ 179 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVF 179 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHH
T ss_pred cccccccccCcccccccCCHHHh
Confidence 4322 22445678889999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-29 Score=258.21 Aligned_cols=168 Identities=17% Similarity=0.153 Sum_probs=139.7
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||+||+|+.. +|+.||||++...... ...++.+|+..+.++ +||||++++++|.+ .
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-------~ 129 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-------G 129 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-------T
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-------C
Confidence 56888999999999999999976 6999999998654332 223466666666655 89999999999986 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+ +|+|.+++... ...++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred CEEEEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEcccee
Confidence 6789999999 67999988753 24699999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++............||+.|+|||+.
T Consensus 204 a~~~~~~~~~~~~~gt~~y~aPE~~ 228 (311)
T 3p1a_A 204 LVELGTAGAGEVQEGDPRYMAPELL 228 (311)
T ss_dssp CEECC------CCCCCGGGCCGGGG
T ss_pred eeecccCCCCcccCCCccccCHhHh
Confidence 9877665555667899999999975
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=251.05 Aligned_cols=258 Identities=23% Similarity=0.264 Sum_probs=224.9
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.+++.|++++|.+... +.+.++++|++|+|++|.+.+..+ +..+++|+.|++++|.....++. +..
T Consensus 88 ~~L~~L~L~~n~i~~~-----------~~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~-~~~ 153 (347)
T 4fmz_A 88 VKLTNLYIGTNKITDI-----------SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSN 153 (347)
T ss_dssp TTCCEEECCSSCCCCC-----------GGGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGG-GTT
T ss_pred CcCCEEEccCCcccCc-----------hHHcCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCcccccc-hhh
Confidence 5789999999876531 257899999999999999987544 99999999999999977655554 899
Q ss_pred CCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEc
Q 006145 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDL 233 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L 233 (659)
+++|++|++++|.+.+..+ +..+++|+.|++++|.+.+. +. +..+++|+.|++++|.+++..+ +..+++|++|++
T Consensus 154 l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l 228 (347)
T 4fmz_A 154 MTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI-SP-LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKI 228 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEEC
T ss_pred CCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccc-cc-ccCCCccceeecccCCCCCCch-hhcCCcCCEEEc
Confidence 9999999999999986544 88999999999999999854 33 8899999999999999987655 889999999999
Q ss_pred ccCCCCCCCC-CCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCC
Q 006145 234 ENNALGPQFP-KVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLF 312 (659)
Q Consensus 234 ~~N~l~~~~~-~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 312 (659)
++|.+++..+ ..+++|+.|++++|.+++. ..+..+++|+.|++++|++++. +.+..+++|+.|++++|++++..|
T Consensus 229 ~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~ 304 (347)
T 4fmz_A 229 GNNKITDLSPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDM 304 (347)
T ss_dssp CSSCCCCCGGGTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGH
T ss_pred cCCccCCCcchhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcCh
Confidence 9999987765 2368999999999999874 5689999999999999999864 468999999999999999999999
Q ss_pred cCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCcccc
Q 006145 313 DDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 313 ~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
..+..+++|+.|++++|++++..| +..+++++.+++++|.++
T Consensus 305 ~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 305 EVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 999999999999999999998766 788999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-29 Score=261.07 Aligned_cols=169 Identities=17% Similarity=0.270 Sum_probs=136.5
Q ss_pred hcCCCCCceeccCcCceEEEEEe----cCCcEEEEEEecccCC----CchHHHHHHHHHHhCCCCCCccceeeeeeeccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL----KNGTFVAIRCLKMKKC----HSTRNFMHHIELISKLRHRHLVSALGHCFECYF 547 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 547 (659)
.++|...+.||+|+||.||+|+. .+|+.||||+++.... .....+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 92 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--- 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence 35688889999999999999996 4689999999975432 233568899999999999999999999976
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEE
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKI 627 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl 627 (659)
.+..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 93 ----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl 162 (327)
T 3a62_A 93 ----GGKLYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKL 162 (327)
T ss_dssp ----SSCEEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEE
T ss_pred ----CCEEEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEE
Confidence 46789999999999999999752 4588999999999999999999998 9999999999999999999999
Q ss_pred ccCcccccccc-ccccceecccccccCCCCC
Q 006145 628 SSYNLPLLAEN-AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 628 ~DFGla~~~~~-~~~~~~~~gt~~y~aPE~~ 657 (659)
+|||+++.... .......+||+.|+|||+.
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~ 193 (327)
T 3a62_A 163 TDFGLCKESIHDGTVTHTFCGTIEYMAPEIL 193 (327)
T ss_dssp CCCSCC----------CTTSSCCTTSCHHHH
T ss_pred EeCCcccccccCCccccccCCCcCccCHhhC
Confidence 99999975432 2233456899999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=256.64 Aligned_cols=169 Identities=18% Similarity=0.308 Sum_probs=142.7
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|...+.||+|+||+||+|+..+|+.||||++...... ..+.+.+|++++++++||||+++++++.+ .+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~ 92 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-------ER 92 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-------SS
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-------CC
Confidence 4668888999999999999999988999999999754322 23678999999999999999999999875 46
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++ +|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 166 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA 166 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCc
Confidence 78999999985 888888753 24589999999999999999999998 9999999999999999999999999999
Q ss_pred cccccc-cccceecccccccCCCCC
Q 006145 634 LLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
+..... .......||+.|+|||+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~ 191 (311)
T 3niz_A 167 RAFGIPVRSYTHEVVTLWYRAPDVL 191 (311)
T ss_dssp EETTSCCC---CCCCCCTTCCHHHH
T ss_pred eecCCCcccccCCcccCCcCCHHHh
Confidence 876432 334556899999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=251.25 Aligned_cols=169 Identities=15% Similarity=0.207 Sum_probs=150.7
Q ss_pred hcCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|...+.||+|+||.||+|+... +..||+|++........+++.+|++++++++||||+++++++.+ .+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------~~~ 80 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-------NTD 80 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-------SSE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-------CCe
Confidence 3557888999999999999999764 78999999987666667889999999999999999999999976 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceee---cCCcceEEccCc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL---DQNLVAKISSYN 631 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl---d~~~~~kl~DFG 631 (659)
.++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 89999999999999998752 4589999999999999999999998 99999999999999 788999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++.............||+.|+|||+.
T Consensus 155 ~~~~~~~~~~~~~~~~t~~y~aPE~~ 180 (277)
T 3f3z_A 155 LAARFKPGKMMRTKVGTPYYVSPQVL 180 (277)
T ss_dssp TCEECCTTSCBCCCCSCTTTCCHHHH
T ss_pred cceeccCccchhccCCCCCccChHHh
Confidence 99877666666677899999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-29 Score=273.44 Aligned_cols=169 Identities=18% Similarity=0.287 Sum_probs=136.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+++++.++||||++++++|..
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------- 219 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT------- 219 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-------
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-------
Confidence 467888999999999999999965 59999999997542 2334568899999999999999999999986
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcC-CCCCCccccCCCCCceeecCCcceEEccC
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT-GIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+..++|||||++|+|.+++... ..+++..+..++.|+++||+|||+ . +|+||||||+|||++.++.+||+||
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DF 293 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDF 293 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCC
T ss_pred CCEEEEEEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccC
Confidence 56789999999999999999752 468999999999999999999997 7 9999999999999999999999999
Q ss_pred ccccccc-cccccceecccccccCCCCC
Q 006145 631 NLPLLAE-NAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~-~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+++... ........+||+.|||||++
T Consensus 294 G~a~~~~~~~~~~~~~~gt~~y~aPE~~ 321 (446)
T 4ejn_A 294 GLCKEGIKDGATMKTFCGTPEYLAPEVL 321 (446)
T ss_dssp CCCCTTCC-----CCSSSCGGGCCHHHH
T ss_pred CCceeccCCCcccccccCCccccCHhhc
Confidence 9997643 33344667899999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-29 Score=264.72 Aligned_cols=169 Identities=18% Similarity=0.310 Sum_probs=138.2
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHHHHHH-HhCCCCCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMHHIEL-ISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.++|...+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|..+ ++.++|||||++++++.+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~------ 110 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT------ 110 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC------
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe------
Confidence 356888899999999999999976 489999999976542 223457777776 577899999999999876
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+..|+||||+++|+|.+++++. ..+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 111 -~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 111 -ADKLYFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDF 183 (373)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeC
Confidence 56799999999999999999752 4688999999999999999999998 9999999999999999999999999
Q ss_pred cccccc-ccccccceecccccccCCCCC
Q 006145 631 NLPLLA-ENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~-~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+++.. .........+||+.|||||++
T Consensus 184 G~a~~~~~~~~~~~~~~gt~~y~aPE~~ 211 (373)
T 2r5t_A 184 GLCKENIEHNSTTSTFCGTPEYLAPEVL 211 (373)
T ss_dssp CBCGGGBCCCCCCCSBSCCCCCCCHHHH
T ss_pred ccccccccCCCccccccCCccccCHHHh
Confidence 999764 333345667899999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=261.93 Aligned_cols=168 Identities=18% Similarity=0.239 Sum_probs=137.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|...+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.++++++|||||++++++.+ .+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-------~~~ 90 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILT-------PTH 90 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------SSE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEee-------CCE
Confidence 467888999999999999999976 699999999975432 34678999999999999999999999986 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc--eEEccCcc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV--AKISSYNL 632 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~--~kl~DFGl 632 (659)
.++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 89999999999999999752 4589999999999999999999998 9999999999999987765 99999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++...........+||+.|+|||++
T Consensus 165 a~~~~~~~~~~~~~gt~~y~aPE~~ 189 (361)
T 3uc3_A 165 SKSSVLHSQPKSTVGTPAYIAPEVL 189 (361)
T ss_dssp C---------------CTTSCHHHH
T ss_pred cccccccCCCCCCcCCCCcCChhhh
Confidence 9865544455667899999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=259.35 Aligned_cols=170 Identities=14% Similarity=0.202 Sum_probs=149.2
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--------chHHHHHHHHHHhCCCCCCccceeeeeeec
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--------STRNFMHHIELISKLRHRHLVSALGHCFEC 545 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 545 (659)
..++|...+.||+|+||.||+|+.. +++.||||+++..... ..+.+.+|++++++++||||+++++++.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~- 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN- 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 3467888999999999999999954 5999999999765321 23468899999999999999999999975
Q ss_pred cccCCCCceeEEEEeccCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc
Q 006145 546 YFDDSSVSRIFLIFEYVPNG-TLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV 624 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~G-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~ 624 (659)
.+..++||||+.+| +|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 101 ------~~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 101 ------QGFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp ------SSEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSC
T ss_pred ------CCEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCc
Confidence 56789999999877 999999863 4699999999999999999999998 9999999999999999999
Q ss_pred eEEccCccccccccccccceecccccccCCCCC
Q 006145 625 AKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 ~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+||+|||+++...........+||+.|+|||+.
T Consensus 169 ~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 201 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVL 201 (335)
T ss_dssp EEECCCTTCEECCTTCCBCEECSCGGGCCHHHH
T ss_pred EEEeecccceECCCCCceeccCCCccccChhhh
Confidence 999999999887666666678899999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=260.96 Aligned_cols=168 Identities=20% Similarity=0.303 Sum_probs=130.1
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
..++|...+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||++++++|.+ .+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------~~ 121 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET-------PT 121 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC-------SS
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec-------CC
Confidence 3567888999999999999999976 48899999997543 34568899999999999999999999976 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC---CcceEEccC
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ---NLVAKISSY 630 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl~DF 630 (659)
..++||||+++|+|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccC
Confidence 789999999999999999752 4589999999999999999999998 9999999999999975 889999999
Q ss_pred ccccccccccccceecccccccCCCCC
Q 006145 631 NLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+++...........+||+.|+|||+.
T Consensus 196 g~a~~~~~~~~~~~~~gt~~y~aPE~~ 222 (349)
T 2w4o_A 196 GLSKIVEHQVLMKTVCGTPGYCAPEIL 222 (349)
T ss_dssp C----------------CGGGSCHHHH
T ss_pred ccccccCcccccccccCCCCccCHHHh
Confidence 999877665555667899999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-29 Score=256.59 Aligned_cols=172 Identities=21% Similarity=0.370 Sum_probs=141.6
Q ss_pred hcCCCCCceeccCcCceEEEEEe-----cCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-----KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.++|+..+.||+|+||+||+|++ .+++.||||++........++|.+|++++++++||||++++++|....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 84 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---- 84 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH----
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----
Confidence 35677889999999999999984 258999999997655444567999999999999999999999986522
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 85 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 85 -RRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp -HTSCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred -CCceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccC
Confidence 24579999999999999999753 23589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccc----cceecccccccCCCCC
Q 006145 631 NLPLLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
|+++....... .....++..|+|||+.
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 189 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHh
Confidence 99987643321 2334577889999964
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-29 Score=262.40 Aligned_cols=171 Identities=15% Similarity=0.245 Sum_probs=144.8
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC-----CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK-----CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
+.|...+.||+|+||+||+|+.. +|+.||||++.... ....+++.+|+++++.++|||||++++++.+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------ 97 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS------ 97 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE------
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe------
Confidence 46888899999999999999965 59999999996432 1235679999999999999999999999986
Q ss_pred CCceeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc---eE
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV---AK 626 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~---~k 626 (659)
.+..|+||||+++|+|.+++... .....+++..+..++.|+++||+|||+. +|+||||||+|||++.++. +|
T Consensus 98 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vk 173 (351)
T 3c0i_A 98 -DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVK 173 (351)
T ss_dssp -TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEE
T ss_pred -CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEE
Confidence 46789999999999999887632 1234589999999999999999999998 9999999999999986654 99
Q ss_pred EccCccccccccccc-cceecccccccCCCCC
Q 006145 627 ISSYNLPLLAENAEK-VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 627 l~DFGla~~~~~~~~-~~~~~gt~~y~aPE~~ 657 (659)
|+|||+++....... ....+||+.|+|||+.
T Consensus 174 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~ 205 (351)
T 3c0i_A 174 LGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205 (351)
T ss_dssp ECCCTTCEECCTTSCBCCCCCSCGGGCCHHHH
T ss_pred EecCcceeEecCCCeeecCCcCCcCccCHHHH
Confidence 999999977654332 4567899999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=259.01 Aligned_cols=171 Identities=15% Similarity=0.154 Sum_probs=137.6
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCC--------CchHHHHHHHHHHhCCC---------CCCccce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKC--------HSTRNFMHHIELISKLR---------HRHLVSA 538 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~---------H~niv~l 538 (659)
.++|...+.||+|+||+||+|+. +|+.||||+++.... ...+.+.+|++++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35577789999999999999998 689999999976532 12367899999998886 7777776
Q ss_pred eeeeeecccc-----------------------CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 006145 539 LGHCFECYFD-----------------------DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKG 595 (659)
Q Consensus 539 ~g~~~~~~~~-----------------------~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 595 (659)
.+++...... ....+..|+||||+++|++.+.+.+ ..+++..+..++.|++.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 6654321000 0014678999999999987777753 358999999999999999
Q ss_pred hhhhc-CCCCCCccccCCCCCceeecCCc--------------------ceEEccCccccccccccccceecccccccCC
Q 006145 596 IQFLH-TGIVPGVFSNNLKITDILLDQNL--------------------VAKISSYNLPLLAENAEKVGHVIPYSGSIDP 654 (659)
Q Consensus 596 L~yLH-~~~~~~iiHrDlk~~NILld~~~--------------------~~kl~DFGla~~~~~~~~~~~~~gt~~y~aP 654 (659)
|+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ..+||+.||||
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aP 246 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCS
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccCh
Confidence 99999 87 999999999999999886 9999999999876542 45899999999
Q ss_pred CCCC
Q 006145 655 TNSA 658 (659)
Q Consensus 655 E~~~ 658 (659)
|+..
T Consensus 247 E~~~ 250 (336)
T 2vuw_A 247 DLFT 250 (336)
T ss_dssp GGGC
T ss_pred hhhc
Confidence 9863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=264.79 Aligned_cols=173 Identities=22% Similarity=0.348 Sum_probs=149.6
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC-CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK-CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++... ....
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~ 83 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET-----TTRH 83 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT-----TTCC
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC-----CCCe
Confidence 46778899999999999999976 49999999997543 23456789999999999999999999998752 2346
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceee----cCCcceEEccC
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL----DQNLVAKISSY 630 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl----d~~~~~kl~DF 630 (659)
.++||||+++|+|.++++.......+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 799999999999999998643334599999999999999999999998 99999999999999 77888999999
Q ss_pred ccccccccccccceecccccccCCCCC
Q 006145 631 NLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+++............||+.|+|||+.
T Consensus 161 G~a~~~~~~~~~~~~~gt~~y~aPE~~ 187 (396)
T 4eut_A 161 GAARELEDDEQFVSLYGTEEYLHPDMY 187 (396)
T ss_dssp GGCEECCCGGGSSCSSSCCTTCCHHHH
T ss_pred CCceEccCCCccccccCCccccCHHHh
Confidence 999887666666677899999999964
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-29 Score=263.90 Aligned_cols=182 Identities=22% Similarity=0.352 Sum_probs=150.2
Q ss_pred cCHHHHHHhhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCC-chHHHHHHHHHHhCC-CCCCccce
Q 006145 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCH-STRNFMHHIELISKL-RHRHLVSA 538 (659)
Q Consensus 467 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l-~H~niv~l 538 (659)
+...++....++|...+.||+|+||.||+|++. +++.||||+++..... ..+++.+|++++.++ +|||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 455666677889999999999999999999832 4689999999764432 235799999999999 79999999
Q ss_pred eeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCC------------------------------------------
Q 006145 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHA------------------------------------------ 576 (659)
Q Consensus 539 ~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~------------------------------------------ 576 (659)
+++|.+. ....++||||+++|+|.++++....
T Consensus 92 ~~~~~~~------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (359)
T 3vhe_A 92 LGACTKP------GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS 165 (359)
T ss_dssp EEEECST------TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------
T ss_pred eeeeecC------CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccc
Confidence 9999752 3458999999999999999975321
Q ss_pred ---------------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 577 ---------------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 577 ---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 242 (359)
T 3vhe_A 166 GFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 242 (359)
T ss_dssp ------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred ccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceee
Confidence 12289999999999999999999998 999999999999999999999999999976
Q ss_pred ccccc---ccceecccccccCCCCC
Q 006145 636 AENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
..... ......||+.|+|||+.
T Consensus 243 ~~~~~~~~~~~~~~~t~~y~aPE~~ 267 (359)
T 3vhe_A 243 IYKDPDYVRKGDARLPLKWMAPETI 267 (359)
T ss_dssp TTSCTTCEEC--CEECGGGCCHHHH
T ss_pred ecccccchhccccCCCceeEChhhh
Confidence 53322 23456789999999964
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=253.21 Aligned_cols=171 Identities=17% Similarity=0.331 Sum_probs=132.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|...+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+ .+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~ 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-------EN 76 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-------TT
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-------CC
Confidence 467888999999999999999965 599999999975543 234679999999999999999999999875 46
Q ss_pred eeEEEEeccCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 554 RIFLIFEYVPNGTLRSWISEG---HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
..++||||++ |+|.+++... .....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 152 (317)
T 2pmi_A 77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDF 152 (317)
T ss_dssp EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcC
Confidence 7899999998 5999988642 1224589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccc-cccceecccccccCCCCC
Q 006145 631 NLPLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
|+++..... .......||+.|+|||+.
T Consensus 153 g~~~~~~~~~~~~~~~~~t~~y~aPE~~ 180 (317)
T 2pmi_A 153 GLARAFGIPVNTFSSEVVTLWYRAPDVL 180 (317)
T ss_dssp SSCEETTSCCCCCCCCCSCCTTCCHHHH
T ss_pred ccceecCCCcccCCCCcccccccCchHh
Confidence 999766432 233556899999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=250.91 Aligned_cols=168 Identities=17% Similarity=0.304 Sum_probs=143.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|...+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+ .+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~ 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-------DK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-------TT
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-------CC
Confidence 46788899999999999999975 5899999999755432 23678999999999999999999999986 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++ ++.+.+... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 75 ~~~lv~e~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 75 KLTLVFEFCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp EEEEEEECCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 78999999976 666665532 24699999999999999999999998 9999999999999999999999999999
Q ss_pred cccccc-cccceecccccccCCCCC
Q 006145 634 LLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
+..... .......||+.|+|||+.
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~ 173 (292)
T 3o0g_A 149 RAFGIPVRCYSAEVVTLWYRPPDVL 173 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHH
T ss_pred eecCCccccccCCccccCCcChHHH
Confidence 766432 334567899999999964
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=268.78 Aligned_cols=173 Identities=16% Similarity=0.313 Sum_probs=133.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||+||+|+.. +|+.||||++...... ..+++.+|+++|++++|||||++++++.....+ ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--~~ 129 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE--KF 129 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT--TC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc--cC
Confidence 367888999999999999999965 6999999999654322 346799999999999999999999999653221 23
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...|+||||+ +|+|.+++.. ...+++..+..++.||++||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccccc
Confidence 5689999998 4699999985 24699999999999999999999998 999999999999999999999999999
Q ss_pred cccccccc----------------------------ccceecccccccCCCCC
Q 006145 633 PLLAENAE----------------------------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~ 657 (659)
|+...... .....+||++|||||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~ 255 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI 255 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHH
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHh
Confidence 98664221 23456889999999963
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=266.55 Aligned_cols=169 Identities=19% Similarity=0.237 Sum_probs=144.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|++++++++|||||++++++.+ .
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-------~ 82 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-------E 82 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-------S
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-------C
Confidence 566888999999999999999864 6999999999765432 23568999999999999999999999976 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec---CCcceEEcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD---QNLVAKISS 629 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld---~~~~~kl~D 629 (659)
+..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++ +++.+||+|
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~D 156 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLAD 156 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECC
T ss_pred CEEEEEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEcc
Confidence 6789999999999999998753 4699999999999999999999998 999999999999998 457899999
Q ss_pred Ccccccccccc-ccceecccccccCCCCC
Q 006145 630 YNLPLLAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
||+++...... .....+||+.|||||++
T Consensus 157 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l 185 (444)
T 3soa_A 157 FGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185 (444)
T ss_dssp CSSCBCCCTTCCBCCCSCSCGGGCCHHHH
T ss_pred CceeEEecCCCceeecccCCcccCCHHHh
Confidence 99997765433 33567899999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=252.54 Aligned_cols=168 Identities=20% Similarity=0.310 Sum_probs=141.3
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|...+.||+|+||+||+|+..+|+.||||++..... ...+.+.+|++++++++||||+++++++.+ .+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-------KKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-------SSC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-------CCe
Confidence 46778899999999999999987899999999965432 224678999999999999999999999975 457
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++ +|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (288)
T 1ob3_A 75 LVLVFEHLDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148 (288)
T ss_dssp EEEEEECCSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred EEEEEEecCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcccc
Confidence 8999999985 999998753 24689999999999999999999998 99999999999999999999999999997
Q ss_pred ccccc-cccceecccccccCCCCC
Q 006145 635 LAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
..... .......||+.|+|||+.
T Consensus 149 ~~~~~~~~~~~~~~t~~y~aPE~~ 172 (288)
T 1ob3_A 149 AFGIPVRKYTHEIVTLWYRAPDVL 172 (288)
T ss_dssp HHCC---------CCCTTCCHHHH
T ss_pred ccCccccccccccccccccCchhe
Confidence 65432 233556899999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.8e-29 Score=253.17 Aligned_cols=170 Identities=21% Similarity=0.319 Sum_probs=143.9
Q ss_pred hhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..++|...+.||+|+||.||+|+..++..||||+++.... ..+++.+|++++.+++||||++++++|.+ .+.
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------~~~ 93 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-------QRP 93 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-------SSS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEec-------CCC
Confidence 3567788899999999999999998888999999976543 35779999999999999999999999975 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 168 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 168 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred eEEEEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccc
Confidence 89999999999999999752 24599999999999999999999998 99999999999999999999999999997
Q ss_pred cccccc--ccceecccccccCCCCC
Q 006145 635 LAENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
...... ......+|+.|+|||+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (283)
T 3gen_A 169 YVLDDEYTSSVGSKFPVRWSPPEVL 193 (283)
T ss_dssp GBCCHHHHSTTSTTSCGGGCCHHHH
T ss_pred cccccccccccCCccCcccCCHHHh
Confidence 664322 12345577889999974
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=259.29 Aligned_cols=177 Identities=24% Similarity=0.385 Sum_probs=147.1
Q ss_pred HHHHhhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeee
Q 006145 471 ELEEATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCF 543 (659)
Q Consensus 471 ~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 543 (659)
++....++|...+.||+|+||.||+|+.. +++.||||.++..... ..++|.+|++++++++||||++++++|.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 33445678999999999999999999975 3589999999755432 2457999999999999999999999997
Q ss_pred eccccCCCCceeEEEEeccCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHhhhhcCC
Q 006145 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHA---------------------HQSLTWTQRISAAIGVAKGIQFLHTG 602 (659)
Q Consensus 544 ~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~ 602 (659)
+ .+..++||||+++|+|.++++.... ...+++.++..++.|+++||+|||+.
T Consensus 121 ~-------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 193 (343)
T 1luf_A 121 V-------GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193 (343)
T ss_dssp S-------SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred c-------CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 5 4568999999999999999975311 15699999999999999999999998
Q ss_pred CCCCccccCCCCCceeecCCcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 603 IVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 603 ~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
+|+||||||+||++++++.+||+|||+++...... ......+|+.|+|||+.
T Consensus 194 ---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 248 (343)
T 1luf_A 194 ---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 248 (343)
T ss_dssp ---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred ---CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh
Confidence 99999999999999999999999999997653322 22456788999999964
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=269.60 Aligned_cols=172 Identities=20% Similarity=0.335 Sum_probs=147.2
Q ss_pred HHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 473 EEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 473 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
+...++|...+.||+|+||.||+|++.++..||||+++... ...++|.+|+++|++++|||||++++++..
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-------- 254 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-------- 254 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS--------
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC--------
Confidence 34566788889999999999999999888999999997644 346789999999999999999999999853
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++|||||++|+|.++++.. ....+++..+..++.|||+||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred CccEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 4579999999999999999852 123588999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccc--cceecccccccCCCCC
Q 006145 633 PLLAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
++....... .....++..|+|||+.
T Consensus 331 a~~~~~~~~~~~~~~~~~~~y~aPE~~ 357 (454)
T 1qcf_A 331 ARVIEDNEYTAREGAKFPIKWTAPEAI 357 (454)
T ss_dssp GGGBCCHHHHTTCSSSSCGGGSCHHHH
T ss_pred ceEcCCCceeccCCCcccccccCHHHh
Confidence 987643321 2334567899999964
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=270.34 Aligned_cols=171 Identities=19% Similarity=0.285 Sum_probs=147.8
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+ .
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-------~ 257 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-------K 257 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-------S
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-------C
Confidence 56788889999999999999975 59999999996542 2344678999999999999999999999875 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGH-AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
+..|+||||+++|+|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFG 334 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLG 334 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecc
Confidence 67899999999999999987532 134699999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccc-cceecccccccCCCCC
Q 006145 632 LPLLAENAEK-VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~-~~~~~gt~~y~aPE~~ 657 (659)
+++....... ....+||+.|||||++
T Consensus 335 la~~~~~~~~~~~~~~GT~~Y~APE~l 361 (543)
T 3c4z_A 335 LAVELKAGQTKTKGYAGTPGFMAPELL 361 (543)
T ss_dssp TCEECCTTCCCBCCCCSCTTTSCHHHH
T ss_pred eeeeccCCCcccccccCCccccChhhh
Confidence 9987654333 3446899999999975
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-27 Score=256.48 Aligned_cols=254 Identities=23% Similarity=0.268 Sum_probs=125.6
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.+++.|++++|.+.+. ++ +.++++|++|+|++|.+.+..+ ++++++|++|++++|.+++..+ +.+
T Consensus 68 ~~L~~L~Ls~n~l~~~----------~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~ 132 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDI----------TP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKN 132 (466)
T ss_dssp TTCCEEECCSSCCCCC----------GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTT
T ss_pred cCCCEEECCCCccCCc----------hh-hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcC
Confidence 4677888887766533 12 5566777777777777765544 6677777777777777664422 666
Q ss_pred CCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEc
Q 006145 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDL 233 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L 233 (659)
+++|++|++++|.+.+ +| .++.+++|+.|+++ |.+.+.. .+.++++|+.|++++|.+++. +.+..+++|++|++
T Consensus 133 l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l 206 (466)
T 1o6v_A 133 LTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI-SVLAKLTNLESLIA 206 (466)
T ss_dssp CTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEEC
T ss_pred CCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC-hhhccCCCCCEEEe
Confidence 7777777777776654 22 24444444444443 2222211 144455555555555554432 23444455555555
Q ss_pred ccCCCCCCCCC-CCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCC
Q 006145 234 ENNALGPQFPK-VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLF 312 (659)
Q Consensus 234 ~~N~l~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 312 (659)
++|.+++..|. .+++|+.|++++|++++. ..+..+++|+.|++++|.+++..| +..+++|+.|++++|++++..+
T Consensus 207 ~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~ 282 (466)
T 1o6v_A 207 TNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 282 (466)
T ss_dssp CSSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG
T ss_pred cCCcccccccccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc
Confidence 55554443331 134444444444444332 233444444444444444443322 4444444444444444443222
Q ss_pred cCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCcccc
Q 006145 313 DDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 313 ~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
+..+++|+.|++++|++++..| +..+++++.+++++|.++
T Consensus 283 --~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~ 322 (466)
T 1o6v_A 283 --LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNIS 322 (466)
T ss_dssp --GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCS
T ss_pred --ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCC
Confidence 3344444444444444443222 333444444444444443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=248.06 Aligned_cols=169 Identities=21% Similarity=0.324 Sum_probs=146.0
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.++|...+.||+|+||.||+|+..++..||||+++.... ..+++.+|++++.+++||||+++++++.+ ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------~~~~ 78 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK-------EYPI 78 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-------SSSE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc-------CCce
Confidence 456778899999999999999998888999999975543 35679999999999999999999999975 4568
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 79 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred EEEEEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCcccee
Confidence 9999999999999999752 23589999999999999999999998 999999999999999999999999999976
Q ss_pred cccccc--cceecccccccCCCCC
Q 006145 636 AENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
...... .....+|+.|+|||+.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~ 177 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVF 177 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHH
T ss_pred cchhhhhcccCCCcCcccCCHHHH
Confidence 644322 2345567789999974
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-27 Score=240.28 Aligned_cols=221 Identities=24% Similarity=0.246 Sum_probs=156.7
Q ss_pred CEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCC
Q 006145 110 KVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189 (659)
Q Consensus 110 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 189 (659)
+.++.++++++. +|..+ .++|+.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|
T Consensus 14 ~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 577888888765 34433 468999999999998877778889999999999999998888888999999999999999
Q ss_pred c-CCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCC---CcccceEecCCCcCCccCc
Q 006145 190 M-FNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKV---GKKLVTMILSKNKFRSAIP 264 (659)
Q Consensus 190 ~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~~~p 264 (659)
. +....|..|..+++|++|++++|.+++..|. +.++++|++|++++|.+++..+.. +++|+.|++++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 7 7766688888899999999999998887665 788888888888888776554432 3455555555555555444
Q ss_pred hhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcc
Q 006145 265 AEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG 333 (659)
Q Consensus 265 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g 333 (659)
..+..+++|+.|+|++|.+++..|..+..+++|+.|++++|++++..+..+..+++|+.|++++|.++.
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred HHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence 445555555555555555555555555555555555555555555444445555555555555555553
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=270.45 Aligned_cols=171 Identities=19% Similarity=0.356 Sum_probs=147.1
Q ss_pred hhcCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
...+|...+.||+|+||.||+|++.. +..||||.++... ...++|.+|+++|++++|||||+++++|.. .+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------~~ 289 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-------EP 289 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-------SS
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEec-------CC
Confidence 35567788999999999999999775 8899999997544 346789999999999999999999999975 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++|||||++|+|.++++.. ....+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred cEEEEEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccc
Confidence 689999999999999999853 235689999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccc--cceecccccccCCCCC
Q 006145 634 LLAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
+....... .....++..|+|||++
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 391 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESL 391 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHH
T ss_pred eeccCCceeecCCCcCCcceeCHhHH
Confidence 87644322 2334567899999964
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=263.67 Aligned_cols=171 Identities=18% Similarity=0.343 Sum_probs=144.0
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
..++|...+.||+|+||.||+|+.. +++.||||.++..... ..++|.+|+++|++++|||||+++|+|.. .
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-------~ 184 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-------K 184 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-------S
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-------C
Confidence 3466778899999999999999986 6999999999754322 23468999999999999999999999975 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred CCcEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 5689999999999999999752 23589999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccc---ceecccccccCCCCC
Q 006145 633 PLLAENAEKV---GHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~---~~~~gt~~y~aPE~~ 657 (659)
++........ ....++..|+|||+.
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~ 287 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEAL 287 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHH
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHh
Confidence 9765432211 223457789999964
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=257.33 Aligned_cols=182 Identities=18% Similarity=0.254 Sum_probs=145.5
Q ss_pred CHHHHHHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCc-----------hHHHHHHHHHHhCCCCCCcc
Q 006145 468 SLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHS-----------TRNFMHHIELISKLRHRHLV 536 (659)
Q Consensus 468 ~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv 536 (659)
..+++....++|...+.||+|+||.||+|+..+|+.||||++....... .+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4578888899999999999999999999998889999999996543211 26799999999999999999
Q ss_pred ceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCc
Q 006145 537 SALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITD 616 (659)
Q Consensus 537 ~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~N 616 (659)
++++++..... ......++||||++ |+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|
T Consensus 93 ~~~~~~~~~~~--~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 164 (362)
T 3pg1_A 93 GLRDIFVHFEE--PAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN 164 (362)
T ss_dssp CCSEEEEECCT--TTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred ceeeeEEeccC--CCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence 99999865321 22456899999998 6999888753 34699999999999999999999998 99999999999
Q ss_pred eeecCCcceEEccCccccccccccccceecccccccCCCCC
Q 006145 617 ILLDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 617 ILld~~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+++.++.+||+|||+++............||+.|+|||+.
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~ 205 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV 205 (362)
T ss_dssp EEECTTCCEEECCTTC---------------CGGGCCHHHH
T ss_pred EEEcCCCCEEEEecCcccccccccccceecccceecCcHHh
Confidence 99999999999999999876655556677899999999964
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-28 Score=253.10 Aligned_cols=169 Identities=18% Similarity=0.298 Sum_probs=148.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC------chHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH------STRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
.++|...+.||+|+||.||+|+.. +|+.||||.++..... ..+++.+|++++++++||||+++++++.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 86 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN---- 86 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 345788899999999999999976 5999999999754322 24679999999999999999999999975
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc----c
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL----V 624 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~----~ 624 (659)
.+..++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++ .
T Consensus 87 ---~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 87 ---RTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp ---SSEEEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCC
T ss_pred ---CCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCC
Confidence 5678999999999999999985 24689999999999999999999998 999999999999999887 7
Q ss_pred eEEccCccccccccccccceecccccccCCCCC
Q 006145 625 AKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 ~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+||+|||+++............||+.|+|||+.
T Consensus 158 ~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~ 190 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190 (321)
T ss_dssp EEECCCTTCEECCTTCCCCCCCSCGGGCCHHHH
T ss_pred EEEccCccceecCccccccccCCCCCccCcccc
Confidence 999999999877665555667899999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=255.91 Aligned_cols=173 Identities=16% Similarity=0.283 Sum_probs=138.7
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCc---hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHS---TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+|+. .+++.||||+++...... .+.|.+|++++++++||||+++++++..... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~---~ 87 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP---A 87 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET---T
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC---C
Confidence 45688889999999999999996 469999999997654332 2468999999999999999999999875321 1
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....|+||||+++|+|.++++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred CcccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 22459999999999999999752 4689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccc----ccceecccccccCCCCC
Q 006145 632 LPLLAENAE----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~----~~~~~~gt~~y~aPE~~ 657 (659)
+++...... ......||+.|+|||+.
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 191 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQA 191 (311)
T ss_dssp CC------------------CCTTCCHHHH
T ss_pred CcccccccccccccccccCcCcccCCHHHh
Confidence 997654322 22446799999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-28 Score=249.92 Aligned_cols=176 Identities=21% Similarity=0.355 Sum_probs=144.9
Q ss_pred hhcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCC-----CchHHHHHHHHHHhCCC---CCCccceeeeeeec
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKC-----HSTRNFMHHIELISKLR---HRHLVSALGHCFEC 545 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~ 545 (659)
..++|...+.||+|+||+||+|+. .+|+.||||++..... .....+.+|++++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999996 4699999999974332 12356778888877765 99999999999763
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcce
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVA 625 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~ 625 (659)
..+ .....++||||+. |+|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+
T Consensus 87 ~~~--~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 87 RTD--REIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CSS--SEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred CCC--CceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 211 1225799999997 59999998632 23499999999999999999999998 99999999999999999999
Q ss_pred EEccCccccccccccccceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
||+|||+++...........+||+.|+|||+.
T Consensus 160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 191 (308)
T 3g33_A 160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVL 191 (308)
T ss_dssp EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHH
T ss_pred EEeeCccccccCCCcccCCccccccccCchHH
Confidence 99999999877666666778899999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=265.23 Aligned_cols=168 Identities=20% Similarity=0.386 Sum_probs=142.6
Q ss_pred hhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..++|...+.||+|+||.||+|++. |+.||||+++... ..++|.+|+++|++++|||||+++++|... ...
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 261 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE------KGG 261 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT------TSC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC------CCc
Confidence 3466778899999999999999985 7899999997643 457899999999999999999999998751 336
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++|||||++|+|.++++.. ....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 337 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence 89999999999999999853 223579999999999999999999998 99999999999999999999999999998
Q ss_pred ccccccccceecccccccCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
..... .....++..|+|||+.
T Consensus 338 ~~~~~--~~~~~~~~~y~aPE~~ 358 (450)
T 1k9a_A 338 EASST--QDTGKLPVKWTAPEAL 358 (450)
T ss_dssp ECC--------CCCTTTSCHHHH
T ss_pred ccccc--ccCCCCCcceeCHHHh
Confidence 55332 2234678899999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=249.29 Aligned_cols=171 Identities=16% Similarity=0.228 Sum_probs=141.1
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|...+.||+|+||.||+|+.. ++..||+|++..... ...+++.+|++++++++||||+++++++.+ ...
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~ 94 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-------YHN 94 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-------SSE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-------CCe
Confidence 45777899999999999999965 589999999976543 345789999999999999999999999975 567
Q ss_pred eEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec---CCcceEEccC
Q 006145 555 IFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD---QNLVAKISSY 630 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld---~~~~~kl~DF 630 (659)
.++||||+++|+|.+++... .....+++..+..++.|+++||+|||+. +|+||||||+||+++ .++.+||+||
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEee
Confidence 89999999999999988632 1125699999999999999999999998 999999999999994 5688999999
Q ss_pred ccccccccccccceecccccccCCCCC
Q 006145 631 NLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+++............||+.|+|||+.
T Consensus 172 g~a~~~~~~~~~~~~~~t~~y~aPE~~ 198 (285)
T 3is5_A 172 GLAELFKSDEHSTNAAGTALYMAPEVF 198 (285)
T ss_dssp CCCCC----------CTTGGGCCHHHH
T ss_pred ecceecCCcccCcCcccccCcCChHHh
Confidence 999877665556678899999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=250.65 Aligned_cols=161 Identities=17% Similarity=0.192 Sum_probs=124.4
Q ss_pred CceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCCceeEEEE
Q 006145 482 SAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSVSRIFLIF 559 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~~~lV~ 559 (659)
.+.||+|+||.||+|+.. +|+.||||++... ....+.+|++++..++ ||||+++++++.+ ....++||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-------~~~~~lv~ 85 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD-------QLHTFLVM 85 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-------SSEEEEEE
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-------CCEEEEEE
Confidence 478999999999999975 5899999999643 3467889999999997 9999999999976 56789999
Q ss_pred eccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc---ceEEccCcccccc
Q 006145 560 EYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL---VAKISSYNLPLLA 636 (659)
Q Consensus 560 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~---~~kl~DFGla~~~ 636 (659)
||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||+++..
T Consensus 86 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 86 ELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp CCCCSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 999999999999863 4699999999999999999999998 999999999999998665 8999999999765
Q ss_pred ccc-cccceecccccccCCCCCC
Q 006145 637 ENA-EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 637 ~~~-~~~~~~~gt~~y~aPE~~~ 658 (659)
... ......+||+.|+|||+..
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~ 182 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLN 182 (325)
T ss_dssp CC---------------------
T ss_pred CCCCCcccccCCCcCccCHHHhc
Confidence 433 3345678899999999863
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-26 Score=254.08 Aligned_cols=257 Identities=23% Similarity=0.249 Sum_probs=221.0
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.+++.|++.++.+.. +| .+..+++|++|+|++|.+++..+ +.++++|++|++++|.+++..| +.+
T Consensus 46 ~~l~~L~l~~~~i~~-l~----------~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~ 110 (466)
T 1o6v_A 46 DQVTTLQADRLGIKS-ID----------GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LAN 110 (466)
T ss_dssp HTCCEEECCSSCCCC-CT----------TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTT
T ss_pred ccccEEecCCCCCcc-Cc----------chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcC
Confidence 468899998877542 22 36789999999999999988655 9999999999999999997655 999
Q ss_pred CCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEc
Q 006145 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDL 233 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L 233 (659)
+++|++|+|++|.+++. |. +..+++|++|++++|.+++ +| .++.+++|+.|+++ |.+.+. +.+.++++|++|++
T Consensus 111 l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~-~~~~~l~~L~~L~l 184 (466)
T 1o6v_A 111 LTNLTGLTLFNNQITDI-DP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDL-KPLANLTTLERLDI 184 (466)
T ss_dssp CTTCCEEECCSSCCCCC-GG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCC-GGGTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCCCC-hH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCc-hhhccCCCCCEEEC
Confidence 99999999999999865 43 9999999999999999986 44 58999999999997 556554 44999999999999
Q ss_pred ccCCCCCCCCC-CCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCC
Q 006145 234 ENNALGPQFPK-VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLF 312 (659)
Q Consensus 234 ~~N~l~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 312 (659)
++|.+++...- .+++|+.|++++|.+++..| ++.+++|+.|++++|++++. ..+..+++|+.|++++|.+++..+
T Consensus 185 ~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 260 (466)
T 1o6v_A 185 SSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP 260 (466)
T ss_dssp CSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred cCCcCCCChhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh
Confidence 99999865322 25899999999999998766 78899999999999999863 468899999999999999998765
Q ss_pred cCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccCCC
Q 006145 313 DDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAGN 359 (659)
Q Consensus 313 ~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~~ 359 (659)
+..+++|+.|++++|.+++..| +..+++++.+++++|.+++..
T Consensus 261 --~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~ 303 (466)
T 1o6v_A 261 --LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS 303 (466)
T ss_dssp --GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCG
T ss_pred --hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCch
Confidence 8899999999999999997544 788999999999999988643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=254.31 Aligned_cols=167 Identities=13% Similarity=0.170 Sum_probs=143.5
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|...+.||+|+||.||+|+. .+|+.||||.+.... ..+++.+|+++++++ +||||+++++++.. .+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-------~~ 78 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-------GK 78 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-------TT
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEec-------CC
Confidence 35688889999999999999996 469999999987543 234689999999999 89999999999876 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc-----eEEc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV-----AKIS 628 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~-----~kl~ 628 (659)
..++||||+ +|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++. +||+
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred ccEEEEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEE
Confidence 789999999 99999999853 24699999999999999999999998 9999999999999999887 9999
Q ss_pred cCccccccccccc--------cceecccccccCCCCC
Q 006145 629 SYNLPLLAENAEK--------VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~~~--------~~~~~gt~~y~aPE~~ 657 (659)
|||+++....... ....+||+.|+|||+.
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 189 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTH 189 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHH
Confidence 9999986543222 2467899999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=266.19 Aligned_cols=172 Identities=17% Similarity=0.203 Sum_probs=138.9
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||+||+|+.. +|+.||||++..... ...+++.+|+++++.++|||||++++++...... ...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~-~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL-EEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST-TTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc-ccC
Confidence 467888999999999999999865 599999999975422 2346789999999999999999999999652210 123
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...|+|||||++ +|.+.+.. .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 568999999976 57777653 489999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+...........+||+.|+|||++
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~ 235 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVI 235 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHH
T ss_pred eeecCCCcccCCCcccccccCHHHH
Confidence 9887766666778999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-28 Score=249.48 Aligned_cols=168 Identities=18% Similarity=0.284 Sum_probs=139.1
Q ss_pred cCCCC-CceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDT-SAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~-~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
+.|.. .+.||+|+||.||+|+.. +++.||||++........+++.+|++++.++ +||||+++++++.+ .+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-------~~ 84 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-------ED 84 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-------TT
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-------CC
Confidence 45666 378999999999999954 6999999999766555567899999999885 79999999999986 46
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc---eEEccC
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV---AKISSY 630 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~---~kl~DF 630 (659)
..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred EEEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 789999999999999999752 4689999999999999999999998 9999999999999998765 999999
Q ss_pred ccccccccc--------cccceecccccccCCCCC
Q 006145 631 NLPLLAENA--------EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~--------~~~~~~~gt~~y~aPE~~ 657 (659)
|+++..... ......+||+.|+|||+.
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 193 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHH
T ss_pred cCccccccCCccccccccccccccCCcCccChHHh
Confidence 999755321 112345699999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=276.48 Aligned_cols=171 Identities=19% Similarity=0.282 Sum_probs=147.8
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEeccc---CCCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMK---KCHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 549 (659)
..++|...+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|.+++..+ +||+|+++++++.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~----- 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----- 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-----
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-----
Confidence 3567888999999999999999965 5899999999753 223456788999999998 69999999998875
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEcc
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISS 629 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 629 (659)
.+..|+||||+++|+|.++++.. ..+++..+..|+.||+.||+|||+. +||||||||+|||+|+++.+||+|
T Consensus 414 --~~~~~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~D 485 (674)
T 3pfq_A 414 --MDRLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIAD 485 (674)
T ss_dssp --SSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECC
T ss_pred --CCEEEEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEee
Confidence 56789999999999999999852 4699999999999999999999998 999999999999999999999999
Q ss_pred Ccccccc-ccccccceecccccccCCCCCC
Q 006145 630 YNLPLLA-ENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 630 FGla~~~-~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
||+++.. .........+||+.|||||++.
T Consensus 486 FGla~~~~~~~~~~~~~~GT~~Y~APE~l~ 515 (674)
T 3pfq_A 486 FGMCKENIWDGVTTKTFCGTPDYIAPEIIA 515 (674)
T ss_dssp CTTCEECCCTTCCBCCCCSCSSSCCHHHHT
T ss_pred cceeeccccCCcccccccCCCcccCHhhhc
Confidence 9999864 3334456688999999999753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=258.68 Aligned_cols=173 Identities=21% Similarity=0.392 Sum_probs=145.4
Q ss_pred hhcCCCCCceeccCcCceEEEEEec--------CCcEEEEEEecccCCC-chHHHHHHHHHHhCC-CCCCccceeeeeee
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK--------NGTFVAIRCLKMKKCH-STRNFMHHIELISKL-RHRHLVSALGHCFE 544 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 544 (659)
..++|...+.||+|+||.||+|+.. ++..||||+++..... ..+++.+|+++++++ +|||||+++++|..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467888899999999999999852 2468999999765432 236799999999999 89999999999975
Q ss_pred ccccCCCCceeEEEEeccCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccC
Q 006145 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHA-------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNN 611 (659)
Q Consensus 545 ~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrD 611 (659)
.+..++||||+++|+|.+++..... ...+++..+..++.|+++||+|||+. +|+|||
T Consensus 147 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 216 (382)
T 3tt0_A 147 -------DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 216 (382)
T ss_dssp -------SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred -------CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence 4568999999999999999975321 24599999999999999999999998 999999
Q ss_pred CCCCceeecCCcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 612 LKITDILLDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 612 lk~~NILld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
|||+|||+++++.+||+|||+++...... ......+|+.|+|||+.
T Consensus 217 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 265 (382)
T 3tt0_A 217 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 265 (382)
T ss_dssp CCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHH
T ss_pred CCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHh
Confidence 99999999999999999999998664332 23445678899999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-28 Score=259.42 Aligned_cols=170 Identities=16% Similarity=0.238 Sum_probs=133.5
Q ss_pred cCCCCC-ceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHh-CCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTS-AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELIS-KLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~-~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|... +.||+|+||+||+|+.. +|+.||||+++. ...+.+|++++. ..+||||+++++++..... ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~---~~~ 132 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA---GRK 132 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET---TEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeeccc---CCc
Confidence 345554 68999999999999965 599999999863 346788998874 4589999999999864211 135
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC---CcceEEccC
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ---NLVAKISSY 630 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl~DF 630 (659)
..|+|||||++|+|.+++... ....+++..+..|+.||++||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEec
Confidence 689999999999999999863 234699999999999999999999998 9999999999999997 789999999
Q ss_pred ccccccccccccceecccccccCCCCCC
Q 006145 631 NLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 631 Gla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|+++...........+||+.|||||++.
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~ 236 (400)
T 1nxk_A 209 GFAKETTSHNSLTTPCYTPYYVAPEVLG 236 (400)
T ss_dssp TTCEECC-----------CTTCCGGGSC
T ss_pred ccccccCCCCccccCCCCCCccCHhhcC
Confidence 9998776555556788999999999863
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-28 Score=258.60 Aligned_cols=171 Identities=13% Similarity=0.236 Sum_probs=145.6
Q ss_pred hcCCCCCceeccC--cCceEEEEEec-CCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEG--SQGQMYRGRLK-NGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G--~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.++|...+.||+| +||.||+|+.. +|+.||||++....... .+.+.+|++++++++|||||++++++.+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------ 97 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA------ 97 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE------
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE------
Confidence 4568888999999 99999999976 69999999997654322 3568899999999999999999999986
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+..++|||||++|+|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 98 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~df 172 (389)
T 3gni_B 98 -DNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGL 172 (389)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCG
T ss_pred -CCEEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccc
Confidence 567899999999999999997532 24699999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccc--------ccceecccccccCCCCC
Q 006145 631 NLPLLAENAE--------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~--------~~~~~~gt~~y~aPE~~ 657 (659)
|.+....... .....+||+.|+|||+.
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (389)
T 3gni_B 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207 (389)
T ss_dssp GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHH
T ss_pred ccceeeccccccccccccccccccccccccCHHHH
Confidence 9985442211 12335899999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=267.47 Aligned_cols=169 Identities=18% Similarity=0.290 Sum_probs=144.0
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||+||+|+.. ++..||||++.... ....+.+.+|+++++.++|||||+++++|.+ .
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-------~ 108 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-------K 108 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-------S
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-------C
Confidence 345888899999999999999976 58999999997543 2335679999999999999999999999976 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC---cceEEcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN---LVAKISS 629 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~---~~~kl~D 629 (659)
...++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.. +.+||+|
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVD 182 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred CEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEE
Confidence 6789999999999999988752 4689999999999999999999998 99999999999999764 5599999
Q ss_pred CccccccccccccceecccccccCCCCC
Q 006145 630 YNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
||+++...........+||+.|+|||++
T Consensus 183 fG~a~~~~~~~~~~~~~gt~~y~aPE~l 210 (494)
T 3lij_A 183 FGLSAVFENQKKMKERLGTAYYIAPEVL 210 (494)
T ss_dssp CTTCEECBTTBCBCCCCSCTTTCCHHHH
T ss_pred CCCCeECCCCccccccCCCcCeeCHHHH
Confidence 9999887766666778899999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=244.14 Aligned_cols=170 Identities=19% Similarity=0.314 Sum_probs=139.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|+++++.++||||+++++++.+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 82 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST------- 82 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-------
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-------
Confidence 356788899999999999999976 69999999996542 2334679999999999999999999999875
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecc
Confidence 56789999999999999999752 4589999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
++.............|++.|+|||+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 183 (276)
T 2h6d_A 157 LSNMMSDGEFLRTSCGSPNYAAPEVIS 183 (276)
T ss_dssp GGGCCCC-------------CCTGGGT
T ss_pred cccccCCCcceecccCCccccCHHHHc
Confidence 998776555556678999999999853
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=243.07 Aligned_cols=166 Identities=20% Similarity=0.421 Sum_probs=142.0
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc-------hHHHHHHHHHHhCCCCCCccceeeeeeeccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS-------TRNFMHHIELISKLRHRHLVSALGHCFECYF 547 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 547 (659)
.++|...+.||+|+||.||+|+.. +++.||||++....... .+++.+|++++++++||||+++++++.+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 94 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--- 94 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence 466788899999999999999975 69999999996543321 1679999999999999999999998864
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCC--ccccCCCCCceeecCCcc-
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPG--VFSNNLKITDILLDQNLV- 624 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiHrDlk~~NILld~~~~- 624 (659)
..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. + |+||||||+||+++.++.
T Consensus 95 ------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~ 163 (287)
T 4f0f_A 95 ------PPRMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDEN 163 (287)
T ss_dssp ------TTEEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTT
T ss_pred ------CCeEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCC
Confidence 237999999999999988753 34699999999999999999999997 6 999999999999988776
Q ss_pred ----eEEccCccccccccccccceecccccccCCCCC
Q 006145 625 ----AKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 ----~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+||+|||+++.... ......||+.|+|||+.
T Consensus 164 ~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~ 198 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETI 198 (287)
T ss_dssp CSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGS
T ss_pred CceeEEeCCCCccccccc--cccccCCCccccCchhh
Confidence 99999999975533 34557899999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-28 Score=263.03 Aligned_cols=173 Identities=16% Similarity=0.257 Sum_probs=143.0
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ..+++.+|+++|++++||||+++++++...... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~--~~ 102 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL--KF 102 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT--TC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC--cC
Confidence 467888999999999999999965 5899999999754322 346799999999999999999999998753211 12
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...|+||||++ |+|.++++. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CeEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 56899999996 599999985 24699999999999999999999998 999999999999999999999999999
Q ss_pred cccccccc-----------------------ccceecccccccCCCCC
Q 006145 633 PLLAENAE-----------------------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~ 657 (659)
|+...... .....+||++|+|||+.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 223 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 223 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHH
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHH
Confidence 98764322 23567899999999963
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-28 Score=258.56 Aligned_cols=170 Identities=18% Similarity=0.314 Sum_probs=134.3
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~ 550 (659)
..++|...+.||+|+||.||+|+.. +|+.||||++..... ...+++.+|+.++.+++ |||||++++++...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----- 81 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD----- 81 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT-----
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC-----
Confidence 3567889999999999999999965 699999999964422 23456889999999997 99999999998752
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.....|+|||||+ |+|.++++. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DF 153 (388)
T 3oz6_A 82 NDRDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADF 153 (388)
T ss_dssp TSSCEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred CCCEEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCC
Confidence 2346899999997 599999975 3689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccc----------------------ccccceecccccccCCCCC
Q 006145 631 NLPLLAEN----------------------AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~----------------------~~~~~~~~gt~~y~aPE~~ 657 (659)
|+|+.... .......+||++|||||++
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (388)
T 3oz6_A 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL 202 (388)
T ss_dssp TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHh
Confidence 99976532 1123456899999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=249.61 Aligned_cols=167 Identities=20% Similarity=0.338 Sum_probs=143.6
Q ss_pred hcCCCCCceeccCcCceEEEEEecC-C-------cEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN-G-------TFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYF 547 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~-g-------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 547 (659)
.++|...+.||+|+||.||+|+... + ..||+|.+........++|.+|++++++++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC--- 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC---
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe---
Confidence 3567788999999999999998653 4 5799999976655556789999999999999999999999976
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc---
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV--- 624 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~--- 624 (659)
.+..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 84 ----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 154 (289)
T 4fvq_A 84 ----GDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKT 154 (289)
T ss_dssp ----TTCCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGG
T ss_pred ----CCCCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccc
Confidence 45679999999999999999853 23489999999999999999999998 9999999999999998877
Q ss_pred -----eEEccCccccccccccccceecccccccCCCCC
Q 006145 625 -----AKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 -----~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+||+|||++...... ....||+.|+|||+.
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~ 189 (289)
T 4fvq_A 155 GNPPFIKLSDPGISITVLPK---DILQERIPWVPPECI 189 (289)
T ss_dssp TBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHH
T ss_pred cccceeeeccCcccccccCc---cccCCcCcccCHHHh
Confidence 999999999765432 335688999999964
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.2e-28 Score=245.61 Aligned_cols=169 Identities=21% Similarity=0.307 Sum_probs=147.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+ .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~ 77 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-------E 77 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-------S
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-------C
Confidence 467888999999999999999965 5899999999765432 23568899999999999999999999975 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc---eEEcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV---AKISS 629 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~---~kl~D 629 (659)
+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~D 151 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLAD 151 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECC
T ss_pred CEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEee
Confidence 6689999999999999988752 4689999999999999999999998 9999999999999986655 99999
Q ss_pred CccccccccccccceecccccccCCCCC
Q 006145 630 YNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
||++.............||+.|+|||+.
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~y~aPE~~ 179 (284)
T 3kk8_A 152 FGLAIEVNDSEAWHGFAGTPGYLSPEVL 179 (284)
T ss_dssp CTTCEECCSSCBCCCSCSCGGGCCHHHH
T ss_pred ceeeEEcccCccccCCCCCcCCcCchhh
Confidence 9999877666656667899999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-28 Score=255.07 Aligned_cols=174 Identities=20% Similarity=0.368 Sum_probs=151.1
Q ss_pred HHHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--------chHHHHHHHHHHhCC-CCCCccceee
Q 006145 471 ELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--------STRNFMHHIELISKL-RHRHLVSALG 540 (659)
Q Consensus 471 ~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l-~H~niv~l~g 540 (659)
......++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+++++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33445577899999999999999999976 6999999998754321 124588999999999 7999999999
Q ss_pred eeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec
Q 006145 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD 620 (659)
Q Consensus 541 ~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld 620 (659)
++.. ....++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 168 ~~~~-------~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~ 234 (365)
T 2y7j_A 168 SYES-------SSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLD 234 (365)
T ss_dssp EEEB-------SSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred EEee-------CCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 9875 5678999999999999999975 24689999999999999999999998 999999999999999
Q ss_pred CCcceEEccCccccccccccccceecccccccCCCCC
Q 006145 621 QNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 621 ~~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+++.+||+|||++............+||+.|+|||+.
T Consensus 235 ~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~ 271 (365)
T 2y7j_A 235 DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271 (365)
T ss_dssp TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHH
T ss_pred CCCCEEEEecCcccccCCCcccccCCCCCCccChhhc
Confidence 9999999999999877665566678899999999964
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=259.60 Aligned_cols=172 Identities=23% Similarity=0.349 Sum_probs=142.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
.++|...+.||+|+||+||+|++. +++.||||+++.... ....++.+|++++++++|||||++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---- 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 456778899999999999999953 467899999965432 234579999999999999999999999975
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc-
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGH----AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL- 623 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~- 623 (659)
....++||||+++|+|.++++... ....+++.++..++.|+++||+|||+. +|+||||||+|||++.++
T Consensus 146 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 146 ---SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSST
T ss_pred ---CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCC
Confidence 456799999999999999997421 124589999999999999999999998 999999999999999554
Q ss_pred --ceEEccCccccccccc---cccceecccccccCCCCC
Q 006145 624 --VAKISSYNLPLLAENA---EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 624 --~~kl~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~ 657 (659)
.+||+|||+++..... .......||+.|+|||+.
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 258 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF 258 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHH
T ss_pred CceEEECCCccccccccccccccCCCcCCcccEECHHHh
Confidence 5999999999755322 223446789999999964
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.8e-27 Score=262.34 Aligned_cols=120 Identities=30% Similarity=0.336 Sum_probs=109.3
Q ss_pred ccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCC
Q 006145 101 TTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPI 180 (659)
Q Consensus 101 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 180 (659)
..+.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..++++++
T Consensus 46 ~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~ 125 (570)
T 2z63_A 46 YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125 (570)
T ss_dssp TTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTT
T ss_pred hHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCcccccccc
Confidence 46889999999999999999988999999999999999999999888899999999999999999999766667999999
Q ss_pred CCEEEccCCcCCc-cCCcccCCCCCCcEEeccccccccCCC
Q 006145 181 LAVLSLRNNMFNG-TLPDSFSYLENLRVLALSNNHFYGEVP 220 (659)
Q Consensus 181 L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p 220 (659)
|++|++++|.+++ .+|..|+++++|++|++++|++++..+
T Consensus 126 L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~ 166 (570)
T 2z63_A 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (570)
T ss_dssp CCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECG
T ss_pred ccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecH
Confidence 9999999999987 479999999999999999998876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=265.77 Aligned_cols=170 Identities=24% Similarity=0.399 Sum_probs=140.7
Q ss_pred hhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..++|...+.||+|+||.||+|++..+..||||+++... ...++|.+|+++|++++||||++++++|.+ +.
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--------~~ 252 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--------EP 252 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--------SS
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--------Cc
Confidence 456678889999999999999999888889999997654 345789999999999999999999999863 35
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++|||||++|+|.++++.. ....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred eEEEehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccce
Confidence 79999999999999999742 124589999999999999999999998 99999999999999999999999999998
Q ss_pred ccccccc--cceecccccccCCCCC
Q 006145 635 LAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
....... .....++..|+|||+.
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~ 353 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAA 353 (452)
T ss_dssp --------------CCGGGSCHHHH
T ss_pred ecCCCceecccCCcccccccCHhHH
Confidence 7643322 2345678899999964
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=244.22 Aligned_cols=171 Identities=19% Similarity=0.275 Sum_probs=143.6
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
++|.....||+|+||.||+|+.. +++.||||.+........+.+.+|+++++.++||||+++++++.. .+..
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------~~~~ 94 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-------NGFI 94 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-------TTEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-------CCcE
Confidence 34555679999999999999964 589999999986655556789999999999999999999999976 4678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC-CcceEEccCcccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ-NLVAKISSYNLPL 634 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~-~~~~kl~DFGla~ 634 (659)
++||||+++|+|.+++........+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~ 171 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 171 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccc
Confidence 99999999999999998643345678999999999999999999998 9999999999999997 8999999999997
Q ss_pred ccccc-cccceecccccccCCCCC
Q 006145 635 LAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
..... .......||+.|+|||+.
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~ 195 (295)
T 2clq_A 172 RLAGINPCTETFTGTLQYMAPEII 195 (295)
T ss_dssp ESCC-----CCCCCCGGGCCHHHH
T ss_pred ccCCCCCcccccCCCccccChhhh
Confidence 66432 223456799999999964
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-28 Score=265.47 Aligned_cols=170 Identities=19% Similarity=0.305 Sum_probs=146.1
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+ .
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-------~ 93 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-------S 93 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-------S
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-------C
Confidence 356888899999999999999975 69999999996432 3345779999999999999999999999976 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec---CCcceEEcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD---QNLVAKISS 629 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld---~~~~~kl~D 629 (659)
...++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++ .++.+||+|
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~D 167 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIID 167 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred CEEEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEE
Confidence 6789999999999999988752 4689999999999999999999998 999999999999995 456899999
Q ss_pred CccccccccccccceecccccccCCCCCC
Q 006145 630 YNLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 630 FGla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
||+++...........+||+.|+|||++.
T Consensus 168 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 196 (486)
T 3mwu_A 168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196 (486)
T ss_dssp CSCTTTBCCC----CCTTGGGGCCGGGGG
T ss_pred CCcCeECCCCCccCCCcCCCCCCCHHHhC
Confidence 99998776666666788999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=243.31 Aligned_cols=170 Identities=19% Similarity=0.382 Sum_probs=132.6
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+|+. .+|+.||||.+.... ....+++.+|++++++++||||+++++++.+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 82 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED------- 82 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-------
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-------
Confidence 35688889999999999999996 469999999996432 2234679999999999999999999999976
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg 157 (278)
T 3cok_A 83 SNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFG 157 (278)
T ss_dssp SSEEEEEEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeec
Confidence 46789999999999999999853 24689999999999999999999998 99999999999999999999999999
Q ss_pred cccccccc-cccceecccccccCCCCC
Q 006145 632 LPLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
++...... .......||+.|+|||+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~ 184 (278)
T 3cok_A 158 LATQLKMPHEKHYTLCGTPNYISPEIA 184 (278)
T ss_dssp TCEECC---------------------
T ss_pred ceeeccCCCCcceeccCCCCcCCcchh
Confidence 99766432 223456799999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-28 Score=249.85 Aligned_cols=173 Identities=22% Similarity=0.346 Sum_probs=144.5
Q ss_pred hhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYF 547 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 547 (659)
..++|...+.||+|+||.||+|+.. +++.||||+++.... ...+++.+|++++++++||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence 3567888899999999999999852 358999999975432 233679999999999999999999999875
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCC
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGHA---------------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPG 606 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 606 (659)
.+..++||||+++|+|.+++..... ...+++..+..++.|+++||+|||+. +
T Consensus 98 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ 170 (314)
T 2ivs_A 98 ----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---K 170 (314)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ----CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 4568999999999999999975321 13489999999999999999999998 9
Q ss_pred ccccCCCCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 607 VFSNNLKITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 607 iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
|+||||||+||++++++.+||+|||+++....... .....+|+.|+|||+.
T Consensus 171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 224 (314)
T 2ivs_A 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL 224 (314)
T ss_dssp EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHH
T ss_pred CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhh
Confidence 99999999999999999999999999976643222 2345678899999964
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-28 Score=253.50 Aligned_cols=174 Identities=24% Similarity=0.395 Sum_probs=144.0
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccC-CCchHHHHHHHHHHhCC-CCCCccceeeeeeec
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKK-CHSTRNFMHHIELISKL-RHRHLVSALGHCFEC 545 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 545 (659)
...++|...+.||+|+||.||+|+.. ++..||||.+.... ....+.+.+|+++++++ +||||+++++++..
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 120 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL- 120 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-
Confidence 34577888999999999999999962 36689999997543 23346799999999999 89999999999975
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCCCC--------------------CCCCHHHHHHHHHHHHHHhhhhcCCCCC
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAH--------------------QSLTWTQRISAAIGVAKGIQFLHTGIVP 605 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 605 (659)
.+..++||||+++|+|.+++...... ..++|..+..++.|+++||+|||+.
T Consensus 121 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 191 (344)
T 1rjb_A 121 ------SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--- 191 (344)
T ss_dssp ------SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ------CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 45689999999999999999853221 2489999999999999999999998
Q ss_pred CccccCCCCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 606 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 606 ~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
+|+||||||+||+++.++.+||+|||+++....... .....+|+.|+|||+.
T Consensus 192 ~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 246 (344)
T 1rjb_A 192 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 246 (344)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh
Confidence 999999999999999999999999999976643322 2446678899999964
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=265.86 Aligned_cols=169 Identities=18% Similarity=0.265 Sum_probs=145.8
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-------------CchHHHHHHHHHHhCCCCCCccceeee
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-------------HSTRNFMHHIELISKLRHRHLVSALGH 541 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------------~~~~~~~~Ei~~l~~l~H~niv~l~g~ 541 (659)
.++|...+.||+|+||+||+|+.. +++.||||++..... ...+++.+|++++++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 567888999999999999999975 588999999975431 224679999999999999999999999
Q ss_pred eeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC
Q 006145 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ 621 (659)
Q Consensus 542 ~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~ 621 (659)
|.+ ....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 115 ~~~-------~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~ 181 (504)
T 3q5i_A 115 FED-------KKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLEN 181 (504)
T ss_dssp EEC-------SSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESS
T ss_pred EEc-------CCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEec
Confidence 976 56789999999999999998752 4699999999999999999999998 9999999999999987
Q ss_pred Cc---ceEEccCccccccccccccceecccccccCCCCC
Q 006145 622 NL---VAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 622 ~~---~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++ .+||+|||+++...........+||+.|+|||++
T Consensus 182 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 220 (504)
T 3q5i_A 182 KNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL 220 (504)
T ss_dssp TTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHH
T ss_pred CCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHh
Confidence 65 6999999999887766666778899999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=248.76 Aligned_cols=168 Identities=19% Similarity=0.305 Sum_probs=139.4
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|...+.||+|+||+||+|+.. +|+.||||++....... .+.+.+|++++++++||||+++++++.+ .+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------~~ 75 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-------KR 75 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-------TT
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-------CC
Confidence 56888899999999999999976 49999999986544322 3568899999999999999999999976 46
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++++|.++++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEEeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 789999999999999988752 4589999999999999999999998 9999999999999999999999999999
Q ss_pred cccccc-cccceecccccccCCCCC
Q 006145 634 LLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
+..... .......||+.|+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~ 174 (311)
T 4agu_A 150 RLLTGPSDYYDDEVATRWYRSPELL 174 (311)
T ss_dssp EECC------------GGGCCHHHH
T ss_pred hhccCcccccCCCcCCccccChHHH
Confidence 776532 234567899999999964
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-28 Score=253.80 Aligned_cols=165 Identities=20% Similarity=0.348 Sum_probs=142.4
Q ss_pred cCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCc---hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHS---TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
+.|...+.||+|+||.||+|+. .+|+.||||++....... .+++.+|++++++++|||||+++++|.. .
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-------~ 126 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-------E 126 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-------T
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-------C
Confidence 4477889999999999999996 469999999997554322 3568999999999999999999999986 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||++ |+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 127 ~~~~lv~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 127 HTAWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS 200 (348)
T ss_dssp TEEEEEEECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred CeEEEEEecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccC
Confidence 67899999997 6888888632 24689999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++..... ...+||+.|+|||+.
T Consensus 201 a~~~~~~---~~~~gt~~y~aPE~~ 222 (348)
T 1u5q_A 201 ASIMAPA---NSFVGTPYWMAPEVI 222 (348)
T ss_dssp CBSSSSB---CCCCSCGGGCCHHHH
T ss_pred ceecCCC---CcccCCcceeCHhhh
Confidence 9766432 346799999999974
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-28 Score=257.85 Aligned_cols=169 Identities=19% Similarity=0.298 Sum_probs=145.1
Q ss_pred hcCCCCCceeccCcCceEEEEEe----cCCcEEEEEEecccC----CCchHHHHHHHHHHhCC-CCCCccceeeeeeecc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL----KNGTFVAIRCLKMKK----CHSTRNFMHHIELISKL-RHRHLVSALGHCFECY 546 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 546 (659)
.++|...+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++++++ +||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 35788889999999999999997 368999999997532 12345688899999999 69999999999876
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceE
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAK 626 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~k 626 (659)
.+..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+|
T Consensus 131 -----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k 199 (355)
T 1vzo_A 131 -----ETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV 199 (355)
T ss_dssp -----TTEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred -----CceEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEE
Confidence 45789999999999999999752 4689999999999999999999998 999999999999999999999
Q ss_pred EccCccccccccc--cccceecccccccCCCCC
Q 006145 627 ISSYNLPLLAENA--EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 627 l~DFGla~~~~~~--~~~~~~~gt~~y~aPE~~ 657 (659)
|+|||+++..... ......+||+.|+|||+.
T Consensus 200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~ 232 (355)
T 1vzo_A 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232 (355)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHH
T ss_pred EeeCCCCeecccCCCCcccCcccCcCccChhhh
Confidence 9999999765322 223456899999999975
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-26 Score=249.70 Aligned_cols=225 Identities=29% Similarity=0.391 Sum_probs=148.8
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
++|++|++++|.+++ +| .|+++++|++|++++|++++ +|..+ .+|++|++++|++++ +| .++.+++|++|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 577777777777776 55 47777777777777777774 55432 477777777777775 55 4777777777777
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchh
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAE 266 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~ 266 (659)
++|++++ +|... ++|++|++++|.++ .+|++..+++|++|++++|++++ +|....+|+.|++++|++++ +|..
T Consensus 203 ~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N~l~~-l~~~~~~L~~L~l~~N~l~~-l~~~ 275 (454)
T 1jl5_A 203 DNNSLKK-LPDLP---LSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTD-LPEL 275 (454)
T ss_dssp CSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSC-CCCC
T ss_pred CCCcCCc-CCCCc---CcccEEECcCCcCC-cccccCCCCCCCEEECCCCcCCc-ccccccccCEEECCCCcccc-cCcc
Confidence 7777764 44322 46677777777666 44556667777777777776665 33344566666666666655 3332
Q ss_pred ccCCccccEEeccCccccc--CCchhh-------------cCC-CcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCC
Q 006145 267 VSSYYQLQRLDLSSNRFVG--PFPQAL-------------LSL-PSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNL 330 (659)
Q Consensus 267 ~~~l~~L~~L~Ls~N~l~~--~~p~~l-------------~~l-~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~ 330 (659)
+++|+.|++++|++++ .+|..+ ..+ ++|+.|++++|++++ +|.. +++|+.|++++|+
T Consensus 276 ---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~ 348 (454)
T 1jl5_A 276 ---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNH 348 (454)
T ss_dssp ---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSC
T ss_pred ---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCc
Confidence 2445555555555544 222211 123 478888888888886 5543 4788889999998
Q ss_pred CcccCChhhhCCCCCCEEEcCCccccC
Q 006145 331 LTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 331 l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
++ .+|. .+++++.+++++|.+++
T Consensus 349 l~-~lp~---~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 349 LA-EVPE---LPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp CS-CCCC---CCTTCCEEECCSSCCSS
T ss_pred cc-cccc---hhhhccEEECCCCCCCc
Confidence 88 5776 36778889999998886
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.5e-28 Score=249.59 Aligned_cols=167 Identities=17% Similarity=0.339 Sum_probs=134.9
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
++|...+.||+|+||+||+|+.. ++.||||++... ...++|.+|++++++++||||+++++++.+ ..+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---------~~~ 75 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN---------PVC 75 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT---------TTE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---------CcE
Confidence 45777899999999999999975 789999998643 245679999999999999999999998853 369
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc-eEEccCccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV-AKISSYNLPLL 635 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~-~kl~DFGla~~ 635 (659)
+||||+++|+|.++++.......+++..+..++.|+++||+|||+....+|+||||||+||++++++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999999986433345789999999999999999999943238999999999999998876 89999999976
Q ss_pred cccccccceecccccccCCCCC
Q 006145 636 AENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.... .....||+.|+|||+.
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~ 175 (307)
T 2eva_A 156 IQTH--MTNNKGSAAWMAPEVF 175 (307)
T ss_dssp -----------CCTTSSCHHHH
T ss_pred cccc--cccCCCCCceEChhhh
Confidence 5432 2345799999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=244.78 Aligned_cols=168 Identities=18% Similarity=0.323 Sum_probs=142.4
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC------chHHHHHHHHHHhCCCCCCccceeeeeeeccccC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH------STRNFMHHIELISKLRHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 549 (659)
++|...+.||+|+||.||+|+.. +|+.||||.++..... ..+++.+|++++++++||||+++++++.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----- 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence 45778899999999999999976 5999999999754321 24679999999999999999999999976
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc----ce
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL----VA 625 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~----~~ 625 (659)
....++||||+++++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++ .+
T Consensus 80 --~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~ 151 (283)
T 3bhy_A 80 --KTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRI 151 (283)
T ss_dssp --SSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCE
T ss_pred --CCeEEEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCce
Confidence 4678999999999999999975 24689999999999999999999998 999999999999999877 89
Q ss_pred EEccCccccccccccccceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
||+|||++.............|++.|+|||+.
T Consensus 152 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 183 (283)
T 3bhy_A 152 KLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183 (283)
T ss_dssp EECCCTTCEECC--------CCCGGGCCHHHH
T ss_pred EEEecccceeccCCCcccccCCCcCccCccee
Confidence 99999999877655555667899999999964
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=251.36 Aligned_cols=170 Identities=13% Similarity=0.254 Sum_probs=147.6
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCc---h--------------HHHHHHHHHHhCCCCCCccce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHS---T--------------RNFMHHIELISKLRHRHLVSA 538 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~--------------~~~~~Ei~~l~~l~H~niv~l 538 (659)
.++|...+.||+|+||.||+|+. +|+.||||++....... . +.|.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46788899999999999999999 89999999997543211 1 789999999999999999999
Q ss_pred eeeeeeccccCCCCceeEEEEeccCCCChhhh------hcCCCCCCCCCHHHHHHHHHHHHHHhhhhcC-CCCCCccccC
Q 006145 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSW------ISEGHAHQSLTWTQRISAAIGVAKGIQFLHT-GIVPGVFSNN 611 (659)
Q Consensus 539 ~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrD 611 (659)
++++.+ .+..++||||+++|+|.++ +.. .....+++..+..++.|+++||+|||+ . +|+|||
T Consensus 109 ~~~~~~-------~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~d 177 (348)
T 2pml_X 109 EGIITN-------YDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRD 177 (348)
T ss_dssp SEEEES-------SSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCC
T ss_pred EEEEee-------CCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecC
Confidence 999976 4678999999999999999 553 123579999999999999999999998 7 999999
Q ss_pred CCCCceeecCCcceEEccCccccccccccccceecccccccCCCCCC
Q 006145 612 LKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 612 lk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|||+||+++.++.+||+|||++...... ......||+.|+|||+..
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~ 223 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFS 223 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGS
T ss_pred CChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhc
Confidence 9999999999999999999999876443 445678999999999864
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-28 Score=268.37 Aligned_cols=233 Identities=24% Similarity=0.224 Sum_probs=198.0
Q ss_pred CCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEE
Q 006145 105 KLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVL 184 (659)
Q Consensus 105 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (659)
.+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| +..+++|++|+|++|.+++..+ .++|+.|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 44589999999999999989999999999999999999998776 8999999999999999985432 3899999
Q ss_pred EccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCC----CcccceEecCCCcC
Q 006145 185 SLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKV----GKKLVTMILSKNKF 259 (659)
Q Consensus 185 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~----~~~L~~L~l~~N~l 259 (659)
++++|.+++..+. .+++|+.|+|++|.+++.+|. +..+++|++|+|++|.+++.+|.. +++|+.|+|++|.|
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 9999999977654 468899999999999998774 888999999999999999876653 47899999999999
Q ss_pred CccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCc-ccCChh
Q 006145 260 RSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT-GQLPNC 338 (659)
Q Consensus 260 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~-g~ip~~ 338 (659)
++..+ +..+++|+.|+|++|.|++..| .+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|.++ +.+|..
T Consensus 182 ~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~ 257 (487)
T 3oja_A 182 YDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (487)
T ss_dssp CEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHH
T ss_pred ccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHH
Confidence 88632 3468999999999999997544 58899999999999999996 6777888999999999999998 777887
Q ss_pred hhCCCCCCEEEcC
Q 006145 339 LLAGSKNRVVLYA 351 (659)
Q Consensus 339 ~~~~~~l~~l~~~ 351 (659)
+..++.+..+.+.
T Consensus 258 ~~~l~~L~~l~~~ 270 (487)
T 3oja_A 258 FSKNQRVQTVAKQ 270 (487)
T ss_dssp HTTCHHHHHHHHH
T ss_pred HHhCCCCcEEecc
Confidence 7776666555554
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-28 Score=265.34 Aligned_cols=169 Identities=18% Similarity=0.304 Sum_probs=149.0
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------- 97 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED------- 97 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-------
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-------
Confidence 356888899999999999999976 69999999996543 2345679999999999999999999999976
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceee---cCCcceEEc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL---DQNLVAKIS 628 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl---d~~~~~kl~ 628 (659)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 171 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 171 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEE
Confidence 56789999999999999998753 4699999999999999999999998 99999999999999 467899999
Q ss_pred cCccccccccccccceecccccccCCCCC
Q 006145 629 SYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|||+++...........+||+.|+|||++
T Consensus 172 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 200 (484)
T 3nyv_A 172 DFGLSTHFEASKKMKDKIGTAYYIAPEVL 200 (484)
T ss_dssp CTTHHHHBCCCCSHHHHTTGGGTCCHHHH
T ss_pred eeeeeEEcccccccccCCCCccccCceee
Confidence 99999877666666677899999999974
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=242.28 Aligned_cols=170 Identities=21% Similarity=0.398 Sum_probs=143.4
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|...+.||+|+||.||+|+.. |+.||||+++..... ..++|.+|++++++++||||++++++|.+. ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 82 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP-----PAP 82 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT-----TSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC-----CCC
Confidence 356778899999999999999985 889999999765432 235799999999999999999999999752 135
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++|+|.++++.. ....+++..+..++.|+++||+|||+. .++|+||||||+||++++++.++|+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CeEeeecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccce
Confidence 689999999999999999863 234689999999999999999999997 223999999999999999999999999887
Q ss_pred cccccccccceecccccccCCCCC
Q 006145 634 LLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
..... ....||+.|+|||+.
T Consensus 161 ~~~~~----~~~~~t~~y~aPE~~ 180 (271)
T 3kmu_A 161 FSFQS----PGRMYAPAWVAPEAL 180 (271)
T ss_dssp CTTSC----TTCBSCGGGSCHHHH
T ss_pred eeecc----cCccCCccccChhhh
Confidence 54322 335789999999974
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-28 Score=252.83 Aligned_cols=168 Identities=20% Similarity=0.355 Sum_probs=135.5
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcE----EEEEEecccC-CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTF----VAIRCLKMKK-CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
++|...+.||+|+||+||+|+.. +++. ||+|.++... ....++|.+|++++++++||||++++++|.+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 88 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 88 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES------
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec------
Confidence 45778899999999999999964 3443 6888876433 2345789999999999999999999999975
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
...++|+||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 89 --~~~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Df 161 (327)
T 3poz_A 89 --STVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp --SSEEEEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCT
T ss_pred --CCeEEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccC
Confidence 3478999999999999999853 24699999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccc---cceecccccccCCCCC
Q 006145 631 NLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
|+++....... .....+|+.|+|||+.
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 191 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESI 191 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHH
T ss_pred cceeEccCCcccccccCCCccccccChHHh
Confidence 99976643322 2345678899999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-28 Score=249.31 Aligned_cols=171 Identities=19% Similarity=0.353 Sum_probs=147.5
Q ss_pred hhcCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
..++|...+.||+|+||.||+|+... +..||||.+.... ...+++.+|++++++++||||+++++++.+ .+
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------~~ 82 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-------EP 82 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS-------SS
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-------CC
Confidence 45678888999999999999999764 8899999997543 345779999999999999999999999875 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred CEEEEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccc
Confidence 689999999999999999753 235699999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccc--cceecccccccCCCCC
Q 006145 634 LLAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
+....... .....+|+.|+|||+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 184 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESL 184 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHH
T ss_pred eeccCCccccccCCccccCcCChhhh
Confidence 87654332 2445678899999964
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-28 Score=252.08 Aligned_cols=171 Identities=19% Similarity=0.329 Sum_probs=145.8
Q ss_pred cCCCCCceeccCcCceEEEEEe-----cCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRL-----KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
++|...+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++... .
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 97 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP-----G 97 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC-----C
Confidence 5677889999999999999984 35889999999766544456799999999999999999999998742 2
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGG
T ss_pred CceEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccc
Confidence 45689999999999999999752 23589999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccc----cceecccccccCCCCC
Q 006145 632 LPLLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
+++....... .....||..|+|||+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 202 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESL 202 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHH
T ss_pred cceecccCCccceeeccCCccccccCHHHh
Confidence 9986643322 2345688889999964
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-28 Score=253.70 Aligned_cols=182 Identities=13% Similarity=0.262 Sum_probs=132.1
Q ss_pred HHHhhcCCCCCceeccCcCceEEEEEecC-C---cEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeec
Q 006145 472 LEEATNNFDTSAFMGEGSQGQMYRGRLKN-G---TFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFEC 545 (659)
Q Consensus 472 l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-g---~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 545 (659)
+....++|...+.||+|+||.||+|+... + ..||||+++... ....++|.+|++++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 33456789999999999999999999654 3 279999997653 22346799999999999999999999999762
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEG---HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN 622 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~ 622 (659)
... ......++||||+++|+|.+++... .....+++..+..++.|+++||+|||+. +|+||||||+||+++++
T Consensus 98 ~~~-~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 98 RAK-GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp --------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred ccc-cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 211 0012248999999999999998632 1123689999999999999999999998 99999999999999999
Q ss_pred cceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 623 LVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 623 ~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
+.+||+|||+++....... .....+++.|+|||+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 211 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESL 211 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhh
Confidence 9999999999976643322 2345577889999964
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.6e-28 Score=245.22 Aligned_cols=174 Identities=21% Similarity=0.374 Sum_probs=147.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccC-----
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDD----- 549 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~----- 549 (659)
..+|...+.||+|+||.||+|+.. +|+.||||+++... +.+.+|++++++++||||+++++++.....+.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 456888899999999999999976 69999999997533 46789999999999999999999886422110
Q ss_pred ----CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcce
Q 006145 550 ----SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVA 625 (659)
Q Consensus 550 ----~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~ 625 (659)
......++||||+++|+|.++++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 11345799999999999999997421 24689999999999999999999998 99999999999999999999
Q ss_pred EEccCccccccccccccceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
||+|||+++............||+.|+|||+.
T Consensus 162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQI 193 (284)
T ss_dssp EECCCTTCEESSCCSCCCCCCSCCTTSCHHHH
T ss_pred EECcchhheeccccccccccCCcccccChhhh
Confidence 99999999877665555667899999999964
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=240.20 Aligned_cols=170 Identities=21% Similarity=0.305 Sum_probs=147.2
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|+..+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+++++.++||||+++++++.+ .+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~ 78 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-------GN 78 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-------TT
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-------CC
Confidence 356788899999999999999976 699999999975443 334679999999999999999999999976 46
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCc
Confidence 78999999999999999975 24689999999999999999999998 9999999999999999999999999999
Q ss_pred cccccc---cccceecccccccCCCCCC
Q 006145 634 LLAENA---EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 634 ~~~~~~---~~~~~~~gt~~y~aPE~~~ 658 (659)
...... .......||+.|+|||+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 180 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLK 180 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGT
T ss_pred cccCCCcchhcccCCccccCccChHHHh
Confidence 765322 2234568999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=246.80 Aligned_cols=171 Identities=22% Similarity=0.367 Sum_probs=142.3
Q ss_pred cCCCCCceeccCcCceEEEEEe-----cCCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRL-----KNGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
+.|...+.||+|+||.||+|++ .+++.||||+++.... ...+++.+|++++++++||||+++++++...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 95 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED----- 95 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC-----
Confidence 3467789999999999999984 3589999999975432 3447799999999999999999999999762
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df 170 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDF 170 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred CCceEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcc
Confidence 135689999999999999999642 24689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccc----cceecccccccCCCCC
Q 006145 631 NLPLLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
|+++....... .....||..|+|||+.
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 201 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHH
T ss_pred cccccccCCCcceeccCCCCCCccccCCeee
Confidence 99977654332 2345688889999964
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-28 Score=254.56 Aligned_cols=175 Identities=15% Similarity=0.166 Sum_probs=141.5
Q ss_pred HHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC-----CCchHHHHHHHHHHhCCCCCCccceeeeeeecc
Q 006145 473 EEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK-----CHSTRNFMHHIELISKLRHRHLVSALGHCFECY 546 (659)
Q Consensus 473 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 546 (659)
....++|...+.||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++||||++++++|.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-- 99 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED-- 99 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--
Confidence 445677899999999999999999965 58899999996532 2334679999999999999999999999976
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCC-------------------------------------CCCCCCHHHHHHHH
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGH-------------------------------------AHQSLTWTQRISAA 589 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~ 589 (659)
.+..++||||+++|+|.+++.... ....+++..+..++
T Consensus 100 -----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 100 -----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp -----SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred -----CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 567899999999999999985200 01123567788999
Q ss_pred HHHHHHhhhhcCCCCCCccccCCCCCceeecCCc--ceEEccCcccccccccc-----ccceecccccccCCCCC
Q 006145 590 IGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL--VAKISSYNLPLLAENAE-----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 590 ~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~--~~kl~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~~ 657 (659)
.|+++||+|||+. +|+||||||+||+++.++ .+||+|||+++...... ......||+.|+|||+.
T Consensus 175 ~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 246 (345)
T 3hko_A 175 RQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246 (345)
T ss_dssp HHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHH
T ss_pred HHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhh
Confidence 9999999999998 999999999999998776 89999999997653211 23567899999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=242.20 Aligned_cols=169 Identities=21% Similarity=0.335 Sum_probs=145.9
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.++|...+.||+|+||.||+|+..+++.||+|++..... ..+++.+|++++++++||||+++++++.+ .+..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~~ 78 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-------QAPI 78 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-------SSSC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcc-------CCCe
Confidence 356777899999999999999988889999999976543 35789999999999999999999999975 4568
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 79 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp EEEECCCTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred EEEEeCCCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccc
Confidence 9999999999999999753 24689999999999999999999998 999999999999999999999999999976
Q ss_pred ccccc--ccceecccccccCCCCC
Q 006145 636 AENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
..... ......++..|+|||+.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~ 177 (267)
T 3t9t_A 154 VLDDQYTSSTGTKFPVKWASPEVF 177 (267)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHH
T ss_pred cccccccccccccccccccChhhh
Confidence 64322 22345678899999964
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=249.50 Aligned_cols=172 Identities=19% Similarity=0.339 Sum_probs=141.1
Q ss_pred hhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCC--CCCCccceeeeeeeccccCCCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKL--RHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l--~H~niv~l~g~~~~~~~~~~~~ 552 (659)
..++|...+.||+|+||.||+|+.. |+.||||++... ....+.+|.+++... +||||+++++++..... ..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~---~~ 107 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG---SW 107 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG---GG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC---CC
Confidence 4567999999999999999999976 899999998643 234566677776665 89999999999986321 12
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCC-----CCCccccCCCCCceeecCCcceEE
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI-----VPGVFSNNLKITDILLDQNLVAKI 627 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiHrDlk~~NILld~~~~~kl 627 (659)
...++||||+++|+|.++++. ..+++..+..++.|++.||+|||+.+ .++|+||||||+||+++.++.+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 568999999999999999975 36999999999999999999999852 458999999999999999999999
Q ss_pred ccCcccccccccccc-----ceecccccccCCCCC
Q 006145 628 SSYNLPLLAENAEKV-----GHVIPYSGSIDPTNS 657 (659)
Q Consensus 628 ~DFGla~~~~~~~~~-----~~~~gt~~y~aPE~~ 657 (659)
+|||+++........ ...+||+.|+|||+.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 218 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHH
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhc
Confidence 999999765432221 345899999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=248.83 Aligned_cols=173 Identities=23% Similarity=0.350 Sum_probs=145.5
Q ss_pred hhcCCCCCceeccCcCceEEEEEe------cCCcEEEEEEecccCC-CchHHHHHHHHHHhCC-CCCCccceeeeeeecc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRL------KNGTFVAIRCLKMKKC-HSTRNFMHHIELISKL-RHRHLVSALGHCFECY 546 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 546 (659)
..++|...+.||+|+||.||+|+. .+++.||||+++.... ...+.+.+|+++++++ +||||++++++|..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 346788889999999999999985 2478999999975543 2346799999999999 89999999999975
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCC---------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccC
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHA---------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNN 611 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrD 611 (659)
.+..++||||+++|+|.+++..... ...+++..+..++.|+++||+|||+. +|+|||
T Consensus 99 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d 170 (313)
T 1t46_A 99 -----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRD 170 (313)
T ss_dssp -----SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred -----CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence 4568999999999999999975321 12589999999999999999999998 999999
Q ss_pred CCCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 612 LKITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 612 lk~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
|||+||++++++.+||+|||+++....... .....+|+.|+|||+.
T Consensus 171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 219 (313)
T 1t46_A 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI 219 (313)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH
T ss_pred CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHh
Confidence 999999999999999999999977654332 2345678899999964
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-28 Score=247.30 Aligned_cols=170 Identities=24% Similarity=0.382 Sum_probs=145.4
Q ss_pred hhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..++|...+.||+|+||.||+|+..++..||||.++... ...+++.+|++++++++||||+++++++.. +.
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~ 81 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--------EP 81 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--------SS
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC--------CC
Confidence 456788889999999999999998888899999997544 345789999999999999999999998863 34
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++|+|.+++... ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cEEEEecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 79999999999999999742 112689999999999999999999998 99999999999999999999999999997
Q ss_pred ccccccc--cceecccccccCCCCC
Q 006145 635 LAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
....... .....++..|+|||+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~ 182 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAI 182 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHH
T ss_pred cccCcccccccCCCCccCccChhhh
Confidence 7654322 2345577889999964
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.2e-28 Score=251.37 Aligned_cols=168 Identities=21% Similarity=0.336 Sum_probs=138.2
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcE----EEEEEecccC-CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTF----VAIRCLKMKK-CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
++|...+.||+|+||+||+|+.. +++. ||+|.+.... ....+++.+|+.++++++||||++++++|.+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG------ 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB------
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------
Confidence 46777899999999999999964 4543 7888875443 2334568899999999999999999999853
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
+..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 87 --~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Df 159 (325)
T 3kex_A 87 --SSLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADF 159 (325)
T ss_dssp --SSEEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSC
T ss_pred --CccEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCC
Confidence 4589999999999999999853 24689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccc---ccceecccccccCCCCC
Q 006145 631 NLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
|+++...... ......+|..|+|||+.
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 189 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESI 189 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHH
T ss_pred CcccccCcccccccccCCCCcccccChHHh
Confidence 9998764332 23456788899999974
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=244.94 Aligned_cols=169 Identities=19% Similarity=0.309 Sum_probs=132.6
Q ss_pred hcCCCCCceeccCcCceEEEEEecC----CcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN----GTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.++|...+.||+|+||.||+|+... +..||||.++..... ..+.|.+|++++++++||||+++++++.+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc------
Confidence 4667888999999999999999642 567999998754322 23579999999999999999999998743
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
+..++||||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 160 (281)
T 1mp8_A 88 --NPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF 160 (281)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred --CccEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcc
Confidence 4579999999999999999853 24689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccc--cceecccccccCCCCC
Q 006145 631 NLPLLAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
|+++....... .....+|+.|+|||+.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 189 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESI 189 (281)
T ss_dssp ------------------CCGGGCCHHHH
T ss_pred ccccccCcccccccccCCCcccccChhhc
Confidence 99977644332 2345677899999964
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-25 Score=244.43 Aligned_cols=223 Identities=28% Similarity=0.366 Sum_probs=151.7
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
++|++|++++|.+++. |.. .++|++|++++|++++ +| .++++++|++|++++|++++ +|..+ .+|++|++
T Consensus 111 ~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L 180 (454)
T 1jl5_A 111 QSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAA 180 (454)
T ss_dssp TTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEEC
T ss_pred CCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEEC
Confidence 5777788877777652 211 1578888888888875 66 47888888888888888775 56543 47888888
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCC--CcccceEecCCCcCCccCc
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKV--GKKLVTMILSKNKFRSAIP 264 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~--~~~L~~L~l~~N~l~~~~p 264 (659)
++|++++ +| .++++++|+.|++++|++++. |.+ .++|++|++++|.++ .+|.. +++|+.|++++|++++ +|
T Consensus 181 ~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l-~~~--~~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N~l~~-l~ 253 (454)
T 1jl5_A 181 GNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL-PDL--PLSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLKT-LP 253 (454)
T ss_dssp CSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-CCC--CTTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCSS-CC
T ss_pred cCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC-CCC--cCcccEEECcCCcCC-cccccCCCCCCCEEECCCCcCCc-cc
Confidence 8888876 55 577888888888888887763 332 247888888888777 44443 4677888888888876 44
Q ss_pred hhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCC--cCCcCCC-------------CC-CCCCEEECcC
Q 006145 265 AEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG--KLFDDLS-------------CN-PELGFVDLSS 328 (659)
Q Consensus 265 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~--~~p~~~~-------------~~-~~L~~L~ls~ 328 (659)
.. +++|+.|++++|++++ +|.. +++|+.|++++|++++ .+|..+. .+ ++|+.|++++
T Consensus 254 ~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~ 326 (454)
T 1jl5_A 254 DL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSN 326 (454)
T ss_dssp SC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCS
T ss_pred cc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCC
Confidence 32 3678888888888875 4543 3567777777777766 3332221 12 4677777777
Q ss_pred CCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 329 NLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 329 N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
|++++ +|.. +++++.+++++|.++.
T Consensus 327 N~l~~-lp~~---~~~L~~L~L~~N~l~~ 351 (454)
T 1jl5_A 327 NKLIE-LPAL---PPRLERLIASFNHLAE 351 (454)
T ss_dssp SCCSC-CCCC---CTTCCEEECCSSCCSC
T ss_pred Ccccc-cccc---CCcCCEEECCCCcccc
Confidence 77775 5654 3567788888887774
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=244.18 Aligned_cols=169 Identities=18% Similarity=0.263 Sum_probs=146.1
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+|+.. +++.||+|.+...... ..+.+.+|++++++++||||+++++++.+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 86 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED------- 86 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-------
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-------
Confidence 356778899999999999999976 4889999999755322 23568999999999999999999999975
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEecc
Confidence 56789999999999999998752 4689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccc-ccccceecccccccCCCCC
Q 006145 632 LPLLAEN-AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~-~~~~~~~~gt~~y~aPE~~ 657 (659)
+++.... ........||+.|+|||+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~ 187 (294)
T 2rku_A 161 LATKVEYDGERKKVLCGTPNYIAPEVL 187 (294)
T ss_dssp TCEECCSTTCCBCCCCSCCSSCCHHHH
T ss_pred CceecccCccccccccCCCCcCCcchh
Confidence 9976642 2334556799999999974
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-26 Score=258.52 Aligned_cols=268 Identities=23% Similarity=0.258 Sum_probs=172.5
Q ss_pred CCCCCCCCCCCcCCCCC---CCceEeCCCCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCc
Q 006145 49 LSSWNITTEFCNTEPTS---SLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSG 125 (659)
Q Consensus 49 l~~W~~~~~~C~w~~~~---~~gv~C~~~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~ 125 (659)
+++|....+||.|.+.. .....|....++.|++++++++ .+|..+ . ++|++|+|++|.++. +|.
T Consensus 12 w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l---------~--~~L~~L~L~~N~l~~-lp~ 78 (622)
T 3g06_A 12 WSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCL---------P--AHITTLVIPDNNLTS-LPA 78 (622)
T ss_dssp HHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCC---------C--TTCSEEEECSCCCSC-CCC
T ss_pred HHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhh---------C--CCCcEEEecCCCCCC-CCC
Confidence 45687777889885300 0123444456889999988876 444321 1 455555555555543 332
Q ss_pred ccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCC
Q 006145 126 KISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL 205 (659)
Q Consensus 126 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 205 (659)
.+++|++|+|++|+|+ .+|. .+++|++|+|++|.+++ +|. .+++|+.|++++|++++ +|.. +++|
T Consensus 79 ---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L 143 (622)
T 3g06_A 79 ---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGL 143 (622)
T ss_dssp ---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTC
T ss_pred ---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCC
Confidence 3455555555555555 2333 44555555555555543 232 33445555555555542 3322 2444
Q ss_pred cEEeccccccccCCCCC-----------------CCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhcc
Q 006145 206 RVLALSNNHFYGEVPDF-----------------SGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVS 268 (659)
Q Consensus 206 ~~L~Ls~N~l~~~~p~~-----------------~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~ 268 (659)
++|+|++|++++.++.+ ..+++|+.|+|++|.+++ +|...++|+.|++++|.++. +|.
T Consensus 144 ~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~-l~~--- 218 (622)
T 3g06_A 144 QELSVSDNQLASLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTS-LPA--- 218 (622)
T ss_dssp CEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSS-CCC---
T ss_pred CEEECcCCcCCCcCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-CCCccchhhEEECcCCcccc-cCC---
Confidence 55555555444322111 234777888888888775 44456778888888888874 443
Q ss_pred CCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEE
Q 006145 269 SYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVV 348 (659)
Q Consensus 269 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l 348 (659)
.+++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+. +|. .+++|+.|+|++|+|+ .+|..+..+++++.+
T Consensus 219 ~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L 289 (622)
T 3g06_A 219 LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTV 289 (622)
T ss_dssp CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEE
T ss_pred CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEE
Confidence 24789999999999986 56 566899999999999984 555 5688999999999999 889999999999999
Q ss_pred EcCCccccCC
Q 006145 349 LYARNCLAAG 358 (659)
Q Consensus 349 ~~~~N~l~~~ 358 (659)
++++|.+++.
T Consensus 290 ~L~~N~l~~~ 299 (622)
T 3g06_A 290 NLEGNPLSER 299 (622)
T ss_dssp ECCSCCCCHH
T ss_pred EecCCCCCCc
Confidence 9999998764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=250.46 Aligned_cols=169 Identities=18% Similarity=0.263 Sum_probs=146.5
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+++.. +++.||+|.+...... ..+.+.+|++++++++||||+++++++.+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------- 112 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED------- 112 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-------
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-------
Confidence 466888899999999999999976 4889999999754322 23568999999999999999999999976
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..++||||+++++|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 113 NDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeecc
Confidence 46789999999999999998752 4689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccc-ccccceecccccccCCCCC
Q 006145 632 LPLLAEN-AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~-~~~~~~~~gt~~y~aPE~~ 657 (659)
+++.... ........||+.|+|||+.
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~ 213 (335)
T 2owb_A 187 LATKVEYDGERKKVLCGTPNYIAPEVL 213 (335)
T ss_dssp TCEECCSTTCCBCCCCSCCSSCCHHHH
T ss_pred CceecccCcccccccCCCccccCHHHh
Confidence 9976642 2334557899999999964
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=251.72 Aligned_cols=167 Identities=14% Similarity=0.271 Sum_probs=139.5
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCC--chHHHHHHHHHHhCCCC--CCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH--STRNFMHHIELISKLRH--RHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+|+..+++.||||++...... ..+++.+|++++.+++| +||+++++++.+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~------- 80 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT------- 80 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-------
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-------
Confidence 3457788999999999999999888999999999755432 23679999999999986 999999999976
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++||| +.+|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++ ++.+||+|||
T Consensus 81 ~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG 152 (343)
T 3dbq_A 81 DQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFG 152 (343)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred CCEEEEEEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecc
Confidence 567899999 5688999999863 4689999999999999999999998 999999999999997 6789999999
Q ss_pred cccccccccc---cceecccccccCCCCC
Q 006145 632 LPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
+++....... ....+||+.|+|||+.
T Consensus 153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 181 (343)
T 3dbq_A 153 IANQMQPDTTSVVKDSQVGTVNYMPPEAI 181 (343)
T ss_dssp SSCCC------------CCCCSSCCHHHH
T ss_pred cccccCcccccccCCCCcCCcCcCCHHHH
Confidence 9987643322 2456899999999974
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=242.40 Aligned_cols=169 Identities=20% Similarity=0.355 Sum_probs=132.4
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCC----CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKC----HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+|+.. |+.||||+++.... ...+.+.+|+++++.++||||++++++|.+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 77 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK------- 77 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-------
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-------
Confidence 356778899999999999999975 89999999875432 224679999999999999999999999975
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC--------Cc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ--------NL 623 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~--------~~ 623 (659)
.+..++||||+++|+|.+++.. ..+++..+..++.|+++||+|||+....+|+||||||+||++++ ++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 78 EPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp C--CEEEEECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred CCceEEEEEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCc
Confidence 4568999999999999999964 46899999999999999999999982233999999999999986 67
Q ss_pred ceEEccCccccccccccccceecccccccCCCCC
Q 006145 624 VAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 624 ~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.+||+|||+++...... .....||+.|+|||+.
T Consensus 154 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~ 186 (271)
T 3dtc_A 154 ILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVI 186 (271)
T ss_dssp CEEECCCCC--------------CCGGGSCHHHH
T ss_pred ceEEccCCccccccccc-ccCCCCccceeCHHHh
Confidence 89999999997664432 2356799999999963
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=245.51 Aligned_cols=169 Identities=19% Similarity=0.362 Sum_probs=143.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|...+.||+|+||.||+|+.. +|+.||||.++.......+.+.+|++++++++||||+++++++.+ .+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~ 80 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-------TTH 80 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-------SSE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-------CCE
Confidence 356778899999999999999975 699999999986554445679999999999999999999999875 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceee---cCCcceEEccCc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL---DQNLVAKISSYN 631 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl---d~~~~~kl~DFG 631 (659)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred EEEEEEcCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 89999999999999998752 4689999999999999999999998 99999999999999 778999999999
Q ss_pred cccccccccccceecccccccCCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+++..... ......||+.|+|||+..
T Consensus 155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~ 180 (304)
T 2jam_A 155 LSKMEQNG-IMSTACGTPGYVAPEVLA 180 (304)
T ss_dssp TTCCCCCB-TTHHHHSCCCBCCTTTBS
T ss_pred cceecCCC-ccccccCCCCccChHHhc
Confidence 99765432 334567999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-28 Score=254.13 Aligned_cols=180 Identities=20% Similarity=0.322 Sum_probs=148.8
Q ss_pred CHHHHHHhhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceee
Q 006145 468 SLEELEEATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALG 540 (659)
Q Consensus 468 ~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g 540 (659)
..+++....++|...+.||+|+||.||+|+.. +++.||||.+...... ...+|.+|++++++++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 33455556788999999999999999999854 3788999999754322 2356999999999999999999999
Q ss_pred eeeeccccCCCCceeEEEEeccCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCC
Q 006145 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGH-------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLK 613 (659)
Q Consensus 541 ~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 613 (659)
++.+ .+..++||||+++|+|.++++... ....+++..+..++.|+++||+|||+. +|+|||||
T Consensus 96 ~~~~-------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dik 165 (322)
T 1p4o_A 96 VVSQ-------GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLA 165 (322)
T ss_dssp EECS-------SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCS
T ss_pred EEcc-------CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCc
Confidence 9975 456899999999999999987421 124579999999999999999999998 99999999
Q ss_pred CCceeecCCcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 614 ITDILLDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 614 ~~NILld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
|+||+++.++.+||+|||+++...... ......+|+.|+|||+.
T Consensus 166 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 212 (322)
T 1p4o_A 166 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 212 (322)
T ss_dssp GGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH
T ss_pred cceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhh
Confidence 999999999999999999997654322 12345678899999964
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-26 Score=232.00 Aligned_cols=166 Identities=27% Similarity=0.302 Sum_probs=99.6
Q ss_pred CCCCcCCCCCCCceEeCCCCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcE
Q 006145 56 TEFCNTEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEI 135 (659)
Q Consensus 56 ~~~C~w~~~~~~gv~C~~~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 135 (659)
.++|.|.| ....|. ..++.+++++++++. +|. .+. ++|+.|+|++|++++..+..|.++++|++
T Consensus 2 ~~~C~~~~---~~C~c~-~~~~~l~~~~~~l~~-ip~---------~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~ 65 (270)
T 2o6q_A 2 EALCKKDG---GVCSCN-NNKNSVDCSSKKLTA-IPS---------NIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRL 65 (270)
T ss_dssp CCCBGGGT---CSBEEE-TTTTEEECTTSCCSS-CCS---------CCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCE
T ss_pred CccCCCCC---CCCEeC-CCCCEEEccCCCCCc-cCC---------CCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCE
Confidence 47899975 234443 346678888776653 332 111 35677777777776666666777777777
Q ss_pred EEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEecccccc
Q 006145 136 LNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHF 215 (659)
Q Consensus 136 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 215 (659)
|+|++|.++...+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|..+++|++|+|++|++
T Consensus 66 L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 145 (270)
T 2o6q_A 66 LYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL 145 (270)
T ss_dssp EECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcC
Confidence 77777777654444456666666666666666655555566666666666666666655555556666666666666655
Q ss_pred ccCCCC-CCCCCcCCEEEcccCC
Q 006145 216 YGEVPD-FSGLTYLQVLDLENNA 237 (659)
Q Consensus 216 ~~~~p~-~~~l~~L~~L~L~~N~ 237 (659)
++.++. |..+++|++|+|++|.
T Consensus 146 ~~~~~~~~~~l~~L~~L~L~~n~ 168 (270)
T 2o6q_A 146 QSLPKGVFDKLTSLKELRLYNNQ 168 (270)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSC
T ss_pred CccCHhHccCCcccceeEecCCc
Confidence 544433 4444444444444433
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=249.43 Aligned_cols=173 Identities=20% Similarity=0.406 Sum_probs=143.8
Q ss_pred hhcCCCCCceeccCcCceEEEEEec--------CCcEEEEEEecccCCC-chHHHHHHHHHHhCC-CCCCccceeeeeee
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK--------NGTFVAIRCLKMKKCH-STRNFMHHIELISKL-RHRHLVSALGHCFE 544 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 544 (659)
..++|...+.||+|+||.||+|+.. ++..||||+++..... ..+++.+|+++++++ +||||++++++|..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3567888899999999999999863 4778999999754322 345799999999999 89999999999975
Q ss_pred ccccCCCCceeEEEEeccCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccC
Q 006145 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHA-------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNN 611 (659)
Q Consensus 545 ~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrD 611 (659)
.+..++||||+++|+|.+++..... ...+++..+..++.|+++||+|||+. +|+|||
T Consensus 113 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 182 (334)
T 2pvf_A 113 -------DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRD 182 (334)
T ss_dssp -------SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred -------CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCC
Confidence 4568999999999999999985321 13489999999999999999999998 999999
Q ss_pred CCCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 612 LKITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 612 lk~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
|||+||+++.++.+||+|||+++....... .....+|+.|+|||+.
T Consensus 183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 231 (334)
T 2pvf_A 183 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231 (334)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHH
T ss_pred CccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHh
Confidence 999999999999999999999976644322 2345678899999964
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=247.54 Aligned_cols=172 Identities=20% Similarity=0.408 Sum_probs=138.5
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHH--HhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIEL--ISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|...+.||+|+||.||+|+. +++.||||++.... ..++..|.++ +..++||||+++++++.....+ ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~--~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD--GRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT--SCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccC--CCc
Confidence 45788889999999999999987 58999999997433 3445555555 4458999999999877542221 244
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCC------CCCccccCCCCCceeecCCcceEE
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI------VPGVFSNNLKITDILLDQNLVAKI 627 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~iiHrDlk~~NILld~~~~~kl 627 (659)
..++||||+++|+|.+++.. ...+|..+..++.|+++||+|||+.+ .++|+||||||+|||++.++.+||
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred eEEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 67899999999999999975 34689999999999999999999863 348999999999999999999999
Q ss_pred ccCcccccccccc---------ccceecccccccCCCCC
Q 006145 628 SSYNLPLLAENAE---------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 628 ~DFGla~~~~~~~---------~~~~~~gt~~y~aPE~~ 657 (659)
+|||+++...... .....+||+.|+|||+.
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 200 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVL 200 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHH
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhh
Confidence 9999997654321 12345799999999975
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-28 Score=253.59 Aligned_cols=241 Identities=23% Similarity=0.225 Sum_probs=207.7
Q ss_pred ccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCC
Q 006145 103 LVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILA 182 (659)
Q Consensus 103 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (659)
+..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|++|+|++|++++. | ..++|+
T Consensus 30 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l-~----~~~~L~ 102 (317)
T 3o53_A 30 RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL-L----VGPSIE 102 (317)
T ss_dssp HTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEE-E----ECTTCC
T ss_pred hccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccc-c----CCCCcC
Confidence 4467799999999999999888999999999999999999997665 89999999999999999753 2 348999
Q ss_pred EEEccCCcCCccCCcccCCCCCCcEEeccccccccCCC-CCCCCCcCCEEEcccCCCCCCCCCC----CcccceEecCCC
Q 006145 183 VLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP-DFSGLTYLQVLDLENNALGPQFPKV----GKKLVTMILSKN 257 (659)
Q Consensus 183 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~----~~~L~~L~l~~N 257 (659)
+|++++|.+++..+. .+++|+.|++++|++++..+ .+..+++|++|+|++|.+++..+.. +++|++|++++|
T Consensus 103 ~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N 179 (317)
T 3o53_A 103 TLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179 (317)
T ss_dssp EEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTS
T ss_pred EEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCC
Confidence 999999999976554 36789999999999998877 4888999999999999998866543 478999999999
Q ss_pred cCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCc-ccCC
Q 006145 258 KFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT-GQLP 336 (659)
Q Consensus 258 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~-g~ip 336 (659)
.+++. | ....+++|+.|+|++|++++ +|..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|.++ +.+|
T Consensus 180 ~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~ 255 (317)
T 3o53_A 180 FIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLR 255 (317)
T ss_dssp CCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHH
T ss_pred cCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHH
Confidence 99876 3 33458999999999999996 4555999999999999999999 46888999999999999999999 8888
Q ss_pred hhhhCCCCCCEEEcCCc-cccC
Q 006145 337 NCLLAGSKNRVVLYARN-CLAA 357 (659)
Q Consensus 337 ~~~~~~~~l~~l~~~~N-~l~~ 357 (659)
..+..+++++.+++.++ .+.+
T Consensus 256 ~~~~~~~~L~~l~l~~~~~l~~ 277 (317)
T 3o53_A 256 DFFSKNQRVQTVAKQTVKKLTG 277 (317)
T ss_dssp HHHHTCHHHHHHHHHHHHHHHS
T ss_pred HHHhccccceEEECCCchhccC
Confidence 88888888888887743 4554
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=244.68 Aligned_cols=170 Identities=11% Similarity=0.224 Sum_probs=139.9
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc---hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS---TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+|+.. +++.||||++....... .+++.+|++++++++||||+++++++..
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~------- 105 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI------- 105 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-------
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-------
Confidence 467889999999999999999975 58999999997553322 3578999999999999999999999976
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred CCeEEEEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCc
Confidence 46789999999999999999852 4689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccc--ccceecccccccCCCCCC
Q 006145 632 LPLLAENAE--KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 632 la~~~~~~~--~~~~~~gt~~y~aPE~~~ 658 (659)
++....... ......|++.|+|||+..
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 208 (309)
T 2h34_A 180 IASATTDEKLTQLGNTVGTLYYMAPERFS 208 (309)
T ss_dssp C----------------CCGGGCCGGGTC
T ss_pred cCccccccccccccccCCCcCccCHHHHc
Confidence 997664332 234568999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.7e-28 Score=251.65 Aligned_cols=170 Identities=20% Similarity=0.345 Sum_probs=135.9
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
...++|...+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|++++++++||||+++++++.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 104 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH------ 104 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE------
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec------
Confidence 34567899999999999999999955 6999999999755432 23568899999999999999999999986
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec-----CCcce
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD-----QNLVA 625 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld-----~~~~~ 625 (659)
.+..++||||++ |+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++ +++.+
T Consensus 105 -~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 176 (329)
T 3gbz_A 105 -NHRLHLIFEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVL 176 (329)
T ss_dssp -TTEEEEEEECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEE
T ss_pred -CCEEEEEEecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceE
Confidence 567899999998 5999999863 4589999999999999999999998 999999999999994 45669
Q ss_pred EEccCccccccccc-cccceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
||+|||+++..... ......+||+.|+|||+.
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~ 209 (329)
T 3gbz_A 177 KIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209 (329)
T ss_dssp EECCTTHHHHHC-----------CCTTCCHHHH
T ss_pred EECcCCCccccCCcccccCCCcCCccccCHHHh
Confidence 99999999766432 334566889999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=243.53 Aligned_cols=168 Identities=20% Similarity=0.351 Sum_probs=141.9
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|++++++++||||+++++++.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 80 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD------- 80 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-------
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-------
Confidence 467888899999999999999965 48899999986432 1234679999999999999999999999976
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg 154 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 154 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCC
T ss_pred CCEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEecc
Confidence 46789999999999999999752 4589999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++...... ......||+.|+|||+.
T Consensus 155 ~~~~~~~~-~~~~~~~~~~y~aPE~~ 179 (279)
T 3fdn_A 155 WSVHAPSS-RRTDLCGTLDYLPPEMI 179 (279)
T ss_dssp EESCC---------CCCCTTCCHHHH
T ss_pred ccccCCcc-cccccCCCCCccCHhHh
Confidence 98655432 23456899999999974
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=254.32 Aligned_cols=169 Identities=20% Similarity=0.336 Sum_probs=131.9
Q ss_pred CCCCCceeccCcCceEEEEEecC----CcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKN----GTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.|...+.||+|+||.||+|+..+ +..||||.++.... ...++|.+|++++++++||||++++++|... .
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~------~ 163 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS------E 163 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC------S
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC------C
Confidence 35566899999999999998642 24689999875432 2346799999999999999999999998641 3
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~ 238 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGL 238 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred CCeEEEEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccc
Confidence 4679999999999999999853 34689999999999999999999998 999999999999999999999999999
Q ss_pred cccccccc-----ccceecccccccCCCCC
Q 006145 633 PLLAENAE-----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~-----~~~~~~gt~~y~aPE~~ 657 (659)
++...... ......+|+.|+|||+.
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 268 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESL 268 (373)
T ss_dssp -------------------CCGGGSCHHHH
T ss_pred cccccccccccccccCCCCCcccccChHHh
Confidence 97653322 12345678899999964
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=7.1e-28 Score=268.82 Aligned_cols=170 Identities=24% Similarity=0.399 Sum_probs=145.6
Q ss_pred hhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..++|...+.||+|+||.||+|++..+..||||+++... ...++|.+|+++|++++|+|||+++++|.+ +.
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------~~ 335 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--------EP 335 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--------SS
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee--------cc
Confidence 456677889999999999999999888889999997654 345789999999999999999999999863 35
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++|||||++|+|.++++.. ....+++.++..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred ceEeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 79999999999999999742 124589999999999999999999998 99999999999999999999999999998
Q ss_pred ccccccc--cceecccccccCCCCC
Q 006145 635 LAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
....... .....++..|+|||+.
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~ 436 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAA 436 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHH
T ss_pred ecCCCceecccCCcCcccccCHHHh
Confidence 7643221 2334577899999964
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=251.56 Aligned_cols=170 Identities=23% Similarity=0.370 Sum_probs=139.5
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc-----hHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS-----TRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
..++|...+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|++++++++||||+++++++.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 83 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH---- 83 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC----
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee----
Confidence 4567999999999999999999975 59999999997543211 2468899999999999999999999875
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
.+..++||||+++ +|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 84 ---~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 84 ---KSNISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp ---TTCCEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred ---CCceEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEE
Confidence 4568999999986 899888753 34688999999999999999999998 99999999999999999999999
Q ss_pred cCcccccccc-ccccceecccccccCCCCC
Q 006145 629 SYNLPLLAEN-AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~-~~~~~~~~gt~~y~aPE~~ 657 (659)
|||+++.... .......+||+.|+|||+.
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~ 184 (346)
T 1ua2_A 155 DFGLAKSFGSPNRAYTHQVVTRWYRAPELL 184 (346)
T ss_dssp CCGGGSTTTSCCCCCCCSCCCCTTCCHHHH
T ss_pred ecccceeccCCcccCCcccccccccCchHh
Confidence 9999976643 2334567899999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=253.84 Aligned_cols=177 Identities=15% Similarity=0.202 Sum_probs=142.0
Q ss_pred HHhhcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccC--
Q 006145 473 EEATNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDD-- 549 (659)
Q Consensus 473 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~-- 549 (659)
....++|...+.||+|+||+||+|+. .+|+.||||++..... ...+|+++++.++|||||++++++.......
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999996 4699999999865432 2347999999999999999999986532110
Q ss_pred -----------------------------CCCceeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhh
Q 006145 550 -----------------------------SSVSRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFL 599 (659)
Q Consensus 550 -----------------------------~~~~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yL 599 (659)
......++||||++ |+|.+.+... .....+++..+..++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 12345789999998 5888777531 1235699999999999999999999
Q ss_pred cCCCCCCccccCCCCCceeec-CCcceEEccCccccccccccccceecccccccCCCCC
Q 006145 600 HTGIVPGVFSNNLKITDILLD-QNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 600 H~~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+. +|+||||||+||+++ +++.+||+|||+++............||+.|+|||+.
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~ 213 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELM 213 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHh
Confidence 998 999999999999998 6899999999999877666666677899999999964
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=254.50 Aligned_cols=166 Identities=14% Similarity=0.268 Sum_probs=140.2
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCC--chHHHHHHHHHHhCCC--CCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH--STRNFMHHIELISKLR--HRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~~~~ 552 (659)
.+|...+.||+|+||.||+|+..+++.||||++...... ..+++.+|+++|++++ |||||++++++.. .
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-------~ 128 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-------D 128 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-------S
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-------C
Confidence 458888999999999999999888999999999755432 2367999999999996 5999999999976 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..|+||| +.+|+|.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||++ ++.+||+|||+
T Consensus 129 ~~~~lv~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~ 200 (390)
T 2zmd_A 129 QYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGI 200 (390)
T ss_dssp SEEEEEEE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSS
T ss_pred CEEEEEEe-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCc
Confidence 56899999 5688999999863 4689999999999999999999998 999999999999996 58999999999
Q ss_pred cccccccc---ccceecccccccCCCCC
Q 006145 633 PLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
++...... .....+||+.|||||++
T Consensus 201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 228 (390)
T 2zmd_A 201 ANQMQPDTTSVVKDSQVGAVNYMPPEAI 228 (390)
T ss_dssp SCCC---------CCSCCCGGGCCHHHH
T ss_pred cccccCCCccccCCCCCcCCCccChHHh
Confidence 98764332 22456899999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=254.11 Aligned_cols=176 Identities=20% Similarity=0.275 Sum_probs=148.1
Q ss_pred cCHHHHHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCC-----CCCccceee
Q 006145 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-----HRHLVSALG 540 (659)
Q Consensus 467 ~~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----H~niv~l~g 540 (659)
+++.+.....++|...+.||+|+||+||+|+.. +++.||||+++... ...+.+.+|++++++++ |||||++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 334444455788999999999999999999974 58999999997422 23456888999999986 999999999
Q ss_pred eeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec
Q 006145 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD 620 (659)
Q Consensus 541 ~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld 620 (659)
++.. .+..++||||+ +|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++
T Consensus 104 ~~~~-------~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 171 (360)
T 3llt_A 104 KFMY-------YDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLD 171 (360)
T ss_dssp EEEE-------TTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEES
T ss_pred eeeE-------CCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEc
Confidence 9986 46789999999 999999998532 24589999999999999999999998 999999999999998
Q ss_pred C-------------------------CcceEEccCccccccccccccceecccccccCCCCC
Q 006145 621 Q-------------------------NLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 621 ~-------------------------~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+ ++.+||+|||+++.... ......||+.|+|||+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~ 231 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVI 231 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHH
Confidence 6 78999999999986543 23456899999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=241.51 Aligned_cols=169 Identities=18% Similarity=0.254 Sum_probs=143.0
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+|+.. +++.||||+++..... ...++.+|+..+.++ +||||+++++++.+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~------- 82 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE------- 82 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-------
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-------
Confidence 466888899999999999999976 6999999999764322 345789999999999 89999999999976
Q ss_pred CceeEEEEeccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC--------
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGH-AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN-------- 622 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~-------- 622 (659)
.+..++||||+++|+|.+++.... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~ 159 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASE 159 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccc
Confidence 567899999999999999997421 124689999999999999999999998 99999999999999844
Q ss_pred -----------cceEEccCccccccccccccceecccccccCCCCC
Q 006145 623 -----------LVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 623 -----------~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
..+||+|||++....... ...||+.|+|||+.
T Consensus 160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~ 202 (289)
T 1x8b_A 160 EGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVL 202 (289)
T ss_dssp ----------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHH
T ss_pred ccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHh
Confidence 479999999997765432 34699999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=244.49 Aligned_cols=170 Identities=17% Similarity=0.287 Sum_probs=148.3
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---------chHHHHHHHHHHhCCC-CCCccceeeeee
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---------STRNFMHHIELISKLR-HRHLVSALGHCF 543 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---------~~~~~~~Ei~~l~~l~-H~niv~l~g~~~ 543 (659)
..++|...+.||+|+||.||+|+.. +|+.||||.++..... ..+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3567888999999999999999975 5899999999754311 1246889999999996 999999999997
Q ss_pred eccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc
Q 006145 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL 623 (659)
Q Consensus 544 ~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~ 623 (659)
. ....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 95 ~-------~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~ 161 (298)
T 1phk_A 95 T-------NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDM 161 (298)
T ss_dssp C-------SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred c-------CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCC
Confidence 5 56789999999999999999852 4689999999999999999999998 999999999999999999
Q ss_pred ceEEccCccccccccccccceecccccccCCCCC
Q 006145 624 VAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 624 ~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.+||+|||++.............|++.|+|||+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 195 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 195 (298)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHH
T ss_pred cEEEecccchhhcCCCcccccccCCccccCHHHh
Confidence 9999999999877665556667899999999964
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-27 Score=239.90 Aligned_cols=171 Identities=23% Similarity=0.286 Sum_probs=142.9
Q ss_pred CCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
|...+.||+|+||.||+|+.. ++..||+|.+...... ..+.+.+|++++++++||||+++++++..... .....
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~~ 104 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK---GKKCI 104 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS---SCEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC---CCceE
Confidence 556678999999999999965 5889999999755432 23569999999999999999999999875221 24568
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec-CCcceEEccCcccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD-QNLVAKISSYNLPL 634 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~ 634 (659)
++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. .++|+||||||+||+++ +++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999999752 4689999999999999999999997 12299999999999998 78999999999997
Q ss_pred ccccccccceecccccccCCCCC
Q 006145 635 LAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
..... ......||+.|+|||+.
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~ 202 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMY 202 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGG
T ss_pred ccccc-ccccccCCcCcCCHHHH
Confidence 65433 34556799999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=248.68 Aligned_cols=168 Identities=17% Similarity=0.260 Sum_probs=141.9
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--------CchHHHHHHHHHHhCCCCCCccceeeeeeecc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--------HSTRNFMHHIELISKLRHRHLVSALGHCFECY 546 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 546 (659)
.++|...+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 456888999999999999999965 589999999965421 122458999999999999999999999864
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc--
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV-- 624 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~-- 624 (659)
+..++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 87 ------~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~ 154 (322)
T 2ycf_A 87 ------EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDC 154 (322)
T ss_dssp ------SSEEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSC
T ss_pred ------CceEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCC
Confidence 337999999999999999875 24689999999999999999999998 9999999999999987654
Q ss_pred -eEEccCccccccccccccceecccccccCCCCC
Q 006145 625 -AKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 -~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+||+|||+++............||+.|+|||+.
T Consensus 155 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~ 188 (322)
T 2ycf_A 155 LIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188 (322)
T ss_dssp CEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHH
T ss_pred eEEEccCccceecccccccccccCCcCccCchhh
Confidence 999999999877655445567899999999973
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=254.24 Aligned_cols=173 Identities=10% Similarity=0.113 Sum_probs=139.6
Q ss_pred hcCCCCCceeccCcCceEEEEEecC------CcEEEEEEecccCCC-----------chHHHHHHHHHHhCCCCCCccce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN------GTFVAIRCLKMKKCH-----------STRNFMHHIELISKLRHRHLVSA 538 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~l 538 (659)
.++|...+.||+|+||.||+|++.. ++.||||++...... ....+.+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578889999999999999999764 478999998654311 11235566777888999999999
Q ss_pred eeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCcee
Q 006145 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDIL 618 (659)
Q Consensus 539 ~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 618 (659)
++++..... .....++||||+ +|+|.+++... ...+++..+..|+.|+++||+|||+. +|+||||||+|||
T Consensus 114 ~~~~~~~~~---~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nil 184 (364)
T 3op5_A 114 WGSGLHDKN---GKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLL 184 (364)
T ss_dssp EEEEEEEET---TEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred EeeeeeccC---CcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEE
Confidence 999976321 124579999999 99999999753 34699999999999999999999998 9999999999999
Q ss_pred ec--CCcceEEccCccccccccccc--------cceecccccccCCCCC
Q 006145 619 LD--QNLVAKISSYNLPLLAENAEK--------VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 619 ld--~~~~~kl~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~~ 657 (659)
++ .++.+||+|||+++....... ....+||+.|||||+.
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 233 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH 233 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh
Confidence 99 889999999999976643221 1345699999999975
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=235.38 Aligned_cols=208 Identities=23% Similarity=0.164 Sum_probs=156.6
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
++|++|+|++|.+++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 46888888888888877778888888888888888888777777888888888888888888777788888888888888
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccC-CC-CCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCc
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGE-VP-DFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIP 264 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p 264 (659)
++|.+++..+..++.+++|++|++++|.+++. +| .+..+++|++|+|++|.++ +..+
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~---------------------~~~~ 166 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ---------------------SIYC 166 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC---------------------EECG
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCC---------------------cCCH
Confidence 88888877666788888888888888888763 34 3777777777777666654 3344
Q ss_pred hhccCCcccc----EEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCC
Q 006145 265 AEVSSYYQLQ----RLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLP 336 (659)
Q Consensus 265 ~~~~~l~~L~----~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip 336 (659)
..+..+++|+ .|++++|.+++..+..+ ...+|+.|++++|++++..+..+..+++|+.|++++|++++..|
T Consensus 167 ~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp GGGHHHHTCTTCCEEEECCSSCCCEECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred HHhhhhhhccccceeeecCCCcccccCcccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 4455455555 67778887775444444 33478888888888887666667778888888888888876554
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=247.00 Aligned_cols=176 Identities=16% Similarity=0.171 Sum_probs=144.9
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|...+.||+|+||.||+|+. .+|+.||||++........+.+.+|++++++++||||+++++++.... .....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER---GAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE---TTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc---CCCce
Confidence 46788899999999999999996 469999999997654444567999999999999999999999997421 12356
Q ss_pred eEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 555 IFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
.++||||+++|+|.+++... .....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 89999999999999998742 1235699999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccc----------ccceecccccccCCCCC
Q 006145 634 LLAENAE----------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~----------~~~~~~gt~~y~aPE~~ 657 (659)
....... ......||+.|+|||+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 215 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELF 215 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGS
T ss_pred hhcccccccccccccccccccccCCcccCCHhHh
Confidence 6553211 11235679999999976
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=243.33 Aligned_cols=170 Identities=19% Similarity=0.324 Sum_probs=140.4
Q ss_pred cCCCCCceeccCcCceEEEEEecC----CcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN----GTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.+|...+.||+|+||.||+|+..+ +..||||.+..... ...+++.+|++++++++||||++++++|...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 98 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS------ 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS------
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC------
Confidence 456777999999999999998643 33689999875432 2346799999999999999999999998641
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..++||||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg 173 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFG 173 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred CCceEEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccc
Confidence 45679999999999999999753 34689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccc-----ccceecccccccCCCCC
Q 006145 632 LPLLAENAE-----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~-----~~~~~~gt~~y~aPE~~ 657 (659)
+++...... ......+|+.|+|||+.
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 204 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESL 204 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHH
T ss_pred ccccccccchhccccccCCCCCccccChHHh
Confidence 997654322 22445678899999964
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=250.86 Aligned_cols=165 Identities=16% Similarity=0.228 Sum_probs=140.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|...+.||+|+||.||+|+.. +|+.||||+++.... .+.+|++++.++ +||||+++++++.+ .+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~-------~~ 89 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDD-------GK 89 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEEC-------SS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEc-------CC
Confidence 456888899999999999999975 589999999975432 345788888888 79999999999975 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC----cceEEcc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN----LVAKISS 629 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~----~~~kl~D 629 (659)
..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||++.++ +.+||+|
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~D 163 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICD 163 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred EEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEE
Confidence 789999999999999999753 4689999999999999999999998 99999999999998533 3599999
Q ss_pred Cccccccccc-cccceecccccccCCCCC
Q 006145 630 YNLPLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
||+++..... ......+||+.|+|||+.
T Consensus 164 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~ 192 (342)
T 2qr7_A 164 FGFAKQLRAENGLLMTPCYTANFVAPEVL 192 (342)
T ss_dssp CTTCEECBCTTCCBCCSSCCSSCCCHHHH
T ss_pred CCCcccCcCCCCceeccCCCccccCHHHh
Confidence 9999866433 334567899999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=248.13 Aligned_cols=171 Identities=20% Similarity=0.359 Sum_probs=144.7
Q ss_pred HHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhC--CCCCCccceeeeeeeccccCC
Q 006145 473 EEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISK--LRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 473 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~~~~~ 550 (659)
....++|...+.||+|+||.||+|+. +|+.||||++... ..+++.+|++++.. ++||||+++++++.....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~--- 110 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG--- 110 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS---
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC---
Confidence 33456799999999999999999998 4899999999643 34678889998887 789999999999876211
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhc--------CCCCCCccccCCCCCceeecCC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH--------TGIVPGVFSNNLKITDILLDQN 622 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiHrDlk~~NILld~~ 622 (659)
.....++||||+++|+|.+++.+ ..+++..+..++.|+++||+||| +. +|+||||||+||+++++
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN 183 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT
T ss_pred ccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC
Confidence 11368999999999999999975 35899999999999999999999 65 99999999999999999
Q ss_pred cceEEccCcccccccccc-----ccceecccccccCCCCC
Q 006145 623 LVAKISSYNLPLLAENAE-----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 623 ~~~kl~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~~ 657 (659)
+.+||+|||+++...... ......||+.|+|||+.
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 223 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHH
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhh
Confidence 999999999997665433 22456899999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=246.04 Aligned_cols=165 Identities=14% Similarity=0.229 Sum_probs=144.8
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|+..+.||+|+||.||+|+. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+. ...
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~-----~~~ 106 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP-----VSR 106 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT-----TTC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccC-----CCC
Confidence 35688889999999999999986 46999999998743 3577999999999997 99999999998752 245
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc-ceEEccCcc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL-VAKISSYNL 632 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~DFGl 632 (659)
..++||||+++++|.++++. +++..+..++.|+++||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 107 ~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp CEEEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceEEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 68999999999999999863 88999999999999999999998 999999999999999776 899999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++............||..|+|||+.
T Consensus 178 a~~~~~~~~~~~~~~~~~y~aPE~~ 202 (330)
T 3nsz_A 178 AEFYHPGQEYNVRVASRYFKGPELL 202 (330)
T ss_dssp CEECCTTCCCCSCCSCGGGCCHHHH
T ss_pred ceEcCCCCccccccccccccChhhh
Confidence 9877666666677899999999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=249.37 Aligned_cols=180 Identities=14% Similarity=0.206 Sum_probs=133.5
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCC-CCCccceeeeeeecccc-CCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRHLVSALGHCFECYFD-DSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~-~~~~ 552 (659)
..+|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++.++. ||||+++++++...... ....
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 456888899999999999999965 69999999996654444567999999999996 99999999999643221 1224
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||+. |+|.+++........+++..+..++.|++.||+|||+. .++|+||||||+||+++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 56899999996 79999886422235699999999999999999999997 12299999999999999999999999999
Q ss_pred cccccccccc-------------ceecccccccCCCCC
Q 006145 633 PLLAENAEKV-------------GHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~-------------~~~~gt~~y~aPE~~ 657 (659)
++........ ....||+.|+|||+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222 (337)
T ss_dssp CBCCSSCC------------------------------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence 9766432221 245699999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=247.02 Aligned_cols=172 Identities=21% Similarity=0.378 Sum_probs=144.5
Q ss_pred hcCCCCCceeccCcCceEEEEEe-----cCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-----KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.++|...+.||+|+||.||+|++ .+|+.||||++........+++.+|++++++++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA----- 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec-----
Confidence 34577789999999999999984 35899999999865544557899999999999999999999998752
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.....++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCC
T ss_pred CCCceEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecC
Confidence 134679999999999999999853 24589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccc----cceecccccccCCCCC
Q 006145 631 NLPLLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
|+++....... .....++..|+|||+.
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 220 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHH
T ss_pred cchhhccccccccccccCCCCceeEECchhh
Confidence 99987644322 2334677889999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=267.28 Aligned_cols=161 Identities=20% Similarity=0.285 Sum_probs=134.4
Q ss_pred eeccCcCceEEEEEec---CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEEE
Q 006145 484 FMGEGSQGQMYRGRLK---NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIF 559 (659)
Q Consensus 484 ~ig~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~ 559 (659)
.||+|+||.||+|++. ++..||||+++.... ...++|.+|+++|++++|||||+++++|.. +..++||
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--------~~~~lv~ 414 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--------EALMLVM 414 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--------SSEEEEE
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--------CCeEEEE
Confidence 7999999999999864 467899999976533 345789999999999999999999999864 3489999
Q ss_pred eccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccccc
Q 006145 560 EYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENA 639 (659)
Q Consensus 560 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~ 639 (659)
|||++|+|.+++... ...+++..+..++.||++||+|||+. +||||||||+|||+++++.+||+|||+++.....
T Consensus 415 E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 999999999999753 34699999999999999999999998 9999999999999999999999999999876432
Q ss_pred cc----cceecccccccCCCCC
Q 006145 640 EK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 640 ~~----~~~~~gt~~y~aPE~~ 657 (659)
.. .....+++.|||||+.
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~ 511 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECI 511 (613)
T ss_dssp ------------CCTTSCHHHH
T ss_pred CceeeeccCCCCccceeCHhhh
Confidence 21 1233456889999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=246.04 Aligned_cols=170 Identities=18% Similarity=0.368 Sum_probs=141.5
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|...+.||+|+||.||+|+.. +|+.||+|.+........+++.+|++++++++||||+++++++.. .+.
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~~ 90 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-------DGK 90 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-------C-C
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-------CCe
Confidence 467888899999999999999976 489999999987665567889999999999999999999999976 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 89999999999999998742 24589999999999999999999998 99999999999999999999999999985
Q ss_pred cccc-ccccceecccccccCCCCC
Q 006145 635 LAEN-AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~-~~~~~~~~gt~~y~aPE~~ 657 (659)
.... ........||+.|+|||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~ 189 (302)
T 2j7t_A 166 KNLKTLQKRDSFIGTPYWMAPEVV 189 (302)
T ss_dssp HHHHHHHC-----CCGGGCCHHHH
T ss_pred cccccccccccccCChhhcCCeee
Confidence 4322 1223456799999999964
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=247.82 Aligned_cols=181 Identities=22% Similarity=0.349 Sum_probs=149.4
Q ss_pred CHHHHHHhhcCCCCCceeccCcCceEEEEEe------cCCcEEEEEEecccCCC-chHHHHHHHHHHhCC-CCCCcccee
Q 006145 468 SLEELEEATNNFDTSAFMGEGSQGQMYRGRL------KNGTFVAIRCLKMKKCH-STRNFMHHIELISKL-RHRHLVSAL 539 (659)
Q Consensus 468 ~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l-~H~niv~l~ 539 (659)
...++....++|...+.||+|+||.||+|+. .+++.||||+++..... ..+++.+|++++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 4445555678899999999999999999984 24789999999765432 235799999999999 699999999
Q ss_pred eeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCC
Q 006145 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHA-------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPG 606 (659)
Q Consensus 540 g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 606 (659)
++|... ....++||||+++|+|.+++..... ...+++..+..++.|+++||+|||+. +
T Consensus 98 ~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ 168 (316)
T 2xir_A 98 GACTKP------GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---K 168 (316)
T ss_dssp EEECCT------TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred EEEecC------CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 998751 3458999999999999999986321 12389999999999999999999998 9
Q ss_pred ccccCCCCCceeecCCcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 607 VFSNNLKITDILLDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 607 iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
|+||||||+||++++++.+||+|||+++...... ......+|+.|+|||+.
T Consensus 169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (316)
T 2xir_A 169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 222 (316)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH
T ss_pred cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhh
Confidence 9999999999999999999999999997654322 22456788999999964
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=247.66 Aligned_cols=173 Identities=18% Similarity=0.229 Sum_probs=142.1
Q ss_pred HhhcCCCCC-ceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCC-CCCccceeeeeeecccc
Q 006145 474 EATNNFDTS-AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLR-HRHLVSALGHCFECYFD 548 (659)
Q Consensus 474 ~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 548 (659)
...+.|... +.||+|+||.||+|+.. +|+.||||+++..... ...++.+|++++.+++ ||||+++++++..
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~---- 100 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN---- 100 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe----
Confidence 334456665 78999999999999976 5999999999764432 3467999999999995 6999999999975
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC---Ccce
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ---NLVA 625 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~---~~~~ 625 (659)
.+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+
T Consensus 101 ---~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 101 ---TSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp ---SSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred ---CCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence 56789999999999999998652 235699999999999999999999998 9999999999999997 7899
Q ss_pred EEccCccccccccccccceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
||+|||+++............||+.|+|||+.
T Consensus 174 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 205 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACELREIMGTPEYLAPEIL 205 (327)
T ss_dssp EECCGGGCEEC---------CCCGGGCCHHHH
T ss_pred EEeeCccccccCCccccccccCCcCccCCeee
Confidence 99999999887665556677899999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=242.87 Aligned_cols=167 Identities=17% Similarity=0.338 Sum_probs=132.9
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|...+.||+|+||.||+|+.. ..||||+++..... ..+.|.+|++++++++||||+++++++.. .
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------~ 92 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--------P 92 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--------S
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC--------C
Confidence 567888899999999999999864 35999999765432 23579999999999999999999997643 4
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred ccEEEEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceec
Confidence 579999999999999999753 35699999999999999999999998 9999999999999999999999999999
Q ss_pred ccccc---ccccceecccccccCCCCC
Q 006145 634 LLAEN---AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~---~~~~~~~~gt~~y~aPE~~ 657 (659)
+.... ........||+.|+|||+.
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~ 194 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVI 194 (289)
T ss_dssp ----------------CCCTTCCHHHH
T ss_pred cccccccccccccccCCCccccCchhh
Confidence 75532 2233456799999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-27 Score=241.41 Aligned_cols=168 Identities=17% Similarity=0.332 Sum_probs=146.8
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.+.|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+ ..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~ 93 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-------DT 93 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-------TT
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-------CC
Confidence 355778899999999999999864 599999999976543 345789999999999999999999999986 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++|+|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~ 166 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA 166 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccc
Confidence 78999999999999999974 4689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccc-ccceecccccccCCCCC
Q 006145 634 LLAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
....... ......||+.|+|||+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~ 191 (303)
T 3a7i_A 167 GQLTDTQIKRNTFVGTPFWMAPEVI 191 (303)
T ss_dssp EECBTTBCCBCCCCSCGGGCCHHHH
T ss_pred eecCccccccCccCCCcCccCHHHH
Confidence 7664332 33556899999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=251.75 Aligned_cols=171 Identities=15% Similarity=0.233 Sum_probs=138.2
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ..+++.+|+++++.++||||+++++++...... ...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~-~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL-DDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST-TTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc-ccC
Confidence 467888899999999999999964 6999999999654322 235789999999999999999999998752110 112
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...|+||||+ +++|.++++. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 4579999999 8899999975 3589999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++.... .....++|+.|+|||+.
T Consensus 175 a~~~~~--~~~~~~~t~~y~aPE~~ 197 (367)
T 1cm8_A 175 ARQADS--EMTGYVVTRWYRAPEVI 197 (367)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHH
T ss_pred cccccc--ccCcCcCCCCcCCHHHH
Confidence 987643 24456899999999964
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=250.12 Aligned_cols=168 Identities=15% Similarity=0.311 Sum_probs=135.9
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc-hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS-TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|...+.||+|+||+||+|+.. +++.||||+++...... ...+.+|++++++++||||+++++++.+ .+.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~~ 74 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-------EKS 74 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-------SSC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-------CCE
Confidence 46788899999999999999976 69999999997544222 2356789999999999999999999975 466
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||++ |+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 75 LTLVFEYLD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLAR 148 (324)
T ss_dssp EEEEEECCS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred EEEEecccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccc
Confidence 899999997 5999998753 24689999999999999999999998 99999999999999999999999999997
Q ss_pred cccc-ccccceecccccccCCCCC
Q 006145 635 LAEN-AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~-~~~~~~~~gt~~y~aPE~~ 657 (659)
.... .......+||+.|+|||+.
T Consensus 149 ~~~~~~~~~~~~~~t~~y~aPE~~ 172 (324)
T 3mtl_A 149 AKSIPTKTYDNEVVTLWYRPPDIL 172 (324)
T ss_dssp CC------------CGGGCCHHHH
T ss_pred cccCCccccccccCcccccChhhh
Confidence 6543 2233556889999999964
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-27 Score=246.02 Aligned_cols=171 Identities=26% Similarity=0.424 Sum_probs=140.8
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcE--EEEEEecccC-CCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTF--VAIRCLKMKK-CHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~--vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~ 551 (659)
++|...+.||+|+||.||+|+.. +|.. ||||.++... ....+++.+|+++++++ +||||+++++++.+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~------- 97 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH------- 97 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-------
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-------
Confidence 56888899999999999999965 4664 4999987533 23346799999999999 89999999999976
Q ss_pred CceeEEEEeccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCcee
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGH-------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDIL 618 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 618 (659)
.+..++||||+++|+|.+++.... ....+++..+..++.|+++||+|||+. +|+||||||+||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl 174 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL 174 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEE
Confidence 467899999999999999997532 124689999999999999999999998 9999999999999
Q ss_pred ecCCcceEEccCccccccccccccceecccccccCCCCC
Q 006145 619 LDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 619 ld~~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++.++.+||+|||+++............+++.|+|||+.
T Consensus 175 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 213 (327)
T 1fvr_A 175 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL 213 (327)
T ss_dssp ECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHH
T ss_pred EcCCCeEEEcccCcCccccccccccCCCCCccccChhhh
Confidence 999999999999999765444444556678899999964
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=248.52 Aligned_cols=183 Identities=17% Similarity=0.184 Sum_probs=137.8
Q ss_pred HHHHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 470 EELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 470 ~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
++.....++|...+.||+|+||.||+|+.. +|+.||||++.... .....+.+|++.++.++||||+++++++......
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 445567789999999999999999999975 59999999986543 2335677888899999999999999999763322
Q ss_pred CCCCceeEEEEeccCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHhhhhc--CCCCCCccccCCCCCceeecC-Ccc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISE-GHAHQSLTWTQRISAAIGVAKGIQFLH--TGIVPGVFSNNLKITDILLDQ-NLV 624 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~iiHrDlk~~NILld~-~~~ 624 (659)
.......++||||+++ +|.+.+.. ......+++..+..++.|++.||+||| +. +|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 2223347899999987 55444331 112356899999999999999999999 76 9999999999999996 899
Q ss_pred eEEccCccccccccccccceecccccccCCCCC
Q 006145 625 AKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 625 ~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+||+|||+++............||+.|+|||+.
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 203 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELI 203 (360)
T ss_dssp EEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHH
T ss_pred EEEeeCCCceecCCCCCcccccCCcceeCHHHH
Confidence 999999999877665556667899999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=246.77 Aligned_cols=169 Identities=24% Similarity=0.365 Sum_probs=140.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|++++++++||||++++++|.+ .
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~ 96 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-------K 96 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-------T
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-------C
Confidence 456788899999999999999976 49999999986554322 3458899999999999999999999986 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCC
Confidence 6789999999999999887642 4599999999999999999999998 999999999999999999999999999
Q ss_pred cccccc-ccccceecccccccCCCCC
Q 006145 633 PLLAEN-AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~-~~~~~~~~gt~~y~aPE~~ 657 (659)
++.... ........||+.|+|||+.
T Consensus 171 ~~~~~~~~~~~~~~~~t~~y~aPE~~ 196 (331)
T 4aaa_A 171 ARTLAAPGEVYDDEVATRWYRAPELL 196 (331)
T ss_dssp C------------CCCCCTTCCHHHH
T ss_pred ceeecCCccccCCCcCCccccCcccc
Confidence 976543 2334567899999999964
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-27 Score=244.02 Aligned_cols=167 Identities=22% Similarity=0.392 Sum_probs=141.5
Q ss_pred CCCCceeccCcCceEEEEEec-----CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 479 FDTSAFMGEGSQGQMYRGRLK-----NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
|...+.||+|+||+||++.+. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+. ..
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 107 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA-----GA 107 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TT
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC-----CC
Confidence 377899999999999998753 588999999976532 2245699999999999999999999999862 23
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred ceEEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccc
Confidence 568999999999999999985 3489999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccc----cceecccccccCCCCC
Q 006145 633 PLLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
++....... .....+|..|+|||+.
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 209 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECL 209 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHh
Confidence 987654322 2345688889999974
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=269.08 Aligned_cols=161 Identities=19% Similarity=0.283 Sum_probs=134.2
Q ss_pred ceeccCcCceEEEEEec---CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLK---NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||.||+|.+. +++.||||+++..... ..++|.+|+++|++++|||||+++++|.. +..++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--------~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--------ESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--------SSEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--------CCEEE
Confidence 47999999999999753 4678999999765432 24689999999999999999999999863 34799
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
|||||++|+|.++++. ...+++..+..|+.||+.||+|||+. +||||||||+|||+++++.+||+|||+++...
T Consensus 447 v~E~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp EEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred EEEccCCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 9999999999999975 24689999999999999999999998 99999999999999999999999999997664
Q ss_pred cccc----cceecccccccCCCCC
Q 006145 638 NAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 ~~~~----~~~~~gt~~y~aPE~~ 657 (659)
.... .....+|+.|+|||++
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~ 544 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECI 544 (635)
T ss_dssp C-------------CGGGSCHHHH
T ss_pred cCccccccccCCCCceeeeChhhh
Confidence 3321 2344577899999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=256.32 Aligned_cols=172 Identities=20% Similarity=0.273 Sum_probs=139.4
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.+|...+.||+|+||.||+|+.. +|+.||||++.... +.+.+|+++|++++|||||+++++|...... ......
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~-~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEK-KDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETT-TTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCC-CcceeE
Confidence 35777899999999999999975 59999999986432 2244799999999999999999998753221 112346
Q ss_pred EEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC-cceEEccCccc
Q 006145 556 FLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN-LVAKISSYNLP 633 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla 633 (659)
++||||+++ ++.+.+... .....+++..+..++.|+++||+|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999986 676665421 1235799999999999999999999998 99999999999999965 67899999999
Q ss_pred cccccccccceecccccccCCCCC
Q 006145 634 LLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+...........+||+.|||||++
T Consensus 205 ~~~~~~~~~~~~~~t~~y~aPE~~ 228 (420)
T 1j1b_A 205 KQLVRGEPNVSYICSRYYRAPELI 228 (420)
T ss_dssp EECCTTCCCCSCCSCTTSCCHHHH
T ss_pred hhcccCCCceeeeeCCCcCCHHHH
Confidence 877555555667899999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=240.06 Aligned_cols=167 Identities=20% Similarity=0.332 Sum_probs=145.0
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++.+ .
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~ 86 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-------R 86 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-------S
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-------C
Confidence 56788899999999999999976 58899999996432 2234679999999999999999999999975 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~ 160 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGW 160 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccc
Confidence 6789999999999999999752 3589999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+...... ......|++.|+|||+.
T Consensus 161 ~~~~~~~-~~~~~~~~~~y~aPE~~ 184 (284)
T 2vgo_A 161 SVHAPSL-RRRTMCGTLDYLPPEMI 184 (284)
T ss_dssp CEECSSS-CBCCCCSCGGGCCHHHH
T ss_pred cccCccc-ccccccCCCCcCCHHHh
Confidence 9765432 23456899999999964
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=250.53 Aligned_cols=172 Identities=16% Similarity=0.198 Sum_probs=133.8
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ..+++.+|+++++.++||||+++++++...... ...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL-EEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST-TTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccc-ccc
Confidence 467888899999999999999965 5899999999754322 235689999999999999999999998752210 112
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||+++ +|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 468999999975 88888863 489999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++...........+||+.|+|||+.
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~ 198 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVI 198 (371)
T ss_dssp ----------------CTTCCHHHH
T ss_pred ccccccccccCCceecCCccCHHHh
Confidence 9877655555667899999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.8e-27 Score=240.32 Aligned_cols=167 Identities=12% Similarity=0.140 Sum_probs=143.1
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ..+++.+|+++++++ +|+||+++++++.+ ..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-------~~ 79 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-------GL 79 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-------TT
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC-------Cc
Confidence 35688889999999999999995 469999999986443 335688999999999 79999999999875 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc-----eEEc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV-----AKIS 628 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~-----~kl~ 628 (659)
..++||||+ +|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred eeEEEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 789999999 99999999853 24599999999999999999999998 9999999999999987776 9999
Q ss_pred cCcccccccccc--------ccceecccccccCCCCC
Q 006145 629 SYNLPLLAENAE--------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~~--------~~~~~~gt~~y~aPE~~ 657 (659)
|||+++...... ......||+.|+|||+.
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 190 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 190 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhh
Confidence 999997664432 23456799999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.9e-27 Score=246.14 Aligned_cols=175 Identities=16% Similarity=0.320 Sum_probs=143.1
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeecccc-CCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFD-DSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~~~~ 552 (659)
++|...+.||+|+||.||+|+.. +|+.||||++...... ....+.+|++++++++||||+++++++...... ....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 56888899999999999999974 6999999998654322 245789999999999999999999999763210 0113
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++||||+++ +|.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999985 888877653 24699999999999999999999998 999999999999999999999999999
Q ss_pred cccccc-----ccccceecccccccCCCCC
Q 006145 633 PLLAEN-----AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~-----~~~~~~~~gt~~y~aPE~~ 657 (659)
++.... ........||+.|+|||+.
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 200 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELL 200 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHH
T ss_pred cccccccccccccccCCcccccCccCchhh
Confidence 976542 2223556889999999964
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=252.01 Aligned_cols=169 Identities=14% Similarity=0.274 Sum_probs=143.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|...+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+ .+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------~~ 104 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-------DG 104 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-------TT
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-------CC
Confidence 356788899999999999999976 5999999999765322 23579999999999999999999999986 46
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++|+|.++++.. ..+++..+..++.+++.||+|||+.+ +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEEECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 789999999999999999852 35899999999999999999999831 7999999999999999999999999999
Q ss_pred cccccccccceecccccccCCCCC
Q 006145 634 LLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+..... ......||+.|+|||+.
T Consensus 180 ~~~~~~-~~~~~~gt~~y~aPE~~ 202 (360)
T 3eqc_A 180 GQLIDS-MANSFVGTRSYMSPERL 202 (360)
T ss_dssp HHHHHH-C----CCCCTTCCHHHH
T ss_pred cccccc-cccCCCCCCCeECHHHH
Confidence 755332 23456899999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-27 Score=245.19 Aligned_cols=169 Identities=22% Similarity=0.382 Sum_probs=135.7
Q ss_pred cCCCCCceeccCcCceEEEEEecC-----CcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN-----GTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
++|...+.||+|+||.||+|+... +..||||.++..... ...+|.+|++++++++||||+++++++..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 117 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK------ 117 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec------
Confidence 455667899999999999998653 346999999754332 23569999999999999999999999875
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 118 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 118 -YKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred -CCCcEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCC
Confidence 45689999999999999999753 24699999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccc----cceecccccccCCCCC
Q 006145 631 NLPLLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
|+++....... .....+|+.|+|||+.
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 222 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222 (333)
T ss_dssp CC-----------------CCCGGGSCHHHH
T ss_pred CcchhhccccccccccCCCCccccccCchhc
Confidence 99976643221 2234567899999964
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=9.4e-27 Score=238.71 Aligned_cols=168 Identities=19% Similarity=0.278 Sum_probs=140.5
Q ss_pred cCCCCCc-eeccCcCceEEEEEec---CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSA-FMGEGSQGQMYRGRLK---NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~-~ig~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
++|...+ .||+|+||.||+|+.. ++..||||+++.... ...+++.+|++++++++||||+++++++..
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------- 81 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------- 81 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-------
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-------
Confidence 3444445 8999999999999854 578899999976532 234679999999999999999999999843
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
+..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCT
T ss_pred -CCcEEEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECccc
Confidence 4589999999999999999742 34699999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccc----cceecccccccCCCCC
Q 006145 632 LPLLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
+++....... .....+|+.|+|||+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 185 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECI 185 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHH
T ss_pred ceeeeccCcceeeccccccccccccCHHHh
Confidence 9976643222 1334568899999964
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=253.28 Aligned_cols=173 Identities=17% Similarity=0.215 Sum_probs=139.7
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
.+|...+.||+|+||+||+|+...+..||+|++..... ...+|+++++.++|||||++++++..... .......+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGD-KKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESS-SSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCC-CCCceEEE
Confidence 45778899999999999999987777799998864332 22379999999999999999999975321 11233478
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec-CCcceEEccCccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD-QNLVAKISSYNLPLL 635 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~~ 635 (659)
+||||++++.+....+.......+++..+..++.|+++||+|||+. +|+||||||+|||++ +++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999998754443332111235699999999999999999999998 999999999999999 789999999999987
Q ss_pred cccccccceecccccccCCCCC
Q 006145 636 AENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
..........+||+.|+|||++
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~ 213 (394)
T 4e7w_A 192 LIAGEPNVSYICSRYYRAPELI 213 (394)
T ss_dssp CCTTCCCCSSCSCGGGCCHHHH
T ss_pred ccCCCCCcccccCcCccCHHHH
Confidence 7665556677899999999964
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=241.98 Aligned_cols=169 Identities=18% Similarity=0.270 Sum_probs=138.6
Q ss_pred hhcCCCCCc-eeccCcCceEEEEEec---CCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 475 ATNNFDTSA-FMGEGSQGQMYRGRLK---NGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 475 ~~~~~~~~~-~ig~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
..++|...+ .||+|+||.||+|.+. +++.||||+++...... .+++.+|+++++.++||||+++++++.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 88 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE----- 88 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----
Confidence 345676777 9999999999999643 37899999997654322 467999999999999999999999984
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
.+..++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ---~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~ 159 (291)
T 1xbb_A 89 ---AESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKIS 159 (291)
T ss_dssp ---SSSEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred ---CCCcEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEc
Confidence 34589999999999999999862 4589999999999999999999998 99999999999999999999999
Q ss_pred cCccccccccccc----cceecccccccCCCCC
Q 006145 629 SYNLPLLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
|||+++....... .....+++.|+|||+.
T Consensus 160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 192 (291)
T 1xbb_A 160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192 (291)
T ss_dssp CCTTCEECCTTCSEEEC----CCCGGGCCHHHH
T ss_pred cCCcceeeccCCCcccccccCCCCceeeChHHh
Confidence 9999976643322 1234567889999964
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-27 Score=248.22 Aligned_cols=172 Identities=15% Similarity=0.286 Sum_probs=144.9
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|...+.||+|+||.||+|+.. +++.||||++...... ..+++.+|++++++++||||+++++++.....+ ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE--QMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT--TCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc--ccc
Confidence 457888999999999999999965 5889999999754322 236799999999999999999999999753221 134
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 6899999997 599999875 3589999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccc----cceecccccccCCCCC
Q 006145 634 LLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
+....... ....+||+.|+|||+.
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 203 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIM 203 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHh
Confidence 76643322 2456899999999963
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=240.64 Aligned_cols=169 Identities=20% Similarity=0.356 Sum_probs=140.0
Q ss_pred hcCCCCCceeccCcCceEEEEEecC----CcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN----GTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.++|...+.||+|+||.||+|+... +..||||.+..... ...++|.+|++++++++||||+++++++.+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------ 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE------ 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS------
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC------
Confidence 4668888999999999999998643 34699999976532 234679999999999999999999998863
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
+..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 85 --~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 85 --EPTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCC
T ss_pred --CCCEEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCcc
Confidence 3468999999999999999752 24589999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccc--ccceecccccccCCCCC
Q 006145 631 NLPLLAENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
|+++...... ......+++.|+|||+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 186 (281)
T 3cc6_A 158 GLSRYIEDEDYYKASVTRLPIKWMSPESI 186 (281)
T ss_dssp CGGGCC---------CCCCCGGGCCHHHH
T ss_pred CCCcccccccccccccCCCCcceeCchhh
Confidence 9997664432 22445678899999964
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-27 Score=240.98 Aligned_cols=176 Identities=19% Similarity=0.337 Sum_probs=140.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccc------c
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYF------D 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------~ 548 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ...+++.+|++++++++||||++++++|.+... .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 456888899999999999999965 69999999996432 234679999999999999999999999865210 0
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
.......++||||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 01245689999999999999999852 24578899999999999999999998 99999999999999999999999
Q ss_pred cCccccccccc---------------cccceecccccccCCCCC
Q 006145 629 SYNLPLLAENA---------------EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~---------------~~~~~~~gt~~y~aPE~~ 657 (659)
|||+++..... .......||+.|+|||+.
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 202 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL 202 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccc
Confidence 99999765421 123456799999999974
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=248.47 Aligned_cols=174 Identities=22% Similarity=0.357 Sum_probs=144.5
Q ss_pred HhhcCCCCCceeccCcCceEEEEEecC-C-----cEEEEEEecccCCC-chHHHHHHHHHHhCC-CCCCccceeeeeeec
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLKN-G-----TFVAIRCLKMKKCH-STRNFMHHIELISKL-RHRHLVSALGHCFEC 545 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 545 (659)
...++|...+.||+|+||.||+|+... + ..||||.+...... ..+.+.+|+++++++ +||||++++++|..
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 121 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH- 121 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence 345778889999999999999999642 3 48999999755432 345799999999999 89999999999975
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCC
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGH-----------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKI 614 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~ 614 (659)
.+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||
T Consensus 122 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 192 (333)
T 2i1m_A 122 ------GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAA 192 (333)
T ss_dssp ------SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred ------CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCccc
Confidence 456899999999999999987421 124589999999999999999999998 999999999
Q ss_pred CceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 615 TDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 615 ~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
+||++++++.+||+|||+++....... .....+|+.|+|||+.
T Consensus 193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 238 (333)
T 2i1m_A 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 238 (333)
T ss_dssp GGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHH
T ss_pred ceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHh
Confidence 999999999999999999976543322 2345678899999964
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=241.35 Aligned_cols=174 Identities=17% Similarity=0.326 Sum_probs=144.1
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||+|.+...... ..+.+.+|++++++++||||+++++++.+.. .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 79 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT-----N 79 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG-----G
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC-----C
Confidence 356788899999999999999975 5999999999765432 2356999999999999999999999886521 3
Q ss_pred ceeEEEEeccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCC-----ccccCCCCCceeecCCcceE
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGH-AHQSLTWTQRISAAIGVAKGIQFLHTGIVPG-----VFSNNLKITDILLDQNLVAK 626 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-----iiHrDlk~~NILld~~~~~k 626 (659)
...++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. + |+||||||+||++++++.+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~k 156 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVK 156 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEE
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEE
Confidence 56899999999999999997421 234599999999999999999999997 6 99999999999999999999
Q ss_pred EccCccccccccccc-cceecccccccCCCCC
Q 006145 627 ISSYNLPLLAENAEK-VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 627 l~DFGla~~~~~~~~-~~~~~gt~~y~aPE~~ 657 (659)
|+|||+++....... .....||+.|+|||+.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 188 (279)
T 2w5a_A 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188 (279)
T ss_dssp ECCCCHHHHC---CHHHHHHHSCCTTCCHHHH
T ss_pred EecCchheeeccccccccccCCCccccChHHh
Confidence 999999976643322 3456799999999964
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-28 Score=256.61 Aligned_cols=175 Identities=13% Similarity=0.186 Sum_probs=136.0
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccC---CCchHHHHHHH---HHHhCCCCCCcccee-------ee
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKK---CHSTRNFMHHI---ELISKLRHRHLVSAL-------GH 541 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~ 541 (659)
.++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.|.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46688889999999999999996 469999999997442 22346799999 566666899999999 44
Q ss_pred eeeccc-------cCCCC---ceeEEEEeccCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCc
Q 006145 542 CFECYF-------DDSSV---SRIFLIFEYVPNGTLRSWISEGH----AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGV 607 (659)
Q Consensus 542 ~~~~~~-------~~~~~---~~~~lV~Ey~~~GsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 607 (659)
+.+... .+... ...|+||||+ +|+|.+++.... ....++|..+..|+.|+++||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 432100 00000 0378999999 689999997421 112355788899999999999999998 99
Q ss_pred cccCCCCCceeecCCcceEEccCccccccccccccceecccccccCCCCC
Q 006145 608 FSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 608 iHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||+.
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~ 274 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELE 274 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhh
Confidence 9999999999999999999999999986433 3455677 999999975
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=9.9e-27 Score=239.78 Aligned_cols=169 Identities=20% Similarity=0.366 Sum_probs=142.2
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|...+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.. .+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~ 75 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-------EN 75 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-------TT
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEec-------CC
Confidence 56788899999999999999976 699999999975432 224678999999999999999999999986 46
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||++ |+|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~ 150 (299)
T 2r3i_A 76 KLYLVFEFLH-QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 150 (299)
T ss_dssp EEEEEEECCS-EEHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECSTTHH
T ss_pred ceEEEEEccc-CCHHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHeEEcCCCCEEECcchhh
Confidence 7899999998 69999987532 24689999999999999999999998 9999999999999999999999999999
Q ss_pred cccccc-cccceecccccccCCCCC
Q 006145 634 LLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
+..... .......+|+.|+|||+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~ 175 (299)
T 2r3i_A 151 RAFGVPVRTYTHEVVTLWYRAPEIL 175 (299)
T ss_dssp HHHCCCSBCTTSCBCCCTTCCHHHH
T ss_pred hhccCCccccCcccccccccCcHHh
Confidence 765432 233456789999999964
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=238.48 Aligned_cols=172 Identities=18% Similarity=0.303 Sum_probs=142.9
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC----CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK----CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 78 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE----- 78 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-----
Confidence 467999999999999999999965 58999999997542 23346799999999999999999999998641
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.....++||||+++| |.+++... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 79 ~~~~~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~df 153 (305)
T 2wtk_C 79 EKQKMYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISAL 153 (305)
T ss_dssp ---CEEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCCeEEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecc
Confidence 145689999999886 77777642 235699999999999999999999998 9999999999999999999999999
Q ss_pred cccccccc---ccccceecccccccCCCCC
Q 006145 631 NLPLLAEN---AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~---~~~~~~~~gt~~y~aPE~~ 657 (659)
|++..... ........||+.|+|||+.
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 183 (305)
T 2wtk_C 154 GVAEALHPFAADDTCRTSQGSPAFQPPEIA 183 (305)
T ss_dssp TTCEECCTTCSSCEECCCCSCGGGCCHHHH
T ss_pred ccccccCccccccccccCCCCCCCcChhhc
Confidence 99976542 2223456799999999974
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-27 Score=244.43 Aligned_cols=235 Identities=20% Similarity=0.170 Sum_probs=202.7
Q ss_pred CCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccC
Q 006145 109 LKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRN 188 (659)
Q Consensus 109 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 188 (659)
++.++++.+.+...++..+..+++|++|+|++|.+++..|..|.++++|++|+|++|.+++..| +..+++|++|+|++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 4556667777766666677788999999999999998888899999999999999999987655 99999999999999
Q ss_pred CcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCC---CcccceEecCCCcCCccCch
Q 006145 189 NMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKV---GKKLVTMILSKNKFRSAIPA 265 (659)
Q Consensus 189 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~~~p~ 265 (659)
|.+++.. .+++|++|++++|++++..+. .+++|++|++++|.+++..+.. +++|+.|++++|.+++..|.
T Consensus 90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~--~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 162 (317)
T 3o53_A 90 NYVQELL-----VGPSIETLHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162 (317)
T ss_dssp SEEEEEE-----ECTTCCEEECCSSCCSEEEEC--CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG
T ss_pred Ccccccc-----CCCCcCEEECCCCccCCcCcc--ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH
Confidence 9998533 348999999999999987654 3688999999999999876654 47899999999999998887
Q ss_pred hc-cCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCC
Q 006145 266 EV-SSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSK 344 (659)
Q Consensus 266 ~~-~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~ 344 (659)
.+ ..+++|+.|+|++|.+++. |. ...+++|+.|++++|++++.. ..+..+++|+.|++++|+++ .+|..+..+++
T Consensus 163 ~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~-~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~ 238 (317)
T 3o53_A 163 ELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238 (317)
T ss_dssp GGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCC-EECTTCCCCTT
T ss_pred HHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcch-hhhcccCcccEEECcCCccc-chhhHhhcCCC
Confidence 77 4789999999999999865 43 345899999999999999654 45888999999999999999 58888989999
Q ss_pred CCEEEcCCcccc
Q 006145 345 NRVVLYARNCLA 356 (659)
Q Consensus 345 l~~l~~~~N~l~ 356 (659)
++.+++++|.+.
T Consensus 239 L~~L~l~~N~~~ 250 (317)
T 3o53_A 239 LEHFDLRGNGFH 250 (317)
T ss_dssp CCEEECTTCCCB
T ss_pred CCEEEccCCCcc
Confidence 999999999886
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=240.69 Aligned_cols=180 Identities=15% Similarity=0.306 Sum_probs=135.7
Q ss_pred HHhhcCCCCCceeccCcCceEEEEEec----CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeecc
Q 006145 473 EEATNNFDTSAFMGEGSQGQMYRGRLK----NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECY 546 (659)
Q Consensus 473 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 546 (659)
....++|...+.||+|+||.||+|+.. ++..||||+++..... ..+++.+|++++++++||||+++++++.+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 344567888899999999999999864 3558999999755432 2356999999999999999999999997632
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEG---HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL 623 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~ 623 (659)
.. .....++||||+++|+|.+++... .....+++..+..++.|+++||+|||+. +|+||||||+||++++++
T Consensus 110 ~~--~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 110 SQ--GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred cc--CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 11 112469999999999999998521 2235699999999999999999999998 999999999999999999
Q ss_pred ceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 624 VAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 624 ~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
.+||+|||+++...... ......+++.|+|||+.
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 221 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL 221 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhh
Confidence 99999999997664332 12345678899999974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-27 Score=243.71 Aligned_cols=169 Identities=20% Similarity=0.353 Sum_probs=135.1
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcE----EEEEEecccC-CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTF----VAIRCLKMKK-CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 549 (659)
.++|...+.||+|+||.||+|+.. +++. ||+|.+.... ....+++.+|++++++++||||++++++|..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 356888899999999999999964 4543 5777775433 3345789999999999999999999999975
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEcc
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISS 629 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 629 (659)
...++|+||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 89 ---~~~~~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~D 160 (327)
T 3lzb_A 89 ---STVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 160 (327)
T ss_dssp ---SSEEEEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred ---CCceEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEcc
Confidence 3478999999999999999753 24689999999999999999999998 999999999999999999999999
Q ss_pred Cccccccccccc---cceecccccccCCCCC
Q 006145 630 YNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
||+++....... .....+|+.|+|||+.
T Consensus 161 fG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 191 (327)
T 3lzb_A 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191 (327)
T ss_dssp TTC----------------CCCGGGSCHHHH
T ss_pred CcceeEccCccccccccCCCccccccCHHHH
Confidence 999976643322 2345578899999964
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-27 Score=264.58 Aligned_cols=159 Identities=11% Similarity=0.125 Sum_probs=124.1
Q ss_pred eeccCcCceEEEEE-ecCCcEEEEEEecccCCC----------chHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCC
Q 006145 484 FMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCH----------STRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 484 ~ig~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~----------~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~ 551 (659)
..+.|+.|.+..++ ...|+.+|||.+...... ..++|.+|+++|+++ .|+||+++++++.+
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed------- 313 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN------- 313 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-------
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-------
Confidence 34566666666655 335899999999754311 125699999999999 69999999999976
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....||||||++||+|.+++.+. ..++.. +|+.||+.||+|+|+. +||||||||+|||+++++.+||+|||
T Consensus 314 ~~~~yLVMEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFG 384 (569)
T 4azs_A 314 AQSGWLVMEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFG 384 (569)
T ss_dssp SSEEEEEEECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecc
Confidence 56799999999999999999863 346653 5899999999999999 99999999999999999999999999
Q ss_pred cccccccc-cccceecccccccCCCCCC
Q 006145 632 LPLLAENA-EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 632 la~~~~~~-~~~~~~~gt~~y~aPE~~~ 658 (659)
+|+..... ......+||+.|||||++.
T Consensus 385 lAr~~~~~~~~~~t~vGTp~YmAPE~l~ 412 (569)
T 4azs_A 385 SIVTTPQDCSWPTNLVQSFFVFVNELFA 412 (569)
T ss_dssp TEESCC---CCSHHHHHHHHHHHHHHC-
T ss_pred cCeeCCCCCccccCceechhhccHHHhC
Confidence 99866433 3446689999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=240.27 Aligned_cols=169 Identities=22% Similarity=0.378 Sum_probs=141.6
Q ss_pred hhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
..++|...+.||+|+||.||+|+.. +|+.||||.+.... ..+++.+|++++++++||||+++++++.. .+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK-------NT 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-------TT
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe-------CC
Confidence 3567888899999999999999976 49999999997543 35779999999999999999999999986 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 172 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA 172 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccc
Confidence 789999999999999998732 24689999999999999999999998 9999999999999999999999999999
Q ss_pred cccccc-cccceecccccccCCCCC
Q 006145 634 LLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
...... .......||+.|+|||+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~y~aPE~~ 197 (314)
T 3com_A 173 GQLTDTMAKRNTVIGTPFWMAPEVI 197 (314)
T ss_dssp EECBTTBSCBCCCCSCGGGCCHHHH
T ss_pred hhhhhhccccCccCCCCCccChhhc
Confidence 765433 233456899999999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-27 Score=242.87 Aligned_cols=174 Identities=17% Similarity=0.319 Sum_probs=128.3
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
...++|...+.||+|+||.||+|+.. +++.||||++..... ...+++.+|++++++++||||+++++++..
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------- 84 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV------- 84 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-------
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-------
Confidence 34578889999999999999999964 689999999865432 234678999999999999999999999976
Q ss_pred CceeEEEEeccCCCChhhhhcC-----CCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceE
Q 006145 552 VSRIFLIFEYVPNGTLRSWISE-----GHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAK 626 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~k 626 (659)
.+..++||||+++|+|.+++.. ......+++..+..++.|+++||+|||+. +|+||||||+||++++++.+|
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEE
Confidence 4568999999999999999863 11234689999999999999999999998 999999999999999999999
Q ss_pred EccCcccccccccc------ccceecccccccCCCCC
Q 006145 627 ISSYNLPLLAENAE------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 627 l~DFGla~~~~~~~------~~~~~~gt~~y~aPE~~ 657 (659)
|+|||++....... ......||+.|+|||+.
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHH
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHh
Confidence 99999987553321 12346799999999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=242.37 Aligned_cols=176 Identities=19% Similarity=0.335 Sum_probs=146.1
Q ss_pred hhcCCCCCceeccCcCceEEEEEec--CCcEEEEEEecccCC--CchHHHHHHHHHHhCC---CCCCccceeeeeeeccc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK--NGTFVAIRCLKMKKC--HSTRNFMHHIELISKL---RHRHLVSALGHCFECYF 547 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~ 547 (659)
+.++|...+.||+|+||.||+|+.. +|+.||||+++.... .....+.+|+++++.+ +||||++++++|.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4577889999999999999999973 588999999975432 2234677888877766 89999999999873211
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEE
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKI 627 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl 627 (659)
+ .....++||||++ |+|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 89 ~--~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 89 D--RETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp S--SEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred C--CCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEE
Confidence 1 1456899999998 69999997532 24589999999999999999999998 9999999999999999999999
Q ss_pred ccCccccccccccccceecccccccCCCCC
Q 006145 628 SSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 628 ~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+|||+++............||+.|+|||+.
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 191 (326)
T 1blx_A 162 ADFGLARIYSFQMALTSVVVTLWYRAPEVL 191 (326)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHH
T ss_pred ecCcccccccCCCCccccccccceeCHHHH
Confidence 999999877655555667899999999974
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=238.10 Aligned_cols=168 Identities=18% Similarity=0.286 Sum_probs=140.0
Q ss_pred CCCCceeccCcCceEEEEEecC----CcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 479 FDTSAFMGEGSQGQMYRGRLKN----GTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
|...+.||+|+||.||+|+..+ +..||+|.+..... ...+.|.+|++++++++||||+++++++.+. ..
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~ 96 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP------EG 96 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS------SS
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC------CC
Confidence 4456899999999999998542 33799999975433 2346799999999999999999999999751 23
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||+.+|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~ 171 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLA 171 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred CcEEEEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCc
Confidence 358999999999999999853 35689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccc-----ccceecccccccCCCCC
Q 006145 634 LLAENAE-----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~-----~~~~~~gt~~y~aPE~~ 657 (659)
+...... ......+|+.|+|||+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 200 (298)
T 3pls_A 172 RDILDREYYSVQQHRHARLPVKWTALESL 200 (298)
T ss_dssp CTTTTGGGGCSCCSSCTTCGGGGSCHHHH
T ss_pred ccccCCcccccccCcCCCCCccccChhhh
Confidence 7553322 22456788999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.5e-27 Score=249.20 Aligned_cols=171 Identities=13% Similarity=0.239 Sum_probs=125.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ..+++.+|+++++.++||||+++++++...... ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~-~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL-EEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG-GGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc-ccC
Confidence 367888899999999999999954 6999999999654322 345788999999999999999999998642110 012
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...|+|+||+ +++|.++++. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 4579999999 6899999874 4699999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++.... .....+||+.|+|||+.
T Consensus 179 a~~~~~--~~~~~~~t~~y~aPE~~ 201 (367)
T 2fst_X 179 ARHTAD--EMTGYVATRWYRAPEIM 201 (367)
T ss_dssp --------------CCCTTCCHHHH
T ss_pred cccccc--cCCCcCcCcCccChHHH
Confidence 986543 24457899999999964
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=240.84 Aligned_cols=174 Identities=16% Similarity=0.287 Sum_probs=137.4
Q ss_pred hcCCCCCceeccCcCceEEEEEecC-CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeecccc------
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFD------ 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~------ 548 (659)
.++|...+.||+|+||.||+|+... |+.||||++........+++.+|++++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3567888999999999999999764 999999999765544457799999999999999999999988532110
Q ss_pred -CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec-CCcceE
Q 006145 549 -DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD-QNLVAK 626 (659)
Q Consensus 549 -~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld-~~~~~k 626 (659)
.......++||||++ |+|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 012357899999998 699999974 4689999999999999999999998 999999999999998 568999
Q ss_pred EccCccccccccc----cccceecccccccCCCCC
Q 006145 627 ISSYNLPLLAENA----EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 627 l~DFGla~~~~~~----~~~~~~~gt~~y~aPE~~ 657 (659)
|+|||+++..... .......+|..|+|||+.
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLL 196 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHh
Confidence 9999999866432 122445679999999964
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-27 Score=240.18 Aligned_cols=167 Identities=20% Similarity=0.389 Sum_probs=134.8
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.++|...+.||+|+||.||+|+.. |+.||||+++... ..++|.+|++++++++||||+++++++.+. .+..
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~ 90 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE------KGGL 90 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--------CC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC------CCce
Confidence 466888899999999999999875 8899999997543 457799999999999999999999998641 3468
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++||||+++|+|.+++... ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp EEEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EEEEecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccc
Confidence 9999999999999999752 112378999999999999999999998 999999999999999999999999999976
Q ss_pred cccccccceecccccccCCCCC
Q 006145 636 AENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.... .....+++.|+|||+.
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~ 186 (278)
T 1byg_A 167 ASST--QDTGKLPVKWTAPEAL 186 (278)
T ss_dssp -----------CCTTTSCHHHH
T ss_pred cccc--ccCCCccccccCHHHh
Confidence 5432 2334678899999964
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=249.44 Aligned_cols=165 Identities=19% Similarity=0.278 Sum_probs=125.0
Q ss_pred CceeccCcCceEEEEEec---CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEEE
Q 006145 482 SAFMGEGSQGQMYRGRLK---NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLI 558 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~lV 558 (659)
.++||+|+||+||+|+.. +++.||||++.... ..+.+.+|+++|++++|||||++++++... .....++|
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~~~lv 98 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH-----ADRKVWLL 98 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEET-----TTTEEEEE
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecC-----CCCeEEEE
Confidence 468999999999999965 47899999997543 345789999999999999999999999652 24578999
Q ss_pred EeccCCCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceee----cCCcceEEc
Q 006145 559 FEYVPNGTLRSWISEG------HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL----DQNLVAKIS 628 (659)
Q Consensus 559 ~Ey~~~GsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl----d~~~~~kl~ 628 (659)
|||++ |+|.+++... .....+++..+..|+.|++.||+|||+. +|+||||||+|||+ ++++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99997 4888877521 1123599999999999999999999998 99999999999999 677999999
Q ss_pred cCccccccccc----cccceecccccccCCCCC
Q 006145 629 SYNLPLLAENA----EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~----~~~~~~~gt~~y~aPE~~ 657 (659)
|||+++..... ......+||+.|+|||++
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 207 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhh
Confidence 99999876432 233557899999999965
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=239.14 Aligned_cols=172 Identities=15% Similarity=0.272 Sum_probs=134.1
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||.||+|+.. +|+.||||+++..... ..+++.+|++++++++||||+++++++..
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------- 103 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE------- 103 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-------
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-------
Confidence 356888899999999999999964 6999999999754322 23568999999999999999999999986
Q ss_pred CceeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+..++||||+++|+|.+++... .....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Df 180 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL 180 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEec
Confidence 45789999999999999998631 1234689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccc-ccceecccccccCCCCC
Q 006145 631 NLPLLAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
|+++...... ......|++.|+|||+.
T Consensus 181 g~~~~~~~~~~~~~~~~~~~~y~aPE~~ 208 (310)
T 2wqm_A 181 GLGRFFSSKTTAAHSLVGTPYYMSPERI 208 (310)
T ss_dssp ------------------CCSSCCHHHH
T ss_pred cceeeecCCCccccccCCCeeEeChHHh
Confidence 9997664332 23456799999999964
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5e-27 Score=245.23 Aligned_cols=184 Identities=18% Similarity=0.359 Sum_probs=146.0
Q ss_pred CHHHHHHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeec
Q 006145 468 SLEELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFEC 545 (659)
Q Consensus 468 ~~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 545 (659)
+++++....++|...+.||+|+||.||+|+.. +|+.||||++.... ...+++.+|+++++++ +||||+++++++...
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 33444456788999999999999999999974 69999999997543 3457899999999999 799999999999763
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcce
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVA 625 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~ 625 (659)
... ...+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 94 ~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 94 NPP-GMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp C---CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCE
T ss_pred cCc-cccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCE
Confidence 211 11356899999999999999997532 24689999999999999999999998 99999999999999999999
Q ss_pred EEccCccccccccc-cccceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
||+|||++...... .......||+.|+|||+.
T Consensus 169 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 201 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201 (326)
T ss_dssp EECCCTTTC-------------CCGGGCCHHHH
T ss_pred EEeeCcCceecCcCccccccccCCccccChhhh
Confidence 99999999766432 223456799999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=267.11 Aligned_cols=168 Identities=17% Similarity=0.252 Sum_probs=139.5
Q ss_pred hcCCCCCceeccCcCceEEEEEec--CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK--NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~--~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.|.+|++++++++|||||+++++|...... ..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~--~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH--GD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT--SC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC--CC
Confidence 367888999999999999999975 589999999865432 2235689999999999999999999999863210 11
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...|+||||+++|+|.+++.. .++|.++..|+.||++||+|||+. +||||||||+|||++++ .+||+|||+
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 226999999999999988753 589999999999999999999998 99999999999999986 899999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++..... ....||+.|||||+.
T Consensus 228 a~~~~~~---~~~~gt~~y~aPE~~ 249 (681)
T 2pzi_A 228 VSRINSF---GYLYGTPGFQAPEIV 249 (681)
T ss_dssp CEETTCC---SCCCCCTTTSCTTHH
T ss_pred chhcccC---CccCCCccccCHHHH
Confidence 9876543 456799999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=244.39 Aligned_cols=172 Identities=17% Similarity=0.304 Sum_probs=142.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ...++.+|++++++++||||+++++++....+. ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE--NFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST--TCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC--ccc
Confidence 467888899999999999999975 5999999999654322 235688999999999999999999998753221 135
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++||||++ |+|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 6899999997 699999875 3689999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccc-----------cceecccccccCCCCC
Q 006145 634 LLAENAEK-----------VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~-----------~~~~~gt~~y~aPE~~ 657 (659)
+....... ....+||+.|+|||+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 194 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVM 194 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeee
Confidence 76542211 2235789999999963
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=243.15 Aligned_cols=172 Identities=23% Similarity=0.355 Sum_probs=139.1
Q ss_pred hcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
.++|...+.||+|+||.||+|+.. +++.||||.+..... ....++.+|+.++++++||||+++++++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC----
Confidence 467888899999999999999842 477999999964432 234579999999999999999999999975
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCC----CCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC---
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHA----HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ--- 621 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~--- 621 (659)
....++||||+++|+|.+++..... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 105 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~ 178 (327)
T 2yfx_A 105 ---SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGP 178 (327)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSST
T ss_pred ---CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCC
Confidence 4567999999999999999985321 14589999999999999999999998 9999999999999994
Q ss_pred CcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 622 NLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 622 ~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
+..+||+|||+++...... ......+|+.|+|||+.
T Consensus 179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 217 (327)
T 2yfx_A 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 217 (327)
T ss_dssp TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHH
T ss_pred cceEEECccccccccccccccccCCCcCCCcceeCHhHh
Confidence 4569999999997553322 22345688999999964
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=255.25 Aligned_cols=215 Identities=20% Similarity=0.163 Sum_probs=190.5
Q ss_pred CCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEE
Q 006145 129 RLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVL 208 (659)
Q Consensus 129 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 208 (659)
.+++|+.|+|++|.+++..|..|.++++|++|+|++|.+++..| ++.+++|++|+|++|.+++..+ .++|+.|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 44589999999999999888999999999999999999997766 9999999999999999985432 3899999
Q ss_pred eccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCC---CcccceEecCCCcCCccCchhcc-CCccccEEeccCcccc
Q 006145 209 ALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKV---GKKLVTMILSKNKFRSAIPAEVS-SYYQLQRLDLSSNRFV 284 (659)
Q Consensus 209 ~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~ 284 (659)
++++|.+++.++. .+++|+.|+|++|.+++..|.. +++|+.|+|++|.+++.+|..+. .+++|+.|+|++|.|+
T Consensus 105 ~L~~N~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~ 182 (487)
T 3oja_A 105 HAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (487)
T ss_dssp ECCSSCCCCEEEC--CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred ECcCCcCCCCCcc--ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence 9999999987664 4688999999999999887754 57899999999999998888886 7999999999999999
Q ss_pred cCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCcccc
Q 006145 285 GPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 285 ~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
+. |. +..+++|+.|+|++|++++..| .+..+++|+.|++++|.+++ +|..+..++++..+++++|.+.
T Consensus 183 ~~-~~-~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 183 DV-KG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp EE-EC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred cc-cc-cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence 76 33 4469999999999999997655 48889999999999999995 8888888999999999999886
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=236.93 Aligned_cols=169 Identities=19% Similarity=0.303 Sum_probs=146.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC--CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK--CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.. .
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------~ 93 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-------S 93 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-------S
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-------C
Confidence 456888999999999999999976 69999999996543 2345679999999999999999999999975 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC---cceEEcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN---LVAKISS 629 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~---~~~kl~D 629 (659)
+..++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.+ +.+||+|
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~D 167 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIID 167 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred CeEEEEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEec
Confidence 6789999999999999988752 3689999999999999999999998 99999999999999754 4799999
Q ss_pred CccccccccccccceecccccccCCCCC
Q 006145 630 YNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
||+++............||+.|+|||+.
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~ 195 (287)
T 2wei_A 168 FGLSTCFQQNTKMKDRIGTAYYIAPEVL 195 (287)
T ss_dssp TTGGGTBCCCSSCSCHHHHHTTCCHHHH
T ss_pred cCcceeecCCCccccccCcccccChHHh
Confidence 9999877655555566799999999964
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-27 Score=245.89 Aligned_cols=172 Identities=10% Similarity=0.106 Sum_probs=136.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec----CCcEEEEEEecccCCC-----------chHHHHHHHHHHhCCCCCCccceee
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK----NGTFVAIRCLKMKKCH-----------STRNFMHHIELISKLRHRHLVSALG 540 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~l~g 540 (659)
.++|...+.||+|+||.||+|+.. ++..||||++...... ..+.+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 356888899999999999999975 5788999998754321 1234778899999999999999999
Q ss_pred eeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec
Q 006145 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD 620 (659)
Q Consensus 541 ~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld 620 (659)
++.... ......++||||+ +|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 116 ~~~~~~---~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 116 SGLTEF---KGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG 185 (345)
T ss_dssp EEEEES---SSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccccc---CCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc
Confidence 997622 1245789999999 99999999853 3699999999999999999999998 999999999999999
Q ss_pred CCc--ceEEccCcccccccccc--------ccceecccccccCCCCC
Q 006145 621 QNL--VAKISSYNLPLLAENAE--------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 621 ~~~--~~kl~DFGla~~~~~~~--------~~~~~~gt~~y~aPE~~ 657 (659)
.++ .+||+|||+++...... ......||+.|+|||+.
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 232 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH 232 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHh
Confidence 887 99999999997663321 11456899999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=238.12 Aligned_cols=172 Identities=13% Similarity=0.211 Sum_probs=129.8
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc-h-HHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS-T-RNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~-~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||||+++...... . +.+.++...++.++||||+++++++.+ .
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-------~ 78 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-------E 78 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-------S
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-------c
Confidence 466888899999999999999964 69999999997543221 2 234555556888999999999999986 4
Q ss_pred ceeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
+..++||||++ |+|.+++... .....+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||
T Consensus 79 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 79 GDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp SSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred CCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecC
Confidence 56899999997 5888877531 1235799999999999999999999984 289999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+++............||+.|+|||+.
T Consensus 156 ~~~~~~~~~~~~~~~~t~~y~aPE~~ 181 (290)
T 3fme_A 156 ISGYLVDDVAKDIDAGCKPYMAPERI 181 (290)
T ss_dssp --------------CCCCCCSCHHHH
T ss_pred CcccccccccccccCCCccccChhhc
Confidence 99877665555566899999999984
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=228.49 Aligned_cols=206 Identities=24% Similarity=0.246 Sum_probs=125.1
Q ss_pred CCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEE
Q 006145 105 KLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVL 184 (659)
Q Consensus 105 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (659)
.+++|+.|++++|.+... ..+..+++|++|+|++|.+++ + ..+.++++|++|+|++|.+++..|..|..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 114 (272)
T 3rfs_A 39 ELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKEL 114 (272)
T ss_dssp HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred cccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEE
Confidence 445555555555554321 124455555555555555543 1 244555555555555555554444445555555555
Q ss_pred EccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccC
Q 006145 185 SLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAI 263 (659)
Q Consensus 185 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~ 263 (659)
+|++|++++..|..|+++++|++|++++|++++.++. +..+++|+ .|++++|++++..
T Consensus 115 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~---------------------~L~l~~n~l~~~~ 173 (272)
T 3rfs_A 115 VLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLT---------------------ELDLSYNQLQSLP 173 (272)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC---------------------EEECCSSCCCCCC
T ss_pred ECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCC---------------------EEECCCCCcCccC
Confidence 5555555544444455555555555555555544433 34444444 4444555555555
Q ss_pred chhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCC
Q 006145 264 PAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAG 342 (659)
Q Consensus 264 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~ 342 (659)
+..+..+++|+.|+|++|++++..|..+..+++|+.|++++|.+.+. ++.|+.++++.|+++|.+|..++.+
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred HHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence 66677888888888888888887777788888888888888887754 4567888888888888888877653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=7e-27 Score=247.11 Aligned_cols=166 Identities=13% Similarity=0.179 Sum_probs=138.5
Q ss_pred hcCCCCCceeccCcCceEEEEEecC---------CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccc---------
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN---------GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVS--------- 537 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~--------- 537 (659)
.++|...+.||+|+||.||+|+... ++.||||.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3578888999999999999999763 789999998743 46889999999999999998
Q ss_pred ------eeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccC
Q 006145 538 ------ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNN 611 (659)
Q Consensus 538 ------l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrD 611 (659)
+++++.. .....++||||+ +|+|.+++... ....+++..+..++.|+++||+|||+. +|+|||
T Consensus 116 ~~~i~~~~~~~~~------~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~D 184 (352)
T 2jii_A 116 LLAIPTCMGFGVH------QDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGN 184 (352)
T ss_dssp TCSCCCCCEEEEE------TTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSC
T ss_pred ccCccchhhcccc------CCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCC
Confidence 5566653 145789999999 99999999853 125699999999999999999999998 999999
Q ss_pred CCCCceeecCCc--ceEEccCccccccccccc--------cceecccccccCCCCC
Q 006145 612 LKITDILLDQNL--VAKISSYNLPLLAENAEK--------VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 612 lk~~NILld~~~--~~kl~DFGla~~~~~~~~--------~~~~~gt~~y~aPE~~ 657 (659)
|||+||+++.++ .+||+|||+++....... .....||+.|+|||+.
T Consensus 185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 240 (352)
T 2jii_A 185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH 240 (352)
T ss_dssp CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH
T ss_pred CCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH
Confidence 999999999998 999999999976643221 1345899999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=244.29 Aligned_cols=170 Identities=15% Similarity=0.254 Sum_probs=138.0
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++....... .+++.+|++++++++||||+++++++...... ...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL-RNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS-TTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc-ccc
Confidence 457888899999999999999965 59999999997543322 35789999999999999999999999752210 011
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||+. |+|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 23499999997 699888753 489999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++.... .....+||+.|+|||+.
T Consensus 191 a~~~~~--~~~~~~~t~~y~aPE~~ 213 (371)
T 4exu_A 191 ARHADA--EMTGYVVTRWYRAPEVI 213 (371)
T ss_dssp C----------CTTCCCTTSCHHHH
T ss_pred cccccc--CcCCcccCccccCHHHh
Confidence 986643 23456889999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=235.23 Aligned_cols=168 Identities=14% Similarity=0.191 Sum_probs=142.8
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ..+++.+|+++++.++|++++..++++... .+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~------~~~ 79 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAE------GDY 79 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEE------TTE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCC------CCc
Confidence 46788899999999999999996 569999999987544 235689999999999999988888777541 456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceee---cCCcceEEccCc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL---DQNLVAKISSYN 631 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl---d~~~~~kl~DFG 631 (659)
.++||||+ +|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++ ++++.+||+|||
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 153 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred eEEEEEec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence 89999999 99999999742 24699999999999999999999998 99999999999999 578999999999
Q ss_pred cccccccccc--------cceecccccccCCCCC
Q 006145 632 LPLLAENAEK--------VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~--------~~~~~gt~~y~aPE~~ 657 (659)
+++....... .....||+.|+|||+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 187 (296)
T 3uzp_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTH 187 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHH
T ss_pred CcccccccccccccccccccccccccccCChhhh
Confidence 9976644322 2456899999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=248.38 Aligned_cols=167 Identities=19% Similarity=0.234 Sum_probs=140.5
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCC------CCCCccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKL------RHRHLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~~ 548 (659)
..+|...+.||+|+||+||+|+.. +++.||||+++... ...+++.+|+++++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~---- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF---- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc----
Confidence 456888899999999999999865 58999999997532 2235678888888776 57799999999986
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc--eE
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV--AK 626 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~--~k 626 (659)
....++||||+. |+|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++. +|
T Consensus 171 ---~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vk 242 (429)
T 3kvw_A 171 ---RNHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIK 242 (429)
T ss_dssp ---TTEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEE
T ss_pred ---CCeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceE
Confidence 567899999996 69999987532 24599999999999999999999998 9999999999999999887 99
Q ss_pred EccCccccccccccccceecccccccCCCCC
Q 006145 627 ISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 627 l~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+|||+++.... .....+||+.|||||++
T Consensus 243 L~DFG~a~~~~~--~~~~~~gt~~y~aPE~~ 271 (429)
T 3kvw_A 243 VIDFGSSCYEHQ--RVYTYIQSRFYRAPEVI 271 (429)
T ss_dssp ECCCTTCEETTC--CCCSSCSCGGGCCHHHH
T ss_pred EeecccceecCC--cccccCCCCCccChHHH
Confidence 999999976543 33456899999999974
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=234.57 Aligned_cols=169 Identities=14% Similarity=0.185 Sum_probs=139.8
Q ss_pred hhcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
..++|...+.||+|+||.||+|+. .+++.||||++..... .+++.+|+++++.++|++++..+++|... .+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~------~~ 78 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE------GD 78 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEE------TT
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCC------CC
Confidence 457799999999999999999996 4699999998765432 34688999999999999988888887642 45
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceee---cCCcceEEccC
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL---DQNLVAKISSY 630 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl---d~~~~~kl~DF 630 (659)
..++||||+ +|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+||
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Df 152 (296)
T 4hgt_A 79 YNVMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred ceEEEEEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecC
Confidence 689999999 99999999742 24699999999999999999999998 99999999999999 78899999999
Q ss_pred ccccccccccc--------cceecccccccCCCCC
Q 006145 631 NLPLLAENAEK--------VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~--------~~~~~gt~~y~aPE~~ 657 (659)
|+++....... .....||+.|+|||+.
T Consensus 153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 187 (296)
T 4hgt_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 187 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHH
T ss_pred ccceeccCcccCccCCCCcccccCCCccccchHHh
Confidence 99976644322 2356899999999975
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.2e-25 Score=222.63 Aligned_cols=207 Identities=20% Similarity=0.148 Sum_probs=177.1
Q ss_pred CCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEec
Q 006145 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLAL 210 (659)
Q Consensus 131 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 210 (659)
++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 47999999999999877778999999999999999998877778999999999999999999888888999999999999
Q ss_pred cccccccCCC-CCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCch
Q 006145 211 SNNHFYGEVP-DFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQ 289 (659)
Q Consensus 211 s~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 289 (659)
++|++++..+ .+..+++|++|++++|.+++ ..+|..+..+++|+.|+|++|++++..+.
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--------------------~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~ 167 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQS--------------------FKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCC--------------------CCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccce--------------------ecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence 9999888766 47788888888777776532 12578899999999999999999988888
Q ss_pred hhcCCCccc----EEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccCC
Q 006145 290 ALLSLPSIT----YLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAAG 358 (659)
Q Consensus 290 ~l~~l~~L~----~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~~ 358 (659)
.+..+++|+ .|++++|++++..+..+. ..+|+.|++++|++++..+..+..+++++.+++++|.+++.
T Consensus 168 ~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp GGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred HhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence 887777777 899999999977666554 45899999999999977666778899999999999999853
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-26 Score=260.11 Aligned_cols=171 Identities=19% Similarity=0.299 Sum_probs=140.8
Q ss_pred HhhcCCCCCceeccCcCceEEEEEecC----CcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLKN----GTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
...++|...+.||+|+||.||+|++.. +..||||+++..... ..++|.+|+.++++++|||||+++|++.+
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---- 462 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---- 462 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 345678888999999999999998642 568999998754322 23679999999999999999999999853
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
+..++||||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+
T Consensus 463 ----~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 463 ----NPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred ----CceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEE
Confidence 4579999999999999999853 24689999999999999999999998 99999999999999999999999
Q ss_pred cCccccccccccc--cceecccccccCCCCC
Q 006145 629 SYNLPLLAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
|||+++....... .....+|+.|||||+.
T Consensus 534 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~ 564 (656)
T 2j0j_A 534 DFGLSRYMEDSTYYKASKGKLPIKWMAPESI 564 (656)
T ss_dssp CCCCCCSCCC----------CCGGGCCHHHH
T ss_pred ecCCCeecCCCcceeccCCCCCcceeCHHHh
Confidence 9999987644332 2345677899999964
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=240.66 Aligned_cols=170 Identities=15% Similarity=0.253 Sum_probs=137.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++....... .+++.+|++++++++||||+++++++...... ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL-RNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG-GGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc-ccc
Confidence 356778899999999999999965 59999999997543222 35789999999999999999999998752110 001
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||++ |+|.+++.. .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 23599999997 699988753 489999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++.... ......||+.|+|||+.
T Consensus 173 ~~~~~~--~~~~~~~t~~y~aPE~~ 195 (353)
T 3coi_A 173 ARHADA--EMTGYVVTRWYRAPEVI 195 (353)
T ss_dssp TTC----------CCSBCCSCHHHH
T ss_pred ccCCCC--CccccccCcCcCCHHHH
Confidence 986543 23456889999999964
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=236.00 Aligned_cols=169 Identities=21% Similarity=0.349 Sum_probs=131.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec--CCc--EEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK--NGT--FVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~--~g~--~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
.++|...+.||+|+||.||+|++. +++ .||||+++.... ...+++.+|++++++++||||+++++++.+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 92 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 92 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence 356788899999999999999854 233 699999875432 234679999999999999999999999875
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
...++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 93 ----~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~ 163 (291)
T 1u46_A 93 ----PPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG 163 (291)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred ----CCceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEc
Confidence 2379999999999999999752 23589999999999999999999998 99999999999999999999999
Q ss_pred cCccccccccccc----cceecccccccCCCCC
Q 006145 629 SYNLPLLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 629 DFGla~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
|||+++....... .....+|..|+|||+.
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (291)
T 1u46_A 164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196 (291)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHH
T ss_pred cccccccccccccchhhhccCCCCceeeCchhh
Confidence 9999976643321 2345678899999964
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-24 Score=218.09 Aligned_cols=203 Identities=23% Similarity=0.240 Sum_probs=130.7
Q ss_pred CCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEcc
Q 006145 108 DLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLR 187 (659)
Q Consensus 108 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 187 (659)
+++.+++++++++. +|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|.++...+..|..+++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 35667777776654 444333 466677777777665555566666777777777766665444455666666666666
Q ss_pred CCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchh
Q 006145 188 NNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAE 266 (659)
Q Consensus 188 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~ 266 (659)
+|.+++..+..|.++++|++|+|++|++++..+. |..+++|++|+|++|.+ ++..+..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l---------------------~~~~~~~ 152 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL---------------------QSLPKGV 152 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC---------------------CCCCTTT
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcC---------------------CccCHhH
Confidence 6666655555566666666666666666655544 55555555555555544 3434444
Q ss_pred ccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCccc
Q 006145 267 VSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQ 334 (659)
Q Consensus 267 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ 334 (659)
|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|.+...
T Consensus 153 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 153 FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred ccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 66677777777777777766666677777777777777777766666677777777777777776543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=246.92 Aligned_cols=173 Identities=6% Similarity=-0.049 Sum_probs=124.8
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHH---HHHhCCCCCCcccee-------ee
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHI---ELISKLRHRHLVSAL-------GH 541 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei---~~l~~l~H~niv~l~-------g~ 541 (659)
..+|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+ ++|+. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 345778899999999999999965 6999999999875432 234577784 55666 799988855 33
Q ss_pred eeecccc----------CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHH------HHHHHHHHHHhhhhcCCCCC
Q 006145 542 CFECYFD----------DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQR------ISAAIGVAKGIQFLHTGIVP 605 (659)
Q Consensus 542 ~~~~~~~----------~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~ 605 (659)
+...... .......|+|||||+ |+|.+++.... ..+.+..+ ..++.|+++||+|||+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 3321100 000144799999999 89999998521 23455556 78889999999999998
Q ss_pred CccccCCCCCceeecCCcceEEccCccccccccccccceecccccccCCCCC
Q 006145 606 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 606 ~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||+.
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~ 263 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFL 263 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhc
Confidence 9999999999999999999999999999866432 2245677999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-26 Score=256.74 Aligned_cols=179 Identities=18% Similarity=0.218 Sum_probs=147.8
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|...+.||+|+||.||+|+.. +|+.||||+++.... ...++|.+|++++++++||||+++++++..... ....+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~-~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK-LAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC-CCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc-ccCCC
Confidence 367999999999999999999964 599999999875432 234579999999999999999999998754111 11245
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcc---eEEccC
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLV---AKISSY 630 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~---~kl~DF 630 (659)
..++||||+++|+|.+++........+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 6799999999999999998644444689999999999999999999998 9999999999999997654 999999
Q ss_pred ccccccccccccceecccccccCCCCCC
Q 006145 631 NLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 631 Gla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|+++............||+.|+|||+..
T Consensus 169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~ 196 (676)
T 3qa8_A 169 GYAKELDQGELCTEFVGTLQYLAPELLE 196 (676)
T ss_dssp CCCCBTTSCCCCCCCCSCCTTCSSCSSC
T ss_pred ccccccccccccccccCCcccCChHHhc
Confidence 9998876666566778999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=235.09 Aligned_cols=172 Identities=11% Similarity=0.205 Sum_probs=125.1
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHH-HHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIE-LISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||||+++..... ...++.+|+. +++.++||||+++++++.. .
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-------~ 93 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-------E 93 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-------S
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-------C
Confidence 467788899999999999999975 6999999999765322 2345666666 7888899999999999986 4
Q ss_pred ceeEEEEeccCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 553 SRIFLIFEYVPNGTLRSWISE--GHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
+..++||||+++ +|.+++.. ......+++..+..++.|+++||+|||+. ++|+||||||+||+++.++.+||+||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccC
Confidence 678999999985 88877752 11135689999999999999999999984 38999999999999999999999999
Q ss_pred ccccccccccccceecccccccCCCCC
Q 006145 631 NLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+++............||+.|+|||+.
T Consensus 171 g~~~~~~~~~~~~~~~gt~~y~aPE~~ 197 (327)
T 3aln_A 171 GISGQLVDSIAKTRDAGCRPYMAPERI 197 (327)
T ss_dssp SSSCC----------------------
T ss_pred CCceecccccccccCCCCccccCceee
Confidence 999877555445556899999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-26 Score=239.37 Aligned_cols=171 Identities=19% Similarity=0.239 Sum_probs=138.6
Q ss_pred HHhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC------chHHHHHHHHHHhCC----CCCCccceeee
Q 006145 473 EEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH------STRNFMHHIELISKL----RHRHLVSALGH 541 (659)
Q Consensus 473 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l----~H~niv~l~g~ 541 (659)
....++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344678999999999999999999864 5899999999754321 223467899999888 89999999999
Q ss_pred eeeccccCCCCceeEEEEec-cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec
Q 006145 542 CFECYFDDSSVSRIFLIFEY-VPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD 620 (659)
Q Consensus 542 ~~~~~~~~~~~~~~~lV~Ey-~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld 620 (659)
+.. .+..++|||| +++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++
T Consensus 107 ~~~-------~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 107 FET-------QEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILID 173 (312)
T ss_dssp C------------CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEE
T ss_pred Eec-------CCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEe
Confidence 875 4568999999 7899999999852 4689999999999999999999998 999999999999999
Q ss_pred -CCcceEEccCccccccccccccceecccccccCCCCC
Q 006145 621 -QNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 621 -~~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+++.+||+|||+++..... ......||..|+|||+.
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~ 210 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWI 210 (312)
T ss_dssp TTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHH
T ss_pred CCCCeEEEEEcchhhhcccC-cccccCCcccccCceee
Confidence 8899999999999876543 34556799999999964
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-26 Score=237.64 Aligned_cols=170 Identities=21% Similarity=0.378 Sum_probs=139.8
Q ss_pred HHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 473 EEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 473 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
....++|...+.||+|+||.||+|+... .||+|.++.... ...+.|.+|++++++++||||+++++++.+
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 100 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS------ 100 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC------
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec------
Confidence 3446778889999999999999998753 499999975432 233568899999999999999999999986
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++ ++.+||+||
T Consensus 101 -~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Df 173 (319)
T 2y4i_B 101 -PPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDF 173 (319)
T ss_dssp -SSCEEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCC
T ss_pred -CCceEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeec
Confidence 45689999999999999999853 24689999999999999999999998 999999999999998 679999999
Q ss_pred cccccccc------ccccceecccccccCCCCC
Q 006145 631 NLPLLAEN------AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~------~~~~~~~~gt~~y~aPE~~ 657 (659)
|+++.... ........||+.|+|||+.
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 206 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHH
T ss_pred CCccccccccccccccccccCCCcccccChHHh
Confidence 99865421 1222445699999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-26 Score=246.67 Aligned_cols=167 Identities=16% Similarity=0.212 Sum_probs=131.8
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..+|...+.||+|+||+||.....+|+.||||++.... ...+.+|+++++++ +|||||++++++.+ ...
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-------~~~ 92 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKD-------RQF 92 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEE-------TTE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEec-------CCE
Confidence 34577789999999999665555679999999996533 23467899999999 79999999999876 467
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC-----CcceEEcc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ-----NLVAKISS 629 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~-----~~~~kl~D 629 (659)
.|+||||++ |+|.+++.... ....+..+..++.|+++||+|||+. +|+||||||+|||++. ...+||+|
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~D 166 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISD 166 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred EEEEEECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence 899999996 59999998532 2345556778999999999999998 9999999999999953 34688999
Q ss_pred Cccccccccc----cccceecccccccCCCCCC
Q 006145 630 YNLPLLAENA----EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 630 FGla~~~~~~----~~~~~~~gt~~y~aPE~~~ 658 (659)
||+++..... ......+||+.|||||++.
T Consensus 167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~ 199 (432)
T 3p23_A 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199 (432)
T ss_dssp TTEEECC------------CCSCTTSCCGGGTS
T ss_pred ccceeeccCCCcceeeccccCCCcCccChhhhh
Confidence 9999776433 2234578999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-26 Score=236.98 Aligned_cols=170 Identities=18% Similarity=0.213 Sum_probs=145.0
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC------chHHHHHHHHHHhCCC--CCCccceeeeeee
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH------STRNFMHHIELISKLR--HRHLVSALGHCFE 544 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~ 544 (659)
...++|...+.||+|+||.||+|+.. +++.||||+++..... ..+.+.+|++++++++ |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34567888999999999999999854 6899999999765422 2245788999999996 5999999999976
Q ss_pred ccccCCCCceeEEEEeccCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec-CC
Q 006145 545 CYFDDSSVSRIFLIFEYVPN-GTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD-QN 622 (659)
Q Consensus 545 ~~~~~~~~~~~~lV~Ey~~~-GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld-~~ 622 (659)
.+..++||||+.+ ++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++ ++
T Consensus 120 -------~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 120 -------PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR 186 (320)
T ss_dssp -------SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTT
T ss_pred -------CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCC
Confidence 5678999999986 899999975 24689999999999999999999998 999999999999999 78
Q ss_pred cceEEccCccccccccccccceecccccccCCCCC
Q 006145 623 LVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 623 ~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+.+||+|||+++..... ......||+.|+|||+.
T Consensus 187 ~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~ 220 (320)
T 3a99_A 187 GELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWI 220 (320)
T ss_dssp TEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHH
T ss_pred CCEEEeeCccccccccc-cccCCCCCccCCChHHh
Confidence 99999999999876543 33456799999999964
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=245.25 Aligned_cols=168 Identities=14% Similarity=0.173 Sum_probs=138.4
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|...+.||+|+||.||+|+. .+++.||||++..... ..++.+|+++++.++|++.+..+.++... .+.
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~------~~~ 77 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVE------GDY 77 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEE------TTE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEee------CCE
Confidence 36788899999999999999996 4699999998865442 34688999999999875555444444321 457
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceee---cCCcceEEccCc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL---DQNLVAKISSYN 631 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl---d~~~~~kl~DFG 631 (659)
.++||||+ +|+|.+++... ...+++..+..|+.||+.||+|||+. +||||||||+|||+ ++++.+||+|||
T Consensus 78 ~~lvme~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFG 151 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEEECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCC
Confidence 89999999 99999999742 24699999999999999999999998 99999999999999 688999999999
Q ss_pred cccccccccc--------cceecccccccCCCCC
Q 006145 632 LPLLAENAEK--------VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~--------~~~~~gt~~y~aPE~~ 657 (659)
+++....... .....||+.|+|||+.
T Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~ 185 (483)
T 3sv0_A 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTH 185 (483)
T ss_dssp TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred cceeccCCccccccccccccccCCCccccCHHHh
Confidence 9987644322 2367899999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=233.85 Aligned_cols=169 Identities=14% Similarity=0.258 Sum_probs=139.0
Q ss_pred HhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCC--chHHHHHHHHHHhCCC--CCCccceeeeeeeccccC
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH--STRNFMHHIELISKLR--HRHLVSALGHCFECYFDD 549 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~ 549 (659)
...++|...+.||+|+||.||+|+..+++.||||++...... ..+++.+|++++.+++ |+||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----- 99 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----- 99 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-----
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-----
Confidence 345678888999999999999999888999999999754432 2367999999999997 5999999999976
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEcc
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISS 629 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 629 (659)
.+..++||| +.+|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++ +.+||+|
T Consensus 100 --~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 100 --DQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp --SSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECC
T ss_pred --CCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEee
Confidence 457899999 5688999999863 4689999999999999999999998 9999999999999974 8999999
Q ss_pred Cccccccccccc---cceecccccccCCCCC
Q 006145 630 YNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
||+++....... .....||+.|+|||+.
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 200 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHH
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHH
Confidence 999976643322 2456799999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=233.40 Aligned_cols=170 Identities=18% Similarity=0.224 Sum_probs=121.4
Q ss_pred hcCCCCC-ceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTS-AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~-~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|... +.||+|+||.||+|+.. +|+.||||++... .+...+....++.++||||+++++++..... ...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~---~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHH---GKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET---TEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccC---CCc
Confidence 4667774 56999999999999976 5999999998642 1222223334667799999999999875221 134
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC---CcceEEccC
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ---NLVAKISSY 630 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl~DF 630 (659)
..++||||+++|+|.+++... ....+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 579999999999999999863 234699999999999999999999998 9999999999999986 456999999
Q ss_pred ccccccccccccceecccccccCCCCC
Q 006145 631 NLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+++..... ......||+.|+|||+.
T Consensus 176 g~~~~~~~~-~~~~~~~t~~y~aPE~~ 201 (336)
T 3fhr_A 176 GFAKETTQN-ALQTPCYTPYYVAPEVL 201 (336)
T ss_dssp TTCEEC---------------------
T ss_pred ccceecccc-ccccCCCCcCccChhhh
Confidence 999766432 33456889999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=235.71 Aligned_cols=167 Identities=19% Similarity=0.271 Sum_probs=140.6
Q ss_pred hcCCCCCceeccCcCceEEEEEe-c-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCC------ccceeeeeeeccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-K-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRH------LVSALGHCFECYF 547 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~ 547 (659)
.++|...+.||+|+||.||+|+. . +|+.||||+++... ...+.+.+|+++++.++|++ |+++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~--- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH--- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE---
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc---
Confidence 35788889999999999999986 3 58999999996432 23467889999999887654 9999999876
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC------
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ------ 621 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~------ 621 (659)
.+..++||||+ +|+|.+++... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 89 ----~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 89 ----HGHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp ----TTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEE
T ss_pred ----CCcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccc
Confidence 46789999999 88999999753 234689999999999999999999998 9999999999999987
Q ss_pred -------------CcceEEccCccccccccccccceecccccccCCCCC
Q 006145 622 -------------NLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 622 -------------~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++.+||+|||+++.... ......||+.|+|||+.
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~ 206 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVI 206 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHH
T ss_pred cCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHh
Confidence 66899999999976543 23456899999999975
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-24 Score=219.26 Aligned_cols=202 Identities=26% Similarity=0.254 Sum_probs=104.7
Q ss_pred ccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCC
Q 006145 103 LVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILA 182 (659)
Q Consensus 103 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (659)
+.++++|+.+++++++++. +|..+. ++|+.|+|++|.+++..|..|.++++|++|+|++|.+++. |.. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCC
T ss_pred ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCC
Confidence 4556666666666666653 333332 4566666666666655555566666666666666665532 221 4555555
Q ss_pred EEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCc
Q 006145 183 VLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRS 261 (659)
Q Consensus 183 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~ 261 (659)
+|+|++|+++ .+|..+..+++|++|+|++|++++.++. |.++++|++|+|++|++ ++
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l---------------------~~ 138 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL---------------------KT 138 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCC---------------------CC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCC---------------------Cc
Confidence 5555555555 4455555555555555555555544433 44444444444444333 22
Q ss_pred cCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCc
Q 006145 262 AIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT 332 (659)
Q Consensus 262 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~ 332 (659)
..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++ .+|..+...+.|+.+++++|.+.
T Consensus 139 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 23333445555555555555555444444455555555555555555 33444444444555555554443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-26 Score=245.78 Aligned_cols=165 Identities=18% Similarity=0.202 Sum_probs=126.7
Q ss_pred CCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCCceeEE
Q 006145 479 FDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +|||||++++++.+ .+..++
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-------~~~~~l 86 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETT-------DRFLYI 86 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-------SSEEEE
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEec-------CCeEEE
Confidence 3445789999999998776667999999998653 245688999999876 89999999998875 567899
Q ss_pred EEeccCCCChhhhhcCCCCCC----CCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC-----------
Q 006145 558 IFEYVPNGTLRSWISEGHAHQ----SLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN----------- 622 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~----------- 622 (659)
||||+. |+|.+++....... ..++..+..++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCC
Confidence 999995 69999998532111 113345678999999999999998 99999999999999754
Q ss_pred --cceEEccCccccccccccc-----cceecccccccCCCCC
Q 006145 623 --LVAKISSYNLPLLAENAEK-----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 623 --~~~kl~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~~ 657 (659)
+.+||+|||+++....... ....+||+.|||||++
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 204 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL 204 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHH
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHh
Confidence 4899999999987654321 2356899999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=241.75 Aligned_cols=172 Identities=20% Similarity=0.248 Sum_probs=140.2
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCC--------CCCccceeeeeeecc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLR--------HRHLVSALGHCFECY 546 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~g~~~~~~ 546 (659)
.++|...+.||+|+||+||+|+.. +++.||||+++... ...+.+.+|++++++++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 367888999999999999999864 58999999997432 23467899999999985 788999999987421
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc---
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL--- 623 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~--- 623 (659)
. .....++||||+ +|++.+++... ....+++..+..++.|+++||+|||+.+ +|+||||||+|||++.++
T Consensus 115 ~---~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 115 V---NGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp T---TEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred C---CCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence 1 145789999999 56777766542 2246999999999999999999999853 899999999999999775
Q ss_pred ----------------------------------------------ceEEccCccccccccccccceecccccccCCCCC
Q 006145 624 ----------------------------------------------VAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 624 ----------------------------------------------~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.+||+|||+++..... ....+||+.|||||+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhh
Confidence 7999999999876432 3456899999999964
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-24 Score=218.29 Aligned_cols=205 Identities=24% Similarity=0.189 Sum_probs=170.9
Q ss_pred ccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCC
Q 006145 126 KISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL 205 (659)
Q Consensus 126 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 205 (659)
.+.++++|+.+++++|.++ .+|..+. ++|+.|+|++|.+++..|..|..+++|++|+|++|.+++..+ .+.+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcC
Confidence 3677889999999999998 5666554 688999999999988888889999999999999999986543 2788999
Q ss_pred cEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCccccc
Q 006145 206 RVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVG 285 (659)
Q Consensus 206 ~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 285 (659)
+.|+|++|+++..+..+..+++|++|+|++|+++ +..|..|..+++|+.|+|++|+|++
T Consensus 80 ~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~---------------------~l~~~~~~~l~~L~~L~L~~N~l~~ 138 (290)
T 1p9a_G 80 GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT---------------------SLPLGALRGLGELQELYLKGNELKT 138 (290)
T ss_dssp CEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCC---------------------CCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred CEEECCCCcCCcCchhhccCCCCCEEECCCCcCc---------------------ccCHHHHcCCCCCCEEECCCCCCCc
Confidence 9999999999866555788888888877776654 4445668888899999999999998
Q ss_pred CCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 286 PFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 286 ~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+++ .+|..+....+++.+++.+|.+.+
T Consensus 139 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 77778888999999999999999777777788999999999999998 788888888889999999998764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=226.29 Aligned_cols=222 Identities=20% Similarity=0.188 Sum_probs=144.5
Q ss_pred CCCCCEEEecCCCCcCCCCc---ccCCCCCCcEEEcccCcCcccCChhc--cCCCCCcEEEeecCCCCCCCc----cccC
Q 006145 106 LPDLKVLRLVSLGLWGPLSG---KISRLSSLEILNMSSNFLNGAIPQEL--SILTSLQTLILDENMLAGRVP----DWLG 176 (659)
Q Consensus 106 l~~L~~L~L~~n~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~l~ 176 (659)
-..++.|.+..+.++...-. .+..+++|++|+|++|.+++..|..+ .++++|++|+|++|.+++..| ..+.
T Consensus 63 ~~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~ 142 (310)
T 4glp_A 63 ALRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW 142 (310)
T ss_dssp SCCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred hcceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence 34578888888776532111 12345679999999999998888887 889999999999999987665 3456
Q ss_pred CCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccC---CCC--CCCCCcCCEEEcccCCCCCCCC------CC
Q 006145 177 SLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGE---VPD--FSGLTYLQVLDLENNALGPQFP------KV 245 (659)
Q Consensus 177 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~--~~~l~~L~~L~L~~N~l~~~~~------~~ 245 (659)
.+++|++|+|++|.+++..|..|+.+++|++|+|++|++.+. .+. +..+++|++|+|++|.++...+ ..
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~ 222 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAA 222 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHH
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhc
Confidence 788999999999999888888888999999999999987652 222 4677888888888887753211 01
Q ss_pred CcccceEecCCCcCCccCchhccCC---ccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCC
Q 006145 246 GKKLVTMILSKNKFRSAIPAEVSSY---YQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELG 322 (659)
Q Consensus 246 ~~~L~~L~l~~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~ 322 (659)
+++|++|+|++|++++.+|..+..+ ++|++|+|++|+|+ .+|..+. ++|+.|+|++|++++. |. +..+++|+
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~ 297 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD 297 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence 2455555555555555545444444 35555555555555 3444432 4555555555555542 11 33445555
Q ss_pred EEECcCCCCc
Q 006145 323 FVDLSSNLLT 332 (659)
Q Consensus 323 ~L~ls~N~l~ 332 (659)
.|++++|+++
T Consensus 298 ~L~L~~N~l~ 307 (310)
T 4glp_A 298 NLTLDGNPFL 307 (310)
T ss_dssp CEECSSTTTS
T ss_pred EEECcCCCCC
Confidence 5555555544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=217.60 Aligned_cols=205 Identities=26% Similarity=0.266 Sum_probs=172.3
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.+++.|++.++.+... +.+..+++|++|+|++|.+++. ..+..+++|++|+|++|.+++..|..|.+
T Consensus 41 ~~L~~L~l~~~~i~~~-----------~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~ 107 (272)
T 3rfs_A 41 NSIDQIIANNSDIKSV-----------QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDK 107 (272)
T ss_dssp TTCCEEECTTSCCCCC-----------TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTT
T ss_pred cceeeeeeCCCCcccc-----------cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcC
Confidence 4688999998875521 2477899999999999999874 47999999999999999999888888999
Q ss_pred CCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEE
Q 006145 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLD 232 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~ 232 (659)
+++|++|+|++|++++..|..|+.+++|++|+|++|.+++..|..|+.+++|+.|++++|++++.++. +..+++|++|+
T Consensus 108 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 187 (272)
T 3rfs_A 108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLR 187 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEE
Confidence 99999999999999988888899999999999999999988888889999999999999999987776 68888888888
Q ss_pred cccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCC
Q 006145 233 LENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLF 312 (659)
Q Consensus 233 L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p 312 (659)
|++|.++ +..|..+..+++|+.|+|++|.+.+. +++|+.|+++.|+++|.+|
T Consensus 188 L~~N~l~---------------------~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip 239 (272)
T 3rfs_A 188 LYQNQLK---------------------SVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVR 239 (272)
T ss_dssp CCSSCCS---------------------CCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBB
T ss_pred CCCCcCC---------------------ccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCccc
Confidence 8877765 44445566777788888888877643 4567778888888888888
Q ss_pred cCCCCCC
Q 006145 313 DDLSCNP 319 (659)
Q Consensus 313 ~~~~~~~ 319 (659)
..++.++
T Consensus 240 ~~~~~~~ 246 (272)
T 3rfs_A 240 NSAGSVA 246 (272)
T ss_dssp CTTSCBC
T ss_pred CcccccC
Confidence 7776544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-25 Score=230.77 Aligned_cols=169 Identities=15% Similarity=0.280 Sum_probs=123.7
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc-h-HHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS-T-RNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~-~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||.||+|+.. +|+.||||++....... . +.+.++..+++.++||||+++++++.+ .
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-------~ 96 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-------N 96 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-------S
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-------C
Confidence 456778899999999999999975 69999999997654322 2 234455567888999999999999976 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcC-CCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT-GIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
+..++||||+ ++.+..+.... ...+++..+..++.|+++||+|||+ . +|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 170 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFG 170 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred CcEEEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECC
Confidence 6789999999 44555554421 2468999999999999999999998 5 89999999999999999999999999
Q ss_pred cccccccccccceecccccccCCCCC
Q 006145 632 LPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+++............||+.|+|||+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (318)
T 2dyl_A 171 ISGRLVDDKAKDRSAGCAAYMAPERI 196 (318)
T ss_dssp TC--------------CCTTCCHHHH
T ss_pred CchhccCCccccccCCCccccChhhc
Confidence 99776555555567899999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-25 Score=236.51 Aligned_cols=169 Identities=19% Similarity=0.258 Sum_probs=139.5
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCC-CC-----Cccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HR-----HLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~~~~~~~~ 548 (659)
.++|...+.||+|+||+||+|+.. +++.||||+++... ...+++.+|+++++.++ |+ +|+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~---- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF---- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE----
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc----
Confidence 567888999999999999999965 58899999997432 22456788998888885 55 49999999876
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec--CCcceE
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD--QNLVAK 626 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld--~~~~~k 626 (659)
.+..++||||++ |+|.+++.... ...+++..+..++.|++.||+|||++ ..+|+||||||+|||++ .++.+|
T Consensus 128 ---~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 128 ---RNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp ---TTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEE
T ss_pred ---CCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEE
Confidence 467899999996 59999998532 24589999999999999999999952 23899999999999995 578899
Q ss_pred EccCccccccccccccceecccccccCCCCC
Q 006145 627 ISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 627 l~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+|||+++.... .....+||+.|+|||+.
T Consensus 202 L~DFG~a~~~~~--~~~~~~~t~~y~aPE~~ 230 (382)
T 2vx3_A 202 IVDFGSSCQLGQ--RIYQYIQSRFYRSPEVL 230 (382)
T ss_dssp ECCCTTCEETTC--CCCSSCSCGGGCCHHHH
T ss_pred EEeccCceeccc--ccccccCCccccChHHH
Confidence 999999987643 23457899999999975
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-23 Score=235.94 Aligned_cols=208 Identities=27% Similarity=0.263 Sum_probs=148.7
Q ss_pred CCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEE
Q 006145 106 LPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLS 185 (659)
Q Consensus 106 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 185 (659)
+++|++|+|++|.+++. |. .+++|+.|++++|++++ +|.. +++|++|+|++|++++ +|. .+++|+.|+
T Consensus 100 l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~ 167 (622)
T 3g06_A 100 PPGLLELSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLW 167 (622)
T ss_dssp CTTCCEEEECSCCCCCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred CCCCCEEECcCCcCCCC-CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEE
Confidence 34444555555444432 21 34445555555555542 3322 2555555555555553 332 234555555
Q ss_pred ccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCch
Q 006145 186 LRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPA 265 (659)
Q Consensus 186 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~ 265 (659)
+++|.+++ +| ..+++|+.|++++|++++.++ .+++|+.|++++|.++. +|...++|+.|++++|+|++ +|
T Consensus 168 L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~---~~~~L~~L~L~~N~l~~-l~~~~~~L~~L~Ls~N~L~~-lp- 237 (622)
T 3g06_A 168 AYNNQLTS-LP---MLPSGLQELSVSDNQLASLPT---LPSELYKLWAYNNRLTS-LPALPSGLKELIVSGNRLTS-LP- 237 (622)
T ss_dssp CCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSS-CCCCCTTCCEEECCSSCCSC-CC-
T ss_pred CCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCC---ccchhhEEECcCCcccc-cCCCCCCCCEEEccCCccCc-CC-
Confidence 55555553 34 345889999999999987443 24789999999999985 55567899999999999987 56
Q ss_pred hccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCC
Q 006145 266 EVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAG 342 (659)
Q Consensus 266 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~ 342 (659)
..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+
T Consensus 238 --~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 238 --VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307 (622)
T ss_dssp --CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred --CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence 56789999999999999 4665 6789999999999999 778889999999999999999999999877654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-25 Score=231.77 Aligned_cols=167 Identities=14% Similarity=0.237 Sum_probs=138.8
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CC-cEEEEEEecccCCCchHHHHHHHHHHhCCCCCC------ccceeeeeeeccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NG-TFVAIRCLKMKKCHSTRNFMHHIELISKLRHRH------LVSALGHCFECYF 547 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~ 547 (659)
.++|...+.||+|+||+||+|+.. ++ +.||||+++... ...+.+.+|++++++++|++ ++.+.+++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~--- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE---
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee---
Confidence 467888999999999999999965 34 789999997432 23457889999999997766 8999888876
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceee--------
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL-------- 619 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl-------- 619 (659)
.+..++||||+ +|++.+++... ....+++..+..++.|+++||+|||+. +|+||||||+|||+
T Consensus 94 ----~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 94 ----HGHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp ----TTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEE
T ss_pred ----CCeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccc
Confidence 46789999999 66787777642 224699999999999999999999998 99999999999999
Q ss_pred -----------cCCcceEEccCccccccccccccceecccccccCCCCC
Q 006145 620 -----------DQNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 620 -----------d~~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+.++.+||+|||+++.... ......||+.|+|||+.
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~ 211 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVI 211 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHH
T ss_pred ccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeee
Confidence 6678999999999976543 23456899999999975
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-25 Score=247.10 Aligned_cols=154 Identities=12% Similarity=0.155 Sum_probs=120.8
Q ss_pred CCCceeccCcCceEEEEEecCCcEEEEEEecccCCCc--------hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 480 DTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHS--------TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 480 ~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
...+.||+|+||+||+|+. .++.+|+|+........ .++|.+|++++++++||||+++..++..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~------- 410 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD------- 410 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-------
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-------
Confidence 3467899999999999954 47889999875432211 2458999999999999999977666664
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..|+||||+++|+|.++++. +..++.|+++||+|||+. +|+||||||+|||+++ .+||+|||
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFG 474 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFG 474 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCT
T ss_pred CCccEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECc
Confidence 3456999999999999999874 468999999999999998 9999999999999998 99999999
Q ss_pred cccccccccc--------cceecccccccCCCCC
Q 006145 632 LPLLAENAEK--------VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~--------~~~~~gt~~y~aPE~~ 657 (659)
+++....... ....+||+.|||||+.
T Consensus 475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~ 508 (540)
T 3en9_A 475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIW 508 (540)
T ss_dssp TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred cCEECCCccccccchhhhhhhhcCCCCcCCHHHH
Confidence 9987755332 2367899999999974
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-23 Score=209.06 Aligned_cols=195 Identities=18% Similarity=0.209 Sum_probs=137.7
Q ss_pred CCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCc-CcccCChhccCCCCCcEEEeec-CCCCCCCccccCCCCCCCEEE
Q 006145 108 DLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNF-LNGAIPQELSILTSLQTLILDE-NMLAGRVPDWLGSLPILAVLS 185 (659)
Q Consensus 108 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~ 185 (659)
+|++|+|++|++++..+..|.++++|++|++++|. +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 78889999998888888788888899999999886 7766666788888888888888 888876667888888888888
Q ss_pred ccCCcCCccCCcccCCCCCCc---EEecccc-ccccCCCC-CCCCCcCC-EEEcccCCCCCCCCCCCcccceEecCCCcC
Q 006145 186 LRNNMFNGTLPDSFSYLENLR---VLALSNN-HFYGEVPD-FSGLTYLQ-VLDLENNALGPQFPKVGKKLVTMILSKNKF 259 (659)
Q Consensus 186 L~~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~-~~~l~~L~-~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l 259 (659)
+++|.+++ +|. |..+++|+ +|++++| ++++.++. |.++++|+ +|++++|.++.
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~------------------- 170 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS------------------- 170 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCE-------------------
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcc-------------------
Confidence 88888885 665 77777777 8888888 77766654 77777777 77777666542
Q ss_pred CccCchhccCCccccEEeccCcc-cccCCchhhcCC-CcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCC
Q 006145 260 RSAIPAEVSSYYQLQRLDLSSNR-FVGPFPQALLSL-PSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSN 329 (659)
Q Consensus 260 ~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l-~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N 329 (659)
+|......++|+.|+|++|+ +++..+..|..+ ++|+.|++++|++++. |.. .+++|+.|+++++
T Consensus 171 ---i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 171 ---VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp ---ECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred ---cCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 22222122556666666663 654445555666 6666666666666533 222 3455666666554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.9e-25 Score=232.91 Aligned_cols=172 Identities=16% Similarity=0.234 Sum_probs=140.9
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCC-----------CCCccceeeeee
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-----------HRHLVSALGHCF 543 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~ 543 (659)
.++|...+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|++++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 356888899999999999999964 69999999997432 23456889999999886 899999999997
Q ss_pred eccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec---
Q 006145 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD--- 620 (659)
Q Consensus 544 ~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld--- 620 (659)
.... .....++||||+ +|+|.+++.... ...+++..+..++.|++.||+|||+.+ +|+||||||+|||++
T Consensus 97 ~~~~---~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 97 HKGP---NGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEET---TEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred ccCC---CCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence 5321 123689999999 889999997532 245899999999999999999999842 899999999999994
Q ss_pred ---CCcceEEccCccccccccccccceecccccccCCCCC
Q 006145 621 ---QNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 621 ---~~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
..+.+||+|||+++..... .....||+.|+|||+.
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~ 207 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVL 207 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHH
T ss_pred CCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHH
Confidence 4458999999999776432 3456899999999974
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=4e-24 Score=221.85 Aligned_cols=200 Identities=22% Similarity=0.203 Sum_probs=173.0
Q ss_pred CCCCCCEEEecCCCCcCCCCccc--CCCCCCcEEEcccCcCcccCC----hhccCCCCCcEEEeecCCCCCCCccccCCC
Q 006145 105 KLPDLKVLRLVSLGLWGPLSGKI--SRLSSLEILNMSSNFLNGAIP----QELSILTSLQTLILDENMLAGRVPDWLGSL 178 (659)
Q Consensus 105 ~l~~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 178 (659)
.+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..| ..+..+++|++|+|++|++.+..|..|+.+
T Consensus 89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 168 (310)
T 4glp_A 89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF 168 (310)
T ss_dssp HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence 35679999999999999999998 999999999999999998766 445689999999999999998888999999
Q ss_pred CCCCEEEccCCcCCcc--C--CcccCCCCCCcEEeccccccccCCCC----CCCCCcCCEEEcccCCCCCCCCCC---C-
Q 006145 179 PILAVLSLRNNMFNGT--L--PDSFSYLENLRVLALSNNHFYGEVPD----FSGLTYLQVLDLENNALGPQFPKV---G- 246 (659)
Q Consensus 179 ~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~l~~L~~L~L~~N~l~~~~~~~---~- 246 (659)
++|++|+|++|++.+. + +..++.+++|++|+|++|+++...+. +..+++|++|+|++|.+++..|.. +
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 248 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM 248 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence 9999999999998753 2 23347899999999999999753331 568899999999999999986643 2
Q ss_pred --cccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCC
Q 006145 247 --KKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG 309 (659)
Q Consensus 247 --~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 309 (659)
++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|+|++|+++.
T Consensus 249 ~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 249 WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 69999999999998 5777764 7999999999999974 43 6788999999999999974
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=209.64 Aligned_cols=190 Identities=27% Similarity=0.272 Sum_probs=121.0
Q ss_pred CCCcCCCCCCCceEeCCCCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEE
Q 006145 57 EFCNTEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEIL 136 (659)
Q Consensus 57 ~~C~w~~~~~~gv~C~~~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 136 (659)
+||.|. |+.|.. ..+.++++++.+.. +|. .+. ++|+.|+|++|.+++..+..|.++++|++|
T Consensus 3 ~Cp~~~-----gC~C~~-~~~~l~~~~~~l~~-~p~---------~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L 64 (251)
T 3m19_A 3 TCETVT-----GCTCNE-GKKEVDCQGKSLDS-VPS---------GIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWL 64 (251)
T ss_dssp -CHHHH-----SSEEEG-GGTEEECTTCCCSS-CCS---------CCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCCC-----ceEcCC-CCeEEecCCCCccc-cCC---------CCC--CCCCEEEccCCCcCccCHhHhcCcccCCEE
Confidence 577775 688942 34567887776552 222 222 467777777777777777777777777777
Q ss_pred EcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccc
Q 006145 137 NMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFY 216 (659)
Q Consensus 137 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 216 (659)
+|++|.+++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+++
T Consensus 65 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 144 (251)
T 3m19_A 65 NLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ 144 (251)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCC
Confidence 77777777666666777777777777777777666666677777777777777777555555666667777777666666
Q ss_pred cCCCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCccccc
Q 006145 217 GEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVG 285 (659)
Q Consensus 217 ~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 285 (659)
+.++. |..+++|++|+|++|.++ +..+..+..+++|+.|+|++|.+++
T Consensus 145 ~~~~~~~~~l~~L~~L~L~~N~l~---------------------~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 145 SIPAGAFDKLTNLQTLSLSTNQLQ---------------------SVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCS---------------------CCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred ccCHHHcCcCcCCCEEECCCCcCC---------------------ccCHHHHhCCCCCCEEEeeCCceeC
Confidence 55553 555555555555555443 3333344555555555555555554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.5e-24 Score=217.10 Aligned_cols=143 Identities=11% Similarity=0.069 Sum_probs=125.9
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc---hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS---TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|...+.||+|+||.||+|+.. +|+.||||.+....... .++|.+|++++++++||||+++++++.+ .
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-------~ 103 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-------R 103 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-------T
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-------C
Confidence 56888899999999999999976 49999999997654332 2679999999999999999999999986 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..|+||||+++|+|.++++.. ....+..+|+.|+++||+|||+. +|+||||||+||++++++.+||+++|.
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~ 175 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPAT 175 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCC
T ss_pred CcEEEEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccc
Confidence 6789999999999999999641 35567899999999999999998 999999999999999999999998876
Q ss_pred cc
Q 006145 633 PL 634 (659)
Q Consensus 633 a~ 634 (659)
..
T Consensus 176 ~~ 177 (286)
T 3uqc_A 176 MP 177 (286)
T ss_dssp CT
T ss_pred cC
Confidence 53
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=8.8e-26 Score=241.78 Aligned_cols=236 Identities=22% Similarity=0.248 Sum_probs=148.5
Q ss_pred ccccCCCCCCEEEecCCCCcCCCC----cccCCCCCCcEEEcccC---cCcccCChhc-------cCCCCCcEEEeecCC
Q 006145 101 TTLVKLPDLKVLRLVSLGLWGPLS----GKISRLSSLEILNMSSN---FLNGAIPQEL-------SILTSLQTLILDENM 166 (659)
Q Consensus 101 ~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~Ls~N~ 166 (659)
..+..+++|++|+|++|.+++..+ ..|..+++|++|+|++| ++++.+|..+ ..+++|++|+|++|.
T Consensus 26 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 105 (386)
T 2ca6_A 26 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 105 (386)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCc
Confidence 345556666666666666655422 23556666666666663 3344445443 455666666666666
Q ss_pred CCC----CCccccCCCCCCCEEEccCCcCCccCCcccC----CC---------CCCcEEeccccccc-cCCC----CCCC
Q 006145 167 LAG----RVPDWLGSLPILAVLSLRNNMFNGTLPDSFS----YL---------ENLRVLALSNNHFY-GEVP----DFSG 224 (659)
Q Consensus 167 l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~Ls~N~l~-~~~p----~~~~ 224 (659)
+.+ .+|..+..+++|++|+|++|.+++..+..+. .+ ++|++|+|++|+++ +.++ .+..
T Consensus 106 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~ 185 (386)
T 2ca6_A 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185 (386)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHh
Confidence 654 3455555566666666666665433222222 22 45555555555554 2222 1333
Q ss_pred CCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCC--c---cCchhccCCccccEEeccCcccc----cCCchhhcCCC
Q 006145 225 LTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFR--S---AIPAEVSSYYQLQRLDLSSNRFV----GPFPQALLSLP 295 (659)
Q Consensus 225 l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~l~~l~ 295 (659)
+++ |+.|++++|+++ | .+|..+..+++|+.|+|++|.++ +.+|..+..++
T Consensus 186 ~~~---------------------L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~ 244 (386)
T 2ca6_A 186 HRL---------------------LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 244 (386)
T ss_dssp CTT---------------------CCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred CCC---------------------cCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCC
Confidence 444 455555555554 2 34446778888888888888886 56788888888
Q ss_pred cccEEeccCCcCCCc----CCcCC--CCCCCCCEEECcCCCCcc----cCChhh-hCCCCCCEEEcCCccccC
Q 006145 296 SITYLNIADNKLTGK----LFDDL--SCNPELGFVDLSSNLLTG----QLPNCL-LAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 296 ~L~~L~l~~N~l~~~----~p~~~--~~~~~L~~L~ls~N~l~g----~ip~~~-~~~~~l~~l~~~~N~l~~ 357 (659)
+|+.|+|++|.+++. ++..+ +.+++|+.|+|++|.+++ .+|..+ ..+++++.+++++|.+++
T Consensus 245 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred CcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 888899988888865 45555 347889999999999887 588877 557889999999998874
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.90 E-value=4e-26 Score=250.06 Aligned_cols=277 Identities=21% Similarity=0.185 Sum_probs=179.9
Q ss_pred CEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCccc-----CCCCCCcEEEcccCcCccc---
Q 006145 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKI-----SRLSSLEILNMSSNFLNGA--- 146 (659)
Q Consensus 75 ~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~--- 146 (659)
+++.|+|++|.+... ....++..+.++++|++|+|++|.+++..+..+ ..+++|++|+|++|.+++.
T Consensus 86 ~L~~L~L~~n~i~~~-----~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~ 160 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGA-----GCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE 160 (461)
T ss_dssp CCCEEECTTSCCBGG-----GHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred ceeEEEccCCCCCHH-----HHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH
Confidence 466666666654310 011234556677777777777777765433332 2245677777777777753
Q ss_pred -CChhccCCCCCcEEEeecCCCCCCCccccC-----CCCCCCEEEccCCcCCcc----CCcccCCCCCCcEEeccccccc
Q 006145 147 -IPQELSILTSLQTLILDENMLAGRVPDWLG-----SLPILAVLSLRNNMFNGT----LPDSFSYLENLRVLALSNNHFY 216 (659)
Q Consensus 147 -~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 216 (659)
++..+..+++|++|+|++|.+....+..+. .+++|++|+|++|.+++. ++..+..+++|++|++++|.++
T Consensus 161 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~ 240 (461)
T 1z7x_W 161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240 (461)
T ss_dssp HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCC
Confidence 355566677777777777777654443333 255777777777777753 4666667777888888877776
Q ss_pred cCC-----CC-CCCCCcCCEEEcccCCCCCC----CCCC---CcccceEecCCCcCCccCchhccC-----CccccEEec
Q 006145 217 GEV-----PD-FSGLTYLQVLDLENNALGPQ----FPKV---GKKLVTMILSKNKFRSAIPAEVSS-----YYQLQRLDL 278 (659)
Q Consensus 217 ~~~-----p~-~~~l~~L~~L~L~~N~l~~~----~~~~---~~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~L 278 (659)
... +. +..+++|++|++++|.++.. ++.. .++|++|++++|.+.+..+..+.. .++|+.|+|
T Consensus 241 ~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L 320 (461)
T 1z7x_W 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320 (461)
T ss_dssp HHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred hHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEc
Confidence 531 22 33567788888888877653 2322 467778888888776544433322 257888888
Q ss_pred cCcccccC----CchhhcCCCcccEEeccCCcCCCcCCcCCC-----CCCCCCEEECcCCCCcc----cCChhhhCCCCC
Q 006145 279 SSNRFVGP----FPQALLSLPSITYLNIADNKLTGKLFDDLS-----CNPELGFVDLSSNLLTG----QLPNCLLAGSKN 345 (659)
Q Consensus 279 s~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~L~~L~ls~N~l~g----~ip~~~~~~~~l 345 (659)
++|.+++. +|..+..+++|+.|++++|++++..+..+. ..++|+.|++++|.+++ .+|..+..++++
T Consensus 321 ~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L 400 (461)
T 1z7x_W 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL 400 (461)
T ss_dssp TTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCC
T ss_pred CCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCc
Confidence 88877754 466667778888888888877765443332 15678888888888875 677777777888
Q ss_pred CEEEcCCcccc
Q 006145 346 RVVLYARNCLA 356 (659)
Q Consensus 346 ~~l~~~~N~l~ 356 (659)
+.+++++|.++
T Consensus 401 ~~L~l~~N~i~ 411 (461)
T 1z7x_W 401 RELDLSNNCLG 411 (461)
T ss_dssp CEEECCSSSCC
T ss_pred cEEECCCCCCC
Confidence 88888887765
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.5e-23 Score=204.84 Aligned_cols=197 Identities=17% Similarity=0.201 Sum_probs=166.4
Q ss_pred CCCcEEEcccCcCcccCChhccCCCCCcEEEeecCC-CCCCCccccCCCCCCCEEEccC-CcCCccCCcccCCCCCCcEE
Q 006145 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENM-LAGRVPDWLGSLPILAVLSLRN-NMFNGTLPDSFSYLENLRVL 208 (659)
Q Consensus 131 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L 208 (659)
++|++|+|++|++++..+..|.++++|++|+|++|. +++..+..|.++++|++|++++ |.+++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 389999999999998777789999999999999997 8876677899999999999998 99998777889999999999
Q ss_pred eccccccccCCCCCCCCCcCC---EEEcccC-CCCCCCCCCCcccceEecCCCcCCccCchhccCCcccc-EEeccCccc
Q 006145 209 ALSNNHFYGEVPDFSGLTYLQ---VLDLENN-ALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQ-RLDLSSNRF 283 (659)
Q Consensus 209 ~Ls~N~l~~~~p~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l 283 (659)
++++|++++ +|.|..+++|+ +|++++| .+ ++..+..|..+++|+ .|++++|++
T Consensus 111 ~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N~~l---------------------~~i~~~~~~~l~~L~~~L~l~~n~l 168 (239)
T 2xwt_C 111 GIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYM---------------------TSIPVNAFQGLCNETLTLKLYNNGF 168 (239)
T ss_dssp EEEEECCCS-CCCCTTCCBCCSEEEEEEESCTTC---------------------CEECTTTTTTTBSSEEEEECCSCCC
T ss_pred eCCCCCCcc-ccccccccccccccEEECCCCcch---------------------hhcCcccccchhcceeEEEcCCCCC
Confidence 999999987 55588887777 7666666 44 455556788999999 999999999
Q ss_pred ccCCchhhcCCCcccEEeccCCc-CCCcCCcCCCCC-CCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCc
Q 006145 284 VGPFPQALLSLPSITYLNIADNK-LTGKLFDDLSCN-PELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARN 353 (659)
Q Consensus 284 ~~~~p~~l~~l~~L~~L~l~~N~-l~~~~p~~~~~~-~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N 353 (659)
+ .+|......++|+.|++++|+ +++..+..+..+ ++|+.||+++|+++ .+|.. .+.+++.+.+.++
T Consensus 169 ~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 169 T-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp C-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTTC
T ss_pred c-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccCc
Confidence 9 555544444899999999995 998778889999 99999999999999 45554 5667888887765
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=9.9e-26 Score=236.39 Aligned_cols=230 Identities=19% Similarity=0.152 Sum_probs=162.7
Q ss_pred CCcCCCCCCCceEeCCCCEeEEEeCCCCCCCCCCCCCcCCcccccccCC--CCCCEEEecCCCCcCCCCcccCCCCCCcE
Q 006145 58 FCNTEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKL--PDLKVLRLVSLGLWGPLSGKISRLSSLEI 135 (659)
Q Consensus 58 ~C~w~~~~~~gv~C~~~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 135 (659)
|..|. ++.|+...++.++++++.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++
T Consensus 36 c~~W~-----~~~~~~~~~~~l~l~~~~~~------------~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~ 97 (336)
T 2ast_B 36 CKRWY-----RLASDESLWQTLDLTGKNLH------------PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQH 97 (336)
T ss_dssp CHHHH-----HHHTCSTTSSEEECTTCBCC------------HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCE
T ss_pred HHHHH-----HHhcCchhheeeccccccCC------------HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCE
Confidence 44675 46666556888999887654 2244555 7899999999999888776 567999999
Q ss_pred EEcccCcCccc-CChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCC-cCCcc-CCcccCCCCCCcEEeccc
Q 006145 136 LNMSSNFLNGA-IPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN-MFNGT-LPDSFSYLENLRVLALSN 212 (659)
Q Consensus 136 L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~ 212 (659)
|+|++|.+++. +|..+..+++|++|+|++|.+++..|..++.+++|++|+|++| .+++. +|..+.++++|++|++++
T Consensus 98 L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~ 177 (336)
T 2ast_B 98 MDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSW 177 (336)
T ss_dssp EECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCC
T ss_pred EEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCC
Confidence 99999999876 8888999999999999999998888889999999999999999 67763 677788899999999999
Q ss_pred c-ccccC-CCC-CCCCC-cCCEEEcccCC--CC-CCCCC---CCcccceEecCCCc-CCccCchhccCCccccEEeccCc
Q 006145 213 N-HFYGE-VPD-FSGLT-YLQVLDLENNA--LG-PQFPK---VGKKLVTMILSKNK-FRSAIPAEVSSYYQLQRLDLSSN 281 (659)
Q Consensus 213 N-~l~~~-~p~-~~~l~-~L~~L~L~~N~--l~-~~~~~---~~~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~Ls~N 281 (659)
| .+++. ++. +..++ +|++|++++|. ++ +.++. .+++|+.|++++|. +++..+..+..+++|+.|++++|
T Consensus 178 ~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~ 257 (336)
T 2ast_B 178 CFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 257 (336)
T ss_dssp CTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred CCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCC
Confidence 9 88763 333 67788 88888888883 43 11221 13455555555555 44444445555555555555555
Q ss_pred c-cccCCchhhcCCCcccEEeccCC
Q 006145 282 R-FVGPFPQALLSLPSITYLNIADN 305 (659)
Q Consensus 282 ~-l~~~~p~~l~~l~~L~~L~l~~N 305 (659)
. +.......+.++++|+.|++++|
T Consensus 258 ~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 258 YDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp TTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCHHHHHHHhcCCCCCEEeccCc
Confidence 3 11111113445555555555555
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-22 Score=203.46 Aligned_cols=179 Identities=22% Similarity=0.227 Sum_probs=110.2
Q ss_pred CCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEecc
Q 006145 132 SLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALS 211 (659)
Q Consensus 132 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 211 (659)
..+.+++++|.++ .+|..+. ++|+.|+|++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 3455566666555 4444433 456666666666665555556666666666666666665555556666666666666
Q ss_pred ccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchh
Q 006145 212 NNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQA 290 (659)
Q Consensus 212 ~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 290 (659)
+|++++.++. |..+++|++|+|++|.++ +..+..|..+++|+.|+|++|+|++..+..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~---------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 150 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLK---------------------SLPSGVFDRLTKLKELRLNTNQLQSIPAGA 150 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCC---------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCC---------------------CcChhHhccCCcccEEECcCCcCCccCHHH
Confidence 6666655443 455555555555555443 333334556666777777777776655556
Q ss_pred hcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCccc
Q 006145 291 LLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQ 334 (659)
Q Consensus 291 l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ 334 (659)
|..+++|++|+|++|++++..+..+..+++|+.|++++|++++.
T Consensus 151 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 151 FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 77777777777777777766666677777777777777777665
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.5e-24 Score=236.45 Aligned_cols=209 Identities=24% Similarity=0.339 Sum_probs=158.6
Q ss_pred CCCCCCCCCCC-----cCCCCCCCce-EeCCCCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCC
Q 006145 49 LSSWNITTEFC-----NTEPTSSLTV-VCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGP 122 (659)
Q Consensus 49 l~~W~~~~~~C-----~w~~~~~~gv-~C~~~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~ 122 (659)
+.+|..+.++| .|. ++ .|...+++.|+|++|++.+ +|.. + +++|++|+|++|.++ .
T Consensus 33 l~~W~~~~~~~~~~~~~~~-----~l~~C~~~~L~~L~Ls~n~L~~-lp~~---------l--~~~L~~L~Ls~N~l~-~ 94 (571)
T 3cvr_A 33 WDKWEKQALPGENRNEAVS-----LLKECLINQFSELQLNRLNLSS-LPDN---------L--PPQITVLEITQNALI-S 94 (571)
T ss_dssp HHHHHTTCCTTCCHHHHHH-----HHHHHHHTTCSEEECCSSCCSC-CCSC---------C--CTTCSEEECCSSCCS-C
T ss_pred HHHHhccCCccccccchhh-----hccccccCCccEEEeCCCCCCc-cCHh---------H--cCCCCEEECcCCCCc-c
Confidence 45676667788 564 67 7876789999999998775 5542 2 267999999999998 5
Q ss_pred CCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCC
Q 006145 123 LSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYL 202 (659)
Q Consensus 123 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 202 (659)
+| ..+++|++|+|++|.|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|.|++ +|. .+
T Consensus 95 ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l 159 (571)
T 3cvr_A 95 LP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LP 159 (571)
T ss_dssp CC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CC
T ss_pred cc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cC
Confidence 66 457899999999999987 777 665 89999999999987 666 68899999999999986 665 57
Q ss_pred CCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCccc-------ceEecCCCcCCccCchhccCCccccE
Q 006145 203 ENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKL-------VTMILSKNKFRSAIPAEVSSYYQLQR 275 (659)
Q Consensus 203 ~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L-------~~L~l~~N~l~~~~p~~~~~l~~L~~ 275 (659)
++|+.|+|++|+|++. |.|. ++|+.|+|++|.|+..++ ...+| +.|+|++|+|+. +|..+..+++|+.
T Consensus 160 ~~L~~L~Ls~N~L~~l-p~l~--~~L~~L~Ls~N~L~~lp~-~~~~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~ 234 (571)
T 3cvr_A 160 TSLEVLSVRNNQLTFL-PELP--ESLEALDVSTNLLESLPA-VPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCT 234 (571)
T ss_dssp TTCCEEECCSSCCSCC-CCCC--TTCCEEECCSSCCSSCCC-CC--------CCEEEECCSSCCCC-CCGGGGGSCTTEE
T ss_pred CCcCEEECCCCCCCCc-chhh--CCCCEEECcCCCCCchhh-HHHhhhcccccceEEecCCCccee-cCHHHhcCCCCCE
Confidence 8899999999999884 4455 889999999988874433 44466 777777777764 6666666777777
Q ss_pred EeccCcccccCCchhhcCCC
Q 006145 276 LDLSSNRFVGPFPQALLSLP 295 (659)
Q Consensus 276 L~Ls~N~l~~~~p~~l~~l~ 295 (659)
|+|++|.|++.+|..+..+.
T Consensus 235 L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 235 IILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp EECCSSSCCHHHHHHHHHHH
T ss_pred EEeeCCcCCCcCHHHHHHhh
Confidence 77777777777777766554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.5e-25 Score=232.92 Aligned_cols=246 Identities=22% Similarity=0.160 Sum_probs=154.7
Q ss_pred EEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCC----hhccCCC-CCcEEEeecCCCCCCCccccCCC-----CC
Q 006145 111 VLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIP----QELSILT-SLQTLILDENMLAGRVPDWLGSL-----PI 180 (659)
Q Consensus 111 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l-----~~ 180 (659)
+++|+.|+++|.+|..+...++|++|||++|.+++..+ ..+.+++ +|++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35666677777666666666667777777777765555 5566666 67777777777766666555553 67
Q ss_pred CCEEEccCCcCCccCCcccC----CC-CCCcEEeccccccccCCCC-----CCC-CCcCCEEEcccCCCCCCCCCC----
Q 006145 181 LAVLSLRNNMFNGTLPDSFS----YL-ENLRVLALSNNHFYGEVPD-----FSG-LTYLQVLDLENNALGPQFPKV---- 245 (659)
Q Consensus 181 L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~~p~-----~~~-l~~L~~L~L~~N~l~~~~~~~---- 245 (659)
|++|+|++|.+++..+..+. .+ ++|++|+|++|++++..+. +.. .++|++|+|++|.++...+..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 77777777777665555333 33 6777777777777655442 333 256777777777766432221
Q ss_pred ---C-cccceEecCCCcCCccCchhcc----CC-ccccEEeccCcccccC----CchhhcCC-CcccEEeccCCcCCCcC
Q 006145 246 ---G-KKLVTMILSKNKFRSAIPAEVS----SY-YQLQRLDLSSNRFVGP----FPQALLSL-PSITYLNIADNKLTGKL 311 (659)
Q Consensus 246 ---~-~~L~~L~l~~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~----~p~~l~~l-~~L~~L~l~~N~l~~~~ 311 (659)
. .+|++|+|++|++++..+..+. .+ ++|+.|||++|.|++. ++..+..+ ++|+.|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 1 3677777777777766654433 33 4777777777777652 44455553 47777777777777644
Q ss_pred C----cCCCCCCCCCEEECcCCCCcccC-------ChhhhCCCCCCEEEcCCcccc
Q 006145 312 F----DDLSCNPELGFVDLSSNLLTGQL-------PNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 312 p----~~~~~~~~L~~L~ls~N~l~g~i-------p~~~~~~~~l~~l~~~~N~l~ 356 (659)
+ ..+..+++|+.|++++|.+++.. +..+..+++++.+++++|.+.
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~ 297 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCC
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCC
Confidence 3 33456677777777777744322 223445566777777777765
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=6.3e-25 Score=235.11 Aligned_cols=224 Identities=18% Similarity=0.220 Sum_probs=164.5
Q ss_pred CCCcccCCCCCCcEEEcccCcCcccCC----hhccCCCCCcEEEeecC---CCCCCCcccc-------CCCCCCCEEEcc
Q 006145 122 PLSGKISRLSSLEILNMSSNFLNGAIP----QELSILTSLQTLILDEN---MLAGRVPDWL-------GSLPILAVLSLR 187 (659)
Q Consensus 122 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N---~l~~~~p~~l-------~~l~~L~~L~L~ 187 (659)
.++..+..+++|+.|+|++|.+++..+ ..+..+++|++|+|++| ++.+.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 456677788889999999998886543 34668888888988885 4555666555 677888888888
Q ss_pred CCcCCc----cCCcccCCCCCCcEEeccccccccCCCC-----CCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCc
Q 006145 188 NNMFNG----TLPDSFSYLENLRVLALSNNHFYGEVPD-----FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNK 258 (659)
Q Consensus 188 ~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-----~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~ 258 (659)
+|.+++ .+|..+..+++|++|+|++|.++...+. +..+ ..|.+.+. .++|++|++++|+
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l--------~~~~~~~~----~~~L~~L~L~~n~ 170 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL--------AVNKKAKN----APPLRSIICGRNR 170 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHH--------HHHHHHHT----CCCCCEEECCSSC
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHH--------hhhhhccc----CCCCcEEECCCCC
Confidence 888876 4667777788888888888877543221 2222 00000000 0344444555555
Q ss_pred CC-ccCc---hhccCCccccEEeccCcccc--c---CCchhhcCCCcccEEeccCCcCC----CcCCcCCCCCCCCCEEE
Q 006145 259 FR-SAIP---AEVSSYYQLQRLDLSSNRFV--G---PFPQALLSLPSITYLNIADNKLT----GKLFDDLSCNPELGFVD 325 (659)
Q Consensus 259 l~-~~~p---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~l~~l~~L~~L~l~~N~l~----~~~p~~~~~~~~L~~L~ 325 (659)
++ +.+| ..+..+++|+.|+|++|+++ | ..|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+
T Consensus 171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~ 250 (386)
T 2ca6_A 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 250 (386)
T ss_dssp CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence 54 3344 46778899999999999998 3 45558899999999999999997 67788889999999999
Q ss_pred CcCCCCccc----CChhhhC--CCCCCEEEcCCccccC
Q 006145 326 LSSNLLTGQ----LPNCLLA--GSKNRVVLYARNCLAA 357 (659)
Q Consensus 326 ls~N~l~g~----ip~~~~~--~~~l~~l~~~~N~l~~ 357 (659)
|++|.+++. +|..+.. +++++.+++++|.++.
T Consensus 251 L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred CCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence 999999976 6777744 8999999999999875
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=7.8e-23 Score=211.85 Aligned_cols=193 Identities=25% Similarity=0.354 Sum_probs=109.2
Q ss_pred cCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCE
Q 006145 104 VKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAV 183 (659)
Q Consensus 104 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 183 (659)
.++++|+.|++++|.+.. +| .+..+++|++|+|++|.+++..+ +.++++|++|+|++|.+++ +| .+..+++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~ 111 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKT 111 (308)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCE
T ss_pred HHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCE
Confidence 345566666666666544 23 35566666666666666654322 5666666666666666653 22 4556666666
Q ss_pred EEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccC
Q 006145 184 LSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAI 263 (659)
Q Consensus 184 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~ 263 (659)
|+|++|.+++ +|. +..+++|+.|++++|++++..+ +..+++|++|+|++|.++ +.
T Consensus 112 L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~---------------------~~- 166 (308)
T 1h6u_A 112 LDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVS---------------------DL- 166 (308)
T ss_dssp EECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCC---------------------CC-
T ss_pred EECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCC---------------------CC-
Confidence 6666666654 222 5556666666666666554333 555555555555555443 32
Q ss_pred chhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCc
Q 006145 264 PAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT 332 (659)
Q Consensus 264 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~ 332 (659)
+. +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|+++
T Consensus 167 ~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 167 TP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred hh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence 22 5556666666666666654332 5566666666666666665442 556666666666666665
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-24 Score=229.23 Aligned_cols=252 Identities=18% Similarity=0.143 Sum_probs=198.9
Q ss_pred EEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCC----cccCCCC-CCcEEEcccCcCcccCChhccC
Q 006145 79 LHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLS----GKISRLS-SLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 79 L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
++++.+++++.+| ..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|.+++..+..+..
T Consensus 3 ~~ls~n~~~~~~~---------~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 73 (362)
T 3goz_A 3 YKLTLHPGSNPVE---------EFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73 (362)
T ss_dssp EECCCCTTCCHHH---------HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred cccccccchHHHH---------HHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHH
Confidence 4566666554433 344455669999999999988877 7788898 9999999999999888877777
Q ss_pred C-----CCCcEEEeecCCCCCCCccccC----CC-CCCCEEEccCCcCCccCCccc----CC-CCCCcEEeccccccccC
Q 006145 154 L-----TSLQTLILDENMLAGRVPDWLG----SL-PILAVLSLRNNMFNGTLPDSF----SY-LENLRVLALSNNHFYGE 218 (659)
Q Consensus 154 l-----~~L~~L~Ls~N~l~~~~p~~l~----~l-~~L~~L~L~~N~l~~~~p~~~----~~-l~~L~~L~Ls~N~l~~~ 218 (659)
+ ++|++|+|++|.+++..+..+. .+ ++|++|+|++|.+++..+..+ .. .++|++|+|++|.++..
T Consensus 74 ~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 153 (362)
T 3goz_A 74 ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK 153 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGS
T ss_pred HHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHH
Confidence 5 9999999999999987776544 44 899999999999987766554 34 36999999999999864
Q ss_pred CCC-----CCCCC-cCCEEEcccCCCCCCCCCC-------C-cccceEecCCCcCCcc----CchhccC-CccccEEecc
Q 006145 219 VPD-----FSGLT-YLQVLDLENNALGPQFPKV-------G-KKLVTMILSKNKFRSA----IPAEVSS-YYQLQRLDLS 279 (659)
Q Consensus 219 ~p~-----~~~l~-~L~~L~L~~N~l~~~~~~~-------~-~~L~~L~l~~N~l~~~----~p~~~~~-l~~L~~L~Ls 279 (659)
... +..++ +|++|+|++|.+++..+.. . ++|+.|+|++|.+++. ++..+.. .++|+.|+|+
T Consensus 154 ~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls 233 (362)
T 3goz_A 154 SSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLC 233 (362)
T ss_dssp CHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECC
T ss_pred HHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECc
Confidence 332 44554 9999999999998766531 2 5899999999999874 4555555 4599999999
Q ss_pred CcccccCCc----hhhcCCCcccEEeccCCcCCCcC-------CcCCCCCCCCCEEECcCCCCcccCChhh
Q 006145 280 SNRFVGPFP----QALLSLPSITYLNIADNKLTGKL-------FDDLSCNPELGFVDLSSNLLTGQLPNCL 339 (659)
Q Consensus 280 ~N~l~~~~p----~~l~~l~~L~~L~l~~N~l~~~~-------p~~~~~~~~L~~L~ls~N~l~g~ip~~~ 339 (659)
+|.+++..+ ..+..+++|+.|+|++|.+.+.. +..+..+++|+.||+++|++.+..|..+
T Consensus 234 ~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~ 304 (362)
T 3goz_A 234 LNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPI 304 (362)
T ss_dssp SSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHH
Confidence 999987655 34577899999999999965443 3467788999999999999987755544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=197.50 Aligned_cols=162 Identities=25% Similarity=0.215 Sum_probs=121.1
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence 47888888888888777777888888888888888888666666788888888888888888666666788888888888
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCch
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPA 265 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~ 265 (659)
++|++++..+..|.++++|+.|+|++|++++.++. +..+++|++|++++|.+.+
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~------------------------- 162 (208)
T 2o6s_A 108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC------------------------- 162 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------------------------
T ss_pred CCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------------------------
Confidence 88888876666678888888888888888776665 6677777777777665432
Q ss_pred hccCCccccEEeccCcccccCCchhhcCCCc
Q 006145 266 EVSSYYQLQRLDLSSNRFVGPFPQALLSLPS 296 (659)
Q Consensus 266 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 296 (659)
.+++|+.|+++.|+++|.+|.+++.++.
T Consensus 163 ---~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 163 ---TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ---CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ---CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 2335566666666666666666555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.8e-23 Score=211.81 Aligned_cols=149 Identities=17% Similarity=0.290 Sum_probs=126.0
Q ss_pred cCCCCC-ceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHH-hCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTS-AFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELI-SKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~-~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|... +.||+|+||.||+|+.. +++.||||+++. ...+.+|++++ +..+||||+++++++..... ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~---~~~ 88 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA---GRK 88 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET---TEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC---CCc
Confidence 445555 77999999999999964 699999999863 35678899888 66689999999999864211 135
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC---CcceEEccC
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ---NLVAKISSY 630 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl~DF 630 (659)
..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 689999999999999999863 234699999999999999999999998 9999999999999998 789999999
Q ss_pred ccccccc
Q 006145 631 NLPLLAE 637 (659)
Q Consensus 631 Gla~~~~ 637 (659)
|+++...
T Consensus 165 g~a~~~~ 171 (299)
T 3m2w_A 165 GFAKETT 171 (299)
T ss_dssp TTCEECT
T ss_pred ccccccc
Confidence 9997654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.2e-24 Score=230.02 Aligned_cols=175 Identities=15% Similarity=0.187 Sum_probs=129.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC---chHHHHHHHHHHhCCCC-CCccceeee---------
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH---STRNFMHHIELISKLRH-RHLVSALGH--------- 541 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H-~niv~l~g~--------- 541 (659)
...|...+.||+|+||+||+|+.. +|+.||||++...... ..+.|.+|+.+++.++| +|......+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 445667789999999999999954 6999999998743322 24679999999999987 332222111
Q ss_pred eeeccc-------cC---CCCceeEEEEeccCCCChhhhhcC----CCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCc
Q 006145 542 CFECYF-------DD---SSVSRIFLIFEYVPNGTLRSWISE----GHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGV 607 (659)
Q Consensus 542 ~~~~~~-------~~---~~~~~~~lV~Ey~~~GsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 607 (659)
+..... .. ......+++|+++ +|+|.++++. ......++|..+..++.|+++||+|||+. +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 110000 00 0012356777766 6799998841 11234588999999999999999999998 99
Q ss_pred cccCCCCCceeecCCcceEEccCccccccccccccceecccccccCCCCC
Q 006145 608 FSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 608 iHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|||||||+|||++.++.+||+|||+++..... ....+| +.|||||+.
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~ 279 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETT 279 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhh
Confidence 99999999999999999999999999766443 455678 999999975
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=210.07 Aligned_cols=191 Identities=24% Similarity=0.334 Sum_probs=153.4
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.+++.|+++++.+.. ++ .+..+++|++|+|++|.+++..+ +..+++|++|+|++|.+++ +| .+..
T Consensus 41 ~~L~~L~l~~~~i~~-l~----------~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~ 105 (308)
T 1h6u_A 41 DGITTLSAFGTGVTT-IE----------GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAG 105 (308)
T ss_dssp HTCCEEECTTSCCCC-CT----------TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTT
T ss_pred CCcCEEEeeCCCccC-ch----------hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcC
Confidence 579999999987653 12 46789999999999999987655 9999999999999999986 34 6999
Q ss_pred CCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEc
Q 006145 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDL 233 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L 233 (659)
+++|++|+|++|++++ +|. +..+++|++|++++|.+++..+ +..+++|+.|+|++|++++..+ +..+++|+.|++
T Consensus 106 l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l 180 (308)
T 1h6u_A 106 LQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKA 180 (308)
T ss_dssp CTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEEC
Confidence 9999999999999986 443 9999999999999999996544 8999999999999999997655 889999999999
Q ss_pred ccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCC
Q 006145 234 ENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG 309 (659)
Q Consensus 234 ~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 309 (659)
++|.+++..+ +..+++|+.|+|++|++++..| +..+++|+.|++++|++++
T Consensus 181 ~~n~l~~~~~-----------------------l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 181 DDNKISDISP-----------------------LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CSSCCCCCGG-----------------------GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred CCCccCcChh-----------------------hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 8888754322 4555666666666666664332 5666666666666666654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-25 Score=244.60 Aligned_cols=229 Identities=24% Similarity=0.212 Sum_probs=96.9
Q ss_pred cCCCCCCEEEecCCCCcC----CCCcccCCCCCCcEEEcccCcCcccCChhc-cCCC----CCcEEEeecCCCCC----C
Q 006145 104 VKLPDLKVLRLVSLGLWG----PLSGKISRLSSLEILNMSSNFLNGAIPQEL-SILT----SLQTLILDENMLAG----R 170 (659)
Q Consensus 104 ~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~----~L~~L~Ls~N~l~~----~ 170 (659)
..+++|++|+|++|.+++ .++..+..+++|++|+|++|.++...+..+ ..++ +|++|+|++|.++. .
T Consensus 25 ~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~ 104 (461)
T 1z7x_W 25 PLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV 104 (461)
T ss_dssp HHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHH
T ss_pred hhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHH
Confidence 344455555555555442 233444444555555555555543322222 1233 35555555555442 3
Q ss_pred CccccCCCCCCCEEEccCCcCCccCCccc-----CCCCCCcEEeccccccccCC----C-CCCCCCcCCEEEcccCCCCC
Q 006145 171 VPDWLGSLPILAVLSLRNNMFNGTLPDSF-----SYLENLRVLALSNNHFYGEV----P-DFSGLTYLQVLDLENNALGP 240 (659)
Q Consensus 171 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~----p-~~~~l~~L~~L~L~~N~l~~ 240 (659)
+|..+..+++|++|+|++|.+++..+..+ ...++|++|+|++|++++.. + .+..+++|++|++++|.++.
T Consensus 105 l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 184 (461)
T 1z7x_W 105 LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184 (461)
T ss_dssp HHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcch
Confidence 34445555555555555555443222211 12334555555555444321 1 13334445555555544432
Q ss_pred CCCCC--------CcccceEecCCCcCCcc----CchhccCCccccEEeccCcccccCC-----chhhcCCCcccEEecc
Q 006145 241 QFPKV--------GKKLVTMILSKNKFRSA----IPAEVSSYYQLQRLDLSSNRFVGPF-----PQALLSLPSITYLNIA 303 (659)
Q Consensus 241 ~~~~~--------~~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~-----p~~l~~l~~L~~L~l~ 303 (659)
..+.. .++|+.|++++|.+++. ++..+..+++|+.|++++|.+++.. +..+..+++|+.|+++
T Consensus 185 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~ 264 (461)
T 1z7x_W 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIW 264 (461)
T ss_dssp HHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECc
Confidence 21110 12444444444444432 2333444444444444444443221 1112234444444444
Q ss_pred CCcCCCc----CCcCCCCCCCCCEEECcCCCCc
Q 006145 304 DNKLTGK----LFDDLSCNPELGFVDLSSNLLT 332 (659)
Q Consensus 304 ~N~l~~~----~p~~~~~~~~L~~L~ls~N~l~ 332 (659)
+|++++. ++..+..+++|+.|++++|.++
T Consensus 265 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~ 297 (461)
T 1z7x_W 265 ECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297 (461)
T ss_dssp TSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred CCCCCHHHHHHHHHHHhhCCCcceEECCCCCCc
Confidence 4444432 2333333444444444444444
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-23 Score=214.25 Aligned_cols=143 Identities=11% Similarity=0.108 Sum_probs=115.8
Q ss_pred HHHHHHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCC------------------chHHHHHHHHHHhCC
Q 006145 469 LEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH------------------STRNFMHHIELISKL 530 (659)
Q Consensus 469 ~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~------------------~~~~~~~Ei~~l~~l 530 (659)
+..+......|...+.||+|+||.||+|+..+|+.||||.++..... ...++.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 44555566667777999999999999999977999999999643211 234689999999999
Q ss_pred CCCCccceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCcccc
Q 006145 531 RHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSN 610 (659)
Q Consensus 531 ~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHr 610 (659)
+ | +++.+++.. +..++||||+++|+|.+ +.. .....++.|+++||+|||+. +|+||
T Consensus 162 ~--~-~~v~~~~~~--------~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHr 217 (282)
T 1zar_A 162 Q--G-LAVPKVYAW--------EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHG 217 (282)
T ss_dssp T--T-SSSCCEEEE--------ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred c--C-CCcCeEEec--------cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeC
Confidence 9 5 667665532 34699999999999999 532 12346999999999999998 99999
Q ss_pred CCCCCceeecCCcceEEccCcccccc
Q 006145 611 NLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 611 Dlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
||||+|||++ ++.+||+|||+|+..
T Consensus 218 Dlkp~NILl~-~~~vkl~DFG~a~~~ 242 (282)
T 1zar_A 218 DLSQYNVLVS-EEGIWIIDFPQSVEV 242 (282)
T ss_dssp CCSTTSEEEE-TTEEEECCCTTCEET
T ss_pred CCCHHHEEEE-CCcEEEEECCCCeEC
Confidence 9999999999 999999999999744
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=3e-22 Score=223.08 Aligned_cols=187 Identities=22% Similarity=0.357 Sum_probs=101.4
Q ss_pred CCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEcc
Q 006145 108 DLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLR 187 (659)
Q Consensus 108 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 187 (659)
+|+.|+|++|++++ +|..+. ++|++|+|++|.|+ .+| ..+++|++|+|++|+|++ +|. +.. +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 55555555555554 443332 45555555555555 344 234555555555555554 444 333 45555555
Q ss_pred CCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhc
Q 006145 188 NNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEV 267 (659)
Q Consensus 188 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~ 267 (659)
+|.|++ +|. .+++|+.|+|++|+|++ +|..+++|+.|+|++|+|++ +|. |
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~------------------------lp~~l~~L~~L~Ls~N~L~~-lp~-l 178 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM------------------------LPELPTSLEVLSVRNNQLTF-LPE-L 178 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC------------------------CCCCCTTCCEEECCSSCCSC-CCC-C
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc------------------------CCCcCCCcCEEECCCCCCCC-cch-h
Confidence 555554 333 34455555555555544 22233445555555555554 444 4
Q ss_pred cCCccccEEeccCcccccCCchhhcCCCcc-------cEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhh
Q 006145 268 SSYYQLQRLDLSSNRFVGPFPQALLSLPSI-------TYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLL 340 (659)
Q Consensus 268 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L-------~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~ 340 (659)
. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+.
T Consensus 179 ~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 251 (571)
T 3cvr_A 179 P--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLS 251 (571)
T ss_dssp C--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHH
T ss_pred h--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHH
Confidence 3 56666666666666 4554 433 55 77777777777 4566666677777777777777777777665
Q ss_pred CC
Q 006145 341 AG 342 (659)
Q Consensus 341 ~~ 342 (659)
.+
T Consensus 252 ~l 253 (571)
T 3cvr_A 252 QQ 253 (571)
T ss_dssp HH
T ss_pred Hh
Confidence 43
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=8.2e-22 Score=208.01 Aligned_cols=218 Identities=21% Similarity=0.118 Sum_probs=141.1
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCCh-hccCCCCCcE-EEeecCCCCCCCccccCCCCCCCEE
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQ-ELSILTSLQT-LILDENMLAGRVPDWLGSLPILAVL 184 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~-L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (659)
+++++|+|++|+|+...+++|.++++|++|+|++|++.+.+|. .|.++++|++ ++++.|+++...|+.|..+++|++|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 4788999999999877777899999999999999998776664 5788888765 6667788887778888899999999
Q ss_pred EccCCcCCccCCcccCCCCCCcEEeccc-cccccCCCC-CCCCC-cCCEEEcccCCCCCCCCCC--CcccceEecCC-Cc
Q 006145 185 SLRNNMFNGTLPDSFSYLENLRVLALSN-NHFYGEVPD-FSGLT-YLQVLDLENNALGPQFPKV--GKKLVTMILSK-NK 258 (659)
Q Consensus 185 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~-~~~l~-~L~~L~L~~N~l~~~~~~~--~~~L~~L~l~~-N~ 258 (659)
++++|++++..+..+....++..|++.+ |++....+. |..+. .++.|+|++|+|+...+.. ..+|+.|++++ |.
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~ 189 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNN 189 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTT
T ss_pred cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCc
Confidence 9999998877666777777788888865 455544443 55553 5677777777776544433 24555666654 33
Q ss_pred CCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcC
Q 006145 259 FRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSS 328 (659)
Q Consensus 259 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~ 328 (659)
++...+..|..+++|+.|||++|+|+...+..+. +|+.|.+.+++--..+| .+..+++|+.+++++
T Consensus 190 l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~---~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~ 255 (350)
T 4ay9_X 190 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLE---NLKKLRARSTYNLKKLP-TLEKLVALMEASLTY 255 (350)
T ss_dssp CCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT---TCCEEECTTCTTCCCCC-CTTTCCSCCEEECSC
T ss_pred ccCCCHHHhccCcccchhhcCCCCcCccChhhhc---cchHhhhccCCCcCcCC-CchhCcChhhCcCCC
Confidence 3332223455666666666666666533222232 33333333222222333 244455555555543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=8.6e-24 Score=221.61 Aligned_cols=246 Identities=16% Similarity=0.135 Sum_probs=201.4
Q ss_pred CCCEEEecCCCCcCCCCcccCCC--CCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCC-CccccCCCCCCCEE
Q 006145 108 DLKVLRLVSLGLWGPLSGKISRL--SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGR-VPDWLGSLPILAVL 184 (659)
Q Consensus 108 ~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L 184 (659)
.++.|++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4789999999886 5667777 8999999999999987766 66899999999999999876 88899999999999
Q ss_pred EccCCcCCccCCcccCCCCCCcEEecccc-ccccC-CCC-CCCCCcCCEEEcccC-CCCCC-CCC---CCc-ccceEecC
Q 006145 185 SLRNNMFNGTLPDSFSYLENLRVLALSNN-HFYGE-VPD-FSGLTYLQVLDLENN-ALGPQ-FPK---VGK-KLVTMILS 255 (659)
Q Consensus 185 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~-~~~l~~L~~L~L~~N-~l~~~-~~~---~~~-~L~~L~l~ 255 (659)
+|++|.+++..|..++.+++|++|+|++| .+++. ++. +.++++|++|++++| .+++. ++. .++ +|++|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999999889999999999999999999 67752 444 788999999999999 88753 333 256 99999999
Q ss_pred CC--cCC-ccCchhccCCccccEEeccCcc-cccCCchhhcCCCcccEEeccCCc-CCCcCCcCCCCCCCCCEEECcCCC
Q 006145 256 KN--KFR-SAIPAEVSSYYQLQRLDLSSNR-FVGPFPQALLSLPSITYLNIADNK-LTGKLFDDLSCNPELGFVDLSSNL 330 (659)
Q Consensus 256 ~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~l~~N~-l~~~~p~~~~~~~~L~~L~ls~N~ 330 (659)
+| .++ +.+|..+..+++|+.|++++|. +++..+..+..+++|+.|++++|. ++......+..+++|+.|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 99 566 5677888899999999999999 787888899999999999999995 33222235788999999999999
Q ss_pred CcccCChhhhCCCCCCEEEcCCccccCCCC
Q 006145 331 LTGQLPNCLLAGSKNRVVLYARNCLAAGNE 360 (659)
Q Consensus 331 l~g~ip~~~~~~~~l~~l~~~~N~l~~~~~ 360 (659)
++...-..+. ..+..+.++.|.+++..+
T Consensus 283 i~~~~~~~l~--~~l~~L~l~~n~l~~~~~ 310 (336)
T 2ast_B 283 VPDGTLQLLK--EALPHLQINCSHFTTIAR 310 (336)
T ss_dssp SCTTCHHHHH--HHSTTSEESCCCSCCTTC
T ss_pred cCHHHHHHHH--hhCcceEEecccCccccC
Confidence 4432212222 124556688999986543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.6e-21 Score=186.62 Aligned_cols=161 Identities=27% Similarity=0.273 Sum_probs=106.8
Q ss_pred CCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEec
Q 006145 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLAL 210 (659)
Q Consensus 131 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 210 (659)
++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|.++++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence 47777888888777665666777777777777777777655556677777777777777777655555677777777777
Q ss_pred cccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCch
Q 006145 211 SNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQ 289 (659)
Q Consensus 211 s~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 289 (659)
++|++++.++. |..+++|++|+|++|.+ ++..+..+..+++|+.|++++|.+.+
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l---------------------~~~~~~~~~~l~~L~~L~l~~N~~~~---- 162 (208)
T 2o6s_A 108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQL---------------------KSVPDGVFDRLTSLQYIWLHDNPWDC---- 162 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCC---------------------SCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred CCCcCcccCHhHhccCCcCCEEECCCCcc---------------------ceeCHHHhccCCCccEEEecCCCeec----
Confidence 77777665554 55566666555555544 33333445666777777777776653
Q ss_pred hhcCCCcccEEeccCCcCCCcCCcCCCCCC
Q 006145 290 ALLSLPSITYLNIADNKLTGKLFDDLSCNP 319 (659)
Q Consensus 290 ~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 319 (659)
.+++|+.|+++.|+++|.+|+.++.++
T Consensus 163 ---~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 163 ---TCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp ---CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred ---CCCCHHHHHHHHHhCCceeeccCcccc
Confidence 345666677777777777776665544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.7e-20 Score=197.94 Aligned_cols=235 Identities=17% Similarity=0.084 Sum_probs=180.4
Q ss_pred EEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCc-cccCCCCCCCE-EEccCC
Q 006145 112 LRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVP-DWLGSLPILAV-LSLRNN 189 (659)
Q Consensus 112 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~-L~L~~N 189 (659)
++-++++++ .+|..+ .++|+.|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|.. +.+++|
T Consensus 14 v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N 90 (350)
T 4ay9_X 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90 (350)
T ss_dssp EEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEET
T ss_pred EEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCC
Confidence 344455554 345444 3689999999999996656689999999999999999987776 47889999876 667789
Q ss_pred cCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEccc-CCCCCCCCCC----CcccceEecCCCcCCccC
Q 006145 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLEN-NALGPQFPKV----GKKLVTMILSKNKFRSAI 263 (659)
Q Consensus 190 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~-N~l~~~~~~~----~~~L~~L~l~~N~l~~~~ 263 (659)
+++...|..|.++++|++|++++|+++..++. +....++..|++.+ |.+....+.. ...++.|+|++|+|+. +
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~-i 169 (350)
T 4ay9_X 91 NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-I 169 (350)
T ss_dssp TCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-E
T ss_pred cccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC-C
Confidence 99988899999999999999999999877664 66677888999976 5565444432 3568899999999986 4
Q ss_pred chhccCCccccEEeccC-cccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCC
Q 006145 264 PAEVSSYYQLQRLDLSS-NRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAG 342 (659)
Q Consensus 264 p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~ 342 (659)
|.......+|+.|++++ |.++...+..|..+++|+.|+|++|+|+...+..+ .+|+.|.+.++.--..+|. +..+
T Consensus 170 ~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~---~~L~~L~~l~~~~l~~lP~-l~~l 245 (350)
T 4ay9_X 170 HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL---ENLKKLRARSTYNLKKLPT-LEKL 245 (350)
T ss_dssp CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSC---TTCCEEECTTCTTCCCCCC-TTTC
T ss_pred ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhh---ccchHhhhccCCCcCcCCC-chhC
Confidence 55555667899999986 56654444578999999999999999996555444 5566666655544447774 6778
Q ss_pred CCCCEEEcCCcc
Q 006145 343 SKNRVVLYARNC 354 (659)
Q Consensus 343 ~~l~~l~~~~N~ 354 (659)
++|+.+++.++.
T Consensus 246 ~~L~~l~l~~~~ 257 (350)
T 4ay9_X 246 VALMEASLTYPS 257 (350)
T ss_dssp CSCCEEECSCHH
T ss_pred cChhhCcCCCCc
Confidence 889988887653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.5e-22 Score=231.41 Aligned_cols=225 Identities=19% Similarity=0.197 Sum_probs=124.8
Q ss_pred CCHHHHHHHHHHHhcCCCC--CCCCCCCCC-CCCCcCCCCCCCceEeCCCCEeEEEeCCCCCCCCCCCCCcCCccccccc
Q 006145 28 LQSSQAQTLLRIQGLLNNP--AVLSSWNIT-TEFCNTEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLV 104 (659)
Q Consensus 28 ~~~~~~~aLl~~k~~l~~~--~~l~~W~~~-~~~C~w~~~~~~gv~C~~~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~ 104 (659)
....++++|+++...+..+ ..-..|... +..+.|. ++.+...+++.|+|.++.+... +.
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~s~~~~~~l~L~~n~~~~~-~~------------ 190 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTAT-----NSAVSTPLTPKIELFANGKDEA-NQ------------ 190 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCC-----CceecCCccceEEeeCCCCCcc-hh------------
Confidence 4567888999998765321 123346433 3456675 5777778899999988776532 11
Q ss_pred CCCCCCEEEecCCCCcC---------CCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCcccc
Q 006145 105 KLPDLKVLRLVSLGLWG---------PLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWL 175 (659)
Q Consensus 105 ~l~~L~~L~L~~n~l~~---------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 175 (659)
..|+.++|+.|.+.+ ..|..|..+++|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|
T Consensus 191 --~~l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~ 266 (727)
T 4b8c_D 191 --ALLQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEI 266 (727)
T ss_dssp ---------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGG
T ss_pred --hHhhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhh
Confidence 122333343333322 45778899999999999999998 78888889999999999999998 889999
Q ss_pred CCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCc----ccce
Q 006145 176 GSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGK----KLVT 251 (659)
Q Consensus 176 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~----~L~~ 251 (659)
++|++|++|+|++|.|+ .+|..|++|++|++|+|++|.|+..+..|+.+++|++|+|++|.|++.+|..+. .+..
T Consensus 267 ~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~ 345 (727)
T 4b8c_D 267 KNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLI 345 (727)
T ss_dssp GGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHH
T ss_pred hCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhH
Confidence 99999999999999999 789999999999999999999986555699999999999988888776665432 1223
Q ss_pred EecCCCcCCccCchhccCCccccEEeccCc
Q 006145 252 MILSKNKFRSAIPAEVSSYYQLQRLDLSSN 281 (659)
Q Consensus 252 L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 281 (659)
++|++|.+++.+|.. |+.|++++|
T Consensus 346 l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 346 FYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp HHHHHCCCCCCCCCC---------------
T ss_pred HhhccCcccCcCccc------cceeEeecc
Confidence 556666666666543 344455544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.4e-20 Score=184.48 Aligned_cols=164 Identities=24% Similarity=0.205 Sum_probs=138.0
Q ss_pred CCCCCCCCCCcCCCCCCCceEeCCCCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCC
Q 006145 50 SSWNITTEFCNTEPTSSLTVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISR 129 (659)
Q Consensus 50 ~~W~~~~~~C~w~~~~~~gv~C~~~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~ 129 (659)
.-|......|+|. +|.|...+++ .+|. .+. ++|++|+|++|.+++..|..|.+
T Consensus 10 ~~~~~~~~~Cs~~-----~v~c~~~~l~-----------~ip~---------~~~--~~L~~L~Ls~n~i~~~~~~~~~~ 62 (229)
T 3e6j_A 10 SAACPSQCSCSGT-----TVDCRSKRHA-----------SVPA---------GIP--TNAQILYLHDNQITKLEPGVFDS 62 (229)
T ss_dssp -CCCCTTCEEETT-----EEECTTSCCS-----------SCCS---------CCC--TTCSEEECCSSCCCCCCTTTTTT
T ss_pred hccCCCCCEEeCC-----EeEccCCCcC-----------ccCC---------CCC--CCCCEEEcCCCccCccCHHHhhC
Confidence 3466678889997 6999643322 2222 222 78999999999999999999999
Q ss_pred CCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEe
Q 006145 130 LSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLA 209 (659)
Q Consensus 130 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 209 (659)
+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+
T Consensus 63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 141 (229)
T 3e6j_A 63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEE
T ss_pred ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEE
Confidence 999999999999998666677899999999999999999877788899999999999999999 7888999999999999
Q ss_pred ccccccccCCCC-CCCCCcCCEEEcccCCCCCC
Q 006145 210 LSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQ 241 (659)
Q Consensus 210 Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~ 241 (659)
|++|++++.++. |..+++|+.|+|++|.+...
T Consensus 142 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 142 LDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 999999987765 88899999999988877643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=212.78 Aligned_cols=172 Identities=27% Similarity=0.332 Sum_probs=87.9
Q ss_pred cCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCE
Q 006145 104 VKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAV 183 (659)
Q Consensus 104 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 183 (659)
..|++|+.|+|++|.+... | .|..|++|+.|+|++|.|++..| +..+++|+.|+|++|.+.+ +| .+..+++|+.
T Consensus 40 ~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~ 113 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKS 113 (605)
T ss_dssp HHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCE
T ss_pred hcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCE
Confidence 3445555555555555432 2 35555555555555555554333 5555555555555555543 22 4555555555
Q ss_pred EEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccC
Q 006145 184 LSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAI 263 (659)
Q Consensus 184 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~ 263 (659)
|+|++|.+++ + +.+..+++|+.|+|++|.+++. +.+..+++|+.|+|++|.+ ++..
T Consensus 114 L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l---------------------~~~~ 169 (605)
T 1m9s_A 114 LSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQI---------------------SDIV 169 (605)
T ss_dssp EECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCC---------------------CCCG
T ss_pred EEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcC---------------------CCch
Confidence 5555555553 2 2355555555555555555543 4445555555555555544 4433
Q ss_pred chhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCC
Q 006145 264 PAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG 309 (659)
Q Consensus 264 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 309 (659)
| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++
T Consensus 170 ~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 170 P--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp G--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred h--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 3 55555555555555555542 235555555555555555554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=210.18 Aligned_cols=190 Identities=22% Similarity=0.290 Sum_probs=143.2
Q ss_pred CCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccC
Q 006145 109 LKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRN 188 (659)
Q Consensus 109 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 188 (659)
+..+++..+.+...++ +..|++|+.|+|++|.+.. +| .+..+++|+.|+|++|++++..| +..+++|+.|+|++
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 3444555555555433 4567778888888888763 34 47777888888888888775444 77777788888888
Q ss_pred CcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhcc
Q 006145 189 NMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVS 268 (659)
Q Consensus 189 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~ 268 (659)
|.+++ +| .+..+++|+.|+|++|.+++ ++.+..+++|+.|+|++|.+ ++. ..+.
T Consensus 97 N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l---------------------~~l--~~l~ 150 (605)
T 1m9s_A 97 NKIKD-LS-SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKI---------------------TDI--TVLS 150 (605)
T ss_dssp SCCCC-CT-TSTTCTTCCEEECTTSCCCC-CGGGGGCTTCSEEECCSSCC---------------------CCC--GGGG
T ss_pred CCCCC-Ch-hhccCCCCCEEEecCCCCCC-CccccCCCccCEEECCCCcc---------------------CCc--hhhc
Confidence 77774 33 57777777777777777775 35566667777766666655 332 4678
Q ss_pred CCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCccc
Q 006145 269 SYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQ 334 (659)
Q Consensus 269 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ 334 (659)
.+++|+.|+|++|.|++..| +..+++|+.|+|++|+|++. +.+..+++|+.|+|++|++++.
T Consensus 151 ~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 151 RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp SCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred ccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 89999999999999998766 99999999999999999974 4588999999999999999864
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=8.3e-20 Score=187.43 Aligned_cols=105 Identities=26% Similarity=0.338 Sum_probs=55.5
Q ss_pred CCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcE
Q 006145 128 SRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRV 207 (659)
Q Consensus 128 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 207 (659)
..+++|+.|++++|.++.. | .+..+++|++|+|++|++++..| +..+++|++|+|++|.+++ +| .+..+++|+.
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence 3455555555555555422 2 25555555555555555554322 5555555555555555553 22 2555566666
Q ss_pred EeccccccccCCCCCCCCCcCCEEEcccCCCC
Q 006145 208 LALSNNHFYGEVPDFSGLTYLQVLDLENNALG 239 (659)
Q Consensus 208 L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~ 239 (659)
|+|++|++++. +.+..+++|++|++++|.++
T Consensus 117 L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~ 147 (291)
T 1h6t_A 117 LSLEHNGISDI-NGLVHLPQLESLYLGNNKIT 147 (291)
T ss_dssp EECTTSCCCCC-GGGGGCTTCCEEECCSSCCC
T ss_pred EECCCCcCCCC-hhhcCCCCCCEEEccCCcCC
Confidence 66666655542 44555555555555555543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=9.7e-20 Score=186.92 Aligned_cols=173 Identities=27% Similarity=0.322 Sum_probs=106.9
Q ss_pred ccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCC
Q 006145 103 LVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILA 182 (659)
Q Consensus 103 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (659)
+..+++|+.|++++|.+... + .+..+++|+.|+|++|++++..| +.++++|++|+|++|.+++ +| .+..+++|+
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~ 115 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLK 115 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCC
T ss_pred hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCC
Confidence 34566677777777766544 2 36667777777777777765433 6677777777777777664 23 366777777
Q ss_pred EEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCcc
Q 006145 183 VLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSA 262 (659)
Q Consensus 183 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~ 262 (659)
+|+|++|.+++. +.+..+++|+.|++++|++++. +.+..+++|++|++++|.++ +.
T Consensus 116 ~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~---------------------~~ 171 (291)
T 1h6t_A 116 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQIS---------------------DI 171 (291)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCC---------------------CC
T ss_pred EEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccc---------------------cc
Confidence 777777777643 3566677777777777776654 45666666666655555442 22
Q ss_pred CchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCC
Q 006145 263 IPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG 309 (659)
Q Consensus 263 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 309 (659)
.| +..+++|+.|+|++|.+++ +| .+..+++|+.|++++|+++.
T Consensus 172 ~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 172 VP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp GG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred hh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 12 5556666666666666654 33 25666666666666666553
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=3.5e-19 Score=174.94 Aligned_cols=133 Identities=26% Similarity=0.296 Sum_probs=122.5
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
++|+.|+|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|+...+..|..+++|++|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 57999999999999988889999999999999999999888999999999999999999999766677899999999999
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCC
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALG 239 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~ 239 (659)
++|++++..|..|.++++|+.|+|++|++++..+. |..+++|++|+|++|.+.
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 99999998899999999999999999999988876 888999999999888764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-19 Score=190.97 Aligned_cols=139 Identities=24% Similarity=0.195 Sum_probs=90.7
Q ss_pred ceEeCCCCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccC-CCCCCcEEEcccCcCccc
Q 006145 68 TVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKIS-RLSSLEILNMSSNFLNGA 146 (659)
Q Consensus 68 gv~C~~~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~ 146 (659)
.+.|.. ..++++++++.. +|. .+. +.++.|+|++|++++..+..|. ++++|+.|+|++|+|++.
T Consensus 15 ~C~C~~---~~l~c~~~~l~~-iP~---------~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i 79 (361)
T 2xot_A 15 NCLCAS---NILSCSKQQLPN-VPQ---------SLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFI 79 (361)
T ss_dssp TCEEET---TEEECCSSCCSS-CCS---------SCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEE
T ss_pred CCEECC---CEEEeCCCCcCc-cCc---------cCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCcc
Confidence 467753 356777766543 232 111 2467777777777776666666 777777777777777766
Q ss_pred CChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCC
Q 006145 147 IPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD 221 (659)
Q Consensus 147 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 221 (659)
.|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.++.
T Consensus 80 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~ 154 (361)
T 2xot_A 80 SSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVE 154 (361)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGG
T ss_pred ChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHH
Confidence 666677777777777777777666556666777777777777777666666666666666666666666654443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.8e-19 Score=174.70 Aligned_cols=80 Identities=25% Similarity=0.367 Sum_probs=37.9
Q ss_pred EEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccc
Q 006145 135 ILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNH 214 (659)
Q Consensus 135 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 214 (659)
.+++++|.++ .+|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 3444444444 3333322 344555555555544444444555555555555555554444555555555555555554
Q ss_pred ccc
Q 006145 215 FYG 217 (659)
Q Consensus 215 l~~ 217 (659)
|+.
T Consensus 92 l~~ 94 (220)
T 2v9t_B 92 ITE 94 (220)
T ss_dssp CCC
T ss_pred CCc
Confidence 443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=6.2e-19 Score=173.13 Aligned_cols=158 Identities=23% Similarity=0.266 Sum_probs=134.2
Q ss_pred ceEeCCCCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCC-cccCCCCCCcEEEcccCcCccc
Q 006145 68 TVVCYEESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLS-GKISRLSSLEILNMSSNFLNGA 146 (659)
Q Consensus 68 gv~C~~~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ 146 (659)
+++|.. +.++++++.++. +|. .+ .+.+++|+|++|.+++..| ..|..+++|++|+|++|.|++.
T Consensus 8 ~C~C~~---~~l~~s~n~l~~-iP~---------~~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i 72 (220)
T 2v70_A 8 KCRCEG---TTVDCSNQKLNK-IPE---------HI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDI 72 (220)
T ss_dssp TCEEET---TEEECCSSCCSS-CCS---------CC--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEE
T ss_pred CCEECC---CEeEeCCCCccc-Ccc---------CC--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEE
Confidence 355643 367778777653 333 22 2346899999999998865 5689999999999999999988
Q ss_pred CChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCC
Q 006145 147 IPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGL 225 (659)
Q Consensus 147 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l 225 (659)
.|..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..|. |..+
T Consensus 73 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 152 (220)
T 2v70_A 73 EEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTL 152 (220)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTC
T ss_pred CHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCC
Confidence 888999999999999999999988888899999999999999999999999999999999999999999998775 8889
Q ss_pred CcCCEEEcccCCCCC
Q 006145 226 TYLQVLDLENNALGP 240 (659)
Q Consensus 226 ~~L~~L~L~~N~l~~ 240 (659)
++|++|+|++|.+..
T Consensus 153 ~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 153 HSLSTLNLLANPFNC 167 (220)
T ss_dssp TTCCEEECCSCCEEC
T ss_pred CCCCEEEecCcCCcC
Confidence 999999998888754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=192.48 Aligned_cols=175 Identities=27% Similarity=0.261 Sum_probs=97.4
Q ss_pred CEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhcc-CCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccC
Q 006145 110 KVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELS-ILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRN 188 (659)
Q Consensus 110 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 188 (659)
+.+++++++++. +|..+. +.++.|+|++|+|++..+..+. ++++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 456666666654 343332 2466666666666655555555 666666666666666655555666666666666666
Q ss_pred CcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhc
Q 006145 189 NMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEV 267 (659)
Q Consensus 189 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~ 267 (659)
|+|++..+..|.++++|+.|+|++|++++..|. |.++++|+.|+|++|.|+. ..+..|
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~---------------------l~~~~~ 156 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR---------------------FPVELI 156 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS---------------------CCGGGT
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe---------------------eCHHHh
Confidence 666655555566666666666666666555443 5555555555555554432 111112
Q ss_pred ---cCCccccEEeccCcccccCCchhhcCCCcc--cEEeccCCcCC
Q 006145 268 ---SSYYQLQRLDLSSNRFVGPFPQALLSLPSI--TYLNIADNKLT 308 (659)
Q Consensus 268 ---~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L--~~L~l~~N~l~ 308 (659)
..+++|+.|+|++|+|++..+..+..++.+ +.|+|++|.+.
T Consensus 157 ~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp C----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 345566666666666665444555555542 45555555443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=6.9e-19 Score=172.82 Aligned_cols=134 Identities=25% Similarity=0.251 Sum_probs=76.6
Q ss_pred CEEEccCCcCCccCC-cccCCCCCCcEEeccccccccCCC-CCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcC
Q 006145 182 AVLSLRNNMFNGTLP-DSFSYLENLRVLALSNNHFYGEVP-DFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKF 259 (659)
Q Consensus 182 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l 259 (659)
++|+|++|++++..| ..|..+++|+.|+|++|++++..+ .|.++++|++|+|++|.+
T Consensus 35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l--------------------- 93 (220)
T 2v70_A 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL--------------------- 93 (220)
T ss_dssp SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC---------------------
T ss_pred CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCcc---------------------
Confidence 444444444444332 224444555555555555544443 244444444444444333
Q ss_pred CccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCC
Q 006145 260 RSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLP 336 (659)
Q Consensus 260 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip 336 (659)
++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..+..+++|+.|++++|.+++..+
T Consensus 94 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 94 ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 23334445566666666666666666666666777777777777777776667777777777777777777765544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=9.9e-19 Score=172.83 Aligned_cols=81 Identities=26% Similarity=0.288 Sum_probs=38.0
Q ss_pred EEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccc
Q 006145 135 ILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNH 214 (659)
Q Consensus 135 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 214 (659)
.++.+++.++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 23 ~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 23 TVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 4444444443 3343322 445555555555554444445555555555555555543333334444445555444444
Q ss_pred cccC
Q 006145 215 FYGE 218 (659)
Q Consensus 215 l~~~ 218 (659)
+++.
T Consensus 100 l~~l 103 (229)
T 3e6j_A 100 LTVL 103 (229)
T ss_dssp CCCC
T ss_pred CCcc
Confidence 4433
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=7.5e-20 Score=184.31 Aligned_cols=140 Identities=9% Similarity=0.097 Sum_probs=106.2
Q ss_pred CCCCceeccCcCceEEEEEe-cCCcE--EEEEEecccCCCc------------------------hHHHHHHHHHHhCCC
Q 006145 479 FDTSAFMGEGSQGQMYRGRL-KNGTF--VAIRCLKMKKCHS------------------------TRNFMHHIELISKLR 531 (659)
Q Consensus 479 ~~~~~~ig~G~~g~Vy~~~~-~~g~~--vavK~l~~~~~~~------------------------~~~~~~Ei~~l~~l~ 531 (659)
|...+.||+|+||.||+|+. .+|+. ||||+++...... ...+.+|++.|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678999999999999997 67999 9999875431110 125889999999998
Q ss_pred CCCccceeeeeeeccccCCCCceeEEEEeccCC-C----ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhc-CCCCC
Q 006145 532 HRHLVSALGHCFECYFDDSSVSRIFLIFEYVPN-G----TLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH-TGIVP 605 (659)
Q Consensus 532 H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~-G----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~ 605 (659)
|+++....-+.. ...+|||||+.+ | +|.++... .++.....++.|++.||+||| +.
T Consensus 129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~--- 190 (258)
T 1zth_A 129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA--- 190 (258)
T ss_dssp HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---
T ss_pred hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---
Confidence 886532222221 136899999942 5 56555432 234456789999999999999 87
Q ss_pred CccccCCCCCceeecCCcceEEccCcccccccc
Q 006145 606 GVFSNNLKITDILLDQNLVAKISSYNLPLLAEN 638 (659)
Q Consensus 606 ~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 638 (659)
+|+||||||+|||+++ .++|+|||+|.....
T Consensus 191 givHrDlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 191 ELVHADLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp CEECSSCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred CEEeCCCCHHHEEEcC--cEEEEECcccccCCC
Confidence 9999999999999998 999999999976543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.8e-20 Score=214.39 Aligned_cols=215 Identities=19% Similarity=0.178 Sum_probs=103.9
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcc---------cCChhccCCCCCcEEEeecCCCCCCCccccCC
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNG---------AIPQELSILTSLQTLILDENMLAGRVPDWLGS 177 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 177 (659)
+.++.|+|..|.+... +.. .|+.++|+.|.|.+ ..|..+..+++|+.|+|++|.+. .+|..+..
T Consensus 173 ~~~~~l~L~~n~~~~~-~~~-----~l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~ 245 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-NQA-----LLQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFK 245 (727)
T ss_dssp -------------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGG
T ss_pred CccceEEeeCCCCCcc-hhh-----HhhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcC
Confidence 5577888888887663 322 23444444444432 44666777777888888888776 66666667
Q ss_pred CCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCC
Q 006145 178 LPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKN 257 (659)
Q Consensus 178 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N 257 (659)
+++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+..+..|++|++|++|+|++|.|+
T Consensus 246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~------------------ 306 (727)
T 4b8c_D 246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT------------------ 306 (727)
T ss_dssp CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC------------------
T ss_pred CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC------------------
Confidence 777888888888777 6777777777788888887777744344777777777777666552
Q ss_pred cCCccCchhccCCccccEEeccCcccccCCchhhcCCCc-ccEEeccCCcCCCcCCcCCCCCCCCCEEECcCC-------
Q 006145 258 KFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPS-ITYLNIADNKLTGKLFDDLSCNPELGFVDLSSN------- 329 (659)
Q Consensus 258 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N------- 329 (659)
.+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.++|.+|.. |..|+++.|
T Consensus 307 ----~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~ 376 (727)
T 4b8c_D 307 ----TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREY 376 (727)
T ss_dssp ----CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----------------------
T ss_pred ----ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeeccccccccc
Confidence 46667888888888888888888888877765432 234778888888877764 345666666
Q ss_pred -CCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 330 -LLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 330 -~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
.+++.++..+..+.++....++.|.+.+
T Consensus 377 ~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 377 DSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp -------------------------CCCG
T ss_pred CCccccccchhhcccccceeeeecccccc
Confidence 3333334444455556666777777653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=4.2e-22 Score=222.83 Aligned_cols=201 Identities=20% Similarity=0.192 Sum_probs=120.7
Q ss_pred CCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCC-------------CCCCCccccCCCCCCCEEE-ccCCcCCc
Q 006145 128 SRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENM-------------LAGRVPDWLGSLPILAVLS-LRNNMFNG 193 (659)
Q Consensus 128 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~l~~l~~L~~L~-L~~N~l~~ 193 (659)
..+++|+.|+|++|+++ .+|..++++++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 55667777777777775 667777777777777775554 4445555555555555555 4444321
Q ss_pred cCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCC--CcccceEecCCCcCCccCchhccCCc
Q 006145 194 TLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKV--GKKLVTMILSKNKFRSAIPAEVSSYY 271 (659)
Q Consensus 194 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~--~~~L~~L~l~~N~l~~~~p~~~~~l~ 271 (659)
+|+.+.+++|.++...+ ..|+.|+|++|.|++. |.. +++|+.|+|++|+|+ .+|..++.++
T Consensus 424 ----------~L~~l~l~~n~i~~l~~-----~~L~~L~Ls~n~l~~l-p~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 486 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEY-----ADVRVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALR 486 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHH-----TTCSEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCC-CCCGGGGGCT
T ss_pred ----------hhhhhhhhcccccccCc-----cCceEEEecCCCCCCC-cCccccccCcEeecCccccc-ccchhhhcCC
Confidence 22333333343333221 1245555555555442 222 234555555555555 5667777777
Q ss_pred cccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcC-CcCCCCCCCCCEEECcCCCCcccCChh---hhCCCCCCE
Q 006145 272 QLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKL-FDDLSCNPELGFVDLSSNLLTGQLPNC---LLAGSKNRV 347 (659)
Q Consensus 272 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~-p~~~~~~~~L~~L~ls~N~l~g~ip~~---~~~~~~l~~ 347 (659)
+|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..+..+++|+.|+|++|++++.+|.. +..+++|+.
T Consensus 487 ~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~ 564 (567)
T 1dce_A 487 CLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564 (567)
T ss_dssp TCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSE
T ss_pred CCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCc
Confidence 77777777777775 56 6777777777777777777766 777777777777777777777654432 223556666
Q ss_pred EE
Q 006145 348 VL 349 (659)
Q Consensus 348 l~ 349 (659)
|+
T Consensus 565 L~ 566 (567)
T 1dce_A 565 IL 566 (567)
T ss_dssp EE
T ss_pred cC
Confidence 54
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.5e-19 Score=169.84 Aligned_cols=106 Identities=16% Similarity=0.214 Sum_probs=49.2
Q ss_pred CCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEE
Q 006145 105 KLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVL 184 (659)
Q Consensus 105 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (659)
.+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|+|++|.+++..|..++.+++|++|
T Consensus 42 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 117 (197)
T 4ezg_A 42 QMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117 (197)
T ss_dssp HHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred hcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence 3444455555555444 223 3444455555555555333 12234444445555555554444444444444444444
Q ss_pred EccCCcCCccCCcccCCCCCCcEEeccccc
Q 006145 185 SLRNNMFNGTLPDSFSYLENLRVLALSNNH 214 (659)
Q Consensus 185 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 214 (659)
++++|.+++..|..++.+++|++|++++|.
T Consensus 118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 118 DISHSAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp ECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred EecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence 444444444444444444444444444444
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.77 E-value=6.5e-21 Score=215.40 Aligned_cols=132 Identities=8% Similarity=0.058 Sum_probs=75.7
Q ss_pred CCcCCEEEcccCCCCCCCCC----CCcccceEecC----CCcCCcc-----CchhccCCccccEEeccCc--ccccCCch
Q 006145 225 LTYLQVLDLENNALGPQFPK----VGKKLVTMILS----KNKFRSA-----IPAEVSSYYQLQRLDLSSN--RFVGPFPQ 289 (659)
Q Consensus 225 l~~L~~L~L~~N~l~~~~~~----~~~~L~~L~l~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~ 289 (659)
+++|++|+++.|.+++..+. .+++|+.|+++ .|.+++. ++..+.++++|+.|++++| .+++..+.
T Consensus 377 ~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~ 456 (592)
T 3ogk_B 377 CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLS 456 (592)
T ss_dssp CTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHH
T ss_pred CccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHH
Confidence 45555555555554432221 13456666664 5555543 2333555666677776543 25544444
Q ss_pred hhc-CCCcccEEeccCCcCCC-cCCcCCCCCCCCCEEECcCCCCccc-CChhhhCCCCCCEEEcCCcccc
Q 006145 290 ALL-SLPSITYLNIADNKLTG-KLFDDLSCNPELGFVDLSSNLLTGQ-LPNCLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 290 ~l~-~l~~L~~L~l~~N~l~~-~~p~~~~~~~~L~~L~ls~N~l~g~-ip~~~~~~~~l~~l~~~~N~l~ 356 (659)
.+. .+++|+.|++++|++++ .++..+..+++|+.|++++|.+++. ++.....+++|+.+++++|.++
T Consensus 457 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it 526 (592)
T 3ogk_B 457 YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526 (592)
T ss_dssp HHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCC
T ss_pred HHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCC
Confidence 443 36777777777777765 2334445667777777777777654 3444456677777777777765
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.3e-19 Score=180.14 Aligned_cols=171 Identities=19% Similarity=0.240 Sum_probs=125.2
Q ss_pred CCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEE
Q 006145 129 RLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVL 208 (659)
Q Consensus 129 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 208 (659)
.+.++..++++.|.+++. + .+..+++|++|++++|.++ .+| .+..+++|+.|+|++|++++..| +.++++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 566777888888888743 3 5677888888888888887 455 67778888888888888875443 7788888888
Q ss_pred eccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCc
Q 006145 209 ALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFP 288 (659)
Q Consensus 209 ~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 288 (659)
+|++|++++. |.+.. ++|++|+|++|.+ ++ ++ .+..+++|+.|+|++|++++. |
T Consensus 91 ~L~~N~l~~l-~~~~~-~~L~~L~L~~N~l---------------------~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~ 144 (263)
T 1xeu_A 91 SVNRNRLKNL-NGIPS-ACLSRLFLDNNEL---------------------RD-TD-SLIHLKNLEILSIRNNKLKSI-V 144 (263)
T ss_dssp ECCSSCCSCC-TTCCC-SSCCEEECCSSCC---------------------SB-SG-GGTTCTTCCEEECTTSCCCBC-G
T ss_pred ECCCCccCCc-Ccccc-CcccEEEccCCcc---------------------CC-Ch-hhcCcccccEEECCCCcCCCC-h
Confidence 8888887763 33333 5566666655554 33 22 477788888888888888764 3
Q ss_pred hhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCccc
Q 006145 289 QALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQ 334 (659)
Q Consensus 289 ~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ 334 (659)
.+..+++|+.|++++|++++. ..+..+++|+.|++++|.+++.
T Consensus 145 -~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 145 -MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred -HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 577888888888888888876 5677788888888888888754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-18 Score=166.93 Aligned_cols=153 Identities=13% Similarity=0.213 Sum_probs=92.9
Q ss_pred cCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCc
Q 006145 127 ISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLR 206 (659)
Q Consensus 127 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 206 (659)
...+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|.+++..|..|+.+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 356677788888888777 555 5777777888888777654 334677777777777777777766666777777777
Q ss_pred EEeccccccccCCCC-CCCCCcCCEEEcccCC-CCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccc
Q 006145 207 VLALSNNHFYGEVPD-FSGLTYLQVLDLENNA-LGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFV 284 (659)
Q Consensus 207 ~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~-l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 284 (659)
+|++++|++++..+. +..+++|++|++++|. ++ .+| .+..+++|+.|++++|.++
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~----------------------~~~-~l~~l~~L~~L~l~~n~i~ 172 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT----------------------DIM-PLKTLPELKSLNIQFDGVH 172 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC----------------------CCG-GGGGCSSCCEEECTTBCCC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc----------------------ccH-hhcCCCCCCEEECCCCCCc
Confidence 777777777654333 5555666665555554 21 122 3444555555555555554
Q ss_pred cCCchhhcCCCcccEEeccCCcCC
Q 006145 285 GPFPQALLSLPSITYLNIADNKLT 308 (659)
Q Consensus 285 ~~~p~~l~~l~~L~~L~l~~N~l~ 308 (659)
+ ++ .+..+++|+.|++++|++.
T Consensus 173 ~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 173 D-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp C-CT-TGGGCSSCCEEEECBC---
T ss_pred C-hH-HhccCCCCCEEEeeCcccC
Confidence 3 22 3444555555555555443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=3e-19 Score=180.41 Aligned_cols=171 Identities=22% Similarity=0.293 Sum_probs=125.9
Q ss_pred CCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEE
Q 006145 105 KLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVL 184 (659)
Q Consensus 105 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (659)
++.++..++++.|.+++.. .+..+++|+.|++++|.++ .+| .+..+++|++|+|++|++++..| +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 4555667778888876644 5778889999999999887 455 68888999999999999886544 8889999999
Q ss_pred EccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCc
Q 006145 185 SLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIP 264 (659)
Q Consensus 185 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p 264 (659)
+|++|++++ +|.. .. ++|+.|+|++|++++. +.+..+++|+.|+|++|++++. |
T Consensus 91 ~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~~-~~l~~l~~L~~L~Ls~N~i~~~----------------------~ 144 (263)
T 1xeu_A 91 SVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRDT-DSLIHLKNLEILSIRNNKLKSI----------------------V 144 (263)
T ss_dssp ECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSBS-GGGTTCTTCCEEECTTSCCCBC----------------------G
T ss_pred ECCCCccCC-cCcc-cc-CcccEEEccCCccCCC-hhhcCcccccEEECCCCcCCCC----------------------h
Confidence 999999885 4433 33 8899999999998874 5688888888888887776532 2
Q ss_pred hhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCc
Q 006145 265 AEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGK 310 (659)
Q Consensus 265 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 310 (659)
.+..+++|+.|+|++|++++. ..+..+++|+.|++++|.+++.
T Consensus 145 -~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 145 -MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred -HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 355566666666666666654 4566666677777777666644
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.76 E-value=8.1e-21 Score=214.65 Aligned_cols=227 Identities=13% Similarity=0.024 Sum_probs=110.1
Q ss_pred CCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCC---CCCccccCCCCCCCEEEccCCcCCccCCcccCCCCC
Q 006145 128 SRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLA---GRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLEN 204 (659)
Q Consensus 128 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~---~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 204 (659)
.++++|+.|+|++|.+.+ +|..+.++++|+.|+++.+... +..+..+..+++|+.|+++++. .+.+|..+..+++
T Consensus 217 ~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~ 294 (592)
T 3ogk_B 217 RNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQ 294 (592)
T ss_dssp HHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGG
T ss_pred hhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCC
Confidence 344444444444444442 3344444444444444432111 1222334444455555554432 2345666677778
Q ss_pred CcEEeccccccccCCC-C-CCCCCcCCEEEcccCCCCCCCCC---CCcccceEecC-----------CCcCCcc-Cchhc
Q 006145 205 LRVLALSNNHFYGEVP-D-FSGLTYLQVLDLENNALGPQFPK---VGKKLVTMILS-----------KNKFRSA-IPAEV 267 (659)
Q Consensus 205 L~~L~Ls~N~l~~~~p-~-~~~l~~L~~L~L~~N~l~~~~~~---~~~~L~~L~l~-----------~N~l~~~-~p~~~ 267 (659)
|++|+|++|.+++... . +..+++|++|+++++...+.++. .+++|++|+++ .|.+++. ++..+
T Consensus 295 L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~ 374 (592)
T 3ogk_B 295 IRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALA 374 (592)
T ss_dssp CCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHH
T ss_pred CcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHH
Confidence 8888888877654322 1 45666777777763211111111 13456666666 2444432 12223
Q ss_pred cCCccccEEeccCcccccCCchhhcC-CCcccEEecc----CCcCCCc-----CCcCCCCCCCCCEEECcCC--CCcccC
Q 006145 268 SSYYQLQRLDLSSNRFVGPFPQALLS-LPSITYLNIA----DNKLTGK-----LFDDLSCNPELGFVDLSSN--LLTGQL 335 (659)
Q Consensus 268 ~~l~~L~~L~Ls~N~l~~~~p~~l~~-l~~L~~L~l~----~N~l~~~-----~p~~~~~~~~L~~L~ls~N--~l~g~i 335 (659)
..+++|++|+++.|++++..+..+.. +++|+.|+++ .|++++. ++..+..+++|+.|+++++ .+++..
T Consensus 375 ~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~ 454 (592)
T 3ogk_B 375 QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG 454 (592)
T ss_dssp HHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHH
T ss_pred hhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHH
Confidence 34566666666666666555555544 5666666664 4555542 1222334555555555432 244443
Q ss_pred ChhhhC-CCCCCEEEcCCcccc
Q 006145 336 PNCLLA-GSKNRVVLYARNCLA 356 (659)
Q Consensus 336 p~~~~~-~~~l~~l~~~~N~l~ 356 (659)
+..+.. +++++.++++.|.++
T Consensus 455 ~~~~~~~~~~L~~L~L~~n~l~ 476 (592)
T 3ogk_B 455 LSYIGQYSPNVRWMLLGYVGES 476 (592)
T ss_dssp HHHHHHSCTTCCEEEECSCCSS
T ss_pred HHHHHHhCccceEeeccCCCCC
Confidence 333332 445555555555543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=4.3e-21 Score=214.69 Aligned_cols=189 Identities=19% Similarity=0.154 Sum_probs=161.2
Q ss_pred cCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCc-------------CCccCCcccCCCCCCcEEe-cccccccc
Q 006145 152 SILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM-------------FNGTLPDSFSYLENLRVLA-LSNNHFYG 217 (659)
Q Consensus 152 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~l~~ 217 (659)
..+++|+.|+|++|++. .+|..++++++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 56788889999999886 778888888899988887775 5667777788888888888 676654
Q ss_pred CCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcc
Q 006145 218 EVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSI 297 (659)
Q Consensus 218 ~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 297 (659)
.+|..+.+++|.++...+ ..|+.|+|++|+|++ +|. ++.+++|+.|+|++|+|+ .+|..++.+++|
T Consensus 423 --------~~L~~l~l~~n~i~~l~~---~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L 488 (567)
T 1dce_A 423 --------DDLRSKFLLENSVLKMEY---ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCL 488 (567)
T ss_dssp --------HHHHHHHHHHHHHHHHHH---TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTC
T ss_pred --------chhhhhhhhcccccccCc---cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCC
Confidence 245566677777654332 258999999999988 676 999999999999999999 789999999999
Q ss_pred cEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccC-ChhhhCCCCCCEEEcCCccccCCC
Q 006145 298 TYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQL-PNCLLAGSKNRVVLYARNCLAAGN 359 (659)
Q Consensus 298 ~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~i-p~~~~~~~~l~~l~~~~N~l~~~~ 359 (659)
+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.+ |..+..+++|+.+++++|.+++..
T Consensus 489 ~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 549 (567)
T 1dce_A 489 EVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549 (567)
T ss_dssp CEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred CEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence 999999999997 66 8999999999999999999887 999999999999999999998654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=4.2e-18 Score=163.45 Aligned_cols=113 Identities=27% Similarity=0.285 Sum_probs=87.3
Q ss_pred CCCEEEecCCCCcCCCCc-ccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 108 DLKVLRLVSLGLWGPLSG-KISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 108 ~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
+|++|+|++|.+++..+. .|..+++|++|+|++|.|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 677888888888776654 4777888888888888888777777888888888888888887777777777788888888
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccCCC
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP 220 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 220 (659)
++|++++..|..|..+++|++|+|++|.+++..+
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 8888877777777777777777777777776543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-17 Score=159.54 Aligned_cols=131 Identities=23% Similarity=0.261 Sum_probs=111.9
Q ss_pred CEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCCh-hccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccC
Q 006145 110 KVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQ-ELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRN 188 (659)
Q Consensus 110 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 188 (659)
+.+++++|++ +.+|..+.. +|++|+|++|.|++..+. .|.++++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l-~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGL-KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCC-SSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCc-CcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 4566666766 345555543 899999999999877665 489999999999999999999999999999999999999
Q ss_pred CcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCC
Q 006145 189 NMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFP 243 (659)
Q Consensus 189 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~ 243 (659)
|+|++..|..|.++++|++|+|++|++++.+|. |..+++|++|+|++|.+.+..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 999999888899999999999999999998775 8889999999999988875443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2.2e-17 Score=154.65 Aligned_cols=135 Identities=24% Similarity=0.218 Sum_probs=118.6
Q ss_pred CCCCCCEEEecCCCCc-CCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCE
Q 006145 105 KLPDLKVLRLVSLGLW-GPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAV 183 (659)
Q Consensus 105 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 183 (659)
..++|+.|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3478999999999998 78888899999999999999999865 67899999999999999999888888888999999
Q ss_pred EEccCCcCCccC-CcccCCCCCCcEEeccccccccCCC----CCCCCCcCCEEEcccCCCCCC
Q 006145 184 LSLRNNMFNGTL-PDSFSYLENLRVLALSNNHFYGEVP----DFSGLTYLQVLDLENNALGPQ 241 (659)
Q Consensus 184 L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~l~~L~~L~L~~N~l~~~ 241 (659)
|+|++|.+++.. +..+..+++|+.|++++|.+++.++ .+..+++|++|++++|.+...
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 999999998642 2788999999999999999998877 488899999999999987543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.6e-17 Score=150.95 Aligned_cols=129 Identities=27% Similarity=0.257 Sum_probs=112.4
Q ss_pred CCCCCCEEEecCCCCc-CCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCE
Q 006145 105 KLPDLKVLRLVSLGLW-GPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAV 183 (659)
Q Consensus 105 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 183 (659)
..++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..+.++++|++|+|++|.+++.+|..+..+++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3467899999999998 78888889999999999999999866 67889999999999999999888888888999999
Q ss_pred EEccCCcCCcc-CCcccCCCCCCcEEeccccccccCCC----CCCCCCcCCEEEccc
Q 006145 184 LSLRNNMFNGT-LPDSFSYLENLRVLALSNNHFYGEVP----DFSGLTYLQVLDLEN 235 (659)
Q Consensus 184 L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~l~~L~~L~L~~ 235 (659)
|++++|.+++. .|..++.+++|++|++++|.+++.++ .+..+++|+.|++++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99999999874 44788999999999999999998776 378889999998763
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=9e-17 Score=150.49 Aligned_cols=85 Identities=28% Similarity=0.221 Sum_probs=56.1
Q ss_pred CCCcEEEcccCcCc-ccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEe
Q 006145 131 SSLEILNMSSNFLN-GAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLA 209 (659)
Q Consensus 131 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 209 (659)
++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|.+++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 56777777777776 56666666677777777777776644 5566666666666666666665665555566666666
Q ss_pred cccccccc
Q 006145 210 LSNNHFYG 217 (659)
Q Consensus 210 Ls~N~l~~ 217 (659)
|++|++++
T Consensus 102 Ls~N~l~~ 109 (168)
T 2ell_A 102 LSGNKLKD 109 (168)
T ss_dssp CBSSSCCS
T ss_pred ccCCccCc
Confidence 66666554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=4.4e-16 Score=147.16 Aligned_cols=114 Identities=25% Similarity=0.260 Sum_probs=77.0
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
++|+.|++++|.+++..+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..+..+++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 46777777777777666666677777777777777777555555667777777777777777655556666777777777
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccCCC
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP 220 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 220 (659)
++|.+++..+..|..+++|+.|+|++|.+.+..|
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 7777765544455666666666666666665444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=1e-15 Score=146.91 Aligned_cols=106 Identities=25% Similarity=0.332 Sum_probs=53.9
Q ss_pred CCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEecc
Q 006145 132 SLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALS 211 (659)
Q Consensus 132 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 211 (659)
+|+.|+|++|.|+ .+|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 4444555555544 344445555555555555555554444445555555555555555554444455555555555555
Q ss_pred ccccccCCCC-CCCCCcCCEEEcccCCC
Q 006145 212 NNHFYGEVPD-FSGLTYLQVLDLENNAL 238 (659)
Q Consensus 212 ~N~l~~~~p~-~~~l~~L~~L~L~~N~l 238 (659)
+|++++.++. |..+++|+.|+|++|.+
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 138 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPL 138 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCE
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCe
Confidence 5555544443 44555555555555544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-16 Score=167.87 Aligned_cols=145 Identities=13% Similarity=0.151 Sum_probs=101.1
Q ss_pred HHHHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCC-----C---------chHHHH--------HHHHHHh
Q 006145 471 ELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKC-----H---------STRNFM--------HHIELIS 528 (659)
Q Consensus 471 ~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----~---------~~~~~~--------~Ei~~l~ 528 (659)
.+.....-|.....||+|++|.||+|...+|+.||||+++.... . ...... +|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33333334788899999999999999988899999998753210 0 111222 3444555
Q ss_pred CCCCCCccceeeeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCcc
Q 006145 529 KLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVF 608 (659)
Q Consensus 529 ~l~H~niv~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 608 (659)
++.+.++....-+.. ...+|||||+++++|.++... .....++.|++.+|.|||+. +||
T Consensus 169 rL~~~gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIV 227 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLI 227 (397)
T ss_dssp HHHHTTCSCCCEEEE---------ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEE
T ss_pred HHHhcCCCCCeeeec---------cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCc
Confidence 553333221111111 124799999999998876432 12346789999999999998 999
Q ss_pred ccCCCCCceeecCCc----------ceEEccCcccccc
Q 006145 609 SNNLKITDILLDQNL----------VAKISSYNLPLLA 636 (659)
Q Consensus 609 HrDlk~~NILld~~~----------~~kl~DFGla~~~ 636 (659)
||||||.|||+++++ .+.|.||+-+...
T Consensus 228 HrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 228 HGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999999998876 3899999987543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.8e-15 Score=142.92 Aligned_cols=130 Identities=28% Similarity=0.266 Sum_probs=102.0
Q ss_pred CEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCC
Q 006145 110 KVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189 (659)
Q Consensus 110 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 189 (659)
+.+++++|+++. +|..+ .++|+.|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 445566666644 33333 368899999999998776677888999999999999998776777888999999999999
Q ss_pred cCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCC
Q 006145 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQF 242 (659)
Q Consensus 190 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~ 242 (659)
.+++..+..|..+++|+.|+|++|++++.++. +..+++|++|+|++|.+.+..
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 99877777788889999999999988877665 577888888888888776544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=2.3e-16 Score=144.60 Aligned_cols=128 Identities=24% Similarity=0.133 Sum_probs=103.2
Q ss_pred CCCCCcEEEcccCcCc-ccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcE
Q 006145 129 RLSSLEILNMSSNFLN-GAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRV 207 (659)
Q Consensus 129 ~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 207 (659)
..++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|.+++.+|..+..+++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3478999999999998 78888888999999999999999865 77888999999999999998878888888899999
Q ss_pred EeccccccccCC--CCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCc---hhccCCccccEEecc
Q 006145 208 LALSNNHFYGEV--PDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIP---AEVSSYYQLQRLDLS 279 (659)
Q Consensus 208 L~Ls~N~l~~~~--p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p---~~~~~l~~L~~L~Ls 279 (659)
|++++|++++.. ..+..+++|++|++++|.++ +..+ ..+..+++|+.||++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~---------------------~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT---------------------NLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG---------------------GSTTHHHHHHHHCTTCCEETTB
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCccc---------------------chHHHHHHHHHHCCCcccccCC
Confidence 999999988743 45778888888777776654 3333 356777777777765
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.4e-17 Score=187.94 Aligned_cols=274 Identities=17% Similarity=0.120 Sum_probs=131.1
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccC----CCCCCcEEEcccCc--Ccc-c
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKIS----RLSSLEILNMSSNF--LNG-A 146 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~----~l~~L~~L~Ls~N~--l~~-~ 146 (659)
.+++.|+|.++...+ ...++..+.++++|++|+|++|.+++..+..+. .+++|+.|++++|. ++. .
T Consensus 130 ~~L~~L~L~~~~~~~-------~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~ 202 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFS-------TDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSA 202 (594)
T ss_dssp TTCCEEEEESCEEEE-------HHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHH
T ss_pred CCCcEEeCCCcCCCC-------HHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHH
Confidence 478888888763110 011222334677777777777776655443333 55677777777775 221 1
Q ss_pred CChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCc--------------------------CC----ccCC
Q 006145 147 IPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM--------------------------FN----GTLP 196 (659)
Q Consensus 147 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~--------------------------l~----~~~p 196 (659)
++..+.++++|++|+|++|...+.+|..+..+++|+.|+++.+. +. +.+|
T Consensus 203 l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~ 282 (594)
T 2p1m_B 203 LERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLP 282 (594)
T ss_dssp HHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGG
T ss_pred HHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHH
Confidence 12223445777777777662222244444444555555433221 10 1122
Q ss_pred cccCCCCCCcEEeccccccccCCC-C-CCCCCcCCEEEcccC---------------------------------CCCCC
Q 006145 197 DSFSYLENLRVLALSNNHFYGEVP-D-FSGLTYLQVLDLENN---------------------------------ALGPQ 241 (659)
Q Consensus 197 ~~~~~l~~L~~L~Ls~N~l~~~~p-~-~~~l~~L~~L~L~~N---------------------------------~l~~~ 241 (659)
..+..+++|+.|+|++|.+++... . +..+++|++|++++| .+++.
T Consensus 283 ~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~ 362 (594)
T 2p1m_B 283 AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQ 362 (594)
T ss_dssp GGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHH
T ss_pred HHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCccCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHH
Confidence 222244556666665555443211 1 334455555555544 11110
Q ss_pred CC----CCCcccceEecCCCcCCccCchhcc-CCccccEEecc--C----ccccc-----CCchhhcCCCcccEEeccCC
Q 006145 242 FP----KVGKKLVTMILSKNKFRSAIPAEVS-SYYQLQRLDLS--S----NRFVG-----PFPQALLSLPSITYLNIADN 305 (659)
Q Consensus 242 ~~----~~~~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~-----~~p~~l~~l~~L~~L~l~~N 305 (659)
.. ..+++|+.|+++.|.+++..+..+. .+++|+.|+++ + |++++ .++..+..+++|+.|++++
T Consensus 363 ~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~- 441 (594)
T 2p1m_B 363 GLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG- 441 (594)
T ss_dssp HHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-
T ss_pred HHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-
Confidence 00 0123445555544554443333332 34555555555 2 33331 1122244455555555544
Q ss_pred cCCCcCCcCCCC-CCCCCEEECcCCCCcccCChhh-hCCCCCCEEEcCCccc
Q 006145 306 KLTGKLFDDLSC-NPELGFVDLSSNLLTGQLPNCL-LAGSKNRVVLYARNCL 355 (659)
Q Consensus 306 ~l~~~~p~~~~~-~~~L~~L~ls~N~l~g~ip~~~-~~~~~l~~l~~~~N~l 355 (659)
.+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.+++++|.+
T Consensus 442 ~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 442 LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 444333333332 5566666666666655444433 4456666666666655
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.61 E-value=4.3e-18 Score=192.28 Aligned_cols=202 Identities=14% Similarity=0.039 Sum_probs=130.1
Q ss_pred CCCCCcEEEeecCCCCCCCc-cccCCCCCCCEEEccCCcCCc-cCCcccCCCCCCcEEeccc---------cccccCC-C
Q 006145 153 ILTSLQTLILDENMLAGRVP-DWLGSLPILAVLSLRNNMFNG-TLPDSFSYLENLRVLALSN---------NHFYGEV-P 220 (659)
Q Consensus 153 ~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~---------N~l~~~~-p 220 (659)
.+++|++|+|++|.+++... ..+..+++|+.|++++| ++. .++.....+++|+.|++++ |.+++.. .
T Consensus 287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~ 365 (594)
T 2p1m_B 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLV 365 (594)
T ss_dssp HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHH
T ss_pred hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHH
Confidence 44555556665555443221 22445566666666655 221 1122222456666666632 2332211 1
Q ss_pred CC-CCCCcCCEEEcccCCCCCCCCC----CCcccceEecC--C----CcCCcc-----CchhccCCccccEEeccCcccc
Q 006145 221 DF-SGLTYLQVLDLENNALGPQFPK----VGKKLVTMILS--K----NKFRSA-----IPAEVSSYYQLQRLDLSSNRFV 284 (659)
Q Consensus 221 ~~-~~l~~L~~L~L~~N~l~~~~~~----~~~~L~~L~l~--~----N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~ 284 (659)
.+ .++++|+.|+++.|.+++..+. .+++|+.|+++ + |.++.. ++..+..+++|+.|+|++ +++
T Consensus 366 ~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~ 444 (594)
T 2p1m_B 366 SVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLT 444 (594)
T ss_dssp HHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCC
T ss_pred HHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-ccc
Confidence 11 2478899999988888754332 25789999999 4 566532 223367789999999987 777
Q ss_pred cCCchhhcC-CCcccEEeccCCcCCCcCCcCC-CCCCCCCEEECcCCCCcccCCh-hhhCCCCCCEEEcCCcccc
Q 006145 285 GPFPQALLS-LPSITYLNIADNKLTGKLFDDL-SCNPELGFVDLSSNLLTGQLPN-CLLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 285 ~~~p~~l~~-l~~L~~L~l~~N~l~~~~p~~~-~~~~~L~~L~ls~N~l~g~ip~-~~~~~~~l~~l~~~~N~l~ 356 (659)
+..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|.+++..+. ....+++|+.+++++|.++
T Consensus 445 ~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 445 DKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp HHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred HHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 666666665 8999999999999987655444 5689999999999999765544 3345788999999988653
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=5.5e-15 Score=141.75 Aligned_cols=128 Identities=20% Similarity=0.205 Sum_probs=97.5
Q ss_pred CEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCC
Q 006145 229 QVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLT 308 (659)
Q Consensus 229 ~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 308 (659)
+++++++|.++..+.....+|+.|++++|+|+ .+|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+
T Consensus 13 ~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~ 91 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91 (193)
T ss_dssp TEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccC
Confidence 34555555555444334456667777777775 46678888888888888888888877778888888888888888888
Q ss_pred CcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 309 GKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 309 ~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
+..|..|..+++|+.|+|++|++++..+..+..+++++.+++++|.+.+
T Consensus 92 ~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 92 CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp BCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred EeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 8877788888888888888888886555567778888888888887764
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.60 E-value=7.1e-18 Score=162.68 Aligned_cols=147 Identities=23% Similarity=0.305 Sum_probs=71.2
Q ss_pred CCCCcEEEcccCcCcccCCh------hccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCC
Q 006145 130 LSSLEILNMSSNFLNGAIPQ------ELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLE 203 (659)
Q Consensus 130 l~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 203 (659)
...++.++++.|.++|.+|. .+..+++|++|+|++|.+++ +| .+..+++|+.|++++|.++ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 34444444444444444443 45555555555555555543 34 4445555555555555554 3444444445
Q ss_pred CCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCc-hhccCCccccEEeccCcc
Q 006145 204 NLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIP-AEVSSYYQLQRLDLSSNR 282 (659)
Q Consensus 204 ~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~ 282 (659)
+|+.|+|++|++++. |.+..+++|++|++++|.++ +..+ ..+..+++|+.|++++|.
T Consensus 94 ~L~~L~L~~N~l~~l-~~~~~l~~L~~L~l~~N~i~---------------------~~~~~~~l~~l~~L~~L~l~~N~ 151 (198)
T 1ds9_A 94 TLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKIT---------------------NWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp HCSEEEEEEEECCCH-HHHHHHHHSSEEEESEEECC---------------------CHHHHHHHTTTTTCSEEEECSCH
T ss_pred cCCEEECcCCcCCcC-CccccCCCCCEEECCCCcCC---------------------chhHHHHHhcCCCCCEEEecCCc
Confidence 555555555555442 23444444444444444332 1111 245555566666666666
Q ss_pred cccCCch----------hhcCCCcccEEe
Q 006145 283 FVGPFPQ----------ALLSLPSITYLN 301 (659)
Q Consensus 283 l~~~~p~----------~l~~l~~L~~L~ 301 (659)
+++.+|. .+..+++|+.||
T Consensus 152 l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld 180 (198)
T 1ds9_A 152 LYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHHHHTTTTHHHHHHHHHHHCSSCSEEC
T ss_pred cccccccccchHHHHHHHHHhCCCcEEEC
Confidence 5554443 245555555554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.59 E-value=3e-15 Score=156.21 Aligned_cols=236 Identities=16% Similarity=0.175 Sum_probs=158.7
Q ss_pred CCCCCEEEecCCCCc--CCCCcccCCCCCCcEEEcccCcCcccCChhccC--------CCCCcEEEeecCCCCCCCcccc
Q 006145 106 LPDLKVLRLVSLGLW--GPLSGKISRLSSLEILNMSSNFLNGAIPQELSI--------LTSLQTLILDENMLAGRVPDWL 175 (659)
Q Consensus 106 l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~l 175 (659)
+++|+.|||++|++. ...+. .++.++.+.+..|.+ .+..|.+ +++|+.|+|.+ .++..-+.+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCccc---ccccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 677777888777776 22222 222244454444432 2344556 88888888888 7776666778
Q ss_pred CCCCCCCEEEccCCcCCccCCcccCCCCCCcEEecccccccc---CCC--CCCCCCcC----------------------
Q 006145 176 GSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYG---EVP--DFSGLTYL---------------------- 228 (659)
Q Consensus 176 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~p--~~~~l~~L---------------------- 228 (659)
.++++|+.|++++|.+....+..|.++.++..+.+..+.... .+. .|.++..|
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~ 200 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQ 200 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCC
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccC
Confidence 888888888888888877777778887777777766532210 111 13333333
Q ss_pred ----CEEEcccCCCCCCC---CCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCccc-EE
Q 006145 229 ----QVLDLENNALGPQF---PKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSIT-YL 300 (659)
Q Consensus 229 ----~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~-~L 300 (659)
..+.+.++-....+ ...+++|+.++|++|+++...+..|.++++|+.|+|.+| ++..-+.+|.++++|+ .+
T Consensus 201 ~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l 279 (329)
T 3sb4_A 201 PRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTL 279 (329)
T ss_dssp GGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred ccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEE
Confidence 33333332110000 001467888899988888777777888999999999887 7766677888888998 89
Q ss_pred eccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEc
Q 006145 301 NIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLY 350 (659)
Q Consensus 301 ~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~ 350 (659)
++.+ +++..-+..|..+++|+.+++++|+++..-+..+..+++|+.++.
T Consensus 280 ~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 280 ELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 8888 777666788888899999999888888666667778888877653
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.58 E-value=1.6e-15 Score=143.22 Aligned_cols=132 Identities=20% Similarity=0.241 Sum_probs=102.1
Q ss_pred cccCCCCCCEEEecCCCCcCCCCcccCCCC-CCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCC
Q 006145 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLS-SLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPI 180 (659)
Q Consensus 102 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 180 (659)
.+.++++|+.|+|++|+++. +|. +..+. +|++|+|++|.+++. ..+..+++|++|+|++|.+++..|..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 35567788888888888875 454 44444 888888888888865 56888888888888888888655555688888
Q ss_pred CCEEEccCCcCCccCCc--ccCCCCCCcEEeccccccccCCCC----CCCCCcCCEEEcccCCC
Q 006145 181 LAVLSLRNNMFNGTLPD--SFSYLENLRVLALSNNHFYGEVPD----FSGLTYLQVLDLENNAL 238 (659)
Q Consensus 181 L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~----~~~l~~L~~L~L~~N~l 238 (659)
|++|+|++|.++ .+|. .+..+++|+.|++++|.++..++. +..+++|++||+++|.+
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCH
Confidence 888888888886 4565 788888888888888888765443 77788888888888765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=3e-15 Score=141.24 Aligned_cols=86 Identities=19% Similarity=0.128 Sum_probs=42.4
Q ss_pred cCCCCCCcEEEcccCcCcccCChhccCC-CCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCC
Q 006145 127 ISRLSSLEILNMSSNFLNGAIPQELSIL-TSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL 205 (659)
Q Consensus 127 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 205 (659)
+.++++|+.|++++|.++. +|. +..+ ++|++|+|++|.+++. ..+..+++|++|+|++|.+++..|..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 4455566666666666652 333 2222 2555555555555543 344555555555555555553333333444455
Q ss_pred cEEeccccccc
Q 006145 206 RVLALSNNHFY 216 (659)
Q Consensus 206 ~~L~Ls~N~l~ 216 (659)
++|+|++|+++
T Consensus 91 ~~L~L~~N~i~ 101 (176)
T 1a9n_A 91 TELILTNNSLV 101 (176)
T ss_dssp CEEECCSCCCC
T ss_pred CEEECCCCcCC
Confidence 55555544443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=2.1e-17 Score=159.38 Aligned_cols=137 Identities=23% Similarity=0.211 Sum_probs=73.9
Q ss_pred ccCCCCCcEEEeecCCCCCCCcc------ccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCC
Q 006145 151 LSILTSLQTLILDENMLAGRVPD------WLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSG 224 (659)
Q Consensus 151 ~~~l~~L~~L~Ls~N~l~~~~p~------~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 224 (659)
+.....++.++++.|.+.|.+|. .+..+++|++|+|++|.+++ +| .+.++++|+.|++++|.++..+..+..
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~ 91 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAV 91 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhc
Confidence 44556677777777777766665 55555566666666555554 44 555555555555555555522211333
Q ss_pred CCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCc-hhhcCCCcccEEecc
Q 006145 225 LTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFP-QALLSLPSITYLNIA 303 (659)
Q Consensus 225 l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~l~ 303 (659)
+++|++|+|++|.+ ++ +| .+..+++|+.|++++|++++..+ ..+..+++|++|+++
T Consensus 92 ~~~L~~L~L~~N~l---------------------~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~ 148 (198)
T 1ds9_A 92 ADTLEELWISYNQI---------------------AS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLA 148 (198)
T ss_dssp HHHCSEEEEEEEEC---------------------CC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEEC
T ss_pred CCcCCEEECcCCcC---------------------Cc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEec
Confidence 34444444444433 22 23 35556666666666666654221 355566666666666
Q ss_pred CCcCCCcCC
Q 006145 304 DNKLTGKLF 312 (659)
Q Consensus 304 ~N~l~~~~p 312 (659)
+|.+++.+|
T Consensus 149 ~N~l~~~~~ 157 (198)
T 1ds9_A 149 GNPLYNDYK 157 (198)
T ss_dssp SCHHHHHHH
T ss_pred CCccccccc
Confidence 666655444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=6.7e-14 Score=131.20 Aligned_cols=87 Identities=26% Similarity=0.297 Sum_probs=43.9
Q ss_pred CCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEec
Q 006145 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLAL 210 (659)
Q Consensus 131 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 210 (659)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 44555555555555444444555555555555555555444444455555555555555555444444555555555555
Q ss_pred ccccccc
Q 006145 211 SNNHFYG 217 (659)
Q Consensus 211 s~N~l~~ 217 (659)
++|.++.
T Consensus 110 ~~N~~~c 116 (170)
T 3g39_A 110 LNNPWDC 116 (170)
T ss_dssp CSSCBCT
T ss_pred CCCCCCC
Confidence 5555443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=1.1e-13 Score=129.68 Aligned_cols=109 Identities=19% Similarity=0.166 Sum_probs=88.2
Q ss_pred CCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcC
Q 006145 228 LQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKL 307 (659)
Q Consensus 228 L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l 307 (659)
.+.+++++|.++..+....++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|
T Consensus 11 ~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l 90 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL 90 (170)
T ss_dssp TTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence 45666666666655444556777788888888888888888999999999999999987777788999999999999999
Q ss_pred CCcCCcCCCCCCCCCEEECcCCCCcccCC
Q 006145 308 TGKLFDDLSCNPELGFVDLSSNLLTGQLP 336 (659)
Q Consensus 308 ~~~~p~~~~~~~~L~~L~ls~N~l~g~ip 336 (659)
++..+..+..+++|+.|+|++|.++...+
T Consensus 91 ~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 91 KSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 98777778888999999999998886544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.3e-13 Score=129.86 Aligned_cols=87 Identities=23% Similarity=0.279 Sum_probs=44.7
Q ss_pred CCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEec
Q 006145 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLAL 210 (659)
Q Consensus 131 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 210 (659)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 44555555555555444555555555555555555555433334455555555555555555433334555555555555
Q ss_pred ccccccc
Q 006145 211 SNNHFYG 217 (659)
Q Consensus 211 s~N~l~~ 217 (659)
++|.+..
T Consensus 113 ~~N~~~c 119 (174)
T 2r9u_A 113 YNNPWDC 119 (174)
T ss_dssp CSSCBCT
T ss_pred CCCCccc
Confidence 5555543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.1e-13 Score=144.29 Aligned_cols=238 Identities=13% Similarity=0.066 Sum_probs=147.3
Q ss_pred CCEeEEEeCCCCCC--CCCCCCCcCCcccccccCCCCCCEEEecCC-----CCcCCCCcccCCCCCCcEEEcccCcCccc
Q 006145 74 ESITQLHIVGNKRA--PMLPLSFSMDSFVTTLVKLPDLKVLRLVSL-----GLWGPLSGKISRLSSLEILNMSSNFLNGA 146 (659)
Q Consensus 74 ~~v~~L~l~~~~~~--~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n-----~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 146 (659)
.+++.|||++|++. ...+. .++.++.+.+..| .|.+..+..+.++++|+.|+|++ .++..
T Consensus 49 ~~L~~LdLs~n~i~~~~~~~~------------~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I 115 (329)
T 3sb4_A 49 PSLKVLDISNAEIKMYSGKAG------------TYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNI 115 (329)
T ss_dssp TTCCEEEEEEEEECCEEESSS------------SSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEE
T ss_pred ccCeEEecCcceeEEecCccc------------cccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccch
Confidence 46899999998876 11111 1111233333333 22222222222277777777777 66655
Q ss_pred CChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCc----CCccCCcccCCCCCCc-EEec-----------
Q 006145 147 IPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM----FNGTLPDSFSYLENLR-VLAL----------- 210 (659)
Q Consensus 147 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~----l~~~~p~~~~~l~~L~-~L~L----------- 210 (659)
-+.+|.++++|+.|+|++|.+....+..|.++.++..+.+..+. ....-+..|.++.+|+ .+++
T Consensus 116 ~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~ 195 (329)
T 3sb4_A 116 EDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIM 195 (329)
T ss_dssp CTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHH
T ss_pred hHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHh
Confidence 55667777777777777777765556667666666666555422 1112222343444443 2222
Q ss_pred --------------cccccccCCCCC-CCCCcCCEEEcccCCCCCCCCCC---CcccceEecCCCcCCccCchhccCCcc
Q 006145 211 --------------SNNHFYGEVPDF-SGLTYLQVLDLENNALGPQFPKV---GKKLVTMILSKNKFRSAIPAEVSSYYQ 272 (659)
Q Consensus 211 --------------s~N~l~~~~p~~-~~l~~L~~L~L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~~~p~~~~~l~~ 272 (659)
.++-.......+ ..+++|+.|+|++|+++...+.. +.+|+.+++.+| ++..-+..|.++++
T Consensus 196 ~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~ 274 (329)
T 3sb4_A 196 KAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGR 274 (329)
T ss_dssp HTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred hcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChh
Confidence 221000000001 12677788888877776544443 467778888877 66666778999999
Q ss_pred cc-EEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEEC
Q 006145 273 LQ-RLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDL 326 (659)
Q Consensus 273 L~-~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~l 326 (659)
|+ .+++.+ +++..-+.+|.++++|+.+++++|+++...+..|..+++|+.++.
T Consensus 275 L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 275 LAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred ccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 99 999988 777667789999999999999999999888889999999998863
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=4.1e-13 Score=126.29 Aligned_cols=106 Identities=18% Similarity=0.189 Sum_probs=80.0
Q ss_pred CEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCC
Q 006145 229 QVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLT 308 (659)
Q Consensus 229 ~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 308 (659)
+.+++++|.++..+....++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+|+
T Consensus 15 ~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~ 94 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLK 94 (174)
T ss_dssp SEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccc
Confidence 45666666665444444566777777777777777778888888888888888888766666788888888888888888
Q ss_pred CcCCcCCCCCCCCCEEECcCCCCccc
Q 006145 309 GKLFDDLSCNPELGFVDLSSNLLTGQ 334 (659)
Q Consensus 309 ~~~p~~~~~~~~L~~L~ls~N~l~g~ 334 (659)
+..+..+..+++|+.|+|++|.+...
T Consensus 95 ~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 95 SIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred eeCHHHhccccCCCEEEeCCCCcccc
Confidence 76666688888888888888888743
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.42 E-value=6.6e-12 Score=134.19 Aligned_cols=238 Identities=11% Similarity=0.053 Sum_probs=112.3
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
..++.+.+.. .++..-..+|.+. +|+.++|..| ++..-..+|.++ +|+.+.|.. .+...-+..|.++++|+.++|
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 3444444432 2333334444443 4555555444 333333344442 455555543 343333345555555555555
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccCCC-CCCCCCcCCEEEcccCCCCCCCCCC--CcccceEecCCCcCCccC
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP-DFSGLTYLQVLDLENNALGPQFPKV--GKKLVTMILSKNKFRSAI 263 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~L~~N~l~~~~~~~--~~~L~~L~l~~N~l~~~~ 263 (659)
++|.++......|. ..+|+.+.|..+ ++.... .|.++++|+.+++..| ++..-... ..+|+.+.+ .|.++..-
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~~~L~~i~l-p~~i~~I~ 263 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRESGITTVKL-PNGVTNIA 263 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTTCCCSEEEE-ETTCCEEC
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCccccccccCCccEEEe-CCCccEEC
Confidence 55555533333333 345555555433 332222 1555555555555443 21111111 134555555 33344444
Q ss_pred chhccCCccccEEeccCcccc-----cCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChh
Q 006145 264 PAEVSSYYQLQRLDLSSNRFV-----GPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNC 338 (659)
Q Consensus 264 p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~ 338 (659)
+..|.++++|+.+++.+|.+. ...+..|.++++|+.++|. |.++..-...|..+++|+.+++.+| ++..-+..
T Consensus 264 ~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~a 341 (401)
T 4fdw_A 264 SRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSA 341 (401)
T ss_dssp TTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTS
T ss_pred hhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHh
Confidence 455666666666666655543 2334456666666666666 3355444455666666666666443 44233344
Q ss_pred hhCCCCCCEEEcCCcccc
Q 006145 339 LLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 339 ~~~~~~l~~l~~~~N~l~ 356 (659)
+..+ +|+.+.+.+|.+.
T Consensus 342 F~~~-~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 342 FNNT-GIKEVKVEGTTPP 358 (401)
T ss_dssp SSSS-CCCEEEECCSSCC
T ss_pred CCCC-CCCEEEEcCCCCc
Confidence 5555 6666666665443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.9e-11 Score=130.55 Aligned_cols=243 Identities=11% Similarity=0.050 Sum_probs=185.2
Q ss_pred cccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCC
Q 006145 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPIL 181 (659)
Q Consensus 102 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 181 (659)
.+.+. +|+.+.|..+ ++..-..+|.+. +|+.+++.. .++..-+.+|.++++|+.++|+.|+++..-...|. .++|
T Consensus 131 aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L 205 (401)
T 4fdw_A 131 AFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGI 205 (401)
T ss_dssp TTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCC
T ss_pred hcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-eccc
Confidence 34454 7999998776 776677788884 799999986 67756677899999999999999999855555665 6899
Q ss_pred CEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCC---CCcccceEecCCC
Q 006145 182 AVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPK---VGKKLVTMILSKN 257 (659)
Q Consensus 182 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~---~~~~L~~L~l~~N 257 (659)
+.+.|.++ ++..-...|.++++|+.+++..| ++..... |.+ .+|+.+.+.+ .++..... .+.+|+.+++.+|
T Consensus 206 ~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp~-~i~~I~~~aF~~c~~L~~l~l~~~ 281 (401)
T 4fdw_A 206 EEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLPN-GVTNIASRAFYYCPELAEVTTYGS 281 (401)
T ss_dssp SEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEET-TCCEECTTTTTTCTTCCEEEEESS
T ss_pred CEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeCC-CccEEChhHhhCCCCCCEEEeCCc
Confidence 99999854 77677778999999999999875 4433333 666 7899999954 44333222 3578999999888
Q ss_pred cCC-----ccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCc
Q 006145 258 KFR-----SAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLT 332 (659)
Q Consensus 258 ~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~ 332 (659)
.+. ...+..|.++++|+.++|. |.++..-..+|.++.+|+.++|.+| ++..-...|..+ +|+.+++++|.+.
T Consensus 282 ~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 282 TFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPP 358 (401)
T ss_dssp CCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCC
T ss_pred cccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCc
Confidence 775 3456779999999999999 4577666788999999999999665 776667788888 9999999999887
Q ss_pred ccCChhhhCCC-CCCEEEcCCcccc
Q 006145 333 GQLPNCLLAGS-KNRVVLYARNCLA 356 (659)
Q Consensus 333 g~ip~~~~~~~-~l~~l~~~~N~l~ 356 (659)
...+..+..++ .+..+.+..|.+.
T Consensus 359 ~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 359 QVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp BCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred ccccccccCCCCCccEEEeCHHHHH
Confidence 55555555553 5677887776543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=3.1e-12 Score=134.18 Aligned_cols=66 Identities=23% Similarity=0.219 Sum_probs=28.3
Q ss_pred cCCCCCCcEEEccc-CcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCC
Q 006145 127 ISRLSSLEILNMSS-NFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFN 192 (659)
Q Consensus 127 ~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 192 (659)
|..+++|+.|+|++ |.|++..|..|.+|++|++|+|++|+|++..|..|.+|++|+.|+|++|+|+
T Consensus 27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 93 (347)
T 2ifg_A 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (347)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccc
Confidence 44444444444442 4444333344444444444444444444444444444444444444444444
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=5e-12 Score=132.58 Aligned_cols=102 Identities=25% Similarity=0.245 Sum_probs=89.0
Q ss_pred EEEcccC-cCcccCChhccCCCCCcEEEeec-CCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccc
Q 006145 135 ILNMSSN-FLNGAIPQELSILTSLQTLILDE-NMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSN 212 (659)
Q Consensus 135 ~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 212 (659)
.++++++ +|+ .+|. +..+++|++|+|++ |+|++..|..|++|++|+.|+|++|+|++..|..|.+|++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4688888 888 5788 99999999999996 999988888999999999999999999999999999999999999999
Q ss_pred cccccCCCC-CCCCCcCCEEEcccCCCC
Q 006145 213 NHFYGEVPD-FSGLTYLQVLDLENNALG 239 (659)
Q Consensus 213 N~l~~~~p~-~~~l~~L~~L~L~~N~l~ 239 (659)
|+|++.++. |..++ |+.|+|.+|.+.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 999988776 44444 888888888775
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=4.4e-14 Score=149.59 Aligned_cols=110 Identities=19% Similarity=0.162 Sum_probs=52.7
Q ss_pred CCCCEEEecCCCCcCCCCcccCC-----CCCCcEEEcccCcCcccCChhc-cCCCCCcEEEeecCCCCCCCcccc-----
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISR-----LSSLEILNMSSNFLNGAIPQEL-SILTSLQTLILDENMLAGRVPDWL----- 175 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~l----- 175 (659)
+.|+.|+|++|.++......+.. .++|+.|+|++|.++..-...+ ..+++|+.|+|++|.++......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 45666666666665433322222 2566666666666653322222 234456666666666543322222
Q ss_pred CCCCCCCEEEccCCcCCcc----CCcccCCCCCCcEEeccccccc
Q 006145 176 GSLPILAVLSLRNNMFNGT----LPDSFSYLENLRVLALSNNHFY 216 (659)
Q Consensus 176 ~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 216 (659)
...++|+.|+|++|.|+.. ++..+..+++|++|+|++|.++
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence 2344555555555555421 2222334444444444444443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=2.1e-11 Score=122.41 Aligned_cols=148 Identities=9% Similarity=-0.038 Sum_probs=113.5
Q ss_pred HHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCC
Q 006145 473 EEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 473 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~ 551 (659)
......|.....++.|+.+.||++... +..+++|+..........++.+|+++++.+. |..+.++++++..
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~------- 81 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH------- 81 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-------
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-------
Confidence 334456777777888888999999854 6889999987543233456899999999885 6778889988865
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCC-----------------------------
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTG----------------------------- 602 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------- 602 (659)
.+..|+||||++|.+|.+.+.. ......++.+++++++.||+.
T Consensus 82 ~~~~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred CCceEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence 4568999999999999876421 112347888999999999981
Q ss_pred ---------------------------CCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 603 ---------------------------IVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 603 ---------------------------~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
..+.++|+|+++.||+++++..+.|.||+.+...
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 0145899999999999987766789999988544
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.6e-13 Score=145.34 Aligned_cols=73 Identities=19% Similarity=0.141 Sum_probs=39.2
Q ss_pred cCCccccEEeccCccccc----CCchhhcCCCcccEEeccCCcCCCc----CCcCCCCCCCCCEEECcCCCCcccCChhh
Q 006145 268 SSYYQLQRLDLSSNRFVG----PFPQALLSLPSITYLNIADNKLTGK----LFDDLSCNPELGFVDLSSNLLTGQLPNCL 339 (659)
Q Consensus 268 ~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~~~~~L~~L~ls~N~l~g~ip~~~ 339 (659)
...++|++|+|++|.|+. .++..+...++|+.|+|++|.++.. ++..+...+.|+.|||++|.|+..-...+
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 444555555555555542 1234455555666666666666542 22233345667777777777765444444
Q ss_pred h
Q 006145 340 L 340 (659)
Q Consensus 340 ~ 340 (659)
.
T Consensus 260 ~ 260 (372)
T 3un9_A 260 R 260 (372)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=4.9e-11 Score=119.32 Aligned_cols=131 Identities=15% Similarity=0.102 Sum_probs=97.1
Q ss_pred ccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCC--ccceeeeeeeccccCCCCceeEEEEeccC
Q 006145 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRH--LVSALGHCFECYFDDSSVSRIFLIFEYVP 563 (659)
Q Consensus 486 g~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~~~~~~~~lV~Ey~~ 563 (659)
+.|..+.||++...+|..+++|..... ....+.+|+++++.+++.+ +.+++++... .+..++||||++
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-------~~~~~~v~e~i~ 98 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-------AGRDWLLLGEVP 98 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-------SSCEEEEEECCS
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-------CCCCEEEEEecC
Confidence 455569999998777888999997543 2356889999999886545 4457776653 345799999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCC----------------------------------------
Q 006145 564 NGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI---------------------------------------- 603 (659)
Q Consensus 564 ~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------- 603 (659)
|.++. ... .+ ...++.++++.|+.||+..
T Consensus 99 G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 99 GQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp SEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred CcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 98884 221 11 2367778888888888741
Q ss_pred ---------------CCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 604 ---------------VPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 604 ---------------~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
.+.++|+|++|.||+++++..+.|.|||.+....
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~ 216 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 216 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence 1239999999999999987777899999986553
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=4.7e-10 Score=118.15 Aligned_cols=146 Identities=12% Similarity=0.189 Sum_probs=107.6
Q ss_pred CceeccCcCceEEEEEecCCcEEEEEEec--ccCC-CchHHHHHHHHHHhCCC--CCCccceeeeeeeccccCCCCceeE
Q 006145 482 SAFMGEGSQGQMYRGRLKNGTFVAIRCLK--MKKC-HSTRNFMHHIELISKLR--HRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~~g~~vavK~l~--~~~~-~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
.+.++.|.++.||+....+ ..+++|+.. .... ....++.+|+++++.++ +..+.++++++.+.. ..+..+
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~----~~g~~~ 117 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES----VIGRAF 117 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT----TTSSCE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC----ccCCeE
Confidence 4678999999999998764 578888775 3321 22356889999999887 456788888876521 124579
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCC---------------------------------
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI--------------------------------- 603 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------- 603 (659)
+||||++|..+.+... ..++..++..++.++++.|+.||+..
T Consensus 118 ~vme~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999999988864221 24778889999999999999999720
Q ss_pred ----------------------CCCccccCCCCCceeecCCcc--eEEccCccccccc
Q 006145 604 ----------------------VPGVFSNNLKITDILLDQNLV--AKISSYNLPLLAE 637 (659)
Q Consensus 604 ----------------------~~~iiHrDlk~~NILld~~~~--~kl~DFGla~~~~ 637 (659)
.+.++|+|+++.||++++++. +.|.||+.+...+
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 257999999999999997753 6899999987554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.93 E-value=3.4e-10 Score=118.85 Aligned_cols=40 Identities=18% Similarity=0.331 Sum_probs=21.2
Q ss_pred CccccEEeccCcccccC----CchhhcCCCcccEEeccCCcCCC
Q 006145 270 YYQLQRLDLSSNRFVGP----FPQALLSLPSITYLNIADNKLTG 309 (659)
Q Consensus 270 l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~ 309 (659)
+++|+.|+|+.|.+.+. ++..+..+++|+.|+|++|.++.
T Consensus 278 ~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp GGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 45566666666655542 22223345566666666665553
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.90 E-value=2.2e-10 Score=120.27 Aligned_cols=85 Identities=18% Similarity=0.263 Sum_probs=56.2
Q ss_pred CCccccEEeccCcccccCCchhhc---CCCcccEEeccCCcCCCc----CCcCCCCCCCCCEEECcCCCCcccCChhhhC
Q 006145 269 SYYQLQRLDLSSNRFVGPFPQALL---SLPSITYLNIADNKLTGK----LFDDLSCNPELGFVDLSSNLLTGQLPNCLLA 341 (659)
Q Consensus 269 ~l~~L~~L~Ls~N~l~~~~p~~l~---~l~~L~~L~l~~N~l~~~----~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~ 341 (659)
.+++|+.|+|++|.+....+..+. .+++|++|+|+.|.+++. ++..+..+++|+.|+|++|.++...-..+..
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~ 329 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence 467888888888887654443333 578899999999888763 3334456788999999988887543333332
Q ss_pred CCCCCEEEcCCcc
Q 006145 342 GSKNRVVLYARNC 354 (659)
Q Consensus 342 ~~~l~~l~~~~N~ 354 (659)
.- ...++++.|.
T Consensus 330 al-g~~~~~~~~~ 341 (362)
T 2ra8_A 330 SL-PMKIDVSDSQ 341 (362)
T ss_dssp HC-CSEEECCSBC
T ss_pred Hc-CCEEEecCCc
Confidence 11 3456777665
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.88 E-value=2.9e-08 Score=105.81 Aligned_cols=220 Identities=14% Similarity=0.065 Sum_probs=114.1
Q ss_pred CcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCC
Q 006145 124 SGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLE 203 (659)
Q Consensus 124 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 203 (659)
..+|.++++|+.+.+..+.. ..-...|.++++|+.+++..| +...-...|.++..|+.+.+..+... +.+.+....
T Consensus 155 ~~aF~~c~~L~~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~ 230 (394)
T 4fs7_A 155 DEAFATCESLEYVSLPDSME-TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKT 230 (394)
T ss_dssp TTTTTTCTTCCEEECCTTCC-EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTC
T ss_pred hhhhcccCCCcEEecCCccc-eeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccC
Confidence 44567777777777765532 234455677777777777655 33333456666666766666554332 222333445
Q ss_pred CCcEEeccccccccCCCCCCCCCcCCEEEcccCCCC--CCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCc
Q 006145 204 NLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALG--PQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSN 281 (659)
Q Consensus 204 ~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~--~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 281 (659)
+|+.+.+..+.-.-....|.++..|+.+.+..+... .........++.+....+.+ ....|..+.+|+.+.+..+
T Consensus 231 ~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~ 307 (394)
T 4fs7_A 231 GVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS 307 (394)
T ss_dssp CCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT
T ss_pred CCceEEECCCceecccccccccccceeEEcCCCcceeeccccccccccceeccCceee---ccccccccccccccccccc
Confidence 566665543321111112555666666666554321 11111233444444443322 1234555666666666543
Q ss_pred ccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCc
Q 006145 282 RFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARN 353 (659)
Q Consensus 282 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N 353 (659)
++..-..+|.++.+|+.++|.++ ++..-...|..+.+|+.+++..| ++..-..++..+.+|+.+.+..+
T Consensus 308 -i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 308 -VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp -CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred -cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 44333455666666666666533 44333455666666666666555 44223345556666666665443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.84 E-value=4.8e-08 Score=104.07 Aligned_cols=242 Identities=13% Similarity=0.064 Sum_probs=140.5
Q ss_pred cccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCC---------------
Q 006145 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENM--------------- 166 (659)
Q Consensus 102 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~--------------- 166 (659)
.+.++.+|+.+.|.. .++..-..+|.++++|+.++|..+ ++..-...|.++++|+.+.+..+-
T Consensus 66 AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~~ 143 (394)
T 4fs7_A 66 AFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFKE 143 (394)
T ss_dssp TTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCSE
T ss_pred HhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeecccccc
Confidence 355666777777753 355555566777777777777544 443334456666666655544321
Q ss_pred ------CCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCC-CCCCCCcCCEEEcccCCCC
Q 006145 167 ------LAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVP-DFSGLTYLQVLDLENNALG 239 (659)
Q Consensus 167 ------l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~L~~N~l~ 239 (659)
....-...|.++++|+.+.+.++. ...-...|.++.+|+.+++..| ++.... .|.++..|+.+.+..+...
T Consensus 144 ~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~ 221 (394)
T 4fs7_A 144 ITIPEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY 221 (394)
T ss_dssp EECCTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE
T ss_pred cccCccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE
Confidence 111112346667777777776543 3244455667777777777655 221111 2555555555554433211
Q ss_pred -CC-----------------------CCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCC
Q 006145 240 -PQ-----------------------FPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLP 295 (659)
Q Consensus 240 -~~-----------------------~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 295 (659)
+. ......+|+.+.+..+.. ......|..+..++.+....+.+. ...|..+.
T Consensus 222 i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~-~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~ 297 (394)
T 4fs7_A 222 LGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKL-RIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCS 297 (394)
T ss_dssp ECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTC-EECSCTTTTCTTCCEEEECSSEEC---TTTTTTCT
T ss_pred eehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcc-eeeccccccccccceeccCceeec---cccccccc
Confidence 00 011123455555544432 233345566666666666555432 34677889
Q ss_pred cccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCc
Q 006145 296 SITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARN 353 (659)
Q Consensus 296 ~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N 353 (659)
+|+.+.+.++ ++..-...|..+.+|+.+++.++ ++..-..++.++.+|+.+.+..|
T Consensus 298 ~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 298 SLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp TCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred cccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 9999999765 66555667889999999999755 66333567888899999988766
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.71 E-value=1.2e-10 Score=116.37 Aligned_cols=104 Identities=19% Similarity=0.212 Sum_probs=63.6
Q ss_pred cCCCCCCcE--EEcccCcCc---ccCChhccCCCCCcEEEeecCCCCC--CCccccCCCCCCCEEEccCCcCCccCCccc
Q 006145 127 ISRLSSLEI--LNMSSNFLN---GAIPQELSILTSLQTLILDENMLAG--RVPDWLGSLPILAVLSLRNNMFNGTLPDSF 199 (659)
Q Consensus 127 ~~~l~~L~~--L~Ls~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 199 (659)
|...+.|+. ++++.|... +.++-...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 334444554 566666432 2222223467777777777777776 4456666777777777777777754 233
Q ss_pred CCCC--CCcEEeccccccccCCCC--------CCCCCcCCEEE
Q 006145 200 SYLE--NLRVLALSNNHFYGEVPD--------FSGLTYLQVLD 232 (659)
Q Consensus 200 ~~l~--~L~~L~Ls~N~l~~~~p~--------~~~l~~L~~L~ 232 (659)
..++ +|++|+|++|.+.+.+|+ +..+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 3333 777777777777765552 45566676665
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.56 E-value=5.6e-06 Score=87.94 Aligned_cols=85 Identities=15% Similarity=0.169 Sum_probs=44.2
Q ss_pred hccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCC
Q 006145 266 EVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKN 345 (659)
Q Consensus 266 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l 345 (659)
.|.++++|+.+.+. +.++..-...|.++.+|+.++|..+ ++..-...|..+.+|+.+.+..+ ++..-...+.++.+|
T Consensus 283 aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L 359 (394)
T 4gt6_A 283 AFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTAL 359 (394)
T ss_dssp TTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTC
T ss_pred ccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCC
Confidence 34555555555554 3333333445556666666666543 44333445666666666666443 432223345556666
Q ss_pred CEEEcCCc
Q 006145 346 RVVLYARN 353 (659)
Q Consensus 346 ~~l~~~~N 353 (659)
+.+.+.+|
T Consensus 360 ~~i~~~~~ 367 (394)
T 4gt6_A 360 NNIEYSGS 367 (394)
T ss_dssp CEEEESSC
T ss_pred CEEEECCc
Confidence 66666554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.51 E-value=1.7e-08 Score=95.55 Aligned_cols=114 Identities=14% Similarity=0.206 Sum_probs=67.2
Q ss_pred cccCCCCCCEEEecCC-CCcCC----CCcccCCCCCCcEEEcccCcCccc----CChhccCCCCCcEEEeecCCCCCC--
Q 006145 102 TLVKLPDLKVLRLVSL-GLWGP----LSGKISRLSSLEILNMSSNFLNGA----IPQELSILTSLQTLILDENMLAGR-- 170 (659)
Q Consensus 102 ~l~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-- 170 (659)
.+...+.|++|+|++| .+... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|...
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 4556777777777777 66532 334455667777777777777532 334445556677777777776532
Q ss_pred --CccccCCCCCCCEEEc--cCCcCCcc----CCcccCCCCCCcEEecccccc
Q 006145 171 --VPDWLGSLPILAVLSL--RNNMFNGT----LPDSFSYLENLRVLALSNNHF 215 (659)
Q Consensus 171 --~p~~l~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l 215 (659)
+...+...++|++|+| ++|.+... +...+...++|++|+|++|.+
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 3344555566666666 55666532 222333445566666665554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.50 E-value=6.6e-09 Score=103.67 Aligned_cols=80 Identities=25% Similarity=0.218 Sum_probs=66.3
Q ss_pred CCCCCCcEEEcccCcCcc--cCChhccCCCCCcEEEeecCCCCCCCccccCCCC--CCCEEEccCCcCCccCCc------
Q 006145 128 SRLSSLEILNMSSNFLNG--AIPQELSILTSLQTLILDENMLAGRVPDWLGSLP--ILAVLSLRNNMFNGTLPD------ 197 (659)
Q Consensus 128 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~--~L~~L~L~~N~l~~~~p~------ 197 (659)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|+
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 568899999999999998 5667788999999999999999875 3344444 899999999999987773
Q ss_pred -ccCCCCCCcEEe
Q 006145 198 -SFSYLENLRVLA 209 (659)
Q Consensus 198 -~~~~l~~L~~L~ 209 (659)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 367889999887
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.43 E-value=3.7e-07 Score=93.46 Aligned_cols=141 Identities=16% Similarity=0.229 Sum_probs=98.1
Q ss_pred CceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCC-CCC--ccceeeeeeeccccCCCCceeEEE
Q 006145 482 SAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRH--LVSALGHCFECYFDDSSVSRIFLI 558 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~n--iv~l~g~~~~~~~~~~~~~~~~lV 558 (659)
.+.++.|....||+.. ..+++|+-... .....+.+|+++|+.+. +.. +.++++++... ......|+|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~----~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS----ETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC----SSCSCSCEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC----CCCCcceEE
Confidence 3568899999999863 45888886432 23467899999998874 333 33444333210 011235899
Q ss_pred EeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCC------------------------------------
Q 006145 559 FEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTG------------------------------------ 602 (659)
Q Consensus 559 ~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------ 602 (659)
|||++|.++.+.... .++..++..++.++++.++.||+.
T Consensus 95 m~~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp EECCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred EcccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 999999888753321 366777788888888888888851
Q ss_pred -------------------CCCCccccCCCCCceeecC--CcceEEccCccccccc
Q 006145 603 -------------------IVPGVFSNNLKITDILLDQ--NLVAKISSYNLPLLAE 637 (659)
Q Consensus 603 -------------------~~~~iiHrDlk~~NILld~--~~~~kl~DFGla~~~~ 637 (659)
..+.++|+|+++.||++++ ...+.|.||+.+...+
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence 1246899999999999998 5668899999986543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.38 E-value=3.5e-08 Score=93.31 Aligned_cols=116 Identities=15% Similarity=0.117 Sum_probs=78.8
Q ss_pred CCcccCCCCCCcEEEcccC-cCccc----CChhccCCCCCcEEEeecCCCCCC----CccccCCCCCCCEEEccCCcCCc
Q 006145 123 LSGKISRLSSLEILNMSSN-FLNGA----IPQELSILTSLQTLILDENMLAGR----VPDWLGSLPILAVLSLRNNMFNG 193 (659)
Q Consensus 123 ~p~~~~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~ 193 (659)
+...+...++|+.|+|++| .+... +...+...++|++|+|++|.+... +...+...++|++|+|++|.|..
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3445677889999999998 88632 445567778899999999888642 23445556778888888888874
Q ss_pred c----CCcccCCCCCCcEEec--cccccccCC-----CCCCCCCcCCEEEcccCCC
Q 006145 194 T----LPDSFSYLENLRVLAL--SNNHFYGEV-----PDFSGLTYLQVLDLENNAL 238 (659)
Q Consensus 194 ~----~p~~~~~l~~L~~L~L--s~N~l~~~~-----p~~~~l~~L~~L~L~~N~l 238 (659)
. +...+...++|++|+| ++|.+...- ..+...++|++|+|++|.+
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 3 3455666777888888 677775421 1144456677777666654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.35 E-value=2.5e-05 Score=82.89 Aligned_cols=244 Identities=11% Similarity=0.091 Sum_probs=134.1
Q ss_pred ccCCC-CCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCc---CcccCChhccCCCCCcEEEeecCCCCCCCccccCCC
Q 006145 103 LVKLP-DLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNF---LNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSL 178 (659)
Q Consensus 103 l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 178 (659)
+.++. .|+.+.+..+ ++..-..+|.++++|+.+.++.|. ++..-..+|.++.+|+.+.+..+ ++..-...|..+
T Consensus 59 F~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c 136 (394)
T 4gt6_A 59 FCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHC 136 (394)
T ss_dssp TTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTC
T ss_pred ccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhh
Confidence 34442 4666666543 555555667777777777766653 43333445666666666665443 333334456666
Q ss_pred CCCCEEEccCCcCCccCCcccCCCCCCcEEeccccc----------------------cccCCCCCCCCCcCCEEEcccC
Q 006145 179 PILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNH----------------------FYGEVPDFSGLTYLQVLDLENN 236 (659)
Q Consensus 179 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~----------------------l~~~~p~~~~l~~L~~L~L~~N 236 (659)
.+|+.+.+..+ +...-...|.++.+|+.+.+..+- ..-....|.++.+|.......+
T Consensus 137 ~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~~~~I~~~aF~~~~l~~i~ip~~~~~i~~~af~~c~~l~~~~~~~~ 215 (394)
T 4gt6_A 137 EELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDSVTAIEERAFTGTALTQIHIPAKVTRIGTNAFSECFALSTITSDSE 215 (394)
T ss_dssp TTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCCCSEEEECTTCCEECTTTTTTCTTCCEEEECCS
T ss_pred cccccccccce-eeeecccceecccccccccccceeeEeccccccccceeEEEECCcccccccchhhhccccceeccccc
Confidence 66666666543 232334455666666666665431 1111112334444444443332
Q ss_pred CCCCCCCCC----------------CcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEE
Q 006145 237 ALGPQFPKV----------------GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYL 300 (659)
Q Consensus 237 ~l~~~~~~~----------------~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 300 (659)
.....--.. ...+..+.+. +.++..-...|.++.+|+.+.+.++..+ .-...|.++++|+.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i 293 (394)
T 4gt6_A 216 SYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDI 293 (394)
T ss_dssp SSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEE
T ss_pred ccccccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccccccccc
Confidence 221100000 0011112111 1222222345778888999988765443 445678888999999
Q ss_pred eccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCc
Q 006145 301 NIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARN 353 (659)
Q Consensus 301 ~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N 353 (659)
.+. +.++..-...|..+.+|+.+++..+ ++..-..++..+.+|+.+.+..+
T Consensus 294 ~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s 344 (394)
T 4gt6_A 294 EFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS 344 (394)
T ss_dssp ECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT
T ss_pred cCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc
Confidence 986 4566555567888899999999765 55333456777888888887544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=3.7e-06 Score=84.25 Aligned_cols=137 Identities=13% Similarity=0.055 Sum_probs=93.6
Q ss_pred eeccCcCc-eEEEEEecC-CcEEEEEEecccCCCchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCCceeEEEEe
Q 006145 484 FMGEGSQG-QMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 484 ~ig~G~~g-~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
.+..|..| .||+..... +..+.+|+-... ...++.+|.+.|+.+. +--+.++++++.+ .+..++|||
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-------~~~~~lvme 100 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRT-------PDDAWLLTT 100 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-------TTEEEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEE-------CCeEEEEEE
Confidence 44556555 689987654 667889986532 3457889999988774 3346677887765 456799999
Q ss_pred ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCC--------------------------------------
Q 006145 561 YVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTG-------------------------------------- 602 (659)
Q Consensus 561 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------------------------------------- 602 (659)
++++.++.+..... ...+..++.++++.|+-||..
T Consensus 101 ~l~G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp CCCSEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred eeCCccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 99998876654321 112234455555555555531
Q ss_pred -----------------CCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 603 -----------------IVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 603 -----------------~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
..+.++|+|+.+.||++++++.+-|.||+.+...+
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD 225 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence 11247999999999999988777899999986553
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=3.7e-06 Score=86.07 Aligned_cols=139 Identities=14% Similarity=0.074 Sum_probs=92.8
Q ss_pred ceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCC---CccceeeeeeeccccCCCCceeEEEE
Q 006145 483 AFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHR---HLVSALGHCFECYFDDSSVSRIFLIF 559 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~~~~~~~~~~~~lV~ 559 (659)
+.++.|....||+. |..+++|+-... .....+.+|+++|+.+.+. .+.+++.++.. ..+..++||
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~------~~g~~~~v~ 92 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR------SDGNPFVGY 92 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC------TTSCEEEEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc------CCCceEEEE
Confidence 56778888899987 566888874321 2245789999999998753 35556655542 134568999
Q ss_pred eccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCC-------------------------------------
Q 006145 560 EYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTG------------------------------------- 602 (659)
Q Consensus 560 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------- 602 (659)
||++|.++.+..-. .++..++..++.++++.|+.||+.
T Consensus 93 e~i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 93 RKVQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp ECCCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred eccCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 99999888653211 234444455555555555555531
Q ss_pred --------------------CCCCccccCCCCCceeecC---Ccc-eEEccCcccccccc
Q 006145 603 --------------------IVPGVFSNNLKITDILLDQ---NLV-AKISSYNLPLLAEN 638 (659)
Q Consensus 603 --------------------~~~~iiHrDlk~~NILld~---~~~-~kl~DFGla~~~~~ 638 (659)
..+.++|+|+++.||++++ ++. ..|.||+.+...+.
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~ 227 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP 227 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence 2345799999999999997 455 58999998865543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.23 E-value=7.9e-05 Score=78.43 Aligned_cols=240 Identities=11% Similarity=-0.029 Sum_probs=122.2
Q ss_pred cccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCC
Q 006145 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPIL 181 (659)
Q Consensus 102 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 181 (659)
.+.++.+|+.++|..+ ++..-..+|.++ +|+.+.+..+ ++..-..+|.+ .+|+.+.+..+- ...-...|.+. +|
T Consensus 64 aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp~~~-~~i~~~~F~~~-~l 137 (379)
T 4h09_A 64 NFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFPGAT-TEIGNYIFYNS-SV 137 (379)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECCTTC-CEECTTTTTTC-CC
T ss_pred HhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCCCcc-ccccccccccc-ee
Confidence 4567778888887643 555555667666 5666666543 33233334444 367777776542 21222333332 45
Q ss_pred CEEEccCCcCCccCCcccCCCCCCcEEeccccccccC------------------------------------CCCCCCC
Q 006145 182 AVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGE------------------------------------VPDFSGL 225 (659)
Q Consensus 182 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~------------------------------------~p~~~~l 225 (659)
+.+.+..+ ++..-...|.++.+|+.+.+..+..... ...+...
T Consensus 138 ~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~ 216 (379)
T 4h09_A 138 KRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYGFSYG 216 (379)
T ss_dssp CEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTTTTTC
T ss_pred eeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEeecccccc
Confidence 55554432 3334445566667777666554322110 0013334
Q ss_pred CcCCEEEcccCCCC--CCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEecc
Q 006145 226 TYLQVLDLENNALG--PQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIA 303 (659)
Q Consensus 226 ~~L~~L~L~~N~l~--~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~ 303 (659)
.+|+.+.+..+--. ........+|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|..+.+|+.+.+.
T Consensus 217 ~~l~~i~~~~~~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~ 294 (379)
T 4h09_A 217 KNLKKITITSGVTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMD 294 (379)
T ss_dssp SSCSEEECCTTCCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEEC
T ss_pred cccceeeeccceeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccccccc
Confidence 44444444332100 000111345555555543 43333445666666666666533 333334456666777777776
Q ss_pred CCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcC
Q 006145 304 DNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYA 351 (659)
Q Consensus 304 ~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~ 351 (659)
++.++..-...|..+.+|+.++|..+ ++-.-..++.++.+|+.+.+.
T Consensus 295 ~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 295 NSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp CTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred ccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 66666555556666667777776544 432223345555666555543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=6.4e-06 Score=86.14 Aligned_cols=83 Identities=11% Similarity=0.034 Sum_probs=55.8
Q ss_pred cee-ccCcCceEEEEEec-------CCcEEEEEEecccC---CCchHHHHHHHHHHhCCC-C--CCccceeeeeeecccc
Q 006145 483 AFM-GEGSQGQMYRGRLK-------NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLR-H--RHLVSALGHCFECYFD 548 (659)
Q Consensus 483 ~~i-g~G~~g~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~ 548 (659)
+.| +.|....+|+.... ++..+++|+-.... ......+.+|+++++.+. + -.+.++++++.+..
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~-- 103 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD-- 103 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST--
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC--
Confidence 566 77888999998764 26678888865432 112246788988888874 2 35667777765411
Q ss_pred CCCCceeEEEEeccCCCChhh
Q 006145 549 DSSVSRIFLIFEYVPNGTLRS 569 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~ 569 (659)
..+..++||||++|..+.+
T Consensus 104 --~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 --VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp --TTSSCEEEEECCCCBCCCB
T ss_pred --ccCCceEEEEecCCCChhh
Confidence 0134689999999877654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.00 E-value=0.00045 Score=72.57 Aligned_cols=241 Identities=11% Similarity=0.029 Sum_probs=147.7
Q ss_pred ccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCC
Q 006145 103 LVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILA 182 (659)
Q Consensus 103 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (659)
+....+|+.+.+.. .++..-..+|.++++|+.++|..+ ++..-..+|.++ +|+.+.+..+ +...-...|.. .+|+
T Consensus 42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~ 116 (379)
T 4h09_A 42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLD 116 (379)
T ss_dssp GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCS
T ss_pred cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcc
Confidence 44566788888865 466666788999999999999755 664555678777 6888887654 44333345554 4899
Q ss_pred EEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCC---------------------
Q 006145 183 VLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQ--------------------- 241 (659)
Q Consensus 183 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~--------------------- 241 (659)
.+.+..+ +...-...|.+. +|+.+.+..+--.-....|..+.+++.+.+..+.....
T Consensus 117 ~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (379)
T 4h09_A 117 DFEFPGA-TTEIGNYIFYNS-SVKRIVIPKSVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAK 194 (379)
T ss_dssp EEECCTT-CCEECTTTTTTC-CCCEEEECTTCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTC
T ss_pred cccCCCc-cccccccccccc-eeeeeeccceeeccccchhcccccccccccccccceeecccceecccccceeccccccc
Confidence 9999765 332334455554 57666665442211122377778888877765432110
Q ss_pred ------CCC-----------CCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccC
Q 006145 242 ------FPK-----------VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIAD 304 (659)
Q Consensus 242 ------~~~-----------~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~ 304 (659)
+|. ...+|+.+.+..+ +.......|.++..|+.+.+..+ ++..-...|.++.+|+.+.+..
T Consensus 195 ~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~ 272 (379)
T 4h09_A 195 TGTEFTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYA 272 (379)
T ss_dssp CCSEEECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECC
T ss_pred cccccccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccccc
Confidence 000 0123444444322 33333445666677777777655 4444455677777777777754
Q ss_pred CcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCc
Q 006145 305 NKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARN 353 (659)
Q Consensus 305 N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N 353 (659)
+ ++......|..+.+|+.+++.++.++..-+.++..+.+|+.+.+..+
T Consensus 273 ~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 273 K-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp C-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred c-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 3 44344456777778888888777776444456667777777776543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.81 E-value=6.2e-05 Score=76.07 Aligned_cols=76 Identities=18% Similarity=0.137 Sum_probs=55.3
Q ss_pred CCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCC---CCccceeeeeeeccccCCCCceeEE
Q 006145 481 TSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRH---RHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 481 ~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
..+.+|.|..+.||+.++.+|+.|.||+-..........|.+|++.|+.+.- --+.+++++. .-++
T Consensus 19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-----------~~~l 87 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-----------DRTL 87 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-----------TTEE
T ss_pred EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-----------CceE
Confidence 3467899999999999999999999998765443334568899998887742 2344444432 1379
Q ss_pred EEeccCCCCh
Q 006145 558 IFEYVPNGTL 567 (659)
Q Consensus 558 V~Ey~~~GsL 567 (659)
||||++.+..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.74 E-value=7.8e-05 Score=77.07 Aligned_cols=148 Identities=9% Similarity=0.111 Sum_probs=80.1
Q ss_pred ceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCC--CCccceeeeeeeccccCCCCceeEEEEe
Q 006145 483 AFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRH--RHLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
+.|+.|..+.||+....+| .+++|+... ...+...|++++..+.. -.+.+++......... ...+..++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~-~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYS-KHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCE-EETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEE-EECCEEEEEEE
Confidence 3455567889999987655 488998864 22344455555554431 1233333210000000 01345789999
Q ss_pred ccCCCChh--------------hhhcC--C-C--C------CCCCCHHHHH-----------------------------
Q 006145 561 YVPNGTLR--------------SWISE--G-H--A------HQSLTWTQRI----------------------------- 586 (659)
Q Consensus 561 y~~~GsL~--------------~~l~~--~-~--~------~~~l~~~~~~----------------------------- 586 (659)
|++|.++. ..+|. . . . ...-.|....
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986553 01221 0 0 0 0112343211
Q ss_pred --HHHHHHHHHhhhhcC----------CCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 587 --SAAIGVAKGIQFLHT----------GIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 587 --~i~~~ia~~L~yLH~----------~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
.+...+.+++++|+. ...+.++|+|+.+.||+++.++.+.|.||+.+...
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 011123346667763 12458999999999999988888999999988544
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=9.7e-05 Score=78.36 Aligned_cols=75 Identities=8% Similarity=-0.001 Sum_probs=48.4
Q ss_pred CceeccCcCceEEEEEec-CCcEEEEEEecccCC-------CchHHHHHHHHHHhCCCC--CCc-cceeeeeeeccccCC
Q 006145 482 SAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-------HSTRNFMHHIELISKLRH--RHL-VSALGHCFECYFDDS 550 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~H--~ni-v~l~g~~~~~~~~~~ 550 (659)
.+.+|.|..+.||+++.. +++.|+||....... ....++.+|+++++.+.. +.. .+++.+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------- 106 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------- 106 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--------
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--------
Confidence 467899999999999864 478899998653211 123457889888887742 333 3454332
Q ss_pred CCceeEEEEeccCCC
Q 006145 551 SVSRIFLIFEYVPNG 565 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~G 565 (659)
.+..++||||+++.
T Consensus 107 -~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 107 -TEMAVTVMEDLSHL 120 (397)
T ss_dssp -TTTTEEEECCCTTS
T ss_pred -CCccEEEEEeCCCc
Confidence 22358999999864
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.53 E-value=3.7e-05 Score=71.10 Aligned_cols=82 Identities=12% Similarity=0.064 Sum_probs=40.8
Q ss_pred CCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCc-CcccCChhccCC----CCCcEEEeecCC-CCCCCccccCCCCCC
Q 006145 108 DLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNF-LNGAIPQELSIL----TSLQTLILDENM-LAGRVPDWLGSLPIL 181 (659)
Q Consensus 108 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~l~~l~~L 181 (659)
.|+.|||+++.++..--..+.++++|+.|+|++|. ++..--..++.+ ++|++|+|++|. ++..-=..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 46666666666554433445566666666666663 443222233332 246666666553 432222234445555
Q ss_pred CEEEccCC
Q 006145 182 AVLSLRNN 189 (659)
Q Consensus 182 ~~L~L~~N 189 (659)
+.|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555544
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.49 E-value=3.2e-05 Score=71.49 Aligned_cols=83 Identities=11% Similarity=0.083 Sum_probs=48.9
Q ss_pred CCCcEEEcccCcCcccCChhccCCCCCcEEEeecCC-CCCCCccccCCC----CCCCEEEccCCc-CCccCCcccCCCCC
Q 006145 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENM-LAGRVPDWLGSL----PILAVLSLRNNM-FNGTLPDSFSYLEN 204 (659)
Q Consensus 131 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~ 204 (659)
.+|+.|||+++.++..--..+.++++|+.|+|++|. ++..-=..+..+ ++|++|+|++|. ++..-=..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 468888888888765434456677778888887774 443222234443 256777776653 54322223455566
Q ss_pred CcEEecccc
Q 006145 205 LRVLALSNN 213 (659)
Q Consensus 205 L~~L~Ls~N 213 (659)
|+.|+|+++
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 666666655
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0014 Score=66.86 Aligned_cols=138 Identities=10% Similarity=0.115 Sum_probs=90.7
Q ss_pred CceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCC---CCCccceeeeeeeccccCCCCceeEEE
Q 006145 482 SAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLR---HRHLVSALGHCFECYFDDSSVSRIFLI 558 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~~~~~~~~lV 558 (659)
.+.|+.|....+|+... ++..+++|+-... ....|.+|++.|+.+. ...+.++++++.. .+..++|
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-------~g~~~lv 109 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-------QGHSFLL 109 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-------SSEEEEE
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-------CCceEEE
Confidence 46788999999999886 4667888887532 3466889998888874 3567888887754 3568999
Q ss_pred EeccCCCChhh-----------hhcCCCC--C-----------------CCCCHHHHH---HHH--HH------------
Q 006145 559 FEYVPNGTLRS-----------WISEGHA--H-----------------QSLTWTQRI---SAA--IG------------ 591 (659)
Q Consensus 559 ~Ey~~~GsL~~-----------~l~~~~~--~-----------------~~l~~~~~~---~i~--~~------------ 591 (659)
|||+++..+.. .||.... . -.-+|.... ++. .+
T Consensus 110 me~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~ 189 (312)
T 3jr1_A 110 LEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNI 189 (312)
T ss_dssp EECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCH
T ss_pred EEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHH
Confidence 99999876521 1232111 0 012565422 111 11
Q ss_pred --HHH-Hhhhhc-CCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 592 --VAK-GIQFLH-TGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 592 --ia~-~L~yLH-~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
+.+ ..+.|. ....|.++|+|+.+.||+++.++ +.|.||.
T Consensus 190 ~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 190 DLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 122342 22467899999999999999887 8899984
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.001 Score=68.06 Aligned_cols=166 Identities=10% Similarity=0.135 Sum_probs=89.4
Q ss_pred cCHHHHHHhhcCCCCC-----ceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCC--cccee
Q 006145 467 FSLEELEEATNNFDTS-----AFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRH--LVSAL 539 (659)
Q Consensus 467 ~~~~~l~~~~~~~~~~-----~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~ 539 (659)
++.+++......|... +.|+.|....+|+....+| .+++|...... ..+++..|++++..+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 5566666666666552 3456677789999987656 57788876421 2345667777777664222 23333
Q ss_pred eeeeeccccCCCCceeEEEEeccCCCChhh--------------hhcCC--C--CC-----CCCCHHHHHHH--------
Q 006145 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRS--------------WISEG--H--AH-----QSLTWTQRISA-------- 588 (659)
Q Consensus 540 g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~--------------~l~~~--~--~~-----~~l~~~~~~~i-------- 588 (659)
......... ...+..++|+||++|..+.. .+|.. . .. ....|.....-
T Consensus 84 ~~~~g~~~~-~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 84 PRKDGELLG-ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CBTTCCSCE-EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred CCCCCCEEE-EECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 211000000 00245689999999865421 11210 0 00 00124331110
Q ss_pred ----HHHHHHHhhhhcC----CCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 589 ----AIGVAKGIQFLHT----GIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 589 ----~~~ia~~L~yLH~----~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
...+.+.++++++ ...+.++|+|+.+.||+++++..+.|.||+.+...
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g 218 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACND 218 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccCc
Confidence 0113344455542 22357899999999999998766689999987543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0014 Score=69.88 Aligned_cols=33 Identities=6% Similarity=0.237 Sum_probs=28.5
Q ss_pred CCccccCCCCCceeecCCcceEEccCcccccccc
Q 006145 605 PGVFSNNLKITDILLDQNLVAKISSYNLPLLAEN 638 (659)
Q Consensus 605 ~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~ 638 (659)
+.++|+|+++.||++++++ ++|.||+.+.....
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p 264 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM 264 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCch
Confidence 4899999999999998776 99999999876543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0067 Score=62.04 Aligned_cols=148 Identities=5% Similarity=0.060 Sum_probs=82.2
Q ss_pred ceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCC--CccceeeeeeeccccCCCCceeEEEEe
Q 006145 483 AFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHR--HLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
..++ |....||+....+|+.+++|...... ....++..|.+++..+... .+.+++.. ++..-....+..++|||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence 3466 77789999887778789999986432 2345677788887777422 24444443 11000000245688999
Q ss_pred ccCCCChhh-----------h---hcC----CC--CCCCCCHHHH----HHH---------------HHHHHHHhhhhcC
Q 006145 561 YVPNGTLRS-----------W---ISE----GH--AHQSLTWTQR----ISA---------------AIGVAKGIQFLHT 601 (659)
Q Consensus 561 y~~~GsL~~-----------~---l~~----~~--~~~~l~~~~~----~~i---------------~~~ia~~L~yLH~ 601 (659)
|++|.++.. . +|. .. .....++... ..+ ...+.+.++.+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 998755421 0 111 00 0112233211 000 0011111222221
Q ss_pred ----CCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 602 ----GIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 602 ----~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
...+.++|+|+++.||+++ + .+.|.||+.+...
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1234689999999999999 4 8999999887544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0003 Score=66.28 Aligned_cols=87 Identities=13% Similarity=0.123 Sum_probs=48.0
Q ss_pred ccCCCCCCEEEecCC-CCcCC----CCcccCCCCCCcEEEcccCcCcc----cCChhccCCCCCcEEEeecCCCCCC---
Q 006145 103 LVKLPDLKVLRLVSL-GLWGP----LSGKISRLSSLEILNMSSNFLNG----AIPQELSILTSLQTLILDENMLAGR--- 170 (659)
Q Consensus 103 l~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~--- 170 (659)
+.+-+.|+.|+|++| .+... +-..+..-+.|+.|+|++|.|.. .+...+..-+.|+.|+|+.|.|...
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 345566777777764 55321 23345555677777777777752 2233444556677777777766532
Q ss_pred -CccccCCCCCCCEEEccCC
Q 006145 171 -VPDWLGSLPILAVLSLRNN 189 (659)
Q Consensus 171 -~p~~l~~l~~L~~L~L~~N 189 (659)
+-+.+..-+.|+.|+|++|
T Consensus 117 ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHhhCCceeEEECCCC
Confidence 1223344445666666543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.003 Score=67.49 Aligned_cols=72 Identities=19% Similarity=0.256 Sum_probs=48.4
Q ss_pred ceeccCcCceEEEEEecC--------CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCc-cceeeeeeeccccCCCCc
Q 006145 483 AFMGEGSQGQMYRGRLKN--------GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHL-VSALGHCFECYFDDSSVS 553 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~~~~~ 553 (659)
+.|+.|....+|++...+ +..+++|+.... .....+.+|..+++.+...++ .++++.+.+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~--------- 147 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG--------- 147 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---------
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC---------
Confidence 567778888999998753 478899987431 112566789988888753334 556654421
Q ss_pred eeEEEEeccCCCCh
Q 006145 554 RIFLIFEYVPNGTL 567 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL 567 (659)
.+|+||+++.++
T Consensus 148 --g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 --GRLEEYIPSRPL 159 (429)
T ss_dssp --EEEECCCCEEEC
T ss_pred --CEEEEEeCCccc
Confidence 389999986444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0078 Score=61.78 Aligned_cols=34 Identities=6% Similarity=0.034 Sum_probs=28.6
Q ss_pred CCCccccCCCCCceeecCC----cceEEccCccccccc
Q 006145 604 VPGVFSNNLKITDILLDQN----LVAKISSYNLPLLAE 637 (659)
Q Consensus 604 ~~~iiHrDlk~~NILld~~----~~~kl~DFGla~~~~ 637 (659)
.+.++|+|+.+.||+++++ ..+.|.||+.+....
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 4579999999999999875 678999999886553
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0029 Score=55.47 Aligned_cols=54 Identities=15% Similarity=0.227 Sum_probs=23.5
Q ss_pred EEEcccCCCC--CCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCccc
Q 006145 230 VLDLENNALG--PQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRF 283 (659)
Q Consensus 230 ~L~L~~N~l~--~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 283 (659)
.++.+++.++ ..+.....+|+.|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4445555444 22222233444444444444443344444444444444444443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0044 Score=62.67 Aligned_cols=140 Identities=10% Similarity=-0.012 Sum_probs=74.8
Q ss_pred CceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCc-cceeeeeeeccccCCCCceeEEEEe
Q 006145 482 SAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHL-VSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
.+.|+.|....+|+. ..+++|+...... ...+..+|+++++.+....+ .++++++. +.-++|+|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~---------~~~~~v~e 87 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVDP---------ATGVMVTR 87 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT---------TTCCEEEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEEC---------CCCEEEEe
Confidence 577888999999998 4588887754321 11223567777776643233 35554332 22478999
Q ss_pred cc-CCCChhh------------------hhcCCCCC--CCCCHHHHH-HHHHH--------------HHHHh----hhhc
Q 006145 561 YV-PNGTLRS------------------WISEGHAH--QSLTWTQRI-SAAIG--------------VAKGI----QFLH 600 (659)
Q Consensus 561 y~-~~GsL~~------------------~l~~~~~~--~~l~~~~~~-~i~~~--------------ia~~L----~yLH 600 (659)
|+ ++.++.. -+|..... ...+...++ .+... +.+.+ +.+.
T Consensus 88 ~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~ 167 (301)
T 3dxq_A 88 YIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALA 167 (301)
T ss_dssp CCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHH
T ss_pred ecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHH
Confidence 99 5544431 11211100 011111111 11100 01111 1111
Q ss_pred -CCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 601 -TGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 601 -~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
....+.++|+|+.+.||+ .+++.+.+.||..+...+
T Consensus 168 ~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 168 AHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp SSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred hcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 122346899999999999 666778999999886543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.56 E-value=0.00055 Score=64.45 Aligned_cols=88 Identities=13% Similarity=0.173 Sum_probs=54.6
Q ss_pred ccCCCCCCcEEEcccC-cCcc----cCChhccCCCCCcEEEeecCCCCCC----CccccCCCCCCCEEEccCCcCCcc--
Q 006145 126 KISRLSSLEILNMSSN-FLNG----AIPQELSILTSLQTLILDENMLAGR----VPDWLGSLPILAVLSLRNNMFNGT-- 194 (659)
Q Consensus 126 ~~~~l~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~-- 194 (659)
.+.+-+.|+.|+|++| .|.. .+-..+..-+.|+.|+|++|+|... +-+.+..-+.|+.|+|++|.|...
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3455678888888885 6642 2345566677888888888887632 223344456677777777777642
Q ss_pred --CCcccCCCCCCcEEecccc
Q 006145 195 --LPDSFSYLENLRVLALSNN 213 (659)
Q Consensus 195 --~p~~~~~l~~L~~L~Ls~N 213 (659)
+-+.+..-+.|+.|+|++|
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHhhCCceeEEECCCC
Confidence 2223444455677777654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.012 Score=63.24 Aligned_cols=73 Identities=12% Similarity=0.037 Sum_probs=45.9
Q ss_pred ceeccCcCceEEEEEecC-CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCc-cceeeeeeeccccCCCCceeEEEEe
Q 006145 483 AFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHL-VSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
+.|+.|-...+|+....+ +..+++|+..... ...-+-.+|.+++..+...++ .++++++. + .+|||
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~---------~--G~v~e 181 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT---------N--GRIEE 181 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET---------T--EEEEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC---------C--eEEEE
Confidence 567778888999998765 4778888874322 111122578888888865445 45665542 1 35999
Q ss_pred ccCCCCh
Q 006145 561 YVPNGTL 567 (659)
Q Consensus 561 y~~~GsL 567 (659)
|+++.++
T Consensus 182 ~I~G~~l 188 (458)
T 2qg7_A 182 FMDGYAL 188 (458)
T ss_dssp CCCSEEC
T ss_pred eeCCccC
Confidence 9987554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0099 Score=62.21 Aligned_cols=142 Identities=11% Similarity=0.075 Sum_probs=82.4
Q ss_pred ceeccCcCceEEEEEecC--------CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCC-ccceeeeeeeccccCCCCc
Q 006145 483 AFMGEGSQGQMYRGRLKN--------GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRH-LVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~~~~~ 553 (659)
+.+..|-...+|++...+ ++.+++|+... .......+.+|.++++.+.-.+ ..++++++. +
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~---------~ 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP---------E 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET---------T
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC---------C
Confidence 456667778899998752 47889998632 1223456778999888774222 345555542 1
Q ss_pred eeEEEEeccCCCChhhh-----------------hcCCC--CCCCCC--HHHHHHHHHHHHH------------------
Q 006145 554 RIFLIFEYVPNGTLRSW-----------------ISEGH--AHQSLT--WTQRISAAIGVAK------------------ 594 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~ia~------------------ 594 (659)
.+||||++|.++..- ||... ...... |.+..++..++..
T Consensus 126 --g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 203 (379)
T 3feg_A 126 --GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK 203 (379)
T ss_dssp --EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred --ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence 399999998665311 12111 011222 3444444443322
Q ss_pred -Hhhhhc----C-CCCCCccccCCCCCceeecCC----cceEEccCcccccc
Q 006145 595 -GIQFLH----T-GIVPGVFSNNLKITDILLDQN----LVAKISSYNLPLLA 636 (659)
Q Consensus 595 -~L~yLH----~-~~~~~iiHrDlk~~NILld~~----~~~kl~DFGla~~~ 636 (659)
.+++|. . .....++|+|+.+.||+++++ +.+.+.||..+...
T Consensus 204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 122222 1 223468999999999999876 78999999988544
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0036 Score=54.80 Aligned_cols=34 Identities=26% Similarity=0.278 Sum_probs=13.0
Q ss_pred CCEEEccCCcCCccCCcccCCCCCCcEEeccccc
Q 006145 181 LAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNH 214 (659)
Q Consensus 181 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 214 (659)
|+.|+|++|+|+..-+..|..+++|+.|+|++|.
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP 66 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANP 66 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCC
Confidence 3333333333333222333334444444444443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.11 E-value=0.0073 Score=63.01 Aligned_cols=73 Identities=18% Similarity=0.119 Sum_probs=42.3
Q ss_pred ceeccCcCceEEEEEecC---------CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCc-cceeeeeeeccccCCCC
Q 006145 483 AFMGEGSQGQMYRGRLKN---------GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHL-VSALGHCFECYFDDSSV 552 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~~~~ 552 (659)
..++.|....+|+....+ +..+++|+..... ....+..+|.++++.+...++ .++++...
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~--------- 108 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTFN--------- 108 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEET---------
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEecC---------
Confidence 456777778999998653 2678888764321 111124578877777753333 35554321
Q ss_pred ceeEEEEeccCCCCh
Q 006145 553 SRIFLIFEYVPNGTL 567 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL 567 (659)
-++||||++|.++
T Consensus 109 --~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 --GGRIEEWLYGDPL 121 (369)
T ss_dssp --TEEEEECCCSEEC
T ss_pred --CcEEEEEecCCcC
Confidence 2689999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.77 E-value=0.071 Score=54.79 Aligned_cols=34 Identities=15% Similarity=0.256 Sum_probs=29.0
Q ss_pred CCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 604 VPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 604 ~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
.+.++|+|+.+.||++++++.+.|.||+.+...+
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 3578999999999999988889999998875443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.93 E-value=0.017 Score=39.38 Aligned_cols=32 Identities=16% Similarity=0.209 Sum_probs=17.7
Q ss_pred ceeeeehhhHHHHHHHHHHHHHHhhhhhhccc
Q 006145 389 KAVLALSIIGGIIGGISLVVIAFLLVRRTKSK 420 (659)
Q Consensus 389 ~~~i~~~ii~~~v~~i~l~~~~~~~~rr~~~~ 420 (659)
...++++++++++++++++++.++++|||+.+
T Consensus 10 ~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 10 IPSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred cceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 34466666666665555555555555555443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.65 E-value=0.017 Score=39.24 Aligned_cols=30 Identities=27% Similarity=0.379 Sum_probs=15.6
Q ss_pred eeeehhhHHHHHHHHHHHHHHhhhhhhccc
Q 006145 391 VLALSIIGGIIGGISLVVIAFLLVRRTKSK 420 (659)
Q Consensus 391 ~i~~~ii~~~v~~i~l~~~~~~~~rr~~~~ 420 (659)
.+++++++++++++++++..++++|||+.+
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 455555555555444444455555555443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.50 E-value=0.3 Score=51.63 Aligned_cols=73 Identities=11% Similarity=0.047 Sum_probs=45.9
Q ss_pred ceeccCcCceEEEEEecC--------CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCC-ccceeeeeeeccccCCCCc
Q 006145 483 AFMGEGSQGQMYRGRLKN--------GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRH-LVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~~~~~ 553 (659)
+.+..|-...+|+....+ +..+++|+..... ...-+-.+|.++++.+.-.+ ..++++.+.
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~---------- 144 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP---------- 144 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----------
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----------
Confidence 456667778999998763 5788888864322 11223457888777774223 345554321
Q ss_pred eeEEEEeccCCCCh
Q 006145 554 RIFLIFEYVPNGTL 567 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL 567 (659)
-++||||++|.+|
T Consensus 145 -~~~I~efI~G~~l 157 (424)
T 3mes_A 145 -EGRIEEFIDGEPL 157 (424)
T ss_dssp -TEEEEECCCSEEC
T ss_pred -CCEEEEEeCCccC
Confidence 2789999998664
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.70 E-value=0.18 Score=34.17 Aligned_cols=10 Identities=20% Similarity=0.378 Sum_probs=4.3
Q ss_pred HHhhhhhhcc
Q 006145 410 AFLLVRRTKS 419 (659)
Q Consensus 410 ~~~~~rr~~~ 419 (659)
.++++|||+.
T Consensus 31 ~~~~~RRR~~ 40 (44)
T 2jwa_A 31 FGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHCS
T ss_pred HHhheehhhh
Confidence 3444454443
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=86.21 E-value=0.34 Score=31.87 Aligned_cols=26 Identities=27% Similarity=0.337 Sum_probs=11.8
Q ss_pred eeeehhhHHHHHHHHHH-HHHHhhhhh
Q 006145 391 VLALSIIGGIIGGISLV-VIAFLLVRR 416 (659)
Q Consensus 391 ~i~~~ii~~~v~~i~l~-~~~~~~~rr 416 (659)
..+++++++++++++++ ++++|++||
T Consensus 11 GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 11 GEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CceeeeehHHHHHHHHHHHHHHHHeec
Confidence 34455555555444433 334444443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.06 E-value=0.12 Score=55.42 Aligned_cols=60 Identities=7% Similarity=-0.043 Sum_probs=18.1
Q ss_pred CceeccCcCceEEEEEecC-CcEEEE------EEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeee
Q 006145 482 SAFMGEGSQGQMYRGRLKN-GTFVAI------RCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFE 544 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~~-g~~vav------K~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 544 (659)
.+.+| ||.||+|.+.. ..+||| |..+.... +...+|.+|..+++..+|||+++.++|...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 35565 99999999864 467888 76654332 223578999999999999999999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 659 | ||||
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-25 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-24 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-23 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-23 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-23 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-23 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-22 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-22 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-22 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-22 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-22 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-21 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-21 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-20 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-19 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-19 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-19 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-19 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-19 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-19 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-19 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-19 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-18 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-18 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-05 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-18 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-18 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-18 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-17 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-17 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-17 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-17 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-17 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-17 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-17 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-16 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-16 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-16 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-04 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-15 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-15 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-14 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-14 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-14 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-13 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-13 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-13 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-13 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-13 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-12 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-12 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-12 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-12 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-12 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-12 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-11 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-10 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-10 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-09 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-09 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (256), Expect = 9e-25
Identities = 43/181 (23%), Positives = 77/181 (42%), Gaps = 26/181 (14%)
Query: 466 TFSLEELEEATNNFDTSAFM---------GEGSQGQMYRGRLK----NGTFVAIRCLKMK 512
F+ E+ EA F + G G G++ G LK FVAI+ LK
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 513 KCHST-RNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI 571
R+F+ ++ + H +++ E S + + +I E++ NG+L S++
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIH-----LEGVVTKS--TPVMIITEFMENGSLDSFL 118
Query: 572 SEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631
+ T Q + G+A G+++L +L +IL++ NLV K+S +
Sbjct: 119 RQNDGQF--TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFG 173
Query: 632 L 632
L
Sbjct: 174 L 174
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 3e-24
Identities = 34/163 (20%), Positives = 74/163 (45%), Gaps = 13/163 (7%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFEC 545
G+G G + G + G VA++C+K + + F+ ++++LRH +LV LG E
Sbjct: 16 GKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE- 71
Query: 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVP 605
++++ EY+ G+L ++ L + ++ V + +++L
Sbjct: 72 -----EKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEG---N 122
Query: 606 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPY 648
+L ++L+ ++ VAK+S + L A + + G +
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK 165
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 1e-23
Identities = 39/155 (25%), Positives = 72/155 (46%), Gaps = 13/155 (8%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFEC 545
G G G+++ G T VA++ LK + S F+ L+ +L+H+ LV +
Sbjct: 22 GAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79
Query: 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVP 605
I++I EY+ NG+L ++ + + LT + + A +A+G+ F+
Sbjct: 80 -------EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---R 128
Query: 606 GVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640
+L+ +IL+ L KI+ + L L E+ E
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 3e-23
Identities = 33/156 (21%), Positives = 63/156 (40%), Gaps = 13/156 (8%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLV 536
+ +G G G + G+ + VAI+ +K + S F+ +++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 537 SALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGI 596
G C + IF+I EY+ NG L +++ Q + V + +
Sbjct: 63 QLYGVCTKQ-------RPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAM 113
Query: 597 QFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
++L + +L + L++ V K+S + L
Sbjct: 114 EYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGL 146
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 5e-23
Identities = 43/179 (24%), Positives = 80/179 (44%), Gaps = 13/179 (7%)
Query: 462 PAYRTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFM 521
P + + + E + +G+G G+++ G T VAI+ LK S F+
Sbjct: 2 PQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFL 60
Query: 522 HHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLT 581
+++ KLRH LV S I+++ EY+ G+L ++ +G + L
Sbjct: 61 QEAQVMKKLRHEKLVQLYAVV--------SEEPIYIVTEYMSKGSLLDFL-KGETGKYLR 111
Query: 582 WTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640
Q + A +A G+ ++ +L+ +IL+ +NLV K++ + L L E+ E
Sbjct: 112 LPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (240), Expect = 7e-23
Identities = 34/185 (18%), Positives = 71/185 (38%), Gaps = 17/185 (9%)
Query: 470 EELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKC--HSTRNFMHHIELI 527
++ E +G GS G +Y+G+ VA++ L + + F + + ++
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 528 SKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRIS 587
K RH +++ +G+ + ++ ++ +L + + I
Sbjct: 59 RKTRHVNILLFMGYSTAPQ--------LAIVTQWCEGSSLYHHLHI--IETKFEMIKLID 108
Query: 588 AAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIP 647
A A+G+ +LH + +LK +I L ++L KI + L +
Sbjct: 109 IARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165
Query: 648 YSGSI 652
SGSI
Sbjct: 166 LSGSI 170
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 1e-22
Identities = 37/169 (21%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 486 GEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFEC 545
G+G G+++RG+ + G VA++ ++ S I LRH +++ + +
Sbjct: 12 GKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK- 68
Query: 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIV- 604
D+ + ++++L+ +Y +G+L +++ ++T I A+ A G+ LH IV
Sbjct: 69 --DNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 605 ----PGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPYS 649
P + +LK +IL+ +N I+ L + ++A + P
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 96.3 bits (239), Expect = 1e-22
Identities = 30/165 (18%), Positives = 69/165 (41%), Gaps = 13/165 (7%)
Query: 465 RTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHSTRNFMHH 523
+ + ++ E + +G G G++Y G K VA++ LK F+
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKE 63
Query: 524 IELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWT 583
++ +++H +LV LG C ++I E++ G L ++ E + Q ++
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTRE-------PPFYIITEFMTYGNLLDYLRECN-RQEVSAV 115
Query: 584 QRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+ A ++ +++L +L + L+ +N + K++
Sbjct: 116 VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVA 157
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.1 bits (236), Expect = 2e-22
Identities = 34/164 (20%), Positives = 67/164 (40%), Gaps = 13/164 (7%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLV 536
+ +G G G ++ G N VAI+ ++ + S +F+ E++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 537 SALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGI 596
G C E + I L+FE++ +G L ++ + + + V +G
Sbjct: 64 QLYGVCLEQ-------APICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEG- 113
Query: 597 QFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640
+ V +L + L+ +N V K+S + + + +
Sbjct: 114 --MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.9 bits (238), Expect = 3e-22
Identities = 25/159 (15%), Positives = 68/159 (42%), Gaps = 14/159 (8%)
Query: 472 LEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRN-FMHHIELISK 529
+E ++F+ + +G G+ G +++ K +G +A + + ++ + RN + ++++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 530 LRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAA 589
++V G + I + E++ G+L + + +
Sbjct: 61 CNSPYIVGFYGAFYSD-------GEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVS 110
Query: 590 IGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
I V KG+ +L + ++K ++IL++ K+
Sbjct: 111 IAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLC 147
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.9 bits (233), Expect = 9e-22
Identities = 24/148 (16%), Positives = 65/148 (43%), Gaps = 13/148 (8%)
Query: 486 GEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
G+G+ G++Y+ + K A + + K ++M I++++ H ++V +
Sbjct: 21 GDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV----KLLD 76
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIV 604
++ + + ++++ E+ G + + + E + LT +Q + +LH
Sbjct: 77 AFYYE---NNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD--- 128
Query: 605 PGVFSNNLKITDILLDQNLVAKISSYNL 632
+ +LK +IL + K++ + +
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGV 156
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.6 bits (227), Expect = 3e-21
Identities = 33/184 (17%), Positives = 73/184 (39%), Gaps = 17/184 (9%)
Query: 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHST--RNFMHHIELISKLRHRH 534
+++ +G GS G+ + R K +G + + L + + + L+ +L+H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 535 LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVA 593
+V + D + + ++++ EY G L S I++G Q L + +
Sbjct: 65 IV-----RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 594 KGIQFLH--TGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPYSGS 651
++ H + V +LK ++ LD K+ + L A + H ++ +
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL------ARILNHDTSFAKA 173
Query: 652 IDPT 655
T
Sbjct: 174 FVGT 177
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 91.4 bits (226), Expect = 8e-21
Identities = 41/193 (21%), Positives = 77/193 (39%), Gaps = 38/193 (19%)
Query: 468 SLEELEEATNNFDTSAFMGEGSQGQMYRGRLKN------GTFVAIRCLKMKKCHSTR-NF 520
L LE NN + +GEG+ G++++ R T VA++ LK + + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 521 MHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAH--- 577
L+++ + ++V LG C + L+FEY+ G L ++ H
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVG-------KPMCLLFEYMAYGDLNEFLRSMSPHTVC 116
Query: 578 ------------------QSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILL 619
L+ +++ A VA G+ +L +L + L+
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLV 173
Query: 620 DQNLVAKISSYNL 632
+N+V KI+ + L
Sbjct: 174 GENMVVKIADFGL 186
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 90.4 bits (224), Expect = 1e-20
Identities = 30/147 (20%), Positives = 59/147 (40%), Gaps = 17/147 (11%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHST---RNFMHHIELISKLRHRHLVSALGH 541
G GS G +Y R ++N VAI+ + S ++ + + + KLRH + +
Sbjct: 24 GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI----Q 79
Query: 542 CFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT 601
CY + +L+ EY + L + + G +G+ +LH+
Sbjct: 80 YRGCYLRE---HTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 602 GIVPGVFSNNLKITDILLDQNLVAKIS 628
+ ++K +ILL + + K+
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLG 157
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.2 bits (218), Expect = 7e-20
Identities = 32/168 (19%), Positives = 66/168 (39%), Gaps = 18/168 (10%)
Query: 470 EELEEATNNFDTSAF-MGEGSQGQMYRGRLK---NGTFVAIRCLKMKKCHS-TRNFMHHI 524
++L +N + +G G+ G + +G + VAI+ LK + T M
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 525 ELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQ 584
+++ +L + ++V +G C + L+ E G L ++ + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE--------ALMLVMEMAGGGPLHKFLVG--KREEIPVSN 110
Query: 585 RISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
V+ G+++L +L ++LL AKIS + L
Sbjct: 111 VAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGL 155
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 87.1 bits (214), Expect = 3e-19
Identities = 87/318 (27%), Positives = 131/318 (41%), Gaps = 21/318 (6%)
Query: 31 SQAQTLLRIQGLLNNPAVLSSWNITTEFCNTEPTSSLTVVCYEES----ITQLHIVGNKR 86
Q LL+I+ L NP LSSW TT+ CN + L V+C ++ + L + G
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNR---TWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 87 APMLPLSFSMDSFVTTLVKLPDLKVLRLVSL-GLWGPLSGKISRLSSLEILNMSSNFLNG 145
P+ S L LP L L + + L GP+ I++L+ L L ++ ++G
Sbjct: 63 PKPYPIPSS-------LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG 115
Query: 146 AIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL 205
AIP LS + +L TL N L+G +P + SLP L ++ N +G +PDS+ L
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175
Query: 206 RV-LALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIP 264
+ +S N G++P L +DL N L + S
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 265 AEVSSYYQLQRL--DLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELG 322
DL +NR G PQ L L + LN++ N L G++
Sbjct: 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFD 294
Query: 323 FVDLSSN-LLTG-QLPNC 338
++N L G LP C
Sbjct: 295 VSAYANNKCLCGSPLPAC 312
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 3e-19
Identities = 32/152 (21%), Positives = 59/152 (38%), Gaps = 18/152 (11%)
Query: 486 GEGSQGQMYRGRLKN----GTFVAIRCLKMKKCHSTR-NFMHHIELISKLRHRHLVSALG 540
GEG G +++G + VAI+ K S R F+ + + H H+V +G
Sbjct: 16 GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 75
Query: 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH 600
E +++I E G LRS++ SL I A ++ + +L
Sbjct: 76 VITENP--------VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLE 125
Query: 601 TGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+ ++ ++L+ N K+ + L
Sbjct: 126 S---KRFVHRDIAARNVLVSSNDCVKLGDFGL 154
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (211), Expect = 4e-19
Identities = 36/179 (20%), Positives = 68/179 (37%), Gaps = 15/179 (8%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRH 534
++D +GEG+ G++ + VA++ + MK+ N I + L H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 535 LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAK 594
+V GH E + +L EY G L I + +
Sbjct: 65 VVKFYGHRREG-------NIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMA 114
Query: 595 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSID 653
G+ +LH G+ ++K ++LLD+ KIS + L + + + G++
Sbjct: 115 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 85.5 bits (211), Expect = 5e-19
Identities = 28/188 (14%), Positives = 66/188 (35%), Gaps = 24/188 (12%)
Query: 478 NFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHST---------RNFMHHIELI 527
N++ +G G + R A++ + + S + ++++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 528 SKLR-HRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRI 586
K+ H +++ FL+F+ + G L ++ +L+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNT-------FFFLVFDLMKKGELFDYL---TEKVTLSEKETR 113
Query: 587 SAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVI 646
+ + I LH + +LK +ILLD ++ K++ + + EK+ V
Sbjct: 114 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 170
Query: 647 PYSGSIDP 654
+ P
Sbjct: 171 GTPSYLAP 178
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.2 bits (210), Expect = 6e-19
Identities = 28/152 (18%), Positives = 57/152 (37%), Gaps = 19/152 (12%)
Query: 486 GEGSQGQMYRGRLKN---GTFVAIRCLKMKKCHST--RNFMHHIELISKLRHRHLVSALG 540
G G+ G + +G + VA++ LK + + ++ +L + ++V +G
Sbjct: 16 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 75
Query: 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH 600
C L+ E G L ++ ++ + I V+ G+++L
Sbjct: 76 ICEA--------ESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE 124
Query: 601 TGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+L ++LL AKIS + L
Sbjct: 125 E---SNFVHRDLAARNVLLVTQHYAKISDFGL 153
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.6 bits (209), Expect = 7e-19
Identities = 34/172 (19%), Positives = 70/172 (40%), Gaps = 24/172 (13%)
Query: 465 RTFSLEELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHST---RNF 520
R ++LE +F+ +G+G G +Y R K + +A++ L +
Sbjct: 1 RQWALE-------DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 521 MHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSL 580
+E+ S LRH +++ G+ + +R++LI EY P GT+ +
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDA-------TRVYLILEYAPLGTVYREL---QKLSKF 103
Query: 581 TWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+ + +A + + H+ V ++K ++LL KI+ +
Sbjct: 104 DEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGW 152
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.0 bits (210), Expect = 8e-19
Identities = 27/148 (18%), Positives = 65/148 (43%), Gaps = 15/148 (10%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
G+G+ G +Y + G VAIR + +++ ++ I ++ + ++ ++V+ L
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIV 604
++++ EY+ G+L ++E Q + + ++FLH+
Sbjct: 89 G-------DELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHSN-- 135
Query: 605 PGVFSNNLKITDILLDQNLVAKISSYNL 632
V ++K +ILL + K++ +
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGF 162
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.4 bits (208), Expect = 9e-19
Identities = 35/154 (22%), Positives = 61/154 (39%), Gaps = 20/154 (12%)
Query: 486 GEGSQGQMYRGRLK----NGTFVAIRCLKMKKCHS---TRNFMHHIELISKLRHRHLVSA 538
G+GS G + RG VA++CLK +F+ + + L HR+L+
Sbjct: 17 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 76
Query: 539 LGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQF 598
G + ++ E P G+L + + H L R A+ VA+G+ +
Sbjct: 77 YGVVLTPP--------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGY 126
Query: 599 LHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
L + +L ++LL + KI + L
Sbjct: 127 LES---KRFIHRDLAARNLLLATRDLVKIGDFGL 157
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.3 bits (208), Expect = 1e-18
Identities = 35/151 (23%), Positives = 61/151 (40%), Gaps = 11/151 (7%)
Query: 486 GEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHST--RNFMHHIELISKLRHRHLVSALGHC 542
G GS +Y+G VA L+ +K + + F E++ L+H ++V
Sbjct: 18 GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSW 77
Query: 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTG 602
I L+ E + +GTL++++ + + S + KG+QFLHT
Sbjct: 78 ESTVKGKKC---IVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 603 IVPGVFSNNLKITDILL-DQNLVAKISSYNL 632
P + +LK +I + KI L
Sbjct: 132 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 85.5 bits (211), Expect = 1e-18
Identities = 32/181 (17%), Positives = 71/181 (39%), Gaps = 15/181 (8%)
Query: 477 NNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHL 535
+++D +G G+ G ++R G A + + I+ +S LRH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 536 VSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKG 595
V + + + DD + + +I+E++ G L +++ H ++ + + V KG
Sbjct: 86 V----NLHDAFEDD---NEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKG 136
Query: 596 IQFLHTGIVPGVFSNNLKITDILL--DQNLVAKISSYNLPLLAENAEKVGHVIPYSGSID 653
+ +H +LK +I+ ++ K+ + L + + V +
Sbjct: 137 LCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193
Query: 654 P 654
P
Sbjct: 194 P 194
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.4 bits (208), Expect = 2e-18
Identities = 34/160 (21%), Positives = 66/160 (41%), Gaps = 16/160 (10%)
Query: 486 GEGSQGQMYRGRLKN----GTFVAIRCL-KMKKCHSTRNFMHHIELISKLRHRHLVSALG 540
G G G +Y G L + A++ L ++ F+ ++ H +++S LG
Sbjct: 36 GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLG 95
Query: 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH 600
C S ++ Y+ +G LR++I + + T I + VAKG++FL
Sbjct: 96 ICLR------SEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 601 TGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE 640
+ +L + +LD+ K++ + L + E
Sbjct: 148 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.4 bits (210), Expect = 2e-18
Identities = 52/202 (25%), Positives = 81/202 (40%), Gaps = 12/202 (5%)
Query: 128 SRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLR 187
++L++LE L ++N ++ P ILT+L L L+ N L L SL L L L
Sbjct: 194 AKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 188 NNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGK 247
NN + P S L L L L N P + EN K
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 248 KLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKL 307
L + L N P VSS +LQRL ++N+ +L +L +I +L+ N++
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQI 363
Query: 308 TGKLFDDLSCNPELGFVDLSSN 329
+ L+ + + L+
Sbjct: 364 SD--LTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.7 bits (177), Expect = 3e-14
Identities = 47/183 (25%), Positives = 75/183 (40%), Gaps = 10/183 (5%)
Query: 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNN 213
LT+L++LI N ++ P + L LSL N + + L NL L L+NN
Sbjct: 196 LTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 214 HFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQL 273
P SGLT L L L N + P G +T + N+ + + +S+ L
Sbjct: 252 QISNLAP-LSGLTKLTELKLGANQISNISPLAGLTALTNL-ELNENQLEDISPISNLKNL 309
Query: 274 QRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG 333
L L N P + SL + L A+NK++ L+ + ++ N ++
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365
Query: 334 QLP 336
P
Sbjct: 366 LTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.9 bits (167), Expect = 5e-13
Identities = 38/169 (22%), Positives = 63/169 (37%), Gaps = 27/169 (15%)
Query: 89 MLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIP 148
L L+ + + TL L +L L L + + +S L+ L L + +N ++ P
Sbjct: 223 ELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280
Query: 149 --------------------QELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRN 188
+S L +L L L N ++ P + SL L L N
Sbjct: 281 LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFAN 338
Query: 189 NMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNA 237
N + S + L N+ L+ +N P + LT + L L + A
Sbjct: 339 NKVSD--VSSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.0 bits (157), Expect = 8e-12
Identities = 38/172 (22%), Positives = 65/172 (37%), Gaps = 28/172 (16%)
Query: 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENM 166
+L L L L G ++ L++L L++++N ++ P LS LT L L L N
Sbjct: 219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274
Query: 167 LAGRVP--------------------DWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLR 206
++ P + +L L L+L N + P S L L+
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 332
Query: 207 VLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVG-KKLVTMILSKN 257
L +NN V + LT + L +N + P ++ + L+
Sbjct: 333 RLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 4e-05
Identities = 52/258 (20%), Positives = 101/258 (39%), Gaps = 27/258 (10%)
Query: 100 VTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQT 159
+ L + L+ LG+ + G + L++L +N S+N L P L LT L
Sbjct: 37 TVSQTDLDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 92
Query: 160 LILDENMLAGRVPDWLGSLPIL----------------AVLSLRNNMFNGTLPDSFSYLE 203
++++ N +A P + R + + T+ D +
Sbjct: 93 ILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSG 152
Query: 204 NLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVG-KKLVTMILSKNKFRSA 262
+ LS + ++ + LT L+ LD+ +N + L ++I + N+
Sbjct: 153 LTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDI 212
Query: 263 IPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELG 322
P + L L L+ N+ L SL ++T L++A+N+++ LS +L
Sbjct: 213 TP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLT 266
Query: 323 FVDLSSNLLTGQLPNCLL 340
+ L +N ++ P L
Sbjct: 267 ELKLGANQISNISPLAGL 284
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 2e-18
Identities = 34/197 (17%), Positives = 70/197 (35%), Gaps = 24/197 (12%)
Query: 470 EELEEATNNFDTSAFMGEGSQGQMYRGRLKN------GTFVAIRCLKMKKCHSTR-NFMH 522
+E E A S +G+GS G +Y G K T VAI+ + R F++
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72
Query: 523 HIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI-------SEGH 575
++ + H+V LG + +I E + G L+S++ +
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQG-------QPTLVIMELMTRGDLKSYLRSLRPAMANNP 125
Query: 576 AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635
+ ++ I A +A G+ +L+ +L + ++ ++ KI + +
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182
Query: 636 AENAEKVGHVIPYSGSI 652
+ +
Sbjct: 183 IYETDYYRKGGKGLLPV 199
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (205), Expect = 3e-18
Identities = 40/181 (22%), Positives = 76/181 (41%), Gaps = 23/181 (12%)
Query: 476 TNNFDTSAF-----MGEGSQGQMYRGRLKNGT-----FVAIRCLKMKKCHSTR-NFMHHI 524
T S +G G G++Y+G LK + VAI+ LK R +F+
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 525 ELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQ 584
++ + H +++ G + + +I EY+ NG L ++ E + Q
Sbjct: 61 GIMGQFSHHNIIRLEGVISKY-------KPMMIITEYMENGALDKFLREKDGE--FSVLQ 111
Query: 585 RISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGH 644
+ G+A G+++L +L +IL++ NLV K+S + L + E+ + +
Sbjct: 112 LVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 168
Query: 645 V 645
Sbjct: 169 T 169
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 83.5 bits (206), Expect = 4e-18
Identities = 29/179 (16%), Positives = 64/179 (35%), Gaps = 12/179 (6%)
Query: 470 EELEEATNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTR-NFMHHIELI 527
++ E+ + +D +G G+ ++ + VAI+C+ K + + I ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 528 SKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRIS 587
K++H ++V + Y ++LI + V G L I T
Sbjct: 62 HKIKHPNIV----ALDDIYESGG---HLYLIMQLVSGGELFDRI---VEKGFYTERDASR 111
Query: 588 AAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVI 646
V +++LH + + LD++ IS + L + + +
Sbjct: 112 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 170
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.1 bits (202), Expect = 2e-17
Identities = 33/163 (20%), Positives = 59/163 (36%), Gaps = 20/163 (12%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHST------RNFMHHIELISK 529
N+F +G G G++Y R G A++CL K+ N + L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 530 LRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAA 589
+V + ++ I + + G L +S+ A
Sbjct: 64 GDCPFIV----CMSYAFHTPD---KLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYA 113
Query: 590 IGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+ G++ +H V +LK +ILLD++ +IS L
Sbjct: 114 AEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGL 153
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 81.6 bits (201), Expect = 3e-17
Identities = 21/144 (14%), Positives = 55/144 (38%), Gaps = 13/144 (9%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
G G+ G ++R G + + + I ++++L H L+ + +
Sbjct: 38 GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI----NLHD 93
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIV 604
+ D + LI E++ G L I+ ++ + I+ +G++ +H
Sbjct: 94 AFEDK---YEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHE--- 145
Query: 605 PGVFSNNLKITDILLDQNLVAKIS 628
+ ++K +I+ + + +
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVK 169
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.6 bits (198), Expect = 3e-17
Identities = 42/174 (24%), Positives = 76/174 (43%), Gaps = 28/174 (16%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLKNG---TFVAIRCLKMKKCHS-TRNFMHHIELISKL-R 531
N+ +GEG+ GQ+ + R+K AI+ +K R+F +E++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 532 HRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAH-------------Q 578
H ++++ LG C ++L EY P+G L ++ +
Sbjct: 70 HPNIINLLGACEHR-------GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 579 SLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+L+ Q + A VA+G+ +L +L +IL+ +N VAKI+ + L
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 173
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.4 bits (200), Expect = 3e-17
Identities = 32/146 (21%), Positives = 66/146 (45%), Gaps = 9/146 (6%)
Query: 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLV 536
++ + +G GS G +Y+ +L +G VAI+ + K R ++++ KL H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 537 SALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGI 596
L + F + + L+ +YVP R A Q+L + + +
Sbjct: 77 R-LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 597 QFLHTGIVPGVFSNNLKITDILLDQN 622
++H+ G+ ++K ++LLD +
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPD 158
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.2 bits (197), Expect = 7e-17
Identities = 42/184 (22%), Positives = 71/184 (38%), Gaps = 38/184 (20%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLKN------GTFVAIRCLKMKKCHSTRN-FMHHIELISK 529
N + +G G+ G++ VA++ LK K S R M ++++++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 530 L-RHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI----------------- 571
L H ++V+ LG C I+LIFEY G L +++
Sbjct: 97 LGSHENIVNLLGACTLS-------GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 149
Query: 572 ---SEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
E LT+ + A VAKG++FL +L ++L+ V KI
Sbjct: 150 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKIC 206
Query: 629 SYNL 632
+ L
Sbjct: 207 DFGL 210
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 7e-17
Identities = 37/196 (18%), Positives = 63/196 (32%), Gaps = 28/196 (14%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCHST-RNFMHHIELISK 529
+ +G G+ GQ+ VA++ LK HS R M ++++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 530 LRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI-------------SEGHA 576
+ H V L + +I E+ G L +++ E
Sbjct: 73 IGHHLNVVNLLGAC-----TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 127
Query: 577 HQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636
LT I + VAKG++FL + +L +ILL + V KI + L
Sbjct: 128 KDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDI 184
Query: 637 ENAEKVGHVIPYSGSI 652
+
Sbjct: 185 YKDPDYVRKGDARLPL 200
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.9 bits (194), Expect = 9e-17
Identities = 32/154 (20%), Positives = 60/154 (38%), Gaps = 17/154 (11%)
Query: 478 NFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHS---TRNFMHHIELISKLRHR 533
+F +GEGS + R L AI+ L+ + +++S+L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 534 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVA 593
V + + DD +++ Y NG L +I S T +
Sbjct: 69 FFV----KLYFTFQDD---EKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIV 118
Query: 594 KGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKI 627
+++LH G+ +LK +ILL++++ +I
Sbjct: 119 SALEYLHG---KGIIHRDLKPENILLNEDMHIQI 149
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 78.6 bits (193), Expect = 1e-16
Identities = 26/157 (16%), Positives = 59/157 (37%), Gaps = 13/157 (8%)
Query: 476 TNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHST---RNFMHHIELISKLR 531
++ ++ +G G +++ R L+ VA++ L+ F + + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 532 HRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIG 591
H +V+ + + +++ EYV TLR + H +T + I
Sbjct: 66 HPAIVAVYDTGEA---ETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIAD 119
Query: 592 VAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+ + F H G+ ++K +I++ K+
Sbjct: 120 ACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVM 153
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (194), Expect = 2e-16
Identities = 24/161 (14%), Positives = 63/161 (39%), Gaps = 12/161 (7%)
Query: 474 EATNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRN-FMHHIELISKLR 531
+ + +++GEG+ G + N VAI+ + + + + I+++ + R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 532 HRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIG 591
H +++ + + + ++ L + H L+
Sbjct: 65 HENIIGINDIIRAPTIEQ---MKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQ 117
Query: 592 VAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+ +G++++H+ V +LK +++LL+ KI + L
Sbjct: 118 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 155
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (192), Expect = 2e-16
Identities = 36/170 (21%), Positives = 62/170 (36%), Gaps = 33/170 (19%)
Query: 486 GEGSQGQMYRGRLK------NGTFVAIRCLKMKKCHSTRN-FMHHIELISKL-RHRHLVS 537
G G+ G++ VA++ LK + R M ++++S L H ++V+
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGH---------------AHQSLTW 582
LG C +I EY G L +++ +L
Sbjct: 92 LLGACTI-------GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 583 TQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+S + VAKG+ FL + +L +ILL + KI + L
Sbjct: 145 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGL 191
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (183), Expect = 3e-15
Identities = 35/182 (19%), Positives = 69/182 (37%), Gaps = 19/182 (10%)
Query: 479 FDTSAFMGEGSQGQMYRGRLKN-----GTFVAIRCLKMKKC-HSTRNFMHHIELISKLRH 532
F +G G+ G +Y+G VAI+ L+ + + + +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 533 RHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGV 592
H+ LG C S + LI + +P G L ++ E + ++ + +
Sbjct: 71 PHVCRLLGICLT--------STVQLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQI 120
Query: 593 AKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSI 652
AKG+ +L + +L ++L+ KI+ + L L EK H I
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 653 DP 654
Sbjct: 178 KW 179
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 74.7 bits (182), Expect = 3e-15
Identities = 48/230 (20%), Positives = 84/230 (36%), Gaps = 7/230 (3%)
Query: 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENM 166
PD +L L + + G L +L L + +N ++ P + L L+ L L +N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 167 LAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYG---EVPDFS 223
L +L L V N F+ L + V+ L N E F
Sbjct: 91 LKELPEKMPKTLQELRVH---ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
Query: 224 GLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRF 283
G+ L + + + + + L + L NK A + L +L LS N
Sbjct: 148 GMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
Query: 284 VGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG 333
+L + P + L++ +NKL + + + V L +N ++
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLVKVPGGL-ADHKYIQVVYLHNNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 64.3 bits (155), Expect = 8e-12
Identities = 49/234 (20%), Positives = 81/234 (34%), Gaps = 33/234 (14%)
Query: 132 SLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMF 191
L ++ S L +P++L L L N + +L L L L NN
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 192 NGTLPDSFSYLENLRVLALSNNHFYGEVPD----------------------FSGLTYLQ 229
+ P +F+ L L L LS N F+GL +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 230 VLDLENNALGPQFPKVG-----KKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFV 284
V++L N L + G KKL + ++ + IP + L L L N+
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLPP--SLTELHLDGNKIT 184
Query: 285 GPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNC 338
+L L ++ L ++ N ++ L+ P L + L++N L
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL 238
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 60.1 bits (144), Expect = 2e-10
Identities = 44/267 (16%), Positives = 79/267 (29%), Gaps = 46/267 (17%)
Query: 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLE 134
L + NK + F L +L L L++ + G + L LE
Sbjct: 32 DTALLDLQNNKITEIKDGDFK---------NLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 135 ILNMSSNFLNGAIPQELSILTSLQT-----------------------LILDENMLAGRV 171
L +S N L + L L+ L + +G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142
Query: 172 PDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQV 230
+ L+ + + + T+P +L L L N GL L
Sbjct: 143 NGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAK 199
Query: 231 LDLENNA---LGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRF---- 283
L L N+ + L + L+ NK +P ++ + +Q + L +N
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIG 258
Query: 284 --VGPFPQALLSLPSITYLNIADNKLT 308
P S + +++ N +
Sbjct: 259 SNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 17/91 (18%), Positives = 29/91 (31%)
Query: 249 LVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLT 308
+ L NK + + L L L +N+ P A L + L ++ N+L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 309 GKLFDDLSCNPELGFVDLSSNLLTGQLPNCL 339
EL + + + N L
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGL 123
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.1 bits (184), Expect = 3e-15
Identities = 23/139 (16%), Positives = 49/139 (35%), Gaps = 14/139 (10%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCF 543
G G G++ + + A+ K +EL + + H+V +
Sbjct: 21 GLGINGKVLQIFNKRTQEKFAL-----KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 544 ECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI 603
Y + ++ E + G L S I + Q+ T + + + IQ+LH+
Sbjct: 76 NLYAGRK---CLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS-- 129
Query: 604 VPGVFSNNLKITDILLDQN 622
+ ++K ++L
Sbjct: 130 -INIAHRDVKPENLLYTSK 147
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.1 bits (181), Expect = 4e-15
Identities = 34/190 (17%), Positives = 76/190 (40%), Gaps = 33/190 (17%)
Query: 486 GEGSQGQMYRGRLK--------NGTFVAIRCLKMKKCHS-TRNFMHHIELISKL-RHRHL 535
GEG+ GQ+ T VA++ LK + + +E++ + +H+++
Sbjct: 22 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 81
Query: 536 VSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWI-------------SEGHAHQSLTW 582
++ LG C + +++I EY G LR ++ + + L+
Sbjct: 82 INLLGACTQD-------GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 583 TQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKV 642
+S A VA+G+++L + +L ++L+ ++ V KI+ + L + +
Sbjct: 135 KDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 643 GHVIPYSGSI 652
+
Sbjct: 192 KKTTNGRLPV 201
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.2 bits (179), Expect = 1e-14
Identities = 25/143 (17%), Positives = 56/143 (39%), Gaps = 14/143 (9%)
Query: 486 GEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
G G G ++R + + +K+K I +++ RHR+++ H E
Sbjct: 14 GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNIL----HLHE 68
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIV 604
+ + +IFE++ + I+ L + +S V + +QFLH+
Sbjct: 69 SFESME---ELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHS--- 120
Query: 605 PGVFSNNLKITDILLDQNLVAKI 627
+ +++ +I+ + I
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTI 143
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 71.5 bits (174), Expect = 3e-14
Identities = 28/158 (17%), Positives = 63/158 (39%), Gaps = 15/158 (9%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHST--RNFMHHIELISKLRHRH 534
+ +GEG+ G +Y+ + G A++ ++++K + I ++ +L+H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 535 LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAK 594
+V R+ L+FE++ + L S + +
Sbjct: 62 IVKLYDVIHTKK-------RLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLN 111
Query: 595 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
GI + H V +LK ++L+++ KI+ + L
Sbjct: 112 GIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGL 146
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.3 bits (171), Expect = 9e-14
Identities = 26/160 (16%), Positives = 73/160 (45%), Gaps = 10/160 (6%)
Query: 477 NNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHST--RNFMHHIELISKLRHR 533
+ ++ A +G+G+ G++++ R K G VA++ + M+ + I+++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 534 HLVSALGHCFEC-YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGV 592
++V+ + C + I+L+F++ + + T ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQML 126
Query: 593 AKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
G+ ++H + ++K ++L+ ++ V K++ + L
Sbjct: 127 LNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.9 bits (170), Expect = 1e-13
Identities = 34/151 (22%), Positives = 67/151 (44%), Gaps = 19/151 (12%)
Query: 484 FMGEGSQGQMYRGRLKN-GTFVAIRCLKMKKCHST-----RNFMHHIELISKLRHRHLVS 537
F+GEG +Y+ R KN VAI+ +K+ R + I+L+ +L H +++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII- 63
Query: 538 ALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQ 597
+ + S I L+F+++ LT + + + +G++
Sbjct: 64 ---GLLDAFGHK---SNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLE 114
Query: 598 FLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+LH + +LK ++LLD+N V K++
Sbjct: 115 YLHQ---HWILHRDLKPNNLLLDENGVLKLA 142
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.1 bits (171), Expect = 1e-13
Identities = 38/161 (23%), Positives = 66/161 (40%), Gaps = 18/161 (11%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS---TRNFMHHIELISK-LR 531
+F +G+GS G+++ K F AI+ LK M ++S
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 532 HRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIG 591
H L H F + +F + EY+ G L I + ++ A
Sbjct: 62 HPFLT----HMFCTFQTKE---NLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAE 111
Query: 592 VAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+ G+QFLH+ G+ +LK+ +ILLD++ KI+ + +
Sbjct: 112 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGM 149
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (169), Expect = 3e-13
Identities = 27/173 (15%), Positives = 66/173 (38%), Gaps = 16/173 (9%)
Query: 467 FSLEELEEAT----NNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHST--RN 519
F +E+ + + +G G+ G + + G VAI+ L +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 520 FMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQS 579
+ L+ +RH +++ L D + +L+ ++ + + H+
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLD-DFTDFYLVMPFMGT-----DLGKLMKHEK 117
Query: 580 LTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
L + + KG++++H G+ +LK ++ ++++ KI + L
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 167
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 68.6 bits (167), Expect = 3e-13
Identities = 34/166 (20%), Positives = 67/166 (40%), Gaps = 24/166 (14%)
Query: 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS---TRNFMH 522
+SL+ +F +G GS G+++ R + NG + A++ LK + +
Sbjct: 1 YSLQ-------DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 523 HIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTW 582
++S + H ++ G + +IF+I +Y+ G L S + +
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDA-------QQIFMIMDYIEGGELFSLLRKSQ-RFPNPV 105
Query: 583 TQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628
+ +A + L + +LK +ILLD+N KI+
Sbjct: 106 AKFYAAEV-----CLALEYLHSKDIIYRDLKPENILLDKNGHIKIT 146
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.0 bits (165), Expect = 5e-13
Identities = 33/188 (17%), Positives = 75/188 (39%), Gaps = 14/188 (7%)
Query: 475 ATNNFDTSAFMGEGSQGQMYRGRLK--NGTFVAIRCLKMKKCHST--RNFMHHIELISKL 530
A ++ A +GEG+ G++++ R G FVA++ ++++ + + + ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 531 ---RHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRIS 587
H ++V C D +++ L+FE+V + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRE--TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM- 121
Query: 588 AAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAEKVGHVIP 647
+ +G+ FLH+ V +LK +IL+ + K++ + L + + V+
Sbjct: 122 -MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 177
Query: 648 YSGSIDPT 655
P
Sbjct: 178 TLWYRAPE 185
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 67.2 bits (163), Expect = 1e-12
Identities = 25/173 (14%), Positives = 66/173 (38%), Gaps = 20/173 (11%)
Query: 477 NNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRH 534
+++ +G G +++ + N V ++ LK K + I+++ LR +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 535 LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAK 594
+++ D L+FE+V N + Q+LT + K
Sbjct: 92 IITLAD-----IVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILK 140
Query: 595 GIQFLHTGIVPGVFSNNLKITDILLD-QNLVAKISSYNLPLLAENAEKVGHVI 646
+ + H+ G+ ++K ++++D ++ ++ + L ++ +
Sbjct: 141 ALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 190
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.7 bits (162), Expect = 2e-12
Identities = 29/160 (18%), Positives = 67/160 (41%), Gaps = 17/160 (10%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHST---RNFMHHIELISKLRH 532
N+FD +G+G+ G++ R K G + A++ L+ + + + + ++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 533 RHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGV 592
L + + R+ + EY G L + + T + +
Sbjct: 65 PFLT-------ALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEI 114
Query: 593 AKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+++LH+ V ++K+ +++LD++ KI+ + L
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL 151
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.9 bits (160), Expect = 2e-12
Identities = 34/167 (20%), Positives = 70/167 (41%), Gaps = 23/167 (13%)
Query: 467 FSLEELEEATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRN------ 519
F E ++ + +DT +G G + + R K G A + +K ++ S+R
Sbjct: 3 FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 520 FMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQS 579
+ ++ +++H +++ E Y + + + LI E V G L ++ +S
Sbjct: 60 IEREVSILKEIQHPNVI----TLHEVYENK---TDVILILELVAGGELFDFL---AEKES 109
Query: 580 LTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAK 626
LT + + G+ +LH+ + +LK +I+L V K
Sbjct: 110 LTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPK 153
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 66.0 bits (160), Expect = 2e-12
Identities = 17/116 (14%), Positives = 38/116 (32%), Gaps = 12/116 (10%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFE 544
G GS G +Y G + G VAI+ +K H ++ ++ + + C
Sbjct: 16 GSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGA 73
Query: 545 CYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH 600
++ E + + + + + A + I+++H
Sbjct: 74 ------EGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH 120
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.3 bits (158), Expect = 4e-12
Identities = 31/158 (19%), Positives = 69/158 (43%), Gaps = 15/158 (9%)
Query: 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHST--RNFMHHIELISKLRHRH 534
NF +GEG+ G +Y+ R K G VA++ +++ + I L+ +L H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 535 LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAK 594
+V + + ++++L+FE++ + + A + S + +
Sbjct: 63 IV----KLLDVIHTE---NKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQ 113
Query: 595 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
G+ F H+ V +LK ++L++ K++ + L
Sbjct: 114 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGL 148
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 64.8 bits (157), Expect = 8e-12
Identities = 25/160 (15%), Positives = 63/160 (39%), Gaps = 17/160 (10%)
Query: 477 NNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTR---NFMHHIELISKLRH 532
+ FD +G GS G++ + ++G A++ L +K + + ++ ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 533 RHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGV 592
LV + ++++ EYV G + S + + A +
Sbjct: 101 PFLVKLEFSFKDNSN-------LYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQI 150
Query: 593 AKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
++LH+ + +LK ++L+DQ +++ +
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF 187
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.1 bits (147), Expect = 9e-11
Identities = 27/159 (16%), Positives = 69/159 (43%), Gaps = 16/159 (10%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHST--RNFMHHIELISKLRHR 533
++ +GEG+ G +++ + + VA++ +++ + + I L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 534 HLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVA 593
++V ++ L+FE+ + + + L S +
Sbjct: 62 NIVRLHDVLHSDK-------KLTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLL 111
Query: 594 KGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
KG+ F H+ V +LK ++L+++N K++++ L
Sbjct: 112 KGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGL 147
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.0 bits (147), Expect = 1e-10
Identities = 31/164 (18%), Positives = 71/164 (43%), Gaps = 20/164 (12%)
Query: 477 NNFDTSAFMGEGSQGQMYRGRL----KNGTFVAIRCLK----MKKCHSTRNFMHHIELIS 528
NF+ +G G+ G+++ R G A++ LK ++K +T + +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 529 KLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISA 588
+R + L + F+ + +++ LI +Y+ G L + + + T +
Sbjct: 84 HIRQSPFLVTLHYAFQ------TETKLHLILDYINGGELFTHL---SQRERFTEHEVQIY 134
Query: 589 AIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632
+ ++ LH G+ ++K+ +ILLD N ++ + L
Sbjct: 135 VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 175
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 59.1 bits (142), Expect = 4e-10
Identities = 20/148 (13%), Positives = 44/148 (29%), Gaps = 15/148 (10%)
Query: 477 NNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHL 535
++ +GEGS G ++ G L N VAI+ + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTG 62
Query: 536 VSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKG 595
+ + + + L+ + + G + AA +
Sbjct: 63 IPNVYYFGQEG------LHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLAR 113
Query: 596 IQFLHTGIVPGVFSNNLKITDILLDQNL 623
+Q +H + ++K + L+ +
Sbjct: 114 VQSIHE---KSLVYRDIKPDNFLIGRPN 138
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.1 bits (142), Expect = 5e-10
Identities = 20/143 (13%), Positives = 48/143 (33%), Gaps = 10/143 (6%)
Query: 462 PAYRTFSLEELE-EATNNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHST-- 517
P + L + E + + +G G+ G + K G VA++ L
Sbjct: 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 518 RNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAH 577
+ + L+ ++H +++ L + + ++ L +
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNI----VKC 115
Query: 578 QSLTWTQRISAAIGVAKGIQFLH 600
Q LT + +G++++H
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIH 138
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 55.1 bits (132), Expect = 6e-10
Identities = 27/106 (25%), Positives = 43/106 (40%), Gaps = 2/106 (1%)
Query: 206 RVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPA 265
RVL L++ + L + LDL +N L P + +L +
Sbjct: 1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 266 EVSSYYQLQRLDLSSNRFVG-PFPQALLSLPSITYLNIADNKLTGK 310
V++ +LQ L L +NR Q L+S P + LN+ N L +
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.9 bits (116), Expect = 1e-07
Identities = 29/123 (23%), Positives = 48/123 (39%), Gaps = 7/123 (5%)
Query: 183 VLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQF 242
VL L + T+ L + L LS+N P + L L+VL +NAL
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 243 PKVGKKLV-TMILSKNKFRS-AIPAEVSSYYQLQRLDLSSNRFVG--PFPQALLS-LPSI 297
+ ++L N+ + A + S +L L+L N + L LPS+
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119
Query: 298 TYL 300
+ +
Sbjct: 120 SSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 3e-05
Identities = 27/106 (25%), Positives = 42/106 (39%), Gaps = 7/106 (6%)
Query: 135 ILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGT 194
+L+++ L + L L + L L N L P L +L L VL +N
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN- 57
Query: 195 LPDSFSYLENLRVLALSNNHFYG--EVPDFSGLTYLQVLDLENNAL 238
D + L L+ L L NN + L +L+L+ N+L
Sbjct: 58 -VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.0 bits (139), Expect = 1e-09
Identities = 21/118 (17%), Positives = 41/118 (34%), Gaps = 10/118 (8%)
Query: 486 GEGSQGQMYRGR-LKNGTFVAIRCLKMKKCHST--RNFMHHIELISKLRHRHLVSALGHC 542
G G+QG + VAI+ L + T + + L+ + H++++S L
Sbjct: 26 GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN-V 84
Query: 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLH 600
F ++L+ E + + L + + GI+ LH
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLH 136
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.2 bits (135), Expect = 2e-09
Identities = 26/153 (16%), Positives = 51/153 (33%), Gaps = 17/153 (11%)
Query: 477 NNFDTSAFMGEGSQGQMYRGR-LKNGTFVAIRCLKMKKC------HSTRNFMHHIELISK 529
+ + +G G G +Y G + + VAI+ ++ + + + L+ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 530 LRHRHLVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAA 589
+ S + + + S LI E +L S
Sbjct: 64 VSSGF--SGVIRLLDWFERPDS---FVLILERPEPVQDLFDFI--TERGALQEELARSFF 116
Query: 590 IGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN 622
V + ++ H GV ++K +IL+D N
Sbjct: 117 WQVLEAVRHCHN---CGVLHRDIKDENILIDLN 146
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.6 bits (132), Expect = 5e-09
Identities = 36/181 (19%), Positives = 57/181 (31%), Gaps = 28/181 (15%)
Query: 106 LPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDEN 165
L L L L GL G L++L+ L + N L L +L L L N
Sbjct: 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163
Query: 166 MLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLE---------------------- 203
++ L L L L N P +F L
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223
Query: 204 --NLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPK--VGKKLVTMILSKNKF 259
L+ L L++N + + +LQ ++ + P+ G+ L L+ N
Sbjct: 224 LRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKR--LAANDL 281
Query: 260 R 260
+
Sbjct: 282 Q 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.2 bits (131), Expect = 7e-09
Identities = 46/208 (22%), Positives = 74/208 (35%), Gaps = 5/208 (2%)
Query: 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNM 190
++ + + + N ++ +L L L N+LA L +L L L +N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 191 FNGTL-PDSFSYLENLRVLALSNNHFYGEVPDFSGLTY-LQVLDLENNALG---PQFPKV 245
++ P +F L L L L P LQ L L++NAL +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 246 GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADN 305
L + L N+ S + L RL L NR P A L + L + N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 306 KLTGKLFDDLSCNPELGFVDLSSNLLTG 333
L+ + L+ L ++ L+ N
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVC 239
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 53.6 bits (128), Expect = 7e-09
Identities = 15/153 (9%), Positives = 45/153 (29%), Gaps = 26/153 (16%)
Query: 485 MGEGSQGQMYRGRLKNGTFVAI----------RCLKMKKCHSTRNFMHHIELISKLRHRH 534
MGEG + ++ + + + +K K+ + +F ++ R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 535 LVSALGHCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAK 594
L G + ++ E ++ + + + +
Sbjct: 68 LQKLQGLAVPKVYA---WEGNAVLMEL--------IDAKELYRVRVENPDEV--LDMILE 114
Query: 595 GIQFLHTGIVPGVFSNNLKITDILLDQNLVAKI 627
+ + G+ +L ++L+ + + I
Sbjct: 115 EVAKFYH---RGIVHGDLSQYNVLVSEEGIWII 144
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 31/178 (17%), Positives = 49/178 (27%), Gaps = 2/178 (1%)
Query: 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILD-ENMLAGRVPDWLGSLPILAVLSLRNN 189
IL++S N L L T L L LD + +V L L L + +
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ 90
Query: 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKL 249
+ + G + L L + E L P KL
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150
Query: 250 VTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKL 307
+ L+ N ++ L L L N P+ + + + N
Sbjct: 151 EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 36/206 (17%), Positives = 67/206 (32%), Gaps = 31/206 (15%)
Query: 150 ELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLA 209
E+S + S + D+ L +P L +L L N+ + L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 210 LSNNHFYGEVPDFSGLTYLQVLDLEN--------------------------NALGPQFP 243
L ++ L L LDL + +L
Sbjct: 62 LDRAELT-KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 244 KVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIA 303
+ +L + L N+ ++ P ++ +L++L L++N L L ++ L +
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 304 DNKLTGKLFDDLSCNPELGFVDLSSN 329
+N L + + L F L N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (85), Expect = 0.003
Identities = 15/56 (26%), Positives = 25/56 (44%), Gaps = 1/56 (1%)
Query: 137 NMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFN 192
++++N L L+ L +L TL+L EN L +P +L L N +
Sbjct: 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 7e-07
Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 9/78 (11%)
Query: 130 LSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189
SLE LN+S+N L +P ++ L+ LI N L VP+ + L L + N
Sbjct: 283 PPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHL-AEVPELPQN---LKQLHVEYN 334
Query: 190 MFNGTLPDSFSYLENLRV 207
PD +E+LR+
Sbjct: 335 PLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 4e-06
Identities = 20/95 (21%), Positives = 37/95 (38%), Gaps = 8/95 (8%)
Query: 186 LRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKV 245
N + + +L L +SNN E+P + L+ L N L + P++
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELP--ALPPRLERLIASFNHLA-EVPEL 322
Query: 246 GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSS 280
+ L + + N R P S ++ L ++S
Sbjct: 323 PQNLKQLHVEYNPLRE-FPDIPES---VEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 3e-05
Identities = 17/94 (18%), Positives = 30/94 (31%), Gaps = 8/94 (8%)
Query: 137 NMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLP 196
N + I + SL+ L + N L +P L L N +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320
Query: 197 DSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQV 230
+ +NL+ L + N + L++
Sbjct: 321 EL---PQNLKQLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 6e-04
Identities = 15/69 (21%), Positives = 25/69 (36%), Gaps = 8/69 (11%)
Query: 241 QFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYL 300
+ L + +S NK +PA L+RL S N P+ ++ L
Sbjct: 278 SLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLAE-VPE---LPQNLKQL 329
Query: 301 NIADNKLTG 309
++ N L
Sbjct: 330 HVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.004
Identities = 11/58 (18%), Positives = 27/58 (46%), Gaps = 4/58 (6%)
Query: 204 NLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRS 261
L L+N +P+ +L+ L N+L + P++ + L ++++ N ++
Sbjct: 39 QAHELELNNLGL-SSLPEL--PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 3e-06
Identities = 40/246 (16%), Positives = 77/246 (31%), Gaps = 19/246 (7%)
Query: 109 LKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNG-AIPQELSILTSLQTLILDENML 167
+ R + PL+ S ++ +++S++ + + LS + LQ L L+ L
Sbjct: 25 VIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83
Query: 168 AGRVPDWLGSLPILAVLSLRN--NMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGL 225
+ + + L L L+L L S L L LS + E +
Sbjct: 84 SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 143
Query: 226 TYLQVLDLENNALG-----------PQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQ 274
++ + N G + + + ++ E LQ
Sbjct: 144 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203
Query: 275 RLDLSSNRFVGP-FPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG 333
L LS + P L +P++ L + G L P L ++ + T
Sbjct: 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTT 260
Query: 334 QLPNCL 339
+
Sbjct: 261 IARPTI 266
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 7e-05
Identities = 21/96 (21%), Positives = 42/96 (43%), Gaps = 4/96 (4%)
Query: 229 QVLDLENNALGPQFPK--VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGP 286
Q LDL L P + + ++ ++ F AE S +++Q +DLS++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRS-FMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 287 FPQALLS-LPSITYLNIADNKLTGKLFDDLSCNPEL 321
+LS + L++ +L+ + + L+ N L
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNL 97
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 0.001
Identities = 14/81 (17%), Positives = 28/81 (34%), Gaps = 2/81 (2%)
Query: 274 QRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTG 333
Q LDL+ LLS + + + L + S + +DLS++++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEV 60
Query: 334 QLPNCLLAGSKNRVVLYARNC 354
+ +L+ L
Sbjct: 61 STLHGILSQCSKLQNLSLEGL 81
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 17/99 (17%), Positives = 34/99 (34%), Gaps = 3/99 (3%)
Query: 206 RVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGK--KLVTMILSKNKF-RSA 262
+ L L+ + + +V + + + + ++ M LS + S
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 62
Query: 263 IPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLN 301
+ +S +LQ L L R P L ++ LN
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 3e-06
Identities = 33/162 (20%), Positives = 49/162 (30%), Gaps = 28/162 (17%)
Query: 147 IPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLR 206
+ +S LD L R L + I VL+ R++M TL + L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELL 68
Query: 207 VLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAE 266
L LSNN Y S + L + LS N+ +S +
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKA------------------PNLKILNLSGNELKSERELD 110
Query: 267 VSSYYQLQRLDLSSNRFVGPFPQA-------LLSLPSITYLN 301
+L+ L L N F P + L+
Sbjct: 111 KIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 3e-06
Identities = 19/78 (24%), Positives = 31/78 (39%), Gaps = 5/78 (6%)
Query: 273 LQRLDLSSNRFV-GPFPQALLSLPSITYLNIADNKLTGK----LFDDLSCNPELGFVDLS 327
+Q LD+ + + L L + + D LT + L NP L ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 328 SNLLTGQLPNCLLAGSKN 345
SN L +C+L G +
Sbjct: 64 SNELGDVGVHCVLQGLQT 81
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 1e-05
Identities = 16/97 (16%), Positives = 33/97 (34%), Gaps = 9/97 (9%)
Query: 259 FRSAIPAEVSSYYQLQRLDLSSNRF----VGPFPQALLSLPSITYLNIADNKLTGK---- 310
R L+ L L+ LL+ S+ L++++N L
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 311 LFDDLSCNP-ELGFVDLSSNLLTGQLPNCLLAGSKNR 346
L + + L + L + ++ + L A K++
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 8e-05
Identities = 22/104 (21%), Positives = 38/104 (36%), Gaps = 13/104 (12%)
Query: 118 GLWGPLSGKISRLSSLEILNMSSNFLNG----AIPQELSILTSLQTLILDENMLAGRVPD 173
G+ G S L +L ++ ++ ++ L SL+ L L N L
Sbjct: 356 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 415
Query: 174 WLGS-----LPILAVLSLRNNMFNGTLPDSFSYLE----NLRVL 208
L +L L L + ++ + D LE +LRV+
Sbjct: 416 QLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 9e-05
Identities = 20/95 (21%), Positives = 36/95 (37%), Gaps = 10/95 (10%)
Query: 132 SLEILNMSSNFLNGA-IPQELSILTSLQTLILDENML----AGRVPDWLGSLPILAVLSL 186
++ L++ L+ A + L +L Q + LD+ L + L P LA L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 187 RNNMFNGTLPDSF-----SYLENLRVLALSNNHFY 216
R+N + ++ L+L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 1e-04
Identities = 14/91 (15%), Positives = 32/91 (35%), Gaps = 10/91 (10%)
Query: 249 LVTMILSKNKFRSAIPAEVSSY-YQLQRLDLSSNRF----VGPFPQALLSLPSITYLNIA 303
+ ++ + + A AE+ Q Q + L AL P++ LN+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 304 DNKLTGKLFDDL-----SCNPELGFVDLSSN 329
N+L + + + ++ + L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 4e-04
Identities = 23/90 (25%), Positives = 38/90 (42%), Gaps = 13/90 (14%)
Query: 109 LKVLRLVSLGL----WGPLSGKISRLSSLEILNMSSNFLNGAIPQELS-----ILTSLQT 159
L+VL L + L+ + SL L++S+N L A +L L+
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 160 LILDENMLAGRVPDWLGSL----PILAVLS 185
L+L + + + D L +L P L V+S
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 6e-04
Identities = 15/84 (17%), Positives = 24/84 (28%), Gaps = 10/84 (11%)
Query: 172 PDWLGSLPILAVLSLRNNMFNGT----LPDSFSYLENLRVLALSNNHFYGEVPD------ 221
+L VL L + + + L + +LR L LSNN
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 222 FSGLTYLQVLDLENNALGPQFPKV 245
L+ L L + +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 7e-04
Identities = 10/70 (14%), Positives = 21/70 (30%), Gaps = 6/70 (8%)
Query: 181 LAVLSLRNNMFNGT-LPDSFSYLENLRVLALSNNHFYGEVPD-----FSGLTYLQVLDLE 234
+ L ++ + + L+ +V+ L + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 235 NNALGPQFPK 244
+N LG
Sbjct: 64 SNELGDVGVH 73
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 6e-05
Identities = 31/199 (15%), Positives = 60/199 (30%), Gaps = 12/199 (6%)
Query: 130 LSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189
+ N+ + A+ Q L S+ +I + + + + LP + L L N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKL 249
+ L+NL L L N + N +L
Sbjct: 79 KLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 250 VTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG 309
++ L NK + L+ + + P L + L ++ N ++
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAG----LTKLQNLYLSKNHISD 192
Query: 310 KLFDDLSCNPELGFVDLSS 328
L+ L ++L S
Sbjct: 193 --LRALAGLKNLDVLELFS 209
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 20/97 (20%), Positives = 36/97 (37%)
Query: 172 PDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVL 231
L L L+L +N + +P SF +L +L L L++N F +L+
Sbjct: 95 NKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKK 154
Query: 232 DLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVS 268
L A P + + L ++F+ +
Sbjct: 155 SLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSENSEG 191
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 16/64 (25%), Positives = 25/64 (39%), Gaps = 3/64 (4%)
Query: 172 PDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVL 231
L +L L L +N + P + L NL + L NN V + + L ++
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD-VSPLANTSNLFIV 222
Query: 232 DLEN 235
L N
Sbjct: 223 TLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 33/224 (14%), Positives = 75/224 (33%), Gaps = 15/224 (6%)
Query: 107 PDLKVLRLVSLGLWGP-LSGKISR--LSSLEILNMSSNFLNGAIPQELSILTSLQTLILD 163
PD + + + ++ +++ L + L+ + + + L +L L L
Sbjct: 14 PDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 164 ENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFS 223
+N + L +L + L L N + L + + S
Sbjct: 72 DNQI--TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 224 GLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRF 283
L L + + + LS + + +++ +L L N+
Sbjct: 130 NLQVLYLDLNQIT----NISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKI 185
Query: 284 VGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLS 327
P L SLP++ +++ +N+++ L+ L V L+
Sbjct: 186 SDISP--LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 16/62 (25%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 127 ISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186
++ LS L L N ++ P L+ L +L + L N ++ P L + L +++L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 187 RN 188
N
Sbjct: 225 TN 226
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 5e-04
Identities = 20/131 (15%), Positives = 41/131 (31%), Gaps = 9/131 (6%)
Query: 178 LPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNA 237
L LR + + + L+ + S+N ++ F L L+ L + NN
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNR 74
Query: 238 ---LGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFP----QA 290
+G + L +IL+ N + + + V
Sbjct: 75 ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYV 134
Query: 291 LLSLPSITYLN 301
+ +P + L+
Sbjct: 135 IYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.003
Identities = 13/87 (14%), Positives = 29/87 (33%), Gaps = 1/87 (1%)
Query: 198 SFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVG-KKLVTMILSK 256
++ R L L + L +D +N + ++L T++++
Sbjct: 13 QYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNN 72
Query: 257 NKFRSAIPAEVSSYYQLQRLDLSSNRF 283
N+ + L L L++N
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSL 99
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.003
Identities = 12/78 (15%), Positives = 21/78 (26%), Gaps = 1/78 (1%)
Query: 160 LILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEV 219
L L++N + + + NN D F +L +S +
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 220 PD-FSGLTYLQVLDLENN 236
L L+ N
Sbjct: 218 SYGLENLKKLRARSTYNL 235
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 659 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.98 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.98 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.98 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.97 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.97 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.96 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.96 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.96 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.95 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.95 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.9 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.66 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.58 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.48 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.47 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.45 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.32 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.3 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.21 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.41 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.25 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.21 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.87 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.62 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.46 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.2 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.86 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.82 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.45 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.82 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.73 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=6.1e-44 Score=369.44 Aligned_cols=292 Identities=28% Similarity=0.419 Sum_probs=228.1
Q ss_pred CCCHHHHHHHHHHHhcCCCCCCCCCCCCCCCCCc--CCCCCCCceEeCC----CCEeEEEeCCCCCCCCCCCCCcCCccc
Q 006145 27 QLQSSQAQTLLRIQGLLNNPAVLSSWNITTEFCN--TEPTSSLTVVCYE----ESITQLHIVGNKRAPMLPLSFSMDSFV 100 (659)
Q Consensus 27 ~~~~~~~~aLl~~k~~l~~~~~l~~W~~~~~~C~--w~~~~~~gv~C~~----~~v~~L~l~~~~~~~~l~~~~~~~~~~ 100 (659)
-|.++|++||++||+.+.+|..+++|..++|||. |. ||+|+. .||++|+|+++.+.|.. .+|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~-----gv~C~~~~~~~~v~~L~L~~~~l~g~~-------~lp 69 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWL-----GVLCDTDTQTYRVNNLDLSGLNLPKPY-------PIP 69 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCST-----TEEECCSSSCCCEEEEEEECCCCSSCE-------ECC
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCC-----CeEEeCCCCcEEEEEEECCCCCCCCCC-------CCC
Confidence 4899999999999999999888999998899995 86 799963 37999999998877632 245
Q ss_pred ccccCCCCCCEEEecC-CCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCC
Q 006145 101 TTLVKLPDLKVLRLVS-LGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLP 179 (659)
Q Consensus 101 ~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 179 (659)
+.+.+|++|++|+|++ |+++|.+|.+|++|++|++|+|++|++.+..|..+..+..|+.+++++|.+.+.+|..+++++
T Consensus 70 ~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~ 149 (313)
T d1ogqa_ 70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149 (313)
T ss_dssp GGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCT
T ss_pred hHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCc
Confidence 6788999999999986 789999999999999999999999999988888899999999999999999989999999999
Q ss_pred CCCEEEccCCcCCccCCcccCCCCCC-cEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCC
Q 006145 180 ILAVLSLRNNMFNGTLPDSFSYLENL-RVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKN 257 (659)
Q Consensus 180 ~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N 257 (659)
+|+.+++++|.++|.+|..+..+.++ +.+++++|++++..|. +..+. +..+++++ |
T Consensus 150 ~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~-~~~l~l~~---------------------~ 207 (313)
T d1ogqa_ 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSR---------------------N 207 (313)
T ss_dssp TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCS---------------------S
T ss_pred ccceeeccccccccccccccccccccccccccccccccccccccccccc-cccccccc---------------------c
Confidence 99999999999999999888888776 7888888988887765 44433 33455544 4
Q ss_pred cCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCCh
Q 006145 258 KFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPN 337 (659)
Q Consensus 258 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~ 337 (659)
.+.+.+|..+..+++|+.|++++|.+.+.+| .+..+++|+.|+|++|+++|.+|+.++.+++|++|||++|+|+|.+|.
T Consensus 208 ~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred ccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 4555666666666666666666666665544 466666666777777777666666666666677777777777666664
Q ss_pred hhhCCCCCCEEEcCCcc
Q 006145 338 CLLAGSKNRVVLYARNC 354 (659)
Q Consensus 338 ~~~~~~~l~~l~~~~N~ 354 (659)
+..+.++..+++++|+
T Consensus 287 -~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 287 -GGNLQRFDVSAYANNK 302 (313)
T ss_dssp -STTGGGSCGGGTCSSS
T ss_pred -cccCCCCCHHHhCCCc
Confidence 3455566666666664
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=306.52 Aligned_cols=168 Identities=21% Similarity=0.309 Sum_probs=145.4
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|+..+.||+|+||+||+|+.+ +|+.||||+++.... +..+++.+|+++|++++|||||++++++.+ .+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-------~~~ 77 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-------GNI 77 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-------TTE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-------Cce
Confidence 56888899999999999999975 699999999975543 234579999999999999999999999987 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.|+||||+++|+|.+++.. ...+++.++..++.|+++||+|||+. +||||||||+|||+++++.+||+|||+|+
T Consensus 78 ~~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp EEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEeccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhhe
Confidence 8999999999999999975 34699999999999999999999998 99999999999999999999999999998
Q ss_pred ccccc---cccceecccccccCCCCC
Q 006145 635 LAENA---EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~---~~~~~~~gt~~y~aPE~~ 657 (659)
..... ......+||+.|||||++
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~ 177 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELL 177 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHH
T ss_pred eeccCCccccccceeeCcCccCHhHh
Confidence 76432 223567899999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-36 Score=305.84 Aligned_cols=168 Identities=17% Similarity=0.321 Sum_probs=150.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
++|...+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+ .+..
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-------~~~~ 92 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-------GDEL 92 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-------TTEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-------CCEE
Confidence 46899999999999999999964 699999999987665566789999999999999999999999986 5679
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
|+|||||++|+|.+++.+ ..+++.++..++.|++.||+|||+. +||||||||+|||++.++.+||+|||+|+.
T Consensus 93 ~ivmEy~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (293)
T ss_dssp EEEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhee
Confidence 999999999999998875 3589999999999999999999998 999999999999999999999999999987
Q ss_pred cccc-cccceecccccccCCCCCC
Q 006145 636 AENA-EKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 636 ~~~~-~~~~~~~gt~~y~aPE~~~ 658 (659)
.... ......+||+.|||||++.
T Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~~~ 189 (293)
T d1yhwa1 166 ITPEQSKRSTMVGTPYWMAPEVVT 189 (293)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHS
T ss_pred eccccccccccccCCCccChhhhc
Confidence 6433 3446678999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-36 Score=307.40 Aligned_cols=168 Identities=18% Similarity=0.335 Sum_probs=141.4
Q ss_pred hhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
..++|...+.||+|+||+||+|+++ ..||||+++.... ...++|.+|+++|++++|||||+++|++.+
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-------- 75 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-------- 75 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--------
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--------
Confidence 3567889999999999999999874 3699999975432 334679999999999999999999999863
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++|||||++|+|.++++.. ...++|..+..|+.|||+||+|||+. +||||||||+|||+|+++.+||+|||+
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGL 150 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred cEEEEEEecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccc
Confidence 3579999999999999999753 24699999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc---cccceecccccccCCCCC
Q 006145 633 PLLAENA---EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~---~~~~~~~gt~~y~aPE~~ 657 (659)
|+..... .......||+.|||||++
T Consensus 151 a~~~~~~~~~~~~~~~~gt~~y~APE~l 178 (276)
T d1uwha_ 151 ATVKSRWSGSHQFEQLSGSILWMAPEVI 178 (276)
T ss_dssp SCC------------CCCCGGGCCHHHH
T ss_pred eeeccccCCcccccccccCcccCCHHHH
Confidence 9776432 233557899999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-37 Score=309.26 Aligned_cols=170 Identities=24% Similarity=0.382 Sum_probs=147.7
Q ss_pred hhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
..++|...+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|+|.+ +.
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--------~~ 81 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--------EP 81 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--------SS
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc--------CC
Confidence 456788889999999999999999888999999997544 345789999999999999999999998863 35
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++||||+++|+|.+++... ....++|..+.+|+.|||+||+|||+. +|+||||||+|||+|+++.+||+|||+|+
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceE
Confidence 79999999999999988642 123599999999999999999999998 99999999999999999999999999998
Q ss_pred ccccccc--cceecccccccCCCCC
Q 006145 635 LAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
...+... .....||+.|||||++
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~ 182 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAI 182 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHH
T ss_pred EccCCccccccccCCcccccChHHH
Confidence 7754332 2456789999999975
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-36 Score=302.89 Aligned_cols=168 Identities=21% Similarity=0.350 Sum_probs=138.3
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
++|+..+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|.+ .+..+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-------~~~~~ 76 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-------QAPIC 76 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-------SSSCE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc-------CCceE
Confidence 4577788999999999999999889999999997544 345789999999999999999999999976 45689
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+|||||++|+|.++++.. ...++|..+..|+.|||+||+|||+. +|+||||||+|||+|+++.+||+|||+++..
T Consensus 77 lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp EEEECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred EEEEecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheec
Confidence 999999999999998753 35689999999999999999999998 9999999999999999999999999999876
Q ss_pred ccccc--cceecccccccCCCCC
Q 006145 637 ENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
..... .....||+.|||||++
T Consensus 152 ~~~~~~~~~~~~gt~~y~aPE~l 174 (263)
T d1sm2a_ 152 LDDQYTSSTGTKFPVKWASPEVF 174 (263)
T ss_dssp -------------CTTSCCHHHH
T ss_pred cCCCceeecceecCcccCChHHh
Confidence 44332 2446799999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-36 Score=309.24 Aligned_cols=172 Identities=19% Similarity=0.343 Sum_probs=149.4
Q ss_pred HhhcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 474 EATNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 474 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
...++|...+.||+|+||+||+|++. +|+.||||+++... ...++|.+|+++|++++|||||+++|+|.+ .
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-------~ 85 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-------E 85 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-------S
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEee-------C
Confidence 34567888899999999999999976 58999999997544 346789999999999999999999999976 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++|||||++|+|.+++... ....++|..+..|+.|||+||+|||+. +||||||||+|||+|+++.+||+|||+
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred CeeEEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccc
Confidence 6689999999999999999753 235799999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccc--cceecccccccCCCCC
Q 006145 633 PLLAENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
|+....... .....||+.|||||++
T Consensus 162 a~~~~~~~~~~~~~~~g~~~y~aPE~~ 188 (287)
T d1opja_ 162 SRLMTGDTYTAHAGAKFPIKWTAPESL 188 (287)
T ss_dssp TTTCCSSSSEEETTEEECGGGCCHHHH
T ss_pred eeecCCCCceeeccccccccccChHHH
Confidence 987654332 2446689999999974
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.3e-36 Score=305.58 Aligned_cols=168 Identities=24% Similarity=0.398 Sum_probs=131.8
Q ss_pred CCCCCceeccCcCceEEEEEecC-C---cEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKN-G---TFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~-g---~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
+|...+.||+|+||+||+|+++. | ..||||++...... ..++|.+|+++|++++|||||+++|+|.+ .
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-------~ 99 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-------S 99 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-------S
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-------C
Confidence 34456789999999999999753 3 36899998754433 34579999999999999999999999975 4
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..++|||||++|+|.++++.. ...++|.++..|+.|||+||+|||+. +||||||||+|||+|+++++||+|||+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred CEEEEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCccc
Confidence 6689999999999999988753 34699999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccc------ceecccccccCCCCC
Q 006145 633 PLLAENAEKV------GHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~------~~~~gt~~y~aPE~~ 657 (659)
|+........ ....||+.|||||+.
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 205 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205 (299)
T ss_dssp ---------------------CGGGSCHHHH
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHH
Confidence 9876443221 234678999999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=298.31 Aligned_cols=168 Identities=20% Similarity=0.352 Sum_probs=148.0
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+ .
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-------~ 78 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-------A 78 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-------S
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-------C
Confidence 46888899999999999999975 59999999996432 2345679999999999999999999999986 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..|+|||||++|+|.+++... ..+++..+..++.||++||+|||+. +||||||||+|||+++++.+||+|||+
T Consensus 79 ~~~~ivmEy~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 79 TRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred CEEEEEEeecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccce
Confidence 6789999999999999999852 4699999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|+..... .....+||+.|||||++.
T Consensus 153 a~~~~~~-~~~~~~Gt~~Y~APE~~~ 177 (263)
T d2j4za1 153 SVHAPSS-RRTTLCGTLDYLPPEMIE 177 (263)
T ss_dssp CSCCCCC-CCEETTEEGGGCCHHHHT
T ss_pred eeecCCC-cccccCCCCcccCHHHHc
Confidence 9876543 345678999999999863
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-36 Score=303.98 Aligned_cols=169 Identities=16% Similarity=0.328 Sum_probs=149.0
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
+.|+..+.||+|+||+||+|+.. +|+.||||+++.......++|.+|+++|++++|||||++++++.+ .+..
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-------~~~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-------ENNL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-------TTEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-------CCeE
Confidence 45778899999999999999965 699999999987665566789999999999999999999999986 5678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++|||||++|+|.+++.+. ...+++.++..++.|+++||+|||+. +||||||||+|||++.++.+||+|||+|+.
T Consensus 85 ~lvmEy~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp EEEEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhc
Confidence 9999999999999997642 24699999999999999999999998 999999999999999999999999999976
Q ss_pred cccc-cccceecccccccCCCCC
Q 006145 636 AENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
.... ......+||+.|||||++
T Consensus 160 ~~~~~~~~~~~~Gt~~y~APE~l 182 (288)
T d2jfla1 160 NTRTIQRRDSFIGTPYWMAPEVV 182 (288)
T ss_dssp CHHHHHHHTCCCSCCTTCCHHHH
T ss_pred cCCCcccccccccccccCCHHHH
Confidence 5432 234567899999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-36 Score=309.39 Aligned_cols=168 Identities=14% Similarity=0.279 Sum_probs=145.9
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.++|+..+.||+|+||+||+|+.. +|+.||||+++..... ..+++.+|+++|++++|||||+++++|.+ .+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------~~ 77 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-------DG 77 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-------SS
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-------CC
Confidence 567888999999999999999965 6999999999765333 34679999999999999999999999986 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcC-CCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT-GIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
..|+|||||++|+|.+++++. ..+++..+..++.|+++||+|||+ + +|+||||||+|||+++++.+||+|||+
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred EEEEEEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCC
Confidence 799999999999999999752 469999999999999999999996 5 899999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+...+. .....+||+.|||||++
T Consensus 152 a~~~~~~-~~~~~~GT~~Y~APEvl 175 (322)
T d1s9ja_ 152 SGQLIDS-MANSFVGTRSYMSPERL 175 (322)
T ss_dssp CHHHHHH-TC---CCSSCCCCHHHH
T ss_pred ccccCCC-ccccccCCccccCchHH
Confidence 9866442 33457999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-36 Score=301.58 Aligned_cols=177 Identities=17% Similarity=0.305 Sum_probs=136.0
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc--hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS--TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|+..+.||+|+||+||+|+.+ +|+.||||.++...... .+.|.+|+++|++++|||||++++++.+. ..+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~ 78 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR-----TNT 78 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---------
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC-----CCC
Confidence 56888999999999999999965 69999999997654332 35699999999999999999999998752 235
Q ss_pred eeEEEEeccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHhhhhcCCC--CCCccccCCCCCceeecCCcceEEccC
Q 006145 554 RIFLIFEYVPNGTLRSWISEG-HAHQSLTWTQRISAAIGVAKGIQFLHTGI--VPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
..|+|||||++|+|.+++.+. .....+++..+..++.|++.||+|||+.. ..+||||||||+|||+++++.+||+||
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 689999999999999998632 12356999999999999999999999851 135999999999999999999999999
Q ss_pred cccccccccc-ccceecccccccCCCCCC
Q 006145 631 NLPLLAENAE-KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 631 Gla~~~~~~~-~~~~~~gt~~y~aPE~~~ 658 (659)
|+|+...... .....+||+.|||||++.
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~ 187 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMN 187 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHT
T ss_pred cceeecccCCCccccCCCCcccCCHHHHc
Confidence 9998765433 345678999999999763
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-34 Score=291.87 Aligned_cols=170 Identities=23% Similarity=0.282 Sum_probs=142.6
Q ss_pred CCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 480 DTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 480 ~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
...+.||+|+||+||+|+.. +++.||||++...... ..++|.+|+++|++++|||||++++++.+... .....|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~---~~~~~~ 88 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK---GKKCIV 88 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS---SCEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc---cCCEEE
Confidence 34568999999999999965 5889999999765432 23569999999999999999999999875221 235689
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec-CCcceEEccCccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD-QNLVAKISSYNLPLL 635 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld-~~~~~kl~DFGla~~ 635 (659)
+||||+++|+|.+++.+. ..+++..+..++.||++||+|||+. .++||||||||+|||++ +++.+||+|||+|+.
T Consensus 89 ivmE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 999999999999999752 4689999999999999999999996 23499999999999996 579999999999986
Q ss_pred cccccccceecccccccCCCCC
Q 006145 636 AENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
... ......+||+.|||||+.
T Consensus 165 ~~~-~~~~~~~GT~~Y~aPE~~ 185 (270)
T d1t4ha_ 165 KRA-SFAKAVIGTPEFMAPEMY 185 (270)
T ss_dssp CCT-TSBEESCSSCCCCCGGGG
T ss_pred ccC-CccCCcccCccccCHHHh
Confidence 543 334567899999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-35 Score=300.24 Aligned_cols=170 Identities=20% Similarity=0.322 Sum_probs=130.9
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.+.|+..+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++|++++|||||++++++.+ .+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-------~~ 80 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-------GG 80 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-------SS
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-------CC
Confidence 356888899999999999999975 5999999999765432 23568899999999999999999999976 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec---CCcceEEccC
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD---QNLVAKISSY 630 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld---~~~~~kl~DF 630 (659)
..|+|||||++|+|.+++.+ ...+++.....++.|++.||+|||+. +||||||||+||+++ +++.+||+||
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEeccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEecc
Confidence 79999999999999999985 24699999999999999999999998 999999999999994 5789999999
Q ss_pred ccccccccccccceecccccccCCCCCC
Q 006145 631 NLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 631 Gla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|+|+...........+||+.|||||++.
T Consensus 155 G~a~~~~~~~~~~~~~GT~~y~APE~~~ 182 (307)
T d1a06a_ 155 GLSKMEDPGSVLSTACGTPGYVAPEVLA 182 (307)
T ss_dssp ------------------CTTSCHHHHT
T ss_pred ceeEEccCCCeeeeeeeCccccCcHHHc
Confidence 9998877666667789999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.3e-35 Score=304.64 Aligned_cols=170 Identities=18% Similarity=0.278 Sum_probs=151.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+ .+.
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-------~~~ 97 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-------DNE 97 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-------TTE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-------CCE
Confidence 357888999999999999999965 699999999976554455679999999999999999999999986 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec--CCcceEEccCcc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD--QNLVAKISSYNL 632 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld--~~~~~kl~DFGl 632 (659)
.|+|||||++|+|.+++.+. ...+++..+..|+.||+.||+|||+. +||||||||+|||++ .++.+||+|||+
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEEcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecch
Confidence 99999999999999999643 24699999999999999999999998 999999999999996 458899999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+............||+.|||||++
T Consensus 173 a~~~~~~~~~~~~~gT~~Y~aPEv~ 197 (350)
T d1koaa2 173 TAHLDPKQSVKVTTGTAEFAAPEVA 197 (350)
T ss_dssp CEECCTTSCEEEECSCTTTCCHHHH
T ss_pred heecccccccceecCcccccCHHHH
Confidence 9988776667778999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-34 Score=288.51 Aligned_cols=168 Identities=21% Similarity=0.318 Sum_probs=148.1
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
++|+..+.||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++|||||+++|+|.+ .+..+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-------~~~~~ 75 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-------QRPIF 75 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECC-------SSSEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEee-------CCceE
Confidence 57888999999999999999998899999999986543 45789999999999999999999999975 46789
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.+++... ...++|..+.+++.|+|+||+|||+. +|+||||||+||++|+++.+||+|||+++..
T Consensus 76 iv~Ey~~~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~ 150 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 150 (258)
T ss_dssp EEEECCTTEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred EEEEccCCCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheec
Confidence 999999999999997753 34689999999999999999999998 9999999999999999999999999999766
Q ss_pred ccccc--cceecccccccCCCCC
Q 006145 637 ENAEK--VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~--~~~~~gt~~y~aPE~~ 657 (659)
..... .....||+.|||||..
T Consensus 151 ~~~~~~~~~~~~~t~~y~aPE~~ 173 (258)
T d1k2pa_ 151 LDDEYTSSVGSKFPVRWSPPEVL 173 (258)
T ss_dssp SSSSCCCCCCSCCCGGGCCHHHH
T ss_pred cCCCceeecccCCCCCcCCcHHh
Confidence 44332 2346789999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-35 Score=299.25 Aligned_cols=164 Identities=19% Similarity=0.308 Sum_probs=143.9
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc---hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS---TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
.|+..+.||+|+||+||+|+.. +|+.||||+++...... .++|.+|+++|++++|||||++++++.+ .+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-------~~ 88 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-------EH 88 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-------TT
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-------CC
Confidence 4778899999999999999964 69999999997654332 2568999999999999999999999986 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..|+|||||++|+|..++.. ...+++.++..++.||++||+|||+. +||||||||+|||+++++.+||+|||+|
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a 162 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA 162 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred EEEEEEEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccc
Confidence 79999999999999877654 24699999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccccceecccccccCCCCC
Q 006145 634 LLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+.... ....+||+.|||||++
T Consensus 163 ~~~~~---~~~~~GT~~Y~APE~~ 183 (309)
T d1u5ra_ 163 SIMAP---ANSFVGTPYWMAPEVI 183 (309)
T ss_dssp BSSSS---BCCCCSCGGGCCHHHH
T ss_pred cccCC---CCccccCccccCHHHH
Confidence 86643 3456899999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-35 Score=297.77 Aligned_cols=168 Identities=18% Similarity=0.297 Sum_probs=144.7
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+ .
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-------~ 80 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-------D 80 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-------S
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-------C
Confidence 46888999999999999999975 69999999997532 2344679999999999999999999999976 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..|+|||||++|+|.+++... ..+++..+..++.|++.||+|||+. +||||||||+|||+++++.+||+|||+
T Consensus 81 ~~~~ivmEy~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 81 EKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGT 154 (288)
T ss_dssp SEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEeccccc
Confidence 6789999999999999998752 4699999999999999999999998 999999999999999999999999999
Q ss_pred ccccccc---cccceecccccccCCCCC
Q 006145 633 PLLAENA---EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~---~~~~~~~gt~~y~aPE~~ 657 (659)
|+..... ......+||+.|||||++
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~ 182 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELL 182 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHH
T ss_pred ceecccCCcccccccccCCccccCceee
Confidence 9876432 223457899999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-35 Score=300.23 Aligned_cols=169 Identities=24% Similarity=0.403 Sum_probs=141.4
Q ss_pred hcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.++|...+.||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++|||||+++|+|.+ +..
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~--------~~~ 86 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--------EPI 86 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--------SSC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec--------CCe
Confidence 46788899999999999999999888899999997544 345789999999999999999999999853 357
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
++|||||++|+|.+++.... ...++|.++..|+.|||+||+|||+. +|+||||||+|||+|+++++||+|||+|+.
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhh
Confidence 99999999999999887421 24599999999999999999999998 999999999999999999999999999987
Q ss_pred ccccc--ccceecccccccCCCCC
Q 006145 636 AENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
..... ......||+.|||||++
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~ 186 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAA 186 (285)
T ss_dssp -------------CCGGGSCHHHH
T ss_pred ccCCCceeeccccccccccChHHH
Confidence 64333 23456799999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-34 Score=294.63 Aligned_cols=168 Identities=19% Similarity=0.281 Sum_probs=141.4
Q ss_pred cCCCCCc-eeccCcCceEEEEEec---CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSA-FMGEGSQGQMYRGRLK---NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~-~ig~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
++|...+ +||+|+||+||+|+++ ++..||||+++..... ..++|.+|+++|++++|||||+++|+|.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------- 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------- 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-------
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-------
Confidence 3455556 4999999999999864 3568999999754432 34679999999999999999999999864
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
+..|+|||||++|+|.+++... ...++|..+.+++.|||+||+|||+. +||||||||+|||++.++.+||+|||
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFG 154 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFG 154 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCT
T ss_pred -CeEEEEEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccch
Confidence 3579999999999999998643 34699999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccc----cceecccccccCCCCC
Q 006145 632 LPLLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
+|+....... .....||+.|||||++
T Consensus 155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 184 (285)
T d1u59a_ 155 LSKALGADDSYYTARSAGKWPLKWYAPECI 184 (285)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHH
T ss_pred hhhcccccccccccccccccCccccChHHH
Confidence 9987643322 2345789999999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-34 Score=293.48 Aligned_cols=161 Identities=19% Similarity=0.281 Sum_probs=134.7
Q ss_pred ceeccCcCceEEEEEecC---CcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeEE
Q 006145 483 AFMGEGSQGQMYRGRLKN---GTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIFL 557 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~---g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~l 557 (659)
+.||+|+||+||+|.+++ ++.||||+++..... ..++|.+|+++|++++|||||+++|+|.. +..++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~--------~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--------ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--------SSEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc--------CCEEE
Confidence 579999999999998653 568999999754332 23579999999999999999999999863 34789
Q ss_pred EEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccccc
Q 006145 558 IFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAE 637 (659)
Q Consensus 558 V~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~ 637 (659)
|||||++|+|.++++.. ..++|..+.+|+.|||+||+|||+. +||||||||+|||++.++.+||+|||+++...
T Consensus 85 vmE~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158 (277)
T ss_dssp EEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcc
Confidence 99999999999999862 4699999999999999999999998 99999999999999999999999999998664
Q ss_pred cccc----cceecccccccCCCCC
Q 006145 638 NAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 638 ~~~~----~~~~~gt~~y~aPE~~ 657 (659)
.... .....||+.|||||++
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l 182 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECI 182 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHH
T ss_pred ccccccccccccCCCceecCchhh
Confidence 3322 2345789999999964
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-34 Score=301.13 Aligned_cols=170 Identities=16% Similarity=0.247 Sum_probs=151.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
++|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+ .+..
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-------~~~~ 101 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-------KYEM 101 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-------SSEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-------CCEE
Confidence 56888999999999999999964 699999999976554445678999999999999999999999976 5678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec--CCcceEEccCccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD--QNLVAKISSYNLP 633 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld--~~~~~kl~DFGla 633 (659)
|+|||||++|+|.+++... ...+++.+...|+.||+.||+|||+. +||||||||+|||++ .++.+||+|||+|
T Consensus 102 ~ivmE~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp EEEEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEcCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccc
Confidence 9999999999999987642 34699999999999999999999998 999999999999998 5789999999999
Q ss_pred cccccccccceecccccccCCCCCC
Q 006145 634 LLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 634 ~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+............||+.|||||++.
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~ 201 (352)
T d1koba_ 177 TKLNPDEIVKVTTATAEFAAPEIVD 201 (352)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHT
T ss_pred eecCCCCceeeccCcccccCHHHHc
Confidence 9887776777889999999999764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=294.19 Aligned_cols=169 Identities=22% Similarity=0.382 Sum_probs=137.1
Q ss_pred cCCCCCceeccCcCceEEEEEecCC-----cEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNG-----TFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g-----~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
+.|+..++||+|+||+||+|+++.. ..||||+++..... ...+|.+|++++++++|||||+++|+|.+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~------ 80 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK------ 80 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec------
Confidence 3467789999999999999997642 47999999754432 23579999999999999999999999976
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
.+..++|||||.+|++.+++... ...++|.++.+++.|||+||+|||+. +||||||||+|||+|.++.+||+||
T Consensus 81 -~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DF 154 (283)
T d1mqba_ 81 -YKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDF 154 (283)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred -CCceEEEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEccc
Confidence 45689999999999999988753 35699999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccc----ccceecccccccCCCCC
Q 006145 631 NLPLLAENAE----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~----~~~~~~gt~~y~aPE~~ 657 (659)
|+++...... ......||+.|||||++
T Consensus 155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l 185 (283)
T d1mqba_ 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185 (283)
T ss_dssp CC-----------------CCCGGGSCHHHH
T ss_pred chhhcccCCCccceEeccCCCCccccCHHHH
Confidence 9998764432 22345789999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-34 Score=298.00 Aligned_cols=170 Identities=18% Similarity=0.293 Sum_probs=149.8
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|+..+.||+|+||+||+|+.+ +|+.||||++++.. ....+.+.+|+++|++++|||||++++++.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------- 76 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT------- 76 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-------
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-------
Confidence 356888999999999999999964 69999999997542 3345779999999999999999999999986
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..|+|||||++|+|.+++.+. ..+++.....++.|++.||+|||+. +||||||||+|||+|+++.+||+|||
T Consensus 77 ~~~~~iv~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 77 HDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccccceeccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecc
Confidence 56799999999999999999862 4689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccc-ccccceecccccccCCCCCC
Q 006145 632 LPLLAEN-AEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 632 la~~~~~-~~~~~~~~gt~~y~aPE~~~ 658 (659)
+|+.... .......+||+.|||||++.
T Consensus 151 ~a~~~~~~~~~~~~~~GT~~Y~aPE~~~ 178 (337)
T d1o6la_ 151 LCKEGISDGATMKTFCGTPEYLAPEVLE 178 (337)
T ss_dssp TCBCSCCTTCCBCCCEECGGGCCGGGGS
T ss_pred cccccccCCcccccceeCHHHhhhhhcc
Confidence 9986543 34456689999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-34 Score=291.85 Aligned_cols=168 Identities=19% Similarity=0.305 Sum_probs=149.0
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC------chHHHHHHHHHHhCCCCCCccceeeeeeeccccC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH------STRNFMHHIELISKLRHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 549 (659)
+.|+..+.||+|+||+||+|+.+ +|+.||||+++..... ..++|.+|+++|++++|||||++++++.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----- 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----- 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----
Confidence 56888999999999999999975 6999999999754321 24679999999999999999999999986
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc----ce
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL----VA 625 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~----~~ 625 (659)
.+..|+|||||++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+
T Consensus 85 --~~~~~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~v 156 (293)
T d1jksa_ 85 --KTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRI 156 (293)
T ss_dssp --SSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCE
T ss_pred --CCEEEEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccce
Confidence 56799999999999999999752 4699999999999999999999998 999999999999998776 49
Q ss_pred EEccCccccccccccccceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|++|||+|+............||+.|||||++
T Consensus 157 kl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~ 188 (293)
T d1jksa_ 157 KIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188 (293)
T ss_dssp EECCCTTCEECTTSCBCSCCCCCGGGCCHHHH
T ss_pred EecchhhhhhcCCCccccccCCCCcccCHHHH
Confidence 99999999888766666778999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-34 Score=294.70 Aligned_cols=167 Identities=22% Similarity=0.349 Sum_probs=147.5
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+ .
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-------~ 76 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-------A 76 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-------S
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-------C
Confidence 56888899999999999999964 69999999997432 3345779999999999999999999999986 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
+..|+|||||++|+|.+++... ..+++.....++.||+.||+|||+. +||||||||+|||+|.++.+||+|||+
T Consensus 77 ~~~~ivmE~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 77 QQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp SEEEEEECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred CeeeeEeeecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCcc
Confidence 6799999999999999998863 4688899999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|+..... ....+||+.|||||++.
T Consensus 151 a~~~~~~--~~~~~Gt~~Y~APE~l~ 174 (316)
T d1fota_ 151 AKYVPDV--TYTLCGTPDYIAPEVVS 174 (316)
T ss_dssp CEECSSC--BCCCCSCTTTCCHHHHT
T ss_pred ceEeccc--cccccCcccccCHHHHc
Confidence 9877543 34578999999999863
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-34 Score=295.79 Aligned_cols=173 Identities=24% Similarity=0.405 Sum_probs=143.2
Q ss_pred hhcCCCCCceeccCcCceEEEEEecC-C-----cEEEEEEecccC-CCchHHHHHHHHHHhCC-CCCCccceeeeeeecc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLKN-G-----TFVAIRCLKMKK-CHSTRNFMHHIELISKL-RHRHLVSALGHCFECY 546 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 546 (659)
..++|+..+.||+|+||+||+|+... + ..||||.+.... ......|.+|+++|.++ +|||||+++|+|.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence 45678888999999999999999643 2 369999986543 23346799999999998 89999999999976
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHhhhhcCCCCCC
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGHA--------------------HQSLTWTQRISAAIGVAKGIQFLHTGIVPG 606 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 606 (659)
.+..++|||||++|+|.++++.... ...++|..++.|+.|||+||+|||+. +
T Consensus 113 -----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~ 184 (325)
T d1rjba_ 113 -----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---S 184 (325)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred -----CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 5678999999999999999975321 13589999999999999999999998 9
Q ss_pred ccccCCCCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 607 VFSNNLKITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 607 iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
||||||||+|||+|.++.+||+|||+|+....... .....||+.|||||++
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l 238 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH
Confidence 99999999999999999999999999987654332 2456789999999964
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-33 Score=284.91 Aligned_cols=168 Identities=18% Similarity=0.311 Sum_probs=149.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc---------hHHHHHHHHHHhCCC-CCCccceeeeeeec
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS---------TRNFMHHIELISKLR-HRHLVSALGHCFEC 545 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---------~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~ 545 (659)
++|+..+.||+|+||+||+|+.. +|+.||||+++...... .+.+.+|++++++++ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 57888999999999999999964 69999999997653221 135889999999997 9999999999986
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcce
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVA 625 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~ 625 (659)
.+..|||||||++|||.++++. ...+++.++..++.||++||+|||+. +|+||||||+|||+++++.+
T Consensus 82 ------~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 82 ------NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp ------SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred ------CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCe
Confidence 5679999999999999999975 24699999999999999999999998 99999999999999999999
Q ss_pred EEccCccccccccccccceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
||+|||+++...........+||+.|+|||+.
T Consensus 150 kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~ 181 (277)
T d1phka_ 150 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181 (277)
T ss_dssp EECCCTTCEECCTTCCBCCCCSCGGGCCHHHH
T ss_pred EEccchheeEccCCCceeeeeccCCCCCHHHh
Confidence 99999999887766666778899999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-34 Score=290.69 Aligned_cols=178 Identities=24% Similarity=0.382 Sum_probs=148.7
Q ss_pred HHHHHhhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCCc-hHHHHHHHHHHhCCCCCCccceeeee
Q 006145 470 EELEEATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCHS-TRNFMHHIELISKLRHRHLVSALGHC 542 (659)
Q Consensus 470 ~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~ 542 (659)
.+++.++++|+..+.||+|+||+||+|+++ +++.||||+++...... .++|.+|+++|++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345567888999999999999999999864 35789999997654332 35799999999999999999999999
Q ss_pred eeccccCCCCceeEEEEeccCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHhhhhcC
Q 006145 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISEGH---------------------AHQSLTWTQRISAAIGVAKGIQFLHT 601 (659)
Q Consensus 543 ~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~ 601 (659)
.. ....++||||+++|+|.++++... ....++|..++.|+.|+|+||+|||+
T Consensus 86 ~~-------~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~ 158 (301)
T d1lufa_ 86 AV-------GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 158 (301)
T ss_dssp CS-------SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cc-------CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc
Confidence 76 456899999999999999986321 12358999999999999999999999
Q ss_pred CCCCCccccCCCCCceeecCCcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 602 GIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 602 ~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
. +||||||||+|||+|.++.+||+|||+|+...+.. ......||+.|||||+.
T Consensus 159 ~---~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~ 214 (301)
T d1lufa_ 159 R---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 214 (301)
T ss_dssp T---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred C---CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH
Confidence 8 99999999999999999999999999997664332 22456789999999964
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.3e-33 Score=287.56 Aligned_cols=169 Identities=21% Similarity=0.370 Sum_probs=137.7
Q ss_pred CCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHH--HHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIE--LISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~--~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
+|...+.||+|+||+||+|++ +|+.||||+++... .+++.+|.+ .+..++|||||+++|+|.+... .....
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~---~~~~~ 76 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNG---TWTQL 76 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS---SSEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC---cceEE
Confidence 456678999999999999997 58999999996432 344444544 5567899999999999986321 23468
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCC-----CCCccccCCCCCceeecCCcceEEccC
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI-----VPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
++|||||++|+|.+++++ ..++|.++.+++.|+|+||+|+|+.. .++||||||||+|||+|+++.+||+||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 999999999999999985 36999999999999999999999731 359999999999999999999999999
Q ss_pred cccccccccc-----ccceecccccccCCCCC
Q 006145 631 NLPLLAENAE-----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~-----~~~~~~gt~~y~aPE~~ 657 (659)
|+++...... .....+||+.|||||++
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 184 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHH
T ss_pred CccccccCCCcceeccccceecccCcCChhhc
Confidence 9998764332 23457899999999975
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.98 E-value=4.7e-33 Score=287.12 Aligned_cols=231 Identities=27% Similarity=0.394 Sum_probs=198.2
Q ss_pred CCCEEEecCCCCcC--CCCcccCCCCCCcEEEccc-CcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEE
Q 006145 108 DLKVLRLVSLGLWG--PLSGKISRLSSLEILNMSS-NFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVL 184 (659)
Q Consensus 108 ~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (659)
+++.|+|++|+++| .+|.++++|++|++|+|++ |+++|.+|..|++|++|++|+|++|++.+..|..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 57788999998887 4788899999999999986 88888888889999999999999999888888888888888999
Q ss_pred EccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccC
Q 006145 185 SLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAI 263 (659)
Q Consensus 185 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~ 263 (659)
++++|.+.+.+|..++++++|+.+++++|.+++.+|. +..+..+ ++.+++++|++++..
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l--------------------~~~l~~~~n~l~~~~ 190 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL--------------------FTSMTISRNRLTGKI 190 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT--------------------CCEEECCSSEEEEEC
T ss_pred ccccccccccCchhhccCcccceeecccccccccccccccccccc--------------------ccccccccccccccc
Confidence 9988888888888888888888888888888887775 5555443 234455566667778
Q ss_pred chhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCC
Q 006145 264 PAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGS 343 (659)
Q Consensus 264 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~ 343 (659)
|..+..+..+ .+++++|.+.+.+|..+..+++|+.+++++|.+++.+| .+..+++|+.|||++|+++|.+|..+..++
T Consensus 191 ~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~ 268 (313)
T d1ogqa_ 191 PPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268 (313)
T ss_dssp CGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCT
T ss_pred cccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCC
Confidence 8888777554 79999999999999999999999999999999998766 588899999999999999999999999999
Q ss_pred CCCEEEcCCccccCCCC
Q 006145 344 KNRVVLYARNCLAAGNE 360 (659)
Q Consensus 344 ~l~~l~~~~N~l~~~~~ 360 (659)
+|+.+++++|.++|..|
T Consensus 269 ~L~~L~Ls~N~l~g~iP 285 (313)
T d1ogqa_ 269 FLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp TCCEEECCSSEEEEECC
T ss_pred CCCEEECcCCcccccCC
Confidence 99999999999997654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.98 E-value=4.8e-33 Score=290.51 Aligned_cols=166 Identities=17% Similarity=0.271 Sum_probs=147.1
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
++|+..+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.+ .
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-------~ 113 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-------N 113 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-------S
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-------c
Confidence 56888999999999999999975 69999999996432 2345679999999999999999999999976 5
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++||||+.+|+|.+++.+. ..+++.....++.||+.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 114 ~~~~~v~e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 114 SNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeecee
Confidence 6789999999999999999752 4699999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+..... ....+||+.|||||++
T Consensus 188 a~~~~~~--~~~~~Gt~~Y~APE~~ 210 (350)
T d1rdqe_ 188 AKRVKGR--TWTLCGTPEALAPEII 210 (350)
T ss_dssp CEECSSC--BCCCEECGGGCCHHHH
T ss_pred eeecccc--cccccCccccCCHHHH
Confidence 9877543 3457899999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=4.7e-33 Score=292.15 Aligned_cols=169 Identities=21% Similarity=0.300 Sum_probs=143.9
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC---CchHHHHH---HHHHHhCCCCCCccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC---HSTRNFMH---HIELISKLRHRHLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~---Ei~~l~~l~H~niv~l~g~~~~~~~~ 548 (659)
.++|...+.||+|+||+||+|+.. +|+.||||++..... .....+.+ |+++++.++|||||++++++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~---- 78 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---- 78 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE----
Confidence 357888999999999999999965 699999999964321 22233444 4778888999999999999976
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
.+..|+|||||++|+|.+++.+. ..+++..+..++.||+.||+|||+. +||||||||+|||+++++.+||+
T Consensus 79 ---~~~~~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~ 149 (364)
T d1omwa3 79 ---PDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS 149 (364)
T ss_dssp ---SSEEEEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEEC
T ss_pred ---CCEEEEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEe
Confidence 56799999999999999999752 4688999999999999999999998 99999999999999999999999
Q ss_pred cCccccccccccccceecccccccCCCCCC
Q 006145 629 SYNLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 629 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|||+|+..... .....+||+.|||||++.
T Consensus 150 DFGla~~~~~~-~~~~~~GT~~y~APE~~~ 178 (364)
T d1omwa3 150 DLGLACDFSKK-KPHASVGTHGYMAPEVLQ 178 (364)
T ss_dssp CCTTCEECSSS-CCCSCCSCGGGCCHHHHS
T ss_pred eeceeeecCCC-cccccccccccchhHHhh
Confidence 99999876543 345578999999999763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-33 Score=287.77 Aligned_cols=180 Identities=22% Similarity=0.342 Sum_probs=139.2
Q ss_pred HHHHHHhhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCC-chHHHHHHHHHHhCC-CCCCccceee
Q 006145 469 LEELEEATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCH-STRNFMHHIELISKL-RHRHLVSALG 540 (659)
Q Consensus 469 ~~~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l-~H~niv~l~g 540 (659)
.++++...++|+..+.||+|+||+||+|+.. +++.||||+++..... ..+++.+|++.+.++ +|+|||.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3444455678889999999999999999854 3568999999754432 345788898888877 6899999999
Q ss_pred eeeeccccCCCCceeEEEEeccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCc
Q 006145 541 HCFECYFDDSSVSRIFLIFEYVPNGTLRSWISEGH-------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGV 607 (659)
Q Consensus 541 ~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 607 (659)
++.+. ....++|||||++|+|.++++... ....++|.++..++.|||+||+|||+. +|
T Consensus 85 ~~~~~------~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~i 155 (299)
T d1ywna1 85 ACTKP------GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KC 155 (299)
T ss_dssp EECST------TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eeccC------CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CC
Confidence 88751 346899999999999999997421 124589999999999999999999998 99
Q ss_pred cccCCCCCceeecCCcceEEccCcccccccccc---ccceecccccccCCCCC
Q 006145 608 FSNNLKITDILLDQNLVAKISSYNLPLLAENAE---KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 608 iHrDlk~~NILld~~~~~kl~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~ 657 (659)
|||||||+|||+|+++.+||+|||+|+...... ......||+.|||||++
T Consensus 156 vHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 208 (299)
T d1ywna1 156 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 208 (299)
T ss_dssp CCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHH
T ss_pred cCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHh
Confidence 999999999999999999999999998654332 23456899999999964
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.2e-33 Score=286.43 Aligned_cols=168 Identities=20% Similarity=0.354 Sum_probs=138.5
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCc----EEEEEEecccC-CCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGT----FVAIRCLKMKK-CHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.+|+..+.||+|+||+||+|++. +|+ .||||+++... .+..++|.+|++++++++|||||+++|+|.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 35888899999999999999964 344 58999886543 3345789999999999999999999999975
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
+..++++||+.+|+|.+++... ...++|..+.+++.|||+||+|||+. +||||||||+|||+|.++.+||+||
T Consensus 83 --~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DF 155 (317)
T d1xkka_ 83 --STVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 155 (317)
T ss_dssp --SSEEEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCC
T ss_pred --CCeeEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecc
Confidence 3468999999999999988753 35799999999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccc---cceecccccccCCCCC
Q 006145 631 NLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
|+|+....... .....||+.|||||++
T Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l 185 (317)
T d1xkka_ 156 GLAKLLGAEEKEYHAEGGKVPIKWMALESI 185 (317)
T ss_dssp SHHHHTTTTCC--------CCTTTSCHHHH
T ss_pred ccceecccccccccccccccCccccChHHH
Confidence 99987643322 2345789999999974
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-33 Score=281.64 Aligned_cols=166 Identities=20% Similarity=0.392 Sum_probs=135.1
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
++|+..+.||+|+||.||+|+++ |+.||||+++... ..++|.+|++++++++|||||+++|+|.+. .+..+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------~~~~~ 77 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE------KGGLY 77 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--------CCE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEec------CCcEE
Confidence 45667789999999999999985 7899999997543 457899999999999999999999999641 34579
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+||||+++|+|.++++.. ....++|..+++|+.|||+||+|||+. +|+||||||+||+++.++.+|++|||+++..
T Consensus 78 lv~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp EEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceec
Confidence 999999999999999742 123589999999999999999999998 9999999999999999999999999999876
Q ss_pred ccccccceecccccccCCCCC
Q 006145 637 ENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~~~~~~~gt~~y~aPE~~ 657 (659)
... .....+|..|||||++
T Consensus 154 ~~~--~~~~~~~~~y~aPE~l 172 (262)
T d1byga_ 154 SST--QDTGKLPVKWTAPEAL 172 (262)
T ss_dssp ----------CCTTTSCHHHH
T ss_pred CCC--CccccccccCCChHHH
Confidence 443 3445789999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-32 Score=282.69 Aligned_cols=169 Identities=15% Similarity=0.210 Sum_probs=148.6
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
.++|...+.||+|+||+||+|+.. +|+.||||.++... .+...+.+|+++|+.++|||||++++++.+ .+.
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-------~~~ 75 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES-------MEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-------TTE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-------CCE
Confidence 356888899999999999999965 69999999997643 234568899999999999999999999986 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC--cceEEccCcc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN--LVAKISSYNL 632 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~--~~~kl~DFGl 632 (659)
.|+|||||++|+|.+++... ...+++.+...|+.||++||+|||+. +|+||||||+|||++.+ ..+||+|||+
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccch
Confidence 99999999999999999753 24689999999999999999999998 99999999999999854 5899999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++............+|+.|||||..
T Consensus 151 ~~~~~~~~~~~~~~~t~~y~ape~~ 175 (321)
T d1tkia_ 151 ARQLKPGDNFRLLFTAPEYYAPEVH 175 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHH
T ss_pred hhccccCCcccccccccccccchhc
Confidence 9887766666778999999999964
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.8e-33 Score=282.94 Aligned_cols=169 Identities=20% Similarity=0.326 Sum_probs=133.3
Q ss_pred hcCCCCCceeccCcCceEEEEEecC----CcEEEEEEecccCCCc-hHHHHHHHHHHhCCCCCCccceeeeeeeccccCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN----GTFVAIRCLKMKKCHS-TRNFMHHIELISKLRHRHLVSALGHCFECYFDDS 550 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~ 550 (659)
.++|...+.||+|+||+||+|++.. +..||||.++...... .+.|.+|++++++++|||||+++|+|.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 4678888999999999999998642 4579999986544332 3569999999999999999999999853
Q ss_pred CCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccC
Q 006145 551 SVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSY 630 (659)
Q Consensus 551 ~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DF 630 (659)
+..++||||+++|+|.+++... ...+++..+..++.||++||+|||+. +||||||||+||++++++.+||+||
T Consensus 80 --~~~~iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~Df 152 (273)
T d1mp8a_ 80 --NPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF 152 (273)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred --CeEEEEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccc
Confidence 4579999999999999987753 34699999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccc--ccceecccccccCCCCC
Q 006145 631 NLPLLAENAE--KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 631 Gla~~~~~~~--~~~~~~gt~~y~aPE~~ 657 (659)
|+|+...... ......||+.|||||++
T Consensus 153 G~a~~~~~~~~~~~~~~~gt~~y~apE~l 181 (273)
T d1mp8a_ 153 GLSRYMEDSTYYKASKGKLPIKWMAPESI 181 (273)
T ss_dssp ------------------CCGGGCCHHHH
T ss_pred hhheeccCCcceeccceecCcccchhhHh
Confidence 9998764332 23456789999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-32 Score=283.78 Aligned_cols=169 Identities=23% Similarity=0.351 Sum_probs=145.7
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccC---CCchHHHHHHHHHHh-CCCCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKK---CHSTRNFMHHIELIS-KLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++. .++|||||++++++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~------- 74 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT------- 74 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-------
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-------
Confidence 56888899999999999999965 69999999997532 234566788888765 6899999999999986
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
.+..|+|||||++|+|.++++.. ..+++.++..++.||+.||+|||+. +||||||||+|||+++++.+||+|||
T Consensus 75 ~~~~yivmEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 75 KENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCceeEEEeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccc
Confidence 56799999999999999999852 4588999999999999999999998 99999999999999999999999999
Q ss_pred ccccccc-ccccceecccccccCCCCCC
Q 006145 632 LPLLAEN-AEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 632 la~~~~~-~~~~~~~~gt~~y~aPE~~~ 658 (659)
+|+.... ........||+.|||||++.
T Consensus 149 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 176 (320)
T d1xjda_ 149 MCKENMLGDAKTNTFCGTPDYIAPEILL 176 (320)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHT
T ss_pred hhhhcccccccccccCCCCCcCCHHHHc
Confidence 9976543 33345578999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-32 Score=282.76 Aligned_cols=171 Identities=26% Similarity=0.417 Sum_probs=142.4
Q ss_pred cCCCCCceeccCcCceEEEEEecC-Cc--EEEEEEecccC-CCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN-GT--FVAIRCLKMKK-CHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~-g~--~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~ 551 (659)
++|+..+.||+|+||+||+|++++ |. .||||+++... .+..++|.+|+++|+++ +|||||+++|+|.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~------- 82 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH------- 82 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-------
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-------
Confidence 567778999999999999999754 44 57888886443 23456799999999999 79999999999986
Q ss_pred CceeEEEEeccCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCcee
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEG-------------HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDIL 618 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 618 (659)
.+..++||||+++|+|.++++.. .....++|.++.+++.|||+||.|+|+. +||||||||+|||
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL 159 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL 159 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEE
Confidence 56789999999999999999753 1235799999999999999999999998 9999999999999
Q ss_pred ecCCcceEEccCccccccccccccceecccccccCCCCC
Q 006145 619 LDQNLVAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 619 ld~~~~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
++.++.+||+|||+++............||..|+|||.+
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l 198 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL 198 (309)
T ss_dssp ECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHH
T ss_pred EcCCCceEEccccccccccccccccceecCCcccchHHh
Confidence 999999999999999877655555567899999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-32 Score=284.14 Aligned_cols=171 Identities=15% Similarity=0.242 Sum_probs=144.4
Q ss_pred hcCCCCC-ceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCC-CCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTS-AFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKL-RHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~-~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|... +.||+|+||+||+|+. .+|+.||||+++. ...+.+|++++.++ +|||||++++++.+... ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~---~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA---GR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET---TE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc---CC
Confidence 3567665 4699999999999996 4699999999863 35678999987654 89999999999865211 13
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC---CcceEEcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ---NLVAKISS 629 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~---~~~~kl~D 629 (659)
...|+|||||++|+|.+++.+. +...+++.++..|+.|++.||+|||+. +|+||||||+|||+++ ++.+||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred CEEEEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence 5689999999999999999853 235699999999999999999999998 9999999999999985 46799999
Q ss_pred CccccccccccccceecccccccCCCCCC
Q 006145 630 YNLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 630 FGla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
||+|+...........+||+.|||||+..
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 186 (335)
T d2ozaa1 158 FGFAKETTSHNSLTTPCYTPYYVAPEVLG 186 (335)
T ss_dssp CTTCEECCCCCCCCCCSCCCSSCCCCCCC
T ss_pred cceeeeccCCCccccccCCcccCCcHHHc
Confidence 99998877666667789999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=1.7e-32 Score=277.74 Aligned_cols=173 Identities=16% Similarity=0.265 Sum_probs=140.0
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCc---hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS---TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~ 551 (659)
.++|...+.||+|+||+||+|+.. +|+.||||+++.....+ .++|.+|++++++++|||||++++++..... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~---~ 82 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP---A 82 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS---S
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC---C
Confidence 356888999999999999999964 69999999997654332 2469999999999999999999999976321 1
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....|+||||+++|+|.+++... ..+++.++..++.|+++||+|||+. +||||||||+|||++.++..+++|||
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred CceEEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhh
Confidence 34579999999999999988752 4699999999999999999999998 99999999999999999999999999
Q ss_pred cccccccc----cccceecccccccCCCCC
Q 006145 632 LPLLAENA----EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~----~~~~~~~gt~~y~aPE~~ 657 (659)
.++..... ......+||+.|||||++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~ 186 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQA 186 (277)
T ss_dssp TCEECC----------------TTCCHHHH
T ss_pred hhhhhccccccccccccccCcccccCHHHH
Confidence 98655322 233567899999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-32 Score=281.81 Aligned_cols=163 Identities=23% Similarity=0.331 Sum_probs=137.2
Q ss_pred CceeccCcCceEEEEEec-CCcEEEEEEecccCCCc-----hHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 482 SAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHS-----TRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-----~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
.++||+|+||+||+|+.. +|+.||||+++...... .+.+.+|+++|++++|||||++++++.+ .+..
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-------~~~~ 75 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-------KSNI 75 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-------TTCC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-------CCce
Confidence 478999999999999965 59999999997543221 2468999999999999999999999976 5678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccccc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
|+||||+++|++..+... ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.
T Consensus 76 ~ivmE~~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp EEEEECCSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eehhhhhcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccc
Confidence 999999999888776653 35688899999999999999999998 999999999999999999999999999976
Q ss_pred ccccc-ccceecccccccCCCCC
Q 006145 636 AENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
..... .....+||+.|||||++
T Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~ 172 (299)
T d1ua2a_ 150 FGSPNRAYTHQVVTRWYRAPELL 172 (299)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHH
T ss_pred cCCCcccccceecChhhccHHHH
Confidence 64433 33557899999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.3e-32 Score=277.59 Aligned_cols=165 Identities=20% Similarity=0.353 Sum_probs=139.5
Q ss_pred CceeccCcCceEEEEEecC----CcEEEEEEecccCC-CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 482 SAFMGEGSQGQMYRGRLKN----GTFVAIRCLKMKKC-HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 482 ~~~ig~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
.++||+|+||+||+|++.+ ...||||+++.... ...++|.+|+++|++++|||||+++|+|... ....+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS------EGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET------TTEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec------CCceE
Confidence 4789999999999999753 23699999975332 2346799999999999999999999998752 34689
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
+|||||++|+|.++++.. ...++|..+++++.|+|+||.|+|+. +|+||||||+|||+|+++.+||+|||+++..
T Consensus 106 lv~E~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp EEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred EEEEEeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhc
Confidence 999999999999998853 34688999999999999999999998 9999999999999999999999999999866
Q ss_pred cccc-----ccceecccccccCCCCC
Q 006145 637 ENAE-----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 637 ~~~~-----~~~~~~gt~~y~aPE~~ 657 (659)
.... ......||+.|+|||..
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~ 206 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESL 206 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHH
T ss_pred cccccccceecccccccccccChHHH
Confidence 4322 22346789999999964
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-32 Score=282.74 Aligned_cols=175 Identities=19% Similarity=0.313 Sum_probs=146.4
Q ss_pred HHhhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeec
Q 006145 473 EEATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFEC 545 (659)
Q Consensus 473 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 545 (659)
+...++|...+.||+|+||.||+|++. +++.||||+++..... ....|.+|++++++++|||||+++|+|..
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~- 94 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ- 94 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-
Confidence 334567788899999999999999864 3678999999754332 23469999999999999999999999975
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCC-------CCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCcee
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEG-------HAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDIL 618 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 618 (659)
.+..++|||||++|+|.++++.. .....++|..+.+++.|+|+||.|||+. +|+||||||+|||
T Consensus 95 ------~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiL 165 (308)
T d1p4oa_ 95 ------GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 165 (308)
T ss_dssp ------SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred ------CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCcee
Confidence 45689999999999999988631 2234589999999999999999999998 9999999999999
Q ss_pred ecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 619 LDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 619 ld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
+|+++++||+|||+|+....... .....||+.|||||++
T Consensus 166 ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l 207 (308)
T d1p4oa_ 166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 207 (308)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH
T ss_pred ecCCceEEEeecccceeccCCcceeeccceecccccCCHHHH
Confidence 99999999999999986644322 2445789999999974
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-32 Score=276.51 Aligned_cols=168 Identities=21% Similarity=0.349 Sum_probs=131.5
Q ss_pred cCCCCCceeccCcCceEEEEEecC--C--cEEEEEEecccCC---CchHHHHHHHHHHhCCCCCCccceeeeeeeccccC
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKN--G--TFVAIRCLKMKKC---HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDD 549 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~--g--~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 549 (659)
++|+..+.||+|+||.||+|++.. + ..||||+++.... +..++|.+|+++|++++|||||+++|+|.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 457778999999999999998642 3 3789999875432 223679999999999999999999999964
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEcc
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISS 629 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~D 629 (659)
...++|||||++|++.+++... ...++|..++.++.|+|+||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 83 ---~~~~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~D 154 (273)
T d1u46a_ 83 ---PPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGD 154 (273)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred ---cchheeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeecc
Confidence 3468999999999999987742 24699999999999999999999998 999999999999999999999999
Q ss_pred Cccccccccccc----cceecccccccCCCCC
Q 006145 630 YNLPLLAENAEK----VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~~~----~~~~~gt~~y~aPE~~ 657 (659)
||+++....... .....|+..|||||++
T Consensus 155 fGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 186 (273)
T d1u46a_ 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186 (273)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHH
T ss_pred chhhhhcccCCCcceecCccccCcccCCHHHH
Confidence 999987643322 2345688899999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.2e-32 Score=277.11 Aligned_cols=169 Identities=20% Similarity=0.365 Sum_probs=141.6
Q ss_pred cCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|...+.||+|+||+||+|+. .+|+.||||+++.... ...+++.+|+++|++++|||||++++++.+ .+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-------~~ 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-------EN 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-------TT
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-------cc
Confidence 5788899999999999999996 4699999999975432 234679999999999999999999999987 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..|+||||+.+ ++.+++... ....+++..+..++.|++.||+|||+. +||||||||+|||++.++.+||+|||+|
T Consensus 75 ~~~iv~e~~~~-~~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 75 KLYLVFEFLHQ-DLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 149 (298)
T ss_dssp EEEEEEECCSE-EHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred ceeEEEeecCC-chhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcc
Confidence 79999999976 444444422 234699999999999999999999998 9999999999999999999999999999
Q ss_pred ccccc-ccccceecccccccCCCCC
Q 006145 634 LLAEN-AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~-~~~~~~~~gt~~y~aPE~~ 657 (659)
+.... ........||+.|+|||..
T Consensus 150 ~~~~~~~~~~~~~~gt~~y~apE~~ 174 (298)
T d1gz8a_ 150 RAFGVPVRTYTHEVVTLWYRAPEIL 174 (298)
T ss_dssp HHHCCCSBCTTCCBCCCTTCCHHHH
T ss_pred eeccCCcccceeecccceeeehhhh
Confidence 76643 3344567899999999964
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-31 Score=276.26 Aligned_cols=173 Identities=23% Similarity=0.342 Sum_probs=146.3
Q ss_pred hhcCCCCCceeccCcCceEEEEEec------CCcEEEEEEecccCCC-chHHHHHHHHHHhCC-CCCCccceeeeeeecc
Q 006145 475 ATNNFDTSAFMGEGSQGQMYRGRLK------NGTFVAIRCLKMKKCH-STRNFMHHIELISKL-RHRHLVSALGHCFECY 546 (659)
Q Consensus 475 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 546 (659)
..++|+..+.||+|+||.||+|++. +++.||||+++..... ...+|.+|+++++++ +|||||+++|+|.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 4567778899999999999999852 4679999999765432 335799999999999 69999999999976
Q ss_pred ccCCCCceeEEEEeccCCCChhhhhcCCC---------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccC
Q 006145 547 FDDSSVSRIFLIFEYVPNGTLRSWISEGH---------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNN 611 (659)
Q Consensus 547 ~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrD 611 (659)
.+..++|||||++|+|.+++++.. ....+++..+.+++.|||+||+|||+. +|||||
T Consensus 99 -----~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrD 170 (311)
T d1t46a_ 99 -----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRD 170 (311)
T ss_dssp -----SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred -----CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 456899999999999999997532 123689999999999999999999998 999999
Q ss_pred CCCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 612 LKITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 612 lk~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
|||+||++|.++.+|++|||+++....... .....||+.|||||+.
T Consensus 171 LKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 219 (311)
T d1t46a_ 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI 219 (311)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH
T ss_pred cccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHh
Confidence 999999999999999999999987654322 2456899999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=1.2e-31 Score=272.78 Aligned_cols=168 Identities=19% Similarity=0.277 Sum_probs=142.1
Q ss_pred cCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|+..+.||+|+||+||+|+.++|+.||||+++.... ...++|.+|+.+|++++|||||++++++.+ .+.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-------~~~ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-------KKR 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-------SSC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-------CCc
Confidence 57888899999999999999998999999999965432 234689999999999999999999999986 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
.++|+||+.++.+..+.+. ...+++..+..++.||+.||+|||+. +||||||||+|||++.++.+|++|||++.
T Consensus 75 ~~i~~e~~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148 (286)
T ss_dssp EEEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred eeEEEEeehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccce
Confidence 8999999988777777654 35699999999999999999999998 99999999999999999999999999997
Q ss_pred ccccc-cccceecccccccCCCCC
Q 006145 635 LAENA-EKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 635 ~~~~~-~~~~~~~gt~~y~aPE~~ 657 (659)
..... .......+++.|+|||..
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~ 172 (286)
T d1ob3a_ 149 AFGIPVRKYTHEIVTLWYRAPDVL 172 (286)
T ss_dssp HHCC---------CCCTTCCHHHH
T ss_pred ecccCccccceecccchhhhHHHH
Confidence 66433 234556799999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.4e-32 Score=272.22 Aligned_cols=167 Identities=19% Similarity=0.223 Sum_probs=142.2
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC------chHHHHHHHHHHhCCC--CCCccceeeeeeeccc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH------STRNFMHHIELISKLR--HRHLVSALGHCFECYF 547 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~ 547 (659)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... ...++.+|+++|++++ |||||++++++.+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~--- 80 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--- 80 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC---
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee---
Confidence 46888899999999999999964 6999999999754322 1245789999999986 8999999999976
Q ss_pred cCCCCceeEEEEeccCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC-cce
Q 006145 548 DDSSVSRIFLIFEYVPN-GTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN-LVA 625 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~-GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~-~~~ 625 (659)
.+..++||||+.+ +++.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.+ +.+
T Consensus 81 ----~~~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 81 ----PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp ----SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEE
T ss_pred ----CCeEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeE
Confidence 5678999999976 688888875 24699999999999999999999998 99999999999999954 799
Q ss_pred EEccCccccccccccccceecccccccCCCCC
Q 006145 626 KISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 626 kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
||+|||+|+..... .....+||+.|||||+.
T Consensus 151 kl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~ 181 (273)
T d1xwsa_ 151 KLIDFGSGALLKDT-VYTDFDGTRVYSPPEWI 181 (273)
T ss_dssp EECCCTTCEECCSS-CBCCCCSCGGGSCHHHH
T ss_pred EECccccceecccc-cccccccCCCcCCHHHH
Confidence 99999999876443 34567899999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-31 Score=273.12 Aligned_cols=172 Identities=20% Similarity=0.384 Sum_probs=140.6
Q ss_pred hcCCCCCceeccCcCceEEEEEecC--------CcEEEEEEecccCCC-chHHHHHHHHHHhCC-CCCCccceeeeeeec
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLKN--------GTFVAIRCLKMKKCH-STRNFMHHIELISKL-RHRHLVSALGHCFEC 545 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 545 (659)
.++|...+.||+|+||.||+|+... +..||||+++..... ...++.+|+..+.++ +|||||+++|+|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 4677788999999999999998532 347999999765432 346789999999888 89999999999986
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCC
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGH-------------AHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNL 612 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl 612 (659)
.+..++|||||++|+|.++++... ....++|.++++++.|+|.||+|||+. +||||||
T Consensus 91 ------~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDi 161 (299)
T d1fgka_ 91 ------DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDL 161 (299)
T ss_dssp ------SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ------CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeee
Confidence 456899999999999999997532 124689999999999999999999998 9999999
Q ss_pred CCCceeecCCcceEEccCccccccccccc---cceecccccccCCCCC
Q 006145 613 KITDILLDQNLVAKISSYNLPLLAENAEK---VGHVIPYSGSIDPTNS 657 (659)
Q Consensus 613 k~~NILld~~~~~kl~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~ 657 (659)
||+|||++.++.+||+|||+++....... .....||+.|||||++
T Consensus 162 Kp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l 209 (299)
T d1fgka_ 162 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 209 (299)
T ss_dssp SGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH
T ss_pred cccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHh
Confidence 99999999999999999999987654332 3447899999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-31 Score=272.19 Aligned_cols=176 Identities=19% Similarity=0.310 Sum_probs=145.4
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cC-CcEEEEEEecccCCC--chHHHHHHHHHHhCC---CCCCccceeeeeeecccc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KN-GTFVAIRCLKMKKCH--STRNFMHHIELISKL---RHRHLVSALGHCFECYFD 548 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~-g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~ 548 (659)
.++|+..+.||+|+||+||+|+. .+ ++.||||+++..... ...++.+|+++|+.+ +|||||+++++|.....+
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46889999999999999999996 34 678999999754322 234577888877665 799999999999753321
Q ss_pred CCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEc
Q 006145 549 DSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKIS 628 (659)
Q Consensus 549 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~ 628 (659)
.....+++|||+++|++....... ...+++.....++.|++.||+|||+. +||||||||+|||+++++.+||+
T Consensus 86 --~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 --RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp --SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred --cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeec
Confidence 235689999999988776554432 35689999999999999999999998 99999999999999999999999
Q ss_pred cCccccccccccccceecccccccCCCCCC
Q 006145 629 SYNLPLLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 629 DFGla~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
|||+++...........+||+.|||||++.
T Consensus 159 dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~ 188 (305)
T d1blxa_ 159 DFGLARIYSFQMALTSVVVTLWYRAPEVLL 188 (305)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHT
T ss_pred chhhhhhhcccccCCCcccChhhcCcchhc
Confidence 999998877666677889999999999753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.4e-31 Score=275.73 Aligned_cols=172 Identities=20% Similarity=0.261 Sum_probs=140.2
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCceeE
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRIF 556 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 556 (659)
+|+..++||+|+||+||+|+.. +|+.||||+++.... .+.+|+++|++++|||||+++++|...... ......+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~-~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEK-KDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--C-CSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCcc-CCceEEE
Confidence 4667789999999999999975 599999999975432 234799999999999999999999753321 1244678
Q ss_pred EEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCc-ceEEccCccccc
Q 006145 557 LIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNL-VAKISSYNLPLL 635 (659)
Q Consensus 557 lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~-~~kl~DFGla~~ 635 (659)
+|||||++|.+..+.+.......+++.++..++.||++||+|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 9999998765444433212245799999999999999999999998 999999999999999775 899999999987
Q ss_pred cccccccceecccccccCCCCC
Q 006145 636 AENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 636 ~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
..........+||+.|+|||..
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~ 194 (350)
T d1q5ka_ 173 LVRGEPNVSYICSRYYRAPELI 194 (350)
T ss_dssp CCTTSCCCSCCSCTTSCCHHHH
T ss_pred ccCCcccccccccccccChHHh
Confidence 7666666778999999999964
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=1e-30 Score=271.21 Aligned_cols=164 Identities=14% Similarity=0.233 Sum_probs=143.8
Q ss_pred cCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCCchHHHHHHHHHHhCCC-CCCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|...+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++... ....
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~-----~~~~ 106 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP-----VSRT 106 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT-----TTCS
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec-----CCCc
Confidence 5788899999999999999996 46999999999643 3567999999999995 99999999998742 2456
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC-cceEEccCccc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN-LVAKISSYNLP 633 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~-~~~kl~DFGla 633 (659)
.++|||||++|+|.++.+ .+++..+..++.||++||+|||+. +||||||||+|||++.+ ..+||+|||+|
T Consensus 107 ~~~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a 177 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177 (328)
T ss_dssp EEEEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred eeEEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccc
Confidence 899999999999987643 489999999999999999999998 99999999999999965 46999999999
Q ss_pred cccccccccceecccccccCCCCC
Q 006145 634 LLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+...........++|+.|+|||..
T Consensus 178 ~~~~~~~~~~~~~~t~~y~aPE~~ 201 (328)
T d3bqca1 178 EFYHPGQEYNVRVASRYFKGPELL 201 (328)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHH
T ss_pred eeccCCCcccccccCccccCcccc
Confidence 888776667778999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.1e-30 Score=272.90 Aligned_cols=173 Identities=15% Similarity=0.233 Sum_probs=140.2
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCC-chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCH-STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
+.+|...+.||+|+||+||+|+. .+|+.||||+++..... ..+++.+|+++|++++|||||++++++...... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~---~~ 83 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE---QM 83 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT---TC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc---cc
Confidence 34688889999999999999985 47999999999754422 245789999999999999999999999753221 12
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++++||+.+|+|.+++.. ..+++.....++.|++.||+|||+. +||||||||+|||+|.++.+||+|||+|
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence 23455566779999999975 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccc----ccceecccccccCCCCCC
Q 006145 634 LLAENAE----KVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 634 ~~~~~~~----~~~~~~gt~~y~aPE~~~ 658 (659)
+...... .....+||+.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 185 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIML 185 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTT
T ss_pred eeccCCCccceeeccccccceechHHHhh
Confidence 7653322 235678999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9e-30 Score=266.11 Aligned_cols=171 Identities=15% Similarity=0.233 Sum_probs=138.4
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++|++++|||||+++++|...... ...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~-~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL-DDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST-TTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc-ccc
Confidence 467888899999999999999964 6999999999754332 235789999999999999999999999753211 123
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...|+||||+ +++|.++.+. ..+++..+..++.|++.||+|||+. +||||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 4579999999 5688887764 4699999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
|+..+. .....+||+.|||||..
T Consensus 168 a~~~~~--~~~~~~~t~~y~aPE~~ 190 (346)
T d1cm8a_ 168 ARQADS--EMTGYVVTRWYRAPEVI 190 (346)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHH
T ss_pred eeccCC--ccccccccccccCHHHH
Confidence 987654 34567899999999964
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.3e-29 Score=261.70 Aligned_cols=176 Identities=15% Similarity=0.282 Sum_probs=139.3
Q ss_pred hcCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCC--CchHHHHHHHHHHhCCCCCCccceeeeeeeccccC-CC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKC--HSTRNFMHHIELISKLRHRHLVSALGHCFECYFDD-SS 551 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~-~~ 551 (659)
.++|+..+.||+|+||+||+|+.. +|+.||||++..... ...+++.+|+++|++++||||+++++++....... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 367888899999999999999964 699999999865432 23467999999999999999999999986532111 12
Q ss_pred CceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCc
Q 006145 552 VSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYN 631 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFG 631 (659)
....++||||++++.+..+... ...++......++.|+++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 3468999999998777655443 34688899999999999999999998 99999999999999999999999999
Q ss_pred ccccccccc-----ccceecccccccCCCCC
Q 006145 632 LPLLAENAE-----KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 632 la~~~~~~~-----~~~~~~gt~~y~aPE~~ 657 (659)
+++...... .....+||+.|+|||.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 193 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHH
Confidence 997654222 22446899999999964
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.3e-29 Score=256.55 Aligned_cols=168 Identities=17% Similarity=0.272 Sum_probs=145.3
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... ..+++.+|+++|+.++|||||+++++|.+ ..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-------~~ 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-------DK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-------SS
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-------cc
Confidence 46888899999999999999964 6999999999755432 34679999999999999999999999986 56
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..++|+||+.++++..+++. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||.+
T Consensus 75 ~~~iv~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a 148 (292)
T d1unla_ 75 KLTLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp EEEEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred ceeEEeeecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchh
Confidence 78999999999999988875 35688999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccc-ccceecccccccCCCCC
Q 006145 634 LLAENAE-KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 634 ~~~~~~~-~~~~~~gt~~y~aPE~~ 657 (659)
+...... ......+++.|+|||..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~ 173 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVL 173 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHH
T ss_pred hcccCCCccceeeccccchhhhhHh
Confidence 8765433 33445678889999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.96 E-value=3.2e-29 Score=255.38 Aligned_cols=166 Identities=12% Similarity=0.150 Sum_probs=139.5
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCC-CCccceeeeeeeccccCCCCce
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRH-RHLVSALGHCFECYFDDSSVSR 554 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~~~~~~ 554 (659)
++|...+.||+|+||+||+|+.. +|+.||||++.... ...++.+|+++++.++| +||+.+++++.+ ...
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-------~~~ 75 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-------GLH 75 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-------TTE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeec-------CCc
Confidence 56888899999999999999965 69999999986543 23457889999999975 899999998876 567
Q ss_pred eEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecC-----CcceEEcc
Q 006145 555 IFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQ-----NLVAKISS 629 (659)
Q Consensus 555 ~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~-----~~~~kl~D 629 (659)
.++||||+ +|+|.++++.. ...+++..+..++.|++.||+|||+. +||||||||+|||++. ++.+||+|
T Consensus 76 ~~~vme~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 76 NVLVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred cEEEEEec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcc
Confidence 89999999 68999998753 24689999999999999999999998 9999999999999974 57899999
Q ss_pred Ccccccccccc--------ccceecccccccCCCCC
Q 006145 630 YNLPLLAENAE--------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 630 FGla~~~~~~~--------~~~~~~gt~~y~aPE~~ 657 (659)
||+|+...... .....+||+.|||||+.
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~ 185 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred cceeEEcccCccccceeecccCceEEchhhcCHHHh
Confidence 99998664321 23456899999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.3e-29 Score=261.63 Aligned_cols=172 Identities=17% Similarity=0.206 Sum_probs=132.0
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVS 553 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 553 (659)
++|...+.||+|+||+||+|+.. +|+.||||++...... ...++.+|++++++++|||||++++++...... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~-~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL-EEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST-TTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc-ccCc
Confidence 57888999999999999999965 6999999999755432 234689999999999999999999998753221 1246
Q ss_pred eeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCccc
Q 006145 554 RIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNLP 633 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla 633 (659)
..|+|||||.+| +.+.+.. .+++.....++.||+.||+|||+. +|+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 789999999765 4455542 489999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccccceecccccccCCCCCC
Q 006145 634 LLAENAEKVGHVIPYSGSIDPTNSA 658 (659)
Q Consensus 634 ~~~~~~~~~~~~~gt~~y~aPE~~~ 658 (659)
+...........++|+.|+|||++.
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~ 191 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVIL 191 (355)
T ss_dssp --------------CCTTCCHHHHT
T ss_pred hccccccccccccccccccChhhhc
Confidence 8777666667789999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.7e-29 Score=261.68 Aligned_cols=171 Identities=13% Similarity=0.204 Sum_probs=140.1
Q ss_pred hcCCCCCceeccCcCceEEEEEe-cCCcEEEEEEecccCCC--chHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCC
Q 006145 476 TNNFDTSAFMGEGSQGQMYRGRL-KNGTFVAIRCLKMKKCH--STRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSV 552 (659)
Q Consensus 476 ~~~~~~~~~ig~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~ 552 (659)
.++|...+.||+|+||+||+|+. .+|+.||||+++..... ..+++.+|+++|++++|||||++++++...... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~--~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL--EE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST--TT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc--cc
Confidence 45788899999999999999995 46999999999765432 235689999999999999999999988642211 12
Q ss_pred ceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEEccCcc
Q 006145 553 SRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKISSYNL 632 (659)
Q Consensus 553 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl~DFGl 632 (659)
...++|+||+.+|+|.++++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||+
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred CceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence 345667788889999999974 3599999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceecccccccCCCCC
Q 006145 633 PLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
+..... ......||+.|||||+.
T Consensus 168 a~~~~~--~~~~~~g~~~y~apE~~ 190 (348)
T d2gfsa1 168 ARHTDD--EMTGYVATRWYRAPEIM 190 (348)
T ss_dssp --CCTG--GGSSSCHHHHTSCHHHH
T ss_pred hcccCc--ccccccccccccCchhh
Confidence 976543 34557899999999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.7e-29 Score=259.03 Aligned_cols=168 Identities=20% Similarity=0.307 Sum_probs=143.5
Q ss_pred cCCCCCceeccCcCceEEEEEec----CCcEEEEEEecccC----CCchHHHHHHHHHHhCCCC-CCccceeeeeeeccc
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK----NGTFVAIRCLKMKK----CHSTRNFMHHIELISKLRH-RHLVSALGHCFECYF 547 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~ 547 (659)
++|+..+.||+|+||+||+|+.. +|+.||||.++... ....+.+.+|++++++++| |||+++++++.+
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--- 100 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 100 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc---
Confidence 56888999999999999999842 48999999996532 2234678999999999976 899999999876
Q ss_pred cCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCCcceEE
Q 006145 548 DDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQNLVAKI 627 (659)
Q Consensus 548 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~~~~kl 627 (659)
....++||||+.+|+|.+++... ..+.......++.|++.||+|+|+. +||||||||+|||+|.++.+||
T Consensus 101 ----~~~~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL 170 (322)
T d1vzoa_ 101 ----ETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL 170 (322)
T ss_dssp ----TTEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred ----CCceeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEE
Confidence 56799999999999999999853 3567888899999999999999998 9999999999999999999999
Q ss_pred ccCcccccccc--ccccceecccccccCCCCC
Q 006145 628 SSYNLPLLAEN--AEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 628 ~DFGla~~~~~--~~~~~~~~gt~~y~aPE~~ 657 (659)
+|||+++.... ........|++.|+|||..
T Consensus 171 ~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~ 202 (322)
T d1vzoa_ 171 TDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202 (322)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHH
T ss_pred eeccchhhhcccccccccccccccccchhHHh
Confidence 99999976533 2233557899999999964
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=1.2e-28 Score=252.21 Aligned_cols=167 Identities=14% Similarity=0.193 Sum_probs=136.1
Q ss_pred cCCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCccceeeeeeeccccCCCCcee
Q 006145 477 NNFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHLVSALGHCFECYFDDSSVSRI 555 (659)
Q Consensus 477 ~~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 555 (659)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ...++.+|+++++.++|+|+|..+++|... .+..
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~------~~~~ 78 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAE------GDYN 78 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEE------TTEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEec------CCEE
Confidence 46888999999999999999964 69999999987543 234688999999999988877777666541 4678
Q ss_pred EEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeec---CCcceEEccCcc
Q 006145 556 FLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLD---QNLVAKISSYNL 632 (659)
Q Consensus 556 ~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld---~~~~~kl~DFGl 632 (659)
++||||+ +|++.+.+... ...+++..+..++.|+++||+|||+. +||||||||+|||++ .+..+|++|||+
T Consensus 79 ~ivme~~-~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152 (299)
T ss_dssp EEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred EEEEEEc-CCchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCc
Confidence 9999999 45776666532 34699999999999999999999998 999999999999876 356799999999
Q ss_pred cccccccc--------ccceecccccccCCCCC
Q 006145 633 PLLAENAE--------KVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 633 a~~~~~~~--------~~~~~~gt~~y~aPE~~ 657 (659)
|+...... .....+||+.|||||+.
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 185 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTH 185 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHH
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHH
Confidence 98764322 22456899999999964
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=6.6e-26 Score=232.16 Aligned_cols=245 Identities=21% Similarity=0.248 Sum_probs=215.5
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEc
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSL 186 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (659)
+++++|+|++|+++...+..|.++++|++|++++|.+....|..|.++++|++|++++|+++ .+|..+ ...|..|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~ 107 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRV 107 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEEC
T ss_pred CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccch--hhhhhhhhc
Confidence 57999999999999888889999999999999999999888889999999999999999998 466543 468999999
Q ss_pred cCCcCCccCCcccCCCCCCcEEeccccccccC--CC-CCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccC
Q 006145 187 RNNMFNGTLPDSFSYLENLRVLALSNNHFYGE--VP-DFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAI 263 (659)
Q Consensus 187 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p-~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~ 263 (659)
.+|.+.+..+..+.....+..++...|..... .+ .+..+++|+.+++++|.+........++|+.|++++|..++..
T Consensus 108 ~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~~L~l~~n~~~~~~ 187 (305)
T d1xkua_ 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVD 187 (305)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEEC
T ss_pred cccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcccCCccCEEECCCCcCCCCC
Confidence 99999987777788888999999998865433 22 3888999999999999998766666789999999999999999
Q ss_pred chhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCCh-h----
Q 006145 264 PAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPN-C---- 338 (659)
Q Consensus 264 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~-~---- 338 (659)
+..+..++.++.|++++|.+++..+.++..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|+|+ .++. .
T Consensus 188 ~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~ 265 (305)
T d1xkua_ 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPP 265 (305)
T ss_dssp TGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCS
T ss_pred hhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccChhhccCc
Confidence 999999999999999999999988999999999999999999998 56889999999999999999998 4443 2
Q ss_pred --hhCCCCCCEEEcCCcccc
Q 006145 339 --LLAGSKNRVVLYARNCLA 356 (659)
Q Consensus 339 --~~~~~~l~~l~~~~N~l~ 356 (659)
......+..+++.+|.+.
T Consensus 266 ~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 266 GYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp SCCTTSCCCSEEECCSSSSC
T ss_pred chhcccCCCCEEECCCCcCc
Confidence 234567899999999875
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=8.6e-26 Score=228.93 Aligned_cols=203 Identities=23% Similarity=0.208 Sum_probs=154.1
Q ss_pred CCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEee-cCCCCCCCccccCCCCCCCEEE
Q 006145 107 PDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILD-ENMLAGRVPDWLGSLPILAVLS 185 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~~l~~l~~L~~L~ 185 (659)
+++++|+|++|+|+...+..|.++++|++|++++|.+....+..+.+++.++.++.. .|.++...|..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 467899999999988777889999999999999999988888888888888888765 5566666678888999999999
Q ss_pred ccCCcCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCC---CcccceEecCCCcCCc
Q 006145 186 LRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKV---GKKLVTMILSKNKFRS 261 (659)
Q Consensus 186 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~ 261 (659)
+++|.+....+..+..+++|+.+++++|++++.++. |..+++|+.|++++|+++...+.. .++|+.+++++|++++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 999998877777888888999999999998877665 777888888888888776554433 3456666666666666
Q ss_pred cCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCC
Q 006145 262 AIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTG 309 (659)
Q Consensus 262 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 309 (659)
..|..|..+++|+.||+++|.+.+..|..|..+++|++|++++|.+..
T Consensus 192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 666666666666666666666666556666666666666666666553
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.92 E-value=3.7e-24 Score=225.68 Aligned_cols=258 Identities=22% Similarity=0.238 Sum_probs=160.3
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.++++|+++++++.. + +.+..+++|++|+|++|++++..| |+++++|++|++++|.+++.. .+++
T Consensus 44 ~~l~~L~l~~~~I~~-l----------~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~--~l~~ 108 (384)
T d2omza2 44 DQVTTLQADRLGIKS-I----------DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLAN 108 (384)
T ss_dssp TTCCEEECCSSCCCC-C----------TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTT
T ss_pred CCCCEEECCCCCCCC-c----------cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccccc--cccc
Confidence 467888888776542 1 235677788888888888876532 778888888888888887543 2777
Q ss_pred CCCCcEEEeecCCCCCCC--------------------------------------------------------------
Q 006145 154 LTSLQTLILDENMLAGRV-------------------------------------------------------------- 171 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~-------------------------------------------------------------- 171 (659)
+++|+.|++++|.+++..
T Consensus 109 l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (384)
T d2omza2 109 LTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188 (384)
T ss_dssp CTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccc
Confidence 888888888777665311
Q ss_pred -ccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCC-Cccc
Q 006145 172 -PDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKV-GKKL 249 (659)
Q Consensus 172 -p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~-~~~L 249 (659)
+..+..+++++.+++++|.+++..| +..+++|+.|++++|.++. ++.+..+++|+.|++++|.+++..+.. .++|
T Consensus 189 ~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~L 265 (384)
T d2omza2 189 DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAPLSGLTKL 265 (384)
T ss_dssp CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTC
T ss_pred cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-cchhhcccccchhccccCccCCCCcccccccC
Confidence 1123445667777777777775443 3456677777777777664 345666777777777777776654432 4667
Q ss_pred ceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCC
Q 006145 250 VTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSN 329 (659)
Q Consensus 250 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N 329 (659)
+.|++++|++++.. .+..++.++.++++.|.+++. ..+..+++++.|++++|++++..+ +..+++|+.|++++|
T Consensus 266 ~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n 339 (384)
T d2omza2 266 TELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANN 339 (384)
T ss_dssp SEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSS
T ss_pred CEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCC
Confidence 77777777766532 244555556666666655531 235555566666666666654322 445556666666666
Q ss_pred CCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 330 LLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 330 ~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
++++ +| .+..+++|+.+++++|.+++
T Consensus 340 ~l~~-l~-~l~~l~~L~~L~l~~N~l~~ 365 (384)
T d2omza2 340 KVSD-VS-SLANLTNINWLSAGHNQISD 365 (384)
T ss_dssp CCCC-CG-GGGGCTTCCEEECCSSCCCB
T ss_pred CCCC-Ch-hHcCCCCCCEEECCCCcCCC
Confidence 6553 33 35555666666666665553
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.6e-23 Score=211.97 Aligned_cols=222 Identities=22% Similarity=0.174 Sum_probs=146.7
Q ss_pred EEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEcc-CC
Q 006145 111 VLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLR-NN 189 (659)
Q Consensus 111 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~-~N 189 (659)
.++.++++++ .+|..+. +.+++|+|++|+|+...+..|.++++|++|++++|++.+..+..+..++.+..++.. .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 3566666665 4455443 567888888888886666678888888888888888887777777778888887664 55
Q ss_pred cCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhcc
Q 006145 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVS 268 (659)
Q Consensus 190 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~ 268 (659)
.++...|..|.++++|++|++++|.+....+. +...++|+.+++++|++++.. +..|.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~---------------------~~~f~ 150 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP---------------------DDTFR 150 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC---------------------TTTTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccC---------------------hhHhc
Confidence 66666677788888888888888877665544 666677777777776665433 34455
Q ss_pred CCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEE
Q 006145 269 SYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVV 348 (659)
Q Consensus 269 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l 348 (659)
.+++|+.|++++|+|++..|..|..+++|+.+++++|++++..|..|..+++|+.||+++|++++..|..+..+.+++.+
T Consensus 151 ~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L 230 (284)
T d1ozna_ 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEE
T ss_pred cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEE
Confidence 55555666666666555555555556666666666666665555556556666666666666665555555555566666
Q ss_pred EcCCcccc
Q 006145 349 LYARNCLA 356 (659)
Q Consensus 349 ~~~~N~l~ 356 (659)
++++|.+.
T Consensus 231 ~l~~N~l~ 238 (284)
T d1ozna_ 231 RLNDNPWV 238 (284)
T ss_dssp ECCSSCEE
T ss_pred EecCCCCC
Confidence 66666554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.5e-23 Score=210.12 Aligned_cols=196 Identities=23% Similarity=0.190 Sum_probs=94.3
Q ss_pred CCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEe
Q 006145 130 LSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLA 209 (659)
Q Consensus 130 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 209 (659)
.+.+...|.+++.++ .+|+.+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|+.|+
T Consensus 9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 83 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLD 83 (266)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEE
T ss_pred cCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccccc
Confidence 334444455555555 3444332 345555555555554444455555555555555555552 22 244555666666
Q ss_pred ccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCC---CcccceEecCCCcCCccCchhccCCccccEEeccCcccccC
Q 006145 210 LSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKV---GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGP 286 (659)
Q Consensus 210 Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 286 (659)
|++|++++..+.+.++++|++|++++|.+....+.. ..++..|++++|.++...+..+..+++|+.|++++|+|++.
T Consensus 84 Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 84 LSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (266)
T ss_dssp CCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred cccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccccc
Confidence 666666555445555555555555555543322211 12233333333333333333444444555555555555544
Q ss_pred CchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCC
Q 006145 287 FPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLL 331 (659)
Q Consensus 287 ~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l 331 (659)
.+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|.+
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred CccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 4444444555555555555544 3444444444444444444444
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3.9e-23 Score=207.04 Aligned_cols=202 Identities=21% Similarity=0.155 Sum_probs=182.9
Q ss_pred ccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCE
Q 006145 151 LSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQV 230 (659)
Q Consensus 151 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~ 230 (659)
..+.+.+.+.+.+++.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+. +|.+..+++|++
T Consensus 6 ~~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~~~~~l~~L~~ 81 (266)
T d1p9ag_ 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGT 81 (266)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECCSCCTTCCE
T ss_pred EcccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cccccccccccc
Confidence 356677888899999998 5787664 589999999999998777889999999999999999985 566789999999
Q ss_pred EEcccCCCCCCCCCC--CcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCC
Q 006145 231 LDLENNALGPQFPKV--GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLT 308 (659)
Q Consensus 231 L~L~~N~l~~~~~~~--~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 308 (659)
|+|++|+++...+.. +++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+++
T Consensus 82 L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 82 LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp EECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 999999998765543 579999999999999988889999999999999999999888888899999999999999999
Q ss_pred CcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 309 GKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 309 ~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
+..+..+..+++|+.|||++|+|+ .+|..+..+++++.+++++|.+.+
T Consensus 162 ~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 988899999999999999999999 899999999999999999998864
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.90 E-value=2.1e-22 Score=205.78 Aligned_cols=257 Identities=20% Similarity=0.233 Sum_probs=214.5
Q ss_pred ceEeCC-----------CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEE
Q 006145 68 TVVCYE-----------ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEIL 136 (659)
Q Consensus 68 gv~C~~-----------~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 136 (659)
+|.|.+ ..++.|+|++|+++...+. .+.++++|++|++++|.+....|..|.++++|+.|
T Consensus 14 ~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~---------~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L 84 (305)
T d1xkua_ 14 VVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDG---------DFKNLKNLHTLILINNKISKISPGAFAPLVKLERL 84 (305)
T ss_dssp EEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTT---------TTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred EEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChh---------HhhccccccccccccccccccchhhhhCCCccCEe
Confidence 688854 3477889998876543222 56789999999999999999889999999999999
Q ss_pred EcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCC--ccCCcccCCCCCCcEEeccccc
Q 006145 137 NMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFN--GTLPDSFSYLENLRVLALSNNH 214 (659)
Q Consensus 137 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~ 214 (659)
++++|+++ .+|..+ ...|+.|++++|.+.+..+..+.....+..++...|... ...+..|..+++|+.+++++|.
T Consensus 85 ~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~ 161 (305)
T d1xkua_ 85 YLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161 (305)
T ss_dssp ECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred cccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCC
Confidence 99999998 466543 468999999999999877778888899999999988643 4456678899999999999999
Q ss_pred cccCCCCCCCCCcCCEEEcccCCCCCCCCCC---CcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchhh
Q 006145 215 FYGEVPDFSGLTYLQVLDLENNALGPQFPKV---GKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQAL 291 (659)
Q Consensus 215 l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~---~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 291 (659)
++..... .+++|+.|++++|...+..+.. .+.++.|++++|.+.+..+..+.++++|++|+|++|+|+ .+|.+|
T Consensus 162 l~~l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l 238 (305)
T d1xkua_ 162 ITTIPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 238 (305)
T ss_dssp CCSCCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTT
T ss_pred ccccCcc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccc
Confidence 8864433 3689999999999998777654 467899999999999999999999999999999999998 578899
Q ss_pred cCCCcccEEeccCCcCCCcCCcC------CCCCCCCCEEECcCCCCc-ccCChhh
Q 006145 292 LSLPSITYLNIADNKLTGKLFDD------LSCNPELGFVDLSSNLLT-GQLPNCL 339 (659)
Q Consensus 292 ~~l~~L~~L~l~~N~l~~~~p~~------~~~~~~L~~L~ls~N~l~-g~ip~~~ 339 (659)
..+++|++|+|++|+|+...... ...++.|+.|+|++|.+. ..++...
T Consensus 239 ~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~ 293 (305)
T d1xkua_ 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 293 (305)
T ss_dssp TTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGG
T ss_pred ccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhH
Confidence 99999999999999999653333 346788999999999985 4555543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.89 E-value=1.7e-24 Score=227.20 Aligned_cols=169 Identities=14% Similarity=0.191 Sum_probs=132.4
Q ss_pred CCCCCceeccCcCceEEEEEec-CCcEEEEEEecccCCCchHHHHHHHHHHhCCC-----------CCCccceeeeeeec
Q 006145 478 NFDTSAFMGEGSQGQMYRGRLK-NGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-----------HRHLVSALGHCFEC 545 (659)
Q Consensus 478 ~~~~~~~ig~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~~ 545 (659)
+|...+.||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|++++++++ |+|||++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4888899999999999999964 699999999975432 2356788999888775 57899999988652
Q ss_pred cccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcC-CCCCCccccCCCCCceeecCCc-
Q 006145 546 YFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT-GIVPGVFSNNLKITDILLDQNL- 623 (659)
Q Consensus 546 ~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NILld~~~- 623 (659)
. ....+++++++..+..............+++..+..++.||++||+|||+ . +|+||||||+|||++.++
T Consensus 93 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 93 G-----PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp E-----TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEET
T ss_pred c-----ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCc
Confidence 2 34567777777665544333322334578899999999999999999997 5 899999999999998654
Q ss_pred -----ceEEccCccccccccccccceecccccccCCCCC
Q 006145 624 -----VAKISSYNLPLLAENAEKVGHVIPYSGSIDPTNS 657 (659)
Q Consensus 624 -----~~kl~DFGla~~~~~~~~~~~~~gt~~y~aPE~~ 657 (659)
.+|++|||.+..... .....+||+.|||||+.
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~ 201 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVL 201 (362)
T ss_dssp TTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHH
T ss_pred ccccceeeEeeccccccccc--ccccccccccccChhhc
Confidence 499999999975533 33557899999999964
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=8.4e-22 Score=207.37 Aligned_cols=239 Identities=25% Similarity=0.303 Sum_probs=179.3
Q ss_pred cCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCE
Q 006145 104 VKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAV 183 (659)
Q Consensus 104 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 183 (659)
..+.+|++|++++++++.. +.+..|++|++|||++|+|++. | .++++++|++|++++|++.+. + .++.+++|+.
T Consensus 41 ~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~ 114 (384)
T d2omza2 41 TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADI-T-PLANLTNLTG 114 (384)
T ss_dssp HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCE
T ss_pred HHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccccc-c-cccccccccc
Confidence 4577899999999999763 3588999999999999999964 4 399999999999999999864 3 3899999999
Q ss_pred EEccCCcCCccCC---------------------------------------------------------------cccC
Q 006145 184 LSLRNNMFNGTLP---------------------------------------------------------------DSFS 200 (659)
Q Consensus 184 L~L~~N~l~~~~p---------------------------------------------------------------~~~~ 200 (659)
|++++|.+++..+ ..+.
T Consensus 115 L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (384)
T d2omza2 115 LTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194 (384)
T ss_dssp EECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccc
Confidence 9999988874221 1234
Q ss_pred CCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCC-CCCcccceEecCCCcCCccCchhccCCccccEEecc
Q 006145 201 YLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFP-KVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLS 279 (659)
Q Consensus 201 ~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~-~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 279 (659)
.+++++.|++++|.+++..| +...++|++|++++|.++.... ..+++|+.|++++|.+++..+ +..+++|+.|+++
T Consensus 195 ~l~~~~~l~l~~n~i~~~~~-~~~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~ 271 (384)
T d2omza2 195 KLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 271 (384)
T ss_dssp GCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred cccccceeeccCCccCCCCc-ccccCCCCEEECCCCCCCCcchhhcccccchhccccCccCCCCc--ccccccCCEeecc
Confidence 45666677777777665433 4556677777777777665321 124677777777777766433 6667777777777
Q ss_pred CcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCCccccC
Q 006145 280 SNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYARNCLAA 357 (659)
Q Consensus 280 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~N~l~~ 357 (659)
+|.+++.. .+..++.++.++++.|.+++. ..+..++.++.|++++|++++.. .+..+++|+.+++++|.++.
T Consensus 272 ~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~ 343 (384)
T d2omza2 272 ANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD 343 (384)
T ss_dssp SSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC
T ss_pred CcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC
Confidence 77776533 266677777777777777652 34677899999999999999753 37788999999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=6.4e-22 Score=187.77 Aligned_cols=132 Identities=11% Similarity=0.099 Sum_probs=104.5
Q ss_pred CCceeccCcCceEEEEEecCCcEEEEEEecccCCC-----c-------------hHHHHHHHHHHhCCCCCCccceeeee
Q 006145 481 TSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCH-----S-------------TRNFMHHIELISKLRHRHLVSALGHC 542 (659)
Q Consensus 481 ~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-----~-------------~~~~~~Ei~~l~~l~H~niv~l~g~~ 542 (659)
..+.||+|+||+||+|+..+|+.||||+++..... . ...+.+|.+.+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 45899999999999999888999999987532110 0 12356788899999999999887643
Q ss_pred eeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCCCCCccccCCCCCceeecCC
Q 006145 543 FECYFDDSSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGIVPGVFSNNLKITDILLDQN 622 (659)
Q Consensus 543 ~~~~~~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILld~~ 622 (659)
. .++||||++++.+.++ ++.....++.|+++|++|||+. +|+||||||+|||++++
T Consensus 84 ~-----------~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~ 139 (191)
T d1zara2 84 G-----------NAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE 139 (191)
T ss_dssp T-----------TEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT
T ss_pred C-----------CEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC
Confidence 2 3799999988665442 2233467899999999999998 99999999999999965
Q ss_pred cceEEccCccccccc
Q 006145 623 LVAKISSYNLPLLAE 637 (659)
Q Consensus 623 ~~~kl~DFGla~~~~ 637 (659)
+ ++++|||+|....
T Consensus 140 ~-~~liDFG~a~~~~ 153 (191)
T d1zara2 140 G-IWIIDFPQSVEVG 153 (191)
T ss_dssp E-EEECCCTTCEETT
T ss_pred C-EEEEECCCcccCC
Confidence 4 8999999997654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=5.9e-19 Score=171.81 Aligned_cols=200 Identities=20% Similarity=0.274 Sum_probs=117.6
Q ss_pred EecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCC
Q 006145 113 RLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFN 192 (659)
Q Consensus 113 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 192 (659)
+++.+.+++.+ .+..|.+|+.|++++|.|+. ++ .+..+++|++|++++|++++..| +..+++|++|++++|.++
T Consensus 25 ~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~ 98 (227)
T d1h6ua2 25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK 98 (227)
T ss_dssp HTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS
T ss_pred HhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc
Confidence 34444444433 23456666666666666663 33 46666666666666666664332 566666666666666665
Q ss_pred ccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCC-CCcccceEecCCCcCCccCchhccCCc
Q 006145 193 GTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPK-VGKKLVTMILSKNKFRSAIPAEVSSYY 271 (659)
Q Consensus 193 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~~~l~ 271 (659)
.++ .+..+++|+.+++++|...+. +.+...+.++.+.++.+.+....+. ..++|+.|++++|.+.+.. .+++++
T Consensus 99 -~i~-~l~~l~~L~~l~l~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~ 173 (227)
T d1h6ua2 99 -NVS-AIAGLQSIKTLDLTSTQITDV-TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLS 173 (227)
T ss_dssp -CCG-GGTTCTTCCEEECTTSCCCCC-GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCT
T ss_pred -ccc-ccccccccccccccccccccc-chhccccchhhhhchhhhhchhhhhccccccccccccccccccch--hhcccc
Confidence 232 456666666666666665532 2345556666666666665443322 2345566666666554422 366677
Q ss_pred cccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECc
Q 006145 272 QLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLS 327 (659)
Q Consensus 272 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls 327 (659)
+|+.|+|++|++++ +| .+..+++|++|+|++|++++..| +..+++|+.|+++
T Consensus 174 ~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 174 KLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp TCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred cceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 77777777777764 33 26667777777777777764332 5666777777765
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=9.3e-19 Score=171.96 Aligned_cols=198 Identities=19% Similarity=0.135 Sum_probs=103.9
Q ss_pred CCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCC-hhccCCCCCcEEEeec-CCCCCCCccccCCCCCCCEEE
Q 006145 108 DLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIP-QELSILTSLQTLILDE-NMLAGRVPDWLGSLPILAVLS 185 (659)
Q Consensus 108 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~ 185 (659)
++++|+|++|.++...+..|.++++|++|+|++|.+...+| ..|.+++++++|++.. |++....+..|.++++|+.|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 56777777777766555567777777777777776665443 3466667777766653 555555556666666666666
Q ss_pred ccCCcCCccCCc-ccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccC
Q 006145 186 LRNNMFNGTLPD-SFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAI 263 (659)
Q Consensus 186 L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~ 263 (659)
+++|.+....+. .+..++.|..+...++.+....+. |.+++ ..+..|++++|+++...
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~--------------------~~l~~L~l~~n~l~~i~ 169 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS--------------------FESVILWLNKNGIQEIH 169 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSB--------------------SSCEEEECCSSCCCEEC
T ss_pred cchhhhccccccccccccccccccccccccccccccccccccc--------------------ccceeeecccccccccc
Confidence 666666532221 122334444444444444433222 33332 23334444444444322
Q ss_pred chhccCCccccE-EeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEEC
Q 006145 264 PAEVSSYYQLQR-LDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDL 326 (659)
Q Consensus 264 p~~~~~l~~L~~-L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~l 326 (659)
+..+ +..+++. +++++|+++...+..|.++++|++|+|++|+++...+..+..+++|+.+++
T Consensus 170 ~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 170 NCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp TTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred cccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 2222 2233333 334555555333344555666666666666665443444555555444443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=3.9e-19 Score=173.13 Aligned_cols=208 Identities=21% Similarity=0.237 Sum_probs=173.9
Q ss_pred CCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEE
Q 006145 129 RLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVL 208 (659)
Q Consensus 129 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 208 (659)
.|.++..++++.+.+++.+ .+..+.+|+.|++++|.++. ++ .+..+++|++|++++|++++..| +.++++|+.|
T Consensus 17 ~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l 90 (227)
T d1h6ua2 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL 90 (227)
T ss_dssp HHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred HHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccc
Confidence 3455566788889988765 35678899999999999984 54 58999999999999999986544 8999999999
Q ss_pred eccccccccCCCCCCCCCcCCEEEcccCCCCCCCCC-CCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCC
Q 006145 209 ALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPK-VGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPF 287 (659)
Q Consensus 209 ~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~-~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 287 (659)
++++|.++ .++.+.++++|+.+++++|...+..+. ....+..+.++.+.+.... .+..+++|+.|++++|.+.+..
T Consensus 91 ~~~~n~~~-~i~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~ 167 (227)
T d1h6ua2 91 ELSGNPLK-NVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT 167 (227)
T ss_dssp ECCSCCCS-CCGGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG
T ss_pred cccccccc-ccccccccccccccccccccccccchhccccchhhhhchhhhhchhh--hhccccccccccccccccccch
Confidence 99999987 466789999999999999998776553 3578899999999987643 4678899999999999997543
Q ss_pred chhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcC
Q 006145 288 PQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYA 351 (659)
Q Consensus 288 p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~ 351 (659)
.+.++++|+.|++++|++++. + .+..+++|+.|++++|++++ +| .+..+++|+.++++
T Consensus 168 --~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 168 --PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVTLT 225 (227)
T ss_dssp --GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEEEE
T ss_pred --hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEEEee
Confidence 388999999999999999864 3 37889999999999999995 54 37788999999885
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=3.2e-19 Score=168.97 Aligned_cols=112 Identities=28% Similarity=0.298 Sum_probs=80.8
Q ss_pred CCCCEEEecCCCCcCC-CCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEE
Q 006145 107 PDLKVLRLVSLGLWGP-LSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLS 185 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 185 (659)
+++++|+|++|.|++. .+..|.++++|+.|+|++|.+.+..+..+..+++|++|+|++|+++...|..|.++++|++|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 4677777777777653 355667777777777777777777777777777777777777777766666777777777777
Q ss_pred ccCCcCCccCCcccCCCCCCcEEeccccccccC
Q 006145 186 LRNNMFNGTLPDSFSYLENLRVLALSNNHFYGE 218 (659)
Q Consensus 186 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 218 (659)
|++|+|++..|+.|..+++|++|+|++|.+...
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cCCccccccCHHHhcCCcccccccccccccccc
Confidence 777777766666777777777777777766543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.8e-18 Score=164.83 Aligned_cols=179 Identities=22% Similarity=0.294 Sum_probs=106.3
Q ss_pred EecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCC
Q 006145 113 RLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFN 192 (659)
Q Consensus 113 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 192 (659)
++..+.+++.++. ..|.+|+.|++++|.++.. + .+..+++|++|+|++|++++ ++ .++.+++|++|++++|+++
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc
Confidence 3444455444432 2456677777777776642 2 36667777777777777764 33 2566777777777777766
Q ss_pred ccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCcc
Q 006145 193 GTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQ 272 (659)
Q Consensus 193 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~ 272 (659)
+ +| .+.++++|+.|++++|.+.. ++.+..+++|+.+++++|.++. +..+..+++
T Consensus 104 ~-l~-~l~~l~~L~~L~l~~~~~~~-~~~l~~l~~l~~l~~~~n~l~~-----------------------~~~~~~l~~ 157 (210)
T d1h6ta2 104 D-LS-SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD-----------------------ITVLSRLTK 157 (210)
T ss_dssp C-GG-GGTTCTTCCEEECTTSCCCC-CGGGGGCTTCCEEECCSSCCCC-----------------------CGGGGGCTT
T ss_pred c-cc-cccccccccccccccccccc-cccccccccccccccccccccc-----------------------ccccccccc
Confidence 3 33 46667777777777776643 3446666666666666665532 123445556
Q ss_pred ccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECc
Q 006145 273 LQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLS 327 (659)
Q Consensus 273 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls 327 (659)
|+.+++++|++++. + .+.++++|+.|++++|+++. +| .+..+++|++|+|+
T Consensus 158 L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 158 LDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp CSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred cccccccccccccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 66666666666542 2 25666666666666666653 33 35666666666664
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=1.3e-18 Score=164.80 Aligned_cols=127 Identities=24% Similarity=0.258 Sum_probs=108.0
Q ss_pred EEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccC-ChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCC
Q 006145 111 VLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAI-PQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189 (659)
Q Consensus 111 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 189 (659)
.++.++++++. +|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|.+.+..+..+..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 34455555553 454443 68999999999998655 566899999999999999999999999999999999999999
Q ss_pred cCCccCCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCC
Q 006145 190 MFNGTLPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGP 240 (659)
Q Consensus 190 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~ 240 (659)
+|++..|..|.++++|++|+|++|+|++..+. |..+++|++|+|++|.+..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence 99988888999999999999999999998876 8899999999999988754
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.75 E-value=1.1e-16 Score=165.17 Aligned_cols=248 Identities=24% Similarity=0.266 Sum_probs=162.9
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccC
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSI 153 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 153 (659)
.+++.|||++++++. +|. .+++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++..
T Consensus 38 ~~l~~LdLs~~~L~~-lp~------------~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l--- 96 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPE------------LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL--- 96 (353)
T ss_dssp HTCSEEECTTSCCSC-CCS------------CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---
T ss_pred cCCCEEEeCCCCCCC-CCC------------CCCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---
Confidence 457788988887652 342 2457888899988887 45654 457888888888887 34421
Q ss_pred CCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCC------------------cccCCCCCCcEEecccccc
Q 006145 154 LTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLP------------------DSFSYLENLRVLALSNNHF 215 (659)
Q Consensus 154 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p------------------~~~~~l~~L~~L~Ls~N~l 215 (659)
.+.|++|++++|.+. .+|. ++.+++|+.|++++|.+....+ ..+..++.++.|++++|.+
T Consensus 97 p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~ 174 (353)
T d1jl5a_ 97 PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSL 174 (353)
T ss_dssp CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCC
T ss_pred ccccccccccccccc-cccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceecccccccc
Confidence 146888888888887 4564 5778888888888887763221 2345567777788777765
Q ss_pred ccC-------------------CCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEE
Q 006145 216 YGE-------------------VPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRL 276 (659)
Q Consensus 216 ~~~-------------------~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 276 (659)
... ++.+..++.|+.+++++|.... ++....++..+.+..|.+.... .. ...+...
T Consensus 175 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~~~~~l~~~~~~~~~~~~~~-~~---~~~l~~~ 249 (353)
T d1jl5a_ 175 KKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLP-EL---PQSLTFL 249 (353)
T ss_dssp SSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCC-CC---CTTCCEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccc-cc---ccccccc
Confidence 432 2335567788888888877654 4455566677777777665422 11 1222233
Q ss_pred eccCccccc----------------CCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhh
Q 006145 277 DLSSNRFVG----------------PFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLL 340 (659)
Q Consensus 277 ~Ls~N~l~~----------------~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~ 340 (659)
++..|.+.+ .++.....+++|++|+|++|+|+ .+|.. +++|+.|++++|+|+ .+|..
T Consensus 250 ~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~-- 322 (353)
T d1jl5a_ 250 DVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL-- 322 (353)
T ss_dssp ECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC--
T ss_pred ccccccccccccccchhcccccccCccccccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc--
Confidence 332222211 11122234578999999999988 46643 578899999999998 67764
Q ss_pred CCCCCCEEEcCCccccC
Q 006145 341 AGSKNRVVLYARNCLAA 357 (659)
Q Consensus 341 ~~~~l~~l~~~~N~l~~ 357 (659)
..+|+.+++++|.++.
T Consensus 323 -~~~L~~L~L~~N~L~~ 338 (353)
T d1jl5a_ 323 -PQNLKQLHVEYNPLRE 338 (353)
T ss_dssp -CTTCCEEECCSSCCSS
T ss_pred -cCCCCEEECcCCcCCC
Confidence 3568899999998874
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=4e-18 Score=163.74 Aligned_cols=186 Identities=22% Similarity=0.264 Sum_probs=148.0
Q ss_pred CCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEec
Q 006145 131 SSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLAL 210 (659)
Q Consensus 131 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 210 (659)
.++...+++.+.+++.++. ..+.+|+.|++++|.++.. + .+..+++|++|+|++|++++. + .++++++|++|++
T Consensus 24 ~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l 97 (210)
T d1h6ta2 24 AETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFL 97 (210)
T ss_dssp HHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEEC
T ss_pred HHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCc-c-ccccCcccccccc
Confidence 3444557778888776664 3567889999999998753 3 377889999999999998864 3 3678899999999
Q ss_pred cccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCchh
Q 006145 211 SNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQA 290 (659)
Q Consensus 211 s~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 290 (659)
++|++++ +|.+.++++|+.|++++|.+. . ...+..+++|+.+++++|.+++ +..
T Consensus 98 ~~n~i~~-l~~l~~l~~L~~L~l~~~~~~---------------------~--~~~l~~l~~l~~l~~~~n~l~~--~~~ 151 (210)
T d1h6ta2 98 DENKVKD-LSSLKDLKKLKSLSLEHNGIS---------------------D--INGLVHLPQLESLYLGNNKITD--ITV 151 (210)
T ss_dssp CSSCCCC-GGGGTTCTTCCEEECTTSCCC---------------------C--CGGGGGCTTCCEEECCSSCCCC--CGG
T ss_pred ccccccc-ccccccccccccccccccccc---------------------c--cccccccccccccccccccccc--ccc
Confidence 9998875 456888888888888777652 1 2357788999999999999975 346
Q ss_pred hcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEEEcCC
Q 006145 291 LLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVVLYAR 352 (659)
Q Consensus 291 l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l~~~~ 352 (659)
+..+++|+.+++++|++++.. .+..+++|+.|++++|+++ .+| .+..+++|+.+++++
T Consensus 152 ~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 152 LSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred ccccccccccccccccccccc--cccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 788999999999999998643 3889999999999999998 566 588899999999864
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=1.7e-17 Score=162.81 Aligned_cols=214 Identities=18% Similarity=0.130 Sum_probs=142.1
Q ss_pred CEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCc-cccCCCCCCCEEEcc-
Q 006145 110 KVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVP-DWLGSLPILAVLSLR- 187 (659)
Q Consensus 110 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~- 187 (659)
+.++.++.+++ .+|..+. +++++|+|++|.|+...+..|.++++|++|+|++|.+...+| ..|.+++++++|.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 56777777776 4554442 467888888888875555567788888888888887765443 457777788877765
Q ss_pred CCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhc
Q 006145 188 NNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEV 267 (659)
Q Consensus 188 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~ 267 (659)
.|.+....+..|.++++|+.|++++|.+.... .+..+.+++ .+..+..+++.+....+..|
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~-~~~~~~~l~------------------~l~~~~~~n~~l~~i~~~~~ 148 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLP-DVHKIHSLQ------------------KVLLDIQDNINIHTIERNSF 148 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCC-CCTTTCBSS------------------CEEEEEESCTTCCEECTTSS
T ss_pred cccccccccccccccccccccccchhhhcccc-ccccccccc------------------cccccccccccccccccccc
Confidence 35677666777777788888888777776432 222222222 22233334444444444555
Q ss_pred cCCc-cccEEeccCcccccCCchhhcCCCcccEE-eccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCCh-hhhCCCC
Q 006145 268 SSYY-QLQRLDLSSNRFVGPFPQALLSLPSITYL-NIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPN-CLLAGSK 344 (659)
Q Consensus 268 ~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L-~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~-~~~~~~~ 344 (659)
..++ .++.|++++|+++...+. .....++..+ ++++|+++...+..|..+++|+.||+++|+|+ .+|. .+..+++
T Consensus 149 ~~~~~~l~~L~l~~n~l~~i~~~-~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~ 226 (242)
T d1xwdc1 149 VGLSFESVILWLNKNGIQEIHNC-AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKK 226 (242)
T ss_dssp TTSBSSCEEEECCSSCCCEECTT-TTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCE
T ss_pred ccccccceeeecccccccccccc-cccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCCcc
Confidence 5554 788999999999864444 4455555555 57888898665667899999999999999999 5554 4444444
Q ss_pred CCE
Q 006145 345 NRV 347 (659)
Q Consensus 345 l~~ 347 (659)
|+.
T Consensus 227 L~~ 229 (242)
T d1xwdc1 227 LRA 229 (242)
T ss_dssp EES
T ss_pred ccc
Confidence 443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=2.5e-17 Score=156.66 Aligned_cols=175 Identities=25% Similarity=0.337 Sum_probs=92.2
Q ss_pred ecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCc
Q 006145 114 LVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNG 193 (659)
Q Consensus 114 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 193 (659)
++.+.+++.++ ...+.+|+.|++++|.++. ++ .+..+++|++|+|++|++++..| ++++++|++|++++|.+..
T Consensus 25 l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~ 98 (199)
T d2omxa2 25 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 98 (199)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred hCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCccccccccccccccc
Confidence 34444444332 2345566666666666652 22 35556666666666666654322 5666666666666666552
Q ss_pred cCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccc
Q 006145 194 TLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQL 273 (659)
Q Consensus 194 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L 273 (659)
+| .+.++++|+.|++++|.+.. ++.+..+++|+.|++++|++.. + ..+..+++|
T Consensus 99 -~~-~l~~l~~L~~L~l~~~~~~~-~~~~~~l~~L~~L~l~~n~l~~----------------------~-~~l~~~~~L 152 (199)
T d2omxa2 99 -IT-PLANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELSSNTISD----------------------I-SALSGLTSL 152 (199)
T ss_dssp -CG-GGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCC----------------------C-GGGTTCTTC
T ss_pred -cc-cccccccccccccccccccc-ccccchhhhhHHhhhhhhhhcc----------------------c-ccccccccc
Confidence 22 35566666666666665543 2335555556665555554431 1 134455555
Q ss_pred cEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEE
Q 006145 274 QRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFV 324 (659)
Q Consensus 274 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L 324 (659)
+.|++++|++++. + .+.++++|+.|++++|+++. ++ .+..+++|+.|
T Consensus 153 ~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 153 QQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp SEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 5555555555532 2 25555666666666666553 22 34455555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=1.4e-17 Score=158.55 Aligned_cols=183 Identities=24% Similarity=0.282 Sum_probs=141.5
Q ss_pred CCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEe
Q 006145 130 LSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLA 209 (659)
Q Consensus 130 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 209 (659)
+.++..+.++.+.+++.++. ..+.+|++|++++|.++. ++ .+..+++|++|++++|++++..| ++++++|+.|+
T Consensus 17 l~~~i~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 90 (199)
T d2omxa2 17 LAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 90 (199)
T ss_dssp HHHHHHHHTTCSSTTSEECH--HHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred HHHHHHHHhCCCCCCCccCH--HHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCccccccc
Confidence 44455567788888766543 467888899999998874 33 47788888999999888886433 88888888888
Q ss_pred ccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCccCchhccCCccccEEeccCcccccCCch
Q 006145 210 LSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFPQ 289 (659)
Q Consensus 210 Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 289 (659)
+++|.+.. ++.+.++++|+.|++++|.+. . ...+..+++|+.|++++|++.. + +
T Consensus 91 l~~n~~~~-~~~l~~l~~L~~L~l~~~~~~---------------------~--~~~~~~l~~L~~L~l~~n~l~~-~-~ 144 (199)
T d2omxa2 91 MNNNQIAD-ITPLANLTNLTGLTLFNNQIT---------------------D--IDPLKNLTNLNRLELSSNTISD-I-S 144 (199)
T ss_dssp CCSSCCCC-CGGGTTCTTCSEEECCSSCCC---------------------C--CGGGTTCTTCSEEECCSSCCCC-C-G
T ss_pred cccccccc-ccccccccccccccccccccc---------------------c--ccccchhhhhHHhhhhhhhhcc-c-c
Confidence 88888764 345777888888877776553 2 1346788999999999999974 3 3
Q ss_pred hhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhhCCCCCCEE
Q 006145 290 ALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLLAGSKNRVV 348 (659)
Q Consensus 290 ~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~~~~~l~~l 348 (659)
.+..+++|+.|++.+|++++.. .+..+++|+.|++++|+++. +| .+..+++|+.|
T Consensus 145 ~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 145 ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 5889999999999999998753 48899999999999999985 55 47778877764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.66 E-value=7.3e-15 Score=151.31 Aligned_cols=241 Identities=22% Similarity=0.210 Sum_probs=157.2
Q ss_pred CCEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcCCCCcccCCC-CCCcEEEcccCcCcccCChhcc
Q 006145 74 ESITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWGPLSGKISRL-SSLEILNMSSNFLNGAIPQELS 152 (659)
Q Consensus 74 ~~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~ 152 (659)
.+++.|+|++|+++ .+|. .+.+|+.|++++|.++.. + .+ +.|++|++++|.+. .+|. ++
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~------------~~~~L~~L~l~~n~l~~l-~----~lp~~L~~L~L~~n~l~-~lp~-~~ 117 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPE------------LPQSLKSLLVDNNNLKAL-S----DLPPLLEYLGVSNNQLE-KLPE-LQ 117 (353)
T ss_dssp TTCSEEECCSSCCS-SCCC------------CCTTCCEEECCSSCCSCC-C----SCCTTCCEEECCSSCCS-SCCC-CT
T ss_pred CCCCEEECCCCCCc-cccc------------chhhhhhhhhhhcccchh-h----hhccccccccccccccc-cccc-hh
Confidence 36889999998876 3342 134677777777776532 2 22 35777888888776 4553 56
Q ss_pred CCCCCcEEEeecCCCCCCC------------------ccccCCCCCCCEEEccCCcCCccC------------------C
Q 006145 153 ILTSLQTLILDENMLAGRV------------------PDWLGSLPILAVLSLRNNMFNGTL------------------P 196 (659)
Q Consensus 153 ~l~~L~~L~Ls~N~l~~~~------------------p~~l~~l~~L~~L~L~~N~l~~~~------------------p 196 (659)
.+++|+.|++++|.+.... +..+..++.++.|++++|.+.... .
T Consensus 118 ~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~ 197 (353)
T d1jl5a_ 118 NSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEEL 197 (353)
T ss_dssp TCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSC
T ss_pred hhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccccccccccccccccccc
Confidence 7777888877777665321 223556777888888877765321 1
Q ss_pred cccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCc---------------
Q 006145 197 DSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRS--------------- 261 (659)
Q Consensus 197 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~--------------- 261 (659)
..+..++.|+.+++++|....... ...++..+.+..|.+.... .....+...++..|.+.+
T Consensus 198 ~~~~~l~~L~~l~l~~n~~~~~~~---~~~~l~~~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~ 273 (353)
T d1jl5a_ 198 PELQNLPFLTTIYADNNLLKTLPD---LPPSLEALNVRDNYLTDLP-ELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273 (353)
T ss_dssp CCCTTCTTCCEEECCSSCCSSCCS---CCTTCCEEECCSSCCSCCC-CCCTTCCEEECCSSCCSEESCCCTTCCEEECCS
T ss_pred cccccccccccccccccccccccc---ccccccccccccccccccc-cccccccccccccccccccccccchhccccccc
Confidence 235668899999999998765332 3456777888888775432 222333333333332221
Q ss_pred -cCchhccCCccccEEeccCcccccCCchhhcCCCcccEEeccCCcCCCcCCcCCCCCCCCCEEECcCCCCcccCChhhh
Q 006145 262 -AIPAEVSSYYQLQRLDLSSNRFVGPFPQALLSLPSITYLNIADNKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNCLL 340 (659)
Q Consensus 262 -~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~~~ 340 (659)
.++.....+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|++++|+++ .+|....
T Consensus 274 ~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~ 344 (353)
T d1jl5a_ 274 NEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPE 344 (353)
T ss_dssp SCCSEECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCT
T ss_pred CccccccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcccc
Confidence 11112234678999999999998 56753 678999999999998 56653 468999999999998 6776433
Q ss_pred CCCCCCEEEc
Q 006145 341 AGSKNRVVLY 350 (659)
Q Consensus 341 ~~~~l~~l~~ 350 (659)
.++.|.+
T Consensus 345 ---~L~~L~~ 351 (353)
T d1jl5a_ 345 ---SVEDLRM 351 (353)
T ss_dssp ---TCCEEEC
T ss_pred ---ccCeeEC
Confidence 3444443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=4.5e-17 Score=174.27 Aligned_cols=274 Identities=23% Similarity=0.240 Sum_probs=160.0
Q ss_pred CEeEEEeCCCCCCCCCCCCCcCCcccccccCCCCCCEEEecCCCCcC----CCCcccCCCCCCcEEEcccCcCccc----
Q 006145 75 SITQLHIVGNKRAPMLPLSFSMDSFVTTLVKLPDLKVLRLVSLGLWG----PLSGKISRLSSLEILNMSSNFLNGA---- 146 (659)
Q Consensus 75 ~v~~L~l~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~---- 146 (659)
+++.||+++++++. ..+...+..+++|+.|+|++|+++. .+...+..+++|+.|||++|.|+..
T Consensus 3 ~l~~ld~~~~~i~~--------~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~ 74 (460)
T d1z7xw1 3 DIQSLDIQCEELSD--------ARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHC 74 (460)
T ss_dssp EEEEEEEESCCCCH--------HHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHH
T ss_pred CCCEEEeeCCcCCh--------HHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHH
Confidence 46778888776652 1222334456667777777776652 2344456667777777777766421
Q ss_pred CChhcc-CCCCCcEEEeecCCCCCC----CccccCCCCCCCEEEccCCcCCccCC-------------------------
Q 006145 147 IPQELS-ILTSLQTLILDENMLAGR----VPDWLGSLPILAVLSLRNNMFNGTLP------------------------- 196 (659)
Q Consensus 147 ~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p------------------------- 196 (659)
+...+. ...+|++|+|++|+++.. ++..+..+++|++|+|++|.++....
T Consensus 75 l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~ 154 (460)
T d1z7xw1 75 VLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS 154 (460)
T ss_dssp HHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCB
T ss_pred HHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccc
Confidence 112221 224577777777776533 34456666777777777766542100
Q ss_pred --------cccCCCCCCcEEecc---------------------------------------------------------
Q 006145 197 --------DSFSYLENLRVLALS--------------------------------------------------------- 211 (659)
Q Consensus 197 --------~~~~~l~~L~~L~Ls--------------------------------------------------------- 211 (659)
..+.....++.++++
T Consensus 155 ~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~ 234 (460)
T d1z7xw1 155 AASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALG 234 (460)
T ss_dssp GGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECC
T ss_pred hhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchh
Confidence 000011223333333
Q ss_pred ccccccC-----CCC-CCCCCcCCEEEcccCCCCCCCCC-------CCcccceEecCCCcCCccCchhc-----cCCccc
Q 006145 212 NNHFYGE-----VPD-FSGLTYLQVLDLENNALGPQFPK-------VGKKLVTMILSKNKFRSAIPAEV-----SSYYQL 273 (659)
Q Consensus 212 ~N~l~~~-----~p~-~~~l~~L~~L~L~~N~l~~~~~~-------~~~~L~~L~l~~N~l~~~~p~~~-----~~l~~L 273 (659)
+|.+... .+. ......|+.|++++|.+...... ..+.+..+++++|.++......+ .....|
T Consensus 235 ~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L 314 (460)
T d1z7xw1 235 SNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL 314 (460)
T ss_dssp SSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCC
T ss_pred hccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccc
Confidence 2222110 000 22356799999999987643221 14578888888888764322211 234578
Q ss_pred cEEeccCcccccCCch----hhcCCCcccEEeccCCcCCCc----CCcCCC-CCCCCCEEECcCCCCcc----cCChhhh
Q 006145 274 QRLDLSSNRFVGPFPQ----ALLSLPSITYLNIADNKLTGK----LFDDLS-CNPELGFVDLSSNLLTG----QLPNCLL 340 (659)
Q Consensus 274 ~~L~Ls~N~l~~~~p~----~l~~l~~L~~L~l~~N~l~~~----~p~~~~-~~~~L~~L~ls~N~l~g----~ip~~~~ 340 (659)
+.+++++|.++..... .+...++|+.|+|++|+++.. ++..+. ..+.|+.|+|++|.|+. .++..+.
T Consensus 315 ~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~ 394 (460)
T d1z7xw1 315 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLL 394 (460)
T ss_dssp CEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHH
T ss_pred ccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHh
Confidence 8888888888754333 334556788888888888642 233332 45678888888888874 3455666
Q ss_pred CCCCCCEEEcCCcccc
Q 006145 341 AGSKNRVVLYARNCLA 356 (659)
Q Consensus 341 ~~~~l~~l~~~~N~l~ 356 (659)
.+++++.+++++|+++
T Consensus 395 ~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 395 ANHSLRELDLSNNCLG 410 (460)
T ss_dssp HCCCCCEEECCSSSCC
T ss_pred cCCCCCEEECCCCcCC
Confidence 7788888888888876
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=1.4e-14 Score=125.96 Aligned_cols=104 Identities=29% Similarity=0.343 Sum_probs=77.5
Q ss_pred CEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCC
Q 006145 110 KVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189 (659)
Q Consensus 110 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 189 (659)
|+|+|++|+++.. + .+..+++|++||+++|.|+ .+|+.++.+++|++|++++|.|+. +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 4678888888643 3 3778888888888888887 567778888888888888888874 44 4778888888888888
Q ss_pred cCCccC-CcccCCCCCCcEEeccccccccC
Q 006145 190 MFNGTL-PDSFSYLENLRVLALSNNHFYGE 218 (659)
Q Consensus 190 ~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~ 218 (659)
+++... ...+..+++|+.|++++|+++..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 887432 24577788888888888887653
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=2.5e-14 Score=124.32 Aligned_cols=101 Identities=26% Similarity=0.345 Sum_probs=85.7
Q ss_pred cEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEecccc
Q 006145 134 EILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNN 213 (659)
Q Consensus 134 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 213 (659)
|+|||++|+++ .+| .+..+++|++|++++|+|+ .+|+.++.+++|+.|++++|.|+. +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 58999999998 555 4889999999999999998 578889999999999999999985 45 5889999999999999
Q ss_pred ccccCCC--CCCCCCcCCEEEcccCCCC
Q 006145 214 HFYGEVP--DFSGLTYLQVLDLENNALG 239 (659)
Q Consensus 214 ~l~~~~p--~~~~l~~L~~L~L~~N~l~ 239 (659)
+++.... .+..+++|++|++++|.++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 9986542 4788888999988888775
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=9e-15 Score=133.61 Aligned_cols=128 Identities=20% Similarity=0.199 Sum_probs=91.4
Q ss_pred cccCCCCCCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCC
Q 006145 102 TLVKLPDLKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPIL 181 (659)
Q Consensus 102 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 181 (659)
.+.+...|+.|+|++|+++.. ++.+..+++|+.|||++|.|+. ++ .|..+++|++|+|++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 345667788888888888654 5566778888888888888874 43 47778888888888888876555556678888
Q ss_pred CEEEccCCcCCccCC-cccCCCCCCcEEeccccccccCCC----CCCCCCcCCEEE
Q 006145 182 AVLSLRNNMFNGTLP-DSFSYLENLRVLALSNNHFYGEVP----DFSGLTYLQVLD 232 (659)
Q Consensus 182 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~l~~L~~L~ 232 (659)
+.|++++|+++..-. ..+..+++|++|++++|.++.... .+..+++|++||
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 888888888774211 356777888888888887765432 156677777776
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.7e-15 Score=152.16 Aligned_cols=218 Identities=19% Similarity=0.155 Sum_probs=127.4
Q ss_pred CCEEEecCCCCcCCCCcccCCCCCCcEEEcccCcCccc-CChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEcc
Q 006145 109 LKVLRLVSLGLWGPLSGKISRLSSLEILNMSSNFLNGA-IPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLR 187 (659)
Q Consensus 109 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 187 (659)
+..+.++.......+.. .....+|++|||++|.++.. ++..+..+++|++|+|++|.++...+..++.+++|++|+++
T Consensus 25 ~~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls 103 (284)
T d2astb2 25 VIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103 (284)
T ss_dssp CSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEeeccccccccchhh-hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence 44566655554433332 33456788888888777643 34456777888888888887777777777777888888887
Q ss_pred CC-cCCcc-CCcccCCCCCCcEEecccc-ccccC-CC-CCC-CCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCc
Q 006145 188 NN-MFNGT-LPDSFSYLENLRVLALSNN-HFYGE-VP-DFS-GLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRS 261 (659)
Q Consensus 188 ~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~-~p-~~~-~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~ 261 (659)
++ .++.. +...+.++++|++|+++++ .++.. +. .+. ..++|+.|+++++. +.++.
T Consensus 104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~-------------------~~i~~ 164 (284)
T d2astb2 104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR-------------------KNLQK 164 (284)
T ss_dssp TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG-------------------GGSCH
T ss_pred ccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccc-------------------ccccc
Confidence 74 45421 1222345677777777764 33221 11 111 23456666665431 11221
Q ss_pred c-CchhccCCccccEEeccCc-ccccCCchhhcCCCcccEEeccC-CcCCCcCCcCCCCCCCCCEEECcCCCCcccCChh
Q 006145 262 A-IPAEVSSYYQLQRLDLSSN-RFVGPFPQALLSLPSITYLNIAD-NKLTGKLFDDLSCNPELGFVDLSSNLLTGQLPNC 338 (659)
Q Consensus 262 ~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~l~~-N~l~~~~p~~~~~~~~L~~L~ls~N~l~g~ip~~ 338 (659)
. +...+.++++|++|++++| .+++..+..+.++++|++|++++ +.+++.....++.+++|+.|+++++--.+.++..
T Consensus 165 ~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l 244 (284)
T d2astb2 165 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL 244 (284)
T ss_dssp HHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHH
T ss_pred ccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHH
Confidence 1 2223345677777777765 46666666777777777787777 3566655556677777888887776222333333
Q ss_pred hhCCCCCC
Q 006145 339 LLAGSKNR 346 (659)
Q Consensus 339 ~~~~~~l~ 346 (659)
...+++++
T Consensus 245 ~~~lp~L~ 252 (284)
T d2astb2 245 KEALPHLQ 252 (284)
T ss_dssp HHHSTTSE
T ss_pred HHhCcccc
Confidence 33444443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=1.8e-14 Score=131.52 Aligned_cols=111 Identities=17% Similarity=0.114 Sum_probs=89.0
Q ss_pred ccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCC
Q 006145 126 KISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENL 205 (659)
Q Consensus 126 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 205 (659)
.|.+..+|+.|||++|+|+ .+|..+..+++|+.|+|++|+++. ++ .|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 4667888999999999998 457767889999999999999984 43 57889999999999999986666666788999
Q ss_pred cEEeccccccccCC--CCCCCCCcCCEEEcccCCCC
Q 006145 206 RVLALSNNHFYGEV--PDFSGLTYLQVLDLENNALG 239 (659)
Q Consensus 206 ~~L~Ls~N~l~~~~--p~~~~l~~L~~L~L~~N~l~ 239 (659)
+.|++++|+++... ..+..+++|++|++++|.++
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccceeccccccccccccccccccccchhhcCCCccc
Confidence 99999999887542 34677788888888777653
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=9.9e-16 Score=163.64 Aligned_cols=251 Identities=20% Similarity=0.154 Sum_probs=173.2
Q ss_pred CCCCEEEecCCCCcCCC-CcccCCCCCCcEEEcccCcCcc----cCChhccCCCCCcEEEeecCCCCCC----CccccC-
Q 006145 107 PDLKVLRLVSLGLWGPL-SGKISRLSSLEILNMSSNFLNG----AIPQELSILTSLQTLILDENMLAGR----VPDWLG- 176 (659)
Q Consensus 107 ~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~- 176 (659)
++|+.||+++|++++.. ...+..+++|+.|+|++|.++. .++..+..+++|++|||++|.|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36899999999998742 4446778999999999999873 4556678999999999999998521 223332
Q ss_pred CCCCCCEEEccCCcCCcc----CCcccCCCCCCcEEeccccccccCC----------------------CC---------
Q 006145 177 SLPILAVLSLRNNMFNGT----LPDSFSYLENLRVLALSNNHFYGEV----------------------PD--------- 221 (659)
Q Consensus 177 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----------------------p~--------- 221 (659)
..++|+.|+|++|+++.. ++..+..+++|++|+|++|.++... +.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 345899999999999753 4567888999999999999874310 00
Q ss_pred ---CCCCCcCCEEEcccCCC-----------------------------CCCC---------------------------
Q 006145 222 ---FSGLTYLQVLDLENNAL-----------------------------GPQF--------------------------- 242 (659)
Q Consensus 222 ---~~~l~~L~~L~L~~N~l-----------------------------~~~~--------------------------- 242 (659)
+.....++.++++++.. ...-
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence 01123344444443322 1000
Q ss_pred ---------CCCCcccceEecCCCcCCccC----chhccCCccccEEeccCcccccCCchhh-----cCCCcccEEeccC
Q 006145 243 ---------PKVGKKLVTMILSKNKFRSAI----PAEVSSYYQLQRLDLSSNRFVGPFPQAL-----LSLPSITYLNIAD 304 (659)
Q Consensus 243 ---------~~~~~~L~~L~l~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~l-----~~l~~L~~L~l~~ 304 (659)
......++.+++++|.+.... ...+...+.++.+++++|.++......+ .....|+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~ 321 (460)
T d1z7xw1 242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 321 (460)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred ccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence 001235778888888876432 2335567889999999999874322222 2346899999999
Q ss_pred CcCCCcCCc----CCCCCCCCCEEECcCCCCccc----CChhhh-CCCCCCEEEcCCccccC
Q 006145 305 NKLTGKLFD----DLSCNPELGFVDLSSNLLTGQ----LPNCLL-AGSKNRVVLYARNCLAA 357 (659)
Q Consensus 305 N~l~~~~p~----~~~~~~~L~~L~ls~N~l~g~----ip~~~~-~~~~l~~l~~~~N~l~~ 357 (659)
|.++..... .+...++|+.|||++|+++.. ++..+. ....|+.|++++|.++.
T Consensus 322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~ 383 (460)
T d1z7xw1 322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 383 (460)
T ss_dssp SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred cchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCCh
Confidence 998865332 234557899999999999753 344443 35679999999998863
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=3.6e-15 Score=154.02 Aligned_cols=234 Identities=22% Similarity=0.208 Sum_probs=124.2
Q ss_pred cccCCCCCCEEEecCCCCcCC----CCcccCCCCCCcEEEcccCcCccc----------CChhccCCCCCcEEEeecCCC
Q 006145 102 TLVKLPDLKVLRLVSLGLWGP----LSGKISRLSSLEILNMSSNFLNGA----------IPQELSILTSLQTLILDENML 167 (659)
Q Consensus 102 ~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----------~p~~~~~l~~L~~L~Ls~N~l 167 (659)
.+.+...|+.|+|++|.+... +...+...++|+.|+++++..... +...+..+++|+.|+|++|.+
T Consensus 26 ~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i 105 (344)
T d2ca6a1 26 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF 105 (344)
T ss_dssp HHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCC
T ss_pred HHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccc
Confidence 455566666677766665332 223345566666666665543311 112234455666666666655
Q ss_pred CCC----CccccCCCCCCCEEEccCCcCCccCCcc-------------cCCCCCCcEEeccccccccCCC-----CCCCC
Q 006145 168 AGR----VPDWLGSLPILAVLSLRNNMFNGTLPDS-------------FSYLENLRVLALSNNHFYGEVP-----DFSGL 225 (659)
Q Consensus 168 ~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~-------------~~~l~~L~~L~Ls~N~l~~~~p-----~~~~l 225 (659)
... +...+...++|++|++++|.+...-... ....+.|+.|++++|+++..-- .+...
T Consensus 106 ~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~ 185 (344)
T d2ca6a1 106 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 185 (344)
T ss_dssp CTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHC
T ss_pred ccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhh
Confidence 433 2223334555566666555543110000 1123344444444444331100 02223
Q ss_pred CcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCcc-----CchhccCCccccEEeccCcccccC----CchhhcCCCc
Q 006145 226 TYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSA-----IPAEVSSYYQLQRLDLSSNRFVGP----FPQALLSLPS 296 (659)
Q Consensus 226 ~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~ 296 (659)
..|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++
T Consensus 186 ---------------------~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~ 244 (344)
T d2ca6a1 186 ---------------------RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244 (344)
T ss_dssp ---------------------TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred ---------------------hhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccccccccc
Confidence 3455555555555431 223355667788888888877532 3455667788
Q ss_pred ccEEeccCCcCCCcCCc----CCC--CCCCCCEEECcCCCCccc----CChhhh-CCCCCCEEEcCCcccc
Q 006145 297 ITYLNIADNKLTGKLFD----DLS--CNPELGFVDLSSNLLTGQ----LPNCLL-AGSKNRVVLYARNCLA 356 (659)
Q Consensus 297 L~~L~l~~N~l~~~~p~----~~~--~~~~L~~L~ls~N~l~g~----ip~~~~-~~~~l~~l~~~~N~l~ 356 (659)
|++|+|++|.+++.-.. .+. ..+.|+.||+++|+++.. +...+. ..++++.+++++|++.
T Consensus 245 L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred chhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 88888888887653221 121 235688888888887642 333332 4567888888888875
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.1e-14 Score=146.19 Aligned_cols=213 Identities=19% Similarity=0.145 Sum_probs=144.4
Q ss_pred cCCCCCCEEEecCCCCcCC-CCcccCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecC-CCCCC-CccccCCCCC
Q 006145 104 VKLPDLKVLRLVSLGLWGP-LSGKISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDEN-MLAGR-VPDWLGSLPI 180 (659)
Q Consensus 104 ~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~l~~l~~ 180 (659)
....+|++|+|+++.++.. ++..+.++++|++|+|++|.+++..+..+..+++|++|+|+++ .++.. +...+.++++
T Consensus 43 ~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~ 122 (284)
T d2astb2 43 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122 (284)
T ss_dssp CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred ccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHh
Confidence 3556899999999988654 4556789999999999999999888889999999999999995 55422 2233457899
Q ss_pred CCEEEccCC-cCCcc-CCcccC-CCCCCcEEecccc--ccccC-CCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEe
Q 006145 181 LAVLSLRNN-MFNGT-LPDSFS-YLENLRVLALSNN--HFYGE-VPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMI 253 (659)
Q Consensus 181 L~~L~L~~N-~l~~~-~p~~~~-~l~~L~~L~Ls~N--~l~~~-~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~ 253 (659)
|++|+++++ .++.. ++..+. ..++|+.|+++++ .++.. +.. +.++++|++|++++|.
T Consensus 123 L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~---------------- 186 (284)
T d2astb2 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV---------------- 186 (284)
T ss_dssp CCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT----------------
T ss_pred ccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccccccccccc----------------
Confidence 999999986 45421 222333 3578999999874 33321 122 3456778888777653
Q ss_pred cCCCcCCccCchhccCCccccEEeccCc-ccccCCchhhcCCCcccEEeccCCcCCC-cCCcCCCCCCCCCEEECcCCCC
Q 006145 254 LSKNKFRSAIPAEVSSYYQLQRLDLSSN-RFVGPFPQALLSLPSITYLNIADNKLTG-KLFDDLSCNPELGFVDLSSNLL 331 (659)
Q Consensus 254 l~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~l~~N~l~~-~~p~~~~~~~~L~~L~ls~N~l 331 (659)
.+++.....+..+++|++|+|++| .+++.....+.++++|+.|+++++ ++. .+......+|+| ++..+++
T Consensus 187 ----~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L---~i~~~~l 258 (284)
T d2astb2 187 ----MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHL---QINCSHF 258 (284)
T ss_dssp ----TCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTS---EESCCCS
T ss_pred ----CCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCccc---cccCccC
Confidence 233444556677788888888874 666665666778888888888776 321 111112234444 4566777
Q ss_pred cccCChhhh
Q 006145 332 TGQLPNCLL 340 (659)
Q Consensus 332 ~g~ip~~~~ 340 (659)
++..++.++
T Consensus 259 s~~~~~~~~ 267 (284)
T d2astb2 259 TTIARPTIG 267 (284)
T ss_dssp CCTTCSSCS
T ss_pred CCCCCCccC
Confidence 765555544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.42 E-value=1.2e-14 Score=150.11 Aligned_cols=226 Identities=19% Similarity=0.199 Sum_probs=137.0
Q ss_pred CCcccCCCCCCcEEEcccCcCccc----CChhccCCCCCcEEEeecCCCCCC---Cc-------cccCCCCCCCEEEccC
Q 006145 123 LSGKISRLSSLEILNMSSNFLNGA----IPQELSILTSLQTLILDENMLAGR---VP-------DWLGSLPILAVLSLRN 188 (659)
Q Consensus 123 ~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~---~p-------~~l~~l~~L~~L~L~~ 188 (659)
+...+.....|+.|+|++|.+... +-..+...++|+.|+++++..... .| ..+..+++|+.|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 344566678888888888887532 334456678888888887654321 11 2244566677777777
Q ss_pred CcCCcc----CCcccCCCCCCcEEeccccccccCCCC-CCCCCcCCEEEcccCCCCCCCCCCCcccceEecCCCcCCcc-
Q 006145 189 NMFNGT----LPDSFSYLENLRVLALSNNHFYGEVPD-FSGLTYLQVLDLENNALGPQFPKVGKKLVTMILSKNKFRSA- 262 (659)
Q Consensus 189 N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~l~~~- 262 (659)
|.++.. +...+...++|+.|++++|.+...-.. +.. .|..+.... .......|+.+.+++|++...
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~~~~~------~~~~~~~L~~l~l~~n~i~~~~ 174 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQELAVNK------KAKNAPPLRSIICGRNRLENGS 174 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHHHHHH------HHHTCCCCCEEECCSSCCTGGG
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccc--ccccccccc------ccccCcccceeecccccccccc
Confidence 766543 222334456666666666655321000 000 000000000 000113455555555555432
Q ss_pred ---CchhccCCccccEEeccCcccccC-----CchhhcCCCcccEEeccCCcCCCc----CCcCCCCCCCCCEEECcCCC
Q 006145 263 ---IPAEVSSYYQLQRLDLSSNRFVGP-----FPQALLSLPSITYLNIADNKLTGK----LFDDLSCNPELGFVDLSSNL 330 (659)
Q Consensus 263 ---~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~~~~~L~~L~ls~N~ 330 (659)
+...+...+.|+.|+|++|.+... +...+..+++|+.|+|++|.++.. +...+..+++|+.|++++|.
T Consensus 175 ~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~ 254 (344)
T d2ca6a1 175 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 254 (344)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCC
T ss_pred cccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCc
Confidence 233456678999999999998642 334567889999999999998643 34456788999999999999
Q ss_pred CcccCChhh----h--CCCCCCEEEcCCcccc
Q 006145 331 LTGQLPNCL----L--AGSKNRVVLYARNCLA 356 (659)
Q Consensus 331 l~g~ip~~~----~--~~~~l~~l~~~~N~l~ 356 (659)
+++.-...+ . ....++.+++++|.++
T Consensus 255 i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 255 LSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp CCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred cCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 986433333 2 2357899999999876
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.32 E-value=1.2e-14 Score=137.48 Aligned_cols=17 Identities=24% Similarity=0.364 Sum_probs=7.4
Q ss_pred ccCCccccEEeccCccc
Q 006145 267 VSSYYQLQRLDLSSNRF 283 (659)
Q Consensus 267 ~~~l~~L~~L~Ls~N~l 283 (659)
+..+++|+.|+|++|.+
T Consensus 136 l~~l~~L~~L~L~~N~l 152 (198)
T d1m9la_ 136 LAALDKLEDLLLAGNPL 152 (198)
T ss_dssp HTTTTTCSEEEECSSHH
T ss_pred ccCCCccceeecCCCcc
Confidence 33444444444444444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.30 E-value=3.1e-14 Score=134.55 Aligned_cols=117 Identities=24% Similarity=0.227 Sum_probs=62.7
Q ss_pred CccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEeccccccccCCCCCCCCCcCCEEEcccCCCCCCCCCCCcccc
Q 006145 171 VPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLALSNNHFYGEVPDFSGLTYLQVLDLENNALGPQFPKVGKKLV 250 (659)
Q Consensus 171 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~ 250 (659)
+|..+..+++|++|+|++|+|+ .++ .+..+++|+.|+|++|.++...+.+..++ +|+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~---------------------~L~ 96 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVAD---------------------TLE 96 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHH---------------------HCC
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccccccccccccc---------------------ccc
Confidence 3344555555555555555554 222 24445555555555555442211112222 344
Q ss_pred eEecCCCcCCccCchhccCCccccEEeccCcccccCCc-hhhcCCCcccEEeccCCcCCCcCC
Q 006145 251 TMILSKNKFRSAIPAEVSSYYQLQRLDLSSNRFVGPFP-QALLSLPSITYLNIADNKLTGKLF 312 (659)
Q Consensus 251 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p 312 (659)
.|++++|+++. + ..+..+++|+.|++++|+|+.... ..+..+++|+.|++++|.++...+
T Consensus 97 ~L~l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 97 ELWISYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp EEECSEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccccccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 44444444443 2 246667788888888888764321 457777888888888877765433
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=9.1e-12 Score=112.47 Aligned_cols=106 Identities=22% Similarity=0.097 Sum_probs=66.8
Q ss_pred CCcEEEcccCcCcccCChhccCCCCCcEEEeecC-CCCCCCccccCCCCCCCEEEccCCcCCccCCcccCCCCCCcEEec
Q 006145 132 SLEILNMSSNFLNGAIPQELSILTSLQTLILDEN-MLAGRVPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLENLRVLAL 210 (659)
Q Consensus 132 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 210 (659)
..+.++.+++.+. .+|..+..+++|++|++++| .++..-+..|.++++|+.|+|++|+|+...|..|..+++|++|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3445666666665 45555666666777776554 365554556677777777777777777666666777777777777
Q ss_pred cccccccCCCCCCCCCcCCEEEcccCCC
Q 006145 211 SNNHFYGEVPDFSGLTYLQVLDLENNAL 238 (659)
Q Consensus 211 s~N~l~~~~p~~~~l~~L~~L~L~~N~l 238 (659)
++|+|+...+......+|+.|+|++|.+
T Consensus 88 s~N~l~~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 88 SFNALESLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp CSSCCSCCCSTTTCSCCCCEEECCSSCC
T ss_pred cCCCCcccChhhhccccccccccCCCcc
Confidence 7777765555533333566666666655
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.21 E-value=3.2e-11 Score=108.76 Aligned_cols=104 Identities=22% Similarity=0.155 Sum_probs=60.4
Q ss_pred EEEecCCCCcCCCCcccCCCCCCcEEEcccC-cCcccCChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCC
Q 006145 111 VLRLVSLGLWGPLSGKISRLSSLEILNMSSN-FLNGAIPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNN 189 (659)
Q Consensus 111 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 189 (659)
.++.+++++.. .|..+..+++|+.|++++| .++..-+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|
T Consensus 12 ~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 34444444432 3444555666666666544 355444455666666666666666666555666666666666666666
Q ss_pred cCCccCCcccCCCCCCcEEeccccccc
Q 006145 190 MFNGTLPDSFSYLENLRVLALSNNHFY 216 (659)
Q Consensus 190 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 216 (659)
+|+...+..|.. .+|+.|+|++|.+.
T Consensus 91 ~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 91 ALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp CCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred CCcccChhhhcc-ccccccccCCCccc
Confidence 666333333333 35677777777653
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.41 E-value=5.9e-09 Score=94.19 Aligned_cols=105 Identities=20% Similarity=0.124 Sum_probs=61.5
Q ss_pred cCCCCCCcEEEcccCcCcccCChhccCCCCCcEEEeecCCCCCC--CccccCCCCCCCEEEccCCcCCccCCcccCCCCC
Q 006145 127 ISRLSSLEILNMSSNFLNGAIPQELSILTSLQTLILDENMLAGR--VPDWLGSLPILAVLSLRNNMFNGTLPDSFSYLEN 204 (659)
Q Consensus 127 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 204 (659)
+..+..+..|+...|... .++..+.++++|++|+|++|+|+.. ++..+..+++|+.|+|++|.++..-+-.+....+
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 333444444555444433 3444455677777777777777643 2344566777777777777777433323334456
Q ss_pred CcEEeccccccccCCCC--------CCCCCcCCEEE
Q 006145 205 LRVLALSNNHFYGEVPD--------FSGLTYLQVLD 232 (659)
Q Consensus 205 L~~L~Ls~N~l~~~~p~--------~~~l~~L~~L~ 232 (659)
|+.|++++|.+...... +..+++|+.||
T Consensus 117 L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 77777777777655432 44567777664
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.25 E-value=5.2e-06 Score=80.29 Aligned_cols=150 Identities=10% Similarity=-0.016 Sum_probs=97.2
Q ss_pred HHHHhhcCCCCCceeccCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCC-CCCccceeeeeeeccccC
Q 006145 471 ELEEATNNFDTSAFMGEGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLR-HRHLVSALGHCFECYFDD 549 (659)
Q Consensus 471 ~l~~~~~~~~~~~~ig~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 549 (659)
++.+.-+.|...+..+-++.+.||+... +++.+.+|+...........+.+|...+..+. +--+.++++++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~----- 81 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH----- 81 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-----
Confidence 4444455554444333333468999865 35667888886655444556788888877664 4335666766654
Q ss_pred CCCceeEEEEeccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcCCC--------------------------
Q 006145 550 SSVSRIFLIFEYVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHTGI-------------------------- 603 (659)
Q Consensus 550 ~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------- 603 (659)
.+..++|||++++.++.+..... -. ...++.++++.++.||+..
T Consensus 82 --~~~~~lv~~~l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T d1j7la_ 82 --DGWSNLLMSEADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp --TTEEEEEEECCSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred --CCceEEEEEeccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence 45679999999998886544321 11 2334555555666666310
Q ss_pred ------------------------------CCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 604 ------------------------------VPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 604 ------------------------------~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
.+.++|+|+.|.||+++++...-|.||+.+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 123789999999999998877789999988654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.21 E-value=3e-08 Score=89.40 Aligned_cols=86 Identities=22% Similarity=0.070 Sum_probs=55.3
Q ss_pred CcccCCCCCCcEEEcccCcCccc--CChhccCCCCCcEEEeecCCCCCCCccccCCCCCCCEEEccCCcCCccCCc----
Q 006145 124 SGKISRLSSLEILNMSSNFLNGA--IPQELSILTSLQTLILDENMLAGRVPDWLGSLPILAVLSLRNNMFNGTLPD---- 197 (659)
Q Consensus 124 p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~---- 197 (659)
+..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|.++..-+-.+....+|+.|++++|.+......
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y 137 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence 33445677777777777777743 234566777788888888877743332333445677788888877755442
Q ss_pred ---ccCCCCCCcEEe
Q 006145 198 ---SFSYLENLRVLA 209 (659)
Q Consensus 198 ---~~~~l~~L~~L~ 209 (659)
.+..+++|+.||
T Consensus 138 ~~~i~~~~P~L~~LD 152 (162)
T d1koha1 138 ISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHTTSTTCCEET
T ss_pred HHHHHHHCCCCCEEC
Confidence 255677888776
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.87 E-value=6e-05 Score=72.07 Aligned_cols=132 Identities=15% Similarity=0.097 Sum_probs=82.8
Q ss_pred eeccCcC-ceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCC--CCccceeeeeeeccccCCCCceeEEEEe
Q 006145 484 FMGEGSQ-GQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRH--RHLVSALGHCFECYFDDSSVSRIFLIFE 560 (659)
Q Consensus 484 ~ig~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~~~~~~~~lV~E 560 (659)
.+..|.. +.||+....++..+++|.-.... ..++.+|++.++.+.. --+.++++++.+ .+..++|||
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-------~~~~~~v~~ 86 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTE-------AGRDWLLLG 86 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-------SSCEEEEEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeeccc-------ccceEEEEE
Confidence 3344443 57899988778888999765433 2346778777776643 335566766554 456799999
Q ss_pred ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHhhhhcC---------------------------------------
Q 006145 561 YVPNGTLRSWISEGHAHQSLTWTQRISAAIGVAKGIQFLHT--------------------------------------- 601 (659)
Q Consensus 561 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~--------------------------------------- 601 (659)
|+++.++.+.. .. ....+.++++.|+-||+
T Consensus 87 ~i~G~~~~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (255)
T d1nd4a_ 87 EVPGQDLLSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 155 (255)
T ss_dssp CCSSEETTTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred eeecccccccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhh
Confidence 99986664311 00 01111222222222221
Q ss_pred ------------C----CCCCccccCCCCCceeecCCcceEEccCcccccc
Q 006145 602 ------------G----IVPGVFSNNLKITDILLDQNLVAKISSYNLPLLA 636 (659)
Q Consensus 602 ------------~----~~~~iiHrDlk~~NILld~~~~~kl~DFGla~~~ 636 (659)
. ..+.++|+|+.|.||+++++..+-|.||+.+...
T Consensus 156 ~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 156 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 1 1134799999999999998877889999988654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.62 E-value=9.3e-06 Score=72.87 Aligned_cols=87 Identities=13% Similarity=0.125 Sum_probs=45.2
Q ss_pred CCCCCCEEEecCC-CCcCC----CCcccCCCCCCcEEEcccCcCccc----CChhccCCCCCcEEEeecCCCCCC----C
Q 006145 105 KLPDLKVLRLVSL-GLWGP----LSGKISRLSSLEILNMSSNFLNGA----IPQELSILTSLQTLILDENMLAGR----V 171 (659)
Q Consensus 105 ~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~ 171 (659)
+.+.|+.|+|+++ .++.. +-..+...++|+.|+|++|.+... +...+...+.|++|+|++|.+... +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4466777777653 34321 222345556677777777666521 223344456666666666665532 1
Q ss_pred ccccCCCCCCCEEEccCCcC
Q 006145 172 PDWLGSLPILAVLSLRNNMF 191 (659)
Q Consensus 172 p~~l~~l~~L~~L~L~~N~l 191 (659)
-..+...++|++|+|++|.+
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSS
T ss_pred HHHHHhCCcCCEEECCCCcC
Confidence 12344445555555555543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.46 E-value=2.2e-05 Score=70.32 Aligned_cols=89 Identities=12% Similarity=0.169 Sum_probs=53.9
Q ss_pred CCCCCCcEEEcccC-cCccc----CChhccCCCCCcEEEeecCCCCCC----CccccCCCCCCCEEEccCCcCCcc----
Q 006145 128 SRLSSLEILNMSSN-FLNGA----IPQELSILTSLQTLILDENMLAGR----VPDWLGSLPILAVLSLRNNMFNGT---- 194 (659)
Q Consensus 128 ~~l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~---- 194 (659)
.+.++|+.|+|+++ .++.. +-..+...++|++|+|++|.+... +...+...+.|+.|+|++|.++..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34578888888864 45422 233456677788888888877532 223344556777777777776642
Q ss_pred CCcccCCCCCCcEEeccccccc
Q 006145 195 LPDSFSYLENLRVLALSNNHFY 216 (659)
Q Consensus 195 ~p~~~~~l~~L~~L~Ls~N~l~ 216 (659)
+-..+...++|++|+|++|.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHhCCcCCEEECCCCcCC
Confidence 1223455566777777666543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.20 E-value=0.00066 Score=69.25 Aligned_cols=76 Identities=7% Similarity=-0.018 Sum_probs=47.3
Q ss_pred ceeccCcCceEEEEEecC-CcEEEEEEeccc----C---CCchHHHHHHHHHHhCCC-C--CCccceeeeeeeccccCCC
Q 006145 483 AFMGEGSQGQMYRGRLKN-GTFVAIRCLKMK----K---CHSTRNFMHHIELISKLR-H--RHLVSALGHCFECYFDDSS 551 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~-g~~vavK~l~~~----~---~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~~~~ 551 (659)
+.||.|....||+....+ ++.|+||.-... . .....+..+|.+.|+.+. + ..+.+++.+..
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~-------- 103 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-------- 103 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--------
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--------
Confidence 568999999999998765 678999965321 1 112234566887777652 2 34555554432
Q ss_pred CceeEEEEeccCCCCh
Q 006145 552 VSRIFLIFEYVPNGTL 567 (659)
Q Consensus 552 ~~~~~lV~Ey~~~GsL 567 (659)
+..++||||+++..+
T Consensus 104 -~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 104 -EMAVTVMEDLSHLKI 118 (392)
T ss_dssp -TTTEEEECCCTTSEE
T ss_pred -CCCEEEEeccCCccc
Confidence 345899999987543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.86 E-value=8.7e-05 Score=66.11 Aligned_cols=110 Identities=15% Similarity=0.217 Sum_probs=56.5
Q ss_pred cCCCCCCEEEecC-CCCcCC----CCcccCCCCCCcEEEcccCcCccc----CChhccCCCCCcEEEeecCCCCCC----
Q 006145 104 VKLPDLKVLRLVS-LGLWGP----LSGKISRLSSLEILNMSSNFLNGA----IPQELSILTSLQTLILDENMLAGR---- 170 (659)
Q Consensus 104 ~~l~~L~~L~L~~-n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~---- 170 (659)
.+.+.|++|+|++ +.++.. +-..+...++|+.|+|++|.++.. +-..+...++|+.|++++|.+...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3556777777765 334321 223345666777777777766532 223344556677777766666422
Q ss_pred CccccCCCCCCCEEEcc--CCcCCc----cCCcccCCCCCCcEEecccc
Q 006145 171 VPDWLGSLPILAVLSLR--NNMFNG----TLPDSFSYLENLRVLALSNN 213 (659)
Q Consensus 171 ~p~~l~~l~~L~~L~L~--~N~l~~----~~p~~~~~l~~L~~L~Ls~N 213 (659)
+-..+...++|+.++|+ +|.+.. .+.+.+...++|+.|+++.+
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 12334455556554443 344432 12223344555555555444
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.82 E-value=0.0016 Score=64.32 Aligned_cols=140 Identities=6% Similarity=0.105 Sum_probs=77.1
Q ss_pred ceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCc--cceeeeeeeccccCCCCceeEEEEeccCCCChh
Q 006145 491 GQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHL--VSALGHCFECYFDDSSVSRIFLIFEYVPNGTLR 568 (659)
Q Consensus 491 g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~ 568 (659)
-.||+++..+|..+++|..+... ...+++..|.+.+..+....| +..+. ..+.......+..+.|++|++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~--~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVA--FNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCC--BTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCcee--cCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 37999999999999999986543 245678888888877743222 22211 11000001134578899999874432
Q ss_pred h-----------h---hc----CC--CCCCCCCHH----------------------HHHHHHHHHHHHhh-hhcCCCCC
Q 006145 569 S-----------W---IS----EG--HAHQSLTWT----------------------QRISAAIGVAKGIQ-FLHTGIVP 605 (659)
Q Consensus 569 ~-----------~---l~----~~--~~~~~l~~~----------------------~~~~i~~~ia~~L~-yLH~~~~~ 605 (659)
. . +| .. .....+++. .....+..+...+. +..+....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 0 11 00 001112211 11112222222222 12233345
Q ss_pred CccccCCCCCceeecCCcceEEccCccccc
Q 006145 606 GVFSNNLKITDILLDQNLVAKISSYNLPLL 635 (659)
Q Consensus 606 ~iiHrDlk~~NILld~~~~~kl~DFGla~~ 635 (659)
.+||+|+.+.|||++++ ..+.||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 78999999999999754 45889988753
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.45 E-value=0.0002 Score=63.66 Aligned_cols=110 Identities=15% Similarity=0.131 Sum_probs=66.4
Q ss_pred cCCCCCCcEEEccc-CcCccc----CChhccCCCCCcEEEeecCCCCCCC----ccccCCCCCCCEEEccCCcCCcc---
Q 006145 127 ISRLSSLEILNMSS-NFLNGA----IPQELSILTSLQTLILDENMLAGRV----PDWLGSLPILAVLSLRNNMFNGT--- 194 (659)
Q Consensus 127 ~~~l~~L~~L~Ls~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~l~~l~~L~~L~L~~N~l~~~--- 194 (659)
..+.++|+.|+|++ +.++.. +-..+...++|++|+|++|.+.... -..+...++|+.|++++|.+...
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 35668888888887 456422 2344567788888888888876432 22345567788888888777532
Q ss_pred -CCcccCCCCCCcEEec--cccccccC----C-CCCCCCCcCCEEEcccC
Q 006145 195 -LPDSFSYLENLRVLAL--SNNHFYGE----V-PDFSGLTYLQVLDLENN 236 (659)
Q Consensus 195 -~p~~~~~l~~L~~L~L--s~N~l~~~----~-p~~~~l~~L~~L~L~~N 236 (659)
+-..+...++|+.++| ++|.+... + ..+...++|+.|+++.+
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 2234556677776544 44555321 1 11445566666666544
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.82 E-value=0.016 Score=58.55 Aligned_cols=72 Identities=19% Similarity=0.259 Sum_probs=46.6
Q ss_pred ceeccCcCceEEEEEecC--------CcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCc-cceeeeeeeccccCCCCc
Q 006145 483 AFMGEGSQGQMYRGRLKN--------GTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHL-VSALGHCFECYFDDSSVS 553 (659)
Q Consensus 483 ~~ig~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~~~~~ 553 (659)
+.|+-|-.-.+|+...++ .+.|.+++.- . .....+..+|.++++.+.-.++ .++++++.+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--------- 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG--------- 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---------
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---------
Confidence 457767777899998654 2456666654 2 2233456688888887753344 466766532
Q ss_pred eeEEEEeccCCCCh
Q 006145 554 RIFLIFEYVPNGTL 567 (659)
Q Consensus 554 ~~~lV~Ey~~~GsL 567 (659)
.+|+||+++-++
T Consensus 117 --g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 --GRLEEYIPSRPL 128 (395)
T ss_dssp --EEEECCCCEEEC
T ss_pred --ceEEEEeccccC
Confidence 689999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.73 E-value=0.094 Score=50.60 Aligned_cols=164 Identities=9% Similarity=0.090 Sum_probs=83.1
Q ss_pred cCHHHHHHhhcCCCCCceec-----cCcCceEEEEEecCCcEEEEEEecccCCCchHHHHHHHHHHhCCCCCCc--ccee
Q 006145 467 FSLEELEEATNNFDTSAFMG-----EGSQGQMYRGRLKNGTFVAIRCLKMKKCHSTRNFMHHIELISKLRHRHL--VSAL 539 (659)
Q Consensus 467 ~~~~~l~~~~~~~~~~~~ig-----~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni--v~l~ 539 (659)
++.+|+.....+|...+... .|---+.|+.+..+|+ +++|+..... ..++...|++++..+...++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 46678888888887765543 4444678999877665 7888875432 23445556666666632221 1111
Q ss_pred eeeeeccccCCCCceeEEEEeccCCCChhhh--------------hc----CCC---CCCCCCH----------------
Q 006145 540 GHCFECYFDDSSVSRIFLIFEYVPNGTLRSW--------------IS----EGH---AHQSLTW---------------- 582 (659)
Q Consensus 540 g~~~~~~~~~~~~~~~~lV~Ey~~~GsL~~~--------------l~----~~~---~~~~l~~---------------- 582 (659)
... ++..-..-......++.+..+...... ++ ... ......+
T Consensus 80 ~~~-~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 80 PRK-DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CBT-TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred eec-CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 110 000000012345667777766433210 01 000 0000000
Q ss_pred -HHHHHHHHHHHHHhhhhc-CCCCCCccccCCCCCceeecCCcceEEccCcccc
Q 006145 583 -TQRISAAIGVAKGIQFLH-TGIVPGVFSNNLKITDILLDQNLVAKISSYNLPL 634 (659)
Q Consensus 583 -~~~~~i~~~ia~~L~yLH-~~~~~~iiHrDlk~~NILld~~~~~kl~DFGla~ 634 (659)
......+......+.-.+ .....++||+|+.+.||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 001111111122222222 1234479999999999999998877899999884
|